PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hsu, JH; Lawlor, ER				Hsu, J. H.; Lawlor, E. R.			BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma	ONCOGENE			English	Article						BMI-1; polycomb; YAP; contact inhibition; Hippo pathway; Ewing sarcoma	POLYCOMB GROUP PROTEINS; CELL SELF-RENEWAL; GENE-PRODUCT; ORGAN SIZE; HIPPO; GROWTH; STEM; PROLIFERATION; MERLIN; KIBRA	The polycomb group family protein BMI-1 is over-expressed by and functions as an oncogene in many different human cancers. We have previously shown that BMI-1 promotes the tumorigenicity of Ewing sarcoma family tumors (ESFTs) and that this is mediated independently of CDKN2A repression. In this study, we have discovered that high levels of BMI-1 confer resistance to contact inhibition in ESFT cells. Using stable retroviral transduction, we evaluated the consequences of BMI-1 knockdown on the growth of CDKN2A wild-type and mutant ESFT cells in subconfluent and confluent conditions. Although knockdown of BMI-1 had no effect on proliferation in low-density cultures, at high cell densities it resulted in cell cycle arrest and death. The normal cell contact inhibition response is mediated, in large part, by the recently described Hippo pathway which functions to inhibit cell proliferation and promote cell death by inactivating the Yes-Associated Protein (YAP). Significantly, we found that YAP levels, activity and expression did not diminish in confluent ESFT cells that expressed high levels of BMI-1. In contrast, YAP expression and nuclear localization were reduced in confluent BMI-1 knockdown cells suggesting that silencing of BMI-1 restored contact inhibition by restoring normal activation of the Hippo-YAP growth-suppressor pathway. Importantly, knockdown of YAP in ESFT cells resulted in profound inhibition of cell proliferation and anchorage-independent colony formation suggesting that stabilization and continued expression of YAP is critical for ESFT growth and tumorigenicity. Together, these studies reveal a previously unrecognized link between BMI-1, contact inhibition and the Hippo-YAP pathway and suggest that resistance to contact inhibition in BMI-1 overexpressing cancer cells may be in part a result of Hippo inhibition and aberrant stabilization of YAP. Oncogene (2011) 30, 2077-2085; doi:10.1038/onc.2010.571; published online 20 December 2010	[Hsu, J. H.; Lawlor, E. R.] Univ Michigan, Dept Pediat, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Hsu, J. H.] Univ So Calif, Genet Mol & Cellular Biol Program, Los Angeles, CA USA; [Lawlor, E. R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Southern California; University of Michigan System; University of Michigan	Lawlor, ER (corresponding author), Univ Michigan, Dept Pediat, Div Hematol Oncol, 1150 Med Ctr Dr,MSRBIII Room 1220A, Ann Arbor, MI 48109 USA.	elawlor@med.umich.edu			TJ Martell Foundation; NIH/NCI [1R01CA134604-01]; California Institute for Regenerative Medicine Training (CIRM) [1R01CA134604-01, T1-00004]; NATIONAL CANCER INSTITUTE [R01CA134604] Funding Source: NIH RePORTER	TJ Martell Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine Training (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Long Hung and Asim Beg for technical support, members of the Lawlor lab for helpful discussion, Dr T Triche and the Children's Oncology Cell Bank (COGCELL.org) for cell lines. This work was initiated at Childrens Hospital Los Angeles (CHLA) with support from the TJ Martell Foundation. JHH was supported by CIRM training Grant T1-00004 and ERL by NIH/NCI 1R01CA134604-01.; Grant support: California Institute for Regenerative Medicine Training Grant T1-00004 (JHH), 1R01CA134604-01 ( ERL).	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Ban J, 2006, ADV EXP MED BIOL, V587, P41; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; LIM R, 1981, P NATL ACAD SCI-BIOL, V78, P4373, DOI 10.1073/pnas.78.7.4373; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Meltzer Paul S, 2007, Cell Stem Cell, V1, P13, DOI 10.1016/j.stem.2007.05.011; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; RODESCH F, 1973, EXP CELL RES, V76, P55, DOI 10.1016/0014-4827(73)90418-7; SILLETTI S, 1995, INT J CANCER, V63, P100, DOI 10.1002/ijc.2910630118; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	40	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2077	2085		10.1038/onc.2010.571	http://dx.doi.org/10.1038/onc.2010.571			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21170084	Green Accepted			2022-12-25	WOS:000289977400011
J	Rana, T; Misra, S; Mittal, MK; Farrow, AL; Wilson, KT; Linton, MF; Fazio, S; Willis, IM; Chaudhuri, G				Rana, Tanu; Misra, Smita; Mittal, Mukul K.; Farrow, Anitra L.; Wilson, Keith T.; Linton, MacRae F.; Fazio, Sergio; Willis, Ian M.; Chaudhuri, Gautam			Mechanism of Down-regulation of RNA Polymerase III-transcribed Non-coding RNA Genes in Macrophages by Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTORS; DIFFERENTIAL EXPRESSION; GP63 LEVEL; B2 RNA; INFECTION; AMAZONENSIS; REPRESSOR; PROMASTIGOTES; DETERMINANTS; DEGRADATION	The parasitic protozoan Leishmania invades mammalian macrophages to establish infection. We reported previously that Leishmania manipulates the expression of several non-coding RNA genes (e. g. Alu RNA, B1 RNA, and signal recognition particle RNA) in macrophages to favor the establishment of their infection in the phagolysosomes of these cells (Ueda, Y., and Chaudhuri, G. (2000) J. Biol. Chem. 275, 19428-19432; Misra, S., Tripathi, M. K., and Chaudhuri, G. (2005) J. Biol. Chem. 280, 29364-29373). We report here the mechanism of this down-regulation. We found that the non-coding RNA (ncRNA) genes that are repressed by Leishmania infection in macrophages contain a "B-box" in their promoters and thus require the polymerase III transcription factor TFIIIC for their expression. We also found that Leishmania promastigotes through their surface protease (leishmanolysin or gp63) activate the thrombin receptor PAR1 in the macrophages. This activation of PAR1 raised the cytosolic concentration of Ca2+ into the micromolar range, thereby activating the Ca2+-dependent protease mu-calpain. mu-Calpain then degraded TFIIIC110 to inhibit the expression of the selected ncRNA genes. Avirulent stocks of Leishmania not expressing surface gp63 failed to down-regulate ncRNAs in the exposed macrophages. Inhibition of PAR1 or calpain 1 in macrophages made them resistant to Leishmania infection. These data suggest that macrophage PAR1 and calpain 1 are potential drug targets against leishmaniasis.	[Rana, Tanu; Misra, Smita; Mittal, Mukul K.; Farrow, Anitra L.; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Wilson, Keith T.] Vanderbilt Univ, Div Gastroenterol, Nashville, TN 37232 USA; [Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Div Cardiovasc Med, Nashville, TN 37232 USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Willis, Ian/0000-0001-6599-2395; Mittal, Mukul/0000-0002-9795-7372; Wilson, Keith/0000-0003-4421-1830	National Institutes of Health, NIAID [5R01AI042327, 1R21AI076757-01A1]; National Institutes of Health, NIGMS [3 S06 GM008037-34-S2];  [R01HL65709];  [R01HL57986];  [1R01GM085177];  [2T32AI007281-21A1];  [5R25GM059994-10]; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065709, R01HL057986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076757, T32AI007281, R01AI042327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, S06GM008037, R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI042327 and 1R21AI076757-01A1 from the NIAID and Grant 3 S06 GM008037-34-S2 from the NIGMS (to G. C.), Grants R01HL65709 and R01HL57986 (to S. F.), Grant 1R01GM085177 (to I. M. W.), and Institutional Training Grants 2T32AI007281-21A1 and 5R25GM059994-10 (as a graduate student stipend to A. L. F.).	Alexander J, 1999, J CELL SCI, V112, P2993; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Bahou WF, 2003, CURR TOP DEV BIOL, V54, P343, DOI 10.1016/S0070-2153(03)54014-5; Bates PA, 2006, TRENDS PARASITOL, V22, P447, DOI 10.1016/j.pt.2006.08.003; Benyamin Y, 2006, FEBS J, V273, P3413, DOI 10.1111/j.1742-4658.2006.05353.x; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; CHANG KP, 1990, ANNU REV MICROBIOL, V44, P499, DOI 10.1146/annurev.mi.44.100190.002435; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Chen DQ, 2000, INFECT IMMUN, V68, P80, DOI 10.1128/IAI.68.1.80-86.2000; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Corradin S, 2002, BIOCHEM J, V367, P761, DOI 10.1042/BJ20020386; Coughlin Sr, 2002, COLD SPRING HARB SYM, V67, P197, DOI 10.1101/sqb.2002.67.197; Dahl JA, 2007, FRONT BIOSCI-LANDMRK, V12, P4925, DOI 10.2741/2438; Demarchi F, 2007, CELL CYCLE, V6, P136; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Englert M, 2004, BIOCHIMIE, V86, P867, DOI 10.1016/j.biochi.2004.10.012; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Handman E, 2000, ADV PARASIT, V44, P1; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Innes F, 2006, NUCLEIC ACIDS RES, V34, P3399, DOI 10.1093/nar/gkl432; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Matlashewski G, 2001, MED MICROBIOL IMMUN, V190, P37, DOI 10.1007/s004300100076; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MCGWIRE B, 1994, MOL BIOCHEM PARASIT, V66, P345, DOI 10.1016/0166-6851(94)90160-0; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x; Petrocca F, 2009, ADV IMMUNOL, V102, P227, DOI 10.1016/S0065-2776(09)01204-8; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Rasbach KA, 2008, ARCH BIOCHEM BIOPHYS, V478, P130, DOI 10.1016/j.abb.2008.08.003; RICHES DWH, 1988, J IMMUNOL, V141, P180; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; STURGES MR, 1994, J BIOL CHEM, V269, P5712; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; TZINIA AK, 1991, MOL BIOCHEM PARASIT, V47, P83, DOI 10.1016/0166-6851(91)90150-5; Ueda Y, 2000, J BIOL CHEM, V275, P19428, DOI 10.1074/jbc.M001336200; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Yao CQ, 2010, INFECT IMMUN, V78, P22, DOI 10.1128/IAI.00776-09; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	69	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6614	6626		10.1074/jbc.M110.181735	http://dx.doi.org/10.1074/jbc.M110.181735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149457	hybrid, Green Published			2022-12-25	WOS:000287476400070
J	Vetterli, L; Brun, T; Giovannoni, L; Bosco, D; Maechler, P				Vetterli, Laurene; Brun, Thierry; Giovannoni, Laurianne; Bosco, Domenico; Maechler, Pierre			Resveratrol Potentiates Glucose-stimulated Insulin Secretion in INS-1E beta-Cells and Human Islets through a SIRT1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; UNCOUPLING PROTEIN-2; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; INCREASED DOSAGE; GENE-EXPRESSION; SIRT1; SIRTUINS; METABOLISM	Resveratrol, a polyphenol compound, is known for its effects on energy homeostasis. With properties of energy sensors mediating effects of calorie restriction, sirtuins are targets of resveratrol. The mammalian sirtuin homolog SIRT1 is a protein deacetylase playing a role in glucose metabolism and islet function. Here, we investigated the effects of resveratrol and possible link with SIRT1 in beta-cells. Insulinoma INS-1E cells and human islets were cultured with resveratrol before analyzing their physiological responses. Treatment of INS-1E cells for 24 h with 25 mu M resveratrol resulted in marked potentiation of glucose-stimulated insulin secretion. This effect was associated with elevated glycolytic flux, resulting in increased glucose oxidation, ATP generation, and mitochondrial oxygen consumption. Such changes correlated with up-regulation of key genes for beta-cell function, i.e. Glut2, glucokinase, Pdx-1, Hnf-1 alpha, and Tfam. In human islets, chronic resveratrol treatment similarly increased both the glucose secretory response and expression of the same set of genes, eventually restoring the glucose response in islets obtained from one type 2 diabetic donor. Overexpression of Sirt1 in INS-1E cells potentiated resveratrol effects on insulin secretion. Conversely, inhibition of SIRT1 achieved either by expression of an inactive mutant or by using the EX-527 inhibitor, both abolished resveratrol effects on glucose responses. Treatment of INS-1E cells with EX-527 also prevented resveratrol-induced up-regulation of Glut2, glucokinase, Pdx-1, and Tfam. Resveratrol markedly enhanced the glucose response of INS-1E cells and human islets, even after removal of the compound from the medium. These effects were mediated by and fully dependent on active SIRT1, defining a new role for SIRT1 in the regulation of insulin secretion.	[Vetterli, Laurene; Brun, Thierry; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Giovannoni, Laurianne; Bosco, Domenico] Univ Geneva, Med Ctr, Dept Surg, CH-1211 Geneva, Switzerland; Geneva Univ Hosp, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Maechler, P (corresponding author), Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Pierre.Maechler@unige.ch	giovannoni, laurianne/AAH-2648-2022; giovannoni, laurianne/AFM-0316-2022	Maechler, Pierre/0000-0002-2005-1433; Bosco, Domenico/0000-0003-3453-9613; BRUN, Thierry/0000-0002-1659-4283	Swiss National Science Foundation; State of Geneva; Juvenile Diabetes Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by the Swiss National Science Foundation (to P. M.) and the State of Geneva.; We are grateful to Deborah Strebel, Clarissa Bartley, and Gaelle Chaffard for technical assistance; Francoise Assimacopoulos-Jeannet for helpful scientific advice; and to Joseph Rodgers and Pere Puigserver for SIRT1-related adenoviruses and accompanying precious instructions. Fresh human islets were obtained thanks to the European Consortium for Islet Transplantation "Islet for Research" distribution program sponsored by the Juvenile Diabetes Research Foundation. This study was part of the Geneva Programme for Metabolic Disorders (GeMet).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Szkudelski T, 2006, EUR J PHARMACOL, V552, P176, DOI 10.1016/j.ejphar.2006.09.046; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Woods TM, 2004, ANN PHARMACOTHER, V38, P887, DOI 10.1345/aph.1D219; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004	67	119	122	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6049	6060		10.1074/jbc.M110.176842	http://dx.doi.org/10.1074/jbc.M110.176842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21163946	Green Published, hybrid			2022-12-25	WOS:000287476400013
J	Lacerda, HM; Richiardi, L; Pettersson, A; Corbin, M; Merletti, F; Akre, O				Lacerda, Hadriano M.; Richiardi, Lorenzo; Pettersson, Andreas; Corbin, Marine; Merletti, Franco; Akre, Olof			Cancer Risk in Mothers of Men Operated for Undescended Testis	PLOS ONE			English	Article							TESTICULAR CANCER; OVARIAN-CANCER; EUROPEAN COUNTRIES; LUNG-CANCER; CRYPTORCHIDISM; SMOKING; AGE; COHORT	Background: Undescended testis, or cryptorchidism, occurs in 2-5% of boys born at term, and by 12 months of age about 1% of all boys have manifest cryptorchidism. Several hormonal substances control this process and disruption of the foetal sex-hormones balance is a potential cause of undescended testis, however, to a great extent the aetiology of cryptorchidism is unclear. Methodology: To study risk factors involved in the aetiology of undescended testis, we assessed cancer risk in 15,885 mothers of men operated for undescended testis in Sweden. Women were followed-up for a median period of 23 years during which 811 first primary malignancies occurred. Their cancer incidence was compared with that in the general population estimating standardized incidence ratio (SIR) and corresponding 95% confidence interval (CI). Principal Findings: The overall cancer risk experienced by the mothers of cryptorchid men did not differ significantly from that of the general population (SIR = 0.94; 95% C.I. = 0.88-1.01). Specifically, there was a reduction in ovarian cancer risk (SIR = 0.72; 95% C.I. = 0.51-0.99), while the risk of lung (SIR = 1.38 95% C.I. 1.03-1.81) and biliary tract/liver cancer (SIR: 1.76, 95% CI: 1.03-2.82) were increased. Conclusions: Although we cannot rule out the role of chance, our data suggest a positive association between undescended testis and maternal lung cancer and a negative association with ovarian cancer, where the first may be partly attributable to smoking and the second to an altered hormonal milieu during pregnancy and thus both exposures may be risk factors for cryptorchidism.	[Lacerda, Hadriano M.; Richiardi, Lorenzo; Corbin, Marine; Merletti, Franco; Akre, Olof] Univ Turin, Canc Epidemiol Unit, CPO, I-10124 Turin, Italy; [Lacerda, Hadriano M.; Richiardi, Lorenzo; Corbin, Marine; Merletti, Franco; Akre, Olof] Univ Turin, CeRMS, I-10124 Turin, Italy; [Pettersson, Andreas; Akre, Olof] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Corbin, Marine] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of Turin; University of Turin; Karolinska Institutet; Massey University	Lacerda, HM (corresponding author), Univ Turin, Canc Epidemiol Unit, CPO, I-10124 Turin, Italy.	hadrilac@gmail.com	richiardi, lorenzo/J-3480-2018	richiardi, lorenzo/0000-0003-0316-9402	Swedish Cancer Society [4952-B04-01XAA]; Region of Piedmont; Stockholm County Council; Karolinska Institutet; Compagnia San Paolo Foundation; Italian Association for Research on Cancer	Swedish Cancer Society(Swedish Cancer Society); Region of Piedmont(Regione Piemonte); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Compagnia San Paolo Foundation(Compagnia di San Paolo); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro)	The authors were funded by the Swedish Cancer Society (4952-B04-01XAA). The work of Hadriano M. Lacerda was supported by a grant from the Region of Piedmont, and Olof Akre is supported by a grant from the Stockholm County Council and Karolinska Institutet. Lorenzo Richiardi was supported by grants from Compagnia San Paolo Foundation and the Italian Association for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; Biggs ML, 2002, EPIDEMIOLOGY, V13, P197, DOI 10.1097/00001648-200203000-00015; Brekelmans CTM, 2003, CURR OPIN OBSTET GYN, V15, P63, DOI 10.1097/00001703-200302000-00010; Cnattingius S, 2008, CANCER EPIDEM BIOMAR, V17, P2344, DOI 10.1158/1055-9965.EPI-08-0390; FERNANADA M, 2007, E CAM, P1; GERTIG D, 2008, TXB CANC EPIDEMIOLOG; Gorlova OY, 2007, INT J CANCER, V121, P111, DOI 10.1002/ijc.22615; Hemminki K, 2006, INT J ANDROL, V29, P205, DOI 10.1111/j.1365-2605.2005.00599.x; Jensen MS, 2007, EPIDEMIOLOGY, V18, P220, DOI 10.1097/01.ede.0000254061.90686.9f; Jones ME, 1998, PAEDIATR PERINAT EP, V12, P383; Kaijser M, 2003, CANCER EPIDEM BIOMAR, V12, P643; Levy JB, 1995, J ANDROL, V16, P459; McGlynn KA, 2006, CANCER EPIDEM BIOMAR, V15, P1820, DOI 10.1158/1055-9965.EPI-06-0389; McGlynn KA, 2006, INT J EPIDEMIOL, V35, P787, DOI 10.1093/ije/dyl024; Mucci LA, 2007, CANCER EPIDEM BIOMAR, V16, P1828, DOI 10.1158/1055-9965.EPI-06-0962; MUIR C, 1991, CANC REGISTRATION PR; PETTERSSON A, 2007, NEW ENGLAND J MED; PETTERSSON A, 2007, INT J CANC; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Richiardi L, 2004, CANCER EPIDEM BIOMAR, V13, P2157; SWEDEN S, 2007, BACKGROUND FACTS POP; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412	26	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14285	10.1371/journal.pone.0014285	http://dx.doi.org/10.1371/journal.pone.0014285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170324	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400009
J	Dong, MH; Bettencourt, R; Barrett-Connor, E; Loomba, R				Dong, Mamie H.; Bettencourt, Ricki; Barrett-Connor, Elizabeth; Loomba, Rohit			Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BODY-MASS INDEX; SERUM ALANINE; PLASMA ADIPONECTIN; METABOLIC SYNDROME; UNITED-STATES; HEALTHY-SUBJECTS; NATIONAL-HEALTH; VIRUS-INFECTION; HEART-DISEASE	Background: Serum alanine aminotransferase (ALT) is a marker of liver injury. The 2005 American Gastroenterology Association Future Trends Committee report states that serum ALT levels remain constant with age. This study examines the association between serum ALT and age in a community-dwelling cohort in the United States. Methods: A cross-sectional study of 2,364 (54% female) participants aged 30-93 years from the Rancho Bernardo Study cohort who attended a research clinic visit in 1984-87. Demographic, metabolic co-variates, ALT, bilirubin, gamma glutamyl transferase (GGT), albumin, and adiposity signaling biomarkers (leptin, IL-6, adiponectin, ghrelin) were measured. Participants were divided into four-groups based upon age quartile, and multivariable-adjusted least squares of means (LSM) were examined (p for trend <0.05). Results: ALT decreased with increasing age, with mean ALT levels (IU/L) of 23, 21, 20, and 17 for those between quartile ages 30-62, 63-71, 72-77, and 78-93 years (p < 0.0001). Trends of decreasing LSM ALT with age and the decreasing prevalence of categorically defined elevated serum ALT with age remained robust after adjusting for sex, alcohol use, metabolic syndrome components, and biomarkers of adiposity (p-value <0.0001), and was not materially changed after adjusting for bilirubin, GGT, and albumin. Conclusions: ALT levels decrease with age in both men and women independent of metabolic syndrome components, adiposity signaling biomarkers, and other commonly used liver function tests. Further studies are needed to understand the mechanisms responsible for a decline in ALT with age, and to establish the optimal cut-point of normal ALT in the elderly.	[Dong, Mamie H.; Loomba, Rohit] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Bettencourt, Ricki; Barrett-Connor, Elizabeth; Loomba, Rohit] Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dong, MH (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA.	roloomba@ucsd.edu	Bettencourt, Ricki/M-3531-2019; Loomba, Rohit/AAE-7831-2019	Loomba, Rohit/0000-0002-4845-9991	American Gastroenterological Association (AGA) Foundation; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; UCSD Digestive Diseases Research Development Center, U.S. PHS [DK080506]; National Institutes of Health [RO1AG28507, R37AG007181, RO1DK31801]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, R01DK031801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028507, R37AG007181] Funding Source: NIH RePORTER	American Gastroenterological Association (AGA) Foundation; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; UCSD Digestive Diseases Research Development Center, U.S. PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported in part by the American Gastroenterological Association (AGA) Foundation - Sucampo - ASP Designated Research Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award; Funding was provided by Atlantic Philanthropies, Inc, the John A. Hartford Foundation, the Association of Specialty Professors, and the American Gastroenterological Association to Rohit Loomba, MD, MHSc. This research was funded in part with the support of the UCSD Digestive Diseases Research Development Center, U.S. PHS grant #DK080506. This work was supported in part by the National Institutes of Health grants RO1AG28507, R37AG007181, and RO1DK31801 to Elizabeth Barrett-Connor, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Angulo P, 1999, HEPATOLOGY, V30, p406A; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; BARRETTCONNOR E, 1989, JAMA-J AM MED ASSOC, V261, P2095, DOI 10.1001/jama.261.14.2095; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Calvaruso V, 2009, J VIRAL HEPATITIS, V16, P529, DOI 10.1111/j.1365-2893.2009.01150.x; Carlson JJ, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-32; Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P616, DOI 10.1631/jzus.B0720016; Choi KM, 2004, EUR J ENDOCRINOL, V150, P715, DOI 10.1530/eje.0.1500715; Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x; Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x; Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677; Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0; Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Hall KE, 2005, GASTROENTEROLOGY, V129, P1305, DOI 10.1053/j.gastro.2005.06.013; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Kamada Y, 2009, J CLIN GASTROENTEROL, V43, P995, DOI 10.1097/MCG.0b013e3181962de8; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Khedmat H, 2007, WORLD J GASTROENTERO, V13, P889, DOI 10.3748/wjg.v13.i6.889; Langenberg C, 2005, AM J EPIDEMIOL, V162, P1189, DOI 10.1093/aje/kwi338; Langenberg C, 2006, DIABETES CARE, V29, P1363, DOI 10.2337/dc05-2385; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082; Leclercq I, 1999, ACTA GASTRO-ENT BELG, V62, P16; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; Liu CM, 2005, WORLD J GASTROENTERO, V11, P1616, DOI 10.3748/wjg.v11.i11.1616; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Lu JY, 2007, INTERN MED J, V37, P365, DOI 10.1111/j.1445-5994.2007.01364.x; Maahs DM, 2005, CIRCULATION, V111, P747, DOI 10.1161/01.CIR.0000155251.03724.A5; McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328; Miyaaki H, 2008, LIVER INT, V28, P519, DOI 10.1111/j.1478-3231.2007.01614.x; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Mohamadnejad M, 2003, WORLD J GASTROENTERO, V9, P2322; Patt CH, 2003, DIGEST DIS SCI, V48, P797, DOI 10.1023/A:1022809430756; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Ruhl CE, 2004, AM J CLIN NUTR, V80, P576; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sakai Y, 1997, HEPATOLOGY, V25, P421; Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315; Tarantino G, 2007, CLIN INVEST MED, V30, pE192, DOI 10.25011/cim.v30i5.2895; Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462; 1976, PREV MED, V5, P207	48	59	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14254	10.1371/journal.pone.0014254	http://dx.doi.org/10.1371/journal.pone.0014254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170382	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100008
J	Hasson, D; Gustavsson, P				Hasson, Dan; Gustavsson, Petter			Declining Sleep Quality among Nurses: A Population-Based Four-Year Longitudinal Study on the Transition from Nursing Education to Working Life	PLOS ONE			English	Article							AUSTRALIAN NURSES; STAFF NURSE; STRESS; INSOMNIA; FATIGUE; SATISFACTION; HEALTH; SAMPLE; CARE; PERFORMANCE	Background: Several studies have established impaired sleep is a common problem among nurses. Overworked, fatigued and stressed nurses are at a higher risk of making mistakes that threaten patient safety as well as their own health. The aim of the present study was to longitudinally monitor the development of sleep quality in nurses, starting from the last semester at the university, with three subsequent annual follow-ups once the nurses had entered working life. Methodology/Principal Findings: Nationwide, longitudinal questionnaire study of nursing students and newly qualified nurses in Sweden. The results imply a continuous decline in sleep quality among nurses during the three years of follow-up, starting from their last semester of nursing education and continuing for three years into their working life. The most pronounced short-term decline in sleep quality seems to occur in the transition between student life and working life. Conclusion/Significance: This finding is important since it may affect the quality of care and the health of nurses negatively.	[Hasson, Dan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hasson, Dan] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Gustavsson, Petter] Karolinska Inst, Dept Clin Neurosci, Psychol Sect, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Hasson, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	dan.hasson@ki.se	Hasson, Dan/T-9262-2019	Gustavsson, Petter/0000-0001-9571-9349	AFA (Arbetsmarknadens Forsakringsaktiebolag); FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life; Tysta Skolan	AFA (Arbetsmarknadens Forsakringsaktiebolag); FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Tysta Skolan	The LANE study has been made possible by funding from the insurance company AFA (Arbetsmarknadens Forsakringsaktiebolag). DH is supported by a grant from FAS (Swedish Council for Working Life and Social Research) Centre for Research on Hearing Problems in Working Life and Tysta Skolan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L H, 2001, LDI Issue Brief, V6, P1; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Akerstedt T, 2007, PHYSIOL BEHAV, V90, P209, DOI 10.1016/j.physbeh.2006.09.007; Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; Akerstedt Torbjorn, 2004, Lakartidningen, V101, P1501; Ancoli-Israel S, 1999, SLEEP, V22, pS347; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; BENNETT P, 2001, STRESS NURSES COPING, P55; Bird J, 1995, Nurs Stand, V9, P18; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cohen J, 1977, STAT POWER ANAL BEHA, p[xv, 474]; Demerouti E, 2000, J ADV NURS, V32, P454, DOI 10.1046/j.1365-2648.2000.01496.x; Edell-Gustafsson UM, 2002, SCAND J CARING SCI, V16, P179, DOI 10.1046/j.1471-6712.2002.00078.x; ESCOT C, 2001, STRESS LEVELS NURSIN, P273; GOLD DR, 1992, AM J PUBLIC HEALTH, V82, P1011, DOI 10.2105/AJPH.82.7.1011; Goldstein DS, 2002, STRESS, V5, P54, DOI 10.1080/10253890290012345; GRAYTOFT P, 1981, SOC SCI MED-MED SOC, V15, P639, DOI 10.1016/0271-7123(81)90087-0; HALLSTEN L, 2004, ARBETSLIV HALSA 2004, P151; Hasselhorn HM, 2003, WORKING CONDITIONS I; Healy CM, 2000, J ADV NURS, V31, P681, DOI 10.1046/j.1365-2648.2000.01323.x; Hughes RG, 2004, AM J NURS, V104, P36, DOI 10.1097/00000446-200403000-00017; Jean-Louis G, 2000, SLEEP, V23, P1115; Johnson C J, 2003, J Nurs Manag, V11, P336, DOI 10.1046/j.1365-2834.2003.00404.x; Josten EJC, 2003, J ADV NURS, V44, P643, DOI 10.1046/j.0309-2402.2003.02854.x; Kramer M., 1974, REALITY SHOCK WHY NU; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; KRYGER MH, 2007, 2007 SLEEP AM POLL; Linton SJ, 2004, BRIT J HEALTH PSYCH, V9, P127, DOI 10.1348/135910704773891005; Maben J, 1998, J CLIN NURS, V7, P145, DOI 10.1046/j.1365-2702.1998.00119.x; MARSHALL GD, 2000, ENCY STRESS, P626; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGrath A, 2003, INT J NURS STUD, V40, P555, DOI 10.1016/S0020-7489(03)00058-0; MCGRATH A, 2003, INT J NURS STUD, V26, P359; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; MILLER C, 2004, LEARNING 1 3 YEARS P; Moore Charlotte, 2006, Br J Nurs, V15, P540; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Morin CM, 2003, INSOMNIA CLIN GUIDE; Muecke S, 2005, J ADV NURS, V50, P433, DOI 10.1111/j.1365-2648.2005.03409.x; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Page A., 2004, KEEPING PATIENTS SAF; Piko B, 1999, J R SOC PROMO HEALTH, V119, P156, DOI 10.1177/146642409911900304; Rogers AE, 2003, SLEEP, V26, pA423; Schenck CH, 2003, JAMA-J AM MED ASSOC, V289, P2475, DOI 10.1001/jama.289.19.2475; Scott LD, 2006, J NURS ADMIN, V36, P86, DOI 10.1097/00005110-200602000-00007; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Trinkoff AM, 2003, J NURS ADMIN, V33, P153, DOI 10.1097/00005110-200303000-00006; Trinkoff AM, 2003, AM J PREV MED, V24, P270, DOI 10.1016/S0749-3797(02)00639-6; VANCAUTER E, 2000, ENCY STRESS, P447; VGONTZAS AN, 2000, ENCY STRESS, P449; WEINFURT KP, 2000, READING UNDERSTANDIN, pR13; WEST M, 1989, J OCCUP PSYCHOL, V62, P271, DOI 10.1111/j.2044-8325.1989.tb00500.x; Whitehead J, 2001, Br J Nurs, V10, P330; Whitehead J., 2001, BR J NURS, V10, P334; WILLENBERG HS, 2000, ENCY STRESS, P709; Winwood PC, 2006, J ADV NURS, V56, P679, DOI 10.1111/j.1365-2648.2006.04055.x; Winwood PC, 2006, J ADV NURS, V56, P438, DOI 10.1111/j.1365-2648.2006.04011.x	62	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14265	10.1371/journal.pone.0014265	http://dx.doi.org/10.1371/journal.pone.0014265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170381	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100015
J	Martin, T; Lu, SW; van Tilbeurgh, H; Ripoll, DR; Dixelius, C; Turgeon, BG; Debuchy, R				Martin, Tom; Lu, Shun-Wen; van Tilbeurgh, Herman; Ripoll, Daniel R.; Dixelius, Christina; Turgeon, B. Gillian; Debuchy, Robert			Tracing the Origin of the Fungal alpha 1 Domain Places Its Ancestor in the HMG-Box Superfamily: Implication for Fungal Mating-Type Evolution	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRANSCRIPTION FACTOR; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BASIS; SEX GENES; SEQUENCE; DNA; LOCI; IDENTIFICATION	Background: Fungal mating types in self-incompatible Pezizomycotina are specified by one of two alternate sequences occupying the same locus on corresponding chromosomes. One sequence is characterized by a gene encoding an HMG protein, while the hallmark of the other is a gene encoding a protein with an alpha 1 domain showing similarity to the M protein of Saccharomyces cerevisiae. DNA-binding HMG proteins are ubiquitous and well characterized. In contrast, alpha 1 domain proteins have limited distribution and their evolutionary origin is obscure, precluding a complete understanding of mating-type evolution in Ascomycota. Although much work has focused on the role of the S. cerevisiae Mat alpha 1p protein as a transcription factor, it has not yet been placed in any of the large families of sequence-specific DNA-binding proteins. Methodology/Principal Findings: We present sequence comparisons, phylogenetic analyses, and in silico predictions of secondary and tertiary structures, which support our hypothesis that the alpha 1 domain is related to the HMG domain. We have also characterized a new conserved motif in alpha 1 proteins of Pezizomycotina. This motif is immediately adjacent to and downstream of the alpha 1 domain and consists of a core sequence Y-[LMIF]-x(3)-G-[WL] embedded in a larger conserved motif. Conclusions/Significance: Our data suggest that extant alpha 1-box genes originated from an ancestral HMG gene, which confirms the current model of mating-type evolution within the fungal kingdom. We propose to incorporate alpha 1 proteins in a new subclass of HMG proteins termed MAT alpha_ HMG.	[Martin, Tom; Dixelius, Christina] Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala Bioctr, Uppsala, Sweden; [Lu, Shun-Wen; Ripoll, Daniel R.; Turgeon, B. Gillian] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [van Tilbeurgh, Herman] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Debuchy, Robert] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France	Swedish University of Agricultural Sciences; Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martin, T (corresponding author), Swedish Univ Agr Sci SLU, Dept Plant Biol & Forest Genet, Uppsala Bioctr, Uppsala, Sweden.	robert.debuchy@igmors.u-psud.fr	Debuchy, Robert/J-3040-2012	Debuchy, Robert/0000-0003-1206-0361; Turgeon, Barbara/0000-0001-7979-7662	Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU); NSF; Agence nationale de la recherche (ANR) [ANR-05-BLAN-0385];  [SWE-2005-453]	Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU); NSF(National Science Foundation (NSF)); Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); 	TM is supported by Sida SWE-2005-453 (http://www.sida.se) and the Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU) (http://www.slu.se/sv/fakulteter/nl). SWL was supported by an NSF grant to BGT (http://www.nsf.gov/). CD is supported by the Swedish University of Agricultural Sciences (Sveriges lantbruksuniversitet, SLU) (http://www.slu.se/sv/fakulteter/nl). RD is supported by contract ANR-05-BLAN-0385 from the Agence nationale de la recherche (ANR) (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Casselton L, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P536; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; Cerdan R, 2001, PROTEIN SCI, V10, P504, DOI 10.1110/ps.35501; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DENNY P, 1992, NUCLEIC ACIDS RES, V20, P2887, DOI 10.1093/nar/20.11.2887; Dyer PS, 2008, CURR BIOL, V18, pR207, DOI 10.1016/j.cub.2008.01.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser JA, 2007, EUKARYOT CELL, V6, P622, DOI 10.1128/EC.00018-07; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; HAGEN DC, 1993, MOL CELL BIOL, V13, P6866, DOI 10.1128/MCB.13.11.6866; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KAHMANN R, 1995, CURR OPIN GENET DEV, V5, P559, DOI 10.1016/0959-437X(95)80023-9; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Lee SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010539; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; McGuire IC, 2001, FUNGAL GENET BIOL, V34, P131, DOI 10.1006/fgbi.2001.1295; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Nielsen O, 1996, MOL GEN GENET, V253, P387, DOI 10.1007/PL00008604; Nixon CE, 2010, GENETICS, V185, P497, DOI 10.1534/genetics.110.115907; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; PHILLEY ML, 1994, GENETICS, V137, P715; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Sadreyev RI, 2009, NUCLEIC ACIDS RES, V37, pW90, DOI 10.1093/nar/gkp360; Saupe S, 1996, MOL GEN GENET, V250, P115, DOI 10.1007/BF02191831; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tsong Annie E., 2007, P75; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Turgeon B. Gillian, 2007, P93; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P533, DOI 10.1023/B:EJPP.0000032393.72921.5b; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; Yokoyama E, 2003, APPL ENVIRON MICROB, V69, P5019, DOI 10.1128/AEM.69.8.5019-5022.2003; YUAN YLO, 1993, GENE DEV, V7, P1584, DOI 10.1101/gad.7.8.1584; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	76	68	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15199	10.1371/journal.pone.0015199	http://dx.doi.org/10.1371/journal.pone.0015199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170349	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100027
J	Steckbeck, JD; Sun, CQ; Sturgeon, TJ; Montelaro, RC				Steckbeck, Jonathan D.; Sun, Chengqun; Sturgeon, Timothy J.; Montelaro, Ronald C.			Topology of the C-Terminal Tail of HIV-1 gp41: Differential Exposure of the Kennedy Epitope on Cell and Viral Membranes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; CYTOPLASMIC TAIL; TYPE-1 MATRIX; TRANSMEMBRANE GLYCOPROTEIN; SYNTHETIC PEPTIDES; PROTEIN TOPOLOGY; SURFACE; FUSION; REGION	The C-terminal tail (CTT) of the HIV-1 gp41 envelope (Env) protein is increasingly recognized as an important determinant of Env structure and functional properties, including fusogenicity and antigenicity. While the CTT has been commonly referred to as the "intracytoplasmic domain'' based on the assumption of an exclusive localization inside the membrane lipid bilayer, early antigenicity studies and recent biochemical analyses have produced a credible case for surface exposure of specific CTT sequences, including the classical "Kennedy epitope'' (KE) of gp41, leading to an alternative model of gp41 topology with multiple membrane-spanning domains. The current study was designed to test these conflicting models of CTT topology by characterizing the exposure of native CTT sequences and substituted VSV-G epitope tags in cell-and virion-associated Env to reference monoclonal antibodies (MAbs). Surface staining and FACS analysis of intact, Env-expressing cells demonstrated that the KE is accessible to binding by MAbs directed to both an inserted VSV-G epitope tag and the native KE sequence. Importantly, the VSV-G tag was only reactive when inserted into the KE; no reactivity was observed in cells expressing Env with the VSV-G tag inserted into the LLP2 domain. In contrast to cell-surface expressed Env, no binding of KE-directed MAbs was observed to Env on the surface of intact virions using either immune precipitation or surface plasmon resonance spectroscopy. These data indicate apparently distinct CTT topologies for virion-and cell-associated Env species and add to the case for a reconsideration of CTT topology that is more complex than currently envisioned.	[Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Sun, Chengqun; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	rmont@pitt.edu			National Institutes of Health (NIH) [1R21 AI070033]; National Institute of Allergy and Infectious Diseases [5T32 AI065380-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533, R21AI070033, T32AI065380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) Grant 1R21 AI070033 (RCM) and by NIH Grant 5T32 AI065380-05 (JDS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, BIOCHEM BIOPH RES CO, V276, P157, DOI 10.1006/bbrc.2000.3457; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Chan WE, 2005, J VIROL, V79, P8374, DOI 10.1128/JVI.79.13.8374-8387.2005; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Cheung L, 2005, J GEN VIROL, V86, P131, DOI 10.1099/vir.0.80439-0; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FUJII G, 1992, PROTEIN SCI, V1, P1454, DOI 10.1002/pro.5560011107; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Heap CJ, 2005, J GEN VIROL, V86, P1499, DOI 10.1099/vir.0.80414-0; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; LUCIW PA, 2002, FIELDS VIROLOGY, P1881; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Reading SA, 2003, VIROLOGY, V315, P362, DOI 10.1016/S0042-6822(03)00533-6; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; ROWELL JF, 1995, J IMMUNOL, V155, P473; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2006, J MED PRIMATOL, V35, P248, DOI 10.1111/j.1600-0684.2006.00173.x; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; YUAN T, 1995, BIOCHEMISTRY-US, V34, P10690, DOI 10.1021/bi00033a045; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	59	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15261	10.1371/journal.pone.0015261	http://dx.doi.org/10.1371/journal.pone.0015261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151874	gold, Green Published, Green Accepted			2022-12-25	WOS:000285041800012
J	Foucaud, J; Burns, JG; Mery, F				Foucaud, Julien; Burns, James G.; Mery, Frederic			Use of Spatial Information and Search Strategies in a Water Maze Analog in Drosophila melanogaster	PLOS ONE			English	Article							VISUAL-PATTERN MEMORY; SEX-DIFFERENCES; PLACE MEMORY; EMIGRATION BEHAVIOR; GENETIC DISSECTION; ANIMAL COGNITION; CENTRAL COMPLEX; NAVIGATION; HIPPOCAMPUS; MICE	Learning the spatial organization of the environment is crucial to fitness in most animal species. Understanding proximate and ultimate factors underpinning spatial memory is thus a major goal in the study of animal behavior. Despite considerable interest in various aspects of its behavior and biology, the model species Drosophila melanogaster lacks a standardized apparatus to investigate spatial learning and memory. We propose here a novel apparatus, the heat maze, conceptually based on the Morris water maze used in rodents. Using the heat maze, we demonstrate that D. melanogaster flies are able to use either proximal or distal visual cues to increase their performance in navigating to a safe zone. We also show that flies are actively using the orientation of distal visual cues when relevant in targeting the safe zone, i.e., Drosophila display spatial learning. Parameter-based classification of search strategies demonstrated the progressive use of spatially precise search strategies during learning. We discuss the opportunity to unravel the mechanistic and evolutionary bases of spatial learning in Drosophila using the heat maze.	[Foucaud, Julien; Burns, James G.; Mery, Frederic] UPR CNRS 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Burns, James G.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Mississauga	Foucaud, J (corresponding author), UPR CNRS 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France.	julien.foucaud@legs.cnrs-gif.fr		Foucaud, Julien/0000-0003-2272-3149	European Research Council under European Community/ERC [FP7/2007-2013, 209540]	European Research Council under European Community/ERC(European Research Council (ERC))	This work was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 209540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMASSARITEULE M, 1985, BEHAV BRAIN RES, V17, P9, DOI 10.1016/0166-4328(85)90003-8; Balschun D, 2003, J NEUROSCI, V23, P6304; Barkley CL, 2007, BEHAV NEUROSCI, V121, P291, DOI 10.1037/0735-7044.121.2.291; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; Brembs B, 2009, CURR BIOL, V19, P1351, DOI 10.1016/j.cub.2009.06.014; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Burns JG, 2006, BEHAV ECOL, V17, P48, DOI 10.1093/beheco/arj002; Carman HM, 2002, NEUROBIOL LEARN MEM, V78, P332, DOI 10.1006/nlme.2002.4062; Chai XJ, 2010, BEHAV BRAIN RES, V208, P336, DOI 10.1016/j.bbr.2009.11.039; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; Dyer FC, 1996, J EXP BIOL, V199, P147; GALEA LAM, 1994, BRAIN RES, V635, P18, DOI 10.1016/0006-8993(94)91419-2; Garelick MG, 2009, J NEUROSCI, V29, P10835, DOI 10.1523/JNEUROSCI.0553-09.2009; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Holscher C, 2003, REV NEUROSCIENCE, V14, P253; Iliadi KG, 2002, BEHAV GENET, V32, P173, DOI 10.1023/A:1016017028041; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jones CM, 2003, BEHAV NEUROSCI, V117, P403, DOI 10.1037/0735-7044.117.3.403; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Markow TA, 2000, OIKOS, V89, P378, DOI 10.1034/j.1600-0706.2000.890219.x; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Menzel R, 2000, P ROY SOC B-BIOL SCI, V267, P961, DOI 10.1098/rspb.2000.1097; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Micheau J, 2004, BEHAV NEUROSCI, V118, P1022, DOI 10.1037/0735-7044.118.5.1022; MIKASA K, 1992, JPN J GENET, V67, P463, DOI 10.1266/jjg.67.463; MIKASA K, 1980, RES NOTES, V55, P111; Mizunami M, 1998, J COMP NEUROL, V402, P520; Mizunami Makoto, 1993, P199; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pitman JL, 2009, FLY, V3, P3, DOI 10.4161/fly.3.1.7726; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; R-Development-Core-Team, 2010, R LANGUAGE ENV STAT; Roudez RJ, 2008, BIOL INVASIONS, V10, P1191, DOI 10.1007/s10530-007-9195-9; Save E, 2000, BEHAV BRAIN RES, V109, P195, DOI 10.1016/S0166-4328(99)00173-4; Shettleworth SJ, 2005, BEHAV PROCESS, V69, P147, DOI 10.1016/j.beproc.2005.02.016; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2010, J COMP PHYSIOL A, V196, P299, DOI 10.1007/s00359-010-0517-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tamara C, 2010, ANIM COGN, V13, P565, DOI 10.1007/s10071-009-0307-z; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wehner R, 1996, J EXP BIOL, V199, pAR1; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zars M, 2009, NATURWISSENSCHAFTEN, V96, P927, DOI 10.1007/s00114-009-0550-9; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; ZOLADEK L, 1978, ANIM LEARN BEHAV, V6, P77, DOI 10.3758/BF03212006	69	40	40	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15231	10.1371/journal.pone.0015231	http://dx.doi.org/10.1371/journal.pone.0015231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151940	Green Submitted, gold, Green Published			2022-12-25	WOS:000284939600034
J	Gatton, ML; Cheng, Q				Gatton, Michelle L.; Cheng, Qin			Interrupting Malaria Transmission: Quantifying the Impact of Interventions in Regions of Low to Moderate Transmission	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; SUB-SAHARAN AFRICA; MODEL; INTENSITY; DYNAMICS; PATTERNS; IMMUNITY; VIETNAM; VACCINE; RATES	Malaria has been eliminated from over 40 countries with an additional 39 currently planning for, or committed to, elimination. Information on the likely impact of available interventions, and the required time, is urgently needed to help plan resource allocation. Mathematical modelling has been used to investigate the impact of various interventions; the strength of the conclusions is boosted when several models with differing formulation produce similar data. Here we predict by using an individual-based stochastic simulation model of seasonal Plasmodium falciparum transmission that transmission can be interrupted and parasite reintroductions controlled in villages of 1,000 individuals where the entomological inoculation rate is <7 infectious bites per person per year using chemotherapy and bed net strategies. Above this transmission intensity bed nets and symptomatic treatment alone were not sufficient to interrupt transmission and control the importation of malaria for at least 150 days. Our model results suggest that 1) stochastic events impact the likelihood of successfully interrupting transmission with large variability in the times required, 2) the relative reduction in morbidity caused by the interventions were age-group specific, changing over time, and 3) the post-intervention changes in morbidity were larger than the corresponding impact on transmission. These results generally agree with the conclusions from previously published models. However the model also predicted changes in parasite population structure as a result of improved treatment of symptomatic individuals; the survival probability of introduced parasites reduced leading to an increase in the prevalence of sub-patent infections in semi-immune individuals. This novel finding requires further investigation in the field because, if confirmed, such a change would have a negative impact on attempts to eliminate the disease from areas of moderate transmission.	[Gatton, Michelle L.; Cheng, Qin] Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia; [Gatton, Michelle L.] Griffith Med Res Coll, Brisbane, Qld, Australia; [Cheng, Qin] Australian Army Malaria Inst, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Gatton, ML (corresponding author), Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia.	michelle.gatton@qimr.edu.au	Gatton, Michelle/H-3139-2019; Cheng, Qin/AAO-2198-2020	Gatton, Michelle/0000-0003-1188-609X; Cheng, Qin/0000-0001-7776-4437	National Institutes of Health [2RO1 AI-47500]; NHMRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health grant 2RO1 AI-47500. M. L. G. was supported in part by an NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; [Anonymous], MALARIA PRINCIPLES P; [Anonymous], 2008, GLOB MAL CONTR EL RE; Boyd M. F., 1937, American Journal of Tropical Medicine, V17, P213; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BURKOT TR, 1990, AM J TROP MED HYG, V43, P321, DOI 10.4269/ajtmh.1990.43.321; COATNEY GR, 1971, PRIMATE MALARIA; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49; Dicko A, 2007, AM J TROP MED HYG, V77, P1028, DOI 10.4269/ajtmh.2007.77.1028; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garnham PCC, 1966, MALARIA PARASITES OT; Gatton ML, 2006, J ANTIMICROB CHEMOTH, V58, P47, DOI 10.1093/jac/dkl158; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; Gatton ML, 2004, PARASITOLOGY, V128, P367, DOI 10.1017/S0031182003004608; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Giao PT, 2005, TROP MED INT HEALTH, V10, P919, DOI 10.1111/j.1365-3156.2005.01472.x; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Koella JC, 1996, PARASITOLOGY, V113, P105, DOI 10.1017/S0031182000066348; KROEGER A, 1995, AM J TROP MED HYG, V53, P313, DOI 10.4269/ajtmh.1995.53.313; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; McKenzie FE, 2002, AM J TROP MED HYG, V67, P571, DOI 10.4269/ajtmh.2002.67.571; Moonen B, 2009, SHRINKING MALARIA MA, P1; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Orjuela-Sanchez P, 2009, PARASITOLOGY, V136, P1097, DOI 10.1017/S0031182009990539; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; Rieckmann KH, 2006, ANN TROP MED PARASIT, V100, P647, DOI 10.1179/136485906X112185; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; *UN SECR DEP EC SO, 2007, WORLD POP PROSP 2004; Van Nam N, 2005, TROP MED INT HEALTH, V10, P357, DOI 10.1111/j.1365-3156.2005.01387.x; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; *WHO, 2006, LIF TABL WHO MEMB ST; World Health Organization, 2007, MAL EL FIELD MAN LOW	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15149	10.1371/journal.pone.0015149	http://dx.doi.org/10.1371/journal.pone.0015149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152042	Green Published, Green Submitted, gold			2022-12-25	WOS:000284868000027
J	Glessner, JT; Wang, K; Sleiman, PMA; Zhang, HT; Kim, CE; Flory, JH; Bradfield, JP; Imielinski, M; Frackelton, EC; Qiu, HJ; Mentch, F; Grant, SFA; Hakonarson, H				Glessner, Joseph T.; Wang, Kai; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Qiu, Haijun; Mentch, Frank; Grant, Struan F. A.; Hakonarson, Hakon			Duplication of the SLIT3 Locus on 5q35.1 Predisposes to Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION	Major depressive disorder (MDD) is a common psychiatric and behavioral disorder. To discover novel variants conferring risk to MDD, we conducted a whole-genome scan of copy number variation (CNV), including 1,693 MDD cases and 4,506 controls genotyped on the Perlegen 600K platform. The most significant locus was observed on 5q35.1, harboring the SLIT3 gene (P = 2x10(-3)). Extending the controls with 30,000 subjects typed on the Illumina 550 k array, we found the CNV to remain exclusive to MDD cases (P = 3.2x10(-9)). Duplication was observed in 5 unrelated MDD cases encompassing 646 kb with highly similar breakpoints. SLIT3 is integral to repulsive axon guidance based on binding to Roundabout receptors. Duplication of 5q35.1 is a highly penetrant variation accounting for 0.7% of the subset of 647 cases harboring large CNVs, using a threshold of a minimum of 10 SNPs and 100 kb. This study leverages a large dataset of MDD cases and controls for the analysis of CNVs with matched platform and ethnicity. SLIT3 duplication is a novel association which explains a definitive proportion of the largely unknown etiology of MDD.	[Glessner, Joseph T.; Wang, Kai; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Qiu, Haijun; Mentch, Frank; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Glessner, JT (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu		Glessner, Joseph/0000-0001-5131-2811	Children's Hospital of Philadelphia; Cotswold Foundation; National Center for Research Resources [U54 RR020278-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; Cotswold Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study is supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia (HH) and by a Research Development Award from the Cotswold Foundation (HH & SFAG). The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278-01 (S. Gabriel, principal investigator) from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; HAKONARSON H, 2009, P 59 ANN M AM SOC HU; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knowles JA, 2009, MOL PSYCHIAT; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; MUGLIA P, 2008, MOL PSYCHIAT; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	16	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15463	10.1371/journal.pone.0015463	http://dx.doi.org/10.1371/journal.pone.0015463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152026	Green Published, gold, Green Submitted			2022-12-25	WOS:000284821300020
J	Chintagari, NR; Jin, N; Gao, L; Wang, Y; Xi, D; Liu, L				Chintagari, Narendranath Reddy; Jin, Nili; Gao, Li; Wang, Yang; Xi, Dong; Liu, Lin			Role of GABA Receptors in Fetal Lung Development in Rats	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; GAMMA-AMINOBUTYRIC-ACID; ALVEOLAR EPITHELIAL-CELLS; SMOOTH MUSCLE ACTIN; TRACHEAL OCCLUSION; CLEFT-PALATE; PULMONARY HYPOPLASIA; MICE DEFICIENT; KNOCKOUT MICE; II CELLS	Fluid accumulation is critical for lung distension and normal development. The multi-subunit c-amino butyric acid type A receptors (GABA(A)) mainly act by mediating chloride ion (Cl-) fluxes. Since fetal lung actively secretes Cl- -rich fluid, we investigated the role of GABA(A) receptors in fetal lung development. The physiological ligand, GABA, and its synthesizing enzyme, glutamic acid decarboxylase, were predominantly localized to saccular epithelium. To examine the effect of activating GABA(A) receptors in fetal lung development in vivo, timed-pregnant rats of day 18 gestation underwent an in utero surgery for the administration of GABA(A) receptor modulators into the fetuses. The fetal lungs were isolated on day 21 of gestation and analyzed for changes in fetal lung development. Fetuses injected with GABA had a significantly higher body weight and lung weight when compared to phosphate-buffered saline (control)-injected fetuses. GABA-injected fetal lungs had a higher number of saccules than the control. GABA increased the number of alveolar epithelial type II cells as indicated by surfactant protein C-positive cells. However, GABA decreased the number of alpha-smooth muscle actin-positive myofibroblasts, but did not affect the number of Clara cells or alveolar type I cells. GABA-mediated effects were blocked by the GABA(A) receptor antagonist, bicuculline. GABA also increased cell proliferation and Cl- efflux in fetal distal lung epithelial cells. In conclusion, our results indicate that GABA(A) receptors accelerate fetal lung development, likely through an enhanced cell proliferation and/or fluid secretion.	[Chintagari, Narendranath Reddy; Jin, Nili; Gao, Li; Wang, Yang; Xi, Dong; Liu, Lin] Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Lundberg Kienlen Lung Biol & Toxicol Lab, Dept Physiol Sci, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Wang, Yang/G-4496-2014	Wang, Yang/0000-0002-2626-478X	NIH [HL083188, HL087884]; Center for Veterinary Health Sciences, Oklahoma State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087884, R01HL083188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Veterinary Health Sciences, Oklahoma State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL083188 and NIH HL087884 (LL), and a seed grant from the Center for Veterinary Health Sciences, Oklahoma State University (NRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Barghorn A, 1998, PEDIATR PATHOL LAB M, V18, P5, DOI 10.1080/107710498174173; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaisdell CJ, 2004, AM J PHYSIOL-LUNG C, V286, pL420, DOI 10.1152/ajplung.00113.2003; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Chiu P, 2008, PRENATAL DIAG, V28, P592, DOI 10.1002/pd.2007; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; Davies LA, 2008, MOL THER, V16, P812, DOI 10.1038/mt.2008.25; De Paepe ME, 1999, AM J RESP CELL MOL, V21, P65, DOI 10.1165/ajrcmb.21.1.3511; FAUZA DO, 1994, J PEDIATR SURG, V29, P882, DOI 10.1016/0022-3468(94)90008-6; Flecknoe S, 2000, AM J PHYSIOL-LUNG C, V278, pL1180, DOI 10.1152/ajplung.2000.278.6.L1180; Geigerseder Christof, 2004, Reprod Biol Endocrinol, V2, P13, DOI 10.1186/1477-7827-2-13; Gillie DJ, 2001, AM J RESP CELL MOL, V25, P14, DOI 10.1165/ajrcmb.25.1.4500; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; HARRISON MR, 1994, JAMA-J AM MED ASSOC, V271, P382, DOI 10.1001/jama.271.5.382; HILL AC, 1994, ANN THORAC SURG, V57, P946, DOI 10.1016/0003-4975(94)90211-9; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; HOOPER SB, 1995, CLIN EXP PHARMACOL P, V22, P235, DOI 10.1111/j.1440-1681.1995.tb01988.x; Ingbar DH, 1996, AM J PHYSIOL-LUNG C, V270, pL619, DOI 10.1152/ajplung.1996.270.4.L619; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Jin N, 2008, GENE EXPR PATTERNS, V8, P397, DOI 10.1016/j.gep.2008.04.008; Jin NL, 2006, J BIOL CHEM, V281, P36012, DOI 10.1074/jbc.M606895200; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kitterman JA, 2002, AM J PHYSIOL-LUNG C, V282, pL431, DOI 10.1152/ajplung.00161.2001; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Koivusalo AI, 2008, J PEDIATR SURG, V43, P279, DOI 10.1016/j.jpedsurg.2007.10.014; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Maltais F, 2003, AM J PHYSIOL-LUNG C, V284, pL622, DOI 10.1152/ajplung.00079.2002; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; MOYA FR, 1995, AM J OBSTET GYNECOL, V173, P1401, DOI 10.1016/0002-9378(95)90624-X; MURRAY CB, 1995, AM J RESP CELL MOL, V12, P597, DOI 10.1165/ajrcmb.12.6.7766424; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Stege G, 2003, PEDIATRICS, V112, P532, DOI 10.1542/peds.112.3.532; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; TENBRINCK R, 1990, J PEDIATR SURG, V25, P426, DOI 10.1016/0022-3468(90)90386-N; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Walter EC, 2009, AM J RESP CRIT CARE, V180, P176, DOI 10.1164/rccm.200901-0046OC; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200	47	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14171	10.1371/journal.pone.0014171	http://dx.doi.org/10.1371/journal.pone.0014171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152393	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100047
J	Corbett, NP; Blimkie, D; Ho, KC; Cai, B; Sutherland, DP; Kallos, A; Crabtree, J; Rein-Weston, A; Lavoie, PM; Turvey, SE; Hawkins, NR; Self, SG; Wilson, CB; Hajjar, AM; Fortuno, ES; Kollmann, TR				Corbett, Nathan P.; Blimkie, Darren; Ho, Kevin C.; Cai, Bing; Sutherland, Darren P.; Kallos, Arlene; Crabtree, Juliet; Rein-Weston, Annie; Lavoie, Pascal M.; Turvey, Stuart E.; Hawkins, Natalie R.; Self, Steven G.; Wilson, Christopher B.; Hajjar, Adeline M.; Fortuno, Edgardo S., III; Kollmann, Tobias R.			Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; FLOW-CYTOMETRY; VACCINE DEVELOPMENT; HUMAN NEWBORN; AGE; BIRTH; INFECTIONS; CHILDHOOD; MIFLOWCYT; INFANT	Newborns and young infants suffer increased infectious morbidity and mortality as compared to older children and adults. Morbidity and mortality due to infection are highest during the first weeks of life, decreasing over several years. Furthermore, most vaccines are not administered around birth, but over the first few years of life. A more complete understanding of the ontogeny of the immune system over the first years of life is thus urgently needed. Here, we applied the most comprehensive analysis focused on the innate immune response following TLR stimulation over the first 2 years of life in the largest such longitudinal cohort studied to-date (35 subjects). We found that innate TLR responses (i) known to support Th17 adaptive immune responses (IL-23, IL-6) peaked around birth and declined over the following 2 years only to increase again by adulthood; (ii) potentially supporting antiviral defense (IFN-alpha) reached adult level function by 1 year of age; (iii) known to support Th1 type immunity (IL-12p70, IFN-gamma) slowly rose from a low at birth but remained far below adult responses even at 2 years of age; (iv) inducing IL-10 production steadily declined from a high around birth to adult levels by 1 or 2 years of age, and; (v) leading to production of TNF-alpha or IL-1 beta varied by stimuli. Our data contradict the notion of a linear progression from an 'immature' neonatal to a 'mature' adult pattern, but instead indicate the existence of qualitative and quantitative age-specific changes in innate immune reactivity in response to TLR stimulation.	[Corbett, Nathan P.; Blimkie, Darren; Ho, Kevin C.; Cai, Bing; Sutherland, Darren P.; Kallos, Arlene; Lavoie, Pascal M.; Turvey, Stuart E.; Fortuno, Edgardo S., III; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Crabtree, Juliet; Rein-Weston, Annie; Hajjar, Adeline M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Hawkins, Natalie R.; Self, Steven G.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Wilson, Christopher B.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of British Columbia; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Bill & Melinda Gates Foundation	Corbett, NP (corresponding author), Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollm@mac.com	Turvey, Stuart/HGV-1191-2022	Crabtree, Juliet/0000-0003-4921-0087; Turvey, Stuart/0000-0003-1599-1065; Hajjar, Adeline/0000-0002-4838-8070; Fortuno, Edgardo/0000-0001-5294-1679; Corbett, Nathan/0000-0002-7114-8788; Kollmann, Tobias/0000-0003-2403-9762; Lavoie, Pascal/0000-0002-2205-0362	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01 AI50023]; AllerGen NCE [07-A1A, 07-B2B]; Michael Smith Foundation for Health Research; National Sciences and Engineering Research Council; Burroughs Wellcome Fund; Canadian Institutes of Health Research; SickKids Foundation; Child & Family Research Institute; Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050023] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AllerGen NCE; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SickKids Foundation; Child & Family Research Institute; Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a National Institute of Allergy and Infectious Diseases, National Institutes of Health Grant number: N01 AI50023 (http://www.nih.gov), AllerGen NCE Grant numbers: 07-A1A, 07-B2B (http://www.allergen-nce.ca), the Michael Smith Foundation for Health Research (http://www.msfhr.org), and the National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca). TRK is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (http://www.bwfund.org), and by a Canadian Institutes of Health Research Training Grant in the Canadian Child Health Clinician Scientist Program in partnership with SickKids Foundation, Child & Family Research Institute (BC), and Women & Children's Health Research Institute (Alberta), Manitoba Institute of Child Health (http://cchcsp.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Blimkie D, 2010, CYTOM PART A, V77A, P546, DOI 10.1002/cyto.a.20862; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kato K, 1935, J PEDIATR-US, V7, P7, DOI 10.1016/S0022-3476(35)80143-1; Klein J.O., 2006, CURRENT CONCEPTS INF; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lewis D. B., 2006, INFECT DIS FETUS NEW, P25; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Schultz C, 2002, CLIN DIAGN LAB IMMUN, V9, P295, DOI 10.1128/CDLI.9.2.295-298.2002; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	36	125	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15041	10.1371/journal.pone.0015041	http://dx.doi.org/10.1371/journal.pone.0015041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152080	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100053
J	Raghavan, K; Ruskin, HJ; Perrin, D; Goasmat, F; Burns, J				Raghavan, Karthika; Ruskin, Heather J.; Perrin, Dimitri; Goasmat, Francois; Burns, John			Computational Micromodel for Epigenetic Mechanisms	PLOS ONE			English	Article							HISTONE-MODIFICATION; METHYLATION; CANCER; ACETYLATION	Characterization of the epigenetic profile of humans since the initial breakthrough on the human genome project has strongly established the key role of histone modifications and DNA methylation. These dynamic elements interact to determine the normal level of expression or methylation status of the constituent genes in the genome. Recently, considerable evidence has been put forward to demonstrate that environmental stress implicitly alters epigenetic patterns causing imbalance that can lead to cancer initiation. This chain of consequences has motivated attempts to computationally model the influence of histone modification and DNA methylation in gene expression and investigate their intrinsic interdependency. In this paper, we explore the relation between DNA methylation and transcription and characterize in detail the histone modifications for specific DNA methylation levels using a stochastic approach.	[Raghavan, Karthika; Ruskin, Heather J.; Perrin, Dimitri; Goasmat, Francois] Dublin City Univ, Ctr Sci Comp & Complex Syst Modeling, Dublin 9, Ireland; [Burns, John] Inst Technol, Tallaght, Ireland	Dublin City University; Institute of Technology Tralee; Technological University Dublin	Raghavan, K (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modeling, Dublin 9, Ireland.	kaghavan@computing.dcu.ie	Perrin, Dimitri/H-8630-2013	Perrin, Dimitri/0000-0002-4007-5256; Burns, John/0000-0001-9194-4995; Burns, John/0000-0003-2701-4229	Science Foundation Ireland [07/RFP/CMSR724]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Financial support from Science Foundation Ireland (Research Frontiers Programme 07/RFP/CMSR724) is warmly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIS C.D., 2007, EPIGENETICS; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; DOERFLER W, 1990, FEBS LETT, V268, P329, DOI 10.1016/0014-5793(90)81280-2; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JUNG I, 2009, IBC, V1, P1; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Perrin D, 2008, ERCIM NEWS, P46; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Sun JM, 2007, NUCLEIC ACIDS RES, V35, P6640, DOI 10.1093/nar/gkm737; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; Turner B., 2001, CHROMATIN GENE REGUL; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang LW, 2007, J PROTEOME RES, V6, P81, DOI 10.1021/pr060139u	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14031	10.1371/journal.pone.0014031	http://dx.doi.org/10.1371/journal.pone.0014031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152421	gold, Green Submitted, Green Published			2022-12-25	WOS:000284755100004
J	Yang, C; McCoy, K; Davis, JL; Schmidt-Supprian, M; Sasaki, Y; Faccio, R; Novack, DV				Yang, Chang; McCoy, Kathleen; Davis, Jennifer L.; Schmidt-Supprian, Marc; Sasaki, Yoshiteru; Faccio, Roberta; Novack, Deborah Veis			NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; TUMOR-NECROSIS-FACTOR; CELL-DIFFERENTIATION; MULTIPLE-MYELOMA; MICE; ACTIVATION; PATHWAY; INDUCTION; LIGAND	Background: Maintenance of healthy bone requires the balanced activities of osteoclasts (OCs), which resorb bone, and osteoblasts, which build bone. Disproportionate action of OCs is responsible for the bone loss associated with postmenopausal osteoporosis and rheumatoid arthritis. NF-kappa B inducing kinase (NIK) controls activation of the alternative NF-kappa B pathway, a critical pathway for OC differentiation. Under basal conditions, TRAF3-mediated NIK degradation prevents downstream signaling, and disruption of the NIK: TRAF3 interaction stabilizes NIK leading to constitutive activation of the alternative NF-kappa B pathway. Methodology/Principal Findings: Using transgenic mice with OC-lineage expression of NIK lacking its TRAF3 binding domain (NT3), we now find that alternative NF-kappa B activation enhances not only OC differentiation but also OC function. Activating NT3 with either lysozyme M Cre or cathepsinK Cre causes high turnover osteoporosis with increased activity of OCs and osteoblasts. In vitro, NT3-expressing precursors form OCs more quickly and at lower doses of RANKL. When cultured on bone, they exhibit larger actin rings and increased resorptive activity. OC-specific NT3 transgenic mice also have an exaggerated osteolytic response to the serum transfer model of arthritis. Conclusions: Constitutive activation of NIK drives enhanced osteoclastogenesis and bone resorption, both in basal conditions and in response to inflammatory stimuli.	[Yang, Chang; McCoy, Kathleen; Davis, Jennifer L.; Novack, Deborah Veis] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA; [Novack, Deborah Veis] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Faccio, Roberta] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63110 USA; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sasaki, Yoshiteru] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Max Planck Society; RIKEN	Yang, C (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA.	novack@wustl.edu	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Novack, Deborah/0000-0001-7101-5582	National Institutes of Health (NIH) [AR052705, EB007568, AR52921, 63181]; Barnes-Jewish Foundation; Children's Discovery Institute; Arthritis Foundation; Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR057235]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053628, R01AR052705, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007568] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Foundation; Children's Discovery Institute; Arthritis Foundation; Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by the National Institutes of Health (NIH), grant numbers AR052705 and EB007568 (DVN) and AR52921 and 63181 (RF), the Barnes-Jewish Foundation (DVN), the Children's Discovery Institute (RF and DVN), and the Arthritis Foundation (RF). Histological and microCT analysis was supported in part by the Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), grant number AR057235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Iwasawa M, 2009, J CLIN INVEST, V119, P3149, DOI 10.1172/JCI39819; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nadiminty N, 2007, BIOCHEM BIOPH RES CO, V359, P379, DOI 10.1016/j.bbrc.2007.05.119; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; NOVACK DV, 2009, AGEING RES REV; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; YAMADA H, 1991, BLOOD, V78, P1988; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	34	103	118	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15383	10.1371/journal.pone.0015383	http://dx.doi.org/10.1371/journal.pone.0015383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21151480	Green Published, gold, Green Submitted			2022-12-25	WOS:000283920000021
J	Jan, A; Adolfsson, O; Allaman, I; Buccarello, AL; Magistretti, PJ; Pfeifer, A; Muhs, A; Lashuel, HA				Jan, Asad; Adolfsson, Oskar; Allaman, Igor; Buccarello, Anna-Lucia; Magistretti, Pierre J.; Pfeifer, Andrea; Muhs, Andreas; Lashuel, Hilal A.			A beta 42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete A beta 42 Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE INHIBITOR; INSULIN-DEGRADING ENZYME; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; PLAQUE-FORMATION; MOUSE MODEL; PEPTIDE	The identification of toxic A beta species and/or the process of their formation is crucial for understanding the mechanism(s) of A beta neurotoxicity in Alzheimer disease and also for the development of effective diagnostic and therapeutic interventions. To elucidate the structural basis of A beta toxicity, we developed different procedures to isolate A beta species of defined size and morphology distribution, and we investigated their toxicity in different cell lines and primary neurons. We observed that crude A beta 42 preparations, containing a monomeric and heterogeneous mixture of A beta 42 oligomers, were more toxic than purified monomeric, protofibrillar fractions, or fibrils. The toxicity of protofibrils was directly linked to their interactions with monomeric A beta 42 and strongly dependent on their ability to convert into amyloid fibrils. Subfractionation of protofibrils diminished their fibrillization and toxicity, whereas reintroduction of monomeric A beta 42 into purified protofibril fractions restored amyloid formation and enhanced their toxicity. Selective removal of monomeric A beta 42 from these preparations, using insulin-degrading enzyme, reversed the toxicity of A beta 42 protofibrils. Together, our findings demonstrate that A beta 42 toxicity is not linked to specific prefibrillar aggregate(s) but rather to the ability of these species to grow and undergo fibril formation, which depends on the presence of monomeric A beta 42. These findings contribute significantly to the understanding of amyloid formation and toxicity in Alzheimer disease, provide novel insight into mechanisms of A beta protofibril toxicity, and important implications for designing anti-amyloid therapies.	[Jan, Asad; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Adolfsson, Oskar; Buccarello, Anna-Lucia; Pfeifer, Andrea; Muhs, Andreas] Ecole Polytech Fed Lausanne, AC Immune, PSE B, CH-1015 Lausanne, Switzerland; [Allaman, Igor; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Jan, Asad/AAZ-2920-2021; Lashuel, Hilal/M-3500-2017; Jan, Asad/D-4389-2009; Allaman, Igor/R-8092-2016	Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; Allaman, Igor/0000-0002-7525-0536; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss Federal Institute of Technology Lausanne; Swiss National Foundation [310000-110027]	Swiss Federal Institute of Technology Lausanne; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss Federal Institute of Technology Lausanne and Grant 310000-110027 from the Swiss National Foundation.	Aisen PS, 2007, CURR ALZHEIMER RES, V4, P473, DOI 10.2174/156720507781788882; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Glenner G G, 1984, Appl Pathol, V2, P357; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D M, 1998, Methods Mol Biol, V79, P179; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SISODIA SS, 1992, ANN NY ACAD SCI, V674, P53, DOI 10.1111/j.1749-6632.1992.tb27476.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	60	153	155	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8585	8596		10.1074/jbc.M110.172411	http://dx.doi.org/10.1074/jbc.M110.172411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21156804	Green Published, hybrid			2022-12-25	WOS:000288013300085
J	Vionnet, C; Roubaty, C; Ejsing, CS; Knudsen, J; Conzelmann, A				Vionnet, Christine; Roubaty, Carole; Ejsing, Christer S.; Knudsen, Jens; Conzelmann, Andreas			Yeast Cells Lacking All Known Ceramide Synthases Continue to Make Complex Sphingolipids and to Incorporate Ceramides into Glycosylphosphatidylinositol (GPI) Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; CHAIN FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HEAT-STRESS; ENDOPLASMIC-RETICULUM; SPHINGOID BASE; AUR1 GENE; PROTEINS; AUREOBASIDIN	In yeast, the inositolphosphorylceramides mostly contain C26:0 fatty acids. Inositolphosphorylceramides were considered to be important for viability because the inositolphosphorylceramide synthase AUR1 is essential. However, lcb1 Delta cells, unable to make sphingoid bases and inositolphosphorylceramides, are viable if they harbor SLC1-1, a gain of function mutation in the 1-acyl-glycerol-3-phosphate acyltransferase SLC1. SLC1-1 allows the incorporation of C26:0 fatty acids into phosphatidylinositol (PI), thus generating PI '', an abnormal, C26-containing PI, presumably acting as surrogate for inositolphosphorylceramide. Here we show that the lethality of the simultaneous deletion of the known ceramide synthases LAG1/LAC1/LIP1 and YPC1/YDC1 can be rescued by the expression of SLC1-1 or the overexpression of AUR1. Moreover, lag1 Delta lac1 Delta ypc1 Delta ydc1 Delta (4 Delta) quadruple mutants have been reported to be viable in certain genetic backgrounds but to still make some abnormal uncharacterized inositol-containing sphingolipids. Indeed, we find that 4 Delta quadruple mutants make substantial amounts of unphysiological inositolphosphorylphytosphingosines but that they also still make small amounts of normal inositolphosphorylceramides. Moreover, 4 Delta strains incorporate exogenously added sphingoid bases into inositolphosphorylceramides, indicating that these cells still possess an unknown pathway allowing the synthesis of ceramides. 4 Delta cells also still add quite normal amounts of ceramides to glycosylphosphatidylinositol anchors. Synthesis of inositolphosphorylceramides and inositolphosphorylphytosphingosines is operated by Aur1p and is essential for growth of all 4 Delta cells unless they contain SLC1-1. PI '', however, is made without the help of Aur1p. Furthermore, mannosylation of PI '' is required for the survival of sphingolipid-deficient strains, which depend on SLC1-1. In contrast to lcb1 Delta SLC1-1, 4 Delta SLC1-1 cells grow at 37 degrees C but remain thermosensitive at 44 degrees C.	[Vionnet, Christine; Roubaty, Carole; Conzelmann, Andreas] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; [Ejsing, Christer S.; Knudsen, Jens] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Fribourg; University of Southern Denmark	Conzelmann, A (corresponding author), Univ Fribourg, Dept Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	Swiss National Science Foundation [31-67188.01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31-67188.01 from the Swiss National Science Foundation.	Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Ghugtyal V, 2007, MOL MICROBIOL, V65, P1493, DOI 10.1111/j.1365-2958.2007.05883.x; Guillas I, 2000, METHOD ENZYMOL, V312, P506; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; HANSON BA, 1980, J LIPID RES, V21, P309; HashidaOkado T, 1996, MOL GEN GENET, V251, P236; Hearn JD, 2003, J BIOL CHEM, V278, P3679, DOI 10.1074/jbc.M209170200; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; LESTER RL, 1993, J BIOL CHEM, V268, P845; Lisman Q, 2004, J BIOL CHEM, V279, P1020, DOI 10.1074/jbc.M306119200; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mir SS, 2009, MOL CELL BIOL, V29, P187, DOI 10.1128/MCB.02271-07; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Pittet M, 2006, GLYCOBIOLOGY, V16, P155, DOI 10.1093/glycob/cwj043; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Thevissen K, 2005, FEBS LETT, V579, P1973, DOI 10.1016/j.febslet.2005.02.043; Uemura S, 2003, J BIOL CHEM, V278, P45049, DOI 10.1074/jbc.M305498200; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zhu YH, 2006, J BIOL CHEM, V281, P19830, DOI 10.1074/jbc.M601425200	59	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6769	6779		10.1074/jbc.M110.176875	http://dx.doi.org/10.1074/jbc.M110.176875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173150	hybrid, Green Published			2022-12-25	WOS:000287476400084
J	Yadav, S; Aneja, R; Kumar, P; Datt, M; Sinha, S; Sahni, G				Yadav, Suman; Aneja, Rachna; Kumar, Prakash; Datt, Manish; Sinha, Sonali; Sahni, Girish			Identification through Combinatorial Random and Rational Mutagenesis of a Substrate-interacting Exosite in the gamma Domain of Streptokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CHLOROMETHYL KETONES; BLOOD-COAGULATION PROTEINASES; PLASMINOGEN-ACTIVATOR COMPLEX; MACROMOLECULAR SUBSTRATE; FLUORESCENCE PROBES; CATALYTIC DOMAIN; RECOMBINANT STAPHYLOKINASE; CONFORMATIONAL ACTIVATION; AFFINITY-CHROMATOGRAPHY; SPECTROSCOPIC PROBES	To identify new structure-function correlations in the gamma domain of streptokinase, mutants were generated by error-prone random mutagenesis of the gamma domain and its adjoining region in the beta domain followed by functional screening specifically for substrate plasminogen activation. Single-site mutants derived from various multipoint mutation clusters identified the importance of discrete residues in the gamma domain that are important for substrate processing. Among the various residues, aspartate at position 328 was identified as critical for substrate human plasminogen activation through extensive mutagenesis of its side chain, namely D328R, D328H, D328N, and D328A. Other mutants found to be important in substrate plasminogen activation were, namely, R319H, N339S, K334A, K334E, and L335Q. When examined for their 1:1 interaction with human plasmin, these mutants were found to retain the native-like high affinity for plasmin and also to generate amidolytic activity with partner plasminogen in a manner similar to wild type streptokinase. Moreover, cofactor activities of the mutants precomplexed with plasmin against microplasminogen as the substrate as well as in silico modeling studies suggested that the region 315-340 of the gamma domain interacts with the serine protease domain of the macromolecular substrate. Overall, our results identify the presence of a substrate specific exosite in the gamma domain of streptokinase.	[Yadav, Suman; Aneja, Rachna; Kumar, Prakash; Datt, Manish; Sinha, Sonali; Sahni, Girish] Inst Microbial Technol, CSIR, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), Inst Microbial Technol, CSIR, Sector 39-A, Chandigarh 160036, India.	sahni@imtech.res.in	Datt, Manish/AAD-6989-2019; Sinha, Prakash Kumar/K-6048-2013	Sinha, Prakash Kumar/0000-0002-2067-5676; Datt, Manish/0000-0002-9578-4113	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was largely supported with intramural funds from the Council of Scientific and Industrial Research, India.	Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; BAJAJ AP, 1977, J BIOL CHEM, V252, P492; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; COLLEN D, 1993, EUR J BIOCHEM, V216, P307, DOI 10.1111/j.1432-1033.1993.tb18147.x; COLLEN D, 1993, J BIOL CHEM, V268, P8284; Dahiya M, 2005, FEBS LETT, V579, P1565, DOI 10.1016/j.febslet.2005.01.066; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAWSON KM, 1994, BIOCHEMISTRY-US, V33, P12042, DOI 10.1021/bi00206a005; DERENZO EC, 1967, J BIOL CHEM, V242, P533; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; Fay WP, 1998, THROMB HAEMOSTASIS, V79, P985; HUANG TT, 1989, MOL MICROBIOL, V3, P197, DOI 10.1111/j.1365-2958.1989.tb01808.x; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Jespers L, 1998, BIOCHEMISTRY-US, V37, P6380, DOI 10.1021/bi972807i; Kim DM, 2002, BIOCHEM BIOPH RES CO, V290, P585, DOI 10.1006/bbrc.2001.6238; Lin LF, 1996, BIOCHEMISTRY-US, V35, P16879, DOI 10.1021/bi961531w; MALKE H, 1984, MOL GEN GENET, V196, P360, DOI 10.1007/BF00328072; MALKE H, 1984, P NATL ACAD SCI-BIOL, V81, P3557, DOI 10.1073/pnas.81.11.3557; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Mundada LV, 2003, J BIOL CHEM, V278, P24421, DOI 10.1074/jbc.M301825200; Nihalani D, 1997, PROTEIN SCI, V6, P1284, DOI 10.1002/pro.5560060616; Nihalani D, 1995, BIOCHEM BIOPH RES CO, V217, P1245, DOI 10.1006/bbrc.1995.2902; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; Parrado J, 1996, PROTEIN SCI, V5, P693; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Pratap J, 1996, BIOCHEM BIOPH RES CO, V227, P303, DOI 10.1006/bbrc.1996.1504; RADEK JT, 1989, J BIOL CHEM, V264, P9915; RADEK JT, 1993, METHOD ENZYMOL, V223, P145; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; ROBBINS KC, 1981, METHOD ENZYMOL, V80, P379; ROBBINS KC, 1983, THROMB HAEMOSTASIS, V50, P787; RODRIGUEZ P, 1995, EUR J BIOCHEM, V229, P83, DOI 10.1111/j.1432-1033.1995.tb20441.x; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; SCHICK LA, 1973, BIOCHEMISTRY-US, V12, P4315, DOI 10.1021/bi00746a003; SUMMARIA L, 1982, BIOCHEMISTRY-US, V21, P2056, DOI 10.1021/bi00538a012; Sundram V, 2003, J BIOL CHEM, V278, P30569, DOI 10.1074/jbc.M303799200; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1984, BIOCHEMISTRY-US, V23, P3799, DOI 10.1021/bi00312a002; Wu DH, 2001, J BIOL CHEM, V276, P15025, DOI 10.1074/jbc.M005935200; Yadav S, 2008, BBA-PROTEINS PROTEOM, V1784, P1310, DOI 10.1016/j.bbapap.2008.05.013; YOUNG KC, 1995, J BIOL CHEM, V270, P29601, DOI 10.1074/jbc.270.49.29601	68	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6458	6469		10.1074/jbc.M110.152355	http://dx.doi.org/10.1074/jbc.M110.152355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169351	Green Published, hybrid			2022-12-25	WOS:000287476400056
J	Arnold, SEJ; Faruq, S; Savolainen, V; McOwan, PW; Chittka, L				Arnold, Sarah E. J.; Faruq, Samia; Savolainen, Vincent; McOwan, Peter W.; Chittka, Lars			FReD: The Floral Reflectance Database - A Web Portal for Analyses of Flower Colour	PLOS ONE			English	Article							INSECT POLLINATORS; VISUAL-SYSTEM; VISION; COMMUNITIES; ANTIRRHINUM; ULTRAVIOLET; GRASSLAND; PHENOLOGY; HONEYBEE; SIGNALS	Background: Flower colour is of great importance in various fields relating to floral biology and pollinator behaviour. However, subjective human judgements of flower colour may be inaccurate and are irrelevant to the ecology and vision of the flower's pollinators. For precise, detailed information about the colours of flowers, a full reflectance spectrum for the flower of interest should be used rather than relying on such human assessments. Methodology/Principal Findings: The Floral Reflectance Database (FReD) has been developed to make an extensive collection of such data available to researchers. It is freely available at http://www.reflectance.co.uk. The database allows users to download spectral reflectance data for flower species collected from all over the world. These could, for example, be used in modelling interactions between pollinator vision and plant signals, or analyses of flower colours in various habitats. The database contains functions for calculating flower colour loci according to widely-used models of bee colour space, reflectance graphs of the spectra and an option to search for flowers with similar colours in bee colour space. Conclusions/Significance: The Floral Reflectance Database is a valuable new tool for researchers interested in the colours of flowers and their association with pollinator colour vision, containing raw spectral reflectance data for a large number of flower species.	[Arnold, Sarah E. J.; Chittka, Lars] Queen Mary Univ London, Res Ctr Psychol, Sch Biol & Chem Sci, London, England; [Faruq, Samia; McOwan, Peter W.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Savolainen, Vincent] Imperial Coll London, Ascot, Berks, England; [Savolainen, Vincent] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Royal Botanic Gardens, Kew	Arnold, SEJ (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, England.	l.chittka@qmul.ac.uk	Arnold, Sarah/H-6490-2019; Chittka, Lars/C-3110-2012	Arnold, Sarah/0000-0001-7345-0529; Chittka, Lars/0000-0001-8153-1732; Savolainen, Vincent/0000-0001-5350-9984	Biotechnology and Biological Sciences Research Council [BBS/S/L/2005/12155A]; Royal Botanic Gardens, Kew; Royal Society; Natural Environment Research Council [NE/F002769/1] Funding Source: researchfish; NERC [NE/F002769/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Botanic Gardens, Kew; Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge the following funding sources: A studentship from the Biotechnology and Biological Sciences Research Council (BBS/S/L/2005/12155A) to SEJA with support from the Royal Botanic Gardens, Kew and The Royal Society Wolfson Award to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA K, 1987, NATURWISSENSCHAFTEN, V74, P297, DOI 10.1007/BF00366422; Arnold SEJ, 2009, ISR J PLANT SCI, V57, P211, DOI 10.1560/IJPS.57.3.211; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; BACKHAUS W, 1987, BIOL CYBERN, V55, P321, DOI 10.1007/BF02281978; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Chittka L., 2005, PRACTICAL POLLINATIO, P157; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; de Ibarra NH, 2009, J COMP PHYSIOL A, V195, P319, DOI 10.1007/s00359-009-0412-0; Dyer AG, 1996, AUST J BOT, V44, P473, DOI 10.1071/BT9960473; FRANTS VI, 1991, J AM SOC INFORM SCI, V42, P16, DOI 10.1002/(SICI)1097-4571(199101)42:1<16::AID-ASI3>3.0.CO;2-I; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; Kevan P.G., 1983, P3; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; KEVAN PG, 1972, CAN J BOTANY, V50, P2289, DOI 10.1139/b72-298; KEVAN PG, 1978, LINNEAN SOC S SERIES, V6, P51; LUNAU K, 1990, J COMP PHYSIOL A, V166, P827; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; MALONEY LT, 1986, J OPT SOC AM A, V3, pP43; MCCANN M T, 1986, Michigan Botanist, V25, P66; Menzel R., 1989, P281; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; MENZEL R, 1983, J COMP PHYSIOL, V151, P441, DOI 10.1007/BF00605460; MENZEL R, 1990, COLOR VISION FLOWER; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PENNY JHJ, 1983, NEW PHYTOL, V95, P707, DOI 10.1111/j.1469-8137.1983.tb03534.x; Proctor M., 1996, NATURAL HIST POLLINA; Tastard E, 2008, ARTHROPOD-PLANT INTE, V2, P237, DOI 10.1007/s11829-008-9046-3; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P103, DOI 10.1080/07929978.1997.10676677; Warren J, 2005, GRASS FORAGE SCI, V60, P332, DOI 10.1111/j.1365-2494.2005.00482.x; Waser N.M., 1983, P241; WEEVERS T, 1952, ACTA BOT NEERL, V1, P81; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	40	77	79	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14287	10.1371/journal.pone.0014287	http://dx.doi.org/10.1371/journal.pone.0014287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170326	Green Accepted, gold, Green Published			2022-12-25	WOS:000285181400010
J	Chattopadhyay, R; Velmurugan, S; Chakiath, C; Donkor, LA; Milhous, W; Barnwell, JW; Collins, WE; Hoffman, SL				Chattopadhyay, Rana; Velmurugan, Soundarapandian; Chakiath, Chinnamma; Donkor, Lucy Andrews; Milhous, Wilbur; Barnwell, John W.; Collins, William E.; Hoffman, Stephen L.			Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria	PLOS ONE			English	Article							EXOERYTHROCYTIC PARASITES; MOLECULAR ANALYSIS; PRIMAQUINE; RELAPSES; HYPNOZOITES; ANTIBODIES; FALCIPARUM; CULTURE; VACCINE; STRAIN	Plasmodium vivax (Pv) is the second most important human malaria parasite. Recent data indicate that the impact of Pv malaria on the health and economies of the developing world has been dramatically underestimated. Pv has a unique feature in its life cycle. Uninucleate sporozoites (spz), after invasion of human hepatocytes, either proceed to develop into tens of thousands of merozoites within the infected hepatocytes or remain as dormant forms called hypnozoites, which cause relapses of malaria months to several years after the primary infection. Elimination of malaria caused by Pv will be facilitated by developing a safe, highly effective drug that eliminates Pv liver stages, including hypnozoites. Identification and development of such a drug would be facilitated by the development of a medium to high throughput assay for screening drugs against Pv liver stages. We undertook the present pilot study to (1) assess the feasibility of producing large quantities of purified, vialed, cryopreserved Pv sporozoites and (2) establish a system for culturing the liver stages of Pv in order to assess the effects of drugs on the liver stages of Pv. We used primaquine (PQ) to establish this assay model, because PQ is the only licensed drug known to clear all Pv hepatocyte stages, including hypnozoites, and the effect of PQ on Pv hepatocyte stage development in vitro has not previously been reported. We report that we have established the capacity to reproducibly infect hepatoma cells with purified, cyropreserved Pv spz from the same lot, quantitate the primary outcome variable of infected hepatoma cells and demonstrate the inhibitory activity of primaquine on the infected hepatoma cells. We have also identified small parasite forms that may be hypnozoites. These data provide the foundation for finalizing a medium throughput, high content assay to identify new drugs for the elimination of all Pv liver stages.	[Chattopadhyay, Rana; Velmurugan, Soundarapandian; Chakiath, Chinnamma; Donkor, Lucy Andrews; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Milhous, Wilbur] Walter Reed Army Inst Res, Silver Spring, MD USA; [Barnwell, John W.; Collins, William E.] Ctr Dis Control & Prevent, CDC NCID Malaria Branch, Natl Ctr Infect Dis, Chamblee, GA USA	Sanaria Inc.; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA	Chattopadhyay, R (corresponding author), Sanaria Inc, Rockville, MD USA.	slhoffman@sanaria.com	Murugan, Vel/AAX-9679-2020; Murugan, Vel/AAA-3554-2019	Murugan, Vel/0000-0002-7368-7742; 	Sanaria; Medicine for Malaria Venture	Sanaria; Medicine for Malaria Venture	Funding for this project was provided by a grant by Sanaria (www.sanaria.com) and Medicine for Malaria Venture (www.mmv.org). Sanaria, a for-profit organization, played a critical role in design, execution, analysis and publication of this work. MMV, a not-for-profit public-private partnership, participated in study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY SB, 1987, EXP PARASITOL, V64, P188, DOI 10.1016/0014-4894(87)90142-1; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; BATES MD, 1990, AM J TROP MED HYG, V42, P532, DOI 10.4269/ajtmh.1990.42.532; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; Kitchener S, 2007, AM J TROP MED HYG, V76, P494, DOI 10.4269/ajtmh.2007.76.494; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P1291, DOI 10.4269/ajtmh.1982.31.1291; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Roberts L, 2008, SCIENCE, V322, P26, DOI 10.1126/science.322.5898.26; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Sharma A, 2009, J VECTOR DIS, V46, P141; Sina Barbara, 2002, Trends in Parasitology, V18, P287, DOI 10.1016/S1471-4922(02)02329-2; Smoak BL, 1997, AM J TROP MED HYG, V56, P231, DOI 10.4269/ajtmh.1997.56.231; Sullivan JS, 2001, J PARASITOL, V87, P1398, DOI 10.1645/0022-3395(2001)087[1398:AOASOP]2.0.CO;2; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; World Health Organization, 2008, WORLD MAL REP	28	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14275	10.1371/journal.pone.0014275	http://dx.doi.org/10.1371/journal.pone.0014275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151554	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800008
J	Borges, TJ; Porto, BN; Teixeira, CA; Rodrigues, M; Machado, FD; Ornaghi, AP; de Souza, APD; Maito, F; Pavanelli, WR; Silva, JS; Bonorino, C				Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Pavanelli, Wander R.; Silva, Joao S.; Bonorino, Cristina			Prolonged Survival of Allografts Induced by Mycobacterial Hsp70 Is Dependent on CD4+CD25+Regulatory T Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DENDRITIC CELLS; ADJUVANT ARTHRITIS; INTERLEUKIN-10 PRODUCTION; ORGAN-TRANSPLANTATION; LYMPH-NODES; ANTIGEN; HEAT-SHOCK-PROTEIN-70; PROLIFERATION; TUBERCULOSIS	Background: Heat shock proteins (Hsps) are stress induced proteins with immunomodulatory properties. The Hsp70 of Mycobacterium tuberculosis (TBHsp70) has been shown to have an anti-inflammatory role on rodent autoimmune arthritis models, and the protective effects were demonstrated to be dependent on interleukin-10 (IL-10). We have previously observed that TBHsp70 inhibited maturation of dendritic cells (DCs) and induced IL-10 production by these cells, as well as in synovial fluid cells. Methodology/Principal Findings: We investigated if TBHsp70 could inhibit allograft rejection in two murine allograft systems, a transplanted allogeneic melanoma and a regular skin allograft. In both systems, treatment with TBHsp70 significantly inhibited rejection of the graft, and correlated with regulatory T cells (Tregs) recruitment. This effect was not tumor mediated because injection of TBHsp70 in tumor-free mice induced an increase of Tregs in the draining lymph nodes as well as inhibition of proliferation of lymph node T cells and an increase in IL-10 production. Finally, TBHsp70 inhibited skin allograft acute rejection, and depletion of Tregs using a monoclonal antibody completely abolished this effect. Conclusions/Significance: We present the first evidence for an immunosuppressive role for this protein in a graft rejection system, using an innovative approach - immersion of the graft tissue in TBHsp70 solution instead of protein injection. Also, this is the first study that demonstrates dependence on Treg cells for the immunosuppressive role of TBHsp70. This finding is relevant for the elucidation of the immunomodulatory mechanism of TBHsp70. We propose that this protein can be used not only for chronic inflammatory diseases, but is also useful for organ transplantation management.	[Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Borges, Thiago J.; Porto, Barbara N.; Teixeira, Cesar A.; Rodrigues, Marcelle; Machado, Felipe D.; Ornaghi, Ana Paula; de Souza, Ana Paula D.; Maito, Fabio; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Porto Alegre, RS, Brazil; [Pavanelli, Wander R.] Univ Estadual Londrina, Dept Patol Geral, Londrina, Brazil; [Silva, Joao S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Imunol, Ribeirao Preto, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Estadual de Londrina; Universidade de Sao Paulo	Borges, TJ (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	cbonorino@pucrs.br	Duarte, Ana/S-1904-2016; Bonorino, Cristina/U-2780-2019; Borges, Thiago/Q-3711-2019; Souza, Ana/J-9534-2015; Silva, Joao/A-4484-2008; Duarte, Ana/GRT-0033-2022	Duarte, Ana/0000-0002-6021-5068; Borges, Thiago/0000-0002-6554-0169; Silva, Joao/0000-0002-3410-3927; 	Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP)	Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Souza AP, 2009, EXPERT REV ANTICANC, V9, P1317, DOI [10.1586/era.09.88, 10.1586/ERA.09.88]; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Guarrera JV, 2008, CURR OPIN ORGAN TRAN, V13, P148, DOI 10.1097/MOT.0b013e3282f63930; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Khoruts A, 2004, EUR J IMMUNOL, V34, P1085, DOI 10.1002/eji.200324170; Kim JI, 2009, AM J TRANSPLANT, V9, P2736, DOI 10.1111/j.1600-6143.2009.02847.x; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MEHLERT A, 1989, MOL MICROBIOL, V3, P125, DOI 10.1111/j.1365-2958.1989.tb01801.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Nabel GJ, 1999, NATURE, V397, P471, DOI 10.1038/17207; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Okada Y, 2009, GEN THORAC CARDIOVAS, V57, P635, DOI 10.1007/s11748-009-0492-3; Ouyang J, 2010, SCAND J IMMUNOL, V71, P336, DOI 10.1111/j.1365-3083.2010.02384.x; Prakken BJ, 2001, J IMMUNOL, V167, P4147, DOI 10.4049/jimmunol.167.8.4147; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schonder Kristine S, 2010, Paediatr Drugs, V12, P35, DOI 10.2165/11316180-000000000-00000; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; SHARMA S K, 1986, Biotechnology and Applied Biochemistry, V8, P5; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Tanaka S, 1999, J IMMUNOL, V163, P5560; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Turnquist HR, 2010, METHODS MOL BIOL, V595, P135, DOI 10.1007/978-1-60761-421-0_8; Ulmansky R, 2002, J IMMUNOL, V168, P6463, DOI 10.4049/jimmunol.168.12.6463; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Wieten L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004186; Yamagami S, 2002, CORNEA, V21, P405, DOI 10.1097/00003226-200205000-00014; Yuan XD, 2010, TRANSPL INT, V23, P561, DOI 10.1111/j.1432-2277.2009.01047.x; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013	46	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14264	10.1371/journal.pone.0014264	http://dx.doi.org/10.1371/journal.pone.0014264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170379	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100014
J	Le Blastier, S; Hamels, A; Cabeen, M; Schille, L; Tilquin, F; Dieu, M; Raes, M; Matroule, JY				Le Blastier, Sophie; Hamels, Aurore; Cabeen, Matthew; Schille, Lionel; Tilquin, Francoise; Dieu, Marc; Raes, Martine; Matroule, Jean-Yves			Phosphate Starvation Triggers Production and Secretion of an Extracellular Lipoprotein in Caulobacter crescentus	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; II SECRETION; KLEBSIELLA-PNEUMONIAE; SORTING SIGNALS; OUTER-MEMBRANE; PATHWAY; PULLULANASE	Life in oligotrophic environments necessitates quick adaptive responses to a sudden lack of nutrients. Secretion of specific degradative enzymes into the extracellular medium is a means to mobilize the required nutrient from nearby sources. The aquatic bacterium Caulobacter crescentus must often face changes in its environment such as phosphate limitation. Evidence reported in this paper indicates that under phosphate starvation, C. crescentus produces a membrane surface-anchored lipoprotein named ElpS subsequently released into the extracellular medium. A complete set of 12 genes encoding a type II secretion system (T2SS) is located adjacent to the elpS locus in the C. crescentus genome. Deletion of this T2SS impairs release of ElpS in the environment, which surprisingly remains present at the cell surface, indicating that the T2SS is not involved in the translocation of ElpS to the outer membrane but rather in its release. Accordingly, treatment with protease inhibitors prevents release of ElpS in the extracellular medium suggesting that ElpS secretion relies on a T2SS-secreted protease. Finally, secretion of ElpS is associated with an increase in alkaline phosphatase activity in culture supernatants, suggesting a role of the secreted protein in inorganic phosphate mobilization. In conclusion, we have shown that upon phosphate starvation, C. crescentus produces an outer membrane bound lipoprotein, ElpS, which is further cleaved and released in the extracellular medium in a T2SS-dependent manner. Our data suggest that ElpS is associated with an alkaline phosphatase activity, thereby allowing the bacterium to gather inorganic phosphates from a poor environment.	[Le Blastier, Sophie; Hamels, Aurore; Schille, Lionel; Tilquin, Francoise; Matroule, Jean-Yves] Univ Namur, Unite Rech Biol Mol, Namur, Belgium; [Cabeen, Matthew] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Dieu, Marc; Raes, Martine] Univ Namur, Unite Rech Biol Cellulaire, Namur, Belgium	University of Namur; Yale University; University of Namur	Le Blastier, S (corresponding author), Univ Namur, Unite Rech Biol Mol, Namur, Belgium.	jean-yves.matroule@fundp.ac.be		Dieu, Marc/0000-0002-3902-542X	University of Namur; FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium)	University of Namur; FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the University of Namur and by an FRS-FNRS (Fond National pour la Recherche Scientifique, Belgium) research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Cavard D, 2002, J BACTERIOL, V184, P3723, DOI 10.1128/JB.184.13.3723-3733.2002; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Corbett M, 2005, MOL PLANT MICROBE IN, V18, P334, DOI 10.1094/MPMI-18-0334; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; DENFERT C, 1987, MOL MICROBIOL, V1, P107, DOI 10.1111/j.1365-2958.1987.tb00534.x; DeShazer D, 1999, J BACTERIOL, V181, P4661, DOI 10.1128/JB.181.15.4661-4664.1999; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Lewenza S, 2008, J BACTERIOL, V190, P6119, DOI 10.1128/JB.00603-08; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Parche S, 1997, J BACTERIOL, V179, P4631, DOI 10.1128/jb.179.14.4631-4634.1997; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; POINDEXTER JS, 1984, ARCH MICROBIOL, V138, P140, DOI 10.1007/BF00413014; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; POQUET I, 1993, MOL MICROBIOL, V9, P1061, DOI 10.1111/j.1365-2958.1993.tb01235.x; PUGSLEY AP, 1986, J BACTERIOL, V166, P1083, DOI 10.1128/jb.166.3.1083-1088.1986; PUGSLEY AP, 1991, J BIOL CHEM, V266, P13640; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rittmann D, 2005, APPL ENVIRON MICROB, V71, P4339, DOI 10.1128/AEM.71.8.4339-4344.2005; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Roussel-Jazede V, 2010, INFECT IMMUN, V78, P3083, DOI 10.1128/IAI.01193-09; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; SCHMIDT JM, 1969, J BACTERIOL, V98, P816, DOI 10.1128/JB.98.2.816-817.1969; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tjalsma H, 1999, J BIOL CHEM, V274, P1698, DOI 10.1074/jbc.274.3.1698; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; WILLSKY GR, 1976, J BACTERIOL, V127, P595, DOI 10.1128/JB.127.1.595-609.1976	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14198	10.1371/journal.pone.0014198	http://dx.doi.org/10.1371/journal.pone.0014198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152032	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000012
J	Malinowska, M; Wilkinson, FL; Langford-Smith, KJ; Langford-Smith, A; Brown, JR; Crawford, BE; Vanier, MT; Grynkiewicz, G; Wynn, RF; Wraith, JE; Wegrzyn, G; Bigger, BW				Malinowska, Marcelina; Wilkinson, Fiona L.; Langford-Smith, Kia J.; Langford-Smith, Alex; Brown, Jillian R.; Crawford, Brett E.; Vanier, Marie T.; Grynkiewicz, Grzegorz; Wynn, Rob F.; Wraith, J. Ed; Wegrzyn, Grzegorz; Bigger, Brian W.			Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease	PLOS ONE			English	Article							SUBSTRATE REDUCTION THERAPY; ENZYME REPLACEMENT THERAPY; N-BUTYLDEOXYNOJIRIMYCIN; SANFILIPPO-SYNDROME; CHRONIC SAFETY; IIIB; PROTEIN; RATS; MICE; ACTIVATION	Background: Neurodegenerative metabolic disorders such as mucopolysaccharidosis IIIB (MPSIIIB or Sanfilippo disease) accumulate undegraded substrates in the brain and are often unresponsive to enzyme replacement treatments due to the impermeability of the blood brain barrier to enzyme. MPSIIIB is characterised by behavioural difficulties, cognitive and later motor decline, with death in the second decade of life. Most of these neurodegenerative lysosomal storage diseases lack effective treatments. We recently described significant reductions of accumulated heparan sulphate substrate in liver of a mouse model of MPSIIIB using the tyrosine kinase inhibitor genistein. Methodology/Principal Findings: We report here that high doses of genistein aglycone, given continuously over a 9 month period to MPSIIIB mice, significantly reduce lysosomal storage, heparan sulphate substrate and neuroinflammation in the cerebral cortex and hippocampus, resulting in correction of the behavioural defects observed. Improvements in synaptic vesicle protein expression and secondary storage in the cerebral cortex were also observed. Conclusions/Significance: Genistein may prove useful as a substrate reduction agent to delay clinical onset of MPSIIIB and, due to its multimodal action, may provide a treatment adjunct for several other neurodegenerative metabolic diseases.	[Malinowska, Marcelina; Wilkinson, Fiona L.; Langford-Smith, Kia J.; Langford-Smith, Alex; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Mucopolysaccharidosis MPS Stem Cell Res Grp, Manchester, Lancs, England; [Malinowska, Marcelina; Wegrzyn, Grzegorz] Univ Gdansk, Fac Biol, Dept Mol Biol, PL-80952 Gdansk, Poland; [Brown, Jillian R.; Crawford, Brett E.] Zacharon Pharmaceut Inc, San Diego, CA USA; [Vanier, Marie T.] Lyon Univ, Unit 820, INSERM, Lyon, France; [Grynkiewicz, Grzegorz] Pharmaceut Res Inst, Warsaw, Poland; [Wynn, Rob F.; Bigger, Brian W.] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Bone Marrow Transplant Unit, Manchester, Lancs, England; [Wraith, J. Ed] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Fahrenheit Universities; University of Gdansk; BioMarin Pharmaceutical Inc.; Zacharon Pharmaceuticals Inc.; Institut National de la Sante et de la Recherche Medicale (Inserm); Pharmaceutical Research Institute - Poland; Royal Manchester Children's Hospital; University of Manchester; University of Manchester	Malinowska, M (corresponding author), Univ Manchester, Fac Med & Human Sci, Mucopolysaccharidosis MPS Stem Cell Res Grp, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Wegrzyn, Grzegorz/AAL-1179-2020; Grynkiewicz, Grzegorz/E-6967-2019; Langford-Smith, Alex/K-7624-2017; Langford-Smith, Kia/H-5255-2011; Langford-Smith, Alex/H-5249-2011; Wegrzyn, Grzegorz/ABD-6699-2020; Malinowska, Marcelina/Q-9362-2018; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wegrzyn, Grzegorz/0000-0003-4042-7466; Malinowska, Marcelina/0000-0002-5586-4354; Wilkinson, Fiona/0000-0002-0358-3489; Wynn, robert/0000-0002-6046-8428; Bigger, Brian/0000-0002-9708-1112	UK Society for Mucopolysaccharide Diseases [J4G/25/04]; Ministry of Science and Higher Education (Poland) [N302 046 32/3603]; EU [TEAM/2008-2/7]; Polish MPS Society; Manchester Biomedical Research Centre; InnoDoktorant; European Social Fund; Program of Introduction of Modern Education Elements at University of Gdansk	UK Society for Mucopolysaccharide Diseases; Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); EU(European Commission); Polish MPS Society; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); InnoDoktorant; European Social Fund(European Social Fund (ESF)); Program of Introduction of Modern Education Elements at University of Gdansk	This work was funded by the UK Society for Mucopolysaccharide Diseases (J4G/25/04), with contributions from the Japanese Society of the Patients and Families with MPS, MPS Schweiz, Gesellschaft fur Mukopolysaccharidosen, Asociacion MPS Espana, The Irish Society for Mucopolysaccharide Diseases, the Canadian Society for Mucopolysaccharide and Related Diseases, the National MPS Society, the Swedish MPS Society, Gesellschaft fur MPS e.V., VKS, with partial support by Ministry of Science and Higher Education (Poland) (N302 046 32/3603) and Foundation for Polish Science Team Programme, co-financed by the EU European Regional Development Fund (TEAM/2008-2/7). Support from the Polish MPS Society and the Manchester Biomedical Research Centre is also acknowledged. MM was supported by the InnoDoktorant, scholarships for PhD students from the European Social Fund, and by the Program of Introduction of Modern Education Elements at University of Gdansk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also as Jillian R. Brown and Brett E. Crawford are affiliated to Zacharon Pharmaceuticals Inc, Zacharon Pharmaceuticals Inc did play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ARCHER LD, J NEUROSCI RES, V88, P233; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Gografe SI, 2009, COMPARATIVE MED, V59, P139; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kong LY, 1997, NEUROCHEM INT, V30, P491, DOI 10.1016/S0197-0186(96)00086-1; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; Marini H, 2007, ANN INTERN MED, V146, P839, DOI 10.7326/0003-4819-146-12-200706190-00005; McClain RM, 2005, FOOD CHEM TOXICOL, V43, P1461, DOI 10.1016/j.fct.2005.02.017; McClain RM, 2006, FOOD CHEM TOXICOL, V44, P56, DOI 10.1016/j.fct.2005.05.021; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Netland EE, 1998, NEUROBIOL AGING, V19, P201, DOI 10.1016/S0197-4580(98)00047-5; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paxinos F, 2004, MOUSE BRAIN STEREOTA; Piotrowska E, 2008, CURR THER RES CLIN E, V69, P166, DOI 10.1016/j.curtheres.2008.04.002; Piotrowska E, 2006, EUR J HUM GENET, V14, P846, DOI 10.1038/sj.ejhg.5201623; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sfakianos J, 1997, J NUTR, V127, P1260, DOI 10.1093/jn/127.7.1260; Tsai TH, 2005, J CHROMATOGR A, V1073, P317, DOI 10.1016/j.chroma.2004.10.048; Valstar MI, 2008, J INHERIT METAB DIS; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang XJ, 2005, NEUROREPORT, V16, P267, DOI 10.1097/00001756-200502280-00013; Warri A, 2008, BRIT J CANCER, V98, P1485, DOI 10.1038/sj.bjc.6604321; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307	37	106	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14192	10.1371/journal.pone.0014192	http://dx.doi.org/10.1371/journal.pone.0014192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152017	Green Published, Green Submitted, gold			2022-12-25	WOS:000284821300009
J	Ferrada, E; Wagner, A				Ferrada, Evandro; Wagner, Andreas			Evolutionary Innovations and the Organization of Protein Functions in Genotype Space	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PUNCTUATED EVOLUTION; DNA-POLYMERASES; SELECTION; DATABASE; FOLD; CLASSIFICATION; DESIGNABILITY; SUPERFAMILIES; CONSTRAINTS	The organization of protein structures in protein genotype space is well studied. The same does not hold for protein functions, whose organization is important to understand how novel protein functions can arise through blind evolutionary searches of sequence space. In systems other than proteins, two organizational features of genotype space facilitate phenotypic innovation. The first is that genotypes with the same phenotype form vast and connected genotype networks. The second is that different neighborhoods in this space contain different novel phenotypes. We here characterize the organization of enzymatic functions in protein genotype space, using a data set of more than 30,000 proteins with known structure and function. We show that different neighborhoods of genotype space contain proteins with very different functions. This property both facilitates evolutionary innovation through exploration of a genotype network, and it constrains the evolution of novel phenotypes. The phenotypic diversity of different neighborhoods is caused by the fact that some functions can be carried out by multiple structures. We show that the space of protein functions is not homogeneous, and different genotype neighborhoods tend to contain a different spectrum of functions, whose diversity increases with increasing distance of these neighborhoods in sequence space. Whether a protein with a given function can evolve specific new functions is thus determined by the protein's location in sequence space.	[Ferrada, Evandro; Wagner, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA; [Ferrada, Evandro; Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of Zurich; The Santa Fe Institute; Swiss Institute of Bioinformatics; University of New Mexico	Ferrada, E (corresponding author), Univ Zurich, Dept Biochem, Zurich, Switzerland.	e.ferrada@bioc.uzh.ch		Ferrada, Evandro/0000-0003-3242-1726	Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; University of Zurich; UZH Forschungskredit	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; UZH Forschungskredit	AW acknowledges support through Swiss National Science Foundation grants 315200-116814, 315200-119697 and 315230-129708, as well as through the YeastX project of SystemsX.ch, and the University Priority Research Program in systems biology at the University of Zurich. EF acknowledges support through UZH Forschungskredit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; AMUNDSON R, 1994, PHILOS SCI, V61, P556, DOI 10.1086/289822; [Anonymous], 1980, CODING INFORM THEORY; ARONSON HEG, 1994, PROTEIN SCI, V3, P1706, DOI 10.1002/pro.5560031009; Axe DD, 2004, J MOL BIOL, V341, P1295, DOI 10.1016/j.jmb.2004.06.058; Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Buchler NEG, 1999, PROTEINS, V34, P113; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; CHOTHIA C, 1987, COLD SPRING HARB SYM, V52, P399, DOI 10.1101/SQB.1987.052.01.046; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; FINKELSTEIN AV, 1995, SUBCELLULAR BIOCH, V24; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hodin J, 2000, MOD AN FORM WORKSH F; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kunin V, 2005, BIOINFORMATICS, V21, P2618, DOI 10.1093/bioinformatics/bti386; Kussell E, 2005, PROTEIN PEPTIDE LETT, V12, P111, DOI 10.2174/0929866053005881; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Mann M., 2009, P 5 WORKSH CONSTR BA; Mantaci S, 2008, INT J APPROX REASON, V47, P109, DOI 10.1016/j.ijar.2007.03.011; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; MICHAEL SF, 1992, P NATL ACAD SCI USA, V89, P4796, DOI 10.1073/pnas.89.11.4796; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; PAWLOWSKI K, 2000, PAC S BIOCOMPUT, V8, P42; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; REIDHAAROLSON JF, 1990, PROTEINS, V7, P306, DOI 10.1002/prot.340070403; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Xia Y, 2004, CURR OPIN STRUC BIOL, V14, P202, DOI 10.1016/j.sbi.2004.03.001	63	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14172	10.1371/journal.pone.0014172	http://dx.doi.org/10.1371/journal.pone.0014172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152394	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000284755100048
J	Garcia-Faroldi, G; Rodriguez, CE; Urdiales, JL; Perez-Pomares, JM; Davilla, JC; Pejler, G; Sanchez-Jimenez, F; Fajardo, I				Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Perez-Pomares, Jose M.; Davilla, Jose C.; Pejler, Gunnar; Sanchez-Jimenez, Francisca; Fajardo, Ignacio			Polyamines Are Present in Mast Cell Secretory Granules and Are Important for Granule Homeostasis	PLOS ONE			English	Article							MAJOR VAULT PROTEIN; ORNITHINE-DECARBOXYLASE; SERGLYCIN PROTEOGLYCAN; MAMMALIAN-CELLS; GENE-EXPRESSION; ALBUMIN UPTAKE; STORAGE; KINASE; PROTEASES; RECEPTOR	Background: Mast cell secretory granules accommodate a large number of components, many of which interact with highly sulfated serglycin proteoglycan (PG) present within the granules. Polyamines (putrescine, spermidine and spermine) are absolutely required for the survival of the vast majority of living cells. Given the reported ability of polyamines to interact with PGs, we investigated the possibility that polyamines may be components of mast cell secretory granules. Methodology/Principal Findings: Spermidine was released by mouse bone marrow derived mast cells (BMMCs) after degranulation induced by IgE/anti-IgE or calcium ionophore A23187. Additionally, both spermidine and spermine were detected in isolated mouse mast cell granules. Further, depletion of polyamines by culturing BMMCs with alpha-difluoromethylomithine (DFMO) caused aberrant secretory granule ultrastructure, impaired histamine storage, reduced serotonin levels and increased beta-hexosaminidase content. A proteomic approach revealed that DFMO-induced polyamine depletion caused an alteration in the levels of a number of proteins, many of which are connected either with the regulated exocytosis or with the endocytic system. Conclusions/Significance: Taken together, our results show evidence that polyamines are present in mast cell secretory granules and, furthermore, indicate an essential role of these polycations during the biogenesis and homeostasis of these organelles.	[Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Sanchez-Jimenez, Francisca; Fajardo, Ignacio] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Sanchez-Jimenez, Francisca; Fajardo, Ignacio] Univ Malaga, Fac Sci, CIBER ER, E-29071 Malaga, Spain; [Perez-Pomares, Jose M.] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Davilla, Jose C.] Univ Malaga, Fac Sci, Dept Cell Biol Genet & Physiol, E-29071 Malaga, Spain; [Pejler, Gunnar] Swedish Univ Agr Sci, Uppsala Biomed Ctr BMC, Dept Anat Physiol & Biochem, Uppsala, Sweden	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Swedish University of Agricultural Sciences; Uppsala University	Garcia-Faroldi, G (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain.	ifajardo@uma.es	Urdiales, José Luis/K-1125-2014; Jiménez, Francisca María Sánchez/H-2513-2015; Rodríguez, Carlos/AAJ-6122-2020; Perez-Pomares, Jose/G-7885-2015; Fajardo, Ignacio/L-2943-2014	Urdiales, José Luis/0000-0002-2519-9293; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Rodríguez, Carlos/0000-0002-6831-0588; Perez-Pomares, Jose/0000-0001-5487-7252; Fajardo, Ignacio/0000-0001-6676-7579; Davila Cansino, Jose Carlos/0000-0001-7016-288X	Ministerio de Ciencia e Innovacion, Spain [SAF2008-02522]; Junta de Andalucia, Spain [P07-CVI-02999, BIO-267]; Fundacion Ramon Areces (Spain); European Union (EU)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Fundacion Ramon Areces (Spain); European Union (EU)(CGIAREuropean Commission)	This work was supported by grants SAF2008-02522 (Ministerio de Ciencia e Innovacion, Spain), P07-CVI-02999 and BIO-267 group (Junta de Andalucia, Spain) and funds provided by Fundacion Ramon Areces (Spain). It was also helped by the European Cooperation in Science and Technology (COST) Action BM0806, supported by the European Union (EU) Framework Programme for Research and Technological Development (RTD). The CIBER-ER is an initiative of the Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; AMENDE LM, 1985, BIOCHIM BIOPHYS ACTA, V812, P713, DOI 10.1016/0005-2736(85)90265-2; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Belting M, 1996, GLYCOBIOLOGY, V6, P121, DOI 10.1093/glycob/6.2.121; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Braga T, 2009, MOL IMMUNOL, V46, P422, DOI 10.1016/j.molimm.2008.10.019; BRAND K, 1987, J BIOL CHEM, V262, P15232; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fajardo I, 2001, BIOCHEM PHARMACOL, V61, P1101, DOI 10.1016/S0006-2952(01)00567-6; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garcia-Faroldi G, 2009, J CELL BIOCHEM, V108, P261, DOI 10.1002/jcb.22246; Gross B, 2002, EUR J IMMUNOL, V32, P1121; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Herlevsen M, 2007, MOL CANCER THER, V6, P1804, DOI 10.1158/1535-7163.MCT-06-0372; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2005, AM J PHYSIOL-RENAL, V288, pF1227, DOI 10.1152/ajprenal.00428.2003; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Kim JY, 2008, INT ARCH ALLERGY IMM, V146, P287, DOI 10.1159/000121463; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; KRUGER PG, 1980, EXP CELL RES, V129, P83, DOI 10.1016/0014-4827(80)90333-X; KUROSAWA M, 1989, J ALLERGY CLIN IMMUN, V84, P118, DOI 10.1016/0091-6749(89)90185-1; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Chica J, 2001, BIOCHEM BIOPH RES CO, V285, P437, DOI 10.1006/bbrc.2001.5192; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	60	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15071	10.1371/journal.pone.0015071	http://dx.doi.org/10.1371/journal.pone.0015071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151498	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100059
J	Allende, ML; Bektas, M; Lee, BG; Bonifacino, E; Kang, JM; Tuymetova, G; Chen, WP; Saba, JD; Proia, RL				Allende, Maria L.; Bektas, Meryem; Lee, Bridgin G.; Bonifacino, Eliana; Kang, Jiman; Tuymetova, Galina; Chen, WeiPing; Saba, Julie D.; Proia, Richard L.			Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; VASCULAR S1P GRADIENT; DOUBLE-NULL MICE; P-SELECTIN; IN-VIVO; BIOACTIVE SPHINGOLIPIDS; LEUKOCYTE RECRUITMENT; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; KINASE 1	Sphingosine-1-phosphate (S1P) lyase catalyzes the degradation of S1P, a potent signaling lysosphingolipid. Mice with an inactive S1P lyase gene are impaired in the capacity to degrade S1P, resulting in highly elevated S1P levels. These S1P lyase-deficient mice have low numbers of lymphocytes and high numbers of neutrophils in their blood. We found that the S1P lyase-deficient mice exhibited features of an inflammatory response including elevated levels of pro-inflammatory cytokines and an increased expression of genes in liver associated with an acute-phase response. However, the recruitment of their neutrophils into inflamed tissues was impaired and their neutrophils were defective in migration to chemotactic stimulus. The IL-23/IL-17/granulocyte-colony stimulating factor (G-CSF) cytokine-controlled loop regulating neutrophil homeostasis, which is dependent on neutrophil trafficking to tissues, was disturbed in S1P lyase-deficient mice. Deletion of the S1P4 receptor partially decreased the neutrophilia and inflammation in S1P lyase-deficient mice, implicating S1P receptor signaling in the phenotype. Thus, a genetic block in S1P degradation elicits a pro-inflammatory response but impairs neutrophil migration from blood into tissues.	[Allende, Maria L.; Bektas, Meryem; Lee, Bridgin G.; Bonifacino, Eliana; Kang, Jiman; Tuymetova, Galina; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Chen, WeiPing] NIDDK, Microarray Core Lab, NIH, Bethesda, MD 20892 USA; [Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	proia@nih.gov	Proia, Richard L/A-7908-2012; Chen, Wei/GZK-7348-2022	Bektas, Meryem/0000-0001-8080-7557; Proia, Richard/0000-0003-0456-1270	National Institutes of Health, NIDDK [CA77528]; National Institutes of Health [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA077528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015, ZIADK056017, ZIADK056018] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIDDK by Public Health Service Grant CA77528 (to J.D.S.) and National Institutes of Health Grant C06 RR018823 (to the Medical University of South Carolina Lipomics Core).	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Allende ML, 2008, FASEB J, V22, P307, DOI 10.1096/fj.07-9087com; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Candelore MR, 2002, BIOCHEM BIOPH RES CO, V297, P600; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins RG, 2001, BLOOD, V98, P727, DOI 10.1182/blood.V98.3.727; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Ding ZM, 1999, J IMMUNOL, V163, P5029; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Etzioni A, 2007, ADV EXP MED BIOL, V601, P51; Forlow SB, 2002, FASEB J, V16, P1488, DOI 10.1096/fj.02-0230com; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Forlow SB, 2000, J CLIN INVEST, V106, P1457, DOI 10.1172/JCI10555; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jolly PS, 2005, BLOOD, V105, P4736, DOI 10.1182/blood-2004-12-4686; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; KUIJPERS TW, 1991, BLOOD, V78, P1105; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009277; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; WILSON RW, 1993, J IMMUNOL, V151, P1571; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yatomi Y, 2000, BLOOD, V96, P3431; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	73	127	133	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7348	7358		10.1074/jbc.M110.171819	http://dx.doi.org/10.1074/jbc.M110.171819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21173151	Green Published, hybrid			2022-12-25	WOS:000287737300051
J	Polanska, UM; Edwards, E; Fernig, DG; Kinnunen, TK				Polanska, Urszula M.; Edwards, Elisabeth; Fernig, David G.; Kinnunen, Tarja K.			The Cooperation of FGF Receptor and Klotho Is Involved in Excretory Canal Development and Regulation of Metabolic Homeostasis in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTS ENCODING MEMBRANE; C-ELEGANS; BETA-KLOTHO; SIGNALING PATHWAY; TRPV5 CHANNEL; GENE; PROTEIN; SYSTEM; CELL; MAINTENANCE	FGFs have traditionally been associated with cell proliferation, morphogenesis, and development; yet, a subfamily of FGFs (FGF19, -21, and -23) functions as hormones to regulate glucose, lipid, phosphate, and vitamin D metabolism with impact on energy balance and aging. In mammals, Klotho and beta-Klotho are type 1 transmembrane proteins that function as obligatory co-factors for endocrine FGFs to bind to their cognate FGF receptors (FGFRs). Mutations in Klotho/beta-Klotho or fgf19, -21, or -23 are associated with a number of human diseases, including autosomal dominant hypophosphatemic rickets, premature aging disorders, and diabetes. The Caenorhabditis elegans genome contains two paralogues of Klotho/beta-Klotho, klo-1, and klo-2. klo-1 is expressed in the C. elegans excretory canal, which is structurally and functionally paralogous to the vertebrate kidney. KLO-1 associates with EGL-15/FGFR, suggesting a role for KLO-1 in the fluid homeostasis phenotype described previously for egl-15/fgfr mutants. Altered levels of EGL-15/FGFR signaling lead to defects in excretory canal development and function in C. elegans. These results suggest an evolutionarily conserved function for the FGFR-Klotho complex in the development of excretory organs such as the mammalian kidney and the worm excretory canal. These results also suggest an evolutionarily conserved function for the FGFR-Klotho axis in metabolic regulation.	[Polanska, Urszula M.; Edwards, Elisabeth; Fernig, David G.; Kinnunen, Tarja K.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Kinnunen, TK (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	T.K.Kinnunen@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Kinnunen, Dr Tarja K/0000-0001-5630-2233	National Institutes of Health National Center for Research Resources; C. elegans Knock-out Consortium; European Union; North West Cancer Research Fund; Cancer and Polio Research Fund; Medical Research Council; Medical Research Council [G0601549] Funding Source: researchfish; MRC [G0601549] Funding Source: UKRI	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); C. elegans Knock-out Consortium; European Union(European Commission); North West Cancer Research Fund; Cancer and Polio Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Some strains used in this study were obtained from the Caenorhabditis Genetics Center, which is supported by the National Institutes of Health National Center for Research Resources, and by the C. elegans Knock-out Consortium. This work was supported by a European Union Marie Curie Early Stage Training Programme (to U. M. P.), by the North West Cancer Research Fund and the Cancer and Polio Research Fund (to D. G. F.), and by the Medical Research Council (to T. K. K.).	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Birnbaum D, 2005, DEV DYNAM, V232, P247, DOI 10.1002/dvdy.20219; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2010, PFLUG ARCH EUR J PHY, V459, P333, DOI 10.1007/s00424-009-0722-7; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Polanska UM, 2009, J BIOL CHEM, V284, P33030, DOI 10.1074/jbc.M109.058925; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Roubin R, 1999, ONCOGENE, V18, P6741, DOI 10.1038/sj.onc.1203074; Sasson IE, 2004, DEVELOPMENT, V131, P5381, DOI 10.1242/dev.01423; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315	42	18	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5657	5666		10.1074/jbc.M110.173039	http://dx.doi.org/10.1074/jbc.M110.173039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21177529	Green Published, hybrid			2022-12-25	WOS:000287230600075
J	Fraile-Ramos, A; Cepeda, V; Elstak, E; van der Sluijs, P				Fraile-Ramos, Alberto; Cepeda, Victoria; Elstak, Edo; van der Sluijs, Peter			Rab27a Is Required for Human Cytomegalovirus Assembly	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MONOCLONAL-ANTIBODIES; ENVELOPMENT; CELLS; COMPARTMENTS; TEGUMENT; IDENTIFICATION; LOCALIZATION; GLYCOPROTEIN; REACTIVATION	Human cytomegalovirus (HCMV) completes its final envelopment on intracellular membranes before it is released from the cell. The mechanisms underlying these processes are not understood. Here we studied the role of Rab27a, a regulator of lysosome-related organelle transport, in HCMV production. HCMV infection increased Rab27a expression, and recruitment of Rab27a to membranous strutures at the assembly site. Immuno-gold labelling demonstrated association of Rab27a with viral envelopes. CMV production was reduced after knock-down of Rab27a, and in Rab27a-deficient ashen melanocytes. This study shows a requirement for Rab27a in the CMV life cycle and suggests that CMV and LRO biogenesis share common molecular mechanisms.	[Fraile-Ramos, Alberto; Cepeda, Victoria] CSIC, Dept Mol & Cell Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Elstak, Edo; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Utrecht University Medical Center	Fraile-Ramos, A (corresponding author), CSIC, Dept Mol & Cell Biol, Ctr Nacl Biotecnol, Madrid, Spain.	alberto.fraile@cnb.csic.es	Fraile-Ramos, Alberto/M-2072-2017	Fraile-Ramos, Alberto/0000-0002-0701-5454	Ramon y Cajal contract; Spanish Ministry of Science and Innovation [BFU2006-14379/BMC, BFU2009-07569/BMC]	Ramon y Cajal contract(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	AF-R was supported by a Ramon y Cajal contract and by Grants BFU2006-14379/BMC and BFU2009-07569/BMC from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Cekinovic D, 2008, J VIROL, V82, P12172, DOI 10.1128/JVI.01214-08; Cepeda V, 2010, CELL MICROBIOL, V12, P386, DOI 10.1111/j.1462-5822.2009.01405.x; CRANAGE MP, 1988, J VIROL, V62, P1416, DOI 10.1128/JVI.62.4.1416-1422.1988; Das S, 2007, J VIROL, V81, P11861, DOI 10.1128/JVI.01077-07; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2007, CELL MICROBIOL, V9, P2955, DOI 10.1111/j.1462-5822.2007.01024.x; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Homman-Loudiyi M, 2003, J VIROL, V77, P3191, DOI 10.1128/JVI.77.5.3191-3203.2003; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moorman NJ, 2010, MOL CELL PROTEOMICS, V9, P851, DOI 10.1074/mcp.M900485-MCP200; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; NOWAK B, 1984, VIROLOGY, V132, P325, DOI 10.1016/0042-6822(84)90039-4; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Seo JY, 2006, J VIROL, V80, P5611, DOI 10.1128/JVI.02630-05; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; TOOZE J, 1993, EUR J CELL BIOL, V60, P163; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002	37	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15318	10.1371/journal.pone.0015318	http://dx.doi.org/10.1371/journal.pone.0015318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170347	gold, Green Submitted, Green Published			2022-12-25	WOS:000285084100034
J	Taki, Y; Hashizume, H; Sassa, Y; Takeuchi, H; Asano, M; Asano, K; Kawashima, R				Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Asano, Michiko; Asano, Kohei; Kawashima, Ryuta			Breakfast Staple Types Affect Brain Gray Matter Volume and Cognitive Function in Healthy Children	PLOS ONE			English	Article							GLYCEMIC INDEX; SCHOOL BREAKFAST; CORTICAL DEVELOPMENT; ADOLESCENTS; PERFORMANCE; INTELLIGENCE; ATTENTION; DIET; IQ; DENSITY	Childhood diet is important for brain development. Furthermore, the quality of breakfast is thought to affect the cognitive functioning of well-nourished children. To analyze the relationship among breakfast staple type, gray matter volume, and intelligence quotient (IQ) in 290 healthy children, we used magnetic resonance images and applied voxel-based morphometry. We divided subjects into rice, bread, and both groups according to their breakfast staple. We showed that the rice group had a significantly larger gray matter ratio (gray matter volume percentage divided by intracranial volume) and significantly larger regional gray matter volumes of several regions, including the left superior temporal gyrus. The bread group had significantly larger regional gray and white matter volumes of several regions, including the right frontoparietal region. The perceptual organization index (POI; IQ subcomponent) of the rice group was significantly higher than that of the bread group. All analyses were adjusted for age, gender, intracranial volume, socioeconomic status, average weekly frequency of having breakfast, and number of side dishes eaten for breakfast. Although several factors may have affected the results, one possible mechanism underlying the difference between the bread and the rice groups may be the difference in the glycemic index (GI) of these two substances; foods with a low GI are associated with less blood-glucose fluctuation than are those with a high GI. Our study suggests that breakfast staple type affects brain gray and white matter volumes and cognitive function in healthy children; therefore, a diet of optimal nutrition is important for brain maturation during childhood and adolescence.	[Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Asano, Michiko; Asano, Kohei; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Taki, Y (corresponding author), Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ytaki@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid for Young Scientists (B), 20790875, from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Busch CR, 2002, PHYSIOL BEHAV, V77, P333, DOI 10.1016/S0031-9384(02)00882-X; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; CONNERS CK, 1983, J PSYCHIATR RES, V17, P193, DOI 10.1016/0022-3956(82)90022-X; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fujita K, 2006, JAPANESE WECHSLER AD; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Lozano RH, 2006, NUTR HOSP, V21, P346; Horwood LJ, 2001, ARCH DIS CHILD-FETAL, V84, pF23, DOI 10.1136/fn.84.1.F23; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ingwersen J, 2007, APPETITE, V49, P240, DOI 10.1016/j.appet.2006.06.009; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Mahoney CR, 2005, PHYSIOL BEHAV, V85, P635, DOI 10.1016/j.physbeh.2005.06.023; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morales IF, 2008, NUTR HOSP, V23, P383; Murphy JM, 1998, ARCH PEDIAT ADOL MED, V152, P899; Noriega JAV, 2000, ARCH LATINOAM NUTR, V50, P35; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; POLLITT E, 1981, AM J CLIN NUTR, V34, P1526, DOI 10.1093/ajcn/34.8.1526; POLLITT E, 1983, J PSYCHIATR RES, V17, P169, DOI 10.1016/0022-3956(82)90018-8; Pollitt E, 1998, AM J CLIN NUTR, V67, p747S, DOI 10.1093/ajcn/67.4.747S; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Roberts SB, 2000, NUTR REV, V58, P163, DOI 10.1111/j.1753-4887.2000.tb01855.x; Sasaki S., 2002, Journal of Community Nutrition, V4, P83; *SCI TECHN AG J, 1997, STAND TABL FOOD COMP; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shemilt I, 2004, CHILD CARE HLTH DEV, V30, P413, DOI 10.1111/j.1365-2214.2004.00453.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Ueno K, 1998, WECHSLER INTELLIGENC, V3rd; Vaisman N, 1996, ARCH PEDIAT ADOL MED, V150, P1089, DOI 10.1001/archpedi.1996.02170350091016; Wesnes KA, 2003, APPETITE, V41, P329, DOI 10.1016/j.appet.2003.08.009; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X	44	63	64	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15213	10.1371/journal.pone.0015213	http://dx.doi.org/10.1371/journal.pone.0015213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170334	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100031
J	Acevedo, P; Ruiz-Fons, F; Estrada, R; Marquez, AL; Miranda, MA; Gortazar, C; Lucientes, J				Acevedo, Pelayo; Ruiz-Fons, Francisco; Estrada, Rosa; Luz Marquez, Ana; Angel Miranda, Miguel; Gortazar, Christian; Lucientes, Javier			A Broad Assessment of Factors Determining Culicoides imicola Abundance: Modelling the Present and Forecasting Its Future in Climate Change Scenarios	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE VIRUS; SPECIES DISTRIBUTION; SEASONAL DISTRIBUTION; SPATIAL-DISTRIBUTION; WILD RUMINANTS; VECTOR; DISTRIBUTIONS; OBSOLETUS; RANGE	Bluetongue (BT) is still present in Europe and the introduction of new serotypes from endemic areas in the African continent is a possible threat. Culicoides imicola remains one of the most relevant BT vectors in Spain and research on the environmental determinants driving its life cycle is key to preventing and controlling BT. Our aim was to improve our understanding of the biotic and abiotic determinants of C. imicola by modelling its present abundance, studying the spatial pattern of predicted abundance in relation to BT outbreaks, and investigating how the predicted current distribution and abundance patterns might change under future (2011-2040) scenarios of climate change according to the Intergovernmental Panel on Climate Change. C. imicola abundance data from the bluetongue national surveillance programme were modelled with spatial, topoclimatic, host and soil factors. The influence of these factors was further assessed by variation partitioning procedures. The predicted abundance of C. imicola was also projected to a future period. Variation partitioning demonstrated that the pure effect of host and topoclimate factors explained a high percentage (>80%) of the variation. The pure effect of soil followed in importance in explaining the abundance of C. imicola. A close link was confirmed between C. imicola abundance and BT outbreaks. To the best of our knowledge, this study is the first to consider wild and domestic hosts in predictive modelling for an arthropod vector. The main findings regarding the near future show that there is no evidence to suggest that there will be an important increase in the distribution range of C. imicola; this contrasts with an expected increase in abundance in the areas where it is already present in mainland Spain. What may be expected regarding the future scenario for orbiviruses in mainland Spain, is that higher predicted C. imicola abundance may significantly change the rate of transmission of orbiviruses.	[Acevedo, Pelayo; Luz Marquez, Ana] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Ruiz-Fons, Francisco; Gortazar, Christian] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Dept Anim Hlth, Ciudad Real, Spain; [Ruiz-Fons, Francisco] Inst Vasco Invest & Desarrollo Agr Neiker Tecnali, Dept Anim Hlth, Derio, Spain; [Estrada, Rosa; Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Zaragoza, Spain; [Angel Miranda, Miguel] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Zaragoza; Universitat de les Illes Balears	Acevedo, P (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	pacevedo@irec.csic.es	Ruiz-Fons, Francisco/K-3161-2014; Acevedo, Pelayo/L-6737-2013; Márquez, Ana Luz/K-8345-2014; Gortazar, Christian/E-7918-2012; Miranda, Miguel/I-8718-2019	Ruiz-Fons, Francisco/0000-0002-0820-5292; Acevedo, Pelayo/0000-0002-3509-7696; Márquez, Ana Luz/0000-0001-5586-9334; Gortazar, Christian/0000-0003-0012-4006; Miranda, Miguel/0000-0003-0770-2593	Castilla-La Mancha [POII09-0141-8176]; Principado de Asturias; FEDER [CGL2009-11316/BOS]; Spanish Ministry of Science and Innovation; Castilla-La Mancha and Principado de Asturias	Castilla-La Mancha; Principado de Asturias(Principality of Asturias); FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Castilla-La Mancha and Principado de Asturias	This study was supported by grant POII09-0141-8176 (Castilla-La Mancha) and by funds from Castilla-La Mancha and Principado de Asturias. P. Acevedo currently holds a Juan de la Cierva research contract awarded by the Spanish Ministry of Science and Innovation-European Social Fund and partially by the project CGL2009-11316/BOS - FEDER. F. Ruiz-Fons is currently supported by the Spanish Ministry of Science and Innovation under a contract awarded by the 'Instituto de Salud Carlos III'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alzaga V, 2009, NATURWISSENSCHAFTEN, V96, P1157, DOI 10.1007/s00114-009-0577-y; Barbosa A.M., 2005, Wildlife Biology in Practice, V1, P3; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Baylis M, 2004, VETER ITAL SER, V40, P176; Baylis M, 1997, MED VET ENTOMOL, V11, P203, DOI 10.1111/j.1365-2915.1997.tb00397.x; Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boyce MS, 2001, J WILDLIFE MANAGE, V65, P498, DOI 10.2307/3803103; BRAVERMAN Y, 1974, MOSQ NEWS, V34, P303; Brunet M, 2007, GENERACION ESCENARIO; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Calistri P, 2003, J VET MED B, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Caracappa S, 2003, VET REC, V153, P71, DOI 10.1136/vr.153.3.71; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2009, J APPL ECOL, V46, P1332, DOI 10.1111/j.1365-2664.2009.01723.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eastman JR, 2004, IDRISI KILIMANJARO G; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Estrada-Pena A, 2007, J MED ENTOMOL, V44, P1130, DOI 10.1603/0022-2585(2007)44[1130:CNOTSI]2.0.CO;2; Estrada-Pena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002999; *EUR ENV AG, 2000, NATLAN NAT LAND COV; FONT I, 2000, CLIMATOLOGI ESPANA P; Fowler J., 1998, PRACTICAL STAT FIELD, P130; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hudson P., 2002, ECOLOGY WILDLIFE DIS; I. G. M. E, 1979, MAP HIDR NAC EXPL MA; Jimenez-Valverde A, 2006, ENVIRON ENTOMOL, V35, P1491, DOI 10.1603/0046-225X-35.6.1491; Kirkeby C, 2009, ENTOMOL FENNICA, V20, P228; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MARQUEZ AL, 2010, CLIMATIC CH IN PRESS; Meiswinkel R, 1997, ONDERSTEPOORT J VET, V64, P81; Meiswinkel R, 1998, ARCH VIROL, P69; MEISWINKEL R, 1994, INFECT DIS LIVESTOCK, V1, P93; Miranda MA, 2004, VETER ITAL SER, V40, P292; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Nakicenovic N., 2000, IPCC SPECIAL REPORT; NICHOLSON SE, 1994, REMOTE SENS ENVIRON, V50, P107, DOI 10.1016/0034-4257(94)90038-8; Ortega MD, 1998, ARCH VIROL, P85; Ortega MD, 1999, J AM MOSQUITO CONTR, V15, P391; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pearce J, 2001, BIOL CONSERV, V98, P33, DOI 10.1016/S0006-3207(00)00139-7; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Ruiz-Fons F, 2008, EUR J WILDLIFE RES, V54, P549, DOI 10.1007/s10344-008-0179-6; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Savini L, 2006, Vet Ital, V42, P201; Scheiner SM, 2009, ECOHEALTH, V6, P483, DOI 10.1007/s10393-010-0298-x; Slenning BD, 2010, VET PATHOL, V47, P28, DOI 10.1177/0300985809354465; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; Watson DM, 1999, ECOGRAPHY, V22, P582, DOI 10.1111/j.1600-0587.1999.tb00547.x; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; 2008, EFSA J, V735, P1	84	87	90	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14236	10.1371/journal.pone.0014236	http://dx.doi.org/10.1371/journal.pone.0014236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151914	Green Submitted, Green Published, gold			2022-12-25	WOS:000284995300008
J	Ferreira, L; Castano, SV; Sanchez-Juanes, F; Gonzalez-Cabrero, S; Menegotto, F; Orduna-Domingo, A; Gonzalez-Buitrago, JM; Munoz-Bellido, JL				Ferreira, Laura; Vega Castano, Silvia; Sanchez-Juanes, Fernando; Gonzalez-Cabrero, Sandra; Menegotto, Fabiola; Orduna-Domingo, Antonio; Manuel Gonzalez-Buitrago, Jose; Luis Munoz-Bellido, Juan			Identification of Brucella by MALDI-TOF Mass Spectrometry. Fast and Reliable Identification from Agar Plates and Blood Cultures	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; RAPID IDENTIFICATION; GENUS BRUCELLA; PCR ASSAY; MELITENSIS; BACTERIA; DIFFERENTIATION; DIAGNOSIS	Background: MALDI-TOF mass spectrometry (MS) is a reliable method for bacteria identification. Some databases used for this purpose lack reference profiles for Brucella species, which is still an important pathogen in wide areas around the world. We report the creation of profiles for MALDI-TOF Biotyper 2.0 database (Bruker Daltonics, Germany) and their usefulness for identifying brucellae from culture plates and blood cultures. Methodology/Principal Findings: We created MALDI Biotyper 2.0 profiles for type strains belonging to B. melitensis biotypes 1, 2 and 3; B. abortus biotypes 1, 2, 5 and 9; B. suis, B. canis, B ceti and B. pinnipedialis. Then, 131 clinical isolates grown on plate cultures were used in triplicate to check identification. Identification at genus level was always correct, although in most cases the three replicates reported different identification at species level. Simulated blood cultures were performed with type strains belonging to the main human pathogenic species (B. melitensis, B. abortus, B. suis and B. canis), and studied by MALDI-TOF MS in triplicate. Identification at genus level was always correct. Conclusions/Significance: MALDI-TOF MS is reliable for Brucella identification to the genus level from culture plates and directly from blood culture bottles.	[Ferreira, Laura; Sanchez-Juanes, Fernando; Manuel Gonzalez-Buitrago, Jose] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain; [Vega Castano, Silvia; Luis Munoz-Bellido, Juan] Hosp Univ Salamanca, Dept Microbiol, Salamanca, Spain; [Gonzalez-Cabrero, Sandra; Menegotto, Fabiola; Orduna-Domingo, Antonio] Univ Valladolid, Dept Anat Patol Microbiol Med Prevent & Salud Pub, Valladolid, Spain; [Manuel Gonzalez-Buitrago, Jose] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain; [Luis Munoz-Bellido, Juan] Univ Salamanca, Dept Med Prevent Salud Publ & Microbiol Med, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; Universidad de Valladolid; University of Salamanca; University of Salamanca	Ferreira, L (corresponding author), Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain.	jlmubel@usal.es	IBSAL, Secretaría/H-3719-2011; MUNOZ-BELLIDO, JUAN LUIS/B-3684-2017; Sánchez-Juanes, Fernando/AAO-2626-2020	MUNOZ-BELLIDO, JUAN LUIS/0000-0002-5981-8785; Gonzalez-Buitrago, Jose Manuel/0000-0003-4674-071X; Sanchez-Juanes, Fernando/0000-0003-1687-5891	Consejeria de Sanidad, Junta de Castilla y Leon (Spain); Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura)	Consejeria de Sanidad, Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura)(Instituto de Salud Carlos IIISpanish Government)	This work was partly supported by a grant from the Consejeria de Sanidad, Junta de Castilla y Leon (Spain) and by the Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZA J, 1995, CLIN INFECT DIS, V20, P1241, DOI 10.1093/clinids/20.5.1241; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Brew SD, 1999, VET REC, V144, P483; Bricker BJ, 2000, J CLIN MICROBIOL, V38, P1258, DOI 10.1128/JCM.38.3.1258-1262.2000; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Elsaghir AAF, 2003, J MED MICROBIOL, V52, P441, DOI 10.1099/jmm.0.05153-0; FERREIRA L, CLIN MICROBIOL 0428; Ferreira L, 2010, ENFERM INFEC MICR CL, V28, P492, DOI 10.1016/j.eimc.2009.12.009; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lindquist D, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P815; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Navarro E, 2004, EXPERT REV MOL DIAGN, V4, P115, DOI 10.1586/14737159.4.1.115; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Queipo-Ortuno MI, 2005, CLIN INFECT DIS, V40, P260, DOI 10.1086/426818; Seibold E, 2010, J CLIN MICROBIOL, V48, P1061, DOI 10.1128/JCM.01953-09; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; SOLERA J, 1995, ANTIMICROB AGENTS CH, V39, P2061, DOI 10.1128/AAC.39.9.2061; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; VERGER JM, 1987, ANN INST PASTEUR MIC, V138, P235, DOI 10.1016/0769-2609(87)90199-2; Vizcaino N, 2000, MICROBES INFECT, V2, P1089, DOI 10.1016/S1286-4579(00)01263-6; Yagupsky P, 1997, J CLIN MICROBIOL, V35, P1382, DOI 10.1128/JCM.35.6.1382-1384.1997; ZA J, 1992, ANN INTERN MED, V17, P25	25	57	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14235	10.1371/journal.pone.0014235	http://dx.doi.org/10.1371/journal.pone.0014235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151913	Green Published, Green Submitted, gold			2022-12-25	WOS:000284995300007
J	Gao, DY; Jin, GD; Yao, BL; Zhang, DH; Gu, LL; Lu, ZM; Gong, QM; Lone, YC; Deng, QA; Zhang, XX				Gao, De-Yong; Jin, Gen-Di; Yao, Bi-Lian; Zhang, Dong-Hua; Gu, Lei-Lei; Lu, Zhi-Meng; Gong, Qiming; Lone, Yu-Chun; Deng, Qiang; Zhang, Xin-Xin			Characterization of the Specific CD4(+) T Cell Response against the F Protein during Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTIONS; TRANSGENIC MICE; HCV INFECTION; CORE PROTEIN; B-VIRUS; PROGRESS; CLEARANCE	Background: The hepatitis C virus (HCV) Alternate Reading Frame Protein (ARFP or F protein) presents a double-frame shift product of the HCV core gene. We and others have previously reported that the specific antibodies against the F protein could be raised in the sera of HCV chronically infected patients. However, the specific CD4(+) T cell responses against the F protein during HCV infection and the pathological implications remained unclear. In the current study, we screened the MHC class II-presenting epitopes of the F protein through HLA-transgenic mouse models and eventually validated the specific CD4+ T cell responses in HCV chronically infected patients. Methodology: DNA vaccination in HLA-DR1 and-DP4 transgenic mouse models, proliferation assay to test the F protein specific T cell response, genotyping of Chronic HCV patients and testing the F-peptide stimulated T cell response in the peripheral blood mononuclear cell (PBMC) by in vitro expansion and interferon (IFN)- gamma intracellular staining. Principal Findings: At least three peptides within HCV F protein were identified as HLA-DR or HLA-DP4 presenting epitopes by the proliferation assays in mouse models. Further study with human PBMCs evidenced the specific CD4(+) T cell responses against HCV F protein as well in patients chronically infected with HCV. Conclusion: The current study provided the evidence for the first time that HCV F protein could elicit specific CD4(+) T cell response, which may provide an insight into the immunopathogenesis during HCV chronic infection.	[Gao, De-Yong; Jin, Gen-Di; Yao, Bi-Lian; Zhang, Dong-Hua; Gu, Lei-Lei; Lu, Zhi-Meng; Gong, Qiming; Zhang, Xin-Xin] Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [Gao, De-Yong] Shanghai Jiao Tong Univ, Songjiang Hosp, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Lone, Yu-Chun] Hop Paul Brousse, INSERM, U542, Villejuif, France; [Deng, Qiang] Chinese Acad Sci, Unit Tumor Virol, Inst Pasteur Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Gao, DY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China.	dengqiang@sibs.ac.cn; zhangxinxin@rjh.com.cn		LONE, Yu Chun/0000-0002-7417-4930	National Nature Science Grant [30471523, 30671839]; National Special Key Research Grant [2008ZX10005-009]; CAS [KSCX1-YW-10]	National Nature Science Grant; National Special Key Research Grant; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This study was supported by National Nature Science Grant (30471523 and 30671839), National Special Key Research Grant (2008ZX10005-009), and Major Program of Knowledge Innovation, CAS (KSCX1-YW-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Barrett S, 1999, J HEPATOL, V30, P979, DOI 10.1016/S0168-8278(99)80249-9; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Drouin C, 2010, J CLIN VIROL, V47, P102, DOI 10.1016/j.jcv.2009.10.016; Eckels DD, 2000, IMMUNOL REV, V174, P90, DOI 10.1034/j.1600-0528.2002.017403.x; Gao DY, 2008, J CLIN MICROBIOL, V46, P3746, DOI 10.1128/JCM.00612-08; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Mancini M, 1996, J BIOTECHNOL, V44, P47, DOI 10.1016/0168-1656(95)00098-4; Mancini-Bourgine M, 2007, J VIROL, V81, P4963, DOI 10.1128/JVI.02619-06; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NAKABAYASHI H, 1984, GANN, V75, P151; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Rosen HR, 2002, HEPATOLOGY, V35, P190, DOI 10.1053/jhep.2002.30293; Semmo N, 2007, J VIRAL HEPATITIS, V14, P492, DOI 10.1111/j.1365-2893.2007.00842.x; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Tsai SL, 1997, HEPATOLOGY, V25, P449; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Vassilaki N, 2009, IUBMB LIFE, V61, P739, DOI 10.1002/iub.201; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; Woitas RP, 1997, J IMMUNOL, V159, P1012	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14237	10.1371/journal.pone.0014237	http://dx.doi.org/10.1371/journal.pone.0014237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151917	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300009
J	Grizenkova, J; Akhtar, S; Collinge, J; Lloyd, SE				Grizenkova, Julia; Akhtar, Shaheen; Collinge, John; Lloyd, Sarah E.			The Retinoic Acid Receptor Beta (Rarb) Region of Mmu14 Is Associated with Prion Disease Incubation Time in Mouse	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; PROTEIN; GENE; EXPRESSION; PERIOD; COMPLEX; LINKAGE	In neurodegenerative conditions such as Alzheimer's and prion disease it has been shown that host genetic background can have a significant effect on susceptibility. Indeed, human genome-wide association studies (GWAS) have implicated several candidate genes. Understanding such genetic susceptibility is relevant to risks of developing variant CJD (vCJD) in populations exposed to bovine spongiform encephalopathy (BSE) and understanding mechanisms of neurodegeneration. In mice, aspects of prion disease susceptibility can be modelled by examining the incubation period following experimental inoculation. Quantitative trait linkage studies have already identified multiple candidate genes; however, it is also possible to take an individual candidate gene approach. Rarb and Stmn2 were selected as candidates based on the known association with vCJD. Because of the increasing overlap described between prion and Alzheimer's diseases we also chose Clu, Picalm and Cr1, which were identified as part of Alzheimer's disease GWAS. Clusterin (Clu) was considered to be of particular interest as it has already been implicated in prion disease. Approximately 1,000 heterogeneous stock (HS) mice were inoculated intra-cerebrally with Chandler/RML prions and incubation times were recorded. Candidate genes were evaluated by sequencing the whole transcript including exon-intron boundaries and potential promoters in the parental lines of the HS mice. Representative SNPs were genotyped in the HS mice. No SNPs were identified in Cr1 and no statistical association with incubation time was seen for Clu (P=0.96) and Picalm (P=0.91). Significant associations were seen for both Stmn2 (P=0.04) and Rarb (P=0.0005), however, this was only highly significant for Rarb. This data provides significant further support for a role for the Rarb region of Mmu14 and Stmn2 in prion disease.	[Grizenkova, Julia] UCL, MRC Prion Unit, London, England; UCL, Dept Neurodegenerat Dis, UCL Inst Neurol, London, England	University of London; University College London; University of London; University College London	Grizenkova, J (corresponding author), UCL, MRC Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk			Medical Research Council UK; MRC [MC_U123160652] Funding Source: UKRI; Medical Research Council [MC_U123160652] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council UK. http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate C, 2004, J NEUROSCI METH, V138, P217, DOI 10.1016/j.jneumeth.2004.04.001; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cabral ALB, 2002, J BIOL CHEM, V277, P5675, DOI 10.1074/jbc.M104815200; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HITZEMANN B, 1994, J PHARMACOL EXP THER, V271, P969; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LANDER ES, 1989, GENETICS, V121, P185; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moreno CR, 2003, GENETICS, V165, P2085; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PARKIN ET, 2007, P NATL ACAD SCI US; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Xu F, 2008, BBA-MOL BASIS DIS, V1782, P615, DOI 10.1016/j.bbadis.2008.08.004; Yamazaki K, 2003, BIOCHEM BIOPH RES CO, V305, P1034, DOI 10.1016/S0006-291X(03)00801-5	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15019	10.1371/journal.pone.0015019	http://dx.doi.org/10.1371/journal.pone.0015019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151910	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300013
J	Bartee, E; Eyster, CA; Viswanathan, K; Mansouri, M; Donaldson, JG; Fruh, K				Bartee, Eric; Eyster, Craig A.; Viswanathan, Kasinath; Mansouri, Mandana; Donaldson, Julie G.; Frueh, Klaus			Membrane-Associated RING-CH Proteins Associate with Bap31 and Target CD81 and CD44 to Lysosomes	PLOS ONE			English	Article							MHC CLASS-II; COMPLEX CLASS-I; E3 UBIQUITIN LIGASE; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; DENDRITIC CELLS; AMINO-ACIDS; MASS-SPECTROMETRY; MARCH-II; MOLECULES	Membrane-associated RING-CH (MARCH) proteins represent a family of transmembrane ubiquitin ligases modulating intracellular trafficking and turnover of transmembrane protein targets. While homologous proteins encoded by gamma-2 herpesviruses and leporipoxviruses have been studied extensively, limited information is available regarding the physiological targets of cellular MARCH proteins. To identify host cell proteins targeted by the human MARCH-VIII ubiquitin ligase we used stable isotope labeling of amino-acids in cell culture (SILAC) to monitor MARCH-dependent changes in the membrane proteomes of human fibroblasts. Unexpectedly, we observed that MARCH-VIII reduced the surface expression of Bap31, a chaperone that predominantly resides in the endoplasmic reticulum (ER). We demonstrate that Bap31 associates with the transmembrane domains of several MARCH proteins and controls intracellular transport of MARCH proteins. In addition, we observed that MARCH-VIII reduced the surface expression of the hyaluronic acid-receptor CD44 and both MARCH-VIII and MARCH-IV sequestered the tetraspanin CD81 in endo-lysosomal vesicles. Moreover, gene knockdown of MARCH-IV increased surface levels of endogenous CD81 suggesting a constitutive involvement of this family of ubiquitin ligases in the turnover of tetraspanins. Our data thus suggest a role of MARCH-VIII and MARCH-IV in the regulated turnover of CD81 and CD44, two ubiquitously expressed, multifunctional proteins.	[Bartee, Eric] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Viswanathan, Kasinath; Mansouri, Mandana; Frueh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Eyster, Craig A.; Donaldson, Julie G.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bartee, E (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	Fruehk@ohsu.edu		Frueh, Klaus/0000-0001-8014-3877; Bartee, Eric/0000-0003-1793-446X	National Institutes of Health [RO1 CA/AI 094011, R21 CA 109674]; National Center for Research Resources [RR00163]; Ruth L. Kirschstein National Research Service Awards [T32 AI007472]; Oregon Health and Science University Tartar Trust; NATIONAL CANCER INSTITUTE [R21CA109674, R01CA094011] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000163, P51RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University Tartar Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by National Institutes of Health (RO1 CA/AI 094011, R21 CA 109674) and the National Center for Research Resources (RR00163) to K.F. and by the Ruth L. Kirschstein National Research Service Awards T32 AI007472 and the Oregon Health and Science University Tartar Trust to E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Abe F, 2009, J IMMUNOL, V182, P4776, DOI 10.4049/jimmunol.0800242; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de la Hera A, 1989, Int Immunol, V1, P598, DOI 10.1093/intimm/1.6.598; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Ducret A, 2003, EUR J BIOCHEM, V270, P342, DOI 10.1046/j.1432-1033.2003.03395.x; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Gottlinger HG, 2008, NATURE, V451, P406, DOI 10.1038/nature06364; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; ISHIDO S, MOL CELLS, V29, P229; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Regan JA, 2008, J VIROL, V82, P10042, DOI 10.1128/JVI.01240-08; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Szczesna-Skorupa E, 2006, J BIOL CHEM, V281, P4142, DOI 10.1074/jbc.M509522200; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200	58	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15132	10.1371/journal.pone.0015132	http://dx.doi.org/10.1371/journal.pone.0015132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151997	gold, Green Submitted, Green Published			2022-12-25	WOS:000284868000025
J	Xu, B; Gerin, I; Miao, HZ; Dang, VP; Johnson, CN; Xu, RC; Chen, XW; Cawthorn, WP; MacDougald, OA; Koenig, RJ				Xu, Bin; Gerin, Isabelle; Miao, Hongzhi; Dang Vu-Phan; Johnson, Craig N.; Xu, Ruichuan; Chen, Xiao-Wei; Cawthorn, William P.; MacDougald, Ormond A.; Koenig, Ronald J.			Multiple Roles for the Non-Coding RNA SRA in Regulation of Adipogenesis and Insulin Sensitivity	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; DEPENDENT KINASE INHIBITORS; BINDING PROTEIN-ALPHA; STROMAL CELL CLONE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; PPAR-GAMMA; HORMONE-RECEPTOR; ENERGY-BALANCE; C/EBP-ALPHA	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a master transcriptional regulator of adipogenesis. Hence, the identification of PPAR gamma coactivators should help reveal mechanisms controlling gene expression in adipose tissue development and physiology. We show that the non-coding RNA, Steroid receptor RNA Activator (SRA), associates with PPAR gamma and coactivates PPAR gamma-dependent reporter gene expression. Overexpression of SRA in ST2 mesenchymal precursor cells promotes their differentiation into adipocytes. Conversely, knockdown of endogenous SRA inhibits 3T3-L1 preadipocyte differentiation. Microarray analysis reveals hundreds of SRA-responsive genes in adipocytes, including genes involved in the cell cycle, and insulin and TNF alpha signaling pathways. Some functions of SRA may involve mechanisms other than coactivation of PPAR gamma. SRA in adipocytes increases both glucose uptake and phosphorylation of Akt and FOXO1 in response to insulin. SRA promotes S-phase entry during mitotic clonal expansion, decreases expression of the cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1, and increases phosphorylation of Cdk1/Cdc2. SRA also inhibits the expression of adipocyte-related inflammatory genes and TNF alpha-induced phosphorylation of c-Jun NH(2)-terminal kinase. In conclusion, SRA enhances adipogenesis and adipocyte function through multiple pathways.	[Xu, Bin; Xu, Ruichuan; MacDougald, Ormond A.; Koenig, Ronald J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Gerin, Isabelle; Cawthorn, William P.; MacDougald, Ormond A.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Miao, Hongzhi] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Dang Vu-Phan] Univ Michigan, Med Ctr, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Johnson, Craig N.] Univ Michigan, Med Ctr, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Xiao-Wei] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu	Cawthorn, William P./Y-2115-2019; Chen, Xiaowei/F-7026-2014; Cawthorn, William/K-1945-2012	Cawthorn, William P./0000-0001-7832-5057; Cawthorn, William/0000-0001-7832-5057; MacDougald, Ormond/0000-0001-6907-7960; Johnson, Craig/0000-0003-3955-7394; Chen, Xiao-Wei/0000-0001-6466-6248	Michigan Diabetes Research and Training Center (NIH) [5P60-DK020572]; National Institutes of Health [DK51563]; Belgian Funds National de la Recherche Scientifique; University of Michigan Center for Organogenesis; Royal Commission for the Exhibition (UK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051563, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Funds National de la Recherche Scientifique; University of Michigan Center for Organogenesis(University of Michigan System); Royal Commission for the Exhibition (UK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Pilot and Feasibility Grant and the Cell and Molecular Biology Core of the Michigan Diabetes Research and Training Center (NIH Grant 5P60-DK020572) (B.X., R.J.K), National Institutes of Health grant DK51563 to O.A.M., fellowships to I. G. from the Belgian Funds National de la Recherche Scientifique and the University of Michigan Center for Organogenesis, and Postdoctoral Research Fellowship to W.P.C. from the Royal Commission for the Exhibition of 1851 (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Ding J, 2003, BIOSCI BIOTECH BIOCH, V67, P314, DOI 10.1271/bbb.67.314; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fleming I, 1998, BIOCHEM J, V333, P719, DOI 10.1042/bj3330719; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Lebrun P, 2008, ACTA PHYSIOL, V192, P29, DOI 10.1111/j.1748-1716.2007.01782.x; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Xu B, 2004, J BIOL CHEM, V279, P33051, DOI 10.1074/jbc.M404930200; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhao XS, 2007, MOL ENDOCRINOL, V21, P686, DOI 10.1210/me.2006-0414; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	75	141	160	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14199	10.1371/journal.pone.0014199	http://dx.doi.org/10.1371/journal.pone.0014199			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152033	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000013
J	Saraswati, S; Alfaro, MP; Thorne, CA; Atkinson, J; Lee, E; Young, PP				Saraswati, Sarika; Alfaro, Maria P.; Thorne, Curtis A.; Atkinson, James; Lee, Ethan; Young, Pampee P.			Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling	PLOS ONE			English	Article							CATENIN DOWN-REGULATION; ISOLATED RAT HEARTS; BETA-CATENIN; SIGNALING PATHWAY; MYOCARDIAL INFARCT; PLASMA-MEMBRANE; STEM-CELLS; AXIN; TISSUE; PHOSPHORYLATION	Wnt signaling plays an important role in developmental and stem cell biology. To test the hypothesis that temporary inhibition of Wnt signaling will enhance granulation tissue and promote angiogenesis in tissue repair, we employed a recently characterized small molecule Wnt inhibitor. Pyrvinium is an FDA-approved drug that we identified as a Wnt inhibitor in a chemical screen for small molecules that stabilize beta-catenin and inhibit Axin degradation. Our subsequent characterization of pyrvinium has revealed that its critical cellular target in the Wnt pathway is Casein Kinase 1 alpha. Daily administration of pyrvinium directly into polyvinyl alcohol (PVA) sponges implanted subcutaneously in mice generated better organized and vascularized granulation tissue; this compound also increased the proliferative index of the tissue within the sponges. To evaluate its effect in myocardial repair, we induced a myocardial infarction (MI) by coronary artery ligation and administered a single intramyocardial dose of pyrvinium. Mice were evaluated by echocardiography at 7 and 30 days post-MI and treatment; post mortem hearts were evaluated by histology at 30 days. Pyrvinium reduced adverse cardiac remodeling demonstrated by decreased left ventricular internal diameter in diastole (LVIDD) as compared to a control compound. Increased Ki-67(+) cells were observed in peri-infarct and distal myocardium of pyrvinium-treated animals. These results need to be further followed-up to determine if therapeutic inhibition of canonical Wnt may avert adverse remodeling after ischemic injury and its impact on myocardial repair and regeneration.	[Saraswati, Sarika; Alfaro, Maria P.; Atkinson, James; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Thorne, Curtis A.; Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN USA; [Atkinson, James; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Saraswati, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu			National Institutes of Health (NIH) [R01-HL088424, HL08842402S1, RO1-GM081635]; Veterans Affairs merit award; American Cancer Society [RSG-05-126-01]; National Cancer Institute [P50 CA95103]; National Institutes of Health [1 R01 GM081635-01]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006528] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01-HL088424, HL08842402S1, RO1-GM081635 and a Veterans Affairs merit award to PPY; American Cancer Society Research Scholar Grant RSG-05-126-01, National Cancer Institute Grant GI SPORE P50 CA95103, and National Institutes of Health Grant 1 R01 GM081635-01 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Bak I, 2006, AM J PHYSIOL-HEART C, V291, pH1329, DOI 10.1152/ajpheart.01243.2005; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Juhasz B, 2007, ANTIOXID REDOX SIGN, V9, P1851, DOI 10.1089/ars.2006.1535; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Kovacs P, 2001, N-S ARCH PHARMACOL, V364, P501, DOI 10.1007/s002100100483; KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9; LaFramboise WA, 2005, J MOL CELL CARDIOL, V38, P103, DOI 10.1016/j.yjmcc.2004.09.011; Malekar P, 2010, HYPERTENSION, V55, P939, DOI 10.1161/HYPERTENSIONAHA.109.141127; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Oerlemans MI, 2009, CIRCULATION, V120, pS847; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Prabhu SD, 2005, J MOL CELL CARDIOL, V38, P547, DOI 10.1016/j.yjmcc.2005.01.014; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V42, P1487, DOI 10.1016/j.freeradbiomed.2007.02.011; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van de Schans VAM, 2007, HYPERTENSION, V49, P473, DOI 10.1161/01.HYP.0000255946.55091.24; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105	52	115	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15521	10.1371/journal.pone.0015521	http://dx.doi.org/10.1371/journal.pone.0015521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21170416	Green Submitted, gold, Green Published			2022-12-25	WOS:000284686500045
J	Fujita, K; Sakamoto, S; Ono, Y; Wakao, M; Suda, Y; Kitahara, K; Suganuma, T				Fujita, Kiyotaka; Sakamoto, Shiho; Ono, Yuki; Wakao, Masahiro; Suda, Yasuo; Kitahara, Kanefumi; Suganuma, Toshihiko			Molecular Cloning and Characterization of a beta-L-Arabinobiosidase in Bifidobacterium longum That Belongs to a Novel Glycoside Hydrolase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-EXCHANGE CHROMATOGRAPHY; PULSED AMPEROMETRIC DETECTION; ALPHA-L-ARABINOFURANOSIDASE; HYDROXYPROLINE-ARABINOSIDES; SEQUENCE SIMILARITIES; POTENTIAL PREBIOTICS; SOLANUM-TUBEROSUM; POTATO LECTIN; IN-VITRO; CARBOHYDRATE	Extensin is a glycoprotein that is rich in hydroxyprolines linked to beta-L-arabinofuranosides. In this study, we cloned a hypBA2 gene that encodes a novel beta-L-arabinobiosidase from Bifidobacterium longum JCM 1217. This enzyme does not have any sequence similarity with other glycoside hydrolase families but has 38-98% identity to hypothetical proteins in Bifidobacterium and Xanthomonas strains. The recombinant enzyme liberated L-arabinofuranose (Araf)-beta 1,2-Araf disaccharide from carrot extensin, potato lectin, and Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(3)-Hyp) but not Araf-alpha 1,3-Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(4)-Hyp) or Araf-beta 1,2-Araf-beta-Hyp (Ara(2)-Hyp), which indicated that it was specific for unmodified Ara(3)-Hyp substrate. The enzyme also transglycosylated 1-alkanols with retention of the anomeric configuration. This is the first report of an enzyme that hydrolyzes Hyplinked beta-L-arabinofuranosides, which defines a new family of glycoside hydrolases, glycoside hydrolase family 121.	[Fujita, Kiyotaka; Sakamoto, Shiho; Ono, Yuki; Kitahara, Kanefumi; Suganuma, Toshihiko] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan	Kagoshima University; Kagoshima University	Fujita, K (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan.	kfujita@ms.kagoshima-u.ac.jp		Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [22780094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Young Scientists (B) 22780094 from the Japan Society for the Promotion of Science.	AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; BIAVATI B, 1982, INT J SYST BACTERIOL, V32, P358, DOI 10.1099/00207713-32-3-358; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Campargue C, 1998, ANAL BIOCHEM, V257, P20, DOI 10.1006/abio.1997.2526; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cardoso SM, 2002, CARBOHYD RES, V337, P917, DOI 10.1016/S0008-6215(02)00082-4; Ciopraga J, 2000, J BIOCHEM, V128, P855, DOI 10.1093/oxfordjournals.jbchem.a022824; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; Gueimonde M, 2007, ARCH MICROBIOL, V187, P145, DOI 10.1007/s00203-006-0181-x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOLMES EW, 1979, ANAL BIOCHEM, V93, P167, DOI 10.1016/S0003-2697(79)80060-3; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Magliano TMA, 1998, J EXP BOT, V49, P1491, DOI 10.1093/jexbot/49.326.1491; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Pastell H, 2009, J AGR FOOD CHEM, V57, P8598, DOI 10.1021/jf901397b; ROY D, 1990, J APPL BACTERIOL, V69, P739, DOI 10.1111/j.1365-2672.1990.tb01571.x; Salvador LD, 2000, J AGR FOOD CHEM, V48, P3448, DOI 10.1021/jf991089z; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Suzuki Y, 2004, J JPN SOC HORTIC SCI, V73, P574, DOI 10.2503/jjshs.73.574; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; Van Den Broek LAM, 2008, INNOV FOOD SCI EMERG, V9, P401, DOI 10.1016/j.ifset.2007.12.006; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121	36	39	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5143	5150		10.1074/jbc.M110.190512	http://dx.doi.org/10.1074/jbc.M110.190512			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149454	hybrid, Green Published			2022-12-25	WOS:000287230600022
J	Werner-Allen, JW; Lee, CJ; Liu, P; Nicely, NI; Wang, S; Greenleaf, AL; Zhou, P				Werner-Allen, Jon W.; Lee, Chul-Jin; Liu, Pengda; Nicely, Nathan I.; Wang, Su; Greenleaf, Arno L.; Zhou, Pei			cis-Proline-mediated Ser(P)(5) Dephosphorylation by the RNA Polymerase II C-terminal Domain Phosphatase Ssu72	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESS1 PROLYL-ISOMERASE; MESSENGER-RNA; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; ASSOCIATING PROTEINS; TYROSINE-PHOSPHATASE; CIS/TRANS ISOMERASES; YEAST; PHOSPHORYLATION; RECOGNITION	RNA polymerase II coordinates co-transcriptional events by recruiting distinct sets of nuclear factors to specific stages of transcription via changes of phosphorylation patterns along its C-terminal domain (CTD). Although it has become increasingly clear that proline isomerization also helps regulate CTD-associated processes, the molecular basis of its role is unknown. Here, we report the structure of the Ser(P)(5) CTD phosphatase Ssu72 in complex with substrate, revealing a remarkable CTD conformation with the Ser(P)(5)-Pro(6) motif in the cis configuration. We show that the cis-Ser(P)(5)-Pro(6) isomer is the minor population in solution and that Ess1-catalyzed cis-trans-proline isomerization facilitates rapid dephosphorylation by Ssu72, providing an explanation for recently discovered in vivo connections between these enzymes and a revised model for CTD-mediated small nuclear RNA termination. This work presents the first structural evidence of a cis-proline-specific enzyme and an unexpected mechanism of isomer-based regulation of phosphorylation, with broad implications for CTD biology.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Zhou, P (corresponding author), 270 Sands Bldg,Res Dr, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	, PEP-MX Core/AGV-4051-2022; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health [GM079376, GM040505]; Kamin Fellowship; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505, R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kamin Fellowship; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079376 (to P.Z.) and GM040505 (to A.L.G.). This work was also supported by a Kamin Fellowship (to J.W.W.-A.).; Crystal screening was performed at the Duke University Medical Center X-ray Crystallography Shared Resource. Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found on the SER-CAT web page. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38. We thank Louis Metzger and Jeffrey Boyles for enlightening discussions.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Palancade B, 2004, J MOL BIOL, V335, P415, DOI 10.1016/j.jmb.2003.10.036; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Toth G, 2001, PROTEINS, V43, P373, DOI 10.1002/prot.1050; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Weiwad M, 2004, J MOL BIOL, V339, P635, DOI 10.1016/j.jmb.2004.02.021; Wu WH, 1999, GENETICS, V153, P643; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Xu YX, 2004, CELL CYCLE, V3, P432; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	44	97	98	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5717	5726		10.1074/jbc.M110.197129	http://dx.doi.org/10.1074/jbc.M110.197129			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159777	hybrid, Green Published			2022-12-25	WOS:000287230600080
J	Kau, JH; Sun, DS; Huang, HS; Lien, TS; Huang, HH; Lin, HC; Chang, HH				Kau, Jyh-Hwa; Sun, Der-Shan; Huang, Hsuan-Shun; Lien, Te-Sheng; Huang, Hsin-Hsien; Lin, Hung-Chi; Chang, Hsin-Hou			Sublethal Doses of Anthrax Lethal Toxin on the Suppression of Macrophage Phagocytosis	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; MAP-KINASE-KINASE; BACILLUS-ANTHRACIS; MAMMALIAN-CELLS; ESCHERICHIA-COLI; PROTEIN; PHOSPHORYLATION; BACTERIA; APOPTOSIS; ADHESION	Background: Lethal toxin (LT), the major virulence factor produced by Bacillus anthracis, has been shown to suppress the immune system, which is beneficial to the establishment of B. anthracis infections. It has been suggested that the suppression of MEK/MAPK signaling pathways of leukocytes contributes to LT-mediated immunosuppressive effects. However, the involvement of MAPK independent pathways has not been clearly elucidated; nor has the crucial role played by LT in the early stages of infection. Determining whether LT exerts any pathological effects before being enriched to an MEK inhibitory level is an important next step in the furtherance of this field. Methodology/Principal Findings: Using a cell culture model, we determined that low doses of LT inhibited phagocytosis of macrophages, without influencing MAPK pathways. Consistent low doses of LT significantly suppressed bacterial clearance and enhanced the mortality of mice with bacteremia, without suppressing the MEK1 of splenic and peripheral blood mononuclear cells. Conclusion/Significance: These results suggest that LT suppresses the phagocytes in a dose range lower than that required to suppress MEK1 in the early stages of infection.	[Kau, Jyh-Hwa; Huang, Hsin-Hsien; Lin, Hung-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Sun, Der-Shan; Huang, Hsuan-Shun; Lien, Te-Sheng; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	National Defense Medical Center; Tzu Chi University	Kau, JH (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [95-2311-B-320-006, 96-2311-B-320-005-MY3, 99-2311-B-320-003-MY3]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. 95-2311-B-320-006, 96-2311-B-320-005-MY3 and 99-2311-B-320-003-MY3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Chang HH, 2003, CELL BIOL INT, V27, P123, DOI 10.1016/S1065-6995(02)00295-0; Chang HH, 2002, J INFECT DIS, V186, P743, DOI 10.1086/342600; Chang HH, 2000, J BIOMED SCI, V7, P42, DOI 10.1159/000025428; Chang HH, 2000, J BIOTECHNOL, V78, P115, DOI 10.1016/S0168-1656(99)00227-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coombes BK, 2004, CURR BIOL, V14, pR856, DOI 10.1016/j.cub.2004.09.043; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Cui XZ, 2006, J INFECT DIS, V193, P829, DOI 10.1086/500468; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; HUANG HS, 2010, BLOOD IN PRESS; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; LIAO GJ, 1994, BLOOD, V83, P2294; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Scherle PA, 1998, J IMMUNOL, V161, P5681; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394	51	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14289	10.1371/journal.pone.0014289	http://dx.doi.org/10.1371/journal.pone.0014289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170330	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400012
J	Djawe, K; Huang, L; Daly, KR; Levin, L; Koch, J; Schwartzman, A; Fong, S; Roth, B; Subramanian, A; Grieco, K; Jarlsberg, L; Walzer, PD				Djawe, Kpandja; Huang, Laurence; Daly, Kieran R.; Levin, Linda; Koch, Judy; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah; Walzer, Peter D.			Serum Antibody Levels to the Pneumocystis jirovecii Major Surface Glycoprotein in the Diagnosis of P. jirovecii Pneumonia in HIV plus Patients	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; SEROLOGIC RESPONSES; CARINII-PNEUMONIA; HUMORAL IMMUNITY; IGG ANTIBODIES; ANTIGEN; PREDICTORS; PROGRESSION; VACCINE; GLUCAN	Pneumocystis jirovecii remains an important cause of fatal pneumonia (Pneumocystis pneumonia or PcP) in HIV+ patients and other immunocompromised hosts. Despite many previous attempts, a clinically useful serologic test for P. jirovecii infection has never been developed. Methods/Principal Findings: We analyzed serum antibody responses to the P. jirovecii major surface glycoprotein recombinant fragment C1 (MsgC1) in 110 HIV+ patients with active PcP (cases) and 63 HIV+ patients with pneumonia due to other causes (controls) by an enzyme-linked immunosorbent assay (ELISA). The cases had significantly higher IgG and IgM antibody levels to MsgC1 than the controls at hospital admission (week 0) and intervals up to at least 1 month thereafter. The sensitivity, specificity and positive predictive value (PPV) of IgG antibody levels increased from 57.2%, 61.7% and 71.5% at week 0 to 63.4%, 100%, and 100%, respectively, at weeks 3-4. The sensitivity, specificity and PPV of IgM antibody levels rose from 59.7%, 61.3%, and 79.3% at week 0 to 74.6%, 73.7%, and 89.8%, respectively, at weeks 3-4. Multivariate analysis revealed that a diagnosis of PcP was the only independent predictor of high IgG and IgM antibody levels to MsgC1. A high LDH level, a nonspecific marker of lung damage, was an independent predictor of low IgG antibody levels to MsgC1. Conclusions/Significance: The results suggest that the ELISA shows promise as an aid to the diagnosis of PCP in situations where diagnostic procedures cannot be performed. Further studies in other patient populations are needed to better define the usefulness of this serologic test.	[Djawe, Kpandja; Daly, Kieran R.; Koch, Judy; Walzer, Peter D.] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA; [Djawe, Kpandja; Levin, Linda; Walzer, Peter D.] Univ Coll Med, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Huang, Laurence; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Huang, Laurence; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Daly, Kieran R.; Koch, Judy; Walzer, Peter D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati	Djawe, K (corresponding author), Vet Affairs Med Ctr, Cincinnati, OH 45267 USA.	peter.walzer@med.va.gov	Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Fong, Serena/0000-0002-9803-3016; Jarlsberg, Leah/0000-0001-6548-6337	Medical Research Service; Department of Veterans Affairs [RO1AI-06492]; National Institutes of Health (NIH) [K24 HL087713, R01 HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, K24HL087713] Funding Source: NIH RePORTER	Medical Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Medical Research Service, Department of Veterans Affairs, RO1AI-06492 (to PDW), National Institutes of Health (NIH) K24 HL087713 and R01 HL090335 (LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; BURNS SM, 1990, J INFECTION, V20, P33, DOI 10.1016/S0163-4453(90)92280-X; Cagigi A, 2008, VACCINE, V26, P3016, DOI 10.1016/j.vaccine.2007.11.063; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Davis JL, 2008, THORAX, V63, P329, DOI 10.1136/thx.2007.088104; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DJAWE K, 2010, INTERNAT J IN PRESS; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; ELVIN K, 1994, SCAND J INFECT DIS, V26, P33, DOI 10.3109/00365549409008588; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; GARBE TR, 1994, INFECT IMMUN, V62, P3092, DOI 10.1128/IAI.62.8.3092-3101.1994; GOLDENBERG DM, 1994, J NUD MED, V35, P1034; HOFMANN B, 1985, J INFECT DIS, V152, P838, DOI 10.1093/infdis/152.4.838; HUANG L, 1995, AM J RESP CRIT CARE, V151, P1866, DOI 10.1164/ajrccm.151.6.7767533; Kaplan JE, 1998, J INFECT DIS, V178, P1126, DOI 10.1086/515658; KEELY SP, 1995, J INFECT DIS, V172, P595, DOI 10.1093/infdis/172.2.595; KOVACS JA, 1993, J BIOL CHEM, V268, P6034; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Kroon FP, 1997, CLIN INFECT DIS, V25, P600, DOI 10.1086/513750; Kutty G, 2003, INFECT IMMUN, V71, P571, DOI 10.1128/IAI.71.1.571-574.2003; Laursen AL, 1998, SCAND J INFECT DIS, V30, P495, DOI 10.1080/00365549850161511; LUNDGREN B, 1993, SCAND J INFECT DIS, V25, P515, DOI 10.3109/00365549309008535; LUNDGREN B, 1992, J INFECT DIS, V165, P1151, DOI 10.1093/infdis/165.6.1151; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2008, CLIN INFECT DIS, V47, pE64, DOI 10.1086/591701; MORROW BM, 2010, PEDIAT INFECT DIS J; Nkinin SW, 2009, ACTA TROP, V112, P219, DOI 10.1016/j.actatropica.2009.07.030; PEGLOW SL, 1990, J INFECT DIS, V161, P296, DOI 10.1093/infdis/161.2.296; PIFER LLW, 1987, J CLIN MICROBIOL, V25, P991, DOI 10.1128/JCM.25.6.991-995.1987; Pisculli ML, 2008, CLIN INFECT DIS, V46, P1928, DOI 10.1086/588564; Rimland D, 2002, AIDS, V16, P85, DOI 10.1097/00002030-200201040-00011; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Singh MP, 2005, BRIT J BIOMED SCI, V62, P81, DOI 10.1080/09674845.2005.11732690; Stansell JD, 1997, AM J RESP CRIT CARE, V155, P60, DOI 10.1164/ajrccm.155.1.9001290; Stringer JR, 2001, INFECT IMMUN, V69, P627, DOI 10.1128/IAI.69.2.627-639.2001; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Walzer PD, 1999, CLIN DIAGN LAB IMMUN, V6, P149, DOI 10.1128/CDLI.6.2.149-155.1999; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803; Watanabe T, 2009, CLIN INFECT DIS, V49, P1128, DOI 10.1086/605579	47	20	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14259	10.1371/journal.pone.0014259	http://dx.doi.org/10.1371/journal.pone.0014259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151564	gold, Green Submitted, Green Published			2022-12-25	WOS:000285135800002
J	Wilson, ME; Boumaza, I; Lacomis, D; Bowser, R				Wilson, Meghan E.; Boumaza, Imene; Lacomis, David; Bowser, Robert			Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							IN-VIVO; CEREBROSPINAL-FLUID; PROGNOSTIC-FACTORS; ALS; DEATH; CSF; IDENTIFICATION; EXPRESSION; SURVIVAL; NEURONS	Amyotrophic lateral sclerosis (ALS) is a fatal neurologic disease characterized by progressive motor neuron degeneration. Clinical disease management is hindered by both a lengthy diagnostic process and the absence of effective treatments. Reliable panels of diagnostic, surrogate, and prognostic biomarkers are needed to accelerate disease diagnosis and expedite drug development. The cysteine protease inhibitor cystatin C has recently gained interest as a candidate diagnostic biomarker for ALS, but further studies are required to fully characterize its biomarker utility. We used quantitative enzyme-linked immunosorbent assay (ELISA) to assess initial and longitudinal cerebrospinal fluid (CSF) and plasma cystatin C levels in 104 ALS patients and controls. Cystatin C levels in ALS patients were significantly elevated in plasma and reduced in CSF compared to healthy controls, but did not differ significantly from neurologic disease controls. In addition, the direction of longitudinal change in CSF cystatin C levels correlated to the rate of ALS disease progression, and initial CSF cystatin C levels were predictive of patient survival, suggesting that cystatin C may function as a surrogate marker of disease progression and survival. These data verify prior results for reduced cystatin C levels in the CSF of ALS patients, identify increased cystatin C levels in the plasma of ALS patients, and reveal correlations between CSF cystatin C levels to both ALS disease progression and patient survival.	[Wilson, Meghan E.; Boumaza, Imene; Bowser, Robert] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Lacomis, David] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wilson, ME (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	bowserrp@upmc.edu			University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research; NIH [NS061867]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS061867, R01NS061867] Funding Source: NIH RePORTER	University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research funding was provided by the University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research and NIH grant NS061867 to Robert Bowser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowser R, 2006, EXPERT REV MOL DIAGN, V6, P387, DOI 10.1586/14737159.6.3.387; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, pS1, DOI 10.1080/14660820050515638; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; DiBernardo AB, 2006, BBA-MOL BASIS DIS, V1762, P1139, DOI 10.1016/j.bbadis.2006.03.007; GEORGE PM, 1989, CLIN CHEM, V35, P179; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Louwerse ES, 1997, J NEUROL SCI, V152, pS10, DOI 10.1016/S0022-510X(97)00238-4; Madero M, 2009, CURR OPIN NEPHROL HY, V18, P258, DOI 10.1097/MNH.0b013e328326f3dd; Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nagai A, 2002, ANN NY ACAD SCI, V977, P315, DOI 10.1111/j.1749-6632.2002.tb04832.x; Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.020; Okamoto K, 2008, NEUROPATHOLOGY, V28, P109, DOI 10.1111/j.1440-1789.2007.00873.x; Paraoan L, 2007, EXP EYE RES, V84, P1019, DOI 10.1016/j.exer.2006.01.024; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Ryberg H, 2008, EXPERT REV PROTEOMIC, V5, P249, DOI 10.1586/14789450.5.2.249; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Sorensen EJ, 2004, AMYOTROPH LATERAL SC, V5, P86, DOI 10.1080/17434470410020030; Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311; Traynor BJ, 2004, NEUROLOGY, V63, P1933, DOI 10.1212/01.WNL.0000144345.49510.4E; Tsuji-Akimoto S, 2009, NEUROSCI LETT, V452, P52, DOI 10.1016/j.neulet.2009.01.026; TU GF, 1992, AM J PHYSIOL, V263, pR195, DOI 10.1152/ajpregu.1992.263.1.R195; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Wagner KR, 2009, NEUROLOGY, V72, P11, DOI 10.1212/01.wnl.0000338538.18938.9d; Xu L, 2005, NEUROBIOL DIS, V18, P152, DOI 10.1016/j.nbd.2004.08.012	30	63	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15133	10.1371/journal.pone.0015133	http://dx.doi.org/10.1371/journal.pone.0015133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151566	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000285135800015
J	Fowler, CB; Chesnick, IE; Moore, CD; O'Leary, TJ; Mason, JT				Fowler, Carol B.; Chesnick, Ingrid E.; Moore, Cedric D.; O'Leary, Timothy J.; Mason, Jeffrey T.			Elevated Pressure Improves the Extraction and Identification of Proteins Recovered from Formalin-Fixed, Paraffin-Embedded Tissue Surrogates	PLOS ONE			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; NONMETASTATIC LUNG ADENOCARCINOMA; EGG-WHITE LYSOZYME; ANTIGEN RETRIEVAL; PROTEOMIC ANALYSIS; HYDROSTATIC-PRESSURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; SERUM-ALBUMIN; X-RAY	Background: Proteomic studies of formalin-fixed paraffin-embedded (FFPE) tissues are frustrated by the inability to extract proteins from archival tissue in a form suitable for analysis by 2-D gel electrophoresis or mass spectrometry. This inability arises from the difficulty of reversing formaldehyde-induced protein adducts and cross-links within FFPE tissues. We previously reported the use of elevated hydrostatic pressure as a method for efficient protein recovery from a hen egg-white lysozyme tissue surrogate, a model system developed to study formalin fixation and histochemical processing. Principal Findings: In this study, we demonstrate the utility of elevated hydrostatic pressure as a method for efficient protein recovery from FFPE mouse liver tissue and a complex multi-protein FFPE tissue surrogate comprised of hen egg-white lysozyme, bovine carbonic anhydrase, bovine ribonuclease A, bovine serum albumin, and equine myoglobin (55:15:15:10:5 wt%). Mass spectrometry of the FFPE tissue surrogates retrieved under elevated pressure showed that both the low and high-abundance proteins were identified with sequence coverage comparable to that of the surrogate mixture prior to formaldehyde treatment. In contrast, non-pressure-extracted tissue surrogate samples yielded few positive and many false peptide identifications. Studies with soluble formalin-treated bovine ribonuclease A demonstrated that pressure modestly inhibited the rate of reversal (hydrolysis) of formaldehyde-induced protein cross-links. Dynamic light scattering studies suggest that elevated hydrostatic pressure and heat facilitate the recovery of proteins free of formaldehyde adducts and cross-links by promoting protein unfolding and hydration with a concomitant reduction in the average size of the protein aggregates. Conclusions: These studies demonstrate that elevated hydrostatic pressure treatment is a promising approach for improving the recovery of proteins from FFPE tissues in a form suitable for proteomic analysis.	[Fowler, Carol B.; Chesnick, Ingrid E.; Moore, Cedric D.; Mason, Jeffrey T.] Armed Forces Inst Pathol, Dept Biophys, Rockville, MD USA; [Fowler, Carol B.; O'Leary, Timothy J.] Vet Hlth Adm, Biomed Lab Res & Dev Serv, Washington, DC USA	United States Department of Defense; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Fowler, CB (corresponding author), Armed Forces Inst Pathol, Dept Biophys, Rockville, MD USA.	carol.fowler1@us.army.mil	Oleary, Timothy/AAF-2829-2021; Oleary, Timothy/AAE-5219-2021	O'LEARY, TIMOTHY/0000-0002-2435-9136	National Cancer Institute, National Institutes of Health [1R21 CA134359]; NATIONAL CANCER INSTITUTE [R21CA134359] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under grants 1R21 CA134359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; AZIMZADEH O, 2010, J PROTEOME RES; Balgley BM, 2009, J PROTEOME RES, V8, P917, DOI 10.1021/pr800503u; BERTHOU J, 1983, PROC R SOC SER B-BIO, V217, P471, DOI 10.1098/rspb.1983.0021; Bratthauer GL, 2010, METHODS MOL BIOL, V588, P93, DOI 10.1007/978-1-59745-324-0_13; Buxbaum JL, 2010, J PANCREAS, V11, P536; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Caudle WM, 2010, EXPERT REV NEUROTHER, V10, P925, DOI [10.1586/ern.10.54, 10.1586/ERN.10.54]; Fleron M, 2010, J PROTEOMICS, V73, P1986, DOI 10.1016/j.jprot.2010.06.003; Fowler CB, 2008, LAB INVEST, V88, p365A; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Fowler CB, 2007, LAB INVEST, V87, P836, DOI 10.1038/labinvest.3700596; Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020; Guo T, 2007, J HISTOCHEM CYTOCHEM, V55, P763, DOI 10.1369/jhc.7A7177.2007; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Kobashigawa Y, 1999, PROTEIN SCI, V8, P2765; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; Machida K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013470; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; Moreno FJ, 2003, J AGR FOOD CHEM, V51, P394, DOI 10.1021/jf025731s; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; POOLE S, 1984, J SCI FOOD AGR, V35, P701, DOI 10.1002/jsfa.2740350618; PRIETO DA, 2005, BIOTECHNIQUES S, V0038, P00032, DOI DOI 10.2144/05386SU06; Rait VK, 2004, LAB INVEST, V84, P300, DOI 10.1038/labinvest.3700041; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Refaee M, 2003, J MOL BIOL, V327, P857, DOI 10.1016/S0022-2836(03)00209-2; Reymond MA, 2007, ADV CLIN CHEM, V44, P103, DOI 10.1016/S0065-2423(07)44004-5; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; Strader MB, 2006, ANAL CHEM, V78, P125, DOI 10.1021/ac051348l; Valera VA, 2010, J CANCER, V1, P184; Velic A, 2010, SEMIN NEPHROL, V30, P487, DOI 10.1016/j.semnephrol.2010.07.006; Voshol H, 2009, FEBS J, V276, P6871, DOI 10.1111/j.1742-4658.2009.07395.x; WLODAWER A, 1982, J BIOL CHEM, V257, P1325; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768	43	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14253	10.1371/journal.pone.0014253	http://dx.doi.org/10.1371/journal.pone.0014253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170380	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100007
J	Howe, LD; Tilling, K; Benfield, L; Logue, J; Sattar, N; Ness, AR; Smith, GD; Lawlor, DA				Howe, Laura D.; Tilling, Kate; Benfield, Li; Logue, Jennifer; Sattar, Naveed; Ness, Andy R.; Smith, George Davey; Lawlor, Debbie A.			Changes in Ponderal Index and Body Mass Index across Childhood and Their Associations with Fat Mass and Cardiovascular Risk Factors at Age 15	PLOS ONE			English	Article							INFANCY WEIGHT-GAIN; OVERWEIGHT; ADOLESCENTS; CHILDREN; OBESITY; PREVALENCE; BMI	Background: Little is known about whether associations between childhood adiposity and later adverse cardiovascular health outcomes are driven by tracking of overweight from childhood to adulthood and/or by vascular and metabolic changes from childhood overweight that persist into adulthood. Our objective is to characterise associations between trajectories of adiposity across childhood and a wide range of cardiovascular risk factors measured in adolescence, and explore the extent to which these are mediated by fat mass at age 15. Methods and Findings: Using data from the Avon Longitudinal Study of Parents and Children, we estimated individual trajectories of ponderal index (PI) from 0-2 years and BMI from 2-10 years using random-effects linear spline models (N = 4601). We explored associations between PI/BMI trajectories and DXA-determined total-body fat-mass and cardiovascular risk factors at 15 years (systolic and diastolic blood pressure, fasting LDL-and HDL-cholesterol, triglycerides, C-reactive protein, glucose, insulin) with and without adjustment for confounders. Changes in PI/BMI during all periods of infancy and childhood were associated with greater DXA-determined fat-mass at age 15. BMI changes in childhood, but not PI changes from 0-2 years, were associated with most cardiovascular risk factors in adolescence; associations tended to be strongest for BMI changes in later childhood (ages 8.5-10), and were largely mediated by fat mass at age 15. Conclusion: Changes in PI/BMI from 0-10 years were associated with greater fat-mass at age 15. Greater increases in BMI from age 8.5-10 years are most strongly associated with cardiovascular risk factors at age 15, with much of these associations mediated by fat-mass at this age. We found little evidence supporting previous reports that rapid PI changes in infancy are associated with future cardiovascular risk. This study suggests that associations between early overweight and subsequent adverse cardiovascular health are largely due to overweight children tending to remain overweight.	[Howe, Laura D.; Benfield, Li; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Howe, Laura D.; Tilling, Kate; Benfield, Li; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Logue, Jennifer; Sattar, Naveed] Univ Glasgow, Fac Med, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ness, Andy R.] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Glasgow; University of Bristol	Howe, LD (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	laura.howe@bristol.ac.uk	Tilling, Kate/AAY-1578-2021; Davey Smith, George/A-7407-2013; Ness, Andy R/M-7612-2013; Logue, Jennifer/O-5076-2019; Berryman, Katie/J-4236-2014	Davey Smith, George/0000-0002-1407-8314; Ness, Andy R/0000-0003-3548-9523; Logue, Jennifer/0000-0001-9549-2738; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lawlor, Debbie A/0000-0002-6793-2262; Howe, Laura/0000-0003-3357-2796; Tilling, Kate/0000-0002-1010-8926	National Institutes of Health (NIH) [R01 DK077659]; UK Economic and Social Research Council [RES-060-23-0011]; UK Medical Research Council (MRC); Wellcome Trust; University of Bristol; UK MRC [G0600705]; ESRC [ES/E00234X/1] Funding Source: UKRI; MRC [G0600705] Funding Source: UKRI; Economic and Social Research Council [ES/E00234X/1] Funding Source: researchfish; Medical Research Council [G9815508, G0600705] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants from the National Institutes of Health (NIH) (R01 DK077659) and the UK Economic and Social Research Council (RES-060-23-0011). The latter provides the salary for LH. The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol provide core funding support for ALSPAC. The UK MRC (G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole T J, 2004, BMC Pediatr, V4, P6; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; FALASCHETTI E, 2010, EUROPEAN HE IN PRESS; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Skinner AC, 2009, PEDIATRICS, V124, pE905, DOI 10.1542/peds.2009-0179; *STATACORP, 2010, STAT 11 0 VERS; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747	21	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15186	10.1371/journal.pone.0015186	http://dx.doi.org/10.1371/journal.pone.0015186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170348	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100026
J	Ritsema, T; van Zanten, M; Leon-Reyes, A; Voesenek, LACJ; Millenaar, FF; Pieterse, CMJ; Peeters, AJM				Ritsema, Tita; van Zanten, Martijn; Leon-Reyes, Antonio; Voesenek, Laurentius A. C. J.; Millenaar, Frank F.; Pieterse, Corne M. J.; Peeters, Anton J. M.			Kinome Profiling Reveals an Interaction Between Jasmonate, Salicylate and Light Control of Hyponastic Petiole Growth in Arabidopsis thaliana	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PHYTOCHROME-A; PROTEIN-KINASES; TRANSCRIPTION FACTOR; METHYL JASMONATE; CELL-CYCLE; SIGNAL-TRANSDUCTION; NATURAL VARIATION; RESPONSIVE GENES; PLANT-RESISTANCE	Plants defend themselves against infection by biotic attackers by producing distinct phytohormones. Especially jasmonic acid (JA) and salicylic acid (SA) are well known defense-inducing hormones. Here, the effects of MeJA and SA on the Arabidopsis thaliana kinome were monitored using PepChip arrays containing kinase substrate peptides to analyze posttranslational interactions in MeJA and SA signaling pathways and to test if kinome profiling can provide leads to predict posttranslational events in plant signaling. MeJA and SA mediate differential phosphorylation of substrates for many kinase families. Also some plant specific substrates were differentially phosphorylated, including peptides derived from Phytochrome A, and Photosystem II D protein. This indicates that MeJA and SA mediate cross-talk between defense signaling and light responses. We tested the predicted effects of MeJA and SA using light-mediated upward leaf movement (differential petiole growth also called hyponastic growth). We found that MeJA, infestation by the JA-inducing insect herbivore Pieris rapae, and SA suppressed low light-induced hyponastic growth. MeJA and SA acted in a synergistic fashion via two (partially) divergent signaling routes. This work demonstrates that kinome profiling using PepChip arrays can be a valuable complementary, similar to omics tool to give directions towards predicting behavior of organisms after a given stimulus and can be used to obtain leads for physiological relevant phenomena in planta.	[Ritsema, Tita; van Zanten, Martijn; Leon-Reyes, Antonio; Voesenek, Laurentius A. C. J.; Millenaar, Frank F.; Pieterse, Corne M. J.; Peeters, Anton J. M.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Voesenek, Laurentius A. C. J.; Pieterse, Corne M. J.] Ctr BioSyst Genom, Wageningen, Netherlands	Utrecht University; Centre for BioSystems Genomics	Ritsema, T (corresponding author), Amsterdam Mol Therapeut, Amsterdam, Netherlands.		Pieterse, Corné/A-9326-2011; Peeters, Anton J.M./B-9610-2011; Voesenek, Laurentius A.C.J./B-9661-2011; van Zanten, Martijn/G-1969-2010	Pieterse, Corné/0000-0002-5473-4646; van Zanten, Martijn/0000-0002-2810-7374; Leon-Reyes, Antonio/0000-0001-9142-9694; Voesenek, Laurentius/0000-0002-3361-3837	TI Pharma [T3-103]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Dutch Organization for Scientific Research [865.04.002]	TI Pharma; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by TI Pharma (http://www.tipharma.com) grant: T3-103 (TR) and VICI grant 865.04.002 from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (http://www.nwo.nl), which is the Dutch Organization for Scientific Research (CMJP and TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Alvarez R, 2003, PLANT PHYSIOL, V132, P1097, DOI 10.1104/pp.103.023937; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Azad AK, 2004, PLANT CELL PHYSIOL, V45, P608, DOI 10.1093/pcp/pch069; Ballare CL, 2009, PLANT CELL ENVIRON, V32, P713, DOI 10.1111/j.1365-3040.2009.01958.x; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Benschop JJ, 2007, PLANT PHYSIOL, V143, P1013, DOI 10.1104/pp.106.092700; Booij-James IS, 2002, PLANT PHYSIOL, V130, P2069, DOI 10.1104/pp.013441; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen IC, 2007, PLANT PHYSIOL, V143, P1189, DOI 10.1104/pp.106.094185; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cox MCH, 2004, PLANT PHYSIOL, V136, P2948, DOI 10.1104/pp.104.049197; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Eisenbarth DA, 2005, J EXP BOT, V56, P1831, DOI 10.1093/jxb/eri173; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Feilner Tanja, 2007, V355, P379; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2007, PLANT J, V50, P108, DOI 10.1111/j.1365-313X.2007.03036.x; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; Jensen AB, 1998, PLANT J, V13, P691, DOI 10.1046/j.1365-313X.1998.00069.x; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kramer A, 2004, PHYTOCHEMISTRY, V65, P1777, DOI 10.1016/j.phytochem.2004.04.009; Kurashige NS, 2005, AM J BOT, V92, P21, DOI 10.3732/ajb.92.1.21; Lam WKF, 2001, J ECON ENTOMOL, V94, P1459, DOI 10.1603/0022-0493-94.6.1459; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; McGuire R, 2005, FUNCT ECOL, V19, P1025, DOI 10.1111/j.1365-2435.2005.01047.x; MCMICHAEL RW, 1990, BIOCHEMISTRY-US, V29, P3872, DOI 10.1021/bi00468a011; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Millenaar FF, 2009, NEW PHYTOL, V184, P141, DOI 10.1111/j.1469-8137.2009.02921.x; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Riemann M, 2009, PLANTA, V229, P1035, DOI 10.1007/s00425-009-0891-9; Ritsema T, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-3; Ritsema T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006605; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; Smith H, 1997, PLANT PHYSIOL, V114, P637, DOI 10.1104/pp.114.2.637; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stulemeijer IJE, 2007, PLANT PHYSIOL, V144, P1481, DOI 10.1104/pp.107.101063; Swiatek A, 2004, FEBS LETT, V572, P118, DOI 10.1016/j.febslet.2004.07.018; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thum KE, 2001, PLANT CELL, V13, P2747, DOI 10.1105/tpc.13.12.2747; Trupkin SA, 2007, PLANT MOL BIOL, V63, P669, DOI 10.1007/s11103-006-9115-x; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van Zanten M, 2010, CRIT REV PLANT SCI, V29, P300, DOI 10.1080/07352689.2010.502086; Winz RA, 2001, PLANT PHYSIOL, V125, P2189, DOI 10.1104/pp.125.4.2189; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Zhai QZ, 2007, PLANT CELL PHYSIOL, V48, P1061, DOI 10.1093/pcp/pcm076	82	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14255	10.1371/journal.pone.0014255	http://dx.doi.org/10.1371/journal.pone.0014255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170386	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100009
J	Bruno, JC; Freitag, NE				Bruno, Joseph C., Jr.; Freitag, Nancy E.			Constitutive Activation of PrfA Tilts the Balance of Listeria monocytogenes Fitness Towards Life within the Host versus Environmental Survival	PLOS ONE			English	Article							CENTRAL VIRULENCE REGULATOR; IN-VITRO TRANSCRIPTION; SIGMA-B; GENE-EXPRESSION; PLEIOTROPIC ACTIVATOR; MUTATIONAL ACTIVATION; CARBON METABOLISM; STRESS TOLERANCE; ACID TOLERANCE; GROWTH	PrfA is a key regulator of Listeria monocytogenes pathogenesis and induces the expression of multiple virulence factors within the infected host. PrfA is post-translationally regulated such that the protein becomes activated upon bacterial entry into the cell cytosol. The signal that triggers PrfA activation remains unknown, however mutations have been identified (prfA* mutations) that lock the protein into a high activity state. In this report we examine the consequences of constitutive PrfA activation on L. monocytogenes fitness both in vitro and in vivo. Whereas prfA* mutants were hyper-virulent during animal infection, the mutants were compromised for fitness in broth culture and under conditions of stress. Broth culture prfA*-associated fitness defects were alleviated when glycerol was provided as the principal carbon source; under these conditions prfA* mutants exhibited a competitive advantage over wild type strains. Glycerol and other three carbon sugars have been reported to serve as primary carbon sources for L. monocytogenes during cytosolic growth, thus prfA* mutants are metabolically-primed for replication within eukaryotic cells. These results indicate the critical need for environment-appropriate regulation of PrfA activity to enable L. monocytogenes to optimize bacterial fitness inside and outside of host cells.	[Bruno, Joseph C., Jr.; Freitag, Nancy E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bruno, JC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	nfreitag@uic.edu			NIAID [AI41816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041816, R29AI041816, R01AI041816] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public health service grant AI41816 (N.E.F) from NIAID. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P6848, DOI 10.1128/AEM.00442-08; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; Auerbuch V, 2001, INFECT IMMUN, V69, P5953, DOI 10.1128/IAI.69.9.5953-5957.2001; Barbuddhe SB, 2009, CURR TOP MICROBIOL, V337, P173, DOI 10.1007/978-3-642-01846-6_6; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Blackman IC, 1996, J FOOD PROTECT, V59, P827, DOI 10.4315/0362-028X-59.8.827; Bohne J, 1996, MOL MICROBIOL, V20, P1189, DOI 10.1111/j.1365-2958.1996.tb02639.x; Bortolussi R, 2008, CAN MED ASSOC J, V179, P795, DOI 10.1503/cmaj.081377; Bubert A, 1999, MOL GEN GENET, V261, P323, DOI 10.1007/s004380050973; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1097; Davis MJ, 1996, MICROBIOL-UK, V142, P2975, DOI 10.1099/13500872-142-10-2975; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; EDMAN DC, 1968, J BACTERIOL, V96, P352, DOI 10.1128/JB.96.2.352-357.1968; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fenlon D. R., 1999, Listeria, listeriosis and food safety., P21; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; Freitag NE, 1999, INFECT IMMUN, V67, P1844; FREITAG NE, 1994, MOL MICROBIOL, V12, P845, DOI 10.1111/j.1365-2958.1994.tb01070.x; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; GRAY ML, 1966, BACTERIOL REV, V30, P309, DOI 10.1128/MMBR.30.2.309-382.1966; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kazmierczak MJ, 2006, MICROBIOL-SGM, V152, P1827, DOI 10.1099/mic.0.28758-0; Kim H, 2005, MICROBIOL-SGM, V151, P3215, DOI 10.1099/mic.0.28070-0; Kim H, 2004, INFECT IMMUN, V72, P7374, DOI 10.1128/IAI.72.12.7374-7378.2004; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lalic-Multhaler M, 2001, MOL MICROBIOL, V42, P111, DOI 10.1046/j.1365-2958.2001.02607.x; LAMPIDIS R, 1994, MOL MICROBIOL, V13, P141, DOI 10.1111/j.1365-2958.1994.tb00409.x; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Miner MD, 2008, MICROB PATHOGENESIS, V45, P273, DOI 10.1016/j.micpath.2008.06.006; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; O'Byrne CP, 2008, ADV APPL MICROBIOL, V65, P115, DOI 10.1016/S0065-2164(08)00605-9; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; PARK SF, 1993, MOL MICROBIOL, V8, P653, DOI 10.1111/j.1365-2958.1993.tb01609.x; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; Rauch M, 2005, J BACTERIOL, V187, P800, DOI 10.1128/JB.187.2.800-804.2005; Renzoni A, 1997, INFECT IMMUN, V65, P1515, DOI 10.1128/IAI.65.4.1515-1518.1997; Ripio MT, 1998, FEMS MICROBIOL LETT, V158, P45, DOI 10.1016/S0378-1097(97)00498-9; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Ripio MT, 1996, RES MICROBIOL, V147, P371, DOI 10.1016/0923-2508(96)84712-7; Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005; Rocourt J., 1999, Listeria, listeriosis and food safety., P1; Rouquette C, 1996, MOL MICROBIOL, V21, P977, DOI 10.1046/j.1365-2958.1996.641432.x; Ryser E. T., 1999, Listeria, listeriosis and food safety., P299; Schmid B, 2009, APPL ENVIRON MICROB, V75, P1621, DOI 10.1128/AEM.02154-08; Schwab U, 2005, FEMS MICROBIOL LETT, V245, P329, DOI 10.1016/j.femsle.2005.03.025; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; SHEEHAN B, 1995, J BACTERIOL, V177, P6469, DOI 10.1128/jb.177.22.6469-6476.1995; Shetron-Rama LM, 2003, MOL MICROBIOL, V48, P1537, DOI 10.1046/j.1365-2958.2003.03534.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vega Y, 2004, MOL MICROBIOL, V52, P1553, DOI 10.1111/j.1365-2958.2004.04052.x; Vega Y, 1998, J BACTERIOL, V180, P6655, DOI 10.1128/JB.180.24.6655-6660.1998; Velge P, 2007, MICROBIOL-SGM, V153, P995, DOI 10.1099/mic.0.2006/002238-0; Vugia D., 2009, Morbidity and Mortality Weekly Report, V58, P333; Walecka E, 2009, POL J VET SCI, V12, P575; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; YOUNGMAN P, 1987, PLASMIDS PRACTICAL A, P79	90	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15138	10.1371/journal.pone.0015138	http://dx.doi.org/10.1371/journal.pone.0015138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151923	Green Published, gold, Green Submitted			2022-12-25	WOS:000285041800007
J	Levitan, O; Sudhaus, S; LaRoche, J; Berman-Frank, I				Levitan, Orly; Sudhaus, Stefanie; LaRoche, Julie; Berman-Frank, Ilana			The Influence of pCO(2) and Temperature on Gene Expression of Carbon and Nitrogen Pathways in Trichodesmium IMS101	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; MARINE CYANOBACTERIUM; N-2 FIXATION; CO2-CONCENTRATING MECHANISM; NATURAL-POPULATIONS; LIGHT; PHOTOSYNTHESIS; PCR; METABOLISM; DIVERSITY	Growth, protein amount, and activity levels of metabolic pathways in Trichodesmium are influenced by environmental changes such as elevated pCO(2) and temperature. This study examines changes in the expression of essential metabolic genes in Trichodesmium grown under a matrix of pCO(2) (400 and 900 mu atm) and temperature (25 and 31 degrees C). Using RT-qPCR, we studied 21 genes related to four metabolic functional groups: CO2 concentrating mechanism (bicA1, bicA2, ccmM, ccmK2, ccmK3, ndhF4, ndhD4, ndhL, chpX), energy metabolism (atpB, sod, prx, glcD), nitrogen metabolism (glnA, hetR, nifH), and inorganic carbon fixation and photosynthesis (rbcL, rca, psaB, psaC, psbA). nifH and most photosynthetic genes exhibited relatively high abundance and their expression was influenced by both environmental parameters. A two to three orders of magnitude increase was observed for glnA and hetR only when both pCO(2) and temperature were elevated. CO2 concentrating mechanism genes were not affected by pCO(2) and temperature and their expression levels were markedly lower than that of the nitrogen metabolism and photosynthetic genes. Many of the CO2 concentrating mechanism genes were co-expressed throughout the day. Our results demonstrate that in Trichodesmium, CO2 concentrating mechanism genes are constitutively expressed. Co-expression of genes from different functional groups were frequently observed during the first half of the photoperiod when oxygenic photosynthesis and N-2 fixation take place, pointing at the tight and complex regulation of gene expression in Trichodesmium. Here we provide new data linking environmental changes of pCO(2) and temperature to gene expression in Trichodesmium. Although gene expression indicates an active metabolic pathway, there is often an uncoupling between transcription and enzyme activity, such that transcript level cannot usually be directly extrapolated to metabolic activity.	[Levitan, Orly; Berman-Frank, Ilana] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Sudhaus, Stefanie; LaRoche, Julie] Univ Kiel, IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany	Bar Ilan University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Levitan, O (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	levitao@gmail.com	LaRoche, Julie/A-1109-2010	Levitan, Orly/0000-0001-5248-8501; LaRoche, Julie/0000-0003-4809-6411; Berman-Frank, Ilana/0000-0003-3497-1844	BMBF-MOST [1950]; Reiger Fellowship for Environmental Studies; Israeli Ministry of Science; Office of Science of the U. S. Department of Energy [DE-AC02-05CH11231]	BMBF-MOST(Federal Ministry of Education & Research (BMBF)); Reiger Fellowship for Environmental Studies; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Office of Science of the U. S. Department of Energy(United States Department of Energy (DOE))	This work was conducted as part of the BMBF-MOST grant No. 1950 to IBF and JLR. O. Levitan was supported by a Reiger Fellowship for Environmental Studies and by the Eshkol scholarship from the Israeli Ministry of Science. Trichodesmium genome published on the Joint Genome Institute (JGI) website (http://genome.jgi-psf.org/finished_microbes/trier/trier.home.html), conducted by the U. S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpenter EJ, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P141, DOI 10.1016/B978-0-12-372522-6.00004-9; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Chen YB, 1999, PLANT MOL BIOL, V41, P89, DOI 10.1023/A:1006231805030; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; El-Shehawy R, 2003, MICROBIOL-SGM, V149, P1139, DOI 10.1099/mic.0.26170-0; Hewson I, 2009, ISME J, V3, P1286, DOI 10.1038/ismej.2009.75; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Janson S, 1998, FEMS MICROBIOL LETT, V168, P173, DOI 10.1111/j.1574-6968.1998.tb13270.x; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Kaneko T, 1996, PLANT MOL BIOL, V31, P193, DOI 10.1007/BF00020621; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kaplan A, 1994, MOL BIOL CYANOBACTER, P469, DOI DOI 10.1007/978-94-011-0227-8_15; Kaplan Aaron, 2008, P305; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Kupper H, 2004, PLANT PHYSIOL, V135, P2120, DOI 10.1104/pp.104.045963; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Levitan O, 2010, ENVIRON MICROBIOL, V12, P1899, DOI 10.1111/j.1462-2920.2010.02195.x; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; OHKI K, 1992, J GEN MICROBIOL, V138, P2679, DOI 10.1099/00221287-138-12-2679; PALMQVIST K, 1994, PHYSIOL PLANTARUM, V90, P537; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; POSTGATE JR, 1998, ORIGINS UNIT NITROGE; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sandh G, 2009, FEMS MICROBIOL LETT, V295, P281, DOI 10.1111/j.1574-6968.2009.01608.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Shi T, 2010, ISME J, V4, P621, DOI 10.1038/ismej.2009.148; Stork T, 2005, J EXP BOT, V56, P3193, DOI 10.1093/jxb/eri316; Sultemeyer D, 1998, PLANT PHYSIOL, V116, P183, DOI 10.1104/pp.116.1.183; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Woodger FJ, 2007, J BACTERIOL, V189, P3335, DOI 10.1128/JB.01745-06; Wyman M, 1996, APPL ENVIRON MICROB, V62, P1073, DOI 10.1128/AEM.62.3.1073-1075.1996; Wyman M, 1999, APPL ENVIRON MICROB, V65, P3651; ZEHR JP, 1993, APPL ENVIRON MICROB, V59, P669, DOI 10.1128/AEM.59.3.669-676.1993; Zhang JY, 2009, MICROBIOL-SGM, V155, P1418, DOI 10.1099/mic.0.027540-0	59	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15104	10.1371/journal.pone.0015104	http://dx.doi.org/10.1371/journal.pone.0015104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151907	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000284995300015
J	Dreon, MS; Ituarte, S; Heras, H				Sebastian Dreon, Marcos; Ituarte, Santiago; Heras, Horacio			The Role of the Proteinase Inhibitor Ovorubin in Apple Snail Eggs Resembles Plant Embryo Defense against Predation	PLOS ONE			English	Article							POMACEA-CANALICULATA GASTROPODA; TRYPSIN-INHIBITOR; BIOCHEMICAL-COMPOSITION; PROTEASE INHIBITOR; ALBUMIN GLAND; STABILITY; MOLLUSCA; AMPULLARIIDAE; SEEDS; LIPOPROTEIN	Background: Fieldwork has thoroughly established that most eggs are intensely predated. Among the few exceptions are the aerial egg clutches from the aquatic snail Pomacea canaliculata which have virtually no predators. Its defenses are advertised by the pigmented ovorubin perivitellin providing a conspicuous reddish coloration. The nature of the defense however, was not clear, except for a screening for defenses that identified a neurotoxic perivitellin with lethal effect on rodents. Ovorubin is a proteinase inhibitor (PI) whose role to protect against pathogens was taken for granted, according to the prevailing assumption. Through biochemical, biophysical and feeding experiments we studied the proteinase inhibitor function of ovorubin in egg defenses. Methodology/Principal Findings: Mass spectrometry sequencing indicated ovorubin belongs to the Kunitz-type serine proteinase inhibitor family. It specifically binds trypsin as determined by small angle X-ray scattering (SAXS) and cross-linking studies but, in contrast to the classical assumption, it does not prevent bacterial growth. Ovorubin was found extremely resistant to in vitro gastrointestinal proteolysis. Moreover feeding studies showed that ovorubin ingestion diminishes growth rate in rats indicating that this highly stable PI is capable of surviving passage through the gastrointestinal tract in a biologically active form. Conclusions: To our knowledge, this is the first direct evidence of the interaction of an egg PI with a digestive protease of potential predators, limiting predator's ability to digest egg nutrients. This role has not been reported in the animal kingdom but it is similar to plant defenses against herbivory. Further, this would be the only defense model with no trade-offs between conspicuousness and noxiousness by encoding into the same molecule both the aposematic warning signal and an antinutritive/antidigestive defense. These defenses, combined with a neurotoxin and probably unpalatable factors would explain the near absence of predators, opening new perspectives in the study of the evolution and ecology of egg defensive strategies.	[Sebastian Dreon, Marcos; Ituarte, Santiago; Heras, Horacio] CONICET Univ Nacl La Plata, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Dreon, MS (corresponding author), CONICET Univ Nacl La Plata, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	h-heras@med.unlp.edu.ar	; Heras, Horacio/R-9555-2018	Ituarte, Santiago/0000-0002-3670-2843; Heras, Horacio/0000-0003-3379-0216	Consejo Nacional de Investigaciones Cientificas y Tecnicas [5888]; Comision de Investigaciones Cientificas; LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia [D11A-SAXS1-7586/06, 8583]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Comision de Investigaciones Cientificas; LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia	This work was partially supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP No. 5888 to HH and Comision de Investigaciones Cientificas 2009 to MSD. The authors also thank LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia for access to their facilities and partial financial support (Projects D11A-SAXS1-7586/06 and 8583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EA, 1996, VELIGER, V39, P142; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; Birk Y, 1996, Arch Latinoam Nutr, V44, p26S; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Chye ML, 2006, IN VITRO CELL DEV-PL, V42, P100, DOI 10.1079/IVP2005741; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Denbow D. Michael, 2000, P299, DOI 10.1016/B978-012747605-6/50013-4; Dreon M, 2002, J EXP ZOOL, V292, P323, DOI 10.1002/jez.10043; Dreon MS, 2008, FEBS J, V275, P4522, DOI 10.1111/j.1742-4658.2008.06595.x; Dreon MS, 2007, ARCH BIOCHEM BIOPHYS, V460, P107, DOI 10.1016/j.abb.2006.12.033; Dreon MS, 2006, BIOCELL, V30, P359; Dreon MS, 2004, MOL REPROD DEV, V68, P359, DOI 10.1002/mrd.20078; Dreon MS, 2004, ARCH BIOCHEM BIOPHYS, V422, P1, DOI 10.1016/j.abb.2003.11.018; Dreon MS, 2003, MOL CELL BIOCHEM, V243, P9, DOI 10.1023/A:1021616610241; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; Estebenet AL, 2002, BIOCELL, V26, P83; Estebenet Alejandra L., 1993, Apex (Brussels), V8, P129; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; Garcia VA, 2004, PROTEIN J, V23, P343, DOI 10.1023/B:JOPC.0000032654.67733.d5; Garin CF, 1996, J EXP ZOOL, V276, P307, DOI 10.1002/(SICI)1097-010X(19961201)276:5&lt;307::AID-JEZ1&gt;3.0.CO;2-S; HAJOS G, 1995, J AGR FOOD CHEM, V43, P165, DOI 10.1021/jf00049a030; Hammersley A., 1997, ESRF97HAO2T; Han YP, 2008, COMP BIOCHEM PHYS B, V149, P58, DOI 10.1016/j.cbpb.2007.08.003; Heras H, 2007, COMP BIOCHEM PHYS C, V146, P158, DOI 10.1016/j.cbpc.2006.10.013; Heras H, 1998, J EXP ZOOL, V280, P375, DOI 10.1002/(SICI)1097-010X(19980415)280:6<375::AID-JEZ1>3.3.CO;2-V; Heras H, 2008, TOXICON, V52, P481, DOI 10.1016/j.toxicon.2008.06.022; Ituarte S, 2010, COMP BIOCHEM PHYS B, V157, P66, DOI 10.1016/j.cbpb.2010.05.004; Moreno FJ, 2007, BIOMED PHARMACOTHER, V61, P50, DOI 10.1016/j.biopha.2006.10.005; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; KAMIYA H, 2006, SUBSERIES MARINE MOL; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2; Maketon M, 2009, MALACOLOGIA, V51, P181, DOI 10.4002/040.051.0114; Moreno FJ, 2005, BBA-PROTEINS PROTEOM, V1752, P142, DOI 10.1016/j.bbapap.2005.07.022; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Mosolov VV, 2005, APPL BIOCHEM MICRO+, V41, P227, DOI 10.1007/s10438-005-0040-6; Mukai ST, 2004, INVERTEBR BIOL, V123, P83; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; Nagle GT, 1999, INVERTEBR REPROD DEV, V36, P171, DOI 10.1080/07924259.1999.9652695; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Nation JI, 2002, INSECT PHYSL BIOCH, P27; NORDEN DA, 1972, COMP BIOCHEM PHYSIOL, V42, P569, DOI 10.1016/0305-0491(72)90319-7; PAPAYANNOPOULOS IA, 1992, PROTEIN SCI, V1, P278; PECHENIK JA, 1986, AM MALACOL BULL, V4, P165; POLYA GM, 2003, STUDIES NATURAL PROD, P567; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; RANDALL D, 1997, ECKERT ANIMAL PHYSL, P683; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Roch P, 1998, DEV COMP IMMUNOL, V22, P1, DOI 10.1016/S0145-305X(97)00047-5; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Sasaki SD, 2006, BIOCHEM BIOPH RES CO, V341, P266, DOI 10.1016/j.bbrc.2005.12.178; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; SNYDER NFR, 1971, BEHAVIOUR, V40, P175, DOI 10.1163/156853971X00384; Stevens Lewis, 1996, Science Progress, V79, P65; Teles RCL, 2005, BIOPHYS J, V88, P3509, DOI 10.1529/biophysj.104.045682; Frassa MV, 2010, BBA-PROTEINS PROTEOM, V1804, P1492, DOI 10.1016/j.bbapap.2010.02.013; WALSH TA, 1991, PLANT PHYSIOL, V97, P15, DOI 10.1104/pp.97.1.15; WINGATE VPM, 1989, J BIOL CHEM, V264, P17734; Yusa Y, 2001, J MOLLUS STUD, V67, P275, DOI 10.1093/mollus/67.3.275	66	46	50	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15059	10.1371/journal.pone.0015059	http://dx.doi.org/10.1371/journal.pone.0015059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151935	Green Published, gold			2022-12-25	WOS:000284939600022
J	Campana, MG; Whitten, CM; Edwards, CJ; Stock, F; Murphy, AM; Binns, MM; Barker, GWW; Bower, MA				Campana, Michael G.; Whitten, C. Mark; Edwards, Ceiridwen J.; Stock, Frauke; Murphy, Angela M.; Binns, Matthew M.; Barker, Graeme W. W.; Bower, Mim A.			Accurate Determination of Phenotypic Information from Historic Thoroughbred Horses by Single Base Extension	PLOS ONE			English	Article							ANCIENT-DNA; COAT COLOR; GENE; RELIABILITY; MUTATION; SAMPLES; HAIR; MC1R	Historic DNA data have the potential to identify phenotypic information otherwise invisible in the historical, archaeological and palaeontological record. In order to determine whether a single nucleotide polymorphism typing protocol based on single based extension (SNaPshot (TM)) could produce reliable phenotypic data from historic samples, we genotyped three coat colour markers for a sample of historic Thoroughbred horses for which both phenotypic and correct genotypic information were known from pedigree information in the General Stud Book. Experimental results were consistent with the pedigrees in all cases. Thus we demonstrate that historic DNA techniques can produce reliable phenotypic information from museum specimens.	[Campana, Michael G.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Whitten, C. Mark; Murphy, Angela M.; Binns, Matthew M.] Univ London Royal Vet Coll, London, England; [Edwards, Ceiridwen J.; Stock, Frauke] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Barker, Graeme W. W.; Bower, Mim A.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3DZ, England	University of Cambridge; University of London; University of London Royal Veterinary College; Trinity College Dublin; University of Cambridge	Campana, MG (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.	mgc32@cam.ac.uk	Edwards, Ceiridwen/F-8855-2010	Edwards, Ceiridwen/0000-0001-9126-1377; Campana, Michael/0000-0003-0461-6462	Horserace Betting Levy Board [VET/PRJ/722]; D M McDonald Grants Awards Fund; Leverhulme Trust [F/09 757/B]; University of Cambridge	Horserace Betting Levy Board; D M McDonald Grants Awards Fund; Leverhulme Trust(Leverhulme Trust); University of Cambridge(University of Cambridge)	This work was supported by the Horserace Betting Levy Board (grant VET/PRJ/722, http://www.hblb.org.uk/), the D M McDonald Grants & Awards Fund 2008 (www.mcdonald.cam.ac.uk) and the Leverhulme Trust (grant F/09 757/B, http://www.leverhulme.org.uk/). The Overseas Research Studentship, the Cambridge Overseas, and Peterhouse, University of Cambridge supported M. G. C. (www.cam.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouakaze C, 2007, INT J LEGAL MED, V121, P493, DOI 10.1007/s00414-007-0177-3; Bower MA, 2005, NUCLEIC ACIDS RES, V33, P2549, DOI 10.1093/nar/gki550; BOWER MA, TRUTH BONES SC UNPUB; Cooper A, 2000, SCIENCE, V289, P1139; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Miller CR, 2002, GENETICS, V160, P357; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Rieder S, 2009, J ANIM BREED GENET, V126, P415, DOI 10.1111/j.1439-0388.2009.00832.x; Royo LJ, 2008, J ANIM SCI, V86, P1291, DOI 10.2527/jas.2007-0498; Sanchez JJ, 2006, NAT PROTOC, V1, P1370, DOI 10.1038/nprot.2006.247; Spencer M, 2004, AM J HUM GENET, V75, P240, DOI 10.1086/422826; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15172	10.1371/journal.pone.0015172	http://dx.doi.org/10.1371/journal.pone.0015172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152043	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000284868000029
J	Joo, Y; Ha, S; Hong, BH; Kim, JA; Chang, KA; Liew, H; Kim, S; Sun, W; Kim, JH; Chong, YH; Suh, YH; Kim, HS				Joo, Yuyoung; Ha, Sungji; Hong, Bo-Hyun; Kim, Jeong A.; Chang, Keun-A; Liew, Hyunjeong; Kim, Seonghan; Sun, Woong; Kim, Joung-Hun; Chong, Young Hae; Suh, Yoo-Hun; Kim, Hye-Sun			Amyloid Precursor Protein Binding Protein-1 Modulates Cell Cycle Progression in Fetal Neural Stem Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEDD8 CONJUGATION; TERMINAL REGION; APP-BP1; APOPTOSIS; UBIQUITIN; NEURONS; PHOSPHORYLATION; SYSTEM; FAMILY	Amyloid precursor protein binding protein-1 (APP-BP1) binds to the carboxyl terminus of the amyloid precursor protein (APP) and serves as the bipartite activation enzyme for the ubiquitin-like protein, NEDD8. In the present study, we explored the physiological role of APP-BP1 in the cell cycle progression of fetal neural stem cells. Our results show that cell cycle progression of the cells is arrested at the G1 phase by depletion of APP-BP1, which results in a marked decrease in the proliferation of the cells. This action of APP-BP1 is antagonistically regulated by the interaction with APP. Consistent with the evidence that APP-BP1 function is critical for cell cycle progression, the amount of APP-BP1 varies depending upon cell cycle phase, with culminating expression at S-phase. Furthermore, our FRET experiment revealed that phosphorylation of APP at threonine 668, known to occur during the G2/M phase, is required for the interaction between APP and APP-BP1. We also found a moderate ubiquitous level of APP-BP1 mRNA in developing embryonic and early postnatal brains; however, APP-BP1 expression is reduced by P12, and only low levels of APP-BP1 were found in the adult brain. In the cerebral cortex of E16 rats, substantial expression of both APP-BP1 and APP mRNAs was observed in the ventricular zone. Collectively, these results indicate that APP-BP1 plays an important role in the cell cycle progression of fetal neural stem cells, through the interaction with APP, which is fostered by phopshorylation of threonine 668.	[Joo, Yuyoung; Ha, Sungji; Hong, Bo-Hyun; Kim, Jeong A.; Chang, Keun-A; Liew, Hyunjeong; Kim, Seonghan; Suh, Yoo-Hun; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Sun, Woong] Korea Univ, Sch Med, Dept Anat, Seoul, South Korea; [Kim, Joung-Hun] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Chong, Young Hae] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH); Ewha Womans University; Seoul National University (SNU)	Joo, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea.	hyisun@snu.ac.kr	Suh, Yoo-Hun/J-2761-2012; Kim, Hye Sun/J-2752-2012	Liew, Hyunjeong/0000-0002-3910-374X; sun, woong/0000-0003-1792-4894	Brain Research Center; National Research Foundation of Korea [2008-314-E00179]; Ministry of Education, Science and Technology, Republic of Korea [ROI-2008-000-20275-0]	Brain Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Brain Research Center of the Twenty-First Century Frontier Research Program Grant and National Research Foundation of Korea Grants 2008-314-E00179 awarded to J-H. Kim and ROI-2008-000-20275-0 awarded to H-S Kim by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2010, CELL DEATH DIFFER, V17, P78, DOI 10.1038/cdd.2009.104; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Chen YZ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-3; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chen YZ, 2003, J NEUROCHEM, V85, P801, DOI 10.1046/j.1471-4159.2003.01727.x; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kim HJ, 2007, CELL DEATH DIFFER, V14, P103, DOI 10.1038/sj.cdd.4401935; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kitahara R, 2006, J MOL BIOL, V363, P395, DOI 10.1016/j.jmb.2006.07.074; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; OHTA M, 1993, DEV BRAIN RES, V75, P151, DOI 10.1016/0165-3806(93)90019-7; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sakuma M, 2009, J NEUROCHEM, V109, P465, DOI 10.1111/j.1471-4159.2009.05988.x; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Tang BL, 2007, J NEUROCHEM, V100, P314, DOI 10.1111/j.1471-4159.2006.04215.x; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14203	10.1371/journal.pone.0014203	http://dx.doi.org/10.1371/journal.pone.0014203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151996	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000017
J	Pannekoek, Y; Dickx, V; Beeckman, DSA; Jolley, KA; Keijzers, WC; Vretou, E; Maiden, MCJ; Vanrompay, D; van der Ende, A				Pannekoek, Yvonne; Dickx, Veerle; Beeckman, Delphine S. A.; Jolley, Keith A.; Keijzers, Wendy C.; Vretou, Evangelia; Maiden, Martin C. J.; Vanrompay, Daisy; van der Ende, Arie			Multi Locus Sequence Typing of Chlamydia Reveals an Association between Chlamydia psittaci Genotypes and Host Species	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CHLAMYDOPHILA-PSITTACI; PET BIRDS; INFECTION; STRAINS; TRANSMISSION; ABORTION; PNEUMONIAE; FAMILY; IDENTIFICATION	Chlamydia comprises a group of obligate intracellular bacterial parasites responsible for a variety of diseases in humans and animals, including several zoonoses. Chlamydia trachomatis causes diseases such as trachoma, urogenital infection and lymphogranuloma venereum with severe morbidity. Chlamydia pneumoniae is a common cause of community-acquired respiratory tract infections. Chlamydia psittaci, causing zoonotic pneumonia in humans, is usually hosted by birds, while Chlamydia abortus, causing abortion and fetal death in mammals, including humans, is mainly hosted by goats and sheep. We used multi-locus sequence typing to asses the population structure of Chlamydia. In total, 132 Chlamydia isolates were analyzed, including 60 C. trachomatis, 18 C. pneumoniae, 16 C. abortus, 34 C. psittaci and one of each of C. pecorum, C. caviae, C. muridarum and C. felis. Cluster analyses utilizing the Neighbour-Joining algorithm with the maximum composite likelihood model of concatenated sequences of 7 housekeeping fragments showed that C. psittaci 84/2334 isolated from a parrot grouped together with the C. abortus isolates from goats and sheep. Cluster analyses of the individual alleles showed that in all instances C. psittaci 84/2334 formed one group with C. abortus. Moving 84/2334 from the C. psittaci group to the C. abortus group resulted in a significant increase in the number of fixed differences and elimination of the number of shared mutations between C. psittaci and C. abortus. C. psittaci M56 from a muskrat branched separately from the main group of C. psittaci isolates. C. psittaci genotypes appeared to be associated with host species. The phylogentic tree of C. psittaci did not follow that of its host bird species, suggesting host species jumps. In conclusion, we report for the first time an association between C. psittaci genotypes with host species.	[Pannekoek, Yvonne; Keijzers, Wendy C.; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Dickx, Veerle; Beeckman, Delphine S. A.; Vanrompay, Daisy] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Jolley, Keith A.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Vretou, Evangelia] Hellenic Pasteur Inst, Dept Microbiol, Biotechnol Lab, Athens, Greece	University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; University of Oxford	Pannekoek, Y (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	a.vanderende@amc.uva.nl	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; Jolley, Keith/ABE-8587-2020; van der Ende, Arie/A-4346-2012	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Jolley, Keith/0000-0002-0751-0287; Beeckman, Delphine/0000-0002-5239-2558; Pannekoek, Yvonne/0000-0003-1154-652X; van der Ende, Arie/0000-0003-1298-3086	Wellcome Trust; Federal Public Service of Health, Food Chain Safety and Environment [RF-6177]; European Commission [512061]; Belgian Federal Public Service of Health, Food Chain Safety and Environment [RF-6177]	Wellcome Trust(Wellcome Trust); Federal Public Service of Health, Food Chain Safety and Environment; European Commission(European CommissionEuropean Commission Joint Research Centre); Belgian Federal Public Service of Health, Food Chain Safety and Environment	The development of the Chlamydiales MLST web site has been funded by the Wellcome Trust. Veerle Dickx is funded by the Federal Public Service of Health, Food Chain Safety and Environment (convention RF-6177). This research was partly funded by the Sixth Framework Programme of the European Commission, Proposal/Contract no.: 512061 (Network of Excellence 'European Virtual Institute for Functional Genomics of Bacterial Pathogens' [http://www.noe-epg.uni-wuerzburg.de]) and partially by the Belgian Federal Public Service of Health, Food Chain Safety and Environment (convention RF-6177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; BUXTON D, 1986, VET REC, V118, P510, DOI 10.1136/vr.118.18.510; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Essig A, 1995, CLIN INFECT DIS, V21, P1495, DOI 10.1093/clinids/21.6.1495; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Francis T, 1938, J EXP MED, V68, P147, DOI 10.1084/jem.68.2.147; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Harkinezhad T, 2007, J MED MICROBIOL, V56, P1097, DOI 10.1099/jmm.0.47157-0; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heddema ER, 2006, J MED MICROBIOL, V55, P1571, DOI 10.1099/jmm.0.46692-0; Herrmann B, 2000, INT J SYST EVOL MICR, V50, P149, DOI 10.1099/00207713-50-1-149; HINTON DG, 1993, AUST VET J, V70, P174, DOI 10.1111/j.1751-0813.1993.tb06123.x; Hughes C, 1997, INFECT CONT HOSP EP, V18, P165; HUMINER D, 1988, LANCET, V2, P615; HUMINER D, 1992, ISRAEL J MED SCI, V28, P739; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaibu H, 2006, JPN J INFECT DIS, V59, P349; Kern JM, 2009, FEMS IMMUNOL MED MIC, V55, P131, DOI 10.1111/j.1574-695X.2008.00514.x; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Meijer A, 2004, EUR J CLIN MICROBIOL, V23, P487, DOI 10.1007/s10096-004-1139-z; Mitchell CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000903; Moroney JF, 1998, CLIN INFECT DIS, V26, P1425, DOI 10.1086/516368; Morrison RP, 2003, J CLIN INVEST, V111, P1647, DOI 10.1172/JCI200318770; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Pannekoek Y, 2001, INFECT IMMUN, V69, P4654, DOI 10.1128/IAI.69.7.4654-4656.2001; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pospischil A, 2002, SCHWEIZ ARCH TIERH, V144, P463, DOI 10.1024/0036-7281.144.9.463; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Saito T, 2005, J CLIN MICROBIOL, V43, P3011, DOI 10.1128/JCM.43.6.3011-3013.2005; SALINAS J, 1995, VET MICROBIOL, V43, P219, DOI 10.1016/0378-1135(94)00100-B; SaltiMontesanto V, 1997, AM J VET RES, V58, P228; SAYADA C, 1995, RES MICROBIOL, V146, P155, DOI 10.1016/0923-2508(96)80893-X; SMITH JM, 1992, J MOL EVOL, V34, P126; SOURIAU A, 1993, VET REC, V132, P217, DOI 10.1136/vr.132.9.217; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P78, DOI 10.1016/j.vetmic.2008.09.047; Van Loock M, 2003, INT J SYST EVOL MICR, V53, P761, DOI 10.1099/ijs.0.02329-0; Vanrompay D, 1997, RES MICROBIOL, V148, P327, DOI 10.1016/S0923-2508(97)81588-4; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; Verminnen K, 2008, J CLIN MICROBIOL, V46, P281, DOI 10.1128/JCM.01153-07; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Walder G, 2005, OBSTET GYNECOL, V106, P1215, DOI 10.1097/01.AOG.0000161060.69470.9c; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Yatsentyuk SP, 2007, RUSS J GENET+, V43, P1215, DOI 10.1134/S1022795407110026	66	78	79	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14179	10.1371/journal.pone.0014179	http://dx.doi.org/10.1371/journal.pone.0014179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152037	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000005
J	Sokolov, MV; Neumann, RD				Sokolov, Mykyta V.; Neumann, Ronald D.			Radiation-Induced Bystander Effects in Cultured Human Stem Cells	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; MEDIATED INTERCELLULAR COMMUNICATION; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; ALPHA-PARTICLE; DNA-DAMAGE; MICROBEAM IRRADIATION; CELLULAR-RESPONSE; LET RADIATION; GLIOMA-CELLS	Background: The radiation-induced "bystander effect" (RIBE) was shown to occur in a number of experimental systems both in vitro and in vivo as a result of exposure to ionizing radiation (IR). RIBE manifests itself by intercellular communication from irradiated cells to non-irradiated cells which may cause DNA damage and eventual death in these bystander cells. It is known that human stem cells (hSC) are ultimately involved in numerous crucial biological processes such as embryologic development; maintenance of normal homeostasis; aging; and aging-related pathologies such as cancerogenesis and other diseases. However, very little is known about radiation-induced bystander effect in hSC. To mechanistically interrogate RIBE responses and to gain novel insights into RIBE specifically in hSC compartment, both medium transfer and cell co-culture bystander protocols were employed. Methodology/Principal Findings: Human bone-marrow mesenchymal stem cells (hMSC) and embryonic stem cells (hESC) were irradiated with doses 0.2 Gy, 2 Gy and 10 Gy of X-rays, allowed to recover either for 1 hr or 24 hr. Then conditioned medium was collected and transferred to non-irradiated hSC for time course studies. In addition, irradiated hMSC were labeled with a vital CMRA dye and co-cultured with non-irradiated bystander hMSC. The medium transfer data showed no evidence for RIBE either in hMSC and hESC by the criteria of induction of DNA damage and for apoptotic cell death compared to non-irradiated cells (p>0.05). A lack of robust RIBE was also demonstrated in hMSC co-cultured with irradiated cells (p>0.05). Conclusions/Significance: These data indicate that hSC might not be susceptible to damaging effects of RIBE signaling compared to differentiated adult human somatic cells as shown previously. This finding could have profound implications in a field of radiation biology/oncology, in evaluating radiation risk of IR exposures, and for the safety and efficacy of hSC regenerative-based therapies.	[Sokolov, Mykyta V.; Neumann, Ronald D.] NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Sokolov, MV (corresponding author), NIH, Div Nucl Med, Dept Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	sokolovm@mail.nih.gov			National Institutes of Health, Clinical Center; CLINICAL CENTER [ZIACL060001] Funding Source: NIH RePORTER	National Institutes of Health, Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research was supported by the Intramural Research Program of the National Institutes of Health, Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asur R, 2010, MUTAT RES-FUND MOL M, V686, P15, DOI 10.1016/j.mrfmmm.2009.12.007; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Bertucci A, 2009, J RADIAT RES, V50, pA49, DOI 10.1269/jrr.08132S; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Chou CH, 2007, CLIN CANCER RES, V13, P851, DOI 10.1158/1078-0432.CCR-06-2459; Cogan N, 2010, MUTAT RES-FUND MOL M, V683, P1, DOI 10.1016/j.mrfmmm.2009.09.012; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Elkind MM, 1967, RADIOBIOLOGY CULTURE, p[XVI, 615]; Ermakov A. V., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P42; Facoetti A, 2006, RADIAT PROT DOSIM, V122, P271, DOI 10.1093/rpd/ncl431; Fournier C, 2009, RADIAT RES, V171, P530, DOI 10.1667/RR1457.1; Ghandhi SA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-31; Groesser T, 2008, RADIAT RES, V170, P794, DOI 10.1667/RR1458.1; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Han W, 2010, CARCINOGENESIS, V31, P275, DOI 10.1093/carcin/bgp301; Iyer R, 2000, CANCER RES, V60, P1290; KADHIM MA, 1994, LANCET, V344, P987, DOI 10.1016/S0140-6736(94)91643-8; Kadhim MA, 2010, MUTAT RES-FUND MOL M, V688, P91, DOI 10.1016/j.mrfmmm.2010.03.013; Kanasugi Y, 2007, INT J RADIAT BIOL, V83, P73, DOI 10.1080/09553000601121116; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kashino G, 2007, MUTAT RES-FUND MOL M, V619, P134, DOI 10.1016/j.mrfmmm.2007.02.005; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2008, INT J RADIAT ONCOL, V70, P554, DOI 10.1016/j.ijrobp.2007.09.039; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; MAUNEY J, 2010, MATRIX BIOL; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2001, CARCINOGENESIS, V22, P1465, DOI 10.1093/carcin/22.9.1465; Mothersill C, 2010, RADIAT RES, V174, P119, DOI 10.1667/RR2036.1; NAGASAWA H, 1992, CANCER RES, V52, P6394; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao CL, 2006, RADIAT RES, V166, P479, DOI 10.1667/RR3600.1; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Sokolov MV, 2007, CELL CYCLE, V6, P2210, DOI 10.4161/cc.6.18.4682; Sokolov MV, 2010, GENE, V455, P8, DOI 10.1016/j.gene.2010.01.006; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Terzoudi GI, 2010, RADIAT RES, V173, P789, DOI 10.1667/RR2023.1; VALLEPRIETO A, 2010, STEM CELLS DEV; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhang Y, 2009, MUTAT RES-FUND MOL M, V671, P20, DOI 10.1016/j.mrfmmm.2009.08.006	54	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14195	10.1371/journal.pone.0014195	http://dx.doi.org/10.1371/journal.pone.0014195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152027	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000011
J	Heimann, E; Jones, HA; Resjo, S; Manganiello, VC; Stenson, L; Degerman, E				Heimann, Emilia; Jones, Helena A.; Resjo, Svante; Manganiello, Vincent C.; Stenson, Lena; Degerman, Eva			Expression and Regulation of Cyclic Nucleotide Phosphodiesterases in Human and Rat Pancreatic Islets	PLOS ONE			English	Article							INSULIN-INDUCED PHOSPHORYLATION; GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE B; CAMP-PHOSPHODIESTERASE; ANTILIPOLYTIC ACTION; GLUCOSE-INTOLERANCE; ENERGY HOMEOSTASIS; IN-VITRO; SECRETION; ACTIVATION	As shown by transgenic mouse models and by using phosphodiesterase 3 (PDE3) inhibitors, PDE3B has an important role in the regulation of insulin secretion in pancreatic beta-cells. However, very little is known about the regulation of the enzyme. Here, we show that PDE3B is activated in response to high glucose, insulin and cAMP elevation in rat pancreatic islets and INS-1 (832/13) cells. Activation by glucose was not affected by the presence of diazoxide. PDE3B activation was coupled to an increase as well as a decrease in total phosphorylation of the enzyme. In addition to PDE3B, several other PDEs were detected in human pancreatic islets: PDE1, PDE3, PDE4C, PDE7A, PDE8A and PDE10A. We conclude that PDE3B is activated in response to agents relevant for beta-cell function and that activation is linked to increased as well as decreased phosphorylation of the enzyme. Moreover, we conclude that several PDEs are present in human pancreatic islets.	[Heimann, Emilia; Jones, Helena A.; Resjo, Svante; Stenson, Lena; Degerman, Eva] Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden; [Manganiello, Vincent C.] NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Lund University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Heimann, E (corresponding author), Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden.	emilia.heimann@med.lu.se	Jones, Helena/C-8847-2013	Jones, Helena/0000-0002-3948-161X	Swedish Research Council [3362]; Swedish Diabetes Association; Swedish Society of Medicine; A. Pahlsson foundation; P. Hakansson foundation; Novo Nordisk Foundation, Denmark; Royal Physiographic Society in Lund; Lund University Diabetes Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Society of Medicine; A. Pahlsson foundation; P. Hakansson foundation; Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Royal Physiographic Society in Lund; Lund University Diabetes Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council Project 3362 (to ED); the Swedish Diabetes Association (http://www.diabetes.se/); the Swedish Society of Medicine; the A. Pahlsson and P. Hakansson foundations; Novo Nordisk Foundation, Denmark (http://www.novonordiskfonden.dk/en/index.asp); the Royal Physiographic Society in Lund (http://www.fysiografen.se/); and Lund University Diabetes Center (http://www.ludc.med.lu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2000, J IMMUNOL, V164, P4678, DOI 10.4049/jimmunol.164.9.4678; Ahmad M, 2000, BRIT J PHARMACOL, V129, P1228, DOI 10.1038/sj.bjp.0703165; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; BEAVO JA, 2007, CYCLIC NUCL PHOSPHOD; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantin LD, 2007, BIOORG MED CHEM LETT, V17, P2869, DOI 10.1016/j.bmcl.2007.02.061; Cheung P, 2003, METABOLISM, V52, P1496, DOI 10.1016/S0026-0495(03)00271-3; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; DEGERMAN E, 2007, CYCLIC NUCLEOTIDE PH, P79; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; ElMetwally M, 1997, EUR J PHARMACOL, V324, P227, DOI 10.1016/S0014-2999(97)00076-9; ERIKSSON H, 1995, BBA-MOL CELL RES, V1266, P101, DOI 10.1016/0167-4889(94)00237-9; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Harndahl L, 2002, J BIOL CHEM, V277, P37446, DOI 10.1074/jbc.M205401200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; KREYMANN B, 1987, LANCET, V2, P1300; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; MURAD F, 1971, P NATL ACAD SCI USA, V68, P736, DOI 10.1073/pnas.68.4.736; Parker JC, 1997, BIOCHEM BIOPH RES CO, V236, P665, DOI 10.1006/bbrc.1997.7034; Parker JC, 1995, BIOCHEM BIOPH RES CO, V217, P916, DOI 10.1006/bbrc.1995.2858; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Rahn T, 1996, J BIOL CHEM, V271, P11575, DOI 10.1074/jbc.271.19.11575; RASCON A, 1994, J BIOL CHEM, V269, P11962; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SHAFIEENICK R, 1995, BRIT J PHARMACOL, V115, P1486, DOI 10.1111/j.1476-5381.1995.tb16641.x; SHIBATA H, 1990, BIOCHEM BIOPH RES CO, V170, P533, DOI 10.1016/0006-291X(90)92124-I; Sjoholm A, 2002, ENDOCRINOLOGY, V143, P4592, DOI 10.1210/en.2002-220672; SJOHOLM A, 1993, BIOSCIENCE REP, V13, P349, DOI 10.1007/BF01150479; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; TAIRA M, 1993, J BIOL CHEM, V268, P18573; Vander Mierde D, 2007, ENDOCRINOLOGY, V148, P609, DOI 10.1210/en.2006-1012; Waddleton D, 2008, BIOCHEM PHARMACOL, V76, P884, DOI 10.1016/j.bcp.2008.07.025; Walz HA, 2007, CELL SIGNAL, V19, P1505, DOI 10.1016/j.cellsig.2007.01.030; Walz HA, 2006, J ENDOCRINOL, V189, P629, DOI 10.1677/joe.1.06522; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920; Zhao AZ, 1997, P NATL ACAD SCI USA, V94, P3223, DOI 10.1073/pnas.94.7.3223; Zmuda-Trzebiatowska E, 2006, CELL SIGNAL, V18, P382, DOI 10.1016/j.cellsig.2005.05.007	48	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14191	10.1371/journal.pone.0014191	http://dx.doi.org/10.1371/journal.pone.0014191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152070	Green Submitted, gold, Green Published			2022-12-25	WOS:000284821300008
J	Riveros, C; Mellor, D; Gandhi, KS; McKay, FC; Cox, MB; Berretta, R; Vaezpour, SY; Inostroza-Ponta, M; Broadley, SA; Heard, RN; Vucic, S; Stewart, GJ; Williams, DW; Scott, RJ; Lechner-Scott, J; Booth, DR; Moscato, P				Riveros, Carlos; Mellor, Drew; Gandhi, Kaushal S.; McKay, Fiona C.; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Broadley, Simon A.; Heard, Robert N.; Vucic, Stephen; Stewart, Graeme J.; Williams, David W.; Scott, Rodney J.; Lechner-Scott, Jeanette; Booth, David R.; Moscato, Pablo		ANZgene Multiple Sclerosis Genetic	A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis	PLOS ONE			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-TYROSINE-PHOSPHATASE; CARBONIC-ANHYDRASE-II; OLIGODENDROCYTE PROGENITOR DIFFERENTIATION; MONOCLONAL-ANTIBODY TREATMENT; DEPENDENT DIABETES-MELLITUS; YIN YANG 1	Background: Several lines of evidence suggest that transcription factors are involved in the pathogenesis of Multiple Sclerosis (MS) but complete mapping of the whole network has been elusive. One of the reasons is that there are several clinical subtypes of MS and transcription factors that may be involved in one subtype may not be in others. We investigate the possibility that this network could be mapped using microarray technologies and contemporary bioinformatics methods on a dataset derived from whole blood in 99 untreated MS patients (36 Relapse Remitting MS, 43 Primary Progressive MS, and 20 Secondary Progressive MS) and 45 age-matched healthy controls. Methodology/Principal Findings: We have used two different analytical methodologies: a non-standard differential expression analysis and a differential co-expression analysis, which have converged on a significant number of regulatory motifs that are statistically overrepresented in genes that are either differentially expressed (or differentially co-expressed) in cases and controls (e. g., V$KROX_Q6, p-value, <3.31E-6; V$CREBP1_Q2, p-value, < 9.93E-6, V$YY1_02, p-value, <1.65E-5). Conclusions/Significance: Our analysis uncovered a network of transcription factors that potentially dysregulate several genes in MS or one or more of its disease subtypes. The most significant transcription factor motifs were for the Early Growth Response EGR/KROX family, ATF2, YY1 (Yin and Yang 1), E2F-1/DP-1 and E2F-4/DP-2 heterodimers, SOX5, and CREB and ATF families. These transcription factors are involved in early T-lymphocyte specification and commitment as well as in oligodendrocyte dedifferentiation and development, both pathways that have significant biological plausibility in MS causation.	[Riveros, Carlos; Mellor, Drew; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Scott, Rodney J.; Lechner-Scott, Jeanette; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia; [Riveros, Carlos; Mellor, Drew; Cox, Mathew B.; Berretta, Regina; Vaezpour, S. Yahya; Inostroza-Ponta, Mario; Scott, Rodney J.; Lechner-Scott, Jeanette; Moscato, Pablo] Hunter Med Res Inst, Newcastle, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, St Lucia, Qld, Australia; [Gandhi, Kaushal S.; McKay, Fiona C.; Heard, Robert N.; Vucic, Stephen; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Broadley, Simon A.] Griffith Univ, Sch Med, Brisbane, Qld 4111, Australia; [Broadley, Simon A.] Gold Coast Hosp, Dept Neurol, Southport, Qld, Australia; [Williams, David W.] Univ Newcastle, John Hunter Hosp, Newcastle, NSW 2308, Australia; [Vaezpour, S. Yahya] Amirkabir Univ Technol, Dept Comp Engn, Tehran, Iran; [Mellor, Drew] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, Australia; [Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Sydney; Westmead Institute for Medical Research; Griffith University; Gold Coast University Hospital; John Hunter Hospital; University of Newcastle; Amirkabir University of Technology; University of Western Australia; Universidad de Santiago de Chile	Riveros, C (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	Scott, Rodney J/B-2827-2013; Riveros, Carlos/F-3373-2012; Foote, Simon J/F-2802-2013; Inostroza-Ponta, Mario/G-7548-2012; Riveros, Carlos/A-6880-2013; MOSCATO, PABLO ALBERTO/G-7668-2013; Kermode, Allan/G-3568-2019; Browning, Brian L/A-1178-2010; Slee, Mark/J-4731-2015	Scott, Rodney J/0000-0001-7724-3404; Riveros, Carlos/0000-0002-2551-7618; Kermode, Allan/0000-0002-4476-4016; Browning, Brian L/0000-0001-6454-6633; Field, Judith/0000-0002-7089-0999; McKay, Fiona Catherine/0000-0002-9610-0668; Stankovich, Jim/0000-0001-9344-7749; Berretta, Regina/0000-0002-4420-3446; Inostroza-Ponta, Mario/0000-0003-1295-8972; Kilpatrick, Trevor/0000-0003-3999-085X; Vucic, Steve/0000-0002-8323-873X; Moscato, Pablo/0000-0003-2570-5966; Slee, Mark/0000-0003-4323-2453; Lechner-Scott, Jeannette/0000-0002-3850-447X	Australian Research Council Centre of Excellence in Bioinformatics; Australian Research Council [LP0776744, DP0559755, DP0773279]; University of Newcastle; Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas [060919IP]; John Hunter Hospital Charitable Trust; Macquarie Bank; Multiple Sclerosis Research Australia	Australian Research Council Centre of Excellence in Bioinformatics(Australian Research Council); Australian Research Council(Australian Research Council); University of Newcastle; Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas; John Hunter Hospital Charitable Trust; Macquarie Bank; Multiple Sclerosis Research Australia	This project had the following sources of funding: Australian Research Council Centre of Excellence in Bioinformatics (PM), Australian Research Council Linkage Project LP0776744 (ANZgene, MS Research Australia), Australian Research Council Discovery project DP0559755 (PM and RB) and DP0773279 (PM, RS and DM). The University of Newcastle via central funding to the Priority Research Centre in Bioinformatics, Biomarker Discovery and Information-based Medicine (PM, RS, RB, CR, DM, MIP). The University of Newcastle's Strategic Initiative Fund for project: Newcastle Bioinformatics Initiative, 2003-2007 (PM, RB, MIP). Universidad de Santiago de Chile, Departamento de Investigaciones Cientificas y Tecnologicas project 060919IP (MIP). Australia Research Council Biogen Idec PhD award (KG). Grant from the John Hunter Hospital Charitable Trust Fund and a special grant from Macquarie Bank (MBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank people with MS in Australia and New Zealand for supporting this research. We are grateful to Multiple Sclerosis Research Australia for supporting this project, and in particular to the expediting efforts from Mr Jeremy Wright and Ms Christine Remediakis.	Ai WD, 2000, J VIROL, V74, P5198, DOI 10.1128/JVI.74.11.5198-5205.2000; Akkad DA, 2009, J AUTOIMMUN, V32, P110, DOI 10.1016/j.jaut.2009.01.002; Akl H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-85; Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184; Alter M, 2006, NEUROLOGY, V66, P1061, DOI 10.1212/01.wnl.0000204194.47925.0d; ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Avasarala JR, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-2; Avossa D, 2006, NEUROSCIENCE, V138, P1179, DOI 10.1016/j.neuroscience.2005.12.009; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Awasthi A, 2008, J CLIN IMMUNOL, V28, P660, DOI 10.1007/s10875-008-9239-7; Azimi N, 2000, AIDS RES HUM RETROV, V16, P1717, DOI 10.1089/08892220050193209; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; BAN EMH, 1994, IMMUNOL RES, V13, P1, DOI 10.1007/BF02918219; BAN M, 2009, EUR J HUM GENET; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Benjamins JA, 2003, NEUROCHEM RES, V28, P143, DOI 10.1023/A:1021612615554; Berndt JA, 2001, J NEUROCHEM, V77, P935, DOI 10.1046/j.1471-4159.2001.00307.x; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Brightt JJ, 2008, EXPERT OPIN THER TAR, V12, P1565, DOI [10.1517/14728220802515400, 10.1517/14728220802515400 ]; Brynedal B, 2009, P NATL ACAD SCI USA, V106, pE58, DOI 10.1073/pnas.0904338106; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; CAMMER W, 1995, J NEUROSCI RES, V40, P451, DOI 10.1002/jnr.490400404; Cammer W, 1998, NEUROCHEM RES, V23, P407, DOI 10.1023/A:1022421920265; Caserta S, 2007, TRENDS IMMUNOL, V28, P245, DOI 10.1016/j.it.2007.04.006; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang X, 2006, CLIN IMMUNOL, V121, P274, DOI 10.1016/j.clim.2006.07.004; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coles AJ, 1998, MULT SCLER, V4, P232, DOI 10.1177/135245859800400327; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Colombatti M, 2001, GLIA, V35, P224, DOI 10.1002/glia.1087; Compston Alastair., 2005, MCALPINES MULTIPLE S, V4th; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Dediu D, 2008, J THEOR BIOL, V254, P400, DOI 10.1016/j.jtbi.2008.05.028; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; Dobson-Stone C, 2007, NEUROIMAGE, V37, P394, DOI 10.1016/j.neuroimage.2007.05.011; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards S, 1998, J NEUROL NEUROSUR PS, V64, P736, DOI 10.1136/jnnp.64.6.736; EGGERT M, 2006, FRONTIERS MED CHEM, V3, P383; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Fayyad U., 1993, INT JOINT C ART INT; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Fernandez-Malave E, 2006, BLOOD, V108, P3420, DOI 10.1182/blood-2006-03-010850; FERNER RE, 1995, J NEUROL NEUROSUR PS, V58, P582, DOI 10.1136/jnnp.58.5.582; Fischer A, 2005, CURR OPIN ALLERGY CL, V5, P491, DOI 10.1097/01.all.0000191886.12645.79; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flores N, 2003, J NEUROIMMUNOL, V135, P141, DOI 10.1016/S0165-5728(02)00440-X; Fortunato G, 2008, J INTERF CYTOK RES, V28, P141, DOI 10.1089/jir.2007.0049; FRANCIS DA, 1991, HUM IMMUNOL, V32, P119, DOI 10.1016/0198-8859(91)90108-L; Frisullo G, 2009, IMMUNOLOGY, V127, P418, DOI 10.1111/j.1365-2567.2008.02963.x; Frisullo G, 2008, J NEUROIMMUNOL, V205, P126, DOI 10.1016/j.jneuroim.2008.09.003; Frost P, 2008, MED HYPOTHESES, V70, P17, DOI 10.1016/j.mehy.2007.04.039; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; GANDHI KS, HUM MOL GENET; Gardner JM, 2009, NAT IMMUNOL, V10, P934, DOI 10.1038/ni0909-934; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Gerhauser I, 2007, J NEUROIMMUNOL, V188, P86, DOI 10.1016/j.jneuroim.2007.05.019; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grekova MC, 1996, ANN NEUROL, V40, P108, DOI 10.1002/ana.410400117; Grekova MC, 2000, J NEUROIMMUNOL, V106, P214, DOI 10.1016/S0165-5728(99)00264-7; Grekova MC, 2002, LAB INVEST, V82, P1131, DOI 10.1097/01.LAB.0000029149.3881.84; Grunebaum E, 2006, IMMUNOL RES, V35, P117, DOI 10.1385/IR:35:1:117; Guennoun R, 2001, MOL BRAIN RES, V90, P75, DOI 10.1016/S0169-328X(01)00094-8; Guo J, 2001, J BIOL CHEM, V276, P48871, DOI 10.1074/jbc.M101592200; Guo J, 2008, J ALLERGY CLIN IMMUN, V122, P195, DOI 10.1016/j.jaci.2008.03.012; GUTMANN DH, 1993, J NEUROSCI RES, V36, P216, DOI 10.1002/jnr.490360212; Guy J, 2008, OPHTHAL RES, V40, P212, DOI 10.1159/000119879; Habib AA, 1998, J NEUROCHEM, V70, P1704; Habib AA, 1998, ONCOGENE, V16, P1525, DOI 10.1038/sj.onc.1201683; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hawkes CH, 2009, MULT SCLER J, V15, P661, DOI 10.1177/1352458509104592; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; He Y, 2007, NEURON GLIA BIOL, V3, P221, DOI 10.1017/S1740925X08000057; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; HILLEL SP, 1994, ANN NEUROL, V36, pS25; HILLERT J, 1992, J NEUROL NEUROSUR PS, V55, P887, DOI 10.1136/jnnp.55.10.887; Hilliard B, 1999, J IMMUNOL, V163, P2937; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hirst CL, 2008, J NEUROL, V255, P231, DOI 10.1007/s00415-008-0696-y; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Hong J, 2006, P NATL ACAD SCI USA, V103, P5024, DOI 10.1073/pnas.0508784103; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; INOSTROZAPONTA M, 2007, LECT NOTES COMPUTER; *INT MULT SCLER GE, 2008, GENES IMMUN, V10, P11; Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Ji HB, 2002, J BIOL CHEM, V277, P47898, DOI 10.1074/jbc.M201025200; JOHNSTONE D, 2008, P 19 INT C GEN INF G; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Jones JL, 2008, NEURODEGENER DIS, V5, P27, DOI 10.1159/000109935; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Khalil MI, 2008, J VIROL, V82, P11723, DOI 10.1128/JVI.01322-08; Kida E, 2006, J NEUROPATH EXP NEUR, V65, P664, DOI 10.1097/01.jnen.0000225905.52002.3e; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Kim SM, 2009, AM J PHYSIOL-RENAL, V296, pF382, DOI 10.1152/ajprenal.90543.2008; Klotz L, 2009, NEUROSCI LETT, V449, P81, DOI 10.1016/j.neulet.2008.10.066; KNUTSON B, 2009, J GEN VIROL; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Larocque D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005867; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lorentzen AR, 2009, ANN NEUROL, V65, P658, DOI 10.1002/ana.21695; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; Magnaghi V, 2007, J MOL NEUROSCI, V31, P149, DOI 10.1385/JMN/31:02:149; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Mckay FC, 2008, J AUTOIMMUN, V31, P52, DOI 10.1016/j.jaut.2008.02.003; Mendes Alexandre, 2008, V141, P131; Mercier G, 2001, MOL BRAIN RES, V97, P137, DOI 10.1016/S0169-328X(01)00311-4; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Miterski B, 2002, GENES IMMUN, V3, P211, DOI 10.1038/sj.gene.6363846; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Montes M, 2009, CLIN IMMUNOL, V130, P133, DOI 10.1016/j.clim.2008.08.030; MOREAU T, 1994, LANCET, V344, P298, DOI 10.1016/S0140-6736(94)91339-0; Moreau T, 1996, Mult Scler, V1, P357; Morgenthaler NG, 1997, AUTOIMMUNITY, V25, P203, DOI 10.3109/08916939708994729; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Mrak RE, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-5; Muhammad F, 2009, AM J MED GENET A, V149A, P926, DOI 10.1002/ajmg.a.32749; Mullin M, 2007, FEBS LETT, V581, P4309, DOI 10.1016/j.febslet.2007.07.077; Muraro PA, 2007, NEUROTHERAPEUTICS, V4, P676, DOI 10.1016/j.nurt.2007.07.003; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nguyen VT, 2002, J BIOL CHEM, V277, P13796, DOI 10.1074/jbc.M111906200; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Keefe GM, 2002, J NEUROVIROL, V8, P496, DOI 10.1080/13550280290100941; Oh J, 2005, J VIROL, V79, P12852, DOI 10.1128/JVI.79.20.12852-12860.2005; Oh SJ, 2008, BONE MARROW TRANSPL, V41, P1047, DOI 10.1038/bmt.2008.37; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; OLERUP O, 1989, P NATL ACAD SCI USA, V86, P7113, DOI 10.1073/pnas.86.18.7113; Olsen JK, 2001, J CLIN INVEST, V108, P311; Pan QH, 2004, J BIOL CHEM, V279, P51068, DOI 10.1074/jbc.M406145200; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Peng SL, 2008, FRONT BIOSCI-LANDMRK, V13, P4218, DOI 10.2741/3001; Perini P, 2001, J NEUROL NEUROSUR PS, V71, P679, DOI 10.1136/jnnp.71.5.679; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Petro TM, 2005, IMMUNOL LETT, V97, P47, DOI 10.1016/j.imlet.2004.09.013; Plumb J, 2006, MULT SCLER J, V12, P375, DOI 10.1191/135248506ms1276oa; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pollard KS, 2009, SCI AM, V300, P44, DOI 10.1038/scientificamerican0509-44; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pugliatti M, 2008, ACTA NEUROL SCAND, V117, P34, DOI 10.1111/j.1600-0404.2008.01029.x; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Ramagopalan SV, 2008, TRENDS NEUROSCI, V31, P645, DOI 10.1016/j.tins.2008.09.001; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Rodriguez M, 2006, FASEB J, V20, P343, DOI 10.1096/fj.05-4650fje; Roifman CM, 2004, CURR OPIN ALLERGY CL, V4, P479, DOI 10.1097/00130832-200412000-00002; Roifman CM, 2005, IMMUNOL REV, V203, P143, DOI 10.1111/j.0105-2896.2005.00236.x; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Rosenbaum T, 1999, ANN NY ACAD SCI, V883, P203, DOI 10.1111/j.1749-6632.1999.tb08583.x; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Roth TM, 2007, GLIA, V55, P1123, DOI 10.1002/glia.20534; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Rothenberg EV, 2004, SEMIN IMMUNOL, V16, P227, DOI 10.1016/j.smim.2004.08.002; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Saadi A, 2009, EUR J MED GENET, V52, P180, DOI 10.1016/j.ejmg.2009.03.013; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P452, DOI 10.1007/s00401-004-0838-y; Satoh J, 2008, DIS MARKERS, V25, P27, DOI 10.1155/2008/824640; Schellekens J, 2008, MOL IMMUNOL, V45, P2255, DOI 10.1016/j.molimm.2007.11.014; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Schmidli RS, 1998, AUTOIMMUNITY, V28, P15, DOI 10.3109/08916939808993841; Schmidt S, 2004, J LEUKOCYTE BIOL, V75, P478, DOI 10.1189/jlb.0803402; SCHMITT SG, 2009, INVEST OPHTHALMOL VI; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Seiwa C, 2002, J NEUROSCI RES, V69, P305, DOI 10.1002/jnr.10291; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Shimizu S, 2001, BIOCHEM BIOPH RES CO, V288, P165, DOI 10.1006/bbrc.2001.5754; SIBLEY WA, 1985, LANCET, V1, P1313; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Simpson B S, 2007, Int MS J, V14, P48; Smestad C, 2008, J NEUROL, V255, P49, DOI 10.1007/s00415-007-0659-8; Sock E, 1997, J NEUROCHEM, V68, P1911; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Su H, 2004, IMMUNITY, V21, P133, DOI 10.1016/j.immuni.2004.07.015; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tajouri L, 2003, MOL BRAIN RES, V119, P170, DOI 10.1016/j.molbrainres.2003.09.008; Takada H, 2005, EUR J PEDIATR, V164, P311, DOI 10.1007/s00431-005-1639-6; Taki S, 2002, CYTOKINE GROWTH F R, V13, P379, DOI 10.1016/S1359-6101(02)00023-0; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Thompson AJ, 2000, ANN NEUROL, V47, P831; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Williams AJK, 2008, DIABETOLOGIA, V51, P1444, DOI 10.1007/s00125-008-1047-3; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Wu Shourong, 2007, Nucleic Acids Symp Ser (Oxf), P347; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Yui MA, 2004, J IMMUNOL, V173, P5381, DOI 10.4049/jimmunol.173.9.5381; Zaheer S, 2007, NEUROCHEM RES, V32, P2123, DOI 10.1007/s11064-007-9383-0; Zalani S, 1997, J VIROL, V71, P3268, DOI 10.1128/JVI.71.4.3268-3274.1997; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	285	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14176	10.1371/journal.pone.0014176	http://dx.doi.org/10.1371/journal.pone.0014176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152067	Green Published, gold			2022-12-25	WOS:000284821300001
J	He, J; Chen, DW; Bing, Y				He Jun; Chen Daiwen; Yu Bing			Metabolic and Transcriptomic Responses of Weaned Pigs Induced by Different Dietary Amylose and Amylopectin Ratio	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID OXIDATION; LIPID-METABOLISM; ADIPOSE-TISSUE; AMINO-ACIDS; MICE; CARBOHYDRATE; LIVER; GLUCOSE	Starch is one of the major dietary energy sources for mammals. However, the nutritional value of starch largely depends on its amylose and amylopectin ratio. In this study, the overall metabolic and transcriptomic responses of weaned pigs fed with different dietary starches were assessed. Sixteen weaned pigs were randomly allotted to two experimental diets containing either of pure cassava starch (CS) or maize starch (MS) as the sole energy source (the amylose-amylopectin ratio were 0.25 and 0.43, respectively). Results indicated that the body weight gain was not affected by different dietary starches. However, a moderate fatty liver was observed in CS-fed group. Long-term ingestion of CS not only increased the total liver fat content, but significantly elevated the liver triglyceride and cholesterol content (P < 0.05). In addition, the serum insulin and cholesterol concentrations were both elevated in CS-fed group (P < 0.05). Microarray analysis led to the identification of 648 genes differentially expressed in liver (P < 0.05), and a lot of them were involved in lipid and carbohydrate metabolism. Additionally, pathway analysis indicated that both the insulin and PPAR signaling pathways were acutely affected by dietary amylose-amylopectin ratio. Long-term ingestion of CS activated the transcription of lipogenic genes such as hmgr and fasn, but decreased the expression of lipolytic genes such as aox1, ppara and fbp. The microarray results correlated well with the measurements of several key enzymes involved in hepatic lipid metabolism. Our results suggested that both the metabolic and transcriptomic responses of weaned pigs were tightly regulated by dietary starch composition, and a high amylose ratio starch (i.e MS) may be more healthful for mammals as the long-term energy source by down-regulation of hepatic lipogenesis and steroidogenesis.	[He Jun; Chen Daiwen; Yu Bing] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [He Jun; Chen Daiwen; Yu Bing] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	He, J (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	daiwenc@yahoo.com	He, Jun/G-5896-2010		China Ministry of Education [IRTO555-5]	China Ministry of Education(Ministry of Education, China)	This work was granted by Program for Changjiang Scholars and Innovative Research Team in University with grant No. IRTO555-5, China Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Englyst HN, 1996, BRIT J NUTR, V75, P327, DOI 10.1079/BJN19960137; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; GhusainChoueiri AA, 1995, BRIT J NUTR, V74, P821, DOI 10.1079/BJN19950009; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; IDE T, 1987, LIPIDS, V22, P6, DOI 10.1007/BF02534867; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kashireddy PV, 2004, HEPATOL RES, V30, P104, DOI 10.1016/j.hepres.2004.06.004; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Li TJ, 2008, ANIMAL, V2, P723, DOI 10.1017/S1751731108001614; Li TJ, 2007, LIVEST SCI, V109, P73, DOI 10.1016/j.livsci.2007.01.073; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Nagai Y, 2007, FEBS LETT, V581, P218, DOI 10.1016/j.febslet.2006.12.014; National Research Council, 1998, NUTR REQ SWIN, Vtenth; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Scribner KB, 2007, OBESITY, V15, P2190, DOI 10.1038/oby.2007.260; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Sondike SB, 2003, J PEDIATR-US, V142, P253, DOI 10.1067/mpd.2003.4; Stevnebo A, 2006, ANIM FEED SCI TECH, V130, P23, DOI 10.1016/j.anifeedsci.2006.01.015; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; VanderMeulen J, 1997, BRIT J NUTR, V78, P533, DOI 10.1079/BJN19970173; Wolever TMS, 2000, BRIT J NUTR, V83, pS97; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; YING YL, 2004, J ANIM FEED SCI, V13, P523; Yu L, 2010, J IND MICROBIOL BIOT, V37, P313, DOI 10.1007/s10295-009-0676-y	37	30	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15110	10.1371/journal.pone.0015110	http://dx.doi.org/10.1371/journal.pone.0015110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152049	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100075
J	Zhu, YZ; Cai, CS; Zhang, W; Guo, HX; Zhang, JP; Ji, YY; Ma, GY; Wu, JL; Li, QT; Lu, CP; Guo, XK				Zhu, Yong-Zhang; Cai, Cheng-Song; Zhang, Wei; Guo, Hong-Xiong; Zhang, Jin-Ping; Ji, Ya-Yong; Ma, Guang-Yuan; Wu, Jia-Lin; Li, Qing-Tian; Lu, Cheng-Ping; Guo, Xiao-Kui			Immunoproteomic Analysis of Human Serological Antibody Responses to Vaccination with Whole-Cell Pertussis Vaccine (WCV)	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; STREPTOCOCCUS-SUIS TYPE-2; GROUP-A STREPTOCOCCUS; BORDETELLA-PERTUSSIS; 2-DIMENSIONAL ELECTROPHORESIS; IMMUNOGENIC PROTEINS; EXTRACELLULAR PROTEINS; SYSTEMIC CANDIDIASIS; BACILLUS-ANTHRACIS; PROTEOME ANALYSIS	Background: Pertussis (whooping cough) caused by Bordetella pertussis (B.p), continues to be a serious public health threat. Vaccination is the most economical and effective strategy for preventing and controlling pertussis. However, few systematic investigations of actual human immune responses to pertussis vaccines have been performed. Therefore, we utilized a combination of two-dimensional electrophoresis (2-DE), immunoblotting, and mass spectrometry to reveal the entire antigenic proteome of whole-cell pertussis vaccine (WCV) targeted by the human immune system as a first step toward evaluating the repertoire of human humoral immune responses against WCV. Methodology/Principal Findings: Immunoproteomic profiling of total membrane enriched proteins and extracellular proteins of Chinese WCV strain 58003 identified a total of 30 immunoreactive proteins. Seven are known pertussis antigens including Pertactin, Serum resistance protein, chaperonin GroEL and two OMP porins. Sixteen have been documented to be immunogenic in other pathogens but not in B.p, and the immunogenicity of the last seven proteins was found for the first time. Furthermore, by comparison of the human and murine immunoproteomes of B.p, with the exception of four human immunoreactive proteins that were also reactive with mouse immune sera, a unique group of antigens including more than 20 novel immunoreactive proteins that uniquely reacted with human immune serum was confirmed. Conclusions/Significance: This study is the first time that the repertoire of human serum antibody responses against WCV was comprehensively investigated, and a small number of previously unidentified antigens of WCV were also found by means of the classic immunoproteomic strategy. Further research on these newly identified predominant antigens of B.p exclusively against humans will not only remarkably accelerate the development of diagnostic biomarkers and subunit vaccines but also provide detailed insight into human immunity mechanisms against WCV. In particular, this work highlights the heterogeneity of the B.p immunoreactivity patterns of the mouse model and the human host.	[Zhu, Yong-Zhang; Cai, Cheng-Song; Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Zhu, Yong-Zhang; Zhang, Jin-Ping; Ji, Ya-Yong; Ma, Guang-Yuan; Wu, Jia-Lin] WuXi Ctr Dis Prevent & Control, Mol Biol Lab, Wuxi, Peoples R China; [Zhang, Wei; Lu, Cheng-Ping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Dis Diagnost & Immunol, Nanjing, Peoples R China; [Guo, Hong-Xiong] Jiangsu Ctr Dis Prevent & Control, Dept STD & AIDS Prevent & Control, Nanjing, Peoples R China; [Li, Qing-Tian] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Lab Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Shanghai Jiao Tong University	Zhu, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China.	qingtianli@gmail.com; microbiology@sjtu.edu.cn	Guo, Hongxiong/GPS-7405-2022	Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30900051]; Natural Science Foundation of Jiangsu Province of China [BK2010158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	This work was supported by The National Natural Science Foundation of China (Grant No: 30900051) and The Natural Science Foundation of Jiangsu Province of China (Grant No: BK2010158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2006, J IMMUNOL METHODS, V309, P34, DOI 10.1016/j.jim.2005.11.003; Alam SI, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-162; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Argiro L, 2000, VACCINE, V18, P2039, DOI 10.1016/S0264-410X(99)00521-6; ARMSTRONG SK, 1986, J BACTERIOL, V166, P212, DOI 10.1128/jb.166.1.212-216.1986; Ayalew S, 2010, PROTEOMICS, V10, P2151, DOI 10.1002/pmic.200900557; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Bumann D, 2002, INFECT IMMUN, V70, P6494, DOI 10.1128/IAI.70.11.6494-6498.2002; Caro V, 2008, J CLIN MICROBIOL, V46, P2125, DOI 10.1128/JCM.02484-07; CHARLES IG, 1991, EUR J IMMUNOL, V21, P1147, DOI 10.1002/eji.1830210509; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; COONEY BJ, 1993, INFECT IMMUN, V61, P4682, DOI 10.1128/IAI.61.11.4682-4688.1993; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Das P, 2002, LANCET INFECT DIS, V2, P322, DOI 10.1016/S1473-3099(02)00308-0; DELGIUDICE G, 1993, J IMMUNOL, V150, P2025; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Elahi S, 2005, INFECT IMMUN, V73, P3636, DOI 10.1128/IAI.73.6.3636-3645.2005; Elder KD, 2004, INFECT IMMUN, V72, P5919, DOI 10.1128/IAI.72.10.5919-5924.2004; Erttmann KD, 2005, BBA-MOL BASIS DIS, V1741, P85, DOI 10.1016/j.bbadis.2004.12.010; Fuchslocher B, 2003, INFECT IMMUN, V71, P3043, DOI 10.1128/IAI.71.6.3043-3052.2003; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; GRANDI G, 2004, GENOMICS PROTEOMICS; Guiso N, 2009, CLIN INFECT DIS, V49, P1565, DOI 10.1086/644733; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; JOHNSON FD, 1994, J BACTERIOL, V176, P5350, DOI 10.1128/JB.176.17.5350-5356.1994; Jones AL, 2007, J IMMUNOL, V179, P3196, DOI 10.4049/jimmunol.179.5.3196; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Li H, 2010, J PROTEOME RES, V9, P2573, DOI 10.1021/pr1000219; Liao YH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-172; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2009, MICROBIOL-SGM, V155, P2641, DOI 10.1099/mic.0.029918-0; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Oliver DC, 2001, VACCINE, V20, P235, DOI 10.1016/S0264-410X(01)00269-9; Packard ER, 2004, J MED MICROBIOL, V53, P355, DOI 10.1099/jmm.0.05515-0; Peng XX, 2004, VACCINE, V22, P2750, DOI 10.1016/j.vaccine.2004.01.038; Vidakovics ML, 2007, J PROTEOME RES, V6, P2518, DOI 10.1021/pr060681i; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; POOLMAN J, 1990, OUTER MEMBRANE VESIC, P202; REDD SC, 1988, J CLIN MICROBIOL, V26, P1373, DOI 10.1128/JCM.26.7.1373-1377.1988; REDHEAD K, 1984, INFECT IMMUN, V44, P724, DOI 10.1128/IAI.44.3.724-729.1984; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Salim KY, 2005, INFECT IMMUN, V73, P6026, DOI 10.1128/IAI.73.9.6026-6038.2005; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Shin GW, 2009, VET MICROBIOL, V139, P113, DOI 10.1016/j.vetmic.2009.05.007; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS83, DOI 10.1097/01.inf.0000160919.94330.1a; TeixeiraGomes AP, 1997, ELECTROPHORESIS, V18, P1491, DOI 10.1002/elps.1150180824; THOMAS MG, 1989, J INFECT DIS, V159, P211, DOI 10.1093/infdis/159.2.211; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; van den Berg BM, 1999, INFECT IMMUN, V67, P1050, DOI 10.1128/IAI.67.3.1050-1055.1999; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; *WHO, 2006, WORLD HLTH REP 2004; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; WOODS DE, 1989, INFECT IMMUN, V57, P1018, DOI 10.1128/IAI.57.4.1018-1024.1989; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; YAN F, 2009, VET J; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294; Zhu YZ, 2008, OMICS, V12, P161, DOI 10.1089/omi.2008.0029	87	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13915	10.1371/journal.pone.0013915	http://dx.doi.org/10.1371/journal.pone.0013915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21170113	Green Submitted, gold, Green Published			2022-12-25	WOS:000284035900020
J	Li, LY; Dai, HY; Yeh, FL; Kan, SF; Lang, J; Hsu, JL; Jeng, LB; Chen, YH; Sher, YP; Lin, WC; Hung, MC				Li, L-Y; Dai, H-Y; Yeh, F-L; Kan, S-F; Lang, J.; Hsu, J. L.; Jeng, L-B; Chen, Y-H; Sher, Y-P; Lin, W-C; Hung, M-C			Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy	ONCOGENE			English	Article						liver cancer; alpha-fetoprotein; non-viral gene therapy; VISA	ALPHA-FETOPROTEIN PROMOTER; LIVER-CANCER; EXPRESSION; VECTOR; TUMOR; CONSTRUCTION; REPLICATION; SURVIVAL; CELL; DNA	Hepatocellular carcinoma (HCC), the third leading cause of cancer death in the world, is the most general type of primary liver cancer. Although current treatment modalities, such as liver transplantation, resection, percutaneous ablation, transarterial embolization, chemotherapy and radiotherapy are potentially curative, these methods are not universally applicable to all of HCC patients, especially for those with poor prognosis in which no effective remedy is available. Therefore, development of novel therapeutic approach for the treatment of HCC is urgently needed. In the current study, we developed a promising HCC-targeted gene therapy vector driven by liver cancer-specific alpha-fetoprotein promoter/enhancer coupled to an established platform technology. The activity of this expression vector is comparable with or even higher than that of strong cytomegalovirus (CMV) promoter and exhibits strong promoter activity in liver cancer cells/tumors, but has nearly no or very low activity in normal cells/organs in vitro and in orthotopic animal models in vivo. Its cancer specificity exceeds that of the CMV promoter, which expresses non-specifically in both normal and tumor cells. In addition, targeted expression of a therapeutic BikDD, a mutant of proapoptotic gene Bik effectively and preferentially killed liver cancer cells, but not normal cells and significantly repressed growth of HCC tumors, and prolonged survival in multiple xenograft and syngeneic orthotopic mouse models of HCC through intravenous systemic gene delivery. Importantly, systemic administration of BikDD by our expression vector exerted no systemically acute toxicity compared with CMV-BikDD in mice. Taken together, this study elucidates a relatively safe and highly effective and specific systemic gene therapy strategy for liver cancer, and is worthy of further development for future clinical trials. Oncogene (2011) 30, 1773-1783; doi:10.1038/onc.2010.558; published online 13 December 2010	[Li, L-Y; Dai, H-Y; Yeh, F-L; Kan, S-F; Chen, Y-H; Sher, Y-P; Hung, M-C] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Li, L-Y; Hung, M-C] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Li, L-Y] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lang, J.; Hsu, J. L.; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Jeng, L-B] China Med Univ, Dept Surg, Taichung, Taiwan; [Jeng, L-B] China Med Univ, Dept Med, Taichung, Taiwan; [Lin, W-C] China Med Univ, Dept Pharmacol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Li, LY (corresponding author), China Med Univ & Hosp, Ctr Mol Med, Taichung 40447, Taiwan.	lyl@mail.cmu.edu.tw; mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Li, Long-Yuan/0000-0001-7472-8318	 [DOH97-TD-I-111-TM003];  [DOH98-TD-I-111-TM002];  [NHRI-EX98-9603BC];  [DOH98-TD-G-111-030];  [NSC96-3111-B-039];  [NSC97-3111-B-039];  [DOH99-TD-C-111-005]	; ; ; ; ; ; 	This work was supported by grants from DOH97-TD-I-111-TM003, DOH98-TD-I-111-TM002, NHRI-EX98-9603BC (to L-YL), DOH98-TD-G-111-030 (to M-CH), NSC96-3111-B-039, NSC97-3111-B-039 and DOH99-TD-C-111-005 (to M-CH and L-YL).	Abelev GI, 1999, SEMIN CANCER BIOL, V9, P95, DOI 10.1006/scbi.1998.0084; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Bui LA, 1997, HUM GENE THER, V8, P2173, DOI 10.1089/hum.1997.8.18-2173; Chen JS, 2004, CANCER GENE THER, V11, P740, DOI 10.1038/sj.cgt.7700752; CHEN SH, 1992, CANCER RES, V52, P1329; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Guan M, 2006, CANCER RES, V66, P1620, DOI 10.1158/0008-5472.CAN-05-0877; Hoofnagle JH, 2004, GASTROENTEROLOGY, V127, pS319, DOI 10.1053/j.gastro.2004.09.047; Ido A, 2001, CANCER RES, V61, P3016; IZUMI R, 1992, J SURG ONCOL, V49, P151, DOI 10.1002/jso.2930490305; Kim JW, 2003, CARCINOGENESIS, V24, P363, DOI 10.1093/carcin/24.3.363; Lemken ML, 2005, WORLD J GASTROENTERO, V11, P5295, DOI 10.3748/wjg.v11.i34.5295; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu SY, 2003, WORLD J GASTROENTERO, V9, P688, DOI 10.3748/wjg.v9.i4.688; Ma SH, 2010, GENE THER, V17, P905, DOI 10.1038/gt.2010.34; Mawatari F, 1998, CANCER GENE THER, V5, P301; NAKABAYASHI H, 1991, MOL CELL BIOL, V11, P5885, DOI 10.1128/MCB.11.12.5885; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ren XW, 2006, CANCER GENE THER, V13, P159, DOI 10.1038/sj.cgt.7700868; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Shi YJ, 2004, WORLD J GASTROENTERO, V10, P186; STILLWAGON GB, 1991, INT J RADIAT ONCOL, V20, P65, DOI 10.1016/0360-3016(91)90139-U; Suriawinata A, 2004, SEMIN LIVER DIS, V24, P77; Takahashi M, 2002, MOL THER, V5, P627, DOI 10.1006/mthe.2002.0589; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Xie XM, 2009, MOL CANCER THER, V8, P2375, DOI 10.1158/1535-7163.MCT-09-0056; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	29	26	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	15					1773	1783		10.1038/onc.2010.558	http://dx.doi.org/10.1038/onc.2010.558			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21151169	Bronze			2022-12-25	WOS:000289512200005
J	Alvarez-Flores, MP; Furlin, D; Ramos, OHP; Balan, A; Konno, K; Chudzinski-Tavassi, AM				Alvarez-Flores, Miryam Paola; Furlin, Daniel; Ramos, Oscar H. P.; Balan, Andrea; Konno, Katsuhiro; Chudzinski-Tavassi, Ana Marisa			Losac, the First Hemolin that Exhibits Procogulant Activity through Selective Factor X Proteolytic Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-X; INSECT-IMMUNE PROTEIN; RUSSELLS VIPER VENOM; NEURAL CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; CATALYTIC ANTIBODIES; CRYSTAL-STRUCTURE; BLOOD-COAGULATION; MANDUCA-SEXTA; PHOSPHOLIPID-VESICLES	Envenoming by the contact of human skin with Lonomia obliqua caterpillars promotes a hemorrhagic syndrome characterized by a consumptive coagulopathy. Losac (Lonomia obliqua Stuart factor activator) is a component of the bristle of L. obliqua that is probably partially responsible for the observed syndrome because it activates factor X and is recognized by an effective antilonomic serum. Here we unveil the proteolytic activity of Losac and demonstrate the feasibility of its recombinant production. On the other hand, Losac has no homology to known proteases, but it can be inhibited by PMSF, a serine protease inhibitor. Instead, it shows closer homology to members of the hemolin family of proteins, a group of cell adhesion molecules. The recombinant protein (rLosac) shortened the coagulation time of normal and deficient plasmas, whereas it was ineffective in factor X-deficient plasma unless reconstituted with this protein. rLosac was able to activate factor X in a dose-and time-dependent manner but not gamma-carboxyglutamic acid domainless factor X. Moreover, phospholipids and calcium ions increased rLosac activity. Also, rLosac had no effect on fibrin or fibrinogen, indicating its specificity for blood coagulation activation. Linear double reciprocal plots indicate that rLosac follows a Michaelis-Menten kinetics. Cleavage of factor X by rLosac resulted in fragments that are compatible with those generated by RVV-X (a well known factor X activator). Together, our results validate Losac as the first protein from the hemolin family exhibiting procoagulant activity through selective proteolysis on coagulation factor X.	[Alvarez-Flores, Miryam Paola; Furlin, Daniel; Ramos, Oscar H. P.; Chudzinski-Tavassi, Ana Marisa] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil; [Balan, Andrea] Ctr Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil; [Konno, Katsuhiro; Chudzinski-Tavassi, Ana Marisa] Inst Butantan, Ctr Toxinol Aplicada, BR-05503900 Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan	Chudzinski-Tavassi, AM (corresponding author), Biochem & Biophys Lab, Av Vital Brasil 1500, BR-05503900 Sao Paulo, Brazil.	amchudzinski@butantan.gov.br	Balan, Andrea/D-1891-2014; Alvarez-Flores, Miryam/I-1848-2012; Pereira Ramos, Oscar Henrique/E-1862-2013	Balan, Andrea/0000-0001-6199-3198; Alvarez-Flores, Miryam/0000-0002-7986-923X; Pereira Ramos, Oscar Henrique/0000-0002-5788-4500; Konno, Katsuhiro/0000-0002-1949-1845	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/51813-0, 07/51889-7, 08/54092-5]; Conselho Nacional de Desenvolvimento Cientfico e Tecnologico; Centro de Toxinologia Aplicada	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centro de Toxinologia Aplicada	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 07/51813-0, 07/51889-7, and 08/54092-5 and fellowships from Conselho Nacional de Desenvolvimento Cientfico e Tecnologico (to M. P. A.-F. and A. M. C.-T.). This work was also supported by grants from Centro de Toxinologia Aplicada.	Flores MPA, 2009, PATHOPHYSIOL HAEMO T, V37, P1, DOI 10.1159/000320067; Aye TT, 2008, J INSECT PHYSIOL, V54, P1301, DOI 10.1016/j.jinsphys.2008.07.003; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Bettencourt R, 2000, MECH DEVELOP, V95, P301, DOI 10.1016/S0925-4773(00)00359-2; Bettencourt R, 1997, EUR J BIOCHEM, V250, P630, DOI 10.1111/j.1432-1033.1997.00630.x; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Bettencourt R, 1999, EUR J BIOCHEM, V266, P964, DOI 10.1046/j.1432-1327.1999.00934.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen HS, 2008, FEBS J, V275, P3944, DOI 10.1111/j.1742-4658.2008.06540.x; Chudzinski-Tavassi AM, 2005, PATHOPHYSIOL HAEMO T, V34, P228, DOI 10.1159/000092429; Daffre S, 1997, FEBS LETT, V408, P127, DOI 10.1016/S0014-5793(97)00397-9; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; Faye Ingrid, 1998, P173; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gabibov A, 2006, IMMUNOL LETT, V103, P1, DOI 10.1016/j.imlet.2005.10.012; Golinelli-Pimpaneau B, 2000, CURR OPIN STRUC BIOL, V10, P697, DOI 10.1016/S0959-440X(00)00157-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUO JC, 1995, P NATL ACAD SCI USA, V92, P1694, DOI 10.1073/pnas.92.5.1694; Hanson CV, 2005, CURR OPIN BIOTECH, V16, P631, DOI 10.1016/j.copbio.2005.10.003; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Hoffman M, 2007, HEMATOL ONCOL CLIN N, V21, P1, DOI 10.1016/j.hoc.2006.11.004; JESPERSEN J, 1983, HAEMOSTASIS, V13, P301; KAMINISHI H, 1994, FEMS MICROBIOL LETT, V121, P327, DOI 10.1016/0378-1097(94)90312-3; KANOST MR, 1994, ARCH INSECT BIOCHEM, V27, P123, DOI 10.1002/arch.940270205; Lacroix-Desmazes S, 2006, IMMUNOL LETT, V103, P3, DOI 10.1016/j.imlet.2005.10.007; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; Li WL, 2005, DEV COMP IMMUNOL, V29, P853, DOI 10.1016/j.dci.2005.02.003; LINDSTROMDINNETZ I, 1995, EUR J BIOCHEM, V230, P920, DOI 10.1111/j.1432-1033.1995.tb20637.x; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; Morita Takashi, 1998, P179; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Ramos CRR, 2001, MEM I OSWALDO CRUZ, V96, P131, DOI 10.1590/S0074-02762001000900019; Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325; Richter G, 2002, BRIT J HAEMATOL, V119, P1042, DOI 10.1046/j.1365-2141.2002.03954.x; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Rucinska M, 1997, Rocz Akad Med Bialymst, V42 Suppl 1, P110; SAKODA M, 1976, J BIOCHEM-TOKYO, V80, P547, DOI 10.1093/oxfordjournals.jbchem.a131310; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; SKOGEN WF, 1983, BIOCHEM BIOPH RES CO, V111, P14, DOI 10.1016/S0006-291X(83)80110-7; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; TAKEYA H, 1992, J BIOL CHEM, V267, P14109; Tans G, 2001, HAEMOSTASIS, V31, P225; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; VANDIEIJEN G, 1981, BIOCHEMISTRY-US, V20, P7096, DOI 10.1021/bi00528a007; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Yu XQ, 1999, ARCH INSECT BIOCHEM, V42, P198, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;198::AID-ARCH4&gt;3.0.CO;2-G; Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355, DOI 10.1055/s-0037-1613453; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444	62	14	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6918	6928		10.1074/jbc.M110.167718	http://dx.doi.org/10.1074/jbc.M110.167718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177860	Green Published, hybrid			2022-12-25	WOS:000287737300007
J	Murata, H; Sakaguchi, M; Jin, Y; Sakaguchi, Y; Futami, J; Yamada, H; Kataoka, K; Huh, NH				Murata, Hitoshi; Sakaguchi, Masakiyo; Jin, Yu; Sakaguchi, Yoshihiko; Futami, Jun-ichiro; Yamada, Hidenori; Kataoka, Ken; Huh, Nam-ho			A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1 ACTIVATION OF AKT VIA MTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; RICTOR-MTOR COMPLEX; OXIDATIVE STRESS; PINK1; MUTATIONS; GROWTH; GENE; AKT/PKB; PHOSPHORYLATION; MICE	Accumulating evidence indicates that dysfunction of mitochondria is a common feature of Parkinson disease. Functional loss of a familial Parkinson disease-linked gene, BRPK/PINK1 (PINK1), results in deterioration of mitochondrial functions and eventual neuronal cell death. A mitochondrial chaperone protein has been shown to be a substrate of PINK1 kinase activity. In this study, we demonstrated that PINK1 has another action point in the cytoplasm. Phosphorylation of Akt at Ser-473 was enhanced by overexpression of PINK1, and the Akt activation was crucial for protection of SH-SY5Y cells from various cytotoxic agents, including oxidative stress. Enhanced Akt phosphorylation was not due to activation of phosphatidylinositol 3-kinase but due to activation of mammalian target of rapamycin complex 2 (mTORC2) by PINK1. Rictor, a specific component of mTORC2, was phosphorylated by overexpression of PINK1. Furthermore, overexpression of PINK1 enhanced cell motility. These results indicate that PINK1 exerts its cytoprotective function not only in mitochondria but also in the cytoplasm through activation of mTORC2.	[Kataoka, Ken; Huh, Nam-ho] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan; [Futami, Jun-ichiro; Yamada, Hidenori] Okayama Univ, Dept Biosci & Biotechnol, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Okayama University; University of Miyazaki; Okayama University	Huh, NH (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; FUTAMI, Junichiro/B-2578-2011; YAMADA, Hidenori/B-2639-2011; MURATA, Hitoshi/B-2327-2011; HUH, Nam-ho/B-1613-2011; KATAOKA, Ken/B-1607-2011	FUTAMI, Junichiro/0000-0002-0020-2855; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20015031]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant 20015031 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. H.).	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Criscuolo C, 2006, MOVEMENT DISORD, V21, P1265, DOI 10.1002/mds.20933; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kessler KR, 2005, J NEURAL TRANSM, V112, P1345, DOI 10.1007/s00702-005-0281-9; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	41	97	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7182	7189		10.1074/jbc.M110.179390	http://dx.doi.org/10.1074/jbc.M110.179390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177249	Green Published, hybrid			2022-12-25	WOS:000287737300035
J	Colombi, M; Molle, KD; Benjamin, D; Rattenbacher-Kiser, K; Schaefer, C; Betz, C; Thiemeyer, A; Regenass, U; Hall, MN; Moroni, C				Colombi, M.; Molle, K. D.; Benjamin, D.; Rattenbacher-Kiser, K.; Schaefer, C.; Betz, C.; Thiemeyer, A.; Regenass, U.; Hall, M. N.; Moroni, C.			Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction	ONCOGENE			English	Article						shRNA screen; mTOR addiction; IL-3 dependence; mitochondria; drug targets	LENTIVIRAL RNAI LIBRARY; CANCER-CELLS; GLUT4 TRANSLOCATION; PROTEIN; KINASE; EXPRESSION; METABOLISM; GENE; IDENTIFICATION; INHIBITION	Release from growth factor dependence and acquisition of signalling pathway addiction are critical steps in oncogenesis. To identify genes required on mammalian target of rapamycin (mTOR) addiction, we performed a genome-wide short hairpin RNA screen on a v-H-ras-transformed Pten-deficient cell line that displayed two alternative growth modes, interleukin (IL)-3-independent/mTOR-addicted proliferation (transformed growth mode) and IL-3-dependent/mTOR-non-addicted proliferation (normal growth mode). We screened for genes required only in the absence of IL-3 and thus specifically for the transformed growth mode. The top 800 hits from this conditional lethal screen were analyzed in silico and 235 hits were subsequently rescreened in two additional Pten-deficient cell lines to generate a core set of 47 genes. Hits included genes encoding mTOR and the mTOR complex 2 (mTORC2) component rictor and several genes encoding mitochondrial functions including components of the respiratory chain, adenosine triphosphate synthase, the mitochondrial ribosome and mitochondrial fission factor. Small interfering RNA knockdown against a sizeable fraction of these genes triggered apoptosis in human cancer cell lines but not in normal fibroblasts. We conclude that mTORC2-addicted cells require mitochondrial functions that may be novel drug targets in human cancer. Oncogene (2011) 30, 1551-1565; doi: 10.1038/onc.2010.539; published online 20 December 2010	[Colombi, M.; Molle, K. D.; Benjamin, D.; Betz, C.; Thiemeyer, A.; Hall, M. N.; Moroni, C.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Rattenbacher-Kiser, K.; Schaefer, C.] Univ Basel, Inst Med Microbiol, CH-4056 Basel, Switzerland; [Regenass, U.] Actel Pharmaceut Ltd, Allschwil, Switzerland	University of Basel; University of Basel; Actelion Pharmaceuticals Ltd	Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch; christoph.moroni@unibas.ch	Betz, Charles/B-7444-2008	Betz, Charles/0000-0002-9837-6916; Hall, Michael N/0000-0002-2998-0757	Commission of Technology and Innovation (CTI); Swiss National Science Foundation; Swiss Cancer League; Louis-Jeantet Foundation	Commission of Technology and Innovation (CTI); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Louis-Jeantet Foundation	We thank TW Sturgill for comments and Dr F Wenzel for providing normal human fibroblasts. We acknowledge support from the Commission of Technology and Innovation (CTI) (CM, MNH and UR), the Swiss National Science Foundation (CM and MNH) and the Swiss Cancer League and the Louis-Jeantet Foundation (MNH).	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dang CV, 2010, MOL CELL BIOL, V30, P1300, DOI 10.1128/MCB.01661-09; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gonez LJ, 2008, MOL MED, V14, P697, DOI 10.2119/2008-00072.Gonez; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Heyward CA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-25; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Jung HC, 2005, LIFE SCI, V77, P1249, DOI 10.1016/j.lfs.2005.02.009; Kiser KF, 2006, ONCOGENE, V25, P6595, DOI 10.1038/sj.onc.1209673; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mueller BA, 2009, CURR PHARM DESIGN, V15, P120, DOI 10.2174/138161209787002933; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; NAIR APK, 1992, ONCOGENE, V7, P1963; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Thaimattam R, 2007, CURR PHARM DESIGN, V13, P2751, DOI 10.2174/138161207781757042; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WITTWER AJ, 1980, P NATL ACAD SCI-BIOL, V77, P4484, DOI 10.1073/pnas.77.8.4484; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	46	32	32	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	13					1551	1565		10.1038/onc.2010.539	http://dx.doi.org/10.1038/onc.2010.539			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21170086				2022-12-25	WOS:000288998300006
J	Zhang, L; Pei, YF; Li, JA; Papasian, CJ; Deng, HW				Zhang, Lei; Pei, Yu-Fang; Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen			Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions	PLOS ONE			English	Article							POPULATION STRATIFICATION; GENETIC ASSOCIATION; WIDE ASSOCIATION; COMMON DISEASES; SEQUENCE; ALLELES; SPECTRUM; HDL	When testing association between rare variants and diseases, an efficient analytical approach involves considering a set of variants in a genomic region as the unit of analysis. One factor complicating this approach is that the vast majority of rare variants in practical applications are believed to represent background neutral variation. As a result, analyzing a single set with all variants may not represent a powerful approach. Here, we propose two alternative strategies. In the first, we analyze the subsets of rare variants exhaustively. In the second, we categorize variants selectively into two subsets: one in which variants are overrepresented in cases, and the other in which variants are overrepresented in controls. When the proportion of neutral variants is moderate to large we show, by simulations, that the both proposed strategies improve the statistical power over methods analyzing a single set with total variants. When applied to a real sequencing association study, the proposed methods consistently produce smaller p-values than their competitors. When applied to another real sequencing dataset to study the difference of rare allele distributions between ethnic populations, the proposed methods detect the overrepresentation of variants between the CHB (Chinese Han in Beijing) and YRI (Yoruba people of Ibadan) populations with small p-values. Additional analyses suggest that there is no difference between the CHB and CHD (Chinese Han in Denver) datasets, as expected. Finally, when applied to the CHB and JPT (Japanese people in Tokyo) populations, existing methods fail to detect any difference, while it is detected by the proposed methods in several regions.	[Zhang, Lei; Pei, Yu-Fang; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Engn, Beijing, Peoples R China	University of Shanghai for Science & Technology; University of Missouri System; University of Missouri Kansas City; Beijing Jiaotong University	Zhang, L (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	dengh@umkc.edu	Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	National Science Foundation of China; National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huo Ying Dong Education Foundation, Hunan Province; Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The investigators of this work benefited from the support of grants from the National Science Foundation of China, National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973), Huo Ying Dong Education Foundation, Hunan Province, and the Ministry of Education of China. Computing support was partially provided by the High Performance Computing Cluster Center at Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hindorff LA, 2009, CATALOG PUBLISHED GE; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	36	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14288	10.1371/journal.pone.0014288	http://dx.doi.org/10.1371/journal.pone.0014288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170328	Green Submitted, Green Published, gold			2022-12-25	WOS:000285181400011
J	Gupta, R; Dandu, M; Packel, L; Rutherford, G; Leiter, K; Phaladze, N; Korte, FPD; Iacopino, V; Weiser, SD				Gupta, Reshma; Dandu, Madhavi; Packel, Laura; Rutherford, George; Leiter, Karen; Phaladze, Nthabiseng; Korte, Fiona Percy-de; Iacopino, Vincent; Weiser, Sheri D.			Depression and HIV in Botswana: A Population-Based Study on Gender-Specific Socioeconomic and Behavioral Correlates	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; MENTAL-DISORDERS; SOUTH-AFRICA; PSYCHIATRIC-DISORDERS; DISEASE PROGRESSION; PERCEIVED STRESS; WOMEN; SYMPTOMS; HEALTH; PREVALENCE	Background: Depression is a leading contributor to the burden of disease worldwide, a critical barrier to HIV prevention and a common serious HIV co-morbidity. However, depression screening and treatment are limited in sub-Saharan Africa, and there are few population-level studies examining the prevalence and gender-specific factors associated with depression. Methods: We conducted a cross-sectional population-based study of 18-49 year-old adults from five districts in Botswana with the highest prevalence of HIV-infection. We examined the prevalence of depressive symptoms, using a Hopkins Symptom Checklist for Depression (HSCL-D) score of >= 1.75 to define depression, and correlates of depression using multivariate logistic regression stratified by sex. Results: Of 1,268 participants surveyed, 25.3% of women and 31.4% of men had depression. Among women, lower education (adjusted odds ratio [AOR] 2.07, 95% confidence interval [1.30-3.32]), higher income (1.77 [1.09-2.86]), and lack of control in sexual decision-making (2.35 [1.46-3.81]) were positively associated with depression. Among men, being single (1.95 [1.02-3.74]), living in a rural area (1.63 [1.02-2.65]), having frequent visits to a health provider (3.29 [1.88-5.74]), anticipated HIV stigma (fearing discrimination if HIV status was revealed) (2.04 [1.27-3.29]), and intergenerational sex (2.28 [1.17-4.41]) were independently associated with depression. Discussion: Depression is highly prevalent in Botswana, and its correlates are gender-specific. Our findings suggest multiple targets for screening and prevention of depression and highlight the need to integrate mental health counseling and treatment into primary health care to decrease morbidity and improve HIV management efforts.	[Gupta, Reshma; Dandu, Madhavi] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA; [Dandu, Madhavi; Packel, Laura; Rutherford, George] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rutherford, George] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Phaladze, Nthabiseng] Univ Botswana, Sch Nursing, Gaborone, Botswana; [Iacopino, Vincent] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Weiser, Sheri D.] Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Botswana; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gupta, R (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA 94143 USA.	r44gupta@yahoo.com			Physicians for Human Rights; Tides Foundation; NIH/NCRR/ODUCSF-CTSI [TL1 RR024129]; NIMH [K23 MH079713-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713] Funding Source: NIH RePORTER	Physicians for Human Rights; Tides Foundation; NIH/NCRR/ODUCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by Physicians for Human Rights and the Tides Foundation. Reshma Gupta acknowledges support by NIH/NCRR/ODUCSF-CTSI Grant Number TL1 RR024129. Dr. Weiser acknowledges funding through NIMH K23 MH079713-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; [Anonymous], 2008, EP FACT SHEET HIV AI; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; BANKOLE A, 2004, AFRICAN POPULATI OCT, P21; Boarts JM, 2009, J EVID-INFORM SOC WO, V6, P4, DOI 10.1080/15433710802633247; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Boris NW, 2008, ARCH PEDIAT ADOL MED, V162, P836, DOI 10.1001/archpedi.162.9.836; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Chipimo PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-298; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; COSTELLO EJ, 1991, PSYCHIATRY, V54, P292; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Deyessa N, 2008, SCAND J PUBLIC HEALT, V36, P589, DOI 10.1177/1403494808086976; Evans DL, 1997, AM J PSYCHIAT, V154, P630, DOI 10.1176/ajp.154.5.630; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Fleischer NL, 2007, EPIDEMIOLOGY, V18, P678, DOI 10.1097/EDE.0b013e3181567fc5; GARCIAALVAREZ R, 1986, PSYCHOPATHOLOGY, V19, P22, DOI 10.1159/000285128; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gureje O, 2007, LANCET, V370, P957, DOI 10.1016/S0140-6736(07)61446-9; Hallman, 2004, SOCIOECONOMIC DISADV; Hamad R, 2008, J EPIDEMIOL COMMUN H, V62, P538, DOI 10.1136/jech.2007.066191; Hand GA, 2006, AIDS CARE, V18, P1011, DOI 10.1080/09540120600568376; Holzemer WL, 2007, J ADV NURS, V58, P541, DOI 10.1111/j.1365-2648.2007.04244.x; Holzemer WL, 1999, AIDS PATIENT CARE ST, V13, P185, DOI 10.1089/apc.1999.13.185; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hughes J, 2004, DISABIL REHABIL, V26, P371, DOI 10.1080/09638280410001662932; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; MYER L, 2008, SOC SCI MED, V66, P147; *NAT ARLV PROJ TEA, 2006, MAS ANT THER PROGR B; Olley BO, 2006, J PSYCHOSOM RES, V61, P479, DOI 10.1016/j.jpsychores.2006.03.010; Patel V, 1997, BRIT J PSYCHIAT, V171, P60, DOI 10.1192/bjp.171.1.60; Rogers G, 2003, HIV Med, V4, P271, DOI 10.1046/j.1468-1293.2003.00155.x; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rowan PJ, 2002, PSYCHOL MED, V32, P903, DOI 10.1017/S0033291702005767; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; SMART T, 2005, HIV AIDS TREATMENT P; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Sorrell JBJ, 2005, CULT HEALTH SEX, V7, P585, DOI [10.1080/136910500250198, 10.1080/13691050500250198]; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Thavichachart Nuntika, 2001, Journal of the Medical Association of Thailand, V84, pS118; Uwakwe R, 2000, INT J GERIATR PSYCH, V15, P355, DOI 10.1002/(SICI)1099-1166(200004)15:4<355::AID-GPS126>3.0.CO;2-8; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044	54	59	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14252	10.1371/journal.pone.0014252	http://dx.doi.org/10.1371/journal.pone.0014252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170384	Green Published, gold			2022-12-25	WOS:000285084100006
J	Lu, SQ; Zhang, Y; Long, MA				Lue, Shouqin; Zhang, Yan; Long, Mian			Visualization of Allostery in P-Selectin Lectin Domain Using MD Simulations	PLOS ONE			English	Article							FORMS CATCH BONDS; MOLECULAR-DYNAMICS; CELL-ADHESION; LIGAND RECOGNITION; LEUKOCYTE ADHESION; BINDING; SHEAR; FORCE; DISSOCIATION; INTEGRIN	Allostery of P-selectin lectin (Lec) domain followed by an epithelial growth factor (EGF)-like domain is essential for its biological functionality, but the underlying pathways have not been well understood. Here the molecular dynamics simulations were performed on the crystallized structures to visualize the dynamic conformational change for state 1 (S1) or state 2 (S2) Lec domain with respective bent (B) or extended (E) EGF orientation. Simulations illustrated that both S1 and S2 conformations were unable to switch from one to another directly. Instead, a novel S1' conformation was observed from S1 when crystallized B-S1 or reconstructed "E-S1" structure was employed, which was superposed well with that of equilibrated S1 Lec domain alone. It was also indicated that the corresponding allosteric pathway from S1 to S1' conformation started with the separation between residues Q30 and K67 and terminated with the release of residue N87 from residue C109. These results provided an insight into understanding the structural transition and the structure-function relationship of P-selectin allostery.	[Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China; [Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lue, Shouqin; Zhang, Yan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Lu, SQ (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100080, Peoples R China.	mlong@imech.ac.cn			National Natural Science Foundation of China [10702075, 30670172, 30730032, 10332060]; National Key Basic Research Foundation of China [2006CB910303]; CAS [KSCX2-YW-N-011, KJCX2-YW-L08]; National High Technology Research and Development Program of China [2007AA02Z306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); CAS(Chinese Academy of Sciences); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China grants 10702075, 30670172, 30730032, and 10332060 (http://www.nsfc.gov.cn/Portal0/default106.htm), National Key Basic Research Foundation of China grant 2006CB910303 (http://www.most.gov.cn/eng/index.htm), Knowledge Innovation Program of CAS grants KSCX2-YW-N-011 and KJCX2-YW-L08 (http://english.cas.cn/), and National High Technology Research and Development Program of China grant 2007AA02Z306 (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; Croce K, 1998, BIOCHEMISTRY-US, V37, P16472, DOI 10.1021/bi981341g; Dwir O, 2000, J BIOL CHEM, V275, P18682, DOI 10.1074/jbc.M001103200; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lue Shouqin, 2005, Molecular & Cellular Biomechanics, V2, P161; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Thomas WE, 2009, CURR OPIN STRUC BIOL, V19, P50, DOI 10.1016/j.sbi.2008.12.006; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	29	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15417	10.1371/journal.pone.0015417	http://dx.doi.org/10.1371/journal.pone.0015417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170343	gold, Green Published, Green Submitted			2022-12-25	WOS:000285084100036
J	Rule, NO; Garrett, JV; Ambady, N				Rule, Nicholas O.; Garrett, James V.; Ambady, Nalini			On the Perception of Religious Group Membership from Faces	PLOS ONE			English	Article							SKIN COLOR DISTRIBUTION; MALE SEXUAL ORIENTATION; FACIAL ATTRACTIVENESS; HEALTH; MORMONS; AGE; CATEGORIZATION; MORTALITY; ACCURACY; SYMMETRY	Background: The study of social categorization has largely been confined to examining groups distinguished by perceptually obvious cues. Yet many ecologically important group distinctions are less clear, permitting insights into the general processes involved in person perception. Although religious group membership is thought to be perceptually ambiguous, folk beliefs suggest that Mormons and non-Mormons can be categorized from their appearance. We tested whether Mormons could be distinguished from non-Mormons and investigated the basis for this effect to gain insight to how subtle perceptual cues can support complex social categorizations. Methodology/Principal Findings: Participants categorized Mormons' and non-Mormons' faces or facial features according to their group membership. Individuals could distinguish between the two groups significantly better than chance guessing from their full faces and faces without hair, with eyes and mouth covered, without outer face shape, and inverted 180 degrees; but not from isolated features (i.e., eyes, nose, or mouth). Perceivers' estimations of their accuracy did not match their actual accuracy. Exploration of the remaining features showed that Mormons and non-Mormons significantly differed in perceived health and that these perceptions were related to perceptions of skin quality, as demonstrated in a structural equation model representing the contributions of skin color and skin texture. Other judgments related to health (facial attractiveness, facial symmetry, and structural aspects related to body weight) did not differ between the two groups. Perceptions of health were also responsible for differences in perceived spirituality, explaining folk hypotheses that Mormons are distinct because they appear more spiritual than non-Mormons. Conclusions/Significance: Subtle markers of group membership can influence how others are perceived and categorized. Perceptions of health from non-obvious and minimal cues distinguished individuals according to their religious group membership. These data illustrate how the non-conscious detection of very subtle differences in others' appearances supports cognitively complex judgments such as social categorization.	[Rule, Nicholas O.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Garrett, James V.; Ambady, Nalini] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	University of Toronto; Tufts University	Rule, NO (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	rule@psych.utoronto.ca			National Science Foundation [BCS-0435547]; Canada Research Chair fellowship	National Science Foundation(National Science Foundation (NSF)); Canada Research Chair fellowship	This research was supported by a National Science Foundation Graduate Research Fellowship and Canada Research Chair fellowship to Nicholas O. Rule and National Science Foundation grant BCS-0435547 to Nalini Ambady (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Brebner JL, 2009, EUR J SOC PSYCHOL, V39, P1109, DOI 10.1002/ejsp.600; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cortina JM, 2002, J MANAGE, V28, P339, DOI 10.1016/S0149-2063(02)00131-9; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; ELLIS HD, 1975, INT J PSYCHOL, V10, P119, DOI 10.1080/00207597508247325; Enstrom JE, 2008, PREV MED, V46, P133, DOI 10.1016/j.ypmed.2007.07.030; ENSTROM JE, 1978, CANCER, V42, P1943, DOI 10.1002/1097-0142(197810)42:4<1943::AID-CNCR2820420437>3.0.CO;2-L; ENSTROM JE, 1989, J NATL CANCER I, V81, P1807, DOI 10.1093/jnci/81.23.1807; Fink B, 2008, J EUR ACAD DERMATOL, V22, P493, DOI 10.1111/j.1468-3083.2007.02512.x; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2004, EVOL HUM BEHAV, V25, P24, DOI 10.1016/S1090-5138(03)00080-1; Kline R.B., 1998, STRUCT EQU MODELING; LYON JL, 1994, CANCER CAUSE CONTROL, V5, P149, DOI 10.1007/BF01830261; MacLin OH, 2003, PERCEPTION, V32, P249, DOI 10.1068/p5046; MacLin OH, 2001, PSYCHOL PUBLIC POL L, V7, P98, DOI 10.1037//1076-8971.7.1.98; Macrae CN, 2005, J PERS SOC PSYCHOL, V89, P686, DOI 10.1037/0022-3514.89.5.686; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Merrill R. M., 2004, DEMOGR RES, V10, P61; Pratt Parley P., 1855, KEY SCI THEOLOGY; QUANTY MB, 1975, J PERS SOC PSYCHOL, V32, P449, DOI 10.1037/h0077093; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2007, PSYCHON B REV, V14, P687, DOI 10.3758/BF03196822; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P343, DOI 10.1037/a0018589; Rule NO, 2009, PERCEPTION, V38, P1688, DOI 10.1068/p6384; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Zebrowitz L. A., 1997, READING FACES WINDOW	49	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14241	10.1371/journal.pone.0014241	http://dx.doi.org/10.1371/journal.pone.0014241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	690XB	21151864	Green Published, gold			2022-12-25	WOS:000285041800002
J	Shrikhande, GV; Scali, ST; da Silva, CG; Damrauer, SM; Csizmadia, E; Putheti, P; Matthey, M; Arjoon, R; Patel, R; Siracuse, JJ; Maccariello, ER; Andersen, ND; Monahan, T; Peterson, C; Essayagh, S; Studer, P; Guedes, RP; Kocher, O; Usheva, A; Veves, A; Kaczmarek, E; Ferran, C				Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Putheti, Prabhakar; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kocher, Olivier; Usheva, Anny; Veves, Aristidis; Kaczmarek, Elzbieta; Ferran, Christiane			O-Glycosylation Regulates Ubiquitination and Degradation of the Anti-Inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic ApoE-Null Mice	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELL ACTIVATION; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; GLYCEMIC CONTROL; FACTOR-ALPHA; NUCLEOCYTOPLASMIC GLYCOSYLATION; HEXOSAMINE PATHWAY; GLUCOSE-TRANSPORT	Background: Accelerated atherosclerosis is the leading cause of morbidity and mortality in diabetic patients. Hyperglycemia is a recognized independent risk factor for heightened atherogenesis in diabetes mellitus (DM). However, our understanding of the mechanisms underlying glucose damage to the vasculature remains incomplete. Methodology/Principal Findings: High glucose and hyperglycemia reduced upregulation of the NF-kappa B inhibitory and atheroprotective protein A20 in human coronary endothelial (EC) and smooth muscle cell (SMC) cultures challenged with Tumor Necrosis Factor alpha (TNF), aortae of diabetic mice following Lipopolysaccharide (LPS) injection used as an inflammatory insult and in failed vein-grafts of diabetic patients. Decreased vascular expression of A20 did not relate to defective transcription, as A20 mRNA levels were similar or even higher in EC/SMC cultured in high glucose, in vessels of diabetic C57BL/6 and FBV/N mice, and in failed vein grafts of diabetic patients, when compared to controls. Rather, decreased A20 expression correlated with post-translational O-Glucosamine-N-Acetylation (O-GlcNAcylation) and ubiquitination of A20, targeting it for proteasomal degradation. Restoring A20 levels by inhibiting O-GlcNAcylation, blocking proteasome activity, or overexpressing A20, blocked upregulation of the receptor for advanced glycation end-products (RAGE) and phosphorylation of PKC beta II, two prime atherogenic signals triggered by high glucose in EC/SMC. A20 gene transfer to the aortic arch of diabetic ApoE null mice that develop accelerated atherosclerosis, attenuated vascular expression of RAGE and phospho-PKC beta II, significantly reducing atherosclerosis. Conclusions: High glucose/hyperglycemia regulate vascular A20 expression via O-GlcNAcylation-dependent ubiquitination and proteasomal degradation. This could be key to the pathogenesis of accelerated atherosclerosis in diabetes.	[Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kaczmarek, Elzbieta; Ferran, Christiane] Harvard Univ, Sch Med, Dept Surg, Div Vasc Surg, Boston, MA 02115 USA; [Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kaczmarek, Elzbieta; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Sch Med,Dept Med, Boston, MA 02215 USA; [Putheti, Prabhakar; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med,Dept Med, Boston, MA 02215 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Pathol, Sch Med,Dept Med, Boston, MA 02215 USA; [Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol, Sch Med,Dept Med, Boston, MA 02215 USA; [Veves, Aristidis] Harvard Univ, Sch Med, Joslin Beth Israel Deaconess Foot Ctr, Boston, MA USA; [Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Microcirculat Lab, Sch Med,Dept Med, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Nephrol, Sch Med,Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Shrikhande, GV (corresponding author), Columbia Univ, Med Ctr, Div Vasc Surg, New York, NY 10027 USA.	cferran@bidmc.harvard.edu	Angolano, Cleide/AAZ-4154-2021; Siracuse, Jeffrey/AAN-2987-2020	Damrauer, Scott/0000-0001-8009-1632; Andersen, Nicholas/0000-0002-0905-1694; Matthey, Michaela/0000-0002-1841-2906	National Institutes of Health (NIH) [HL080130, RO1 DK063275, HL057791, HL075678, HL062458, HL07734]; Juvenile Diabetes Research Foundation [1-2007-567]; American Diabetes Association; Swiss National foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458, R01HL075678, R01HL080130, R01HL057791, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Swiss National foundation(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (NIH) Research Project Grant Program (R01) grants HL080130, RO1 DK063275, and HL057791; Juvenile Diabetes Research Foundation grant 1-2007-567 to CF; NIH R01 grant HL075678; an American Diabetes Association clinical research grant to AV; and NIH RO1 grant HL062458 to AU. GVS, STS, SMD, VIP, JSJ, CP and MDF are recipients of a fellowship award from the NIH T32 fellowship grant HL07734. PS is the recipient of a fellowship grant from the Swiss National foundation. RPG is the recipient of a research fellowship grant from the CNPQ, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2006, INVEST OPHTH VIS SCI, V47, P86, DOI 10.1167/iovs.05-0757; Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butkinaree C., 2009, BIOCHIM BIOPHYS ACTA, V1800, P96; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Faxon DP, 2004, CIRCULATION, V109, P2617, DOI 10.1161/01.CIR.0000128520.37674.EF; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; FOSS MC, 1992, BRAZ J MED BIOL RES, V25, P239; GUINEZ C, 2008, FASEB J; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; HUTTI JE, 2007, MOL CELL BIOL; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kouroedov A, 2004, CIRCULATION, V110, P91, DOI 10.1161/01.CIR.0000133384.38551.A8; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Lechleitner M, 2000, J INTERN MED, V248, P67, DOI 10.1046/j.1365-2796.2000.00705.x; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Medzihradszky Katalin F., 2008, V446, P293, DOI 10.1007/978-1-60327-084-7_21; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tuttle KR, 2003, AM J KIDNEY DIS, V42, P456, DOI 10.1016/S0272-6386(03)00741-8; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willfort-Ehringer A, 2004, DIABETOLOGIA, V47, P400, DOI 10.1007/s00125-004-1345-3; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Zachara Natasha Elizabeth, 2004, Methods Mol Biol, V284, P175; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	57	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14240	10.1371/journal.pone.0014240	http://dx.doi.org/10.1371/journal.pone.0014240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151899	Green Submitted, gold, Green Published			2022-12-25	WOS:000284995300012
J	Zhou, YM; Li, MH; Cheng, XB; Wang, CG; Fan, AN; Shi, LX; Wang, XX; Han, SJ				Zhou, Yumei; Li, Mai-He; Cheng, Xu-Bing; Wang, Cun-Guo; Fan, A-Nan; Shi, Lian-Xuan; Wang, Xiu-Xiu; Han, Shijie			Soil Respiration in Relation to Photosynthesis of Quercus mongolica Trees at Elevated CO2	PLOS ONE			English	Article							ATMOSPHERIC-CARBON-DIOXIDE; PINE PINUS-PONDEROSA; FINE-ROOT PRODUCTION; TEMPERATE FOREST; N FERTILIZATION; WATER-CONTENT; GAS-EXCHANGE; EFFLUX; RESPONSES; NITROGEN	Knowledge of soil respiration and photosynthesis under elevated CO2 is crucial for exactly understanding and predicting the carbon balance in forest ecosystems in a rapid CO2-enriched world. Quercus mongolica Fischer ex Ledebour seedlings were planted in open-top chambers exposed to elevated CO2 (EC = 500 mu mol mol(-1)) and ambient CO2 (AC = 370 mu mol mol(-1)) from 2005 to 2008. Daily, seasonal and inter-annual variations in soil respiration and photosynthetic assimilation were measured during 2007 and 2008 growing seasons. EC significantly stimulated the daytime soil respiration by 24.5% (322.4 at EC vs. 259.0 mg CO2 m(-2) hr(-1) at AC) in 2007 and 21.0% (281.2 at EC vs. 232.6 mg CO2 m(-2) hr(-1) at AC) in 2008, and increased the daytime CO2 assimilation by 28.8% (624.1 at EC vs. 484.6 mg CO2 m(-2) hr(-1) at AC) across the two growing seasons. The temporal variation in soil respiration was positively correlated with the aboveground photosynthesis, soil temperature, and soil water content at both EC and AC. EC did not affect the temperature sensitivity of soil respiration. The increased daytime soil respiration at EC resulted mainly from the increased aboveground photosynthesis. The present study indicates that increases in CO2 fixation of plants in a CO2-rich world will rapidly return to the atmosphere by increased soil respiration.	[Zhou, Yumei; Cheng, Xu-Bing; Wang, Cun-Guo; Han, Shijie] Chinese Acad Sci, Dept Forest Ecol, Inst Appl Ecol, Shenyang, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Tree Physiol Grp, Birmensdorf, Switzerland; [Cheng, Xu-Bing; Wang, Cun-Guo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Fan, A-Nan] Dalian Forest Inst, Dalian, Peoples R China; [Shi, Lian-Xuan] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Wang, Xiu-Xiu] Chinese Acad Sci, Res Stn Changbai Mt Forest Ecosyst, Erdao, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Normal University - China; Chinese Academy of Sciences	Zhou, YM (corresponding author), Chinese Acad Sci, Dept Forest Ecol, Inst Appl Ecol, Shenyang, Peoples R China.	zhouyumei73@126.com	Zhou, Yu/HHN-3071-2022; Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	Chinese Academy of Sciences [KZCX2-YW-JC404]; National Natural Science Foundation of China [40930107]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the important research direction project of the Chinese Academy of Sciences (KZCX2-YW-JC404) and projects of key program of the National Natural Science Foundation of China (40930107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; Aranjuelo I, 2009, GLOBAL CHANGE BIOL, V15, P97, DOI 10.1111/j.1365-2486.2008.01829.x; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Ball AS, 2000, SOIL BIOL BIOCHEM, V32, P721, DOI 10.1016/S0038-0717(99)00198-4; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1510, DOI 10.1016/j.soilbio.2009.04.011; Barron-Gafford G, 2005, GLOBAL CHANGE BIOL, V11, P1220, DOI 10.1111/j.1365-2486.2005.00985.x; Bernhardt ES, 2006, BIOGEOCHEMISTRY, V77, P91, DOI 10.1007/s10533-005-1062-0; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Butnor JR, 2003, GLOBAL CHANGE BIOL, V9, P849, DOI 10.1046/j.1365-2486.2003.00630.x; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; Cheng WX, 1998, PLANT SOIL, V202, P167, DOI 10.1023/A:1004315321332; Curtis PS, 2000, ECOL APPL, V10, P3, DOI 10.2307/2640982; Daly E, 2009, BIOGEOCHEMISTRY, V94, P271, DOI 10.1007/s10533-009-9327-7; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson Eric A., 2009, P187, DOI 10.1007/978-1-4419-0026-5_8; Drake JE, 2008, PLANT CELL ENVIRON, V31, P1663, DOI 10.1111/j.1365-3040.2008.01869.x; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Griffin KL, 1997, PLANT SOIL, V190, P11, DOI 10.1023/A:1004253232103; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Jach ME, 2000, ANN BOT-LONDON, V85, P789, DOI 10.1006/anbo.2000.1138; Janssens IA, 1998, GLOBAL CHANGE BIOL, V4, P871, DOI 10.1046/j.1365-2486.1998.00199.x; JOHNSON D, 1994, PLANT SOIL, V165, P129, DOI 10.1007/BF00009969; Khomik M, 2006, AGR FOREST METEOROL, V140, P244, DOI 10.1016/j.agrformet.2006.08.006; King JS, 2004, GLOBAL CHANGE BIOL, V10, P1027, DOI 10.1111/j.1529-8817.2003.00789.x; King JS, 2001, OECOLOGIA, V128, P237, DOI 10.1007/s004420100656; Liberloo M, 2007, NEW PHYTOL, V173, P537, DOI 10.1111/j.1469-8137.2006.01926.x; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Lin GH, 2001, PLANT SOIL, V229, P259, DOI 10.1023/A:1004883221036; LIU SY, 1995, TREE PHYSIOL, V15, P351, DOI 10.1093/treephys/15.6.351; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; Mielnick PC, 2000, SOIL BIOL BIOCHEM, V32, P221, DOI 10.1016/S0038-0717(99)00150-9; Moren AS, 2000, AGR FOREST METEOROL, V101, P1, DOI 10.1016/S0168-1923(99)00160-4; Niinisto SM, 2004, GLOBAL CHANGE BIOL, V10, P1363, DOI 10.1111/j.1365-2486.2004.00799.x; Nsabimana D, 2009, SOIL BIOL BIOCHEM, V41, P396, DOI 10.1016/j.soilbio.2008.12.004; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Pregitzer KS, 2000, NEW PHYTOL, V147, P105, DOI 10.1046/j.1469-8137.2000.00689.x; PREGITZER KS, 1995, NEW PHYTOL, V129, P579, DOI 10.1111/j.1469-8137.1995.tb03025.x; Pregitzer KS, 2000, ECOL APPL, V10, P18, DOI 10.1890/1051-0761(2000)010[0018:IEOACA]2.0.CO;2; Pregitzer K, 2006, OECOLOGIA, V148, P503, DOI 10.1007/s00442-006-0381-8; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Sholtis JD, 2004, NEW PHYTOL, V162, P343, DOI 10.1111/j.1469-8137.2004.01028.x; Soe ARB, 2004, PLANT SOIL, V262, P85, DOI 10.1023/B:PLSO.0000037025.78016.9b; Sommerkorn M, 2008, SOIL BIOL BIOCHEM, V40, P1792, DOI 10.1016/j.soilbio.2008.03.002; Steinmann KTW, 2004, OECOLOGIA, V141, P489, DOI 10.1007/s00442-004-1674-4; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Taneva L, 2008, SOIL BIOL BIOCHEM, V40, P2670, DOI 10.1016/j.soilbio.2008.07.013; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Thomas SM, 2000, GLOBAL CHANGE BIOL, V6, P393, DOI 10.1046/j.1365-2486.2000.00321.x; Tingey DT, 2006, SOIL BIOL BIOCHEM, V38, P1764, DOI 10.1016/j.soilbio.2005.12.003; Tingey DT, 2006, NEW PHYTOL, V170, P107, DOI 10.1111/j.1469-8137.2006.01646.x; Vose JM, 1997, PLANT SOIL, V190, P19, DOI 10.1023/A:1004204129128; VOSE JM, 1995, CAN J FOREST RES, V25, P1243, DOI 10.1139/x95-137; Wieser G, 2004, TREE PHYSIOL, V24, P475, DOI 10.1093/treephys/24.4.475; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x; ZHENG JQ, 2008, THESIS	70	13	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15134	10.1371/journal.pone.0015134	http://dx.doi.org/10.1371/journal.pone.0015134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151897	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300017
J	Mohan, S; Sheena, A; Poulose, N; Anilkumar, G				Mohan, Suma; Sheena, Aswathy; Poulose, Ninu; Anilkumar, Gopalakrishnapillai			Molecular Dynamics Simulation Studies of GLUT4: Substrate-Free and Substrate-Induced Dynamics and ATP-Mediated Glucose Transport Inhibition	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ERYTHROCYTE SUGAR TRANSPORTER; INSULIN-INDUCED TRANSLOCATION; INTERHELICAL HYDROGEN-BONDS; CONFORMATIONAL-CHANGE; DOPAMINE TRANSPORTER; LACTOSE PERMEASE; OUTER HELIX; TRANSMEMBRANE SEGMENT-3; 3-DIMENSIONAL STRUCTURE	Background: Glucose transporter 4 (GLUT4) is an insulin facilitated glucose transporter that plays an important role in maintaining blood glucose homeostasis. GLUT4 is sequestered into intracellular vesicles in unstimulated cells and translocated to the plasma membrane by various stimuli. Understanding the structural details of GLUT4 will provide insights into the mechanism of glucose transport and its regulation. To date, a crystal structure for GLUT4 is not available. However, earlier work from our laboratory proposed a well validated homology model for GLUT4 based on the experimental data available on GLUT1 and the crystal structure data obtained from the glycerol 3-phosphate transporter. Methodology/Principal Findings: In the present study, the dynamic behavior of GLUT4 in a membrane environment was analyzed using three forms of GLUT4 (apo, substrate and ATP-substrate bound states). Apo form simulation analysis revealed an extracellular open conformation of GLUT4 in the membrane favoring easy exofacial binding of substrate. Simulation studies with the substrate bound form proposed a stable state of GLUT4 with glucose, which can be a substrate-occluded state of the transporter. Principal component analysis suggested a clockwise movement for the domains in the apo form, whereas ATP substrate-bound form induced an anti-clockwise rotation. Simulation studies suggested distinct conformational changes for the GLUT4 domains in the ATP substrate-bound form and favor a constricted behavior for the transport channel. Various inter-domain hydrogen bonds and switching of a salt-bridge network from E345-R350-E409 to E345-R169-E409 contributed to this ATP-mediated channel constriction favoring substrate occlusion and prevention of its release into cytoplasm. These data are consistent with the biochemical studies, suggesting an inhibitory role for ATP in GLUT-mediated glucose transport. Conclusions/Significance: In the absence of a crystal structure for any glucose transporter, this study provides mechanistic details of the conformational changes in GLUT4 induced by substrate and its regulator.	[Mohan, Suma; Sheena, Aswathy; Poulose, Ninu; Anilkumar, Gopalakrishnapillai] Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Mohan, S (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India.	ammasanil@am.amrita.edu	gopala, Anilkumar/AAG-2713-2021; Mohan S, Suma/GNW-4180-2022	Mohan S, Suma/0000-0001-7692-163X; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisio A, 2004, J BIOL CHEM, V279, P26540, DOI 10.1074/jbc.M402303200; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arinaminpathy Y, 2003, FEBS LETT, V553, P321, DOI 10.1016/S0014-5793(03)01036-6; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Bazuine M, 2005, BIOCHEM BIOPH RES CO, V326, P511, DOI 10.1016/j.bbrc.2004.11.055; BEGUM N, 1993, J BIOL CHEM, V268, P3352; Bennett M, 2006, BIOCHEMISTRY-US, V45, P8088, DOI 10.1021/bi060355g; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARRUTHERS A, 1986, J BIOL CHEM, V261, P1028; CHANG KI, 1974, J BIOL CHEM, V249, P3170; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Cloherty EK, 2002, BIOCHEMISTRY-US, V41, P12639, DOI 10.1021/bi0259002; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; D'rozario RSG, 2008, MOL MEMBR BIOL, V25, P571, DOI 10.1080/09687680802549113; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; DeLano W.L., PYMOL MOL GRAPHICS S; Dwyer DS, 2001, PROTEINS, V42, P531, DOI 10.1002/1097-0134(20010301)42:4<531::AID-PROT110>3.3.CO;2-0; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Heard KS, 2000, BIOCHEMISTRY-US, V39, P3005, DOI 10.1021/bi991931u; HEBERT DN, 1986, J BIOL CHEM, V261, P93; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Lachaal M, 2001, BBA-BIOMEMBRANES, V1511, P123, DOI 10.1016/S0005-2736(01)00272-3; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Law RJ, 2009, BIOPHYS J, V97, P1586, DOI 10.1016/j.bpj.2009.06.044; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 2001, BLOOD CELL MOL DIS, V27, P139, DOI 10.1006/bcmd.2000.0359; *LLC, 2008, GLID; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Melis C, 2008, BIOPHYS J, V95, P4115, DOI 10.1529/biophysj.107.127589; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; Mohan S, 2009, J BIOMOL STRUCT DYN, V26, P455, DOI 10.1080/07391102.2009.10507260; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; O'Mara ML, 2005, BIOPHYS J, V88, p150A; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Osolodkin DI, 2009, J MOL GRAPH MODEL, V27, P813, DOI 10.1016/j.jmgm.2008.12.004; PADMAVATHI GV, 2009, ONLINE J BIOINFO, V10, P1; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; Prasad CNV, 2009, BIOCHEM BIOPH RES CO, V380, P39, DOI 10.1016/j.bbrc.2009.01.008; REUSCH JEB, 1993, J BIOL CHEM, V268, P3348; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Saladino AC, 2005, BIOPHYS J, V88, P1009, DOI 10.1529/biophysj.104.053421; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; XMGRACE, XMGRACE; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993; Zaid H, 2009, BIOCHEM J, V419, P475, DOI 10.1042/BJ20081319; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7; Zuniga FA, 2001, J BIOL CHEM, V276, P44970, DOI 10.1074/jbc.M107350200; PRODRG	97	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14217	10.1371/journal.pone.0014217	http://dx.doi.org/10.1371/journal.pone.0014217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151967	Green Published, Green Submitted, gold			2022-12-25	WOS:000284939600010
J	Fukui, Y; Ihara, S				Fukui, Yasuhisa; Ihara, Sayoko			A Mutant of SWAP-70, a Phosphatidylinositoltrisphosphate Binding Protein, Transforms Mouse Embryo Fibroblasts, Which Is Inhibited by Sanguinarine	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; APOPTOSIS; ACTIN; CELLS	SWAP-70, a phosphatidylinositol trisphosphate (PtdIns(3,4,5)P-3) binding protein, has been suggested to be involved in transformation of mouse embryo fibroblasts (MEFs) as well as membrane ruffling after growth factor stimulation of the cells. A mutant, SWAP-70-374, was found to be able to bind to F-actin in vitro, whereas wild-type SWAP-70 failed to do so. This mutant was present at the plasma membrane without any stimulation while the wild-type protein was present only in the cytosol unless cells were stimulated with EGF. Expression of this mutant in MEFs resulted in morphologic transformation, fast growth, and loss of contact inhibition, suggesting that SWAP-70 with this mutation can transform the cells. ERK1/2 was activated in SWAP-70-374-transformed cells. Use of MEK inhibitors revealed that the ERK1/2 pathway does not affect the cell growth of MEFs but is responsible for loss of contact inhibition. To investigate the function of SWAP-70 further, drugs that can inhibit SWAP-70-dependent cell responses were screened. Among various drugs, sanguinarine was found to inhibit transformation of MEFs by SWAP-70-374. This drug was able to inhibit SWAP-70-mediated membrane ruffling as well, suggesting that its effect was closely related to the SWAP-70 signaling pathway. These results suggest that SWAP-70-374 can activate some signaling pathways, including the ERK1/2 pathway, to transform MEFs.	[Fukui, Yasuhisa] Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan; [Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ihara, Sayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Hoshi University; National Health Research Institutes - Taiwan; University of Tokyo	Fukui, Y (corresponding author), Hoshi Univ, Lab Signal Transduct, Tokyo 142, Japan.	990412@nhri.org.tw	Fukui, Yasuhisa/E-8806-2010		Ministry of Education, Science, Sports, and Culture of Japan [20013044, 20580096]; Takeda Science Foundation; National Institute of Biomedical Innovation, Japan; National Health Research Institutes, Taiwan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	Grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, #20013044 and #20580096 (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm) to Y.F. and S.I., a grant from Takeda Science Foundation (http://www.takeda-sci.or.jp/) to S.I., a grant from the National Institute of Biomedical Innovation, Japan (http://www.nibio.go.jp/) to Y.F., and a grant from National Health Research Institutes, Taiwan (http://www.nhri.org.tw) to Y.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2007, PHOTOCHEM PHOTOBIOL, V83, P986, DOI 10.1111/j.1751-1097.2007.00156.x; Ahsan H, 2007, CANCER LETT, V249, P198, DOI 10.1016/j.canlet.2006.08.018; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; De Stefano I, 2009, BIOCHEM PHARMACOL, V78, P1374, DOI 10.1016/j.bcp.2009.07.011; Fukui Y, 2007, BIOCHEM BIOPH RES CO, V356, P512, DOI 10.1016/j.bbrc.2007.03.011; Heerema AE, 2004, APPL IMMUNOHISTO M M, V12, P21; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Jang BC, 2009, TOXICOL IN VITRO, V23, P281, DOI 10.1016/j.tiv.2008.12.013; Larsson DE, 2010, ANTICANCER RES, V30, P149; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Murugan AK, 2008, IUBMB LIFE, V60, P236, DOI 10.1002/iub.33; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Seol HJ, 2009, TRANSL ONCOL, V2, P300, DOI 10.1593/tlo.09172; Serafim TL, 2008, BIOCHEM PHARMACOL, V76, P1459, DOI 10.1016/j.bcp.2008.07.013; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14180	10.1371/journal.pone.0014180	http://dx.doi.org/10.1371/journal.pone.0014180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152038	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000006
J	Untersmayr, E; Diesner, SC; Oostingh, GJ; Selzle, K; Pfaller, T; Schultz, C; Zhang, YY; Krishnamurthy, D; Starkl, P; Knittelfelder, R; Forster-Waldl, E; Pollak, A; Scheiner, O; Poschl, U; Jensen-Jarolim, E; Duschl, A				Untersmayr, Eva; Diesner, Susanne C.; Oostingh, Gertie Janneke; Selzle, Kathrin; Pfaller, Tobias; Schultz, Cornelia; Zhang, Yingyi; Krishnamurthy, Durga; Starkl, Philipp; Knittelfelder, Regina; Foerster-Waldl, Elisabeth; Pollak, Arnold; Scheiner, Otto; Poeschl, Ulrich; Jensen-Jarolim, Erika; Duschl, Albert			Nitration of the Egg-Allergen Ovalbumin Enhances Protein Allergenicity but Reduces the Risk for Oral Sensitization in a Murine Model of Food Allergy	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SITE-DIRECTED MUTAGENESIS; NITRIC-OXIDE SYNTHASE; CHEMICAL-MODIFICATION; AIR-POLLUTION; BIRCH POLLEN; BALB/C MICE; CELL LINES; IN-VITRO; IGE	Background: Nitration of proteins on tyrosine residues, which can occur due to polluted air under "ummer smog" conditions, has been shown to increase the allergic potential of allergens. Since nitration of tyrosine residues is also observed during inflammatory responses, this modification could directly influence protein immunogenicity and might therefore contribute to food allergy induction. In the current study we have analyzed the impact of protein nitration on sensitization via the oral route. Methodology/Principal Findings: BALB/c mice were immunized intragastrically by feeding untreated ovalbumin (OVA), sham-nitrated ovalbumin (snOVA) or nitrated ovalbumin (nOVA) with or without concomitant acid-suppression. To analyze the impact of the sensitization route, the allergens were also injected intraperitoneally. Animals being fed OVA or snOVA under acid-suppressive medication developed significantly elevated levels of IgE, and increased titers of specific IgG1 and IgG2a antibodies. Interestingly, oral immunizations of nOVA under anti-acid treatment did not result in IgG and IgE formation. In contrast, intraperitoneal immunization induced high levels of OVA specific IgE, which were significantly increased in the group that received nOVA by injection. Furthermore, nOVA triggered significantly enhanced mediator release from RBL cells passively sensitized with sera from allergic mice. Gastric digestion experiments demonstrated protein nitration to interfere with protein stability as nOVA was easily degraded, whereas OVA and snOVA remained stable up to 120 min. Additionally, HPLC-chip-MS/MS analysis showed that one tyrosine residue (Y-107) being very efficiently nitrated is part of an ovalbumin epitope recognized exclusively after oral sensitization. Conclusions/Significance: These data indicated that despite the enhanced triggering capacity in existing allergy, nitration of OVA may be associated with a reduced de novo sensitizing capability via the oral route due to enhanced protein digestibility and/or changes in antibody epitopes.	[Untersmayr, Eva; Diesner, Susanne C.; Schultz, Cornelia; Krishnamurthy, Durga; Starkl, Philipp; Knittelfelder, Regina; Scheiner, Otto; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Diesner, Susanne C.; Foerster-Waldl, Elisabeth; Pollak, Arnold] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Oostingh, Gertie Janneke; Pfaller, Tobias; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Selzle, Kathrin; Zhang, Yingyi; Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55128 Mainz, Germany	Medical University of Vienna; Medical University of Vienna; Salzburg University; Max Planck Society	Untersmayr, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	eva.untersmayr@meduniwien.ac.at	Duschl, Albert/E-5872-2011; Jensen-Jarolim, Erika/C-5120-2018; Zhang, Yingyi/I-2312-2017; Untersmayr, Eva/GRY-4470-2022; Pöschl, Ulrich/A-6263-2010; Zhang, Yingyi/G-8276-2012; Oostingh, Gertie Janneke/HHC-1098-2022	Duschl, Albert/0000-0002-7034-9860; Jensen-Jarolim, Erika/0000-0003-4019-5765; Zhang, Yingyi/0000-0002-6919-9148; Pöschl, Ulrich/0000-0003-1412-3557; Diesner-Treiber, Susanne/0000-0001-8955-4752; Forster-Waldl, Elisabeth/0000-0002-8484-9890; Untersmayr, Eva/0000-0002-1963-499X; Oostingh, Gertie Janneke/0000-0001-5083-217X; Starkl, Philipp/0000-0001-7521-129X	Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [P21577-B11, APW01205FW]; Austrian Science Fund (FWF) [P 21577] Funding Source: researchfish	Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by P21577-B11 and APW01205FW of the Austrian Science funds FWF (Fonds zur Foerderung der wissenschaftlichen Forschung; www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubier M, 2005, B ACAD NAT MED PARIS, V189, P1419, DOI 10.1016/S0001-4079(19)33452-1; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Bommel H, 2000, J ALLERGY CLIN IMMUN, V105, P796, DOI 10.1067/mai.2000.105124; Borchers AT, 2005, J ASTHMA, V42, P225, DOI 10.1081/JAS-200051302; BUDAGOVSKAIA VN, 1984, VOP PITANIYA, V3, P30; Corrado G, 1998, SCAND J GASTROENTERO, V33, P1135, DOI 10.1080/00365529850172467; De Lazzari F, 1994, Minerva Gastroenterol Dietol, V40, P1; DELAZZARI F, 1994, ITAL J GASTROENTEROL, V26, P7; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Figura N, 1999, ITAL J GASTROENTEROL, V31, P186; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; Henmar H, 2008, CLIN EXP IMMUNOL, V153, P316, DOI 10.1111/j.1365-2249.2008.03710.x; Hoffmann A, 1999, ALLERGY, V54, P446, DOI 10.1034/j.1398-9995.1999.00917.x; Holen E, 1996, CLIN EXP ALLERGY, V26, P1080, DOI 10.1046/j.1365-2222.1996.d01-412.x; Ibarrola I, 2004, CLIN EXP ALLERGY, V34, P303, DOI 10.1111/j.1365-2222.2004.01859.x; KAHLERT H, 1992, MOL IMMUNOL, V29, P1191, DOI 10.1016/0161-5890(92)90055-3; Matysiak-Budnik T, 2004, AM J GASTROENTEROL, V99, P225, DOI 10.1111/j.1572-0241.2004.04080.x; Matysiak-Budnik T, 2002, J PEDIATR GASTR NUTR, V34, P5, DOI 10.1097/00005176-200201000-00003; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; MITRA I, 1992, BIOCHEM INT, V26, P25; OKA T, 1970, FEBS LETT, V10, P222, DOI 10.1016/0014-5793(70)80633-0; Oldreive C, 2001, FREE RADICAL RES, V35, P215, DOI 10.1080/10715760100300761; Pannala AS, 2006, FREE RADICAL BIO MED, V41, P896, DOI 10.1016/j.freeradbiomed.2006.05.010; Sakaguchi AA, 1999, FREE RADICAL BIO MED, V27, P781, DOI 10.1016/S0891-5849(99)00124-0; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Scholl L, 2005, AM J CLIN NUTR, V81, P154; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; TROUT GE, 1969, BIOCHEMISTRY-US, V8, P4183, DOI 10.1021/bi00838a041; Untersmayr E, 2005, FASEB J, V19, P656, DOI 10.1096/fj.04-3170fje; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Untersmayr E, 2008, MECH AGEING DEV, V129, P120, DOI 10.1016/j.mad.2007.10.015; Untersmayr E, 2006, PHARMACOL THERAPEUT, V112, P787, DOI 10.1016/j.pharmthera.2006.06.004; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Wurtzen PA, 2007, INT ARCH ALLERGY IMM, V144, P287, DOI 10.1159/000106317; Zhang JW, 1999, BIOCHEM BIOPH RES CO, V261, P610, DOI 10.1006/bbrc.1999.1078; Zhang YY, 2011, ANAL BIOANAL CHEM, V399, P459, DOI 10.1007/s00216-010-4280-9	44	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14210	10.1371/journal.pone.0014210	http://dx.doi.org/10.1371/journal.pone.0014210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151984	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000020
J	de Greeff, SC; de Melker, HE; van Gageldonk, PGM; Schellekens, JFP; van der Klis, FRM; Mollema, L; Mooi, FR; Berbers, GAM				de Greeff, Sabine C.; de Melker, Hester E.; van Gageldonk, Pieter G. M.; Schellekens, Joop F. P.; van der Klis, Fiona R. M.; Mollema, Liesbeth; Mooi, Frits R.; Berbers, Guy A. M.			Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis	PLOS ONE			English	Article							DISEASE BURDEN; VACCINATION; INFECTION; POPULATION; TOXIN; EPIDEMIOLOGY; ANTIBODIES; ANTITOXIN; SEROEPIDEMIOLOGY; SENSITIVITY	Background: In many countries, the reported pertussis has increased despite high vaccination coverage. However, accurate determination of the burden of disease is hampered by reporting artifacts. The infection frequency is more reliably estimated on the basis of the prevalence of high IgG concentrations against pertussis toxin (IgG-Ptx). We determined whether the increase in reported pertussis in the last decade is associated with an increase in the number of infections. Methodology/Principal Findings: In a cross-sectional population-based serosurveillance study conducted in 2006-07, from a randomly selected age-stratified sample of 7,903 persons, serum IgG-Ptx concentrations were analyzed using a fluorescent bead-based multiplex immuno assay. In 2006-07, 9.3% (95% CI 8.5-10.1) of the population above 9 years of age had an IgG-Ptx concentration above 62.5 EU/ml (suggestive for pertussis infection in the past year), which was more than double compared to 1995-96 (4.0%; 95% CI 3.3-4.7). The reported incidence showed a similar increase as the seroprevalence between both periods. Conclusions: Although changes in the vaccination program have reduced pertussis morbidity in childhood, they have not affected the increased infection rate in adolescent and adult pertussis. Indeed, the high circulation of B. pertussis in the latter age-categories may limit the effectiveness of pediatric vaccination.	[de Greeff, Sabine C.; de Melker, Hester E.; Mollema, Liesbeth] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Gageldonk, Pieter G. M.; van der Klis, Fiona R. M.; Mooi, Frits R.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Schellekens, Joop F. P.] Infect Dis Lab, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	de Greeff, SC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	sabine.de.greeff@rivm.nl		van Gageldonk, Pieter/0000-0003-2753-9674				Aguas R, 2006, LANCET INFECT DIS, V6, P112, DOI 10.1016/S1473-3099(06)70384-X; BERBERS GAM, 2008, SEROLOGISCH ONDERZOE; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2009, EPIDEMIOL INFECT, V137, P1388, DOI 10.1017/S0950268809002489; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; EDWARDS KM, 1995, PEDIATRICS, V96, P548; Forsyth Kevin, 2005, Pediatr Infect Dis J, V24, pS93, DOI 10.1097/01.inf.0000160921.74004.12; Giammanco A, 2003, VACCINE, V22, P112, DOI 10.1016/S0264-410X(03)00514-0; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Hallander HO, 2005, VACCINE, V23, P5359, DOI 10.1016/j.vaccine.2005.06.009; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hellenbrand W, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-22; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; MEADE BD, 1995, PEDIATRICS, V96, P570; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nagel J, 1985, Dev Biol Stand, V61, P325; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Quinn HE, 2010, EPIDEMIOL INFECT, V138, P426, DOI 10.1017/S0950268809990707; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Teunis PFM, 2002, EPIDEMIOL INFECT, V129, P479, DOI 10.1017/S0950268802007896; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833	36	136	139	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14183	10.1371/journal.pone.0014183	http://dx.doi.org/10.1371/journal.pone.0014183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152071	gold, Green Published, Green Submitted			2022-12-25	WOS:000284821300004
J	Hall, LML; Moran, CN; Milne, GR; Wilson, J; MacFarlane, NG; Forouhi, NG; Hariharan, N; Salt, IP; Sattar, N; Gill, JMR				Hall, Lesley M. L.; Moran, Colin N.; Milne, Gillian R.; Wilson, John; MacFarlane, Niall G.; Forouhi, Nita G.; Hariharan, Narayanan; Salt, Ian P.; Sattar, Naveed; Gill, Jason M. R.			Fat Oxidation, Fitness and Skeletal Muscle Expression of Oxidative/Lipid Metabolism Genes in South Asians: Implications for Insulin Resistance?	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; CORONARY-HEART-DISEASE; POLYCYSTIC-OVARY-SYNDROME; MAXIMAL OXYGEN INTAKE; WEIGHT-LOSS; GLUCOSE-TRANSPORT; ADIPOSE-TISSUE; IN-VIVO; STIMULATED PHOSPHORYLATION; MITOCHONDRIAL CAPACITY	Background: South Asians are more insulin resistant than Europeans, which cannot be fully explained by differences in adiposity. We investigated whether differences in oxidative capacity and capacity for fatty acid utilisation in South Asians might contribute, using a range of whole-body and skeletal muscle measures. Methodology/Principal Findings: Twenty men of South Asian ethnic origin and 20 age and BMI-matched men of white European descent underwent exercise and metabolic testing and provided a muscle biopsy to determine expression of oxidative and lipid metabolism genes and of insulin signalling proteins. In analyses adjusted for age, BMI, fat mass and physical activity, South Asians, compared to Europeans, exhibited; reduced insulin sensitivity by 26% (p = 0.010); lower VO(2max) (40.6+/-6.6 vs 52.4+/-5.7 ml.kg(-1).min(-1), p = 0.001); and reduced fat oxidation during submaximal exercise at the same relative (3.77+/-2.02 vs 6.55+/-2.60 mg.kg(-1).min(-1) at 55% VO(2max), p = 0.013), and absolute (3.46+/-2.20 vs 6.00+/-1.93 mg.kg(-1).min(-1) at 25 ml O(2).kg(-1).min(-1), p = 0.021), exercise intensities. South Asians exhibited significantly higher skeletal muscle gene expression of CPT1A and FASN and significantly lower skeletal muscle protein expression of PI3K and PKB Ser473 phosphorylation. Fat oxidation during submaximal exercise and VO2max both correlated significantly with insulin sensitivity index and PKB Ser473 phosphorylation, with VO2max or fat oxidation during exercise explaining 10-13% of the variance in insulin sensitivity index, independent of age, body composition and physical activity. Conclusions/Significance: These data indicate that reduced oxidative capacity and capacity for fatty acid utilisation at the whole body level are key features of the insulin resistant phenotype observed in South Asians, but that this is not the consequence of reduced skeletal muscle expression of oxidative and lipid metabolism genes.	[Hall, Lesley M. L.; Moran, Colin N.; Milne, Gillian R.; Wilson, John; Salt, Ian P.; Sattar, Naveed; Gill, Jason M. R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [MacFarlane, Niall G.] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Forouhi, Nita G.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Hariharan, Narayanan] Pfizer Global Res & Dev, Collegeville, PA USA	University of Glasgow; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Pfizer	Hall, LML (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk	Moran, Colin Neil/F-5416-2011	Moran, Colin Neil/0000-0001-6226-8131; Forouhi, Nita/0000-0002-5041-248X; Salt, Ian/0000-0003-0055-3724	Diabetes UK [06/0003224]; Translational Medicine Research Collaboration [CVMD-GU-004]; MRC [MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_UP_A100_1003] Funding Source: researchfish	Diabetes UK(Diabetes UK); Translational Medicine Research Collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from Diabetes UK (www.diabetes.org.uk) (Grant number: 06/0003224) and an award (Grant number: CVMD-GU-004) from the Translational Medicine Research Collaboration (www.tmrc.co.uk), a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow and Clyde), Scottish Enterprise and Pfizer (formerly Wyeth) Pharmaceuticals. The funders had no role in study design, data collection or decision to publish.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; Adochio R, 2009, ENDOCRINOLOGY, V150, P1165, DOI 10.1210/en.2008-0437; ANDREASSON K, 1991, ACTA PHYSIOL SCAND, V142, P255, DOI 10.1111/j.1748-1716.1991.tb09154.x; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Bruce CR, 2004, MED SCI SPORT EXER, V36, P1196, DOI 10.1249/01.MSS.0000074670.03001.98; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cubbon RM, 2010, ARTERIOSCL THROM VAS, V30, P878, DOI 10.1161/ATVBAHA.109.201012; Davey GJG, 2000, J EXERC PHYSL, V3, P12; FEHILY AM, 1987, HUM NUTR-APPL NUTR, V41A, P319; FLATT JP, 1985, J CLIN INVEST, V76, P1019, DOI 10.1172/JCI112054; Forouhi NG, 1999, DIABETOLOGIA, V42, P932, DOI 10.1007/s001250051250; Forouhi NG, 2003, BLOOD COAGUL FIBRIN, V14, P755, DOI 10.1097/00001721-200312000-00011; Frayn Keith N., 1997, P101; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Goodpaster B, 2003, DIABETES, V52, pA236; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; Hammarstedt A, 2005, DIABETOLOGIA, V48, P96, DOI 10.1007/s00125-004-1612-3; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hardy C P, 1985, Br J Sports Med, V19, P217; Hedman A, 2000, ACTA PHYSIOL SCAND, V169, P125; Helge JW, 2006, EUR J APPL PHYSIOL, V97, P566, DOI 10.1007/s00421-006-0220-y; HENRIKSSON KG, 1979, ACTA NEUROL SCAND, V59, P317; Hepple RT, 1997, J APPL PHYSIOL, V82, P1305, DOI 10.1152/jappl.1997.82.4.1305; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1998, DIABETES, V47, pA237; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; LITHELL H, 1981, DIABETES, V30, P19, DOI 10.2337/diabetes.30.1.19; Marfell-Jones M, 2006, INT STANDARDS ANTHR; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Melanson EL, 2005, OBES RES, V13, P2102, DOI 10.1038/oby.2005.261; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Moran CN, 2011, METABOLISM, V60, P206, DOI 10.1016/j.metabol.2009.12.026; Murphy C, 2007, ARTERIOSCL THROM VAS, V27, P936, DOI 10.1161/01.ATV.0000258788.11372.d0; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nyholm B, 2004, EUR J ENDOCRINOL, V150, P207, DOI 10.1530/eje.0.1500207; Ostergard T, 2006, AM J PHYSIOL-ENDOC M, V290, pE998, DOI 10.1152/ajpendo.00012.2005; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Riou ME, 2009, APPL PHYSIOL NUTR ME, V34, P99, DOI 10.1139/H08-144; Sahlin K, 2007, AM J PHYSIOL-ENDOC M, V292, pE223, DOI 10.1152/ajpendo.00266.2006; Saltin B, 1986, ACTA PHYSL SCAND S, V556, P21; Schenk S, 2009, J PHYSIOL-LONDON, V587, P4949, DOI 10.1113/jphysiol.2009.175489; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Stentz Frankie B., 2007, Genomics Proteomics & Bioinformatics, V5, P216, DOI 10.1016/S1672-0229(08)60009-1; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	75	74	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14197	10.1371/journal.pone.0014197	http://dx.doi.org/10.1371/journal.pone.0014197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152018	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000284821300012
J	Gupta, K; Kumar, P; Chatterji, D				Gupta, Kajal; Kumar, Prasun; Chatterji, Dipankar			Identification, Activity and Disulfide Connectivity of C-di-GMP Regulating Proteins Mycobacterium tuberculosis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CYCLIC DIGUANYLATE; DOMAIN PROTEIN; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BIOFILM FORMATION; GENE-EXPRESSION; IN-VITRO; EAL; GGDEF	C-di-GMP, a bacterial second messenger plays a key role in survival and adaptation of bacteria under different environmental conditions. The level of c-di-GMP is regulated by two opposing activities, namely diguanylate cyclase (DGC) and phosphodiesterase (PDE-A) exhibited by GGDEF and EAL domain, respectively in the same protein. Previously, we reported a bifunctional GGDEF-EAL domain protein, MSDGC-1 from Mycobacterium smegmatis showing both these activities (Kumar and Chatterji, 2008). In this current report, we have identified and characterized the homologous protein from Mycobacterium tuberculosis (Rv 1354c) named as MtbDGC. MtbDGC is also a bifunctional protein, which can synthesize and degrade c-di-GMP in vitro. Further we expressed Mtbdgc in M. smegmatis and it was able to complement the MSDGC-1 knock out strain by restoring the long term survival of M. smegmatis. Another protein Rv 1357c, named as MtbPDE, is an EAL domain protein and degrades c-di-GMP to pGpG in vitro. Rv1354c and 1357c have seven cysteine amino acids in their sequence, distributed along the full length of the protein. Disulfide bonds play an important role in stabilizing protein structure and regulating protein function. By proteolytic digestion and mass spectrometric analysis of MtbDGC, connectivity between cysteine pairs Cys(94)-Cys(584), Cys(2)-Cys(479) and Cys(429)-Cys(614) was determined, whereas the third cysteine (Cys(406)) from N terminal was found to be free in MtbDGC protein, which was further confirmed by alkylation with iodoacetamide labeling. Bioinformatics modeling investigations also supported the pattern of disulfide connectivity obtained by Mass spectrometric analysis. Cys(406) was mutated to serine by site directed mutagenesis and the mutant MtbC406S was not found to be active and was not able to synthesize or degrade c-di-GMP. The disulfide connectivity established here would help further in understanding the structure - function relationship in MtbDGC.	[Gupta, Kajal; Kumar, Prasun; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gupta, K (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	kajalgupta@mbu.iisc.ernet.in	Gupta, Kajal/A-6472-2018; kumar, prasun/A-5474-2012; kumar, prasun/H-8634-2013; Kumar, Prasun/I-4083-2014	kumar, prasun/0000-0002-2008-3347; Chatterji, Dipankar/0000-0002-9985-0632; Gupta, Kajal/0000-0002-0665-1539	Department of Biotechnology, Government of India; Department of Biotechnology; DBT-BINC, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; DBT-BINC, Government of India(Department of Biotechnology (DBT) India)	This work is financially supported by the Department of Biotechnology, Government of India. KG would like to thank the Department of Biotechnology and PK would like to thank DBT-BINC, Government of India, for the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2001, PYMOL MOL GRAPH SYST; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barik S, 1996, Methods Mol Biol, V57, P203; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Clark ED, 1999, METHOD ENZYMOL, V309, P217; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu CH, 2007, PROTEINS, V67, P262, DOI 10.1002/prot.21309; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mormann M, 2008, ANAL BIOANAL CHEM, V392, P831, DOI 10.1007/s00216-008-2258-7; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; REGINE H, 2009, NAT REV MICORBIOL, V7, P263; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; RYJENKOW DA, 2005, J BACTERIOL, V187, P1972; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALONA C, 2009, P NATL ACAD SCI USA, V106, P7997; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Shang F, 2009, INFECT IMMUN, V77, P2849, DOI 10.1128/IAI.01405-08; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; TAKAGI T, 1997, BIOCHIM BIOPHYS ACTA, V578, P68; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu J, 1997, PROTEIN SCI, V6, P391; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K	58	37	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15072	10.1371/journal.pone.0015072	http://dx.doi.org/10.1371/journal.pone.0015072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151497	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100060
J	Ronconi, RA; Ryan, PG; Ropert-Coudert, Y				Ronconi, Robert A.; Ryan, Peter G.; Ropert-Coudert, Yan			Diving of Great Shearwaters (Puffinus gravis) in Cold and Warm Water Regions of the South Atlantic Ocean	PLOS ONE			English	Article							FORAGING ECOLOGY; DIVE DEPTH; TASMANIA; FISHERY; DIET	Background: Among the most widespread seabirds in the world, shearwaters of the genus Puffinus are also some of the deepest diving members of the Procellariiformes. Maximum diving depths are known for several Puffinus species, but dive depths or diving behaviour have never been recorded for great shearwaters (P. gravis), the largest member of this genus. This study reports the first high sampling rate (2 s) of depth and diving behaviour for Puffinus shearwaters. Methodology/Principal Findings: Time-depth recorders (TDRs) were deployed on two female great shearwaters nesting on Inaccessible Island in the South Atlantic Ocean, recording 10 consecutive days of diving activity. Remote sensing imagery and movement patterns of 8 males tracked by satellite telemetry over the same period were used to identify probable foraging areas used by TDR-equipped females. The deepest and longest dive was to 18.9 m and lasted 40 s, but most (>50%) dives were <2 m deep. Diving was most frequent near dawn and dusk, with <0.5% of dives occurring at night. The two individuals foraged in contrasting oceanographic conditions, one in cold (8 to 10 degrees C) water of the Sub-Antarctic Front, likely 1000 km south of the breeding colony, and the other in warmer (10 to 16 degrees C) water of the Sub-tropical Frontal Zone, at the same latitude as the colony, possibly on the Patagonian Shelf, 4000 km away. The cold water bird spent fewer days commuting, conducted four times as many dives as the warm water bird, dived deeper on average, and had a greater proportion of bottom time during dives. Conclusions/Significance: General patterns of diving activity were consistent with those of other shearwaters foraging in cold and warm water habitats. Great shearwaters are likely adapted to forage in a wide range of oceanographic conditions, foraging mostly with shallow dives but capable of deep diving.	[Ronconi, Robert A.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Ryan, Peter G.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Ropert-Coudert, Yan] Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France	Dalhousie University; National Research Foundation - South Africa; University of Cape Town	Ronconi, RA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	rronconi@dal.ca		Ryan, Peter/0000-0002-3356-2056	European Commission; BirdLife International; United States Fish and Wildlife Service; University of Cape Town; Killam Trust; Dalhousie University	European Commission(European CommissionEuropean Commission Joint Research Centre); BirdLife International; United States Fish and Wildlife Service(US Fish & Wildlife Service); University of Cape Town; Killam Trust; Dalhousie University	Financial support was provided by South African National Antarctic Programme, the European Commission's EDF-9 through the South Atlantic Invasive Species project, BirdLife International, the United States Fish and Wildlife Service, and the University of Cape Town. R. A. R. was supported by the Killam Trust, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JS, 2003, SCI MAR, V67, P129, DOI 10.3989/scimar.2003.67s2129; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; BROWN RGB, 1978, CONDOR, V80, P123, DOI 10.2307/1367911; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bull Leigh S., 2005, Marine Ornithology, V33, P27; Burger AE, 2001, AUK, V118, P755, DOI 10.1642/0004-8038(2001)118[0755:DDOS]2.0.CO;2; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Cuthbert RJ, 2005, EMU, V105, P305, DOI 10.1071/MU05036; Elliott H. F. I., 1957, Ibis, V99, P545, DOI 10.1111/j.1474-919X.1957.tb03049.x; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; HAGAN Y, 1952, BIRDS TRISTAN CUNHA; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Keitt BS, 2000, AUK, V117, P507, DOI 10.1642/0004-8038(2000)117[0507:DDADOT]2.0.CO;2; Kuroda N., 1954, CLASSIFICATION PHYLO; Mougin JL, 1998, REV ECOL-TERRE VIE, V53, P69; Peck DR, 2006, J AVIAN BIOL, V37, P245, DOI 10.1111/j.2006.0908-8857.03558.x; Petry MV, 2008, MAR BIOL, V154, P613, DOI 10.1007/s00227-008-0954-7; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Rayner MJ, 2008, MAR ECOL PROG SER, V370, P271, DOI 10.3354/meps07660; REES EIS, 1961, SEA SWALLOW, V14, P54; Rowan M. K., 1952, Ibis, V94, P97, DOI 10.1111/j.1474-919X.1952.tb01791.x; RYAN P.G., 2007, FIELD GUIDE ANIMALS; RYAN PG, TRISTAN THR IN PRESS; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Shealer David A., 2002, P137; WARHAM J, 1977, NEW ZEAL J ZOOL, V4, P73, DOI 10.1080/03014223.1977.9517938; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; WILLIAMS TD, 1992, AUK, V109, P223, DOI 10.2307/4088190; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; WILSON RP, 1995, POLAR BIOL, V15, P575	36	45	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15508	10.1371/journal.pone.0015508	http://dx.doi.org/10.1371/journal.pone.0015508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152089	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100088
J	Tomatis, VM; Trenchi, A; Gomez, GA; Daniotti, JL				Tomatis, Vanesa M.; Trenchi, Alejandra; Gomez, Guillermo A.; Daniotti, Jose L.			Acyl-Protein Thioesterase 2 Catalizes the Deacylation of Peripheral Membrane-Associated GAP-43	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN-43; DYNAMIC FATTY ACYLATION; GTP-BINDING PROTEINS; H-RAS; NEUROMODULIN GAP-43; NEURONAL DEVELOPMENT; PRENYLATED PROTEINS; TARGETING DOMAIN; PLASMA-MEMBRANE; PALMITOYLATION	An acylation/deacylation cycle is necessary to maintain the steady-state subcellular distribution and biological activity of S-acylated peripheral proteins. Despite the progress that has been made in identifying and characterizing palmitoyl-transferases (PATs), much less is known about the thioesterases involved in protein deacylation. In this work, we investigated the deacylation of growth-associated protein-43 (GAP-43), a dually acylated protein at cysteine residues 3 and 4. Using fluorescent fusion constructs, we measured in vivo the rate of deacylation of GAP-43 and its single acylated mutants in Chinese hamster ovary (CHO)-K1 and human HeLa cells. Biochemical and live cell imaging experiments demonstrated that single acylated mutants were completely deacylated with similar kinetic in both cell types. By RT-PCR we observed that acyl-protein thioesterase 1 (APT-1), the only bona fide thioesterase shown to mediate deacylation in vivo, is expressed in HeLa cells, but not in CHO-K1 cells. However, APT-1 overexpression neither increased the deacylation rate of single acylated GAP-43 nor affected the steady-state subcellular distribution of dually acylated GAP-43 both in CHO-K1 and HeLa cells, indicating that GAP-43 deacylation is not mediated by APT-1. Accordingly, we performed a bioinformatic search to identify putative candidates with acyl-protein thioesterase activity. Among several candidates, we found that APT-2 is expressed both in CHO-K1 and HeLa cells and its overexpression increased the deacylation rate of single acylated GAP-43 and affected the steady-state localization of diacylated GAP-43 and H-Ras. Thus, the results demonstrate that APT-2 is the protein thioesterase involved in the acylation/deacylation cycle operating in GAP-43 subcellular distribution.	[Tomatis, Vanesa M.; Trenchi, Alejandra; Gomez, Guillermo A.; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET,Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Tomatis, VM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	daniotti@dqb.fcq.unc.edu.ar	Tomatis, Vanesa/D-5367-2017; Gomez, Guillermo/J-2993-2014	Tomatis, Vanesa/0000-0003-4379-8502; Gomez, Guillermo/0000-0002-0494-2404	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar) and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina (www.mincyt.cba.gov.ar). V. M. T., A. T. and G. A. G. were recipients of CONICET (Argentina) Fellowship. J.L.D is a career investigator of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker LP, 1997, NEUROSCI LETT, V234, P156, DOI 10.1016/S0304-3940(97)00667-8; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhatnagar RS, 1997, TRENDS CELL BIOL, V7, P14, DOI 10.1016/S0962-8924(97)10044-7; Biewenga JE, 1996, ACTA BIOCHIM POL, V43, P327; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Cho SG, 2000, J NEUROSCI RES, V59, P32, DOI 10.1002/(SICI)1097-4547(20000101)59:1<32::AID-JNR5>3.0.CO;2-A; COGGINS PJ, 1991, J NEUROCHEM, V56, P1095, DOI 10.1111/j.1471-4159.1991.tb11398.x; De Moliner KL, 2005, J NEUROSCI RES, V79, P652, DOI 10.1002/jnr.20388; Deck P, 2005, ANGEW CHEM INT EDIT, V44, P4975, DOI 10.1002/anie.200462625; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Denny JB, 2004, EUR J BIOCHEM, V271, P2480, DOI 10.1111/j.1432-1033.2004.04179.x; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AE, 2001, J BIOL CHEM, V276, P44984, DOI 10.1074/jbc.M103049200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fishman MC, 1996, PERSPECT DEV NEUROBI, V4, P193; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gomez GA, 2005, J BIOL CHEM, V280, P34997, DOI 10.1074/jbc.M506256200; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; LIU YC, 1994, J NEUROSCI, V14, P5807; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; NEWMAN CMH, 1993, BIOCHIM BIOPHYS ACTA, V1155, P79, DOI 10.1016/0304-419X(93)90023-6; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STOCKER KM, 1992, DEV BIOL, V149, P406, DOI 10.1016/0012-1606(92)90295-R; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	65	91	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15045	10.1371/journal.pone.0015045	http://dx.doi.org/10.1371/journal.pone.0015045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152083	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100054
J	Altman, BJ; Jacobs, SR; Mason, EF; Michalek, RD; MacIntyre, AN; Coloff, JL; Ilkayeva, O; Jia, W; He, YW; Rathmell, JC				Altman, B. J.; Jacobs, S. R.; Mason, E. F.; Michalek, R. D.; MacIntyre, A. N.; Coloff, J. L.; Ilkayeva, O.; Jia, W.; He, Y-W; Rathmell, J. C.			Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis	ONCOGENE			English	Article						autophagy; BCR-Abl; Puma; apoptosis; metabolism; p53	INDUCED ACTIVATION; INDUCED APOPTOSIS; METABOLIC STRESS; TUMOR-SUPPRESSOR; STEM-CELLS; SURVIVAL; PROTEIN; DEATH; CANCER; GROWTH	Hematopoietic cells normally require cell extrinsic signals to maintain metabolism and survival. In contrast, cancer cells can express constitutively active oncogenic kinases such as BCR-Abl that promote these processes independent of extrinsic growth factors. When cells receive insufficient growth signals or when oncogenic kinases are inhibited, glucose metabolism decreases and the self-digestive process of autophagy is elevated to degrade bulk cytoplasm and organelles. Although autophagy has been proposed to provide a cell-intrinsic nutrient supply for mitochondrial oxidative metabolism and to maintain cellular homeostasis through degradation of damaged organelles or protein aggregates, its acute role in growth factor deprivation or inhibition of oncogenic kinases remains poorly understood. We therefore developed a growth factor-dependent hematopoietic cell culture model in which autophagy can be acutely disrupted through conditional Cre-mediated excision of the autophagy-essential gene Atg3. Treated cells rapidly lost their ability to perform autophagy and underwent cell cycle arrest and apoptosis. Although Atg3 was essential for optimal upregulation of mitochondrial oxidative pathways in growth factor withdrawal, this metabolic contribution of autophagy did not appear critical for cell survival, as provision of exogenous pyruvate or lipids could not completely rescue Atg3 deficiency. Instead, autophagy suppressed a stress response that otherwise led to p53 phosphorylation and upregulation of p21 and the proapoptotic Bcl-2 family protein Puma. Importantly, BCR-Abl-expressing cells had low basal levels of autophagy, but were highly dependent on this process, and rapidly underwent apoptosis upon disruption of autophagy through Atg3 deletion or treatment with chemical autophagy inhibitors. This dependence on autophagy extended in vivo, as Atg3 deletion also prevented BCR-Abl-mediated leukemogenesis in a cell transfer model. Together these data demonstrate a critical role for autophagy to mitigate cell stress, and that cells expressing the oncogenic kinase BCR-Abl appear particularly dependent on autophagy for cell survival and leukemogenesis. Oncogene (2011) 30, 1855-1867; doi: 10.1038/onc.2010.561; published online 13 December 2010	[Altman, B. J.; Jacobs, S. R.; Mason, E. F.; Michalek, R. D.; MacIntyre, A. N.; Coloff, J. L.; Ilkayeva, O.; Rathmell, J. C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ilkayeva, O.; Rathmell, J. C.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Jia, W.; He, Y-W; Rathmell, J. C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	jeff.rathmell@duke.edu	Altman, Brian J./X-2783-2019	Altman, Brian J./0000-0002-3954-4916; Macintyre, Andrew/0000-0002-5297-0207	NIH [R01 CA123350, F30 HL094044]; Leukemia and Lymphoma Society Scholar Award; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 CA123350 (JCR), Leukemia and Lymphoma Society Scholar Award (JCR), Alex's Lemonade Stand (JCR) and Gabrielle's Angel Foundation for Cancer Research (JCR). JCR is the Bernard Osher Fellow of the American Asthma Foundation. EFM is supported by NIH F30 HL094044 and RDM is supported by the Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute.	Altman BJ, 2009, AUTOPHAGY, V5, P569, DOI 10.4161/auto.5.4.8254; Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Darzynkiewicz Z, 2001, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0705s00; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kamitsuji Y, 2008, CELL DEATH DIFFER, V15, P1712, DOI 10.1038/cdd.2008.107; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mason EF, 2010, CANCER RES, V70, P8066, DOI 10.1158/0008-5472.CAN-10-0608; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Modi H, 2007, BLOOD, V109, P5411, DOI 10.1182/blood-2006-06-032490; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	59	100	111	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1855	1867		10.1038/onc.2010.561	http://dx.doi.org/10.1038/onc.2010.561			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21151168	Green Accepted			2022-12-25	WOS:000289777700002
J	Long, KK; Montano, M; Pavlath, GK				Long, Kimberly K.; Montano, Monty; Pavlath, Grace K.			Sca-1 is negatively regulated by TGF-beta 1 in myogenic cells	FASEB JOURNAL			English	Article						skeletal muscle; regeneration; fibrosis	TRANSFORMING-GROWTH-FACTOR; SKELETAL-MUSCLE REGENERATION; BETA TGF-BETA; STEM-CELL; INFLAMMATORY MYOPATHIES; CYTOKINE EXPRESSION; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; PATHWAY	Sca-1 (stem cell antigen-1) is a member of the Ly-6 family of proteins and regulates cell proliferation, differentiation, and self-renewal in multiple tissues. In skeletal muscle, Sca-1 inhibits both proliferation and differentiation of myogenic cells. Sca-1 expression is dynamically regulated during muscle regeneration, and mice lacking Sca-1 display increased fibrosis following muscle injury. Here, we show that Sca-1 expression is negatively regulated by TGF-beta 1 and that this inhibition is dependent on Smad3. We demonstrate that levels of TGF-beta 1 in skeletal muscle rapidly increase on injury and that the majority of this TGF beta 1 is produced by infiltrating macrophages. Sca-1 is expressed in multiple cell types, and we demonstrate that TGF-beta 1 represses Sca-1 expression in T cells and other immune cell populations derived from the spleen, indicating that regulation by TGF-beta 1 is a general feature of Sca-1 expression in multiple cell types. Elucidation of the mechanisms by which Sca-1 expression is regulated may aid in the understanding of muscle homeostasis, potentially identifying novel therapeutic targets for muscle diseases.-Long, K., Montano, M., Pavlath, G. K. Sca-1 is negatively regulated by TGF-beta 1 in myogenic cells. FASEB J. 25, 1156-1165 (2011). www.fasebj.org	[Long, Kimberly K.; Pavlath, Grace K.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Long, Kimberly K.; Montano, Monty] Boston Med Ctr, Dept Infect Dis, Boston, MA USA	Emory University; Boston Medical Center	Pavlath, GK (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.	gpavlat@emory.edu		Montano, Monty/0000-0002-1473-887X	U.S. National Institutes of Health [AR051372, AR055115]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055115, R01AR051372] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health grants AR051372 (G. K. P.) and AR055115 (M. M.), as well as a development grant from the Muscular Dystrophy Association (K.K.L.).	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BAMEZAI A, 1995, J IMMUNOL, V154, P4233; Bamezai A, 2004, ARCH IMMUNOL THER EX, V52, P255; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Hayes SA, 2001, CANCER RES, V61, P2112; Henderson SC, 2002, J IMMUNOL, V168, P118, DOI 10.4049/jimmunol.168.1.118; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Khodadoust MM, 1999, J IMMUNOL, V163, P811; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LEHTO M, 1986, ARCH ORTHOP TRAUM SU, V104, P366, DOI 10.1007/BF00454432; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; LI Y, 2001, CURR OPIN ORTHOP, V12, P409, DOI DOI 10.1097/00001433-200110000-00008; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Moustakas A, 2001, J CELL SCI, V114, P4359; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Otis JS, 2005, EXP CELL RES, V310, P417, DOI 10.1016/j.yexcr.2005.08.009; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; SANSILVESTRI P, 1995, BLOOD, V86, P1729, DOI 10.1182/blood.V86.5.1729.bloodjournal8651729; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YUTOKU M, 1974, J IMMUNOL, V112, P1774; ZENTELLA A, 1992, P NATL ACAD SCI USA, V89, P5176, DOI 10.1073/pnas.89.11.5176	49	16	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1156	1165		10.1096/fj.10-170308	http://dx.doi.org/10.1096/fj.10-170308			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21156809	Green Published			2022-12-25	WOS:000288982800005
J	van Rooijen, BD; Claessens, MMAE; Subramaniam, V				van Rooijen, Bart D.; Claessens, Mireille M. A. E.; Subramaniam, Vinod			Membrane Permeabilization by Oligomeric alpha-Synuclein: In Search of the Mechanism	PLOS ONE			English	Article							SOLUBLE AMYLOID OLIGOMERS; PARKINSONS-DISEASE; VESICLE PERMEABILIZATION; BILAYER-MEMBRANES; LIPID-BILAYERS; ION CHANNELS; MUTATION; PATHOGENESIS; AGGREGATION; INSERTION	Background: The question of how the aggregation of the neuronal protein alpha-synuclein contributes to neuronal toxicity in Parkinson's disease has been the subject of intensive research over the past decade. Recently, attention has shifted from the amyloid fibrils to soluble oligomeric intermediates in the alpha-synuclein aggregation process. These oligomers are hypothesized to be cytotoxic and to permeabilize cellular membranes, possibly by forming pore-like complexes in the bilayer. Although the subject of alpha-synuclein oligomer-membrane interactions has attracted much attention, there is only limited evidence that supports the pore formation by alpha-synuclein oligomers. In addition the existing data are contradictory. Methodology/Principal Findings: Here we have studied the mechanism of lipid bilayer disruption by a well-characterized alpha-synuclein oligomer species in detail using a number of in vitro bilayer systems and assays. Dye efflux from vesicles induced by oligomeric alpha-synuclein was found to be a fast all-or-none process. Individual vesicles swiftly lose their contents but overall vesicle morphology remains unaltered. A newly developed assay based on a dextran-coupled dye showed that non-equilibrium processes dominate the disruption of the vesicles. The membrane is highly permeable to solute influx directly after oligomer addition, after which membrane integrity is partly restored. The permeabilization of the membrane is possibly related to the intrinsic instability of the bilayer. Vesicles composed of negatively charged lipids, which are generally used for measuring alpha-synuclein-lipid interactions, were unstable to protein adsorption in general. Conclusions/Significance: The dye efflux from negatively charged vesicles upon addition of alpha-synuclein has been hypothesized to occur through the formation of oligomeric membrane pores. However, our results show that the dye efflux characteristics are consistent with bilayer defects caused by membrane instability. These data shed new insights into potential mechanisms of toxicity of oligomeric alpha-synuclein species.	[van Rooijen, Bart D.; Claessens, Mireille M. A. E.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	van Rooijen, BD (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	v.subramaniam@utwente.nl	Subramaniam, Vinod/B-4197-2010	Subramaniam, Vinod/0000-0001-6712-7266	Nanotechnology network in the Netherlands (NanoNed) [7921]; Faculty of Science and Technology at the University of Twente	Nanotechnology network in the Netherlands (NanoNed); Faculty of Science and Technology at the University of Twente	This work was part of the Nanotechnology network in the Netherlands (NanoNed), project number 7921 within the NanoNed program BioNanoSystems. Funding from the Faculty of Science and Technology at the University of Twente is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; HAUSER H, 1984, BIOCHEMISTRY-US, V23, P34, DOI 10.1021/bi00296a006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KIM HY, 2009, J AM CHEM SOC; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ladokhin AS, 1995, BIOPHYS J, V69, P1964, DOI 10.1016/S0006-3495(95)80066-4; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RUBAS W, 1995, J DRUG TARGET, V3, P15, DOI 10.3109/10611869509015928; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shoemaker SD, 2002, BIOPHYS J, V83, P2007, DOI 10.1016/S0006-3495(02)73962-3; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	37	103	109	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14292	10.1371/journal.pone.0014292	http://dx.doi.org/10.1371/journal.pone.0014292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179192	Green Published, gold			2022-12-25	WOS:000285246900006
J	Garcia, O; Torres, M; Helguera, P; Coskun, P; Busciglio, J				Garcia, Octavio; Torres, Maria; Helguera, Pablo; Coskun, Pinar; Busciglio, Jorge			A Role for Thrombospondin-1 Deficits in Astrocyte-Mediated Spine and Synaptic Pathology in Down's Syndrome	PLOS ONE			English	Article							TRISOMY 16 MOUSE; HUMAN CORTICAL-NEURONS; HUMAN-CHROMOSOME 21; DENDRITIC SPINES; CEREBRAL-CORTEX; GLIAL-CELLS; ALZHEIMER-DISEASE; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; STRUCTURAL ABNORMALITIES	Background: Down's syndrome (DS) is the most common genetic cause of mental retardation. Reduced number and aberrant architecture of dendritic spines are common features of DS neuropathology. However, the mechanisms involved in DS spine alterations are not known. In addition to a relevant role in synapse formation and maintenance, astrocytes can regulate spine dynamics by releasing soluble factors or by physical contact with neurons. We have previously shown impaired mitochondrial function in DS astrocytes leading to metabolic alterations in protein processing and secretion. In this study, we investigated whether deficits in astrocyte function contribute to DS spine pathology. Methodology/Principal Findings: Using a human astrocyte/rat hippocampal neuron coculture, we found that DS astrocytes are directly involved in the development of spine malformations and reduced synaptic density. We also show that thrombospondin 1 (TSP-1), an astrocyte-secreted protein, possesses a potent modulatory effect on spine number and morphology, and that both DS brains and DS astrocytes exhibit marked deficits in TSP-1 protein expression. Depletion of TSP-1 from normal astrocytes resulted in dramatic changes in spine morphology, while restoration of TSP-1 levels prevented DS astrocyte-mediated spine and synaptic alterations. Astrocyte cultures derived from TSP-1 KO mice exhibited similar deficits to support spine formation and structure than DS astrocytes. Conclusions/Significance: These results indicate that human astrocytes promote spine and synapse formation, identify astrocyte dysfunction as a significant factor of spine and synaptic pathology in the DS brain, and provide a mechanistic rationale for the exploration of TSP-1-based therapies to treat spine and synaptic pathology in DS and other neurological conditions.	[Garcia, Octavio; Torres, Maria; Helguera, Pablo; Coskun, Pinar; Busciglio, Jorge] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Garcia, O (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	jbuscigl@uci.edu	Garcia, Octavio/AAF-2127-2020	Garcia, Octavio/0000-0002-5792-0209; Coskun, E. Pinar/0000-0002-8010-8403	Larry L. Hillblom Foundation; National Institutes of Health [HD38466]; Alzheimers Disease Research Center [AG16573]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Disease Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from The Larry L. Hillblom Foundation and the National Institutes of Health (grant no. HD38466, and Alzheimers Disease Research Center grant no. AG16573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; Bambrick LL, 2003, J NEUROSCI RES, V73, P89, DOI 10.1002/jnr.10630; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Booth GE, 2000, DEVELOPMENT, V127, P237; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Caceres M, 2007, CEREB CORTEX, V17, P2312, DOI 10.1093/cercor/bhl140; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Franciotta D, 2006, NEUROSCI LETT, V395, P67, DOI 10.1016/j.neulet.2005.10.048; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Guazzarotti L, 2009, AJIDD-AM J INTELLECT, V114, P100, DOI 10.1352/2009.114.100-109; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hallam DM, 2000, J NEUROIMMUNOL, V110, P66, DOI 10.1016/S0165-5728(00)00289-7; Hallam DM, 1998, NEUROSCI LETT, V252, P17, DOI 10.1016/S0304-3940(98)00541-2; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayashi K, 1996, J NEUROSCI, V16, P7161; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Iwamoto T, 2009, ARCH ORAL BIOL, V54, P963, DOI 10.1016/j.archoralbio.2009.07.009; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; JORGENSEN OS, 1990, J NEUROL SCI, V98, P63; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Kobayashi C, 2007, J COMP NEUROL, V503, P618, DOI 10.1002/cne.21408; Kurt MA, 2004, BRAIN RES, V1022, P101, DOI 10.1016/j.brainres.2004.06.075; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Lymn JS, 1999, ARTERIOSCL THROM VAS, V19, P2133, DOI 10.1161/01.ATV.19.9.2133; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; MAHESHWARI RK, 1980, NATURE, V287, P454, DOI 10.1038/287454a0; MARINPAD.M, 1972, BRAIN RES, V44, P625, DOI 10.1016/0006-8993(72)90324-1; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Maroun LE, 1996, J THEOR BIOL, V181, P41, DOI 10.1006/jtbi.1996.0113; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; MURPHY M, 1992, J IMMUNOL, V149, P2506; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nelson PG, 1997, P NATL ACAD SCI USA, V94, P12644, DOI 10.1073/pnas.94.23.12644; NICKOLOFF BJ, 1988, J INVEST DERMATOL, V91, P213, DOI 10.1111/1523-1747.ep12465005; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; PAPA M, 1995, J NEUROSCI, V15, P1; Pelsman A, 2003, INT J DEV NEUROSCI, V21, P117, DOI 10.1016/S0736-5748(03)00031-5; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Roberts DD, 2007, CLIN CANCER RES, V13, P795, DOI 10.1158/1078-0432.CCR-06-1758; Sebastia J, 2004, EUR J NEUROSCI, V20, P2355, DOI 10.1111/j.1460-9568.2004.03686.x; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; TAKASHIMA S, 1994, J INTELL DISABIL RES, V38, P265; TAN YH, 1976, NATURE, V260, P141, DOI 10.1038/260141a0; TAN YH, 1974, SCIENCE, V186, P61, DOI 10.1126/science.186.4158.61; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; ZIHNI L, 1994, LEUKEMIA RES, V18, P1, DOI 10.1016/0145-2126(94)90002-7; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	114	75	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14200	10.1371/journal.pone.0014200	http://dx.doi.org/10.1371/journal.pone.0014200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152035	gold, Green Published			2022-12-25	WOS:000284868000014
J	Gibson, EM; Wang, C; Tjho, S; Khattar, N; Kriegsfeld, LJ				Gibson, Erin M.; Wang, Connie; Tjho, Stephanie; Khattar, Neera; Kriegsfeld, Lance J.			Experimental 'Jet Lag' Inhibits Adult Neurogenesis and Produces Long-Term Cognitive Deficits in Female Hamsters	PLOS ONE			English	Article							LIGHT-DARK CYCLE; MALE SIBERIAN HAMSTERS; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; SHIFT-WORK; CELL-PROLIFERATION; CIRCADIAN-RHYTHMS; LUTEINIZING-HORMONE; SLEEP-DEPRIVATION; PROMOTES SURVIVAL	Background: Circadian disruptions through frequent transmeridian travel, rotating shift work, and poor sleep hygiene are associated with an array of physical and mental health maladies, including marked deficits in human cognitive function. Despite anecdotal and correlational reports suggesting a negative impact of circadian disruptions on brain function, this possibility has not been experimentally examined. Methodology/Principal Findings: In the present study, we investigated whether experimental 'jet lag' (i.e., phase advances of the light: dark cycle) negatively impacts learning and memory and whether any deficits observed are associated with reductions in hippocampal cell proliferation and neurogenesis. Because insults to circadian timing alter circulating glucocorticoid and sex steroid concentrations, both of which influence neurogenesis and learning/memory, we assessed the contribution of these endocrine factors to any observed alterations. Circadian disruption resulted in pronounced deficits in learning and memory paralleled by marked reductions in hippocampal cell proliferation and neurogenesis. Significantly, deficits in hippocampal-dependent learning and memory were not only seen during the period of the circadian disruption, but also persisted well after the cessation of jet lag, suggesting long-lasting negative consequences on brain function. Conclusions/Significance: Together, these findings support the view that circadian disruptions suppress hippocampal neurogenesis via a glucocorticoid-independent mechanism, imposing pronounced and persistent impairments on learning and memory.	[Gibson, Erin M.; Wang, Connie; Tjho, Stephanie; Khattar, Neera; Kriegsfeld, Lance J.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kriegsfeld, Lance J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gibson, EM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	Kriegsfeld@berkeley.edu		Gibson, Erin/0000-0001-9749-3814	University of California, Berkeley; National Institutes of Health [HD-050470]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050470] Funding Source: NIH RePORTER	University of California, Berkeley(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by The Hellman Award (University of California, Berkeley) and National Institutes of Health Grant HD-050470 (L.J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborg G, 1996, INT J EPIDEMIOL, V25, P783, DOI 10.1093/ije/25.4.783; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anand S, 2004, BIOL REPROD, V70, P1033, DOI 10.1095/biolreprod.103.019380; Anand S, 2002, ENDOCRINOLOGY, V143, P2178, DOI 10.1210/en.143.6.2178; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Barha CK, 2009, J NEUROENDOCRINOL, V21, P155, DOI 10.1111/j.1365-2826.2008.01809.x; Barker JM, 2008, NEUROSCIENCE, V152, P888, DOI 10.1016/j.neuroscience.2007.10.071; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869; Cain SW, 2004, PHYSIOL BEHAV, V82, P339, DOI 10.1016/j.physbeh.2004.04.004; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cho K, 2000, J NEUROSCI, V20, part. no.; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Daniel JM, 1997, HORM BEHAV, V32, P217, DOI 10.1006/hbeh.1997.1433; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Frick KM, 2001, BEHAV NEUROSCI, V115, P229, DOI 10.1037//0735-7044.115.1.229; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; GOLOMBEK DA, 1993, CHRONOBIOL INT, V10, P435, DOI 10.3109/07420529309059719; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Jasnow AM, 2001, HORM BEHAV, V40, P428, DOI 10.1006/hbeh.2001.1708; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P204, DOI 10.5271/sjweh.1000; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Maywood ES, 2007, COLD SPRING HARB SYM, V72, P85, DOI 10.1101/sqb.2007.72.005; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; ORSINI M, 1961, P ANIMAL CARE PANEL, V14, P193; OTTENWELLER JE, 1985, LIFE SCI, V37, P1551, DOI 10.1016/0024-3205(85)90188-2; Pizzio GA, 2005, EUR J NEUROSCI, V22, P665, DOI 10.1111/j.1460-9568.2005.04247.x; POOLE CJM, 1992, BRIT J IND MED, V49, P513; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Ralph MR, 2002, BEHAV BRAIN RES, V136, P179, DOI 10.1016/S0166-4328(02)00131-6; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sei H, 2003, LIFE SCI, V73, P53, DOI 10.1016/S0024-3205(03)00251-0; Shors TJ, 2006, ANNU REV PSYCHOL, V57, P55, DOI 10.1146/annurev.psych.57.102904.190205; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SKIPPER JK, 1990, J ADV NURS, V15, P835, DOI 10.1111/j.1365-2648.1990.tb01915.x; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; STEPHAN FK, 1972, PHYSIOL BEHAV, V8, P315, DOI 10.1016/0031-9384(72)90379-4; TAKAMURE M, 1991, PHYSIOL BEHAV, V50, P443, DOI 10.1016/0031-9384(91)90092-3; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Van der Borght K, 2005, BEHAV BRAIN RES, V157, P23, DOI 10.1016/j.bbr.2004.06.004; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wallsser JA, 2006, DEV CELL, V10, P539, DOI 10.1016/j.devcel.2006.04.014; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhu JL, 2004, AM J OBSTET GYNECOL, V191, P285, DOI 10.1016/j.ajog.2003.12.002	81	126	127	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15267	10.1371/journal.pone.0015267	http://dx.doi.org/10.1371/journal.pone.0015267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152025	gold, Green Published, Green Submitted			2022-12-25	WOS:000284821300019
J	Rastegar, F; Gao, JL; Shenaq, D; Luo, Q; Shi, QO; Kim, SH; Jiang, W; Wagner, ER; Huang, EY; Gao, YH; Shen, JK; Yang, K; He, BC; Chen, LA; Zuo, GW; Luo, JY; Luo, XJ; Bi, Y; Liu, X; Li, M; Hu, N; Wang, LY; Luther, G; Luu, HH; Haydon, RC; He, TC				Rastegar, Farbod; Gao, Jian-Li; Shenaq, Deana; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Jiang, Wei; Wagner, Eric R.; Huang, Enyi; Gao, Yanhong; Shen, Jikun; Yang, Ke; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Bi, Yang; Liu, Xing; Li, Mi; Hu, Ning; Wang, Linyuan; Luther, Gaurav; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan			Lysophosphatidic Acid Acyltransferase beta (LPAAT beta) Promotes the Tumor Growth of Human Osteosarcoma	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; EXTREMITY OSTEOSARCOMA; MOLECULAR-MECHANISMS; PULMONARY METASTASES; EXPRESSION; GENE; TARGET; INHIBITION	Background: Osteosarcoma is the most common primary malignancy of bone with poorly characterized molecular pathways important in its pathogenesis. Increasing evidence indicates that elevated lipid biosynthesis is a characteristic feature of cancer. We sought to investigate the role of lysophosphatidic acid acyltransferase beta (LPAAT beta, aka, AGPAT2) in regulating the proliferation and growth of human osteosarcoma cells. LPAAT beta can generate phosphatidic acid, which plays a key role in lipid biosynthesis as well as in cell proliferation and survival. Although elevated expression of LPAAT beta has been reported in several types of human tumors, the role of LPAAT beta in osteosarcoma progression has yet to be elucidated. Methodology/Principal Findings: Endogenous expression of LPAAT beta in osteosarcoma cell lines is analyzed by using semi-quantitative PCR and immunohistochemical staining. Adenovirus-mediated overexpression of LPAAT beta and silencing LPAAT beta expression is employed to determine the effect of LPAAT beta on osteosarcoma cell proliferation and migration in vitro and osteosarcoma tumor growth in vivo. We have found that expression of LPAAT beta is readily detected in 8 of the 10 analyzed human osteosarcoma lines. Exogenous expression of LPAAT beta promotes osteosarcoma cell proliferation and migration, while silencing LPAAT beta expression inhibits these cellular characteristics. We further demonstrate that exogenous expression of LPAAT beta effectively promotes tumor growth, while knockdown of LPAAT beta expression inhibits tumor growth in an orthotopic xenograft model of human osteosarcoma. Conclusions/Significance: Our results strongly suggest that LPAAT beta expression may be associated with the aggressive phenotypes of human osteosarcoma and that LPAAT beta may play an important role in regulating osteosarcoma cell proliferation and tumor growth. Thus, targeting LPAAT beta may be exploited as a novel therapeutic strategy for the clinical management of osteosarcoma. This is especially attractive given the availability of selective pharmacological inhibitors.	[Rastegar, Farbod; Gao, Jian-Li; Shenaq, Deana; Luo, Qing; Shi, Qiong; Kim, Stephanie H.; Jiang, Wei; Wagner, Eric R.; Huang, Enyi; Gao, Yanhong; Shen, Jikun; Yang, Ke; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Bi, Yang; Liu, Xing; Li, Mi; Hu, Ning; Wang, Linyuan; Luther, Gaurav; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Gao, Jian-Li; He, Tong-Chuan] Zhejiang Univ, Sch Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Qing; Bi, Yang; Liu, Xing; Li, Mi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Stem Cell Biol & Therapy Lab, Chongqing, Peoples R China; [Shi, Qiong; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Hu, Ning] Chongqing Med Univ, Diagnost Med Designated Chinese Minist Educ, Key Lab, Chongqing, Peoples R China; [Shi, Qiong; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Jinyong; Luo, Xiaoji; Hu, Ning] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China	University of Chicago; University of Chicago Medical Center; Zhejiang University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Shanghai Jiao Tong University; Army Medical University	Rastegar, F (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA.	tche@surgery.bsd.uchicago.edu	; GAO, JianLi/J-4997-2017	Wagner, Eric/0000-0001-9241-5702; GAO, JianLi/0000-0002-5977-0021	Brinson Foundation; National Institutes of Health; University of Chicago Comprehensive Cancer Center	Brinson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center	The reported work was supported in part by research grants from the Brinson Foundation (TCH), National Institutes of Health (TCH and HHL) and the Animal Imaging Pilot Grant from The University of Chicago Comprehensive Cancer Center (to RCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Burton A, 2006, LANCET ONCOL, V7, P893, DOI 10.1016/S1470-2045(06)70926-3; CHEN L, 2010, J BONE MINER RES; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Coon M, 2003, MOL CANCER THER, V2, P1067; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Diefenbach CSM, 2006, CANCER-AM CANCER SOC, V107, P1511, DOI 10.1002/cncr.22184; Douvas MG, 2006, LEUKEMIA RES, V30, P1027, DOI 10.1016/j.leukres.2005.11.018; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gazitt Y, 2009, INT J ONCOL, V34, P551, DOI 10.3892/ijo_00000181; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Gordon N, 2009, CANCER TREAT RES, V152, P497, DOI 10.1007/978-1-4419-0284-9_29; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hideshima T, 2003, CANCER RES, V63, P8428; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kaste SC, 1999, CANCER-AM CANCER SOC, V86, P1602, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R; La Rosee P, 2006, CLIN CANCER RES, V12, P6540, DOI 10.1158/1078-0432.CCR-06-0140; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2005, CANCER LETT, V229, P135, DOI 10.1016/j.canlet.2005.02.015; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Murphey MD, 1997, RADIOGRAPHICS, V17, P1205, DOI 10.1148/radiographics.17.5.9308111; Niesporek S, 2005, BRIT J CANCER, V92, P1729, DOI 10.1038/sj.bjc.6602528; Pagel JM, 2005, CLIN CANCER RES, V11, P4857, DOI 10.1158/1078-0432.CCR-04-2352; Pakos EE, 2004, CLIN CANCER RES, V10, P6208, DOI 10.1158/1078-0432.CCR-04-0246; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Su YX, 2009, CLIN EXP METASTAS, V26, P599, DOI 10.1007/s10585-009-9259-6; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WARD WG, 1994, J CLIN ONCOL, V12, P1849, DOI 10.1200/JCO.1994.12.9.1849; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Whelan JS, 1997, EUR J CANCER, V33, P1611, DOI 10.1016/S0959-8049(97)00251-7; Yokoyama R, 1998, PATHOL RES PRACT, V194, P615, DOI 10.1016/S0344-0338(98)80096-4; Yonemoto T, 1998, CLIN ORTHOP RELAT R, P194; ZHOU Q, 2009, MED ONCOL	68	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14182	10.1371/journal.pone.0014182	http://dx.doi.org/10.1371/journal.pone.0014182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152068	Green Published, Green Submitted, gold			2022-12-25	WOS:000284821300003
J	Gandelman, OA; Church, VL; Moore, CA; Kiddle, G; Carne, CA; Parmar, S; Jalal, H; Tisi, LC; Murray, JAH				Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Kiddle, Guy; Carne, Christopher A.; Parmar, Surendra; Jalal, Hamid; Tisi, Laurence C.; Murray, James A. H.			Novel Bioluminescent Quantitative Detection of Nucleic Acid Amplification in Real-Time	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; FIREFLY LUCIFERASE; CHLAMYDIA-TRACHOMATIS; ENZYMATIC METHOD; DNA; PYROPHOSPHATE; PCR; QUANTIFICATION; THERMOSTABILITY; MICROBIOLOGY	Background: The real-time monitoring of polynucleotide amplification is at the core of most molecular assays. This conventionally relies on fluorescent detection of the amplicon produced, requiring complex and costly hardware, often restricting it to specialised laboratories. Principal Findings: Here we report the first real-time, closed-tube luminescent reporter system for nucleic acid amplification technologies (NAATs) enabling the progress of amplification to be continuously monitored using simple light measuring equipment. The Bioluminescent Assay in Real-Time (BART) continuously reports through bioluminescent output the exponential increase of inorganic pyrophosphate (PPi) produced during the isothermal amplification of a specific nucleic acid target. BART relies on the coupled conversion of inorganic pyrophosphate (PPi) produced stoichiometrically during nucleic acid synthesis to ATP by the enzyme ATP sulfurylase, and can therefore be coupled to a wide range of isothermal NAATs. During nucleic acid amplification, enzymatic conversion of PPi released during DNA synthesis into ATP is continuously monitored through the bioluminescence generated by thermostable firefly luciferase. The assay shows a unique kinetic signature for nucleic acid amplifications with a readily identifiable light output peak, whose timing is proportional to the concentration of original target nucleic acid. This allows qualitative and quantitative analysis of specific targets, and readily differentiates between negative and positive samples. Since quantitation in BART is based on determination of time-to-peak rather than absolute intensity of light emission, complex or highly sensitive light detectors are not required. Conclusions: The combined chemistries of the BART reporter and amplification require only a constant temperature maintained by a heating block and are shown to be robust in the analysis of clinical samples. Since monitoring the BART reaction requires only a simple light detector, the iNAAT-BART combination is ideal for molecular diagnostic assays in both laboratory and low resource settings.	[Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Kiddle, Guy; Tisi, Laurence C.] Lumora Ltd, Ely, England; [Gandelman, Olga A.; Church, Vicki L.; Moore, Cathy A.; Murray, James A. H.] Univ Cambridge, Inst Biotechnol, Cambridge, England; [Carne, Christopher A.] Addenbrookes Hosp, Clin 1A, Cambridge, England; [Parmar, Surendra; Jalal, Hamid] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England; [Murray, James A. H.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Gandelman, OA (corresponding author), Lumora Ltd, Ely, England.	o.gandelman@lumora.co.uk	Murray, James AH/D-3399-2009	Murray, James AH/0000-0002-2282-3839	Department of Trade and Industry (DTI), UK [4644 (SEC/120/40)]	Department of Trade and Industry (DTI), UK	This research was funded by the Department of Trade and Industry (DTI), UK: grant for research and development: Molecular Diagnostics (project reference: 4644 (SEC/120/40)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi Y, 2006, J BIOTECHNOL, V125, P484, DOI 10.1016/j.jbiotec.2006.04.007; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Brenan Colin, 2005, Drug Discov Today Technol, V2, P247, DOI 10.1016/j.ddtec.2005.08.017; Brovko L. Yu., 1994, Biokhimiya, V59, P273; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cai T, 2008, J CLIN VIROL, V41, P270, DOI 10.1016/j.jcv.2007.11.025; Cali JJ, 2008, EXPERT OPIN DRUG MET, V4, P103, DOI [10.1517/17425255.4.1.103, 10.1517/17425255.4.1.103 ]; Eriksson J, 2004, NUCLEOS NUCLEOT NUCL, V23, P1583, DOI 10.1081/NCN-200031402; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fontes R, 2008, FEBS J, V275, P1500, DOI 10.1111/j.1742-4658.2008.06309.x; GANDELMAN O, 1994, J BIOLUM CHEMILUM, V9, P363, DOI 10.1002/bio.1170090603; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; HANNAH R, 2000, BIOLUMINESCENCE CHEM, P289; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jannes Geert, 2006, V345, P1; Karamohamed S, 1998, BIOTECHNIQUES, V24, P302, DOI 10.2144/98242rr02; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; MIELZYNSKA I, 2004, USING MOL DIAGNOSTIC; MILLER B, 2009, IVD TECHNOLOGY, V15, P35; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; MOYER JD, 1983, ANAL BIOCHEM, V131, P187, DOI 10.1016/0003-2697(83)90152-5; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; NYREN P, 1987, ANAL BIOCHEM, V167, P235, DOI 10.1016/0003-2697(87)90158-8; NYREN P, 1985, ANAL BIOCHEM, V151, P504, DOI 10.1016/0003-2697(85)90211-8; Nyren P, 1997, ANAL BIOCHEM, V244, P367, DOI 10.1006/abio.1996.9913; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Steghens JP, 1998, BIOCHEM J, V336, P109, DOI 10.1042/bj3360109; TABARY T, 1992, J IMMUNOL METHODS, V156, P55, DOI 10.1016/0022-1759(92)90010-Q; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343	33	58	72	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14155	10.1371/journal.pone.0014155	http://dx.doi.org/10.1371/journal.pone.0014155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152399	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000284755100033
J	Green, BS; Gardner, C; Linnane, A; Hawthorne, PJ				Green, Bridget S.; Gardner, Caleb; Linnane, Adrian; Hawthorne, Peter J.			The Good, the Bad and the Recovery in an Assisted Migration	PLOS ONE			English	Article							SOUTHERN ROCK LOBSTER; JASUS-EDWARDSII; CLIMATE-CHANGE; LIFE-HISTORY; SPATIAL VARIATION; MATURITY; GROWTH; SIZE; COLONIZATION; RESILIENCE	Background: Assisted migration or translocation of species to ameliorate effects of habitat loss or changing environment is currently under scrutiny as a conservation tool. A large scale experiment of assisted migration over hundreds of kilometres was tested on a morph from a commercial fishery of southern rock lobster Jasus edwardsii, to enhance depleted populations, improve the yield and sustainability of the fishery, and test resilience to a changing climate. Methodology and Principal Findings: Approximately 10,000 lower-valued, pale-coloured lobsters were moved from deep water to inshore sites (2 in Tasmania [TAS] and 2 in South Australia [SA]) where the high-value, red morph occurs. In TAS this was a northwards movement of 1 degrees latitude. Growth was measured only in TAS lobsters, and reproductive status was recorded in lobsters from all locations. Pale females (TAS) grew 4 times faster than resident pale lobsters from the original site and twice as fast as red lobsters at their new location. Approximately 30% of translocated pale lobsters deferred reproduction for one year after release (SA and TAS), and grew around 1 mm yr(-1) less compared to translocated pale lobsters that did not defer reproduction. In spite of this stress response to translocation, females that deferred reproduction still grew 2-6 mm yr(-1) more than lobsters at the source site. Lobsters have isometric growth whereby volume increases as a cube of length. Consequently despite the one-year hiatus in reproduction, increased growth increases fecundity of translocated lobsters, as the increase in size provided a larger volume for producing and incubating eggs in future years. Conclusions and Significance: Assisted migration improved egg production and growth, despite a temporary stress response, and offers a tool to improve the production, sustainability and resilience of the fishery.	[Green, Bridget S.; Gardner, Caleb] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia; [Linnane, Adrian; Hawthorne, Peter J.] S Australian Res & Dev Inst, Henley Beach, SA, Australia	University of Tasmania	Green, BS (corresponding author), Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia.	bridget.green@utas.edu.au	Green, Bridget/G-3368-2014; Gardner, Caleb/I-7086-2013	Green, Bridget/0000-0001-8214-6430; Gardner, Caleb/0000-0003-0324-4337	Australian CRC Seafood; Australian Fisheries Research Development Corporation [2006/220]	Australian CRC Seafood(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Fisheries Research Development Corporation	This research was supported by Australian CRC Seafood and Australian Fisheries Research Development Corporation grant 2006/220. The funders had no role on study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Bradshaw M, 2004, FISH RES, V67, P99, DOI 10.1016/j.fishres.2003.11.007; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; BURTON MPM, 1994, J ZOOL, V233, P405, DOI 10.1111/j.1469-7998.1994.tb05273.x; Carroll MJ, 2009, BIOL CONSERV, V142, P2114, DOI 10.1016/j.biocon.2009.04.010; Chandrapavan A, 2009, J EXP MAR BIOL ECOL, V375, P9, DOI 10.1016/j.jembe.2009.04.021; Chandrapavan A, 2009, NEW ZEAL J MAR FRESH, V43, P537, DOI 10.1080/00288330909510020; Chapron G, 2008, SCIENCE, V322, P1049, DOI 10.1126/science.322.5904.1049b; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Cochrane A, 2004, SCI PRAC ECOL REST, P40; Davidson I, 2008, SCIENCE, V322, P1048, DOI 10.1126/science.322.5904.1048b; Fischer B, 2009, AM NAT, V173, pE108, DOI 10.1086/596536; Gardner C, 2005, SCI MAR, V69, P123, DOI 10.3989/scimar.2005.69n1123; Gardner C, 2003, B MAR SCI, V73, P653; Gardner C, 2010, TASMANIAN ROCK LOBST; GARDNER C, 2008, REV FISH SCI, V16, P1; Gardner C, 2006, SCI MAR, V70, P423, DOI 10.3989/scimar.2006.70n3423; Godwin H., 1975, HIST BRIT FLORA; Green BS, 2009, MAR BIOL, V156, P1941, DOI 10.1007/s00227-009-1226-x; Green BS, 2009, ICES J MAR SCI, V66, P656, DOI 10.1093/icesjms/fsp030; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harlioglu MM, 2006, REV FISH BIOL FISHER, V16, P171, DOI 10.1007/s11160-006-9010-1; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Johnston FD, 2009, ECOL APPL, V19, P449, DOI 10.1890/07-1507.1; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Linnane A, 2005, NEW ZEAL J MAR FRESH, V39, P335, DOI 10.1080/00288330.2005.9517314; Linnane AJ, 2008, J MAR BIOL ASSOC UK, V88, P583, DOI 10.1017/S0025315408001021; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Linnane A, 2009, FISH RES, V96, P238, DOI 10.1016/j.fishres.2008.11.008; Linnane A, 2009, NEW ZEAL J MAR FRESH, V43, P475, DOI 10.1080/00288330909510016; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Mills DJ, 2006, AQUACULTURE, V254, P256, DOI 10.1016/j.aquaculture.2005.09.007; Mueller JM, 2008, CONSERV BIOL, V22, P562, DOI 10.1111/j.1523-1739.2008.00952.x; Pecl G, 2009, E COAST TASMANIAN RO; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P476, DOI 10.1016/j.tree.2009.05.005; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; RICKLEFS RE, 1994, EVOLUTION, V48, P1080, DOI 10.1111/j.1558-5646.1994.tb05295.x; Rideout RM, 2006, MAR ECOL PROG SER, V320, P267, DOI 10.3354/meps320267; Roff Derek A., 1992; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; Sax DF, 2009, TRENDS ECOL EVOL, V24, P472, DOI 10.1016/j.tree.2009.05.004; Schlaepfer MA, 2009, TRENDS ECOL EVOL, V24, P471, DOI 10.1016/j.tree.2009.05.008; Stearns S.C., 1992, pi; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stelzer CP, 2001, ECOLOGY, V82, P2521; Tavecchia G, 2009, BIOL CONSERV, V142, P3005, DOI 10.1016/j.biocon.2009.07.035; van der Meeren GI, 2000, CAN J FISH AQUAT SCI, V57, P1794, DOI 10.1139/cjfas-57-9-1794; van der Meeren GI, 1997, MAR FRESHWATER RES, V48, P915, DOI 10.1071/MF97126; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Wang QY, 2006, FISH RES, V80, P67, DOI 10.1016/j.fishres.2006.03.015; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	58	26	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14160	10.1371/journal.pone.0014160	http://dx.doi.org/10.1371/journal.pone.0014160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151965	Green Published, gold			2022-12-25	WOS:000284755100038
J	Kotake, Y; Nakagawa, T; Kitagawa, K; Suzuki, S; Liu, N; Kitagawa, M; Xiong, Y				Kotake, Y.; Nakagawa, T.; Kitagawa, K.; Suzuki, S.; Liu, N.; Kitagawa, M.; Xiong, Y.			Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene	ONCOGENE			English	Article						long non-coding RNA; ANRIL; polycomb; p15(INK4B); p16(INK4A); ARF	GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INK4A LOCUS; P16(INK4A); CHROMATIN; PROTEINS; SUSCEPTIBILITY; EXPRESSION; FAMILY; BMI-1	A 42 kb region on human chromosome 9p21 encodes for three distinct tumor suppressors, p16(INK4A), p14(ARF) and p15(INK4B), and is altered in an estimated 30-40% of human tumors. The expression of the INK4A-ARF-INK4B gene cluster is silenced by polycomb during normal cell growth and is activated by oncogenic insults and during aging. How the polycomb is recruited to repress this gene cluster is unclear. Here, we show that expression of oncogenic Ras, which stimulates the expression of p15(INK4B) and p(16INK4A), but not p14ARF, inhibits the expression of ANRIL (antisense non-coding RNA in the INK4 locus), a 3.8 kblong non-coding RNA expressed in the opposite direction from INK4A-ARF-INK4B. We show that the p15(INK4B) locus is bound by SUZ12, a component of polycomb repression complex 2 (PRC2), and is H3K27-trimethylated. Notably, depletion of ANRIL disrupts the SUZ12 binding to the p15(INK4B) locus, increases the expression of p15(INK4B), but not p16(INK4A) or p14(ARF), and inhibits cellular proliferation. Finally, RNA immunoprecipitation demonstrates that ANRIL binds to SUZ12 in vivo. Collectively, these results suggest a model in which ANRIL binds to and recruits PRC2 to repress the expression of p15INK4B locus. Oncogene (2011) 30, 1956-1962; doi: 10.1038/onc.2010.568; published online 13 December 2010	[Kitagawa, M.] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kotake, Y.; Nakagawa, T.; Xiong, Y.] Univ N Carolina, Program Mol Biol & Biotechnol, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Hamamatsu University School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp; yxiong@email.unc.edu			Ministry of Education, Science, Sports, Culture, and Technology of Japan; NIH [CA68377]; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Howard Chang for the insightful discussion during this study, Yaxue Zeng and Matt Smith for helpful discussion and reading the manuscript, Mika Matsumoto, Michiyo Hakamata and Harumi Shiratori for technical assistance. This study is supported by grants from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (YK, MK, SS and KK) and NIH grant CA68377 (YX).	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	35	760	820	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	16					1956	1962		10.1038/onc.2010.568	http://dx.doi.org/10.1038/onc.2010.568			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21151178	Green Accepted, Green Published			2022-12-25	WOS:000289777700011
J	Parra, MK; Gee, S; Mohandas, N; Conboy, JG				Parra, Marilyn K.; Gee, Sherry; Mohandas, Narla; Conboy, John G.			Efficient in Vivo Manipulation of Alternative Pre-mRNA Splicing Events Using Antisense Morpholinos in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTORES DYSTROPHIN EXPRESSION; SPINAL MUSCULAR-ATROPHY; ERYTHROID-DIFFERENTIATION; PROTEIN 4.1R; REGULATORY ELEMENTS; GENE-EXPRESSION; CRITICAL EXON; MOTOR-NEURON; MOUSE MODEL; MDX MICE	Mammalian pre-mRNA alternative splicing mechanisms are typically studied using artificial minigenes in cultured cells, conditions that may not accurately reflect the physiological context of either the pre-mRNA or the splicing machinery. Here, we describe a strategy to investigate splicing of normal endogenous full-length pre-mRNAs under physiological conditions in live mice. This approach employs antisense vivo-morpholinos (vMOs) to mask cis-regulatory sequences or to disrupt splicing factor expression, allowing functional evaluation of splicing regulation in vivo. We applied this strategy to gain mechanistic insight into alternative splicing events involving exons 2 and 16 (E2 and E16) that control the structure and function of cytoskeletal protein 4.1R. In several mouse tissues, inclusion of E16 was substantially inhibited by interfering with a splicing enhancer mechanism using a target protector morpholino that blocked Fox2-dependent splicing enhancers in intron 16 or a splice-blocking morpholino that disrupted Fox2 expression directly. For E2, alternative 3'-splice site choice is coordinated with upstream promoter use across a long 5'-intron such that E1A splices almost exclusively to the distal acceptor (E2dis). vMOs were used to test the in vivo relevance of a deep intron element previously proposed to determine use of E2dis via a two-step intrasplicing model. Two independent vMOs designed against this intronic regulatory element inhibited intrasplicing, robustly switching E1A splicing to the proximal acceptor (E2prox). This finding strongly supports the in vivo physiological relevance of intrasplicing. vMOs represent a powerful tool for alternative splicing studies in vivo and may facilitate exploration of alternative splicing networks in vivo.	[Parra, Marilyn K.; Gee, Sherry; Conboy, John G.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10065 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; New York Blood Center	Conboy, JG (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,Mailstop 84-171, Berkeley, CA 94720 USA.	jgconboy@lbl.gov			National Institutes of Health [HL45182, DK32094]; Office of Science, Office of Biological and Environmental Research, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045182, R01HL045182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45182 (to J. G. C.) and DK32094 (to N. M.). This work was also supported by the Director, Office of Science, Office of Biological and Environmental Research, United States Department of Energy under Contract DE-AC02-05CH11231.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Bonano VI, 2006, RNA, V12, P2073, DOI 10.1261/rna.248506; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DISCHER D, 1993, J BIOL CHEM, V268, P7186; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; HUANG JP, 1993, J BIOL CHEM, V268, P3758; Huang SC, 2009, BLOOD, V114, P4233, DOI 10.1182/blood-2009-02-206219; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moroy T, 2007, RNA, V13, P1155, DOI 10.1261/rna.554607; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Tan JS, 2005, GENOMICS, V86, P701, DOI 10.1016/j.ygeno.2005.08.005; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325; Yang G, 2005, BLOOD, V105, P2146, DOI 10.1182/blood-2004-05-1757; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6033	6039		10.1074/jbc.M110.158154	http://dx.doi.org/10.1074/jbc.M110.158154			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156798	Green Published, hybrid			2022-12-25	WOS:000287476400011
J	Yokoyama, K; Kaji, H; He, JS; Tanaka, C; Hazama, R; Kamigaki, T; Ku, YS; Tohyama, K; Tohyama, Y				Yokoyama, Kunio; Kaji, Hiroaki; He, Jinsong; Tanaka, Chisato; Hazama, Ryoichi; Kamigaki, Takashi; Ku, Yonson; Tohyama, Kaoru; Tohyama, Yumi			Rab27a Negatively Regulates Phagocytosis by Prolongation of the Actin-coating Stage around Phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE; SLAC2-A/MELANOPHILIN; TRAFFICKING; CORONIN-1; BINDING; CD47	Rab27a, a Rab family small GTPase, is involved in the exocytosis of secretory granules in melanocytes and cytotoxic T-cells. Rab27a mutations cause type 2 Griscelli syndrome, which is characterized by immunodeficiency, including uncontrolled macrophage activation known as hemophagocytic syndrome. However, the role of Rab27a in phagocytosis remains elusive. Here, using macrophage-like differentiated HL-60 cells and C3bi-opsonized zymosan as a pathogen-phagocyte model, we show that Rab27a negatively regulates complement-mediated phagocytic activity in association with F-actin remodeling. We found that transfection of Rab27a shRNA into HL-60 cells enhances complement-mediated phagocytosis. To clarify the mechanisms underlying the elevated phagocytosis in Rab27a knockdown cells, we analyzed the process of phagosome formation focusing on F-actin dynamics: F-actin assembly, followed by F-actin extension around the particles and the subsequent degradation of F-actin, leading to internalization of the particles enclosed in phagosomes. Microscopic analysis revealed that these actin-related processes, including F-actin coating and F-actin degradation, proceed more rapidly in Rab27a knockdown cells than in control HL-60 cells. Both elevated phagocytosis and accelerated F-actin remodeling were restored by expression of rescue-Rab27a and Rab27a-Q78L (GTP-bound form), but not by Rab27a-T23N (GDP-bound form). Furthermore, an increased accumulation of Coronin 1A surrounding F-actin coats was observed in Rab27a knockdown cells, suggesting that the function of Coronin 1A is related to the regulation of the F-actin coating. Our findings demonstrate that Rab27a plays a direct regulatory role in the nascent process of phagocytosis by prolongation of the stage of actin coating via suppression of Coronin 1A. This study may contribute to an explanation of the underlying mechanisms of excessive phagocytosis observed in Griscelli syndrome.	[Kaji, Hiroaki; Tanaka, Chisato; Hazama, Ryoichi; Tohyama, Yumi] Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan; [Kaji, Hiroaki] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care, Himeji, Hyogo 6708524, Japan; [Tohyama, Kaoru] Kawasaki Med Sch, Dept Lab Med, Kurashiki, Okayama 7010192, Japan; Kobe Univ, Grad Sch Med, Div Gastroenterol Surg, Kobe, Hyogo 6500017, Japan; [Ku, Yonson] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 6500017, Japan; [Hazama, Ryoichi] Kobe Univ, Grad Sch Med, Div Biochem, Dept Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Himeji Dokkyo University; Himeji Dokkyo University; Kawasaki Medical School; Kobe University; Kobe University; Kobe University	Tohyama, Y (corresponding author), Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan.	ytohyama@himeji-du.ac.jp			Japan Society for the Promotion of Sciences; KAKENHI	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI and a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Sciences (to Y.T. and K.T.).	Chavas LMG, 2008, STRUCTURE, V16, P1468, DOI 10.1016/j.str.2008.07.015; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; Kimura T, 2010, BIOCHEM BIOPH RES CO, V395, P318, DOI 10.1016/j.bbrc.2010.03.173; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Liebl D, 2009, J CELL SCI, V122, P2935, DOI 10.1242/jcs.048355; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Oku T, 2008, J BIOL CHEM, V283, P28918, DOI 10.1074/jbc.M709990200; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsujita K, 2010, J BIOL CHEM, V285, P6781, DOI 10.1074/jbc.M109.057018; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989	25	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5375	5382		10.1074/jbc.M110.171702	http://dx.doi.org/10.1074/jbc.M110.171702			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21169636	hybrid, Green Published			2022-12-25	WOS:000287230600046
J	Huang, CB; Zhou, JW; Zhou, YF; Lu, ZL				Huang, Chang-Bing; Zhou, Jiawei; Zhou, Yifeng; Lu, Zhong-Lin			Contrast and Phase Combination in Binocular Vision	PLOS ONE			English	Article							MASKING-LEVEL DIFFERENCES; VISUAL-CORTEX; CORTICAL-NEURONS; GAIN-CONTROL; SIMPLE CELLS; RIVALRY; SUMMATION; MODEL; ARCHITECTURE; SUPPRESSION	Background: How the visual system combines information from the two eyes to form a unitary binocular representation of the external world is a fundamental question in vision science that has been the focus of many psychophysical and physiological investigations. Ding & Sperling (2006) measured perceived phase of the cyclopean image, and developed a binocular combination model in which each eye exerts gain control on the other eye's signal and over the other eye's gain control. Critically, the relative phase of the monocular sine-waves plays a central role. Methodology/Principal Findings: We used the Ding-Sperling paradigm but measured both the perceived contrast and phase of cyclopean images in three hundred and eighty combinations of base contrast, interocular contrast ratio, eye origin of the probe, and interocular phase difference. We found that the perceived contrast of the cyclopean image was independent of the relative phase of the two monocular gratings, although the perceived phase depended on the relative phase and contrast ratio of the monocular images. We developed a new multi-pathway contrast-gain control model (MCM) that elaborates the Ding-Sperling binocular combination model in two ways: (1) phase and contrast of the cyclopean images are computed in separate pathways, although with shared cross-eye contrast-gain control; and (2) phase-independent local energy from the two monocular images are used in binocular contrast combination. With three free parameters, the model yielded an excellent account of data from all the experimental conditions. Conclusions/Significance: Binocular phase combination depends on the relative phase and contrast ratio of the monocular images but binocular contrast combination is phase-invariant. Our findings suggest the involvement of at least two separate pathways in binocular combination.	[Huang, Chang-Bing; Lu, Zhong-Lin] Univ So Calif, Dept Psychol & Biomed Engn, Grad Program Neurosci, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Zhou, Jiawei; Zhou, Yifeng] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhou, Jiawei; Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	University of Southern California; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, CB (corresponding author), Univ So Calif, Dept Psychol & Biomed Engn, Grad Program Neurosci, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA.	zhonglin@usc.edu	Zhou, Jiawei/J-8770-2013; Zhou, Jiawei/AGN-8024-2022; Huang, Chang-Bing/AAE-2909-2020; HUANG, CHANG-BING/D-3855-2011	Zhou, Jiawei/0000-0003-4220-344X; Lu, Zhong-Lin/0000-0002-7295-727X; huang, chang bing/0000-0003-4694-0834	National Eye Institute [EY017491]; National Natural Science Foundation of China [30630027]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute (EY017491) and the National Natural Science Foundation of China (30630027) supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ANDERSON PA, 1989, VISION RES, V29, P1115, DOI 10.1016/0042-6989(89)90060-6; ARDITI AR, 1981, VISION RES, V21, P329, DOI 10.1016/0042-6989(81)90160-7; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; BLAKE R, 1981, PERCEPT PSYCHOPHYS, V30, P266, DOI 10.3758/BF03214282; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V225, P437, DOI 10.1113/jphysiol.1972.sp009948; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Cormack LK, 1997, PERCEPTION, V26, P1121, DOI 10.1068/p261121; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2007, COMPUTATIONAL VISION IN NEURAL AND MACHINE SYSTEMS, P257; DUDLEY LP, 1951, STEREOPTICS INTRO LO; FRISEN L, 1988, J PHYSIOL-LONDON, V402, P773, DOI 10.1113/jphysiol.1988.sp017233; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Grossberg S, 2006, SPATIAL VISION, V19, P263, DOI 10.1163/156856806776923399; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HENNING GB, 1973, VISION RES, V13, P2455, DOI 10.1016/0042-6989(73)90243-5; HENNING GB, 1977, VISION RES, V17, P399, DOI 10.1016/0042-6989(77)90030-X; HUANG CB, 2010, DEFICIENT BINOCULAR; Huang Chang-Bing, 2009, J Vis, V9, DOI 10.1167/9.3.17; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; LEGGE GE, 1984, VISION RES, V24, P385, DOI 10.1016/0042-6989(84)90064-6; LEGGE GE, 1981, PERCEPT PSYCHOPHYS, V30, P49, DOI 10.3758/BF03206136; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Maehara G, 2005, OPT REV, V12, P76, DOI 10.1007/s10043-004-0076-5; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Moradi F, 2009, J VISION, V9, DOI 10.1167/9.3.13; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pirenne MH, 1943, NATURE, V152, P698, DOI 10.1038/152698a0; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; RAMACHANDRAN VS, 1972, NATURE, V237, P347, DOI 10.1038/237347a0; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; Smith EL, 1997, J NEUROPHYSIOL, V78, P366, DOI 10.1152/jn.1997.78.1.366; van der Smagt MJ, 2005, J NEUROPHYSIOL, V94, P576, DOI 10.1152/jn.00366.2004; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019	47	55	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15075	10.1371/journal.pone.0015075	http://dx.doi.org/10.1371/journal.pone.0015075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151558	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800014
J	Proenca, DN; Francisco, R; Santos, CV; Lopes, A; Fonseca, L; Abrantes, IMO; Morais, PV				Proenca, Diogo Neves; Francisco, Romeu; Santos, Clara Vieira; Lopes, Andre; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.			Diversity of Bacteria Associated with Bursaphelenchus xylophilus and Other Nematodes Isolated from Pinus pinaster Trees with Pine Wilt Disease	PLOS ONE			English	Article							WOOD NEMATODE	The pinewood nematode (PWN), Bursaphelenchus xylophilus, has been thought to be the only causal agent of pine wilt disease (PWD), however, since bacteria have been suggested to play a role in PWD, it is important to know the diversity of the microbial community associated to it. This study aimed to assess the microbial community associated with B. xylophilus and with other nematodes isolated from pine trees, Pinus pinaster, with PWD from three different affected forest areas in Portugal. One hundred and twenty three bacteria strains were isolated from PWN and other nematodes collected from 14 P. pinaster. The bacteria strains were identified by comparative analysis of the 16S rRNA gene partial sequence. All except one Gram-positive strain (Actinobacteria) belonged to the Gram-negative Beta and Gammaproteobacteria. Most isolates belonged to the genus Pseudomonas, Burkholderia and to the family Enterobacteriaceae. Species isolated in higher percentage were Pseudomonas lutea, Yersinia intermedia and Burkholderia tuberum. The major bacterial population associated to the nematodes differed according to the forest area and none of the isolated bacterial species was found in all different forest areas. For each of the sampled areas, 60 to 100% of the isolates produced siderophores and at least 40% produced lipases. The ability to produce siderophores and lipases by most isolates enables these bacteria to have a role in plant physiological response. This research showed a high diversity of the microbial community associated with B. xylophilus and other nematodes isolated from P. pinaster with PWD.	[Proenca, Diogo Neves; Francisco, Romeu; Santos, Clara Vieira; Lopes, Andre; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Inst Marine Res IMAR CMA, Coimbra, Portugal; [Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, Fac Sci & Technol FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Proenca, DN (corresponding author), Inst Marine Res IMAR CMA, Coimbra, Portugal.	pvmorais@ci.uc.pt	Francisco, Romeu/I-1080-2012; Morais, Paula Vasconcelos/C-9756-2014; Proença, Diogo Neves/K-1801-2015; Abrantes, Isabel/CAG-1426-2022	Francisco, Romeu/0000-0002-4643-6075; Morais, Paula Vasconcelos/0000-0002-1939-6389; Proença, Diogo Neves/0000-0002-1284-9082; Abrantes, Isabel/0000-0002-8761-2151; Fonseca, Luis/0000-0001-7405-8916	Fundacao para a Ciencia e a Tecnologia [POCI/AGR/59097/2004]; Fundo Florestal Permanente	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Florestal Permanente	This research was partially supported by the Fundacao para a Ciencia e a Tecnologia (POCI/AGR/59097/2004) http://alfa.fct.mctes.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also partially supported by Fundo Florestal Permanente, through a national project "O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus'' http://www.afn.min-agricultura.pt/ portal/apoios-invest/ffp.	ABRANTES I M O, 1976, Ciencia Biologica Ecologia e Sistematica, V1, P139; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; *EPPO OEPP, 2009, B OEPP EPPO, V39, P344; GUO DS, 2000, J NANJING FOR U, V4, P69; Guo QQ, 2007, J NEMATOL, V39, P243; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Hofte M, 2006, PLANT-ASSOCIATED BACTERIA, P507; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; Hunzicker GM, 2009, PLANTA, V231, P143, DOI 10.1007/s00425-009-1032-1; NICKLE WR, 1981, J NEMATOL, V13, P385; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Peix A, 2004, INT J SYST EVOL MICR, V54, P847, DOI 10.1099/ijs.0.02966-0; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Pirttila AM, 2008, PLANT CELL TISS ORG, V95, P47, DOI 10.1007/s11240-008-9413-x; RAINEY FA, 1992, SYST APPL MICROBIOL, V15, P197, DOI 10.1016/S0723-2020(11)80092-5; Salles JF, 2004, APPL ENVIRON MICROB, V70, P4012, DOI 10.1128/AEM.70.7.4012-4020.2004; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres AR, 2008, J MICROBIOL, V46, P373, DOI 10.1007/s12275-007-0165-9; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; WHITAKER JR, 1995, ACS SYM SER, V600, P2; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; Zhao BG, 2007, J PHYTOPATHOL, V155, P26, DOI 10.1111/j.1439-0434.2006.01188.x; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817	32	68	72	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15191	10.1371/journal.pone.0015191	http://dx.doi.org/10.1371/journal.pone.0015191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151611	gold, Green Published			2022-12-25	WOS:000285135800017
J	Solberg, R; Loberg, EM; Andresen, JH; Wright, MS; Charrat, E; Khrestchatisky, M; Rivera, S; Saugstad, OD				Solberg, Ronnaug; Loberg, Else Marit; Andresen, Jannicke H.; Wright, Marianne S.; Charrat, Eliane; Khrestchatisky, Michel; Rivera, Santiago; Saugstad, Ola Didrik			Resuscitation of Newborn Piglets. Short-Term Influence of FiO(2) on Matrix Metalloproteinases, Caspase-3 and BDNF	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; DOSE-DEPENDENT INCREASE; ROOM-AIR RESUSCITATION; NEURONAL CELL-DEATH; 100-PERCENT OXYGEN; DEVELOPING BRAIN; PATHOLOGICAL APOPTOSIS; ANIMAL-MODELS; INJURY; ACTIVATION	Background: Perinatal hypoxia-ischemia is a major cause of mortality and cerebral morbidity, and using oxygen during newborn resuscitation may further harm the brain. The aim was to examine how supplementary oxygen used for newborn resuscitation would influence early brain tissue injury, cell death and repair processes and the regulation of genes related to apoptosis, neurodegeneration and neuroprotection. Methods and Findings: Anesthetized newborn piglets were subjected to global hypoxia and then randomly assigned to resuscitation with 21%, 40% or 100% O-2 for 30 min and followed for 9 h. An additional group received 100% O-2 for 30 min without preceding hypoxia. The left hemisphere was used for histopathology and immunohistochemistry and the right hemisphere was used for in situ zymography in the corpus striatum; gene expression and the activity of various relevant biofactors were measured in the frontal cortex. There was an increase in the net matrix metalloproteinase gelatinolytic activity in the corpus striatum from piglets resuscitated with 100% oxygen vs. 21%. Hematoxylin-eosin (HE) staining revealed no significant changes. Nine hours after oxygen-assisted resuscitation, caspase-3 expression and activity was increased by 30-40% in the 100% O-2 group (n = 9/10) vs. the 21% O-2 group (n = 10; p<0.04), whereas brain-derived neurotrophic factor (BDNF) activity was decreased by 65% p<0.03. Conclusions: The use of 100% oxygen for resuscitation resulted in increased potentially harmful proteolytic activities and attenuated BDNF activity when compared with 21%. Although there were no significant changes in short term cell loss, hyperoxia seems to cause an early imbalance between neuroprotective and neurotoxic mechanisms that might compromise the final pathological outcome.	[Solberg, Ronnaug; Andresen, Jannicke H.; Wright, Marianne S.; Saugstad, Ola Didrik] Univ Oslo, Dept Paediat Res, Oslo, Norway; [Solberg, Ronnaug; Andresen, Jannicke H.; Wright, Marianne S.; Saugstad, Ola Didrik] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [Solberg, Ronnaug; Andresen, Jannicke H.] Univ Oslo, Dept Surg Res, Oslo, Norway; [Solberg, Ronnaug] Vestfold Cent Hosp, Dept Pediat, Tonsberg, Norway; [Loberg, Else Marit] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Charrat, Eliane; Khrestchatisky, Michel; Rivera, Santiago] Univ Aix Marseille 2, Fac Med, CNRS, UMR NICN 6184, F-13284 Marseille 07, France	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Solberg, R (corresponding author), Univ Oslo, Dept Paediat Res, Oslo, Norway.	ronnaug.solberg@medisin.uio.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254	Health South-East Research Foundation, Norway; Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod	Health South-East Research Foundation, Norway; Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod	This work was supported by Health South-East Research Foundation, Norway and Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; Andresen JH, 2009, J MATERN-FETAL NEO M, V22, P161, DOI 10.1080/14767050802663186; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; CANDELARIOJALIL E, 2008, NEUROSCIENCE; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chiang MC, 2007, NEUROSCI LETT, V421, P67, DOI 10.1016/j.neulet.2007.05.024; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Geddes R, 2001, DEV NEUROSCI-BASEL, V23, P180, DOI 10.1159/000046140; Gerstner B, 2006, J NEUROSCI RES, V84, P306, DOI 10.1002/jnr.20880; Gill MB, 2008, J NEUROSCI RES, V86, P3584, DOI 10.1002/jnr.21795; Greenwood K, 2000, PEDIATR RES, V48, P346, DOI 10.1203/00006450-200009000-00014; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jantzie LL, 2008, RESUSCITATION, V77, P111, DOI 10.1016/j.resuscitation.2007.10.008; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Markus T, 2007, PEDIATR RES, V62, P71, DOI 10.1203/PDR.0b013e31811ead6e; Mattson MP, 2002, AGEING RES REV, V1, pIII; Mendoza-Paredes A, 2008, RESUSCITATION, V76, P261, DOI 10.1016/j.resuscitation.2007.07.022; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Munkeby BH, 2005, PEDIATR RES, V58, P542, DOI 10.1203/01.PDR.0000179407.46810.2D; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nikolaou KE, 2006, ANN NY ACAD SCI, V1092, P426, DOI 10.1196/annals.1365.041; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; O'Brien FE, 2006, PEDIATRICS, V117, P1549, DOI 10.1542/peds.2005-1649; Presti AL, 2006, PEDIATR RES, V60, P55, DOI 10.1203/01.pdr.0000223766.98760.88; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Ranasinghe HS, 2009, NEUROSCIENCE, V158, P732, DOI 10.1016/j.neuroscience.2008.07.069; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; RIVERA S, 2010, J NEUROSCIE IN PRESS; Roohey T, 1997, EARLY HUM DEV, V47, P115, DOI 10.1016/S0378-3782(96)01773-2; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Solberg R, 2010, PEDIATR RES, V67, P250, DOI 10.1203/PDR.0b013e3181cde843; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Takizawa Y, 2006, BRAIN RES, V1095, P200, DOI 10.1016/j.brainres.2006.04.027; Tanaka H, 2004, J NEUROSCI, V24, P2750, DOI 10.1523/JNEUROSCI.5475-03.2004; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	58	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14261	10.1371/journal.pone.0014261	http://dx.doi.org/10.1371/journal.pone.0014261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151608	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800003
J	Blanco-Toribio, A; Muyldermans, S; Frankel, G; Fernandez, LA				Blanco-Toribio, Ana; Muyldermans, Serge; Frankel, Gad; Angel Fernandez, Luis			Direct Injection of Functional Single-Domain Antibodies from E. coli into Human Cells	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEM; ATTENUATED SALMONELLA; CHAIN ANTIBODIES; MAMMALIAN-CELLS; GENOME SEQUENCE; PROTEINS; DELIVERY; THERAPY; CANCER	Intracellular proteins have a great potential as targets for therapeutic antibodies (Abs) but the plasma membrane prevents-access to these antigens. Ab fragments and IgGs are selected and engineered in E. coli and this microorganism may be also an ideal vector for their intracellular delivery. In this work we demonstrate that single-domain Ab (sdAbs) can be engineered to be injected into human cells by E. coli bacteria carrying molecular syringes assembled by a type III protein secretion system (T3SS). The injected sdAbs accumulate in the cytoplasm of HeLa cells at levels ca. 10(5) -10(6) molecules per cell and their functionality is shown by the isolation of sdAb-antigen complexes. Injection of sdAbs does not require bacterial invasion or the transfer of genetic material. These results are proof-of-principle for the capacity of E. coli bacteria to directly deliver intracellular sdAbs (intrabodies) into human cells for analytical and therapeutic purposes.	[Blanco-Toribio, Ana; Angel Fernandez, Luis] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid, Spain; [Muyldermans, Serge] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Muyldermans, Serge] Vrije Univ Brussel, Dept Mol & Cellular Interact, Brussels, Belgium; [Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Imperial College London	Blanco-Toribio, A (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus Cantoblanco Univ Autonoma Madrid, Madrid, Spain.	lafdez@cnb.csic.es	Muyldermans, Serge/AAC-7374-2019; Muyldermans, Serge V/C-6418-2016; Fernández-Herrero, Luis Ángel/AAA-2583-2021; Fernández, Luis Ángel/D-2713-2009	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Fernández-Herrero, Luis Ángel/0000-0001-5920-0638; Fernández, Luis Ángel/0000-0001-5920-0638	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-05201]; European Union [FP6-LSHB-CT-2005-512061]; Wellcome Trust; Royal Society-CSIC [2004GB0017]; Autonomous Community of Madrid [S-BIO-236-2006]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Wellcome Trust(Wellcome Trust); Royal Society-CSIC; Autonomous Community of Madrid	This work was supported by grants to LAF from the Spanish Ministry of Science and Innovation (MICINN) (BIO2008-05201). ABT is a holder of a PhD fellowship from the FPI Program of the Spanish MICINN (http://www.micinn.es/portal/site/MICINN/), Autonomous Community of Madrid (S-BIO-236-2006) (http://www.madrimasd.org/), and the VI Framework Program from the European Union (FP6-LSHB-CT-2005-512061 NoE "EuroPathogenomics") (http://www.noe-epg.uni-wuerzburg.de/). GF is supported by the Wellcome Trust (http://www.wellcome.ac.uk/). This work was partially supported by a Royal Society-CSIC joint grant to GF and LAF (2004GB0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717; Fernandez LA, 2004, CURR OPIN BIOTECH, V15, P364, DOI 10.1016/j.copbio.2004.06.004; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; FORBES NS, 2010, ENG PERFECT BACTERIA; Fraile S, 2004, MOL MICROBIOL, V53, P1109, DOI 10.1111/j.1365-2958.2004.04205.x; Friedlos F, 2008, CLIN CANCER RES, V14, P4259, DOI 10.1158/1078-0432.CCR-07-4800; Fu W, 2008, CANCER SCI, V99, P1172, DOI 10.1111/j.1349-7006.2008.00808.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Henker J, 2008, Z GASTROENTEROL, V46, P874, DOI 10.1055/s-2008-1027463; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lewis GK, 2007, EXPERT REV VACCINES, V6, P431, DOI 10.1586/14760584.6.3.431; Lo A. S. -Y., 2008, V181, P343; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McGonigal K, 2009, APPL BIOCHEM BIOTECH, V157, P226, DOI 10.1007/s12010-008-8266-4; Munera D, 2010, J BACTERIOL, V192, P3534, DOI 10.1128/JB.00046-10; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nishikawa H, 2006, J CLIN INVEST, V116, P1946, DOI 10.1172/JCI28045; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Russmann H, 2003, INFECT IMMUN, V71, P3463, DOI 10.1128/IAI.71.6.3463-3472.2003; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SCHEELE JS, 1995, P NATL ACAD SCI USA, V92, P1097, DOI 10.1073/pnas.92.4.1097; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Singh R, 2006, EXPERT REV VACCINES, V5, P541, DOI 10.1586/14760584.5.4.541; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Stritzker J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-94; Sunden F, 2006, INT J ANTIMICROB AG, V28, pS26, DOI 10.1016/j.ijantimicag.2006.05.007; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Whale AD, 2007, MICROBIOL-SGM, V153, P1743, DOI 10.1099/mic.0.2006/004325-0; Wu Y, 2004, INFECT IMMUN, V72, P6764, DOI 10.1128/IAI.72.12.6764-6772.2004; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; ZHU X, 2010, CANC SCI	77	40	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15227	10.1371/journal.pone.0015227	http://dx.doi.org/10.1371/journal.pone.0015227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170340	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100032
J	Yang, CR; Miao, DQ; Zhang, QH; Guo, L; Tong, JS; Wei, YC; Huang, X; Hou, Y; Schatten, H; Liu, ZH; Sun, QY				Yang, Cai-Rong; Miao, De-Qiang; Zhang, Qing-Hua; Guo, Lei; Tong, Jing-Shan; Wei, Yanchang; Huang, Xin; Hou, Yi; Schatten, Heide; Liu, ZhongHua; Sun, Qing-Yuan			Short-term Preservation of Porcine Oocytes in Ambient Temperature: Novel Approaches	PLOS ONE			English	Article							IN-VITRO MATURATION; EARLY EMBRYO DEVELOPMENT; GERMINAL VESICLE STAGE; PIG OOCYTES; DEVELOPMENTAL COMPETENCE; ADENOSINE-TRIPHOSPHATE; CUMULUS CELLS; ACTIVE MITOCHONDRIA; MEIOTIC MATURATION; CORTICAL GRANULES	The objective of this study was to evaluate the feasibility of preserving porcine oocytes without freezing. To optimize preservation conditions, porcine cumulus-oocyte complexes (COCs) were preserved in TCM-199, porcine follicular fluid (pFF) and FCS at different temperatures (4 degrees C, 20 degrees C, 25 degrees C, 27.5 degrees C, 30 degrees C and 38.5 degrees C) for 1 day, 2 days or 3 days. After preservation, oocyte morphology, germinal vesicle (GV) rate, actin cytoskeleton organization, cortical granule distribution, mitochondrial translocation and intracellular glutathione level were evaluated. Oocyte maturation was indicated by first polar body emission and spindle morphology after in vitro culture. Strikingly, when COCs were stored at 27.5 degrees C for 3 days in pFF or FCS, more than 60% oocytes were still arrested at the GV stage and more than 50% oocytes matured into MII stages after culture. Almost 80% oocytes showed normal actin organization and cortical granule relocation to the cortex, and approximately 50% oocytes showed diffused mitochondria distribution patterns and normal spindle configurations. While stored in TCM-199, all these criteria decreased significantly. Glutathione (GSH) level in the pFF or FCS group was higher than in the TCM-199 group, but lower than in the non-preserved control group. The preserved oocytes could be fertilized and developed to blastocysts (about 10%) with normal cell number, which is clear evidence for their retaining the developmental potentiality after 3d preservation. Thus, we have developed a simple method for preserving immature pig oocytes at an ambient temperature for several days without evident damage of cytoplasm and keeping oocyte developmental competence.	[Yang, Cai-Rong; Miao, De-Qiang; Zhang, Qing-Hua; Guo, Lei; Tong, Jing-Shan; Wei, Yanchang; Huang, Xin; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Cai-Rong; Liu, ZhongHua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; University of Missouri System; University of Missouri Columbia	Yang, CR (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	liu086@yahoo.com; sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021; Miao, Deqiang/F-1226-2015	Yang, Cairong/0000-0001-9594-0529; Miao, Deqiang/0000-0001-9731-9322; Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30930065, 30570944]; Major State Basic Research Program [2006CB944001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (30930065, 30570944), and Major State Basic Research Program to QYS (2006CB944001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg LK, 1997, DEVELOPMENT, V124, P1845; Brad AM, 2003, MOL REPROD DEV, V64, P492, DOI 10.1002/mrd.10254; Brevini TAL, 2007, ANIM REPROD SCI, V98, P23, DOI 10.1016/j.anireprosci.2006.10.018; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; Brevini TAL, 2004, EUR J HISTOCHEM, V48, P347; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; DIDION BA, 1990, J ANIM SCI, V68, P2803; FUNAHASHI H, 1994, BIOL REPROD, V51, P633, DOI 10.1095/biolreprod51.4.633; Gasparrini B, 2006, THERIOGENOLOGY, V65, P275, DOI 10.1016/j.theriogenology.2005.05.036; Gosden R, 1997, BIOESSAYS, V19, P875, DOI 10.1002/bies.950191007; Han D, 2008, MOL REPROD DEV, V75, P838, DOI 10.1002/mrd.20823; Hao ZD, 2009, REPROD FERT DEVELOP, V21, P323, DOI 10.1071/RD08157; Herrick JR, 2003, ANIM REPROD SCI, V78, P123, DOI 10.1016/S0378-4320(03)00081-2; JIANG Q, 1992, J NE AGR COLL, V23, P3; Kim HJ, 2006, J REPROD DEVELOP, V52, P633, DOI 10.1262/jrd.17103; Ledda S, 2007, REPROD FERT DEVELOP, V19, P13, DOI 10.1071/RD06126; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu RH, 2003, ZYGOTE, V11, P299, DOI 10.1017/S0967199403002351; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; SHA W, FERTIL STERIL, V93, P1650; Shi LY, 2007, ANIM REPROD SCI, V100, P128, DOI 10.1016/j.anireprosci.2006.06.020; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sun QY, 2001, MOL REPROD DEV, V60, P481, DOI 10.1002/mrd.1113; Sun XS, 2004, MOL REPROD DEV, V69, P228, DOI 10.1002/mrd.20123; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; TSAFRIRI A, 1975, ENDOCRINOLOGY, V96, P922, DOI 10.1210/endo-96-4-922; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang WH, 1999, BIOL REPROD, V60, P1020, DOI 10.1095/biolreprod60.4.1020; Wang WH, 2000, BIOL REPROD, V62, P1177, DOI 10.1095/biolreprod62.5.1177; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Wessel GM, 2002, DEVELOPMENT, V129, P4315; Wu CH, 2006, MOL REPROD DEV, V73, P1454, DOI 10.1002/mrd.20579; Xu BZ, 2009, ANIM REPROD SCI, V111, P17, DOI 10.1016/j.anireprosci.2008.02.010; Yang X, 1998, THERIOGENOLOGY, V49, P471, DOI 10.1016/S0093-691X(97)00419-6; YOSHIDA M, 1993, BIOL REPROD, V49, P89, DOI 10.1095/biolreprod49.1.89; Zhou GB, 2009, MOL HUM REPROD, V15, P279, DOI 10.1093/molehr/gap016	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14242	10.1371/journal.pone.0014242	http://dx.doi.org/10.1371/journal.pone.0014242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151922	gold, Green Published, Green Submitted			2022-12-25	WOS:000285041800003
J	Wang, LR; Wang, X; Chen, J; Yang, ZY; Yu, LA; Hu, LH; Shen, X				Wang, Lirui; Wang, Xu; Chen, Jing; Yang, Zhengyi; Yu, Liang; Hu, Lihong; Shen, Xu			Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEPATIC STELLATE CELLS; I RECEPTOR KINASE; APOPTOSIS; INHIBITOR; 2C-ALPHA; RATS; 2C; PROLIFERATION; AMPLIFICATION	Background: Over-activation of TGF beta signaling pathway and uncontrolled cell proliferation of hepatic stellate cells (HSCs) play pivotal roles in liver fibrogenesis, while the protein serine/threonine phosphatase PP2C alpha was reported to negatively regulate TGF beta signaling pathway and cell cycle. Our study aimed to investigate the role of PP2C alpha in liver fibrogenesis. Methodology/Principal Findings: The effects of PP2C alpha activation on liver fibrosis were investigated in human HSCs and primary rat HSCs in vitro using western blotting, real-time PCR, nuclear translocation, cell viability and cell cycle analyses. The antifibrogenic effects in carbon tetrachloride (CCl4)-and bile duct ligation (BDL)-induced mice in vivo were assessed using biochemical, histological and immunohistochemical analyses. The results demonstrated that activation of PP2C alpha by overexpression or the new discovered small molecular activator NPLC0393 terminated TGF beta-Smad3 and TGF beta-p38 signaling pathways, induced cell cycle arrest in HSCs and decreased alpha-smooth muscle actin (alpha-SMA) expression, collagen deposition and hepatic hydroxyproline (HYP) level in CCl4- and BDL-induced mice. Conclusions/Significance: Our findings suggested that PP2C alpha activation might be an attractive new strategy for treating liver fibrosis while the small molecular activator NPLC0393 might represent a lead compound for antifibrogenic drug development. Moreover, our study might provide the first evidence for the role of PP2C family members in the fibrotic disease.	[Wang, Lirui; Wang, Xu; Chen, Jing; Yang, Zhengyi; Yu, Liang; Hu, Lihong; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University	Wang, LR (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	simmhlh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn			State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National Natural Science Foundation of China [30925040, 30890044, 10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; Science foundation of Shanghai [08431902900]; E-Institutes of Shanghai Municipal Education Commission [E09013]; Foundation of Chinese Academy of Sciences [KSCX2-YW-R-168, SCX1-YW-02-2]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; Science foundation of Shanghai(Natural Science Foundation of Shanghai); E-Institutes of Shanghai Municipal Education Commission; Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Program of Basic Research of China (grants 2010CB912501, 2007CB914304, 2009CB918502), the National Natural Science Foundation of China (grants 30925040, 30890044, 10979072), Key New Drug Creation and Manufacturing Program (2009ZX09301-001), Science foundation of Shanghai (08431902900), E-Institutes of Shanghai Municipal Education Commission (E09013) and Foundation of Chinese Academy of Sciences (grants KSCX2-YW-R-168, SCX1-YW-02-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen JC, 2000, AM J CHINESE MED, V28, P175, DOI 10.1142/S0192415X00000222; CHEN MH, 2007, J INTEGRATED CHINESE, V9, P1; Chen MH, 2008, J ETHNOPHARMACOL, V117, P309, DOI 10.1016/j.jep.2008.02.009; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Dietrich C, 1997, EXP CELL RES, V232, P72, DOI 10.1006/excr.1997.3507; FENG YLH, 2005, HELV CHIM ACTA, V88, P1126; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lammers T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-65; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lin CC, 2000, AM J CHINESE MED, V28, P87, DOI 10.1142/S0192415X00000118; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; LIU Q, J STEROID BIOCH MOL, V120, P155; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Planaguma A, 2005, FASEB J, V19, P1120, DOI 10.1096/fj.04-2753fje; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sun T, 2006, CYTOKINE, V35, P88, DOI 10.1016/j.cyto.2006.07.013; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wasser S., 1999, Annals Academy of Medicine Singapore, V28, P109; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	47	20	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14230	10.1371/journal.pone.0014230	http://dx.doi.org/10.1371/journal.pone.0014230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151953	gold, Green Submitted, Green Published			2022-12-25	WOS:000284995300002
J	Lv, J; Qiao, H; Liu, HB; Wu, XT; Zhu, JA; Su, JZ; Wang, F; Cui, Y; Zhang, Y				Lv, Jie; Qiao, Hong; Liu, Hongbo; Wu, Xueting; Zhu, Jiang; Su, Jianzhong; Wang, Fang; Cui, Ying; Zhang, Yan			Discovering Cooperative Relationships of Chromatin Modifications in Human T Cells Based on a Proposed Closeness Measure	PLOS ONE			English	Article							HISTONE MODIFICATION PATTERNS; DNA METHYLATION; GENE-EXPRESSION; GENOME-WIDE; CPG ISLANDS; SEMANTIC SIMILARITY; GO TERMS; TRANSCRIPTION; BINDING; EPIGENETICS	Background: Eukaryotic transcription is accompanied by combinatorial chromatin modifications that serve as functional epigenetic markers. Composition of chromatin modifications specifies histone codes that regulate the associated gene. Discovering novel chromatin regulatory relationships are of general interest. Methodology/Principal Findings: Based on the premise that the interaction of chromatin modifications is hypothesized to influence CpG methylation, we present a closeness measure to characterize the regulatory interactions of epigenomic features. The closeness measure is applied to genome-wide CpG methylation and histone modification datasets in human CD4+T cells to select a subset of potential features. To uncover epigenomic and genomic patterns, CpG loci are clustered into nine modules associated with distinct chromatin and genomic signatures based on terms of biological function. We then performed Bayesian network inference to uncover inherent regulatory relationships from the feature selected closeness measure profile and all nine module-specific profiles respectively. The global and module-specific network exhibits topological proximity and modularity. We found that the regulatory patterns of chromatin modifications differ significantly across modules and that distinct patterns are related to specific transcriptional levels and biological function. DNA methylation and genomic features are found to have little regulatory function. The regulatory relationships were partly validated by literature reviews. We also used partial correlation analysis in other cells to verify novel regulatory relationships. Conclusions/Significance: The interactions among chromatin modifications and genomic elements characterized by a closeness measure help elucidate cooperative patterns of chromatin modification in transcriptional regulation and help decipher complex histone codes.	[Lv, Jie; Liu, Hongbo; Wu, Xueting; Zhu, Jiang; Su, Jianzhong; Wang, Fang; Cui, Ying; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Qiao, Hong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Lv, J (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	yanyou1225@yahoo.com.cn	Liu, Hongbo/M-2162-2015; Lyu, Jie/AAP-4077-2020	Liu, Hongbo/0000-0002-0733-8616; Lyu, Jie/0000-0002-6530-5257	National High Tech Development Project of China; 863 Program [2007AA02Z329]; National Natural Science Foundation of China [61075023, 30971645]; Harbin Medical University for Graduate Students [HCXS2010011]	National High Tech Development Project of China(National High Technology Research and Development Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Medical University for Graduate Students	This work was supported in part by the National High Tech Development Project of China, the 863 Program (No. 2007AA02Z329; http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), National Natural Science Foundation of China (Nos. 61075023, 30971645; http://www.nsfc.gov.cn/Portal0/default106.htm) and the Innovation Fund of Harbin Medical University for Graduate Students (No. HCXS2010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2007, EPIGENETICS-US, V2, P227, DOI 10.4161/epi.2.4.5231; Allen ML, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-51; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Choi JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013020; Chung CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009320; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x; Garfinkel Mark D, 2004, Methods Mol Biol, V287, P151; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herranz Michel, 2007, Methods Mol Biol, V361, P25; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hsieh TF, 2005, ANNU REV PLANT BIOL, V56, P327, DOI 10.1146/annurev.arplant.56.032604.144118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; JUNG I, 2009, IBC, V1, P1; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kondo Y, 2009, YONSEI MED J, V50, P455, DOI 10.3349/ymj.2009.50.4.455; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Lv J, 2010, COMPUT BIOL MED, V40, P159, DOI 10.1016/j.compbiomed.2009.11.012; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Su JZ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp882; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006792; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14219	10.1371/journal.pone.0014219	http://dx.doi.org/10.1371/journal.pone.0014219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151929	Green Published, Green Submitted, gold			2022-12-25	WOS:000284939600012
J	Yin, XL; Hou, TW; Liu, Y; Chen, J; Yao, ZY; Ma, CQ; Yang, LJ; Wei, L				Yin, Xiaolin; Hou, Tianwen; Liu, Ying; Chen, Jing; Yao, Zhiyan; Ma, Cuiqing; Yang, Lijuan; Wei, Lin			Association of Toll-Like Receptor 4 Gene Polymorphism and Expression with Urinary Tract Infection Types in Adults	PLOS ONE			English	Article							BLADDER EPITHELIAL-CELLS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; SUSCEPTIBILITY; INTERLEUKIN-8; CXCR1; POLYSACCHARIDES; PYELONEPHRITIS; RECRUITMENT; INNATE	Background: Innate immunity of which Toll-like receptor (TLR) 4 and CXCR1 are key elements plays a central role in the development of urinary tract infection (UTI). Although the relation between the genetics of TLR4 and CXCR1 and UTI is investigated partly, the polymorphisms and expression of TLR4 and CXCR1 in different types of UTI in adults are not extremely clear. Methodology/Principal Findings: This study investigates the presence of TLR4 A (896) G and CXCR1 G (2608) C polymorphisms in 129 UTI patients using RFLP-PCR. Gene and allelic prevalence were compared with 248 healthy controls. Flow cytometry was used to detect TLR4 and CXCR1 expression in the monocytes of UTI patients and healthy controls. TLR4 (896) AG genotype and TLR4 (896) G allele had higher prevalence in UTI (especially in acute cystitis and urethritis) patients, whereas CXCR1 (2608) GC genotype and CXCR1 (2608) C allele had lower prevalence in UTI patients than controls. TLR4 expression was significantly lower in chronic UTI patients than in acute pyelonephritis or healthy controls. CXCR1 expression was similar in both controls and patients. TLR4 expression in chronic UTI patients after astragalus treatment was higher than pre-treatment. Conclusions: The results indicate the relationship between the carrier status of TLR4 (896) G alleles and the development of UTI, especially acute cystitis and urethritis, in adults. TLR4 expression levels are correlated with chronic UTI.	[Yin, Xiaolin; Liu, Ying; Yao, Zhiyan; Ma, Cuiqing; Yang, Lijuan; Wei, Lin] Hebei Med Univ, Dept Immunol, Shijiazhuan, Peoples R China; [Hou, Tianwen; Chen, Jing] Bethune Int Peace Hosp, Dept Lab Med, Shijiazhuan, Peoples R China	Hebei Medical University	Yin, XL (corresponding author), Hebei Med Univ, Dept Immunol, Shijiazhuan, Peoples R China.	weilin_212603@yahoo.com						Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Miyazaki J, 2006, BJU INT, V97, P860, DOI 10.1111/j.1464-410X.2006.06026.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; Song J, 2008, EUR J CLIN INVEST, V38, P21, DOI 10.1111/j.1365-2362.2008.02005.x; Song J, 2008, CURR OPIN MICROBIOL, V11, P66, DOI 10.1016/j.mib.2007.12.001; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Song JM, 2009, P NATL ACAD SCI USA, V106, P14966, DOI 10.1073/pnas.0900527106; Szebeni B, 2006, J PEDIATR GASTR NUTR, V42, P27, DOI 10.1097/01.mpg.0000192246.47959.b2; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yin XL, 2010, BIOCHEM BIOPH RES CO, V397, P232, DOI 10.1016/j.bbrc.2010.05.090; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	26	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14223	10.1371/journal.pone.0014223	http://dx.doi.org/10.1371/journal.pone.0014223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151974	Green Published, gold, Green Submitted			2022-12-25	WOS:000284939600016
J	Achoui, M; Appleton, D; Abdulla, MA; Awang, K; Mohd, MA; Mustafa, MR				Achoui, Mouna; Appleton, David; Abdulla, Mahmood Ameen; Awang, Khalijah; Mohd, Mustafa Ali; Mustafa, Mohd Rais			In Vitro and In Vivo Anti-Inflammatory Activity of 17-O-Acetylacuminolide through the Inhibition of Cytokines, NF-kappa B Translocation and IKK beta Activity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING ACTIVITY; RAW 264.7 MACROPHAGES; BEAD ARRAY ASSAYS; NITRIC-OXIDE; NATURAL-PRODUCTS; FACTOR-ALPHA; INFLAMMATORY RESPONSE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION	Background and Purpose: 17-O-acetylacuminolide (AA), a diterpenoid labdane, was isolated for the first time from the plant species Neouvaria foetida. The anti-inflammatory effects of this compound were studied both in vitro and in vivo. Experimental Approach: Plant extracts were initially tested against LPS-stimulated release of tumor necrosis factor alpha (TNF-alpha) from murine macrophages (RAW264.7 cells). Based on bioassay-guided fractionation, the active compound was identified as AA. AA was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide synthase (iNOS) expression. The inhibition of a panel of inflammatory cytokines (TNF, IL-1 beta, IL-6, KC, and GM-CSF) by AA was assessed at the expression and the mRNA levels. Moreover, the effect of AA on the translocation of the transcription factor nuclear factor kappa B (NF-kappa B) was evaluated in LPS-stimulated RAW264.7 cells and in TNF-stimulated L929 cells. Subsequently, AA was tested in the inhibitor of NF-kappa B kinase beta (IKK beta) activity assay. Lastly, the anti-inflammatory activity of AA in vivo was evaluated by testing TNF production in LPS-stimulated Balb/c mice. Key Results: AA effectively inhibited TNF-alpha release with an IC(50) of 2.7 mu g/mL. Moreover, AA significantly inhibited both NO production and iNOS expression. It significantly and dose-dependently inhibited TNF and IL-1 beta proteins and mRNA expression; as well as IL-6 and KC proteins. Additionally, AA prevented the translocation of NF-kappa B in both cell lines; suggesting that it is acting at a post receptor level. This was confirmed by AA's ability to inhibit IKKb activity, a kinase responsible for activating NF-kappa B, hence providing an insight on AA's mechanism of action. Finally, AA significantly reduced TNF production in vivo. Conclusions and Implications: This study presents the potential utilization of this compound, as a lead for the development of an anti-inflammatory drug.	[Achoui, Mouna; Appleton, David; Mohd, Mustafa Ali; Mustafa, Mohd Rais] Univ Malaya, Dept Pharmacol, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Dept Mol Med, Kuala Lumpur, Malaysia; [Awang, Khalijah] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Achoui, M (corresponding author), Univ Malaya, Dept Pharmacol, Kuala Lumpur, Malaysia.	rais@um.edu.my	Mustafa, Mohamed R/B-1647-2009; AWANG, KHALIJAH/B-8781-2010; Mohd, Mustafa b Ali/B-9184-2010	Mustafa, Mohamed R/0000-0002-7864-5189; AWANG, KHALIJAH/0000-0001-5971-6570; Mohd, Mustafa b Ali/0000-0002-4220-5384	IPPP [PS094/2009A]; Research University, University of Malaya [RG010/09BIO]	IPPP; Research University, University of Malaya(Universiti Malaya)	This work was supported in part by IPPP grant number (PS094/2009A), and Research University grant number (RG010/09BIO), University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BERGMANN S, 1994, J IMMUNOL, V153, P1736; Cheon MS, 2009, J ETHNOPHARMACOL, V122, P473, DOI 10.1016/j.jep.2009.01.034; Cho JY, 1998, PLANTA MED, V64, P594, DOI 10.1055/s-2006-957528; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; de las Heras B, 2003, CURR TOP MED CHEM, V3, P171; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Dinkova-Kostova AT, 2007, MED CHEM, V3, P261, DOI 10.2174/157340607780620680; Dirsch VM, 1998, PLANTA MED, V64, P423, DOI 10.1055/s-2006-957473; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; Folmer F, 2008, BIOCHEM PHARMACOL, V75, P603, DOI 10.1016/j.bcp.2007.07.044; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fukuzawa M, 1997, IMMUNOPHARMACOLOGY, V36, P49, DOI 10.1016/S0162-3109(96)00160-9; GODAMBE SA, 1993, CYTOKINE, V5, P327, DOI 10.1016/1043-4666(93)90064-C; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; James CD, 2009, BIOMED MICRODEVICES, V11, P693, DOI 10.1007/s10544-008-9281-5; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; LEE IS, 1995, TETRAHEDRON, V51, P21; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami A, 2005, BIOCHEM PHARMACOL, V70, P1330, DOI 10.1016/j.bcp.2005.07.032; Nardini E, 2005, J CELL PHYSIOL, V204, P889, DOI 10.1002/jcp.20360; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; OHMORI Y, 1995, J IMMUNOL, V155, P3593; Palozza P, 2003, NUTR CANCER, V47, P76, DOI 10.1207/s15327914nc4701_10; RALPH P, 1977, J EXP MED, V146, P611, DOI 10.1084/jem.146.2.611; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SETHI G, 2003, TRENDS PHARMACOL SCI, V30, P313; Syahida A, 2006, PHARM BIOL, V44, P50, DOI 10.1080/13880200500530765; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; WARREN MK, 1986, J IMMUNOL, V137, P2281; Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576	48	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15105	10.1371/journal.pone.0015105	http://dx.doi.org/10.1371/journal.pone.0015105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152019	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000284821300017
J	Gvritishvili, AG; Leung, KW; Tombran-Tink, J				Gvritishvili, Anzor G.; Leung, Kar Wah; Tombran-Tink, Joyce			Codon Preference Optimization Increases Heterologous PEDF Expression	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; HIGH-LEVEL EXPRESSION; ORTHOTOPIC OSTEOSARCOMA GROWTH; ESCHERICHIA-COLI; TRANSFER-RNA; ANTITUMOR-ACTIVITY; IN-VIVO; GENE; PROTEINS; PURIFICATION	Pigment epithelium-derived factor (PEDF) is widely known for its neurotrophic and antiangiogenic functions. Efficacy studies of PEDF in animal models are limited because of poor heterologous protein yields. Here, we redesigned the human PEDF gene to preferentially match codon frequencies of E coli without altering the amino acid sequence. Following de novo synthesis, codon optimized PEDF (coPEDF) and the wtPEDF genes were cloned into pET32a containing a 5' thioredoxin sequence (Trx) and the recombinant Trx-coPEDF or Trx-wtPEDF fusion constructs expressed in native and two tRNA augmented E coli hosts - BL21-CodonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP, carrying extra copies of tRNA(arg,ile,leu) and tRNA(arg,pro) genes, respectively. Trx-PEDF fusion proteins were isolated using Ni-NTA metal affinity chromatography and PEDF purified after cleavage with factor X alpha. Protein purity and identity were confirmed by western blot, MALDI-TOF, and UV/CD spectral analyses. Expression of the synthetic gene was similar to 3.4 fold greater (212.7 mg/g; 62.1 mg/g wet cells) and purified yields similar to 4 fold greater (41.1 mg/g; 11.3 mg/g wet cell) than wtPEDF in the native host. A small increase in expression of both genes was observed in hosts supplemented with rare tRNA genes compared to the native host but expression of coPEDF was similar to 3 fold greater than wtPEDF in both native and codon-bias-adjusted E coli strains. Delta Gs at -3 to +50 of the Trx site of both fusion genes were -3.9 kcal/mol. Functionally, coPEDF was equally as effective as wtPEDF in reducing oxidative stress, promoting neurite outgrowth, and blocking endothelial tube formation. These findings suggest that while rare tRNA augmentation and mRNA folding energies can significantly contribute to increased protein expression, preferred codon usage, in this case, is advantageous to translational efficiency of biologically active PEDF in E coli. This strategy will undoubtedly fast forward studies to validate therapeutic utility of PEDF in vivo.	[Gvritishvili, Anzor G.; Leung, Kar Wah; Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gvritishvili, AG (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA.	jttink@aol.com	Leung, Kar Wah/I-3844-2012		Ben Franklin award; David Woods Kemper Foundation; Juvenile Diabetes Research Foundation	Ben Franklin award; David Woods Kemper Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This study was supported by the Ben Franklin award, the David Woods Kemper Foundation, and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; BAZZI MD, 1985, BIOPHYS J, V48, P957, DOI 10.1016/S0006-3495(85)83859-5; BECERRA SP, 1993, J BIOL CHEM, V268, P23148; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; BONEKAMP F, 1985, NUCLEIC ACIDS RES, V13, P4113, DOI 10.1093/nar/13.11.4113; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Cai Y., 2010, J BIOINFORMATICS SEQ, V2, P25; Carstens Carsten-Peter, 2003, Methods Mol Biol, V205, P225; Chang SI, 2007, CANCER EPIDEM BIOMAR, V16, P228, DOI 10.1158/1055-9965.EPI-06-0567; Cinquin O, 2001, MOL BIOCHEM PARASIT, V117, P245, DOI 10.1016/S0166-6851(01)00354-1; Crawford SE, 2001, J CELL SCI, V114, P4421; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deana A, 1998, NUCLEIC ACIDS RES, V26, P4778, DOI 10.1093/nar/26.20.4778; Deng TL, 1997, FEBS LETT, V409, P269, DOI 10.1016/S0014-5793(97)00522-X; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2007, J ORTHOP RES, V25, P1671, DOI 10.1002/jor.20434; Ek ETH, 2007, CLIN EXP METASTAS, V24, P93, DOI 10.1007/s10585-007-9062-1; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Feng L, 2000, BIOCHEMISTRY-US, V39, P15399, DOI 10.1021/bi001076a; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Gluck JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010081; GOLIATH R, 1995, AM J HUM GENET, V57, P962; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Guo Y, 2009, PROTEIN EXPRES PURIF, V65, P230, DOI 10.1016/j.pep.2008.12.013; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Hu XY, 1996, PROTEIN EXPRES PURIF, V7, P289, DOI 10.1006/prep.1996.0041; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; LI JN, 1995, J BACTERIOL, V177, P6593, DOI 10.1128/jb.177.22.6593-6600.1995; Mahtabifard A, 2003, J THORAC CARDIOV SUR, V126, P28, DOI 10.1016/S0022-5223(02)73616-7; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; NAMBIAR KP, 1984, SCIENCE, V223, P1299, DOI 10.1126/science.6322300; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ogata N, 2005, AM J OPHTHALMOL, V140, P937, DOI 10.1016/j.ajo.2005.05.037; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Sanchez-Sanchez F, 2008, J BIOTECHNOL, V134, P193, DOI 10.1016/j.jbiotec.2008.01.005; SANDHU KS, 2008, SILICO BIOL, V8; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Smith DWE, 1996, BIOTECHNOL PROGR, V12, P417, DOI 10.1021/bp950056a; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; TINK JT, 2003, TRENDS MOL MED, V9, P244; TINK JT, 2003, NAT REV NEUROSCI, V4, P628; Tombran-Tink J, 1996, Mol Vis, V2, P11; TOMBRANTINK J, 1994, GENOMICS, V19, P266, DOI 10.1006/geno.1994.1057; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Volpert Katja N, 2009, J Ocul Biol Dis Infor, V2, P1, DOI 10.1007/s12177-009-9014-x; WAHAB SZ, 1993, MOL MICROBIOL, V7, P253, DOI 10.1111/j.1365-2958.1993.tb01116.x; Wang QS, 2006, PREP BIOCHEM BIOTECH, V36, P127, DOI 10.1080/10826060500533927; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Zhang T, 2005, BIOTECHNOL LETT, V27, P403, DOI 10.1007/s10529-005-1549-8; Zhou ZY, 2004, PROTEIN EXPRES PURIF, V34, P87, DOI 10.1016/j.pep.2003.11.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	41	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15056	10.1371/journal.pone.0015056	http://dx.doi.org/10.1371/journal.pone.0015056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152082	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100056
J	Petravic, J; Davenport, MP				Petravic, Janka; Davenport, Miles P.			Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection	PLOS ONE			English	Article							T-CELL DEPLETION; VIRAL LOAD; VIRUS; VIREMIA; HIV-1; LYMPHOCYTES; DYNAMICS	Many studies have shown that vaccines inducing CD8+ T cell responses can reduce viral loads and preserve CD4+ T cell numbers in monkey models of HIV infection. The mechanism of viral control by the vaccine-induced CD8+ T cells is usually assumed to be cytolysis of infected cells. However, in addition to cytolysis of infected cells, CD8+ T cells secrete a range of soluble factors that suppress viral replication. We have studied the dynamics of virus and CD4+ T cells in a successful vaccination-challenge model of SHIV infection. We find that better viral control in the acute phase of infection is associated with slower decay of peak viral load. Comparing viral and CD4+ T cell dynamics in acute infection, we find that a cytolytic mode of viral control with direct killing of infected cells is inconsistent with the observed trends. On the other hand, comparison of the predicted effects of noncytolytic CD8+ effector function with the experimental data shows that noncytolytic control provides a better explanation of the experimental results. Our analysis suggests that vaccine-induced CD8+ T cells control SHIV infection by non-cytolytic means.	[Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia	University of New South Wales Sydney	Petravic, J (corresponding author), Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW, Australia.	m.davenport@unsw.edu.au	Petravic, Janka/AAD-9192-2020	Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work is funded by the National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurali M, 2010, J IMMUNOL, V185, P5093, DOI 10.4049/jimmunol.1002204; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Castelli JC, 2002, BLOOD, V99, P4225, DOI 10.1182/blood-2001-11-0078; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lay MDH, 2009, J VIROL, V83, P7517, DOI 10.1128/JVI.00552-09; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Tomaras GD, 2000, P NATL ACAD SCI USA, V97, P3503, DOI 10.1073/pnas.070521097; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15083	10.1371/journal.pone.0015083	http://dx.doi.org/10.1371/journal.pone.0015083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152101	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100065
J	Simonson, MS; Ismail-Beigi, F				Simonson, Michael S.; Ismail-Beigi, Faramarz			Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPRESSION; FIBROSIS; OVEREXPRESSION; DYSFUNCTION; PHYSIOLOGY; DISCOVERY; RELEASE; GROWTH; INJURY	Endothelin-1 (ET-1), a potent vasoconstrictor, has been implicated in the pathogenesis of collagen accumulation, extracellular matrix remodeling, and renal and cardiac fibrosis in diabetes. However, the mechanism by which ET-1 promotes collagen accumulation remains unclear. Here, we analyzed the gene expression profile of ET-1-stimulated mesangial cells to identify determinants of collagen accumulation. In human mesangial cells (a microvascular pericyte that secretes excess collagen in diabetic glomerulosclerosis), ET-1 increased mRNA and protein for MCP-1 (macrophage chemoattractant protein-1) and IL-6. ET-1-induced MCP-1 and IL-6 mRNAs and proteins were blocked by an ETA (but not ETB) receptor antagonist. ET-1/ETA receptor signaling evoked a 7.4-fold increase in collagen accumulation. Exogenous addition of either recombinant MCP-1 or IL-6 increased collagen accumulation by 3.5-fold. Co-stimulation with both MCP-1 and IL-6 did not elevate collagen accumulation further. Neither an MCP-1-neutralizing antibody nor an MCP-1 receptor antagonist inhibited ET-1-induced collagen accumulation. Similarly, neutralizing antibodies against IL-6 or the gp130 subunit of the IL-6 receptor did not attenuate ET-1-induced collagen accumulation. However, co-incubation with MCP-1- and IL-6-neutralizing antibodies inhibited ET-1-induced collagen accumulation by 52%, suggesting a robust autocrine loop wherein MCP-1 and IL-6 are redundant. Taken together, these results demonstrate that an autocrine signaling loop involving MCP-1 and IL-6 contributes to ET-1-induced collagen accumulation.	[Simonson, Michael S.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Simonson, MS (corresponding author), Case Western Reserve Univ, Dept Med, Biomed Res Bldg 427,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mss5@case.edu			Rosenberg Foundation of the Centers for Dialysis Care; Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University	Rosenberg Foundation of the Centers for Dialysis Care; Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University	This work was supported by the Rosenberg Foundation of the Centers for Dialysis Care and the Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University.	Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benigni A, 1998, DIABETES, V47, P450, DOI 10.2337/diabetes.47.3.450; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhein S, 2000, J PHARMACOL EXP THER, V293, P351; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Gagliardini E, 2009, AM J PHYSIOL-RENAL, V297, pF1448, DOI 10.1152/ajprenal.00340.2009; Hocher B, 2001, NEPHRON, V87, P161, DOI 10.1159/000045906; Hocher B, 1997, J CLIN INVEST, V99, P1380, DOI 10.1172/JCI119297; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mishra R, 2003, AM J PHYSIOL-CELL PH, V285, pC1109, DOI 10.1152/ajpcell.00105.2003; Mishra R, 2002, AM J PHYSIOL-RENAL, V283, pF1151, DOI 10.1152/ajprenal.00103.2002; Mishra R, 2008, ARTERIOSCL THROM VAS, V28, P541, DOI 10.1161/ATVBAHA.107.157339; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Sasser JM, 2007, J AM SOC NEPHROL, V18, P143, DOI 10.1681/ASN.2006030208; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Shindo T, 2002, J MOL MED, V80, P105, DOI 10.1007/s00109-001-0284-4; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; Simonson M., 2001, HANDB EXP PHARM, P115; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; Sodhi CP, 2001, AM J PHYSIOL-RENAL, V280, pF667, DOI 10.1152/ajprenal.2001.280.4.F667; Solini A, 2007, GROWTH FACTORS, V25, P392, DOI 10.1080/08977190801892341; Sorokin A, 2003, AM J PHYSIOL-RENAL, V285, pF579, DOI 10.1152/ajprenal.00019.2003; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sutcliffe AM, 2009, BRIT J PHARMACOL, V157, P436, DOI 10.1111/j.1476-5381.2009.00143.x; Watson AMD, 2010, DIABETOLOGIA, V53, P192, DOI 10.1007/s00125-009-1540-3; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang LL, 2004, CIRCULATION, V109, P255, DOI 10.1161/01.CIR.0000105701.98663.D4	39	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11003	11008		10.1074/jbc.M110.190793	http://dx.doi.org/10.1074/jbc.M110.190793			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21169360	Green Published, hybrid			2022-12-25	WOS:000288797100012
J	Kong, RR; Zhang, LL; Hu, LL; Peng, QH; Han, W; Du, XJ; Ke, Y				Kong, Ruirui; Zhang, Liangliang; Hu, Lelin; Peng, Qunhui; Han, Wei; Du, Xiaojuan; Ke, Yang			hALP, A Novel Transcriptional U Three Protein (t-UTP), Activates RNA Polymerase I Transcription by Binding and Acetylating the Upstream Binding Factor (UBF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; NUCLEOLAR TRANSCRIPTION; RDNA TRANSCRIPTION; GENE-TRANSCRIPTION; COMPLEX SL1; HUMAN-CELLS; PHOSPHORYLATION; PROMOTER; RECRUITMENT; SUBUNIT	Transcription of ribosome RNA precursor (pre-rRNA) and pre-rRNA processing are coordinated by a subset of U three proteins (UTPs) known as transcriptional UTPs (t-UTPs), which participate in pre-rRNA transcription in addition to participation in 18 S rRNA processing. However, the mechanism by which t-UTPs function in pre-rRNA transcription remains undetermined. In the present study, we identified hALP, a histone acetyl-transferase as a novel t-UTP. We first showed that hALP is nucleolar, and is associated with U3 snoRNA and required for 18 S rRNA processing. Moreover, depletion of hALP resulted in a decreased level of 47 S pre-rRNA. Ectopic expression of hALP activated the rDNA promoter luciferase reporter and knockdown of hALP inhibited the reporter. In addition, hALP bound rDNA. Taken together these data identify hALP as a novel t-UTP. Immunoprecipitation and GST pulldown experiments showed that hALP binds the upstream binding factor (UBF) in vivo and in vitro. It is of importance that hALP acetylated UBF depending on HAT in vivo, and hALP but not hALP (Delta HAT) facilitated the nuclear translocation of the RNA polymerase I (Pol I)-associated factor 53 (PAF53) from the cytoplasm and promoted the association of UBF with PAF53. Thus, we provide a mechanism in which a novel t-UTP activates Pol I transcription by binding and acetylating UBF.	[Zhang, Liangliang; Hu, Lelin; Han, Wei; Du, Xiaojuan; Ke, Yang] Peking Univ, Canc Res Ctr, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Kong, Ruirui; Peng, Qunhui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Kong, Ruirui; Peng, Qunhui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Genet, Beijing 100142, Peoples R China; [Zhang, Liangliang; Hu, Lelin; Du, Xiaojuan] Peking Univ, Dept Cell Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Canc Res Ctr, Hlth Sci Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 30771224]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131, 2006AA02A402]; National Basic Research Program of China (973 Program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Grants 30571038 and 30771224 from the National Natural Science Foundation of China, Grants 2008AA02Z131 and 2006AA02A402 from the National High Technology Research and Development Program of China (863 Program), and Grant No. 2010CB529303 from the National Basic Research Program of China (973 Program).	Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; CLOS J, 1986, P NATL ACAD SCI USA, V83, P604, DOI 10.1073/pnas.83.3.604; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Guan Li-zhao, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P347; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Halkidou K, 2004, NUCLEIC ACIDS RES, V32, P1654, DOI 10.1093/nar/gkh296; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lin CY, 2006, NUCLEIC ACIDS RES, V34, P4752, DOI 10.1093/nar/gkl581; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; MILLER L, 1969, CHROMOSOMA, V28, P430; MOUGEY EB, 1993, MOL CELL BIOL, V13, P5990, DOI 10.1128/MCB.13.10.5990; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Pluk H, 1998, MOL CELL BIOL, V18, P488, DOI 10.1128/MCB.18.1.488; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhai WG, 1997, GENE DEV, V11, P1605, DOI 10.1101/gad.11.12.1605; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000	57	31	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7139	7148		10.1074/jbc.M110.173393	http://dx.doi.org/10.1074/jbc.M110.173393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177859	Green Published, hybrid			2022-12-25	WOS:000287737300031
J	Yamauchi, Y; Hasegawa, A; Taninaka, A; Mizutani, M; Sugimoto, Y				Yamauchi, Yasuo; Hasegawa, Ayaka; Taninaka, Ai; Mizutani, Masaharu; Sugimoto, Yukihiro			NADPH-dependent Reductases Involved in the Detoxification of Reactive Carbonyls in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAS-CHROMATOGRAPHIC ANALYSIS; LIPID-PEROXIDATION; ALDEHYDE DEHYDROGENASE; ARABIDOPSIS-THALIANA; PROTEIN MODIFICATION; TRANSGENIC PLANTS; GLYOXALASE-I; METHYLGLYOXAL; STRESS; OVEREXPRESSION	Reactive carbonyls, especially alpha,beta-unsaturated carbonyls produced through lipid peroxidation, damage biomolecules such as proteins and nucleotides; elimination of these carbonyls is therefore essential for maintaining cellular homeostasis. In this study, we focused on an NADPH-dependent detoxification of reactive carbonyls in plants and explored the enzyme system involved in this detoxification process. Using acrolein (CH2 = CHCHO) as a model alpha,beta-unsaturated carbonyl, we purified a predominant NADPH-dependent acrolein-reducing enzyme from cucumber leaves, and we identified the enzyme as an alkenal/one oxidoreductase (AOR) catalyzing reduction of an alpha,beta-unsaturated bond. Cloning of cDNA encoding AORs revealed that cucumber contains two distinct AORs, chloroplastic AOR and cytosolic AOR. Homologs of cucumber AORs were found among various plant species, including Arabidopsis, and we confirmed that a homolog of Arabidopsis (At1g23740) also had AOR activity. Phylogenetic analysis showed that these AORs belong to a novel class of AORs. They preferentially reduced alpha,beta-unsaturated ketones rather than alpha,beta-unsaturated aldehydes. Furthermore, we selected candidates of other classes of enzymes involved in NADPH-dependent reduction of carbonyls based on the bioinformatic information, and we found that an aldo-keto reductase (At2g37770) and aldehyde reductases (At1g54870 and At3g04000) were implicated in the reduction of an aldehyde group of saturated aldehydes and methylglyoxal as well as alpha,beta-unsaturated aldehydes in chloroplasts. These results suggest that different classes of NADPH-dependent reductases cooperatively contribute to the detoxification of reactive carbonyls.	[Yamauchi, Yasuo; Hasegawa, Ayaka; Mizutani, Masaharu; Sugimoto, Yukihiro] Kobe Univ, Lab Funct Phytochem, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Taninaka, Ai] Kobe Univ, Fac Agr, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University; Kobe University	Yamauchi, Y (corresponding author), Kobe Univ, Lab Funct Phytochem, Grad Sch Agr Sci, Nada Ku, Rokkodai 1-1, Kobe, Hyogo 6578501, Japan.	yamauchi@kobe-u.ac.jp		Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21658112]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Exploratory Research 21658112 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. Y.).	Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; DENNIS KJ, 1990, LIPIDS, V25, P460, DOI 10.1007/BF02538089; Dick RA, 2001, J BIOL CHEM, V276, P40803, DOI 10.1074/jbc.M105487200; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Forrest GL, 2000, CANCER RES, V60, P5158; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Hanson MR, 2001, J EXP BOT, V52, P529, DOI 10.1093/jexbot/52.356.529; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; KOLB NS, 1994, MOL PHARMACOL, V45, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mano J, 2005, PLANT PHYSIOL, V139, P1773, DOI 10.1104/pp.105.070391; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mano J, 2010, PLANT BIOTECHNOL-NAR, V27, P193, DOI 10.5511/plantbiotechnology.27.193; Mano J, 2009, PLANTA, V230, P639, DOI 10.1007/s00425-009-0964-9; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; Millar AH, 2000, FEBS LETT, V481, P117, DOI 10.1016/S0014-5793(00)01976-1; NIYATISHIRKHODAEE F, 1993, J AGR FOOD CHEM, V41, P227, DOI 10.1021/jf00026a016; Oberschall A, 2000, PLANT J, V24, P437, DOI 10.1046/j.1365-313x.2000.00885.x; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Sommer A, 2001, BIOCHEM J, V353, P445, DOI 10.1042/0264-6021:3530445; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Yadav SK, 2005, FEBS LETT, V579, P6265, DOI 10.1016/j.febslet.2005.10.006; Yamauchi Y, 2002, PLANT CELL PHYSIOL, V43, P1334, DOI 10.1093/pcp/pcf162; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2010, PLANTA, V231, P1077, DOI 10.1007/s00425-010-1112-2; Ye S, 2003, J BACTERIOL, V185, P4144, DOI 10.1128/JB.185.14.4144-4151.2003; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	38	122	132	5	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6999	7009		10.1074/jbc.M110.202226	http://dx.doi.org/10.1074/jbc.M110.202226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169366	Green Published, hybrid			2022-12-25	WOS:000287737300016
J	de Vries, RP; de Vries, E; Moore, KS; Rigter, A; Rottier, PJM; de Haan, CAM				de Vries, Robert P.; de Vries, Erik; Moore, Karen S.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.			Only Two Residues Are Responsible for the Dramatic Difference in Receptor Binding between Swine and New Pandemic H1 Hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY EPITHELIAL-CELLS; INFLUENZA-VIRUS; SWISS-MODEL; SIALIC-ACID; SPECIFICITY; GLYCOSYLATION; TRANSMISSION; ADAPTATION; MICROARRAY; PROTEINS	In view of its critical role in influenza A virus (IAV) tropism and pathogenesis, we evaluated the receptor binding properties of HA proteins of the closely related swine and new pandemic human IAVs. We generated recombinant soluble trimeric H1 ectodomains of several IAVs and analyzed their sialic acid binding properties using fetuin-binding and glycan array analysis. The results show that closely related swine and new pandemic H1 proteins differ dramatically in their ability to bind these receptors. Although new pandemic H1 protein exhibited hardly any binding, swine H1 bound efficiently to a number of alpha 2-6-linked sialyl glycans. The responsible amino acids were identified by analyzing chimeric H1 proteins and by performing systematic site-directed mutagenesis of swine and new pandemic human H1 proteins. The difference was found to map to residues at positions 200 and 227. Although substitution of either residue significantly affected the binding phenotype, substitution of both was found to act synergistically and reverse the phenotype almost completely. Modeling of the T200A and E227A substitutions into the crystal structure of the new pandemic human H1 protein revealed the loss of potential hydrogen bond formation with Gln(191), which is part of the 190-loop of the receptor binding site, and with the penultimate galactose, respectively. Thus, a residue not belonging to the receptor binding site may affect the interaction of HA with its receptor. Interestingly, whereas alanine at position 200 is found in most new pandemic human viruses, the residue at position 227 in these viruses is invariably a glutamic acid.	[de Vries, Robert P.; de Vries, Erik; Moore, Karen S.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands	Utrecht University	de Haan, CAM (corresponding author), Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	c.a.m.dehaan@uu.nl	de Vries, Robert/K-7212-2013	Moore, Kat/0000-0002-5746-4098; de Haan, Cornelis/0000-0002-4459-9874; de Vries, Robert/0000-0002-1586-4464	"Impulse Veterinary Avian Influenza Research" in the Netherlands	"Impulse Veterinary Avian Influenza Research" in the Netherlands	This work was supported by the program "Impulse Veterinary Avian Influenza Research" in the Netherlands.	BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Baz M, 2007, ANTIVIR RES, V74, P159, DOI 10.1016/j.antiviral.2006.10.012; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ilyushina NA, 2010, EMERG INFECT DIS, V16, P314, DOI 10.3201/eid1602.091141; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H., 2010, PLOS CURR, V22, P2	39	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5868	5875		10.1074/jbc.M110.193557	http://dx.doi.org/10.1074/jbc.M110.193557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173148	Green Published, hybrid			2022-12-25	WOS:000287230600095
J	Fang, JD; Chou, HC; Tung, HH; Huang, PY; Lee, SL				Fang, Jung-Da; Chou, Hsiao-Chin; Tung, Hsiu-Hui; Huang, Pao-Yi; Lee, Sheau-Ling			Endogenous Expression of Matriptase in Neural Progenitor Cells Promotes Cell Migration and Neuron Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; HEPATOCYTE GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; BREAST-CANCER CELLS; IN-VITRO; STEM-CELLS; ADULT NEUROGENESIS; BARRIER FUNCTION; ISCHEMIC BRAIN; TUBE CLOSURE	Recent studies show that type II transmembrane serine proteases play important roles in diverse cellular activities and pathological processes. Their expression and functions in the central nervous system, however, are largely unexplored. In this study, we show that the expression of one such member, matriptase (MTP), was cell type-restricted and primarily expressed in neural progenitor (NP) cells and neurons. Blocking MTP expression or MTP activity prevented NP cell traverse of reconstituted basement membrane, whereas overexpression of MTP promoted it. The NP cell mobilization induced by either vascular endothelial growth factor or hepatocyte growth factor was also impaired by knocking down MTP expression. MTP acts upstream of matrix metalloproteinase 2 in promoting NP cell mobility. In embryonic stem cell differentiation to neural cells, MTP knockdown had no effect on entry of embryonic stem cells into the neural lineage. High MTP expression or activity, however, shifts the population dynamics from NP cells toward neurons to favor neuronal differentiation. This is the first report to demonstrate the direct involvement of type II transmembrane serine protease in NP cell function.	[Fang, Jung-Da; Chou, Hsiao-Chin; Tung, Hsiu-Hui; Huang, Pao-Yi; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes Taiwan, R.O.C. [CS-098-PP-09]	National Health Research Institutes Taiwan, R.O.C.(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant CS-098-PP-09 (to S.-L.L.), Taiwan, R.O.C.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Cacci E, 2003, J NEUROSCI RES, V74, P760, DOI 10.1002/jnr.10799; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garzotto D, 2008, J NEUROSCI, V28, P5901, DOI 10.1523/JNEUROSCI.1083-08.2008; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Ito Y, 2006, GLYCOBIOLOGY, V16, P368, DOI 10.1093/glycob/cwj084; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2010, MECH DEVELOP, V127, P82, DOI 10.1016/j.mod.2009.10.004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Ohira K., 2010, CELL MOL LIFE SCI, P1; Parent JM, 1997, J NEUROSCI, V17, P3727; Paxinos G., 2001, MOUSE BRAIN ATLAS; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stallmach R, 2008, BIOCHEM J, V412, P81, DOI 10.1042/BJ20071432; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865	58	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5667	5679		10.1074/jbc.M110.153866	http://dx.doi.org/10.1074/jbc.M110.153866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149451	hybrid, Green Published			2022-12-25	WOS:000287230600076
J	Tanaka, N; Morimoto, Y; Noguchi, Y; Tada, T; Waku, T; Kunugi, S; Morii, T; Lee, YF; Konno, T; Takahashi, N				Tanaka, Naoki; Morimoto, Yumi; Noguchi, Yurika; Tada, Tomoko; Waku, Tomonori; Kunugi, Shigeru; Morii, Takashi; Lee, Yin-Fai; Konno, Takashi; Takahashi, Nobuyuki			The Mechanism of Fibril Formation of a Non-inhibitory Serpin Ovalbumin Revealed by the Identification of Amyloidogenic Core Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-CENTER LOOP; CRYSTAL-STRUCTURE; DISULFIDE BOND; AGGREGATION-PRONE; DENATURED STATE; MUTANT R339T; S-OVALBUMIN; IN-VITRO; POLYMERIZATION; PROTEINS	Ovalbumin (OVA), a non-inhibitory member of the serpin superfamily, forms fibrillar aggregates upon heat-induced denaturation. Recent studies suggested that OVA fibrils are generated by a mechanism similar to that of amyloid fibril formation, which is distinct from polymerization mechanisms proposed for other serpins. In this study, we provide new insights into the mechanism of OVA fibril formation through identification of amyloidogenic core regions using synthetic peptide fragments, site-directed mutagenesis, and limited proteolysis. OVA possesses a single disulfide bond between Cys(73) and Cys(120) in the N-terminal helical region of the protein. Heat treatment of disulfide-reduced OVA resulted in the formation of long straight fibrils that are distinct from the semi-flexible fibrils formed from OVA with an intact disulfide. Computer predictions suggest that helix B (hB) of the N-terminal region, strand 3A, and strands 4-5B are highly beta-aggregation- prone regions. These predictions were confirmed by the fact that synthetic peptides corresponding to these regions formed amyloid fibrils. Site-directed mutagenesis of OVA indicated that V41A substitution in hB interfered with the formation of fibrils. Co-incubation of a soluble peptide fragment of hB with the disulfide-intact full-length OVA consistently promoted formation of long straight fibrils. In addition, the N-terminal helical region of the heat-induced fibril of OVA was protected from limited proteolysis. These results indicate that the heat-induced fibril formation of OVA occurs by a mechanism involving transformation of the N-terminal helical region of the protein to beta-strands, thereby forming sequential intermolecular linkages.	[Tanaka, Naoki; Morimoto, Yumi; Noguchi, Yurika; Tada, Tomoko; Waku, Tomonori; Kunugi, Shigeru] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Morii, Takashi] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Takahashi, Nobuyuki] Kyoto Univ, Grad Sch Agr, Kyoto 6110011, Japan; [Lee, Yin-Fai] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Konno, Takashi] Univ Fukui, Dept Mol Physiol & Biophys, Fukui 9101193, Japan	Kyoto Institute of Technology; Kyoto University; Kyoto University; University of Leicester; University of Fukui	Tanaka, N (corresponding author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	tanaka@kit.ac.jp	Morii, Takashi/AAL-1392-2020	Morii, Takashi/0000-0003-3663-3267	Japanese Ministry of Education, Culture, Sports, Science, and Technology [20550111, 21550154]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-aid for Scientific Research 20550111 and 21550154.	Arii Y, 2002, BIOCHEM J, V363, P403, DOI 10.1042/0264-6021:3630403; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; Broersen K, 2007, BIOMACROMOLECULES, V8, P1648, DOI 10.1021/bm0612283; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Gozu M, 2003, J BIOCHEM, V133, P731, DOI 10.1093/jb/mvg094; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6; Huntington JA, 2009, PRION, V3, P12, DOI 10.4161/pri.3.1.8441; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Knaupp AS, 2010, J MOL BIOL, V396, P375, DOI 10.1016/j.jmb.2009.11.048; Krysmann MJ, 2008, BIOCHEMISTRY-US, V47, P4597, DOI 10.1021/bi8000616; Kuroda Y, 2004, J PEPT SCI, V10, P8, DOI 10.1002/psc.485; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; NEMOTO N, 1993, BIOPOLYMERS, V33, P551, DOI 10.1002/bip.360330405; Onda M, 1997, J BIOL CHEM, V272, P3973, DOI 10.1074/jbc.272.7.3973; Onda M, 2003, J BIOL CHEM, V278, P23600, DOI 10.1074/jbc.M300295200; Onda M, 2008, J BIOL CHEM, V283, P17568, DOI 10.1074/jbc.M709262200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Shirai N, 1997, J BIOCHEM-TOKYO, V121, P787; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; TAKAHASHI N, 1995, GENE, V161, P211, DOI 10.1016/0378-1119(95)00234-W; Takahashi N, 2005, BIOSCI BIOTECH BIOCH, V69, P922, DOI 10.1271/bbb.69.922; TAKAHASHI N, 1992, J BIOL CHEM, V267, P11565; TAKAHASHI N, 1991, J BIOCHEM-TOKYO, V109, P846, DOI 10.1093/oxfordjournals.jbchem.a123469; Takahashi N, 2002, BBA-PROTEINS PROTEOM, V1601, P110, DOI 10.1016/S1570-9639(02)00435-1; Takehara S, 2010, J MOL BIOL, V403, P751, DOI 10.1016/j.jmb.2010.07.047; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Tani F, 1997, PROTEIN SCI, V6, P1491, DOI 10.1002/pro.5560060713; Tani F, 2004, BIOSCI BIOTECH BIOCH, V68, P2466, DOI 10.1271/bbb.68.2466; TATSUMI E, 1994, J BIOL CHEM, V269, P28062; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Weijers M, 2008, BIOMACROMOLECULES, V9, P3165, DOI 10.1021/bm800751e; Yamasaki M, 2003, J BIOL CHEM, V278, P35524, DOI 10.1074/jbc.M305926200; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2010, J BIOL CHEM, V285, P30752, DOI 10.1074/jbc.M110.156042; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	64	36	37	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5884	5894		10.1074/jbc.M110.176396	http://dx.doi.org/10.1074/jbc.M110.176396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156792	Green Published, hybrid			2022-12-25	WOS:000287230600097
J	Bishop, MA; Reynolds, BF; Powers, SP				Bishop, Mary Anne; Reynolds, Brad F.; Powers, Sean P.			An In Situ, Individual-Based Approach to Quantify Connectivity of Marine Fish: Ontogenetic Movements and Residency of Lingcod	PLOS ONE			English	Article							OPHIODON-ELONGATUS; TAGGED LINGCOD; CONSERVATION; MORTALITY; ISLAND	As modern fishery assessments change in an effort to be more accurate and encompass the range of potential ecosystem interactions, critical information on the ecology of species including life history, intra and inter-specific competitive interactions and habitat requirements must be added to the standard fishery-dependent and independent data sets. One species whose movements and habitat associations greatly affects exploitation patterns is lingcod, Ophiodon elongatus, which support an economically important fishery along the coastal waters of the Pacific Coast of North America. High site fidelity and limited movements within nearshore areas are hypothesized to have resulted in high catchability, a major factor that has contributed to overfished stocks. Thus, assessing the level of movement and connectivity among lingcod subpopulations inhabiting nearshore habitats is a prerequisite to determining the condition of lingcod stocks. We used the Pacific Ocean Shelf Tracking (POST) Project acoustic receiver array in Alaska's Prince William Sound to monitor movements and residency of 21 acoustic-tagged lingcod for up to 16 months. Eight of sixteen lingcod (50%) initially aged at 2.5- to 3.5-years-old dispersed from their tag site. Dispersal was highly seasonal, occurring in two, five-week periods from mid-December through January and from mid-April through May. Dispersal in winter may be related to sexually immature lingcod or newly-mature male lingcod being displaced by territorial males. Spring dispersal may be indicative of the onset of migratory behavior where lingcod move out into Prince William Sound and possibly the offshore waters of the Gulf of Alaska. Our results reveal a pattern of ontogenetic dispersal as lingcod approach 4-years-old and exceed 50 cm total length. The large proportion of tagged fish migrating out of Port Gravina, their tagging site, reflects a high level of connectivity among Prince William Sound subpopulations. Our results also support the hypotheses that these subpopulations may be highly susceptible to overfishing because most fish show long residence times.	[Bishop, Mary Anne; Reynolds, Brad F.] Prince William Sound Sci Ctr, Cordova, AK USA; [Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Powers, Sean P.] Ctr Ecosyst Based Fisheries Management, Dauphin Isl, AL USA	Dauphin Island Sea Lab; University of South Alabama	Bishop, MA (corresponding author), Prince William Sound Sci Ctr, Cordova, AK USA.	mbishop@pwssc.org		Powers, Sean/0000-0002-4770-9944	Pacific Ocean Shelf Tracking (POST) Project; Prince William Sound Oil Spill Recovery Institute; Rasmuson Foundation	Pacific Ocean Shelf Tracking (POST) Project; Prince William Sound Oil Spill Recovery Institute; Rasmuson Foundation	Funding for this study was provided by Pacific Ocean Shelf Tracking (POST) Project (www.postcoml.org), Prince William Sound Oil Spill Recovery Institute (www.pws-osri.org) and the Rasmuson Foundation (www.rasmuson.org). The POST Project advised the authors on the Post Gravina acoustic receiver array design and POST maintains ownership of the array. Otherwise, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Brown Evelyn D., 2002, Alaska Fishery Research Bulletin, V9, P75; Brown H, 2010, MAR ECOL PROG SER, V403, P205, DOI 10.3354/meps08465; Cass AJ, 1990, CAN SPEC PUBL FISH A, V109, P40; Gordon David A., 1994, Alaska Fishery Research Bulletin, V1, P140; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; JAGIELO TH, 1990, FISH B-NOAA, V88, P815; JAGIELO TH, 1995, T AM FISH SOC, V124, P170, DOI 10.1577/1548-8659(1995)124<0170:AASOLA>2.3.CO;2; JAGIELO TH, 2005, ASSESSMENT LINGCOD O; King JR, 2005, MOL ECOL, V14, P653, DOI 10.1111/j.1365-294X.2005.02438.x; Logan G., 2005, MANAGEMENT FRAMEWORK; Lowe CG, 2009, MAR COAST FISH, V1, P71, DOI 10.1577/C08-047.1; Martell SJD, 2000, B MAR SCI, V66, P729; MATHEWS SB, 1987, FISH B-NOAA, V85, P153; MATTHEWS KR, 1992, FISH B-NOAA, V90, P784; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; RICHARDS LJ, 1990, CAN J FISH AQUAT SCI, V47, P948, DOI 10.1139/f90-109; SMITH BD, 1990, T AM FISH SOC, V119, P813, DOI 10.1577/1548-8659(1990)119<0813:MAMOTM>2.3.CO;2; Starr RM, 2005, MAR TECHNOL SOC J, V39, P19, DOI 10.4031/002533205787521677; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorson JT, 2010, FISH RES, V101, P38, DOI 10.1016/j.fishres.2009.09.005; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9	24	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14267	10.1371/journal.pone.0014267	http://dx.doi.org/10.1371/journal.pone.0014267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179191	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900003
J	Koh, AY; Mikkelsen, PJ; Smith, RS; Coggshall, KT; Kamei, A; Givskov, M; Lory, S; Pier, GB				Koh, Andrew Y.; Mikkelsen, Per J.; Smith, Roger S.; Coggshall, Kathleen T.; Kamei, Akinobu; Givskov, Michael; Lory, Stephen; Pier, Gerald B.			Utility of In Vivo Transcription Profiling for Identifying Pseudomonas aeruginosa Genes Needed for Gastrointestinal Colonization and Dissemination	PLOS ONE			English	Article							III PROTEIN SECRETION; MURINE MODEL; BACTERIAL VIRULENCE; BIOFILM DEVELOPMENT; TWITCHING MOTILITY; SYSTEMIC SPREAD; CYSTIC-FIBROSIS; EXPRESSION; INFECTIONS; STRAIN	Microarray analysis of Pseudomonas aeruginosa mRNA transcripts expressed in vivo during animal infection has not been previously used to investigate potential virulence factors needed in this setting. We compared mRNA expression in bacterial cells recovered from the gastrointestinal (GI) tracts of P. aeruginosa-colonized mice to that of P. aeruginosa in the drinking water used to colonize the mice. Genes associated with biofilm formation and type III secretion (T3SS) had markedly increased expression in the GI tract. A non-redundant transposon library in P. aeruginosa strain PA14 was used to test mutants in genes identified as having increased transcription during in vivo colonization. All of the Tn-library mutants in biofilm-associated genes had an attenuated ability to form biofilms in vitro, but there were no significant differences in GI colonization and dissemination between these mutants and WT P. aeruginosa PA14. To evaluate T3SS factors, we tested GI colonization and neutropenia-induced dissemination of both deletional (PAO1 and PAK) and insertional (PA14) mutants in four genes in the P. aeruginosa T3SS, exoS or exoU, exoT, and popB. There were no significant differences in GI colonization among these mutant strains and their WT counterparts, whereas rates of survival following dissemination were significantly decreased in mice infected by the T3SS mutant strains. However, there was a variable, strain-dependent effect on overall survival between parental and T3SS mutants. Thus, increased transcription of genes during in vivo murine GI colonization is not predictive of an essential role for the gene product in either colonization or overall survival following induction of neutropenia.	[Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Hematol Oncol, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Infect Dis, Dallas, TX 75390 USA; [Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Mikkelsen, Per J.; Givskov, Michael] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Smith, Roger S.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Coggshall, Kathleen T.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Kamei, Akinobu; Pier, Gerald B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Lory, Stephen] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Copenhagen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Koh, AY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	Andrew.Koh@UTSouthwestern.edu	Koh, Andrew/R-6837-2019; Pier, Gerald/AAO-2692-2021	Koh, Andrew/0000-0003-2172-5126; Pier, Gerald/0000-0002-9112-2331; Givskov, Michael/0000-0001-5004-8609	National Institutes of Health [AI62983, AI22535, AI21451]; Lundbeck Fonden; Oticon Fonden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021451, R37AI021451, K08AI062983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Fonden(Lundbeckfonden); Oticon Fonden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the National Institutes of Health grants AI62983 (AYK), AI22535 (GPB) and AI21451 (SL) and the Lundbeck Fonden and Oticon Fonden (PJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DWK, 2004, BEST PRACT RES CL GA, V18, P387, DOI 10.1016/j.bpg.2003.11.002; Alexander RJ, 1998, DIGEST DIS SCI, V43, P2652, DOI 10.1023/A:1026699126899; Aliaga L, 2002, J MED MICROBIOL, V51, P615, DOI 10.1099/0022-1317-51-7-615; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Bertrand X, 2003, ANN FR ANESTH, V22, P505, DOI 10.1016/S0750-7658(03)00136-9; Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; BODEY GP, 1983, REV INFECT DIS, V5, P279; BRIGHT BD, 1995, PEDIATR PULM, V12, P244; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; COHEN PS, 1985, INFECT IMMUN, V48, P139, DOI 10.1128/IAI.48.1.139-145.1985; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUTTELOD M, CLIN MICROBIOL INFEC; Czuprynski CJ, 2002, APPL ENVIRON MICROB, V68, P2893, DOI 10.1128/AEM.68.6.2893-2900.2002; Dean CR, 2002, FEMS MICROBIOL LETT, V210, P277, DOI 10.1016/S0378-1097(02)00641-9; Fitzsimons NA, 2003, J MICROBIOL METH, V55, P133, DOI 10.1016/S0167-7012(03)00121-0; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Koh AY, 2005, INFECT IMMUN, V73, P2262, DOI 10.1128/IAI.73.4.2262-2272.2005; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; Macfarlane S, 1997, Adv Dent Res, V11, P59; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PIER GB, 1992, INFECT IMMUN, V60, P4768, DOI 10.1128/IAI.60.11.4768-4776.1992; Pizzo P.A., 2002, PRINCIPLES PRACTICE, V4th; PLATT MD, 2008, J BACTERIOL; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reuter S, 2002, CRIT CARE MED, V30, P2222, DOI 10.1097/00003246-200210000-00008; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Whitchurch CB, 2002, J BACTERIOL, V184, P4544, DOI 10.1128/JB.184.16.4544-4554.2002; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilson M., 2005, MICROBIAL INHABITANT; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; 2000, MMWR MORB MORTAL WKL, V49, P1087	50	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15131	10.1371/journal.pone.0015131	http://dx.doi.org/10.1371/journal.pone.0015131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170272	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400017
J	Sun, YZ; Bian, C; Xu, K; Hu, WB; Wang, TY; Cui, J; Wu, HQ; Ling, ZY; Ji, YY; Lin, GM; Tian, L; Zhou, YY; Li, BN; Hu, GY; Yu, N; An, WQ; Pan, RW; Zhou, P; Leng, QB; Huang, Z; Ma, XW; Sun, B				Sun, Yizhuo; Bian, Chao; Xu, Ke; Hu, Weibin; Wang, Tongyan; Cui, Jun; Wu, Hongqiang; Ling, Zhiyang; Ji, Yongyong; Lin, Guomei; Tian, Lin; Zhou, Yanyan; Li, Bingnan; Hu, Guiyu; Yu, Ning; An, Wenqi; Pan, Ruowen; Zhou, Paul; Leng, Qibin; Huang, Zhong; Ma, Xiaowei; Sun, Bing			Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine	PLOS ONE			English	Article							A H1N1 VACCINE; VIRUS; EMERGENCE; RESPONSES; ANTIBODY; HUMANS	Background: The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 deaths worldwide. Vaccines against the 2009 A/H1N1 influenza virus are useful for preventing infection and controlling the pandemic. The kinetics of the immune response following vaccination with the 2009 A/H1N1 influenza vaccine need further investigation. Methodology/Principal Findings: 58 volunteers were vaccinated with a 2009 A/H1N1 pandemic influenza monovalent split-virus vaccine (15 mu g, single-dose). The sera were collected before Day 0 (pre-vaccination) and on Days 3, 5, 10, 14, 21, 30, 45 and 60 post vaccination. Specific antibody responses induced by the vaccination were analyzed using hemagglutination inhibition (HI) assay and enzyme-linked immunosorbent assay (ELISA). After administration of the 2009 A/H1N1 influenza vaccine, specific and protective antibody response with a major subtype of IgG was sufficiently developed as early as Day 10 (seroprotection rate: 93%). This specific antibody response could maintain for at least 60 days without significant reduction. Antibody response induced by the 2009 A/H1N1 influenza vaccine could not render protection against seasonal H1N1 influenza (seroconversion rate: 3% on Day 21). However, volunteers with higher pre-existing seasonal influenza antibody levels (pre-vaccination HI titer >= 1:40, Group 1) more easily developed a strong antibody protection effect against the 2009 A/H1N1 influenza vaccine as compared with those showing lower pre-existing seasonal influenza antibody levels (pre-vaccination HI titer <1:40, Group 2). The titer of the specific antibody against the 2009 A/H1N1 influenza was much higher in Group 1 (geometric mean titer: 146 on Day 21) than that in Group 2 (geometric mean titer: 70 on Day 21). Conclusions/Significance: Recipients could gain sufficient protection as early as 10 days after vaccine administration. The protection could last at least 60 days. Individuals with a stronger pre-existing seasonal influenza antibody response may have a relatively higher potential for developing a stronger humoral immune response after vaccination with the 2009 A/H1N1 pandemic influenza vaccine.	[Sun, Yizhuo; Bian, Chao; Cui, Jun; Wu, Hongqiang; Ling, Zhiyang; Ji, Yongyong; Lin, Guomei; Tian, Lin; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai, Peoples R China; [Xu, Ke; Hu, Weibin; Wang, Tongyan; Hu, Guiyu; Yu, Ning; Zhou, Paul; Leng, Qibin; Huang, Zhong; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Zhou, Yanyan; Li, Bingnan] Shanghai Immune Biotech Co, Shanghai, Peoples R China; [An, Wenqi; Pan, Ruowen; Ma, Xiaowei] Hualan Biol Bacterin Co, Xinxiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Sun, YZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai, Peoples R China.	mxwhualan@126.com; bsun@sibs.ac.cn		LING, Zhiyang/0000-0001-8873-6773	Hualan Biological Bacterin Company; CAS [KSCX2-YW-R-161, KSCX2-YW-R-169]; National Ministry of Science and Technology [20072714]; National Natural Science Foundation of China [30950002, 30623003, 30721065, 30801011, 30870126, 30949019, 90713044]; Technology Commission of Shanghai Municipality [08DZ2291703, 088014199]; Leadership Foundation from the Technology Commission of Shanghai Municipality; National Science and Technology Major Project [2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016]; SPHRF [SPHRF2008001, SPHRF2009001]; National 973 key project [2007CB512404]; E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	Hualan Biological Bacterin Company; CAS(Chinese Academy of Sciences); National Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Leadership Foundation from the Technology Commission of Shanghai Municipality; National Science and Technology Major Project; SPHRF; National 973 key project(National Basic Research Program of China); E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	Hualan Biological Bacterin Company is one of the funders of this research and helped to carry out volunteer recruitment and clinical sample collection. The company was not involved in sample testing and data statistical analysis of this research. This work was also supported by grants from CAS project (KSCX2-YW-R-161, KSCX2-YW-R-169), the National Ministry of Science and Technology (20072714), the National Natural Science Foundation of China (30950002, 30623003, 30721065, 30801011, 30870126, 30949019, 90713044), the Technology Commission of Shanghai Municipality (08DZ2291703, 088014199), the Leadership Foundation from the Technology Commission of Shanghai Municipality, the National Science and Technology Major Project (2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016), SPHRF (SPHRF2008001, SPHRF2009001), a grant from National 973 key project (2007CB512404), a grant from E-institutes of the Shanghai Universities Immunology Division and a grant from the Li Kha Shing Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAYATT R, 1984, J HYG-CAMBRIDGE, V93, P301, DOI 10.1017/S0022172400064834; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; PANDEMIC H1N1 2009 U; 2009, MMWR MORB MORTAL WKL, V58, P521; H1N1 POSTPANDEMIC PE	18	11	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14270	10.1371/journal.pone.0014270	http://dx.doi.org/10.1371/journal.pone.0014270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151563	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800006
J	Caudal, D; Godsil, BP; Mailliet, F; Bergerot, D; Jay, TM				Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.			Acute Stress Induces Contrasting Changes in AMPA Receptor Subunit Phosphorylation within the Prefrontal Cortex, Amygdala and Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GATED ION CHANNELS; SYNAPTIC PLASTICITY; WORKING-MEMORY; IN-VIVO; DEPRESSION; TRAFFICKING; TRANSMISSION; MODEL; RATS	Exposure to stress causes differential neural modifications in various limbic regions, namely the prefrontal cortex, hippocampus and amygdala. We investigated whether alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) phosphorylation is involved with these stress effects. Using an acute inescapable stress protocol with rats, we found opposite effects on AMPA receptor phosphorylation in the medial prefrontal cortex (mPFC) and dorsal hippocampus (DH) compared to the amygdala and ventral hippocampus (VH). After stress, the phosphorylation of Ser831-GluA1 was markedly decreased in the mPFC and DH, whereas the phosphorylation of Ser845-GluA1 was increased in the amygdala and VH. Stress also modulated the GluA2 subunit with a decrease in the phosphorylation of both Tyr876-GluA2 and Ser880-GluA2 residues in the amygdala, and an increase in the phosphorylation of Ser880-GluA2 in the mPFC. These results demonstrate that exposure to acute stress causes subunit-specific and region-specific changes in glutamatergic transmission, which likely lead to the reduced synaptic efficacy in the mPFC and DH and augmented activity in the amygdala and VH. In addition, these findings suggest that modifications of glutamate receptor phosphorylation could mediate the disruptive effects of stress on cognition. They also provide a means to reconcile the contrasting effects that stress has on synaptic plasticity in these regions. Taken together, the results provide support for a brain region-oriented approach to therapeutics.	[Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.] Ctr Psychiat & Neurosci, INSERM U894, Paris, France; [Caudal, Dorian; Godsil, Bill P.; Mailliet, Francois; Bergerot, Damien; Jay, Therese M.] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Caudal, D (corresponding author), Ctr Psychiat & Neurosci, INSERM U894, Paris, France.	therese.jay@inserm.fr	Caudal, Dorian/D-3644-2015; Jay, Therese M/G-2297-2015	Jay, Therese M/0000-0002-2468-1141; Godsil, Bill/0000-0001-7248-4292; Jay, Therese/0000-0003-3553-9236; Caudal, Dorian/0000-0003-4288-3801	INSERM (Institut de la Sante et de la Recherche Medicale); Universite Paris Descartes; French Ministere de l'Education Nationale; INSERM	INSERM (Institut de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes; French Ministere de l'Education Nationale; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from INSERM (Institut de la Sante et de la Recherche Medicale) and Universite Paris Descartes. DC was supported by a fellowship from the French Ministere de l'Education Nationale. BG was supported by a fellowship from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chung HJ, 2000, J NEUROSCI, V20, P7258; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DIAMOND D, 1994, STRESS IMPAIRS LTP H, P411; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; FUMAGALLI F, 2010, HIPPOCAMPUS IN PRESS; Fumagalli F, 2009, J NEUROCHEM, V109, P1733, DOI 10.1111/j.1471-4159.2009.06088.x; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; HOLMES A, 2009, NEUROSCIENCE BIOBEHA, V33; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; LI GH, 2010, INT J PHYSL PATHOPHY, V2, P47; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Mailliet F, 2008, EXP NEUROL, V211, P593, DOI 10.1016/j.expneurol.2008.02.030; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maroun M, 2003, J NEUROSCI, V23, P4406; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Qi HS, 2009, NEUROPHARMACOLOGY, V56, P37, DOI 10.1016/j.neuropharm.2008.06.068; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shakesby AC, 2002, J NEUROSCI, V22, P3638; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Svenningsson P, 2007, EUR J NEUROSCI, V26, P3509, DOI 10.1111/j.1460-9568.2007.05952.x; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Taylor JR, 1999, J NEUROSCI, V19; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460-9568.2004.03294.x; Vouimba RM, 2007, NEUROPHARMACOLOGY, V52, P244, DOI 10.1016/j.neuropharm.2006.07.007; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	51	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15282	10.1371/journal.pone.0015282	http://dx.doi.org/10.1371/journal.pone.0015282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170339	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100033
J	Cettomai, D; Kwasa, J; Kendi, C; Birbeck, GL; Price, RW; Bukusi, EA; Cohen, CR; Meyer, AC				Cettomai, Deanna; Kwasa, Judith; Kendi, Caroline; Birbeck, Gretchen L.; Price, Richard W.; Bukusi, Elizabeth A.; Cohen, Craig R.; Meyer, Ana-Claire			Utility of Quantitative Sensory Testing and Screening Tools in Identifying HIV-Associated Peripheral Neuropathy in Western Kenya: Pilot Testing	PLOS ONE			English	Article							GRADUATED TUNING FORK; RELIABILITY; FOOT; POLYNEUROPATHY; ULCERATION; THRESHOLD	Background/Aim: Neuropathy is the most common neurologic complication of HIV but is widely under-diagnosed in resource-constrained settings. We aimed to identify tools that accurately distinguish individuals with moderate/severe peripheral neuropathy and can be administered by non-physician healthcare workers (HCW) in resource-constrained settings. Methods: We enrolled a convenience sample of 30 HIV-infected outpatients from a Kenyan HIV-care clinic. A HCW administered the Neuropathy Severity Score (NSS), Single Question Neuropathy Screen (Single-QNS), Subjective Peripheral Neuropathy Screen (Subjective-PNS), and Brief Peripheral Neuropathy Screen (Brief-PNS). Monofilament, graduated tuning fork, and two-point discrimination examinations were performed. Tools were validated against a neurologist's clinical assessment of moderate/severe neuropathy. Results: The sample was 57% male, mean age 38.6 years, and mean CD4 count 324 cells/mu L. Neurologist's assessment identified 20% (6/30) with moderate/severe neuropathy. Diagnostic utilities for moderate/severe neuropathy were: Single-QNS - 83% sensitivity, 71% specificity; Subjective-PNS-total - 83% sensitivity, 83% specificity; Subjective-PNS-max and NSS - 67% sensitivity, 92% specificity; Brief-PNS - 0% sensitivity, 92% specificity; monofilament - 100% sensitivity, 88% specificity; graduated tuning fork - 83% sensitivity, 88% specificity; two-point discrimination - 75% sensitivity, 58% specificity. Conclusions: Pilot testing suggests Single-QNS, Subjective-PNS, and monofilament examination accurately identify HIV-infected patients with moderate/severe neuropathy and may be useful diagnostic tools in resource-constrained settings.	[Cettomai, Deanna; Kwasa, Judith; Kendi, Caroline; Bukusi, Elizabeth A.; Meyer, Ana-Claire] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Cettomai, Deanna; Price, Richard W.; Meyer, Ana-Claire] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Birbeck, Gretchen L.] Michigan State Univ, Int Neurol & Psychiat Epidemiol Program, E Lansing, MI 48824 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Kenya Medical Research Institute; University of California System; University of California San Francisco; Michigan State University; University of California System; University of California San Francisco	Cettomai, D (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	meyerac@sfgh.ucsf.edu		Saylor, Deanna/0000-0002-9297-0244; Meyer, Ana-Claire/0000-0002-4906-3059	Fulbright African Regional Research Program; American Academy of Neurology; Doris Duke International; Fogarty International, National Institutes of Health [5 R24 TW00798, 3 R24 TW00798-02S1]; Fogarty International Center through Vanderbilt University; National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); Office of the Director, National Institutes of Health; National Institute of Mental Health (NIMH)	Fulbright African Regional Research Program; American Academy of Neurology; Doris Duke International; Fogarty International, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Fulbright African Regional Research Program, American Academy of Neurology Practice Research Training Fellowship, and Doris Duke International Clinical Research Fellowship. In addition, this study was supported by the Fogarty International Clinical Research Fellowship (5 R24 TW00798; 3 R24 TW00798-02S1) from the National Institutes of Health, Fogarty International Center through Vanderbilt University, the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), Office of the Director, National Institutes of Health and the National Institute of Mental Health (NIMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseculeratne Y M, 2003, J Wound Care, V12, P215; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; DIAMOND JE, 1989, PHYS THER, V69, P797, DOI 10.1093/ptj/69.10.797; Ellis RJ, ARCH NEUROL, V67, P552; KANDIAH P, J NEUROL NE IN PRESS; Kastenbauer T, 2004, DIABETIC MED, V21, P563, DOI 10.1111/j.1464-5491.2004.01205.x; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; Marx RG, 1998, J HAND SURG-BRIT EUR, V23B, P499, DOI 10.1016/S0266-7681(98)80132-0; Mayfield JA, 2000, J FAM PRACTICE, V49, P499; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Merkies ISJ, 2000, J NEUROL NEUROSUR PS, V68, P669, DOI 10.1136/jnnp.68.5.669; Mitchell PD, 2001, LEPROSY REV, V72, P143; Periyasamy R, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-3; THIVOLET C, 1990, DIABETES CARE, V13, P1077, DOI 10.2337/diacare.13.10.1077; Venkataramana AB, 2005, AIDS READ, V15, P348; Venkataramana AB, 2005, AIDS READ, V15, P354; Venkataramana Anita B, 2005, AIDS Read, V15, P341; World Health Organization, 2006, WORLD HLTH REP WORK	19	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14256	10.1371/journal.pone.0014256	http://dx.doi.org/10.1371/journal.pone.0014256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170387	gold, Green Published			2022-12-25	WOS:000285084100010
J	Kashiwagi, T; Hara, K; Nakazono, Y; Hamada, N; Watanabe, H				Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi			Artificial Hybrids of Influenza A Virus RNA Polymerase Reveal PA Subunit Modulates Its Thermal Sensitivity	PLOS ONE			English	Article							SINGLE AMINO-ACID; H1N1 VIRUS; IN-VITRO; CRYSTAL-STRUCTURE; NUCLEAR IMPORT; CAP-BINDING; PB2; REPLICATION; COMPLEX; PROTEIN	Background: Influenza A virus can infect a variety of different hosts and therefore has to adapt to different host temperatures for its efficient viral replication. Influenza virus codes for an RNA polymerase of 3 subunits: PB1, PB2 and PA. It is well known that the PB2 subunit is involved in temperature sensitivity, such as cold adaptation. On the other hand the role of the PA subunit in thermal sensitivity is still poorly understood. Methodology/Principal Findings: To test which polymerase subunit(s) were involved in thermal stress we reconstituted artificial hybrids of influenza RNA polymerase in ribonucleoprotein (RNP) complexes and measured steady-state levels of mRNA, cRNA and vRNA at different temperatures. The PA subunit was involved in modulating RNP activity under thermal stress. Residue 114 of the PA subunit was an important determinant of this activity. Conclusions/Significance: These findings suggested that influenza A virus may acquire an RNA polymerase adapted to different body temperatures of the host by reassortment of the RNA polymerase genes.	[Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Med, Div Infect Dis, Kurume, Fukuoka 830, Japan	Kurume University	Kashiwagi, T (corresponding author), Kurume Univ, Sch Med, Dept Infect Med, Div Infect Dis, Kurume, Fukuoka 830, Japan.	takahito@med.kurume-u.ac.jp			Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan [21791015]	Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by grants from the Ishibashi Foundation for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791015, 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; COX NJ, 1988, VIROLOGY, V167, P554, DOI 10.1016/S0042-6822(88)90118-3; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Danishuddin M, 2009, BIOINFORMATION, V4, P94, DOI 10.6026/97320630004094; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; Kiseleva IV, 2010, J GEN VIROL, V91, P931, DOI 10.1099/vir.0.017996-0; Kuzuhara T, 2009, ACTA CRYSTALLOGR F, V65, P144, DOI 10.1107/S1744309108042942; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; ODAGIRI T, 1986, ARCH VIROL, V88, P91, DOI 10.1007/BF01310893; Palese P., 2007, FIELDS VIROLOGY, P1647; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; World Health Organization, 2010, PAND H1N1 2009; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15140	10.1371/journal.pone.0015140	http://dx.doi.org/10.1371/journal.pone.0015140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151876	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800008
J	Coulon, C; Vinogradov, E; Filloux, A; Sadovskaya, I				Coulon, Charlene; Vinogradov, Evgeny; Filloux, Alain; Sadovskaya, Irina			Chemical Analysis of Cellular and Extracellular Carbohydrates of a Biofilm-Forming Strain Pseudomonas aeruginosa PA14	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYSACCHARIDE; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; SPONTANEOUS RELEASE; O-ANTIGEN; LIPOPOLYSACCHARIDE; GENES; EXPRESSION; MATRIX	Background: Pseudomonas aeruginosa is a Gram-negative bacterium and an opportunistic pathogen, which causes persisting life-threatening infections in cystic fibrosis (CF) patients. Biofilm mode of growth facilitates its survival in a variety of environments. Most P. aeruginosa isolates, including the non-mucoid laboratory strain PA14, are able to form a thick pellicle, which results in a surface-associated biofilm at the air-liquid (A-L) interface in standing liquid cultures. Exopolysaccharides (EPS) are considered as key components in the formation of this biofilm pellicle. In the non-mucoid P. aeruginosa strain PA14, the "scaffolding" polysaccharides of the biofilm matrix, and the molecules responsible for the structural integrity of rigid A-L biofilm have not been identified. Moreover, the role of LPS in this process is unclear, and the chemical structure of the LPS O-antigen of PA14 has not yet been elucidated. Principal Findings: In the present work we carried out a systematic analysis of cellular and extracellular (EC) carbohydrates of P. aeruginosa PA14. We also elucidated the chemical structure of the LPS O-antigen by chemical methods and 2-D NMR spectroscopy. Our results showed that it is composed of linear trisaccharide repeating units, identical to those described for P. aeruginosa Lanyi type O:2a,c (Lanyi-Bergman O-serogroup 10a, 10c; IATS serotype 19) and having the following structure: -4)-alpha-L-GalNAcA-(1-3)-alpha-D-QuiNAc-(1-3)-alpha-L-Rha-(1-. Furthermore, an EC O-antigen polysaccharide (EC O-PS) and the glycerol-phosphorylated cyclic beta-(1,3)-glucans were identified in the culture supernatant of PA14, grown statically in minimal medium. Finally, the extracellular matrix of the thick biofilm formed at the A-L interface contained, in addition to eDNA, important quantities (at least similar to 20% of dry weight) of LPS-like material. Conclusions: We characterized the chemical structure of the LPS O-antigen and showed that the O-antigen polysaccharide is an abundant extracellular carbohydrate of PA14. We present evidence that LPS-like material is found as a component of a biofilm matrix of P. aeruginosa.	[Coulon, Charlene; Sadovskaya, Irina] Univ Lille Nord France, Lille, France; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Coulon, Charlene] Univ Littoral Cote dOpale, LR2B, Bassin Napoleon, Boulogne Mer, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Fac Nat Sci, Div Cell & Mol Biol, London, England; [Sadovskaya, Irina] Univ Littoral Cote dOpale, UMT 08, Boulogne Sur Mer, France	Universite de Lille - ISITE; Universite de Lille; National Research Council Canada; Universite du Littoral-Cote-d'Opale; Imperial College London; Universite du Littoral-Cote-d'Opale	Coulon, C (corresponding author), Univ Lille Nord France, Lille, France.	Irina.Sadovskaya@univ-littoral.fr		Vinogradov, Evgeny/0000-0002-5364-1376	le Ministere de l'Enseignement Superieur et de la Recherche; Arcir [54R01]; Royal Society; ERA-NET Pathogenomics	le Ministere de l'Enseignement Superieur et de la Recherche; Arcir; Royal Society(Royal Society of London); ERA-NET Pathogenomics	This study was supported by le Ministere de l'Enseignement Superieur et de la Recherche to CC and by Arcir 54R01 to IS. AF is supported by the Royal Society and the ERA-NET Pathogenomics grant EPS-MATRIX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2008, BIOMACROMOLECULES, V9, P2799, DOI 10.1021/bm800562r; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; BORDI C, 2010, MOL MICROBIOL; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; CADIEUX JE, 1983, J BACTERIOL, V155, P817, DOI 10.1128/JB.155.2.817-825.1983; CRUTCHLE.MJ, 1967, NATURE, V214, P1052, DOI 10.1038/2141052a0; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Filloux A, 2003, M S-MED SCI, V19, P77, DOI 10.1051/medsci/200319177; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fujise O, 2008, ORAL MICROBIOL IMMUN, V23, P226, DOI 10.1111/j.1399-302X.2007.00416.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; ISHIGURO EE, 1986, J BACTERIOL, V168, P328, DOI 10.1128/jb.168.1.328-333.1986; JOHNSON KG, 1975, CAN J MICROBIOL, V21, P1969, DOI 10.1139/m75-285; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; KNIREL YA, 1982, EUR J BIOCHEM, V125, P221, DOI 10.1111/j.1432-1033.1982.tb06672.x; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; KOCHAROVA NA, 1988, BIOORG KHIM+, V14, P701; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lee YW, 2010, LETT APPL MICROBIOL, V50, P452, DOI 10.1111/j.1472-765X.2010.02813.x; Lequette Y, 2007, MICROBIOL-SGM, V153, P3255, DOI 10.1099/mic.0.2007/008953-0; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nakamura S, 2008, JPN J INFECT DIS, V61, P375; PIER GB, 1984, INFECT IMMUN, V45, P309, DOI 10.1128/IAI.45.2.309-313.1984; PIER GB, 1989, INFECT IMMUN, V57, P426, DOI 10.1128/IAI.57.2.426-431.1989; PIER GB, 1981, INFECT IMMUN, V34, P461, DOI 10.1128/IAI.34.2.461-468.1981; PIER GB, 1978, INFECT IMMUN, V22, P908, DOI 10.1128/IAI.22.3.908-918.1978; PIKE RM, 1974, J GEN MICROBIOL, V81, P59, DOI 10.1099/00221287-81-1-59; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sadovskaya I, 2010, GLYCOBIOLOGY, V20, P895, DOI 10.1093/glycob/cwq047; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Snyder DS, 2006, CARBOHYD RES, V341, P2388, DOI 10.1016/j.carres.2006.06.010; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vasseur P, 2007, BIOCHIMIE, V89, P903, DOI 10.1016/j.biochi.2007.04.002; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100	54	46	48	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14220	10.1371/journal.pone.0014220	http://dx.doi.org/10.1371/journal.pone.0014220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151973	Green Submitted, gold, Green Published			2022-12-25	WOS:000284939600013
J	Roque, H; Ward, JJ; Murrells, L; Brunner, D; Antony, C				Roque, Helio; Ward, Jonathan J.; Murrells, Lindsay; Brunner, Damian; Antony, Claude			The Fission Yeast XMAP215 Homolog Dis1p Is Involved in Microtubule Bundle Organization	PLOS ONE			English	Article							INTERPHASE MICROTUBULES; ELECTRON TOMOGRAPHY; MITOTIC SPINDLES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CELL POLARITY; PROTEINS; KINETOCHORE; DYNAMICS	Microtubules are essential for a variety of fundamental cellular processes such as organelle positioning and control of cell shape. Schizosaccharomyces pombe is an ideal organism for studying the function and organization of microtubules into bundles in interphase cells. Using light microscopy and electron tomography we analyzed the bundle organization of interphase microtubules in S. pombe. We show that cells lacking ase1p and klp2p still contain microtubule bundles. In addition, we show that ase1p is the major determinant of inter-microtubule spacing in interphase bundles since ase1 deleted cells have an inter-microtubule spacing that differs from that observed in wild-type cells. We then identified dis1p, a XMAP215 homologue, as factor that promotes the stabilization of microtubule bundles. In wild-type cells dis1p partially co-localized with ase1p at regions of microtubule overlap. In cells deleted for ase1 and klp2, dis1p accumulated at the overlap regions of interphase microtubule bundles. In cells lacking all three proteins, both microtubule bundling and inter-microtubule spacing were further reduced, suggesting that Dis1p contributes to interphase microtubule bundling.	[Roque, Helio; Ward, Jonathan J.; Murrells, Lindsay; Brunner, Damian; Antony, Claude] European Mol Biol Lab, Cell Biol & Biophys Program, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Roque, H (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, Heidelberg, Germany.	brunner@embl.de; antony@embl.de	Ward, Jonathan/F-8493-2011; antony, claude/K-5342-2013; Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X; Roque, Helio/0000-0002-5930-1989	European Molecular Biology Laboratory; Volkswagenstiftung	European Molecular Biology Laboratory; Volkswagenstiftung(Volkswagen)	HR and LM were funded by the European Molecular Biology Laboratory International PhD Programme. JJW was funded by the Volkswagenstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; BRAUN M, 2009, NAT CELL BIOL; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; GILBERT PFC, 1972, PROC R SOC SER B-BIO, V182, P89, DOI 10.1098/rspb.1972.0068; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hagan IM, 1998, J CELL SCI, V111, P1603; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; HITT AL, 1990, J BIOL CHEM, V265, P1639; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Karsenti E, 2006, NAT CELL BIOL, V8, P1204, DOI 10.1038/ncb1498; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Marsh BJ, 2001, BIOCHEM SOC T, V29, P461, DOI 10.1042/BST0290461; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; OToole ET, 1997, MOL BIOL CELL, V8, P1, DOI 10.1091/mbc.8.1.1; Reinsch S, 1998, J CELL SCI, V111, P2283; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Sawin KE, 2004, J CELL SCI, V117, P689, DOI 10.1242/jcs.00925; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859	61	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14201	10.1371/journal.pone.0014201	http://dx.doi.org/10.1371/journal.pone.0014201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151990	gold, Green Published			2022-12-25	WOS:000284868000015
J	Krueger, C; Hoffmann, FM				Krueger, Chateen; Hoffmann, F. Michael			Identification of Retinoic Acid in a High Content Screen for Agents that Overcome the Anti-Myogenic Effect of TGF-Beta-1	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; SMP-534 ANTIFIBROTIC AGENT; ACTIVATED PROTEIN-KINASE; INJURED SKELETAL-MUSCLE; VITAMIN-D DERIVATIVES; TGF-BETA; MDX MICE; DIABETIC-NEPHROPATHY; ANDROGEN RECEPTOR; EPITHELIAL-CELLS	Background: Transforming growth factor beta 1 (TGF-beta 1) is an inhibitor of muscle cell differentiation that is associated with fibrosis, poor regeneration and poor function in some diseases of muscle. When neutralizing antibodies to TGF-beta 1 or the angiotensin II inhibitor losartan were used to reduce TGF-beta 1 signaling, muscle morphology and function were restored in mouse models of Marfan Syndrome and muscular dystrophy. The goal of our studies was to identify additional agents that overcome the anti-myogenic effect of TGF-beta 1. Methodology/Principal Findings: A high-content cell-based assay was developed in a 96-well plate format that detects the expression of myosin heavy chain (MHC) in C2C12 cells. The assay was used to quantify the dose-dependent responses of C2C12 cell differentiation to TGF-beta 1 and to the TGF-beta 1 Type 1 receptor kinase inhibitor, SB431542. Thirteen agents previously described as promoting C2C12 differentiation in the absence of TGF-beta 1 were screened in the presence of TGF-beta 1. Only all-trans retinoic acid and 9-cis retinoic acid allowed a maximal level of C2C12 cell differentiation in the presence of TGF-beta 1; the angiotensin-converting enzyme inhibitor captopril and 10 nM estrogen provided partial rescue. Vitamin D was a potent inhibitor of retinoic acid-induced myogenesis in the presence of TGF-beta 1. TGF-beta 1 inhibits myoblast differentiation through activation of Smad3; however, retinoic acid did not inhibit TGF-beta 1-induced activation of a Smad3-dependent reporter gene in C2C12 cells. Conclusions/Significance: Retinoic acid alleviated the anti-myogenic effect of TGF-beta 1 by a Smad3-independent mechanism. With regard to the goal of improving muscle regeneration and function in individuals with muscle disease, the identification of retinoic acid is intriguing in that some retinoids are already approved for human therapy. However, retinoids also have well-described adverse effects. The quantitative, high-content assay will be useful to screen for less-toxic retinoids or combinations of agents that promote myoblast differentiation in the presence of TGF-beta 1.	[Krueger, Chateen] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Oncol, Madison, WI 53706 USA; Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Krueger, C (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Oncol, 1400 Univ Ave, Madison, WI 53706 USA.	Hoffmann@oncology.wisc.edu		Hoffmann, F. Michael/0000-0002-2770-9656	Muscular Dystrophy Association [MDA69637]; National Cancer Institute [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by funding from the Muscular Dystrophy Association (www.mda.org) (Grant # MDA69637) and funding for core facilities from the National Cancer Institute (www.cancer.gov) funds to the Paul Carbone Comprehensive Cancer Center (www.cancer.wisc.edu) P30 CA014520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; ARNOLD HH, 1992, J CELL BIOL, V118, P877, DOI 10.1083/jcb.118.4.877; Bastie JN, 2004, MOL ENDOCRINOL, V18, P2685, DOI 10.1210/me.2003-0412; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Borger DR, 2000, VIROLOGY, V270, P397, DOI 10.1006/viro.2000.0282; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; Brisdelli F, 2009, CURR DRUG METAB, V10, P530, DOI 10.2174/138920009789375423; Brown D, 2009, J ENDOCRINOL, V201, P129, DOI 10.1677/JOE-08-0476; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; CARNAC G, 1993, ENDOCRINOLOGY, V133, P2171, DOI 10.1210/en.133.5.2171; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chroni E, 2010, DRUG SAFETY, V33, P25, DOI 10.2165/11319020-000000000-00000; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; De Albuquerque DA, 2004, KIDNEY INT, V65, P846, DOI 10.1111/j.1523-1755.2004.00462.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Garber K, 2009, J NATL CANCER I, V101, P1664, DOI 10.1093/jnci/djp462; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Imai S, 1997, FEBS LETT, V411, P102, DOI 10.1016/S0014-5793(97)00673-X; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwata Y, 2005, BIOCHEM PHARMACOL, V70, P740, DOI 10.1016/j.bcp.2005.05.034; Izumi K, 2009, PROSTATE, V69, P1222, DOI 10.1002/pros.20975; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Kempf W, 2003, HEMATOL ONCOL CLIN N, V17, P1405, DOI 10.1016/S0889-8588(03)00107-2; KOJIMA S, 1993, J CELL PHYSIOL, V155, P323, DOI 10.1002/jcp.1041550213; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; La P, 2003, ONCOGENE, V22, P198, DOI 10.1038/sj.onc.1206100; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774; Lengfelder E, 2005, CRIT REV ONCOL HEMAT, V56, P261, DOI 10.1016/j.critrevonc.2004.08.009; Lens M, 2008, EXPERT OPIN PHARMACO, V9, P1363, DOI 10.1517/14656566.9.8.1363 ; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Mori S, 2007, BIOCHEM BIOPH RES CO, V363, P597, DOI 10.1016/j.bbrc.2007.09.006; Mori S, 2007, BIOCHEM BIOPH RES CO, V353, P369, DOI 10.1016/j.bbrc.2006.12.056; Mucida D, 2007, CELL ADHES MIGR, V1, P142, DOI 10.4161/cam.1.3.5062; Nakae Y, 2008, HISTOCHEM CELL BIOL, V129, P489, DOI 10.1007/s00418-008-0390-2; Naylor AJD, 2009, LIFE SCI, V84, P637, DOI [10.1016/j.lfs.2009.02.011, 10.1016/j.lfs.2009.02.01]; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nunes I, 1996, CANCER RES, V56, P495; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pedraza-Alva G, 2009, BIOCHEM BIOPH RES CO, V389, P360, DOI 10.1016/j.bbrc.2009.08.153; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Portier GL, 1999, IN VITRO CELL DEV-AN, V35, P219, DOI 10.1007/s11626-999-0030-8; REDLICH CA, 1995, AM J RESP CELL MOL, V12, P287, DOI 10.1165/ajrcmb.12.3.7873195; Reimann J, 2000, NEUROMUSCULAR DISORD, V10, P276, DOI 10.1016/S0960-8966(99)00118-2; ROBERTS AB, 1992, CANCER SURV, V14, P205; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Stio M, 2002, IUBMB LIFE, V53, P175, DOI 10.1080/15216540212334; Stio M, 2001, J STEROID BIOCHEM, V77, P213, DOI 10.1016/S0960-0760(01)00059-0; Sugaru E, 2006, AM J NEPHROL, V26, P50, DOI 10.1159/000091786; Sugaru E, 2007, NEPHRON EXP NEPHROL, V105, pE45, DOI 10.1159/000097603; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thielitz A, 2006, DERMATOL THER, V19, P272, DOI 10.1111/j.1529-8019.2006.00084.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vlahopoulos S, 2005, J BIOL CHEM, V280, P7786, DOI 10.1074/JBC.m413992200; WATT KI, 2010, MUSCLE NERVE; Wengrower D, 2004, INFLAMM BOWEL DIS, V10, P536, DOI 10.1097/00054725-200409000-00007; Wrightont KH, 2008, P NATL ACAD SCI USA, V105, P9244, DOI 10.1073/pnas.0800163105; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; XIAO YH, 1995, J CELL BIOL, V129, P1345, DOI 10.1083/jcb.129.5.1345; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Yu ZL, 2006, BIOCHEM BIOPH RES CO, V340, P929, DOI 10.1016/j.bbrc.2005.12.100; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006; Yun CH, 2010, ARCH BIOCHEM BIOPHYS, V495, P8, DOI 10.1016/j.abb.2009.12.003; Zhang Chunlei, 2003, Dermatol Ther, V16, P322, DOI 10.1111/j.1396-0296.2003.01644.x; Zhang H, 2009, CELL PHYSIOL BIOCHEM, V23, P157, DOI 10.1159/000204104; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	97	15	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15511	10.1371/journal.pone.0015511	http://dx.doi.org/10.1371/journal.pone.0015511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152098	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100089
J	Lee, MC; Ting, KK; Adams, S; Brew, BJ; Chung, R; Guillemin, GJ				Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Brew, Bruce J.; Chung, Roger; Guillemin, Gilles J.			Characterisation of the Expression of NMDA Receptors in Human Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; QUINOLINIC ACID; CORTICAL ASTROCYTES; KYNURENINE PATHWAY; ALZHEIMERS-DISEASE; NR2A/B SUBUNITS; HUMAN NEURONS; MICROGLIA; OLIGODENDROCYTES	Astrocytes have long been perceived only as structural and supporting cells within the central nervous system (CNS). However, the discovery that these glial cells may potentially express receptors capable of responding to endogenous neurotransmitters has resulted in the need to reassess astrocytic physiology. The aim of the current study was to characterise the expression of NMDA receptors (NMDARs) in primary human astrocytes, and investigate their response to physiological and excitotoxic concentrations of the known endogenous NMDAR agonists, glutamate and quinolinic acid (QUIN). Primary cultures of human astrocytes were used to examine expression of these receptors at the mRNA level using RT-PCR and qPCR, and at the protein level using immunocytochemistry. The functionality role of the receptors was assessed using intracellular calcium influx experiments and measuring extracellular lactate dehydrogenase (LDH) activity in primary cultures of human astrocytes treated with glutamate and QUIN. We found that all seven currently known NMDAR subunits (NR1, NR2A, NR2B, NR2C, NR2D, NR3A and NR3B) are expressed in astrocytes, but at different levels. Calcium influx studies revealed that both glutamate and QUIN could activate astrocytic NMDARs, which stimulates Ca2+ influx into the cell and can result in dysfunction and death of astrocytes. Our data also show that the NMDAR ion channel blockers, MK801, and memantine can attenuate glutamate and QUIN mediated cell excitotoxicity. This suggests that the mechanism of glutamate and QUIN gliotoxicity is at least partially mediated by excessive stimulation of NMDARs. The present study is the first to provide definitive evidence for the existence of functional NMDAR expression in human primary astrocytes. This discovery has significant implications for redefining the cellular interaction between glia and neurons in both physiological processes and pathological conditions.	[Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Lee, Ming-Chak; Ting, Ka Ka; Adams, Seray; Brew, Bruce J.; Guillemin, Gilles J.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept HIV Med, Sydney, NSW 2010, Australia; [Chung, Roger] Univ Tasmania, Menzies Res Inst, Neurorepair Grp, Hobart, Tas, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of Tasmania; Menzies Institute for Medical Research	Lee, MC (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	g.guillemin@unsw.edu.au	Guillemin, Gilles J/C-3878-2015; Brew, Bruce/J-6513-2012; McLean, Emma/F-4616-2012; Chung, Roger/ABF-8395-2020	Guillemin, Gilles J/0000-0001-8105-4470; Chung, Roger/0000-0002-9286-947X; brew, bruce/0000-0003-0622-1392; Adams, Seray/0000-0002-3700-094X	University of New South Wales; Rebecca L. Cooper Medical Research Foundation; Deb Bailey Foundation	University of New South Wales; Rebecca L. Cooper Medical Research Foundation; Deb Bailey Foundation	This work was supported by the University of New South Wales and the Rebecca L. Cooper Medical Research Foundation and the Deb Bailey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; CHEN Y, 2009, NEUROTOX RES; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Conti F, 1996, GLIA, V17, P254, DOI 10.1002/(SICI)1098-1136(199607)17:3<254::AID-GLIA7>3.0.CO;2-0; Conti F, 1999, CEREB CORTEX, V9, P110, DOI 10.1093/cercor/9.2.110; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Espinosa L, 1999, J PHYSIOL-LONDON, V518, P47, DOI 10.1111/j.1469-7793.1999.0047r.x; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Guillemin G, 1997, J NEUROSCI RES, V49, P576, DOI 10.1002/(SICI)1097-4547(19970901)49:5<576::AID-JNR8>3.0.CO;2-8; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2005, NEUROTOX RES, V7, P103, DOI 10.1007/BF03033781; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, NEUROREPORT, V14, P2311, DOI 10.1097/00001756-200312190-00005; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; Kalariti N, 2004, ANTICANCER RES, V24, P3923; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Magistretti P.J., 2002, NEUROPSYCHOPHARMACOL; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PERKINS MN, 1983, J PHARMACOL EXP THER, V226, P551; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Ting KK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-36; Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007; WALTON HS, 2006, NEUROCHEM INT; Wong R, 2006, BIOESSAYS, V28, P460, DOI 10.1002/bies.20402; YAMANAKA K, 2008, NAT NEUROSCI; Zhang Qi, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P254	40	121	126	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14123	10.1371/journal.pone.0014123	http://dx.doi.org/10.1371/journal.pone.0014123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152063	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100007
J	Medendorp, K; Vreede, L; van Groningen, JJM; Hetterschijt, L; Brugmans, L; Jansen, PAM; van den Hurk, WH; de Bruijn, DRH; van Kessel, AG				Medendorp, Klaas; Vreede, Lilian; van Groningen, Jan J. M.; Hetterschijt, Lisette; Brugmans, Linda; Jansen, Patrick A. M.; van den Hurk, Wilhelmina H.; de Bruijn, Diederik R. H.; van Kessel, Ad Geurts			The Mitotic Arrest Deficient Protein MAD2B Interacts with the Clathrin Light Chain A during Mitosis	PLOS ONE			English	Article							RENAL-CELL CARCINOMAS; SPINDLE; COMPLEX; FUSION; GENE; PRCC; TRANSLOCATION; KINETOCHORES; MEMBRANE; CANCER	Background: Although the mitotic arrest deficient protein MAD2B (MAD2L2) is thought to inhibit the anaphase promoting complex (APC) by binding to CDC20 and/or CDH1 (FZR1), its exact role in cell cycle control still remains to be established. Methodology/Principal Findings: Using a yeast two-hybrid interaction trap we identified the human clathrin light chain A (CLTA) as a novel MAD2B binding protein. A direct interaction was established in mammalian cells via GST pull-down and endogenous co-immunoprecipitation during the G2/M phase of the cell cycle. Through subsequent confocal laser scanning microscopy we found that MAD2B and CLTA co-localize at the mitotic spindle. Clathrin forms a trimeric structure, i.e., the clathrin triskelion, consisting of three heavy chains (CLTC), each with an associated light chain. This clathrin structure has previously been shown to be required for the function of the mitotic spindle through stabilization of kinetochore fibers. Upon siRNA-mediated MAD2B depletion, we found that CLTA was no longer concentrated at the mitotic spindle but, instead, diffusely distributed throughout the cell. In addition, we found a marked increase in the percentage of misaligned chromosomes. Conclusions/Significance: Previously, we identified MAD2B as an interactor of the renal cell carcinoma (RCC)-associated protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs results in an impairment of this interaction and a concomitant failure to shuttle MAD2B to the nucleus. Our current data show that MAD2B interacts with CLTA during the G2/M phase of the cell cycle and that depletion of MAD2B leads to a marked increase in the percentage of misaligned chromosomes and a redistribution of CLTA during mitosis.	[Medendorp, Klaas; Vreede, Lilian; van Groningen, Jan J. M.; Hetterschijt, Lisette; Brugmans, Linda; van den Hurk, Wilhelmina H.; de Bruijn, Diederik R. H.; van Kessel, Ad Geurts] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Jansen, Patrick A. M.] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Medendorp, K (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	a.geurtsvankessel@antrg.umcn.nl	Jansen, Patrick AM/P-5602-2015; de Bruijn, D.R.H./L-4233-2015; van Kessel, Ad Geurts/A-2810-2010; Vreede, Lilian/E-2557-2018		Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BRONS PPT, 1990, CYTOMETRY, V11, P837, DOI 10.1002/cyto.990110710; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/0008-5472.CAN-05-3602; de Bruijn DRH, 2008, ONCOGENE, V27, P653, DOI 10.1038/sj.onc.1210688; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lenart P, 2006, CURR BIOL, V16, pR412, DOI 10.1016/j.cub.2006.05.008; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Medendorp K, 2007, CYTOGENET GENOME RES, V118, P157, DOI 10.1159/000108296; Medendorp K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007020; Medendorp K, 2009, EXP CELL RES, V315, P2399, DOI 10.1016/j.yexcr.2009.04.022; Moore DD, 1995, GLOB MOB SURV; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; van den Hurk WH, 2004, CYTOGENET GENOME RES, V106, P68, DOI 10.1159/000078562; WARREN G, 1993, NATURE, V362, P297, DOI 10.1038/362297a0; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118	34	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15128	10.1371/journal.pone.0015128	http://dx.doi.org/10.1371/journal.pone.0015128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152103	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100083
J	Rhainds, M; Fagan, WF				Rhainds, Marc; Fagan, William F.			Broad-Scale Latitudinal Variation in Female Reproductive Success Contributes to the Maintenance of a Geographic Range Boundary in Bagworms (Lepidoptera: Psychidae)	PLOS ONE			English	Article							MATING SUCCESS; SPECIES RANGE; MOTH; INSECT; LIMITS; POPULATIONS; TIME; EXPANSION; ABUNDANCE; SIZE	Background: Geographic range limits and the factors structuring them are of great interest to biologists, in part because of concerns about how global change may shift range boundaries. However, scientists lack strong mechanistic understanding of the factors that set geographic range limits in empirical systems, especially in animals. Methodology/Principal Findings: Across dozens of populations spread over six degrees of latitude in the American Midwest, female mating success of the evergreen bagworm Thyridopteryx ephemeraeformis (Lepidoptera: Psychidae) declines from similar to 100% to similar to 0% near the edge of the species range. When coupled with additional latitudinal declines in fecundity and in egg and pupal survivorship, a spatial gradient of bagworm reproductive success emerges. This gradient is associated with a progressive decline in local abundance and an increased risk of local population extinction, up to a latitudinal threshold where extremely low female fitness meshes spatially with the species' geographic range boundary. Conclusions/Significance: The reduction in fitness of female bagworms near the geographic range limit, which concords with the abundant centre hypothesis from biogeography, provides a concrete, empirical example of how an Allee effect (increased pre-reproductive mortality of females in sparsely populated areas) may interact with other demographic factors to induce a geographic range limit.	[Rhainds, Marc] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Natural Resources Canada; Canadian Forest Service; University System of Maryland; University of Maryland College Park	Rhainds, M (corresponding author), Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada.	mrhainds@nrcan.gc.ca						Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bird JM, 2005, ECOL ENTOMOL, V30, P510, DOI 10.1111/j.0307-6946.2005.00719.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Contarini M, 2009, ENTOMOL EXP APPL, V133, P307, DOI 10.1111/j.1570-7458.2009.00930.x; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; DEMPSTER JP, 1983, BIOL REV, V58, P461, DOI 10.1111/j.1469-185X.1983.tb00396.x; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; KAUFMANN T, 1968, ANN ENTOMOL SOC AM, V61, P38, DOI 10.1093/aesa/61.1.38; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; LEONHARDT BA, 1983, SCIENCE, V219, P314, DOI 10.1126/science.219.4582.314; MORDEN R D, 1971, Entomological News, V82, P151; Rhainds M, 2009, ANNU REV ENTOMOL, V54, P209, DOI 10.1146/annurev.ento.54.110807.090448; Rhainds M, 2008, ECOL ENTOMOL, V33, P663, DOI 10.1111/j.1365-2311.2008.01027.x; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Rooney TP, 1996, AM MIDL NAT, V136, P84, DOI 10.2307/2426633; Rosenheim JA, 2008, AM NAT, V172, P486, DOI 10.1086/591677; SADOF C, DID BAGWORMS SURVIVE; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAROV AA, 1995, ENVIRON ENTOMOL, V24, P1239, DOI 10.1093/ee/24.5.1239; Sheppard R.F., 1975, Bulletin Ent Soc Amer, V21, P153; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; STILING P, 1988, J ANIM ECOL, V57, P581, DOI 10.2307/4926; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038	33	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14166	10.1371/journal.pone.0014166	http://dx.doi.org/10.1371/journal.pone.0014166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152445	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100043
J	Ferraz-de-Souza, B; Lin, L; Shah, S; Jina, N; Hubank, M; Dattani, MT; Achermann, JC				Ferraz-de-Souza, Bruno; Lin, Lin; Shah, Sonia; Jina, Nipurna; Hubank, Mike; Dattani, Mehul T.; Achermann, John C.			ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland	FASEB JOURNAL			English	Article						adrenal development; adrenal tumorigenesis; transcriptional regulation; angiogenesis; NCI-H295R adrenocortical cells	ADRENOCORTICAL TUMORS; NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTION; MUTATION; BINDING; PROMOTER; DIFFERENTIATION; AMPLIFICATION; ANGIOGENESIS	The nuclear receptor steroidogenic factor-1 (SF-1, NR5A1) is a key regulator of adrenal and gonadal biology. Disruption of SF-1 can lead to disorders of adrenal development, while increased SF-1 dosage has been associated with adrenocortical tumorigenesis. We aimed to identify a novel subset of SF-1 target genes in the adrenal by using chromatin immunoprecipitation (ChIP) microarrays (ChIP-on-chip) combined with systems analysis. SF-1 ChIP-on-chip was performed in NCI-H295R human adrenocortical cells using promoter tiling arrays, leading to the identification of 445 gene loci where SF-1-binding regions were located from 10 kb upstream to 3 kb downstream of a transcriptional start. Network analysis of genes identified as putative SF-1 targets revealed enrichment for angiogenic process networks. A 1.1-kb SF-1-binding region was identified in the angiopoietin 2 (Ang2, ANGPT2) promoter in a highly repetitive region, and SF-1-dependent activation was confirmed in luciferase assays. Angiogenesis is paramount in adrenal development and tumorigenesis, but until now a direct link between SF-1 and vascular remodeling has not been established. We have identified Ang2 as a potentially important novel target of SF-1 in the adrenal gland, indicating that regulation of angiogenesis might be an important additional mechanism by which SF-1 exerts its actions in the adrenal gland.-Ferraz-de-Souza, B., Lin, L., Shah, S., Jina, N., Hubank, M., Dattani, M. T., Achermann, J. C. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland. FASEB J. 25, 1166-1175 (2011). www.fasebj.org	[Ferraz-de-Souza, Bruno; Lin, Lin; Dattani, Mehul T.; Achermann, John C.] UCL, UCL Inst Child Hlth, Dev Endocrinol Res Grp, London WC1N 1EH, England; [Jina, Nipurna; Hubank, Mike] UCL, UCL Genom, London WC1N 1EH, England; [Shah, Sonia] Univ London, Bloomsbury Ctr Bioinformat, London, England	University of London; University College London; University of London; University College London; University of London	Achermann, JC (corresponding author), UCL, UCL Inst Child Hlth, Dev Endocrinol Res Grp, 30 Guilford St, London WC1N 1EH, England.	j.achermann@ich.ucl.ac.uk	Achermann, John/C-5476-2008; Ferraz-de-Souza, Bruno/G-1069-2010; Hubank, Michael JF/C-1837-2008; Achermann, John/N-2906-2019; Shah, Sonia/N-7547-2013	Achermann, John/0000-0001-8787-6272; Ferraz-de-Souza, Bruno/0000-0003-4863-2544; Hubank, Michael JF/0000-0002-2901-0742; Achermann, John/0000-0001-8787-6272; Shah, Sonia/0000-0001-5860-4526	Medical Research Council/Wellcome Trust [G0700089, 082557]; Capes/Brazil [4798066]; Wellcome Trust [079666]; MRC [G0700089, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish	Medical Research Council/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Capes/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to Rahul Parnaik for performing immunohistochemical studies. The authors thank P. S. H. Soon for making the supplemental material to ref. 32 available, Jacky Pallas and Catherine Risebro for useful discussions, and J. Larry Jameson (Northwestern University, Chicago, IL, USA) and Ronald Evans (Salk Institute, San Diego, CA, USA) for plasmids. Human fetal tissue was provided by the Medical Research Council/Wellcome Trust-funded Human Developmental Biology Resource (http://www.hdbr.org) (MRC G0700089; The Wellcome Trust 082557), with technical assistance from Dianne Gerrelli. This work was supported by a Capes scholarship (4798066, Capes/Brazil) to B.F.-D. and a Wellcome Trust Senior Research Fellowship in Clinical Science (079666) to J. C. A. The array data have been submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under series accession no. GSE26144.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Almeida MQ, 2010, J CLIN ENDOCR METAB, V95, P1458, DOI 10.1210/jc.2009-2040; Bach F, 2007, EJSO-EUR J SURG ONC, V33, P7, DOI 10.1016/j.ejso.2006.07.015; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Bland ML, 2004, MOL ENDOCRINOL, V18, P941, DOI 10.1210/me.2003-0333; Bland ML, 2000, P NATL ACAD SCI USA, V97, P14488, DOI 10.1073/pnas.97.26.14488; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Ferraz-De-Souza B, 2009, J CLIN ENDOCR METAB, V94, P678, DOI 10.1210/jc.2008-1064; Figueiredo BC, 2005, J CLIN ENDOCR METAB, V90, P615, DOI 10.1210/jc.2004-0942; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Gizard F, 2002, J BIOL CHEM, V277, P39144, DOI 10.1074/jbc.M205786200; Goto M, 2006, J CLIN INVEST, V116, P953, DOI 10.1172/JCI25091; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Guo IC, 2007, J BIOMED SCI, V14, P509, DOI 10.1007/s11373-007-9177-z; Hu MC, 2001, MOL ENDOCRINOL, V15, P812, DOI 10.1210/me.15.5.812; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Ishimoto H, 2006, J CLIN ENDOCR METAB, V91, P1909, DOI 10.1210/jc.2005-2252; Ishimoto H, 2008, J CLIN ENDOCR METAB, V93, P2402, DOI 10.1210/jc.2007-2509; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Lalli E, 2010, J MOL ENDOCRINOL, V44, P301, DOI 10.1677/JME-09-0143; Liu G, 1999, NEW ENGL J MED, V341, P1731, DOI 10.1056/NEJM199912023412304; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Ramayya MS, 1997, J CLIN ENDOCR METAB, V82, P1799, DOI 10.1210/jc.82.6.1799; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Sbiera S, 2010, J CLIN ENDOCR METAB, V95, pE161, DOI 10.1210/jc.2010-0653; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Soon PSH, 2009, ENDOCR-RELAT CANCER, V16, P573, DOI 10.1677/ERC-08-0237; SUNTHORNTHEPVARAKUL T, 1995, NEW ENGL J MED, V332, P155, DOI 10.1056/NEJM199501193320305; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Val P, 2007, DEVELOPMENT, V134, P2349, DOI 10.1242/dev.004390; West AN, 2007, CANCER RES, V67, P600, DOI 10.1158/0008-5472.CAN-06-3767; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	49	21	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1166	1175		10.1096/fj.10-170522	http://dx.doi.org/10.1096/fj.10-170522			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21163858	Green Published, hybrid			2022-12-25	WOS:000288982800006
J	Siddiqui, IA; Asim, M; Hafeez, BB; Adhami, VM; Tarapore, RS; Mukhtar, H				Siddiqui, Imtiaz A.; Asim, Mohammad; Hafeez, Bilal B.; Adhami, Vaqar M.; Tarapore, Rohinton S.; Mukhtar, Hasan			Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer	FASEB JOURNAL			English	Article						androgen antagonist; androgen receptor signaling; androgen-regulated miRNA; hormone-refractory prostate cancer	NF-KAPPA-B; MICRORNA EXPRESSION; GROWTH-INHIBITION; MESSENGER-RNA; TUMOR-GROWTH; IN-VITRO; APOPTOSIS; CELLS; INDUCTION; EPIGALLOCATECHIN-3-GALLATE	Androgen deprivation therapy is the major treatment for advanced prostate cancer (PCa). However, it is a temporary remission, and the patients almost inevitably develop hormone refractory prostate cancer (HRPC). HRPC is almost incurable, although most HRPC cells still express androgen receptor (AR) and depend on the AR for growth, making AR a prime drug target. Here, we provide evidence that epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, is a direct antagonist of androgen action. In silico modeling and FRET-based competition assay showed that EGCG physically interacts with the ligand-binding domain of AR by replacing a high-affinity labeled ligand (IC50 0.4 mu M). The functional consequence of this interaction was a decrease in AR-mediated transcriptional activation, which was due to EGCG mediated inhibition of interdomain N-C termini interaction of AR. Treatment with EGCG also repressed the transcriptional activation by a hotspot mutant AR (T877A) expressed ectopically as well as the endogenous AR mutant. As the physiological consequence of AR antagonism, EGCG repressed R1881-induced PCa cell growth. In a xenograft model, EGCG was found to inhibit AR nuclear translocation and protein expression. We also observed a significant down-regulation of androgen-regulated miRNA-21 and up-regulation of a tumor suppressor, miRNA-330, in tumors of mice treated with EGCG. Taken together, we provide evidence that EGCG functionally antagonizes androgen action at multiple levels, resulting in inhibition of PCa growth.-Siddiqui, I. A., Asim, M., Hafeez, B. B., Adhami, V. M., Tarapore, R. S., Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 25, 1198-1207 (2011). www.fasebj.org	[Mukhtar, Hasan] Univ Wisconsin, Med Sci Ctr, Dept Dermatol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mukhtar, H (corresponding author), Univ Wisconsin, Med Sci Ctr, Dept Dermatol, B-25,1300 Univ Ave, Madison, WI 53706 USA.	hmukhtar@wisc.edu	Adhami, Vaqar/AAY-2837-2020; Tarapore, Rohinton/J-8300-2012	Adhami, Vaqar/0000-0002-2048-4570; 	U.S. Public Health Service [RO1CA78809, RO1CA101039, RO1CA120451]; U.S. National Institutes of Health [T32 AR 055893]; NATIONAL CANCER INSTITUTE [R01CA078809, R01CA101039, R01CA120451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR055893] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. Aria Baniahmad (University of Jena, Jena, Germany), Albert Brinkmann (University of Rotterdam, Rotterdam, The Netherlands), and Zafar Nawaz (University of Miami, Miami, FL, USA) for providing plasmids used in this study. The authors thank Drs. George Thalman (Institute for Surgical Technology and Biomechanics, Bern University, Bern, Switzerland) and Randall Tibbetts (University of Wisconsin, Madison, WI, USA) for providing C4-2 and CV1 cells, respectively. The authors thank Dr. Kenneth Satyshur (Department of Bacteriology, University of Wisconsin, Madison, WI, USA) for help with in silico studies. This work was supported by U.S. Public Health Service grants RO1CA78809, RO1CA101039, and RO1CA120451 to H. M. I. A. S. was supported by U.S. National Institutes of Health grant T32 AR 055893.	Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269; Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Blot WJ, 1996, EUR J CANCER PREV, V5, P425; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brusselmans K, 2003, INT J CANCER, V106, P856, DOI 10.1002/ijc.11317; Cantin L, 2007, J BIOL CHEM, V282, P30910, DOI 10.1074/jbc.M705524200; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen S, 1998, MOL ENDOCRINOL, V12, P1558, DOI 10.1210/me.12.10.1558; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; CHODAK GW, 1992, J UROLOGY, V147, P798, DOI 10.1016/S0022-5347(17)37389-5; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Gupta S, 2000, TOXICOL APPL PHARM, V164, P82, DOI 10.1006/taap.1999.8885; Gupta S, 1999, CANCER RES, V59, P2115; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708; Henshall SM, 2001, CANCER RES, V61, P423; Hsu CL, 2005, MOL ENDOCRINOL, V19, P350, DOI 10.1210/me.2004-0190; Hyytinen ER, 2002, LAB INVEST, V82, P1591, DOI 10.1097/01.LAB.0000038924.67707.75; Isaacs JT, 2000, JNCI-J NATL CANCER I, V92, P1367, DOI 10.1093/jnci/92.17.1367; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; LIAO SS, 1995, BIOCHEM BIOPH RES CO, V214, P833, DOI 10.1006/bbrc.1995.2362; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Morrissey C, 2007, INT J UROL, V14, P545, DOI 10.1111/j.1442-2042.2007.01774.x; Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; Paschka AG, 1998, CANCER LETT, V130, P1, DOI 10.1016/S0304-3835(98)00084-6; Perry JE, 1996, PROSTATE, P79; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ren FG, 2000, ONCOGENE, V19, P1924, DOI 10.1038/sj.onc.1203511; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ricciardelli C, 2005, PROSTATE, V63, P19, DOI 10.1002/pros.20154; RUIZEVELD D, 1994, AM J PATHOL, V144, P735; Siddiqui IA, 2008, ONCOGENE, V27, P2055, DOI 10.1038/sj.onc.1210840; Siddiqui IA, 2006, CARCINOGENESIS, V27, P833, DOI 10.1093/carcin/bgi323; Siddiqui IA, 2008, PHARM RES-DORDR, V25, P2135, DOI 10.1007/s11095-008-9553-z; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Taplin ME, 1999, CANCER RES, V59, P2511; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; WONG CI, 1993, J BIOL CHEM, V268, P19004; YOUNG CYF, 1992, BIOCHEMISTRY-US, V31, P818, DOI 10.1021/bi00118a026; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; Zhu WH, 2010, AM J THER, V17, P176, DOI 10.1097/MJT.0b013e3181c6c0b2	57	155	164	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1198	1207		10.1096/fj.10-167924	http://dx.doi.org/10.1096/fj.10-167924			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21177307	Green Published			2022-12-25	WOS:000288982800009
J	Westerlund, M; Behbahani, H; Gellhaar, S; Forsell, C; Belin, AC; Anvret, A; Zettergren, A; Nissbrandt, H; Lind, C; Sydow, O; Graff, C; Olson, L; Ankarcrona, M; Galter, D				Westerlund, Marie; Behbahani, Homira; Gellhaar, Sandra; Forsell, Charlotte; Belin, Andrea Carmine; Anvret, Anna; Zettergren, Anna; Nissbrandt, Hans; Lind, Charlotta; Sydow, Olof; Graff, Caroline; Olson, Lars; Ankarcrona, Maria; Galter, Dagmar			Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease	FASEB JOURNAL			English	Article						postmortem tissue; PRSS25; Western blot; in situ hybridization; protease assay	CEREBRAL AMYLOID ANGIOPATHY; SERINE-PROTEASE; PARKINSONS-DISEASE; CELL-DEATH; HUMAN HTRA2; BETA; DEGRADATION; NEPRILYSIN; INHIBITOR; APOPTOSIS	The serine-protease OMI/HTRA2, required for several cellular processes, including mitochondrial function, autophagy, chaperone activity, and apoptosis, has been implicated in the pathogenesis of both Alzheimer's disease (AD) and Parkinson's disease (PD). Western blot quantification of OMI/HTRA2 in frontal cortex of patients with AD (n=10) and control subjects (n=10) in two separate materials indicated reduced processed (active, 35 kDa) OMI/HTRA2 levels, whereas unprocessed (50 kDa) enzyme levels were not significantly different between the groups. Interestingly, the specific protease activity of OMI/HTRA2 was found to be significantly increased in patients with AD (n=10) compared to matched control subjects (n=10) in frontal cortex in two separate materials. Comparison of OMI/HTRA2 mRNA levels in frontal cortex and hippocampus, two brain areas particularly affected by AD, indicated similar levels in patients with AD (n=10) and matched control subjects (n=10). In addition, we analyzed the occurrence of the OMI/HTRA2 variants A141S and G399S in Swedish case-control materials for AD and PD and found a weak association of A141S with AD, but not with PD. In conclusion, our genetic, histological, and biochemical findings give further support to an involvement of OMI/HTRA2 in the pathology of AD; however, further studies are needed to clarify the role of this gene in neurodegeneration.-Westerlund, M., Behbahani, H., Gellhaar, S., Forsell, C., Carmine Belin, A., Anvret, A., Zettergren, A., Nissbrandt, H., Lind, C., Sydow, O., Graff, C., Olson, L., Ankarcrona, M., Galter, D. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease. FASEB J. 25, 1345-1352 (2011). www.fasebj.org	[Westerlund, Marie; Gellhaar, Sandra; Belin, Andrea Carmine; Anvret, Anna; Olson, Lars; Galter, Dagmar] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Behbahani, Homira; Forsell, Charlotte; Ankarcrona, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Sumitomo Pharma Alzheimer Ctr, S-17177 Stockholm, Sweden; [Behbahani, Homira; Forsell, Charlotte; Graff, Caroline; Ankarcrona, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Dis Res Ctr, S-17177 Stockholm, Sweden; [Zettergren, Anna; Nissbrandt, Hans] Gothenburg Univ, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden; [Lind, Charlotta; Sydow, Olof] Karolinska Univ Hosp, Dept Clin Neurosci, Stockholm, Sweden; [Graff, Caroline] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Galter, D (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8,B2 4, S-17177 Stockholm, Sweden.	dagmar.galter@ki.se	Galter, Dagmar/C-4826-2011; Belin, Andrea Carmine/AAV-9933-2021; graff, caroline/A-2545-2009	Galter, Dagmar/0000-0001-6485-6244; Belin, Andrea Carmine/0000-0001-6668-3172; Sydow, Olof/0000-0001-7798-8297; Graff, Caroline/0000-0002-9949-2951; Ankarcrona, Maria/0000-0002-7022-3694	U.S. Public Health Service [PHS/R 24-MH 068855]; Swedish Brain Power; Swedish Research Council; Swedish Parkinson Foundation; Swedish Brain Foundation; Dainippon Sumitomo Pharma (Osaka, Japan); Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Swedish Brain Power; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Brain Foundation; Dainippon Sumitomo Pharma (Osaka, Japan); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Karin Lundstromer, Karin Pernold, Eva Lindqvist, and Ann-Christin Thelander for excellent technical assistance and Prof. Laura Fratiglioni (Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden) for providing control samples from the SNAC-K project. The NBB (Amsterdam, the Netherlands) and the BBKI (Stockholm, Sweden) provided human brain samples from patients and control subjects. Brain tissue was also provided by the HBTRC (Belmont, MA, USA), which is supported in part by U.S. Public Health Service grant PHS/R 24-MH 068855. The authors also thank Dr. Miguel L. Martins (Cell Death Regulation Laboratory, MRC Toxicology Unit, Leicester, UK) for the kind gift of the S276C mutant Omi/HtrA2 protein. This study was supported by research grants from Swedish Brain Power, the Swedish Research Council, the Swedish Parkinson Foundation, the Swedish Brain Foundation, Dainippon Sumitomo Pharma (Osaka, Japan), and Karolinska Institutet Funds.	Alnemri ES, 2007, NAT CELL BIOL, V9, P1227, DOI 10.1038/ncb1107-1227; Behbahani H, 2010, NEUROCHEM INT, V57, P668, DOI 10.1016/j.neuint.2010.08.004; Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Carpentier M, 2002, J NEUROPATH EXP NEUR, V61, P849, DOI 10.1093/jnen/61.10.849; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Galter D, 2007, PHYSIOL BEHAV, V92, P46, DOI 10.1016/j.physbeh.2007.05.046; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kawamoto Y, 2010, NEUROREPORT, V21, P1121, DOI 10.1097/WNR.0b013e328340a731; Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005; Kooistra J, 2009, J ALZHEIMERS DIS, V17, P281, DOI 10.3233/JAD-2009-1037; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Liu ML, 2009, J CELL SCI, V122, P1917, DOI 10.1242/jcs.042226; Liu ML, 2005, MOL CELLS, V20, P83; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Miners JS, 2006, J NEUROPATH EXP NEUR, V65, P1012, DOI 10.1097/01.jnen.0000240463.87886.9a; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Ross OA, 2008, PARKINSONISM RELAT D, V14, P539, DOI 10.1016/j.parkreldis.2008.08.003; Seong YM, 2004, J BIOL CHEM, V279, P37588, DOI 10.1074/jbc.M401408200; Simon-Sanchez J, 2008, HUM MOL GENET, V17, P1988, DOI 10.1093/hmg/ddn096; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Vande Walle L, 2010, CELL RES, V20, P421, DOI 10.1038/cr.2010.18; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200	36	22	27	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1345	1352		10.1096/fj.10-163402	http://dx.doi.org/10.1096/fj.10-163402			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21163861	Green Published			2022-12-25	WOS:000288982800023
J	Hooper, R; Churamani, D; Brailoiu, E; Taylor, CW; Patel, S				Hooper, Robert; Churamani, Dev; Brailoiu, Eugen; Taylor, Colin W.; Patel, Sandip			Membrane Topology of NAADP-sensitive Two-pore Channels and Their Regulation by N-linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; CALCIUM-RELEASE; CA2+ SIGNALS; ACIDIC ORGANELLES; MOBILIZES CALCIUM; ION-CHANNEL; BETA-CELLS; RECEPTOR; MECHANISMS	Two-pore channels (TPCs) localize to the endolysosomal system and have recently emerged as targets for the Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). However, their membrane topology is unknown. Using fluorescence protease protection assays, we show that human TPC1 and TPC2 possess cytosolic N and C termini and therefore an even number of transmembrane regions. Fluorophores placed at position 225 or 347 in TPC1, or 339 in TPC2 were also cytosolic, whereas a fluorophore at position 628 in TPC1 was luminal. These data together with sequence similarity to voltage-gated Ca2+ and Na+ channels, and unbiased in silico predictions are consistent with a topology in which two homologous domains are present, each comprising 6 transmembrane regions and a re-entrant pore loop. Immunocytochemical analysis of selectively permeabilized cells using antipeptide antibodies confirmed that the C-terminal tails of recombinant TPCs are cytosolic and that residues 240-254 of TPC2 prior to putative pore 1 are luminal. Both TPC1 and TPC2 are N-glycosylated with residues 599, 611, and 616 contributing to glycosylation of TPC1. This confirms the luminal position of these residues, which immediately precede the putative pore loop of the second domain. Mutation of all three glycosylation sites in TPC1 enhances NAADP-evoked cytosolic Ca2+ signals. Our data establish essential features of the topology of two-pore channels.	[Hooper, Robert; Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Cambridge	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Taylor, Colin/G-2447-2010; Patel, Sandip/O-9591-2015	Taylor, Colin/0000-0001-7771-1044; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [HL90804]; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/H009736/1]; Wellcome Trust [085295]; BBSRC [BB/H009736/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants from the National Institutes of Health (HL90804, to E. B.), the Biotechnology and Biological Sciences Research Council (BB/G013721/1, to S. P., and BB/H009736/1, to C. W. T.) and the Wellcome Trust (085295, to C. W. T.).	Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Noma K, 2009, J BIOL CHEM, V284, P33139, DOI 10.1074/jbc.M109.021519; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Satler CA, 1998, HUM GENET, V102, P265, DOI 10.1007/s004390050690; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9141	9149		10.1074/jbc.M110.189985	http://dx.doi.org/10.1074/jbc.M110.189985			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21173144	hybrid, Green Published			2022-12-25	WOS:000288247700045
J	Baiet, B; Burel, C; Saint-Jean, B; Louvet, R; Menu-Bouaouiche, L; Kiefer-Meyer, MC; Mathieu-Rivet, E; Lefebvre, T; Castel, H; Carlier, A; Cadoret, JP; Lerouge, P; Bardor, M				Baiet, Berengere; Burel, Carole; Saint-Jean, Bruno; Louvet, Romain; Menu-Bouaouiche, Laurence; Kiefer-Meyer, Marie-Christine; Mathieu-Rivet, Elodie; Lefebvre, Thomas; Castel, Helene; Carlier, Aude; Cadoret, Jean-Paul; Lerouge, Patrice; Bardor, Muriel			N-Glycans of Phaeodactylum tricornutum Diatom and Functional Characterization of Its N-Acetylglucosaminyltransferase I Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; LOBES GENE ENCODES; ARABIDOPSIS-THALIANA; ENDOPLASMIC-RETICULUM; LINKED GLYCANS; LIQUID-CHROMATOGRAPHY; PHYLOGENETIC ANALYSIS; MOLECULAR-CLONING; GOLGI-APPARATUS; MARINE DIATOMS	N-Glycosylation, a major co- and post-translational event in the synthesis of proteins in eukaryotes, is unknown in aquatic photosynthetic microalgae. In this paper, we describe the N-glycosylation pathway in the diatom Phaeodactylum tricornutum. Bio-informatic analysis of its genome revealed the presence of a complete set of sequences potentially encoding for proteins involved in the synthesis of the lipid-linked Glc(3)Man(9)GlcNAc(2)-PP-dolichol N-glycan, some subunits of the oligosaccharyltransferase complex, as well as endoplasmic reticulum glucosidases and chaperones required for protein quality control and, finally, the alpha-mannosidase I involved in the trimming of the N-glycan precursor into Man-5 N-glycan. Moreover, one N-acetylglucosaminyltransferase I, a Golgi glycosyltransferase that initiates the synthesis of complex type N-glycans, was predicted in the P. tricornutum genome. We demonstrated that this gene encodes for an active N-acetylglucosaminyltransferase I, which is able to restore complex type N-glycans maturation in the Chinese hamster ovary Lec1 mutant, defective in its endogeneous N-acetylglucosaminyltransferase I. Consistent with these data, the structural analyses of N-linked glycans demonstrated that P. tricornutum proteins carry mainly high mannose type N-glycans ranging from Man-5 to Man-9. Although representing a minor glycan population, paucimannose N-glycans were also detected, suggesting the occurrence of an N-acetylglucosaminyltransferase I-dependent maturation of N-glycans in this diatom.	[Baiet, Berengere; Burel, Carole; Louvet, Romain; Menu-Bouaouiche, Laurence; Kiefer-Meyer, Marie-Christine; Mathieu-Rivet, Elodie; Lerouge, Patrice; Bardor, Muriel] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, Fac Sci, F-76821 Mont St Aignan, France; [Saint-Jean, Bruno; Carlier, Aude; Cadoret, Jean-Paul] IFREMER, Ctr Nantes, Lab Physiol & Biotechnol Algues, F-44311 Nantes 03, France; [Lefebvre, Thomas; Castel, Helene] Univ Rouen, INSERM, Lab Differenciat & Commun Neuronale & Neuroendocr, Fac Sci,U982,IFRM23, F-76821 Mont St Aignan, France	Universite de Rouen Normandie; Ifremer; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Bardor, M (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01, Singapore 138668, Singapore.		KIEFER-MEYER, Marie-Christine/AAQ-6467-2021; castel, helene/B-8675-2009	castel, helene/0000-0002-8972-5555; Saint-Jean, Bruno/0000-0003-3915-5440; Menu-Bouaouiche, Laurence/0000-0002-8214-5195; Cadoret, Jean-Paul/0000-0001-7542-5474	University of Rouen	University of Rouen	This work was supported by funds from the University of Rouen (to P. L. and M. B.).	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bakker H, 2001, FEBS LETT, V507, P307, DOI 10.1016/S0014-5793(01)02999-4; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bardor M, 2003, PLANT BIOTECHNOL J, V1, P451, DOI 10.1046/j.1467-7652.2003.00041.x; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bougaran GL, 2003, AQUAT LIVING RESOUR, V16, P389, DOI 10.1016/S0990-7440(03)00053-6; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chung CC, 2005, APPL ENVIRON MICROB, V71, P8744, DOI 10.1128/AEM.71.12.8744-8751.2005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; Feng M, 2004, GLYCOBIOLOGY, V14, P909, DOI 10.1093/glycob/cwh110; Fitchette Anne-Catherine, 2007, V355, P317; Fitchette-Laine AC, 1998, METH BIOTEC, V3, P271; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Gnanasambandam A, 2007, PLANT BIOTECHNOL J, V5, P290, DOI 10.1111/j.1467-7652.2007.00241.x; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holmes EH, 2000, J BIOL CHEM, V275, P24237, DOI 10.1074/jbc.M000888200; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kajiura H, 2010, GLYCOBIOLOGY, V20, P235, DOI 10.1093/glycob/cwp170; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kang LK, 2009, J PHYCOL, V45, P864, DOI 10.1111/j.1529-8817.2009.00698.x; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KWIATKOWSKI BA, 1995, GENE, V165, P219, DOI 10.1016/0378-1119(95)00537-G; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima R, 2003, PLANT J, V33, P493, DOI 10.1046/j.1365-313X.2003.01636.x; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Pagny S, 2003, PLANT CELL PHYSIOL, V44, P173, DOI 10.1093/pcp/pcg027; Pagny S, 2003, PLANT J, V33, P189, DOI 10.1046/j.0960-7412.2002.01604.x; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; Salamov A., 2008, NATURE, V456, P239; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Scala S, 2002, PLANT PHYSIOL, V129, P993, DOI 10.1104/pp.010713; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Seveno M, 2008, ANAL BIOCHEM, V379, P66, DOI 10.1016/j.ab.2008.04.034; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; VITALE A, 1984, J CELL BIOL, V99, P133, DOI 10.1083/jcb.99.1.133; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Walne P. R., 1966, Fishery Investigations London (2), V25, P1; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931	76	51	54	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6152	6164		10.1074/jbc.M110.175711	http://dx.doi.org/10.1074/jbc.M110.175711			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169367	Green Published, hybrid			2022-12-25	WOS:000287476400024
J	Frey, AG; Eide, DJ				Frey, Avery G.; Eide, David J.			Roles of Two Activation Domains in Zap1 in the Response to Zinc Deficiency in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; GENE-EXPRESSION; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; MUTATIONAL ANALYSIS; YEAST; PROTEIN; MULTIPLE; COMPLEX; GAL4	Previous studies suggested that the zinc-responsive Zap1 transcriptional activator directly regulates the expression of over 80 genes in Saccharomyces cerevisiae. Many of these genes play key roles to enhance the ability of yeast cells to grow under zinc-limiting conditions. Zap1 is unusual among transcriptional activators in that it contains two activation domains, designated AD1 and AD2, which are regulated independently by zinc. These two domains are evolutionarily conserved among Zap1 orthologs suggesting that they are both important for Zap1 function. In this study, we have examined the roles of AD1 and AD2 in low zinc growth and the regulation of Zap1 target gene expression. Using alleles that are specifically disrupted for either AD1 or AD2 function, we found that these domains are not redundant, and both are important for normal growth in low zinc. AD1 plays the primary role in zinc-responsive gene regulation, whereas AD2 is required for maximal expression of only a few target promoters. AD1 alone is capable of driving full expression of most Zap1 target genes and dictates the kinetics of Zap1 gene induction in response to zinc withdrawal. Surprisingly, we found that AD1 is less active in zinc-limited cells under heat stress and AD2 plays a more important role under those conditions. These results suggest that AD2 may contribute more to Zap1 function when zinc deficiency is combined with other environmental stresses. In the course of these studies, we also found that the heat shock response is induced under conditions of severe zinc deficiency.	[Frey, Avery G.; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	deide@wisc.edu			National Institutes of Health [RO1-GM056285, T32-DK007665]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-GM056285 and T32-DK007665.	Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2000, EMBO J, V19, P3704, DOI 10.1093/emboj/19.14.3704; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, J BIOL CHEM, V281, P25326, DOI 10.1074/jbc.M600655200; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Ding WV, 1997, MOL CELL BIOL, V17, P2538, DOI 10.1128/MCB.17.5.2538; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; FALCHUK KH, 1975, J CELL SCI, V17, P57; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gauci VJ, 2009, FEMS YEAST RES, V9, P1187, DOI 10.1111/j.1567-1364.2009.00557.x; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JOHNSTON M, 1988, GENETICS, V120, P63; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; OTEIZA PI, 1995, J NUTR, V125, P823; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	43	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6844	6854		10.1074/jbc.M110.203927	http://dx.doi.org/10.1074/jbc.M110.203927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177862	Green Published, hybrid			2022-12-25	WOS:000287476400091
J	Yu, C; Sonnen, AFP; George, R; Dessailly, BH; Stagg, LJ; Evans, EJ; Orengo, CA; Stuart, DI; Ladbury, JE; Ikemizu, S; Gilbert, RJC; Davis, SJ				Yu, Chao; Sonnen, Andreas F-P.; George, Roger; Dessailly, Benoit H.; Stagg, Loren J.; Evans, Edward J.; Orengo, Christine A.; Stuart, David I.; Ladbury, John E.; Ikemizu, Shinji; Gilbert, Robert J. C.; Davis, Simon J.			Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY ANALYSIS; CRYSTAL-STRUCTURE; CELL-SURFACE; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNOGLOBULIN SUPERFAMILY; STRUCTURAL GENOMICS; MOLECULAR-BASIS; BINDING DOMAIN; SOLUBLE FORM; PROTEIN	The inhibitory T-cell surface-expressed receptor, cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), which belongs to the class of cell surface proteins phosphorylated by extrinsic tyrosine kinases that also includes antigen receptors, binds the related ligands, B7-1 and B7-2, expressed on antigen-presenting cells. Conformational changes are commonly invoked to explain ligand-induced "triggering" of this class of receptors. Crystal structures of ligand-bound CTLA-4 have been reported, but not the apo form, precluding analysis of the structural changes accompanying ligand binding. The 1.8-angstrom resolution structure of an apo human CTLA-4 homodimer emphasizes the shared evolutionary history of the CTLA-4/CD28 subgroup of the immunoglobulin superfamily and the antigen receptors. The ligand-bound and unbound forms of both CTLA-4 and B7-1 are remarkably similar, in marked contrast to B7-2, whose binding to CTLA-4 has elements of induced fit. Isothermal titration calorimetry reveals that ligand binding by CTLA-4 is enthalpically driven and accompanied by unfavorable entropic changes. The similarity of the thermodynamic parameters determined for the interactions of CTLA-4 with B7-1 and B7-2 suggests that the binding is not highly specific, but the conformational changes observed for B7-2 binding suggest some level of selectivity. The new structure establishes that rigid-body ligand interactions are capable of triggering CTLA-4 phosphorylation by extrinsic kinase(s).	[Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Sonnen, Andreas F-P.; Stuart, David I.; Gilbert, Robert J. C.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [George, Roger; Dessailly, Benoit H.; Orengo, Christine A.; Ladbury, John E.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Stagg, Loren J.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ikemizu, Shinji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto 8620973, Japan	University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of Texas System; UTMD Anderson Cancer Center; Kumamoto University	Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	simon.davis@ndm.ox.ac.uk		Gilbert, Robert/0000-0001-9336-5604; Ladbury, John/0000-0002-6328-7200; Stuart, David/0000-0002-3426-4210	United Kingdom Medical Research Council; Ministry of Education, Culture, Sports, Science and Technology of Japan; Royal Society; Wellcome Trust; Medical Research Council [G19/3, G1100525, G1000099] Funding Source: researchfish; MRC [G19/3, G1000099] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the United Kingdom Medical Research Council.; Supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Royal Society. To whom correspondence may be addressed. Tel.: 44-1865-287535; Fax: 44-1865-287547; E-mail: gilbert@strubi.ox.ac.uk.; Supported by the Wellcome Trust. To whom correspondence may be addressed. Tel.: 44-1865-221336; Fax: 44-1865-222737; E-mail: simon.davis@ndm.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Chang CYY, 2000, ACTA CRYSTALLOGR D, V56, P1468, DOI 10.1107/S0907444900010738; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; Chuang E, 1999, J IMMUNOL, V162, P1270; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Evans EJ, 2003, IMMUNITY, V19, P213, DOI 10.1016/S1074-7613(03)00198-5; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HOWARD TA, 1991, IMMUNOGENETICS, V33, P74, DOI 10.1007/BF00211698; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; JOHNSON P, 1986, NATURE, V323, P74, DOI 10.1038/323074a0; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LAFAGEPOCHITALOFF M, 1990, IMMUNOGENETICS, V31, P198; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; O'Brien R, 2000, PROTEIN SCI, V9, P570; Orengo CA, 1996, METHOD ENZYMOL, V266, P617; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schneider H, 1998, BIOCHEM BIOPH RES CO, V252, P14, DOI 10.1006/bbrc.1998.9559; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Sonnen AFP, 2010, J MOL BIOL, V399, P207, DOI 10.1016/j.jmb.2010.04.011; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	75	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6685	6696		10.1074/jbc.M110.182394	http://dx.doi.org/10.1074/jbc.M110.182394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156796	Green Published, hybrid			2022-12-25	WOS:000287476400076
J	Bresciani, E; Confalonieri, S; Cermenati, S; Cimbro, S; Foglia, E; Beltrame, M; Di Fiore, PP; Cotelli, F				Bresciani, Erica; Confalonieri, Stefano; Cermenati, Solei; Cimbro, Simona; Foglia, Efrem; Beltrame, Monica; Di Fiore, Pier Paolo; Cotelli, Franco			Zebrafish Numb and Numblike Are Involved in Primitive Erythrocyte Differentiation	PLOS ONE			English	Article							MOUSE CORTICAL NEUROGENESIS; MAMMALIAN NUMB; CELL FATE; IN-VIVO; ASYMMETRIC LOCALIZATION; VASCULAR DEVELOPMENT; NOTCH; EXPRESSION; GENE; EMBRYOS	Background: Notch signaling is an evolutionarily conserved regulatory circuitry implicated in cell fate determination in various developmental processes including hematopoietic stem cell self-renewal and differentiation of blood lineages. Known endogenous inhibitors of Notch activity are Numb-Nb and Numblike-Nbl, which play partially redundant functions in specifying and maintaining neuronal differentiation. Nb and Nbl are expressed in most tissues including embryonic and adult hematopoietic tissues in mice and humans, suggesting possible roles for these proteins in hematopoiesis. Methodology and Principal Findings: We employed zebrafish to investigate the possible functional role of Numb and Numblike during hematopoiesis, as this system allows a detailed analysis even in embryos with severe defects that would be lethal in other organisms. Here we describe that nb/nbl knockdown results in severe reduction or absence of embryonic erythrocytes in zebrafish. Interestingly, nb/nbl knocked-down embryos present severe downregulation of the erythroid transcription factor gata1. This results in erythroblasts which fail to mature and undergo apoptosis. Our results indicate that Notch activity is increased in embryos injected with nb/nbl morpholino, and we show that inhibition of Notch activation can partially rescue the hematopoietic phenotype. Conclusions and Significance: Our results provide the first in vivo evidence of an involvement of Numb and Numblike in zebrafish erythroid differentiation during primitive hematopoiesis. Furthermore, we found that, at least in part, the nb/nbl morphant phenotype is due to enhanced Notch activation within hematopoietic districts, which in turn results in primitive erythroid differentiation defects.	[Bresciani, Erica; Cimbro, Simona; Foglia, Efrem; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Confalonieri, Stefano; Di Fiore, Pier Paolo] FIRC Inst Mol Oncol Fdn IFOM, Milan, Italy; [Cermenati, Solei; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Di Fiore, Pier Paolo] European Inst Oncol IEO, Milan, Italy; [Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	University of Milan; IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO); University of Milan	Bresciani, E (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; franco.cotelli@unimi.it	Foglia, Efrem Alessandro/AGW-8220-2022; Confalonieri, Stefano/AAQ-6786-2020; Foglia, Efrem Alessandro/AAF-1840-2020; Di Fiore, Pier Paolo/K-2130-2012; Beltrame, Monica/D-8093-2017	Confalonieri, Stefano/0000-0001-6886-9851; Foglia, Efrem Alessandro/0000-0002-7446-8365; Di Fiore, Pier Paolo/0000-0002-2252-0950; Beltrame, Monica/0000-0001-5094-3494	Fondazione Cariplo [2006.0807]; Progetto Cariplo N.O.B.E.L.; Associazione Italiana per la Ricerca sul Cancro, MIUR; European Community; European Research Commission; Ferrari Foundation; Monzino Foundation	Fondazione Cariplo(Fondazione Cariplo); Progetto Cariplo N.O.B.E.L.; Associazione Italiana per la Ricerca sul Cancro, MIUR(Fondazione AIRC per la ricerca sul cancroMinistry of Education, Universities and Research (MIUR)); European Community(European Commission); European Research Commission(European CommissionEuropean Commission Joint Research Centre); Ferrari Foundation; Monzino Foundation	This study was supported by grants from Fondazione Cariplo (grant number 2006.0807) to M. B. and Progetto Cariplo N.O.B.E.L. (Biological and molecular characterization of cancer stem cells) to F. C. and P. P. D. F, and by grants from the Associazione Italiana per la Ricerca sul Cancro, MIUR, the European Community (FP6 and FP7), the European Research Commission, the Ferrari Foundation and the Monzino Foundation to PPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Durbin L, 2000, DEVELOPMENT, V127, P1703; French MB, 2002, J IMMUNOL, V168, P3173, DOI 10.4049/jimmunol.168.7.3173; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kobayashi M, 2001, DEVELOPMENT, V128, P2341; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Niikura Y, 2006, MECH DEVELOP, V123, P407, DOI 10.1016/j.mod.2006.03.008; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Patterson LJ, 2005, BLOOD, V105, P3502, DOI 10.1182/blood-2004-09-3547; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; THISSE C, 1993, DEVELOPMENT, V119, P1203; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Willett CE, 2001, DEV DYNAM, V222, P694, DOI 10.1002/dvdy.1223; Wilson A, 2007, J IMMUNOL, V178, P6746, DOI 10.4049/jimmunol.178.11.6746; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14296	10.1371/journal.pone.0014296	http://dx.doi.org/10.1371/journal.pone.0014296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179188	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900009
J	Jin, L; Lenz, LL; Cambier, JC				Jin, Lei; Lenz, Laurel L.; Cambier, John C.			Cellular Reactive Oxygen Species Inhibit MPYS Induction of IFN beta	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; CLASS-II; PROTEIN; ADAPTER; INACTIVATION; ACTIVATION; RECEPTOR; DOMAIN; NLRX1	Many inflammatory diseases, as well as infections, are accompanied by elevation in cellular levels of Reactive Oxygen Species (ROS). Here we report that MPYS, a.k.a. STING, which was recently shown to mediate activation of IFN beta expression during infection, is a ROS sensor. ROS induce intermolecular disulfide bonds formation in MPYS homodimer and inhibit MPYS IFN beta stimulatory activity. Cys-64, -148, -292, -309 and the potential C(88)xxC(91) redox motif in MPYS are indispensable for IFN beta stimulation and IRF3 activation. Thus, our results identify a novel mechanism for ROS regulation of IFN beta stimulation.	[Jin, Lei; Lenz, Laurel L.; Cambier, John C.] Univ Colorado, Denver Sch Med & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver	Jin, L (corresponding author), Univ Colorado, Denver Sch Med & Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80202 USA.	cambierj@njhealth.org		jin, lei/0000-0001-6836-1142; Lenz, Laurel/0000-0002-4933-8913; Cambier, John/0000-0002-7803-242X	NIH [3R01AI062739-05S209, 5R01AI062739-05, 5R01AI065638-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062739, R01AI065638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH 3R01AI062739-05S209 (J.C.C), 5R01AI062739-05 (J.C.C), 5R01AI065638-04 (L.L.L). J.C.C is Ida and Cecil Green Professor of Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; CSORDAS G, 2009, BIOCH BIOPHYS ACTA; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; ISHIKAWA H, 2009, NATURE; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2008, IMMUNOL LETT, V116, P184, DOI 10.1016/j.imlet.2007.11.023; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Santos CXC, 2009, ANTIOXID REDOX SIGNA; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15142	10.1371/journal.pone.0015142	http://dx.doi.org/10.1371/journal.pone.0015142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170271	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400018
J	Gryganskyi, AP; Lee, SC; Litvintseva, AP; Smith, ME; Bonito, G; Porter, TM; Anishchenko, IM; Heitman, J; Vilgalys, R				Gryganskyi, Andrii P.; Lee, Soo Chan; Litvintseva, Anastasia P.; Smith, Matthew E.; Bonito, Gregory; Porter, Teresita M.; Anishchenko, Iryna M.; Heitman, Joseph; Vilgalys, Rytas			Structure, Function, and Phylogeny of the Mating Locus in the Rhizopus oryzae Complex	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBUNIT RIBOSOMAL DNA; GENUS RHIZOPUS; IDENTIFICATION; POPULATIONS; ZYGOSPORE; SEX; STRATEGIES; VIRULENCE; MUCORALES	The Rhizopus oryzae species complex is a group of zygomycete fungi that are common, cosmopolitan saprotrophs. Some strains are used beneficially for production of Asian fermented foods but they can also act as opportunistic human pathogens. Although R. oryzae reportedly has a heterothallic (+/-) mating system, most strains have not been observed to undergo sexual reproduction and the genetic structure of its mating locus has not been characterized. Here we report on the mating behavior and genetic structure of the mating locus for 54 isolates of the R. oryzae complex. All 54 strains have a mating locus similar in overall organization to Phycomyces blakesleeanus and Mucor circinelloides (Mucoromycotina, Zygomycota). In all of these fungi, the minus (-) allele features the SexM high mobility group (HMG) gene flanked by an RNA helicase gene and a TP transporter gene (TPT). Within the R. oryzae complex, the plus (+) mating allele includes an inserted region that codes for a BTB/POZ domain gene and the SexP HMG gene. Phylogenetic analyses of multiple genes, including the mating loci (HMG, TPT, RNA helicase), ITS1-5.8S-ITS2 rDNA, RPB2, and LDH genes, identified two distinct groups of strains. These correspond to previously described sibling species R. oryzae sensu stricto and R. delemar. Within each species, discordant gene phylogenies among multiple loci suggest an outcrossing population structure. The hypothesis of random-mating is also supported by a 50:50 ratio of plus and minus mating types in both cryptic species. When crossed with tester strains of the opposite mating type, most isolates of R. delemar failed to produce zygospores, while isolates of R. oryzae produced sterile zygospores. In spite of the reluctance of most strains to mate in vitro, the conserved sex locus structure and evidence for outcrossing suggest that a normal sexual cycle occurs in both species.	[Gryganskyi, Andrii P.; Smith, Matthew E.; Bonito, Gregory; Porter, Teresita M.; Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Gryganskyi, Andrii P.; Anishchenko, Iryna M.] Natl Acad Sci Ukraine, NG Kholodnyi Bot Inst, Dept Mycol, Kiev, Ukraine; [Lee, Soo Chan; Litvintseva, Anastasia P.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; Duke University	Gryganskyi, AP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	apg10@duke.edu	Heitman, Joseph/ABC-6006-2021; Porter, Teresita M/H-4072-2011; M., Anishchenko Iryna/AAC-2366-2020; Smith, Matthew E/A-8115-2012; Smith, Matthew E./ABC-3015-2020	Smith, Matthew E/0000-0002-0878-0932; Smith, Matthew E./0000-0002-0878-0932; Gryganskyi, Andrii/0000-0002-6037-0092; Vilgalys, Rytas/0000-0001-8299-3605	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [AI50113, AI085331]; NIH [AI52080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050113, T32AI052080, R21AI085331] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases R01 grant AI50113 to J. H. and R21 grant AI085331 to J. H. S. C. L. was supported by the NIH Molecular Mycology and Pathogenesis Training Program (AI52080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFEZ SII, 1984, MYCOPATHOLOGIA, V85, P53, DOI 10.1007/BF00436702; Abe A, 2003, BIOSCI BIOTECH BIOCH, V67, P1725, DOI 10.1271/bbb.67.1725; Abe A, 2007, MYCOLOGIA, V99, P714, DOI 10.3852/mycologia.99.5.714; Abe A, 2006, BIOSCI BIOTECH BIOCH, V70, P2387, DOI 10.1271/bbb.60101; AINSWORTH G. C, 1955, TRANS BRIT MYCOL SOC, V38, P369; Aldenderfer MS., 1984, CLUSTER ANAL; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blakeslee AF, 1927, BOT GAZ, V84, P27, DOI 10.1086/333757; Blakeslee AF, 1904, SCIENCE, V19, P0864, DOI 10.1126/science.19.492.864; Blakeslee AF, 1921, BOT GAZ, V72, P162, DOI 10.1086/332909; BROWN J, 2005, AM J HEALTH-SYST PH, V25, P215; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; CONSTANDSEWESTE.TS, 1972, COEFFICIENTS BIOL DI; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CUTTER VM, 1942, B TORREY BOT CLUB, V69, P592; Domsch K.H., 1980, COMPENDIUM SOIL FUNG; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ELLIS JJ, 1985, MYCOLOGIA, V77, P243, DOI 10.2307/3793074; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Fiore-Donno AM, 2001, NEW PHYTOL, V152, P533, DOI 10.1046/j.0028-646X.2001.00271.x; FISHER A, 1892, PHYCOMYCETES MUCORIN, V1, P161; FRYE CB, 1993, MYCOPATHOLOGIA, V124, P139, DOI 10.1007/BF01103730; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GAUGER W, 1965, MYCOLOGIA, V57, P634, DOI 10.2307/3756739; GAUGER WL, 1961, AM J BOT, V48, P427, DOI 10.2307/2439336; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; GEIDUSCHEK E, 1961, ARCH BIOCHEM BIOPHYS, V95, P114, DOI 10.1016/0003-9861(61)90116-3; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Harrington TC, 1999, STRUCTURE DYNAMICS F, V43, P71, DOI DOI 10.1007/978-94-011-4423-0_3; HAWKER LE, 1971, PHILOS T ROY SOC B, V263, P71, DOI 10.1098/rstb.1971.0110; HAWKER LE, 1968, ANN BOT-LONDON, V32, P137, DOI 10.1093/oxfordjournals.aob.a084188; HESSELTINE C, 1961, MYCOLOGIA, V53, P406, DOI 10.2307/3756584; HESSELTINE CW, 1987, MYCOLOGIA, V79, P289, DOI 10.2307/3807661; Ibrahim AS, 2003, ANTIMICROB AGENTS CH, V47, P3343, DOI 10.1128/AAC.47.10.3343-3344.2003; IDNURM A, 2007, SEX FUNGI; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; INUI T, 1965, J GEN APPL MICROBIOL, VS 11, P1, DOI 10.2323/jgam.11.Supplement_1; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kirk PM, 2008, DICT FUNGI; Kito H, 2009, BIOSCI BIOTECH BIOCH, V73, P861, DOI 10.1271/bbb.80773; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Liou Guey-Yuh, 2001, Nova Hedwigia, V72, P231; Liu XY, 2007, SYDOWIA, V59, P235; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maddison W, MESQUITE MODULAR SYS; MILKO AA, 1974, IDENTIFICATION GUIDE; Nielsen K, 2005, GENETICS, V171, P975, DOI 10.1534/genetics.105.045039; Oda Y, 2003, FOOD MICROBIOL, V20, P371, DOI 10.1016/S0740-0020(02)00131-4; Ogawa Yoshio, 2004, Mycoscience, V45, P271, DOI 10.1007/s10267-004-0180-1; Perez G, 2010, MOL ECOL, V19, P1801, DOI 10.1111/j.1365-294X.2010.04584.x; PETRIKKOS GL, 2008, MYCOL NEWSL, V1, P31; Pidoplichko N.M., 1971, ATLAS MUCORALEAN FUN; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Rozen S, 2000, BIOINFORMATICS METHO; Sabouraud R., 1896, TRICHOPHYTIES HUMAIN, P49; Saito K, 2004, ARCH MICROBIOL, V182, P30, DOI 10.1007/s00203-004-0691-3; Schipper MAA, 1996, J MED VET MYCOL, V34, P199; SCHIPPER MAA, 1984, STUD MYCOL, P1; SCHIPPER MAA, 1985, J GEN MICROBIOL, V131, P2359; SCHOLER HJ, 1983, FUNGI PATHOGENIC HUM; Schwarz P, 2006, J CLIN MICROBIOL, V44, P340, DOI 10.1128/JCM.44.2.340-349.2006; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Singh N, 2009, J INFECT DIS, V200, P1002, DOI 10.1086/605445; Skory CD, 2007, CURR GENET, V52, P23, DOI 10.1007/s00294-007-0135-0; Skory CD, 2009, ENZYME MICROB TECH, V44, P242, DOI 10.1016/j.enzmictec.2008.10.009; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White T., 1990, PCR PROTOCOLS GUIDE, P315; WOLF M, 2005, IN SILICO BIOL, V5; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Zoller S, 1999, LICHENOLOGIST, V31, P511	82	56	60	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15273	10.1371/journal.pone.0015273	http://dx.doi.org/10.1371/journal.pone.0015273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151560	Green Published, gold			2022-12-25	WOS:000285135800020
J	Head, ML; Wong, BBM; Brooks, R				Head, Megan L.; Wong, Bob B. M.; Brooks, Robert			Sexual Display and Mate Choice in an Energetically Costly Environment	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; PREDATION RISK; SWIMMING PERFORMANCE; MATING-BEHAVIOR; GEOGRAPHIC-VARIATION; COURTSHIP BEHAVIOR; FEMALE GUPPIES; MALE TRAITS; SELECTION; AVAILABILITY	Sexual displays and mate choice often take place under the same set of environmental conditions and, as a consequence, may be exposed to the same set of environmental constraints. Surprisingly, however, very few studies consider the effects of environmental costs on sexual displays and mate choice simultaneously. We conducted an experiment, manipulating water flow in large flume tanks, to examine how an energetically costly environment might affect the sexual display and mate choice behavior of male and female guppies, Poecilia reticulata. We found that male guppies performed fewer sexual displays and became less choosy, with respect to female size, in the presence of a water current compared to those tested in still water. In contrast to males, female responsive to male displays did not differ between the water current treatments and females exhibited no mate preferences with respect to male size or coloration in either treatment. The results of our study underscore the importance of considering the simultaneous effects of environmental costs on the sexual behaviors of both sexes.	[Head, Megan L.; Brooks, Robert] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Wong, Bob B. M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University		M.L.Head@exeter.ac.uk	Head, Megan/D-2551-2010; Brooks, Robert/A-1251-2008	Brooks, Robert/0000-0001-6926-0781; Head, Megan/0000-0002-8123-7661; Wong, Bob/0000-0001-9352-6500	Australian Research Council	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council grant to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booksmythe I, 2008, ANIM BEHAV, V76, P1775, DOI 10.1016/j.anbehav.2008.07.022; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Dunn AM, 2008, ANIM BEHAV, V76, P1289, DOI 10.1016/j.anbehav.2008.06.013; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ESHEL I, 1979, THEOR POPUL BIOL, V16, P301, DOI 10.1016/0040-5809(79)90019-4; Evans JP, 2002, BEHAV ECOL SOCIOBIOL, V52, P496, DOI 10.1007/s00265-002-0535-6; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Fuller R, 1996, BEHAV ECOL, V7, P69, DOI 10.1093/beheco/7.1.69; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Hebets EA, 2008, ANIM BEHAV, V76, P355, DOI 10.1016/j.anbehav.2007.12.021; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Karino K, 2006, ZOOL SCI, V23, P255, DOI 10.2108/zsj.23.255; Katvala M, 2001, ANIM BEHAV, V62, P133, DOI 10.1006/anbe.2001.1737; Kodric-Brown A, 2005, ENVIRON BIOL FISH, V73, P299, DOI 10.1007/s10641-005-1598-9; Koga T, 1998, P ROY SOC B-BIOL SCI, V265, P1385, DOI 10.1098/rspb.1998.0446; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kolluru GR, 2005, BEHAV ECOL, V16, P294, DOI 10.1093/beheco/arh161; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lopez S, 1999, ANIM BEHAV, V57, P1129, DOI 10.1006/anbe.1998.1064; Magellan K, 2006, ANIM BEHAV, V72, P75, DOI 10.1016/j.anbehav.2005.09.022; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V258, P89, DOI 10.1098/rspb.1994.0147; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Nicoletto PF, 1996, BEHAV ECOL, V7, P272, DOI 10.1093/beheco/7.3.272; Nicoletto PF, 1999, ENVIRON BIOL FISH, V55, P227, DOI 10.1023/A:1007587809618; POULIN R, 1994, P ROY SOC B-BIOL SCI, V256, P183, DOI 10.1098/rspb.1994.0068; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Swan T., 2006, THESIS U SO QUEENSLA; Syriatowicz Alexandra, 2004, BMC Ecology, V4, P5, DOI 10.1186/1472-6785-4-5; TUTTLE MD, 1982, ANIM BEHAV, V30, P393, DOI 10.1016/S0003-3472(82)80050-X; Wong BBM, 2003, P ROY SOC B-BIOL SCI, V270, pS36, DOI 10.1098/rsbl.2003.0003; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	49	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15279	10.1371/journal.pone.0015279	http://dx.doi.org/10.1371/journal.pone.0015279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151610	Green Submitted, Green Published, gold			2022-12-25	WOS:000285135800022
J	Pan, XF; Liao, YH; Liu, YM; Chang, P; Liao, LN; Yang, L; Li, HQ				Pan, Xuefeng; Liao, Yuanhong; Liu, Yunmeng; Chang, Peng; Liao, Lingni; Yang, Li; Li, Hongquan			Transcription of AAT.ATT Triplet Repeats in Escherichia coli Is Silenced by H-NS and IS1E Transposition	PLOS ONE			English	Article							CANNABINOID RECEPTOR GENE; TRINUCLEOTIDE REPEATS; MOLECULAR-BASIS; DNA; BINDING; PROTEIN; STRAND; SITES; POLYMORPHISM; ASSOCIATION	Background: The trinucleotide repeats AAT.ATT are simple DNA sequences that potentially form different types of non-B DNA secondary structures and cause genomic instabilities in vivo. Methodology and Principal Findings: The molecular mechanism underlying the maintenance of a 24-triplet AAT.ATT repeat was examined in E. coli by cloning the repeats into the EcoRI site in plasmid pUC18 and into the attB site on the E. coli genome. Either the AAT or the ATT strand acted as lagging strand template in a replication fork. Propagations of the repeats in either orientation on plasmids did not affect colony morphology when triplet repeat transcription using the lacZ promoter was repressed either by supplementing LacI(Q) in trans or by adding glucose into the medium. In contrast, transparent colonies were formed by inducing transcription of the repeats, suggesting that transcription of AAT.ATT repeats was toxic to cell growth. Meanwhile, significant IS1E transposition events were observed both into the triplet repeats region proximal to the promoter side, the promoter region of the lacZ gene, and into the AAT.ATT region itself. Transposition reversed the transparent colony phenotype back into healthy, convex colonies. In contrast, transcription of an 8-triplet AAT.ATT repeat in either orientation on plasmids did not produce significant changes in cell morphology and did not promote IS1E transposition events. We further found that a role of IS1E transposition into plasmids was to inhibit transcription through the repeats, which was influenced by the presence of the H-NS protein, but not of its paralogue StpA. Conclusions and Significance: Our findings thus suggest that the longer AAT.ATT triplet repeats in E. coli become vulnerable after transcription. H-NS and its facilitated IS1E transposition can silence long triplet repeats transcription and preserve cell growth and survival.	[Pan, Xuefeng; Liao, Yuanhong; Liu, Yunmeng; Chang, Peng; Liao, Lingni; Yang, Li] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Pan, Xuefeng] Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh, Midlothian, Scotland; [Pan, Xuefeng; Li, Hongquan] Hebei Univ, Hlth Sci Ctr, Baoding, Peoples R China	Beijing Institute of Technology; University of Edinburgh; Hebei University	Pan, XF (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	xuefengpancam@yahoo.com.cn		Pan, Xuefeng/0000-0002-7660-659X; Chang, Peng/0000-0003-0890-2685	Natural Science Foundation of the Beijing Institute of Technology, China [1060050320804]; Medical Science foundation of Hebei University, China [2007Z02]; Medical Research Council of the United Kingdom	Natural Science Foundation of the Beijing Institute of Technology, China; Medical Science foundation of Hebei University, China; Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Natural Science Foundation of the Beijing Institute of Technology (1060050320804), China, and the Medical Science foundation of Hebei University(2007Z02), China. And it has also been supported by a grant from Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLON N, 2006, PHARMACOGENOMICS J, V6, P126; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Astolfi P, 2003, GENE, V317, P117, DOI 10.1016/S0378-1119(03)00659-0; Barrero FJ, 2005, PHARMACOGENOMICS J, V5, P135, DOI 10.1038/sj.tpj.6500301; BIEL SW, 1984, GENETICS, V108, P319; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; CHEN J, 2001, BIOTECHNOLOGY, V11, P6; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Dame RT, 2001, BIOCHIMIE, V83, P231; DAYN A, 1992, P NATL ACAD SCI USA, V89, P11406, DOI 10.1073/pnas.89.23.11406; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; ESCOUBAS JM, 1994, J BACTERIOL, V176, P5864, DOI 10.1128/JB.176.18.5864-5867.1994; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Gur-Arie R, 2000, GENOME RES, V10, P62; Hubacek JA, 1999, VASA-J VASCULAR DIS, V28, P169, DOI 10.1024/0301-1526.28.3.169; Kappen LS, 2003, BIOCHEMISTRY-US, V42, P2166, DOI 10.1021/bi020650a; Kosmider B, 2006, NUCLEIC ACIDS RES, V34, P5369, DOI 10.1093/nar/gkl612; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Leung TF, 2005, CLIN EXP ALLERGY, V35, P1288, DOI 10.1111/j.1365-2222.2005.02342.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Lyons-Darden T, 1999, NUCLEIC ACIDS RES, V27, P2235, DOI 10.1093/nar/27.11.2235; Mancuso M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011121; Martinez-Gras I, 2006, EUR ARCH PSY CLIN N, V256, P437, DOI 10.1007/s00406-006-0665-3; Matsutani S, 1997, J MOL BIOL, V267, P548, DOI 10.1006/jmbi.1996.0894; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; OTTA E, 2003, EUR J BIOCHEM, V270, P4755; PAN X, 2006, J GENET GENOMICS, V33, P373; PAN X, 2006, J GENET GENOMICS, V33, P1; Pan XF, 2000, NUCLEIC ACIDS RES, V28, P3178, DOI 10.1093/nar/28.16.3178; Pan XF, 2009, DNA REPAIR, V8, P1321, DOI 10.1016/j.dnarep.2009.08.001; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rouquette C, 2004, J BACTERIOL, V186, P2091, DOI 10.1128/JB.186.7.2091-2098.2004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Shiga Y, 2001, J BACTERIOL, V183, P2476, DOI 10.1128/JB.183.8.2476-2484.2001; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Swingle B, 2004, MOL MICROBIOL, V52, P1055, DOI 10.1111/j.1365-2958.2004.04051.x; TODD J, 2009, FEMS MICROBIOL REV, P1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trotta E, 2000, BIOCHEMISTRY-US, V39, P6799, DOI 10.1021/bi0001473; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YASUZAWA K, 1992, GENE, V122, P9	49	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14271	10.1371/journal.pone.0014271	http://dx.doi.org/10.1371/journal.pone.0014271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151567	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800007
J	Billings, T; Sargent, EE; Szatkiewicz, JP; Leahy, N; Kwak, IY; Bektassova, N; Walker, M; Hassold, T; Graber, JH; Broman, KW; Petkov, PM				Billings, Timothy; Sargent, Evelyn E.; Szatkiewicz, Jin P.; Leahy, Nicole; Kwak, Il-Youp; Bektassova, Nazira; Walker, Michael; Hassold, Terry; Graber, Joel H.; Broman, Karl W.; Petkov, Petko M.			Patterns of Recombination Activity on Mouse Chromosome 11 Revealed by High Resolution Mapping	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; MEIOTIC RECOMBINATION; CROSSOVER INTERFERENCE; GENETIC-CONTROL; SEX-DIFFERENCES; HOT-SPOTS; MAP; INITIATION; HOTSPOT; PRDM9	The success of high resolution genetic mapping of disease predisposition and quantitative trait loci in humans and experimental animals depends on the positions of key crossover events around the gene of interest. In mammals, the majority of recombination occurs at highly delimited 1-2 kb long sites known as recombination hotspots, whose locations and activities are distributed unevenly along the chromosomes and are tightly regulated in a sex specific manner. The factors determining the location of hotspots started to emerge with the finding of PRDM9 as a major hotspot regulator in mammals, however, additional factors modulating hotspot activity and sex specificity are yet to be defined. To address this limitation, we have collected and mapped the locations of 4829 crossover events occurring on mouse chromosome 11 in 5858 meioses of male and female reciprocal F1 hybrids of C57BL/6J and CAST/EiJ mice. This chromosome was chosen for its medium size and high gene density and provided a comparison with our previous analysis of recombination on the longest mouse chromosome 1. Crossovers were mapped to an average resolution of 127 kb, and thirteen hotspots were mapped to,8 kb. Most crossovers occurred in a small number of the most active hotspots. Females had higher recombination rate than males as a consequence of differences in crossover interference and regional variation of sex specific rates along the chromosome. Comparison with chromosome 1 showed that recombination events tend to be positioned in similar fashion along the centromere-telomere axis but independently of the local gene density. It appears that mammalian recombination is regulated on at least three levels, chromosome-wide, regional, and at individual hotspots, and these regulation levels are influenced by sex and genetic background but not by gene content.	[Billings, Timothy; Sargent, Evelyn E.; Szatkiewicz, Jin P.; Leahy, Nicole; Bektassova, Nazira; Walker, Michael; Graber, Joel H.; Petkov, Petko M.] Jackson Lab, Ctr Genome Dynam, Bar Harbor, ME 04609 USA; [Kwak, Il-Youp] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Hassold, Terry] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	Jackson Laboratory; University of Wisconsin System; University of Wisconsin Madison; Washington State University; University of Wisconsin System; University of Wisconsin Madison	Billings, T (corresponding author), Jackson Lab, Ctr Genome Dynam, 600 Main St, Bar Harbor, ME 04609 USA.	Petko.Petkov@jax.org	KWAK, IL YOUP/J-3354-2015	KWAK, IL YOUP/0000-0002-7117-7669; Broman, Karl/0000-0002-4914-6671; Graber, Joel/0000-0001-5137-4553; Petkov, Petko/0000-0002-6694-9150	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health [R01 GM078452, HD21341, P50 GM076468]; National Cancer Institute (NCI) [CA34196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065, R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078452, P50GM076468] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by R01 grants GM078452 to P.M.P. and HD21341 to T.H. and a P50 grant GM076468 to Gary Churchill from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health and by a Cancer Center core grant from the National Cancer Institute (NCI) CA34196 to the Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Anderson LK, 1999, GENETICS, V151, P1569; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 2002, GENETICS, V160, P1123; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kelmenson PM, 2005, GENETICS, V169, P833, DOI 10.1534/genetics.104.035063; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Lorch PD, 2005, GENETICA, V123, P39, DOI 10.1007/s10709-003-2706-4; Lynn A, 2005, AM J HUM GENET, V77, P670, DOI 10.1086/491718; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ng SH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-43; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15340	10.1371/journal.pone.0015340	http://dx.doi.org/10.1371/journal.pone.0015340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170346	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100035
J	Meuwese, MC; Broekhuizen, LN; Kuikhoven, M; Heeneman, S; Lutgens, E; Gijbels, MJJ; Nieuwdorp, M; Peutz, CJ; Stroes, ESG; Vink, H; van den Berg, BM				Meuwese, Marijn C.; Broekhuizen, Lysette N.; Kuikhoven, Mayella; Heeneman, Sylvia; Lutgens, Esther; Gijbels, Marion J. J.; Nieuwdorp, Max; Peutz, Carine J.; Stroes, Erik S. G.; Vink, Hans; van den Berg, Bernard M.			Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							GLYCOCALYX BARRIER PROPERTIES; CAROTID-ARTERY BIFURCATION; GLOMERULAR BARRIER; DEGRADING ENZYMES; CELL GLYCOCALYX; ATHEROSCLEROSIS; PERMEABILITY; ACCUMULATION; PROTEOGLYCANS; VASODILATION	Objective: Functional studies show that disruption of endothelial surface layer (ESL) is accompanied by enhanced sensitivity of the vasculature towards atherogenic stimuli. However, relevance of ESL disruption as causal mechanism for vascular dysfunction remains to be demonstrated. We examined if loss of ESL through enzymatic degradation would affect vascular barrier properties in an atherogenic model. Methods: Eight week old male apolipoprotein E deficient mice on Western-type diet for 10 weeks received continuous active or heat-inactivated hyaluronidase (10 U/hr, i.v.) through an osmotic minipump during 4 weeks. Blood chemistry and anatomic changes in both macrovasculature and kidneys were examined. Results: Infusion with active hyaluronidase resulted in decreased ESL (0.32+/-0.22 mL) and plasma volume (1.03+/-0.18 mL) compared to inactivated hyaluronidase (0.52+/-0.29 mL and 1.28+/-0.08 mL, p<0.05 respectively). Active hyaluronidase increased proteinuria compared to inactive hyaluronidase (0.27+/-0.02 vs. 0.15+/-0.01 mu g/mu g protein/creatinin, p<0.05) without changes in glomerular morphology or development of tubulo-interstitial inflammation. Atherosclerotic lesions in the aortic branches showed increased matrix production (collagen, 32+/-5 vs. 18+/-3%; glycosaminoglycans, 11+/-5 vs. 0.1+/-0.01%, active vs. inactive hyaluronidase, p<0.05). Conclusion: ESL degradation in apoE deficient mice contributes to reduced increased urinary protein excretion without significant changes in renal morphology. Second, the induction of compositional changes in atherogenic plaques by hyaluronidase point towards increased plaque vulnerability. These findings support further efforts to evaluate whether ESL restoration is a valuable target to prevent (micro) vascular disease progression.	[Meuwese, Marijn C.; Broekhuizen, Lysette N.; Nieuwdorp, Max; Stroes, Erik S. G.; Vink, Hans] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kuikhoven, Mayella; Vink, Hans; van den Berg, Bernard M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Heeneman, Sylvia; Lutgens, Esther; Gijbels, Marion J. J.; Peutz, Carine J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Maastricht University	Meuwese, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.vink@fys.unimaas.nl	Lutgens, Esther/E-2919-2010; van den berg, bernard m/D-8444-2014	Lutgens, Esther/0000-0002-2609-5744; van den Berg, Bernard/0000-0002-5726-5777	Dutch Heart Foundation [2006B088]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was partly funded by the Dutch Heart Foundation (grant number 2006B088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2005, PHARM RES-DORDR, V22, P1854, DOI 10.1007/s11095-005-6137-z; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Deen WM, 2004, J CLIN INVEST, V114, P1412, DOI 10.1172/JCI200423577; Grundmann S, 2009, J CELL MOL MED, V13, P3463, DOI 10.1111/j.1582-4934.2009.00735.x; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ikegami-Kawai M, 2004, GLYCOBIOLOGY, V14, P65, DOI 10.1093/glycob/cwh011; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072742.02714.6E; Kolodgie FD, 2004, CURR OPIN LIPIDOL, V15, P575, DOI 10.1097/00041433-200410000-00012; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pappenheimer JR, 2003, J PHYSIOL-LONDON, V553, P561, DOI 10.1113/jphysiol.2003.043257; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van Haaren PMA, 2005, AM J PHYSIOL-HEART C, V289, pH2503, DOI 10.1152/ajpheart.00587.2005; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH447, DOI 10.1152/ajpheart.01298.2004; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Westerterp M, 2007, CIRCULATION, V116, P2173, DOI 10.1161/CIRCULATIONAHA.107.693382; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14262	10.1371/journal.pone.0014262	http://dx.doi.org/10.1371/journal.pone.0014262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170388	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100013
J	Scaria, J; Ponnala, L; Janvilisri, T; Yan, WW; Mueller, LA; Chang, YF				Scaria, Joy; Ponnala, Lalit; Janvilisri, Tavan; Yan, Weiwei; Mueller, Lukas A.; Chang, Yung-Fu			Analysis of Ultra Low Genome Conservation in Clostridium difficile	PLOS ONE			English	Article							COMPARATIVE PHYLOGENOMICS; METABOLIC PATHWAYS; PCR RIBOTYPES; PAN-GENOME; RESISTANCE; PATHOGEN; DIARRHEA; DISEASE; STRAIN; IDENTIFICATION	Microarray-based comparative genome hybridisations (CGH) and genome sequencing of Clostridium difficile isolates have shown that the genomes of this species are highly variable. To further characterize their genome variation, we employed integration of data from CGH, genome sequencing and putative cellular pathways. Transcontinental strain comparison using CGH data confirmed the emergence of a human-specific hypervirulent cluster. However, there was no correlation between total toxin production and hypervirulent phenotype, indicating the possibility of involvement of additional factors towards hypervirulence. Calculation of C. difficile core and pan genome size using CGH and sequence data estimated that the core genome is composed of 947 to 1,033 genes and a pan genome comprised of 9,640 genes. The reconstruction, annotation and analysis of cellular pathways revealed highly conserved pathways despite large genome variation. However, few pathways such as tetrahydrofolate biosynthesis were found to be variable and could be contributing to adaptation towards virulence such as antibiotic resistance.	[Scaria, Joy; Janvilisri, Tavan; Yan, Weiwei; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Ponnala, Lalit] Cornell Univ, Ctr Adv Comp, Ithaca, NY USA; [Janvilisri, Tavan] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Mueller, Lukas A.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Mahidol University; Cornell University; Boyce Thompson Institute for Plant Research	Scaria, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu	Janvilisri, Tavan/O-6679-2019; Mueller, Lukas A/E-8840-2011; Janvilisri, Tavan/C-8391-2015; Scaria, Joy/E-1828-2011	Janvilisri, Tavan/0000-0002-6376-5575; Janvilisri, Tavan/0000-0002-6376-5575; Scaria, Joy/0000-0002-5299-8074	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30054, ZC005-06, ZC008-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030054] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract, N01-AI-30054, Project No. ZC005-06 and ZC008-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2006, J CLIN MICROBIOL, V44, P353, DOI 10.1128/JCM.44.2.353-358.2006; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Debast SB, 2009, CLIN MICROBIOL INFEC, V15, P427, DOI 10.1111/j.1469-0691.2009.02713.x; Doyle MA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-57; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; HE M, 2010, P NATL ACAD SCI US; HENDERSON GB, 1986, METHOD ENZYMOL, V122, P260; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Kim CC, 2002, GENOME BIOL, V3; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Pituch H, 2008, POL J MICROBIOL, V57, P267; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shi J, 2006, NUCLEIC ACIDS RES, V34, P2438, DOI 10.1093/nar/gkl310; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Zhao XL, 1997, P NATL ACAD SCI USA, V94, P13991, DOI 10.1073/pnas.94.25.13991	49	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15147	10.1371/journal.pone.0015147	http://dx.doi.org/10.1371/journal.pone.0015147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170335	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100022
J	Schoneich, S; Hedwig, B				Schoeneich, Stefan; Hedwig, Berthold			Hyperacute Directional Hearing and Phonotactic Steering in the Cricket (Gryllus bimaculatus deGeer)	PLOS ONE			English	Article							SOUND-LOCALIZATION; TELEOGRYLLUS-OCEANICUS; ACOUSTIC ORIENTATION; AUDITORY-BEHAVIOR; CAMPESTRIS L; DISCRIMINATION; ACUITY; LATERALIZATION; COMMUNICATION; INFORMATION	Background: Auditory mate or prey localisation is central to the lifestyle of many animals and requires precise directional hearing. However, when the incident angle of sound approaches 0 degrees azimuth, interaural time and intensity differences gradually vanish. This poses a demanding challenge to animals especially when interaural distances are small. To cope with these limitations imposed by the laws of acoustics, crickets employ a frequency tuned peripheral hearing system. Although this enhances auditory directionality the actual precision of directional hearing and phonotactic steering has never been studied in the behaviourally important frontal range. Principal Findings: Here we analysed the directionality of phonotaxis in female crickets (Gryllus bimaculatus) walking on an open-loop trackball system by measuring their steering accuracy towards male calling song presented at frontal angles of incidence. Within the range of +/-30 degrees, females reliably discriminated the side of acoustic stimulation, even when the sound source deviated by only 1 degrees from the animal's length axis. Moreover, for angles of sound incidence between 1 degrees and 6 degrees the females precisely walked towards the sound source. Measuring the tympanic membrane oscillations of the front leg ears with a laser vibrometer revealed between 0 degrees and 30 degrees a linear increasing function of interaural amplitude differences with a slope of 0.4 dB/degrees. Auditory nerve recordings closely reflected these bilateral differences in afferent response latency and intensity that provide the physiological basis for precise auditory steering. Conclusions: Our experiments demonstrate that an insect hearing system based on a frequency-tuned pressure difference receiver achieves directional hyperacuity which easily rivals best directional hearing in mammals and birds. Moreover, this directional accuracy of the cricket's hearing system is reflected in the animal's phonotactic motor response.	[Schoeneich, Stefan; Hedwig, Berthold] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Schoneich, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ss817@cam.ac.uk; bh202@cam.ac.uk		Schoneich, Stefan/0000-0003-4503-5111	Royal Society [2005/R2]	Royal Society(Royal Society of London)	This work was supported by The Royal Society: Equipment Grant 2005/R2 to BH, http://royalsociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTRUM H, 1940, J COMP PHYSIOL A, V28, P326; BAILEY WJ, 1984, ANIM BEHAV, V32, P816, DOI 10.1016/S0003-3472(84)80158-X; BAILEY WJ, 1977, J EXP BIOL, V67, P61; BOYD P, 1983, J COMP PHYSIOL, V153, P523, DOI 10.1007/BF00612606; Bradbury Jack W., 1998, pi; Carr CE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000405; Faulkes Z, 2000, J NEUROPHYSIOL, V84, P1247, DOI 10.1152/jn.2000.84.3.1247; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; HEDWIG B, 1989, J COMP PHYSIOL A, V164, P409, DOI 10.1007/BF00612999; Heffner RS, 2007, HEARING RES, V234, P1, DOI 10.1016/j.heares.2007.06.001; HEFFNER RS, 1982, J COMP PHYSIOL PSYCH, V96, P926, DOI 10.1037/0735-7036.96.6.926; Hennig RM, 2004, MICROSC RES TECHNIQ, V63, P351, DOI 10.1002/jemt.20052; HORSEMAN G, 1994, J COMP PHYSIOL A, V175, P389, DOI 10.1007/BF00199247; HOY R, 1989, J EXP BIOL, V146, P287; HOY RR, 1978, FED PROC, V37, P2316; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; Huber F., 1989, CRICKET BEHAV NEUROB; Knepper M, 1997, COMPUT METH PROG BIO, V52, P75, DOI 10.1016/S0169-2607(96)01781-6; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Kostarakos K, 2010, J COMP PHYSIOL A, V196, P669, DOI 10.1007/s00359-010-0557-x; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; Larsen O.N., 1989, P364; LARSEN ON, 1978, J COMP PHYSIOL, V123, P217, DOI 10.1007/BF00656874; LARSEN ON, 1984, NATURWISSENSCHAFTEN, V71, P538, DOI 10.1007/BF00455648; Mason AC, 2004, MICROSC RES TECHNIQ, V63, P338, DOI 10.1002/jemt.20050; Mason AC, 2001, NATURE, V410, P686, DOI 10.1038/35070564; Michelsen A, 1998, NEWS PHYSIOL SCI, V13, P32; MICHELSEN A, 1994, J COMP PHYSIOL A, V175, P153, DOI 10.1007/BF00215111; MICHELSEN A, 1995, NATURE, V375, P639, DOI 10.1038/375639a0; MICHELSEN A, 1992, EVOLUTIONARY BIOL HE, P67; Michelsen A, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/011001; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; MORCHEN A, 1978, NATURWISSENSCHAFTEN, V65, P656, DOI 10.1007/BF00401914; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; OLDFIELD BP, 1980, J COMP PHYSIOL, V141, P93, DOI 10.1007/BF00611882; POLLACK GS, 1982, J COMP PHYSIOL, V146, P207, DOI 10.1007/BF00610239; Pollack GS, 2003, J COMP PHYSIOL A, V189, P143, DOI 10.1007/s00359-003-0388-0; RENAUD DL, 1975, J EXP BIOL, V63, P569; RHEINLAENDER J, 1982, PHYSIOL ENTOMOL, V7, P209, DOI 10.1111/j.1365-3032.1982.tb00291.x; Rheinlaender J, 2006, J COMP PHYSIOL A, V192, P389, DOI 10.1007/s00359-005-0078-1; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Robert D, 2001, BIOL BULL, V200, P190, DOI 10.2307/1543314; SCHILDBERGER K, 1994, FORTS ZOOL, V39, P209; SCHMITZ B, 1982, J COMP PHYSIOL, V148, P431, DOI 10.1007/BF00619782; Shen JX, 2008, NATURE, V453, P914, DOI 10.1038/nature06719; SIMMONS JA, 1983, J COMP PHYSIOL, V153, P321, DOI 10.1007/BF00612586; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; von Helversen D, 1997, EXS, V84, P301; Warren R. M., 1999, AUDITORY PERCEPTION; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weber T., 1989, P310; WENDLER G, 1980, NATURWISSENSCHAFTEN, V67, P99, DOI 10.1007/BF01054701; WIESE K, 1985, ZOOL JAHRB ALLG ZOOL, V89, P181; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	56	39	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15141	10.1371/journal.pone.0015141	http://dx.doi.org/10.1371/journal.pone.0015141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170344	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100021
J	Exil, VJ; Avila, DS; Benedetto, A; Exil, EA; Adams, MR; Au, C; Aschner, M				Exil, Vernat J.; Avila, Daiana Silva; Benedetto, Alexandre; Exil, Elizabeth A.; Adams, Margaret R.; Au, Catherine; Aschner, Michael			Stressed-Induced TMEM135 Protein Is Part of a Conserved Genetic Network Involved in Fat Storage and Longevity Regulation in Caenorhabditis elegans	PLOS ONE			English	Article							ACYL-COA DEHYDROGENASE; COENZYME-A DEHYDROGENASE; LIFE-SPAN; C-ELEGANS; ACID OXIDATION; MOLECULAR HETEROGENEITY; TRANSCRIPTION FACTOR; MUTATION ANALYSIS; SUDDEN-DEATH; DEFICIENCY	Disorders of mitochondrial fat metabolism lead to sudden death in infants and children. Although survival is possible, the underlying molecular mechanisms which enable this outcome have not yet been clearly identified. Here we describe a conserved genetic network linking disorders of mitochondrial fat metabolism in mice to mechanisms of fat storage and survival in Caenorhabditis elegans (C. elegans). We have previously documented a mouse model of mitochondrial very-long chain acyl-CoA dehydrogenase (VLCAD) deficiency.[1] We originally reported that the mice survived birth, but, upon exposure to cold and fasting stresses, these mice developed cardiac dysfunction, which greatly reduced survival. We used cDNA microarrays[2,3,4] to outline the induction of several markers of lipid metabolism in the heart at birth in surviving mice. We hypothesized that the induction of fat metabolism genes in the heart at birth is part of a regulatory feedback circuit that plays a critical role in survival.[1] The present study uses a dual approach employing both C57BL/6 mice and the nematode, C. elegans, to focus on TMEM135, a conserved protein which we have found to be upregulated 4.3 (+/- 0.14)-fold in VLCAD-deficient mice at birth. Our studies have demonstrated that TMEM135 is highly expressed in mitochondria and in fat-loaded tissues in the mouse. Further, when fasting and cold stresses were introduced to mice, we observed 3.25 (+/- 0.03)- and 8.2 (+/- 0.31)-fold increases in TMEM135 expression in the heart, respectively. Additionally, we found that deletion of the tmem135 orthologue in C. elegans caused a 41.8% (+/- 2.8%) reduction in fat stores, a reduction in mitochondrial action potential and decreased longevity of the worm. In stark contrast, C. elegans transgenic animals overexpressing TMEM-135 exhibited increased longevity upon exposure to cold stress. Based on these results, we propose that TMEM135 integrates biological processes involving fat metabolism and energy expenditure in both the worm (invertebrates) and in mammalian organisms. The data obtained from our experiments suggest that TMEM135 is part of a regulatory circuit that plays a critical role in the survival of VLCAD-deficient mice and perhaps in other mitochondrial genetic defects of fat metabolism as well.	[Exil, Vernat J.] Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Thomas P Graham Div Pediat Cardiol, Nashville, TN 37240 USA; [Avila, Daiana Silva; Benedetto, Alexandre; Exil, Elizabeth A.; Adams, Margaret R.; Au, Catherine; Aschner, Michael] Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Ctr Mol Toxicol, Nashville, TN USA; [Benedetto, Alexandre; Au, Catherine] UCL, London Ctr Nanotechnol, London, England	Vanderbilt University; Vanderbilt University; University of London; University College London	Exil, VJ (corresponding author), Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Thomas P Graham Div Pediat Cardiol, Nashville, TN 37240 USA.	Vernat.exil@vanderbilt.edu	Avila, Daiana S/I-6617-2012; Benedetto, Alexandre/A-5766-2014; Exil, Vernat/GYD-7777-2022; Benedetto, Alexandre/W-5930-2019	Avila, Daiana S/0000-0002-8673-1909; Benedetto, Alexandre/0000-0002-4593-2114; Benedetto, Alexandre/0000-0002-4593-2114; Au, Catherine/0000-0002-1923-9121; Exil, Vernat/0000-0001-5935-4039	Vanderbilt Physician Scientific Development, American Heart Association (South East Affiliates, AHA) [0355278B]; National Institute of Environmental Health Sciences [ES07731, ES10563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER	Vanderbilt Physician Scientific Development, American Heart Association (South East Affiliates, AHA)(American Heart Association); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Vanderbilt Physician Scientific Development, American Heart Association f(South East Affiliates, AHA Number 0355278B) (Vernat Exil) and National Institute of Environmental Health Sciences, ES07731 and ES10563 (Michael Aschner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Antebi A, 1998, DEVELOPMENT, V125, P1191; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; BELL J, 1999, NATURE, P71; BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9; BRENNER S, 1974, GENETICS, V77, P71; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Exil VJ, 2005, PROG PEDIATR CARDIOL, V20, P143, DOI 10.1016/j.ppedcard.2005.04.005; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; GOTTLIEB S, 1994, GENETICS, V137, P107; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Hedge P., 2000, BIOTECHNIQUES, V29, P548; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu Fangli, 2007, Journal of Genetics and Genomics, V34, P189, DOI 10.1016/S1673-8527(07)60020-4; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pons R, 2000, PEDIATR NEUROL, V22, P98, DOI 10.1016/S0887-8994(99)00132-0; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Souri M, 1996, AM J HUM GENET, V58, P97; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Werdich AA, 2007, AM J PHYSIOL-HEART C, V292, pH2202, DOI 10.1152/ajpheart.00382.2006; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3	43	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14228	10.1371/journal.pone.0014228	http://dx.doi.org/10.1371/journal.pone.0014228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151927	Green Submitted, Green Published, gold			2022-12-25	WOS:000284939600020
J	Andersson, EA; Pilgaard, K; Pisinger, C; Harder, MN; Grarup, N; Faerch, K; Sandholt, C; Poulsen, P; Witte, DR; Jorgensen, T; Vaag, A; Pedersen, O; Hansen, T				Andersson, Ehm A.; Pilgaard, Kasper; Pisinger, Charlotta; Harder, Marie N.; Grarup, Niels; Faerch, Kristine; Sandholt, Camilla; Poulsen, Pernille; Witte, Daniel R.; Jorgensen, Torben; Vaag, Allan; Pedersen, Oluf; Hansen, Torben			Do Gene Variants Influencing Adult Adiposity Affect Birth Weight? A Population-Based Study of 24 Loci in 4,744 Danish Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAT MASS; FTO GENE; OBESITY; RISK; MC4R; CHILDHOOD	Background: Several obesity risk alleles affecting adult adiposity have been identified by the recent wave of genome wide association studies. We aimed to examine the potential effect of these variants on fetal body composition by investigating the variants in relation to birth weight and ponderal index of the newborn. Methodology/Principal Findings: Midwife records from the Danish State Archives provided information on mother's age, parity, as well as birth weight, birth length and prematurity of the newborn in 4,744 individuals of the population-based Inter99 study. Twenty-four risk alleles showing genome-wide associations with adult BMI and/or waist circumference were genotyped. None of the 24 risk variants tested showed an association with birth weight or ponderal index after correction for multiple testing. Birth weight was divided into three categories low (<= 10(th) percentile), normal (10(th) -90(th) percentile) and high birth weight (>= 90th percentile) to allow for non-linear associations. There was no difference in the number of risk alleles between the groups (p = 0.57). No interactions between each risk allele and birth weight in the prediction of adult BMI were observed. An obesity risk score was created by summing up risk alleles. The risk score did not associate with fetal body composition. Moreover there was no interaction between the risk score and birth weight/ponderal index in the prediction of adult BMI. Conclusion: 24 common variants associated with adult adiposity did not affect or interact with birth weight among Danes suggesting that the effects of these variants predominantly arise in the post-natal life.	[Andersson, Ehm A.; Harder, Marie N.; Grarup, Niels; Sandholt, Camilla; Pedersen, Oluf; Hansen, Torben] Hagedorn Res Inst, Gentofte, Denmark; [Pilgaard, Kasper; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pisinger, Charlotta; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben; Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Andersson, EA (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	mngh@hagedorn.dk	Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Witte, Daniel R/C-1722-2008; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019	Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Faerch, Kristine/0000-0002-6127-0448; Pilgaard, Kasper Ascanius/0000-0003-2079-5229; Jorgensen, Torben/0000-0001-9453-2830; Vaag, Allan Arthur/0000-0002-3690-2191; Pisinger, Charlotta/0000-0002-7970-3168	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Union [LSHM-CT-2004-005272]; Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Health Research Council; European Union(European Commission); Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF))	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP), the Danish Health Research Council, the European Union (EXGENESIS, grant no. LSHM-CT-2004-005272), the Danish Diabetes Association and the Danish Council for Independent Research (Medical Sciences). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEN MS, 1918, BMC MED GENET, V11, P58; ANDERSSON EA, DIABETOLOGIA; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; ELKS CE, PLOS MED, V7; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, NAT GENET; HARDY R, HUM MOL GENET, V19, P545; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Parsons TJ, 1999, INT J OBESITY, V23, pS1; PETRY CJ, HORM RES PEDIAT, V73, P275; PILGAARD K, 1944, J DEV ORIGINS HLTH D, P1; Ranadive SA, 2008, ENDOCRIN METAB CLIN, V37, P733, DOI 10.1016/j.ecl.2008.07.003; RZEHAK P, OBES FACTS, V3, P173; SANDHOLT CH, DIABETES; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Vliet-Ostaptchouk JV, 2009, OBES REV, V10, P593, DOI 10.1111/j.1467-789X.2009.00597.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	30	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14190	10.1371/journal.pone.0014190	http://dx.doi.org/10.1371/journal.pone.0014190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152014	Green Published, gold, Green Submitted			2022-12-25	WOS:000284821300007
J	Bishop, DVM				Bishop, Dorothy V. M.			Which Neurodevelopmental Disorders Get Researched and Why?	PLOS ONE			English	Article							RARE	Aim: There are substantial differences in the amount of research concerned with different disorders. This paper considers why. Methods: Bibliographic searches were conducted to identify publications (1985-2009) concerned with 35 neurodevelopmental disorders: Developmental dyslexia, Developmental dyscalculia, Developmental coordination disorder, Speech sound disorder, Specific language impairment, Attention deficit hyperactivity disorder, Autistic spectrum disorder, Tourette syndrome, Intellectual disability, Angelman syndrome, Cerebral palsy, Cornelia de Lange syndrome, Cri du chat syndrome, Down syndrome, Duchenne muscular dystrophy, Fetal alcohol syndrome, Fragile X syndrome, Galactosaemia, Klinefelter syndrome, Lesch-Nyhan syndrome, Lowe syndrome, Marfan syndrome, Neurofibromatosis type 1, Noonan syndrome, Phenylketonuria, Prader-Willi syndrome, Rett syndrome, Rubinstein-Taybi syndrome, Trisomy 18, Tuberous sclerosis, Turner syndrome, Velocardiofacial syndrome, Williams syndrome, XXX and XYY. A publication index reflecting N publications relative to prevalence was derived. Results: The publication index was higher for rare than common conditions. However, this was partly explained by the tendency for rare disorders to be more severe. Interpretation: Although research activity is predictable from severity and prevalence, there are exceptions. Low rates of research, and relatively low levels of NIH funding, characterise conditions that are the domain of a single discipline with limited research resources. Growth in research is not explained by severity, and was exceptionally steep for autism and ADHD.	Univ Oxford, Oxford, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Oxford, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [053335]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant 053335. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahi R, 2001, BRIT MED J, V323, P1461, DOI 10.1136/bmj.323.7327.1461; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ayme S, 2007, BUNDESGESUNDHEITSBLA, V50, P1477, DOI 10.1007/s00103-007-0381-9; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Harris J., 2008, RUTTERS CHILD ADOLES, P459; Leggett V, 2010, DEV MED CHILD NEUROL, V52, P119, DOI 10.1111/j.1469-8749.2009.03545.x; *OFF NAT STAT, 2008, MID 2008 EST HOUS PO; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Udwin O., 1995, BEHAV PHENOTYPES CLI, P90; Van Engeland H., 2008, RUTTERS CHILD ADOLES, P759; WHO, 2012, ICD 10 CLASS MENT BE	12	142	145	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15112	10.1371/journal.pone.0015112	http://dx.doi.org/10.1371/journal.pone.0015112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152085	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100076
J	Heuberger, S; Ellers-Kirk, C; Tabashnik, BE; Carriere, Y				Heuberger, Shannon; Ellers-Kirk, Christa; Tabashnik, Bruce E.; Carriere, Yves			Pollen- and Seed-Mediated Transgene Flow in Commercial Cotton Seed Production Fields	PLOS ONE			English	Article							GENE FLOW; BRASSICA-NAPUS; CONTAMINATION; RESISTANCE; MAIZE; POLLINATION; DISPERSAL; REFUGES	Background: Characterizing the spatial patterns of gene flow from transgenic crops is challenging, making it difficult to design containment strategies for markets that regulate the adventitious presence of transgenes. Insecticidal Bacillus thuringiensis (Bt) cotton is planted on millions of hectares annually and is a potential source of transgene flow. Methodology/Principal Findings: Here we monitored 15 non-Bt cotton (Gossypium hirsutum, L.) seed production fields (some transgenic for herbicide resistance, some not) for gene flow of the Bt cotton cry1Ac transgene. We investigated seed-mediated gene flow, which yields adventitious Bt cotton plants, and pollen-mediated gene flow, which generates outcrossed seeds. A spatially-explicit statistical analysis was used to quantify the effects of nearby Bt and non-Bt cotton fields at various spatial scales, along with the effects of pollinator abundance and adventitious Bt plants in fields, on pollen-mediated gene flow. Adventitious Bt cotton plants, resulting from seed bags and planting error, comprised over 15% of plants sampled from the edges of three seed production fields. In contrast, pollen-mediated gene flow affected less than 1% of the seed sampled from field edges. Variation in outcrossing was better explained by the area of Bt cotton fields within 750 m of the seed production fields than by the area of Bt cotton within larger or smaller spatial scales. Variation in outcrossing was also positively associated with the abundance of honey bees. Conclusions/Significance: A comparison of statistical methods showed that our spatially-explicit analysis was more powerful for understanding the effects of surrounding fields than customary models based on distance. Given the low rates of pollen-mediated gene flow observed in this study, we conclude that careful planting and screening of seeds could be more important than field spacing for limiting gene flow.	[Heuberger, Shannon; Ellers-Kirk, Christa; Tabashnik, Bruce E.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	Heuberger, S (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	heubergs@ag.arizona.edu			Western Region Sustainable Agriculture Research and Education (WSARE) [GW07-004]; Environmental Protection Agency (EPA) [FP 916819]; Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	Western Region Sustainable Agriculture Research and Education (WSARE); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	This work was supported by Western Region Sustainable Agriculture Research and Education (WSARE) Graduate Student Fellow's Grant in Sustainable Agriculture, grant number GW07-004 (http://wsare.usu.edu/) and Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Fellowship, number FP 916819 (http://www.epa.gov/ncer/fellow/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EPA and WSARE have not officially endorsed this publication, and the views expressed may not reflect the views of the EPA or WSARE.; B.E. Tabashnik has received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. He is also a coauthor of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	[Anonymous], 2008, JMP 8 0; Bannert M, 2007, EUR J AGRON, V27, P44, DOI 10.1016/j.eja.2007.01.002; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2009, BASIC APPL ECOL, V10, P597, DOI 10.1016/j.baae.2008.10.010; Ceddia MG, 2009, AGR ECOSYST ENVIRON, V129, P65, DOI 10.1016/j.agee.2008.07.004; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Colbach N, 2010, ECOL MODEL, V221, P225, DOI 10.1016/j.ecolmodel.2009.10.011; Colbach N, 2009, ENVIRON SCI POLLUT R, V16, P348, DOI 10.1007/s11356-008-0080-6; *COMM BIOL CONF GE, 2004, BIOL CONF GEN ENG OR; Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability and The National Research Council T, 2010, IMP GEN ENG CROPS FA; Eckert JE, 1933, J AGRIC RES, V47, P0257; ESRI, 1998, ARCVIEW GIS VERS 3 1; Free J.B., 1970, INSECT POLLINATION C; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Goggi AS, 2006, FIELD CROP RES, V99, P147, DOI 10.1016/j.fcr.2006.04.005; Hayter KE, 2006, J APPL ECOL, V43, P1196, DOI 10.1111/j.1365-2664.2006.01219.x; Heuberger Shannon, 2008, Environmental Biosafety Research, V7, P87, DOI 10.1051/ebr:2008005; Heuberger S, 2008, J ECON ENTOMOL, V101, P504, DOI 10.1603/0022-0493(2008)101[504:EORCBT]2.0.CO;2; Llewellyn D, 1996, MOL BREEDING, V2, P157, DOI 10.1007/BF00441430; Llewellyn D, 2007, AGR ECOSYST ENVIRON, V121, P419, DOI 10.1016/j.agee.2006.11.019; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; MCGREGOR SE, 1959, SCIENCE, V129, P97, DOI 10.1126/science.129.3341.97; MELLON M, 2004, GONE SEED TRANSGENIC; Showalter AM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2201; Smyth S, 2002, NAT BIOTECHNOL, V20, P537, DOI 10.1038/nbt0602-537; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; UMBECK PF, 1991, J ECON ENTOMOL, V84, P1943, DOI 10.1093/jee/84.6.1943; Van Deynze AE, 2005, CROP SCI, V45, P1565, DOI 10.2135/cropsci2004.0463; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Zhang BH, 2005, MOL BIOTECHNOL, V31, P11, DOI 10.1385/MB:31:1:011; Zhang BH, 2000, J GENET, V79, P71, DOI 10.1007/BF02728948	35	44	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14128	10.1371/journal.pone.0014128	http://dx.doi.org/10.1371/journal.pone.0014128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152426	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100009
J	Hsieh, YH; Hogan, MT; Barnes, M; Jett-Goheen, M; Huppert, J; Rompalo, AM; Gaydos, CA				Hsieh, Yu-Hsiang; Hogan, M. Terry; Barnes, Mathilda; Jett-Goheen, Mary; Huppert, Jill; Rompalo, Anne M.; Gaydos, Charlotte A.			Perceptions of an Ideal Point-of-Care Test for Sexually Transmitted Infections - A Qualitative Study of Focus Group Discussions with Medical Providers	PLOS ONE			English	Article							STIGMA; ISSUES; STIS	Background: A point-of-care test (POCT) for sexually transmitted infections (STIs), which offers immediate diagnosis resulting in patients receiving diagnosis and treatment in a single visit, has the ability to address some of the STI control needs. However, needs assessment from STI experts and end users about currently available STI POCTs and their future new development has not been evaluated since World Health Organization Sexually Transmitted Diseases Diagnostics Initiative was formed over 15 years ago. Therefore, our objective was to explore the perceptions of the ideal types of STI POCT for use in health care settings. Methodology/Principal Findings: A qualitative study, encompassing eight focus groups, was conducted from March 2008 through April 2009. Participants included 6 STD clinic directors, 63 clinicians, and 7 public health/laboratory/epidemiology professionals in the STI field. Discussion topics included currently available POCT, perceived barriers to using POCT in clinics, priority STI for the development of new POCT, and characteristics of the ideal POCT. All discussions were recorded and transcribed verbatim. Themes raised as barriers for current POCT included complexity, long time frames of the so-called "rapid" test, multiple time-driven steps, requiring laboratory technician, difficulty in reading result, interruption of workflow, unreliability, and invasiveness. Chlamydia trachomatis was identified as the priority organism for development of a new STI POCT. Themes indicated for the ideal POCT included rapid turnaround (up to 20 minutes), ease of use, non-invasive, accurate (preferred sensitivity and specificity in the range of high 90s), Clinical Laboratory Improvement Amendments (CLIA)-waived, user-friendly (for both patients and staff), compact, durable, and sturdy. Conclusions/Significance: Focus group discussions with STI experts and professionals highlighted chlamydia as the top priority pathogen for POCT development, and identified the qualities of new POCT for STIs. Participants endorsed ease of use, rapid turnaround and high accuracy as essential characteristics of an ideal POCT.	[Hsieh, Yu-Hsiang] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Hogan, M. Terry; Barnes, Mathilda; Jett-Goheen, Mary; Rompalo, Anne M.; Gaydos, Charlotte A.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA; [Huppert, Jill] Cincinnati Childrens Hosp Med Ctr, Div Adolescent Med, Cincinnati, OH USA; [Huppert, Jill] Univ Cincinnati, Coll Med, Div Adolescent Med, Cincinnati, OH USA	Johns Hopkins University; Johns Hopkins University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010		NIH [U54-EB007958, AI068613-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant U54-EB007958 and AI068613-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS US 20; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Cole LA, 2004, AM J OBSTET GYNECOL, V190, P100, DOI 10.1016/j.ajog.2003.08.043; Cunningham SD, 2002, SEX TRANSM INFECT, V78, P334, DOI 10.1136/sti.78.5.334; Greer L, 2008, INFECT DIS CLIN N AM, V22, P601, DOI 10.1016/j.idc.2008.05.010; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine, 1997, HIDD EP CONFR SEX TR; Kane B, 1999, ANN INTERN MED, V130, P870, DOI 10.7326/0003-4819-130-10-199905180-00102; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lichtenstein B, 2003, SOC SCI MED, V57, P2435, DOI 10.1016/j.socscimed.2003.08.002; Mabey D, 2001, SEX TRANSM INFECT, V77, P397, DOI 10.1136/sti.77.6.397; Morgan D. L, 1998, FOCUS GROUP GUIDEBOO; Parrish DD, 2008, SEX TRANSM DIS, V35, pS19, DOI 10.1097/OLQ.0b013e31818f2ae1; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Powell RA, 1996, INT J QUAL HEALTH C, V8, P499, DOI 10.1093/intqhc/8.5.499; Rusch M, 2008, SEX TRANSM DIS, V35, P553, DOI 10.1097/OLQ.0b013e3181685855; Sabido M, 2009, J CLIN MICROBIOL, V47, P475, DOI 10.1128/JCM.01975-08; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; Swain Geoffrey R, 2004, Clin Med Res, V2, P29; *US FDA, 2009, CLIA WAIV; Ward P, 2006, SEX TRANSM INFECT, V82, P506, DOI 10.1136/sti.2005.017962; WHO/OMS, 2001, WHO SEX TRANSM DIS D	22	42	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14144	10.1371/journal.pone.0014144	http://dx.doi.org/10.1371/journal.pone.0014144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152386	Green Published, gold			2022-12-25	WOS:000284755100024
J	Osen, W; Soltek, S; Song, MX; Leuchs, B; Steitz, J; Tuting, T; Eichmuller, SB; Nguyen, XD; Schadendorf, D; Paschen, A				Osen, Wolfram; Soltek, Sabine; Song, Mingxia; Leuchs, Barbara; Steitz, Julia; Tueting, Thomas; Eichmueller, Stefan B.; Nguyen, Xuan-Duc; Schadendorf, Dirk; Paschen, Annette			Screening of Human Tumor Antigens for CD4(+) T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries	PLOS ONE			English	Article							TYROSINASE-RELATED PROTEIN-2; LARGE ESTABLISHED MELANOMA; METASTATIC MELANOMA; CANCER REGRESSION; INFILTRATING LYMPHOCYTES; ANTITUMOR LYMPHOCYTES; GENETIC IMMUNIZATION; DENDRITIC CELL; PHASE-I; IDENTIFICATION	Background: As tumor antigen-specific CD4(+) T cells can mediate strong therapeutic anti-tumor responses in melanoma patients we set out to establish a comprehensive screening strategy for the identification of tumor-specific CD4(+) T cell epitopes suitable for detection, isolation and expansion of tumor-reactive T cells from patients. Methods and Findings: To scan the human melanoma differentiation antigens TRP-1 and TRP-2 for HLA-DRB1*0301-restricted CD4(+) T cell epitopes we applied the following methodology: Splenocytes of HLA-DRB1*0301-transgenic mice immunized with recombinant adenovirus encoding TRP-1 (Ad5.TRP-1) or TRP-2 (Ad5.TRP-2) were tested for their T cell reactivity against combinatorial TRP-1- and TRP-2-specific peptide libraries. CD4(+) T cell epitopes thus identified were validated in the human system by stimulation of peripheral blood mononuclear cells (PBMC) from healthy donors and melanoma patients. Using this strategy we observed that recombinant Ad5 induced strong CD4(+) T cell responses against the heterologous tumor antigens. In Ad5. TRP-2-immunized mice CD4(+) T cell reactivity was detected against the known HLA-DRB1*0301-restricted TRP-2(60-74) epitope and against the new epitope TRP-2(149-163). Importantly, human T cells specifically recognizing target cells loaded with the TRP-2(149-163)-containing library peptide or infected with Ad5. TRP-2 were obtained from healthy individuals, and short term in vitro stimulation of PBMC revealed the presence of epitope-reactive CD4(+) T cells in melanoma patients. Similarly, immunization of mice with Ad5. TRP-1 induced CD4(+) T cell responses against TRP-1-derived peptides that turned out to be recognized also by human T cells, resulting in the identification of TRP-1(284-298) as a new HLA-DRB1*0301-restricted CD4(+) T cell epitope. Conclusions: Our screening approach identified new HLA-DRB1*0301-restricted CD4(+) T cell epitopes derived from melanoma antigens. This strategy is generally applicable to target antigens of other tumor entities and to different HLA class II molecules even without prior characterization of their peptide binding motives.	[Osen, Wolfram; Soltek, Sabine; Eichmueller, Stefan B.] German Canc Res Ctr, Clin Cooperat Unit Dermatooncol, D-6900 Heidelberg, Germany; [Leuchs, Barbara] German Canc Res Ctr, Infect & Canc Program, D-6900 Heidelberg, Germany; [Song, Mingxia; Schadendorf, Dirk; Paschen, Annette] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Steitz, Julia] Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany; [Tueting, Thomas] Univ Bonn, Dept Dermatol, D-5300 Bonn, Germany; [Nguyen, Xuan-Duc] Inst Immunol & Transfus Med, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; RWTH Aachen University; University of Bonn	Osen, W (corresponding author), German Canc Res Ctr, Clin Cooperat Unit Dermatooncol, D-6900 Heidelberg, Germany.	annette.paschen@uk-essen.de	Tüting, Thomas/AAJ-3610-2021; Eichmüller, Stefan B/A-5053-2008; Schadendorf, Dirk/AAE-8206-2019	Tüting, Thomas/0000-0001-7146-0934; Eichmüller, Stefan B/0000-0002-3497-6904; 	EU [518234]	EU(European Commission)	This study was supported by the EU 6th framework "Cancer Immunotherapy" (518234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Giuntoli RL, 2002, CLIN CANCER RES, V8, P922; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mitchell MS, 2002, J CLIN ONCOL, V20, P1075, DOI 10.1200/JCO.20.4.1075; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Naito Y, 1998, CANCER RES, V58, P3491; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Parkhurst MR, 1998, CANCER RES, V58, P4895; Paschen A, 2005, INT J CANCER, V116, P944, DOI 10.1002/ijc.21132; Paschen A, 2005, CLIN CANCER RES, V11, P5241, DOI 10.1158/1078-0432.CCR-05-0170; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rojas JM, 2005, CANCER IMMUNOL IMMUN, V54, P243, DOI 10.1007/s00262-004-0596-7; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shen L, 2004, CANCER IMMUNOL IMMUN, V53, P391, DOI 10.1007/s00262-003-0455-y; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Tobery Timothy W, 2004, Methods Mol Med, V94, P121; Tuting T, 1999, J GENE MED, V1, P400, DOI 10.1002/(SICI)1521-2254(199911/12)1:6<400::AID-JGM68>3.0.CO;2-D; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; WANG RF, 1995, J EXP MED, V181, P1261; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	40	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14137	10.1371/journal.pone.0014137	http://dx.doi.org/10.1371/journal.pone.0014137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152437	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100018
J	Roato, I; Porta, F; Mussa, A; D'Amico, L; Fiore, L; Garelli, D; Spada, M; Ferracini, R				Roato, Ilaria; Porta, Francesco; Mussa, Alessandro; D'Amico, Lucia; Fiore, Ludovica; Garelli, Davide; Spada, Marco; Ferracini, Riccardo			Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase	PLOS ONE			English	Article							PHALANGEAL QUANTITATIVE ULTRASOUND; MINERAL STATUS; RECEPTOR ACTIVATOR; IN-VITRO; CHILDREN; LIGAND; GROWTH; OSTEOPOROSIS; DENSITOMETRY; DEFICIENCY	Background: Phenylketonuria (PKU) is a rare inborn error of metabolism often complicated by a progressive bone impairment of uncertain etiology, as documented by both ionizing and non-ionizing techniques. Methodology: Peripheral blood mononuclear cell (PBMC) cultures were performed to study osteoclastogenesis, in the presence or absence of recombinant human monocyte-colony stimulating factor (M-CSF) and receptor activator of NFkB ligand (RANKL). Flow cytometry was utilized to analyze osteoclast precursors (OCPs) and T cell phenotype. Tumour necrosis factor alpha (TNF-alpha), RANKL and osteoprotegerin (OPG) were quantified in cell culture supernatants by ELISA. The effects of RANKFc and anti-TNF-alpha antibodies were also investigated to determine their ability to inhibit osteoclastogenesis. In addition, bone conditions and phenylalanine levels in PKU patients were clinically evaluated. Principal Findings: Several in vitro studies in PKU patients' cells identified a potential mechanism of bone formation inhibition commonly associated with this disorder. First, PKU patients disclosed an increased osteoclastogenesis compared to healthy controls, both in unstimulated and M-CSF/RANKL stimulated PBMC cultures. OCPs and the measured RANKL/OPG ratio were higher in PKU patients compared to healthy controls. The addition of specific antagonist RANKFc caused osteoclastogenesis inhibition, whereas anti-TNF-a failed to have this effect. Among PBMCs isolated from PKU patients, activated T cells, expressing CD69, CD25 and RANKL were identified. Confirmatory in vivo studies support this proposed model. These in vivo studies included the analysis of osteoclastogenesis in PKU patients, which demonstrated an inverse relation to bone condition assessed by phalangeal Quantitative Ultrasound (QUS). This was also directly related to noncompliance to therapeutic diet reflected by hyperphenylalaninemia. Conclusions: Our results indicate that PKU spontaneous osteoclastogenesis depends on the circulating OCP increase and the activation of T cells. Osteoclastogenesis correlates with clinical parameters, suggesting its value as a diagnostic tool for an early assessment of an increased bone resorption in PKU patients.	[Roato, Ilaria; D'Amico, Lucia; Ferracini, Riccardo] AOU San Giovanni Battista, Ctr Expt Res & Med Studies, Turin, Italy; [Porta, Francesco; Mussa, Alessandro; Fiore, Ludovica; Garelli, Davide; Spada, Marco; Ferracini, Riccardo] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Ferracini, Riccardo] AOU San Giovanni Battista, Dept Orthopaed, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Roato, I (corresponding author), AOU San Giovanni Battista, Ctr Expt Res & Med Studies, Turin, Italy.	roato78@libero.it	Mussa, Alessandro/H-1162-2013; Mussa, Alessandro/AAC-6235-2022; Ferracini, Riccardo/AAL-4622-2020; Porta, Francesco/G-9764-2012	Mussa, Alessandro/0000-0003-2795-6013; Mussa, Alessandro/0000-0003-2795-6013; Spada, Marco/0000-0002-8894-350X; Porta, Francesco/0000-0003-3899-4867; Roato, Ilaria/0000-0003-3029-4743	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata)	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata)(Compagnia di San Paolo)	Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qadreh A, 1998, ACTA PAEDIATR, V87, P1162; ALLEN JR, 1994, AM J CLIN NUTR, V59, P419, DOI 10.1093/ajcn/59.2.419; Baroncelli GI, 2006, BONE, V39, P159, DOI 10.1016/j.bone.2005.12.010; Baroncelli GI, 2008, PEDIATR RES, V63, P220, DOI 10.1203/PDR.0b013e318163a286; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; BICKEL H, 1953, LANCET, V265, P812; Brianza SZM, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:3(030508); Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Cheng S, 1999, CALCIFIED TISSUE INT, V64, P470, DOI 10.1007/s002239900635; Chiu YG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2915; Colucci S, 2004, BLOOD, V104, P3722, DOI 10.1182/blood-2004-02-0474; D'Amelio P, 2004, FASEB J, V18, P410, DOI 10.1096/fj.04-2214fje; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; De Terlizzi F, 2000, J BONE MINER RES, V15, P2458, DOI 10.1359/jbmr.2000.15.12.2458; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Faienza MF, 2009, J CLIN ENDOCR METAB, V94, P2269, DOI 10.1210/jc.2008-2446; Fewtrell MS, 2003, ARCH DIS CHILD, V88, P795, DOI 10.1136/adc.88.9.795; FROST HM, 1990, ANAT RECORD, V226, P433, DOI 10.1002/ar.1092260405; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Grundt A, 2009, BIOCHEM BIOPH RES CO, V389, P550, DOI 10.1016/j.bbrc.2009.09.026; Hillman L, 1996, EUR J PEDIATR, V155, pS148, DOI 10.1007/PL00014234; Hoeks MPA, 2009, NETH J MED, V67, P2; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; MacDonald A, 2006, ARCH DIS CHILD, V91, P588, DOI 10.1136/adc.2005.084285; MCMURRY MP, 1992, AM J CLIN NUTR, V55, P997, DOI 10.1093/ajcn/55.5.997; Mehta SS, 1998, J BONE MINER RES, V13, P114, DOI 10.1359/jbmr.1998.13.1.114; Millet P, 2005, CLIN BIOCHEM, V38, P1127, DOI 10.1016/j.clinbiochem.2005.09.002; Mussa A, 2010, BONE, V46, P1016, DOI 10.1016/j.bone.2009.12.019; Njeh CF, 1997, OSTEOPOROSIS INT, V7, P7, DOI 10.1007/BF01623454; Pluskiewicz W, 2002, OSTEOPOROSIS INT, V13, P353, DOI 10.1007/s001980200039; Porta F., 2008, J INHERIT METAB DIS; Porta F, 2008, ULTRASOUND MED BIOL, V34, P1049, DOI 10.1016/j.ultrasmedbio.2007.12.013; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Roato I, 2008, LUNG CANCER, V61, P109, DOI 10.1016/j.lungcan.2007.10.016; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; Roato I, 2007, ANN NY ACAD SCI, V1117, P377, DOI 10.1196/annals.1402.002; Roato I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003627; Sakata S, 2004, J BONE MINER RES, V19, P924, DOI 10.1359/JBMR.040131; SCRIVER CR, 2001, METABOLIC MOL BASES, V2, P1667; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yannicelli S, 2002, J INHERIT METAB DIS, V25, P347, DOI 10.1023/A:1020191515173; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Yi S., 2008, COCHRANE DB SYST REV, V4; Yoshimatsu M, 2009, BONE, V45, P1010, DOI 10.1016/j.bone.2009.07.079	47	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14167	10.1371/journal.pone.0014167	http://dx.doi.org/10.1371/journal.pone.0014167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152388	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100044
J	Yin, TY; Zhang, XY; Gunter, L; Priya, R; Sykes, R; Davis, M; Wullschleger, SD; Tuskan, GA				Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Sykes, Robert; Davis, Mark; Wullschleger, Stan D.; Tuskan, Gerald A.			Differential Detection of Genetic Loci Underlying Stem and Root Lignin Content in Populus	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; QUANTITATIVE TRAIT LOCI; DUPLICATED GENES; WOOD CHEMISTRY; GENOME; TRICHOCARPA; SEQUENCE; BIOMASS; SYSTEMS; GROWTH	In this study, we established a comprehensive genetic map with a large number of progeny from a three-generation hybrid Populus intercross, and phenotyped the lignin content, S/G ratio and 28 cell wall subcomponents both in stems and roots for the mapping individuals. Phenotypic analysis revealed that lignin content and syringyl-to-guaiacyl (S/G) ratio using pyrolysis molecular beam mass spectroscopy (pyMBMS) varied among mapping individuals. Phenotypic analysis revealed that stem lignin content is significantly higher than that in root and the quantified traits can be classified into four distinct groups, with strong correlations observed among components within organs. Altogether, 179 coordinating QTLs were detected, and they were co-localized into 49 genetic loci, 27 of which appear to be pleiotropic. Many of the detected genetic loci were detected differentially in stem and root. This is the first report of separate genetic loci controlling cell wall phenotypes above and below ground. These results suggest that it may be possible to modify lignin content and composition via breed and/or engineer as a means of simultaneously improving Populus for cellulosic ethanol production and carbon sequestration.	[Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Wullschleger, Stan D.; Tuskan, Gerald A.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Sykes, Robert; Davis, Mark; Tuskan, Gerald A.] Bioenergy Sci Ctr, Oak Ridge, TN USA; [Yin, Tongming] Nanjing Forestry Univ, Key Lab Forest Genet & Gene Engn, Nanjing, Peoples R China; [Sykes, Robert; Davis, Mark] Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Nanjing Forestry University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Yin, TY (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gtk@ornl.gov	Tuskan, Gerald/A-6225-2011; Wullschleger, Stan D/B-8297-2012; Gunter, Lee E/L-3480-2016; Davis, Mark/F-7341-2017	Tuskan, Gerald/0000-0003-0106-1289; Wullschleger, Stan D/0000-0002-9869-0446; Gunter, Lee E/0000-0003-1211-7532; Ranjan, Priya/0000-0002-0357-1939; Davis, Mark/0000-0003-4541-9852	Oak Ridge National Laboratory (ORNL); U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center; US Department of Energy [DE-AC05-00OR22725]	Oak Ridge National Laboratory (ORNL); U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL) and the U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center. ORNL is managed by UT-Battelle, LLC for the US Department of Energy under contract no. DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; CHOW P, 1989, WOOD FIBER SCI, V21, P30; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Davis MF, 2006, TREE PHYSIOL, V26, P557, DOI 10.1093/treephys/26.5.557; Dinus RJ, 2001, APPL BIOCHEM BIOTECH, V91-3, P23, DOI 10.1385/ABAB:91-93:1-9:23; Dinus RJ, 2001, CRIT REV PLANT SCI, V20, P51, DOI 10.1016/S0735-2689(01)80012-5; Elberse IAM, 2004, HEREDITY, V93, P22, DOI 10.1038/sj.hdy.6800467; Foust TD, 2008, BIOMASS RECALCITRANC, P7; Frewen BE, 2000, GENETICS, V154, P837; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Islam-Faridi MN, 2009, CYTOGENET GENOME RES, V125, P74, DOI 10.1159/000218749; Kelleher CT, 2007, PLANT J, V50, P1063, DOI 10.1111/j.1365-313X.2007.03112.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Smith E. Chalmers, 1943, JOUR ARNOLD ARBORETUM, V24, P275; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan G, 1999, APPL BIOCHEM BIOTECH, V77-9, P55, DOI 10.1385/ABAB:77:1-3:55; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Tuskan GA, 2001, FOREST CHRON, V77, P259, DOI 10.5558/tfc77259-2; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P407; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308	45	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14021	10.1371/journal.pone.0014021	http://dx.doi.org/10.1371/journal.pone.0014021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21151641	Green Published, gold			2022-12-25	WOS:000284467200002
J	Chien, WW; Domenech, C; Catallo, R; Kaddar, T; Magaud, JP; Salles, G; Ffrench, M				Chien, W. W.; Domenech, C.; Catallo, R.; Kaddar, T.; Magaud, J-P; Salles, G.; Ffrench, M.			Cyclin-dependent kinase 1 expression is inhibited by p16(INK4a) at the post-transcriptional level through the microRNA pathway	ONCOGENE			English	Article						p(16INK4a); CDK1; cell cycle; microRNA; E2F; post-transcriptional regulation	ACUTE LYMPHOBLASTIC-LEUKEMIA; LUNG-CANCER CELLS; MESSENGER-RNAS; PROLIFERATION; ACTIVATION; REPRESSION; APOPTOSIS; PROTEINS; TRANSFORMATION; TRANSCRIPTION	The p(16INK4a) protein regulates cell cycle progression mainly by inhibiting the activity of G1-phase cyclin-dependent kinases (CDKs) 4 and 6, the subsequent retinoblastoma protein (pRb) phosphorylation and E2F transcription factor release. The p(16INK4a) protein can also repress the activity of other transcription factors, such as c-myc, nuclear factor-kappaB and c-Jun/AP1. Here, we report that, in two p16(-/-), pRb(WT) and p53(WT) cell lines (MCF7 and U87), p(16INK4a) overexpression induces a dramatic decrease in CDK1 protein expression. In response to p(16INK4a), the decreased rate of CDK1 protein synthesis, its unchanged protein half- life, unreduced CDK1 mRNA steady- state levels and mRNA half- life allow us to hypothesize that p(16INK4a) could regulate CDK1 expression at the post- transcriptional level. This CDK1 downregulation is mediated by the 30-untranslated region (30UTR) of CDK1 mRNA as shown by translational inhibition in luciferase assays and is associated with a modified expression balance of microRNAs (miRNAs) that potentially regulate CDK1, analyzed by TaqMan Human microRNA Array. The p16INK4a-induced expression of two miRNAs (miR-410 and miR-650 chosen as an example) in MCF7 cells is confirmed by individual reverse transcriptionqPCR. Furthermore, we show the interaction of miR-410 or miR-650 with CDK1-30UTR by luciferase assays. Endogenous CDK1 expression decreases upon both miRNA overexpression and increases with their simultaneous inhibition. The induction of miR-410, but not miR-650 could be related to the pRb/ E2F pathway. These results demonstrate the post-transcriptional inhibition of CDK1 by p(16INK4a). We suggest that p(16INK4a) may regulate gene expression by modifying the functional equilibrium of transcription factors and consequently the expression balance of miRNAs. Oncogene (2011) 30, 1880-1891; doi: 10.1038/onc. 2010.570; published online 20 December 2010	[Ffrench, M.] Univ Lyon 1, CNRS, UMR ENS HCL 5239, Lab Pathol Cellules Lymphoides,Fac Med Lyon Sud, F-69495 Oullins, Rhone Alpes, France; [Magaud, J-P; Ffrench, M.] Hosp Civils Lyon, CHLS, Hematol Lab, Pierre Benite, France; [Salles, G.] Hosp Civils Lyon, CHLS, Serv Hematol, Pierre Benite, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon; CHU Lyon	Ffrench, M (corresponding author), Univ Lyon 1, CNRS, UMR ENS HCL 5239, Lab Pathol Cellules Lymphoides,Fac Med Lyon Sud, 165 Chemin Grand Revoyet, F-69495 Oullins, Rhone Alpes, France.	martine.ffrench@chu-lyon.fr	Salles, Gilles/Z-2336-2019; Holt, Janet E/B-2415-2013	Salles, Gilles/0000-0002-9541-8666; 	Ligue contre le Cancer of Saone-et-Loire and Rhone; Fondation pour la Recherche Medicale; Canceropole Lyon-Auvergne-Rhone-Alpes	Ligue contre le Cancer of Saone-et-Loire and Rhone; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Canceropole Lyon-Auvergne-Rhone-Alpes	This work was supported by the Ligue contre le Cancer of Saone-et-Loire and Rhone, by the Fondation pour la Recherche Medicale and by the Canceropole Lyon-Auvergne-Rhone-Alpes.	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Baghdassarian N, 1999, CELL GROWTH DIFFER, V10, P405; Baghdassarian N, 1998, EXP CELL RES, V240, P263, DOI 10.1006/excr.1998.3942; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chien WW, 2010, CELL CYCLE, V9, P3286, DOI 10.4161/cc.9.16.12600; Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Haas K, 1997, ONCOGENE, V15, P179, DOI 10.1038/sj.onc.1201171; Hara E, 1996, MOL CELL BIOL, V16, P859; Harada H, 1999, CANCER RES, V59, P3783; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Kamb A, 1994, Nat Genet, V8, P23; Kataoka M, 2000, ONCOGENE, V19, P1589, DOI 10.1038/sj.onc.1203466; Katsuda K, 2002, ONCOGENE, V21, P2108, DOI 10.1038/sj.onc.1205272; Kopper L, 2004, PATHOL ONCOL RES, V10, P69, DOI 10.1007/BF02893458; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moser JJ, 2007, J NEUROSCI RES, V85, P3619, DOI 10.1002/jnr.21439; Nalabothula N, 2007, INT J ONCOL, V30, P669; Nishiwaki E, 2000, MOL CELL BIOL, V20, P7726, DOI 10.1128/MCB.20.20.7726-7734.2000; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Urashima M, 1997, BLOOD, V90, P4106, DOI 10.1182/blood.V90.10.4106; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	52	50	52	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	16					1880	1891		10.1038/onc.2010.570	http://dx.doi.org/10.1038/onc.2010.570			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21170085				2022-12-25	WOS:000289777700004
J	Comb, WC; Cogswell, P; Sitcheran, R; Baldwin, AS				Comb, W. C.; Cogswell, P.; Sitcheran, R.; Baldwin, A. S.			IKK-dependent, NF-kappa B-independent control of autophagic gene expression	ONCOGENE			English	Article						autophagy; IKK; NF-kappa B; LC3; ATG5	TRANSCRIPTION; ACTIVATION; PATHWAYS	The induction of mammalian autophagy, a cellular catabolic bulk-degradation process conserved from humans to yeast, was recently shown to require I kappa B kinase (IKK), the upstream regulator of the nuclear factor (NF)-kappa B pathway. Interestingly, it was shown that this response did not involve NF-kappa B. Thus, the mechanism by which IKK promotes stimulus-induced autophagy is largely unknown. Here, we investigate the role of IKK/NF-kappa B in response to nutrient deprivation, the well-understood autophagy-inducing stimulus. IKK and both the classic and non-canonical pathways of NF-kappa B are robustly induced in response to cellular starvation. Notably, cells lacking either catalytic subunit of IKK (IKK-alpha or IKK-beta) fail to induce autophagy in response to cellular starvation. Importantly, we show that IKK activity but not NF-kappa B controls basal expression of the proautophagic gene LC3. We further demonstrate that starvation induces the expression of LC3 and two other essential autophagic genes ATG5 and Beclin-1 in an IKK-dependent manner. These results indicate that the IKK complex is a central mediator of starvation-induced autophagy in mammalian cells, and suggest that this requirement occurs at least in part through the regulation of autophagic gene expression. Interestingly, NF-kappa B subunits are dispensable for both basal and starvation-induced expression of proautophagic genes. However, starvation-induced activation of NF-kappa B is not inconsequential, as increases in expression of antiapoptotic NF-kappa B target genes such as Birc3 are observed in response to cellular starvation. Thus, IKK likely has multiple roles in response to starvation by regulating NF-kappa B-dependent antiapoptotic gene expression as well as controlling expression of autophagic genes through a yet undetermined mechanism. Oncogene (2011) 30, 1727-1732; doi:10.1038/onc.2010.553; published online 13 December 2010	[Comb, W. C.; Cogswell, P.; Sitcheran, R.; Baldwin, A. S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Comb, W. C.; Baldwin, A. S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Baldwin, A. S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	albert_baldwin@med.unc.edu		Sitcheran, Raquel/0000-0001-8916-9707	NIH [CA75080, AI035098, CA73756]; Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R01AI035098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Dr Alexander Hoffmann for the p65/c-Rel DKO cells and to Dr Denis Guttridge for the RelB <SUP>/</SUP> and p52 <SUP>/</SUP> cells. We thank members of the Baldwin lab for thoughtful discussion and manuscript feedback. Research support was provided by NIH grants CA75080, AI035098, CA73756 and the Waxman Cancer Research Foundation.	Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Shaw J, 2008, P NATL ACAD SCI USA, V105, P20734, DOI 10.1073/pnas.0807735105; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	26	86	90	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1727	1732		10.1038/onc.2010.553	http://dx.doi.org/10.1038/onc.2010.553			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21151171	Green Accepted, Green Submitted			2022-12-25	WOS:000289239400010
J	Yu, X; Wang, Y; DeGraff, DJ; Wills, ML; Matusik, RJ				Yu, X.; Wang, Y.; DeGraff, D. J.; Wills, M. L.; Matusik, R. J.			Wnt/beta-Catenin activation promotes prostate tumor progression in a mouse model	ONCOGENE			English	Article						prostate; Wnt/beta-catenin; AR; Foxa2; T-antigen	SMALL-CELL CARCINOMA; BETA-CATENIN; NEUROENDOCRINE DIFFERENTIATION; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; WNT PATHWAY; ANDROGEN; GROWTH; EXPRESSION; MICROENVIRONMENT	Our previous studies have found that activation of Wnt/beta-catenin signaling resulted in mouse prostatic intraepithelial neoplasia (mPIN). In the large probasin promoter directed SV40-large T-antigen ( LPB- Tag) expressing mouse prostate, mPIN forms with rare areas of adenocarcinoma. Combining expression of both Wnt-signaling and Tag expression in the mouse prostate, we have studied the role of Wnt/beta-catenin signaling in the progression from mPIN to adenocarcinoma. Our results show that the prostates of mice expressing Tag alone or nuclear beta-catenin alone developed mPIN, whereas the activation of both Tag and the Wnt/beta-catenin pathway resulted in invasive prostate adenocarcinoma. Furthermore, Foxa2, a forkhead transcription factor, was induced by active Wnt/beta-catenin signaling, and the expression of Foxa2 was associated with the invasive phenotype in the primary prostate cancer. In the LPB-Tag/dominant active (DA) b-catenin prostates, MMP7, a Wnt/beta-catenin target gene, was upregulated. Furthermore, we also assessed AR and AR signaling pathway in these LPB-Tag/DA beta-catenin mice. Although beta-catenin is a well-known AR co-activator in vitro, our study provides strong in vivo evidences indicating that both AR protein and the AR pathway were downregulated in the prostate of LPB-Tag/DA beta-catenin mice. Histological analysis shows that prostate sections derived from the LPB-Tag/DA beta-catenin mice display neuroendocrine differentiation (NED), but NE cancer does not develop. Together, our findings indicate that Wnt/beta-catenin signaling has an important role in the progression of mPIN to prostate adenocarcinoma. Oncogene (2011) 30, 1868-1879; doi: 10.1038/onc.2010.560; published online 13 December 2010	[Matusik, R. J.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Med Ctr, Nashville, TN 37232 USA; [Wang, Y.] Washington Biotechnol Inc, Columbia, MD USA; [Wills, M. L.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Matusik, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Urol Surg, Med Ctr, A-1302 Med Ctr N, Nashville, TN 37232 USA.	robert.matusik@vanderbilt.edu		Matusik, Robert/0000-0003-2057-9892; Yu, Xiuping/0000-0003-2844-7026	NIH [2R01 CA76142-11, 2R01-DK055748-10]; DOD [PC074022]; American Cancer Society Great Lakes Division; NATIONAL CANCER INSTITUTE [T32CA119925, R01CA076142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); American Cancer Society Great Lakes Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Angela Barth, the Stanford University, for kindly providing the mutant beta-catenin expressing vector, Tom Case and Manik Paul for technical support, Dr Barbara Fingleton and Dr Lynn Matrisian for advice and discussion. Grant support was provided by NIH to RJM (Grant Numbers: 2R01 CA76142-11; 2R01-DK055748-10), DOD to RJM (Grant Number: PC074022), and the Joe C. Davis Foundation. David DeGraff, PhD was supported by the American Cancer Society Great Lakes Division-Michigan Cancer Research Fund Postdoctoral Fellowship.	Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bonfil RD, 2007, UROL ONCOL-SEMIN ORI, V25, P407, DOI 10.1016/j.urolonc.2007.05.008; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Gupta A, 2008, PROSTATE, V68, P50, DOI 10.1002/pros.20650; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huang D, 2008, WORLD J GASTROENTERO, V14, P1823, DOI 10.3748/wjg.14.1823; Huss WJ, 2007, NEOPLASIA, V9, P938, DOI 10.1593/neo.07562; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Kasper S, 1998, LAB INVEST, V78, P319; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; LEVINE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1032, P119, DOI 10.1016/0304-419X(90)90015-S; Masumori N, 2001, CANCER RES, V61, P2239; Millar JBA, 2002, GENOME BIOL, V3; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Polakis P, 2000, GENE DEV, V14, P1837; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Sciarra A, 2003, BJU INT, V91, P438, DOI 10.1046/j.1464-410X.2003.03066.x; Song ZG, 2002, CANCER RES, V62, P5096; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b; Wang YQ, 2006, LAB INVEST, V86, P1074, DOI 10.1038/labinvest.3700463; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang XZ, 2005, CANCER RES, V65, P5263, DOI 10.1158/0008-5472.CAN-05-0162; Yao JL, 2006, AM J SURG PATHOL, V30, P705, DOI 10.1097/00000478-200606000-00005; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009; Zhang XJ, 1997, PROSTATE, V32, P16, DOI 10.1002/(SICI)1097-0045(19970615)32:1<16::AID-PROS3>3.0.CO;2-A	44	104	106	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1868	1879		10.1038/onc.2010.560	http://dx.doi.org/10.1038/onc.2010.560			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21151173	Green Accepted			2022-12-25	WOS:000289777700003
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Identification of Epithelial Na+ Channel (ENaC) Intersubunit Cl- Inhibitory Residues Suggests a Trimeric alpha gamma beta Channel Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-INHIBITION; SODIUM-CHANNEL; BINDING SITE; X-RAY; ACTIVATION; RESOLUTION; SUBUNIT; EXPRESSION; PROTEASES; CLONING	The extracellular domain of the epithelial Na+ channel (ENaC) is exposed to a wide range of anion concentrations in the kidney. We have previously demonstrated that extracellular Cl- inhibits ENaC activity. To identify sites involved in Cl- inhibition, we mutated residues in the extracellular domain of alpha-, beta-, and gamma ENaC that are homologous to the Cl- binding site in acid-sensing ion channel 1a and tested the effect of Cl- on the activity of ENaC expressed in Xenopus oocytes. We identified two Cl- inhibitory sites in ENaC. One is formed by residues in the thumb domain of alpha ENaC and the palm domain of beta ENaC. Mutation of residues at this interface decreased Cl- inhibition and decreased Na+ self-inhibition. The second site is formed by residues at the interface of the thumb domain of beta ENaC and the palm domain of gamma ENaC. Mutation of these residues also decreased Cl- inhibition yet had no effect on Na+ self-inhibition. In contrast, mutations in the thumb domain of gamma ENaC and palm of alpha ENaC had little or no effect on Cl- inhibition or Na+ self-inhibition. The data demonstrate that Cl- inhibits ENaC activity by two distinct Na+-dependent and Na+-independent mechanisms that correspond to the two functional Cl- inhibitory sites. Furthermore, based on the effects of mutagenesis on Cl- inhibition, the additive nature of mutations, and on differences in the mechanisms of Cl- inhibition, the data support a model in which ENaC subunits assemble in an alpha gamma beta orientation (listed clockwise when viewed from the top).	[Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		American Heart Association; National Institutes of Health [HL072256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a predoctoral fellowship grant from the American Heart Association.; Supported by National Institutes of Health Grant HL072256. To whom correspondence should be addressed: 371 EMRB, University of Iowa, Iowa City, IA 52242. E-mail: peter-snyder@uiowa.edu.	BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Rose B. D., 1984, CLIN PHYSL ACID BASE, P274; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	25	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6027	6032		10.1074/jbc.M110.198127	http://dx.doi.org/10.1074/jbc.M110.198127			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149458	hybrid, Green Published			2022-12-25	WOS:000287476400010
J	Kurooka, T; Yamamoto, Y; Takai, Y; Sakisaka, T				Kurooka, Takao; Yamamoto, Yasunori; Takai, Yoshimi; Sakisaka, Toshiaki			Dual Regulation of RA-RhoGAP Activity by Phosphatidic Acid and Rap1 during Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; LYSOPHOSPHATIDIC ACID; ACTIN CYTOSKELETON; MEMBRANE CURVATURE; BINDING PROTEINS; NERVE GROWTH; PC12 CELLS	During neurite outgrowth, Rho small G protein activity is spatiotemporally regulated to organize the neurite sprouting, extension, and branching. We have previously identified a potent Rho GTPase-activating protein (GAP), RA-RhoGAP, as a direct downstream target of Rap1 small G protein in the neurite outgrowth. In addition to the Ras-associating (RA) domain for Rap1 binding, RA-RhoGAP has the pleckstrin homology (PH) domain for lipid binding. Here, we showed that phosphatidic acid (PA) bound to the PH domain and enhanced GAP activity for Rho. RA-RhoGAP induced extension of neurite in a diacylglycerol kinase-mediated synthesis of the PA-dependent manner. Knockdown of RA-RhoGAP reduced the diacylglycerol kinase-induced neurite extension. In contrast to the effect of the RA domain, the PH domain was specifically involved in the neurite extension, not in the sprouting and branching. These results indicate that PA and Rap1 cooperatively regulate RA-RhoGAP activity for promoting neurite outgrowth.	Kobe Univ, Grad Sch Med, Div Membrane Dynam, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University		sakisaka@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; The Japan Epilepsy Research Foundation; Hyogo Science and Technology Association	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Japan Epilepsy Research Foundation; Hyogo Science and Technology Association	This work was supported by grants-in-aid for scientific research and for the Global COE Program F11 from the Ministry of Education, Culture, Sports, Science, and Technology, by a grant provided by The Japan Epilepsy Research Foundation, and by the grant provided by Hyogo Science and Technology Association.	Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jackson SG, 2006, ACTA CRYSTALLOGR D, V62, P324, DOI 10.1107/S0907444905043179; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Picard M, 2009, CELL SIGNAL, V21, P1961, DOI 10.1016/j.cellsig.2009.09.004; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	63	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6832	6843		10.1074/jbc.M110.183772	http://dx.doi.org/10.1074/jbc.M110.183772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169361	Green Published, hybrid			2022-12-25	WOS:000287476400090
J	Bansal, K; Balaji, KN				Bansal, Kushagra; Balaji, Kithiganahalli N.			Intracellular Pathogen Sensor NOD2 Programs Macrophages to Trigger Notch1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; NITRIC-OXIDE; SOCS3 EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; UP-REGULATION; MOUSE MODEL; INFLAMMATION; RECOGNITION; CYCLOOXYGENASE-2	Intracellular pathogen sensor, NOD2, has been implicated in regulation of wide range of anti-inflammatory responses critical during development of a diverse array of inflammatory diseases; however, underlying molecular details are still imprecisely understood. In this study, we demonstrate that NOD2 programs macrophages to trigger Notch1 signaling. Signaling perturbations or genetic approaches suggest signaling integration through cross-talk between Notch1-PI3K during the NOD2-triggered expression of a multitude of immunological parameters including COX-2/PGE(2) and IL-10. NOD2 stimulation enhanced active recruitment of CSL/RBP-Jk on the COX-2 promoter in vivo. Intriguingly, nitric oxide assumes critical importance in NOD2-mediated activation of Notch1 signaling as iNOS(-/-) macrophages exhibited compromised ability to execute NOD2-triggered Notch1 signaling responses. Correlative evidence demonstrates that this mechanism operates in vivo in brain and splenocytes derived from wild type, but not from iNOS(-/-) mice. Importantly, NOD2-driven activation of the Notch1-PI3K signaling axis contributes to its capacity to impart survival of macrophages against TNF-alpha or IFN-gamma-mediated apoptosis and resolution of inflammation. Current investigation identifies Notch1-PI3K as signaling cohorts involved in the NOD2-triggered expression of a battery of genes associated with anti-inflammatory functions. These findings serve as a paradigm to understand the pathogenesis of NOD2-associated inflammatory diseases and clearly pave a way toward development of novel therapeutics.	[Bansal, Kushagra; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in			Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT); VINNOVA (The Swedish Governmental Agency for Innovation Systems); DBT, India; Department of Science and Technology (DST); Council for Scientific and Industrial Research; Indian Institute of Science, Bangalore, India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); VINNOVA (The Swedish Governmental Agency for Innovation Systems)(Vinnova); DBT, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore, India	This work was supported by funds from the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT); a collaborative grant (to the Indian Institute of Science and Karolinska Institute) from VINNOVA (The Swedish Governmental Agency for Innovation Systems) and DBT, India; the Department of Science and Technology (DST); and the Council for Scientific and Industrial Research (to K.N.B.) and by infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions), and University Grants Commission (special assistance).; Supported by a fellowship from the Indian Institute of Science, Bangalore, India.	Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; BETZ M, 1991, J IMMUNOL, V146, P108; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Butler M, 2007, J CROHNS COLITIS, V1, P106, DOI 10.1016/j.crohns.2007.08.006; Chen C, 2010, NAT CHEM BIOL, V6, P401, DOI 10.1038/nchembio.375; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Dumont E, 2000, ONCOGENE, V19, P556, DOI 10.1038/sj.onc.1203352; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goralski KB, 2005, AM J PHYSIOL-GASTR L, V289, pG434, DOI 10.1152/ajpgi.00562.2004; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Harizi H, 2006, CELL MOL IMMUNOL, V3, P271; Henckaerts L, 2007, INFLAMM BOWEL DIS, V13, P235, DOI 10.1002/ibd.20066; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kimura M, 2003, CELL DEATH DIFFER, V10, P718, DOI 10.1038/sj.cdd.4401219; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; NIEUWENHUIJZEN GAP, 1993, ANN SURG, V218, P791, DOI 10.1097/00000658-199312000-00014; Philpott DJ, 2009, NAT IMMUNOL, V10, P455, DOI 10.1038/ni0509-455; Rahman MK, 2010, J IMMUNOL, V184, P7247, DOI 10.4049/jimmunol.0901479; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Seibert K, 1999, NAT MED, V5, P621, DOI 10.1038/9465; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Watanabe J, 2010, AM J PHYSIOL-GASTR L, V298, pG842, DOI 10.1152/ajpgi.00468.2009; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	50	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5823	5835		10.1074/jbc.M110.192393	http://dx.doi.org/10.1074/jbc.M110.192393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156799	Green Published, hybrid			2022-12-25	WOS:000287230600091
J	Chow, CK; Lock, K; Madhavan, M; Corsi, DJ; Gilmore, AB; Subramanian, SV; Li, W; Swaminathan, S; Lopez-Jaramillo, P; Avezum, A; Lear, SA; Dagenais, G; Teo, K; McKee, M; Yusuf, S				Chow, Clara K.; Lock, Karen; Madhavan, Manisha; Corsi, Daniel J.; Gilmore, Anna B.; Subramanian, S. V.; Li, Wei; Swaminathan, Sumathi; Lopez-Jaramillo, Patricio; Avezum, Alvaro; Lear, Scott A.; Dagenais, Gilles; Teo, Koon; McKee, Martin; Yusuf, Salim			Environmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five Countries	PLOS ONE			English	Article							IRVINE-MINNESOTA INVENTORY; MEASURE BUILT ENVIRONMENTS; PHYSICAL-ACTIVITY; SOCIETAL INFLUENCES; RELIABILITY; CONSUMPTION; SETTINGS; VALIDITY; SCIENCE; SCALE	Background: The environment in which people live is known to be important in influencing diet, physical activity, smoking, psychosocial and other risk factors for cardiovascular (CV) disease. However no instrument exists that evaluates communities for these multiple environmental factors and is suitable for use across different communities, regions and countries. This report describes the design and reliability of an instrument to measure environmental determinants of CV risk factors. Method/Principal Findings: The Environmental Profile of Community Health (EPOCH) instrument comprises two parts: (I) an assessment of the physical environment, and (II) an interviewer-administered questionnaire to collect residents' perceptions of their community. We examined the inter-rater reliability amongst 3 observers from each region of the direct observation component of the instrument (EPOCH I) in 93 rural and urban communities in 5 countries (Canada, Colombia, Brazil, China and India). Data collection using the EPOCH instrument was feasible in all communities. Reliability of the instrument was excellent (Intraclass Correlation Coefficient -ICC>0.75) for 24 of 38 items and fair to good (ICC 0.4-0.75) for 14 of 38 items. Conclusion: This report shows data collection with the EPOCH instrument is feasible and direct observation of community measures reliable. The EPOCH instrument will enable further research on environmental determinants of health for population studies from a broad range of settings.	[Chow, Clara K.; Madhavan, Manisha; Corsi, Daniel J.; Teo, Koon; Yusuf, Salim] Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lock, Karen; Gilmore, Anna B.; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Li, Wei] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Swaminathan, Sumathi] St Johns Res Inst, Bangalore, Karnataka, India; [Lopez-Jaramillo, Patricio] Univ Santander, Res Direct, Fdn Oftalmol Santander Clin Carlos Arila Lulle, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Sch Med, Bucaramanga, Colombia; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Gilmore, Anna B.] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McMaster University; Population Health Research Institute; George Institute for Global Health; University of Sydney; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Research Institute; Universidad Industrial de Santander; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Simon Fraser University; University of Bath; Laval University	Chow, CK (corresponding author), Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	clara@phri.ca	gilmore, anna B/I-7130-2012; Avezum, Alvaro/AAP-7687-2020; Corsi, Daniel J/S-4689-2018; Swaminathan, Sumathi/AGI-7678-2022; Avezum, Alvaro AA/K-6137-2016; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	gilmore, anna B/0000-0003-0281-1248; Corsi, Daniel J/0000-0001-7063-3354; Avezum, Alvaro AA/0000-0002-3073-6890; McKee, Marc D/0000-0001-8349-965X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusuf, Salim/0000-0003-4776-5601; Teo, Koon/0000-0002-3731-0956; McKee, Martin/0000-0002-0121-9683	Hamilton Health Sciences [08158]; Heart and Stroke Foundation of Ontario [PLP6567]; Colombian Institute for Science and Technology [6566-04-18062]; Royal Australasian College of Physicians; Public Health (Sidney Sax) Overseas Fellowship; National Health and Medical Research Council; National Heart Foundation of Australia; Heart and Stroke Foundation of Ontario; Health Foundation; National Institutes of Health [NHLBI K25 HL081275]; RWJ Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER; National Institute for Health Research [PDF/01/2008/031] Funding Source: researchfish	Hamilton Health Sciences; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Colombian Institute for Science and Technology; Royal Australasian College of Physicians(General Electric); Public Health (Sidney Sax) Overseas Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RWJ Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Hamilton Health Sciences New Investigator Grant [# 08158 to CC, SY] and a Heart and Stroke Foundation of Ontario Pilot Project Grant [# PLP6567]. Data collection in Colombia was partly supported by the Colombian Institute for Science and Technology [# 6566-04-18062 to PLJ]. CK Chow was supported by a Cottrell fellowship from the Royal Australasian College of Physicians and currently is supported by a Public Health (Sidney Sax) Overseas Fellowship co-funded by the National Health and Medical Research Council and National Heart Foundation of Australia. S Yusuf is supported by an endowed chair from the Heart and Stroke Foundation of Ontario. S Lear is a Canadian Institutes of Health Research New Investigator and the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research at St. Paul' Hospital. A Gilmore is supported by a Health Foundation Clinician Scientist Fellowship. SV Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the RWJ Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamar B, 2006, AM J PUBLIC HEALTH, V96, P1359, DOI 10.2105/AJPH.2005.069617; Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Boarnet MG, 2006, AM J PREV MED, V30, P153, DOI 10.1016/j.amepre.2005.09.018; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Day K, 2006, AM J PREV MED, V30, P144, DOI 10.1016/j.amepre.2005.09.017; Fisher BD, 2008, AM J HEALTH PROMOT, V22, P208, DOI 10.4278/ajhp.22.3.208; FLEISS JL, 1978, PSYCHOMETRIKA, V43, P259, DOI 10.1007/BF02293867; Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; LEVY DT, 2008, ROLE TOBACCO CONTROL, P53; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Pikora TJ, 2006, MED SCI SPORT EXER, V38, P708, DOI 10.1249/01.mss.0000210189.64458.f3; Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thompson VJ, 2007, J NUTR EDUC BEHAV, V39, P2, DOI 10.1016/j.jneb.2006.06.006; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3; White E, 2008, PRINCIPLES EXPOSURE	24	57	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14294	10.1371/journal.pone.0014294	http://dx.doi.org/10.1371/journal.pone.0014294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692UU	21170320	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000285181400013
J	Posadas, I; Santos, P; Blanco, A; Munoz-Fernandez, M; Cena, V				Posadas, Inmaculada; Santos, Pablo; Blanco, Almudena; Munoz-Fernandez, Mariangeles; Cena, Valentin			Acetaminophen Induces Apoptosis in Rat Cortical Neurons	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; INDUCED HEPATOTOXICITY; GLUTATHIONE-REDUCTASE; INDUCED TOXICITY; CREATINE-KINASE; OXIDANT STRESS; UNITED-STATES; BRAIN	Background: Acetaminophen (AAP) is widely prescribed for treatment of mild pain and fever in western countries. It is generally considered a safe drug and the most frequently reported adverse effect associated with acetaminophen is hepatotoxicity, which generally occurs after acute overdose. During AAP overdose, encephalopathy might develop and contribute to morbidity and mortality. Our hypothesis is that AAP causes direct neuronal toxicity contributing to the general AAP toxicity syndrome. Methodology/Principal Findings: We report that AAP causes direct toxicity on rat cortical neurons both in vitro and in vivo as measured by LDH release. We have found that AAP causes concentration-dependent neuronal death in vitro at concentrations (1 and 2 mM) that are reached in human plasma during AAP overdose, and that are also reached in the cerebrospinal fluid of rats for 3 hours following i.p injection of AAP doses (250 and 500 mg/Kg) that are below those required to induce acute hepatic failure in rats. AAP also increases both neuronal cytochrome P450 isoform CYP2E1 enzymatic activity and protein levels as determined by Western blot, leading to neuronal death through mitochondrial-mediated mechanisms that involve cytochrome c release and caspase 3 activation. In addition, in vivo experiments show that i.p. AAP (250 and 500 mg/Kg) injection induces neuronal death in the rat cortex as measured by TUNEL, validating the in vitro data. Conclusions/Significance: The data presented here establish, for the first time, a direct neurotoxic action by AAP both in vivo and in vitro in rats at doses below those required to produce hepatotoxicity and suggest that this neurotoxicity might be involved in the general toxic syndrome observed during patient APP overdose and, possibly, also when AAP doses in the upper dosing schedule are used, especially if other risk factors (moderate drinking, fasting, nutritional impairment) are present.	[Posadas, Inmaculada; Santos, Pablo; Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain; [Blanco, Almudena; Munoz-Fernandez, Mariangeles] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Posadas, Inmaculada; Santos, Pablo; Cena, Valentin] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerativas, Madrid, Spain; [Posadas, Inmaculada; Blanco, Almudena; Munoz-Fernandez, Mariangeles; Cena, Valentin] Inst Salud Carlos III, CIBER Bioingn Biomat & Nanomed, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III	Posadas, I (corresponding author), Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain.	valentin.cena@uclm.es	Cena, Valentin/L-1751-2017; Posadas, Inmaculada/M-1124-2014	Cena, Valentin/0000-0001-8928-3681; Posadas, Inmaculada/0000-0003-1854-3372; Munoz-Fernandez/0000-0002-0813-4500	Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI52112, PI09/02029, PI081434]; Junta de Comunidades de Castilla-La Mancha [PAI07-0063-7844, PII1I09-0163-4002, POII10-0274-3182]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RD06/0006/0035]; Fundacion para la Investigacion del Sida en Espana [FIPSE 240800/09]; Comunidad de Madrid [S-SAL-0159-2006]; Consejeria de Educacion	Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion del Sida en Espana; Comunidad de Madrid(Comunidad de Madrid); Consejeria de Educacion	This work has been supported by grants from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI52112] and Junta de Comunidades de Castilla-La Mancha [PAI07-0063-7844] to I.P.; from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI09/02029], Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RD06/0006/0035], Fundacion para la Investigacion del Sida en Espana [FIPSE 240800/09] and Comunidad de Madrid [S-SAL-0159-2006] to M.A.M-F. and from Fondo de Investigaciones Sanitarias Ministerio de Sanidad y Consumo [PI081434], from Consejeria de Educacion; Junta de Comunidades de Castilla-La Mancha [PII1I09-0163-4002 and POII10-0274-3182] to V.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Amar PJ, 2007, EXPERT OPIN DRUG SAF, V6, P341, DOI 10.1517/14740338.6.4.341; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; Bisaglia M, 2002, NEUROCHEM INT, V41, P43, DOI 10.1016/S0197-0186(01)00136-X; Blantz RC, 1996, AM J KIDNEY DIS, V28, pS3, DOI 10.1016/S0272-6386(96)90561-2; Bolesta S, 2002, ANN PHARMACOTHER, V36, P331; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bosque A, 2005, J LEUKOCYTE BIOL, V77, P568, DOI 10.1189/jlb.0904514; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Botting RM, 2000, CLIN INFECT DIS, V31, pS202, DOI 10.1086/317520; Buzanska L, 2009, STEM CELLS, V27, P2591, DOI 10.1002/stem.179; Casper D, 2000, NEUROSCI LETT, V289, P201, DOI 10.1016/S0304-3940(00)01294-5; Cigremis Y, 2009, MOL CELL BIOCHEM, V323, P31, DOI 10.1007/s11010-008-9961-8; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; David S, 1998, MOL BRAIN RES, V54, P276, DOI 10.1016/S0169-328X(97)00343-4; Dendorfer A, 2005, FREE RADICAL BIO MED, V38, P117, DOI 10.1016/j.freeradbiomed.2004.10.015; Du YS, 1997, J NEUROCHEM, V69, P1382; Eguia L, 1997, PHARMACOTHERAPY, V17, P363; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; FISCHER LJ, 1981, J PHARMACOL EXP THER, V219, P281; Fontana RJ, 2008, MED CLIN N AM, V92, P761, DOI 10.1016/j.mcna.2008.03.005; Fukuda M, 2005, J PHARMACOL SCI, V97, P525, DOI 10.1254/jphs.FP0040752; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Galindo MF, 2003, J NEUROCHEM, V84, P1066, DOI 10.1046/j.1471-4159.2003.01592.x; Gervasini G, 2004, CLIN PHARMACOKINET, V43, P693, DOI 10.2165/00003088-200443110-00001; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HART SGE, 1994, TOXICOL APPL PHARM, V126, P267, DOI 10.1006/taap.1994.1116; Headley J, 2007, EUR J CLIN PHARMACOL, V63, P189, DOI 10.1007/s00228-006-0231-y; HENDERSON PJ, 1970, J BIOL CHEM, V245, P1319; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Jalan R, 2005, NEUROCHEM INT, V47, P78, DOI 10.1016/j.neuint.2005.04.010; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; James LP, 2003, FREE RADICAL RES, V37, P1289, DOI 10.1080/10715760310001617776; Jamshidzadeh A, 2008, FOOD CHEM TOXICOL, V46, P3612, DOI 10.1016/j.fct.2008.09.006; JONES AF, 1993, J CLIN PHARM THER, V18, P5, DOI 10.1111/j.1365-2710.1993.tb00560.x; Jordan J, 2000, BRIT J PHARMACOL, V130, P1496, DOI 10.1038/sj.bjp.0703451; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; Jordan J, 2003, NEUROSCIENCE, V122, P707, DOI 10.1016/j.neuroscience.2003.08.030; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Joshi M, 2006, DRUG METAB DISPOS, V34, P647, DOI 10.1124/dmd.105.008029; Kim YC, 1998, TOXICOLOGY, V128, P53, DOI 10.1016/S0300-483X(98)00046-8; Kon K, 2004, HEPATOLOGY, V40, p647A; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurtovic J, 2003, J INTERN MED, V253, P240, DOI 10.1046/j.1365-2796.2003.01097.x; LARSEN FS, 1995, J HEPATOL, V23, P212, DOI 10.1016/0168-8278(95)80338-6; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Maharaj H, 2006, METAB BRAIN DIS, V21, P189, DOI 10.1007/s11011-006-9012-7; Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; MITCHELL JR, 1973, DRUG METAB DISPOS, V1, P418; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Moffit JS, 2007, TOXICOLOGY, V230, P197, DOI 10.1016/j.tox.2006.11.052; NAGENDRA SN, 1991, LIFE SCI, V49, P23, DOI 10.1016/0024-3205(91)90575-V; Naziroglu M, 2009, J MEMBRANE BIOL, V231, P57, DOI 10.1007/s00232-009-9203-3; Niquet J, 2006, BIOCHEM SOC T, V34, P1347, DOI 10.1042/BST0341347; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Pacheco GS, 2009, METAB BRAIN DIS, V24, P383, DOI 10.1007/s11011-009-9143-8; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Posadas I, 2009, PHARM RES-DORDR, V26, P1181, DOI 10.1007/s11095-009-9839-9; PUNCHARD NA, 1996, FREE RADICALS PRACTI, P1; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Smith SW, 2008, ANN PHARMACOTHER, V42, P1333, DOI 10.1345/aph.1K680; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; Tindberg N, 1996, J NEUROCHEM, V67, P2066, DOI 10.1046/j.1471-4159.1996.67052066.x; Tran A, 2001, TOXICOL APPL PHARM, V170, P145, DOI 10.1006/taap.2000.9091; Tripathy D, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-10; Upadhya SC, 2000, ARCH BIOCHEM BIOPHYS, V373, P23, DOI 10.1006/abbi.1999.1477; Walubo A, 2004, HUM EXP TOXICOL, V23, P49, DOI 10.1191/0960327104ht415oa; Wilcox CM, 2005, J RHEUMATOL, V32, P2218	72	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15360	10.1371/journal.pone.0015360	http://dx.doi.org/10.1371/journal.pone.0015360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170329	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400023
J	Chkonia, E; Roinishvili, M; Makhatadze, N; Tsverava, L; Stroux, A; Neumann, K; Herzog, MH; Brand, A				Chkonia, Eka; Roinishvili, Maya; Makhatadze, Natia; Tsverava, Lidia; Stroux, Andrea; Neumann, Konrad; Herzog, Michael H.; Brand, Andreas			The Shine-Through Masking Paradigm Is a Potential Endophenotype of Schizophrenia	PLOS ONE			English	Article							BACKWARD-MASKING; CONTEXTUAL SUPPRESSION; 1ST-DEGREE RELATIVES; UNAFFECTED SIBLINGS; ADOLESCENTS; PERFORMANCE	Background: To understand the genetics of schizophrenia, a hunt for so-called intermediate phenotypes or endophenotypes is ongoing. Visual masking has been proposed to be such an endophenotype. However, no systematic study has been conducted yet to prove this claim. Here, we present the first study showing that masking meets the most important criteria for an endophenotype. Methodology/Principal Findings: We tested 62 schizophrenic patients, 39 non-affected first-degree relatives, and 38 healthy controls in the shine-through masking paradigm and, in addition, in the Continuous Performance Test (CPT) and the Wisconsin Card Sorting Test (WCST). Most importantly, masking performance of relatives was significantly in between the one of patients and controls in the shine-through paradigm. Moreover, deficits were stable throughout one year. Using receiver operating characteristics (ROC) methods, we show that the shine-through paradigm distinguishes with high sensitivity and specificity between schizophrenic patients, first-order relatives and healthy controls. Conclusions/Significance: The shine-through paradigm is a potential endophenotype.	[Chkonia, Eka; Tsverava, Lidia] Tbilisi State Med Univ, Dept Psychiat, Tbilisi, Georgia; [Roinishvili, Maya] I Beritashvili Inst Physiol, Dept Behav & Cognit Funct, Tbilisi, Georgia; [Makhatadze, Natia] Gotsiridze Psychoneurol Dispensary, Tbilisi, Georgia; [Stroux, Andrea; Neumann, Konrad] Charite, CCM, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Herzog, Michael H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Psychophys, Lausanne, Switzerland; [Brand, Andreas] Klinikum Bremen Ost, Ctr Psychiat & Psychotherapy, Bremen, Germany	Tbilisi State Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Klinikum Bremen-Ost	Chkonia, E (corresponding author), Tbilisi State Med Univ, Dept Psychiat, Tbilisi, Georgia.	echkonia@yahoo.ca	Chkonia, Eka/GQQ-1751-2022; Chkonia, Eka/F-4517-2014	Chkonia, Eka/0000-0002-8817-9679; Chkonia, Eka/0000-0002-8817-9679	Volkswagen Foundation [1/80 096]	Volkswagen Foundation(Volkswagen)	Funding for this study was provided by the Volkswagen Foundation project between Europe and the Orient - A Focus on Research and Higher Education in/on Central Asia and the Caucasus (1/80 096). Volkswagen Foundation had no further role in the study design, in the data collection, data analysis, interpretation, in the writing of the manuscript, and in the decision to submit the paper for publication.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; AUKES MF, 2008, BIOL PSYCHOL; Bedwell JS, 2003, SCHIZOPHR RES, V63, P273, DOI 10.1016/S0920-9964(02)00356-0; Birkett P, 2008, AM J MED GENET B, V147B, P285, DOI 10.1002/ajmg.b.30594; BRAFF DL, 1981, AM J PSYCHIAT, V138, P1051; Brand A, 2004, EUR ARCH PSY CLIN N, V254, P281, DOI 10.1007/s00406-004-0493-2; BRODY D, 1980, J ABNORM PSYCHOL, V89, P617, DOI 10.1037/0021-843X.89.5.617; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MF, 1997, ARCH GEN PSYCHIAT, V54, P465; Green MF, 2006, BIOL PSYCHIAT, V59, P446, DOI 10.1016/j.biopsych.2005.06.035; Green MF, 1997, ARCH GEN PSYCHIAT, V54, P846; Grimsen C, 2007, PSYCHIAT RES, V150, P237, DOI 10.1016/j.psychres.2006.03.021; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hermens F, 2008, PSYCHOL REV, V115, P83, DOI 10.1037/0033-295X.115.1.83; Herzog MH, 2004, PSYCHIAT RES, V129, P55, DOI 10.1016/j.psychres.2004.06.008; Herzog MH, 2003, NEURAL COMPUT, V15, P2091, DOI 10.1162/089976603322297304; Herzog MH, 2001, VISION RES, V41, P2325, DOI 10.1016/S0042-6989(01)00122-5; Holzer L, 2009, J CLIN EXP NEUROPSYC, V31, P641, DOI 10.1080/13803390802438454; Horn W, 1983, LEISTUNGSPRUEFSYSTEM; Keri S, 2005, PSYCHOL MED, V35, P1043, DOI 10.1017/S0033291705004381; Keri S, 2004, NEUROPSYCHOLOGY, V18, P537, DOI 10.1037/0894-4105.18.3.537; Keri S, 2001, PSYCHOL MED, V31, P915, DOI 10.1017/S0033291701004068; LEE J, 2008, SCHIZ RES; Lieb K, 1996, SCHIZOPHR RES, V21, P171, DOI 10.1016/0920-9964(96)00025-4; Macmillan N. A., 1991, DETECTION THEORY USE; MERRITT RD, 1990, J NERV MENT DIS, V178, P186, DOI 10.1097/00005053-199003000-00006; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PARKOSADZE K, 2009, EUR C VIS PERC ECVP; Roinishvili M, 2008, EUR ARCH PSY CLIN N, V258, P210, DOI 10.1007/s00406-007-0780-9; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUND BR, 1993, J NERV MENT DIS, V181, P233, DOI 10.1097/00005053-199304000-00004; Rund BR, 1996, AM J PSYCHIAT, V153, P1154; SACCUZZO DP, 1981, J ABNORM PSYCHOL, V90, P305, DOI 10.1037/0021-843X.90.4.305; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Szoke A, 2005, PSYCHOL MED, V35, P771, DOI 10.1017/S0033291704003460; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Ueland T, 2004, PSYCHIAT RES, V126, P229, DOI 10.1016/j.psychres.2004.02.014	40	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14268	10.1371/journal.pone.0014268	http://dx.doi.org/10.1371/journal.pone.0014268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692ES	21151559	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800005
J	El-Armouche, A; Schwoerer, AP; Neuber, C; Emmons, J; Biermann, D; Christalla, T; Grundhoff, A; Eschenhagen, T; Zimmermann, WH; Ehmke, H				El-Armouche, Ali; Schwoerer, Alexander Peter; Neuber, Christiane; Emmons, Julius; Biermann, Daniel; Christalla, Thomas; Grundhoff, Adam; Eschenhagen, Thomas; Zimmermann, Wolfram Hubertus; Ehmke, Heimo			Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load	PLOS ONE			English	Article							FETAL GENE PROGRAM; HEART-FAILURE; RAT HEARTS; EXPRESSION; FIBROSIS; DISEASE; STRESS; REPOLARIZATION; AUTOPHAGY; PROTECTS	Background: Mechanical overload leads to cardiac hypertrophy and mechanical unloading to cardiac atrophy. Both conditions produce similar transcriptional changes including a re-expression of fetal genes, despite obvious differences in phenotype. MicroRNAs (miRNAs) are discussed as superordinate regulators of global gene networks acting mainly at the translational level. Here, we hypothesized that defined sets of miRNAs may determine the direction of cardiomyocyte plasticity responses. Methodology/Principal Findings: We employed ascending aortic stenosis (AS) and heterotopic heart transplantation (HTX) in syngenic Lewis rats to induce mechanical overloading and unloading, respectively. Heart weight was 26 +/- 3% higher in AS (n = 7) and 33 +/- 2% lower in HTX (n = 7) as compared to sham-operated (n = 6) and healthy controls (n = 7). Small RNAs were enriched from the left ventricles and subjected to quantitative stem-loop specific RT-PCR targeting a panel of 351 miRNAs. In total, 153 miRNAs could be unambiguously detected. Out of 72 miRNAs previously implicated in the cardiovascular system, 40 miRNAs were regulated in AS and/or HTX. Overall, HTX displayed a slightly broader activation pattern for moderately regulated miRNAs. Surprisingly, however, the regulation of individual miRNA expression was strikingly similar in direction and amplitude in AS and HTX with no miRNA being regulated in opposite direction. In contrast, fetal hearts from Lewis rats at embryonic day 18 exhibited an entirely different miRNA expression pattern. Conclusions: Taken together, our findings demonstrate that opposite changes in cardiac workload induce a common miRNA expression pattern which is markedly different from the fetal miRNA expression pattern. The direction of postnatal adaptive cardiac growth does, therefore, not appear to be determined at the level of single miRNAs or a specific set of miRNAs. Moreover, miRNAs themselves are not reprogrammed to a fetal program in response to changes in hemodynamic load.	[El-Armouche, Ali; Emmons, Julius; Zimmermann, Wolfram Hubertus] Univ Med Ctr Goettingen UMG, Dept Pharmacol, Gottingen, Germany; [El-Armouche, Ali; Neuber, Christiane; Biermann, Daniel; Eschenhagen, Thomas; Zimmermann, Wolfram Hubertus] Univ Med Ctr Hamburg Eppendorf, Dept Expt & Clin Pharmacol & Toxicol, Hamburg, Germany; [Schwoerer, Alexander Peter; Ehmke, Heimo] Univ Med Ctr Hamburg Eppendorf, Dept Vegetat Physiol & Pathophysiol, Hamburg, Germany; [Christalla, Thomas; Grundhoff, Adam] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg	El-Armouche, A (corresponding author), Univ Med Ctr Goettingen UMG, Dept Pharmacol, Gottingen, Germany.	ali.el-armouche@med.uni-goettingen.de; schwoerer@uke.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; El-Armouche, Ali/H-3161-2018	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; El-Armouche, Ali/0000-0003-2514-9429; Grundhoff, Adam/0000-0003-0940-7045	Deutsche Forschungsgemeinschaft [DFG-FOR 604]; European Union; German Foundation of Heart Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Foundation of Heart Research	This study was supported by the Deutsche Forschungsgemeinschaft (DFG-FOR 604 to AEA, TE, WHZ and HE), by the European Union (EUGene Heart to AEA and TE) and by the German Foundation of Heart Research (to AEA, APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Ferdous A, 2010, J CARDIOVASC TRANSL, V3, P355, DOI 10.1007/s12265-010-9200-z; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2006, ANN NY ACAD SCI, V1080, P110, DOI 10.1196/annals.1380.011; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P633, DOI 10.1016/j.yjmcc.2008.02.271; SONG XW, 2010, J CELL PHYSL; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wagner M, 2007, PFLUG ARCH EUR J PHY, V454, P595, DOI 10.1007/s00424-007-0227-1; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Watanabe T, 2007, METHOD ENZYMOL, V427, P155, DOI 10.1016/S0076-6879(07)27009-0; Wiesner RJ, 1997, CIRCULATION, V95, P1253	39	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14263	10.1371/journal.pone.0014263	http://dx.doi.org/10.1371/journal.pone.0014263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151612	gold, Green Published, Green Submitted			2022-12-25	WOS:000285135800004
J	Rosti, V; Bonetti, E; Bergamaschi, G; Campanelli, R; Guglielmelli, P; Maestri, M; Magrini, U; Massa, M; Tinelli, C; Viarengo, G; Villani, L; Primignani, M; Vannucchi, AM; Frassoni, F; Barosi, G				Rosti, Vittorio; Bonetti, Elisa; Bergamaschi, Gaetano; Campanelli, Rita; Guglielmelli, Paola; Maestri, Marcello; Magrini, Umberto; Massa, Margherita; Tinelli, Carmine; Viarengo, Gianluca; Villani, Laura; Primignani, Massimo; Vannucchi, Alessandro M.; Frassoni, Francesco; Barosi, Giovanni		AGIMM Investigators	High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis	PLOS ONE			English	Article							JAK2 V617F MUTATION; PROGENITOR CELLS; CIRCULATING CD34(+); MYELOFIBROSIS; DIAGNOSIS; BLOOD	Increased mobilization of circulating endothelial progenitor cells may represent a new biological hallmark of myeloproliferative neoplasms. We measured circulating endothelial colony forming cells (ECFCs) in 106 patients with primary myelofibrosis, fibrotic stage, 49 with prefibrotic myelofibrosis, 59 with essential thrombocythemia or polycythemia vera, and 43 normal controls. Levels of ECFC frequency for patient's characteristics were estimated by using logistic regression in univariate and multivariate setting. The sensitivity, specificity, likelihood ratios, and positive predictive value of increased ECFC frequency were calculated for the significantly associated characteristics. Increased frequency of ECFCs resulted independently associated with history of splanchnic vein thrombosis (adjusted odds ratio = 6.61, 95% CI = 2.54-17.16), and a summary measure of non-active disease, i.e. hemoglobin of 13.8 g/dL or lower, white blood cells count of 7.8 x 10(9)/L or lower, and platelet count of 400 x 10(9)/L or lower (adjusted odds ratio = 4.43, 95% CI = 1.45-13.49) Thirteen patients with splanchnic vein thrombosis non associated with myeloproliferative neoplasms were recruited as controls. We excluded a causal role of splanchnic vein thrombosis in ECFCs increase, since no control had elevated ECFCs. We concluded that increased frequency of ECFCs represents the biological hallmark of a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. The recognition of this disease category copes with the phenotypic mimicry of myeloproliferative neoplasms. Due to inherent performance limitations of ECFCs assay, there is an urgent need to arrive to an acceptable standardization of ECFC assessment.	[Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Magrini, Umberto; Villani, Laura; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy; [Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Magrini, Umberto; Villani, Laura; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; [Bergamaschi, Gaetano] IRCCS Policlin S Matteo Fdn, Dept Internal Med, Unit Clin Med 1, Pavia, Italy; [Guglielmelli, Paola; Vannucchi, Alessandro M.] Univ Florence, Dept Crit Care, Hematol Unit, Florence, Italy; [Guglielmelli, Paola; Vannucchi, Alessandro M.] Ist Toscano Tumori, Florence, Italy; [Maestri, Marcello] IRCCS Policlin S Matteo Fdn, Dept Surg, Pavia, Italy; [Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Lab, Pavia, Italy; [Tinelli, Carmine] Fdn IRCCS Policlin S Matteo Fdn, Biometr Unit, Pavia, Italy; [Viarengo, Gianluca] IRCCS Policlin S Matteo Fdn, Unit Clin Immunol Immunohematol & Transfus Serv, Pavia, Italy; [Primignani, Massimo] IRCCS Ca Granda Osped Maggiore Policlin Fdn, Gastroenterol Unit 3, Milan, Italy; [Frassoni, Francesco] Osped San Martino Genova, Ctr Cellule Staminali & Terapia Cellulare, Genoa, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Genoa; IRCCS AOU San Martino IST	Rosti, V (corresponding author), IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy.	barosig@smatteo.pv.it	Barosi, Giovanni/AAI-1714-2019; Frassoni, Francesco/K-3971-2018; Villani, Laura/K-1794-2018; Pietra, Daniela/F-3931-2016; maestri, marcello/Q-3503-2016; Zini, Roberta/I-6734-2012; Rumi, Elisa/J-7424-2016; Campanelli, Rita/K-4686-2016; Bonetti, Elisa/D-4478-2016; Pieri, Lisa/K-1762-2016; Guglielmelli, Paola/K-7509-2016; Vannucchi, Alessandro M./K-7499-2016; Salati, Simona/J-2344-2012; Rosti, Vittorio/K-1743-2018; Massa, Margherita/K-4682-2016; Carolei, Adriana/AAQ-7656-2021; Bortoluzzi, Stefania/G-8211-2011	Frassoni, Francesco/0000-0003-1262-0648; Villani, Laura/0000-0003-4199-5633; Pietra, Daniela/0000-0002-6575-8766; maestri, marcello/0000-0002-5693-9151; Zini, Roberta/0000-0001-6657-0864; Rumi, Elisa/0000-0002-7572-9504; Campanelli, Rita/0000-0003-4923-2761; Bonetti, Elisa/0000-0002-8406-5252; Pieri, Lisa/0000-0003-1812-8072; Guglielmelli, Paola/0000-0003-1809-284X; Vannucchi, Alessandro M./0000-0001-5755-0730; Salati, Simona/0000-0002-8072-1128; Rosti, Vittorio/0000-0003-4195-2289; Massa, Margherita/0000-0001-8037-0439; Bartalucci, Niccolo/0000-0002-9328-3948; Passamonti, Francesco/0000-0001-8068-5289; Carolei, Adriana/0000-0002-5254-8532; DEJANA, ELISABETTA/0000-0002-0007-0426; Bergamaschi, Gaetano/0000-0002-2796-9765; TENEDINI, Elena/0000-0003-0285-765X; Bortoluzzi, Stefania/0000-0001-8240-3070; Tinelli, Carmine/0000-0002-8749-1978; Arruga, Francesca/0000-0001-5298-9314; PANCRAZZI, ALESSANDRO/0000-0002-6943-6924; Corada, Monica/0000-0001-8220-0871	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	The study was funded by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5 x 1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2009, ACTA HAEMATOL-BASEL, V121, P218, DOI 10.1159/000221962; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; BAROSI G, 1991, CANCER, V68, P2310, DOI 10.1002/1097-0142(19911115)68:10<2310::AID-CNCR2820681034>3.0.CO;2-2; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; BAROSI G, 2007, BLOOD CELL MOL DIS, V38, P280; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; De Stefano V, 2007, J THROMB HAEMOST, V5, P708, DOI 10.1111/j.1538-7836.2007.02424.x; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Leibundgut EO, 2006, HAEMATOLOGICA, V91, P1465; Massa M, 2005, J CLIN ONCOL, V23, P5688, DOI 10.1200/JCO.2005.09.021; Mesa RA, 2000, BLOOD, V96, P3374; Orr DW, 2010, ALIMENT PHARM THER, V31, P1330, DOI 10.1111/j.1365-2036.2010.04299.x; PAGLIUCA A, 1990, Q J MED, V76, P981; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Primignani M, 2006, HEPATOLOGY, V44, P1528, DOI 10.1002/hep.21435; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sozer S, 2008, BLOOD CELL MOL DIS, V41, P284, DOI 10.1016/j.bcmd.2008.06.008; Swerdlow SH., 2008, WHO CLASSIFICATION T, P40; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Tonon L, 1998, BRIT J HAEMATOL, V102, P996, DOI 10.1046/j.1365-2141.1998.00867.x; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	30	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15277	10.1371/journal.pone.0015277	http://dx.doi.org/10.1371/journal.pone.0015277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151606	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800021
J	Yang, Y; Huang, JH; Toth, I; Lichterfeld, M; Yu, XG				Yang, Yue; Huang, Jinghe; Toth, Ildiko; Lichterfeld, Mathias; Yu, Xu G.			Mutational Escape in HIV-1 CTL Epitopes Leads to Increased Binding to Inhibitory Myelomonocytic MHC Class I Receptors	PLOS ONE			English	Article							T-LYMPHOCYTE ESCAPE; DENDRITIC CELLS; INFECTION; RESPONSES	Escape mutations in HIV-1 cytotoxic T cell (CTL) epitopes can abrogate recognition by the TCR of HIV-1-specific CD8+ T cells, but may also change interactions with alternative MHC class I receptors. Here, we show that mutational escape in three HLA-A11-, B8- and B7- restricted immunodominant HIV-1 CTL epitopes consistently enhances binding of the respective peptide/MHC class I complex to Immunoglobulin-like transcript 4 (ILT4), an inhibitory myelomonocytic MHC class I receptor expressed on monocytes and dendritic cells. In contrast, mutational escape in an alternative immunodominant HLA-B57-restricted CTL epitope did not affect ILT4-mediated recognition by myelomonocytic cells. This suggests that in addition to abrogating recognition by HIV-1-specific CD8 T cells, mutational escape in some, but not all CTL epitopes may mediate important immunoregulatory effects by increasing binding properties to ILT4, and augmenting ILT4-mediated inhibitory effects of professional antigen-presenting cells.	[Yang, Yue; Huang, Jinghe; Toth, Ildiko; Yu, Xu G.] Harvard & MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital	Yang, Y (corresponding author), Harvard & MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA.	xyu@partners.org	Huang, Jinghe/O-1986-2015; Lichterfeld, Mathias/B-2042-2008	Lichterfeld, Mathias/0000-0001-9865-8350; Yu, Xu/0000-0002-8295-884X; Huang, Jinghe/0000-0002-1968-871X	National Institutes of Health [R01 AI078799, P01 AI074415]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074415, R01AI078799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (R01 AI078799 and P01 AI074415 to XGY) and the Doris Duke Charitable Foundation (Clinical Scientist Development Award to XGY and ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DSJ, 1999, J EXP MED, V189, P1149, DOI 10.1084/jem.189.7.1149; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Bailey J, 2004, CURR OPIN IMMUNOL, V16, P470, DOI 10.1016/j.coi.2004.05.005; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li DM, 2009, J IMMUNOL, V182, P1033, DOI 10.4049/jimmunol.182.2.1033; Lichterfeld M, 2007, J EXP MED, V204, P2813, DOI 10.1084/jem.20061865; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108	14	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15084	10.1371/journal.pone.0015084	http://dx.doi.org/10.1371/journal.pone.0015084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170342	Green Published, gold			2022-12-25	WOS:000285084100018
J	Peng, QH; Wu, JG; Zhang, Y; Liu, Y; Kong, RR; Hu, LL; Du, XJ; Ke, Y				Peng, Qunhui; Wu, Jianguo; Zhang, Ying; Liu, Yun; Kong, Ruirui; Hu, Lelin; Du, Xiaojuan; Ke, Yang			1A6/DRIM, a Novel t-UTP, Activates RNA Polymerase I Transcription and Promotes Cell Proliferation	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; TATA-BINDING PROTEIN; FACTOR UBF; RDNA TRANSCRIPTION; GENE-EXPRESSION; PHOSPHORYLATION; COMPLEX; P53; ACETYLATION; RECRUITMENT	Background: Ribosome biogenesis is required for protein synthesis and cell proliferation. Ribosome subunits are assembled in the nucleolus following transcription of a 47S ribosome RNA precursor by RNA polymerase I and rRNA processing to produce mature 18S, 28S and 5.8S rRNAs. The 18S rRNA is incorporated into the ribosomal small subunit, whereas the 28S and 5.8S rRNAs are incorporated into the ribosomal large subunit. Pol I transcription and rRNA processing are coordinated processes and this coordination has been demonstrated to be mediated by a subset of U3 proteins known as t-UTPs. Up to date, five t-UTPs have been identified in humans but the mechanism(s) that function in the t-UTP(s) activation of Pol I remain unknown. In this study we have identified 1A6/DRIM, which was identified as UTP20 in our previous study, as a t-UTP. In the present study, we investigated the function and mechanism of 1A6/DRIM in Pol I transcription. Methodology/Principal Findings: Knockdown of 1A6/DRIM by siRNA resulted in a decreased 47S pre-rRNA level as determined by Northern blotting. Ectopic expression of 1A6/DRIM activated and knockdown of 1A6/DRIM inhibited the human rDNA promoter as evaluated with luciferase reporter. Chromatin immunoprecipitation (ChIP) experiments showed that 1A6/DRIM bound UBF and the rDNA promoter. Re-ChIP assay showed that 1A6/DRIM interacts with UBF at the rDNA promoter. Immunoprecipitation confirmed the interaction between 1A6/DRIM and the nucleolar acetyl-transferase hALP. It is of note that knockdown of 1A6/DRIM dramatically inhibited UBF acetylation. A finding of significance was that 1A6/DRIM depletion, as a kind of nucleolar stress, caused an increase in p53 level and inhibited cell proliferation by arresting cells at G1. Conclusions: We identify 1A6/DRIM as a novel t-UTP. Our results suggest that 1A6/DRIM activates Pol I transcription most likely by associating with both hALP and UBF and thereby affecting the acetylation of UBF.	[Peng, Qunhui; Wu, Jianguo; Kong, Ruirui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China; [Zhang, Ying; Liu, Yun; Hu, Lelin; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100871, Peoples R China; [Peng, Qunhui; Wu, Jianguo; Zhang, Ying; Liu, Yun; Kong, Ruirui; Hu, Lelin; Du, Xiaojuan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Peng, QH (corresponding author), Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Wu, Jian/AAU-5221-2020; Du, Xiaojuan/AAY-1186-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Ministry of Science and Technology [2008AA02Z131, 2006AA02A402]; National Natural Science Foundation of China [30771224]; Ministry of Education [985-2-016-24]; National Basic Research Program of China (973 program) [2010CB529303]	National Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by grants from the China key project of National Ministry of Science and Technology grant 2008AA02Z131 and 2006AA02A402, National Natural Science Foundation of China (30771224), the Ministry of Education 985 project of China (No. 985-2-016-24) and by grants from the National Basic Research Program of China (973 program) (Grant No. 2010CB529303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOUGEY EB, 1993, MOL CELL BIOL, V13, P5990, DOI 10.1128/MCB.13.10.5990; OMAHONY DJ, 1991, P NATL ACAD SCI USA, V88, P3180, DOI 10.1073/pnas.88.8.3180; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Stefanovsky VY, 2008, NUCLEIC ACIDS RES, V36, P5093, DOI 10.1093/nar/gkn484; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	43	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14244	10.1371/journal.pone.0014244	http://dx.doi.org/10.1371/journal.pone.0014244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151873	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800004
J	Dawson, K; Thorpe, RS; Malhotra, A				Dawson, Karen; Thorpe, Roger S.; Malhotra, Anita			Estimating Genetic Variability in Non-Model Taxa: A General Procedure for Discriminating Sequence Errors from Actual Variation	PLOS ONE			English	Article							MULTIGENE FAMILIES; POSITIVE SELECTION; EVOLUTION; PCR; DNA; AMPLIFICATION; POLYMORPHISM; DIVERSITY; ARTIFACTS; SNAKE	Genetic variation is the driving force of evolution and as such is of central interest for biologists. However, inadequate discrimination of errors from true genetic variation could lead to incorrect estimates of gene copy number, population genetic parameters, phylogenetic relationships and the deposition of gene and protein sequences in databases that are not actually present in any organism. Misincorporation errors in multi-template PCR cloning methods, still commonly used for obtaining novel gene sequences in non-model species, are difficult to detect, as no previous information may be available about the number of expected copies of genes belonging to multi-gene families. However, studies employing these techniques rarely describe in any great detail how errors arising in the amplification process were detected and accounted for. Here, we estimated the rate of base misincorporation of a widely-used PCR-cloning method, using a single copy mitochondrial gene from a single individual to minimise variation in the template DNA, as 1.62x10(-3) errors per site, or 9.26x10(-5) per site per duplication. The distribution of errors among sequences closely matched that predicted by a binomial distribution function. The empirically estimated error rate was applied to data, obtained using the same methods, from the Phospholipase A(2) toxin family from the pitviper Ovophis monticola. The distribution of differences detected closely matched the expected distribution of errors and we conclude that, when undertaking gene discovery or assessment of genetic diversity using this error-prone method, it will be informative to empirically determine the rate of base misincorporation.	[Dawson, Karen; Thorpe, Roger S.; Malhotra, Anita] Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales	Bangor University	Dawson, K (corresponding author), Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	a.malhotra@bangor.ac.uk		Malhotra, Anita/0000-0002-1738-9046	Natural Environment Research Council [NER/S/A/2005/13423, NER/A/S/2001/01217]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a studentship from the Natural Environment Research Council (studentship numberNER/S/A/2005/13423) to KD and a Natural Environment Research Council grant (grant number NER/A/S/2001/01217) to AM and RST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Hayes W, 1965, GENETICS BACTERIA TH; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ikeda N, 2010, GENE, V461, P15, DOI 10.1016/j.gene.2010.04.001; Jan VM, 2007, TOXICON, V50, P1140, DOI 10.1016/j.toxicon.2007.07.024; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; Kobayashi N, 1999, BIOCHEM GENET, V37, P317, DOI 10.1023/A:1018759210666; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Pook CE, 2009, MOL PHYLOGENET EVOL, V53, P792, DOI 10.1016/j.ympev.2009.08.002; Randi Ettore, 2000, P136; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Speksnijder AGCL, 2001, APPL ENVIRON MICROB, V67, P469, DOI 10.1128/AEM.67.1.469-472.2001; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Ziemert N, 2010, APPL ENVIRON MICROB, V76, P3568, DOI 10.1128/AEM.02858-09; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	28	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15204	10.1371/journal.pone.0015204	http://dx.doi.org/10.1371/journal.pone.0015204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151906	Green Submitted, Green Published, gold			2022-12-25	WOS:000284995300021
J	Plett, D; Toubia, J; Garnett, T; Tester, M; Kaiser, BN; Baumann, U				Plett, Darren; Toubia, John; Garnett, Trevor; Tester, Mark; Kaiser, Brent N.; Baumann, Ute			Dichotomy in the NRT Gene Families of Dicots and Grass Species	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; NITROGEN-USE EFFICIENCY; ARABIDOPSIS NITRATE; RICE GENOME; FUNCTIONAL-CHARACTERIZATION; DRAFT SEQUENCE; UPTAKE SYSTEM; CHL1; CLONING; EXPRESSION	A large proportion of the nitrate (NO32-) acquired by plants from soil is actively transported via members of the NRT families of NO32- transporters. In Arabidopsis, the NRT1 family has eight functionally characterised members and predominantly comprises low-affinity transporters; the NRT2 family contains seven members which appear to be high-affinity transporters; and there are two NRT3 (NAR2) family members which are known to participate in high-affinity transport. A modified reciprocal best hit (RBH) approach was used to identify putative orthologues of the Arabidopsis NRT genes in the four fully sequenced grass genomes (maize, rice, sorghum, Brachypodium). We also included the poplar genome in our analysis to establish whether differences between Arabidopsis and the grasses may be generally applicable to monocots and dicots. Our analysis reveals fundamental differences between Arabidopsis and the grass species in the gene number and family structure of all three families of NRT transporters. All grass species possessed additional NRT1.1 orthologues and appear to lack NRT1.6/NRT1.7 orthologues. There is significant separation in the NRT2 phylogenetic tree between NRT2 genes from dicots and grass species. This indicates that determination of function of NRT2 genes in grass species will not be possible in cereals based simply on sequence homology to functionally characterised Arabidopsis NRT2 genes and that proper functional analysis will be required. Arabidopsis has a unique NRT3.2 gene which may be a fusion of the NRT3.1 and NRT3.2 genes present in all other species examined here. This work provides a framework for future analysis of NO32- transporters and NO32- transport in grass crop species.	[Plett, Darren; Toubia, John; Garnett, Trevor; Tester, Mark; Baumann, Ute] Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Kaiser, Brent N.] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Plett, D (corresponding author), Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	brent.kaiser@adelaide.edu.au	Garnett, Trevor/AAJ-7474-2021; Kaiser, Brent/L-6092-2019; Garnett, Trevor P/G-5023-2011; Kaiser, Brent N/O-7458-2015; Tester, Mark/J-2368-2017	Garnett, Trevor/0000-0003-1664-9659; Kaiser, Brent/0000-0001-6167-2423; Kaiser, Brent N/0000-0001-6167-2423; Tester, Mark/0000-0002-5085-8801; Plett, Darren/0000-0002-9551-8755; Toubia, John/0000-0002-5135-6504	DuPont Pioneer; Australian Research Council [LP0776635]	DuPont Pioneer; Australian Research Council(Australian Research Council)	Funding for this research was obtained from both DuPont Pioneer and from an Australian Research Council (www.arc.gov.au) Linkage Grant (LP0776635) to BNK and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chiu CC, 2004, PLANT CELL PHYSIOL, V45, P1139, DOI 10.1093/pcp/pch143; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; LI J, 2010, PLANT CELL; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Liu JX, 2009, J PLANT NUTR SOIL SC, V172, P230, DOI 10.1002/jpln.200800028; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto M, 2006, PLANT PHYSIOL, V140, P1036, DOI 10.1104/pp.105.074385; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sylvester-Bradley R, 2009, J EXP BOT, V60, P1939, DOI 10.1093/jxb/erp116; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tong Y, 2005, PLANT J, V41, P442, DOI 10.1111/j.1365-313X.2004.02310.x; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Vidmar JJ, 2000, PLANT PHYSIOL, V122, P783, DOI 10.1104/pp.122.3.783; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	43	103	114	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15289	10.1371/journal.pone.0015289	http://dx.doi.org/10.1371/journal.pone.0015289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151904	Green Published, gold			2022-12-25	WOS:000284995300027
J	Vilas-Boas, F; Henrique, D				Vilas-Boas, Filipe; Henrique, Domingos			HES6-1 and HES6-2 Function through Different Mechanisms during Neuronal Differentiation	PLOS ONE			English	Article							NEURAL STEM-CELL; CHICK-EMBRYO; GLIAL DIFFERENTIATION; PROMOTES NEUROGENESIS; TRANSCRIPTION FACTORS; GONADAL DEVELOPMENT; PRONEURAL GENES; NERVOUS-SYSTEM; NOTCH; SPECIFICATION	Background: Notch signalling plays a central role in the mechanisms regulating neuronal differentiation in the vertebrate nervous system. The transcriptional repressors encoded by Hes genes are the main effectors of this pathway, acting in neural progenitors during the lateral inhibition process to repress proneural genes and inhibit differentiation. However, Hes6 genes seem to behave differently: they are expressed in differentiating neurons and facilitate the activity of proneural genes in promoting neurogenesis. Still, the molecular mechanisms underlying this unique function of Hes6 genes are not yet understood. Methodology/Principal Findings: Here, we identify two subgroups of Hes6 genes that seem conserved in most vertebrate species and characterize a novel Hes6 gene in chicken: cHes6-1. The embryonic expression pattern of cHes6-1 suggests roles for this gene in the formation of the pancreas, nervous system and in the generation of body asymmetry. We show that cHes6-1 is negatively regulated by Notch signalling in the developing embryonic spinal cord and in pancreatic progenitors, but requires Notch for the observed asymmetric expression at the lateral mesoderm. Functional studies by ectopic expression in the chick embryonic neural tube revealed that cHES6-1 up-regulates the expression of cDelta1 and cHes5 genes, in contrast with overexpression of cHES6-2, which represses the same genes. We show that this activity of cHES6-2 is dependent on its capacity to bind DNA and repress transcription, while cHES6-1 seems to function by sequestering other HES proteins and inhibit their activity as transcriptional repressors. Conclusions/Significance: Our results indicate that the two chick HES6 proteins act at different phases of neuronal differentiation, contributing to the progression of neurogenesis by different mechanisms: while cHES6-2 represses the transcription of Hes genes, cHES6-1 acts later, sequestering HES proteins. Together, the two cHES6 proteins progressively shut down the Notch-mediated progenitor program and ensure that neuronal differentiation can proceed.	[Vilas-Boas, Filipe; Henrique, Domingos] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal	Universidade de Lisboa	Vilas-Boas, F (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	henrique@fm.ul.pt	Vilas-Boas, Filipe/B-1669-2012; Vilas-Boas, Filipe/H-5261-2019; Henrique, Domingos M/E-5460-2010	Vilas-Boas, Filipe/0000-0002-8060-5370; Vilas-Boas, Filipe/0000-0002-8060-5370; Henrique, Domingos M/0000-0001-8869-1894	Fundacao Ciencia e Tecnologia [PTDC/SAU-OBD/75106/2006]; FCT	Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao Ciencia e Tecnologia (www.fct.mctes.pt), project PTDC/SAU-OBD/75106/2006. Filipe Vilas-Boas is supported a FCT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-63; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bae SK, 2000, DEVELOPMENT, V127, P2933; Ball AJ, 2007, BIOCHEM BIOPH RES CO, V355, P331, DOI 10.1016/j.bbrc.2007.01.153; BELANGERJASMIN S, 2007, J NEUROCHEM; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Cossins J, 2002, DEVELOPMENT, V129, P2195; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Farah MH, 2000, DEVELOPMENT, V127, P693; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fujita S, 2003, CELL STRUCT FUNCT, V28, P205, DOI 10.1247/csf.28.205; Gibert JM, 2003, INT J DEV BIOL, V47, P643; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ishii A, 2008, BIOCHEM BIOPH RES CO, V372, P142, DOI 10.1016/j.bbrc.2008.05.015; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kimura W, 2007, DEV GROWTH DIFFER, V49, P365, DOI [10.1111/j.1440-169x.2007.00933.x, 10.1111/j.1440-169X.2007.00933.x]; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lutolf S, 2002, DEVELOPMENT, V129, P373; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Matsushita S, 1996, ROUX ARCH DEV BIOL, V205, P225, DOI 10.1007/BF00365800; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mittwoch U, 1998, J EXP ZOOL, V281, P466, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;466::AID-JEZ11&gt;3.0.CO;2-7; MURAI K, 2007, DEV BIOL; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Rawdon BB, 2001, DEV DYNAM, V222, P153, DOI 10.1002/dvdy.1177; Raya A, 2004, MECH DEVELOP, V121, P1043, DOI 10.1016/j.mod.2004.05.005; RODEMER ES, 1986, J EMBRYOL EXP MORPH, V98, P269; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434	56	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15459	10.1371/journal.pone.0015459	http://dx.doi.org/10.1371/journal.pone.0015459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151987	gold, Green Submitted, Green Published			2022-12-25	WOS:000284868000033
J	Barel, M; Meibom, K; Charbit, A				Barel, Monique; Meibom, Karin; Charbit, Alain			Nucleolin, a Shuttle Protein Promoting Infection of Human Monocytes by Francisella tularensis	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; MURINE MACROPHAGES; EXPRESSION; ESCAPE; CELLS; COLOCALIZATION; RECEPTOR; REPLICATION; BIOGENESIS; MICROSCOPY	Background: Francisella tularensis is a highly virulent facultative intracellular bacterium, disseminating in vivo mainly within host mononuclear phagocytes. After entry into macrophages, F. tularensis initially resides in a phagosomal compartment, whose maturation is then arrested. Bacteria escape rapidly into the cytoplasm, where they replicate freely. We recently demonstrated that nucleolin, an eukaryotic protein able to traffic from the nucleus to the cell surface, acted as a surface receptor for F. tularensis LVS on human monocyte-like THP-1 cells. Methodology/Principal Findings: Here, we followed the fate of nucleolin once F. tularensis has been endocytosed. We first confirmed by siRNA silencing experiments that expression of nucleolin protein was essential for binding of LVS on human macrophage-type THP-1 cells. We then showed that nucleolin co-localized with intracellular bacteria in the phagosomal compartment. Strikingly, in that compartment, nucleolin also co-localized with LAMP-1, a late endosomal marker. Co-immunoprecipation assays further demonstrated an interaction of nucleolin with LAMP-1. Co-localization of nucleolin with LVS was no longer detectable at 24 h when bacteria were multiplying in the cytoplasm. In contrast, with an iglC mutant of LVS, which remains trapped into the phagosomal compartment, or with inert particles, nucleolin/bacteria co-localization remained almost constant. Conclusions/Significance: We herein confirm the importance of nucleolin expression for LVS binding and its specificity as nucleolin is not involved in binding of another intracellular pathogen as L. monocytogenes or an inert particle. Association of nucleolin with F. tularensis during infection continues intracellularly after endocytosis of the bacteria. The present work therefore unravels for the first time the presence of nucleolin in the phagosomal compartment of macrophages.	[Barel, Monique; Meibom, Karin; Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malades, Paris, France; [Barel, Monique; Meibom, Karin; Charbit, Alain] INSERM, U1002, Unit Pathogenesis Syst Infect, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barel, M (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malades, Paris, France.	monique.barel@inserm.fr	BAREL, Monique/K-3772-2017	Meibom, Karin/0000-0002-2612-6424; charbit, alain/0000-0001-5243-4861; BAREL, Monique/0000-0001-8171-7027	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University Rene Descartes Paris V	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Rene Descartes Paris V	These studies were supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS) and University Rene Descartes Paris V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Gahan CGM, 2001, INFECT IMMUN, V69, P3924, DOI 10.1128/IAI.69.6.3924-3932.2001; Glaser P, 2001, SCIENCE, V294, P849; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hirata D, 2000, CLIN IMMUNOL, V97, P50, DOI 10.1006/clim.2000.4916; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MANDERS EMM, 1992, J CELL SCI, V103, P857; Pierini LM, 2006, CELL MICROBIOL, V8, P1361, DOI 10.1111/j.1462-5822.2006.00719.x; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; ROY L, BIOCH BIOPH IN PRESS; SANCHEZCORRAL P, 1989, J IMMUNOL METHODS, V122, P105, DOI 10.1016/0022-1759(89)90340-2; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; THOMAS H, 2007, CELL MICROBIOL, V9, P2543; Tooker BC, 2004, IMMUNOL LETT, V93, P137, DOI 10.1016/j.imlet.2004.03.005; vanSteensel B, 1996, J CELL SCI, V109, P787	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14193	10.1371/journal.pone.0014193	http://dx.doi.org/10.1371/journal.pone.0014193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152024	Green Published, gold, Green Submitted			2022-12-25	WOS:000284821300010
J	Fallani, FD; Nicosia, V; Sinatra, R; Astolfi, L; Cincotti, F; Mattia, D; Wilke, C; Doud, A; Latora, V; He, B; Babiloni, F				Fallani, Fabrizio De Vico; Nicosia, Vincenzo; Sinatra, Roberta; Astolfi, Laura; Cincotti, Febo; Mattia, Donatella; Wilke, Christopher; Doud, Alex; Latora, Vito; He, Bin; Babiloni, Fabio			Defecting or Not Defecting: How to "Read'' Human Behavior during Cooperative Games by EEG Measurements	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; FUNCTIONAL MAGNETIC-RESONANCE; ANTERIOR CINGULATE CORTEX; CORTICAL RESPONSES; NETWORKS; INTEGRATION; COHERENCE; BRAIN; FLOW	Understanding the neural mechanisms responsible for human social interactions is difficult, since the brain activities of two or more individuals have to be examined simultaneously and correlated with the observed social patterns. We introduce the concept of hyper-brain network, a connectivity pattern representing at once the information flow among the cortical regions of a single brain as well as the relations among the areas of two distinct brains. Graph analysis of hyper-brain networks constructed from the EEG scanning of 26 couples of individuals playing the Iterated Prisoner's Dilemma reveals the possibility to predict non-cooperative interactions during the decision-making phase. The hyper-brain networks of two-defector couples have significantly less inter-brain links and overall higher modularity-i.e., the tendency to form two separate subgraphs-than couples playing cooperative or tit-for-tat strategies. The decision to defect can be "read'' in advance by evaluating the changes of connectivity pattern in the hyper-brain network.	[Fallani, Fabrizio De Vico; Astolfi, Laura; Cincotti, Febo; Mattia, Donatella; Babiloni, Fabio] Sci Inst Res Hospitalizat & Hlth Care IRCCS Fdn S, NEILab, Rome, Italy; [Fallani, Fabrizio De Vico; Babiloni, Fabio] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Nicosia, Vincenzo; Sinatra, Roberta; Latora, Vito] Univ Catania, Complex Syst Lab, Scuola Super Catania, Catania, Italy; [Sinatra, Roberta; Latora, Vito] Univ Catania, Dept Phys & Astron, Catania, Italy; [Sinatra, Roberta; Latora, Vito] Ist Nazl Fis Nucl, I-95129 Catania, Italy; [Astolfi, Laura] Univ Roma La Sapienza, Dept Comp Syst & Informat, Rome, Italy; [Wilke, Christopher; Doud, Alex; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55417 USA; [Wilke, Christopher; Doud, Alex; He, Bin] Univ Minnesota, Ctr Neuroengn, Minneapolis, MN 55417 USA	Sapienza University Rome; University of Catania; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Fallani, FD (corresponding author), Sci Inst Res Hospitalizat & Hlth Care IRCCS Fdn S, NEILab, Rome, Italy.	fabio.babiloni@uniroma1.it	Mattia, Donatella/D-7569-2012; Sinatra, Roberta/G-9836-2012; De Vico Fallani, Fabrizio/A-2157-2010; Nicosia, Vincenzo/C-7890-2013; Cincotti, Febo/C-3664-2008; Babiloni, Fabio/E-5169-2015; Astolfi, Laura/J-9235-2016	Mattia, Donatella/0000-0002-3092-2511; Sinatra, Roberta/0000-0002-7558-1028; Nicosia, Vincenzo/0000-0003-0636-3278; Cincotti, Febo/0000-0003-1898-6480; Babiloni, Fabio/0000-0002-4962-176X; Wilke, Christopher/0000-0003-4147-6040; Astolfi, Laura/0000-0002-1025-7526; Latora, Vito/0000-0002-0984-8038	National Institutes of Health [RO1EB006433, RO1EB007920]; National Science Foundation CBET [0933067]; COST Action NeuroMath [BM0601]; Compagnia San Paolo; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006433, R01EB007920] Funding Source: NIH RePORTER; Directorate For Engineering [0933067] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CBET(National Science Foundation (NSF)); COST Action NeuroMath(European Cooperation in Science and Technology (COST)); Compagnia San Paolo(Compagnia di San Paolo); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by the National Institutes of Health RO1EB006433, RO1EB007920, the National Science Foundation CBET 0933067 and the COST Action NeuroMath (BM0601). This work was also supported by the Compagnia San Paolo within the Project "Social and Emotive Hyperbrain". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Babiloni C, 2004, CLIN NEUROPHYSIOL, V115, P161, DOI 10.1016/S1388-2457(03)00286-4; Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni F, 2000, METHOD INFORM MED, V39, P179; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Fallani FD, 2007, BRAIN TOPOGR, V19, P125, DOI 10.1007/s10548-007-0019-0; DYLANHAYNES J, 2007, CURR BIOL, V17, P323; DYLANHAYNES J, 2006, NAT NEUROSCI, P523; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kaminski M, 2005, PHILOS T R SOC B, V360, P947, DOI 10.1098/rstb.2005.1636; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M. E. J., 2004, PHYS REV, V69; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Osborne MJ, 1999, COURSE GAME THEORY; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sinatra R, 2009, INT J BIFURCAT CHAOS, V19, P665, DOI 10.1142/S0218127409023020; Urbano A, 1997, NEUROREPORT, V8, P3239, DOI 10.1097/00001756-199710200-00011; Walton ME, 2002, J NEUROSCI, V22, P10996	38	130	132	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14187	10.1371/journal.pone.0014187	http://dx.doi.org/10.1371/journal.pone.0014187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152069	gold, Green Published, Green Submitted			2022-12-25	WOS:000284821300005
J	Rathcke, CN; Kjoller, E; Fogh-Andersen, N; Zerahn, B; Vestergaard, H				Rathcke, Camilla Noelle; Kjoller, Erik; Fogh-Andersen, Niels; Zerahn, Bo; Vestergaard, Henrik			NT-proBNP and Circulating Inflammation Markers in Prediction of a Normal Myocardial Scintigraphy in Patients with Symptoms of Coronary Artery Disease	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; ISCHEMIC-HEART-DISEASE; PROGNOSTIC VALUE; CARDIOVASCULAR-DISEASE; NUCLEAR CARDIOLOGY; INFARCTION; YKL-40; RISK; MORTALITY; EXERCISE	Background: Myocardial perfusion imaging (MPI) can detect myocardial perfusion abnormalities but many examinations are without pathological findings. This study examines whether circulating biomarkers can be used as screening modality prior to MPI. Methodology/Principal Findings: 243 patients with an intermediate risk of CAD or with known CAD with renewed suspicion of ischemia were referred to MPI. Blood samples were analyzed for N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP), YKL-40, IL-6, matrix metalloproteinase 9 (MMP-9) and high sensitive C-reactive protein (hsCRP). Patients with myocardial perfusion defects had elevated levels of NT-proBNP (p<0.0001), YKL-40 (p = 0.03) and IL-6 (p = 0.03) but not of hsCRP (p = 0.58) nor of MMP-9 (p = 0.14). The NT-proBNP increase was observed in both genders (p < 0.0001), whereas YKL-40 (p = 0.005) and IL-6 (p = 0.02) were elevated only in men. A NT-proBNP cut off-concentration at 25 ng/l predicted a normal MPI with a negative predictive value >95% regardless of existing CAD. Conclusions: 20-25% of patients suspected of CAD could have been spared a MPI by using a NT-proBNP cut-off concentration at 25 ng/l with a negative predictive value >95%. NT-proBNP has the potential use of being a screening marker of CAD before referral of the patient to MPI.	[Rathcke, Camilla Noelle; Vestergaard, Henrik] Univ Copenhagen, Herlev Hosp, Ctr Endocrinol & Metab, Dept Internal Med, DK-2730 Herlev, Denmark; [Kjoller, Erik] Univ Copenhagen, Herlev Hosp, Dept Cardiol, DK-2730 Herlev, Denmark; [Fogh-Andersen, Niels] Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Zerahn, Bo] Univ Copenhagen, Herlev Hosp, Dept Clin Physiol & Nucl Med, DK-2730 Herlev, Denmark; [Vestergaard, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Rathcke, CN (corresponding author), Univ Copenhagen, Herlev Hosp, Ctr Endocrinol & Metab, Dept Internal Med, DK-2730 Herlev, Denmark.	cnr@dadlnet.dk		Zerahn, Bo/0000-0002-3457-6249; Vestergaard, Henrik/0000-0003-3090-269X	Aase and Ejnar Danielsens Foundation; National Research Foundation of Health and Disease	Aase and Ejnar Danielsens Foundation; National Research Foundation of Health and Disease	The study was supported by grants from Aase and Ejnar Danielsens Foundation and The National Research Foundation of Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN DS, 1995, J AM COLL CARDIOL, V26, P639, DOI 10.1016/0735-1097(95)00218-S; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Clark AN, 2005, Q J NUCL MED MOL IM, V49, P43; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DE NR, 2006, ARTERIOSCLER THROMB, V26, P340; Elhendy A, 2004, J NUCL CARDIOL, V11, P704, DOI 10.1016/j.nuclcard.2004.08.006; Ferroni P, 2003, J INVEST MED, V51, P295, DOI 10.1136/jim-51-05-17; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Heeschen C, 2004, CIRCULATION, V110, P3206, DOI 10.1161/01.CIR.0000147611.92021.2B; Hlatky MA, 2007, AM HEART J, V154, P1043, DOI 10.1016/j.ahj.2007.06.042; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Johansen JS, 2006, DAN MED BULL, V53, P172; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kaushik M, 2010, INT J CARDIOL, V142, P8, DOI 10.1016/j.ijcard.2009.10.033; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Kroll D, 2001, AM J CARDIOL, V87, P381, DOI 10.1016/S0002-9149(00)01387-4; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Majstorov Venjamin, 2008, Prilozi, V29, P67; Mercaldo ND, 2007, STAT MED, V26, P2170, DOI 10.1002/sim.2677; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, piii; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Peer A, 2009, HEART, V95, P297, DOI 10.1136/hrt.2008.145425; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rathcke CN, 2009, DIABETES CARE, V32, P323, DOI 10.2337/dc08-1144; Shark T, 2006, J NUCL CARDIOL, V13, P495, DOI 10.1016/j.nuclcard.2006.03.019; STRATMANN HG, 1994, AM J CARDIOL, V73, P647, DOI 10.1016/0002-9149(94)90927-X; Sukhija R, 2007, AM J CARDIOL, V99, P879, DOI 10.1016/j.amjcard.2006.11.032; Underwood SR, 2004, EUR J NUCL MED MOL I, V31, P261, DOI 10.1007/s00259-003-1344-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Weber Michael, 2006, Exp Clin Cardiol, V11, P99; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P165, DOI 10.1093/oxfordjournals.aje.a113527; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x; Zerahn B, 2000, J NUCL CARDIOL, V7, P616, DOI 10.1067/mnc.2000.109028; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14196	10.1371/journal.pone.0014196	http://dx.doi.org/10.1371/journal.pone.0014196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152016	Green Published, Green Submitted, gold			2022-12-25	WOS:000284821300011
J	Arioli, S; Ragg, E; Scaglioni, L; Fessas, D; Signorelli, M; Karp, M; Daffonchio, D; De Noni, I; Mulas, L; Oggioni, M; Guglielmetti, S; Mora, D				Arioli, Stefania; Ragg, Enzio; Scaglioni, Leonardo; Fessas, Dimitrios; Signorelli, Marco; Karp, Matti; Daffonchio, Daniele; De Noni, Ivano; Mulas, Laura; Oggioni, Marco; Guglielmetti, Simone; Mora, Diego			Alkalizing Reactions Streamline Cellular Metabolism in Acidogenic Microorganisms	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; LACTOCOCCUS-LACTIS; BETA-GALACTOSIDASE; LACTOSE HYDROLYSIS; INTRACELLULAR PH; UREASE; GENOME; MILK; BIOSYNTHESIS	An understanding of the integrated relationships among the principal cellular functions that govern the bioenergetic reactions of an organism is necessary to determine how cells remain viable and optimise their fitness in the environment. Urease is a complex enzyme that catalyzes the hydrolysis of urea to ammonia and carbonic acid. While the induction of urease activity by several microorganisms has been predominantly considered a stress-response that is initiated to generate a nitrogen source in response to a low environmental pH, here we demonstrate a new role of urease in the optimisation of cellular bioenergetics. We show that urea hydrolysis increases the catabolic efficiency of Streptococcus thermophilus, a lactic acid bacterium that is widely used in the industrial manufacture of dairy products. By modulating the intracellular pH and thereby increasing the activity of beta-galactosidase, glycolytic enzymes and lactate dehydrogenase, urease increases the overall change in enthalpy generated by the bioenergetic reactions. A cooperative altruistic behaviour of urease-positive microorganisms on the urease-negative microorganisms within the same environment was also observed. The physiological role of a single enzymatic activity demonstrates a novel and unexpected view of the non-transcriptional regulatory mechanisms that govern the bioenergetics of a bacterial cell, highlighting a new role for cytosol-alkalizing biochemical pathways in acidogenic microorganisms.	[Arioli, Stefania; Fessas, Dimitrios; Signorelli, Marco; Daffonchio, Daniele; De Noni, Ivano; Guglielmetti, Simone; Mora, Diego] Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, Milan, Italy; [Ragg, Enzio; Scaglioni, Leonardo] Univ Milan, Dipartimento Sci Mol Agroalimentari, Milan, Italy; [Karp, Matti] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland; [Mulas, Laura; Oggioni, Marco] Univ Siena, Dipartimento Biol Mol, Lab Microbiol Mol & Biotecnol, I-53100 Siena, Italy	University of Milan; University of Milan; Tampere University; University of Siena	Arioli, S (corresponding author), Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, Milan, Italy.	diego.mora@unimi.it	De Noni, Ivano/B-7250-2015; Guglielmetti, Simone/K-2507-2018; Oggioni, Marco Rinaldo/K-3839-2016; Karp, Matti/G-4227-2014; Daffonchio, Daniele/AAF-4922-2019	Guglielmetti, Simone/0000-0002-8673-8190; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Karp, Matti/0000-0001-6686-4416; Daffonchio, Daniele/0000-0003-0947-925X; DE NONI, IVANO/0000-0003-1281-7053; Scaglioni, Leonardo/0000-0002-9971-100X; Mora, Diego/0000-0002-6692-9301; RAGG, ENZIO MARIA/0000-0002-2757-8369; arioli, stefania/0000-0002-5406-8268	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Sacco S.r.L.	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Sacco S.r.L.	The work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (PRIN 2006) and by Sacco S.r.L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli S, 2007, APPL ENVIRON MICROB, V73, P5789, DOI 10.1128/AEM.00533-07; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Cook AR, 2007, INT J SYST EVOL MICR, V57, P2940, DOI 10.1099/ijs.0.64819-0; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; Geertsma ER, 2005, BIOCHEMISTRY-US, V44, P15889, DOI 10.1021/bi051638w; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Jahns T, 1996, J BACTERIOL, V178, P403, DOI 10.1128/jb.178.2.403-409.1996; Krishnan S, 2000, PROCESS BIOCHEM, V35, P1191, DOI 10.1016/S0032-9592(00)00162-X; Liu H, 2001, BIOCHEMISTRY-US, V40, P5542, DOI 10.1021/bi002426w; Loimaranta V, 1998, ANTIMICROB AGENTS CH, V42, P1906, DOI 10.1128/AAC.42.8.1906; Magni C, 1999, J BACTERIOL, V181, P1451, DOI 10.1128/JB.181.5.1451-1457.1999; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Monnet C, 2005, APPL ENVIRON MICROB, V71, P3376, DOI 10.1128/AEM.71.6.3376-3378.2005; Monnet C, 2004, J DAIRY SCI, V87, P1634, DOI 10.3168/jds.S0022-0302(04)73318-4; Mora D, 2005, MICROBIOL-SGM, V151, P3814, DOI 10.1099/mic.0.28513-0; Mora D, 2005, RES MICROBIOL, V156, P897, DOI 10.1016/j.resmic.2005.04.005; Mora D, 2004, J APPL MICROBIOL, V96, P209, DOI 10.1046/j.1365-2672.2003.02148.x; NANNEN NL, 1991, J DAIRY SCI, V74, P741, DOI 10.3168/jds.S0022-0302(91)78219-2; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Pastink MI, 2009, APPL ENVIRON MICROB, V75, P3627, DOI 10.1128/AEM.00138-09; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Sawatari Y, 2007, APPL ENVIRON MICROB, V73, P3909, DOI 10.1128/AEM.02834-06; SMART JB, 1985, NEW ZEAL J DAIRY SCI, V20, P43; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; YANG Z, 1993, AGR SCI FINLAND, V2, P395, DOI 10.23986/afsci.72665	32	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15520	10.1371/journal.pone.0015520	http://dx.doi.org/10.1371/journal.pone.0015520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152088	Green Published, gold			2022-12-25	WOS:000284755100091
J	Souza, TML; Salluh, JIF; Bozza, FA; Mesquita, M; Soares, M; Motta, FC; Pitrowsky, MT; Oliveira, MD; Mishin, VP; Gubareva, LV; Whitney, A; Rocco, SA; Goncalves, VMC; Marques, VP; Velasco, E; Siqueira, MM				Souza, Thiago Moreno L.; Salluh, Jorge I. F.; Bozza, Fernando A.; Mesquita, Milene; soares, Marcio; Motta, Fernando C.; Pitrowsky, Melissa Tassano; Oliveira, Maria de Lourdes; Mishin, Vasiliy P.; Gubareva, Larissa V.; Whitney, Anne; Rocco, Sandra Amaral; Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo; Siqueira, Marilda M.			H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; A H1N1; OSELTAMIVIR TREATMENT; VIRUS-INFECTION; A(H1N1); MANAGEMENT; PNEUMONIA; MORTALITY; LOAD	Background: The novel influenza A pandemic virus (H1N1pdm) caused considerable morbidity and mortality worldwide in 2009. The aim of the present study was to evaluate the clinical course, duration of viral shedding, H1N1pdm evolution and emergence of antiviral resistance in hospitalized cancer patients with severe H1N1pdm infections during the winter of 2009 in Brazil. Methods: We performed a prospective single-center cohort study in a cancer center in Rio de Janeiro, Brazil. Hospitalized patients with cancer and a confirmed diagnosis of influenza A H1N1pdm were evaluated. The main outcome measures in this study were in-hospital mortality, duration of viral shedding, viral persistence and both functional and molecular analyses of H1N1pdm susceptibility to oseltamivir. Results: A total of 44 hospitalized patients with suspected influenza-like illness were screened. A total of 24 had diagnosed H1N1pdm infections. The overall hospital mortality in our cohort was 21%. Thirteen (54%) patients required intensive care. The median age of the studied cohort was 14.5 years (3-69 years). Eighteen (75%) patients had received chemotherapy in the previous month, and 14 were neutropenic at the onset of influenza. A total of 10 patients were evaluated for their duration of viral shedding, and 5 (50%) displayed prolonged viral shedding (median 23, range = 11-63 days); however, this was not associated with the emergence of a resistant H1N1pdm virus. Viral evolution was observed in sequentially collected samples. Conclusions: Prolonged influenza A H1N1pdm shedding was observed in cancer patients. However, oseltamivir resistance was not detected. Taken together, our data suggest that severely ill cancer patients may constitute a pandemic virus reservoir with major implications for viral propagation.	[Souza, Thiago Moreno L.; Motta, Fernando C.; Oliveira, Maria de Lourdes; Siqueira, Marilda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil; [Salluh, Jorge I. F.; soares, Marcio; Pitrowsky, Melissa Tassano] Hosp Canc I INCA, Intens Care Unit, Rio De Janeiro, Brazil; [Bozza, Fernando A.] Fiocruz MS, Inst Pesquisas Evandro Chagas, Intens Care Unit, BR-21045900 Rio De Janeiro, Brazil; [Rocco, Sandra Amaral] Hosp Canc I INCA, Pediat Intens Care Unit, Rio De Janeiro, Brazil; [Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo] Hosp Canc I INCA, Infect Control Comm, Rio De Janeiro, Brazil; [Goncalves, Vania Maria C.; Marques, Venceslaine Prado; Velasco, Eduardo] Hosp Canc I INCA, Dept Infect Dis, Rio De Janeiro, Brazil; [Mishin, Vasiliy P.; Gubareva, Larissa V.; Whitney, Anne] Ctr Dis Control, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Centers for Disease Control & Prevention - USA	Souza, TML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil.	tmoreno@ioc.fiocruz.br; mmsiq@ioc.fiocruz.br	Soares, Marcio/B-3083-2013; Salluh, Jorge/AAF-2682-2021; Miranda, Milene/ABD-8472-2021; Salluh, Jorge IF/F-6779-2012; dantas, vicente c souza/L-2648-2013; Motta, Fernando/AAJ-2647-2021; Bozza, Fernando A/A-2618-2013; Souza, Thiago Moreno L./G-2900-2012; DE LOURDES A OLIVEIRA, MARIA/H-2474-2018	Soares, Marcio/0000-0003-2503-6088; Salluh, Jorge/0000-0002-8164-1453; Miranda, Milene/0000-0003-0037-059X; Bozza, Fernando A/0000-0003-4878-0256; Souza, Thiago Moreno L./0000-0003-2212-3899; 	Instituto Nacional de Cancer; Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; CNPq; FAPERJ; FAPERJ/SESDEC/CNPq [E-26/110.778/2010]; IOC/Fiocruz; Fiocruz	Instituto Nacional de Cancer; Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ/SESDEC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IOC/Fiocruz; Fiocruz	The work was supported by Instituto Nacional de Cancer (www.inca.gov.br), Instituto Oswaldo Cruz/Fiocruz (www.ioc.fiocruz.br) and Brazilian Ministry of Health/Decit (http://dtr2001.saude.gov.br/sctie/decit/index.htm). Dr. Soares, Dr. Bozza and Dr. Siqueira were supported in part by individual research grants from CNPq (www.cnpq.br). Dr. Souza used, in part, individual research grants from FAPERJ (www.faperj.br). FAPERJ/SESDEC/CNPq provided the grant #E-26/110.778/2010 (PPSUS-DECIT/SCTIE/MS). Thanks are also due to IOC/Fiocruz for providing MM a PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the Instituto Nacional de Cancer, Fiocruz, FAPERJ and CNPq for their support. The authors thank Marc-Alain Widdowson (CDC/CCID/NCIRD) for critical review of the manuscript. Alicia Fry (CDC Atlanta epidemiology intelligence officer) was also extremely helpful in discussions on virus shedding.	Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Casper C, 2010, BLOOD, V115, P1331, DOI 10.1182/blood-2009-11-255455; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cunha BA, 2010, J HOSP INFECT, V74, P278, DOI 10.1016/j.jhin.2009.08.024; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Fleury H, 2009, EUROSURVEILLANCE, V14, P14; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hajjar LA, 2010, ANN ONCOL, V21, P2333, DOI 10.1093/annonc/mdq254; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Kidd IM, 2009, LANCET, V374, P1036, DOI 10.1016/S0140-6736(09)61528-2; Kobayashi Shinichi, 2008, Journal of Infection and Chemotherapy, V14, P308, DOI 10.1007/s10156-008-0615-2; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lapinsky SE, 2010, CRIT CARE MED, V38, pE52, DOI 10.1097/CCM.0b013e3181c85d5f; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McMinn P, 1999, CLIN INFECT DIS, V29, P456, DOI 10.1086/520243; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; *MIN SAUD, 2009, PROT MAN CLIN VIG EP; *MIN SAUD, 2009, DIR ENFR PAND INF H1; *MIN SAUD INF EP, INFL PAND H1N1 2009; Mora M, 2010, EMERG INFECT DIS, V16, P1175, DOI 10.3201/eid1607.091339; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; Redelman-Sidi G, 2010, J INFECTION, V60, P257, DOI 10.1016/j.jinf.2010.01.009; Rouphael NG, 2007, LANCET INFECT DIS, V7, P814, DOI 10.1016/S1473-3099(07)70290-6; Seiter K, 2010, J CLIN ONCOL, V28, pE27, DOI 10.1200/JCO.2009.25.8889; Seville MTA, 2010, TRANSPLANTATION, V90, P571, DOI 10.1097/TP.0b013e3181e86af0; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Takiyama A, 2010, JPN J INFECT DIS, V63, P72; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; *WHO, 2009, PROT VIR SEQ; *WHO, 2009, WEEKLY EPIDEM RECORD; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization, 2009, CDC PROT REALT RTPCR	46	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14158	10.1371/journal.pone.0014158	http://dx.doi.org/10.1371/journal.pone.0014158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152402	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100036
J	Acevedo, KM; Hung, YH; Dalziel, AH; Li, QX; Laughton, K; Wikhe, K; Rembach, A; Roberts, B; Masters, CL; Bush, AI; Camakaris, J				Acevedo, Karla M.; Hung, Ya Hui; Dalziel, Andrew H.; Li, Qiao-Xin; Laughton, Katrina; Wikhe, Krutika; Rembach, Alan; Roberts, Blaine; Masters, Colin L.; Bush, Ashley I.; Camakaris, James			Copper Promotes the Trafficking of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; TRANS-GOLGI NETWORK; TARGETING A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PLASMA-MEMBRANE; REGULATED TRANSPORT; SECRETASE CLEAVAGE; AGGREGATION STATE; REDOX CHEMISTRY	Accumulation of the amyloid beta peptide in the cortical and hippocampal regions of the brain is a major pathological feature of Alzheimer disease. Amyloid beta peptide is generated from the sequential protease cleavage of the amyloid precursor protein (APP). We reported previously that copper increases the level of APP at the cell surface. Here we report that copper, but not iron or zinc, promotes APP trafficking in cultured polarized epithelial cells and neuronal cells. In SH-SY5Y neuronal cells and primary cortical neurons, copper promoted a redistribution of APP from a perinuclear localization to a wider distribution, including neurites. Importantly, a change in APP localization was not attributed to an up-regulation of APP protein synthesis. Using live cell imaging and endocytosis assays, we found that copper promotes an increase in cell surface APP by increasing its exocytosis and reducing its endocytosis, respectively. This study identifies a novel mechanism by which copper regulates the localization and presumably the function of APP, which is of major significance for understanding the role of APP in copper homeostasis and the role of copper in Alzheimer disease.	[Acevedo, Karla M.; Dalziel, Andrew H.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Li, Qiao-Xin; Laughton, Katrina] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Hung, Ya Hui; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Hung, Ya Hui; Li, Qiao-Xin; Laughton, Katrina; Wikhe, Krutika; Rembach, Alan; Roberts, Blaine; Masters, Colin L.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Rembach, Alan] Commonwealth Sci & Res Org CSIRO Mol & Hlth Techn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Hung, Ya Hui/F-1951-2010; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Hung, Ya Hui/0000-0002-5440-2764; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Roberts, Blaine/0000-0001-5466-0053; Acevedo, Karla/0000-0002-7996-3445	National Health and Medical Research Council; Rowden White Foundation; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rowden White Foundation; Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (to J. C. and A. I. B.). The FV1000 Olympus confocal microscope used for this work was co-funded by the Rowden White Foundation.; Supported by the Australian Research Council.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Birkaya B, 2005, J NEUROBIOL, V63, P49, DOI 10.1002/neu.20114; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUSH AI, 1993, J BIOL CHEM, V268, P16109; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Ermolieff J, 2000, BIOCHEMISTRY-US, V39, P12450, DOI 10.1021/bi001494f; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang DL, 2007, BIOCHEMISTRY-US, V46, P9270, DOI 10.1021/bi700508n; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Magaki S, 2007, NEUROSCI LETT, V418, P72, DOI 10.1016/j.neulet.2007.02.077; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; MCGEER EG, 1990, J NEUROSCI RES, V27, P612, DOI 10.1002/jnr.490270422; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Opazo C, 2000, BIOL RES, V33, P125; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Ostrakhovitch EA, 2002, ARCH BIOCHEM BIOPHYS, V397, P232, DOI 10.1006/abbi.2001.2559; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 1998, J NEUROSCI, V18, P6207; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	73	81	81	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8252	8262		10.1074/jbc.M110.128512	http://dx.doi.org/10.1074/jbc.M110.128512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21177866	hybrid, Green Published			2022-12-25	WOS:000288013300055
J	Yang, GY; Liang, B; Zhu, J; Luo, ZG				Yang, Guo-Ying; Liang, Bin; Zhu, Ji; Luo, Zhen-Ge			Calpain Activation by Wingless-type Murine Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Promotes Axonal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BETA-CATENIN; NEURONAL POLARIZATION; PROTEOLYTIC ACTIVITY; MEMBRANE PROTRUSION; FRIZZLED HOMOLOGS; SIGNALING PATHWAY; MAMMALIAN CORTEX; CELL-MIGRATION; CONE FORMATION	Axon development involves spatial-temporal cytoskeletal reorganization. However, how the cytoskeleton remodeling is modulated by extracellular cues is unclear. Here, we report a role of Wnt/Ca2+ signaling in regulating actin and growth cone dynamics. We found that treatment of cultured cortical neurons with Wnt5a, a non-canonical Wnt, either globally or locally, caused an increase in the activity of calpain, a calcium-dependent protease responsible for the cleavage of several actin binding proteins, including spectrin. Treatment with Wnt5a promoted growth cone advance, as well as axonal growth, and these effects were prevented by chelating intracellular calcium, inhibition or down-regulation of calpain, or blockade of spectrin cleavage by competitive peptides. Interestingly, both Wnt5a and activated calpain were found to be mainly distributed in the axon-rich intermediate zone of neocortex. Down-regulating calpain expression interfered with the growth of callosal axons in vivo. Thus, Wnt5a serves as a physiological cue to stimulate localized calpain activity, which in turn promotes growth cone advance and axonal growth.	[Yang, Guo-Ying; Liang, Bin; Zhu, Ji; Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Luo, Zhen-Ge/GNM-7635-2022	Luo, Zhen-Ge/0000-0001-5037-0542	National Natural Science Foundation of China [31021063, 30825013]; National Basic Research Program [2011CBA00403]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Program of Shanghai Subject Chief Scientist [08XD14050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Shanghai Subject Chief Scientist	This work was supported by National Natural Science Foundation of China Grants 31021063 and 30825013, National Basic Research Program Grant 2011CBA00403, Chinese Academy of Sciences Grant KSCX2-YW-R-102, and Program of Shanghai Subject Chief Scientist Grant 08XD14050.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; He X, 2003, DEV CELL, V4, P791, DOI 10.1016/S1534-5807(03)00165-5; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Ishikawa R, 2007, J PHARMACOL SCI, V105, P6, DOI 10.1254/jphs.CP0070071; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; NIXON RA, 1986, J NEUROSCI, V6, P1264; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; SIKORSKI AF, 1991, J CELL BIOL, V114, P313, DOI 10.1083/jcb.114.2.313; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Ziv NE, 1997, J NEUROSCI, V17, P3568; Ziv NE, 1998, J CELL BIOL, V140, P223, DOI 10.1083/jcb.140.1.223	68	7	9	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6566	6576		10.1074/jbc.M110.196568	http://dx.doi.org/10.1074/jbc.M110.196568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177867	Green Published, hybrid			2022-12-25	WOS:000287476400066
J	Ozaki, Y; Matsui, H; Nagamachi, A; Asou, H; Aki, D; Inaba, T				Ozaki, Yuko; Matsui, Hirotaka; Nagamachi, Akiko; Asou, Hiroya; Aki, Daisuke; Inaba, Toshiya			The Dynactin Complex Maintains the Integrity of Metaphasic Centrosomes to Ensure Transition to Anaphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MOLECULAR CHARACTERIZATION; HEMATOPOIETIC PROGENITORS; CYTOPLASMIC DYNEIN; RETROVIRAL VECTORS; HIGH-TITER; P150(GLUED); SUBUNIT; CELLS; MAINTENANCE	The dynactin complex is required for activation of the dynein motor complex, which plays a critical role in various cell functions including mitosis. During metaphase, the dynein-dynactin complex removes spindle checkpoint proteins from kinetochores to facilitate the transition to anaphase. Three components (p150(Glued), dynamitin, and p24) compose a key portion of the dynactin complex, termed the projecting arm. To investigate the roles of the dynactin complex in mitosis, we used RNA interference to down-regulate p24 and p150(Glued) in human cells. In response to p24 down-regulation, we observed cells with delayed metaphase in which chromosomes frequently align abnormally to resemble a "figure eight," resulting in cell death. We attribute the figure eight chromosome alignment to impaired metaphasic centrosomes that lack spindle tension. Like p24, RNA interference of p150(Glued) also induces prometaphase and metaphase delays; however, most of these cells eventually enter anaphase and complete mitosis. Our findings suggest that although both p24 and p150(Glued) components of the dynactin complex contribute to mitotic progression, p24 also appears to play a role in metaphase centrosome integrity, helping to ensure the transition to anaphase.	Hiroshima Univ, Dept Mol Oncol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; Hiroshima Univ, Leukemia Program Project, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Inaba, T (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348553, Japan.	tinaba@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amaro IA, 2008, GENETICS, V178, P703, DOI 10.1534/genetics.107.079103; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Cheung PY, 2004, J BIOL CHEM, V279, P45308, DOI 10.1074/jbc.C400333200; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 2003, MOL BIOL CELL, V14, P2645, DOI 10.1091/mbc.E03-01-0049; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Lu YJ, 2009, CELL STRUCT FUNCT, V34, P31, DOI 10.1247/csf.08040; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114	21	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5589	5598		10.1074/jbc.M110.167742	http://dx.doi.org/10.1074/jbc.M110.167742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163948	Green Published, hybrid			2022-12-25	WOS:000287230600068
J	Kuang, H; Lin, LN; Tsien, JZ				Kuang, Hui; Lin, Longnian; Tsien, Joe Z.			Temporal Dynamics of Distinct CA1 Cell Populations during Unconscious State Induced by Ketamine	PLOS ONE			English	Article							NMDA RECEPTOR-CHANNEL; OSCILLATIONS IN-VIVO; MEMORY CONSOLIDATION; HEALTHY-VOLUNTEERS; THETA RHYTHM; HIPPOCAMPUS; RAT; INTERNEURONS; PHENCYCLIDINE; CONSCIOUSNESS	Ketamine is a widely used dissociative anesthetic which can induce some psychotic-like symptoms and memory deficits in some patients during the post-operative period. To understand its effects on neural population dynamics in the brain, we employed large-scale in vivo ensemble recording techniques to monitor the activity patterns of simultaneously recorded hippocampal CA1 pyramidal cells and various interneurons during several conscious and unconscious states such as awake rest, running, slow wave sleep, and ketamine-induced anesthesia. Our analyses reveal that ketamine induces distinct oscillatory dynamics not only in pyramidal cells but also in at least seven different types of CA1 interneurons including putative basket cells, chandelier cells, bistratified cells, and O-LM cells. These emergent unique oscillatory dynamics may very well reflect the intrinsic temporal relationships within the CA1 circuit. It is conceivable that systematic characterization of network dynamics may eventually lead to better understanding of how ketamine induces unconsciousness and consequently alters the conscious mind.	[Kuang, Hui; Lin, Longnian] E China Normal Univ, Key Lab MOE, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Lin, Longnian] E China Normal Univ, Key Lab STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Tsien, Joe Z.] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA	East China Normal University; East China Normal University; University System of Georgia; Augusta University	Kuang, H (corresponding author), E China Normal Univ, Key Lab MOE, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	jtsien@mcg.edu	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864	National Institutes of Health: National Institute of Mental Health (NIMH) [MH060236]; National Institute on Aging (NIA) [AG024022, AG034663, AG025918]; Amry Research Laboratory [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663, R01AG025918, R01AG024022] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Amry Research Laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from National Institutes of Health: National Institute of Mental Health (NIMH) (MH060236), National Institute on Aging (NIA) (AG024022, AG034663 & AG025918), and from Amry Research Laboratory: USAMRA00002 (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1985, ELECTROEN CLIN NEURO, V61, P77, DOI 10.1016/0013-4694(85)91075-2; BUZSAKI G, 1983, BRAIN RES, V266, P334, DOI 10.1016/0006-8993(83)90665-0; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; CORSSEN G, 1966, ANESTH ANAL CURR RES, V45, P29; Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x; DOMINO EF, 1965, CLIN PHARMACOL THER, V6, P279; DURIEUX ME, 1995, ANESTH ANALG, V81, P57, DOI 10.1097/00000539-199507000-00012; ELLISON G, 1995, BRAIN RES REV, V20, P250, DOI 10.1016/0165-0173(94)00014-G; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; FOX SE, 1981, EXP BRAIN RES, V41, P399; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Grunwald T, 1999, P NATL ACAD SCI USA, V96, P12085, DOI 10.1073/pnas.96.21.12085; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Harborne GC, 1996, J PSYCHOPHARMACOL, V10, P134, DOI 10.1177/026988119601000208; Honey GD, 2005, CEREB CORTEX, V15, P749, DOI 10.1093/cercor/bhh176; HUNT MJ, J PSYCHOPHARMACOL; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAZAREWICZ MT, 2009, J COGN NEUROSCI; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morgan CJA, 2004, NEUROPSYCHOPHARMACOL, V29, P208, DOI 10.1038/sj.npp.1300342; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SIK A, 1995, J NEUROSCI, V15, P6651; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Squire L. R., 1987, MEMORY BRAIN; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Tulving E., 2000, OXFORD HDB MEMORY; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027	50	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15209	10.1371/journal.pone.0015209	http://dx.doi.org/10.1371/journal.pone.0015209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21165147	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100029
J	Wilson, SK; Depczynski, M; Fisher, R; Holmes, TH; O'Leary, RA; Tinkler, P				Wilson, Shaun K.; Depczynski, Martial; Fisher, Rebecca; Holmes, Thomas H.; O'Leary, Rebecca A.; Tinkler, Paul			Habitat Associations of Juvenile Fish at Ningaloo Reef, Western Australia: The Importance of Coral and Algae	PLOS ONE			English	Article							GREAT-BARRIER-REEF; 2 SPATIAL SCALES; BLEACHING EVENT; CLIMATE-CHANGE; SEAGRASS BEDS; RECRUITMENT; SETTLEMENT; DEGRADATION; COMMUNITIES; PREFERENCES	Habitat specificity plays a pivotal role in forming community patterns in coral reef fishes, yet considerable uncertainty remains as to the extent of this selectivity, particularly among newly settled recruits. Here we quantified habitat specificity of juvenile coral reef fish at three ecological levels; algal meadows vs. coral reefs, live vs. dead coral and among different coral morphologies. In total, 6979 individuals from 11 families and 56 species were censused along Ningaloo Reef, Western Australia. Juvenile fishes exhibited divergence in habitat use and specialization among species and at all study scales. Despite the close proximity of coral reef and algal meadows (10's of metres) 25 species were unique to coral reef habitats, and seven to algal meadows. Of the seven unique to algal meadows, several species are known to occupy coral reef habitat as adults, suggesting possible ontogenetic shifts in habitat use. Selectivity between live and dead coral was found to be species-specific. In particular, juvenile scarids were found predominantly on the skeletons of dead coral whereas many damsel and butterfly fishes were closely associated with live coral habitat. Among the coral dependent species, coral morphology played a key role in juvenile distribution. Corymbose corals supported a disproportionate number of coral species and individuals relative to their availability, whereas less complex shapes (i.e. massive & encrusting) were rarely used by juvenile fish. Habitat specialisation by juvenile species of ecological and fisheries importance, for a variety of habitat types, argues strongly for the careful conservation and management of multiple habitat types within marine parks, and indicates that the current emphasis on planning conservation using representative habitat areas is warranted. Furthermore, the close association of many juvenile fish with corals susceptible to climate change related disturbances suggests that identifying and protecting reefs resilient to this should be a conservation priority.	[Wilson, Shaun K.; Holmes, Thomas H.] Marine Sci Program, Dept Environm & Conservat, Div Sci, Kensington, WA, Australia; [Depczynski, Martial; Fisher, Rebecca; O'Leary, Rebecca A.; Tinkler, Paul] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia	Australian Institute of Marine Science; University of Western Australia	Wilson, SK (corresponding author), Marine Sci Program, Dept Environm & Conservat, Div Sci, Kensington, WA, Australia.	shaun.wilson@dec.wa.gov.au	Fisher, Rebecca/C-5459-2011; Wilson, Shaun/K-8597-2019; depczynski, martial/B-7689-2008	Fisher, Rebecca/0000-0001-5148-6731; Wilson, Shaun/0000-0002-4590-0948; depczynski, martial/0000-0001-8723-0076	Western Australian Marine Science Institute (WAMSI); CReefs project of the Census of Marine Life	Western Australian Marine Science Institute (WAMSI); CReefs project of the Census of Marine Life	This project was funded by the Western Australian Marine Science Institute (WAMSI). RF and RAO were supported by the CReefs project of the Census of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2002, MAR ECOL PROG SER, V228, P213, DOI 10.3354/meps228213; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bancroft K., 2000, MMSPINMPNSE262000 DE; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Best NG, 1995, CODA CONVERGENCE DIA; BOOTH DJ, 1994, CORAL REEFS, V13, P81, DOI 10.1007/BF00300765; BOOTH DJ, 1992, J EXP MAR BIOL ECOL, V155, P85, DOI 10.1016/0022-0981(92)90029-A; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caselle JE, 1996, ECOLOGY, V77, P2488, DOI 10.2307/2265748; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; DeMartini EE, 2010, MAR FRESHWATER RES, V61, P532, DOI 10.1071/MF09141; DEPCZYNSKI M, 2010, METHODS MONITORING H; Doherty P.J., 1991, P261; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2007, AFR J MAR SCI, V29, P187, DOI 10.2989/AJMS.2007.29.2.4.187; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gutierrez L, 1998, OECOLOGIA, V115, P268, DOI 10.1007/s004420050516; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jones G.P., 1991, P294; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Lecchini D, 2005, MAR BIOL, V147, P47, DOI 10.1007/s00227-004-1543-z; Lieske E, 1996, CORAL REEF FISHES; Manly B., 1993, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; Pratchett MS, 2008, CORAL REEFS, V27, P541, DOI 10.1007/s00338-008-0357-8; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Randall JE, 1990, FISHES GREAT BARRIER; Sale P.F., 1991, P564; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; Schoepf V, 2010, HYDROBIOLOGIA, V641, P45, DOI 10.1007/s10750-009-0053-x; Shima JS, 2001, ECOLOGY, V82, P2190, DOI 10.2307/2680225; Sumner N.R., 1998, FISHERIES RES REPORT; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; TOLIMIERI N, 1995, OECOLOGIA, V102, P52, DOI 10.1007/BF00333310; UNSWORTH KF, 2010, MAR ECOL-PROG SER, V353, P213; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; WELLINGTON GM, 1992, OECOLOGIA, V90, P500, DOI 10.1007/BF01875443; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	65	89	89	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15185	10.1371/journal.pone.0015185	http://dx.doi.org/10.1371/journal.pone.0015185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151875	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800009
J	Gao, L; Zhou, F; Li, XW; Yang, Y; Ruan, YH; Jin, Q				Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Ruan, Yuhua; Jin, Qi			Anal HPV Infection in HIV-Positive Men Who Have Sex with Men from China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; RISK-FACTORS; PREVALENCE; CANCER; ACQUISITION; CELLS	Background: Anal HPV infection, which contributes to the development of anal warts and anal cancer, is well known to be common among men who have sex with men (MSM), especially among those HIV positives. However, HIV and anal HPV co-infection among MSM has not been addressed in China. Methods: A cross-sectional study was conducted in Beijing and Tianjin, China. Study participants were recruited using multiple methods with the collaboration of local volunteer organizations. Blood and anal swabs were collected for HIV-1 serological test and HPV genotyping. Results: A total of 602 MSM were recruited and laboratory data were available for 578 of them (96.0%). HIV and anal HPV prevalence were 8.5% and 62.1%, respectively. And 48 MSM (8.3%) were found to be co-infected. The HPV genotypes identified most frequently were HPV06 (19.6%), HPV16 (13.0%), HPV52 (8.5%) and HPV11 (7.6%). Different modes of HPV genotypes distribution were observed with respect to HIV status. A strong dose-response relationship was found between HIV seropositivity and multiplicity of HPV genotypes (p<0.001), which is consistent with the observation that anal HPV infection was an independent predictor for HIV infection. Conclusions: A high prevalence of HIV and anal HPV co-infection was observed in the MSM community in Beijing and Tianjin, China. Anal HPV infection was found to be independently associated with increased HIV seropositivity, which suggests the application of HPV vaccine might be a potential strategy to reduce the acquisition of HIV infection though controlling the prevalence of HPV.	[Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Jin, Qi] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, L (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China.	gaolei@ipbcams.ac.cn; jinqi@ipbcams.ac.cn	Jin, Qi/B-5379-2009	Yang, Yu/0000-0002-5611-8951	National Natural Sciences Foundation of China [81001272]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Sciences Foundation of China (Grant No: 81001272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P364; Auvert B, 2010, JAIDS-J ACQ IMM DEF, V53, P111, DOI 10.1097/QAI.0b013e3181b327e7; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; Gage JR, 2000, OBSTET GYNECOL, V96, P879, DOI 10.1016/S0029-7844(00)01057-7; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Kim RH, 2008, INT J ONCOL, V33, P777, DOI 10.3892/ijo_00000064; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Kreuter A, 2009, CURR OPIN INFECT DIS, V22, P109, DOI 10.1097/QCO.0b013e3283229fc8; Mayaud P, 2001, SEX TRANSM INFECT, V77, P248, DOI 10.1136/sti.77.4.248; Nicol AF, 2005, DIAGN MOL PATHOL, V14, P39, DOI 10.1097/01.pas.0000143309.81183.6c; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2000, SEMIN ONCOL, V27, P471; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Safaeian M, 2008, SEX TRANSM INFECT, V84, P306, DOI 10.1136/sti.2007.027318; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; Shah KV, 1997, NEW ENGL J MED, V337, P1386, DOI 10.1056/NEJM199711063371911; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Smith JS, 2010, J INFECT DIS, V201, P1677, DOI 10.1086/652408; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	31	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15256	10.1371/journal.pone.0015256	http://dx.doi.org/10.1371/journal.pone.0015256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151900	Green Submitted, gold, Green Published			2022-12-25	WOS:000284995300025
J	Mosca, TJ; Schwarz, TL				Mosca, Timothy J.; Schwarz, Thomas L.			Drosophila Importin-alpha 2 Is Involved in Synapse, Axon and Muscle Development	PLOS ONE			English	Article							NUCLEAR-TRANSPORT; NUCLEOCYTOPLASMIC TRANSPORT; NEUROMUSCULAR-JUNCTION; FUNCTIONAL COMPONENTS; PROTEIN-COMPOSITION; GUIDANCE RECEPTORS; GENETIC DISSECTION; FASCICLIN-III; ACTIVE ZONES; ALPHA	Nuclear import is required for communication between the cytoplasm and the nucleus and to enact lasting changes in gene transcription following stimuli. Binding to an Importin-a molecule in the cytoplasm is often required to mediate nuclear entry of a signaling protein. As multiple isoforms of Importin-alpha exist, some may be responsible for the entry of distinct cargoes rather than general nuclear import. Indeed, in neuronal systems, Importin-a isoforms can mediate very specific processes such as axonal tiling and communication of an injury signal. To study nuclear import during development, we examined the expression and function of Importin-alpha 2 in Drosophila melanogaster. We found that Importin-alpha 2 was expressed in the nervous system where it was required for normal active zone density at the NMJ and axonal commissure formation in the central nervous system. Other aspects of synaptic morphology at the NMJ and the localization of other synaptic markers appeared normal in importin-alpha 2 mutants. Importin-alpha 2 also functioned in development of the body wall musculature. Mutants in importin-alpha 2 exhibited errors in muscle patterning and organization that could be alleviated by restoring muscle expression of Importin-alpha 2. Thus, Importin-alpha 2 is needed for some processes in the development of both the nervous system and the larval musculature.	[Mosca, Timothy J.; Schwarz, Thomas L.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Mosca, Timothy J.; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mosca, TJ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	thomas.schwarz@childrens.harvard.edu		Mosca, Timothy/0000-0003-3485-0719	Intellectual and Developmental Disabilities Research Center Imaging Core [P30HD18655]; National Institutes of Health [RO1 NS041062, MH075058]; National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	Intellectual and Developmental Disabilities Research Center Imaging Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by support from Intellectual and Developmental Disabilities Research Center Imaging Core (Grant Number P30HD18655), National Institutes of Health Grants RO1 NS041062 and MH075058 (to TLS), and a predoctoral fellowship from the National Defense Science and Engineering Graduate Foundation (to TJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 2004, DEVELOPMENT, V131, P5233, DOI 10.1242/dev.01394; CASH S, 1992, J NEUROSCI, V12, P2051; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Crossley AC, 1978, GENETICS BIOL DROS B, V2, P499; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Fang XD, 2001, DEVELOPMENT, V128, P3349; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Giarre M, 2002, J STRUCT BIOL, V140, P279, DOI 10.1016/S1047-8477(02)00543-9; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; HOOPER JE, 1986, EMBO J, V5, P2321, DOI 10.1002/j.1460-2075.1986.tb04500.x; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Mason DA, 2003, GENETICS, V165, P1943; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun Q, 2000, DEVELOPMENT, V127, P801; Tekotte H, 2002, DEV BIOL, V244, P396, DOI 10.1006/dbio.2002.0612; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	66	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15223	10.1371/journal.pone.0015223	http://dx.doi.org/10.1371/journal.pone.0015223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151903	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300022
J	Perc, M; Wang, Z				Perc, Matjaz; Wang, Zhen			Heterogeneous Aspirations Promote Cooperation in the Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; ALTRUISM; BEHAVIOR; GRAPHS; RULES	To be the fittest is central to proliferation in evolutionary games. Individuals thus adopt the strategies of better performing players in the hope of successful reproduction. In structured populations the array of those that are eligible to act as strategy sources is bounded to the immediate neighbors of each individual. But which one of these strategy sources should potentially be copied? Previous research dealt with this question either by selecting the fittest or by selecting one player uniformly at random. Here we introduce a parameter u that interpolates between these two extreme options. Setting u equal to zero returns the random selection of the opponent, while positive u favor the fitter players. In addition, we divide the population into two groups. Players from group A select their opponents as dictated by the parameter u, while players from group B do so randomly irrespective of u. We denote the fraction of players contained in groups A and B by v and 1-v, respectively. The two parameters u and v allow us to analyze in detail how aspirations in the context of the prisoner's dilemma game influence the evolution of cooperation. We find that for sufficiently positive values of u there exist a robust intermediate v approximate to 0.5 for which cooperation thrives best. The robustness of this observation is tested against different levels of uncertainty in the strategy adoption process K and for different interaction networks. We also provide complete phase diagrams depicting the dependence of the impact of u and v for different values of K, and contrast the validity of our conclusions by means of an alternative model where individual aspiration levels are subject to evolution as well. Our study indicates that heterogeneity in aspirations may be key for the sustainability of cooperation in structured populations.	[Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Wang, Zhen] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	University of Maribor; Nankai University	Perc, M (corresponding author), Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia.	matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Wang, Zhen/H-5017-2011	Perc, Matjaz/0000-0002-3087-541X; Wang, Zhen/0000-0002-8182-2852	Slovenian Research Agency [Z1-2032]; Center for Asia Studies of Nankai University [2010-5]; National Natural Science Foundation of China [10672081]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Center for Asia Studies of Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	MP acknowledges support from the Slovenian Research Agency (Grant No. Z1-2032). ZW acknowledges support from the Center for Asia Studies of Nankai University (Grant No. 2010-5) and from the National Natural Science Foundation of China (Grant No. 10672081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Marshall JAR, 2009, J THEOR BIOL, V260, P386, DOI 10.1016/j.jtbi.2009.07.008; MARSHALL JAR, 2010, BEHAV ECOL IN PRESS; Maynard Smith J., 1982, pi; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK M, 1989, APPL MATH COMPUT, V30, P191, DOI 10.1016/0096-3003(89)90052-0; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Schuster S, 2008, J BIOL PHYS, V34, P1, DOI 10.1007/s10867-008-9101-4; SELTEN R, 1980, J THEOR BIOL, V84, P93, DOI 10.1016/S0022-5193(80)81038-1; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051921; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	66	274	277	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15117	10.1371/journal.pone.0015117	http://dx.doi.org/10.1371/journal.pone.0015117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151898	gold, Green Published, Green Submitted			2022-12-25	WOS:000284995300016
J	Mokni, W; Keravis, T; Etienne-Selloum, N; Walter, A; Kane, MO; Schini-Kerth, VB; Lugnier, C				Mokni, Walid; Keravis, Therese; Etienne-Selloum, Nelly; Walter, Alison; Kane, Modou O.; Schini-Kerth, Valerie B.; Lugnier, Claire			Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; SMOOTH-MUSCLE-CELLS; HEART-FAILURE; GENE-EXPRESSION; PULMONARY-HYPERTENSION; NATRIURETIC-PEPTIDE; PRESSURE-OVERLOAD; IN-VIVO	Left ventricular hypertrophy leads to heart failure and represents a high risk leading to premature death. Cyclic nucleotides (cAMP and cGMP) play a major role in heart contractility and cyclic nucleotide phosphodiesterases (PDEs) are involved in different stages of advanced cardiac diseases. We have investigated their contributions in the very initial stages of left ventricular hypertrophy development. Wistar male rats were treated over two weeks by chronic infusion of angiotensin II using osmotic mini-pumps. Left cardiac ventricles were used as total homogenates for analysis. PDE1 to PDE5 specific activities and protein and mRNA expressions were explored. Rats developed arterial hypertension associated with a slight cardiac hypertrophy (+24%). cAMP-PDE4 activity was specifically increased while cGMP-PDE activities were broadly increased (+130% for PDE1; +76% for PDE2; +113% for PDE5) and associated with increased expressions for PDE1A, PDE1C and PDE5A. The cGMP-PDE1 activation by Ca2+/CaM was reduced. BNP expression was increased by 3.5-fold, while NOX2 expression was reduced by 66% and AMP kinase activation was increased by 64%. In early cardiac hypertrophy induced by angiotensin II, all specific PDE activities in left cardiac ventricles were increased, favoring an increase in cGMP hydrolysis by PDE1, PDE2 and PDE5. Increased cAMP hydrolysis was related to PDE4. We observed the establishment of two cardioprotective mechanisms and we suggest that these mechanisms could lead to increase intracellular cGMP: i) increased expression of BNP could increase "particulate" cGMP pool; ii) increased activation of AMPK, subsequent to increase in PDE4 activity and 5'AMP generation, could elevate "soluble" cGMP pool by enhancing NO bioavailability through NOX2 down-regulation. More studies are needed to support these assumptions. Nevertheless, our results suggest a potential link between PDE4 and AMPK/NOX2 and they point out that cGMP-PDEs, especially PDE1 and PDE2, may be interesting therapeutic targets in preventing cardiac hypertrophy.	[Mokni, Walid; Keravis, Therese; Etienne-Selloum, Nelly; Walter, Alison; Kane, Modou O.; Schini-Kerth, Valerie B.; Lugnier, Claire] Univ Strasbourg, Fac Pharm, CNRS UMR 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mokni, W (corresponding author), Univ Strasbourg, Fac Pharm, CNRS UMR 7213, Illkirch Graffenstaden, France.	claire.lugnier@unistra.fr	lugnier, claire/AAF-3911-2020		CNRS/Universite de Strasbourg	CNRS/Universite de Strasbourg(Centre National de la Recherche Scientifique (CNRS))	Funding from patent sales have supported this work. There was no grant nor specific funder. Claire Lugnier was academic/CNRS co-author to patent deposits made by Neuro3D/CNRS/Universite Louis Pasteur. Following the cessation of Neuro 3D, patents and molecules have been sold by Neuro3D on March 2007 to Via Pharmaceuticals Inc, San Francisco, California, United States of America. The CNRS/Universite de Strasbourg, after renouncing their property rights, got money from this sale and the funding for the research team is part of it. Following are the patents: WO 2004/041258 - UTILISATION D'INHIBITEURS DES PHOSPHODIESTERASES DES NUCLEOTIDES CYCLIQUES, AYANT UNE STRUCTURE BENZODIAZEPINIQUE EN THERAPIE Copropriete UNISTRA/CNRS/Neuro3D/FORENAP. Date de priorite 30/10/2002; phase nationale FR 02/13607; Licence + cession Neuro3D. WO 2004/072078 - DERIVES DE PYRAZOLOTRIAZINE, PROCEDES DE PREPARATION ET UTILISATIONS Copropriete UNISTRA/CNRS/FORENAP Date de priorite 04/02/2003; FR 03/01256; Licence + cession Neuro3D. WO 2002/098865 - INHIBITEURS DES PHOSPHODIESTERASES DES NUCLEOTIDES CYCLIQUES, PREPARATION ET UTILISATIONS DE CES INHIBITEURS Deposant Neuro3D Date de priorite 07/06/2001; FR 01/07458 Licence + cession Neuro3D. This funding was used freely by the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges A, 2009, CIRC RES, V105, P784, DOI 10.1161/CIRCRESAHA.109.197947; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Ang KL, 2002, J NEUROCHEM, V81, P422, DOI 10.1046/j.1471-4159.2002.00903.x; Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Badenhorst D, 2004, SAMJ S AFR MED J, V94, P833; Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; BAYESGENIS A, 1995, AM J CARDIOL, V76, pD54, DOI 10.1016/S0002-9149(99)80493-7; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; COSTE H, 1995, BIOCHEM PHARMACOL, V50, P1577, DOI 10.1016/0006-2952(95)02031-4; Das DK, 2004, J CELL MOL MED, V8, P144, DOI 10.1111/j.1582-4934.2004.tb00270.x; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dolci S, 2006, BIOCHEM BIOPH RES CO, V341, P837, DOI 10.1016/j.bbrc.2006.01.035; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Evgenov OV, 2006, AM J PHYSIOL-LUNG C, V290, pL723, DOI 10.1152/ajplung.00485.2004; Fischmeister R, 2005, COMP BIOCHEM PHYS A, V142, P136, DOI 10.1016/j.cbpb.2005.04.012; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Forfia PR, 2007, J AM COLL CARDIOL, V49, P1079, DOI 10.1016/j.jacc.2006.08.066; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; FUJISAKI H, 1995, J CLIN INVEST, V96, P1059, DOI 10.1172/JCI118092; Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; GUAZZI M, 2008, INT J CARDIOL; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; HASHIMOTO Y, 1989, J BIOL CHEM, V264, P10884; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Keravis T, 2007, J MOL CELL CARDIOL, V42, pS49, DOI 10.1016/j.yjmcc.2007.03.140; Keravis Therese, 2005, V307, P63; Kim D, 2005, J MOL CELL CARDIOL, V38, P175, DOI 10.1016/j.yjmcc.2004.10.013; Kim D, 2001, CIRCULATION, V104, P2338, DOI 10.1161/hc4401.098432; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Kostic MM, 1997, J MOL CELL CARDIOL, V29, P3135, DOI 10.1006/jmcc.1997.0544; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Lewis Gregory D, 2006, Curr Heart Fail Rep, V3, P123, DOI 10.1007/s11897-006-0011-0; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUGNIER C, 1979, BIOCHEM PHARMACOL, V28, P3581; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lugnier C, 1999, BBA-GEN SUBJECTS, V1472, P431, DOI 10.1016/S0304-4165(99)00145-2; LUGNIER C, 1993, EUR HEART J, V14, P141; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; MERY PF, 1996, HANDB IMMUNOPHARM, P81; Miller CL, 2009, CIRC RES, V105, pE19; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; MULLER B, 1990, J CARDIOVASC PHARM, V15, P444, DOI 10.1097/00005344-199003000-00015; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; PODZUWEIT T, 1995, CELL SIGNAL, V7, P733, DOI 10.1016/0898-6568(95)00042-N; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Schermuly RT, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-76; Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298; Schulz E, 2009, CIRC RES, V104, P422, DOI 10.1161/CIRCRESAHA.109.194274; Serneri GGN, 2001, CIRC RES, V88, P961, DOI 10.1161/hh0901.089882; Shimizu-Albergine M, 2003, J NEUROSCI, V23, P6452; Sirker A, 2007, AM J NEPHROL, V27, P649, DOI 10.1159/000109148; Smith CJ, 1997, CIRCULATION, V96, P3116, DOI 10.1161/01.CIR.96.9.3116; Staton JM, 2006, J NEUROL NEUROSUR PS, V77, P1067, DOI 10.1136/jnnp.2006.092106; Stehlik J, 2009, J CARD FAIL, V15, P31, DOI 10.1016/j.cardfail.2008.09.005; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Takahashi K, 2002, HEART VESSELS, V16, P249, DOI 10.1007/s003800200032; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; WANG Y, 2009, CIRCULATION; WEBER KT, 1993, CLIN CARDIOL, V16, P10, DOI 10.1002/clc.4960161404; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Wollert KC, 2003, BRIT J PHARMACOL, V140, P1227, DOI 10.1038/sj.bjp.0705567; Yanaka N, 2003, BIOSCI BIOTECH BIOCH, V67, P973, DOI 10.1271/bbb.67.973; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang M, 2008, CELL SIGNAL, V20, P2231, DOI 10.1016/j.cellsig.2008.08.012; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	96	47	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14227	10.1371/journal.pone.0014227	http://dx.doi.org/10.1371/journal.pone.0014227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151982	gold, Green Submitted, Green Published			2022-12-25	WOS:000284939600019
J	Boyer, M; Madoui, MA; Gimenez, G; La Scola, B; Raoult, D				Boyer, Mickael; Madoui, Mohammed-Amine; Gimenez, Gregory; La Scola, Bernard; Raoult, Didier			Phylogenetic and Phyletic Studies of Informational Genes in Genomes Highlight Existence of a 4(th) Domain of Life Including Giant Viruses	PLOS ONE			English	Article							SEQUENCE; ORIGIN; TREE; REPLICATION; EVOLUTION; DIVERGENT; DATABASE; COMMON; SIRV1	The discovery of Mimivirus, with its very large genome content, made it possible to identify genes common to the three domains of life (Eukarya, Bacteria and Archaea) and to generate controversial phylogenomic trees congruent with that of ribosomal genes, branching Mimivirus at its root. Here we used sequences from metagenomic databases, Marseillevirus and three new viruses extending the Mimiviridae family to generate the phylogenetic trees of eight proteins involved in different steps of DNA processing. Compared to the three ribosomal defined domains, we report a single common origin for Nucleocytoplasmic Large DNA Viruses (NCLDV), DNA processing genes rooted between Archaea and Eukarya, with a topology congruent with that of the ribosomal tree. As for translation, we found in our new viruses, together with Mimivirus, five proteins rooted deeply in the eukaryotic clade. In addition, comparison of informational genes repertoire based on phyletic pattern analysis supports existence of a clade containing NCLDVs clearly distinct from that of Eukarya, Bacteria and Archaea. We hypothesize that the core genome of NCLDV is as ancient as the three currently accepted domains of life.	[Boyer, Mickael; Madoui, Mohammed-Amine; Gimenez, Gregory; La Scola, Bernard; Raoult, Didier] Univ Mediterrane, URMITE, Ctr Natl Rech Sci UMR IRD 6236, Fac Med, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Boyer, M (corresponding author), Univ Mediterrane, URMITE, Ctr Natl Rech Sci UMR IRD 6236, Fac Med, Marseille, France.	didier.raoult@gmail.com	Madoui, Mohammed-Amin/ABC-1017-2020; LA SCOLA, Bernard/P-6477-2016; Madoui, Mohammed-Amin/AAF-3374-2021; RAOULT, Didier/A-8434-2008; Madoui, Mohammed-Amin/GYD-9411-2022; Boyer, Mickaël/F-6608-2013	LA SCOLA, Bernard/0000-0001-8006-7704; Madoui, Mohammed-Amin/0000-0003-4809-2971; RAOULT, Didier/0000-0002-0633-5974; Boyer, Mickaël/0000-0001-5384-1151	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique (CNRS, credits recurrents). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bell PJL, 2001, J MOL EVOL, V53, P251; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P17, DOI 10.1111/j.1749-6632.1987.tb40596.x; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Forterre P, 2006, VIRUS RES, V117, P5, DOI 10.1016/j.virusres.2006.01.010; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; McGeoch D.J., 1995, MOL BASIS VIRUS EVOL, P67; Moliner C, 2009, CLIN MICROBIOL INFEC, V15, P178, DOI 10.1111/j.1469-0691.2008.02216.x; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c6; Senju S, 2000, MOL CELL BIOL, V20, P6195, DOI 10.1128/MCB.20.17.6195-6200.2000; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Villarreal LP, 2010, J THEOR BIOL, V262, P698, DOI 10.1016/j.jtbi.2009.10.014; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	41	109	112	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15530	10.1371/journal.pone.0015530	http://dx.doi.org/10.1371/journal.pone.0015530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151962	Green Published, Green Submitted, gold			2022-12-25	WOS:000284868000035
J	Jonsson, IM; Juuti, JT; Francois, P; AlMajidi, R; Pietiainen, M; Girard, M; Lindholm, C; Saller, MJ; Driessen, AJM; Kuusela, P; Bokarewa, M; Schrenzel, J; Kontinen, VP				Jonsson, Ing-Marie; Juuti, Jarmo T.; Francois, Patrice; AlMajidi, Rana; Pietiainen, Milla; Girard, Myriam; Lindholm, Catharina; Saller, Manfred J.; Driessen, Arnold J. M.; Kuusela, Pentti; Bokarewa, Maria; Schrenzel, Jacques; Kontinen, Vesa P.			Inactivation of the Ecs ABC Transporter of Staphylococcus aureus Attenuates Virulence by Altering Composition and Function of Bacterial Wall	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PROTEIN-A; INTRAMEMBRANE PROTEOLYSIS; HUMAN DEFENSINS; IRON TRANSPORT; MUTANTS; RESISTANCE; HEME; IDENTIFICATION; REPLACEMENT	Background: Ecs is an ATP-binding cassette (ABC) transporter present in aerobic and facultative anaerobic Gram-positive Firmicutes. Inactivation of Bacillus subtilis Ecs causes pleiotropic changes in the bacterial phenotype including inhibition of intramembrane proteolysis. The molecule(s) transported by Ecs is (are) still unknown. Methodology/Principal Findings: In this study we mutated the ecsAB operon in two Staphylococcus aureus strains, Newman and LS-1. Phenotypic and functional characterization of these Ecs deficient mutants revealed a defect in growth, increased autolysis and lysostaphin sensitivity, altered composition of cell wall proteins including the precursor form of staphylokinase and an altered bacterial surface texture. DNA microarray analysis indicated that the Ecs deficiency changed expression of the virulence factor regulator protein Rot accompanied by differential expression of membrane transport proteins, particularly ABC transporters and phosphate-specific transport systems, protein A, adhesins and capsular polysaccharide biosynthesis proteins. Virulence of the ecs mutants was studied in a mouse model of hematogenous S. aureus infection. Mice inoculated with the ecs mutant strains developed markedly milder infections than those inoculated with the wild-type strains and had consequently lower mortality, less weight loss, milder arthritis and decreased persistence of staphylococci in the kidneys. The ecs mutants had higher susceptibility to ribosomal antibiotics and plant alkaloids chelerythrine and sanguinarine. Conclusions/Significance: Our results show that Ecs is essential for staphylococcal virulence and antimicrobial resistance probably since the transport function of Ecs is essential for the normal structure and function of the cell wall. Thus targeting Ecs may be a new approach in combating staphylococcal infection.	[Jonsson, Ing-Marie; Lindholm, Catharina; Bokarewa, Maria] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Juuti, Jarmo T.; AlMajidi, Rana; Pietiainen, Milla; Kontinen, Vesa P.] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Antimicrobial Resistance Unit, Helsinki, Finland; [Francois, Patrice; Girard, Myriam; Schrenzel, Jacques] Univ Geneva, Univ Hosp Geneva, Infect Dis Serv, Genom Res Lab, Geneva, Switzerland; [Saller, Manfred J.; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Kluyver Ctr Genom Ind Fermentat, Haren, Netherlands; [Saller, Manfred J.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [Kuusela, Pentti; Kontinen, Vesa P.] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kuusela, Pentti] Helsinki Univ Cent Hosp Lab, Div Clin Microbiol, Helsinki, Finland	University of Gothenburg; Finland National Institute for Health & Welfare; University of Geneva; University of Groningen; University of Groningen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Jonsson, IM (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	vesa.p.kontinen@helsinki.fi	Institute, Zernike/W-7033-2019; Kontinen, Vesa P/A-2260-2012; Driessen, Arnold J.M./D-1876-2012; Bokarewa, Maria I/A-8114-2019; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020	Bokarewa, Maria I/0000-0001-9424-5145; Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Driessen, Arnold J.M./0000-0001-9258-9104	European Science Foundation; European Commission [ERAS-CT-2003-980409]; Academy of Finland [107438, 113846, 123318]; Helsinki University Central Hospital; Swiss National Science Foundation [3100A0-112370/1, 3100A0-116075]; Swedish Medicial Research Council; Goteborg Medical Society; Swedish Association against Rheumatism; Swedish Foundation for Strategic Research; Goteborg Rheumatism Association	European Science Foundation(European Science Foundation (ESF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Medicial Research Council; Goteborg Medical Society; Swedish Association against Rheumatism; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Goteborg Rheumatism Association	This work, as part of the European Science Foundation (www.esf.org) EUROCORES Programme EuroSCOPE, is supported by funds from the European Commission's Sixth Framework Programme under contract ERAS-CT-2003-980409. This work was also supported by research grants 107438, 113846 and 123318 from the Academy of Finland (www.aka.fi), by the Subsidy of the Helsinki University Central Hospital (www.hus.fi), and by grants 3100A0-112370/1 (awarded to J.S) and 3100A0-116075 (awarded to P. F.) from the Swiss National Science Foundation (www.snf.ch). Furthermore, the work was supported by the Swedish Medicial Research Council (www.vr.se), LUA/ALF Grants, Goteborg Medical Society, Swedish Association against Rheumatism (www.reumatikerforbundet.org), Swedish Foundation for Strategic Research (www.stratresearch.se), and Goteborg Rheumatism Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bramkamp M, 2006, MOL MICROBIOL, V62, P580, DOI 10.1111/j.1365-2958.2006.05402.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Braun V, 2009, BIOMETALS, V22, P3, DOI 10.1007/s10534-008-9199-7; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEJONGE BLM, 1991, J BACTERIOL, V173, P1105, DOI 10.1128/jb.173.3.1105-1110.1991; Falcone M, 2009, EUR J INTERN MED, V20, P343, DOI 10.1016/j.ejim.2008.08.016; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Grundling A, 2006, J BACTERIOL, V188, P6286, DOI 10.1128/JB.00457-06; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Heinrich J, 2008, MICROBIOL-SGM, V154, P1989, DOI 10.1099/mic.0.2008/018648-0; HELLE M, 1988, EUR J IMMUNOL, V18, P1535, DOI 10.1002/eji.1830181010; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; JELSBAK L, 2009, INT J MED MICROBIOL, DOI DOI 10.1016/J.IJMM.2009.1007.1003; Jung KY, 2001, J MED MICROBIOL, V50, P35, DOI 10.1099/0022-1317-50-1-35; KONTINEN VP, 1988, J GEN MICROBIOL, V134, P2333; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MILLER M, PLOS ONE, V5, pE9057; Ohlsen K, 2008, PHARMACOGENOMICS, V9, P1711, DOI 10.2217/14622416.9.11.1711; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Pummi T, 2002, J BACTERIOL, V184, P1010, DOI 10.1128/jb.184.4.1010-1018.2002; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902	40	16	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14209	10.1371/journal.pone.0014209	http://dx.doi.org/10.1371/journal.pone.0014209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151985	Green Published, Green Submitted, gold			2022-12-25	WOS:000284868000019
J	Rizzi, R; Mahata, P; Mathieson, L; Moscato, P				Rizzi, Romeo; Mahata, Pritha; Mathieson, Luke; Moscato, Pablo			Hierarchical Clustering Using the Arithmetic-Harmonic Cut: Complexity and Experiments	PLOS ONE			English	Article							ALGORITHM; CANCER	Clustering, particularly hierarchical clustering, is an important method for understanding and analysing data across a wide variety of knowledge domains with notable utility in systems where the data can be classified in an evolutionary context. This paper introduces a new hierarchical clustering problem defined by a novel objective function we call the arithmetic-harmonic cut. We show that the problem of finding such a cut is NP-hard and APX-hard but is fixed-parameter tractable, which indicates that although the problem is unlikely to have a polynomial time algorithm (even for approximation), exact parameterized and local search based techniques may produce workable algorithms. To this end, we implement a memetic algorithm for the problem and demonstrate the effectiveness of the arithmetic-harmonic cut on a number of datasets including a cancer type dataset and a corona virus dataset. We show favorable performance compared to currently used hierarchical clustering techniques such as k-MEANS, Graclus and NORMALIZED-CUT. The arithmetic-harmonic cut metric overcoming difficulties other hierarchal methods have in representing both intercluster differences and intracluster similarities.	[Rizzi, Romeo] Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy; [Mahata, Pritha] New S Wales Rural Doctors Network, Newcastle, NSW, Australia; [Mathieson, Luke; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Mathieson, Luke; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, Newcastle, NSW, Australia	University of Udine; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Rizzi, R (corresponding author), Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy.	luke.mathieson@newcastle.edu.au	Rizzi, Romeo/J-4224-2012; MOSCATO, PABLO ALBERTO/G-7668-2013	Rizzi, Romeo/0000-0002-2387-0952; Mathieson, Luke/0000-0001-6470-2296; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Centre of Excellence in Bioinformatics [CE0348221]; University of Newcastle; ARC [DP0773279]	Australian Research Council (ARC) Centre of Excellence in Bioinformatics(Australian Research Council); University of Newcastle; ARC(Australian Research Council)	We acknowledge the support of the Australian Research Council (ARC) Centre of Excellence in Bioinformatics (CE0348221), The University of Newcastle, and ARC Discovery Project DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausiello Giorgio, 1999, COMPLEXITY APPROXIMA; Berretta R, 2004, APPL OPTIM, V86, P65; Buriol L, 2004, J HEURISTICS, V10, P483, DOI 10.1023/B:HEUR.0000045321.59202.52; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; FESTA P, 2002, OPTIMIZATION METHODS, V7, P1033; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hansen P., 2001, ESSAYS SURVEYS METAH, P415; Karp R.M., 1972, PROC S COMPLEXITY CO, P85, DOI 10.1007/978-1-4684-2001-2_9.; MAHAJAN M, 1997, EL C COMP COMPL ECCC; MAHATA P, 2006, EVOWORKSHOPS 2006, P67; Mendes A, 2005, INT CONF PARA PROC, P604, DOI 10.1109/ICPPW.2005.34; Merz P, 2000, EVOL COMPUT, V8, P61, DOI 10.1162/106365600568103; Moscato P, 2004, STUD FUZZ SOFT COMP, V141, P53; MOSCATO P, 2003, HDB METAHEURISTICS, P105; MOSCATO P, 2006, HDB APPROXIMATION AL; Moscato P., 1989, 826 CALTECH CONC COM; *NCI NIH, 2010, DEV THER PROGR; PAPADIMITRIOU CH, 1991, J COMPUT SYST SCI, V43, P425, DOI 10.1016/0022-0000(91)90023-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Wang S, 2003, IEEE T PATTERN ANAL, V25, P675, DOI 10.1109/TPAMI.2003.1201819; WEI YC, 1991, IEEE T COMPUT AID D, V10, P911, DOI 10.1109/43.87601; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; WU Z, 1993, IEEE T PATTERN ANAL, V15, P1101, DOI 10.1109/34.244673; Yap YL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-43; [No title captured]	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14067	10.1371/journal.pone.0014067	http://dx.doi.org/10.1371/journal.pone.0014067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151943	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000001
J	Ozer, A; Arikan, DC; Kirecci, E; Ekerbicer, HC				Ozer, Ali; Arikan, Deniz Cemgil; Kirecci, Ekrem; Ekerbicer, Hasan Cetin			Status of Pandemic Influenza Vaccination and Factors Affecting It in Pregnant Women in Kahramanmaras, an Eastern Mediterranean City of Turkey	PLOS ONE			English	Article							IMPACT	Background: Pregnant women are a target group for receipt of influenza vaccine because there appears to be an elevated mortality and morbidity rate associated with influenza virus infection in pregnant women. The goal of this study is to determine the factors affecting the decisions of pregnant women in Turkey to be vaccinated or not for 2009 H1N1 influenza. Methodology: We enrolled 314 of 522 (60.2%) pregnant women who attended to the antenatal clinics of the Medical Faculty of Kahramanmaras Sutcuimam University's Department of Gynecology and Obstetrics between December 23, 2009, and February 1, 2010. We developed a 48-question survey which was completed in a face-to-face interview at the clinic with each pregnant woman. Principal Findings: Of the 314 pregnant women, 27.4% were in the first trimester, 33.8% were in the second trimester, and 38.8% were in the third trimester. Twenty-eight pregnant women (8.9%) got vaccinated. Of all the women interviewed, 68.5% stated that they were comfortable with their decisions about the vaccine, 7.3% stated they were not comfortable, and 24.2% stated that they were hesitant about their decisions. The probability of receiving the 2009 H1N1 vaccine was 3.46 times higher among working women than housewives, 1.85 times higher among women who have a child than those who do not, and 1.29 times higher among women with a high-school education or higher than those with only a secondary-school education and below. Correct knowledge about the minimal risks associated with receipt of influenza vaccine were associated with a significant increase in the probability of receiving the 2009 H1N1 vaccine. Conclusions/Significance: The number of pregnant women in the study group who received the 2009 H1N1 vaccine was very low (8.9%) and two-thirds of them stated that they were comfortable with their decisions concerning the vaccine. Our results may have implications for public health measures to increase the currently low vaccination rate among pregnant women. Further studies are required to confirm whether our findings generalize to other influenza seasons and other settings.	[Ozer, Ali; Ekerbicer, Hasan Cetin] Kahramanmaras Sutcuimam Univ, Fac Med, Dept Publ Hlth, Kahramanmaras, Turkey; [Arikan, Deniz Cemgil] Kahramanmaras Sutcuimam Univ, Fac Med, Dept Obstet & Gynecol, Kahramanmaras, Turkey; [Kirecci, Ekrem] Kahramanmaras Sutcuimam Univ, Sch Hlth, Kahramanmaras, Turkey	Kahramanmaras Sutcu Imam University; Kahramanmaras Sutcu Imam University; Kahramanmaras Sutcu Imam University	Ozer, A (corresponding author), Kahramanmaras Sutcuimam Univ, Fac Med, Dept Publ Hlth, Kahramanmaras, Turkey.	aliozer91@hotmail.com	Ekerbiçer, Hasan Çetin/HHT-0237-2022; özer, ali/ABI-2209-2020	özer, ali/0000-0002-7144-4915				*CDC GOV, 2010, SWIN FLU; *DEP HLTH HUM SERV, 2008, GUID ALL TARG PAND I; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; *EUR CTR DIS PREV, 2009, INFL A H1N1 RISK ASS; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; KURUGOL Z, 2009, TURKIYE KLIN J PEDIA, V18, P358; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nuzum J W, 1976, IMJ Ill Med J, V150, P612; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; Tuyishime Jean-de-Dieu, 2003, J Obstet Gynaecol Can, V25, P1020; World Health Organization, 2009, PAND H1N1 2009; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; 2010, INTERIM RESULTS INFL; 2010, EMEDSCAPE MEDSCAPE	26	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14177	10.1371/journal.pone.0014177	http://dx.doi.org/10.1371/journal.pone.0014177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152073	Green Published, Green Submitted			2022-12-25	WOS:000284821300002
J	Flisikowski, K; Venhoranta, H; Nowacka-Woszuk, J; McKay, SD; Flyckt, A; Taponen, J; Schnabel, R; Schwarzenbacher, H; Szczerbal, I; Lohi, H; Fries, R; Taylor, JF; Switonski, M; Andersson, M				Flisikowski, Krzysztof; Venhoranta, Heli; Nowacka-Woszuk, Joanna; McKay, Stephanie D.; Flyckt, Antti; Taponen, Juhani; Schnabel, Robert; Schwarzenbacher, Hermann; Szczerbal, Izabela; Lohi, Hannes; Fries, Ruedi; Taylor, Jeremy F.; Switonski, Marek; Andersson, Magnus			A Novel Mutation in the Maternally Imprinted PEG3 Domain Results in a Loss of MIMT1 Expression and Causes Abortions and Stillbirths in Cattle (Bos taurus)	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; GENE; METHYLATION	Congenital malformations resulting in late abortions and stillbirths affect the economic wellbeing of producers and the welfare of cattle in breeding programs. An extremely high incidence of stillbirths of "half-sized" calves of normal karyotype and uninflated lungs was diagnosed in the progeny of the Finnish Ayrshire (Bos taurus) bull - YN51. No other visible anatomical abnormalities were apparent in the stillborn calves. We herein describe the positional identification of a 110 kb microdeletion in the maternally imprinted PEG3 domain that results in a loss of paternal MIMT1 expression and causes late term abortion and stillbirth in cattle. Using the BovineSNP50 BeadChip we performed a genome-wide half-sib linkage analysis that identified a 13.3 Mb associated region on BTA18 containing the maternally imprinted PEG3 domain. Within this cluster we found a 110 kb microdeletion that removes a part of the non-protein coding MER1 repeat containing imprinted transcript 1 gene (MIMT1). To confirm the elimination of gene expression in calves inheriting this deletion, we examined the mRNA levels of the three maternally imprinted genes within the PEG3 domain, in brain and cotyledon tissue collected from eight fetuses sired by the proband. None of the fetuses that inherited the microdeletion expressed MIMT1 in either tissue. The mutation, when inherited from the sire, is semi-lethal for his progeny with an observed mortality rate of 85%. The survival of 15% is presumably due to the incomplete silencing of maternally inherited MIMT1 alleles. We designed a PCR-based assay to confirm the existence of the microdeletion in the MIMT1 region that can be used to assist cattle breeders in preventing the stillbirths.	[Flisikowski, Krzysztof; Schwarzenbacher, Hermann; Fries, Ruedi] Tech Univ Munich, Lehrstuhl Tierzucht, D-8050 Freising Weihenstephan, Germany; [Venhoranta, Heli; Flyckt, Antti; Taponen, Juhani; Andersson, Magnus] Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland; [Nowacka-Woszuk, Joanna; Szczerbal, Izabela; Switonski, Marek] Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland; [McKay, Stephanie D.; Schnabel, Robert; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Schwarzenbacher, Hermann] EDV Dienstleistungen GmbH, ZuchtData, Vienna, Austria; [Lohi, Hannes] Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, Folkhalsan Inst Genet,Program Mol Med, Helsinki, Finland	Technical University of Munich; University of Helsinki; Poznan University of Life Sciences; University of Missouri System; University of Missouri Columbia; University of Helsinki	Flisikowski, K (corresponding author), Tech Univ Munich, Lehrstuhl Biotechnol Nutztiere, D-8050 Freising Weihenstephan, Germany.	flisikowski@wzw.tum.de	Lohi, Hannes/F-4596-2011; Szczerbal, Izabela/AFM-9268-2022	Lohi, Hannes/0000-0003-1087-5532; Nowacka-Woszuk, Joanna/0000-0002-1041-3576; Fries, Ruedi/0000-0002-4657-1787; McKay, Stephanie/0000-0003-1434-3111; Switonski, Marek/0000-0003-2539-9508; Schnabel, Robert/0000-0001-5018-7641; Szczerbal, Izabela/0000-0002-4238-0414	Finnish Academy; Mercedes-Zachariksen foundation; Finnish Animal Breeding Association (FABA Service)	Finnish Academy(Academy of Finland); Mercedes-Zachariksen foundation; Finnish Animal Breeding Association (FABA Service)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from the Finnish Academy, Mercedes-Zachariksen foundation and Finnish Animal Breeding Association (FABA Service) is highly appreciated.	Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Biliya S, 2010, EXP BIOL MED, V235, P139, DOI 10.1258/ebm.2009.009251; Bittel Douglas C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009531; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nicholas FW, 2005, PHILOS T R SOC B, V360, P1529, DOI 10.1098/rstb.2005.1674; SEATON A, 2006, P 8 WORLD C GEN APPL; SWITONSKI M, 1987, CYTOGENET CELL GENET, V44, P103, DOI 10.1159/000132353; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	27	49	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15116	10.1371/journal.pone.0015116	http://dx.doi.org/10.1371/journal.pone.0015116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152099	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100078
J	Johnson, AB; Winker, K				Johnson, Andrew B.; Winker, Kevin			Short-Term Hurricane Impacts on a Neotropical Community of Marked Birds and Implications for Early-Stage Community Resilience	PLOS ONE			English	Article							TROPICAL FOREST; POPULATIONS; HUGO; DYNAMICS; GILBERT; SHIFTS; FAT	Populations in fragmented ecosystems risk extirpation through natural disasters, which must be endured rather than avoided. Managing communities for resilience is thus critical, but details are sketchy about the capacity for resilience and its associated properties in vertebrate communities. We studied short-term resilience in a community of individually marked birds, following this community through the catastrophic destruction of its forest habitat by Hurricane Iris in Belize, Central America. We sampled for 58 d immediately before the storm, 28 d beginning 11 d after Hurricane Iris, and for 69 d approximately one year later. Our data showed that the initial capacity for resilience was strong. Many banded individuals remained after the storm, although lower post-hurricane recapture rates revealed increased turnover among individuals. Changes occurred in community dynamics and in abundances among species and guilds. Survivors and immigrants both were critical components of resilience, but in a heterogeneous, species-specific manner. Delayed effects, including higher fat storage and increased species losses, were evident one year later.	[Johnson, Andrew B.; Winker, Kevin] Univ Alaska Museum, Fairbanks, AK USA; [Johnson, Andrew B.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA	University of Alaska System; University of Alaska Fairbanks; University of New Mexico	Johnson, AB (corresponding author), Univ Alaska Museum, Fairbanks, AK USA.	kevin.winker@alaska.edu	Winker, Kevin/M-2042-2014	Winker, Kevin/0000-0002-8985-8104	University of Alaska Museum; U.S. Department of Agriculture [SCA 58-6612-8-022]	University of Alaska Museum; U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by the University of Alaska Museum, an anonymous donor, and the U.S. Department of Agriculture (SCA 58-6612-8-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; [Anonymous], 2001, PANARCHY UNDERSTANDI; ASKINS RA, 1991, BIOTROPICA, V23, P481, DOI 10.2307/2388270; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Beck RJ, 1996, J REHABIL, V62, P28; Cochran W. G., 1963, SAMPLING TECHNIQUES, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diamond J., 1986, COMMUNITY ECOL, P3; Dobbs RC, 2009, WETLANDS, V29, P123, DOI 10.1672/08-78.1; EDWARDS DK, 1981, STUD AVIAN BIOL, V6, P170; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; HAILMAN JP, 1965, BIRD BANDING, V36, P14, DOI 10.2307/4511130; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; JONES HL, 2001, ANNOTATED CHECKLIST; Katti M, 1999, J ANIM ECOL, V68, P815, DOI 10.1046/j.1365-2656.1999.00331.x; Klinger R, 2006, J ANIM ECOL, V75, P1227, DOI 10.1111/j.1365-2656.2006.01158.x; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; LYNCH JF, 1991, BIOTROPICA, V23, P488, DOI 10.2307/2388271; Mallin MA, 2002, BIOSCIENCE, V52, P999, DOI 10.1641/0006-3568(2002)052[0999:IARFMH]2.0.CO;2; Mileti D.S., 1999, DISASTERS DESIGN REA; Paerl HW, 2001, P NATL ACAD SCI USA, V98, P5655, DOI 10.1073/pnas.101097398; PERILLA A, 2002, J SOC CLIN PSYCHOL, V21, P40; Pravosudov VV, 1997, CURR ORNITHOL, V14, P189; REAGAN DP, 1991, BIOTROPICA, V23, P468, DOI 10.2307/2388268; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; ROGERS CM, 1991, J FIELD ORNITHOL, V62, P349; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schoener TW, 2004, P NATL ACAD SCI USA, V101, P177, DOI 10.1073/pnas.0306887101; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stiles F.G., 1989, GUIDE BIRDS COSTA RI; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; WAIDE RB, 1991, BIOTROPICA, V23, P475, DOI 10.2307/2388269; WAUER RH, 1992, WILSON BULL, V104, P656; Whitman AA, 1998, BIOTROPICA, V30, P449, DOI 10.1111/j.1744-7429.1998.tb00079.x; Wiley James W., 1993, Bird Conservation International, V3, P319; WILL T, 1991, BIOTROPICA, V23, P497, DOI 10.2307/2388272; WINKER K, 1990, CONDOR, V92, P444, DOI 10.2307/1368241; WOOLBRIGHT LL, 1991, BIOTROPICA, V23, P462, DOI 10.2307/2388267; WUNDERLE JM, 1995, CONDOR, V97, P879, DOI 10.2307/1369528; WUNDERLE JM, 1992, AUK, V109, P148, DOI 10.2307/4088275; Wunderle Joseph M. Jr, 1996, Conservation Biology Series, V6, P253; Zar J.R., 1999, BIOSTAT ANAL	49	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15109	10.1371/journal.pone.0015109	http://dx.doi.org/10.1371/journal.pone.0015109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152062	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100074
J	Saithong, T; Painter, KJ; Millar, AJ				Saithong, Treenut; Painter, Kevin J.; Millar, Andrew J.			The Contributions of Interlocking Loops and Extensive Nonlinearity to the Properties of Circadian Clock Models	PLOS ONE			English	Article							FEEDBACK LOOPS; ARABIDOPSIS-THALIANA; MOLECULAR-BASES; ROBUSTNESS; DROSOPHILA; RHYTHMS; ENTRAINMENT; SENSITIVITY; OSCILLATOR; COMPONENTS	Background: Sensitivity and robustness are essential properties of circadian clock systems, enabling them to respond to the environment but resist noisy variations. These properties should be recapitulated in computational models of the circadian clock. Highly nonlinear kinetics and multiple loops are often incorporated into models to match experimental time-series data, but these also impact on model properties for clock models. Methodology/Principal Findings: Here, we study the consequences of complicated structure and nonlinearity using simple Goodwin-type oscillators and the complex Arabidopsis circadian clock models. Sensitivity analysis of the simple oscillators implies that an interlocked multi-loop structure reinforces sensitivity/robustness properties, enhancing the response to external and internal variations. Furthermore, we found that reducing the degree of nonlinearity could sometimes enhance the robustness of models, implying that ad hoc incorporation of nonlinearity could be detrimental to a model's perceived credibility. Conclusion: The correct multi-loop structure and degree of nonlinearity are therefore critical in contributing to the desired properties of a model as well as its capacity to match experimental data.	[Saithong, Treenut; Millar, Andrew J.] Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Dept Math, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.; Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh; Heriot Watt University; Heriot Watt University; University of Edinburgh	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	andrew.millar@ed.ac.uk	Painter, Kevin J/D-1055-2010; Millar, Andrew J/G-2423-2012; Saithong, Treenut/L-1395-2019	Painter, Kevin J/0000-0003-3273-6031; Millar, Andrew J/0000-0003-1756-3654; Saithong, Treenut/0000-0003-2888-6854	Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC) [BB/D019621]; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; BBSRC [BB/D019621/1] Funding Source: UKRI	Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TS was supported by the postgraduate studentship from Higher Educational Strategic Scholarships for Frontier Research (SFR), Royal Thai Government. The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) through award BB/D019621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Buceta J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000602; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Doyle FJ, 2006, COMPUT CHEM ENG, V30, P1700, DOI 10.1016/j.compchemeng.2006.05.029; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Eckardt NA, 2005, PLANT CELL, V17, P645, DOI 10.1105/tpc.104.031336; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Ferreira JS, 2006, LECT NOTES CONTR INF, V341, P279; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; KIM J, 2007, BIOPHYSICAL J BIOPHY, pL1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondo T, 2007, COLD SPRING HARB SYM, V72, P47, DOI 10.1101/sqb.2007.72.029; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Kwon YK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-430; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 2008, BIOESSAYS, V30, P590, DOI 10.1002/bies.20762; Lindenschmidt KE, 2006, ECOL MODEL, V190, P72, DOI 10.1016/j.ecolmodel.2005.04.016; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Masuda N, 2008, J COMPUT NEUROSCI, V24, P137, DOI 10.1007/s10827-007-0045-7; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, pS135; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; SAITHONG T, 2010, CONSISTENT ROB UNPUB; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035; Zak DE, 2005, COMPUT CHEM ENG, V29, P663, DOI 10.1016/j.compchemeng.2004.08.021; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	57	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13867	10.1371/journal.pone.0013867	http://dx.doi.org/10.1371/journal.pone.0013867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152419	gold, Green Submitted, Green Published			2022-12-25	WOS:000284755100001
J	Vishnoi, A; Roy, R; Prasad, HK; Bhattacharya, A				Vishnoi, Anchal; Roy, Rahul; Prasad, Hanumanthappa K.; Bhattacharya, Alok			Anchor-Based Whole Genome Phylogeny (ABWGP): A Tool for Inferring Evolutionary Relationship among Closely Related Microorganims	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SEQUENCE ALIGNMENT; GENE ORDER; TREE; REGIONS; IDENTIFICATION; CHROMOSOME; ORGANISMS; STRAINS; LEPROSY	Phenotypic behavior of a group of organisms can be studied using a range of molecular evolutionary tools that help to determine evolutionary relationships. Traditionally a gene or a set of gene sequences was used for generating phylogenetic trees. Incomplete evolutionary information in few selected genes causes problems in phylogenetic tree construction. Whole genomes are used as remedy. Now, the task is to identify the suitable parameters to extract the hidden information from whole genome sequences that truly represent evolutionary information. In this study we explored a random anchor (a stretch of 100 nucleotides) based approach (ABWGP) for finding distance between any two genomes, and used the distance estimates to compute evolutionary trees. A number of strains and species of Mycobacteria were used for this study. Anchor-derived parameters, such as cumulative normalized score, anchor order and indels were computed in a pair-wise manner, and the scores were used to compute distance/phylogenetic trees. The strength of branching was determined by bootstrap analysis. The terminal branches are clearly discernable using the distance estimates described here. In general, different measures gave similar trees except the trees based on indels. Overall the tree topology reflected the known biology of the organisms. This was also true for different strains of Escherichia coli. A new whole genome-based approach has been described here for studying evolutionary relationships among bacterial strains and species.	[Vishnoi, Anchal; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Roy, Rahul] Indian Stat Inst, New Delhi 110016, India; [Prasad, Hanumanthappa K.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Indian Statistical Institute; Indian Statistical Institute Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi	Vishnoi, A (corresponding author), Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India.	alok.bhattacharya@jnu.ac.in	vishnoi, anchal/B-8372-2011		Department of BioTechnology, India; Department of Science and Technology	Department of BioTechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Department of BioTechnology, India. RR was supported by a grant from the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; CHIN DP, 1994, J INFECT DIS, V169, P289, DOI 10.1093/infdis/169.2.289; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Ding GH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003357; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 1995, J MOL EVOL, V41, P1105; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Fukami-Kobayashi K, 2007, MOL BIOL EVOL, V24, P1181, DOI 10.1093/molbev/msm034; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Grishin NV, 2000, GENOME RES, V10, P991, DOI 10.1101/gr.10.7.991; Gu X, 2004, MOL BIOL EVOL, V21, P1401, DOI 10.1093/molbev/msh138; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; House CH, 2002, J MOL EVOL, V54, P539, DOI 10.1007/s00239-001-0054-5; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Lienau EK, 2010, CLADISTICS, V26, P195, DOI 10.1111/j.1096-0031.2009.00288.x; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; *SWOFFORDOLSEN WAD, 1996, PHYL INF MOL SYST, pCH11; Tamames J, 2001, GENOME BIOL, V2; Tekaia F, 1999, GENOME RES, V9, P550; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Vishnoi A, 2007, NUCLEIC ACIDS RES, V35, P3654, DOI 10.1093/nar/gkm209; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; Warren RM, 2000, MOL MICROBIOL, V37, P1405, DOI 10.1046/j.1365-2958.2000.02090.x; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14159	10.1371/journal.pone.0014159	http://dx.doi.org/10.1371/journal.pone.0014159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152403	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100037
J	Sengupta, A; Molkentin, JD; Paik, JH; DePinho, RA; Yutzey, KE				Sengupta, Arunima; Molkentin, Jeffery D.; Paik, Ji-Hye; DePinho, Ronald A.; Yutzey, Katherine E.			FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; APOPTOSIS; HEART; HYPERTROPHY; INJURY; PROLIFERATION; RESPONSES; REVEALS; TBX20	Transcriptional regulatory mechanisms of cardiac oxidative stress resistance are not well defined. FoxO transcription factors are critical mediators of oxidative stress resistance in multiple cell types, but cardioprotective functions have not been reported previously. FoxO function in oxidative stress resistance was investigated in cultured cardiomyocytes and in mice with cardiomyocyte-specific combined deficiency of FoxO1 and FoxO3 subjected to myocardial infarction (MI) or acute ischemia/reperfusion (I/R) injury. Induction of oxidative stress in cardiomyocytes promotes FoxO1 and FoxO3 nuclear localization and target gene activation. Infection of cardiomyocytes with a dominant-negative FoxO1(Delta 256) adenovirus results in a significant increase in reactive oxygen species and cell death, whereas increased FoxO1 or FoxO3 expression reduces reactive oxygen species and cell death. Mice generated with combined conditional deletion of FoxO1 and FoxO3 specifically in cardiomyocytes were subjected to I/R or MI. Loss of FoxO1 and FoxO3 in cardiomyocytes results in a significant increase in infarct area with decreased expression of the antiapoptotic molecules, PTEN-induced kinase1 (PINK1) and CBP/P300-interacting transactivator (CITED2). Expressions of the antioxidants catalase and manganese superoxide dismutase-2 (SOD2) and the autophagy-related proteins LC3II and Gabarapl1 also are decreased following I/R compared with controls. Mice with cardiomyocyte-specific FoxO deficiency subjected to MI have reduced cardiac function, increased scar formation, induction of stress-responsive signaling, and increased apoptotic cell death relative to controls. These data support a critical role for FoxOs in promoting cardiomyocyte survival during conditions of oxidative stress through induction of antioxidants and cell survival pathways.	[Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Inst Heart, Cincinnati, OH 45229 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med Oncol, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Genet, Boston, MA 02115 USA	Cincinnati Children's Hospital Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr ML 7020, Div Mol Cardiovasc Biol, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Yutzey, Katherine/0000-0002-1444-7124; DePinho, Ronald/0000-0002-5625-577X; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [PO1 HL069779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL069779 (to K. E. Y. and J. D. M.).	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Jin ZQ, 2005, AM J PHYSIOL-HEART C, V288, pH2986, DOI 10.1152/ajpheart.01144.2004; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Maillet M, 2009, J CLIN INVEST, V119, P3079, DOI 10.1172/JCI37694; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; MURPHY E, 2008, NATURE, V88, P239; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Wu CG, 2009, AM J PHYSIOL-CELL PH, V297, pC928, DOI 10.1152/ajpcell.00045.2009; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	42	238	254	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7468	7478		10.1074/jbc.M110.179242	http://dx.doi.org/10.1074/jbc.M110.179242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21159781	Green Published, hybrid			2022-12-25	WOS:000287737300061
J	Biegel, E; Muller, V				Biegel, Eva; Mueller, Volker			A Na+-translocating Pyrophosphatase in the Acetogenic Bacterium Acetobacterium woodii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND PYROPHOSPHATASE; POTENTIAL COUPLING SITE; ENERGY-CONSERVATION; INORGANIC PYROPHOSPHATASE; PHOTOTROPHIC BACTERIA; CAFFEATE REDUCTION; ATP SYNTHESIS; SODIUM; PROTON; ION	The anaerobic acetogenic bacterium Acetobacterium woodii employs a novel type of Na+-motive anaerobic respiration, caffeate respiration. However, this respiration is at the thermodynamic limit of energy conservation, and even worse, in the first step, caffeate is activated by caffeyl-CoA synthetase, which hydrolyzes ATP to AMP and pyrophosphate. Here, we have addressed whether or not the energy stored in the anhydride bond of pyrophosphate is conserved by A. woodii. Inverted membrane vesicles of A. woodii have a membrane-bound pyrophosphatase that catalyzes pyrophosphate hydrolysis at a rate of 70-120 milliunits/mg of protein. Pyrophosphatase activity was dependent on the divalent cation Mg2+. In addition, activity was strictly dependent on Na+ with a Km of 1.1 mM. Hydrolysis of pyrophosphate was accompanied by Na-22(+) transport into the lumen of the inverted membrane vesicles. Inhibitor studies revealed that Na-22(+) transport was primary and electrogenic. Next to the Na+-motive ferredoxin: NAD(+) oxidoreductase (Fno or Rnf), the Na+-pyrophosphatase is the second primary Na+-translocating enzyme in A. woodii.	[Biegel, Eva; Mueller, Volker] Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft [SFB 807]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 807).	Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HEISE R, 1993, FEMS MICROBIOL LETT, V112, P261, DOI 10.1111/j.1574-6968.1993.tb06460.x; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V., 2011, J BACTERIOL IN PRESS; Imkamp F, 2002, J BACTERIOL, V184, P1947, DOI 10.1128/JB.184.7.1947-1951.2002; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Muller V, 1995, ARCH MICROBIOL, V164, P363, DOI 10.1007/s002030050276; Muller V, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P251; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Muller V, 2001, BBA-BIOENERGETICS, V1505, P108, DOI 10.1016/S0005-2728(00)00281-4; NAKAMURA T, 1986, J BIOL CHEM, V261, P678; NORE BF, 1990, PHOTOSYNTH RES, V24, P75, DOI 10.1007/BF00032646; NYREN P, 1991, FEMS MICROBIOL LETT, V77, P265, DOI 10.1016/0378-1097(91)90563-P; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schocke L, 1998, EUR J BIOCHEM, V256, P589, DOI 10.1046/j.1432-1327.1998.2560589.x; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; SKULACHEV VP, 1977, FEBS LETT, V74, P1, DOI 10.1016/0014-5793(77)80739-4; SOSA A, 1992, BIOCHEM J, V283, P561, DOI 10.1042/bj2830561; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460	34	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6080	6084		10.1074/jbc.M110.192823	http://dx.doi.org/10.1074/jbc.M110.192823			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173152	Green Published, hybrid			2022-12-25	WOS:000287476400016
J	Fatrai, S; van Gosliga, D; Han, LN; Daenen, SMGJ; Vellenga, E; Schuringa, JJ				Fatrai, Szabolcs; van Gosliga, Djoke; Han, Lina; Daenen, Simon M. G. J.; Vellenga, Edo; Schuringa, Jan Jacob			KRAS(G12V) Enhances Proliferation and Initiates Myelomonocytic Differentiation in Human Stem/Progenitor Cells via Intrinsic and Extrinsic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; ONCOGENIC K-RAS; EX-VIVO EXPANSION; N-RAS; ERYTHROID-DIFFERENTIATION; MYELOID DIFFERENTIATION; PROGENITOR CELLS; MOUSE; GENE; EXPRESSION	In human hematopoietic malignancies, RAS mutations are frequently observed. Yet, little is known about signal transduction pathways that mediate KRAS-induced phenotypes in human CD34(+) stem/progenitor cells. When cultured on bone marrow stroma, we observed that KRAS(G12V)-transduced cord blood (CB) CD34(+) cells displayed a strong proliferative advantage over control cells, which coincided with increased early cobblestone (CAFC) formation and induction of myelomonocytic differentiation. However, the KRAS(G12V)-induced proliferative advantage was transient. By week three no progenitors remained in KRAS(G12V)-transduced cultures and cells were all terminally differentiated into monocytes/macrophages. In line with these results, LTC-IC frequencies were strongly reduced. Both the ERK and p38 MAPK pathways, but not JNK, were activated by KRAS(G12V) and we observed that proliferation and CAFC formation were mediated via ERK, while differentiation was predominantly mediated via p38. Interestingly, we observed that KRAS(G12V)-induced proliferation and CAFC formation, but not differentiation, were largely mediated via secreted factors, since these phenotypes could be recapitulated by treating non-transduced cells with conditioned medium harvested from KRAS(G12V)-transduced cultures. Multiplex cytokine arrays and genome-wide gene expression profiling were performed to gain further insight into the mechanisms by which oncogenic KRAS(G12V) can contribute to the process of leukemic transformation. Thus, angiopoietin-like 6 (ANGPTL6) was identified as an important factor in the KRAS(G12V) secretome that enhanced proliferation of human CB CD34(+) cells.	[Fatrai, Szabolcs; van Gosliga, Djoke; Han, Lina; Daenen, Simon M. G. J.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9700 RB Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Hanzepl 1,Z2-66 DA13, NL-9700 RB Groningen, Netherlands.	j.schuringa@int.umcg.nl	Han, Lina/J-5119-2015	Han, Lina/0000-0003-1538-1734	NWO-VENI; NWO-VIDI; KWF [RUG 2009-4275]	NWO-VENI(Netherlands Organization for Scientific Research (NWO)); NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); KWF	This work was supported by grants from the NWO-VENI (2004), NWO-VIDI (2008), and KWF (RUG 2009-4275).	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; BREIVIK J, 1994, BRIT J CANCER, V69, P367, DOI 10.1038/bjc.1994.67; Chan IT, 2006, BLOOD, V108, P1708, DOI 10.1182/blood-2006-04-015040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Darley RL, 1997, J EXP MED, V185, P1337, DOI 10.1084/jem.185.7.1337; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Geest CR, 2009, BLOOD, V114, P3402, DOI 10.1182/blood-2008-08-175141; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KALRA R, 1994, BLOOD, V84, P3435; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LEMOINE NR, 1988, CANCER RES, V48, P4459; LI SR, 1994, LUNG CANCER-J IASLC, V11, P19, DOI 10.1016/0169-5002(94)90279-8; MILLS NE, 1995, CANCER RES, V55, P1444; Monticone M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-92; O'Hayer KM, 2009, CARCINOGENESIS, V30, P1841, DOI 10.1093/carcin/bgp198; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Onida F, 2002, BLOOD, V99, P840, DOI 10.1182/blood.V99.3.840; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen SW, 2004, EXP HEMATOL, V32, P852, DOI 10.1016/j.exphem.2004.06.001; Shen S, 2007, EXP HEMATOL, V35, P908, DOI 10.1016/j.exphem.2007.02.011; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	41	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6061	6070		10.1074/jbc.M110.201848	http://dx.doi.org/10.1074/jbc.M110.201848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169357	Green Published, hybrid			2022-12-25	WOS:000287476400014
J	Inoue, Y; Iemura, SI; Natsume, T; Miyazawa, K; Imamura, T				Inoue, Yasumichi; Iemura, Shun-ichiro; Natsume, Tohru; Miyazawa, Keiji; Imamura, Takeshi			Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; C-SKI; TUMOR-SUPPRESSOR; HUMAN CANCER; DUAL ROLE; GROWTH; PROTEIN; ACETYLATION; SNON; GENE	Ski was originally identified as an oncogene based on the fact that Ski overexpression transformed chicken and quail embryo fibroblasts. Consistent with these proposed oncogenic roles, Ski is overexpressed in various human tumors. However, whether and how Ski functions in mammalian tumorigenesis has not been fully investigated. Here, we show that Ski interacts with p53 and attenuates the biological functions of p53. Ski overexpression attenuated p53-dependent transactivation, whereas Ski knockdown enhanced the transcriptional activity of p53. Interestingly, Ski bound to the histone deacetylase SIRT1 and stabilized p53-SIRT1 interaction to promote p53 deacetylation, which subsequently decreased the DNA binding activity of p53. Consistent with the ability of Ski to inactivate p53, overexpressing Ski desensitized cells to genotoxic drugs and Nutlin-3, a small-molecule antagonist of Mdm2 that stabilizes p53 and activates the p53 pathway, whereas knocking down Ski increased the cellular sensitivity to these agents. These results indicate that Ski negatively regulates p53 and suggest that the p53-Ski-SIRT1 axis is an attractive target for cancer therapy.	[Inoue, Yasumichi; Imamura, Takeshi] Japan Sci & Technol Agcy, Koto Ku, Tokyo 1358550, Japan; Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Imamura, Takeshi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime 7910295, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Biol Syst Control Team, Koto Ku, Tokyo 1350064, Japan; [Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan	Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Ehime University; National Institute of Advanced Industrial Science & Technology (AIST); University of Yamanashi	Imamura, T (corresponding author), Japan Sci & Technol Agcy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	Natsume, Tohru/M-7627-2018; MIYAZAWA, KEIJI/I-9713-2014	Natsume, Tohru/0000-0002-1510-2582; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22113004, 21025036, 20058038]; Japan Society for the Promotion of Science (JSPS) [20390407, 22700890]; Vehicle Racing Commemorative Foundation; Takeda Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Vehicle Racing Commemorative Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22113004, "Fluorescence Live Imaging," and Grants-in-aid for Scientific Research on Priority Areas 21025036 and 20058038 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by Grant-in-aid for Scientific Research (B) 20390407 and Grant-in-aid for Young Scientists (B) 22700890 from the Japan Society for the Promotion of Science (JSPS).; Supported by the Vehicle Racing Commemorative Foundation, the Takeda Science Foundation, and the Naito Foundation.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Hainaut P, 2000, ADV CANCER RES, V77, P81; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Prives C, 1999, J PATHOL, V187, P112; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	50	18	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6311	6320		10.1074/jbc.M110.177683	http://dx.doi.org/10.1074/jbc.M110.177683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149449	hybrid, Green Published			2022-12-25	WOS:000287476400041
J	Nozoye, T; Nagasaka, S; Kobayashi, T; Takahashi, M; Sato, Y; Sato, Y; Uozumi, N; Nakanishi, H; Nishizawa, NK				Nozoye, Tomoko; Nagasaka, Seiji; Kobayashi, Takanori; Takahashi, Michiko; Sato, Yuki; Sato, Yoko; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			Phytosiderophore Efflux Transporters Are Crucial for Iron Acquisition in Graminaceous Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; NICOTIANAMINE SYNTHASE GENES; TRANSCRIPTION FACTOR; ENHANCED TOLERANCE; DEFICIENT BARLEY; MUGINEIC ACID; RICE; BIOSYNTHESIS; EXPRESSION; PROTEIN	Eukaryotic organisms have developed diverse mechanisms for the acquisition of iron, which is required for their survival. Graminaceous plants use a chelation strategy. They secrete phytosiderophore compounds, which solubilize iron in the soil, and then take up the resulting iron-phytosiderophore complexes. Bacteria and mammals also secrete siderophores to acquire iron. Although phytosiderophore secretion is crucial for plant growth, its molecular mechanism remains unknown. Here, we show that the efflux of deoxymugineic acid, the primary phytosiderophore from rice and barley, involves the TOM1 and HvTOM1 genes, respectively. Xenopus laevis oocytes expressing TOM1 or HvTOM1 released C-14-labeled deoxymugineic acid but not C-14-labeled nicotianamine, a structural analog and biosynthetic precursor of deoxymugineic acid, indicating that the TOM1 and HvTOM1 proteins are the phytosiderophore efflux transporters. Under conditions of iron deficiency, rice and barley roots express high levels of TOM1 and HvTOM1, respectively, and the overexpression of these genes increased tolerance to iron deficiency. In rice roots, the efficiency of deoxymugineic acid secretion was enhanced by overexpression of TOM1 and decreased by its repression, providing further evidence that TOM1 encodes the efflux transporter of deoxymugineic acid. We have also identified two genes encoding efflux transporters of nicotianamine, ENA1 and ENA2. Our identification of phytosiderophore efflux transporters has revealed the final piece in the molecular machinery of iron acquisition in graminaceous plants.	[Nozoye, Tomoko; Nagasaka, Seiji; Kobayashi, Takanori; Takahashi, Michiko; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Sato, Yuki; Sato, Yoko; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; Tohoku University; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019; Nakanishi, Hiromi/C-6461-2015	Uozumi, Nobuyuki/0000-0003-4268-1126; Nakanishi, Hiromi/0000-0001-5556-5058	CREST from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan	CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant of CREST from Japan Science and Technology Agency (to N. K. N.) and by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. K. N. and N. U.).	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Kakei Y, 2009, PLANT CELL PHYSIOL, V50, P1988, DOI 10.1093/pcp/pcp141; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kawai S, 2001, SOIL SCI PLANT NUTR, V47, P265, DOI 10.1080/00380768.2001.10408390; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Kobayashi T, 2008, RICE, V1, P144, DOI 10.1007/s12284-008-9011-x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; NOMOTO K, 1982, J SYN ORG CHEM JPN, V40, P401, DOI 10.5059/yukigoseikyokaishi.40.401; Nozoye T, 2004, SOIL SCI PLANT NUTR, V50, P1125, DOI 10.1080/00380768.2004.10408585; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; SHOJIMA S, 1989, PLANT CELL PHYSIOL, V30, P673; Suzuki M, 2008, SOIL SCI PLANT NUTR, V54, P77, DOI 10.1111/j.1747-0765.2007.00205.x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Takagi S., 1976, SOIL SCI PLANT NUTR, V45, P993; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Takahashi M, 2009, PLANT SOIL, V325, P39, DOI 10.1007/s11104-009-0045-7; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064	44	298	314	4	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5446	5454		10.1074/jbc.M110.180026	http://dx.doi.org/10.1074/jbc.M110.180026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156806	Green Published, hybrid			2022-12-25	WOS:000287230600053
J	Beaulieu, AM; Rath, P; Imhof, M; Siddall, ME; Roberts, J; Schnappinger, D; Nathan, CF				Beaulieu, Aimee M.; Rath, Poonam; Imhof, Marianne; Siddall, Mark E.; Roberts, Julia; Schnappinger, Dirk; Nathan, Carl F.			Genome-Wide Screen for Mycobacterium tuberculosis Genes That Regulate Host Immunity	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; NECROSIS-FACTOR-ALPHA; T-CELL RESPONSES; CORD FACTOR; EXOGENOUS REINFECTION; NITRIC-OXIDE; GUINEA-PIGS; MCE1 OPERON; INFECTION; MICE	In spite of its highly immunogenic properties, Mycobacterium tuberculosis (Mtb) establishes persistent infection in otherwise healthy individuals, making it one of the most widespread and deadly human pathogens. Mtb's prolonged survival may reflect production of microbial factors that prevent even more vigorous immunity (quantitative effect) or that divert the immune response to a non-sterilizing mode (qualitative effect). Disruption of Mtb genes has produced a list of several dozen candidate immunomodulatory factors. Here we used robotic fluorescence microscopy to screen 10,100 loss-of-function transposon mutants of Mtb for their impact on the expression of promoter-reporter constructs for 12 host immune response genes in a mouse macrophage cell line. The screen identified 364 candidate immunoregulatory genes. To illustrate the utility of the candidate list, we confirmed the impact of 35 Mtb mutant strains on expression of endogenous immune response genes in primary macrophages. Detailed analysis focused on a strain of Mtb in which a transposon disrupts Rv0431, a gene encoding a conserved protein of unknown function. This mutant elicited much more macrophage TNF alpha, IL-12p40 and IL-6 in vitro than wild type Mtb, and was attenuated in the mouse. The mutant list provides a platform for exploring the immunobiology of tuberculosis, for example, by combining immunoregulatory mutations in a candidate vaccine strain.	[Beaulieu, Aimee M.; Rath, Poonam; Imhof, Marianne; Roberts, Julia; Schnappinger, Dirk; Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Siddall, Mark E.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Cornell University; American Museum of Natural History (AMNH)	Beaulieu, AM (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	cnathan@med.cornell.edu			Ellison Medical Foundation; NIH [T32 AI07621]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Senior Scholarship in Global Infectious Diseases Research from the Ellison Medical Foundation (CFN) and a T32 predoctoral NIH training, award T32 AI07621 (AMB). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; BEAULIEU AM, 2009, THESIS CORNELL U NEW; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Cheruvu M, 2007, TUBERCULOSIS, V87, P12, DOI 10.1016/j.tube.2006.01.021; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; D'Orazio M, 2001, BIOCHEM J, V359, P17, DOI 10.1042/0264-6021:3590017; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Dannenberg AM, 2001, TUBERCULOSIS, V81, P229, DOI 10.1054/tube.2001.0287; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guidry TV, 2007, MICROBIOL-SGM, V153, P3360, DOI 10.1099/mic.0.2007/010850-0; Guillemard E, 1998, J BIOL REG HOMEOS AG, V12, P106; Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; KUMAR D, CELL, V140, P731; LAZAREVIC V, 1992, J GEN MICROBIOL, V138, P1949, DOI 10.1099/00221287-138-9-1949; Malen H, 2008, SCAND J IMMUNOL, V67, P245, DOI 10.1111/j.1365-3083.2007.02064.x; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; TOBIN DM, CELL, V140, P717; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Uchida Y, 2007, CELL MICROBIOL, V9, P1275, DOI 10.1111/j.1462-5822.2006.00870.x; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; World Health Organization, 2007, TUB; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001	74	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15120	10.1371/journal.pone.0015120	http://dx.doi.org/10.1371/journal.pone.0015120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170273	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400016
J	Wang, CL; Lower, S; Thomas, VP; Williamson, VM				Wang, Congli; Lower, Steven; Thomas, Varghese P.; Williamson, Valerie M.			Root-Knot Nematodes Exhibit Strain-Specific Clumping Behavior That Is Inherited as a Simple Genetic Trait	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; MELOIDOGYNE-HAPLA; NATURAL VARIATION; SOCIAL-BEHAVIOR; CYANIDE; GENOME; SUPPRESSION; ATTRACTION; SEQUENCE	Root-knot nematodes are obligate parasites of a wide range of plant species and can feed only on the cytoplasm of living plant cells. In the absence of a suitable plant host, infective juveniles of strain VW9 of the Northern root-knot nematode, Meloidogyne hapla, when dispersed in Pluronic F-127 gel, aggregate into tight, spherical clumps containing thousands of worms. Aggregation or clumping behavior has been observed in diverse genera in the phylum Nematoda spanning free-living species such as Caenorhabditis elegans as well as both plant and animal parasites. Clumping behavior differs between strains of M. hapla and occurs with other species within this genus where strain-specific differences in clumping ability are also apparent. Exposure of M. hapla juveniles to a gradient formed using low levels of cyanide promotes formation of clumps at a preferred cyanide level. Analysis of F2 lines from a cross of M. hapla strains that differ in clump-forming behavior reveals that the behavior segregates as a single, major locus that can be positioned on the genetic map of this nematode. Clumping behavior may be a survival strategy whose importance and function depend on the niche of the nematode strain or species.	[Wang, Congli; Lower, Steven; Thomas, Varghese P.; Williamson, Valerie M.] Univ Calif Davis, Dept Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Wang, CL (corresponding author), Univ Calif Davis, Dept Nematol, Davis, CA 95616 USA.	vmwilliamson@ucdavis.edu			National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [566000756]; National Science Foundation Division of Environmental Biology [DEB-0120169]; National Science Foundation [IOB-07-44857]	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service (grant number 566000756), the National Science Foundation Division of Environmental Biology (grant number DEB-0120169), and the National Science Foundation award IOB-07-44857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Croll N.A., 1970, BEHAV NEMATODES THEI; CROWE JH, 1975, J EXP ZOOL, V193, P323, DOI 10.1002/jez.1401930308; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gheysen G, 1998, RECENT ADV PHYTOCHEM, V32, P95; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Liu QL, 2006, J NEMATOL, V38, P158; Liu QLL, 2007, GENETICS, V176, P1483, DOI 10.1534/genetics.107.071134; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Moens M, 2009, ANNU REV PHYTOPATHOL, V47, P313, DOI 10.1146/annurev-phyto-080508-081846; O'Leary SA, 2001, BIOCONTROL, V46, P345, DOI 10.1023/A:1011470021857; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; ROBERTS TM, 1977, J PARASITOL, V63, P357, DOI 10.2307/3280078; ROBINSON AF, 1994, J NEMATOL, V26, P46; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Siddiqui IA, 2006, WORLD J MICROB BIOT, V22, P641, DOI 10.1007/s11274-005-9084-2; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Wang CL, 2009, J CHEM ECOL, V35, P1242, DOI 10.1007/s10886-009-9703-8; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; Wharton David A., 2004, P371, DOI 10.1079/9780851998183.0371; Widmer TL, 2002, J NEMATOL, V34, P16; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	31	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15148	10.1371/journal.pone.0015148	http://dx.doi.org/10.1371/journal.pone.0015148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151553	Green Submitted, gold, Green Published			2022-12-25	WOS:000285135800016
J	Casutt-Meyer, S; Renzi, F; Schmaler, M; Jann, NJ; Amstutz, M; Cornelis, GR				Casutt-Meyer, Salome; Renzi, Francesco; Schmaler, Mathias; Jann, Naja J.; Amstutz, Marlise; Cornelis, Guy R.			Oligomeric Coiled-Coil Adhesin YadA Is a Double-Edged Sword	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NEUTROPHIL EXTRACELLULAR TRAPS; MEDIATES SPECIFIC BINDING; YERSINIA-ENTEROCOLITICA; COLLAGEN-BINDING; ENTEROPATHOGENIC YERSINIAE; TRANSCRIPTIONAL ACTIVATOR; HUMAN-GRANULOCYTES; ESCHERICHIA-COLI; INVASIN PROTEIN	Yersinia adhesin A (YadA) is an essential virulence factor for the food-borne pathogens Yersinia enterocolitica and Yersinia pseudotuberculosis. Suprisingly, it is a pseudogene in Yersinia pestis. Even more intriguing, the introduction of a functional yadA gene in Y. pestis EV76 was shown to correlate with a decrease in virulence in a mouse model. Here, we report that wild type (wt) Y. enterocolitica E40, as well as YadA-deprived E40 induced the synthesis of neutrophil extracellular traps (NETs) upon contact with neutrophils, but only YadA-expressing Y. enterocolitica adhered to NETs and were killed. As binding seemed to be a prerequisite for killing, we searched for YadA-binding substrates and detected the presence of collagen within NETs. E40 bacteria expressing V98D,N99A mutant YadA with a severely reduced ability to bind collagen were found to be more resistant to killing, suggesting that collagen binding contributes significantly to sensitivity to NETs. Wt Y. pestis EV76 were resistant to killing by NETs, while recombinant EV76 expressing YadA from either Y. pseudotuberculosis or Y. enterocolitica were sensitive to killing by NETs, outlining the importance of YadA for susceptibility to NET-dependent killing. Recombinant EV76 endowed with YadA from Y. enterocolitica were also less virulent for the mouse than wt EV76, as shown before. In addition, EV76 carrying wt YadA were less virulent for the mouse than EV76 expressing YadA(V98D,N99A). The observation that YadA makes Yersinia sensitive to NETs provides an explanation as for why evolution selected for the inactivation of yadA in the flea-borne Y. pestis and clarifies an old enigma. Since YadA imposes the same cost to the food-borne Yersinia but was nevertheless conserved by evolution, this observation also illustrates the duality of some virulence functions.	[Casutt-Meyer, Salome; Renzi, Francesco; Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland; [Schmaler, Mathias; Jann, Naja J.] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel; University of Basel	Casutt-Meyer, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	guy.cornelis@unibas.ch		Renzi, Francesco/0000-0001-6940-1177	Swiss National Science Foundation [3100A0-128659/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.snf.ch)(grant 3100A0-128659/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; BALLIGAND G, 1985, INFECT IMMUN, V48, P782, DOI 10.1128/IAI.48.3.782-786.1985; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BOLIN I, 1984, INFECT IMMUN, V43, P72; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994; CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; EMODY L, 1989, J BACTERIOL, V171, P6674; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Han YW, 1997, INFECT IMMUN, V65, P327, DOI 10.1128/IAI.65.1.327-330.1997; Heesemann J, 1987, Contrib Microbiol Immunol, V9, P312; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682; JEPSEN LV, 1982, SCAND J CLIN LAB INV, V42, P235; KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987; Koretke KK, 2006, J STRUCT BIOL, V155, P154, DOI 10.1016/j.jsb.2006.03.012; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; PEPE JC, 1990, J BACTERIOL, V172, P3780, DOI 10.1128/jb.172.7.3780-3789.1990; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; SCHULZEKOOPS H, 1992, INFECT IMMUN, V60, P2153, DOI 10.1128/IAI.60.6.2153-2159.1992; SCHULZEKOOPS H, 1993, INFECT IMMUN, V61, P2513, DOI 10.1128/IAI.61.6.2513-2519.1993; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; TAMM A, 1993, MOL MICROBIOL, V10, P995, DOI 10.1111/j.1365-2958.1993.tb00971.x; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Visser LG, 1996, INFECT IMMUN, V64, P1653, DOI 10.1128/IAI.64.5.1653-1658.1996; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Wong KW, 2005, CURR OPIN MICROBIOL, V8, P4, DOI 10.1016/j.mib.2004.12.009; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; YOUNG VB, 1990, MOL MICROBIOL, V4, P1119, DOI 10.1111/j.1365-2958.1990.tb00686.x	56	25	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15159	10.1371/journal.pone.0015159	http://dx.doi.org/10.1371/journal.pone.0015159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170337	Green Submitted, Green Published, gold			2022-12-25	WOS:000285084100024
J	Chen, ZJ; Chen, AY; Cheng, F; Qiu, JM				Chen, Zhaojun; Chen, Aaron Yun; Cheng, Fang; Qiu, Jianming			Chipmunk Parvovirus Is Distinct from Members in the Genus Erythrovirus of the Family Parvoviridae	PLOS ONE			English	Article							TRANSCRIPTION PROFILE; SIMIAN PARVOVIRUS; AUTONOMOUS PARVOVIRUS; UNIQUE FEATURES; MINUTE VIRUS; PROTEIN; IDENTIFICATION; APOPTOSIS; REVEALS; CELLS	The transcription profile of chipmunk parvovirus (ChpPV), a tentative member of the genus Erythrovirus in the subfamily Parvovirinae of the family Parvoviridae, was characterized by transfecting a nearly full-length genome. We found that it is unique from the profiles of human parvovirus B19 and simian parvovirus, the members in the genus Erythrovirus so far characterized, in that the small RNA transcripts were not processed for encoding small non-structural proteins. However, like the large non-structural protein NS1 of the human parvovirus B19, the ChpPV NS1 is a potent inducer of apoptosis. Further phylogenetic analysis of ChpPV with other parvoviruses in the subfamily Parvovirinae indicates that ChpPV is distinct from the members in genus Erythrovirus. Thus, we conclude that ChpPV may represent a new genus in the family Parvoviridae.	[Chen, Zhaojun] Hangzhou Normal Univ, Dept Clin Lab, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhaojun; Chen, Aaron Yun; Cheng, Fang; Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	Hangzhou Normal University; University of Kansas; University of Kansas Medical Center	Chen, ZJ (corresponding author), Hangzhou Normal Univ, Dept Clin Lab, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China.	jqiu@kumc.edu			National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI070723]; National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE) [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070723] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant RO1 AI070723 from National Institute of Allergy and Infectious Diseases (NIAID) and grant P20 RR016443 from the National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; BEARD C, 1989, VIROLOGY, V172, P659, DOI 10.1016/0042-6822(89)90211-0; BRANDENBURGER A, 1990, VIROLOGY, V174, P576, DOI 10.1016/0042-6822(90)90110-D; BROWN KE, 1995, VIROLOGY, V210, P314, DOI 10.1006/viro.1995.1348; Brown KE., 2005, PARVOVIRUSES, P25; Chen AY, 2010, J VIROL, V84, P5615, DOI 10.1128/JVI.02094-09; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Chen ZJ, 2009, VIROLOGY, V394, P276, DOI 10.1016/j.virol.2009.08.044; COTMORE SF, 1983, VIROLOGY, V129, P333, DOI 10.1016/0042-6822(83)90172-1; Cotmore SF, 2005, PARVOVIRUSES, P73; Cotmore SF, 2005, PARVOVIRUSES, P171; Di Piazza M, 2007, J VIROL, V81, P4186, DOI 10.1128/JVI.02601-06; FAUQUET CM, 2004, VIRUS TAXONOMY 8 REP; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Liu ZW, 2004, J VIROL, V78, P12929, DOI 10.1128/JVI.78.23.12929-12939.2004; LUO WX, 1993, VIROLOGY, V195, P448, DOI 10.1006/viro.1993.1395; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; OZAWA K, 1987, J VIROL, V61, P2395, DOI 10.1128/JVI.61.8.2395-2406.1987; PINTEL D, 1983, NUCLEIC ACIDS RES, V11, P1019, DOI 10.1093/nar/11.4.1019; Qiu JM, 2006, J VIROL, V80, P654, DOI 10.1128/JVI.80.2.654-662.2006; Qiu JM, 2000, VIROLOGY, V269, P137, DOI 10.1006/viro.2000.0205; Qiu JM, 2002, MOL CELL BIOL, V22, P3639, DOI 10.1128/MCB.22.11.3639-3652.2002; Qiu JM, 2002, J VIROL, V76, P12435, DOI 10.1128/JVI.76.24.12435-12447.2002; Rayet B, 1998, J VIROL, V72, P8893, DOI 10.1128/JVI.72.11.8893-8903.1998; SCHOBORG RV, 1991, VIROLOGY, V181, P22, DOI 10.1016/0042-6822(91)90466-O; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; ST AJ, 1991, VIROLOGY, V183, P133; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Vashisht K, 2004, J VIROL, V78, P10911, DOI 10.1128/JVI.78.20.10911-10919.2004; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518; Yoto Y, 2006, J VIROL, V80, P1604, DOI 10.1128/JVI.80.3.1604-1609.2006	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15113	10.1371/journal.pone.0015113	http://dx.doi.org/10.1371/journal.pone.0015113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151930	Green Published, gold			2022-12-25	WOS:000284939600027
J	Herzberg-Schafer, SA; Staiger, H; Heni, M; Ketterer, C; Guthoff, M; Kantartzis, K; Machicao, F; Stefan, N; Haring, HU; Fritsche, A				Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas			Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired beta-Cell Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SECRETION; POLYMORPHISMS; SENSITIVITY; VARIANTS; RISK; RESISTANCE; GLYCEMIA; CDKAL1; GENES	Background: To date, fasting state-and different oral glucose tolerance test (OGTT)-derived measures are used to estimate insulin release with reasonable effort in large human cohorts required, e.g., for genetic studies. Here, we evaluated twelve common (or recently introduced) fasting state-/OGTT-derived indices for their suitability to detect genetically determined beta-cell dysfunction. Methodology/Principal Findings: A cohort of 1364 White European individuals at increased risk for type 2 diabetes was characterized by OGTT with glucose, insulin, and C-peptide measurements and genotyped for single nucleotide polymorphisms (SNPs) known to affect glucose-and incretin-stimulated insulin secretion. One fasting state-and eleven OGTT-derived indices were calculated and statistically evaluated. After adjustment for confounding variables, all tested SNPs were significantly associated with at least two insulin secretion measures (p <= 0.05). The indices were ranked according to their associations' statistical power, and the ranks an index obtained for its associations with all the tested SNPs (or a subset) were summed up resulting in a final ranking. This approach revealed area under the curve (AUC)(Insulin(0-30))/AUC(Glucose(0-30)) as the best-ranked index to detect SNP-dependent differences in insulin release. Moreover, AUC(Insulin(0-30))/AUC(Glucose(0-30)), corrected insulin response (CIR), AUC(C-Peptide(0-30))/AUC(Glucose(0-30)), AUC(C-Peptide(0-120))/AUC(Glucose(0-120)), two different formulas for the incremental insulin response from 0-30 min, i.e., the insulinogenic indices (IGI)(2) and IGI(1), and insulin 30 min were significantly higher-ranked than homeostasis model assessment of beta-cell function (HOMA-B; p<0.05). AUC(C-Peptide(0-120))/AUC(Glucose(0-120)) was best-ranked for the detection of SNPs involved in incretin-stimulated insulin secretion. In all analyses, HOMA-beta displayed the highest rank sums and, thus, scored last. Conclusions/Significance: With AUC(Insulin(0-30))/AUC(Glucose(0-30)), CIR, AUC(C-Peptide(0-30))/AUC(Glucose(0-30)), AUCC-(Peptide(0-120))/AUC(Glucose(0-120)), IGI(2), IGI(1), and insulin 30 min, dynamic measures of insulin secretion based on early insulin and C-peptide responses to oral glucose represent measures which are more appropriate to assess genetically determined beta-cell dysfunction than fasting measures, i.e., HOMA-B. Genes predominantly influencing the incretin axis may possibly be best detected by AUC(C-Peptide(0-120))/AUC(Glucose(0-120)).	[Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Herzberg-Schaefer, Silke A.; Staiger, Harald; Heni, Martin; Ketterer, Caroline; Guthoff, Martina; Kantartzis, Konstantinos; Machicao, Fausto; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Herzberg-Schafer, SA (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; Guthoff, Martina/D-3960-2018; Kantartzis, Konstantinos/AAC-3999-2019	Guthoff, Martina/0000-0002-4294-980X; Staiger, Harald/0000-0002-9507-5333; Heni, Martin/0000-0002-8462-3832; Kantartzis, Konstantinos/0000-0002-0584-1138; Stefan, Norbert/0000-0002-2186-9595	German Research Foundation [Fr 1561/5-1, STE 1096/1-1]; Merck Sharp Dohme; German Federal Ministry of Education and Research (BMBF)	German Research Foundation(German Research Foundation (DFG)); Merck Sharp Dohme(Merck & Company); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported in part by grants from the German Research Foundation (Fr 1561/5-1 and Heisenberg-Grant STE 1096/1-1) and Merck Sharp & Dohme, as well as by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schafer SA, 2009, DIABETOLOGIA, V52, P1075, DOI 10.1007/s00125-009-1344-5; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wareham N J, 1995, Diabet Med, V12, P931	23	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14194	10.1371/journal.pone.0014194	http://dx.doi.org/10.1371/journal.pone.0014194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152029	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000010
J	Qiu, N; Cao, L; David, V; Quarles, LD; Xiao, ZS				Qiu, Ni; Cao, Li; David, Valentin; Quarles, L. Darryl; Xiao, Zhousheng			Kif3a Deficiency Reverses the Skeletal Abnormalities in Pkd1 Deficient Mice by Restoring the Balance Between Osteogenesis and Adipogenesis	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; INTRAFLAGELLAR TRANSPORT PROTEINS; PLURIPOTENT MESENCHYMAL CELLS; KINESIN SUPERFAMILY PROTEIN; CATION CHANNEL FUNCTION; MARROW STROMAL CELLS; PRIMARY CILIA; ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; MICROTUBULAR STRUCTURES	Pkd1 localizes to primary cilia in osteoblasts and osteocytes. Targeted deletion of Pkd1 in osteoblasts results in osteopenia and abnormalities in Runx2-mediated osteoblast development. Kif3a, an intraflagellar transport protein required for cilia function, is also expressed in osteoblasts. To assess the relationship between Pkd1 and primary cilia function on bone development, we crossed heterozygous Pkd1- and Kif3a-deficient mice to create compound Pkd1 and Kif3a-deficient mice. Pkd1 haploinsufficiency (Pkd1(+/Delta)) resulted in osteopenia, characterized by decreased bone mineral density, trabecular bone volume, and cortical thickness. In addition, deficiency of Pkd1 resulted in impaired osteoblastic differentiation and enhanced adipogenesis in both primary osteoblasts and/or bone marrow stromal cell cultures. These changes were associated with decreased Runx2 expression, increased PPAR gamma expression, and impaired hedgehog signaling as evidenced by decreased Gli2 expression in bone and osteoblast cultures. In contrast, heterozygous Kif3a(+/Delta) mice display no abnormalities in skeletal development or osteoblast function, but exhibited decreased adipogenic markers in bone and impaired adipogenesis in vitro in association with decreased PPAR gamma expression and upregulation of Gli2. Superimposed Kif3a deficiency onto Pkd1(+/Delta) mice paradoxically corrected the effects of Pkd1 deficiency on bone mass, osteoblastic differentiation, and adipogenesis. In addition, Runx2, PPAR gamma and Gli2 expression in bone and osteoblasts were normalized in compound double Pkd1(+/Delta) and Kif3a(+/Delta) heterozygous mice. The administration of sonic hedgehog, overexpression of Gli2, and the PC1 C-tail construct all increased Gli2 and Runx2-II expression, but decreased PPAR gamma 2 gene expression in C3H10T1/2 cells. Our findings suggest a role for Pkd1 and Kif3a to counterbalance the regulation of osteogenesis and adipogenesis through differential regulation of Runx2 and PPAR gamma by Gli2.	[Qiu, Ni] Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Qiu, Ni; Cao, Li; David, Valentin; Quarles, L. Darryl; Xiao, Zhousheng] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Nephrol, Memphis, TN 38163 USA	Central South University; University of Tennessee System; University of Tennessee Health Science Center	Qiu, N (corresponding author), Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.	dquarles@uthsc.edu; zxiao2@uthsc.edu		xiao, zhousheng/0000-0002-3363-5673; Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health, NIAMS [R21-AR056794]; National Institutes of Health, NIDDK [P50-DK057301, RO1-DK083303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303, P50DK057301] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grant R21-AR056794 (NIAMS), P50-DK057301 (NIDDK), and RO1-DK083303 (NIDDK) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hasegawa T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-71; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Housset C, 2005, GASTROEN CLIN BIOL, V29, P861, DOI 10.1016/S0399-8320(05)86361-4; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hunter AW, 2000, J CELL SCI, V113, P4379; JAMES AW, 2010, TISSUE ENG A; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kolpakova-Hart E, 2008, MATRIX BIOL, V27, P505, DOI 10.1016/j.matbio.2008.05.002; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kudo M, 2004, ENDOCRINOLOGY, V145, P4948, DOI 10.1210/en.2004-0180; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liao GJ, 1999, FASEB J, V13, pS257, DOI 10.1096/fasebj.13.9002.S257; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mie M, 2000, TISSUE ENG, V6, P9, DOI 10.1089/107632700320847; Montalbetti N, 2007, J PHYSIOL-LONDON, V579, P717, DOI 10.1113/jphysiol.2006.125583; Mundy GR, 2008, DEV CELL, V14, P637, DOI 10.1016/j.devcel.2008.04.010; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Okitsu Y, 2007, BIOCHEM BIOPH RES CO, V364, P383, DOI 10.1016/j.bbrc.2007.10.031; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Steenhuis P, 2009, CELLS TISSUES ORGANS, V190, P150, DOI 10.1159/000187633; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tu QS, 2003, J CLIN INVEST, V111, P1029, DOI 10.1172/JCI200317054; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; XIAO Z, J BIOL CHEM, V285, P1177; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	79	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15240	10.1371/journal.pone.0015240	http://dx.doi.org/10.1371/journal.pone.0015240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151991	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000032
J	Saxer, G; Doebeli, M; Travisano, M				Saxer, Gerda; Doebeli, Michael; Travisano, Michael			The Repeatability of Adaptive Radiation During Long-Term Experimental Evolution of Escherichia coli in a Multiple Nutrient Environment	PLOS ONE			English	Article							SYMPATRIC SPECIATION; BACTERIAL MICROCOSMS; ADAPTATION; SELECTION; DIVERSIFICATION; POPULATIONS; DIVERGENCE; DIVERSITY; CONTINGENCY; GENERATIONS	Adaptive radiations occur when a species diversifies into different ecological specialists due to competition for resources and trade-offs associated with the specialization. The evolutionary outcome of an instance of adaptive radiation cannot generally be predicted because chance (stochastic events) and necessity (deterministic events) contribute to the evolution of diversity. With increasing contributions of chance, the degree of parallelism among different instances of adaptive radiations and the predictability of an outcome will decrease. To assess the relative contributions of chance and necessity during adaptive radiation, we performed a selection experiment by evolving twelve independent microcosms of Escherichia coli for 1000 generations in an environment that contained two distinct resources. Specialization to either of these resources involves strong trade-offs in the ability to use the other resource. After selection, we measured three phenotypic traits: 1) fitness, 2) mean colony size, and 3) colony size diversity. We used fitness relative to the ancestor as a measure of adaptation to the selective environment; changes in colony size as a measure of the evolution of new resource specialists because colony size has been shown to correlate with resource specialization; and colony size diversity as a measure of the evolved ecological diversity. Resource competition led to the rapid evolution of phenotypic diversity within microcosms. Measurements of fitness, colony size, and colony size diversity within and among microcosms showed that the repeatability of adaptive radiation was high, despite the evolution of genetic variation within microcosms. Consistent with the observation of parallel evolution, we show that the relative contributions of chance are far smaller and less important than effects due to adaptation for the traits investigated. The two-resource environment imposed similar selection pressures in independent populations and promoted parallel phenotypic adaptive radiations in all independently evolved microcosms.	[Saxer, Gerda; Travisano, Michael] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Saxer, Gerda; Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Saxer, Gerda] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Doebeli, Michael] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Houston System; University of Houston; University of British Columbia; Rice University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Saxer, G (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	gsaxer@rice.edu	Doebeli, Michael/D-5391-2012; Travisano, Michael/AAI-4809-2020	Travisano, Michael/0000-0001-8168-0842	Swiss National Science Foundation (SNSF); National Science Foundation (NSF); University of British Columbia	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Science Foundation (NSF)(National Science Foundation (NSF)); University of British Columbia	The authors were funded by the Swiss National Science Foundation (SNSF), National Science Foundation (NSF), and University of British Columbia through a Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Burch CL, 1999, GENETICS, V151, P921; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; DYKHUIZEN DE, 1983, MICROBIOL REV, V47, P150, DOI 10.1128/MMBR.47.2.150-168.1983; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; HARTL DL, 1985, GENETICS, V111, P655; HELLING RB, 1987, GENETICS, V116, P349; Hendry AP, 2002, EVOLUTION, V56, P1199; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110; Monod J., 1971, CHANCE NECESSITY; Orr HA, 2001, EVOLUTION, V55, P1085; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Saxer G, 2009, P R SOC B, V276, P2065, DOI 10.1098/rspb.2008.1827; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sokal RR, 1995, BIOMETRY; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Spencer CC, 2007, EVOL ECOL RES, V9, P775; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 1997, GENETICS, V146, P471; TRAVISANO M, 1995, EVOLUTION, V49, P189, DOI 10.2307/2410304; Travisano M, 1996, GENETICS, V143, P15; Travisano M., 2009, EXPT EVOLUTION CONCE; Tyerman J, 2005, P ROY SOC B-BIOL SCI, V272, P1393, DOI 10.1098/rspb.2005.3068; Tyerman JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-34; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Wahl LM, 2000, GENETICS, V156, P1437; WRIGHT S, 1988, AM NAT, V131, P115, DOI 10.1086/284777	53	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14184	10.1371/journal.pone.0014184	http://dx.doi.org/10.1371/journal.pone.0014184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152028	Green Published, Green Submitted, gold			2022-12-25	WOS:000284868000008
J	Li, QY; Eklund, AC; Juul, N; Haibe-Kains, B; Workman, CT; Richardson, AL; Szallasi, Z; Swanton, C				Li, Qiyuan; Eklund, Aron C.; Juul, Nicolai; Haibe-Kains, Benjamin; Workman, Christopher T.; Richardson, Andrea L.; Szallasi, Zoltan; Swanton, Charles			Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status	PLOS ONE			English	Article							PRIMARY BREAST-CANCER; ESTROGEN-RECEPTOR STATUS; HISTOLOGIC GRADE; RECURRENCE; PREDICT; CHEMOTHERAPY; RESISTANCE; PATTERNS; SUBTYPES; THERAPY	Background: Expression of the oestrogen receptor (ER) in breast cancer predicts benefit from endocrine therapy. Minimising the frequency of false negative ER status classification is essential to identify all patients with ER positive breast cancers who should be offered endocrine therapies in order to improve clinical outcome. In routine oncological practice ER status is determined by semi-quantitative methods such as immunohistochemistry (IHC) or other immunoassays in which the ER expression level is compared to an empirical threshold[1,2]. The clinical relevance of gene expression-based ER subtypes as compared to IHC-based determination has not been systematically evaluated. Here we attempt to reduce the frequency of false negative ER status classification using two gene expression approaches and compare these methods to IHC based ER status in terms of predictive and prognostic concordance with clinical outcome. Methodology/Principal Findings: Firstly, ER status was discriminated by fitting the bimodal expression of ESR1 to a mixed Gaussian model. The discriminative power of ESR1 suggested bimodal expression as an efficient way to stratify breast cancer; therefore we identified a set of genes whose expression was both strongly bimodal, mimicking ESR expression status, and highly expressed in breast epithelial cell lines, to derive a 23-gene ER expression signature-based classifier. We assessed our classifiers in seven published breast cancer cohorts by comparing the gene expression-based ER status to IHC-based ER status as a predictor of clinical outcome in both untreated and tamoxifen treated cohorts. In untreated breast cancer cohorts, the 23 gene signature-based ER status provided significantly improved prognostic power compared to IHCbased ER status (P = 0.006). In tamoxifen-treated cohorts, the 23 gene ER expression signature predicted clinical outcome (HR = 2.20, P = 0.00035). These complementary ER signature-based strategies estimated that between 15.1% and 21.8% patients of IHC-based negative ER status would be classified with ER positive breast cancer. Conclusion/Significance: Expression-based ER status classification may complement IHC to minimise false negative ER status classification and optimise patient stratification for endocrine therapies.	[Li, Qiyuan; Eklund, Aron C.; Juul, Nicolai; Workman, Christopher T.; Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Haibe-Kains, Benjamin] Harvard Univ, Ctr Canc Computat Biol, Dana Farber Canc Inst, Computat Biol & Funct Genom Lab,Sch Publ Hlth, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Szallasi, Zoltan] Harvard Univ, Childrens Hosp, Harvard MIT Div Hlth Sci & Technol CHIP HST, Informat Program,Sch Med, Boston, MA 02115 USA; [Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London, England; [Swanton, Charles] Royal Marsden Hosp, Breast Unit, Sutton, Surrey, England; [Swanton, Charles] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England	Technical University of Denmark; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Cancer Research UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Li, QY (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	zszallasi@chip.org; Charles.swanton@cancer.org.uk	Workman, Christopher T/K-1066-2015; Haibe-Kains, Benjamin/D-3702-2011	Workman, Christopher T/0000-0002-2210-3743; Haibe-Kains, Benjamin/0000-0002-7684-0079; Birkbak, Nicolai/0000-0003-1613-9587; Szallasi, Zoltan/0000-0001-5395-7509; Eklund, Aron Charles/0000-0003-0861-1001; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK; Medical Research Council; Inflammatory Breast Cancer UK; Danish Council for Independent Research, Medical Sciences (FSS); National Institute of Health [NCI SPORE P50 CA 89393, R21LM008823-01A1, 1R03LM009979-01]; Breast Cancer Research Foundation (BCRF); BioSim (NoE) [LSHB-CT-2004-005137]; MRC [G0701935] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM008823, R03LM009979] Funding Source: NIH RePORTER; Medical Research Council [G0701935] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Inflammatory Breast Cancer UK; Danish Council for Independent Research, Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation (BCRF); BioSim (NoE); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CS is a senior Medical Research Council clinical research fellow and is funded by Cancer Research UK, the Medical Research Council and Inflammatory Breast Cancer UK. ZS and ACE are funded by the Danish Council for Independent Research, Medical Sciences (FSS), the National Institute of Health (grants NCI SPORE P50 CA 89393, R21LM008823-01A1, 1R03LM009979-01) and by the Breast Cancer Research Foundation (BCRF). QL is funded by BioSim (NoE), FP6, LSHB-CT-2004-005137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Allred DC, 2008, ONCOLOGIST, V13, P1134, DOI 10.1634/theoncologist.2008-0184; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; BARNES DMM, 1998, EUROPEAN J CANC, V34; Bessarabova M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S8; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Eklund AC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1116; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gruvberger S, 2001, CANCER RES, V61, P5979; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hilsenbeck SG, 1998, BREAST CANCER RES TR, V52, P227, DOI 10.1023/A:1006133418245; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PODHAJCER OL, 1986, CANCER, V58, P720, DOI 10.1002/1097-0142(19860801)58:3<720::AID-CNCR2820580320>3.0.CO;2-S; POPOVICI V, 2009, NATURE BIOTECHNOL; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Ross JS, 2007, CLIN CANCER RES, V13, P2831, DOI 10.1158/1078-0432.CCR-06-2522; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wang J, 2009, CANCER INFORM, V7, P199; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WEIGELT B, LANCET ONCOL; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; 2001, COCHRANE DATABASE SY	38	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15031	10.1371/journal.pone.0015031	http://dx.doi.org/10.1371/journal.pone.0015031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152022	Green Published, gold, Green Submitted			2022-12-25	WOS:000284821300013
J	Bonde, MM; Hansen, JT; Sanni, SJ; Haunso, S; Gammeltoft, S; Lyngso, C; Hansen, JL				Bonde, Marie Mi; Hansen, Jonas Tind; Sanni, Samra Joke; Haunso, Stig; Gammeltoft, Steen; Lyngso, Christina; Hansen, Jakob Lerche			Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 7TH TRANSMEMBRANE DOMAIN; BETA-ARRESTIN; STRUCTURAL DETERMINANTS; MOLECULAR DETERMINANTS; FUNCTIONAL SELECTIVITY; REGULATED KINASE-1; ACTIVATION SWITCH; CRYSTAL-STRUCTURE; AT(1A) RECEPTOR	Background: Seven transmembrane receptors (7TMRs) can adopt different active conformations facilitating a selective activation of either G protein or beta-arrestin-dependent signaling pathways. This represents an opportunity for development of novel therapeutics targeting selective biological effects of a given receptor. Several studies on pathway separation have been performed, many of these on the Angiotensin II type 1 receptor (AT1R). It has been shown that certain ligands or mutations facilitate internalization and/or recruitment of beta-arrestins without activation of G proteins. However, the underlying molecular mechanisms remain largely unresolved. For instance, it is unclear whether such selective G protein-uncoupling is caused by a lack of ability to interact with G proteins or rather by an increased ability of the receptor to recruit beta-arrestins. Since uncoupling of G proteins by increased ability to recruit beta-arrestins could lead to different cellular or in vivo outcomes than lack of ability to interact with G proteins, it is essential to distinguish between these two mechanisms. Methodology/Principal Findings: We studied five AT1R mutants previously published to display pathway separation: D74N, DRY/AAY, Y292F, N298A, and Y302F (Ballesteros-Weinstein numbering: 2.50, 3.49-3.51, 7.43, 7.49, and 7.53). We find that D74N, DRY/AAY, and N298A mutants are more prone to beta-arrestin recruitment than WT. In contrast, receptor mutants Y292F and Y302F showed impaired ability to recruit beta-arrestin in response to Sar(1)-Ile(4)-Ile(8) (SII) Ang II, a ligand solely activating the beta-arrestin pathway. Conclusions/Significance: Our analysis reveals that the underlying conformations induced by these AT1R mutants most likely represent principally different mechanisms of uncoupling the G protein, which for some mutants may be due to their increased ability to recruit beta-arrestin2. Hereby, these findings have important implications for drug discovery and 7TMR biology and illustrate the necessity of uncovering the exact molecular determinants for G protein-coupling and beta-arrestin recruitment, respectively.	[Bonde, Marie Mi; Haunso, Stig; Hansen, Jakob Lerche] Copenhagen Univ Hosp, Rigshosp, Ctr Heart,Lab Mol Cardiol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Bonde, Marie Mi; Hansen, Jonas Tind; Lyngso, Christina; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Biomed Sci, Copenhagen, Denmark; [Hansen, Jonas Tind; Sanni, Samra Joke; Gammeltoft, Steen; Lyngso, Christina] Glostrup Cty Hosp, Dept Clin Biochem, Glostrup, Denmark	Danmarks Grundforskningsfond; Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen	Bonde, MM (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Heart,Lab Mol Cardiol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	JLHH@novonordisk.com		Sanni, Samra/0000-0002-9708-5674	Danish Heart Foundation; Danish National Research Foundation; Faculty of Health Sciences, University of Copenhagen; Aase og Ejnar Danielsens Foundation; Novo Nordisk Foundation; Augustinus Foundation	Danish Heart Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Faculty of Health Sciences, University of Copenhagen; Aase og Ejnar Danielsens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation	This work was supported by The Danish Heart Foundation: www.hjerteforeningen.dk/forskning; The Danish National Research Foundation: www.dg.dk; The Koebmand i Odense Johan og Hanne Weimann f. Seedorffs legat: applied for through the Faculty of Health Sciences, University of Copenhagen, www.sund.ku.dk; Aase og Ejnar Danielsens Foundation: http://www.danielsensfond.dk/home; The Novo Nordisk Foundation: www.novonordiskfonden.dk; and The Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Aplin M, 2008, TRENDS CARDIOVAS MED, V18, P305, DOI 10.1016/j.tcm.2009.01.003; Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Conchon S, 1998, AM J PHYSIOL-ENDOC M, V274, pE336, DOI 10.1152/ajpendo.1998.274.2.E336; Feng YH, 2005, HYPERTENSION, V46, P419, DOI 10.1161/01.HYP.0000172621.68061.22; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Gripentrog JM, 2000, BIOCHEM J, V352, P399, DOI 10.1042/0264-6021:3520399; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hines J, 2003, BIOCHEM PHARMACOL, V66, P251, DOI 10.1016/S0006-2952(03)00257-0; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MARIE J, 1994, J BIOL CHEM, V269, P20815; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nikiforovich GV, 2006, CHEM BIOL DRUG DES, V68, P239, DOI 10.1111/j.1747-0285.2006.00444.x; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sanni SJ, 2010, BRIT J PHARMACOL, V161, P150, DOI 10.1111/j.1476-5381.2010.00875.x; SANNI SJ, BR J PHARM, V161, P150; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shibata T, 1996, BIOCHEM BIOPH RES CO, V218, P383, DOI 10.1006/bbrc.1996.0067; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; URBAN JD, 2006, J PHARM EXP THER; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Weir MR, 2007, CLIN THER, V29, P1803, DOI 10.1016/j.clinthera.2007.09.019; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yee DK, 2006, MOL ENDOCRINOL, V20, P1924, DOI 10.1210/me.2006-0018; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; ZHOU W, 1994, MOL PHARMACOL, V45, P165	61	25	26	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14135	10.1371/journal.pone.0014135	http://dx.doi.org/10.1371/journal.pone.0014135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152433	Green Submitted, gold, Green Published			2022-12-25	WOS:000284755100016
J	Krosby, M; Rohwer, S				Krosby, Meade; Rohwer, Sievert			Ongoing Movement of the Hermit Warbler X Townsend's Warbler Hybrid Zone	PLOS ONE			English	Article							ASYMMETRIES; CLIMATE	Background: Movements of hybrid zones - areas of overlap and interbreeding between species - are difficult to document empirically. This is true because moving hybrid zones are expected to be rare, and because movement may proceed too slowly to be measured directly. Townsend's warblers (Dendroica townsendi) hybridize with hermit warblers (D. occidentalis) where their ranges overlap in Washington and Oregon. Previous morphological, behavioral, and genetic studies of this hybrid zone suggest that it has been steadily moving into the geographical range of hermit warblers, with the more aggressive Townsend's warblers replacing hermit warblers along,2000 km of the Pacific coast of Canada and Alaska. Ongoing movement of the zone, however, has yet to be empirically demonstrated. Methodology/Principal Findings: We compared recently sampled hybrid zone specimens to those collected 10-20 years earlier, to test directly the long-standing hypothesis of hybrid zone movement between these species. Newly sampled specimens were more Townsend's-like than historical specimens, consistent with ongoing movement of the zone into the geographical range of hermit warblers. Conclusions/Significance: While movement of a hybrid zone may be explained by several possible mechanisms, in this case a wealth of existing evidence suggests that movement is being driven by the competitive displacement of hermit warblers by Townsend's warblers. That no ecological differences have been found between these species, and that replacement of hermit warblers by Townsend's warblers is proceeding downward in latitude and elevation - opposite the directions of range shifts predicted by recent climate change - further support that this movement is not being driven by alternative environmental factors. If the mechanism of competitive displacement is correct, whether this process will ultimately lead to the extinction of hermit warblers will depend on the continued maintenance of the dramatic competitive asymmetry observed between the species.	[Krosby, Meade] Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Burke Museum, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krosby, M (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	mkrosby@u.washington.edu		Krosby, Meade/0000-0001-6235-7839	National Science Foundation; Achievement Rewards for College Scientists Foundation; Burke Museum Eddy Fellowship; Kathryn Hahn Writing Fellowship; Burke Museum's Endowment for Ornithology	National Science Foundation(National Science Foundation (NSF)); Achievement Rewards for College Scientists Foundation(General Electric); Burke Museum Eddy Fellowship; Kathryn Hahn Writing Fellowship; Burke Museum's Endowment for Ornithology	M.K. was supported by a National Science Foundation Graduate Research Fellowship (http://www.nsf.gove/grfp), an Achievement Rewards for College Scientists Foundation Fellowship (http://www.arcsfoundation.org/Seattle), a Burke Museum Eddy Fellowship, and a Kathryn Hahn Writing Fellowship (http://www.biology.washington.edu/Graduate/Scholarships). Specimen collection was funded by the late Garrett Eddy and by the Burke Museum's Endowment for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Harrison RG, 1993, HYBRID ZONES EVOLUTI; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Owen-Ashley NT, 2004, P ROY SOC B-BIOL SCI, V271, pS498, DOI 10.1098/rsbl.2004.0230; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson SF, 2000, BEHAV ECOL, V11, P93, DOI 10.1093/beheco/11.1.93; Pearson SF, 2000, AUK, V117, P175, DOI 10.1642/0004-8038(2000)117[0175:IONOAT]2.0.CO;2; Pearson SF, 2000, BEHAV ECOL, V11, P84, DOI 10.1093/beheco/11.1.84; Rohwer S, 1998, AUK, V115, P284, DOI 10.2307/4089188; Rohwer S, 2001, EVOLUTION, V55, P405; Rohwer S, 2007, AUK, V124, P1347, DOI 10.1642/0004-8038(2007)124[1347:TSCAGF]2.0.CO;2; Walls SC, 2009, GLOBAL CHANGE BIOL, V15, P1903, DOI 10.1111/j.1365-2486.2009.01867.x	14	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14164	10.1371/journal.pone.0014164	http://dx.doi.org/10.1371/journal.pone.0014164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152406	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100041
J	van Schaijk, BCL; Vos, MW; Janse, CJ; Sauerwein, RW; Khan, SM				van Schaijk, Ben C. L.; Vos, Martijn W.; Janse, Chris J.; Sauerwein, Robert W.; Khan, Shahid M.			Removal of Heterologous Sequences from Plasmodium falciparum Mutants Using FLPe-Recombinase	PLOS ONE			English	Article							TARGETED GENE DELETION; CONDITIONAL MUTAGENESIS; NEGATIVE SELECTION; MALARIA PARASITES; GENOME SEQUENCE; TRANSFORMATION; GAMETOCYTES; RESISTANCE; YEAST	Genetically-modified mutants are now indispensable Plasmodium gene-function reagents, which are also being pursued as genetically attenuated parasite vaccines. Currently, the generation of transgenic malaria-parasites requires the use of drug-resistance markers. Here we present the development of an FRT/FLP-recombinase system that enables the generation of transgenic parasites free of resistance genes. We demonstrate in the human malaria parasite, P. falciparum, the complete and efficient removal of the introduced resistance gene. We targeted two neighbouring genes, p52 and p36, using a construct that has a selectable marker cassette flanked by FRT-sequences. This permitted the subsequent removal of the selectable marker cassette by transient transfection of a plasmid that expressed a 37 degrees C thermostable and enhanced FLP-recombinase. This method of removing heterologous DNA sequences from the genome opens up new possibilities in Plasmodium research to sequentially target multiple genes and for using genetically-modified parasites as live, attenuated malaria vaccines.	[van Schaijk, Ben C. L.; Vos, Martijn W.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Leiden Malaria Res Grp, Dept Parasitol, Ctr Infect Dis,Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Schaijk, BCL (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	B.VanSchaijk@mmb.umcn.nl; s.m.khan@lumc.nl	Sauerwein, Robert/C-8519-2013	Khan, Shahid/0000-0002-0533-4670; Janse, Chris J/0000-0002-6410-6205	Top Institute Pharma (Netherlands) [T4-102]; European Community [242095]	Top Institute Pharma (Netherlands)(Netherlands Government); European Community(European Commission)	This study was performed within the framework of Top Institute Pharma (Netherlands) project: T4-102. Chris J. Janse received financial support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N<SUP>o</SUP> 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2010, CELL MICROBIOL, V12, P930, DOI 10.1111/j.1462-5822.2010.01441.x; ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carvalho TG, 2005, CURR ISSUES MOL BIOL, V7, P39, DOI 10.21775/cimb.007.039; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frey J, 2007, VACCINE, V25, P5598, DOI 10.1016/j.vaccine.2006.11.058; Gardiner DL, 2005, MOL BIOCHEM PARASIT, V140, P153, DOI 10.1016/j.molbiopara.2004.12.010; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; O'Neill MT, 2010, INT J PARASITOL; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Sambrook J, 2001, MOL CLONING LAB MANU; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; THAITHONG S, 1981, T ROY SOC TROP MED H, V75, P271, DOI 10.1016/0035-9203(81)90333-3; Thaithong S., 1985, APPL GENETIC ENG RES, P379; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	37	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15121	10.1371/journal.pone.0015121	http://dx.doi.org/10.1371/journal.pone.0015121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152048	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100080
J	Hou, H; Wang, FS; Zhang, WC; Wang, DM; Li, XM; Bartlam, M; Yao, XB; Rao, ZH				Hou, Hai; Wang, Fengsong; Zhang, Wenchi; Wang, Dongmei; Li, Xuemei; Bartlam, Mark; Yao, Xuebiao; Rao, Zihe			Structure-Functional Analyses of CRHSP-24 Plasticity and Dynamics in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; RNA-BINDING PROTEIN; MESSENGER-RNA; DNA-BINDING; PHYSIOLOGICAL SUBSTRATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; RAT-BRAIN; GRANULES	The cold shock domain (CSD) is an evolutionarily conserved nucleic acid binding domain that exhibits binding activity to RNA, ssDNA, and dsDNA. Mammalian CRHSP-24 contains CSD, but its structure-functional relationship has remained elusive. Here we report the crystal structure of human CRHSP-24 and characterization of the molecular trafficking of CRHSP-24 between stress granules and processing bodies in response to oxidative stress. The structure of CRHSP-24 determined by single-wavelength anomalous dispersion exhibits an alpha-helix and a compact beta-barrel formed by five curved anti-parallel beta strands. Ligand binding activity of the CSD is orchestrated by residues Ser(41) to Leu(43). Interestingly, a phosphomimetic S41D mutant abolishes the ssDNA binding in vitro and causes CRHSP-24 liberated from stress granules in vivo without apparent alternation of its localization to the processing bodies. This new class of phosphorylation-regulated interaction between the CSD and nucleic acids is unique in stress granule plasticity. Importantly, the association of CRHSP-24 with stress granules is blocked by PP4/PP2A inhibitor calyculin A as PP2A catalyzes the dephosphorylation of Ser(41) of CRHSP-24. Therefore, we speculate that CRHSP-24 participates in oxidative stress response via a dynamic and temporal association between stress granules and processing bodies.	[Wang, Fengsong; Wang, Dongmei; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Wang, Fengsong; Wang, Dongmei; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Hou, Hai; Zhang, Wenchi; Li, Xuemei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn; raozh@xtal.tsinghua.edu.cn	Yao, Xuebiao/P-5771-2014; Rao, Zihe/HCH-6944-2022; Zhang, Wenchi/E-3389-2015	Bartlam, Mark/0000-0001-5173-5080	Chinese Natural Science Foundation [30900497, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; Chinese 973 Project [2007CB914503, 2010CB912103, 2007CB914304, 2009ZX10603]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Chinese Natural Science Foundation Grants 30900497 (to F. W.) and 90913016 (to X. Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, and Chinese 973 Project Grants 2007CB914503 and 2010CB912103 (to X. Y.), 2007CB914304 (to Z. R.), and 2009ZX10603 (to Z. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Auld GC, 2005, BIOCHEM J, V389, P775, DOI 10.1042/BJ20050733; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Bono E, 2007, ENDOCRINOLOGY, V148, P252, DOI 10.1210/en.2006-0660; Castiglia D, 1996, BIOCHEM BIOPH RES CO, V218, P390, DOI 10.1006/bbrc.1996.0068; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Davies HG, 2000, DEV BIOL, V221, P87, DOI 10.1006/dbio.2000.9658; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Graumann P, 1996, BIOESSAYS, V18, P309, DOI 10.1002/bies.950180409; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jiang WN, 1997, J BIOL CHEM, V272, P196; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 2009, BIOCHEM BIOPH RES CO, V385, P413, DOI 10.1016/j.bbrc.2009.05.096; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Nastasi T, 2000, NEUROREPORT, V11, P2233, DOI 10.1097/00001756-200007140-00034; Nastasi T, 1999, J BIOL CHEM, V274, P24087, DOI 10.1074/jbc.274.34.24087; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; TAFURI SR, 1992, NEW BIOL, V4, P349; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zeeb M, 2003, PROTEIN SCI, V12, P112, DOI 10.1110/ps.0219703	44	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9623	9635		10.1074/jbc.M110.177436	http://dx.doi.org/10.1074/jbc.M110.177436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177848	hybrid, Green Published			2022-12-25	WOS:000288247700087
J	Song, QA; Cannistraro, VJ; Taylor, JS				Song, Qian; Cannistraro, Vincent J.; Taylor, John-Stephen			Rotational Position of a 5-Methylcytosine-containing Cyclobutane Pyrimidine Dimer in a Nucleosome Greatly Affects Its Deamination Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-ETA; GLUCOCORTICOID RESPONSE ELEMENT; SYN THYMINE DIMER; CIS-SYN; UV PHOTOPRODUCT; SKIN-CANCER; IN-VIVO; RECONSTITUTED NUCLEOSOMES; HYDROLYTIC DEAMINATION	C to T mutation hotspots in skin cancers occur primarily at methylated CpG sites that coincide with sites of UV-induced cyclobutane pyrimidine dimer (CPD) formation. These mutations are proposed to arise from the insertion of A by DNA polymerase eta opposite the T that results from deamination of the methylC (C-m) within the CPD. Although the frequency of CPD formation and repair is modestly modulated by its rotational position within a nucleosome, the effect of position on the rate of C-m deamination in a CPD has not been previously studied. We now report that deamination of a (TC)-C-m CPD whose sugar phosphate backbone is positioned against the histone core surface decreases by a factor of 4.7, whereas that of a (TC)-C-m CPD positioned away from the surface increases by a factor of 8.9 when compared with unbound DNA. Because the Cs-m undergoing deamination are in similar steric environments, the difference in rate appears to be a consequence of a difference in the flexibility and compression of the two sites due to DNA bending. Considering that formation of the CPD positioned away from the surface is also enhanced by a factor of two, a T(m)CG site in this position might be expected to have up to an 84-fold higher probability of resulting in a UV-induced C-m to T mutation than one positioned against the surface. These results indicate that rotational position may play an important role in the formation of UV-induced C to T mutation hotspots, as well as in the mutagenic mechanism of other DNA lesions.	[Song, Qian; Cannistraro, Vincent J.; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Institutes of Health [CA40463]; NATIONAL CANCER INSTITUTE [R37CA040463, R01CA040463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA40463 (to J.-S. T.).	Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cannistraro VJ, 2010, NUCLEIC ACIDS RES, V38, P6943, DOI 10.1093/nar/gkq582; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Carpenter M, 2006, NUCLEIC ACIDS RES, V34, P3762, DOI 10.1093/nar/gkl545; Celewicz L, 2005, PHOTOCHEM PHOTOBIOL, V81, P404, DOI 10.1562/2004-06-15-RA-201.1; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DOUKI T, 1994, BIOCHEMISTRY-US, V33, P11942, DOI 10.1021/bi00205a033; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Drouin R, 1997, PHOTOCHEM PHOTOBIOL, V66, P719, DOI 10.1111/j.1751-1097.1997.tb03213.x; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Kosmoski JV, 2001, P NATL ACAD SCI USA, V98, P10113, DOI 10.1073/pnas.181073398; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Lee DH, 2003, J BIOL CHEM, V278, P10314, DOI 10.1074/jbc.M212696200; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Q, 1995, MOL CELL BIOL, V15, P4375; Liu XQ, 2000, J BIOL CHEM, V275, P23729, DOI 10.1074/jbc.M002206200; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Ober M, 2007, J AM CHEM SOC, V129, P6278, DOI 10.1021/ja0706145; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; PEHRSON JR, 1992, NUCLEIC ACIDS RES, V20, P1321, DOI 10.1093/nar/20.6.1321; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sohail A, 2002, BIOCHEMISTRY-US, V41, P11325, DOI 10.1021/bi026332t; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; SUQUET C, 1993, J BIOL CHEM, V268, P23755; Svedruzic ZM, 2005, J BIOL CHEM, V280, P40051, DOI 10.1074/jbc.M509478200; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P1624, DOI 10.1021/bi00458a038; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Tommasi S, 1997, CANCER RES, V57, P4727; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; WANG ZG, 1991, J BIOL CHEM, V266, P22472; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; You HY, 2000, CARCINOGENESIS, V21, P2113, DOI 10.1093/carcin/21.11.2113; You YH, 1999, J MOL BIOL, V293, P493, DOI 10.1006/jmbi.1999.3174; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; You YH, 2001, J MOL BIOL, V305, P389, DOI 10.1006/jmbi.2000.4322; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	57	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6329	6335		10.1074/jbc.M110.183178	http://dx.doi.org/10.1074/jbc.M110.183178			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21160086	Green Published, hybrid			2022-12-25	WOS:000287476400043
J	Chernev, P; Zaharieva, I; Dau, H; Haumann, M				Chernev, Petko; Zaharieva, Ivelina; Dau, Holger; Haumann, Michael			Carboxylate Shifts Steer Interquinone Electron Transfer in Photosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; INDUCED STRUCTURAL-CHANGES; IRON-QUINONE COMPLEX; NON-HEME IRON; PHOTOSYSTEM-II; REACTION CENTERS; RHODOBACTER-SPHAEROIDES; RHODOPSEUDOMONAS-VIRIDIS; PROTON UPTAKE; THERMOSYNECHOCOCCUS-ELONGATUS	Understanding the mechanisms of electron transfer (ET) in photosynthetic reaction centers (RCs) may inspire novel catalysts for sunlight-driven fuel production. The electron exit pathway of type II RCs comprises two quinone molecules working in series and in between a non-heme iron atom with a carboxyl ligand (bicarbonate in photosystem II (PSII), glutamate in bacterial RCs). For decades, the functional role of the iron has remained enigmatic. We tracked the iron site using microsecond-resolution x-ray absorption spectroscopy after laser-flash excitation of PSII. After formation of the reduced primary quinone, Q (A) over bar, the x-ray spectral changes revealed a transition (t(1/2) approximate to 150 mu s) from a bidentate to a monodentate coordination of the bicarbonate at the Fe(II) (carboxylate shift), which reverted concomitantly with the slower ET to the secondary quinone QB. A redox change of the iron during the ET was excluded. Density-functional theory calculations corroborated the carboxylate shift both in PSII and bacterial RCs and disclosed underlying changes in electronic configuration. We propose that the iron-carboxyl complex facilitates the first interquinone ET by optimizing charge distribution and hydrogen bonding within the Q(A)FeQ(B) triad for high yield Q(B) reduction. Formation of a specific priming intermediate by nuclear rearrangements, setting the stage for subsequent ET, may be a common motif in reactions of biological redox cofactors.	[Haumann, Michael] Free Univ Berlin, FB Phys, Inst Expt Phys, D-14195 Berlin, Germany	Free University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, FB Phys, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013; Chernev, Petko/F-9964-2018; Zaharieva, Ivelina S/H-6119-2012	Chernev, Petko/0000-0002-2836-838X; Zaharieva, Ivelina S/0000-0002-4745-5307; Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft [Ha3265/3-1]; Unicat (Berlin Cluster of Excellence); European Union; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Unicat (Berlin Cluster of Excellence); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant Ha3265/3-1 to M. H. and Unicat (Berlin Cluster of Excellence)) and European Union FP7 program (SolarH2 Consortium).; Supported by a Heisenberg fellowship from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Freie Universitat Berlin, FB Physik, Arnimallee 14, 14195 Berlin, Germany. Fax: 49-30-8385-6299; E-mail: michael. haumann@fu-berlin.de.	Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Berthomieu C, 2001, BIOCHEMISTRY-US, V40, P4044, DOI 10.1021/bi002236l; Chen LX, 2005, ANNU REV PHYS CHEM, V56, P221, DOI 10.1146/annurev.physchem.56.092503.141310; Cohen AJ, 2008, SCIENCE, V321, P792, DOI 10.1126/science.1158722; Cramer CJ, 2009, PHYS CHEM CHEM PHYS, V11, P10757, DOI 10.1039/b907148b; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; DEBUS RJ, 1986, BIOCHEMISTRY-US, V25, P2276, DOI 10.1021/bi00356a064; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; DINER BA, 1987, BIOCHIM BIOPHYS ACTA, V895, P107, DOI 10.1016/S0304-4173(87)80010-1; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; DISMUKES GC, 1984, BIOCHIM BIOPHYS ACTA, V764, P253, DOI 10.1016/0005-2728(84)90096-3; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; Goussias C, 2002, BIOCHEMISTRY-US, V41, P15212, DOI 10.1021/bi026223e; Gunner MR, 2008, J BIOENERG BIOMEMBR, V40, P509, DOI 10.1007/s10863-008-9179-1; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; GUST D, 1989, SCIENCE, V244, P35, DOI 10.1126/science.244.4900.35; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; HAUMANN M, 1994, FEBS LETT, V347, P45, DOI 10.1016/0014-5793(94)00495-1; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Hermes S, 2006, BIOCHEMISTRY-US, V45, P353, DOI 10.1021/bi0515725; Hienerwadel R, 1995, BIOCHEMISTRY-US, V34, P16288, DOI 10.1021/bi00050a008; Ishikita H, 2007, BBA-BIOENERGETICS, V1767, P1300, DOI 10.1016/j.bbabio.2007.08.004; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; Kalyanasundaram K, 2010, CURR OPIN BIOTECH, V21, P298, DOI 10.1016/j.copbio.2010.03.021; Kaminskaya O, 2003, BIOCHEMISTRY-US, V42, P8119, DOI 10.1021/bi020606v; Kirchner B, 2007, CURR OPIN CHEM BIOL, V11, P134, DOI 10.1016/j.cbpa.2007.02.026; KIRMAIER C, 1986, P NATL ACAD SCI USA, V83, P6407, DOI 10.1073/pnas.83.17.6407; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; KLEINFELD D, 1984, BIOCHEMISTRY-US, V23, P5780, DOI 10.1021/bi00319a017; Koepke J, 2007, J MOL BIOL, V371, P396, DOI 10.1016/j.jmb.2007.04.082; Krivanek R, 2007, BBA-BIOENERGETICS, V1767, P520, DOI 10.1016/j.bbabio.2007.02.013; Kurreck J, 1996, FEBS LETT, V381, P53, DOI 10.1016/0014-5793(96)00061-0; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Lemercier G, 2004, INORG CHEM, V43, P2105, DOI 10.1021/ic034907k; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; McConnell I, 2010, CHEM BIOL, V17, P434, DOI 10.1016/j.chembiol.2010.05.005; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nabedryk E, 2008, BBA-BIOENERGETICS, V1777, P1229, DOI 10.1016/j.bbabio.2008.06.012; Neese F., 2007, ORCA AB INITIO DENSI; Noodleman L, 2006, J BIOL INORG CHEM, V11, P674, DOI 10.1007/s00775-006-0136-3; OKAMURA MY, 1992, ANNU REV BIOCHEM, V61, P861; Palazzo G, 2008, J AM CHEM SOC, V130, P9353, DOI 10.1021/ja801963a; PARSON WW, 1974, ANNU REV MICROBIOL, V28, P41, DOI 10.1146/annurev.mi.28.100174.000353; Peluso A, 2000, J THEOR BIOL, V207, P101, DOI 10.1006/jtbi.2000.2159; PETROULEAS V, 1994, BBA-BIOENERGETICS, V1188, P271, DOI 10.1016/0005-2728(94)90045-0; RARDIN RL, 1991, NEW J CHEM, V15, P417; Reifarth F, 1998, FEBS LETT, V428, P123, DOI 10.1016/S0014-5793(98)00491-8; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Shen JR, 2011, METHODS MOL BIOL, V684, P41, DOI [10.1007/978.1.60761.925.3_5, 10.1007/978-1-60761-925-3_5]; Sinnecker S, 2006, J PHYS CHEM A, V110, P2235, DOI 10.1021/jp056016z; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Takahashi R, 2009, BIOCHEMISTRY-US, V48, P8994, DOI 10.1021/bi901195e; Veronesi G, 2008, BIOPHYS J, V95, P814, DOI 10.1529/biophysj.108.132654; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Woodbury NW, 1995, ANOXYGENIC PHOTOSYNT, P527, DOI [DOI 10.1007/0-306-47954-0_24, 10.1007/0-306-47954-0_24]; Wraight CA, 2004, FRONT BIOSCI-LANDMRK, V9, P309, DOI 10.2741/1236; Xu Q, 2004, STRUCTURE, V12, P703, DOI 10.1016/j.str.2004.03.001; Zhu ZY, 2005, BIOCHEMISTRY-US, V44, P82, DOI 10.1021/bi048348k	65	28	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5368	5374		10.1074/jbc.M110.202879	http://dx.doi.org/10.1074/jbc.M110.202879			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21169354	Green Published, hybrid			2022-12-25	WOS:000287230600045
J	Fiehn, O; Garvey, WT; Newman, JW; Lok, KH; Hoppel, CL; Adams, SH				Fiehn, Oliver; Garvey, W. Timothy; Newman, John W.; Lok, Kerry H.; Hoppel, Charles L.; Adams, Sean H.			Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; DIET-INDUCED OBESITY; MUSCLE LIPID-CONTENT; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PROTEIN-METABOLISM; WHOLE-BODY; LEUCINE METABOLISM; OXIDATION; RAT	Insulin resistance progressing to type 2 diabetes mellitus (T2DM) is marked by a broad perturbation of macronutrient intermediary metabolism. Understanding the biochemical networks that underlie metabolic homeostasis and how they associate with insulin action will help unravel diabetes etiology and should foster discovery of new biomarkers of disease risk and severity. We examined differences in plasma concentrations of >350 metabolites in fasted obese T2DM vs. obese non-diabetic African-American women, and utilized principal components analysis to identify 158 metabolite components that strongly correlated with fasting HbA1c over a broad range of the latter (r = -0.631; p<0.0001). In addition to many unidentified small molecules, specific metabolites that were increased significantly in T2DM subjects included certain amino acids and their derivatives (i.e., leucine, 2-ketoisocaproate, valine, cystine, histidine), 2-hydroxybutanoate, long-chain fatty acids, and carbohydrate derivatives. Leucine and valine concentrations rose with increasing HbA1c, and significantly correlated with plasma acetylcarnitine concentrations. It is hypothesized that this reflects a close link between abnormalities in glucose homeostasis, amino acid catabolism, and efficiency of fuel combustion in the tricarboxylic acid (TCA) cycle. It is speculated that a mechanism for potential TCA cycle inefficiency concurrent with insulin resistance is "anaplerotic stress" emanating from reduced amino acid-derived carbon flux to TCA cycle intermediates, which if coupled to perturbation in cataplerosis would lead to net reduction in TCA cycle capacity relative to fuel delivery.	[Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Garvey, W. Timothy; Lok, Kerry H.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Garvey, W. Timothy; Lok, Kerry H.] Birmingham VA Med Ctr, Birmingham, AL USA; [Newman, John W.; Adams, Sean H.] Univ Calif Davis, Obes & Metab Res Unit, USDA, Agr Res Serv,Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Newman, John W.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Case Western Reserve University	Fiehn, O (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	sean.h.adams@ars.usda.gov	ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319; Newman, John/0000-0001-9632-6571	USDA-ARS [5306-51530-016-00D]; NIH-NIDDK [R01DK078328-01]; NIH [DK-038764, DK-083562, P01 HL-055782]; Department of Veterans Affairs; UAB Center for Clinical and Translational Science [UL1 RR025777]; UAB Nutrition and Obesity Research Center [P30-DK56336]; UAB Diabetes Research and Training Center [P60 DK079626]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R01DK083562, R01DK078328, P60DK079626] Funding Source: NIH RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); UAB Center for Clinical and Translational Science; UAB Nutrition and Obesity Research Center; UAB Diabetes Research and Training Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was funded in part by the following: intramural USDA-ARS Project 5306-51530-016-00D and NIH-NIDDK R01DK078328-01 (to S.H.A.); NIH grants DK-038764, DK-083562, and P01 HL-055782 and the Merit Review program of the Department of Veterans Affairs (W.T.G.). The authors also acknowledge support from the research core facilities of the UAB Center for Clinical and Translational Science (UL1 RR025777), the UAB Nutrition and Obesity Research Center (P30-DK56336), and the UAB Diabetes Research and Training Center (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Baez-Saldana A, 2004, AM J CLIN NUTR, V79, P238; Bajotto G, 2009, METABOLISM, V58, P1489, DOI 10.1016/j.metabol.2009.04.029; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Devkota S, 2010, CURR OPIN CLIN NUTR, V13, P403, DOI 10.1097/MCO.0b013e32833a7737; Divers J, 2010, J LIPID RES, V51, P586, DOI 10.1194/jlr.M001842; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; FOIS A, 1986, J INHERIT METAB DIS, V9, P284, DOI 10.1007/BF01799663; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Goodpaster BH, 2005, EXERC SPORT SCI REV, V33, P150; GOUGEON R, 1994, DIABETES, V43, P318, DOI 10.2337/diabetes.43.2.318; Gougeon R, 2008, DIABETES CARE, V31, P128, DOI 10.2337/dc07-1268; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Halvatsiotis PG, 2002, DIABETES NUTR METAB, V15, P136; He J, 2004, OBES RES, V12, P761, DOI 10.1038/oby.2004.92; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hoffer LJ, 1998, METABOLISM, V47, P1145, DOI 10.1016/S0026-0495(98)90291-8; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kendall DM, 2009, AM J MED, V122, P37, DOI 10.1016/j.amjmed.2009.03.015; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167; Lara-Castro C, 2008, METABOLISM, V57, P1, DOI 10.1016/j.metabol.2007.05.008; Layman DK, 2008, AM J CLIN NUTR, V87, p1571S, DOI 10.1093/ajcn/87.5.1571S; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; MARCHESINI G, 1991, CLIN NUTR, V10, P105, DOI 10.1016/0261-5614(91)90096-U; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; McLean DC, 2005, AM J PHYS ANTHROPOL, V127, P427, DOI 10.1002/ajpa.20047; Mingrone G, 2003, ATHEROSCLEROSIS, V170, P155, DOI 10.1016/S0021-9150(03)00254-5; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; RANDLE PJ, 1963, LANCET, V1, P785; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Sale MM, 2009, DIABETES, V58, P260, DOI 10.2337/db08-0198; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; STATEN MA, 1986, DIABETES, V35, P1249, DOI 10.2337/diabetes.35.11.1249; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; UMPLEBY AM, 1990, DIABETES RES CLIN PR, V9, P89, DOI 10.1016/0168-8227(90)90014-K; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zoppi CC, 2010, BRIT J NUTR, V103, P1237, DOI 10.1017/S0007114509993060	72	293	295	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15234	10.1371/journal.pone.0015234	http://dx.doi.org/10.1371/journal.pone.0015234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170321	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400022
J	Deshpande, G; Li, ZH; Santhanam, P; Coles, CD; Lynch, ME; Hamann, S; Hu, XP				Deshpande, Gopikrishna; Li, Zhihao; Santhanam, Priya; Coles, Claire D.; Lynch, Mary Ellen; Hamann, Stephan; Hu, Xiaoping			Recursive Cluster Elimination Based Support Vector Machine for Disease State Prediction Using Resting State Functional and Effective Brain Connectivity	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; PRENATAL COCAINE EXPOSURE; FMRI DATA; DRUG-USE; SYSTEMS; MRI; CLASSIFICATION; ACTIVATION; PREGNANCY; CHILDREN	Background: Brain state classification has been accomplished using features such as voxel intensities, derived from functional magnetic resonance imaging (fMRI) data, as inputs to efficient classifiers such as support vector machines (SVM) and is based on the spatial localization model of brain function. With the advent of the connectionist model of brain function, features from brain networks may provide increased discriminatory power for brain state classification. Methodology/Principal Findings: In this study, we introduce a novel framework where in both functional connectivity (FC) based on instantaneous temporal correlation and effective connectivity (EC) based on causal influence in brain networks are used as features in an SVM classifier. In order to derive those features, we adopt a novel approach recently introduced by us called correlation-purged Granger causality (CPGC) in order to obtain both FC and EC from fMRI data simultaneously without the instantaneous correlation contaminating Granger causality. In addition, statistical learning is accelerated and performance accuracy is enhanced by combining recursive cluster elimination (RCE) algorithm with the SVM classifier. We demonstrate the efficacy of the CPGC-based RCE-SVM approach using a specific instance of brain state classification exemplified by disease state prediction. Accordingly, we show that this approach is capable of predicting with 90.3% accuracy whether any given human subject was prenatally exposed to cocaine or not, even when no significant behavioral differences were found between exposed and healthy subjects. Conclusions/Significance: The framework adopted in this work is quite general in nature with prenatal cocaine exposure being only an illustrative example of the power of this approach. In any brain state classification approach using neuroimaging data, including the directional connectivity information may prove to be a performance enhancer. When brain state classification is used for disease state prediction, our approach may aid the clinicians in performing more accurate diagnosis of diseases in situations where in non-neuroimaging biomarkers may be unable to perform differential diagnosis with certainty.	[Deshpande, Gopikrishna] Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Li, Zhihao; Santhanam, Priya; Hu, Xiaoping] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Coles, Claire D.; Lynch, Mary Ellen] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Hamann, Stephan] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Auburn University System; Auburn University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Deshpande, G (corresponding author), Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA.	xhu@bme.gatech.edu	Li, Zhihao/R-4741-2019	Li, Zhihao/0000-0002-6009-7903; Hu, Xiaoping/0000-0001-7014-5983; Deshpande, Gopikrishna/0000-0001-7471-5357	National Institutes of Health [R01 EB002009]; Georgia Research Alliance; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the support from National Institutes of Health (R01 EB002009 to XH) and Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero VH, 2007, J DEV BEHAV PEDIATR, V28, P195, DOI 10.1097/01.DBP.0000268560.72580.f9; [Anonymous], 2005, STUDIES FUZZINESS SO, DOI [DOI 10.1007/B95439, 10.1007/b95439]; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bendersky M, 2006, J PEDIATR PSYCHOL, V31, P71, DOI 10.1093/jpepsy/jsj025; Biswal B, 1998, AM J NEURORADIOL, V19, P1509; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown JV, 1998, DEV PSYCHOL, V34, P540, DOI 10.1037/0012-1649.34.3.540; CECCHI G, 2009, P NIPS 2009 VANC CAN; COLES CD, 1993, INT J ADDICT, V28, P1393, DOI 10.3109/10826089309062192; COLES CD, 1992, NEUROTOXICOL TERATOL, V14, P23, DOI 10.1016/0892-0362(92)90025-6; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DESHPANDE G, 2009, P ISMRM 17 SCI M 200; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hurt H, 2008, J PEDIATR, V152, P371, DOI 10.1016/j.jpeds.2007.08.006; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; LaGasse LL, 2006, ANN NY ACAD SCI, V1094, P313, DOI 10.1196/annals.1376.041; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; LI Z, 2010, HUMAN BRAIN IN PRESS; Li ZH, 2009, NEUROTOXICOL TERATOL, V31, P342, DOI 10.1016/j.ntt.2009.08.005; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Mayes LC, 2002, NEUROTOXICOL TERATOL, V24, P385, DOI 10.1016/S0892-0362(02)00200-3; Mayes LC, 1998, ANN NY ACAD SCI, V846, P126, DOI 10.1111/j.1749-6632.1998.tb09731.x; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sitaram R, 2008, IEEE SIGNAL PROC MAG, V25, P95, DOI 10.1109/MSP2007.910456; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; Talairach J., 1988, COPLANAR STEREOTAXIC; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; WENZEL S, 2001, PRENATAL COCAINE EXP; Yang XW, 2003, PROG NAT SCI-MATER, V13, P750, DOI 10.1080/10020070312331344360; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144	50	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14277	10.1371/journal.pone.0014277	http://dx.doi.org/10.1371/journal.pone.0014277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151556	gold, Green Published			2022-12-25	WOS:000285135800009
J	Ohara-Imaizumi, M; Yoshida, M; Aoyagi, K; Saito, T; Okamura, T; Takenaka, H; Akimoto, Y; Nakamichi, Y; Takanashi-Yanobu, R; Nishiwaki, C; Kawakami, H; Kato, N; Hisanaga, S; Kakei, M; Nagamatsu, S				Ohara-Imaizumi, Mica; Yoshida, Masashi; Aoyagi, Kyota; Saito, Taro; Okamura, Tadashi; Takenaka, Hitoshi; Akimoto, Yoshihiro; Nakamichi, Yoko; Takanashi-Yanobu, Rieko; Nishiwaki, Chiyono; Kawakami, Hayato; Kato, Norihiro; Hisanaga, Shin-ichi; Kakei, Masafumi; Nagamatsu, Shinya			Deletion of CDKAL1 Affects Mitochondrial ATP Generation and First-Phase Insulin Exocytosis	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM; CROSS-TALK; RISK LOCI; ER STRESS; SECRETION; GLUCOSE; CALCIUM; ACTIVATOR	Background: A variant of the CDKAL1 gene was reported to be associated with type 2 diabetes and reduced insulin release in humans; however, the role of CDKAL1 in beta cells is largely unknown. Therefore, to determine the role of CDKAL1 in insulin release from beta cells, we studied insulin release profiles in CDKAL1 gene knockout (CDKAL1 KO) mice. Principal Findings: Total internal reflection fluorescence imaging of CDKAL1 KO beta cells showed that the number of fusion events during first-phase insulin release was reduced. However, there was no significant difference in the number of fusion events during second-phase release or high K+-induced release between WT and KO cells. CDKAL1 deletion resulted in a delayed and slow increase in cytosolic free Ca2+ concentration during high glucose stimulation. Patch-clamp experiments revealed that the responsiveness of ATP-sensitive K+ (K-ATP) channels to glucose was blunted in KO cells. In addition, glucose-induced ATP generation was impaired. Although CDKAL1 is homologous to cyclin-dependent kinase 5 (CDK5) regulatory subunit-associated protein 1, there was no difference in the kinase activity of CDK5 between WT and CDKAL1 KO islets. Conclusions/Significance: We provide the first report describing the function of CDKAL1 in beta cells. Our results indicate that CDKAL1 controls first-phase insulin exocytosis in beta cells by facilitating ATP generation, K-ATP channel responsiveness and the subsequent activity of Ca2+ channels through pathways other than CDK5-mediated regulation.	[Ohara-Imaizumi, Mica; Aoyagi, Kyota; Takenaka, Hitoshi; Nakamichi, Yoko; Nishiwaki, Chiyono; Nagamatsu, Shinya] Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Yoshida, Masashi; Kakei, Masafumi] Jichi Med Univ, Saitama Med Ctr, Sch Med, Dept Med 1, Saitama, Japan; [Saito, Taro; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Okamura, Tadashi; Takanashi-Yanobu, Rieko] Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Tokyo, Japan; [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Dept Anat, Sch Med, Tokyo, Japan; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Tokyo, Japan	Kyorin University; Jichi Medical University; Tokyo Metropolitan University; National Center for Global Health & Medicine - Japan; Kyorin University; National Center for Global Health & Medicine - Japan	Ohara-Imaizumi, M (corresponding author), Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan.	shinya@ks.kyorin-u.ac.jp			Japan Society for Promotion of Science; Sumitomo Foundation; Astellas Foundation for Research on Metabolic Disorders; Research Foundation for Opto-Science and Technology; Kyorin University School of Medicine; NOVARTIS Foundation (Japan) for the Promotion of Science; NIBIO (National Institute of Biomedical Innovation Organization)	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Astellas Foundation for Research on Metabolic Disorders; Research Foundation for Opto-Science and Technology; Kyorin University School of Medicine; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); NIBIO (National Institute of Biomedical Innovation Organization)(National Institute of Biomedical Innovation)	This research was supported by grants from the Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for Promotion of Science (http://www.jsps.go.jp), Sumitomo Foundation (http://www.sumitomo.or.jp), Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai), Research Foundation for Opto-Science and Technology (http://www.refost-hq.jp), Kyorin University School of Medicine Collaboration Project (http://www.kyorin-u.ac.jp), NOVARTIS Foundation (Japan) for the Promotion of Science (http://novartisfound.or.jp/), and the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (National Institute of Biomedical Innovation Organization) (http://www.nibio.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1999, CELL MOL BIOL, V45, P737; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; FILIPPONI P, 1983, ENDOCRINOLOGY, V113, P1972, DOI 10.1210/endo-113-6-1972; GIROIX MH, 1993, BIOCHEM MED METAB B, V50, P301, DOI 10.1006/bmmb.1993.1072; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hughes E, 2006, ENDOCRINOLOGY, V147, P1396, DOI 10.1210/en.2005-1023; Komatsu M, 1998, ENDOCRINOLOGY, V139, P1172, DOI 10.1210/en.139.3.1172; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Nakazaki M, 2002, J PHYSIOL-LONDON, V540, P781; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; OHNOSHOSAKU T, 1987, PFLUG ARCH EUR J PHY, V408, P133, DOI 10.1007/BF00581342; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	36	53	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15553	10.1371/journal.pone.0015553	http://dx.doi.org/10.1371/journal.pone.0015553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151568	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800029
J	Vogt, N; Gibaud, A; Almeida, A; Ourliac-Garnier, I; Debatisse, M; Malfoy, B				Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard			Relationships Linking Amplification Level to Gene Over-Expression in Gliomas	PLOS ONE			English	Article							FACTOR RECEPTOR GENE; TELOMERASE ACTIVITY; CANCER; HTERT; AMPLICON; GROWTH; ONCOGENES; REVEALS; NUMBER; GENOME	Background: Gene amplification is thought to promote over-expression of genes favouring tumour development. Because amplified regions are usually megabase-long, amplification often concerns numerous syntenic or non-syntenic genes, among which only a subset is over-expressed. The rationale for these differences remains poorly understood. Methodology/Principal Finding: To address this question, we used quantitative RT-PCR to determine the expression level of a series of co-amplified genes in five xenografted and one fresh human gliomas. These gliomas were chosen because we have previously characterised in detail the genetic content of their amplicons. In all the cases, the amplified sequences lie on extra-chromosomal DNA molecules, as commonly observed in gliomas. We show here that genes transcribed in non-amplified gliomas are over-expressed when amplified, roughly in proportion to their copy number, while non-expressed genes remain inactive. When specific antibodies were available, we also compared protein expression in amplified and non-amplified tumours. We found that protein accumulation barely correlates with the level of mRNA expression in some of these tumours. Conclusions/Significance: Here we show that the tissue-specific pattern of gene expression is maintained upon amplification in gliomas. Our study relies on a single type of tumour and a limited number of cases. However, it strongly suggests that, even when amplified, genes that are normally silent in a given cell type play no role in tumour progression. The loose relationships between mRNA level and protein accumulation and/or activity indicate that translational or post-translational events play a key role in fine-tuning the final outcome of amplification in gliomas.	[Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] Inst Curie, Ctr Rech, Paris, France; [Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] CNRS, UMR3244, Paris, France; [Vogt, Nicolas; Gibaud, Anne; Almeida, Anna; Ourliac-Garnier, Isabelle; Debatisse, Michelle; Malfoy, Bernard] UPMC, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite	Vogt, N (corresponding author), Inst Curie, Ctr Rech, Paris, France.	bernard.malfoy@curie.fr	Ourliac-Garnier, Isabelle/ABH-4491-2020; Ourliac-Garnier, Isabelle/ABE-3478-2021	Ourliac-Garnier, Isabelle/0000-0002-8159-0959	Association pour la Recherche contre le Cancer [3808]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was partially supported by the Association pour la Recherche contre le Cancer, contract 3808 (http://www.arc-cancer.net/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Boldrini L, 2006, INT J ONCOL, V28, P1555; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Debatisse M, 2005, ADV EXP MED BIOL, V570, P343, DOI 10.1007/1-4020-3764-3_12; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Gibaud A, 2010, HUM MOL GENET, V19, P1276, DOI 10.1093/hmg/ddq004; Gonin-Laurent N, 2007, ONCOGENE, V26, P6106, DOI 10.1038/sj.onc.1210404; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; HALEY JD, 1989, ONCOGENE, V4, P273; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kuuselo R, 2007, CANCER RES, V67, P1943, DOI 10.1158/0008-5472.CAN-06-3387; Lu ZM, 2009, CANCER RES, V69, P9105, DOI 10.1158/0008-5472.CAN-09-2775; MULERIS M, 1994, ONCOGENE, V9, P2717; Myllykangas S, 2007, SEMIN CANCER BIOL, V17, P42, DOI 10.1016/j.semcancer.2006.10.005; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nowak T, 2006, ONCOL REP, V16, P301; Parssinen J, 2007, BRIT J CANCER, V96, P1258, DOI 10.1038/sj.bjc.6603692; Pelosi G, 2007, CLIN CANCER RES, V13, P1995, DOI 10.1158/1078-0432.CCR-06-2483; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao P, 2007, INT J ONCOL, V31, P361; Zhdanova NS, 2007, CHROMOSOME RES, V15, P881, DOI 10.1007/s10577-007-1170-x	37	11	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14249	10.1371/journal.pone.0014249	http://dx.doi.org/10.1371/journal.pone.0014249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170331	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100003
J	Daniels, TF; Wu, XL; Pan, ZX; Michal, JJ; Wright, RW; Killinger, KM; MacNeil, MD; Jiang, ZH				Daniels, Tyler F.; Wu, Xiao-Lin; Pan, Zengxiang; Michal, Jennifer J.; Wright, Raymond W., Jr.; Killinger, Karen M.; MacNeil, Michael D.; Jiang, Zhihua			The Reverse Cholesterol Transport Pathway Improves Understanding of Genetic Networks for Fat Deposition and Muscle Growth in Beef Cattle	PLOS ONE			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-E; LIPOPROTEIN METABOLISM; DENSITY-LIPOPROTEIN; LIPASE; HDL; HYPERCHOLESTEROLEMIA; POLYMORPHISMS; MECHANISMS; RECEPTOR	In the present study, thirteen genes involved in the reverse cholesterol transport (RCT) pathway were investigated for their associations with three fat depositions, eight fatty acid compositions and two growth-related phenotypes in a Wagyu x Limousin reference population, including 6 F-1 bulls, 113 F-1 dams, and 246 F-2 progeny. A total of 37 amplicons were used to screen single nucleotide polymorphisms (SNPs) on 6 F-1 bulls. Among 36 SNPs detected in 11 of these 13 genes, 19 were selected for genotyping by the Sequenom assay design on all F-2 progeny. Single-marker analysis revealed seven SNPs in ATP binding cassette A1, apolipoproteins A1, B and E, phospholipid transfer protein and paraoxinase 1 genes significantly associated with nine phenotypes (P < 0.05). Previously, we reported genetic networks associated with 19 complex phenotypes based on a total of 138 genetic polymorphisms derived from 71 known functional genes. Therefore, after Bonferroni correction, these significant (adjusted P < 0.05) and suggestive (adjusted P < 0.10) associations were then used to identify genetic networks related to the RCT pathway. Multiple-marker analysis suggested possible genetic networks involving the RCT pathway for kidney-pelvic-heart fat percentage, rib-eye area, and subcutaneous fat depth phenotypes with markers derived from paraoxinase 1, apolipoproteins A1 and E, respectively. The present study confirmed that genes involved in cholesterol homeostasis are useful targets for investigating obesity in humans as well as for improving meat quality phenotypes in a livestock production.	[Daniels, Tyler F.; Pan, Zengxiang; Michal, Jennifer J.; Wright, Raymond W., Jr.; Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wu, Xiao-Lin] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Killinger, Karen M.] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [MacNeil, Michael D.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA	Washington State University; University of Wisconsin System; University of Wisconsin Madison; Washington State University; United States Department of Agriculture (USDA)	Daniels, TF (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	jiangz@wsu.edu	Jiang, Zhihua/A-3378-2008; MacNeil, Michael D/A-6772-2009	Jiang, Zhihua/0000-0003-1986-088X; 	Merial Ltd.; Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center	Merial Ltd.; Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center	This work was supported by Merial Ltd. Animal Genomics Research Fund to Z.J. This activity was also funded, in part, with an Emerging Research Issues Internal Competitive Grant from the Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center. Montana Agricultural Experiment Station was responsible for maintaining the cattle; USDA Agricultural Research Service supported collection of phenotypic data and provided DNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander LJ, 2007, ANIM GENET, V38, P506, DOI 10.1111/j.1365-2052.2007.01643.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boekholdt SM, 2006, CLIN GENET, V69, P263, DOI 10.1111/j.1399-0004.2006.00578.x; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Daniels TF, 2009, INT J BIOL SCI, V5, P474; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Goldberg IJ, 1996, J LIPID RES, V37, P693; GROSSER J, 1981, J LIPID RES, V22, P437; Hebbachi AM, 2001, J LIPID RES, V42, P1609; Holleboom AG, 2008, CURR OPIN LIPIDOL, V19, P385, DOI 10.1097/MOL.0b013e328306a043; Hui DY, 2005, SEMIN CELL DEV BIOL, V16, P183, DOI 10.1016/j.semcdb.2005.01.003; Jiang ZH, 2005, BIOCHEM BIOPH RES CO, V334, P516, DOI 10.1016/j.bbrc.2005.06.120; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCoy MG, 2002, J LIPID RES, V43, P921; Mustad VA, 1997, J LIPID RES, V38, P459; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nishida HI, 1997, J BIOL CHEM, V272, P6959, DOI 10.1074/jbc.272.11.6959; NORO A, 1995, J VET MED SCI, V57, P737, DOI 10.1292/jvms.57.737; OSCAI LB, 1982, J APPL PHYSIOL, V52, P1059, DOI 10.1152/jappl.1982.52.4.1059; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rao R, 1997, BIOCHEMISTRY-US, V36, P3645, DOI 10.1021/bi962776b; Rigotti A, 1997, CURR OPIN LIPIDOL, V8, P181, DOI 10.1097/00041433-199706000-00009; Rozen S, 2000, Methods Mol Biol, V132, P365; Rule DC, 2002, J ANIM SCI, V80, P1202; Salkind N., 2007, ENCY MEASUREMENT STA; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Teltathum T, 2009, INT J BIOL SCI, V5, P679; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; WOOLLETT LA, 1992, J LIPID RES, V33, P77; Wu K, 2007, EUR HEART J, V28, P2930, DOI 10.1093/eurheartj/ehm482; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15203	10.1371/journal.pone.0015203	http://dx.doi.org/10.1371/journal.pone.0015203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151936	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600033
J	Manevich, Y; Townsend, DM; Hutchens, S; Tew, KD				Manevich, Yefim; Townsend, Danyelle M.; Hutchens, Steven; Tew, Kenneth D.			Diazeniumdiolate Mediated Nitrosative Stress Alters Nitric Oxide Homeostasis through Intracellular Calcium and S-Glutathionylation of Nitric Oxide Synthetase	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NADPH OXIDASE; SYNTHASE; ACTIVATION; NITROSYLATION; GLUTATHIOLATION; THAPSIGARGIN; REGULATOR; PRODRUG; ROLES	Background: PABA/NO is a diazeniumdiolate that acts as a direct nitrogen monoxide (NO) donor and is in development as an anticancer drug. Its mechanism of action and effect on cells is not yet fully understood. Methodology/Principal Findings: We used HPLC and mass spectrometry to identify a primary nitroaromatic glutathione metabolite of PABA/NO and used fluorescent assays to characterize drug effects on calcium and NO homeostasis, relating these to endothelial nitric oxide synthase (eNOS) activity. Unexpectedly, the glutathione conjugate was found to be a competitive inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) presumably at the same site as thapsigargin, increasing intracellular Ca2+ release and causing auto-regulation of eNOS through S-glutathionylation. Conclusions/Significance: The initial direct release of NO after PABA/NO was followed by an eNOS-mediated generation of NO as a consequence of drug-induced increase in Ca2+ flux and calmodulin (CaM) activation. PABA/NO has a unique dual mechanism of action with direct intracellular NO generation combined with metabolite driven regulation of eNOS activation.	[Manevich, Yefim; Hutchens, Steven; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Manevich, Y (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	tewk@musc.edu			National Institutes of Health [CA08660, CA117259]; South Carolina Centers of Excellence program; National Center for Research Resources [C06 RR015455]; NATIONAL CANCER INSTITUTE [R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Centers of Excellence program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (CA08660 and CA117259) and support from the South Carolina Centers of Excellence program. This work was conducted in a facility constructed with the support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Cohen RA, 2006, TRENDS CARDIOVAS MED, V16, P109, DOI 10.1016/j.tcm.2006.02.001; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Findlay VJ, 2004, MOL PHARMACOL, V65, P1070, DOI 10.1124/mol.65.5.1070; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; GARVEY EP, 1994, ARCH BIOCHEM BIOPHYS, V311, P235, DOI 10.1006/abbi.1994.1232; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Jiang BH, 2004, BIOCHEM BIOPH RES CO, V317, P192, DOI 10.1016/j.bbrc.2004.03.036; Kakui K, 2004, MOL HUM REPROD, V10, P115, DOI 10.1093/molehr/gah023; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Manevich Y, 2001, AM J PHYSIOL-HEART C, V280, pH2126, DOI 10.1152/ajpheart.2001.280.5.H2126; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Patel JM, 1996, AM J RESP CELL MOL, V15, P410, DOI 10.1165/ajrcmb.15.3.8810647; Paula S, 2004, PROTEINS, V56, P595, DOI 10.1002/prot.20105; PISTOIA V, 1980, EXPERIENTIA, V36, P873, DOI 10.1007/BF01978623; Procida K, 1998, FEBS LETT, V439, P127, DOI 10.1016/S0014-5793(98)01352-0; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Saavedra JE, 2001, J ORG CHEM, V66, P3090, DOI 10.1021/jo0016529; SAHIN FKY, 2006, HAEMA, V9, P560; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Scott KD, 2003, CELL IMMUNOL, V222, P58, DOI 10.1016/S0008-8749(03)00077-7; SEIFERT R, 1987, BIOCHEM BIOPH RES CO, V146, P1296, DOI 10.1016/0006-291X(87)90790-X; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; XINHUA J, 2008, DRUG DESIGN DEV THER, V2, P123; Zhang JL, 1998, AM J PHYSIOL-LUNG C, V275, pL288, DOI 10.1152/ajplung.1998.275.2.L288	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14151	10.1371/journal.pone.0014151	http://dx.doi.org/10.1371/journal.pone.0014151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152397	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100030
J	Malapeira, J; Esselens, C; Bech-Serra, JJ; Canals, F; Arribas, J				Malapeira, J.; Esselens, C.; Bech-Serra, J. J.; Canals, F.; Arribas, J.			ADAM17 (TACE) regulates TGF beta signaling through the cleavage of vasorin	ONCOGENE			English	Article						vasorin; ADAM17; TACE; ectodomain shedding; TGF beta	EPITHELIAL-MESENCHYMAL TRANSITIONS; ALPHA-CONVERTING ENZYME; GROWTH-FACTOR-BETA; MATRIX METALLOPROTEINASES; BREAST-CANCER; ACTIVATION; PROTEINS; EGFR; METASTASIS; PROTEASES	The activity of a variety of extracellular signaling factors is tightly regulated by proteins containing A Disintegrin And a Metalloprotease domain ( ADAM) metalloproteases through limited proteolysis. Thus, the identification of ADAM substrates may unveil novel components and mechanisms of cell signaling pathways. We report the identification of the transmembrane protein vasorin (VASN), a transforming growth factor-beta (TGF beta) trap, as a substrate of ADAM17. The metalloprotease efficiently generates a soluble fragment encompassing the extracellular domain of VASN. Despite the importance of TGF beta in normal development and tumor progression, the regulation of VASN is completely unknown. Here, we show that only the soluble form of VASN inhibits TGFb and that the secretion of VASN is tightly controlled by ADAM17. Hence, inhibition of ADAM17 leads to the upregulation of TGFb signaling. Adding a new level of complexity to the function of ADAM17, we finally show that, through the cleavage of VASN, the metalloprotease controls TGFb-mediated epithelial-to-mesenchymal transition. Oncogene (2011) 30, 1912-1922; doi: 10.1038/onc.2010.565; published online 20 December 2010	[Malapeira, J.; Esselens, C.; Arribas, J.] Vall Hebron Univ Hosp, VHIO, Med Oncol Res Program, Barcelona 08035, Spain; [Bech-Serra, J. J.; Canals, F.] Vall Hebron Univ Hosp, Res Inst Fdn, Prote Lab, Barcelona 08035, Spain; [Arribas, J.] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Arribas, J.] ICREA, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; ICREA	Arribas, J (corresponding author), Vall Hebron Univ Hosp, VHIO, Med Oncol Res Program, Psg Vall Hebron 119-129, Barcelona 08035, Spain.	jarribas@vhio.net	Arribas, Joaquin/M-4482-2014; Bech-Serra, Joan Josep/AAA-2330-2020; Malapeira, Jordi/I-7956-2014	Arribas, Joaquin/0000-0002-0504-0664; Bech-Serra, Joan Josep/0000-0003-3486-781X; Esselens, Cary/0000-0001-8876-634X; Malapeira, Jordi/0000-0003-3503-1272	Instituto de Salud Carlos III [PI081154, RD06/0020/0022, PI071058]; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ICREA(ICREA)	We thank Dr Fernando Lopez-Casillas for critical reading of the manuscript. The Proteomics Laboratory is a member of the National Spanish Institute for Proteomics (PROTEORED) and it is funded in part by Fundacio Cellex. CW Esselens is a postdoctoral fellow from the Juan de la Cierva program (Spanish Ministry of Education). This research was supported by Grants from the Instituto de Salud Carlos III (Intrasalud PI081154 and the network of cooperative cancer research (RTICC-RD06/0020/0022) to JA and PI071058	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; de la Torre TV, 2004, BIOCHEM BIOPH RES CO, V314, P1028, DOI 10.1016/j.bbrc.2003.12.186; Esselens CW, 2008, BIOL CHEM, V389, P1075, DOI 10.1515/BC.2008.121; Friedman S, 2009, CANCER RES, V69, p783S; Guo L, 2002, MOL CELL PROTEOMICS, V1, P30, DOI 10.1074/mcp.M100020-MCP200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	29	55	55	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	16					1912	1922		10.1038/onc.2010.565	http://dx.doi.org/10.1038/onc.2010.565			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21170088				2022-12-25	WOS:000289777700007
J	Figiel, M; Chon, H; Cerritelli, SM; Cybulska, M; Crouch, RJ; Nowotny, M				Figiel, Malgorzata; Chon, Hyongi; Cerritelli, Susana M.; Cybulska, Magdalena; Crouch, Robert J.; Nowotny, Marcin			The Structural and Biochemical Characterization of Human RNase H2 Complex Reveals the Molecular Basis for Substrate Recognition and Aicardi-Goutieres Syndrome Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RIBONUCLEASE-H; HII; TYPE-2; MUTATIONS; MECHANISM; SUBUNITS; REMOVAL; HOMOLOG	RNase H2 cleaves RNA sequences that are part of RNA/DNA hybrids or that are incorporated into DNA, thus, preventing genomic instability and the accumulation of aberrant nucleic acid, which in humans induces Aicardi-Goutieres syndrome, a severe autoimmune disorder. The 3.1 angstrom crystal structure of human RNase H2 presented here allowed us to map the positions of all 29 mutations found in Aicardi-Goutieres syndrome patients, several of which were not visible in the previously reported mouse RNase H2. We propose the possible effects of these mutations on the protein stability and function. Bacterial and eukaryotic RNases H2 differ in composition and substrate specificity. Bacterial RNases H2 are monomeric proteins and homologs of the eukaryotic RNases H2 catalytic subunit, which in addition possesses two accessory proteins. The eukaryotic RNase H2 heterotrimeric complex recognizes RNA/DNA hybrids and (5') RNA-DNA(3')/DNA junction hybrids as substrates with similar efficiency, whereas bacterial RNases H2 are highly specialized in the recognition of the (5') RNA-DNA(3') junction and very poorly cleave RNA/DNA hybrids in the presence of Mg2+ ions. Using the crystal structure of the Thermotoga maritima RNase H2-substrate complex, we modeled the human RNase H2-substrate complex and verified the model by mutational analysis. Our model indicates that the difference in substrate preference stems from the different position of the crucial tyrosine residue involved in substrate binding and recognition.	[Figiel, Malgorzata; Cybulska, Magdalena; Nowotny, Marcin] Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland; [Chon, Hyongi; Cerritelli, Susana M.; Crouch, Robert J.] Eunice Kennedy Shriver NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nowotny, M (corresponding author), 4 Trojdena St, PL-02109 Warsaw, Poland.	mnowotny@iimcb.gov.pl	Figiel, Małgorzata/ABF-9197-2020	Nowotny, Marcin/0000-0001-8632-0977; Figiel, Malgorzata/0000-0002-2211-0425	National Institutes of Health, Eunice Kennedy Shriver NICHD; Wellcome Trust [081760]; Polish Ministry of Science and Higher Education [ESRF/73/2006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD. This work was also supported by Wellcome Trust International Senior Fellowship 081760. The access to the European Synchrotron Radiation Facility was financed by the Polish Ministry of Science and Higher Education (Project ESRF/73/2006).	Afonine PV, 2005, CCP4 NEWSL, V42; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Chai Q, 2001, BIOCHEM BIOPH RES CO, V286, P1073, DOI 10.1006/bbrc.2001.5523; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; EDER PS, 1991, J BIOL CHEM, V266, P6472; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gaidamakov SA, 2005, NUCLEIC ACIDS RES, V33, P2166, DOI 10.1093/nar/gki510; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 2008, FEBS J, V275, P5444, DOI 10.1111/j.1742-4658.2008.06673.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x	29	47	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10540	10550		10.1074/jbc.M110.181974	http://dx.doi.org/10.1074/jbc.M110.181974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177858	Green Published, hybrid			2022-12-25	WOS:000288547000070
J	Ma, L; Kaufman, Y; Zhang, JH; Washington, I				Ma, Li; Kaufman, Yardana; Zhang, Junhua; Washington, Ilyas			C20-D-3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT EPITHELIAL-CELLS; AGE-RELATED-CHANGES; VISUAL-ACUITY LOSS; MACULAR DEGENERATION; FUNDUS AUTOFLUORESCENCE; COMPLEMENT-SYSTEM; ANIMAL-MODEL; A2E; ABCR; MUTATIONS	Stargardt disease, also known as juvenile macular degeneration, occurs in approximately one in 10,000 people and results from genetic defects in the ABCA4 gene. The disease is characterized by premature accumulation of lipofuscin in the retinal pigment epithelium (RPE) of the eye and by vision loss. No cure or treatment is available. Although lipofuscin is considered a hallmark of Stargardt disease, its mechanism of formation and its role in disease pathogenesis are poorly understood. In this work we investigated the effects of long-term administration of deuterium-enriched vitamin A, C20-D-3-vitamin A, on RPE lipofuscin deposition and eye function in a mouse model of Stargardt's disease. Results support the notion that lipofuscin forms partly as a result of the aberrant reactivity of vitamin A through the formation of vitamin A dimers, provide evidence that preventing vitamin A dimerization may slow disease related, retinal physiological changes and perhaps vision loss and suggest that administration of C20-D-3-vitamin A may be a potential clinical strategy to ameliorate clinical symptoms resulting from ABCA4 genetic defects.	[Ma, Li; Kaufman, Yardana; Zhang, Junhua; Washington, Ilyas] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA	Columbia University	Washington, I (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA.	iw2101@columbia.edu		W, I/0000-0002-2238-7918	International Retinal Research Foundation; NATIONAL EYE INSTITUTE [R01EY021207] Funding Source: NIH RePORTER	International Retinal Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the International Retinal Research Foundation.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; BERGEN HR, 1988, J LABELLED COMPD RAD, V25, P11; Burns R P, 1980, Trans Am Ophthalmol Soc, V78, P206; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dontsov A E, 2005, Dokl Biochem Biophys, V405, P458, DOI 10.1007/s10628-005-0139-y; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Furr HC, 2005, PUBLIC HEALTH NUTR, V8, P596, DOI 10.1079/PHN2004715; GAILLARD ER, 1995, PHOTOCHEM PHOTOBIOL, V61, P448, DOI 10.1111/j.1751-1097.1995.tb02343.x; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gomes NL, 2009, INVEST OPHTH VIS SCI, V50, P3953, DOI 10.1167/iovs.08-2657; Gouras P, 2008, GRAEF ARCH CLIN EXP, V246, P1403, DOI 10.1007/s00417-008-0911-7; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; HENBEST HB, 1957, J CHEM SOC, P4909, DOI 10.1039/jr9570004909; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; ISHIBASHI T, 1986, INVEST OPHTH VIS SCI, V27, P184; ISLER O, 1949, HELV CHIM ACTA, V32, P489, DOI 10.1002/hlca.19490320218; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; KATZ ML, 1986, MECH AGEING DEV, V35, P291, DOI 10.1016/0047-6374(86)90131-4; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Lei B, 2003, INVEST OPHTH VIS SCI, V44, pU304; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Lorenz B, 2004, OPHTHALMOLOGY, V111, P1585, DOI 10.1016/j.ophtha.2004.01.033; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; MISHIMA H, 1981, A GRAEF ARCH KLIN EX, V216, P209, DOI 10.1007/BF00408162; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Pawar AS, 2008, INVEST OPHTH VIS SCI, V49, P2743, DOI 10.1167/iovs.07-1499; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; RANDO RR, 1982, BIOCHEM BIOPH RES CO, V104, P430, DOI 10.1016/0006-291X(82)90655-6; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; Rozanowska M, 2004, INVEST OPHTH VIS SCI, V45, P1052, DOI 10.1167/iovs.03-0277; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Sivaprasad S, 2006, EYE, V20, P867, DOI 10.1038/sj.eye.6702176; Sparrow JR, 2010, INVEST OPHTH VIS SCI, V51, P4351, DOI 10.1167/iovs.10-5852; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; SPENCER W H, 1965, Trans Am Acad Ophthalmol Otolaryngol, V69, P662; Washington I, 2005, ANGEW CHEM INT EDIT, V44, P7097, DOI 10.1002/anie.200501346; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Yatsenko AN, 2001, HUM GENET, V108, P346, DOI 10.1007/s004390100493; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	77	50	52	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7966	7974		10.1074/jbc.M110.178657	http://dx.doi.org/10.1074/jbc.M110.178657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21156790	Green Published, hybrid			2022-12-25	WOS:000288013300027
J	Fujita, M; Tsuchida, A; Hirata, A; Kobayashi, N; Goto, K; Osumi, K; Hirose, Y; Nakayama, J; Yamanoi, T; Ashida, H; Mizuno, M				Fujita, Masaya; Tsuchida, Akiko; Hirata, Akiko; Kobayashi, Natsumi; Goto, Kohtaro; Osumi, Kenji; Hirose, Yuriko; Nakayama, Jun; Yamanoi, Takashi; Ashida, Hisashi; Mizuno, Mamoru			Glycoside Hydrolase Family 89 alpha-N-acetylglucosaminidase from Clostridium perfringens Specifically Acts on GlcNAc alpha 1,4Gal beta 1R at the Non-reducing Terminus of O-Glycans in Gastric Mucin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-BETA-GALACTOSIDASE; HELICOBACTER-PYLORI INFECTION; CARBOHYDRATE-BINDING MODULES; CELL-TYPE MUCIN; BIFIDOBACTERIUM-LONGUM; MILK OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; EXPRESSION CLONING; MOLECULAR-CLONING; ADENOMA MALIGNUM	In mammals, alpha-linked GlcNAc is primarily found in heparan sulfate/heparin and gastric gland mucous cell type mucin. alpha-N-Acetylglucosaminidases (alpha GNases) belonging to glycoside hydrolase family 89 are widely distributed from bacteria to higher eukaryotes. Human lysosomal alpha GNase is well known to degrade heparin and heparan sulfate. Here, we reveal the substrate specificity of alpha GNase (AgnC) from Clostridium perfringens strain 13, a bacterial homolog of human alpha GNase, by chemically synthesizing a series of disaccharide substrates containing alpha-linked GlcNAc. AgnC was found to release GlcNAc from GlcNAc alpha 1,4Gal beta 1pMP and GlcNAc alpha 1pNP substrates (where pMP and pNP represent p-methoxyphenyl and p-nitrophenyl, respectively). AgnC also released GlcNAc from porcine gastric mucin and cell surface mucin. Because AgnC showed no activity against any of the GlcNAc alpha 1,2Gal beta 1pMP, GlcNAc alpha 1,3Gal beta 1pMP, GlcNAc alpha 1,6Gal beta 1pMP, and GlcNAc alpha 1,4GlcA beta 1pMP substrates, this enzyme may represent a specific glycosidase required for degrading alpha-GlcNAc-capped O-glycans of the class III mucin secreted from the stomach and duodenum. Deletion of the C-terminal region containing several carbohydrate-binding module 32 (CBM32) domains significantly reduced the activity for porcine gastric mucin; however, activity against GlcNAc alpha 1,4Gal beta 1pMP was markedly enhanced. Dot blot and ELISA analyses revealed that the deletion construct containing the C-terminal CBM-C2 to CBM-C6 domains binds strongly to porcine gastric mucin. Consequently, tandem CBM32 domains located near the C terminus of AgnC should function by increasing the affinity for branched or clustered alpha-GlcNAc-containing glycans. The agnC gene-disrupted strain showed significantly reduced growth on the class III mucin-containing medium compared with the wild type strain, suggesting that AgnC might have an important role in dominant growth in intestines.	[Fujita, Masaya; Tsuchida, Akiko; Kobayashi, Natsumi; Goto, Kohtaro; Osumi, Kenji; Hirose, Yuriko; Yamanoi, Takashi; Mizuno, Mamoru] Noguchi Inst, Itabashi Ku, Tokyo 1730003, Japan; [Nakayama, Jun] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; [Hirata, Akiko; Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Shinshu University; Kyoto University	Fujita, M (corresponding author), Noguchi Inst, Itabashi Ku, 1-8-1 Kaga, Tokyo 1730003, Japan.	fujita@noguchi.or.jp; ashida@lif.kyoto-u.ac.jp	Ashida, Hisashi/HCI-0293-2022	Ashida, Hisashi/0000-0001-5844-4075	Kieikai Research Foundation; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	Kieikai Research Foundation(Kieikai Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Kieikai Research Foundation (to H. A.).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Ashida H, 2002, BIOCHEMISTRY-US, V41, P2388, DOI 10.1021/bi011940e; Ashida H, 2001, J BIOL CHEM, V276, P28226, DOI 10.1074/jbc.M103589200; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Ficko-Blean E, 2009, J BIOL CHEM, V284, P9876, DOI 10.1074/jbc.M808954200; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fujita M., 2007, GLYCOCONJ J, V24, P326; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Homer KA, 1996, MICROBIOL-UK, V142, P1221, DOI 10.1099/13500872-142-5-1221; HOMER KA, 1993, INFECT IMMUN, V61, P295, DOI 10.1128/IAI.61.1.295-302.1993; HOPWOOD JJ, 1982, CLIN CHIM ACTA, V120, P77, DOI 10.1016/0009-8981(82)90079-1; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; JANN B, 1994, CARBOHYD RES, V264, P305, DOI 10.1016/S0008-6215(05)80014-X; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Kobayashi M, 2009, CURR DRUG METAB, V10, P29, DOI 10.2174/138920009787048428; Lee H, 2008, GLYCOBIOLOGY, V18, P549, DOI 10.1093/glycob/cwn037; Lee H, 2006, BIOCHEM BIOPH RES CO, V349, P1235, DOI 10.1016/j.bbrc.2006.08.145; LLOYD KO, 1969, J IMMUNOL, V102, P1354; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Ogawa H, 2000, J BIOL CHEM, V275, P19368, DOI 10.1074/jbc.M001888200; Ota H, 2001, AM J CLIN PATHOL, V115, P69; PAROLIS H, 1990, CARBOHYD RES, V200, P449, DOI 10.1016/0008-6215(90)84210-L; ROSEMAN S, 1951, J BIOL CHEM, V191, P607; SCHMIDT RR, 1984, LIEBIGS ANN CHEM, P1343, DOI 10.1002/jlac.198419840710; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Utsugi K, 1999, GYNECOL ONCOL, V75, P345, DOI 10.1006/gyno.1999.5622; VANHALBEEK H, 1983, BIOCHIM BIOPHYS ACTA, V747, P107, DOI 10.1016/0167-4838(83)90128-0; VONFIGURA K, 1977, EUR J BIOCHEM, V80, P535; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; WEISSMANN B, 1967, BIOCHEMISTRY-US, V6, P207, DOI 10.1021/bi00853a033	41	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6479	6489		10.1074/jbc.M110.206722	http://dx.doi.org/10.1074/jbc.M110.206722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177247	hybrid, Green Published			2022-12-25	WOS:000287476400058
J	Helbig, S; Patzer, SI; Schiene-Fischer, C; Zeth, K; Braun, V				Helbig, Stephanie; Patzer, Silke I.; Schiene-Fischer, Cordelia; Zeth, Kornelius; Braun, Volkmar			Activation of Colicin M by the FkpA Prolyl Cis-Trans Isomerase/Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; OUTER-MEMBRANE; PERIPLASMIC PROTEIN; SIGNAL-TRANSDUCTION; CHAPERONE FUNCTION; ISOMERASE; SURA; SKP	Colicin M (Cma) is specifically imported into the periplasm of Escherichia coli and kills the cells. Killing depends on the periplasmic peptidyl prolyl cis-trans isomerase/chaperone FkpA. To identify the Cma prolyl bonds targeted by FkpA, we replaced the 15 proline residues individually with alanine. Seven mutant proteins were fully active; Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1%, and Cma(P107A) displayed 10% of the wild-type activity. Cma(P107A), Cma(P129A), and Cma(P260A), but not Cma(P176A), killed cells after entering the periplasm via osmotic shock, indicating that the former mutants were translocation-deficient; Cma(P129A) did not bind to the FhuA outer membrane receptor. The crystal structures of Cma and Cma(P176A) were identical, excluding inactivation of the activity domain located far from Pro-176. In a new peptidyl prolyl cis-trans isomerase assay, FkpA isomerized the Cma prolyl bond in peptide Phe-Pro-176 at a high rate, but Lys-Pro-107 and Leu-Pro-260 isomerized at only < 10% of that rate. The four mutant proteins secreted into the periplasm via a fused signal sequence were toxic but much less than wild-type Cma. Wild-type and mutant Cma proteins secreted or translocated across the outer membrane by energy-coupled import or unspecific osmotic shock were only active in the presence of FkpA. We propose that Cma unfolds during transfer across the outer or cytoplasmic membrane and refolds to the active form in the periplasm assisted by FkpA. Weak refolding of Cma(P176A) would explain its low activity in all assays. Of the four proline residues identified as being important for Cma activity, Phe-Pro-176 is most likely targeted by FkpA.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Schiene-Fischer, Cordelia] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society; Max Planck Society		volkmar.braun@tuebingen.mpg.de			Max Planck Society; German Science Foundation [BR 30/25-1]; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society, the German Science Foundation (BR 30/25-1), and the Fonds der Chemischen Industrie.	Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; BENSON SA, 1984, P NATL ACAD SCI-BIOL, V81, P3830, DOI 10.1073/pnas.81.12.3830; Betton JM, 2007, PERIPLASM, P141; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Braun M, 2003, J BACTERIOL, V185, P5508, DOI 10.1128/JB.185.18.5508-5518.2003; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; DREHER R, 1985, ARCH MICROBIOL, V140, P343, DOI 10.1007/BF00446975; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Gross P, 1996, MOL GEN GENET, V251, P388, DOI 10.1007/BF02172531; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; Kleinschmidt JH, 2007, PERIPLASM, P30; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; OLSCHLAGER T, 1991, ARCH MICROBIOL, V156, P449, DOI 10.1007/BF00245391; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Ramm K, 2001, J MOL BIOL, V310, P485, DOI 10.1006/jmbi.2001.4747; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; SCHALLER K, 1982, J BACTERIOL, V152, P994; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stymest KH, 2008, FEBS J, V275, P3470, DOI 10.1111/j.1742-4658.2008.06493.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THUMM G, 1988, PLASMID, V20, P75, DOI 10.1016/0147-619X(88)90009-1; TILBY M, 1978, J BACTERIOL, V136, P1189, DOI 10.1128/JB.136.3.1189-1191.1978; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; WEISSHOFF H, 1995, FEBS LETT, V372, P203, DOI 10.1016/0014-5793(95)00982-F; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	54	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6280	6290		10.1074/jbc.M110.165274	http://dx.doi.org/10.1074/jbc.M110.165274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149455	hybrid, Green Published			2022-12-25	WOS:000287476400038
J	Takawira, D; Budinger, GRS; Hopkinson, SB; Jones, JCR				Takawira, Desire; Budinger, G. R. Scott; Hopkinson, Susan B.; Jones, Jonathan C. R.			A Dystroglycan/Plectin Scaffold Mediates Mechanical Pathway Bifurcation in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; DYSTROPHIN-GLYCOPROTEIN COMPLEX; EPIDERMOLYSIS-BULLOSA; SIGNAL-TRANSDUCTION; MUSCULAR-DYSTROPHY; BETA-DYSTROGLYCAN; TIDAL VOLUME; PLECTIN; BINDING	In alveolar epithelial cells (AECs), the membrane-anchored proteoglycan dystroglycan (DG) is a mechanoreceptor that transmits mechanical stretch forces to activate independently the ERK1/2 and the adenosine 5'-monophosphate-activated protein kinase (AMPK) signaling cascades in a process called pathway bifurcation. We tested the hypothesis that the cytoskeleton cross-linker plectin, known to bind both DG and AMPK in muscle cells, acts as a scaffold to regulate DG-mediated mechanical stimulation and pathway bifurcation. We demonstrate that plectin and DG form a complex in AECs and that this complex interacts with ERK1/2 and AMPK. Plectin knockdown reduces DG interaction with AMPK but not with ERK1/2. Despite this, mechanoactivation of both signaling pathways is significantly attenuated in AECs deficient in plectin. Thus, DG has the dual role of mechanical receptor and scaffold for ERK1/2, whereas plectin acts as a scaffold for AMPK signaling but is also required for DG-mediated ERK1/2 activation. We conclude that the DG-plectin complex plays a central role in transmitting mechanical stress from the extracellular matrix to the cytoplasm.	[Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Budinger, G. R. Scott; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 HL092963]; American Heart Association (Midwest Affiliate) [0815527G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Midwest Affiliate)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL092963 (to J. C. R. J. and G. R. S. B.).; Supported by Predoctoral Fellowship Award 0815527G from the American Heart Association (Midwest Affiliate).	Arreola-Mendoza L, 2009, TOXICOL LETT, V191, P279, DOI 10.1016/j.toxlet.2009.09.011; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; Budinger GRS, 2008, AM J RESP CELL MOL, V39, P666, DOI 10.1165/rcmb.2007-0432OC; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; DeBiase PJ, 2006, J HISTOCHEM CYTOCHEM, V54, P665, DOI 10.1369/jhc.5A6889.2006; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Gregor M, 2006, J CELL SCI, V119, P1864, DOI 10.1242/jcs.02891; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jones JCR, 2005, J CELL SCI, V118, P2557, DOI 10.1242/jcs.02395; Karagounis LG, 2009, INT J BIOCHEM CELL B, V41, P2360, DOI 10.1016/j.biocel.2009.07.004; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KLATTE DH, 1989, J CELL BIOL, V109, P3377, DOI 10.1083/jcb.109.6.3377; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Na S, 2009, AM J PHYSIOL-CELL PH, V296, pC868, DOI 10.1152/ajpcell.00604.2008; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vlahakis NE, 2005, AM J RESP CRIT CARE, V171, P1328, DOI 10.1164/rccm.200408-1036SO; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wiche G, 1998, J CELL SCI, V111, P2477; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	65	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6301	6310		10.1074/jbc.M110.178988	http://dx.doi.org/10.1074/jbc.M110.178988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149456	hybrid, Green Published			2022-12-25	WOS:000287476400040
J	Tanaka, M; Mazuyama, E; Arakaki, A; Matsunaga, T				Tanaka, Masayoshi; Mazuyama, Eri; Arakaki, Atsushi; Matsunaga, Tadashi			MMS6 Protein Regulates Crystal Morphology during Nano-sized Magnetite Biomineralization in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN AMB-1; COMPLETE GENOME SEQUENCE; MAGNETOTACTIC BACTERIA; MAGNETOSPIRILLUM-MAGNETICUM; PROTEOMIC ANALYSIS; MAGNETOSOMES; REVEALS; GROWTH; CRYSTALLIZATION; NANOCRYSTALS	Biomineralization, the process by which minerals are deposited by organisms, has attracted considerable attention because this mechanism has shown great potential to inspire bottom-up material syntheses. To understand the mechanism for morphological regulation that occurs during biomineralization, many regulatory proteins have been isolated from various biominerals. However, the molecular mechanisms that regulate the morphology of biominerals remain unclear because there is a lack of in vivo evidence. Magnetotactic bacteria synthesize intracellular magnetosomes that comprise membrane-enveloped single crystalline magnetite (Fe3O4). These nano-sized magnetite crystals (< 100 nm) are bacterial species dependent in shape and size. Mms6 is a protein that is tightly associated with magnetite crystals. Based on in vitro experiments, this protein was first implicated in morphological regulation during nano-sized magnetite biomineralization. In this study, we analyzed the mms6 gene deletion mutant (Delta mms6) of Magnetospirillum magneticum (M. magneticum) AMB-1. Surprisingly, the Delta mms6 strain was found to synthesize the smaller magnetite crystals with uncommon crystal faces, while the wild-type and complementation strains synthesized highly ordered cubo-octahedral crystals. Furthermore, deletion of mms6 gene led to drastic changes in the profiles of the proteins tightly bound to magnetite crystals. It was found that Mms6 plays a role in the in vivo regulation of the crystal structure to impart the cubo-octahedral morphology to the crystals during biomineralization in magnetotactic bacteria. Magnetotactic bacteria synthesize magnetite crystals under ambient conditions via a highly controlled morphological regulation system that uses biological molecules.	[Tanaka, Masayoshi; Mazuyama, Eri; Arakaki, Atsushi; Matsunaga, Tadashi] Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology	Matsunaga, T (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol, 2-24-16 Naka Cho, Tokyo 1848588, Japan.	tmatsuna@cc.tuat.ac.jp	Arakaki, Atsushi/B-9984-2013; Tanaka, Masayoshi/G-1072-2013; Matsunaga, Tadashi/A-6293-2015; Tanaka, Masayoshi/O-5259-2018	Arakaki, Atsushi/0000-0001-6692-9398; Tanaka, Masayoshi/0000-0002-4701-5352; Matsunaga, Tadashi/0000-0002-6216-3687; Tanaka, Masayoshi/0000-0002-4701-5352	Japan Society for the Promotion of Science (JSPS) [20246119]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2206]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (A) (No. 20246119) from the Japan Society for the Promotion of Science (JSPS), and the Grant-in-Aid for Scientific Research on Innovative Areas of "Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control" (No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Alphandery E, 2009, ACS NANO, V3, P1539, DOI 10.1021/nn900289n; Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Avasthi DK, 2010, J NANOSCI NANOTECHNO, V10, P3767, DOI 10.1166/jnn.2010.1979; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; De Yoreo JJ, 2007, CRYSTENGCOMM, V9, P1144, DOI 10.1039/b713006f; Devouard B, 1998, AM MINERAL, V83, P1387, DOI 10.2138/am-1998-11-1228; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Fukuda Y, 2006, FEBS LETT, V580, P801, DOI 10.1016/j.febslet.2006.01.003; Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; Maeda Y, 2008, APPL ENVIRON MICROB, V74, P5139, DOI 10.1128/AEM.00618-08; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Matsunaga T, 2009, PROTEOMICS, V9, P3341, DOI 10.1002/pmic.200800881; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Oaki Y, 2006, ADV FUNCT MATER, V16, P1633, DOI 10.1002/adfm.200600262; Okamura Y, 2003, APPL ENVIRON MICROB, V69, P4274, DOI 10.1128/AEM.69.7.4274-4277.2003; Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200; Posfai M, 1998, AM MINERAL, V83, P1469, DOI 10.2138/am-1998-11-1235; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881; Tanaka M, 2006, PROTEOMICS, V6, P5234, DOI 10.1002/pmic.200500887; Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; Tanaka M, 2010, MOL MICROBIOL, V76, P480, DOI 10.1111/j.1365-2958.2010.07117.x; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang TX, 2005, J AM CHEM SOC, V127, P3246, DOI 10.1021/ja045331g; Xiao JW, 2010, LANGMUIR, V26, P4977, DOI 10.1021/la903641k; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X; Yoshino T, 2004, APPL ENVIRON MICROB, V70, P2880, DOI 10.1128/AEM.70.5.2880-2885.2004; Zhang J. S., 2003, SELF ASSEMBLED NANOS	46	127	136	2	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6386	6392		10.1074/jbc.M110.183434	http://dx.doi.org/10.1074/jbc.M110.183434			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169637	Green Published, hybrid			2022-12-25	WOS:000287476400049
J	Sanchez-Martin, D; Cuesta, AM; Fogal, V; Ruoslahti, E; Alvarez-Vallina, L				Sanchez-Martin, David; Cuesta, Angel M.; Fogal, Valentina; Ruoslahti, Erkki; Alvarez-Vallina, Luis			The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; ENDOTHELIAL-CELLS; IN-VIVO; BINDING-PROTEIN; HOMING PEPTIDE; GLOBULAR HEADS; SURFACE; C1Q; LOCALIZATION; EXPRESSION	Tumor-associated cell surface antigens and tumor-associated vascular markers have been used as a target for cancer intervention strategies. However, both types of targets have limitations due to accessibility, low and/or heterogeneous expression, and presence of tumor-associated serum antigen. It has been previously reported that a mitochondrial/cell surface protein, p32/gC1qR, is the receptor for a tumor-homing peptide, LyP-1, which specifically recognizes an epitope in tumor cells, tumor lymphatics, and tumor-associated macrophages/myeloid cells. Using antibody phage technology, we have generated an anti-p32 human monoclonal antibody (2.15). The 2.15 antibody, expressed in single-chain fragment variable and in trimerbody format, was then characterized in vivo using mice grafted subcutaneously with MDA-MB-231 human breast cancers cells, revealing a highly selective tumor uptake. The intratumoral distribution of the antibody was consistent with the expression pattern of p32 in the surface of some clusters of cells. These results demonstrate the potential of p32 for antibody-based tumor targeting strategies and the utility of the 2.15 antibody as targeting moiety for the selective delivery of imaging and therapeutic agents to tumors.	[Alvarez-Vallina, Luis] Hosp Univ Puerta Hierro, Unidad Inmunol Mol, Madrid 28222, Spain; [Fogal, Valentina; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA; [Ruoslahti, Erkki] Univ Calif Santa Barbara, Vasc Mapping Ctr, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA	Hospital Puerta de Hierro-Majadahonda; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara	Alvarez-Vallina, L (corresponding author), Hosp Univ Puerta Hierro, Unidad Inmunol Mol, C Manuel Falla 1, Madrid 28222, Spain.	lalvarezv.hpth@salud.madrid.org	Cuesta, Angel/F-1668-2011; AM, Cuesta/AAA-9356-2020; Sánchez-Martín, David/C-9927-2013; Álvarez-Vallina, Luis/A-2032-2010; Alvarez-Vallina, Luis/ABD-2431-2020; Alvarez-Vallina, Luis/A-2033-2010	Cuesta, Angel/0000-0002-6596-9600; AM, Cuesta/0000-0002-6596-9600; Sánchez-Martín, David/0000-0002-2712-4762; Alvarez-Vallina, Luis/0000-0003-3053-6757; 	Ministerio de Ciencia e Innovacion [BIO2008-03233]; Comunidad Autonoma de Madrid [BIO-0236-2006]; European Union [SUDOE-FEDER (IMMUNONET-SOE1/P1/E014]; U.S. Department of Defense; Comunidad Autonoma de Madrid/Fondo Social Europeo Training [FPI-000531]; Susan Komen Foundation	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Union(European Commission); U.S. Department of Defense(United States Department of Defense); Comunidad Autonoma de Madrid/Fondo Social Europeo Training(Comunidad de Madrid); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (BIO2008-03233), the Comunidad Autonoma de Madrid (S-BIO-0236-2006), the European Union (SUDOE-FEDER (IMMUNONET-SOE1/P1/E014; to L.A.-V.), and a grant from the U.S. Department of Defense Breast Cancer Program (to E. R.).; Supported by Comunidad Autonoma de Madrid/Fondo Social Europeo Training Grant FPI-000531.; Supported a fellowship from the Susan Komen Foundation.	Begent RHJ, 1996, NAT MED, V2, P979, DOI 10.1038/nm0996-979; Birchler M, 1999, J IMMUNOL METHODS, V231, P239, DOI 10.1016/S0022-1759(99)00160-X; Birchler MT, 2007, OTOLARYNG HEAD NECK, V136, P543, DOI 10.1016/j.otohns.2006.07.027; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Buchsbaum GM, 2004, INT UROGYNECOL J, V15, P432, DOI 10.1007/s00192-004-1181-5; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Cuesta AM, 2010, TRENDS BIOTECHNOL, V28, P355, DOI 10.1016/j.tibtech.2010.03.007; Cuesta AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005381; Dedio J, 1996, FEBS LETT, V399, P255, DOI 10.1016/S0014-5793(96)01339-7; Eggleton P, 2000, CLIN EXP IMMUNOL, V120, P406, DOI 10.1046/j.1365-2249.2000.01218.x; EGGLETON P, 1995, J CLIN INVEST, V95, P1569, DOI 10.1172/JCI117830; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gibson T., 1984, THESIS U CAMBRIDGE C; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; Harries M, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090075; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; JACOBSSON H, 1994, EUR J NUCL MED, V21, P582; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Kuna P, 1996, CLIN IMMUNOL IMMUNOP, V81, P48, DOI 10.1006/clin.1996.0156; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lynch NJ, 1997, FEBS LETT, V418, P111, DOI 10.1016/S0014-5793(97)01348-3; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Mahdi F, 2001, BLOOD, V97, P2342, DOI 10.1182/blood.V97.8.2342; McDevitt MR, 2000, CANCER RES, V60, P6095; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; Nguyen BD, 2009, CURR PROBL DIAGN RAD, V38, P68, DOI 10.1067/j.cpradiol.2007.10.003; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; OIKI S, 1988, J IMMUNOL, V141, P3177; Peerschke EIB, 1996, J IMMUNOL, V157, P4154; PEERSCHKE EIB, 1994, J IMMUNOL, V152, P5896; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Sanz L, 2001, CANCER IMMUNOL IMMUN, V50, P557, DOI 10.1007/s00262-001-0235-5; Silacci M, 2006, PROTEIN ENG DES SEL, V19, P471, DOI 10.1093/protein/gzl033; Steffen AC, 2006, EUR J NUCL MED MOL I, V33, P631, DOI 10.1007/s00259-005-0012-3; Steinberger P, 2002, J LEUKOCYTE BIOL, V71, P133; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; vandenBerg RH, 1997, J IMMUNOL, V158, P3909; Vegh Z, 2003, INT IMMUNOPHARMACOL, V3, P345, DOI 10.1016/S1567-5769(02)00234-5; VOGEL CA, 1993, BRIT J CANCER, V68, P684, DOI 10.1038/bjc.1993.410; YU L, 1995, J VIROL, V69, P3017, DOI 10.1128/JVI.69.5.3017-3023.1995	48	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5197	5203		10.1074/jbc.M110.161927	http://dx.doi.org/10.1074/jbc.M110.161927			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156793	hybrid, Green Published			2022-12-25	WOS:000287230600028
J	Jawad, MU; Garamszegi, N; Garamszegi, SP; Correa-Medina, M; Diez, JA; Wen, R; Scully, SP				Jawad, Muhammad Umar; Garamszegi, Nandor; Garamszegi, Susanna P.; Correa-Medina, Mayrin; Diez, Juan A.; Wen, Rong; Scully, Sean P.			Matrix Metalloproteinase 1: Role in Sarcoma Biology	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN CHONDROSARCOMA; GENE-EXPRESSION; TUMOR PROGRESSION; GROWTH-FACTOR; METALLOELASTASE MMP-12; LUNG METASTASIS; BREAST-CANCER; IN-VITRO; RT-PCR	In carcinomas stromal cells participate in cancer progression by producing proteases such as MMPs. The expression MMP1 is a prognostic factor in human chondrosarcoma, however the role in tumor progression is unknown. Laser capture microdissection and In Situ hybridization were used to determine cellular origin of MMP1 in human sarcomas. A xenogenic model of tumor progression was then used and mice were divided in two groups: each harboring either the control or a stably MMP1 silenced cell line. Animals were sacrificed; the neovascularization, primary tumor volumes, and metastatic burden were assessed. LCM and RNA-ISH analysis revealed MMP1 expression was predominantly localized to the tumor cells in all samples of sarcoma (p = 0.05). The percentage lung metastatic volume at 5 weeks (p = 0.08) and number of spontaneous deaths secondary to systemic tumor burden were lower in MMP1 silenced cell bearing mice. Interestingly, this group also demonstrated a larger primary tumor size (p < 0.04) and increased angiogenesis (p < 0.01). These findings were found to be consistent when experiment was repeated using a second independent MMP1 silencing sequence. Prior clinical trials employing MMP1 inhibitors failed because of a poor understanding of the role of MMPs in tumor progression. The current findings indicating tumor cell production of MMP1 by sarcoma cells is novel and highlights the fundamental differences in MMP biology between carcinomas and sarcomas. The results also emphasize the complex roles of MMP in tumor progression of sarcomas. Not only does metastasis seem to be affected by MMP1 silencing, but also local tumor growth and angiogenesis are affected inversely.	[Jawad, Muhammad Umar; Garamszegi, Nandor; Garamszegi, Susanna P.; Scully, Sean P.] Univ Miami, Miller Sch Med, Univ Miami Hosp, Dept Orthoped, Miami, FL 33136 USA; [Wen, Rong] Univ Miami, Miller Sch Med, McKnight Vis Ctr, Bascom Palmer Eyes Inst,Dept Ophthalmol, Miami, FL 33136 USA; [Correa-Medina, Mayrin; Diez, Juan A.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami	Jawad, MU (corresponding author), Univ Miami, Miller Sch Med, Univ Miami Hosp, Dept Orthoped, Miami, FL 33136 USA.	sscully@med.miami.edu	Diez Juan, Antonio/D-3695-2018; Jawad, Muhammad Umar/A-2672-2017	Jawad, Muhammad Umar/0000-0002-0667-5063	NCI [CA096796]; NATIONAL CANCER INSTITUTE [R01CA096796] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The senior author received funding from NCI (CA096796) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Berend KR, 1998, J BONE JOINT SURG AM, V80A, P11, DOI 10.2106/00004623-199801000-00004; Bhuvarahamurthy V, 2006, ONCOL REP, V15, P1379; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Drummond AH, 1999, ANN NY ACAD SCI, V878, P228, DOI 10.1111/j.1749-6632.1999.tb07688.x; ECK SM, 2008, BREAST CANC RES TREA; Erickson HS, 2007, LAB INVEST, V87, P951, DOI 10.1038/labinvest.3700659; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fong YC, 2004, CLIN CANCER RES, V10, P7329, DOI 10.1158/1078-0432.CCR-04-0900; GARAMSZEGI N, 2008, EXP CELL RE IN PRESS; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Haupt LM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-18; Healey JH, 2008, CLIN ORTHOP RELAT R, V466, P2029, DOI 10.1007/s11999-008-0353-x; Jiang XL, 2003, J ORTHOP RES, V21, P1063, DOI 10.1016/S0736-0266(03)00079-2; Kerkela E, 2002, J PATHOL, V198, P258, DOI 10.1002/path.1198; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; Makino Hiroshi, 2008, BMC Cancer, V8, P210, DOI 10.1186/1471-2407-8-210; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Merchan JR, 2006, JNCI-J NATL CANCER I, V98, P756, DOI 10.1093/jnci/djj208; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; POLYAK K, 2008, TRENDS GENET; Rio MC, 2005, BIOCHIMIE, V87, P299, DOI 10.1016/j.biochi.2004.11.016; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Salmela MT, 2001, BRIT J CANCER, V85, P383, DOI 10.1054/bjoc.2001.1929; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Scully SP, 2000, CLIN ORTHOP RELAT R, pS55; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; SOORIAKUMARAN P, 2008, INT J SURG PATHOL; Thrall DE, 1997, RADIOTHER ONCOL, V44, P171, DOI 10.1016/S0167-8140(97)01931-2; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WITTY JP, 1995, CANCER RES, V55, P1401; Witz IP, 2008, ADV CANCER RES, V100, P203, DOI 10.1016/S0065-230X(08)00007-9; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; Zheng MH, 2000, HUM PATHOL, V31, P804, DOI 10.1053/hupa.2000.8441	48	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14250	10.1371/journal.pone.0014250	http://dx.doi.org/10.1371/journal.pone.0014250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170377	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100004
J	Parise, E; Friederici, AD; Striano, T				Parise, Eugenio; Friederici, Angela D.; Striano, Tricia			"Did You Call Me?" 5-Month-Old Infants Own Name Guides Their Attention	PLOS ONE			English	Article							EYE CONTACT INFLUENCES; JOINT ATTENTION; BRAIN RESPONSES; VOCAL CUES; RECOGNITION; EXPRESSIONS; OBJECTS; AUTISM; MEMORY; WORDS	An infant's own name is a unique social cue. Infants are sensitive to their own name by 4 months of age, but whether they use their names as a social cue is unknown. Electroencephalogram (EEG) was measured as infants heard their own name or stranger's names and while looking at novel objects. Event related brain potentials (ERPs) in response to names revealed that infants differentiate their own name from stranger names from the first phoneme. The amplitude of the ERPs to objects indicated that infants attended more to objects after hearing their own names compared to another name. Thus, by 5 months of age infants not only detect their name, but also use it as a social cue to guide their attention to events and objects in the world.	[Parise, Eugenio; Friederici, Angela D.; Striano, Tricia] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Parise, Eugenio] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary; [Striano, Tricia] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA	Max Planck Society; Central European University; City University of New York (CUNY) System; Hunter College (CUNY)	Parise, E (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	eugenioparise@tiscali.it; tstriano@hunter.cuny.edu	Parise, Eugenio/ABC-3974-2021; Parise, Eugenio/ABD-9940-2021	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370	Alexander von Humboldt Foundation; German Federal Ministry of Education and Research; Humboldt Research Fellowship; Calabria Region, Italy	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Humboldt Research Fellowship(Alexander von Humboldt Foundation); Calabria Region, Italy(Regione Calabria)	This research was supported by the Sofja Kovalevskaja Award granted by the Alexander von Humboldt Foundation, donated by the German Federal Ministry of Education and Research, to T. Striano (http://www.humboldt-foundation.de/web/start.html). In addition, E. Parise was funded by a Humboldt Research Fellowship and by a grant from Calabria Region, Italy (http://www.regione.calabria.it/ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Carmody DP, 2006, BRAIN RES, V1116, P153, DOI 10.1016/j.brainres.2006.07.121; Cleveland A, 2007, INFANT BEHAV DEV, V30, P499, DOI 10.1016/j.infbeh.2006.10.009; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; FRIEDERICI AD, 2008, HDB DEV COGNITIVE NE, P117; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Friedrich M, 2005, NEUROREPORT, V16, P653, DOI 10.1097/00001756-200504250-00028; Grossmann T, 2007, SOC COGN AFFECT NEUR, V2, P284, DOI 10.1093/scan/nsm025; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Grossmann T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00201; Grossmann T, 2010, BIOL LETTERS, V6, P540, DOI 10.1098/rsbl.2009.1069; Hoehl S, 2008, DEVELOPMENTAL SCI, V11, P10, DOI 10.1111/j.1467-7687.2007.00643.x; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Hoehl S, 2009, CHILD DEV, V80, P968, DOI 10.1111/j.1467-8624.2009.01311.x; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Holeckova I, 2008, BRAIN RES, V1189, P152, DOI 10.1016/j.brainres.2007.10.091; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; MAENNEL G, 2010, J COGNITIVE NEUROS S, P291; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; MANDELEMER D, 2003, WHATS NAME INFANTS R; Naatanen R, 2002, NEUROSCI LETT, V318, P49, DOI 10.1016/S0304-3940(01)02438-7; Nelson C.A., 1997, BIOLOGICAL NEUROPSYC; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Parise E, 2008, SOC NEUROSCI-UK, V3, P141, DOI 10.1080/17470910701865458; Parise E, 2007, INFANT BEHAV DEV, V30, P380, DOI 10.1016/j.infbeh.2006.10.006; Reid VM, 2004, NEUROREPORT, V15, P2553, DOI 10.1097/00001756-200411150-00025; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; Sheehan EA, 2008, TRENDS LANG ACQUIS R, V5, P161; Stahl D, 2010, BRAIN DEV-JPN, V32, P305, DOI 10.1016/j.braindev.2009.04.001; Striano T., 2008, SOCIAL COGNITION DEV; Striano T, 2006, SOC COGN AFFECT NEUR, V1, P87, DOI 10.1093/scan/nsl008; Striano T, 2006, EUR J NEUROSCI, V23, P2819, DOI 10.1111/j.1460-9568.2006.04822.x; Thierry G, 2003, NEUROREPORT, V14, P2307, DOI 10.1097/00001756-200312190-00004; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; WALKERANDREWS AS, 1983, INFANT BEHAV DEV, V6, P491, DOI 10.1016/S0163-6383(83)90331-4; Weber C, 2004, COGNITIVE BRAIN RES, V18, P149, DOI 10.1016/j.cogbrainres.2003.10.001; Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029	50	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14208	10.1371/journal.pone.0014208	http://dx.doi.org/10.1371/journal.pone.0014208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	689PF	21151971	Green Published, Green Accepted, gold			2022-12-25	WOS:000284939600005
J	Tsang, SM; Liu, L; Teh, MT; Wheeler, A; Grose, R; Hart, IR; Garrod, DR; Fortune, F; Wan, H				Tsang, Siu Man; Liu, Li; Teh, Muy-Teck; Wheeler, Ann; Grose, Richard; Hart, Ian R.; Garrod, David R.; Fortune, Farida; Wan, Hong			Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of Src	PLOS ONE			English	Article							PEMPHIGUS-VULGARIS-IGG; CELL-CELL ADHESION; GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; CULTURED KERATINOCYTES; IMMUNOELECTRON MICROSCOPY; TYROSINE PHOSPHORYLATION; FAMILY KINASES; DESMOSOMES; PLAKOGLOBIN	Background: Desmoglein 3 (Dsg3), a desmosomal adhesion protein, is expressed in basal and immediate suprabasal layers of skin and across the entire stratified squamous epithelium of oral mucosa. However, increasing evidence suggests that the role of Dsg3 may involve more than just cell-cell adhesion. Methodology/Principal Findings: To determine possible additional roles of Dsg3 during epithelial cell adhesion we used overexpression of full-length human Dsg3 cDNA, and RNAi-mediated knockdown of this molecule in various epithelial cell types. Overexpression of Dsg3 resulted in a reduced level of E-cadherin but a colocalisation with the E-cadherin-catenin complex of the adherens junctions. Concomitantly these transfected cells exhibited marked migratory capacity and the formation of filopodial protrusions. These latter events are consistent with Src activation and, indeed, Src-specific inhibition reversed these phenotypes. Moreover Dsg3 knockdown, which also reversed the decreased level of E-cadherin, partially blocked Src phosphorylation. Conclusions/Significance: Our data are consistent with the possibility that Dsg3, as an up-stream regulator of Src activity, helps regulate adherens junction formation.	[Tsang, Siu Man; Teh, Muy-Teck; Fortune, Farida; Wan, Hong] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Liu, Li] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Infect Dis, London, England; [Wheeler, Ann] Queen Mary Univ London, Barts & London Sch Med & Dent, Imaging Facil, Blizard Inst Cell & Mol Sci, London, England; [Grose, Richard; Hart, Ian R.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc, Tumor Biol Ctr, London, England; [Garrod, David R.] King Saud Univ, Riyadh, Saudi Arabia; [Garrod, David R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; King Saud University; University of Manchester	Tsang, SM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	h.wan@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Garrod, David/0000-0003-0300-3947; Grose, Richard/0000-0002-4738-0173; Wheeler, Ann/0000-0001-8617-827X	Medical Research Council; Institute of Dentistry; Medical Research Council [G113/32, G0700074] Funding Source: researchfish; MRC [G113/32, G0700074] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Dentistry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Career Development Fellowship to HW and by the Institute of Dentistry. Siu Man Tsang is supported by a Medical Research Council funded studentship to Barts and London School of Medicine and Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1996, J INVEST DERMATOL, V106, P351, DOI 10.1111/1523-1747.ep12343081; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Bedane C, 1996, ARCH DERMATOL RES, V288, P343, DOI 10.1007/s004030050061; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Borrmann CM, 2006, EUR J CELL BIOL, V85, P469, DOI 10.1016/j.ejcb.2006.02.009; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Elias PM, 2001, J CELL BIOL, V153, P243, DOI 10.1083/jcb.153.2.243; Ezaki T, 2007, AM J PHYSIOL-GASTR L, V293, pG54, DOI 10.1152/ajpgi.00533.2006; Fukuoka J, 2007, HUM PATHOL, V38, P276, DOI 10.1016/j.humpath.2006.08.006; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Grosheva I, 2001, J CELL SCI, V114, P695; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; HUANG CC, 2009, LARYNGOSCOPE; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Koch PJ, 1998, J CELL SCI, V111, P2529; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Koster MI, 2005, J INVEST DERM SYMP P, V10, P118, DOI 10.1111/j.1087-0024.2005.200416.x; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Liu Zhong-Qi, 2007, Zhonghua Yi Xue Za Zhi, V87, P2541; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Pittella F, 2001, PATHOL RES PRACT, V197, P85, DOI 10.1078/0344-0338-00014; PLOTT RT, 1994, J INVEST DERMATOL, V103, P168, DOI 10.1111/1523-1747.ep12392642; Pulkkinen L, 2002, J INVEST DERMATOL, V119, P1237, DOI 10.1046/j.1523-1747.2002.19645.x; ROH JY, 1995, J INVEST DERMATOL, V104, P720, DOI 10.1111/1523-1747.ep12606963; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Shimizu A, 2002, ARCH DERMATOL RES, V294, P318, DOI 10.1007/s00403-002-0341-z; Shinohara M, 1998, J PATHOL, V184, P369, DOI 10.1002/(SICI)1096-9896(199804)184:4<369::AID-PATH1236>3.0.CO;2-L; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; SUTER MM, 1990, AM J VET RES, V51, P507; Takahashi Hidetoshi, 1995, Journal of Dermatology (Tokyo), V22, P576; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; Wan H, 2007, EXP CELL RES, V313, P2336, DOI 10.1016/j.yexcr.2007.01.010; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	61	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14211	10.1371/journal.pone.0014211	http://dx.doi.org/10.1371/journal.pone.0014211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151980	Green Published, gold, Green Submitted			2022-12-25	WOS:000284939600006
J	Forsman, ZH; Concepcion, GT; Haverkort, RD; Shaw, RW; Maragos, JE; Toonen, RJ				Forsman, Zac H.; Concepcion, Gregory T.; Haverkort, Roxanne D.; Shaw, Ross W.; Maragos, James E.; Toonen, Robert J.			Ecomorph or Endangered Coral? DNA and Microstructure Reveal Hawaiian Species Complexes: Montipora dilatata/flabellata/turgescens & M. patula/verrilli	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENUS ACROPORA; EVOLUTION; MITOCHONDRIAL; HYBRIDIZATION; PLASTICITY; PATTERNS	M. dilatata, M. flabellata, and M. patula and 80 other scleractinian corals were petitioned to be listed under the US Endangered Species Act (ESA), which would have major conservation implications. One of the difficulties with this evaluation is that reproductive boundaries between morphologically defined coral species are often permeable, and morphology can be wildly variable. We examined genetic and morphological variation in Hawaiian Montipora with a suite of molecular markers (mitochondrial: COI, CR, Cyt-B, 16S, ATP6; nuclear: ATPs beta, ITS) and microscopic skeletal measurements. Mitochondrial markers and the ITS region revealed four distinct clades: I) M. patula/M. verrilli, II) M. cf. incrassata, III) M. capitata, IV) M. dilatata/M. flabellata/M. cf. turgescens. These clades are likely to occur outside of Hawai'i according to mitochondrial control region haplotypes from previous studies. The ATPs beta intron data showed a pattern often interpreted as resulting from hybridization and introgression; however, incomplete lineage sorting may be more likely since the multicopy nuclear ITS region was consistent with the mitochondrial data. Furthermore, principal components analysis (PCA) of skeletal microstructure was concordant with the mitochondrial clades, while nominal taxa overlapped. The size and shape of verrucae or papillae contributed most to identifying groups, while colony-level morphology was highly variable. It is not yet clear if these species complexes represent population-level variation or incipient speciation (CA<1MYA), two alternatives that have very different conservation implications. This study highlights the difficulty in understanding the scale of genetic and morphological variation that corresponds to species as opposed to population-level variation, information that is essential for conservation and for understanding coral biodiversity.	[Forsman, Zac H.; Haverkort, Roxanne D.; Toonen, Robert J.] Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Concepcion, Gregory T.] Univ Maryland, College Pk, MD 20742 USA; [Shaw, Ross W.] Grant MacEwan Univ, Dept Biol, Edmonton, AB, Canada; [Maragos, James E.] US Fish & Wildlife Serv, Honolulu, HI USA	University of Hawaii System; University System of Maryland; University of Maryland College Park; United States Department of the Interior; US Fish & Wildlife Service	Forsman, ZH (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	zac@hawaii.edu	Toonen, Rob/K-2891-2012; Shaw, Ross/AAC-5404-2022; Toonen, Rob/V-6230-2019; Forsman, Zac/F-1266-2015	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Forsman, Zac/0000-0002-5837-3614	National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office [NMFS-PRPO-2010-2001945]; NOAA National Marine Sanctuaries Partnership [2005-008/66882]; MacEwan University Research Office and Divisional Arts and Science	National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA National Marine Sanctuaries Partnership; MacEwan University Research Office and Divisional Arts and Science	The work was made possible by funding from a grant from the National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service, Pacific Islands Regional Office; NMFS-PRPO-2010-2001945. ZHF was supported by a fellowship from NOAA National Marine Sanctuaries Partnership MOA#2005-008/66882. RWS was supported by funding from Grant MacEwan University Research Office and Divisional Arts and Science grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HM, 1897, GENUS MONTIPORA GENU; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; CONCEPCION GT, 2009, CONSERVATION GENET R, P1; DRUMMOND AJ, 2009, GENEIOUS V4 8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenner D, 2005, CORALS HAWAII; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; GRAHAM K, 2007, NOAA NATL MARINE FIS; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maragos J. E., 1977, REEF SHORE FAUNA HAW, P158; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; SAKASHITA M, 2009, PETITION LIST 83 COR; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; van Oppen MJH, 1999, P ROY SOC B-BIOL SCI, V266, P179, DOI 10.1098/rspb.1999.0619; van Oppen MJH, 2004, MAR BIOL, V144, P9, DOI 10.1007/s00227-003-1188-3; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; Wells J.W., 1956, TREATISE INVERTEBR F, P328; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6	39	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15021	10.1371/journal.pone.0015021	http://dx.doi.org/10.1371/journal.pone.0015021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151995	gold, Green Published			2022-12-25	WOS:000284868000023
J	Lin, JC; Chang, FY; Fung, CP; Yeh, KM; Chen, CT; Tsai, YK; Siu, LK				Lin, Jung-Chung; Chang, Feng-Yee; Fung, Chang-Phone; Yeh, Kuo-Ming; Chen, Chiung-Tong; Tsai, Yu-Kuo; Siu, L. Kristopher			Do Neutrophils Play a Role in Establishing Liver Abscesses and Distant Metastases Caused by Klebsiella pneumoniae?	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CAPSULAR SEROTYPE K1; DIABETES-MELLITUS; SEPTIC ENDOPHTHALMITIS; POLYMORPHONUCLEAR LEUKOCYTES; NECROTIZING FASCIITIS; NOSOCOMIAL PATHOGENS; EMERGING DISEASE; HIGH PREVALENCE; PHAGOCYTOSIS	Serotype K1 Klebsiella pneumoniae is a major cause of liver abscesses and endophthalmitis. This study was designed to identify the role of neutrophils in the development of distant metastatic complications that were caused by serotype K1 K. pneumoniae. An in vitro cellular model was used to assess serum resistance and neutrophil-mediated killing. BALB/c mice were injected with neutrophils containing phagocytosed K. pneumoniae. Serotype K1 K. pneumoniae was significantly more resistant to serum killing, neutrophil-mediated phagocytosis and intra-cellular killing than non-K1 isolates (p < 0.01). Electron microscopic examination had similar findings as in the bioassay findings. Intraperitoneal injection of neutrophils containing phagocytosed serotype K1 K. pneumoniae led to abscess formation in multiple sites including the subcutaneous tissue, lung, and liver, whereas no abscess formation was observed in mice injected with non-K1 isolates. The resistance of serotype K1 K. pneumoniae to complement- and neutrophil-mediated intracellular killing results in the dissemination of K. pneumoniae via the bloodstream. Escape from neutrophil intracellular killing may contribute to the dissemination and establishment of distant metastases. Thus, neutrophils play a role as a vehicle for helping K. pneumoniae and contributing to the establishment of liver abscess and distant metastatic complications.	[Lin, Jung-Chung; Chang, Feng-Yee; Yeh, Kuo-Ming; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Fung, Chang-Phone] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chiung-Tong] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Tsai, Yu-Kuo; Siu, L. Kristopher] Natl Hlth Res Inst, Div Infect Dis, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	lksiu@nhri.org.tw	Siu, Leung-Kei/C-1368-2010		National Science Council [NSC93-2314-B-016-018, NSC94-2314-B-016-004, NSC95-2314-B-016-001, NSC96-2314-B-016-006-MY12]; Tri-Service General Hospital [DOD96-22, DOD96-32]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from National Science Council (NSC93-2314-B-016-018, NSC94-2314-B-016-004, NSC95-2314-B-016-001, NSC96-2314-B-016-006-MY1&2), Tri-Service General Hospital (DOD96-22 & 96-32) and from National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova O V, 1999, Zh Mikrobiol Epidemiol Immunobiol, P5; BRAYTON RG, 1970, NEW ENGL J MED, V282, P123, DOI 10.1056/NEJM197001152820303; CASANOVA C, 1989, ARCH INTERN MED, V149, P1467, DOI 10.1001/archinte.1989.00390060171048; Chang Feng-Yee, 1995, Journal of the Formosan Medical Association, V94, P232; CHENG D-L, 1991, Archives of Internal Medicine, V151, P1557, DOI 10.1001/archinte.151.8.1557; Chou FF, 1997, WORLD J SURG, V21, P384, DOI 10.1007/PL00012258; CRYZ SJ, 1986, J CLIN MICROBIOL, V23, P687, DOI 10.1128/JCM.23.4.687-690.1986; D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P550, DOI 10.1086/501950; DUGGER KO, 1989, DIAGN MICR INFEC DIS, V12, P199, DOI 10.1016/0732-8893(89)90015-1; Dylewski JS, 1998, CLIN INFECT DIS, V27, P1561, DOI 10.1086/517760; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gauger EJ, 2007, INFECT IMMUN, V75, P3315, DOI 10.1128/IAI.00052-07; Gregory SH, 1996, J IMMUNOL, V157, P2514; HAN SHB, 1995, WESTERN J MED, V162, P220; Higashi T, 1995, Kansenshogaku Zasshi, V69, P1017; HIGHSMITH AK, 1985, INFECT CONT HOSP EP, V6, P75, DOI 10.1017/S0195941700062640; Ho PL, 2000, CLIN INFECT DIS, V30, P989, DOI 10.1086/313791; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lin JC, 2006, J CLIN ENDOCR METAB, V91, P3084, DOI 10.1210/jc.2005-2749; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; MOLENAAR DM, 1976, DIABETES, V25, P880; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; Nielsen SL, 1999, J ANTIMICROB CHEMOTH, V43, P407, DOI 10.1093/jac/43.3.407; PODSCHUN R, 1991, ZBL HYG UMWELTMED, V192, P279; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; PODSCHUN R, 1992, J MED MICROBIOL, V36, P250, DOI 10.1099/00222615-36-4-250; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rhen M, 2003, TRENDS MICROBIOL, V11, P80, DOI 10.1016/S0966-842X(02)00038-0; Saccente M, 1999, CLIN INFECT DIS, V29, P1570, DOI 10.1086/313539; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; WANG JJ, 1994, J GEN VIROL, V75, P2607, DOI 10.1099/0022-1317-75-10-2607; Yarng SS, 1997, OPHTHALMIC SURG LAS, V28, P147; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yoon YH, 2003, RETINA-J RET VIT DIS, V23, P366, DOI 10.1097/00006982-200306000-00013	40	29	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15005	10.1371/journal.pone.0015005	http://dx.doi.org/10.1371/journal.pone.0015005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151499	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100051
J	Nelson, PA; Khodadoust, M; Prodhomme, T; Spencer, C; Patarroyo, JC; Varrin-Doyer, M; Ho, JD; Stroud, RM; Zamvil, SS				Nelson, Patricia A.; Khodadoust, Mojgan; Prodhomme, Thomas; Spencer, Collin; Patarroyo, Juan Carlos; Varrin-Doyer, Michel; Ho, Joseph D.; Stroud, Robert M.; Zamvil, Scott S.			Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CHROMOSOMAL LOCALIZATION; WATER CHANNEL; B-CELLS; ANTIGEN; ENCEPHALOMYELITIS; PATHOGENESIS; ANTIBODIES; DISEASE; EPITOPE	Autoantibodies that target the water channel aquaporin-4 (AQP4) in neuromyelitis optica (NMO) are IgG1, a T cell-dependent Ig subclass. However, a role for AQP4-specific T cells in this CNS inflammatory disease is not known. To evaluate their potential role in CNS autoimmunity, we have identified and characterized T cells that respond to AQP4 in C57BL/6 and SJL/J mice, two strains that are commonly studied in models of CNS inflammatory diseases. Mice were immunized with either overlapping peptides or intact hAQP4 protein encompassing the entire 323 amino acid sequence. T cell determinants identified from examination of the AQP4 peptide (p) library were located within AQP4 p21-40, p91-110, p101-120, p166-180, p231-250 and p261-280 in C57BL/6 mice, and within p11-30, p21-40, p101-120, p126-140 and p261-280 in SJL/J mice. AQP4-specific T cells were CD4(+) and MHC II-restricted. In recall responses to immunization with intact AQP4, T cells responded primarily to p21-40, indicating this region contains the immunodominant T cell epitope(s) for both strains. AQP4 p21-40-primed T cells secreted both IFN-gamma and IL-17. The core immunodominant AQP4 21-40 T cell determinant was mapped to residues 24-35 in C57BL/6 mice and 23-35 in SJL/J mice. Our identification of the AQP4 T cell determinants and characterization of its immunodominant determinant should permit investigators to evaluate the role of AQP4-specific T cells in vivo and to develop AQP4-targeted murine NMO models.	[Nelson, Patricia A.; Khodadoust, Mojgan; Prodhomme, Thomas; Spencer, Collin; Patarroyo, Juan Carlos; Varrin-Doyer, Michel; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ho, Joseph D.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nelson, PA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	zamvil@ucsf.neuroimmunol.org			Guthy Jackson Charitable Foundation; National Institutes of Health (NIH) [RO1 AI073737, RO1 AI059709, RO1 NS063008, 2P50 GM073210]; NMSS [RG 3622, 3913]; Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059709, R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, R37GM024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Guthy Jackson Charitable Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NMSS(National Multiple Sclerosis Society); Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.A.N., M.K., C.S., M.V.-D. and S.S.Z. were supported by a research grant from the Guthy Jackson Charitable Foundation. T. P. is a fellow of the National Multiple Sclerosis Society (NMSS). S.S.Z. was supported by the National Institutes of Health (NIH) (RO1 AI073737, RO1 AI059709, and RO1 NS063008), the NMSS (RG 3622 and 3913) and the Maisin Foundation. R. M. S. was supported by NIH 2P50 GM073210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Guan Pingping, 2006, Appl Bioinformatics, V5, P55, DOI 10.2165/00822942-200605010-00008; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HU X, 2010, NUCL ACIDS RES; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; KISHIMOTO T, 1978, NATURE, V271, P756, DOI 10.1038/271756a0; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Pennesi Giuseppina, 2002, Int Rev Immunol, V21, P67, DOI 10.1080/08830180212059; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; Stuve O, 2002, J IMMUNOL, V169, P6720, DOI 10.4049/jimmunol.169.12.6720; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; Tani T, 2009, J NEUROIMMUNOL, V211, P110, DOI 10.1016/j.jneuroim.2009.04.001; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turtzo LC, 1997, GENOMICS, V41, P267, DOI 10.1006/geno.1997.4641; Warabi Y, 2006, J NEUROL SCI, V249, P145, DOI 10.1016/j.jns.2006.06.011; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	38	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15050	10.1371/journal.pone.0015050	http://dx.doi.org/10.1371/journal.pone.0015050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151500	Green Published, gold			2022-12-25	WOS:000284755100055
J	Saludes, V; Bracho, MA; Valero, O; Ardevol, M; Planas, R; Gonzalez-Candelas, F; Ausina, V; Martro, E				Saludes, Veronica; Alma Bracho, Maria; Valero, Oliver; Ardevol, Merce; Planas, Ramon; Gonzalez-Candelas, Fernando; Ausina, Vicente; Martro, Elisa			Baseline Prediction of Combination Therapy Outcome in Hepatitis C Virus 1b Infected Patients by Discriminant Analysis Using Viral and Host Factors	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ANTIVIRAL THERAPY; PEGYLATED-INTERFERON; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; CORE PROTEIN; GENOTYPE 1B; ASSOCIATION; VARIABILITY; NONRESPONSE	Background: Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy -especially among genotype 1 infected patients-, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At present, treatment cannot be individualized on the basis of any baseline predictor of response. We aimed to identify pre-treatment clinical and virological parameters associated with treatment failure, as well as to assess whether therapy outcome could be predicted at baseline. Methodology: Forty-three HCV subtype 1b (HCV-1b) chronically infected patients treated with pegylated-interferon alpha plus ribavirin were retrospectively studied (21 responders and 22 non-responders). Host (gender, age, weight, transaminase levels, fibrosis stage, and source of infection) and viral-related factors (viral load, and genetic variability in the E1-E2 and Core regions) were assessed. Logistic regression and discriminant analyses were used to develop predictive models. A "leave-one-out" cross-validation method was used to assess the reliability of the discriminant models. Principal Findings: Lower alanine transaminase levels (ALT, p = 0.009), a higher number of quasispecies variants in the E1-E2 region (number of haplotypes, nHap_E1-E2) (p = 0.003), and the absence of both amino acid arginine at position 70 and leucine at position 91 in the Core region (p = 0.039) were significantly associated with treatment failure. Therapy outcome was most accurately predicted by discriminant analysis (90.5% sensitivity and 95.5% specificity, 85.7% sensitivity and 81.8% specificity after cross-validation); the most significant variables included in the predictive model were the Core amino acid pattern, the nHap_E1-E2, and gamma-glutamyl transferase and ALT levels. Conclusions and Significance: Discriminant analysis has been shown as a useful tool to predict treatment outcome using baseline HCV genetic variability and host characteristics. The discriminant models obtained in this study led to accurate predictions in our population of Spanish HCV-1b treatment naive patients.	[Saludes, Veronica; Ausina, Vicente; Martro, Elisa] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Microbiol Serv, Badalona, Spain; [Saludes, Veronica; Alma Bracho, Maria; Gonzalez-Candelas, Fernando; Martro, Elisa] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Alma Bracho, Maria; Gonzalez-Candelas, Fernando] Univ Valencia CSISP UV, Inst Cavanilles, Ctr Super Invest Salud Publ, Unidad Mixta Genom & Salud, Valencia, Spain; [Valero, Oliver] Univ Autonoma Barcelona, Stat Serv, Cerdanyola Del Valles, Spain; [Ardevol, Merce] Hosp Badalona Germans Trias & Pujol, Hosp Pharm, Badalona, Spain; [Planas, Ramon] Hosp Badalona Germans Trias & Pujol, Liver Unit, Badalona, Spain; [Planas, Ramon] CIBER Enfermedades Hepat & Digestivas CIBEREHD, Barcelona, Spain; [Ausina, Vicente] CIBER Enfermedades Resp CIBERES, Bunyola, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Saludes, V (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Microbiol Serv, Badalona, Spain.	emartro.igtp.germanstrias@gencat.cat	Martró, Elisa/K-9688-2015; Bracho, Maria/K-6018-2014; Candelas, Fernando Gonzalez/G-5681-2010; Saludes, Veronica/L-2059-2015	Martró, Elisa/0000-0002-2867-6649; Bracho, Maria/0000-0002-9204-5526; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Saludes, Veronica/0000-0003-2139-3360; AUSINA, VICENTE/0000-0002-1798-9869; Valero, Oliver/0000-0003-0014-9916	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) [PI05/1131, CP09/00044]; "Ministerio de Ciencia e Innovacion" (MICINN) [CP09/00044, CD05/00258, CP07/00078, BFU2008-03000]; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu"; "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain	"Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS)(Instituto de Salud Carlos III); "Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu"; "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain	This study was funded by "Instituto de Salud Carlos III - Fondo de Investigaciones Sanitarias" (ISCIII-FIS) projects PI05/1131 (EM, RP, VA) and CP09/00044 (EM, MA, RP, VA, VS), grant numbers CD05/00258 ("Contratos Postdoctorales de Perfeccionamiento") and CP09/00044 ("Miguel Servet") from "Ministerio de Ciencia e Innovacion" (MICINN), within the "Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion Tecnologica (I+D+I)" (EM); and with support from "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya i del Fons Social Europeu" and "Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica", Spain (VS). This work was also partially supported by ISCIII-FIS projects CP07/00078 (MAB) and BFU2008-03000 (FG-C, MAB) from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2004, J HEPATOL, V40, P831, DOI 10.1016/j.jhep.2004.01.019; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; CUEVAS JM, 2008, J VIRAL HEP IN PRESS; de Lucas S, 2005, J INFECT DIS, V191, P93, DOI 10.1086/426509; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENZE N, 1990, COMMUN STAT THEORY, V19, P3595, DOI 10.1080/03610929008830400; Hofmann WP, 2003, J INFECT DIS, V187, P982, DOI 10.1086/368221; Hoofnagle JH, 2009, J INFECT DIS, V199, P1112, DOI 10.1086/597384; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kronenberger B, 2004, HEPATOLOGY, V40, P1442, DOI 10.1002/hep.20487; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Le Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416, DOI 10.3748/wjg.v13.i17.2416; Lopez-Labrador FX, 2006, J VIRAL HEPATITIS, V13, P104, DOI 10.1111/j.1365-2893.2005.00670.x; Lukasiewicz E, 2010, J VIRAL HEPATITIS, V17, P345, DOI 10.1111/j.1365-2893.2009.01183.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martinez-Bauer E, 2006, HEPATOLOGY, V43, P72, DOI 10.1002/hep.21002; Martro E, 2008, J CLIN MICROBIOL, V46, P192, DOI 10.1128/JCM.01623-07; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MCLACHAN GJ, 1992, DISCRIMINANT ANAL ST; Morishima C, 2006, J INFECT DIS, V193, P931, DOI 10.1086/500952; Morrison D. F., 1967, MULTIVARIATE STAT ME; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raimondi S, 2009, J HEPATOL, V50, P1142, DOI 10.1016/j.jhep.2009.01.019; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Su XW, 2008, J HEPATOL, V49, P184, DOI 10.1016/j.jhep.2008.04.011; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Tsukada H, 2009, GASTROENTEROLOGY, V136, P1796, DOI 10.1053/j.gastro.2009.01.061; Ueda E, 2004, HEPATOL RES, V29, P89, DOI [10.1016/j.jhepres.2004.02.014, 10.1016/j.hepres.2004.02.014]; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; *WHO, 2010, VIR CANC HEP G VIR; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Yeh BI, 2002, J MED VIROL, V66, P481, DOI 10.1002/jmv.2169	57	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14132	10.1371/journal.pone.0014132	http://dx.doi.org/10.1371/journal.pone.0014132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152430	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100013
J	Blume, M; Hliscs, M; Rodriguez-Contreras, D; Sanchez, M; Landfear, S; Lucius, R; Matuschewski, K; Gupta, N				Blume, Martin; Hliscs, Marion; Rodriguez-Contreras, Dayana; Sanchez, Marco; Landfear, Scott; Lucius, Richard; Matuschewski, Kai; Gupta, Nishith			A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs	FASEB JOURNAL			English	Article						sugar transport; metabolic drug target; high-throughput screening	FALCIPARUM-INFECTED ERYTHROCYTES; MALARIA PARASITES; GLUCOSE TRANSPORTERS; EXPRESSION SYSTEM; TOXOPLASMA-GONDII; METABOLISM; VALIDATION; BERGHEI; GROWTH; YEAST	Glucose is considered essential for erythrocytic stages of the malaria parasite, Plasmodium falciparum. Importance of sugar and its permease for hepatic and sexual stages of Plasmodium, however, remains elusive. Moreover, increasing global resistance to current antimalarials necessitates the search for novel drugs. Here, we reveal that hexose transporter 1 (HT1) of Plasmodium berghei can transport glucose (K-m similar to 87 mu M), mannose (K-i similar to 93 mu M), fructose (K-i similar to 0.54 mM), and galactose (K-i similar to 5 mM) in Leishmania mexicana mutant and Xenopus laevis; and, therefore, is functionally equivalent to HT1 of P. falciparum (Glc, K-m similar to 175 mu M; Man, K-i similar to 276 mu M; Fru, K-i similar to 1.25 mM; Gal, K-i similar to 5.86 mM). Notably, a glucose analog, C3361, attenuated hepatic (IC50 similar to 15 mu M) and ookinete development of P. berghei. The PbHT1 could be ablated during intraerythrocytic stages only by concurrent complementation with PbHT1-HA or PfHT1. Together; these results signify that PbHT1 and glucose are required for the entire life cycle of P. berghei. Accordingly, PbHT1 is expressed in the plasma membrane during all parasite stages. To permit a high-throughput screening of PfHT1 inhibitors and their subsequent in vivo assessment, we have generated Saccharomyces cerevisiae mutant expressing codon-optimized PfHT1, and a PfHT1-dependent Delta pbht1 parasite strain. This work provides a platform to facilitate the development of drugs against malaria, and it suggests a disease-control aspect by reducing parasite transmission.-Blume, M., Hliscs, M., Rodriguez-Contreras, D., Sanchez, M., Landfear, S., Lucius, R., Matuschewski, K., Gupta, N. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs. FASEB J. 25, 1218-1229 (2011). www.fasebj.org	[Blume, Martin; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Berlin, Germany; [Hliscs, Marion; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Rodriguez-Contreras, Dayana; Sanchez, Marco; Landfear, Scott] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Humboldt University of Berlin; Max Planck Society; Oregon Health & Science University	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, Berlin, Germany.	gupta.nishith@staff.hu-berlin.de		Matuschewski, Kai/0000-0001-6147-8591; Blume, Martin/0000-0002-6894-3000; Gupta, Nishith/0000-0003-1452-5126; Landfear, Scott/0000-0002-1643-6664	Helmholtz Foundation (Germany); German Research Foundation [SFB618/C7]; U.S. National Institutes of Health [AI25920]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025920] Funding Source: NIH RePORTER	Helmholtz Foundation (Germany)(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Grit Meusel (Humboldt University, Berlin, Germany) for her technical assistance. The doctoral research of M. B. is supported by the Helmholtz Foundation (Germany). This work was also supported by an intramural research grant to K. M., German Research Foundation grant SFB618/C7 to N.G. and R. L., and U.S. National Institutes of Health grant AI25920 to S. L. The NCBI database accession numbers of the nucleotide/protein sequences derived from this research are as follows: PbHT1, HM156735; PfHT1-Synthetic, HM161875; and EtHT1, HM161877.	Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Feistel T, 2008, MOL BIOCHEM PARASIT, V162, P71, DOI 10.1016/j.molbiopara.2008.07.005; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; ROTH EF, 1988, BLOOD, V72, P1922; ROTH EF, 1987, J BIOL CHEM, V262, P15678; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P355, DOI 10.1128/CMR.15.3.355-364.2002; Seeber F, 2008, TRENDS PARASITOL, V24, P468, DOI 10.1016/j.pt.2008.07.004; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Slavic K, 2010, MOL MICROBIOL, V75, P1402, DOI 10.1111/j.1365-2958.2010.07060.x; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Woodrow CJ, 2000, P NATL ACAD SCI USA, V97, P9931, DOI 10.1073/pnas.170153097; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653	34	32	32	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1218	1229		10.1096/fj.10-173278	http://dx.doi.org/10.1096/fj.10-173278			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21169382	Green Published			2022-12-25	WOS:000288982800011
J	Liu, X; Zhao, DZ; James, L; Li, JA; Zeng, HY				Liu, Xin; Zhao, Dezheng; James, Lauralee; Li, Jian; Zeng, Huiyan			Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor	FASEB JOURNAL			English	Article						TEF3; VEGF; DSCR1	VEGF-A; RTEF-1; TISSUES; CLONING; FAMILY; MUSCLE; CELLS	Transcription enhancer factor 3 (TEF3) is known to regulate the expression of muscle-specific genes and to play important roles in muscle development and diseases. However, little is known about its role in vascular endothelial growth factor (VEGF)induced angiogenesis. Most recently, we discovered a novel function of TEF3, in which TEF3 is required for the up-regulation of a proangiogenic factor, Down syndrome candidate region 1 isoform 1L (DSCR1-1L), induced by VEGF-A(165) in endothelial cells. Overexpression of TEF3 isoform 1 (TEF3-1) is sufficient to induce DSCR1-1L expression. Here, we report that knocking down the expression of TEF3 almost completely inhibits VEGF-A(165)-induced proliferation, migration, tube formation, formation of F-actin stress fiber, and in vivo Matrigel angiogenesis. This inhibition cannot be rescued by DSCR1-1L overexpression. Further, overexpression of TEF3-1, but not its nuclear localization signal-deletion mutant (TEF3-Delta NLS), induces human umbilical vein endothelial cell proliferation, migration, tube formation, and formation of F-actin stress fiber, even in the absence of VEGF-A(165) stimulation, which is partially inhibited by DSCR1-1L silencing. Our data demonstrate that TEF3, mainly its nuclear localization, is required for VEGF-A(165)-induced endothelial proliferation, migration, tube formation, and in vivo Matrigel angiogenesis.-Liu, X., Zhao, D., James, L., Li, J., Zeng, H. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor. FASEB J. 25, 1188-1197 (2011). www.fasebj.org	[Zeng, Huiyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Zhao, Dezheng] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [James, Lauralee; Zeng, Huiyan] Beth Israel Deaconess Med Ctr, Mol & Vasc Med Div, Boston, MA 02215 USA; [Li, Jian] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA; [Zhao, Dezheng; James, Lauralee; Zeng, Huiyan] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Zeng, HY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave Res N,RN270F, Boston, MA 02215 USA.	hzeng@bidmc.harvard.edu	LI, RUIJIAN/GYJ-0470-2022		American Cancer Society [RSG-05-118-01-CSM]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society grant RSG-05-118-01-CSM.	Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Folkman J, 1997, EXS, V79, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Hayashi K, 1996, MOL CELL ENDOCRINOL, V123, P205, DOI 10.1016/S0303-7207(96)03909-3; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Liu X, 2008, J BIOL CHEM, V283, P34159, DOI 10.1074/jbc.M806338200; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; Stewart AFR, 1996, GENOMICS, V37, P68, DOI 10.1006/geno.1996.0522; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yockey CE, 1996, J BIOL CHEM, V271, P3727, DOI 10.1074/jbc.271.7.3727; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	19	18	18	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1188	1197		10.1096/fj.10-167619	http://dx.doi.org/10.1096/fj.10-167619			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21169383				2022-12-25	WOS:000288982800008
J	Valverde, RHF; Britto-Borges, T; Lowe, J; Einicker-Lamas, M; Mintz, E; Cuillel, M; Vieyra, A				Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Mintz, Elisabeth; Cuillel, Martine; Vieyra, Adalberto			Two Serine Residues Control Sequential Steps during Catalysis of the Yeast Copper ATPase through Different Mechanisms That Involve Kinase-mediated Phosphorylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; P-TYPE ATPASE; METAL-BINDING DOMAINS; TRANSPORTING ATPASE; FUNCTIONAL-CHARACTERIZATION; PROXIMAL TUBULE; ATP7B; GENE; CELLS; CA2+-ATPASE	Ccc2, the yeast copper-transporting ATPase, pumps copper from the cytosol to the Golgi lumen. During its catalytic cycle, Ccc2 undergoes auto-phosphorylation on Asp(627) and uses the energy gained to transport copper across the cell membrane. We previously demonstrated that cAMP-dependent protein kinase (PKA) controls the energy interconversion E-Cu similar to P -> E-P + Cu when Ser(258) is phosphorylated. We now demonstrate that Ser(258) is essential in vivo for copper homeostasis in extremely low copper and iron concentrations. The S258A mutation abrogates all PKA-mediated phosphorylations of Ccc2, whereas the S971A mutation leads to a 100% increase in its global regulatory phosphorylation. With S258A, the first-order rate constant of catalytic phosphorylation by ATP decreases from 0.057 to 0.030 s(-1), with an 8-fold decrease in the burst of initial phosphorylation. With the S971A mutant, the rate constant decreases to 0.007 s(-1). PKAi(5-24) decreases the amount of the aspartylphosphate intermediate (EP) in Ccc2 wt by 50% within 1 min, but not in S258A, S971A, or S258A/S971A. The increase of the initial burst and the extremely slow phosphorylation when the "phosphomimetic" mutant S258D was assayed (k = 0.0036 s(-1)), indicate that electrostatic and conformational (non-electrostatic) mechanisms are involved in the regulatory role of Ser(258). Accumulation of an ADP-insensitive form in S971A demonstrates that Ser(971) is required to accelerate the hydrolysis of the E-P form during turnover. We propose that Ser(258) and Ser(971) are under long-range intramolecular, reciprocal and concerted control, in a sequential process that is crucial for catalysis and copper transport in the yeast copper ATPase.	[Mintz, Elisabeth; Cuillel, Martine] CEA, DSV, IRTSV, Lab Chim & Biol Met, F-38054 Grenoble, France; [Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21949900 Rio De Janeiro, Brazil; [Mintz, Elisabeth; Cuillel, Martine] Univ Grenoble 1, F-38000 Grenoble, France; [Mintz, Elisabeth; Cuillel, Martine] CNRS, UMR 5249, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Cuillel, M (corresponding author), CEA, DSV, IRTSV, Lab Chim & Biol Met, 17 Rue Martyrs, F-38054 Grenoble, France.	martine.cuillel@cea.fr; avieyra@biof.ufrj.br	Lowe, Jennifer/F-1148-2013; Fisiologia, Ciencias Biologicas/C-2407-2012; Britto-Borges, Thiago/J-4953-2016; Valverde, Rafael H.F./K-6567-2012	Lowe, Jennifer/0000-0001-7378-4561; Britto-Borges, Thiago/0000-0002-6218-4429; Valverde, Rafael H.F./0000-0002-1244-814X	EGIDE (France); CAPES/COFECUB (Brazil/France); CAPES (Brazil); Rio de Janeiro State Funding Agency (FAPERJ, Brazil); Brazilian Research Council (CNPq, Brazil); Programme de Toxicologie Nucleaire Environnementale (France); CAPES/PNPD	EGIDE (France); CAPES/COFECUB (Brazil/France)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro State Funding Agency (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Research Council (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programme de Toxicologie Nucleaire Environnementale (France); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by EGIDE (France), CAPES/COFECUB (Brazil/France) and the CAPES National Program of Post-doctoral Training (Brazil), the Rio de Janeiro State Funding Agency (FAPERJ, Brazil), the Brazilian Research Council (CNPq, Brazil), and the Programme de Toxicologie Nucleaire Environnementale (France).; Recipient of a fellowship from the CAPES/PNPD Program.	Arokium H, 2007, J BIOL CHEM, V282, P35104, DOI 10.1074/jbc.M704891200; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Gromadzka G, 2005, CLIN GENET, V68, P524, DOI 10.1111/j.1399-0004.2005.00528.x; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; Miras R, 2001, PROTEIN EXPRES PURIF, V22, P299, DOI 10.1006/prep.2001.1436; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P349, DOI 10.1007/s10863-007-9123-9; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Valverde RHF, 2008, FEBS LETT, V582, P891, DOI 10.1016/j.febslet.2008.02.022; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	35	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6879	6889		10.1074/jbc.M110.207704	http://dx.doi.org/10.1074/jbc.M110.207704			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21163943	Green Published, hybrid			2022-12-25	WOS:000287737300003
J	Xue, ML; Chow, SO; Dervish, S; Chan, YKA; Julovi, SM; Jackson, CJ				Xue, Meilang; Chow, Shu-Oi; Dervish, Suat; Chan, Yee-Ka Agnes; Julovi, Sohel M.; Jackson, Christopher J.			Activated Protein C Enhances Human Keratinocyte Barrier Integrity via Sequential Activation of Epidermal Growth Factor Receptor and Tie2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL CONTACTS; SIGNALING PATHWAYS; TIGHT JUNCTIONS; ANGIOPOIETIN-1; SKIN; EXPRESSION; SURVIVAL; TRANSACTIVATION; DIFFERENTIATION; PSORIASIS	Keratinocytes play a critical role in maintaining epidermal barrier function. Activated protein C (APC), a natural anticoagulant with anti-inflammatory and endothelial barrier protective properties, significantly increased the barrier impedance of keratinocyte monolayers, measured by electric cell substrate impedance sensing and FITC-dextran flux. In response to APC, Tie2, a tyrosine kinase receptor, was rapidly activated within 30 min, and relocated to cell-cell contacts. APC also increased junction proteins zona occludens, claudin-1 and VE-cadherin. Inhibition of Tie2 by its peptide inhibitor or small interfering RNA abolished the barrier protective effect of APC. Interestingly, APC did not activate Tie2 through its major ligand, angiopoietin-1, but instead acted by binding to endothelial protein C receptor, cleaving protease-activated receptor-1 and transactivating EGF receptor. Furthermore, when activation of Akt, but not ERK, was inhibited, the barrier protective effect of APC on keratinocytes was abolished. Thus, APC activates Tie2, via a mechanism requiring, in sequential order, the receptors, endothelial protein C receptor, protease-activated receptor-1, and EGF receptor, which selectively enhances the PI3K/Akt signaling to enhance junctional complexes and reduce keratinocyte permeability.	[Xue, Meilang; Chow, Shu-Oi; Dervish, Suat; Chan, Yee-Ka Agnes; Julovi, Sohel M.; Jackson, Christopher J.] Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Xue, ML (corresponding author), Univ Sydney, Royal N Shore Hosp, Sutton Res Labs, Level 10,Kolling Bldg, St Leonards, NSW 2065, Australia.	meilang.xue@sydney.edu.au	Julovi, Sohel/AAQ-4539-2020	Julovi, Sohel/0000-0003-0834-2366; Jackson, Christopher/0000-0002-9234-9116; Xue, Meilang/0000-0002-8563-7216	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a career development award and a project grant from the National Health and Medical Research Council.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Feistritzer C, 2006, J IMMUNOL, V176, P1019, DOI 10.4049/jimmunol.176.2.1019; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Honari Shari, 2004, Crit Care Nurs Clin North Am, V16, P1, DOI 10.1016/j.ccell.2003.09.008; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Jost M, 2000, EUR J DERMATOL, V10, P505; Jost M, 2001, J BIOL CHEM, V276, P6320, DOI 10.1074/jbc.M008210200; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Kuroda K, 2001, J INVEST DERMATOL, V116, P713, DOI 10.1046/j.1523-1747.2001.01316.x; Makinde T, 2008, J CELL MOL MED, V12, P810, DOI 10.1111/j.1582-4934.2008.00254.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038; Materazzi S, 2007, J PATHOL, V212, P440, DOI 10.1002/path.2197; McCarthy KM, 2000, J CELL SCI, V113, P3387; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Piepkorn M, 2003, ARCH DERMATOL RES, V295, P93, DOI 10.1007/s00403-003-0391-x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sabri A, 2002, CIRC RES, V91, P532, DOI 10.1161/01.RES.0000035242.96310.45; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Voskas D, 2005, AM J PATHOL, V166, P843, DOI 10.1016/S0002-9440(10)62305-X; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2010, CELL MOL LIFE SCI, V67, P1537, DOI 10.1007/s00018-010-0269-y; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015	47	38	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6742	6750		10.1074/jbc.M110.181388	http://dx.doi.org/10.1074/jbc.M110.181388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173154	Green Published, hybrid			2022-12-25	WOS:000287476400081
J	Hagihara, M; Endo, M; Hata, K; Higuchi, C; Takaoka, K; Yoshikawa, H; Yamashita, T				Hagihara, Meiko; Endo, Mitsuharu; Hata, Katsuhiko; Higuchi, Chikahisa; Takaoka, Kunio; Yoshikawa, Hideki; Yamashita, Toshihide			Neogenin, a Receptor for Bone Morphogenetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPULSIVE GUIDANCE MOLECULE; NEURONAL DIFFERENTIATION; SPINAL-CORD; EXPRESSION; FOREBRAIN; SURVIVAL; RGMA; DCC	Bone morphogenetic proteins (BMPs) regulate many mammalian physiologic and pathophysiologic processes. These proteins bind with the kinase receptors BMPR-I and BMPR-II, thereby activating Smad transcription factor. In this study, we demonstrate that neogenin, a receptor for netrins and proteins of the repulsive guidance molecule family, is a receptor for BMPs and modulates Smad signal transduction. Neogenin was found to bind directly with BMP-2, BMP-4, BMP-6, and BMP-7. Knockdown of neogenin in C2C12 cells resulted in the enhancement of the BMP-2-induced processes of osteoblastic differentiation and phosphorylation of Smad1, Smad5, and Smad8. Conversely, overexpression of neogenin in C2C12 cells suppressed these processes. Our results also indicated that BMP-induced activation of RhoA was mediated by neogenin. Inhibition of RhoA promoted BMP-2-induced processes of osteoblastic differentiation and phosphorylation of Smad1/5/8. However, treatment with Y-27632, an inhibitor of Rho-associated protein kinase, did not modulate BMP-induced phosphorylation of Smad1/5/8. Taken together, our findings suggest that neogenin negatively regulates the functions of BMP and that this effect of neogenin is mediated by the activation of RhoA.	[Hagihara, Meiko; Endo, Mitsuharu; Hata, Katsuhiko; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Higuchi, Chikahisa; Yoshikawa, Hideki] Osaka Univ, Dept Orthoped Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takaoka, Kunio] Osaka City Univ, Dept Orthopaed Surg, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; [Yamashita, Toshihide] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Hata, Katsuhiko/AAA-5015-2021	Yamashita, Toshihide/0000-0003-4559-7018	JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (S) from JSPS.	Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	21	67	71	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5157	5165		10.1074/jbc.M110.180919	http://dx.doi.org/10.1074/jbc.M110.180919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149453	Green Published, hybrid			2022-12-25	WOS:000287230600024
J	Fabrini, R; Bocedi, A; Pallottini, V; Canuti, L; De Canio, M; Urbani, A; Marzano, V; Cornetta, T; Stano, P; Giovanetti, A; Stella, L; Canini, A; Federici, G; Ricci, G				Fabrini, Raffaele; Bocedi, Alessio; Pallottini, Valentina; Canuti, Lorena; De Canio, Michele; Urbani, Andrea; Marzano, Valeria; Cornetta, Tommaso; Stano, Pasquale; Giovanetti, Anna; Stella, Lorenzo; Canini, Antonella; Federici, Giorgio; Ricci, Giorgio			Nuclear Shield: A Multi-Enzyme Task-Force for Nucleus Protection	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SUBCELLULAR-LOCALIZATION; PEROXIDASE ACTIVITY; OXIDATIVE STRESS; ENVELOPE; PROTEIN; EXPRESSION; ISOENZYMES; PRECURSOR; COMPLEX	Background: In eukaryotic cells the nuclear envelope isolates and protects DNA from molecules that could damage its structure or interfere with its processing. Moreover, selected protection enzymes and vitamins act as efficient guardians against toxic compounds both in the nucleoplasm and in the cytosol. The observation that a cytosolic detoxifying and antioxidant enzyme i.e. glutathione transferase is accumulated in the perinuclear region of the rat hepatocytes suggests that other unrecognized modalities of nuclear protection may exist. Here we show evidence for the existence of a safeguard enzyme machinery formed by an hyper-crowding of cationic enzymes and proteins encompassing the nuclear membrane and promoted by electrostatic interactions. Methodology/Principal Findings: Electron spectroscopic imaging, zeta potential measurements, isoelectrofocusing, comet assay and mass spectrometry have been used to characterize this surprising structure that is present in the cells of all rat tissues examined (liver, kidney, heart, lung and brain), and that behaves as a "nuclear shield''. In hepatocytes, this hyper-crowding structure is about 300 nm thick, it is mainly formed by cationic enzymes and the local concentration of key protection enzymes, such as glutathione transferase, catalase and glutathione peroxidase is up to seven times higher than in the cytosol. The catalytic activity of these enzymes, when packed in the shield, is not modified and their relative concentrations vary remarkably in different tissues. Removal of this protective shield renders chromosomes more sensitive to damage by oxidative stress. Specific nuclear proteins anchored to the outer nuclear envelope are likely involved in the shield formation and stabilization. Conclusions/Significance: The characterization of this previously unrecognized nuclear shield in different tissues opens a new interesting scenario for physiological and protection processes in eukaryotic cells. Selection and accumulation of protection enzymes near sensitive targets represents a new safeguard modality which deeply differs from the adaptive response which is based on expression of specific enzymes.	[Fabrini, Raffaele; Stella, Lorenzo; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Bocedi, Alessio; De Canio, Michele; Urbani, Andrea; Marzano, Valeria; Federici, Giorgio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Pallottini, Valentina; Cornetta, Tommaso; Stano, Pasquale] Univ Roma Tre, Dept Biol, Rome, Italy; [Canuti, Lorena; Canini, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Urbani, Andrea; Marzano, Valeria] S Lucia Res Inst IRCCS, Rome, Italy; [Giovanetti, Anna] ENEA CR, Inst Radiat Protect, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Roma Tre University; University of Rome Tor Vergata; IRCCS Santa Lucia; Italian National Agency New Technical Energy & Sustainable Economics Development	Fabrini, R (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.	riccig@uniroma2.it	Stano, Pasquale/ABH-1195-2020; Stano, Pasquale/AGG-8333-2022; Pallottini, Valentina/AAA-3218-2021; Stella, Lorenzo/A-7996-2010; Urbani, Andrea/AAD-1675-2022; De Canio, Michele/AAY-2283-2021; Urbani, Andrea/B-2953-2012; Marzano, Valeria/K-5770-2016	Stano, Pasquale/0000-0002-2228-2825; Pallottini, Valentina/0000-0003-2511-6168; Stella, Lorenzo/0000-0002-5489-7381; De Canio, Michele/0000-0003-2552-7178; Marzano, Valeria/0000-0001-6364-2121; Canini, Antonella/0000-0003-1132-8899; Ricci, Giorgio/0000-0002-7108-2846	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study has been supported by a grant from the Italian Ministry of Education, University and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEI M, 1989, BIOCHIM BIOPHYS ACTA, V995, P279, DOI 10.1016/0167-4838(89)90047-2; Alberts B, 2002, MOL BIOL CELL; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Bulitta C, 1996, BBA-PROTEIN STRUCT M, V1293, P55, DOI 10.1016/0167-4838(95)00241-3; CANINI A, 1993, BOT ACTA, V106, P146, DOI 10.1111/j.1438-8677.1993.tb00351.x; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; DICE JF, 1975, P NATL ACAD SCI USA, V72, P3893, DOI 10.1073/pnas.72.10.3893; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; FARRANTS AKO, 1987, BIOCHEM J, V245, P423, DOI 10.1042/bj2450423; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANKE WW, 1981, J CELL BIOL, V91, pS39, DOI 10.1083/jcb.91.3.39s; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Horowitz GL, 2005, J AUTOM METHOD MANAG, P8, DOI 10.1155/JAMMC.2005.8; Hunter R.J., 1981, ZETA POTENTIAL COLLO; Hurst R, 1998, BIOCHEM J, V332, P97, DOI 10.1042/bj3320097; ISHIKAWA T, 1984, FEBS LETT, V169, P156, DOI 10.1016/0014-5793(84)80309-9; JOHNSON JA, 1993, J NEUROSCI, V13, P2013; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Ma N, 2004, J NEUROCYTOL, V33, P407, DOI 10.1007/s11068-004-4206-6; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; REIMER L, 1975, ULTRAMICROSCOPY, V1, P1, DOI 10.1016/S0304-3991(75)80003-9; ROBERTSON IGC, 1985, BIOCHEM BIOPH RES CO, V127, P80, DOI 10.1016/S0006-291X(85)80128-5; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SOBOLL S, 1995, BIOCHEM J, V311, P889, DOI 10.1042/bj3110889; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wendel A, 1981, Methods Enzymol, V77, P325; YEH HI, 1995, BIOCHEM J, V308, P69, DOI 10.1042/bj3080069; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	51	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14125	10.1371/journal.pone.0014125	http://dx.doi.org/10.1371/journal.pone.0014125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170318	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400001
J	Margolis, EB; Coker, AR; Driscoll, JR; Lemaitre, AI; Fields, HL				Margolis, Elyssa B.; Coker, Allison R.; Driscoll, Joseph R.; Lemaitre, Anne-Iris; Fields, Howard L.			Reliability in the Identification of Midbrain Dopamine Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PHOSPHORYLATION; OPIOIDS	Brain regions typically contain intermixed subpopulations of neurons with different connectivity and neurotransmitters. This complicates identification of neuronal phenotypes in electrophysiological experiments without using direct detection of unique molecular markers. A prime example of this difficulty is the identification of dopamine (DA) neurons in the midbrain ventral tegmental area (VTA). Although immunocytochemistry (ICC) against tyrosine hydroxylase (TH) is widely used to identify DA neurons, a high false negative rate for TH ICC following ex vivo electrophysiology experiments was recently reported, calling into question the validity of comparing DA and non-DA VTA neurons based on post-hoc ICC. However, in whole cell recordings from randomly selected rat VTA neurons we have found that TH labeling is consistently detected in similar to 55% of neurons even after long recording durations (range: 2.5-150 min). This is consistent with our prior anatomical finding that 55% of VTA neurons are TH(+). To directly estimate a false negative rate for our ICC method we recorded VTA neurons from mice in which EGFP production is driven by the TH promoter. All 12 EGFP(+) neurons recorded with a K-gluconate internal solution (as used in our rat recordings) were strongly labeled by TH ICC (recording duration 16.6 +/- 1.8 min). However, using recording electrodes with an internal solution with high Cl(-) concentration reduced the intensity of TH co-labeling, in some cases to background (recording duration 16.7 +/- 0.9 min; n = 10). Thus TH is a highly reliable molecular marker for DA neurons in VTA patch clamp recordings provided compatible microelectrode solutions are used.	[Margolis, Elyssa B.; Coker, Allison R.; Driscoll, Joseph R.; Lemaitre, Anne-Iris; Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Fields, Howard L.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Margolis, EB (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	elyssam@gallo.ucsf.edu	Fields, Howard/ABG-9073-2020		State of California through University of California San Francisco	State of California through University of California San Francisco	This work was supported by funding from the State of California for medical research on alcohol and substance abuse through the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2010, J NEUROSCI, V30, P6689, DOI 10.1523/JNEUROSCI.4453-09.2010; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Iniguez SD, 2010, J NEUROSCI, V30, P7652, DOI 10.1523/JNEUROSCI.0951-10.2010; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; YIM CY, 1980, BRAIN RES, V181, P301; Zhang TA, 2010, NEUROPHARMACOLOGY, V59, P431, DOI 10.1016/j.neuropharm.2010.06.004	14	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15222	10.1371/journal.pone.0015222	http://dx.doi.org/10.1371/journal.pone.0015222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151605	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800019
J	Frietze, S; O'Geen, H; Blahnik, KR; Jin, VX; Farnham, PJ				Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Jin, Victor X.; Farnham, Peggy J.			ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3 ' Ends of ZNF Genes	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTORS; DEVELOPMENTAL REGULATORS; METHYLATION STATES; DNA METHYLATION; H3; GENOME; IDENTIFICATION; REPRESSION; HETEROCHROMATIN	Only a small percentage of human transcription factors (e. g. those associated with a specific differentiation program) are expressed in a given cell type. Thus, cell fate is mainly determined by cell type-specific silencing of transcription factors that drive different cellular lineages. Several histone modifications have been associated with gene silencing, including H3K27me3 and H3K9me3. We have previously shown that genes for the two largest classes of mammalian transcription factors are marked by distinct histone modifications; homeobox genes are marked by H3K27me3 and zinc finger genes are marked by H3K9me3. Several histone methyltransferases (e. g. G9a and SETDB1) may be involved in mediating the H3K9me3 silencing mark. We have used ChIP-chip and ChIP-seq to demonstrate that SETDB1, but not G9a, is associated with regions of the genome enriched for H3K9me3. One current model is that SETDB1 is recruited to specific genomic locations via interaction with the corepressor TRIM28 (KAP1), which is in turn recruited to the genome via interaction with zinc finger transcription factors that contain a Kruppel-associated box (KRAB) domain. However, specific KRAB-ZNFs that recruit TRIM28 (KAP1) and SETDB1 to the genome have not been identified. We now show that ZNF274 (a KRAB-ZNF that contains 5 C2H2 zinc finger domains), can interact with KAP1 both in vivo and in vitro and, using ChIP-seq, we show that ZNF274 binding sites co-localize with SETDB1, KAP1, and H3K9me3 at the 3' ends of zinc finger genes. Knockdown of ZNF274 with siRNAs reduced the levels of KAP1 and SETDB1 recruitment to the binding sites. These studies provide the first identification of a KRAB domain-containing ZNF that is involved in recruitment of the KAP1 and SETDB1 to specific regions of the human genome.	[Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Frietze, Seth; O'Geen, Henriette; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; Ohio State University	Frietze, S (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	pjfarnham@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914	Public Health Service [CA45250, 1U54HG004558]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by Public Health Service grants CA45250 and 1U54HG004558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Engelkamp D, 1996, CURR OPIN GENET DEV, V6, P334, DOI 10.1016/S0959-437X(96)80011-6; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oh HJ, 2006, MOL CELL ENDOCRINOL, V247, P47, DOI 10.1016/j.mce.2005.12.011; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIENCKE JK, 2007, DIFFERENTIALLY EXPRE; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	59	107	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15082	10.1371/journal.pone.0015082	http://dx.doi.org/10.1371/journal.pone.0015082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170338	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100017
J	Alloatti, A; Gupta, S; Gualdron-Lopez, M; Igoillo-Esteve, M; Nguewa, PA; Deumer, G; Wallemacq, P; Altabe, SG; Michels, PAM; Uttaro, AD				Alloatti, Andres; Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Deumer, Gladys; Wallemacq, Pierre; Altabe, Silvia G.; Michels, Paul A. M.; Uttaro, Antonio D.			Genetic and Chemical Evaluation of Trypanosoma brucei Oleate Desaturase as a Candidate Drug Target	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; STEARIC-ACID; BIOSYNTHESIS; ELONGATION; EXPRESSION; PROTOZOAN; ANALOGS; GROWTH; LIPIDS	Background: Trypanosomes can synthesize polyunsaturated fatty acids. Previously, we have shown that they possess stearoyl-CoA desaturase (SCD) and oleate desaturase (OD) to convert stearate (C18) into oleate (C18: 1) and linoleate (C18: 2), respectively. Here we examine if OD is essential to these parasites. Methodology: Cultured procyclic (insect-stage) form (PCF) and bloodstream-form (BSF) Trypanosoma brucei cells were treated with 12- and 13-thiastearic acid (12-TS and 13-TS), inhibitors of OD, and the expression of the enzyme was knocked down by RNA interference. The phenotype of these cells was studied. Principal Findings: Growth of PCF T. brucei was totally inhibited by 100 mu M of 12-TS and 13-TS, with EC50 values of 40 +/- 2 and 30 +/- 2 mu M, respectively. The BSF was more sensitive, with EC50 values of 7 +/- 3 and 2 +/- 1 mu M, respectively. This growth phenotype was due to the inhibitory effect of thiastearates on OD and, to a lesser extent, on SCD. The enzyme inhibition caused a drop in total unsaturated fatty-acid level of the cells, with a slight increase in oleate but a drastic decrease in linoleate level, most probably affecting membrane fluidity. After knocking down OD expression in PCF, the linoleate content was notably reduced, whereas that of oleate drastically increased, maintaining the total unsaturated fatty-acid level unchanged. Interestingly, the growth phenotype of the RNAi-induced cells was similar to that found for thiastearate-treated trypanosomes, with the former cells growing twofold slower than the latter ones, indicating that the linoleate content itself and not only fluidity could be essential for normal membrane functionality. A similar deleterious effect was found after RNAi in BSF, even with a mere 8% reduction of OD activity, indicating that its full activity is essential. Conclusions/Significance: As OD is essential for trypanosomes and is not present in mammalian cells, it is a promising target for chemotherapy of African trypanosomiasis.	[Alloatti, Andres; Altabe, Silvia G.; Uttaro, Antonio D.] Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Biochem Lab, B-1200 Brussels, Belgium; [Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Michels, Paul A. M.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Deumer, Gladys; Wallemacq, Pierre] Catholic Univ Louvain, Dept Clin Chem, Clin Univ St Luc, LTAP, B-1200 Brussels, Belgium	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Alloatti, A (corresponding author), Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	toniuttaro@yahoo.com.ar	Nguewa, Paul/T-6982-2017; Alloatti, Andres/P-3021-2016; Gualdrón-López, Melisa/A-4438-2016; Michels, Paul A/A-5637-2009	Nguewa, Paul/0000-0002-2193-7316; Alloatti, Andres/0000-0003-0555-0653; Gualdrón-López, Melisa/0000-0002-8202-6751; Michels, Paul A/0000-0003-3726-6104; Igoillo-Esteve, Mariana/0000-0002-3264-7912	CONICET, Argentina; "de Duve Institute" postdoctoral fellowship; CONICET; FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica) [5492, 1-13842]	CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); "de Duve Institute" postdoctoral fellowship; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica)(FONCyT)	ADU and SGA are members of the Carrera del Investigador Cienti-fico, CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Argentina. AA has a fellowship from CONICET, Argentina and SG has a "de Duve Institute" postdoctoral fellowship. This work was supported by CONICET and FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica), through Grants PIP 2005 No. 5492 and PICT 2003 No. 1-13842, respectively. Collaboration between the Argentine and Belgian teams was supported through an exchange grant to ADU and PAMM, based on an Agreement for Scientific Cooperation between CONICET (Argentina) and F.N.R.S. (French Community of Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloatti A, 2009, INT J PARASITOL, V39, P985, DOI 10.1016/j.ijpara.2009.01.011; BEACH DH, 1989, MOL BIOCHEM PARASIT, V35, P57, DOI 10.1016/0166-6851(89)90142-4; Berge RK, 2002, CURR OPIN LIPIDOL, V13, P295, DOI 10.1097/00041433-200206000-00010; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRUN R, 1979, ACTA TROP, V36, P289; FlorinChristensen M, 1997, MOL BIOCHEM PARASIT, V88, P25, DOI 10.1016/S0166-6851(97)00056-X; Haughan P.A., 1991, P312; Hovik KE, 1997, BBA-LIPID LIPID MET, V1349, P251, DOI 10.1016/S0005-2760(97)00135-5; Krazy H, 2006, BBA-MOL CELL RES, V1763, P6, DOI 10.1016/j.bbamcr.2005.11.002; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MORRIS LJ, 1966, J LIPID RES, V7, P717; PASCAL RA, 1986, J LIPID RES, V27, P221; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Pettersen RJ, 2008, J CARDIOVASC PHARM, V51, P410, DOI 10.1097/FJC.0b013e3181673be0; RAHMAN MD, 1988, J MED CHEM, V31, P1656, DOI 10.1021/jm00403a029; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14239	10.1371/journal.pone.0014239	http://dx.doi.org/10.1371/journal.pone.0014239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151902	Green Published, Green Submitted, gold			2022-12-25	WOS:000284995300011
J	Luo, Y; Wang, Y; Kuang, SY; Chiang, YH; Hoffer, B				Luo, Yu; Wang, Yun; Kuang, Serena Y.; Chiang, Yung-Hsiao; Hoffer, Barry			Decreased Level of Nurr1 in Heterozygous Young Adult Mice Leads to Exacerbated Acute and Long-Term Toxicity after Repeated Methamphetamine Exposure	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE SYNTHESIS; NEURONS; EXPRESSION; BRAIN; GENE; CELLS; RATS	The abuse of psychostimulants, such as methamphetamine (METH), is prevalent in young adults and could lead to long-term adaptations in the midbrain dopamine system in abstinent human METH abusers. Nurr1 is a gene that is critical for the survival and maintenance of dopaminergic neurons and has been implicated in dopaminergic neuron related disorders. In this study, we examined the synergistic effects of repeated early exposure to methamphetamine in adolescence and reduction in Nurr1 gene levels. METH binge exposure in adolescence led to greater damage in the nigrostrial dopaminergic system when mice were exposed to METH binge later in life, suggesting a long-term adverse effect on the dopaminergic system. Compared to naive mice that received METH binge treatment for the first time, mice pretreated with METH in adolescence showed a greater loss of tyrosine hydroxylase (TH) immunoreactivity in striatum, loss of THir fibers in the substantia nigra reticulata (SNr) as well as decreased dopamine transporter (DAT) level and compromised DA clearance in striatum. These effects were further exacerbated in Nurr1 heterozygous mice. Our data suggest that a prolonged adverse effect exists following adolescent METH binge exposure which may lead to greater damage to the dopaminergic system when exposed to repeated METH later in life. Furthermore, our data support that Nurr1 mutations or deficiency could be a potential genetic predisposition which may lead to higher vulnerability in some individuals.	[Luo, Yu; Wang, Yun; Kuang, Serena Y.; Hoffer, Barry] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan Authorit, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan Authorit, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Luo, Y (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	luoy@mail.nih.gov		Luo, Yu/0000-0002-7939-5505	National Institute on Drug Abuse, National Institutes of Health; Taiwan Authority NSC [98-2314-B-038-011-MY3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000429, ZIADA000461, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Taiwan Authority NSC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, and by Taiwan Authority NSC grant 98-2314-B-038-011-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman C, 2003, BEHAV BRAIN RES, V143, P95, DOI 10.1016/S0166-4328(03)00029-9; Boger HA, 2007, J NEUROSCI, V27, P8816, DOI 10.1523/JNEUROSCI.1067-07.2007; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cass WA, 1999, J NEUROSCI, V19, P7653, DOI 10.1523/JNEUROSCI.19-17-07653.1999; Chou J, 2008, NEUROSCIENCE, V151, P92, DOI 10.1016/j.neuroscience.2007.10.044; ELLISON G, 1978, SCIENCE, V201, P276, DOI 10.1126/science.26975; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; HOTCHKISS AJ, 1980, J PHARMACOL EXP THER, V214, P257; Imam SZ, 2005, FASEB J, V19, P1441, DOI 10.1096/fj.04-3362com; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Larsen KE, 2002, J NEUROSCI, V22, P8951; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; Mark KA, 2004, J NEUROSCI, V24, P11449, DOI 10.1523/JNEUROSCI.3597-04.2004; PRESTON KL, 1985, BRAIN RES, V338, P243, DOI 10.1016/0006-8993(85)90153-2; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Xu PY, 2002, NEUROLOGY, V58, P881, DOI 10.1212/WNL.58.6.881; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	25	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15193	10.1371/journal.pone.0015193	http://dx.doi.org/10.1371/journal.pone.0015193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151937	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600031
J	Jarvinen, TM; Hellquist, A; Koskenmies, S; Einarsdottir, E; Panelius, J; Hasan, T; Julkunen, H; Padyukov, L; Kvarnstrom, M; Wahren-Herlenius, M; Nyberg, F; D'Amato, M; Kere, J; Saarialho-Kere, U				Jarvinen, Tiina M.; Hellquist, Anna; Koskenmies, Sari; Einarsdottir, Elisabet; Panelius, Jaana; Hasan, Taina; Julkunen, Heikki; Padyukov, Leonid; Kvarnstrom, Marika; Wahren-Herlenius, Marie; Nyberg, Filippa; D'Amato, Mauro; Kere, Juha; Saarialho-Kere, Ulpu			Polymorphisms of the ITGAM Gene Confer Higher Risk of Discoid Cutaneous Than of Systemic Lupus Erythematosus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FUNCTIONAL VARIANT; UP-REGULATION; ANTI-RO/SSA; HUMAN SKIN; INTEGRIN; DISEASE; CLASSIFICATION; SUSCEPTIBILITY; ASSOCIATION	Background: Lupus erythematosus (LE) is a heterogeneous disease ranging from mainly skin-restricted manifestations (discoid LE [DLE] and subacute cutaneous LE) to a progressive multisystem disease (systemic LE [SLE]). Genetic association studies have recently identified several strong susceptibility genes for SLE, including integrin alpha M (ITGAM), also known as CD11b, whereas the genetic background of DLE is less clear. Principal Findings: To specifically investigate whether ITGAM is a susceptibility gene not only for SLE, but also for cutaneous DLE, we genotyped 177 patients with DLE, 85 patients with sporadic SLE, 190 index cases from SLE families and 395 population control individuals from Finland for nine genetic markers at the ITGAM locus. SLE patients were further subdivided by the presence or absence of discoid rash and renal involvement. In addition, 235 Finnish and Swedish patients positive for Ro/SSA-autoantibodies were included in a subphenotype analysis. Analysis of the ITGAM coding variant rs1143679 showed highly significant association to DLE in patients without signs of systemic disease (P-value = 4.73x10(-11), OR = 3.20, 95% CI = 2.23-4.57). Significant association was also detected to SLE patients (P-value = 8.29x10(-6), OR = 2.14, 95% CI = 1.52-3.00), and even stronger association was found when stratifying SLE patients by presence of discoid rash (P-value = 3.59x10(-8), OR = 3.76, 95% CI = 2.29-6.18). Significance: We propose ITGAM as a novel susceptibility gene for cutaneous DLE. The risk effect is independent of systemic involvement and has an even stronger genetic influence on the risk of DLE than of SLE.	[Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Dermatol, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Allergol, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Inst Clin Med, Dept Venereol, Helsinki, Finland; [Einarsdottir, Elisabet] Univ Helsinki, Biomedicum Helsinki, Res Programme Mol Med, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Panelius, Jaana; Saarialho-Kere, Ulpu] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Jarvinen, Tiina M.; Koskenmies, Sari; Einarsdottir, Elisabet; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Jarvinen, Tiina M.; Hellquist, Anna; D'Amato, Mauro; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Hasan, Taina] Univ Tampere, Dept Dermatol, FIN-33101 Tampere, Finland; [Hasan, Taina] Tampere Univ Hosp, Tampere, Finland; [Julkunen, Heikki] Univ Helsinki, Cent Hosp, Peijas Hosp, Vantaa, Finland; [Padyukov, Leonid; Kvarnstrom, Marika; Wahren-Herlenius, Marie] Karolinska Inst, Rheumatol Unit, Dept Med, Solna, Sweden; [Nyberg, Filippa] Uppsala Univ, Akad Univ Hosp, Dept Dermatol, Uppsala, Sweden; [Nyberg, Filippa] Danderyd Hosp, Karolinska Inst, Inst Clin Sci, Stockholm, Sweden; [Saarialho-Kere, Ulpu] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Saarialho-Kere, Ulpu] Stockholm Soder Hosp, Karolinska Inst, Dermatol Sect, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Jarvinen, TM (corresponding author), Univ Helsinki, Inst Clin Med, Dept Dermatol, Helsinki, Finland.	juha.kere@ki.se	D'Amato, Mauro/B-5050-2019; Kere, Juha/AAX-9117-2021; D'Amato, Mauro/F-2450-2010; Einarsdottir, Elisabet/B-4912-2013; Wahren-Herlenius, Marie/AAN-6942-2021; Kere, Juha/A-9179-2008; Padyukov, Leonid/A-4890-2009	D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Wahren-Herlenius, Marie/0000-0002-0915-7245; Kere, Juha/0000-0003-1974-0271; Einarsdottir, Elisabet/0000-0003-3101-2285; Padyukov, Leonid/0000-0003-2950-5670; Kvarnstrom, Marika/0000-0002-4948-8380	Finska Lakaresallskapet; Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital [TYH 2008248]; Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine; Maire Lisko Foundation; Biomedicum Helsinki Foundation; Helsinki University; Tampere University Hospital, Finland; Edvard Welander Foundation; Finsen Foundation; Swedish Rheumatism Association; Swedish Foundation for Strategic Research; Stockholm County Council; Goran Gustafsson Foundation; Torsten and Ragnar Soderberg Foundation; Heart-Lung Foundation; King Gustaf V Foundation; Swedish Research Council	Finska Lakaresallskapet; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital; Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine; Maire Lisko Foundation; Biomedicum Helsinki Foundation; Helsinki University; Tampere University Hospital, Finland; Edvard Welander Foundation; Finsen Foundation; Swedish Rheumatism Association; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Stockholm County Council(Stockholm County Council); Goran Gustafsson Foundation; Torsten and Ragnar Soderberg Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Finska Lakaresallskapet, Academy of Finland, Sigrid Juselius Foundation and Helsinki University Central Hospital Research Fund (project TYH 2008248), Helsinki Biomedical Graduate School LERU PhD Program in Biomedicine (TMJ), Maire Lisko Foundation (TMJ), Biomedicum Helsinki Foundation (TMJ), Helsinki University Funds (TMJ), Medical Research Fund of Tampere University Hospital (TH), Finland, Edvard Welander Foundation, Finsen Foundation, the Swedish Rheumatism Association (FN), the Swedish Foundation for Strategic Research, the Stockholm County Council, Goran Gustafsson Foundation, Torsten and Ragnar Soderberg Foundation, Heart-Lung Foundation, King Gustaf V Foundation, the Swedish Rheumatism Association (MWH), and the Swedish Research Council (MWH, USK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; GILLIAM JN, 1981, J AM ACAD DERMATOL, V4, P471, DOI 10.1016/S0190-9622(81)80261-7; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jarvinen TM, 2010, EXP DERMATOL, V19, P123, DOI 10.1111/j.1600-0625.2009.00982.x; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kang KF, 1998, J INVEST DERMATOL, V111, P31, DOI 10.1046/j.1523-1747.1998.00121.x; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Kolgen W, 1999, J INVEST DERMATOL, V113, P4, DOI 10.1046/j.1523-1747.1999.00625.x; Koskenmies S, 2008, LUPUS, V17, P337, DOI 10.1177/0961203307087403; Koskenmies S, 2001, J RHEUMATOL, V28, P758; Kuhn A, 2002, BRIT J DERMATOL, V146, P801, DOI 10.1046/j.1365-2133.2002.04693.x; Kuhn Annegret, 2005, Autoimmun Rev, V4, P66, DOI 10.1016/j.autrev.2004.09.005; Kuhn Annegret, 2008, V10, P119, DOI 10.1159/000131451; Lee HJ, 2006, AUTOIMMUNITY, V39, P433, DOI 10.1080/08916930600886851; Lin JH, 2007, CLIN REV ALLERG IMMU, V33, P85, DOI 10.1007/s12016-007-0031-x; Millard TP, 2001, BRIT J DERMATOL, V145, P229, DOI 10.1046/j.1365-2133.2001.04339.x; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Oke V, 2009, J INVEST DERMATOL, V129, P2000, DOI 10.1038/jid.2008.453; Popovic K, 2007, LUPUS, V16, P10, DOI 10.1177/0961203306073135; Popovic K, 2008, ACTA DERM-VENEREOL, V88, P370, DOI 10.2340/00015555-0473; Popovic K, 2007, ARTHRITIS RHEUM, V56, P255, DOI 10.1002/art.22286; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Suarez A, 2005, ANN RHEUM DIS, V64, P1605, DOI 10.1136/ard.2004.035048; Takahara M, 2003, J INVEST DERMATOL, V120, P802, DOI 10.1046/j.1523-1747.2003.12136.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tengner P, 1998, ARTHRITIS RHEUM-US, V41, P2238, DOI 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V; Vera-Recabarren MA, 2010, CLIN EXP DERMATOL, V35, P729, DOI 10.1111/j.1365-2230.2009.03764.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Werth VP, 2007, BULL HOSP JT DIS, V65, P200; Werth VP, 2000, J INVEST DERMATOL, V115, P726, DOI 10.1046/j.1523-1747.2000.00118.x; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118; Yell JA, 1996, BRIT J DERMATOL, V135, P355, DOI 10.1046/j.1365-2133.1996.d01-1004.x	40	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14212	10.1371/journal.pone.0014212	http://dx.doi.org/10.1371/journal.pone.0014212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151989	Green Submitted, Green Published, gold			2022-12-25	WOS:000284868000021
J	Montgomery, CP; Boyle-Vavra, S; Daum, RS				Montgomery, Christopher P.; Boyle-Vavra, Susan; Daum, Robert S.			Importance of the Global Regulators Agr and SaeRS in the Pathogenesis of CA-MRSA USA300 Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; INFLAMMATORY RESPONSES; GENE-EXPRESSION; IN-VITRO; VIRULENCE; SYSTEM; TRANSCRIPTION; SARA; SIGNAL	CA-MRSA infection, driven by the emergence of the USA300 genetic background, has become epidemic in the United States. USA300 isolates are hypervirulent, compared with other CA- and HA-MRSA strains, in experimental models of necrotizing pneumonia and skin infection. Interestingly, USA300 isolates also have increased expression of core genomic global regulatory and virulence factor genes, including agr and saeRS. To test the hypothesis that agr and saeRS promote the observed hypervirulent phenotype of USA300, isogenic deletion mutants of each were constructed in USA300. The effects of gene deletion on expression and protein abundance of selected downstream virulence genes were assessed by semiquantitative real-time reverse-transcriptase PCR (qRT-PCR) and western blot, respectively. The effects of gene deletion were also assessed in mouse models of necrotizing pneumonia and skin infection. Deletion of saeRS, and, to a lesser extent, agr, resulted in attenuated expression of the genes encoding a-hemolysin (hla) and the Panton-Valentine leukocidin (lukSF-PV). Despite the differences in hla transcription, the toxin was undetectable in culture supernatants of either of the deletion mutants. Deletion of agr, but not saeRS, markedly increased the expression of the gene encoding protein A (spa), which correlated with increased protein abundance. Each deletion mutant demonstrated significant attenuation of virulence, compared with wild-type USA300, in mouse models of necrotizing pneumonia and skin infection. We conclude that agr and saeRS each independently contribute to the remarkable virulence of USA300, likely by means of their effects on expression of secreted toxins.	[Montgomery, Christopher P.] Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA; [Boyle-Vavra, Susan; Daum, Robert S.] Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Montgomery, CP (corresponding author), Univ Chicago, Dept Pediat, Sect Crit Care, Chicago, IL 60637 USA.	cmontgomery@bsd.uchicago.edu		Montgomery, Christopher/0000-0001-7247-0683	Pediatric Critical Care; National Institutes of Health (NIH) [AI076596-01A1, AI040481-08A1]; Grant Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040481, R01AI040481, K08AI076596] Funding Source: NIH RePORTER	Pediatric Critical Care; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pediatric Critical Care Scientist Development Program and the National Institutes of Health (NIH) Grant AI076596-01A1 to C. P. M., and the Grant Healthcare Foundation and NIH Grant AI040481-08A1 to R. S. D. and S.B-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BALABAN N, 1995, FEMS MICROBIOL LETT, V133, P155, DOI 10.1016/0378-1097(95)00356-A; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Bronner S, 2000, APPL ENVIRON MICROB, V66, P3931, DOI 10.1128/AEM.66.9.3931-3938.2000; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; FURTADO N, 2006, TOR 44 M INF DIS SOC; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kornblum J., 1990, MOL BIOL STAPHYLOCOC; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; MONTGOMERY CP, 2009, INFECT IMMUN; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	50	135	139	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15177	10.1371/journal.pone.0015177	http://dx.doi.org/10.1371/journal.pone.0015177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151999	gold, Green Published, Green Submitted			2022-12-25	WOS:000284868000030
J	Povarova, OI; Kuznetsova, IM; Turoverov, KK				Povarova, Olga I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.			Differences in the Pathways of Proteins Unfolding Induced by Urea and Guanidine Hydrochloride: Molten Globule State and Aggregates	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; ALPHA-LACTALBUMIN; ACTIN; INTERMEDIATE; FLUORESCENCE; STABILITY; BINDING	It was shown that at low concentrations guanidine hydrochloride (GdnHCl) can cause aggregation of proteins in partially folded state and that fluorescent dye 1-anilinonaphthalene-8-sulfonic acid (ANS) binds with these aggregates rather than with hydrophobic clusters on the surface of protein in molten globule state. That is why the increase in ANS fluorescence intensity is often recorded in the pathway of protein denaturation by GdnHCl, but not by urea. So what was previously believed to be the molten globule state in the pathway of protein denaturation by GdnHCl, in reality, for some proteins represents the aggregates of partially folded molecules.	[Povarova, Olga I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Povarova, OI (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@mail.cytspb.rssi.ru	Kuznetsova, Irina M./R-9844-2017; Povarova, Olga I/F-9060-2017; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; Povarova, Olga/0000-0003-1568-7493; Turoverov, Konstantin/0000-0002-6977-1896	Russian Academy of Sciences	Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Program "Molecular and Cell Biology'' of the Russian Academy of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUFRIEVA EV, 1994, VYSOKOMOL SOEDIN, V36, P449; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2002, BIOCHEMISTRY-US, V41, P13127, DOI 10.1021/bi026412x; Mason PE, 2004, J AM CHEM SOC, V126, P11462, DOI 10.1021/ja040034x; McDuff FO, 2004, BIOCHEM CELL BIOL, V82, P305, DOI 10.1139/o03-072; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; Pace C N, 1986, Methods Enzymol, V131, P266; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peters CD, 1997, BIOCHEM CELL BIOL, V75, P55, DOI 10.1139/bcb-75-1-55; Povarova OI, 2007, CELL BIOL INT, V31, P405, DOI 10.1016/j.cellbi.2007.01.025; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; REES MK, 1967, J BIOL CHEM, V242, P4449; RODIONOVA NA, 1989, MOL BIOL+, V23, P528; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Toldo LIG, 1997, COMPUT APPL BIOSCI, V13, P475; Turoverov K K, 1998, Tsitologiia, V40, P806; Turoverov KK, 2002, BIOCHEMISTRY-US, V41, P1014, DOI 10.1021/bi015548c; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8	24	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15035	10.1371/journal.pone.0015035	http://dx.doi.org/10.1371/journal.pone.0015035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152408	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100052
J	Hashimoto, K; Ishima, T				Hashimoto, Kenji; Ishima, Tamaki			A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiator Factor eIF4AI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RECEPTORS; MODEL; NEUROPROTECTION; TETRACYCLINE; POTENTIATION; ANTAGONIST; MECHANISMS; INHIBITOR; PATHWAYS	Background: Minocycline, a second-generation tetracycline antibiotic, has potential activity for the treatment of several neurodegenerative and psychiatric disorders. However, its mechanisms of action remain to be determined. Methodology/Principal Findings: We found that minocycline, but not tetracycline, significantly potentiated nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells, in a concentration dependent manner. Furthermore, we found that the endoplasmic reticulum protein inositol 1,4,5-triphosphate (IP3) receptors and several common signaling molecules (PLC-gamma, PI3K, Akt, p38 MAPK, c-Jun N-terminal kinase (JNK), mammalian target of rapamycin (mTOR), and Ras/Raf/ERK/MAPK pathways) might be involved in the active mechanism of minocycline. Moreover, we found that a marked increase of the eukaryotic translation initiation factor eIF4AI protein by minocycline, but not tetracycline, might be involved in the active mechanism for NGF-induced neurite outgrowth. Conclusions/Significance: These findings suggest that eIF4AI might play a role in the novel mechanism of minocycline. Therefore, agents that can increase eIF4AI protein would be novel therapeutic drugs for certain neurodegenerative and psychiatric diseases.	[Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Chiba University	Hashimoto, K (corresponding author), Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	National Center of Neurology and Psychiatry (NCNP), Japan [19-2]	National Center of Neurology and Psychiatry (NCNP), Japan	This is supported by a grant for Intramural Research Grant (19-2) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CYA, 2009, MOL CELL, V36, P920, DOI 10.1016/j.molcel.2009.12.013; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Ferrer I, 2002, NEUROPATH APPL NEURO, V28, P441, DOI 10.1046/j.1365-2990.2002.t01-1-00410.x; FUJITA Y, 2006, PROG NEUROPSYCHOPHAR, V32, P336; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; HASHIMOTO K, 2010, PROG NEUROP IN PRESS; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hu W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004151; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Levine J, 1996, AM J PSYCHIAT, V153, P582; Levkovitz Y, 2007, BRAIN RES, V1154, P154, DOI 10.1016/j.brainres.2007.03.080; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Miyaoka T, 2008, CNS NEUROL DISORD-DR, V7, P376, DOI 10.2174/187152708786441858; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Orsucci D, 2009, CNS NEUROL DISORD-DR, V8, P222; Pae CU, 2008, BIOMED PHARMACOTHER, V62, P308, DOI 10.1016/j.biopha.2007.12.005; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; SOFUOGLU M, 2010, PHARM BIOCH BEHAV, V92, P135; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song Y, 2006, BRAIN RES, V1085, P57, DOI 10.1016/j.brainres.2006.02.042; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TANIBUCHI Y, 2010, GEN HOSP PS IN PRESS; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thomas M, 2004, CURR PHARM DESIGN, V10, P679, DOI 10.2174/1381612043453162; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	60	42	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15430	10.1371/journal.pone.0015430	http://dx.doi.org/10.1371/journal.pone.0015430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21151481	gold, Green Submitted, Green Published			2022-12-25	WOS:000283920000024
J	Higgins, CE; Gross, SS				Higgins, Christina E.; Gross, Steven S.			The N-terminal Peptide of Mammalian GTP Cyclohydrolase I Is an Autoinhibitory Control Element and Contributes to Binding the Allosteric Regulatory Protein GFRP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GUANOSINE TRIPHOSPHATE; REACTION-MECHANISM; ESCHERICHIA-COLI; FUSION PROTEINS; NITRIC-OXIDE; TETRAHYDROBIOPTERIN; BIOSYNTHESIS; INHIBITION; ENZYME	GTP cyclohydrolase I (GTPCH) is the rate-limiting enzyme for biosynthesis of tetrahydrobiopterin (BH4), an obligate cofactor for NO synthases and aromatic amino acid hydroxylases. BH4 can limit its own synthesis by triggering decameric GTPCH to assemble in an inhibitory complex with two GTPCH feedback regulatory protein (GFRP) pentamers. Subsequent phenylalanine binding to the GTPCH center dot GFRP inhibitory complex converts it to a stimulatory complex. An N-terminal inhibitory peptide in GTPCH may also contribute to autoregulation of GTPCH activity, but mechanisms are undefined. To characterize potential regulatory actions of the N-terminal peptide in rat GTPCH, we expressed, purified, and characterized a truncation mutant, devoid of 45 N-terminal amino acids (Delta 45-GTPCH) and contrasted its catalytic and GFRP binding properties to wild type GTPCH (wt-GTPCH). Contrary to prior reports, we show that GFRP binds wt-GTPCH in the absence of any small molecule effector, resulting in allosteric stimulation of GTPCH activity: a 20% increase in V-max, 50% decrease in K-m(GTP), and increase in Hill coefficient to 1.6, from 1.0. These features of GFRP-stimulated wt-GTPCH activity were phenocopied by Delta 45-GTPCH in the absence of bound GFRP. Addition of GFRP to Delta 45-GTPCH failed to elicit complex formation or a substantial further increase in GTPCH catalytic activity. Expression of Delta 45-GTPCH in HEK-293 cells elicited 3-fold greater BH4 accumulation than an equivalent of wt-GTPCH. Together, results indicate that the N-terminal peptide exerts autoinhibitory control over rat GTPCH and is required for GFRP binding on its own. Displacement of the autoinhibitory peptide provides a molecular mechanism for physiological up-regulation of GTPCH activity.	[Higgins, Christina E.; Gross, Steven S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Higgins, Christina E.; Gross, Steven S.] Cornell Univ, Weill Med Coll, Program Neurosci, New York, NY 10021 USA	Cornell University; Cornell University	Gross, SS (corresponding author), 1300 York Ave, New York, NY 10021 USA.	ssgross@med.cornell.edu			National Institutes of Health [R37 HL087062, PO1 HL046403, T32 HL007423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007423, R37HL087062, P01HL046403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 HL087062, PO1 HL046403 (to S. S. G.), and T32 HL007423 (to C. E. H.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; BURG AW, 1968, J BIOL CHEM, V243, P2349; Du JH, 2009, ARTERIOSCL THROM VAS, V29, P2161, DOI 10.1161/ATVBAHA.109.194464; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATAKEYAMA K, 1991, J BIOL CHEM, V266, P765; Higgins C.E., 2010, NITRIC OXIDE-BIOL CH, V2nd Edition, P169, DOI [10.1016/B978-0-12-373866-0.00006-X, DOI 10.1016/B978-0-12-373866-0.00006-X]; HOWELLS DW, 1987, CLIN CHIM ACTA, V167, P23, DOI 10.1016/0009-8981(87)90081-7; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kolinsky MA, 2004, J BIOL CHEM, V279, P40677, DOI 10.1074/jbc.M405370200; Lapize C, 1998, BIOCHEM BIOPH RES CO, V251, P802, DOI 10.1006/bbrc.1998.9552; Li L, 2010, CIRC RES, V106, P328, DOI 10.1161/CIRCRESAHA.109.210658; Luttik MAH, 2008, METAB ENG, V10, P141, DOI 10.1016/j.ymben.2008.02.002; Maita N, 2004, J BIOL CHEM, V279, P51534, DOI 10.1074/jbc.M409440200; Maita N, 2002, P NATL ACAD SCI USA, V99, P1212, DOI 10.1073/pnas.022646999; NAGAI K, 1985, P NATL ACAD SCI USA, V82, P7252, DOI 10.1073/pnas.82.21.7252; Nardese V, 1996, BIOCHEM BIOPH RES CO, V218, P273, DOI 10.1006/bbrc.1996.0048; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; PARKS TD, 1991, VIROLOGY, V182, P17, DOI 10.1016/0042-6822(91)90643-P; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; QUINLAN RA, 1989, J CELL SCI, V93, P71; Rebelo J, 2003, J MOL BIOL, V326, P503, DOI 10.1016/S0022-2836(02)01303-7; Schramek N, 2002, J MOL BIOL, V316, P829, DOI 10.1006/jmbi.2001.5339; Schramek N, 2001, J BIOL CHEM, V276, P44157, DOI 10.1074/jbc.M107306200; SHIOTA T, 1967, J BIOL CHEM, V242, P1961; Suzuki T, 1999, J NEUROCHEM, V73, P2510, DOI 10.1046/j.1471-4159.1999.0732510.x; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WEARNE SJ, 1990, FEBS LETT, V263, P23, DOI 10.1016/0014-5793(90)80696-G; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Xie LJ, 1998, J BIOL CHEM, V273, P21091, DOI 10.1074/jbc.273.33.21091; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	38	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.196204	http://dx.doi.org/10.1074/jbc.M110.196204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21163945	hybrid, Green Published			2022-12-25	WOS:000289077500005
J	Xiong, X; Zhao, Y; He, H; Sun, Y				Xiong, X.; Zhao, Y.; He, H.; Sun, Y.			Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator	ONCOGENE			English	Article						MDM2; p53; protein interplays; ribosomal proteins; ubiquitination	TUMOR-CELL GROWTH; SACCHAROMYCES-CEREVISIAE; ACTIVATES P53; MDM2 BINDING; IN-VIVO; INHIBITION; CARCINOMA; GENE; METALLOPANSTIMULIN; APOPTOSIS	Several ribosomal proteins regulate p53 function by modulating MDM2. We recently found that RPS27L, a RPS27-like protein, is a direct p53-inducible target. Here we showed that RPS27 itself is a p53-repressible target. Furthermore, the N-terminal region of either RPS27L or RPS27 binds to MDM2 on the central acidic domain of MDM2. RPS27L or RPS27 forms an in vivo triplex with MDM2-p53 and competes with p53 for MDM2 binding. Similar to p53, RPS27L, but not RPS27, is a short-lived protein and a novel MDM2 substrate. Degradation of RPS27L requires the RING or acidic domain of MDM2. Ectopic expression of RPS27L or RPS27 inhibits MDM-2-mediated p53 ubiquitination and increases p53 levels by extending p53 protein half-life, whereas siRNA silencing of RPS27L decreases p53 levels by shortening p53 half-life, with a corresponding reduction in p53 transcription activity. RPS27L is mainly localized in the cytoplasm, but upon p53-activating signals, a portion of RPS27L shuttled to the nucleoplasm where it colocalizes with MDM2. Both the cytoplasmic and the nuclear p53, induced by ribosomal stress, were reduced upon RPS27L silencing. Our study reveals a multilevel interplay between RPS27L/S27 and p53-MDM2 axis, with RPS27L functioning as a p53 target, a MDM2 substrate and a p53 regulator. Oncogene (2011) 30, 1798-1811; doi:10.1038/onc.2010.569; published online 20 December 2010	[Xiong, X.; Zhao, Y.; He, H.; Sun, Y.] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sun, Y (corresponding author), Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, 4424B MS-1,1301 Catherine St, Ann Arbor, MI 48109 USA.	sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287; Xiong, Xiufang/0000-0001-6842-3673	National Cancer Institute [CA111554, CA118762]; University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA111554, R01CA118762] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Michigan Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute grants (CA111554 and CA118762), and in part by a grant from the Seth Bonder Endowed Research Fund of the University of Michigan Comprehensive Cancer Center to YS.	Atsuta Y, 2002, CANCER LETT, V182, P101, DOI 10.1016/S0304-3835(02)00068-X; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; CHAN YL, 1993, NUCLEIC ACIDS RES, V21, P649, DOI 10.1093/nar/21.3.649; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; FernandezPol JA, 1997, ANTICANCER RES, V17, P1519; FERNANDEZPOL JA, 1993, J BIOL CHEM, V268, P21198; FERNANDEZPOL JA, 1994, CELL GROWTH DIFFER, V5, P811; FernandezPol JA, 1996, ANTICANCER RES, V16, P2177; Ganger DR, 1997, ANTICANCER RES, V17, P1993; Ganger DR, 2001, CANCER DETECT PREV, V25, P231; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee WJ, 2004, OTOLARYNG HEAD NECK, V131, P466, DOI 10.1016/j.otohns.2004.03.011; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Robinson M, 2003, CANCER BIOL THER, V2, P406, DOI 10.4161/cbt.2.4.437; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stack Brendan C Jr, 2004, World J Surg Oncol, V2, P45, DOI 10.1186/1477-7819-2-45; Sun SH, 2008, CANCER BIOL THER, V7, P845, DOI 10.4161/cbt.7.6.5841; Swaroop M, 2003, ANTICANCER RES, V23, P3167; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wang YW, 2006, CLIN CANCER RES, V12, P4965, DOI 10.1158/1078-0432.CCR-05-2316; WONG JM, 1993, CANCER RES, V53, P1916; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	44	84	85	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	15					1798	1811		10.1038/onc.2010.569	http://dx.doi.org/10.1038/onc.2010.569			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21170087	Green Accepted			2022-12-25	WOS:000289512200007
J	Ando, K; Uemura, K; Kuzuya, A; Maesako, M; Asada-Utsugi, M; Kubota, M; Aoyagi, N; Yoshioka, K; Okawa, K; Inoue, H; Kawamata, J; Shimohama, S; Arai, T; Takahashi, R; Kinoshita, A				Ando, Koichi; Uemura, Kengo; Kuzuya, Akira; Maesako, Masato; Asada-Utsugi, Megumi; Kubota, Masakazu; Aoyagi, Nobuhisa; Yoshioka, Katsuji; Okawa, Katsuya; Inoue, Haruhisa; Kawamata, Jun; Shimohama, Shun; Arai, Tetsuaki; Takahashi, Ryosuke; Kinoshita, Ayae			N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein IMPLICATIONS FOR NEURODEGENERATION IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; SCAFFOLDING PROTEIN; MISSENSE MUTATIONS; NEURITE OUTGROWTH; SYNAPSE LOSS; KINASE; ACTIVATION; PATHWAY; ADHESION; PRESENILIN-1	Synaptic loss, which strongly correlates with the decline of cognitive function, is one of the pathological hallmarks of Alzheimer disease. N-cadherin is a cell adhesion molecule essential for synaptic contact and is involved in the intracellular signaling pathway at the synapse. Here we report that the functional disruption of N-cadherin-mediated cell contact activated p38 MAPK in murine primary neurons, followed by neuronal death. We further observed that treatment with A beta(42) decreased cellular N-cadherin expression through NMDA receptors accompanied by increased phosphorylation of both p38 MAPK and Tau in murine primary neurons. Moreover, expression levels of phosphorylated p38 MAPK were negatively correlated with that of N-cadherin in human brains. Proteomic analysis of human brains identified a novel interaction between N-cadherin and JNK-associated leucine zipper protein (JLP), a scaffolding protein involved in the p38 MAPK signaling pathway. We demonstrated that N-cadherin expression had an inhibitory effect on JLP-mediated p38 MAPK signal activation by decreasing the interaction between JLP and p38 MAPK in COS7 cells. Also, this study demonstrated a novel physical and functional association between N-cadherin and p38 MAPK and suggested neuroprotective roles of cadherin-based synaptic contact. The dissociation of N-cadherin-mediated synaptic contact by A beta may underlie the pathological basis of neurodegeneration such as neuronal death, synaptic loss, and Tau phosphorylation in Alzheimer disease brain.	[Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Aoyagi, Nobuhisa; Kawamata, Jun; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Uemura, Kengo] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Yoshioka, Katsuji] Kanazawa Univ, Canc Res Inst, Div Mol Cell Signaling, Kanazawa, Ishikawa 9201192, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co, Tokyo 1008185, Japan; [Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan; [Arai, Tetsuaki] Tokyo Inst Psychiat, Tokyo 1568585, Japan	Kyoto University; Kyoto University; Harvard University; Massachusetts General Hospital; Kanazawa University; Kyowa Kirin Ltd; Kyoto University; Sapporo Medical University; Tokyo Institute of Psychiatry	Kinoshita, A (corresponding author), Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, 53 Shogoinkawahara Cho, Kyoto 6068507, Japan.	akinoshita@hs.med.kyoto-u.ac.jp		Inoue, Haruhisa/0000-0003-4736-9537				Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Benson DL, 1998, J NEUROSCI, V18, P6892; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ito M, 1999, MOL CELL BIOL, V19, P7539; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; LU M, P NATL ACAD SCI US, V107, P4212; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Reynolds CH, 1997, J NEUROCHEM, V69, P191; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Savage MJ, 2002, J NEUROSCI, V22, P3376; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thinakaran G, 1999, J CLIN INVEST, V104, P1321, DOI 10.1172/JCI8728; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu H, 2010, J BIOL CHEM, V285, P3548, DOI 10.1074/jbc.M109.064113; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhu XW, 2005, NEUROCHEM RES, V30, P791, DOI 10.1007/s11064-005-6872-x; Zhu XW, 2001, J NEUROCHEM, V79, P311, DOI 10.1046/j.1471-4159.2001.00597.x	40	52	58	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7619	7628		10.1074/jbc.M110.158477	http://dx.doi.org/10.1074/jbc.M110.158477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177868	hybrid, Green Published			2022-12-25	WOS:000287737300075
J	Lejard, V; Blais, F; Guerquin, MJ; Bonnet, A; Bonnin, MA; Havis, E; Malbouyres, M; Bidaud, CB; Maro, G; Gilardi-Hebenstreit, P; Rossert, J; Ruggiero, F; Duprez, D				Lejard, Veronique; Blais, Frederic; Guerquin, Marie-Justine; Bonnet, Aline; Bonnin, Marie-Ange; Havis, Emmanuelle; Malbouyres, Maryline; Bidaud, Christelle Bonod; Maro, Geraldine; Gilardi-Hebenstreit, Pascale; Rossert, Jerome; Ruggiero, Florence; Duprez, Delphine			EGR1 and EGR2 Involvement in Vertebrate Tendon Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; PRO-ALPHA-1(I) COLLAGEN PROMOTER; SKELETAL-MUSCLE DIFFERENTIATION; GENE-EXPRESSION; MYOTUBE GUIDANCE; TRANSGENIC MICE; NUCLEAR FACTOR; GROWTH-FACTOR; SCLERAXIS; TRANSCRIPTION	The molecules involved in vertebrate tendon formation during development remain largely unknown. To date, only two DNA-binding proteins have been identified as being involved in vertebrate tendon formation, the basic helix-loop-helix transcription factor Scleraxis and, recently, the Mohawk homeobox gene. We investigated the involvement of the early growth response transcription factors Egr1 and Egr2 in vertebrate tendon formation. We established that Egr1 and Egr2 expression in tendon cells was correlated with the increase of collagen expression during tendon cell differentiation in embryonic limbs. Vertebrate tendon differentiation relies on a muscle-derived FGF (fibroblast growth factor) signal. FGF4 was able to activate the expression of Egr genes and that of the tendon-associated collagens in chick limbs. Egr gene misexpression experiments using the chick model allowed us to establish that either Egr gene has the ability to induce de novo expression of the reference tendon marker scleraxis, the main tendon collagen Col1a1, and other tendon-associated collagens Col3a1, Col5a1, Col12a1, and Col14a1. Mouse mutants for Egr1 or Egr2 displayed reduced amounts of Col1a1 transcripts and a decrease in the number of collagen fibrils in embryonic tendons. Moreover, EGR1 and EGR2 trans-activated the mouse Col1a1 proximal promoter and were recruited to the tendon regulatory regions of this promoter. These results identify EGRs as novel DNA-binding proteins involved in vertebrate tendon differentiation by regulating type I collagen production.	[Havis, Emmanuelle; Duprez, Delphine] Univ Paris 06, UMR7622, CNRS, F-75005 Paris, France; [Lejard, Veronique; Malbouyres, Maryline; Bidaud, Christelle Bonod; Ruggiero, Florence] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086, F-69367 Lyon, France; [Maro, Geraldine; Gilardi-Hebenstreit, Pascale] Ecole Normale Super, INSERM, U784, F-75005 Paris, France; [Rossert, Jerome] Paris Descartes Univ, INSERM, U652, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Duprez, D (corresponding author), Univ Paris 06, UMR7622, CNRS, Campus Jussieu,9 Quai St Bernard,Bat C,6E,Case 24, F-75005 Paris, France.	delphine.duprez@upmc.fr	bonod-bidaud, christelle/AAN-9236-2021; Havis, Emmanuelle/K-1874-2017; Duprez, Delphine/K-1856-2017	Havis, Emmanuelle/0000-0001-5634-3174; Duprez, Delphine/0000-0003-0248-7417; BONOD, Christelle/0000-0002-7180-2727; Bonnin, Marie-Ange/0000-0002-6521-3387; GUERQUIN, Marie-Justine/0000-0002-1752-7250; RUGGIERO, Florence/0000-0003-2915-5359	Association Francaise contre les Myopathies (AFM); Association pour la Recherche sur le Cancer (ARC); Agence Nationale de la Recherche (ANR); sixth PCRDT through the MYORES network of excellence; Rhone-Alpes region; Fondation pour la Recherche Medicale (FRM); MYORES network of excellence; French Ministry of Research	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); sixth PCRDT through the MYORES network of excellence; Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MYORES network of excellence; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the Association Francaise contre les Myopathies (AFM), Association pour la Recherche sur le Cancer (ARC), Agence Nationale de la Recherche (ANR), the sixth PCRDT through the MYORES network of excellence, the Rhone-Alpes region, and the Fondation pour la Recherche Medicale (FRM).; Supported by the Fondation pour la Recherche Medicale (FRM), Agence Nationale de la Recherche (ANR), and the MYORES network of excellence.; Supported by the French Ministry of Research and by the Association Francaise contre les Myopathies (AFM).	Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Becker S, 1997, DEVELOPMENT, V124, P2615; Birk DE, 1997, EUR J CELL BIOL, V72, P352; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bonnet A, 2010, MECH DEVELOP, V127, P120, DOI 10.1016/j.mod.2009.10.001; Bonnin MA, 2005, MECH DEVELOP, V122, P573, DOI 10.1016/j.mod.2004.11.005; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Coulpier F, 2010, J NEUROSCI, V30, P5958, DOI 10.1523/JNEUROSCI.0017-10.2010; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Delfini MC, 2004, DEVELOPMENT, V131, P713, DOI 10.1242/dev.00967; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Havis E, 2006, BIOTECHNIQUES, V40, P34, DOI 10.2144/000112098; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kardon G, 1998, DEVELOPMENT, V125, P4019; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; ROS MA, 1995, ANAT EMBRYOL, V192, P483; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Terraz C, 2002, J BIOL CHEM, V277, P19019, DOI 10.1074/jbc.M200125200; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Volohonsky G, 2007, DEVELOPMENT, V134, P347, DOI 10.1242/dev.02735; Vorbruggen G, 1997, P NATL ACAD SCI USA, V94, P8606, DOI 10.1073/pnas.94.16.8606; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5	50	134	137	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5855	5867		10.1074/jbc.M110.153106	http://dx.doi.org/10.1074/jbc.M110.153106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173153	hybrid, Green Published			2022-12-25	WOS:000287230600094
J	Levic, S; Yamoah, EN				Levic, Snezana; Yamoah, Ebenezer N.			Plasticity in Membrane Cholesterol Contributes toward Electrical Maturation of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER HAIR-CELLS; NEURAL STEM-CELLS; POTASSIUM CURRENTS; SURFACE EXPRESSION; LIPID RAFTS; CHANNELS; LOCALIZATION; MECHANISM; MICE; CAVEOLIN-1	Advances in refining the "fluid mosaic" model of the plasma membrane have revealed that it is wrought with an ordered lipid composition that undergoes remarkable plasticity during cell development. Despite the evidence that specific signaling proteins and ion channels gravitate toward these lipid microdomains, identification of their functional impact remains a formidable challenge. We report that in contrast to matured auditory hair cells, depletion of membrane cholesterol in developing hair cells produced marked potentiation of voltage-gated K+ currents (I-Kv). The enhanced magnitude of I-Kv in developing hair cells was in keeping with the reduced cholesterol-rich microdomains in matured hair cells. Remarkably, potentiation of the cholesterol-sensitive current was sufficient to abolish spontaneous activity, a functional blueprint of developing and regenerating hair cells. Collectively, these findings provide evidence that developmental plasticity of lipid microdomains and the ensuing changes in K+ currents are important determinants of one of the hallmarks in the maturation of hearing.	[Levic, Snezana; Yamoah, Ebenezer N.] Univ Calif Davis, Sch Med, Program Commun Sci, Dept Anesthesiol & Pain Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Sch Med, Program Commun Sci, Dept Anesthesiol & Pain Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu		Levic, Snezana/0000-0002-6171-896X	National Institutes of Health, NIDCD [DC003826]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010917, R01DC003826] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC003826 from NIDCD (to E.N.Y.).	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Christian AE, 1997, J LIPID RES, V38, P2264; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Ehret G, 1976, J Am Audiol Soc, V1, P179; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Huertas-Vazquez A, 2010, HUM GENET, V127, P83, DOI 10.1007/s00439-009-0749-z; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; LeMasurier M, 2007, NAT NEUROSCI, V10, P11, DOI 10.1038/nn0107-11; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Martinez-Marmol R, 2008, J CELL PHYSIOL, V217, P667, DOI 10.1002/jcp.21538; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2010, JARO-J ASSOC RES OTO, V11, P39, DOI 10.1007/s10162-009-0196-5; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Reid PC, 2004, J LIPID RES, V45, P582, DOI 10.1194/jlr.D300032-JLR200; Ren T, 2007, CURR OPIN NEUROBIOL, V17, P498, DOI 10.1016/j.conb.2007.07.013; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; SAITO K, 1990, J ELECTRON MICR TECH, V15, P173, DOI 10.1002/jemt.1060150209; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007923; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x	49	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5768	5773		10.1074/jbc.M110.186486	http://dx.doi.org/10.1074/jbc.M110.186486			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163952	Green Published, hybrid			2022-12-25	WOS:000287230600085
J	Ruiz, S; Brennand, K; Panopoulos, AD; Herrerias, A; Gage, FH; Izpisua-Belmonte, JC				Ruiz, Sergio; Brennand, Kristen; Panopoulos, Athanasia D.; Herrerias, Aida; Gage, Fred H.; Carlos Izpisua-Belmonte, Juan			High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes	PLOS ONE			English	Article							INDUCTION; MOUSE; FIBROBLASTS; LINKING	The reprogramming of human somatic cells to induced pluripotent stem (hiPS) cells enables the possibility of generating patient-specific autologous cells for regenerative medicine. A number of human somatic cell types have been reported to generate hiPS cells, including fibroblasts, keratinocytes and peripheral blood cells, with variable reprogramming efficiencies and kinetics. Here, we show that human astrocytes can also be reprogrammed into hiPS (ASThiPS) cells, with similar efficiencies to keratinocytes, which are currently reported to have one of the highest somatic reprogramming efficiencies. ASThiPS lines were indistinguishable from human embryonic stem (ES) cells based on the expression of pluripotent markers and the ability to differentiate into the three embryonic germ layers in vitro by embryoid body generation and in vivo by teratoma formation after injection into immunodeficient mice. Our data demonstrates that a human differentiated neural cell type can be reprogrammed to pluripotency and is consistent with the universality of the somatic reprogramming procedure.	[Ruiz, Sergio; Panopoulos, Athanasia D.; Carlos Izpisua-Belmonte, Juan] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Brennand, Kristen; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Herrerias, Aida; Carlos Izpisua-Belmonte, Juan] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Ruiz, S (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012; Ruiz, Sergio/G-1561-2016	Brennand, Kristen J/0000-0003-0993-5956; Ruiz, Sergio/0000-0002-0177-6965; Panopoulos, Athanasia/0000-0002-9610-2604	Lookout Fund; G. Harold and Leila Y. Mathers Charitable Foundation; CIRM [RL1-00649, RC1-00115-1]; Ministerio de Ciencia e Innovacion (MICINN); Sanofi-Aventis; Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Fundacion Cellex	Lookout Fund; G. Harold and Leila Y. Mathers Charitable Foundation; CIRM(California Institute for Regenerative Medicine); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Sanofi-Aventis(Sanofi-Aventis); Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Fundacion Cellex(Foundation CELLEX)	Work in this manuscript was supported by the Lookout Fund, the G. Harold and Leila Y. Mathers Charitable Foundation, CIRM RL1-00649 and RC1-00115-1 (F. H. G.) and Ministerio de Ciencia e Innovacion (MICINN), Sanofi-Aventis, Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER), Fundacion Cellex and the G. Harold and Leila Y. Mathers Charitable Foundation (J.C.I.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; CHO HJ, 2010, BLOOD           0503; DENOULET P, 1986, GENE, V50, P289, DOI 10.1016/0378-1119(86)90333-1; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; PAPANDRIKOPOULOU A, 1989, NATURE, V340, P650, DOI 10.1038/340650a0; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PATEL M, 2010, STEM CELL REV   0325; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	34	55	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15526	10.1371/journal.pone.0015526	http://dx.doi.org/10.1371/journal.pone.0015526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21170306	gold, Green Published			2022-12-25	WOS:000285135800028
J	Martens, GA; Jiang, L; Verhaeghen, K; Connolly, JB; Geromanos, SG; Stange, G; Van Oudenhove, L; Devreese, B; Hellemans, KH; Ling, ZD; Van Schravendijk, C; Pipeleers, DG; Vissers, JPC; Gorus, FK				Martens, Geert A.; Jiang, Lei; Verhaeghen, Katrijn; Connolly, Joanne B.; Geromanos, Scott G.; Stange, Geert; Van Oudenhove, Laurence; Devreese, Bart; Hellemans, Karine H.; Ling, Zhidong; Van Schravendijk, Christiaan; Pipeleers, Daniel G.; Vissers, Johannes P. C.; Gorus, Frans K.			Protein Markers for Insulin-Producing Beta Cells with Higher Glucose Sensitivity	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; RAT PANCREATIC-ISLETS; NADH SHUTTLE SYSTEM; GENE-EXPRESSION; SHORT-CHAIN; DEHYDROGENASE COMPLEX; B-CELLS; SECRETION; GLUCOKINASE; HETEROGENEITY	Background and Methodology: Pancreatic beta cells show intercellular differences in their metabolic glucose sensitivity and associated activation of insulin production. To identify protein markers for these variations in functional glucose sensitivity, rat beta cell subpopulations were flow-sorted for their level of glucose-induced NAD(P) H and their proteomes were quantified by label-free data independent alternate scanning LC-MS. Beta cell-selective proteins were also identified through comparison with rat brain and liver tissue and with purified islet alpha cells, after geometrical normalization using 6 stably expressed reference proteins. Principal Findings: All tissues combined, 943 proteins were reliably quantified. In beta cells, 93 out of 467 quantifiable proteins were uniquely detected in this cell type; several other proteins presented a high molar abundance in beta cells. The proteome of the beta cell subpopulation with high metabolic and biosynthetic responsiveness to 7.5 mM glucose was characterized by (i) an on average 50% higher expression of protein biosynthesis regulators such as 40S and 60S ribosomal constituents, NADPH-dependent protein folding factors and translation elongation factors; (ii) 50% higher levels of enzymes involved in glycolysis and in the cytosolic arm of the malate/aspartate-NADH-shuttle. No differences were noticed in mitochondrial enzymes of the Krebs cycle, beta-oxidation or respiratory chain. Conclusions: Quantification of subtle variations in the proteome using alternate scanning LC-MS shows that beta cell metabolic glucose responsiveness is mostly associated with higher levels of glycolytic but not of mitochondrial enzymes.	[Martens, Geert A.; Jiang, Lei; Stange, Geert; Hellemans, Karine H.; Ling, Zhidong; Van Schravendijk, Christiaan; Pipeleers, Daniel G.; Gorus, Frans K.] Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium; [Martens, Geert A.; Verhaeghen, Katrijn; Gorus, Frans K.] UZ Brussel, Univ Hosp Brussels, Brussels, Belgium; [Connolly, Joanne B.; Geromanos, Scott G.; Vissers, Johannes P. C.] Waters Corp, Manchester, Lancs, England; [Van Oudenhove, Laurence; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn L ProBE, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Waters UK; Ghent University	Martens, GA (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium.	geert.martens@vub.ac.be	Devreese, Bart/B-2011-2009; Martens, Geert/ABA-6297-2020; Hellemans, Karine/B-7573-2013; Martens, Geert A./F-6920-2015; Devreese, Bart/K-2841-2019; stange, geert m/C-1092-2009	Devreese, Bart/0000-0002-9764-2581; Martens, Geert/0000-0003-1208-6289; Hellemans, Karine/0000-0001-9306-4369; Martens, Geert A./0000-0003-1208-6289; Devreese, Bart/0000-0002-9764-2581; stange, geert m/0000-0003-3148-1372; Pipeleers, Daniel/0000-0002-6440-2485; Gorus, Frans/0000-0002-9007-6177; Verhaeghen, Katrijn/0000-0001-5099-8962	Research Foundation Flanders [G.0374.08, G.0428.09]; Interuniversity Attraction Poles Programme of the Belgian Science Policy [IUAP P6/40]; Agency for Innovation by Science and Technology [IWT 40084]; Juvenile Diabetes Research Foundation [4-2005-1327]; European Union [241883]	Research Foundation Flanders(FWO); Interuniversity Attraction Poles Programme of the Belgian Science Policy; Agency for Innovation by Science and Technology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This study benefited from support by the Research Foundation Flanders (www.fwo.be Grants G.0374.08 and G.0428.09), by the Interuniversity Attraction Poles Programme of the Belgian Science Policy (www.belspo.be Grant IUAP P6/40), by the Agency for Innovation by Science and Technology (www.iwt.be Grant IWT 40084), by the Juvenile Diabetes Research Foundation (Center grant 4-2005-1327) and the European Union (FP7-project 241883). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Eto K, 1999, J BIOL CHEM, V274, P25386, DOI 10.1074/jbc.274.36.25386; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Ling ZD, 1996, DIABETES, V45, P1774, DOI 10.2337/diabetes.45.12.1774; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 2000, J PHYSIOL-LONDON, V529, P49, DOI 10.1111/j.1469-7793.2000.00049.x; Martens GA, 2006, ENDOCRINOLOGY, V147, P5196, DOI 10.1210/en.2006-0580; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Stange Geert, 2003, Methods Mol Med, V83, P15; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSCHRAVENDIJK CFH, 1992, J BIOL CHEM, V267, P21344; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14214	10.1371/journal.pone.0014214	http://dx.doi.org/10.1371/journal.pone.0014214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151894	Green Published, Green Submitted, gold			2022-12-25	WOS:000284995300001
J	Meek, S; Buehr, M; Sutherland, L; Thomson, A; Mullins, JJ; Smith, AJ; Burdon, T				Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Mullins, John J.; Smith, Andrew J.; Burdon, Tom			Efficient Gene Targeting by Homologous Recombination in Rat Embryonic Stem Cells	PLOS ONE			English	Article							HPRT GENE; MICE; BLASTOCYSTS; EXPRESSION; LOCUS; INTEGRATION; PROMOTER; STRATEGY; GENOME	The rat is the preferred experimental animal in many biological studies. With the recent derivation of authentic rat embryonic stem (ES) cells it is now feasible to apply state-of-the art genetic engineering in this species using homologous recombination. To establish whether rat ES cells are amenable to in vivo recombination, we tested targeted disruption of the hypoxanthine phosphoribosyltransferase (hprt) locus in ES cells derived from both inbred and outbred strains of rats. Targeting vectors that replace exons 7 and 8 of the hprt gene with neomycinR/thymidine kinase selection cassettes were electroporated into male Fisher F344 and Sprague Dawley rat ES cells. Approximately 2% of the G418 resistant colonies also tolerated selection with 6-thioguanine, indicating inactivation of the hprt gene. PCR and Southern blot analysis confirmed correct site-specific targeting of the hprt locus in these clones. Embryoid body and monolayer differentiation of targeted cell lines established that they retained differentiation potential following targeting and selection. This report demonstrates that gene modification via homologous recombination in rat ES cells is efficient, and should facilitate implementation of targeted, genetic manipulation in the rat.	[Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Burdon, Tom] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Burdon, Tom] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Mullins, John J.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Mol Physiol Lab, Edinburgh, Midlothian, Scotland; [Smith, Andrew J.] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Meek, S (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	tom.burdon@roslin.ed.ac.uk			Biological and Biotechnological Science Research Council; Roslin Foundation; Wellcome Trust; BBSRC [BBS/E/R/00001627, BBS/E/R/00001601, BB/H012478/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012478/1, BBS/E/R/00001627, BBS/E/R/00001601] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish	Biological and Biotechnological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Roslin Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biological and Biotechnological Science Research Council and the Roslin Foundation (SM, MB, LS, AT, TB). JJM was the recipient of a Wellcome Trust Principal Research Fellowship and his contribution here was supported by the EURATOOLS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Palais G, 2009, PHYSIOL GENOMICS, V37, P140, DOI 10.1152/physiolgenomics.90328.2008; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; Samuel MS, 2009, GENESIS, V47, P440, DOI 10.1002/dvg.20519; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	22	36	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14225	10.1371/journal.pone.0014225	http://dx.doi.org/10.1371/journal.pone.0014225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151976	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600017
J	Faux, MC; Coates, JL; Kershaw, NJ; Layton, MJ; Burgess, AW				Faux, Maree C.; Coates, Janine L.; Kershaw, Nadia J.; Layton, Meredith J.; Burgess, Antony W.			Independent Interactions of Phosphorylated beta-Catenin with E-Cadherin at Cell-Cell Contacts and APC at Cell Protrusions	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; WNT SIGNALING PATHWAY; TRCP-UBIQUITIN LIGASE; F-BOX PROTEIN; TYROSINE PHOSPHORYLATION; MICROTUBULE STABILITY; MOLECULAR SWITCH; EPITHELIAL-CELLS; ADHESION; CANCER	Background: The APC tumour suppressor functions in several cellular processes including the regulation of beta-catenin in Wnt signalling and in cell adhesion and migration. Findings: In this study, we establish that in epithelial cells N-terminally phosphorylated beta-catenin specifically localises to several subcellular sites including cell-cell contacts and the ends of cell protrusions. N-terminally phosphorylated beta-catenin associates with E-cadherin at adherens junctions and with APC in cell protrusions. We isolated APC-rich protrusions from stimulated cells and detected beta-catenin, GSK3 beta and CK1 alpha, but not axin. The APC/phospho-beta-catenin complex in cell protrusions appears to be distinct from the APC/axin/beta-catenin destruction complex. GSK3b phosphorylates the APC-associated population of beta-catenin, but not the cell junction population. beta-catenin associated with APC is rapidly phosphorylated and dephosphorylated. HGF and wound-induced cell migration promote the localised accumulation of APC and phosphorylated beta-catenin at the leading edge of migrating cells. APC siRNA and analysis of colon cancer cell lines show that functional APC is required for localised phospho-beta-catenin accumulation in cell protrusions. Conclusions: We conclude that N-terminal phosphorylation of beta-catenin does not necessarily lead to its degradation but instead marks distinct functions, such as cell migration and/or adhesion processes. Localised regulation of APC-phospho-beta-catenin complexes may contribute to the tumour suppressor activity of APC.	[Faux, Maree C.; Coates, Janine L.; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Kershaw, Nadia J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Layton, Meredith J.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute; Monash University	Faux, MC (corresponding author), Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia.	Maree.faux@ludwig.edu.au	Kershaw, Nadia/G-5770-2014	Kershaw, Nadia/0000-0002-3554-2622	National Health and Medical Research Council of Australia [487922]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	MCF and AWB are supported by the National Health and Medical Research Council of Australia Program Grant 487922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; HADJIHANNAS MV, EMBO REP, V11, P317; HARRIS ES, MOL BIOL CELL; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, PLOS ONE, V5; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; OLSEN JV, SCI SIGNAL, V3, pRA3; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Polakis P, 2000, GENE DEV, V14, P1837; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sadot E, 2002, J CELL SCI, V115, P2771; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wang ZH, 2003, CANCER RES, V63, P5234; WHITEHEAD RH, 1992, IMMUNOL CELL BIOL, V70, P227, DOI 10.1038/icb.1992.30; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	68	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14127	10.1371/journal.pone.0014127	http://dx.doi.org/10.1371/journal.pone.0014127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152425	gold, Green Published			2022-12-25	WOS:000284755100008
J	Kim, PTW; Hoffman, BG; Plesner, A; Helgason, CD; Verchere, CB; Chung, SW; Warnock, GL; Mui, ALF; Ong, CJ				Kim, Peter T. W.; Hoffman, Brad G.; Plesner, Annette; Helgason, Cheryl D.; Verchere, C. Bruce; Chung, Stephen W.; Warnock, Garth L.; Mui, Alice L. F.; Ong, Christopher J.			Differentiation of Mouse Embryonic Stem Cells into Endoderm without Embryoid Body Formation	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; RETINOIC ACID; DEFINITIVE ENDODERM; EFFICIENT DIFFERENTIATION; PARIETAL ENDODERM; LIVER DEVELOPMENT; INSULIN-RELEASE; EXPRESSION; PANCREAS; GENES	Pluripotent embryonic stem cells hold a great promise as an unlimited source of tissue for treatment of chronic diseases such as Type 1 diabetes. Herein, we describe a protocol using all-trans-retinoic acid, basic fibroblast growth factor and dibutyryl cAMP (DBcAMP) in the absence of embryoid body formation, for differentiation of murine embryonic stem cells into definitive endoderm that may serve as pancreatic precursors. The produced cells were analyzed by quantitative PCR, immunohistochemistry and static insulin release assay for markers of trilaminar embryo, and pancreas. Differentiated cells displayed increased Sox17 and Foxa2 expression consistent with definitive endoderm production. There was minimal production of Sox7, an extraembryonic endoderm marker, and Oct4, a marker of pluripotency. There was minimal mesoderm or neuroectoderm formation based on expression levels of the markers brachyury and Sox1, respectively. Various assays revealed that the cell clusters generated by this protocol express markers of the pancreatic lineage including insulin I, insulin II, C-peptide, PDX-1, carboxypeptidase E, pan-cytokeratin, amylase, glucagon, PAX6, Ngn3 and Nkx6.1. This protocol using all-trans-retinoic acid, DBcAMP, in the absence of embryoid bodies, generated cells that have features of definitive endoderm that may serve as pancreatic endocrine precursors.	[Kim, Peter T. W.; Hoffman, Brad G.; Helgason, Cheryl D.; Chung, Stephen W.; Warnock, Garth L.; Mui, Alice L. F.; Ong, Christopher J.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Plesner, Annette; Verchere, C. Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia	Kim, PTW (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada.	chris.ong@ubc.ca		Hoffman, Brad/0000-0002-5420-4493; Plesner, Annette/0000-0002-2188-7056	UBC Dept. of Surgery; Vancouver Coastal Health Research Institute	UBC Dept. of Surgery; Vancouver Coastal Health Research Institute	This work was funded by Concept Award funding from UBC Dept. of Surgery and Vancouver Coastal Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG SL, 1993, DEVELOPMENT, V119, P1301; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Blumentrath J, 2001, CELL BIOCHEM FUNCT, V19, P159, DOI 10.1002/cbf.907; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Deutsch G, 2001, DEVELOPMENT, V128, P871; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Harris Thomas M, 2002, Funct Integr Genomics, V2, P105, DOI 10.1007/s10142-002-0062-6; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hill CS, 2001, CURR OPIN GENET DEV, V11, P533, DOI 10.1016/S0959-437X(00)00229-X; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kato S, 1999, CELL MOL BIOL, V45, P631; KROON E, 2008, NAT BIOTECHNOL; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopal J, 2003, SCIENCE, V299, P363; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SASAKI H, 1993, DEVELOPMENT, V118, P47; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thompson JR, 2002, MOL CELL ENDOCRINOL, V195, P119, DOI 10.1016/S0303-7207(02)00180-6; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; YAN MH, 1994, NATURE, V372, P798; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	43	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14146	10.1371/journal.pone.0014146	http://dx.doi.org/10.1371/journal.pone.0014146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152387	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100026
J	Pemble, CW; Mehta, PK; Mehra, S; Li, ZM; Nourse, A; Lee, RE; White, SW				Pemble, Charles W.; Mehta, Perdeep K.; Mehra, Smriti; Li, Zhenmei; Nourse, Amanda; Lee, Richard E.; White, Stephen W.			Crystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase center dot Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensis	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; ESCHERICHIA-COLI; ARGININE RESIDUE-82; TERNARY COMPLEX; CRYSTALLOGRAPHY; MECHANISM; SEQUENCE; TARGET; ROLES; ULTRACENTRIFUGATION	The 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) enzymes catalyze sequential metabolic reactions in the folate biosynthetic pathway of bacteria and lower eukaryotes. Both enzymes represent validated targets for the development of novel anti-microbial therapies. We report herein that the genes which encode (HPPK)-H-Ft and (DHPS)-D-Ft from the biowarfare agent Francisella tularensis are fused into a single polypeptide. The potential of simultaneously targeting both modules with pterin binding inhibitors prompted us to characterize the molecular details of the multifunctional complex. Our high resolution crystallographic analyses reveal the structural organization between (HPPK)-H-Ft and (DHPS)-D-Ft which are tethered together by a short linker. Additional structural analyses of substrate complexes reveal that the active sites of each module are virtually indistinguishable from those of the monofunctional enzymes. The fused bifunctional enzyme therefore represents an excellent vehicle for finding inhibitors that engage the pterin binding pockets of both modules that have entirely different architectures. To demonstrate that this approach has the potential of producing novel two-hit inhibitors of the folate pathway, we identify and structurally characterize a fragment-like molecule that simultaneously engages both active sites. Our study provides a molecular framework to study the enzyme mechanisms of HPPK and DHPS, and to design novel and much needed therapeutic compounds to treat infectious diseases.	[Pemble, Charles W.; Mehra, Smriti; Li, Zhenmei; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Mehta, Perdeep K.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Nourse, Amanda] St Jude Childrens Res Hosp, Hartwell Ctr, Memphis, TN 38105 USA; [White, Stephen W.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Pemble, CW (corresponding author), Duke Univ, Duke Med Sch Crystallog, Durham, NC 27706 USA.	richard.lee@stjude.org; stephen.white@stjude.org	Lee, Richard/AAX-3996-2021; Lee, Richard/J-4997-2013; White, Stephen W/N-8164-2018	Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Mehta, Perdeep/0000-0003-4081-8352; Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [AI070721]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was provided by National Institutes of Health grant AI070721, Cancer Center core grant CA21765, and the American Lebanese Syrian Associated Charities (ALSAC) (http://www.stjude.org/stjude/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SER-CAT supporting institutions may be found at www.ser.anl.gov/new/index.html. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babaoglu K, 2004, STRUCTURE, V12, P1705, DOI 10.1016/j.str.2004.07.011; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALBO A, 2007, CURR PROTOC IMMUNOL, pCH18; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blaszczyk J, 2004, BIOCHEMISTRY-US, V43, P1469, DOI 10.1021/bi036053l; Blaszczyk J, 2003, BIOCHEMISTRY-US, V42, P1573, DOI 10.1021/bi0267994; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; BROWN GM, 1971, ADV ENZYMOL RAMB, V35, P35; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Cheok MH, 2009, J PEDIAT HEMATOL ONC, V31, P224, DOI 10.1097/MPH.0b013e318196a2a6; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DOMAGK G., 1935, Deutsche Medizinische Wochenschrift, V61, P250, DOI 10.1055/s-0028-1129486; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GLECKMAN R, 1979, AM J HOSP PHARM, V36, P893, DOI 10.1093/ajhp/36.7.893; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lau Sheung-Mei, 2004, Journal of Microbiology Immunology and Infection, V37, P185; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Li GY, 2006, BIOCHEMISTRY-US, V45, P12573, DOI 10.1021/bi061057m; Li Y, 2002, BIOCHEMISTRY-US, V41, P8777, DOI 10.1021/bi025968h; Li Y, 2003, BIOCHEMISTRY-US, V42, P1581, DOI 10.1021/bi026800z; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Matherly LH, 2001, PROG NUCLEIC ACID RE, V67, P131, DOI 10.1016/S0079-6603(01)67027-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mouillon JM, 2002, BIOCHEM J, V363, P313, DOI 10.1042/0264-6021:3630313; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; Xiao B, 2001, J BIOL CHEM, V276, P40274, DOI 10.1074/jbc.M103837200	54	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14165	10.1371/journal.pone.0014165	http://dx.doi.org/10.1371/journal.pone.0014165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152407	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100042
J	Butcher, AJ; Prihandoko, R; Kong, KC; McWilliams, P; Edwards, JM; Bottrill, A; Mistry, S; Tobin, AB				Butcher, Adrian J.; Prihandoko, Rudi; Kong, Kok Choi; McWilliams, Phillip; Edwards, Jennifer M.; Bottrill, Andrew; Mistry, Sharad; Tobin, Andrew B.			Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; M-3-MUSCARINIC RECEPTOR; BIASED LIGANDS; KINASES; ARRESTINS; ROLES; GRKS	G-protein-coupled receptors are hyper-phosphorylated in a process that controls receptor coupling to downstream signaling pathways. The pattern of receptor phosphorylation has been proposed to generate a "bar code" that can be varied in a tissue-specific manner to direct physiologically relevant receptor signaling. If such a mechanism existed, receptors would be expected to be phosphorylated in a cell/tissue-specific manner. Using tryptic phosphopeptide maps, mass spectrometry, and phospho-specific antibodies, it was determined here that the prototypical G(q/11)-coupled M-3-muscarinic receptor was indeed differentially phosphorylated in various cell and tissue types supporting a role for differential receptor phosphorylation in directing tissue-specific signaling. Furthermore, the phosphorylation profile of the M-3-muscarinic receptor was also dependent on the stimulus. Full and partial agonists to the M3-muscarinic receptor were observed to direct phosphorylation preferentially to specific sites. This hitherto unappreciated property of ligands raises the possibility that one mechanism underlying ligand bias/functional selectivity, a process where ligands direct receptors to preferred signaling pathways, may be centered on the capacity of ligands to promote receptor phosphorylation at specific sites.	[Butcher, Adrian J.; Prihandoko, Rudi; Kong, Kok Choi; McWilliams, Phillip; Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Bottrill, Andrew; Mistry, Sharad] Univ Leicester, Prot & Nucle Acid Chem Lab, Leicester LE1 9HN, Leics, England; [Edwards, Jennifer M.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@le.ac.uk	Bottrill, Andrew/C-6367-2013; Bottrill, Andrew/ABD-1459-2021	Bottrill, Andrew/0000-0002-5182-3643; Bottrill, Andrew/0000-0002-5182-3643	Wellcome Trust [047600]; Heptares Inc.	Wellcome Trust(Wellcome TrustEuropean Commission); Heptares Inc.	This work was supported by Wellcome Trust Grant 047600 and Heptares Inc.	Budd DC, 2001, J BIOL CHEM, V276, P4581, DOI 10.1074/jbc.M008827200; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Lee HM, 1998, J NEUROCHEM, V70, P1189; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Szekeres PG, 1998, MOL PHARMACOL, V53, P759, DOI 10.1124/mol.53.4.759; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Willets JM, 2001, MOL PHARMACOL, V60, P321, DOI 10.1124/mol.60.2.321; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	25	142	143	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11506	11518		10.1074/jbc.M110.154526	http://dx.doi.org/10.1074/jbc.M110.154526			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21177246	Green Published, hybrid			2022-12-25	WOS:000288797100061
J	Plante, I; Stewart, MKG; Barr, K; Allan, AL; Laird, DW				Plante, I.; Stewart, M. K. G.; Barr, K.; Allan, A. L.; Laird, D. W.			Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease	ONCOGENE			English	Article						gap junctions; mammary gland tumor; metastasis; connexin43; ErbB2	GAP-JUNCTIONS; MYOEPITHELIAL CELLS; HUMAN BREAST; GLAND DEVELOPMENT; DOWN-REGULATION; EXPRESSION; CONNEXIN-43; DIFFERENTIATION; CX26; PHOSPHORYLATION	Gap junctions, the channels formed by the connexin (Cx) family of proteins, are responsible for direct intercellular communication. Although connexins are considered as tumor suppressors, their overall role in cancer onset, progression and metastasis is somewhat controversial. This study uses a novel Cx43 mutant mouse model (G60S mice) and cross-breeding strategies to determine the role of Cx43 in all stages of breast tumorigenesis. G60S mice were cross-bred with ErbB2 overexpressing mice, and spontaneous and 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced tumor development was evaluated. Mice were killed when tumors reached similar to 1 cm(3) or when mice showed signs of critical illness. In both spontaneous and DMBA studies, onset of palpable tumors was delayed in G60S mice compared with mice in control groups. Moreover, while tumors from control mice reached the size threshold, most DMBA-exposed Cx43 mutant mice were killed prematurely because of labored breathing, independent of the presence of a palpable tumor. Reduced Cx43 levels in Cx43 mutant mice were accompanied by extensive mammary gland hyperplasia. Lung histology revealed that all Cx43 mutant mice exhibited mammaglobin-positive mammary gland metastases to the lung, and the number of metastases was increased by threefold in Cx43 mutant mice on treatment with DMBA. Thus, while reduced levels of Cx43 delayed the onset of palpable tumors, normal Cx43 levels inhibited mammary gland tumor metastasis to the lungs. Understanding the mechanisms of how Cx43, which is expressed primarily in myoepithelial cells, inhibits mammary gland tumor metastasis is critical as Cx43 is assessed as a candidate for therapeutic intervention. Oncogene (2011) 30, 1681-1692; doi:10.1038/onc.2010.551; published online 13 December 2010	[Plante, I.; Allan, A. L.; Laird, D. W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Stewart, M. K. G.; Barr, K.; Laird, D. W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Allan, A. L.] Univ Western Ontario, Dept Oncol, London, ON N6A 5C1, Canada; [Allan, A. L.] London Reg Canc Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg,Room 00077, London, ON N6A 5C1, Canada.	Dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Plante, Isabelle/AAK-5997-2021	Laird, Dale W/0000-0002-4568-3285; Plante, Isabelle/0000-0003-2080-6450	Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec	Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	We thank David Goodale for his technical assistance. We are grateful to Dr Janet Rossant and team at the Centre for Modeling Human Disease (Toronto, ON, Canada) for providing the mouse model. This research was funded by the Canadian Breast Cancer Research Alliance to DWL, and by Fellowships from the Canadian Institutes of Health Research, the Canadian Institutes of Health Research Strategic Training Program and the Fonds de la Recherche en Sante du Quebec to IP. ALA is supported by a Canadian Institutes of Health Research New Investigator Award.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; Allred DC, 2008, J MAMMARY GLAND BIOL, V13, P279, DOI 10.1007/s10911-008-9093-5; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Bodenstine TM, 2008, CANCER MICROENVIRON, V1, P1, DOI 10.1007/s12307-008-0001-8; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; De Flora S, 2006, INT J ONCOL, V29, P521; El-Sabban ME, 2003, J MAMMARY GLAND BIOL, V8, P463, DOI 10.1023/B:JOMG.0000017432.04930.76; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Foschini MP, 1998, VIRCHOWS ARCH, V432, P303, DOI 10.1007/s004280050170; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hewitt SC, 2002, CANCER RES, V62, P2798; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Jamieson S, 1998, J PATHOL, V184, P37, DOI 10.1002/(SICI)1096-9896(199801)184:1<37::AID-PATH966>3.0.CO;2-D; Kalra J, 2006, CARCINOGENESIS, V27, P2528, DOI 10.1093/carcin/bgl110; Kanczuga-Koda L, 2006, J CLIN PATHOL, V59, P429, DOI 10.1136/jcp.2005.029272; Laird DW, 1999, CANCER RES, V59, P4104; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Manias JL, 2008, CARDIOVASC RES, V80, P385, DOI 10.1093/cvr/cvn203; McLachlan E, 2005, CELL COMMUN ADHES, V12, P279, DOI 10.1080/15419060500514143; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Medina Daniel, 2007, Breast Dis, V28, P63; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Monaghan P, 1996, EXP CELL RES, V223, P29, DOI 10.1006/excr.1996.0055; Nagata K, 2009, J PEDIATR SURG, V44, P2296, DOI 10.1016/j.jpedsurg.2009.07.070; Naoi Y, 2007, BREAST CANCER RES TR, V106, P11, DOI 10.1007/s10549-006-9465-8; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; PITELKA DR, 1973, J CELL BIOL, V56, P797, DOI 10.1083/jcb.56.3.797; Plante I, 2008, DEV BIOL, V318, P312, DOI 10.1016/j.ydbio.2008.03.033; Plante I, 2010, BIOL REPROD, V82, P837, DOI 10.1095/biolreprod.109.081406; Rowse GJ, 1998, CANCER RES, V58, P2675; Saunders MM, 2001, CANCER RES, V61, P1765; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sternlicht MD, 1997, MED HYPOTHESES, V48, P37, DOI 10.1016/S0306-9877(97)90022-0; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Talhouk RS, 2008, EXP CELL RES, V314, P3275, DOI 10.1016/j.yexcr.2008.07.030; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Tsubura A, 2007, MED MOL MORPHOL, V40, P9, DOI 10.1007/s00795-006-0351-6; van de Wouw AJ, 2003, ANN ONCOL, V14, P191, DOI 10.1093/annonc/mdg068; Yang M, 2010, MODERN PATHOL, V23, P654, DOI 10.1038/modpathol.2010.38	51	73	78	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1681	1692		10.1038/onc.2010.551	http://dx.doi.org/10.1038/onc.2010.551			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21151177				2022-12-25	WOS:000289239400006
J	Lee, YH; Schiemann, WP				Lee, Yong-Hun; Schiemann, William P.			Fibromodulin Suppresses Nuclear Factor-kappa B Activity by Inducing the Delayed Degradation of IKBA via a JNK-dependent Pathway Coupled to Fibroblast Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CALPAIN-MEDIATED DEGRADATION; NEGATIVE BREAST-CANCER; TGF-BETA; PROSTATE-CANCER; PROTEIN-KINASE; LYSYL OXIDASE; EXTRACELLULAR-MATRIX; EXPRESSION PATTERNS; SMALL PROTEOGLYCANS	Fibulin-5 (FBLN5) belongs to the Fibulin family of secreted extracellular matrix proteins, and our laboratory first established FBLN5 as a novel target for TGF-beta in fibroblasts and endothelial cells. To better understand the pathophysiology of FBLN5, we carried out microarray analysis to identify fibroblast genes whose expressions were regulated by FBLN5 and TGF-beta. In doing so, we identified fibromodulin (Fmod) as a novel target gene of FBLN5, and we validated the differential expression of Fmod and 12 other FBLN5-regulated genes by semi-quantitative real time PCR. Fmod belongs to the small leucine-rich family of proteoglycans, which are important constituents of mammalian extracellular matrices. Interestingly, parental 3T3-L1 fibroblasts displayed high levels of nuclear factor-kappa B (NF-kappa B) activity, although those engineered to express Fmod constitutively exhibited significantly reduced NF-kappa B activity, suggesting that Fmod functions to inhibit NF-kappa B signaling. By monitoring alterations in the activation of NF-kappa B and the degradation of its inhibitor, I kappa B alpha, we demonstrate for the first time that Fmod contributes to the constitutive degradation of I kappa B alpha protein in 3T3-L1 fibroblasts. Mechanistically, we observed Fmod to delay the degradation of I kappa B alpha by promoting the following: (i) activation of c-Jun N-terminal kinase; (ii) inhibition of calpain and casein kinase 2 activity; and (iii) induction of fibroblast apoptosis. Taken together, our study identified a novel function for Fmod in directing extracellular signaling, particularly the regulation of NF-kappa B activity and cell survival.	[Lee, Yong-Hun; Schiemann, William P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Wolstein Res Bldg,Rm 2131,2103 Cornell Rd, Cleveland, OH 44121 USA.	William.Schiemann@case.edu			National Institutes of Health [CA129359]; Department of Defense [BC084651]; Komen Foundation [BCTR0706967]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129359. This work was also supported by Department of Defense Grant BC084651 and Komen Foundation Grant BCTR0706967 (to W. P. S.).	Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cavin LG, 2003, HEPATOLOGY, V38, P1540, DOI 10.1016/j.hep.2003.09.019; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; DeRisi J, 1996, NAT GENET, V14, P457; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Ferreiro DU, 2010, BIOCHEMISTRY-US, V49, P1560, DOI 10.1021/bi901948j; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kobayashi T, 2003, ACTA DERM-VENEREOL, V83, P105, DOI 10.1080/00015550310007436; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Lee MJ, 2004, J AM COLL SURGEONS, V199, P403, DOI 10.1016/j.jamcollsurg.2004.04.021; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Magee JA, 2001, CANCER RES, V61, P5692; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Petri J B, 1999, Mol Cell Biol Res Commun, V1, P59, DOI 10.1006/mcbr.1999.0113; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Ponnappan Subramaniam, 2005, Immun Ageing, V2, P15, DOI 10.1186/1742-4933-2-15; Provenzano PP, 2005, MATRIX BIOL, V23, P543, DOI 10.1016/j.matbio.2004.09.008; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; SCHIEMANN WP, 1995, P NATL ACAD SCI USA, V92, P5361, DOI 10.1073/pnas.92.12.5361; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; WESTERGRENTHORSSON G, 1991, MATRIX, V11, P177, DOI 10.1016/S0934-8832(11)80156-3; WESTERGRENTHORSSON G, 1993, J CLIN INVEST, V92, P632, DOI 10.1172/JCI116631	65	21	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6414	6422		10.1074/jbc.M110.168682	http://dx.doi.org/10.1074/jbc.M110.168682			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156791	hybrid, Green Published			2022-12-25	WOS:000287476400052
J	Li, CM; Pan, WS; Braunewell, KH; Ames, JB				Li, Congmin; Pan, Wensheng; Braunewell, Karl H.; Ames, James B.			Structural Analysis of Mg2+ and Ca2+ Binding, Myristoylation, and Dimerization of the Neuronal Calcium Sensor and Visinin-like Protein 1 (VILIP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PHOTORECEPTOR GUANYLYL CYCLASE; C6 GLIOMA-CELLS; HIPPOCAMPAL-NEURONS; CA2+-SENSOR PROTEINS; ALZHEIMERS-DISEASE; BOVINE NEUROCALCIN; CRYSTAL-STRUCTURE; CATION-BINDING; IN-VITRO	Visinin-like protein 1 (VILIP-1) belongs to the neuronal calcium sensor family of Ca2+-myristoyl switch proteins that regulate signal transduction in the brain and retina. Here we analyze Ca2+ and Mg2+ binding, characterize metal-induced conformational changes, and determine structural effects of myristoylation and dimerization. Mg2+ binds functionally to VILIP-1 at EF3 (Delta H = +1.8 kcal/mol and K-D = 20 mu M). Un-myristoylated VILIP-1 binds two Ca2+ sequentially at EF2 and EF3 (K-EF3 = 0.1 mu M and K-EF2 = 1-4 mu M), whereas myristoylated VILIP-1 binds two Ca2+ with lower affinity (K-D = 1.2 mu M) and positive cooperativity (Hill slope = 1.5). NMR assignments and structural analysis indicate that Ca2+-free VILIP-1 contains a sequestered myristoyl group like that of recoverin. NMR resonances of the attached myristate exhibit Ca2+-dependent chemical shifts and NOE patterns consistent with Ca2+-induced extrusion of the myristate. VILIP-1 forms a dimer in solution independent of Ca2+ and myristoylation. The dimerization site is composed of residues in EF4 and the loop region between EF3 and EF4, confirmed by mutagenesis. We present the structure of the VILIP-1 dimer and a Ca2+-myristoyl switch to provide structural insights into Ca2+-induced trafficking of nicotinic acetylcholine receptors.	[Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Pan, Wensheng; Braunewell, Karl H.] So Res Inst, Dept Biochem & Mol Biol, Mol & Cellular Neurosci Lab, Birmingham, AL 35205 USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			National Institutes of Health [EY012347, NS059969]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.).	Alekseev AM, 1998, FEBS LETT, V440, P116, DOI 10.1016/S0014-5793(98)01426-4; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Bernstein HG, 2003, NEUROSCI LETT, V339, P95, DOI 10.1016/S0304-3940(02)01482-9; Bernstein HG, 2002, NEUROREPORT, V13, P393, DOI 10.1097/00001756-200203250-00006; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1997, J NEUROCHEM, V68, P2129; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; COX JA, 1994, J BIOL CHEM, V269, P32807; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gierke P, 2008, NEUROBIOL DIS, V32, P162, DOI 10.1016/j.nbd.2008.07.008; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; LADANT D, 1995, J BIOL CHEM, V270, P3179; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Schnurra I, 2001, NEUROBIOL DIS, V8, P900, DOI 10.1006/nbdi.2001.0432; Spilker C, 2002, J NEUROSCI, V22, P7331; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zhao C, 2008, NEUROSCIENCE, V153, P1202, DOI 10.1016/j.neuroscience.2007.10.067; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	57	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6354	6366		10.1074/jbc.M110.173724	http://dx.doi.org/10.1074/jbc.M110.173724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169352	Green Published, hybrid			2022-12-25	WOS:000287476400046
J	Yan, J; Cai, ZH				Yan, Jun; Cai, Zhonghua			Molecular Evolution and Functional Divergence of the Cytochrome P450 3 (CYP3) Family in Actinopterygii (Ray-Finned Fish)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; WHOLE-GENOME DUPLICATION; PHYLOGENETIC ANALYSIS; RATES	Background: The cytochrome P450 (CYP) superfamily is a multifunctional hemethiolate enzyme that is widely distributed from Bacteria to Eukarya. The CYP3 family contains mainly the four subfamilies CYP3A, CYP3B, CYP3C and CYP3D in vertebrates; however, only the Actinopterygii (ray-finned fish) have all four subfamilies and detailed understanding of the evolutionary relationship of Actinopterygii CYP3 family members would be valuable. Methods and Findings: Phylogenetic relationships were constructed to trace the evolutionary history of the Actinopterygii CYP3 family genes. Selection analysis, relative rate tests and functional divergence analysis were combined to interpret the relationship of the site-specific evolution and functional divergence in the Actinopterygii CYP3 family. The results showed that the four CYP3 subfamilies in Actinopterygii might be formed by gene duplication. The first gene duplication event was responsible for divergence of the CYP3B/C clusters from ancient CYP3 before the origin of the Actinopterygii, which corresponded to the fish-specific whole genome duplication (WGD). Tandem repeat duplication in each of the homologue clusters produced stable CYP3B, CYP3C, CYP3A and CYP3D subfamilies. Acceleration of asymmetric evolutionary rates and purifying selection together were the main force for the production of new subfamilies and functional divergence in the new subset after gene duplication, whereas positive selection was detected only in the retained CYP3A subfamily. Furthermore, nearly half of the functional divergence sites appear to be related to substrate recognition, which suggests that site-specific evolution is closely related with functional divergence in the Actinopterygii CYP3 family. Conclusions: The split of fish-specific CYP3 subfamilies was related to the fish-specific WGD, and site-specific acceleration of asymmetric evolutionary rates and purifying selection was the main force for the origin of the new subfamilies and functional divergence in the new subset after gene duplication. Site-specific evolution in substrate recognition was related to functional divergence in the Actinopterygii CYP3 family.	[Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China; [Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Dept Biotechnol, Beijing 100084, Peoples R China; [Yan, Jun; Cai, Zhonghua] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Yan, J (corresponding author), Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China.	caizh@sz.tsinghua.edu.cn			International Cooperative Projects of Shenzhen [ZYA200903260036A]; Shenzhen and Longgang Agricultural Bureau; Shenzhen committee of Science, Industry, Trade and Information Technology of China	International Cooperative Projects of Shenzhen; Shenzhen and Longgang Agricultural Bureau; Shenzhen committee of Science, Industry, Trade and Information Technology of China	This study was supported by grants from the International Cooperative Projects of Shenzhen (ZYA200903260036A), agricultural integrated project from Shenzhen and Longgang Agricultural Bureau, and scientific platform project from Shenzhen committee of Science, Industry, Trade and Information Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Corley-Smith GE, 2006, BIOCHEM BIOPH RES CO, V340, P1039, DOI 10.1016/j.bbrc.2005.12.110; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Siroka Z, 2004, ACTA VET BRNO, V73, P123, DOI 10.2754/avb200473010123; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torimoto N, 2007, DRUG METAB DISPOS, V35, P484, DOI 10.1124/dmd.106.011304; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; YOSHIDA Y, 2000, BIOCH BIOPH RES COMM, V273	43	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14276	10.1371/journal.pone.0014276	http://dx.doi.org/10.1371/journal.pone.0014276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170327	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400007
J	Kronik, N; Kogan, Y; Elishmereni, M; Halevi-Tobias, K; Vuk-Pavlovic, S; Agur, Z				Kronik, Natalie; Kogan, Yuri; Elishmereni, Moran; Halevi-Tobias, Karin; Vuk-Pavlovic, Stanimir; Agur, Zvia			Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models	PLOS ONE			English	Article							APOPTOTIC TUMOR-CELLS; DENDRITIC CELLS; T-CELLS; CHEMOTHERAPY; GROWTH; VACCINATION; STRATEGIES; INDUCTION; DOCETAXEL; INTERVAL	Background: Therapeutic vaccination against disseminated prostate cancer (PCa) is partially effective in some PCa patients. We hypothesized that the efficacy of treatment will be enhanced by individualized vaccination regimens tailored by simple mathematical models. Methodology/Principal Findings: We developed a general mathematical model encompassing the basic interactions of a vaccine, immune system and PCa cells, and validated it by the results of a clinical trial testing an allogeneic PCa whole-cell vaccine. For model validation in the absence of any other pertinent marker, we used the clinically measured changes in prostate-specific antigen (PSA) levels as a correlate of tumor burden. Up to 26 PSA levels measured per patient were divided into each patient's training set and his validation set. The training set, used for model personalization, contained the patient's initial sequence of PSA levels; the validation set contained his subsequent PSA data points. Personalized models were simulated to predict changes in tumor burden and PSA levels and predictions were compared to the validation set. The model accurately predicted PSA levels over the entire measured period in 12 of the 15 vaccination-responsive patients (the coefficient of determination between the predicted and observed PSA values was R-2 = 0.972). The model could not account for the inconsistent changes in PSA levels in 3 of the 15 responsive patients at the end of treatment. Each validated personalized model was simulated under many hypothetical immunotherapy protocols to suggest alternative vaccination regimens. Personalized regimens predicted to enhance the effects of therapy differed among the patients. Conclusions/Significance: Using a few initial measurements, we constructed robust patient-specific models of PCa immunotherapy, which were retrospectively validated by clinical trial results. Our results emphasize the potential value and feasibility of individualized model-suggested immunotherapy protocols.	[Kronik, Natalie; Kogan, Yuri; Elishmereni, Moran; Halevi-Tobias, Karin; Agur, Zvia] Inst Med BioMath, Bene Ataroth, Israel; [Vuk-Pavlovic, Stanimir] Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic	Kronik, N (corresponding author), Holon Inst Technol, Dept Appl Math, Fac Exact Sci, Holon, Israel.	agur@imbm.org			Chai Foundation; NIH [P50CA91956]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	Chai Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	N.K., Y.K., M.E., K.H.T., and Z.A. thank the Chai Foundation for support of this work. S.V.P. gratefully acknowledges the support by Mrs. Adelyn L. Luther, Mayo Clinic Cancer Center, and NIH Grant P50CA91956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalamian-Matheis M, 2007, ADV EXP MED BIOL, V601, P173; ACHARYA RS, 1984, INT J BIOMED COMPUT, V15, P139, DOI 10.1016/0020-7101(84)90026-6; Agur Z., 1994, Random and Computational Dynamics, V2, P279; Agur Z, 2004, DISCRETE CONT DYN-B, V4, P29; AGUR Z, 1992, EUR J CANCER, V28A, P1085, DOI 10.1016/0959-8049(92)90463-C; Agur Z, 2006, OPER RES, V54, P829, DOI 10.1287/opre.1060.0320; Arakelyan L, 2005, EUR J CANCER, V41, P159, DOI 10.1016/j.ejca.2004.09.012; Arakelyan L., 2002, Angiogenesis, V5, P203, DOI 10.1023/A:1023841921971; Bajzer Z, 2005, BIOSYSTEMS, V80, P1, DOI 10.1016/j.biosystems.2004.09.025; BAJZER Z, 1984, SCIENCE, V225, P930, DOI 10.1126/science.6382606; BAJZER Z, 1990, Critical Reviews in Oncogenesis, V2, P53; Brandacher G, 2006, CURR DRUG METAB, V7, P599, DOI 10.2174/138920006778017768; Brill TH, 2009, HUM GENE THER, V20, P1641, DOI 10.1089/hum.2009.101; Bunimovich-Mendrazitsky S, 2008, B MATH BIOL, V70, P2055, DOI 10.1007/s11538-008-9344-z; Cappuccio A, 2007, J THEOR BIOL, V248, P259, DOI 10.1016/j.jtbi.2007.05.015; Cappuccio A, 2006, CANCER RES, V66, P7293, DOI 10.1158/0008-5472.CAN-06-0241; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; COJOCARU L, 1992, MATH BIOSCI, V109, P85, DOI 10.1016/0025-5564(92)90053-Y; Collins C, 2007, CANCER BIOL THER, V6, P1360; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; de Pillis LG, 2006, J THEOR BIOL, V238, P841, DOI 10.1016/j.jtbi.2005.06.037; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; De Vleeschouwer S, 2005, CANCER IMMUNOL IMMUN, V54, P372, DOI 10.1007/s00262-004-0615-8; DEPILLIS LG, 2001, COMP MATH MATH PHYS, V3, P1748; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; ELISHMERENI M, 2008, AACR INT C ADV CANC; Georger TC, 2003, EUR J IMMUNOL, V33, P502, DOI 10.1002/immu.200310026; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gorelik B, 2008, CANCER RES, V68, P9033, DOI 10.1158/0008-5472.CAN-08-1723; HARNEVO LE, 1992, CANCER CHEMOTH PHARM, V30, P469, DOI 10.1007/BF00685599; Harzstark AL, 2009, ONCOLOGIST, V14, P391, DOI 10.1634/theoncologist.2008-0240; Healy CG, 1998, CYTOMETRY, V32, P109, DOI 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Kokhaei P, 2004, LEUKEMIA, V18, P1810, DOI 10.1038/sj.leu.2403517; Kokhaei P, 2003, LEUKEMIA, V17, P894, DOI 10.1038/sj.leu.2402913; Kronik N, 2008, CANCER IMMUNOL IMMUN, V57, P425, DOI 10.1007/s00262-007-0387-z; Kulprathipanja NV, 2004, J NEUROIMMUNOL, V153, P76, DOI 10.1016/j.jneuroim.2004.04.011; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Leon K, 2007, J IMMUNOL, V179, P5659, DOI 10.4049/jimmunol.179.9.5659; Louzoun Y, 2007, IMMUNOL REV, V216, P9; Machiels JP, 2008, J CLIN ONCOL, V26, P5261, DOI 10.1200/JCO.2008.16.9524; Marrari A, 2007, CANCER IMMUNOL IMMUN, V56, P429, DOI 10.1007/s00262-006-0233-8; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Michael A, 2005, CLIN CANCER RES, V11, P4469, DOI 10.1158/1078-0432.CCR-04-2337; Min WP, 2003, J IMMUNOL, V170, P1304, DOI 10.4049/jimmunol.170.3.1304; Nani F, 2000, MATH BIOSCI, V163, P159, DOI 10.1016/S0025-5564(99)00058-9; Olson WC, 2007, REV RECENT CLIN TRIA, V2, P182, DOI 10.2174/157488707781662724; Pawelec G, 2004, FEBS LETT, V567, P63, DOI 10.1016/j.febslet.2004.02.091; Peshwa MV, 1998, PROSTATE, V36, P129, DOI 10.1002/(SICI)1097-0045(19980701)36:2<129::AID-PROS8>3.0.CO;2-D; SCHELLHAMMER PF, 2009, ANN M AM UR ASS APR; Street D, 1997, GYNECOL ONCOL, V65, P265, DOI 10.1006/gyno.1997.4667; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Vuk-Pavlovic S, 2008, BLOOD CELL MOL DIS, V40, P94, DOI 10.1016/j.bcmd.2007.06.025; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Weiner LM, 2008, NEW ENGL J MED, V358, P2664, DOI 10.1056/NEJMp0803663; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; YOUNGA D, 2009, SYSTEMS BIOMEDICINE, pCH15	59	78	81	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15482	10.1371/journal.pone.0015482	http://dx.doi.org/10.1371/journal.pone.0015482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21151630	gold, Green Published, Green Submitted			2022-12-25	WOS:000285084100037
J	Bouffi, C; Bony, C; Courties, G; Jorgensen, C; Noel, D				Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele			IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; PROSTAGLANDIN E-2; CYTOKINE PRODUCTION; PROLIFERATION; GENERATION; MACROPHAGES; LYMPHOCYTE; IMMUNOSUPPRESSION	Background: Based on their capacity to suppress immune responses, multipotent mesenchymal stromal cells (MSC) are intensively studied for various clinical applications. Although it has been shown in vitro that the immunomodulatory effect of MSCs mainly occurs through the secretion of soluble mediators, the mechanism is still not completely understood. The aim of the present study was to better understand the mechanisms underlying the suppressive effect of MSCs in vivo, using cells isolated from mice deficient in the production of inducible nitric oxide synthase (iNOS) or interleukin (IL)-6 in the murine model of collagen-induced arthritis. Principal Findings: In the present study, we show that primary murine MSCs from various strains of mice or isolated from mice deficient for iNOS or IL-6 exhibit different immunosuppressive potential. The immunomodulatory function of MSCs was mainly attributed to IL-6-dependent secretion of prostaglandin E2 (PGE2) with a minor role for NO. To address the role of these molecules in vivo, we used the collagen-induced arthritis as an experimental model of immune-mediated disorder. MSCs effectively inhibited collagen-induced inflammation during a narrow therapeutic window. In contrast to wild type MSCs, IL-6-deficient MSCs and to a lesser extent iNOS-deficient MSCs were not able to reduce the clinical signs of arthritis. Finally, we show that, independently of NO or IL-6 secretion or Treg cell induction, MSCs modulate the host response by inducing a switch to a Th2 immune response. Significance: Our data indicate that MSCs mediate their immunosuppressive effect via two modes of action: locally, they reduce inflammation through the secretion of anti-proliferative mediators, such as NO and mainly PGE2, and systemically they switch the host response from a Th1/Th17 towards a Th2 immune profile.	[Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele] INSERM, Unite 844, Montpellier, France; [Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, Montpellier, France; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol Therapeut, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Bouffi, C (corresponding author), INSERM, Unite 844, Montpellier, France.	daniele.noel@inserm.fr	Noel, Daniele/E-5719-2016	Courties, Gabriel/0000-0002-0003-7407; Noel, Daniele/0000-0002-3498-3776	Inserm Institute, the University of Montpellier I; Agence Nationale de la Recherche	Inserm Institute, the University of Montpellier I(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in the laboratory Inserm U844 is supported by the Inserm Institute, the University of Montpellier I and a grant from the "Agence Nationale de la Recherche" (project ANR Physio 2006 "Immunostem"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparailly F, 1998, J IMMUNOL, V160, P5213; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Bartholomew A, 2001, HUM GENE THER, V12, P1527, DOI 10.1089/10430340152480258; Bour AMJJ, 2000, EXP GERONTOL, V35, P1017, DOI 10.1016/S0531-5565(00)00128-5; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Chen B, 2010, CLIN EXP IMMUNOL, V159, P292, DOI 10.1111/j.1365-2249.2009.04069.x; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Daubener W, 1999, INFECT IMMUN, V67, P5615; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; GONZALEZREY E, 2009, ANN RHEUM DIS; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Marinova-Mutafchieva L, 2006, CLIN EXP IMMUNOL, V146, P287, DOI 10.1111/j.1365-2249.2006.03204.x; Marinova-Mutafchieva L, 2002, ARTHRITIS RHEUM, V46, P507, DOI 10.1002/art.10126; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Perez N, 2002, HUM GENE THER, V13, P2161, DOI 10.1089/104303402320987851; Poggi A, 2008, HUM IMMUNOL, V69, P755, DOI 10.1016/j.humimm.2008.08.278; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sawada T, 1997, J IMMUNOL, V158, P5267; Schurgers E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2939; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shibata Y, 2005, J LEUKOCYTE BIOL, V78, P1281, DOI 10.1189/jlb.0605321; Son Y, 2006, IMMUNOLOGY, V119, P36, DOI 10.1111/j.1365-2567.2006.02402.x; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Takaoka Y, 1999, J BIOCHEM-TOKYO, V126, P553, DOI 10.1093/oxfordjournals.jbchem.a022485; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Vuolteenaho K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/345838; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	51	278	289	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14247	10.1371/journal.pone.0014247	http://dx.doi.org/10.1371/journal.pone.0014247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151872	Green Submitted, Green Published, gold			2022-12-25	WOS:000285041800006
J	Chakarov, N; Kruger, O				Chakarov, Nayden; Krueger, Oliver			Mesopredator Release by an Emergent Superpredator: A Natural Experiment of Predation in a Three Level Guild	PLOS ONE			English	Article							GOSHAWK ACCIPITER-GENTILIS; LIFETIME REPRODUCTIVE SUCCESS; BUZZARD BUTEO-BUTEO; INTRAGUILD PREDATION; COMMON BUZZARD; TOP PREDATORS; RAPTORS; FITNESS; OWL; BIODIVERSITY	Background: Intraguild predation (IGP) is widespread but it is often neglected that guilds commonly include many layers of dominance within. This could obscure the effects of IGP making unclear whether the intermediate or the bottom mesopredator will bear higher costs from the emergence of a new top predator. Methodology/Principal Findings: In one of the most extensive datasets of avian IGP, we analyse the impact of recolonization of a superpredator, the eagle owl Bubo bubo on breeding success, territorial dynamics and population densities of two mesopredators, the northern goshawk Accipiter gentilis and its IG prey, the common buzzard Buteo buteo. The data covers more than two decades and encompass three adjacent plots. Eagle owls only recolonized the central plot during the second decade, thereby providing a natural experiment. Both species showed a decrease in standardized reproductive success and an increase in brood failure within 1.5 km of the superpredator. During the second decade, territory dynamics of goshawks was significantly higher in the central plot compared to both other plots. No such pattern existed in buzzards. Goshawk density in the second decade decreased in the central plot, while it increased in both other plots. Buzzard density in the second decade rapidly increased in the north, remained unchanged in the south and increased moderately in the center in a probable case of mesopredator release. Conclusions/Significance: Our study finds support for top-down control on the intermediate mesopredator and both top-down and bottom-up control of the bottom mesopredator. In the face of considerable costs of IGP, both species probably compete to breed in predator-free refugia, which get mostly occupied by the dominant raptor. Therefore for mesopredators the outcome of IGP might depend directly on the number of dominance levels which supersede them.	[Chakarov, Nayden; Krueger, Oliver] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany	University of Bielefeld	Chakarov, N (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	az.nayden@gmail.com			Volkswagen Foundation [I/84 196]; German Science Foundation (DFG) [KR 2089/2-1]	Volkswagen Foundation(Volkswagen); German Science Foundation (DFG)(German Research Foundation (DFG))	NC was supported by the Volkswagen Foundation within its Evolutionary Biology initiative, grant I/84 196. OK holds a Heisenberg Professorship of the German Science Foundation (DFG) (KR 2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger KM, 2008, ECOL APPL, V18, P599, DOI 10.1890/07-0308.1; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; BRAUNEIS W, 2010, CHARADRIUS, V46, P28; Brommer JE, 1998, J ANIM ECOL, V67, P359, DOI 10.1046/j.1365-2656.1998.00201.x; Burnham KP, 2002, MULTIMODEL INFERENCE; Busche Guenther, 2004, Vogelwarte, V42, P169; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Cramp S., 1980, HDB BIRDS EUROPE MID; del Hoyo J, 2019, HDB BIRDS WORLD ALIV; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; Kruger O, 2005, EVOL ECOL, V19, P467, DOI 10.1007/s10682-005-0293-9; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O, 2001, J ANIM ECOL, V70, P173, DOI 10.1046/j.1365-2656.2001.00481.x; Kruger O, 2007, OECOLOGIA, V152, P459, DOI 10.1007/s00442-007-0677-3; Kruger Oliver, 1996, Vogelwelt, V117, P1; LOURENCO R, 2010, POPULATION ECOLOGY, P1, DOI DOI 10.1007/S10144-10010-10199-10144; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McDonald RA, 2007, DIVERS DISTRIB, V13, P92, DOI 10.1111/j.1366-9516.2006.00303.x; MEBS TH, 1964, J ORNITHOL, V105, P247, DOI 10.1007/BF01672243; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Mylius SD, 2001, AM NAT, V158, P259, DOI 10.1086/321321; Petty SJ, 2003, IBIS, V145, P472, DOI 10.1046/j.1474-919X.2003.00191.x; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2003, J ANIM ECOL, V72, P232, DOI 10.1046/j.1365-2656.2003.00693.x; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sergio F, 2008, IBIS, V150, P132, DOI 10.1111/j.1474-919X.2008.00786.x; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; VONBLOTZEIM UG, 1971, HDB VOGEL MITTELEURO; WALTER B, 2008, BERICHTE NATURWISSEN, V48, P28	39	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15229	10.1371/journal.pone.0015229	http://dx.doi.org/10.1371/journal.pone.0015229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151912	gold, Green Published			2022-12-25	WOS:000284995300023
J	Ersoz, ES; Wright, MH; Gonzalez-Martinez, SC; Langley, CH; Neale, DB				Ersoz, Elhan S.; Wright, Mark H.; Gonzalez-Martinez, Santiago C.; Langley, Charles H.; Neale, David B.			Evolution of Disease Response Genes in Loblolly Pine: Insights from Candidate Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BALANCING SELECTION; TAEDA L.; DIVERSITY; RESISTANCE; LOCUS; HITCHHIKING; EXPRESSION; MUTATION; HISTORY	Background: Host-pathogen interactions that may lead to a competitive co-evolution of virulence and resistance mechanisms present an attractive system to study molecular evolution because strong, recent (or even current) selective pressure is expected at many genomic loci. However, it is unclear whether these selective forces would act to preserve existing diversity, promote novel diversity, or reduce linked neutral diversity during rapid fixation of advantageous alleles. In plants, the lack of adaptive immunity places a larger burden on genetic diversity to ensure survival of plant populations. This burden is even greater if the generation time of the plant is much longer than the generation time of the pathogen. Methodology/Principal Findings: Here, we present nucleotide polymorphism and substitution data for 41 candidate genes from the long-lived forest tree loblolly pine, selected primarily for their prospective influences on host-pathogen interactions. This dataset is analyzed together with 15 drought-tolerance and 13 wood-quality genes from previous studies. A wide range of neutrality tests were performed and tested against expectations from realistic demographic models. Conclusions/Significance: Collectively, our analyses found that axr (auxin response factor), caf1 (chromatin assembly factor) and gatabp1 (gata binding protein 1) candidate genes carry patterns consistent with directional selection and erd3 (early response to drought 3) displays patterns suggestive of a selective sweep, both of which are consistent with the arm-race model of disease response evolution. Furthermore, we have identified patterns consistent with diversifying selection at erf1-like (ethylene responsive factor 1), ccoaoemt (caffeoyl-CoA-O-methyltransferase), cyp450-like (cytochrome p450-like) and pr4.3 (pathogen response 4.3), expected under the trench-warfare evolution model. Finally, a drought-tolerance candidate related to the plant cell wall, lp5, displayed patterns consistent with balancing selection. In conclusion, both arms-race and trench-warfare models seem compatible with patterns of polymorphism found in different disease-response candidate genes, indicating a mixed strategy of disease tolerance evolution for loblolly pine, a major tree crop in southeastern United States.	[Ersoz, Elhan S.; Gonzalez-Martinez, Santiago C.; Neale, David B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wright, Mark H.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Gonzalez-Martinez, Santiago C.] Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Dept Forest Syst & Resources, Ctr Forest Res, Ctr Invest Forestal, Madrid, Spain; [Langley, Charles H.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Neale, David B.] US Forest Serv, Inst Forest Genet, USDA, Davis, CA USA	University of California System; University of California Davis; Cornell University; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service	Ersoz, ES (corresponding author), Syngenta Biotechnol Inc, Stanton, MN USA.	dbneale@ucdavis.edu	Gonzalez-Martinez, Santiago C/H-2014-2012	Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Wright, Mark/0000-0001-8036-1161	University of California; 'Similar toRamon y Cajal' fellowship [RC02-2941]; Cornell Presidential Genomics Initiative Fellowship; NSF [0606461]; USDA/IFAFS [2001-52100-11315]	University of California(University of California System); 'Similar toRamon y Cajal' fellowship; Cornell Presidential Genomics Initiative Fellowship; NSF(National Science Foundation (NSF)); USDA/IFAFS(United States Department of Agriculture (USDA))	The work of Santiago C. Gonzalez-Martinez was supported by a Fulbright/MECD scholarship at University of California (Davis) and the 'similar to Ramon y Cajal' fellowship RC02-2941. The work of Mark Wright was supported by the Cornell Presidential Genomics Initiative Fellowship and NSF #0606461. Funding for this research was provided by ADEPT project USDA/IFAFS grant # 2001-52100-11315 (http://dendrome.ucdavis.edu/adept). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Brown GR, 2003, GENETICS, V164, P1537; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; de Meaux J, 2003, HEREDITY, V91, P345, DOI 10.1038/sj.hdy.6800342; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Emrich SJ, 2007, GENETICS, V175, P429, DOI 10.1534/genetics.106.064006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; FU YX, 1993, GENETICS, V133, P693; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gill GP, 2003, PLANT BIOTECHNOL J, V1, P253, DOI 10.1046/j.1467-7652.2003.00024.x; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hudson RR, 1997, P NATL ACAD SCI USA, V94, P7725, DOI 10.1073/pnas.94.15.7725; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kim Y, 2000, GENETICS, V155, P1415; Kliebenstein DJ, 2002, GENETICS, V161, P1685; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; Moeller DA, 2005, MOL BIOL EVOL, V22, P2480, DOI 10.1093/molbev/msi247; Morse AM, 2004, THEOR APPL GENET, V109, P922, DOI 10.1007/s00122-004-1719-4; Myburg H, 2006, PHYSIOL MOL PLANT P, V68, P79, DOI 10.1016/j.pmpp.2006.07.002; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Schmidtling RC, 1999, SILVAE GENET, V48, P35; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAJIMA F, 1989, GENETICS, V123, P585; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wakeley J, 1997, GENETICS, V145, P847; Warren JA, 2004, APPL ENVIRON MICROB, V70, P441, DOI 10.1128/AEM.70.1.441-451.2004; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson IW, 2001, GENETICS, V158, P1301	39	19	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14234	10.1371/journal.pone.0014234	http://dx.doi.org/10.1371/journal.pone.0014234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151911	Green Submitted, gold, Green Published			2022-12-25	WOS:000284995300006
J	Stapleton, JA; Swartz, JR				Stapleton, James A.; Swartz, James R.			Development of an In Vitro Compartmentalization Screen for High-Throughput Directed Evolution of [FeFe] Hydrogenases	PLOS ONE			English	Article							SINGLE-COPY DNA; ENZYME LIBRARIES; DOUBLE EMULSIONS; SELECTION; PROTEINS; DISPLAY; PCR; AMPLIFICATION; EXPRESSION; SURFACE	Background: [FeFe] hydrogenase enzymes catalyze the formation and dissociation of molecular hydrogen with the help of a complex prosthetic group composed of common elements. The development of energy conversion technologies based on these renewable catalysts has been hindered by their extreme oxygen sensitivity. Attempts to improve the enzymes by directed evolution have failed for want of a screening platform capable of throughputs high enough to adequately sample heavily mutated DNA libraries. In vitro compartmentalization (IVC) is a powerful method capable of screening for multiple-turnover enzymatic activity at very high throughputs. Recent advances have allowed [FeFe] hydrogenases to be expressed and activated in the cell-free protein synthesis reactions on which IVC is based; however, IVC is a demanding technique with which many enzymes have proven incompatible. Methodology/Principal Findings: Here we describe an extremely high-throughput IVC screen for oxygen-tolerant [FeFe] hydrogenases. We demonstrate that the [FeFe] hydrogenase CpI can be expressed and activated within emulsion droplets, and identify a fluorogenic substrate that links activity after oxygen exposure to the generation of a fluorescent signal. We present a screening protocol in which attachment of mutant genes and the proteins they encode to the surfaces of microbeads is followed by three separate emulsion steps for amplification, expression, and evaluation of hydrogenase mutants. We show that beads displaying active hydrogenase can be isolated by fluorescence-activated cell-sorting, and we use the method to enrich such beads from a mock library. Conclusions/Significance: [FeFe] hydrogenases are the most complex enzymes to be produced by cell-free protein synthesis, and the most challenging targets to which IVC has yet been applied. The technique described here is an enabling step towards the development of biocatalysts for a biological hydrogen economy.	[Stapleton, James A.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Stapleton, JA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180	Stanford University; National Defense Science and Engineering (NDSEG)	Stanford University(Stanford University); National Defense Science and Engineering (NDSEG)	This work was funded by the Global Climate and Energy Project (GCEP) at Stanford University (http://gcep.stanford.edu/), as well as a National Defense Science and Engineering (NDSEG) Fellowship (http://ndseg.asee.org/) to JAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Agresti JJ, 2005, P NATL ACAD SCI USA, V102, P16170, DOI 10.1073/pnas.0503733102; Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; Bernath K, 2004, ANAL BIOCHEM, V325, P151, DOI 10.1016/j.ab.2003.10.005; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cohen J, 2005, BIOCHEM SOC T, V33, P80, DOI 10.1042/BST0330080; Davidson Eric A, 2009, Curr Protoc Mol Biol, VChapter 24, DOI 10.1002/0471142727.mb2406s87; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Edd JF, 2008, LAB CHIP, V8, P1262, DOI 10.1039/b805456h; Frenz L, 2008, LANGMUIR, V24, P12073, DOI 10.1021/la801954w; GAN R, 2008, BIOTECHNOL PROGR, V24, P3; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Ghadessy FJ, 2004, PROTEIN ENG DES SEL, V17, P201, DOI 10.1093/protein/gzh025; Griffiths AD, 2003, EMBO J, V22, P24, DOI 10.1093/emboj/cdg014; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; Kelly BT, 2007, CHEM COMMUN, P1773, DOI 10.1039/b616252e; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Kumaresan P, 2008, ANAL CHEM, V80, P3522, DOI 10.1021/ac800327d; Leamon JH, 2006, NAT METHODS, V3, P541, DOI 10.1038/nmeth0706-541; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mastrobattista E, 2005, CHEM BIOL, V12, P1291, DOI 10.1016/j.chembiol.2005.09.016; PECK HD, 1956, J BACTERIOL, V71, P70, DOI 10.1128/JB.71.1.70-80.1956; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pirrung MC, 1996, BIOCONJUGATE CHEM, V7, P317, DOI 10.1021/bc960013v; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schaerli Y, 2009, ANAL CHEM, V81, P302, DOI 10.1021/ac802038c; Sepp A, 2002, FEBS LETT, V532, P455, DOI 10.1016/S0014-5793(02)03740-7; Shah RK, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70053-1; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652	43	52	54	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15275	10.1371/journal.pone.0015275	http://dx.doi.org/10.1371/journal.pone.0015275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151915	Green Submitted, gold, Green Published			2022-12-25	WOS:000284995300026
J	Tsui, DWY; Lam, YMD; Lee, WS; Leung, TY; Lau, TK; Lau, ET; Tang, MHY; Akolekar, R; Nicolaides, KH; Chiu, RWK; Lo, YMD; Chim, SSC				Tsui, Dana W. Y.; Lam, Y. M. Doris; Lee, Wing S.; Leung, Tak Y.; Lau, Tze K.; Lau, Elizabeth T.; Tang, Mary H. Y.; Akolekar, Ranjit; Nicolaides, Kypros H.; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Chim, Stephen S. C.			Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome	PLOS ONE			English	Article							DIFFERENTIAL DNA METHYLATION; MATERNAL PLASMA; FETAL DNA; ALLELIC RATIO; DIGITAL PCR; DIAGNOSIS; ORIGIN; SITES; GENE; EPIGENOMICS	Background: Noninvasive prenatal diagnosis of fetal aneuploidy by maternal plasma analysis is challenging owing to the low fractional and absolute concentrations of fetal DNA in maternal plasma. Previously, we demonstrated for the first time that fetal DNA in maternal plasma could be specifically targeted by epigenetic (DNA methylation) signatures in the placenta. By comparing one such methylated fetal epigenetic marker located on chromosome 21 with another fetal genetic marker located on a reference chromosome in maternal plasma, we could infer the relative dosage of fetal chromosome 21 and noninvasively detect fetal trisomy 21. Here we apply this epigenetic-genetic (EGG) chromosome dosage approach to detect Edwards syndrome (trisomy 18) in the fetus noninvasively. Principal Findings: We have systematically identified methylated fetal epigenetic markers on chromosome 18 by methylated DNA immunoprecipitation (MeDIP) and tiling array analysis with confirmation using quantitative DNA methylation assays. Methylated DNA sequences from an intergenic region between the VAPA and APCDD1 genes (the VAPA-APCDD1 DNA) were detected in pre-delivery, but not post-delivery, maternal plasma samples. The concentrations correlated positively with those of an established fetal genetic marker, ZFY, in pre-delivery maternal plasma. The ratios of methylated VAPA-APCDD1(chr18) to ZFY(chrY) were higher in maternal plasma samples of 9 male trisomy 18 fetuses than those of 27 male euploid fetuses (Mann-Whitney test, P=0.029). We defined the cutoff value for detecting trisomy 18 fetuses as mean+1.96 SD of the EGG ratios of the euploid cases. Eight of 9 trisomy 18 and 1 of 27 euploid cases showed EGG ratios higher than the cutoff value, giving a sensitivity of 88.9% and a specificity of 96.3%. Conclusions: Our data have shown that the methylated VAPA-APCDD1 DNA in maternal plasma is predominantly derived from the fetus. We have demonstrated that this novel fetal epigenetic marker in maternal plasma is useful for the noninvasive detection of fetal trisomy 18.	[Tsui, Dana W. Y.; Lam, Y. M. Doris; Lee, Wing S.; Lau, Tze K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Chim, Stephen S. C.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China; [Tsui, Dana W. Y.; Lam, Y. M. Doris; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Lee, Wing S.; Leung, Tak Y.; Lau, Tze K.; Chim, Stephen S. C.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lau, Elizabeth T.; Tang, Mary H. Y.] Tsan Yuk Hosp, Prenatal Diagnost & Counselling Dept, Hong Kong, Hong Kong, Peoples R China; [Akolekar, Ranjit; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Tsui, DWY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China.	sschim@cuhk.edu.hk	Chim, Stephen SC/O-6271-2016; Tang, Mary Hoi Yin/A-7638-2013; Lo, Yuk Ming Dennis/D-4468-2011	Chim, Stephen SC/0000-0002-2152-7050; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410; Nicolaides, Kypros/0000-0003-1266-0711	University Grants Committee of the Government of the Hong Kong, Special Administration Region, China [AoE/M-04/06]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK462909]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong, Special Administration Region, China; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Li Ka Shing Foundation	This study was supported by the University Grants Committee of the Government of the Hong Kong, Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK462909). Y.M.D. Lo is supported by the Chair Professorship scheme of the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; CHAN KC, 2006, CLIN CHEM; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Diamandis EP, 2010, CLIN CHEM, V56, P1216, DOI 10.1373/clinchem.2010.148007; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lui YNYN, 2002, CLIN CHEM, V48, P421; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Ragoussis J, 2006, PLOS GENET, V2, P920, DOI 10.1371/journal.pgen.0020100; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui DWY, 2007, PRENATAL DIAG, V27, P1212, DOI 10.1002/pd.1897; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	38	23	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15069	10.1371/journal.pone.0015069	http://dx.doi.org/10.1371/journal.pone.0015069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152411	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100058
J	Xu, G; Wu, JY; Zhou, LL; Chen, BH; Sun, ZS; Zhao, FQ; Tao, ZH				Xu, Gang; Wu, Jinyu; Zhou, LingLin; Chen, Binghua; Sun, Zhongsheng; Zhao, Fangqing; Tao, Zhihua			Characterization of the Small RNA Transcriptomes of Androgen Dependent and Independent Prostate Cancer Cell Line by Deep Sequencing	PLOS ONE			English	Article							MOUSE MODEL; EXPRESSION; MECHANISMS; METASTASIS; MICRORNAS; MIR-29; FAMILY; GROWTH; ZEB1	Given the important roles of miRNA in post-transcriptional regulation and its implications for cancer, characterization of miRNA facilitates us to uncover molecular mechanisms underlying the progression of androgen-independent prostate cancer (PCa). The emergence of next-generation sequencing technologies has dramatically changed the speed of all aspects of sequencing in a rapid and cost-effective fashion, which can permit an unbiased, quantitive and in-depth investigation of small RNA transcriptome. In this study, we used high-throughput Illumina sequencing to comprehensively represent the full complement of individual small RNA and to characterize miRNA expression profiles in both the androgen dependent and independent Pca cell line. At least 83 miRNAs are significantly differentially expressed, of which 41 are up-regulated and 42 are down-regulated, indicating these miRNAs may be involved in the transition of LNCaP to an androgen-independent phenotype. In addition, we have identified 43 novel miRNAs from the androgen dependent and independent PCa library and 3 of them are specific to the androgen-independent PCa. Function annotation of target genes indicated that most of these differentially expressed miRNAs tend to target genes involved in signal transduction and cell communication, epically the MAPK signaling pathway. The small RNA transcriptomes obtained in this study provide considerable insights into a better understanding of the expression and function of small RNAs in the development of androgen-independent prostate cancer.	[Xu, Gang; Chen, Binghua; Tao, Zhihua] Wenzhou Med Coll, Ctr Clin Lab Diag, Affiliated Hosp 1, Wenzhou, Peoples R China; [Wu, Jinyu; Zhou, LingLin; Sun, Zhongsheng; Zhao, Fangqing] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Sun, Zhongsheng] Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China; [Zhao, Fangqing] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences	Xu, G (corresponding author), Wenzhou Med Coll, Ctr Clin Lab Diag, Affiliated Hosp 1, Wenzhou, Peoples R China.	sunzs@psych.ac.cn; fuz3@psu.edu; wwwtzh@wz.zj.cn	Zhao, Fangqing/P-6309-2019	Zhao, Fangqing/0000-0002-6216-1235	Zhejiang Provincial Natural Science Foundation of China [Y2100902]; Wenzhou Science and Technology Project [Y20100011]; Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects [2009F82G2090045]; National High Technology Research and Development Program of China [2006AA02A304]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Science and Technology Project; Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Y2100902), Wenzhou Science and Technology Project (Y20100011), Zhejiang Provincial Science and Technology Platform of Analysis and Testing Technology Projects (2009F82G2090045) and National High Technology Research and Development Program of China (2006AA02A304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; COPPOLA V, 2009, ENDOCR RELAT CANC; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gioeli D, 1999, CANCER RES, V59, P279; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schroder FH, 2008, EUR UROL, V53, P1129, DOI 10.1016/j.eururo.2008.01.049; Shi XF, 2004, ACTA CRYSTALLOGR E, V60, pO1255, DOI 10.1107/S1600536804015107; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Tang Y, 2006, CLIN CANCER RES, V12, P169, DOI 10.1158/1078-0432.CCR-05-1388; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	33	64	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15519	10.1371/journal.pone.0015519	http://dx.doi.org/10.1371/journal.pone.0015519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152091	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100090
J	Zimmermann, M; Atmanene, C; Xu, QY; Fouillen, L; Van Dorsselaer, A; Bonnet, D; Marsol, C; Hibert, M; Sanglier-Cianferani, S; Pigault, C; McNamara, LK; Watterson, DM; Haiech, J; Kilhoffer, MC				Zimmermann, Michael; Atmanene, Cedric; Xu, Qingyan; Fouillen, Laetitia; Van Dorsselaer, Alain; Bonnet, Dominique; Marsol, Claire; Hibert, Marcel; Sanglier-Cianferani, Sarah; Pigault, Claire; McNamara, Laurie K.; Watterson, D. Martin; Haiech, Jacques; Kilhoffer, Marie-Claude			Homodimerization of the Death-Associated Protein Kinase Catalytic Domain: Development of a New Small Molecule Fluorescent Reporter	PLOS ONE			English	Article							TUMOR SUPPRESSION; CELL-DEATH; ZIP KINASE; CALMODULIN; APOPTOSIS; POLARIZATION	Background: Death-Associated Protein Kinase (DAPK) is a member of the Ca(2+)/calmodulin regulated serine/threonine protein kinases. Its biological function has been associated with induced cell death, and in vivo use of selective small molecule inhibitors of DAPK catalytic activity has demonstrated that it is a potential therapeutic target for treatment of brain injuries and neurodegenerative diseases. Methodology/Principal Findings: In the in vitro study presented here, we describe the homodimerization of DAPK catalytic domain and the crucial role played by its basic loop structure that is part of the molecular fingerprint of death protein kinases. Nanoelectrospray ionization mass spectrometry of DAPK catalytic domain and a basic loop mutant DAPK protein performed under a variety of conditions was used to detect the monomer-dimer interchange. A chemical biological approach was used to find a fluorescent probe that allowed us to follow the oligomerization state of the protein in solution. Conclusions/Significance: The use of this combined biophysical and chemical biology approach facilitated the elucidation of a monomer-dimer equilibrium in which the basic loop plays a key role, as well as an apparent allosteric conformational change reported by the fluorescent probe that is independent of the basic loop structure.	[Zimmermann, Michael; Xu, Qingyan; Bonnet, Dominique; Marsol, Claire; Hibert, Marcel; Pigault, Claire; Haiech, Jacques; Kilhoffer, Marie-Claude] Univ Strasbourg, Fac Pharm, Ctr Natl Rech Sci, Lab Innovat Therapeut,Unite Mixte Rech 7200, Illkirch Graffenstaden, France; [Atmanene, Cedric; Fouillen, Laetitia; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Univ Strasbourg, Ctr Natl Rech Sci, Unite Mixte Rech 7178,Lab Spectrometrie Masse Bio, Inst Pluridisciplinaire Hubert Curien,Dept Sci An, Strasbourg, France; [Xu, Qingyan] Xiamen Univ, Sch Sci, Xiamen, Fujian Province, Peoples R China; [McNamara, Laurie K.; Watterson, D. Martin] Northwestern Univ, Chicago, IL 60611 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Xiamen University; Northwestern University	Zimmermann, M (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	haiech@pharma.u-strasbg.fr	FOUILLEN, Laetitia/AAV-9710-2020; haiech, jacques J/F-2890-2010; Bonnet, Dominique/N-7275-2014	FOUILLEN, Laetitia/0000-0002-1204-9296; Bonnet, Dominique/0000-0002-8252-9199; Cianferani, Sarah/0000-0003-4013-4129; Zimmermann, Michael/0000-0002-5797-3589; haiech, jacques/0000-0003-2908-8053; Watterson, Daniel/0000-0001-7605-5866	Agence Nationale de Recherche (ANR); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031311] Funding Source: NIH RePORTER	Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by Agence Nationale de Recherche (ANR) programme caphe and by financial support from Centre National de la Recherche Scientifique (CNRS) and University of Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG CD, 1978, INT J PEPT PROT RES, V11, P246; Dagher R, 2006, BBA-MOL CELL RES, V1763, P1250, DOI 10.1016/j.bbamcr.2006.09.027; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; de la Torre JG, 2000, BIOPHYS J, V78, p401A; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; HIBERT M, 2006, Patent No. 2006003330; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; KILHOFFER MC, 1992, BIOCHEMISTRY-US, V31, P8098, DOI 10.1021/bi00149a046; Laue TM, 1992, COMPUTER AIDED INTER, P90; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; RINK H, 1987, TETRAHEDRON LETT, V28, P3787, DOI 10.1016/S0040-4039(00)96384-6; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher AM, 2004, BIOCHEMISTRY-US, V43, P8116, DOI 10.1021/bi049589v; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; Velentza AV, 2003, BIOORG MED CHEM LETT, V13, P3465, DOI 10.1016/S0960-894X(03)00733-9; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200	19	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14120	10.1371/journal.pone.0014120	http://dx.doi.org/10.1371/journal.pone.0014120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152427	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100006
J	Song, XM; Wang, Y; Zhu, Z; Li, CY				Song, Xue-Mei; Wang, Ye; Zhu, Zhao; Li, Chao-Yi			Morphological Bases of Suppressive and Facilitative Spatial Summation in the Striate Cortex of the Cat	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CLASSICAL RECEPTIVE-FIELD; MACAQUE V1 NEURONS; DENDRITIC SPINES; CORTICAL-NEURONS; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; HORIZONTAL CONNECTIONS; CONTEXTUAL MODULATION; INTEGRATION FIELD	In V1 of cats and monkeys, activity of neurons evoked by stimuli within the receptive field can be modulated by stimuli in the extra-receptive field (ERF). This modulating effect can be suppressive (S-ERF) or facilitatory (F-ERF) and plays different roles in visual information processing. Little is known about the cellular bases underlying the different types of ERF modulating effects. Here, we focus on the morphological differences between the S-ERF and F-ERF neurons. Single unit activities were recorded from V1 of the cat. The ERF properties of each neuron were assessed by area-response functions using sinusoidal grating stimuli. On completion of the functional tests, the cells were injected intracellularly with biocytin. The labeled cells were reconstructed and morphologically characterized in terms of the ERF modulation effects. We show that the vast majority of S-ERF neurons and F-ERF neurons are pyramidal cells and that the two types of cells clearly differ in the size of the soma, in complexity of dendrite branching, in spine size and density, and in the range of innervations of the axon collaterals. We propose that different pyramidal cell phenotypes reflect a high degree of specificity of neuronal connections associated with different types of spatial modulation.	[Song, Xue-Mei; Wang, Ye; Zhu, Zhao; Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Chao-Yi] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Minist Educ China, Chengdu 610054, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ministry of Education, China; University of Electronic Science & Technology of China	Song, XM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	cyli@sibs.ac.cn	Song, Xue-Mei/O-5409-2014	Song, Xue-Mei/0000-0001-9062-5829; Wang, Ye/0000-0001-9131-9014	Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60835005]; Shanghai Municipal Committee of Science and Technology [088014158, 098014026]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Major State Basic Research Program (2007CB311001 to CYL), the Natural Science Foundations of China (90820301 and 60835005 to CYL), and Shanghai Municipal Committee of Science and Technology (088014158 and 098014026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki T, 2002, NEUROSCI RES, V43, P207, DOI 10.1016/S0168-0102(02)00038-X; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chisum HJ, 2003, J NEUROSCI, V23, P2947; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEHAY C, 1991, J PHYSIOL-LONDON, V440, P723, DOI 10.1113/jphysiol.1991.sp018732; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Duan H, 2002, NEUROSCIENCE, V114, P349, DOI 10.1016/S0306-4522(02)00305-6; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Jones HE, 2000, EXP BRAIN RES, V135, P279, DOI 10.1007/s002210000574; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1993, J NEUROSCI, V13, P413; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li CY, 1996, NEWS PHYSIOL SCI, V11, P181; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li CY, 1999, P NATL ACAD SCI USA, V96, P4052, DOI 10.1073/pnas.96.7.4052; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Matsubara JA, 1996, J COMP NEUROL, V366, P93; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Shen ZM, 2007, J PHYSIOL-LONDON, V583, P581, DOI 10.1113/jphysiol.2007.130294; SHOLL DA, 1953, J ANAT, V87, P387; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TSO DY, 1986, J NEUROSCI, V6, P1160; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Xu WF, 2005, CEREB CORTEX, V15, P1697, DOI 10.1093/cercor/bhi046; Yao HS, 2002, NEURON, V35, P547, DOI 10.1016/S0896-6273(02)00782-1; Zhu Z, 2002, CEREB CORTEX, V12, P585, DOI 10.1093/cercor/12.6.585; Zipser K, 1996, J NEUROSCI, V16, P7376	66	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15025	10.1371/journal.pone.0015025	http://dx.doi.org/10.1371/journal.pone.0015025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21151335	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500017
J	Franco, HL; Dai, D; Lee, KY; Rubel, CA; Roop, D; Boerboom, D; Jeong, JW; Lydon, JP; Bagchi, IC; Bagchi, MK; DeMayo, FJ				Franco, Heather L.; Dai, Daisy; Lee, Kevin Y.; Rubel, Cory A.; Roop, Dennis; Boerboom, Derek; Jeong, Jae-Wook; Lydon, John P.; Bagchi, Indrani C.; Bagchi, Milan K.; DeMayo, Francesco J.			WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse	FASEB JOURNAL			English	Article						p63; estrogen; Bmp2; Foxo1	LEUKEMIA INHIBITORY FACTOR; BETA-CATENIN; TARGET GENES; UTERUS; EXPRESSION; BLASTOCYST; ESTROGEN; MICE; DIETHYLSTILBESTROL; ACTIVATION	WNT4, a member of the Wnt family of ligands, is critical for the development of the female reproductive tract. Analysis of Wnt4 expression in the adult uterus during pregnancy indicates that it may play a role in the regulation of endometrial stromal cell proliferation, survival, and differentiation, which is required to support the developing embryo. To investigate the role of Wnt4 in adult uterine physiology, conditional ablation of Wnt4 using the PRcre mouse model was accomplished. Ablation of Wnt4 rendered female mice subfertile due to a defect in embryo implantation and subsequent defects in endometrial stromal cell survival, differentiation, and responsiveness to progesterone signaling. In addition to altered stromal cell function, the uteri of PRcre/+ Wnt4(f/f) (Wnt4(d/d)) mice displayed altered epithelial differentiation characterized by a reduction in the number of uterine glands and the emergence of a p63-positive basal cell layer beneath the columnar luminal epithelial cells. The altered epithelial cell phenotype was further escalated by chronic estrogen treatment, which caused squamous cell metaplasia of the uterine epithelium in the Wnt4(d/d) mice. Thus, WNT4 is a critical regulator not only of proper postnatal uterine development, but also embryo implantation and decidualization.-Franco, H. L., Dai, D., Lee, K. Y., Rubel, C. S., Roop, D., Boerboom, D., Jeong, J.-W., Lydon, J.-P., Bagchi, I. C., Bagchi, M. K., DeMayo, F. J. WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J. 25, 1176-1187 (2011). www.fasebj.org	[Franco, Heather L.; Lee, Kevin Y.; Rubel, Cory A.; Jeong, Jae-Wook; Lydon, John P.; DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dai, Daisy; DeMayo, Francesco J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Roop, Dennis] Univ Colorado, Dept Dermatol, Aurora, CO USA; [Roop, Dennis] Univ Colorado, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Boerboom, Derek] Univ Montreal, Dept Biomed Vet, St Hyacinthe, PQ, Canada; [Bagchi, Indrani C.] Univ Illinois, Dept Vet Biosci, Urbana, IL USA; [Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	Baylor College of Medicine; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Universite de Montreal; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	DeMayo, FJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	fdemayo@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Lee, Kevin/0000-0002-1528-7417	U.S. National Institutes of Health (NIH) [R01HD042311, R01HD057873, R01CA77530]; Canadian Institutes of Health Research; Reproductive Biology Training Grant [5T32HD07165]; Baylor Research Advocates for Student Scientists; Winterman Foundation; Houston Livestock Show and Rodeo Scholarship Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54HD0077495, U54HD055787, U54HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057873, U54HD028934, T32HD007165, U54HD055787, R01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reproductive Biology Training Grant; Baylor Research Advocates for Student Scientists; Winterman Foundation; Houston Livestock Show and Rodeo Scholarship Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Joanne S. Richards for assistance with the Wnt4<SUP>f/f</SUP> mice; Sungnam Cho, Jie Yang, and Bryan Ngo for technical assistance; and Sophia Y. Tsai and Janet DeMayo for manuscript preparation. This work was supported by U.S. National Institutes of Health (NIH) grants R01HD042311 (to F.J.D.), R01HD057873 (to J.W.J.), and R01CA77530 (to J.P.L.); an operating grant from the Canadian Institutes of Health Research (to D. B.); Reproductive Biology Training Grant 5T32HD07165 and a scholarship from Baylor Research Advocates for Student Scientists, supported in part by the Winterman Foundation and the Houston Livestock Show and Rodeo Scholarship Fund (to H. L. F.); and Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH grants U54HD0077495 (to F.J.D.), U54HD055787 (to I. C. B., M. K. B., and F.J.D.), and U54HD28934 (to the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core) through a cooperative agreement as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Bonifas JM, 2001, J INVEST DERMATOL, V116, P739, DOI 10.1046/j.1523-1747.2001.01315.x; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chen XM, 2009, REPRODUCTION, V138, P351, DOI 10.1530/REP-09-0090; Cheng JG, 2003, BIOL REPROD, V68, P401, DOI 10.1095/biolreprod.102.009589; Couse JF, 2001, DEV BIOL, V238, P224, DOI 10.1006/dbio.2001.0413; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Goldberg JM, 1999, FERTIL STERIL, V72, P1, DOI 10.1016/S0015-0282(99)00153-3; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Grinius L, 2006, J ENDOCRINOL, V189, P179, DOI 10.1677/joe.1.06451; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Katayama S, 2006, TOXICOL SCI, V91, P419, DOI 10.1093/toxsci/kfj167; Kimber SJ, 2005, REPRODUCTION, V130, P131, DOI 10.1530/rep.1.00304; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Li J, 2005, BIOL REPROD, V72, P700, DOI 10.1095/biolreprod.104.033837; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Mendivil A, 2009, CANCER CONTROL, V16, P46, DOI 10.1177/107327480901600107; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Nagy A., 2003, MANIPULATING MOUSE E; Osada M, 2006, BIOCHEM BIOPH RES CO, V339, P1120, DOI 10.1016/j.bbrc.2005.11.118; Sassoon D, 1999, MOL CELL ENDOCRINOL, V158, P1, DOI 10.1016/S0303-7207(99)00170-7; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024	48	187	200	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1176	1187		10.1096/fj.10-175349	http://dx.doi.org/10.1096/fj.10-175349			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21163860	Green Published			2022-12-25	WOS:000288982800007
J	Reijns, MAM; Bubeck, D; Gibson, LCD; Graham, SC; Baillie, GS; Jones, EY; Jackson, AP				Reijns, Martin A. M.; Bubeck, Doryen; Gibson, Lucien C. D.; Graham, Stephen C.; Baillie, George S.; Jones, E. Yvonne; Jackson, Andrew P.			The Structure of the Human RNase H2 Complex Defines Key Interaction Interfaces Relevant to Enzyme Function and Human Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; PEPTIDE ARRAYS; DNA; MUTATIONS; ELECTROSTATICS; REFINEMENT; ALIGNMENT; SUBUNITS	Ribonuclease H2 (RNase H2) is the major nuclear enzyme involved in the degradation of RNA/DNA hybrids and removal of ribonucleotides misincorporated in genomic DNA. Mutations in each of the three RNase H2 subunits have been implicated in a human auto-inflammatory disorder, Aicardi-Goutieres Syndrome (AGS). To understand how mutations impact on RNase H2 function we determined the crystal structure of the human heterotrimer. In doing so, we correct several key regions of the previously reported murine RNase H2 atomic model and provide biochemical validation for our structural model. Our results provide new insights into how the subunits are arranged to form an enzymatically active complex. In particular, we establish that the RNASEH2A C terminus is a eukaryotic adaptation for binding the two accessory subunits, with residues within it required for enzymatic activity. This C-terminal extension interacts with the RNASEH2C C terminus and both are necessary to form a stable, enzymatically active heterotrimer. Disease mutations cluster at this interface between all three subunits, destabilizing the complex and/or impairing enzyme activity. Altogether, we locate 25 out of 29 residues mutated in AGS patients, establishing a firm basis for future investigations into disease pathogenesis and function of the RNase H2 enzyme.	[Bubeck, Doryen; Graham, Stephen C.; Jones, E. Yvonne] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Reijns, Martin A. M.; Jackson, Andrew P.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Gibson, Lucien C. D.; Baillie, George S.] Univ Glasgow, Inst Neurosci & Psychol, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Graham, Stephen C.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England	University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bubeck, D (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	doryen@strubi.ox.ac.uk; yvonne@strubi.ox.ac.uk	Reijns, Martin/L-4355-2013; Jones, Yvonne/N-8111-2019; Jackson, Andrew P/D-3442-2009; Jones, Yvonne/J-2293-2016	Reijns, Martin/0000-0002-5048-2752; Jones, Yvonne/0000-0002-3834-1893; Jackson, Andrew P/0000-0002-8739-2646; Jones, Yvonne/0000-0002-3834-1893; Graham, Stephen/0000-0003-4547-4034	Medical Research Council; Cancer Research UK; Wellcome Trust [075491/Z04]; EMBO; CRI; SJC; MRC [MC_EX_G0601852, G0900084] Funding Source: UKRI; Medical Research Council [MC_EX_G0601852, G0900084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); EMBO(European Molecular Biology Organization (EMBO)); CRI; SJC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded in part by a Medical Research Council Senior Clinical Fellowship grant (to A. P. J.) and Cancer Research UK grant (to E. Y. J.). The work was also supported by the Wellcome Trust Core Award (Grant 075491/Z04).; Supported by EMBO, CRI, and SJC. To whom correspondence may be addressed. E-mail: doryen@strubi.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; EDER PS, 1991, J BIOL CHEM, V266, P6472; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li X, 2009, FEBS LETT, V583, P3310, DOI 10.1016/j.febslet.2009.09.035; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; MACHIDA Y, 1977, P NATL ACAD SCI USA, V74, P2776, DOI 10.1073/pnas.74.7.2776; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; Smart O., 2008, ANN M ACA KNOXV TN, P137; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winkler DFH, 2009, METHODS MOL BIOL, V570, P157, DOI 10.1007/978-1-60327-394-7_5; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	36	72	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10530	10539		10.1074/jbc.M110.177394	http://dx.doi.org/10.1074/jbc.M110.177394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177854	Green Published, hybrid			2022-12-25	WOS:000288547000069
J	Karpuj, MV; Gelibter-Niv, S; Tiran, A; Rambold, A; Tatzelt, J; Nunziante, M; Schatzl, HM				Karpuj, Marcela Viviana; Gelibter-Niv, Sagit; Tiran, Anat; Rambold, Angelika; Tatzelt, Joerg; Nunziante, Max; Schatzl, Hermann M.			Conditional Modulation of Membrane Protein Expression in Cultured Cells Mediated by Prion Protein Recognition of Short Phosphorothioate Oligodeoxynucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-BINDING; NUCLEIC-ACID; SCRAPIE; ENDOCYTOSIS; MICE; GLYCOSYLATION; PRPC; NEURODEGENERATION; OLIGONUCLEOTIDES; CONTRIBUTES	We demonstrate that the levels of native as well as transfected prion protein (PrP) are lowered in various cell lines exposed to phosphorothioate oligodeoxynucleotides (PS-DNA) and can be rapidly reverted to their normal amounts by removal of PS-DNA. This transient modulation was independent of the glycosylation state of PrP, and in addition, all three PrP glycoforms were susceptible to PS-DNA treatment. Deletion of the N-terminal domain (amino acids 23-99), but not of the other domains of PrP, abrogated its PS-DNA-mediated down-regulation. PrP versions localized in the mitochondria, cytoplasm, or nucleus were not modulated by PS-DNA, indicating that PrP surface exposure is required for executing this effect. Proteins that in their native forms were not responsive to PS-DNA, such as thymocyte antigen 1 (Thy1), Doppel protein (Dpl), green fluorescent protein (GFP), and cyan fluorescent protein (CFP), became susceptible to PS-DNA-mediated down-regulation following introduction of the N terminus of PrP into their sequence. These observations demonstrate the essential role of the N-terminal domain for promoting oligonucleotide-mediated reduction of the PrP level and suggest that transient treatment of cultured cells with PS-DNA may provide a general method for targeted modulation of the levels of desired surface proteins in a conditional and reversible manner.	[Karpuj, Marcela Viviana; Gelibter-Niv, Sagit; Tiran, Anat] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr Food & Environm Qual, Fac Agr, IL-76100 Rehovot, Israel; [Rambold, Angelika; Tatzelt, Joerg] Univ Munich, Dept Neurobiochem, Adolf Butenandt Inst, D-80336 Munich, Germany; [Nunziante, Max; Schatzl, Hermann M.] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Hebrew University of Jerusalem; University of Munich; Technical University of Munich; University of Wyoming; University of Wyoming	Karpuj, MV (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr Food & Environm Qual, Fac Agr, IL-76100 Rehovot, Israel.	mvkarpuj@gmail.com	Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740; Tatzelt, Jorg/0000-0001-5017-5528	Human Frontier Science Program; Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; BMBF (BioDisc) [DIP5.1]; European Union NoE Neuroprion	Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); BMBF (BioDisc)(Federal Ministry of Education & Research (BMBF)); European Union NoE Neuroprion	This work was supported by the Career Development Award Grant, Human Frontier Science Program (to M. V. K.), grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the BMBF (BioDisc, DIP5.1) (to J. T.), and grants from the Deutsche Forschungsgemeinschaft (SFB 596) and European Union NoE Neuroprion (to H. M. S.).	Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; CAPELLARI S, 2000, ALZHEIMERS DIS, V2, P27; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gilch S, 2004, TRAFFIC, V5, P300, DOI 10.1111/j.1600-0854.2004.0175.x; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hollrigel GS, 1998, P ROY SOC B-BIOL SCI, V265, P63, DOI 10.1098/rspb.1998.0265; HORI H, 1981, PLANT PHYSIOL, V67, P882, DOI 10.1104/pp.67.5.882; Karpuj MV, 2007, MOL MED, V13, P190, DOI 10.2119/2006-00073.Karpuj; KELLER GA, 1992, EMBO J, V11, P863, DOI 10.1002/j.1460-2075.1992.tb05124.x; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner Stanley B., 2004, VVolume 41, P961; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; Radford HE, 2010, CURR ISSUES MOL BIOL, V12, P119; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100	46	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6911	6917		10.1074/jbc.M110.194662	http://dx.doi.org/10.1074/jbc.M110.194662			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21156803	Green Published, hybrid			2022-12-25	WOS:000287737300006
J	Joshi, S; Sharma, B; Kaur, S; Majchrzak, B; Ueda, T; Fukunaga, R; Verma, AK; Fish, EN; Platanias, LC				Joshi, Sonali; Sharma, Bhumika; Kaur, Surinder; Majchrzak, Beata; Ueda, Takeshi; Fukunaga, Rikiro; Verma, Amit K.; Fish, Eleanor N.; Platanias, Leonidas C.			Essential Role for Mnk Kinases in Type II Interferon (IFN gamma) Signaling and Its Suppressive Effects on Normal Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; CAP-INDEPENDENT TRANSLATION; TUMOR-NECROSIS-FACTOR; REGULATORY FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL ACTIVATION; EIF4E PHOSPHORYLATION; PROGENITOR CELLS; CELLULAR-RESPONSES	IFN gamma exhibits potent antitumor effects and plays important roles in the innate immunity against cancer. However, the mechanisms accounting for the antiproliferative effects of IFN gamma still remain to be elucidated. We examined the role of Mnk1 (MAPK-interacting protein kinase 1) in IFN gamma signaling. Our data demonstrate that IFN gamma treatment of sensitive cells results in engagement of Mnk1, activation of its kinase domain, and downstream phosphorylation of the cap-binding protein eIF4E on Ser-209. Such engagement of Mnk1 plays an important role in IFN gamma-induced IRF-1 (IFN regulatory factor 1) gene mRNA translation/protein expression and is essential for generation of antiproliferative responses. In studies aimed to determine the role of Mnk1 in the induction of the suppressive effects of IFNs on primitive hematopoietic progenitors, we found that siRNA-mediated Mnk1/2 knockdown results in partial reversal of the suppressive effects of IFN gamma on human CD34+-derived myeloid (CFU-GM) and erythroid (BFU-E) progenitors. These findings establish a key role for the Mnk/eIF4E pathway in the regulatory effects of IFN gamma on normal hematopoiesis and identify Mnk kinases as important elements in the control of IFN gamma-inducible ISG mRNA translation.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Toronto Res Inst, Div Cell & Mol Biol, Univ Hlth Network, Toronto, ON M5G2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G2M1, Canada; [Ueda, Takeshi] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Hiroshima 7378553, Japan; [Fukunaga, Rikiro] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Verma, Amit K.] Albert Einstein Coll Med, Dept Med, Div Hematol Oncol, Bronx, NY 10461 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Hiroshima University; Kyoto University; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Fukunaga, Rikiro/CAG-2891-2022	Ueda, Takeshi/0000-0001-9823-6764	National Institutes of Health [CA77816, CA121192, AG029138, HL08294]; Department of Veterans Affairs; Malkin Scholars Award; NATIONAL CANCER INSTITUTE [R01CA121192, P30CA060553, R01CA077816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Malkin Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, AG029138, and HL08294. This work was also supported by a Merit Review grant from the Department of Veterans Affairs and a Malkin Scholars Award.	Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Bowie ML, 2008, ADV EXP MED BIOL, V617, P367, DOI 10.1007/978-0-387-69080-3_35; BROXMEYER HE, 1986, J IMMUNOL, V136, P4487; Buard A, 1998, CANCER RES, V58, P840; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Horiuchi M, 2006, J BIOL CHEM, V281, P20095, DOI 10.1074/jbc.M603179200; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ishida M, 2003, CIRC RES, V93, P1218, DOI 10.1161/01.RES.0000105570.34585.F2; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Meng QJ, 2005, J IMMUNOL, V174, P6203, DOI 10.4049/jimmunol.174.10.6203; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Salmenpera P, 2003, AM J PHYSIOL-CELL PH, V284, pC1133, DOI 10.1152/ajpcell.00293.2002; SATO T, 1995, BLOOD, V86, P3373, DOI 10.1182/blood.V86.9.3373.bloodjournal8693373; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Uddin S, 2000, J BIOL CHEM, V275, P27634; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wang Y, 2010, GLIA, V58, P195, DOI 10.1002/glia.20912; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Weyand CM, 2011, CURR OPIN RHEUMATOL, V23, P43, DOI 10.1097/BOR.0b013e32833ee946; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	68	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6017	6026		10.1074/jbc.M110.197921	http://dx.doi.org/10.1074/jbc.M110.197921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149447	Green Published, hybrid			2022-12-25	WOS:000287476400009
J	Thomas, CJ; Casquilho-Gray, HE; York, J; DeCamp, DL; Dai, DC; Petrilli, EB; Boger, DL; Slayden, RA; Amberg, SM; Sprang, SR; Nunberg, JH				Thomas, Celestine J.; Casquilho-Gray, Hedi E.; York, Joanne; DeCamp, Dianne L.; Dai, Dongcheng; Petrilli, Erin B.; Boger, Dale L.; Slayden, Richard A.; Amberg, Sean M.; Sprang, Stephen R.; Nunberg, Jack H.			A Specific Interaction of Small Molecule Entry Inhibitors with the Envelope Glycoprotein Complex of the Junin Hemorrhagic Fever Arenavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABLE SIGNAL PEPTIDE; CHORIOMENINGITIS VIRUS GLYCOPROTEIN; RECOMBINANT VACCINIA VIRUS; PH-INDUCED ACTIVATION; IMPORTED LASSA FEVER; MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; REVERSE-TRANSCRIPTASE; AMINO-ACID; GP-C	Arenaviruses are responsible for acute hemorrhagic fevers worldwide and are recognized to pose significant threats to public health and biodefense. Small molecule compounds have recently been discovered that inhibit arenavirus entry and protect against lethal infection in animal models. These chemically distinct inhibitors act on the tripartite envelope glycoprotein (GPC) through its unusual stable signal peptide subunit to stabilize the complex against pH-induced activation of membrane fusion in the endosome. Here, we report the production and characterization of the intact transmembrane GPC complex of Junin arenavirus and its interaction with these inhibitors. The solubilized GPC is antigenically indistinguishable from the native protein and forms a homogeneous trimer in solution. When reconstituted into a lipid bilayer, the purified complex interacts specifically with its cell-surface receptor transferrin receptor-1. We show that small molecule entry inhibitors specific to New World or Old World arenaviruses bind to the membrane-associated GPC complex in accordance with their respective species selectivities and with dissociation constants comparable with concentrations that inhibit GPC-mediated membrane fusion. Furthermore, competitive binding studies reveal that these chemically distinct inhibitors share a common binding pocket on GPC. In conjunction with previous genetic studies, these findings identify the pH-sensing interface of GPC as a highly vulnerable target for antiviral intervention. This work expands our mechanistic understanding of arenavirus entry and provides a foundation to guide the development of small molecule compounds for the treatment of arenavirus hemorrhagic fevers.	[Thomas, Celestine J.; DeCamp, Dianne L.; Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Casquilho-Gray, Hedi E.; York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA; [DeCamp, Dianne L.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Dai, Dongcheng; Amberg, Sean M.] SIGA Technol Inc, Corvallis, OR 97333 USA; [Petrilli, Erin B.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Boger, Dale L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; Colorado State University; Scripps Research Institute	Thomas, CJ (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	celestine.thomas@umontana.edu; jack.nunberg@umontana.edu	Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021	Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277	National Institutes of Health [R01 AI074818, U54 AI065357, P01 CA078045]; Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL CANCER INSTITUTE [P01CA078045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074818, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI074818 and U54 AI065357 (to J. H. N.) and P01 CA078045 (to D. L. B.). D. Dai and S. Amberg are employees of SIGA Technologies, which has interests in the compounds reported.; Recipient of a Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Travel award.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Beyer WR, 2001, J VIROL, V75, P1061, DOI 10.1128/JVI.75.2.1061-1064.2001; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Capul AA, 2007, J VIROL, V81, P9451, DOI 10.1128/JVI.00499-07; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; De Clercq E, 2004, CHEM BIODIVERS, V1, P44, DOI 10.1002/cbdv.200490012; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Department of Health and Human Services, 2007, FED REG, V72, P20117; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Jorgensen WL, 2006, BIOORG MED CHEM LETT, V16, P663, DOI 10.1016/j.bmcl.2005.10.038; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Lee AM, 2008, J BIOL CHEM, V283, P18734, DOI 10.1074/jbc.M802089200; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; MARTIN YC, 1998, DESIGNING BIOACTIVE, P121; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; NIAID, 2011, NIAID CAT A B C PRIO; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Palacios G, 2010, J GEN VIROL, V91, P1315, DOI 10.1099/vir.0.017798-0; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Thomas CJ, 1998, J AM CHEM SOC, V120, P12428, DOI 10.1021/ja981777j; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; York J, 2005, VIROLOGY, V343, P267, DOI 10.1016/j.virol.2005.08.030; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2010, J VIROL, V84, P6119, DOI 10.1128/JVI.02700-09; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08	52	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6192	6200		10.1074/jbc.M110.196428	http://dx.doi.org/10.1074/jbc.M110.196428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159779	Green Published, hybrid			2022-12-25	WOS:000287476400028
J	Geiger, R; Gautschi, M; Thor, F; Hayer, A; Helenius, A				Geiger, Roger; Gautschi, Matthias; Thor, Friederike; Hayer, Arnold; Helenius, Ari			Folding, Quality Control, and Secretion of Pancreatic Ribonuclease in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; G-PROTEIN; ER; PATHWAY; GLYCOSYLATION; GLYCOPROTEINS; STABILITY; CALNEXIN; DISEASES	Although bovine pancreatic RNase is one of the best characterized proteins in respect to structure and in vitro refolding, little is known about its synthesis and maturation in the endoplasmic reticulum (ER) of live cells. We expressed the RNase in live cells and analyzed its folding, quality control, and secretion using pulse-chase analysis and other cell biological techniques. In contrast to the slow in vitro refolding, the protein folded almost instantly after translation and translocation into the ER lumen (t(1/2) < 3 min). Despite high stability of the native protein, only about half of the RNase reached a secretion competent, monomeric form and was rapidly transported from the rough ER via the Golgi complex (t(1/2) = 16 min) to the extracellular space (t(1/2) = 35 min). The rest remained in the ER mainly in the form of dimers and was slowly degraded. The dimers were most likely formed by C-terminal domain swapping since mutation of Asn(113), a residue that stabilizes such dimers, to Ser increased the efficiency of secretion from 59 to 75%. Consistent with stringent ER quality control in vivo, the secreted RNase in the bovine pancreas was mainly monomeric, whereas the enzyme present in the cells also contained 20% dimers. These results suggest that the efficiency of secretion is not only determined by the stability of the native protein but by multiple factors including the stability of secretion-incompetent side products of folding. The presence of N-glycans had little effect on the folding and secretion process.	[Geiger, Roger; Gautschi, Matthias; Thor, Friederike; Hayer, Arnold; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	Hayer, Arnold/W-8863-2019	Hayer, Arnold/0000-0001-7808-8880; Geiger, Roger/0000-0002-8016-1669	Swiss National Research Foundation; ETH Zurich	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Research Foundation and ETH Zurich.	ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CRESTFIELD AM, 1962, ARCH BIOCHEM BIOPHYS, P217; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HIRS CHW, 1953, J BIOL CHEM, V200, P493; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; LAITY JH, 1993, P NATL ACAD SCI USA, V90, P615, DOI 10.1073/pnas.90.2.615; Libonati M, 1996, BIOCHEM J, V318, P287, DOI 10.1042/bj3180287; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Maeda T, 2002, J BIOCHEM, V132, P737, DOI 10.1093/oxfordjournals.jbchem.a003281; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Park C, 2000, PROTEIN SCI, V9, P2026, DOI 10.1110/ps.9.10.2026; Pearce FG, 2009, BIOCHEM BIOPH RES CO, V382, P114, DOI 10.1016/j.bbrc.2009.02.142; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Russo N, 2000, BIOCHEMISTRY-US, V39, P3585, DOI 10.1021/bi992367q; SCHULTZ DA, 1992, PROTEIN SCI, V1, P917, DOI 10.1002/pro.5560010710; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Xu GQ, 2005, BIOCHEMISTRY-US, V44, P9817, DOI 10.1021/bi0506932; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	42	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5813	5822		10.1074/jbc.M110.171694	http://dx.doi.org/10.1074/jbc.M110.171694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156800	hybrid, Green Published			2022-12-25	WOS:000287230600090
J	Jain, V; Liegler, T; Vittinghoff, E; Hartogensis, W; Bacchetti, P; Poole, L; Loeb, L; Pilcher, CD; Grant, RM; Deeks, SG; Hecht, FM				Jain, Vivek; Liegler, Teri; Vittinghoff, Eric; Hartogensis, Wendy; Bacchetti, Peter; Poole, Lauren; Loeb, Lisa; Pilcher, Christopher D.; Grant, Robert M.; Deeks, Steven G.; Hecht, Frederick M.			Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009	PLOS ONE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; PLACEBO-CONTROLLED TRIAL; PERFORMANCE-CHARACTERISTICS; TMC125 ETRAVIRINE; GENOTYPING KIT; DOUBLE-BLIND; INFECTION; TRANSMISSION; EFFICACY; SAFETY	Background: Transmitted HIV-1 drug resistance (TDR) is an ongoing public health problem, representing 10-20% of new HIV infections in many geographic areas. TDR usually arises from two main sources: individuals on antiretroviral therapy (ART) who are failing to achieve virologic suppression, and individuals who acquired TDR and transmit it while still ART-naive. TDR rates can be impacted when novel antiretroviral medications are introduced that allow for greater virologic suppression of source patients. Although several new HIV medications were introduced starting in late 2007, including raltegravir, maraviroc, and etravirine, it is not known whether the prevalence of TDR was subsequently affected in 2008-2009. Methodology/Principal Findings: We performed population sequence genotyping on individuals who were diagnosed with acute or early HIV (<6 months duration) and who enrolled in the Options Project, a prospective cohort, between 2002 and 2009. We used logistic regression to compare the odds of acquiring drug-resistant HIV before versus after the arrival of new ART (2005-2007 vs. 2008-2009). From 2003-2007, TDR rose from 7% to 24%. Prevalence of TDR was then 15% in 2008 and in 2009. While the odds of acquiring TDR were lower in 2008-2009 compared to 2005-2007, this was not statistically significant (odds ratio 0.65, 95% CI 0.31-1.38; p = 0.27). Conclusions: Our study suggests that transmitted drug resistance rose from 2003-2007, but this upward trend did not continue in 2008 and 2009. Nevertheless, the TDR prevalence in 2008-2009 remained substantial, emphasizing that improved management strategies for drug-resistant HIV are needed if TDR is to be further reduced. Continued surveillance for TDR will be important in understanding the full impact of new antiretroviral medications.	[Jain, Vivek; Liegler, Teri; Hartogensis, Wendy; Poole, Lauren; Loeb, Lisa; Pilcher, Christopher D.; Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Vittinghoff, Eric; Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Virol, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Jain, V (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	rhecht@php.ucsf.edu		Grant, Robert/0000-0002-0851-7085; Hecht, Frederick/0000-0002-5782-1171; Loeb Stanga, Lisa/0000-0001-7471-5381	National Institutes of Health, National Institute of Allergy and Infectious Diseases [T32 AI060530, PO1 AI071713, K24AI069994]; University of California San Francisco Center for AIDS Research [P30 AI027763]; University of California San Francisco Clinical and Translational Science Institute [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060530, P01AI071713, K24AI069994] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California San Francisco Center for AIDS Research(University of California System); University of California San Francisco Clinical and Translational Science Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, National Institute of Allergy and Infectious Diseases (T32 AI060530, PO1 AI071713 to FMH, and K24AI069994 to SGD). This work was also supported in part by the University of California San Francisco Center for AIDS Research (P30 AI027763) and the University of California San Francisco Clinical and Translational Science Institute (UL1 RR024131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hicks C, 2009, CLIN INFECT DIS, V48, P931, DOI 10.1086/597290; Hurt CB, 2009, ANTIVIR THER, V14, P673; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Scherrer AU, 2010, JAIDS-J ACQ IMM DEF, V53, P464, DOI 10.1097/QAI.0b013e3181bca4ec; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	27	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15510	10.1371/journal.pone.0015510	http://dx.doi.org/10.1371/journal.pone.0015510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170322	gold, Green Published, Green Submitted			2022-12-25	WOS:000285181400024
J	BasuRay, S; Mukherjee, S; Romero, E; Wilson, MC; Wandinger-Ness, A				BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wilson, Michael C.; Wandinger-Ness, Angela			Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Exhibit Enhanced NGF-Stimulated Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FUNCTIONAL ANALYSES; PROTEIN-KINASE; ACTIVATION; CELLS; NEUROPATHIES; ERK; 2B; COMPARTMENT; MECHANISMS	Missense mutants in the late endosomal Rab7 GTPase cause the autosomal dominant peripheral neuropathy Charcot-Marie-Tooth disease type 2B (CMT2B). As yet, the pathological mechanisms connecting mutant Rab7 protein expression to altered neuronal function are undefined. Here, we analyze the effects Rab7 CMT2B mutants on nerve growth factor (NGF) dependent intracellular signaling in PC12 cells. The nerve growth factor receptor TrkA interacted similarly with Rab7 wildtype and CMT2B mutant proteins, but the mutant proteins significantly enhanced TrkA phosphorylation in response to brief NGF stimulation. Two downstream signaling pathways (Erk1/2 and Akt) that are directly activated in response to phospho-TrkA were differentially affected. Akt signaling, arising in response to activated TrkA at the plasma membrane was unaffected. However Erk1/2 phosphorylation, triggered on signaling endosomes, was increased. Cytoplasmic phospho-Erk1/2 persisted at elevated levels relative to control samples for up to 24 h following NGF stimulation. Nuclear shuttling of phospho Erk1/2, which is required to induce MAPK phosphatase expression and down regulate signaling, was greatly reduced by the Rab7 CMT2B mutants and explains the previously reported inhibition in PC12 neurite outgrowth. In conclusion, the data demonstrate a mechanistic link between Rab7 CMT2B mutants and altered TrkA and Erk1/2 signaling from endosomes.	[BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Canc Res & Treatment Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Wilson, Michael C.] Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	BasuRay, S (corresponding author), Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	wness@unm.edu	Wandinger-Ness, Angela/J-9104-2012	Wandinger-Ness, Angela/0000-0003-0613-3157	National Science Foundation [MCB 0446179, MCB 0956027]; National Institutes of Health [R01 MH48989]; University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was generously supported by the National Science Foundation (MCB 0446179 and MCB 0956027 to AWN); and by the National Institutes of Health (R01 MH48989 to MCW). Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; BERND P, 1984, J BIOL CHEM, V259, P5509; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; COGLI L, 2010, ACTA NEUROPATHOL; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; De Luca A, 2008, BIOCHEM BIOPH RES CO, V372, P283, DOI 10.1016/j.bbrc.2008.05.060; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Feng Y, 2001, METHOD ENZYMOL, V329, P175; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; FUKUDA M, 1995, ONCOGENE, V11, P239; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; MERESSE S, 1995, J CELL SCI, V108, P3349; Mukherjee S, 2005, METHOD ENZYMOL, V403, P650, DOI 10.1016/S0076-6879(05)03056-9; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Parman Y, 2007, CURR OPIN NEUROL, V20, P542, DOI 10.1097/WCO.0b013e32826fbcb7; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Stein MP, 2005, METHOD ENZYMOL, V403, P628, DOI 10.1016/S0076-6879(05)03055-7; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	34	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15351	10.1371/journal.pone.0015351	http://dx.doi.org/10.1371/journal.pone.0015351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151572	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800027
J	Kraft, P; Benz, PM; Austinat, M; Brede, ME; Schuh, K; Walter, U; Stoll, G; Kleinschnitz, C				Kraft, Peter; Benz, Peter Michael; Austinat, Madeleine; Brede, Marc Elmar; Schuh, Kai; Walter, Ulrich; Stoll, Guido; Kleinschnitz, Christoph			Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice	PLOS ONE			English	Article							VASCULAR-ENDOTHELIAL-CADHERIN; CEREBRAL-ARTERY OCCLUSION; ENA/VASP PROTEINS; INJURY; ACTIN; INHIBITION; MODEL; HIF-1-ALPHA; ACTIVATION; REGULATORS	Background: Stroke-induced brain edema formation is a frequent cause of secondary infarct growth and deterioration of neurological function. The molecular mechanisms underlying edema formation after stroke are largely unknown. Vasodilator-stimulated phosphoprotein (VASP) is an important regulator of actin dynamics and stabilizes endothelial barriers through interaction with cell-cell contacts and focal adhesion sites. Hypoxia has been shown to foster vascular leakage by downregulation of VASP in vitro but the significance of VASP for regulating vascular permeability in the hypoxic brain in vivo awaits clarification. Methodology/Principal Findings: Focal cerebral ischemia was induced in Vasp(-/-) mice and wild-type (WT) littermates by transient middle cerebral artery occlusion (tMCAO). Evan's Blue tracer was applied to visualize the extent of blood-brain-barrier (BBB) damage. Brain edema formation and infarct volumes were calculated from 2,3,5-triphenyltetrazolium chloride (TTC)-stained brain slices. Both mouse groups were carefully controlled for anatomical and physiological parameters relevant for edema formation and stroke outcome. BBB damage (p < 0.05) and edema volumes (1.7 mm(3) +/- 0.5 mm(3) versus 0.8 mm(3) +/- 0.4 mm(3); p < 0.0001) were significantly enhanced in Vasp(-/-) mice compared to controls on day 1 after tMCAO. This was accompanied by a significant increase in infarct size (56.1 mm(3) +/- 17.3 mm(3) versus 39.3 mm(3) +/- 10.7 mm(3), respectively; p < 0.01) and a non significant trend (p > 0.05) towards worse neurological outcomes. Conclusion: Our study identifies VASP as critical regulator of BBB maintenance during acute ischemic stroke. Therapeutic modulation of VASP or VASP-dependent signalling pathways could become a novel strategy to combat excessive edema formation in ischemic brain damage.	[Kraft, Peter; Austinat, Madeleine; Stoll, Guido; Kleinschnitz, Christoph] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Benz, Peter Michael; Schuh, Kai; Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Benz, Peter Michael; Schuh, Kai] Univ Wurzburg, Dept Physiol, D-8700 Wurzburg, Germany; [Brede, Marc Elmar] Univ Wurzburg, Dept Anesthesiol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Kraft, P (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	christoph.kleinschnitz@mail.uni-wuerzburg.de	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [SFB 688, TP A2, A13, B1]; Wilhelm Sander-Stiftung, Munchen, Germany [2009.017.1]	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG)); Wilhelm Sander-Stiftung, Munchen, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany, SFB 688, TP A2 (to UW), A13 (to CK), and B1 (to GS) and Wilhelm Sander-Stiftung, Munchen, Germany (2009.017.1 to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; BERECZKI D, 2007, COCHRANE DB SYST REV, V183; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Clark WM, 1997, NEUROL RES, V19, P641; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Davis B, 2010, INT J DEV NEUROSCI, V28, P423, DOI 10.1016/j.ijdevneu.2010.06.010; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Hordijk PL, 1999, J CELL SCI, V112, P1915; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kris AS, 2008, BIOCHEM BIOPH RES CO, V375, P134, DOI 10.1016/j.bbrc.2008.07.132; Lai CH, 2005, BRAIN RES REV, V50, P7, DOI 10.1016/j.brainresrev.2005.03.007; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; QIZILBASH N, 2002, COCHRANE DB SYST REV, V2; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Righetti E, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000096.pub2, DOI 10.1002/14651858.CD000096.PUB2]; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sporbert A, 1999, MOL BRAIN RES, V67, P258, DOI 10.1016/S0169-328X(99)00067-4; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M	52	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15106	10.1371/journal.pone.0015106	http://dx.doi.org/10.1371/journal.pone.0015106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151938	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600026
J	Chu-Shore, J; Westover, MB; Bianchi, MT				Chu-Shore, Jesse; Westover, M. Brandon; Bianchi, Matt T.			Power Law versus Exponential State Transition Dynamics: Application to Sleep-Wake Architecture	PLOS ONE			English	Article							PHYSIOLOGY; PATTERNS; DISEASE; CYCLE	Background: Despite the common experience that interrupted sleep has a negative impact on waking function, the features of human sleep-wake architecture that best distinguish sleep continuity versus fragmentation remain elusive. In this regard, there is growing interest in characterizing sleep architecture using models of the temporal dynamics of sleep-wake stage transitions. In humans and other mammals, the state transitions defining sleep and wake bout durations have been described with exponential and power law models, respectively. However, sleep-wake stage distributions are often complex, and distinguishing between exponential and power law processes is not always straightforward. Although mono-exponential distributions are distinct from power law distributions, multi-exponential distributions may in fact resemble power laws by appearing linear on a log-log plot. Methodology/Principal Findings: To characterize the parameters that may allow these distributions to mimic one another, we systematically fitted multi-exponential-generated distributions with a power law model, and power law-generated distributions with multi-exponential models. We used the Kolmogorov-Smirnov method to investigate goodness of fit for the "incorrect" model over a range of parameters. The "zone of mimicry" of parameters that increased the risk of mistakenly accepting power law fitting resembled empiric time constants obtained in human sleep and wake bout distributions. Conclusions/Significance: Recognizing this uncertainty in model distinction impacts interpretation of transition dynamics (self-organizing versus probabilistic), and the generation of predictive models for clinical classification of normal and pathological sleep architecture.	[Chu-Shore, Jesse] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Westover, M. Brandon] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bianchi, Matt T.] Massachusetts Gen Hosp, Dept Neurol, Sleep Div, Boston, MA 02114 USA; [Bianchi, Matt T.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chu-Shore, J (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	thebianchi@gmail.com		Shore, Jesse/0000-0003-3812-0262	Neurology Department, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer, Inc; Merck Co.	Neurology Department, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer, Inc(Pfizer); Merck Co.(Merck & Company)	Dr. Bianchi receives funding from the Neurology Department, Massachusetts General Hospital, and the Clinical Investigator Training Program: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center, in collaboration with Pfizer, Inc. and Merck & Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Bernstein S, 1929, ACTA MATH-DJURSHOLM, V52, P1; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Buzsaki G., 2006, RHYTHMS BRAIN, P448; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; HAVLIN S, 1995, CHAOS SOLITON FRACT, V6, P171, DOI 10.1016/0960-0779(95)80025-C; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kim JU, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076401; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; LIPSITZ LA, 2004, SCI AGING KNOWLEDGE, pPE16; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Peng Chung-Kang, 1994, Integrative Physiological and Behavioral Science, V29, P283, DOI 10.1007/BF02691332; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Swihart BJ, 2008, J CLIN SLEEP MED, V4, P349; YANG MCK, 1973, BIOMETRICS, V29, P667, DOI 10.2307/2529133	27	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14204	10.1371/journal.pone.0014204	http://dx.doi.org/10.1371/journal.pone.0014204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151998	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000018
J	Zemanick, ET; Wagner, BD; Sagel, SD; Stevens, MJ; Accurso, FJ; Harris, JK				Zemanick, Edith T.; Wagner, Brandie D.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Harris, J. Kirk			Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PERIODONTAL PATHOGENS; PULMONARY INFECTIONS; DIAGNOSTIC-ACCURACY; ANAEROBIC CULTURE; LUNG INFECTIONS; SPUTUM; CHILDREN; DIVERSITY; SAMPLES	The cystic fibrosis (CF) airway microbiome is complex; polymicrobial infections are common, and the presence of fastidious bacteria including anaerobes make culture-based diagnosis challenging. Quantitative real-time PCR (qPCR) offers a culture-independent method for bacterial quantification that may improve diagnosis of CF airway infections; however, the reliability of qPCR applied to CF airway specimens is unknown. We sought to determine the reliability of nine specific bacterial qPCR assays (total bacteria, three typical CF pathogens, and five anaerobes) applied to CF airway specimens. Airway and salivary specimens from clinically stable pediatric CF subjects were collected. Quantitative PCR assay repeatability was determined using triplicate reactions. Split-sample measurements were performed to measure variability introduced by DNA extraction. Results from qPCR were compared to standard microbial culture for Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae, common pathogens in CF. We obtained 84 sputa, 47 oropharyngeal and 27 salivary specimens from 16 pediatric subjects with CF. Quantitative PCR detected bacterial DNA in over 97% of specimens. All qPCR assays were highly reproducible at quantities >10(2) rRNA gene copies/reaction with coefficient of variation less than 20% for over 99% of samples. There was also excellent agreement between samples processed in duplicate. Anaerobic bacteria were highly prevalent and were detected in mean quantities similar to that of typical CF pathogens. Compared to a composite gold standard, qPCR and culture had variable sensitivities for detection of P. aeruginosa, S. aureus and H. influenzae from CF airway samples. By reliably quantifying fastidious airway bacteria, qPCR may improve our understanding of polymicrobial CF lung infections, progression of lung disease and ultimately improve antimicrobial treatments.	[Zemanick, Edith T.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Harris, J. Kirk] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Zemanick, ET (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	zemanick.edith@tchden.org	Zemanick, Edith/D-5260-2017; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Zemanick, Edith T/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; Harris, Jonathan/0000-0002-2378-4202	Cystic Fibrosis Foundation [ZEMANI07DO, ZEMANI08A0]; Colorado Clinical and Translational Science Award (CTSA) [1UL1RR014780]; National Center for Research Resources, National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014780, UL1RR025780] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Colorado Clinical and Translational Science Award (CTSA); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Cystic Fibrosis Foundation grants, numbers ZEMANI07DO and ZEMANI08A0 (http://www.cff.org), and Colorado Clinical and Translational Science Award (CTSA) grant number 1UL1RR014780, Clinical Translational Research Centers Program, National Center for Research Resources, National Institutes of Health (NIH) (http://www.ctsaweb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011; Boutaga K, 2007, J PERIODONTOL, V78, P79, DOI 10.1902/jop.2007.060078; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldstein EJC, 2008, ANAEROBE, V14, P68, DOI 10.1016/j.anaerobe.2008.01.001; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMERSCHLAG MR, 1980, J CLIN MICROBIOL, V11, P552, DOI 10.1128/JCM.11.6.552-557.1980; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Lambiase A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-4; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Muldrew KL, 2009, CURR OPIN PEDIATR, V21, P102, DOI 10.1097/MOP.0b013e328320d87e; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rosey AL, 2007, J MICROBIOL METH, V68, P88, DOI 10.1016/j.mimet.2006.06.010; Rubin BK, 2009, RESP CARE, V54, P726, DOI 10.4187/002013209790983269; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van Belkum A, 2000, FEMS IMMUNOL MED MIC, V27, P51, DOI 10.1111/j.1574-695X.2000.tb01411.x; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221	39	53	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15101	10.1371/journal.pone.0015101	http://dx.doi.org/10.1371/journal.pone.0015101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152087	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100072
J	Kozlov, SV; Graham, ME; Jakob, B; Tobias, F; Kijas, AW; Tanuji, M; Chen, PL; Robinson, PJ; Taucher-Scholz, G; Suzuki, K; So, SR; Chen, DV; Lavin, MF				Kozlov, Sergei V.; Graham, Mark E.; Jakob, Burkhard; Tobias, Frank; Kijas, Amanda W.; Tanuji, Marcel; Chen, Philip; Robinson, Phillip J.; Taucher-Scholz, Gisela; Suzuki, Keiji; So, Sairai; Chen, David; Lavin, Martin F.			Autophosphorylation and ATM Activation ADDITIONAL SITES ADD TO THE COMPLEXITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; MRN COMPLEX; NUCLEAR FOCI; N-TERMINUS; PROTEIN; PHOSPHORYLATION; NBS1; RECRUITMENT	The recognition and signaling of DNA double strand breaks involves the participation of multiple proteins, including the protein kinase ATM (mutated in ataxia-telangiectasia). ATM kinase is activated in the vicinity of the break and is recruited to the break site by the Mre11-Rad50-Nbs1 complex, where it is fully activated. In human cells, the activation process involves autophosphorylation on three sites (Ser(367), Ser(1893), and Ser(1981)) and acetylation on Lys(3016). We now describe the identification of a new ATM phosphorylation site, Thr(P)(1885) and an additional autophosphorylation site, Ser(P)(2996), that is highly DNA damage-inducible. We also confirm that human and murine ATM share five identical phosphorylation sites. We targeted the ATM phosphorylation sites, Ser(367) and Ser(2996), for further study by generating phosphospecific antibodies against these sites and demonstrated that phosphorylation of both was rapidly induced by radiation. These phosphorylations were abolished by a specific inhibitor of ATM and were dependent on ATM and the Mre11-Rad50-Nbs1 complex. As found for Ser(P)(1981), ATM phosphorylated at Ser(367) and Ser(2996) localized to sites of DNA damage induced by radiation, but ATM recruitment was not dependent on phosphorylation at these sites. Phosphorylation at Ser(367) and Ser(2996) was functionally important because mutant forms of ATM were defective in correcting the S phase checkpoint defect and restoring radioresistance in ataxia-telangiectasia cells. These data provide further support for the importance of autophosphorylation in the activation and function of ATM in vivo.	[Kozlov, Sergei V.; Kijas, Amanda W.; Tanuji, Marcel; Chen, Philip; Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Graham, Mark E.; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Jakob, Burkhard; Tobias, Frank; Taucher-Scholz, Gisela] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Suzuki, Keiji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Nagasaki 8528523, Japan; [So, Sairai; Chen, David] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Children's Medical Research Institute - Australia; University of Sydney; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Nagasaki University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Queensland	Kozlov, SV (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	sergei.kozlov@qimr.edu.au; martin.lavin@qimr.edu.au	Chen, Phang-Lang/J-5031-2013; Classen, Scott/AAY-8176-2020; Kozlov, Sergei/T-9779-2019; Jakob, Burkhard/D-2047-2013; Kozlov, Sergei/M-2067-2014; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011; Lavin, Martin F/F-5961-2014	Jakob, Burkhard/0000-0003-2404-377X; Kozlov, Sergei/0000-0001-6183-7339; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313; Lavin, Martin F/0000-0002-5940-4769; Kijas, Amanda/0000-0001-8538-7766	National Institutes of Health [CA050519, CA92584]; National Health and Medical Research Council; GSI Helmholtzzentrum fur Schwerionenforschung GmbH; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA050519, R37CA050519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); GSI Helmholtzzentrum fur Schwerionenforschung GmbH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA050519 and CA92584 (to D. C.). This work was also supported by grants from the National Health and Medical Research Council (to M. F. L.) and GSI Helmholtzzentrum fur Schwerionenforschung GmbH (to G.T.-S. and B.J.).	ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen XP, 2007, EXP CELL RES, V313, P1667, DOI 10.1016/j.yexcr.2007.02.015; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandes N, 2005, J BIOL CHEM, V280, P15158, DOI 10.1074/jbc.M412065200; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; HOULDSWORTH J, 1983, BIOCHEM INT, V6, P349; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jakob B, 2000, RADIAT RES, V154, P398, DOI 10.1667/0033-7587(2000)154[0398:ILCPRR]2.0.CO;2; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kozlov S, 2003, J BIOL CHEM, V278, P9309, DOI 10.1074/jbc.M300003200; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lemeer S, 2008, MOL CELL PROTEOMICS, V7, P2176, DOI 10.1074/mcp.M800081-MCP200; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; RASIO D, 1995, CANCER RES, V55, P6053; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; TAUCHERSCHOLZ G, 2007, ION IRRADIATION TOOL, V1, P453; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021	74	136	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9107	9119		10.1074/jbc.M110.204065	http://dx.doi.org/10.1074/jbc.M110.204065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21149446	Green Published, hybrid			2022-12-25	WOS:000288247700041
J	He, ZH; Cai, J; Lim, JW; Kroll, K; Ma, LA				He, Zhenhua; Cai, Jing; Lim, Jong-Won; Kroll, Kristen; Ma, Liang			A Novel KRAB Domain-containing Zinc Finger Transcription Factor ZNF431 Directly Represses Patched1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEXES; SONIC HEDGEHOG; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; PROTEINS; GENE; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS	Kruppel- like zinc finger transcription factors compose the largest transcription factor family in the mammalian genome. However, the functions for the majority of these transcription factors as well as their in vivo downstream targets are not clear. We have functionally characterized a novel KRAB domain zinc finger transcription factor ZNF431 using both in vitro and in vivo assays. ZNF431 is a nuclear transcriptional repressor whose repressive activity depends on its association with HDAC1 and -2. Using the limb mesenchymal cell line MPLB, we identified Patched1 as a direct transcriptional target of ZNF431. Promoter analyses revealed three ZNF431 binding sites that bind to ZNF431 both in vitro and in vivo as revealed by gel-shift and chromatin immunoprecipitation, respectively. Mutations of these three sites abolished ZNF431 repression in transient transfection assays. Moreover, overexpressing ZNF431 in MPLB cells or in Xenopus and mouse embryos strongly repressed Patched1 expression. On the other hand, shRNA knockdown of ZNF431 in MPLB cells elevated Patched1 expression. Finally, hedgehog signaling readout was reduced in ZNF431 overexpression but elevated in ZNF431 knockdown MPLB cells. Our results indicate that ZNF431 directly represses Patched1 expression and likely functions to repress the hedgehog response in cells.	[He, Zhenhua; Cai, Jing; Ma, Liang] Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA; [Lim, Jong-Won; Kroll, Kristen; Ma, Liang] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Ma, LA (corresponding author), Campus Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA.	lima@dom.wustl.edu	Lim, Jong-Won/AAB-3761-2021	Kroll, Kristen/0000-0002-5450-6694	National Institutes of Health [ES014482, ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597, R01ES014482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014482 and ES016597.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hennemann H, 2003, J BIOL CHEM, V278, P28799, DOI 10.1074/jbc.M207196200; Hering TM, 2004, EXP CELL RES, V299, P137, DOI 10.1016/j.yexcr.2004.05.030; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nagao K, 2005, GENOMICS, V85, P462, DOI 10.1016/j.ygeno.2004.11.014; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; TREVINO C, 1993, PROG CLIN BIOL RES, V383, P295; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	40	12	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7279	7289		10.1074/jbc.M110.178780	http://dx.doi.org/10.1074/jbc.M110.178780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177534	Green Published, hybrid			2022-12-25	WOS:000287737300044
J	Posey, AD; Pytel, P; Gardikiotes, K; Demonbreun, AR; Rainey, M; George, M; Band, H; McNally, EM				Posey, Avery D., Jr.; Pytel, Peter; Gardikiotes, Konstantina; Demonbreun, Alexis R.; Rainey, Mark; George, Manju; Band, Hamid; McNally, Elizabeth M.			Endocytic Recycling Proteins EHD1 and EHD2 Interact with Fer-1-like-5 (Fer1L5) and Mediate Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; PHOSPHOLIPID-BINDING; SYNAPTOTAGMIN-I; PLASMA-MEMBRANE; DOMAIN; MYOFERLIN; GENE; DYSFERLIN; COMPLEX; MUSCLE	The mammalian ferlins are calcium-sensing, C2 domain-containing proteins involved in vesicle trafficking. Myoferlin and dysferlin regulate myoblast fusion and muscle membrane resealing, respectively. Correspondingly, myoferlin is most highly expressed in singly nucleated myoblasts, whereas dysferlin expression is increased in mature, multinucleated myotubes. Myoferlin also mediates endocytic recycling and participates in trafficking the insulin-like growth factor receptor. We have now characterized a novel member of the ferlin family, Fer1L5, because of its high homology to dysferlin and myoferlin. We found that Fer1L5 protein is expressed in small myotubes that contain only two to four nuclei. We also found that Fer1L5 protein binds directly to the endocytic recycling proteins EHD1 and EHD2 and that the second C2 domain in Fer1L5 mediates this interaction. Reduction of EHD1 and/or EHD2 inhibits myoblast fusion, and EHD2 is required for normal translocation of Fer1L5 to the plasma membrane. The characterization of Fer1L5 and its interaction with EHD1 and EHD2 underscores the complex requirement of ferlin proteins and mediators of endocytic recycling for membrane trafficking events during myotube formation.	[Posey, Avery D., Jr.; McNally, Elizabeth M.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Gardikiotes, Konstantina; Demonbreun, Alexis R.; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rainey, Mark; George, Manju; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Nebraska System; University of Nebraska Medical Center	McNally, EM (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, 5841 S Maryland,MC6088, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019; Posey, Avery D./P-4890-2019; Band, Hamid/AAF-4701-2020	Posey, Avery D./0000-0001-8711-629X; Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	National Institutes of Health [NS047726, CA105489, CA99163, CA87986, CA116552, T32 HL7381]; Muscular Dystrophy Association; Jain Foundation; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA099163, R01CA105489, R01CA087986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Jain Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047726 (to E. M. M.), CA105489 (to H. B.), CA99163 (to H. B.), CA87986 (to H. B.), CA116552 (to H. B.), and T32 HL7381. This work was also supported by the Muscular Dystrophy Association and the Jain Foundation.	Achanzar WE, 1997, J CELL SCI, V110, P1073; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Enmon JL, 2000, BIOCHEMISTRY-US, V39, P4309, DOI 10.1021/bi9927383; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park SW, 2004, J AM COLL CARDIOL, V43, p50A, DOI 10.1016/S0735-1097(04)90213-6; Patel P, 2008, J MOL BIOL, V379, P981, DOI 10.1016/j.jmb.2008.04.046; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peuvot J, 1999, J THEOR BIOL, V198, P173, DOI 10.1006/jtbi.1999.0908; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	47	39	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7379	7388		10.1074/jbc.M110.157222	http://dx.doi.org/10.1074/jbc.M110.157222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177873	Green Published, hybrid			2022-12-25	WOS:000287737300054
J	Sommer, ME; Hofmann, KP; Heck, M				Sommer, Martha E.; Hofmann, Klaus Peter; Heck, Martin			Arrestin-Rhodopsin Binding Stoichiometry in Isolated Rod Outer Segment Membranes Depends on the Percentage of Activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; METARHODOPSIN-II; MONOMERIC RHODOPSIN; VISUAL ARRESTIN; FUNCTIONAL UNIT; DISK MEMBRANES; BOVINE; LIGHT; PHOSPHORYLATION	In the rod cell of the retina, arrestin is responsible for blocking signaling of the G-protein-coupled receptor rhodopsin. The general visual signal transduction model implies that arrestin must be able to interact with a single light-activated, phosphorylated rhodopsin molecule (Rho*P), as would be generated at physiologically relevant low light levels. However, the elongated bi-lobed structure of arrestin suggests that it might be able to accommodate two rhodopsin molecules. In this study, we directly addressed the question of binding stoichiometry by quantifying arrestin binding to Rho*P in isolated rod outer segment membranes. We manipulated the "photoactivation density," i.e. the percentage of active receptors in the membrane, with the use of a light flash or by partially regenerating membranes containing phosphorylated opsin with 11-cis-retinal. Curiously, we found that the apparent arrestin-Rho*P binding stoichiometry was linearly dependent on the photoactivation density, with one-to-one binding at low photoactivation density and one-to-two binding at high photoactivation density. We also observed that, irrespective of the photoactivation density, a single arrestin molecule was able to stabilize the active metarhodopsin II conformation of only a single Rho*P. We hypothesize that, although arrestin requires at least a single Rho*P to bind the membrane, a single arrestin can actually interact with a pair of receptors. The ability of arrestin to interact with heterogeneous receptor pairs composed of two different photo-intermediate states would be well suited to the rod cell, which functions at low light intensity but is routinely exposed to several orders of magnitude more light.	[Sommer, Martha E.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Heck, M (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	martin.heck@charite.de		Sommer, Martha E./0000-0003-0493-8584	National Science Foundation [0700410]; Deutsche Forschungsgemeinschaft [SFB 740, HE 2704/1-1, SO 1037/1-1]	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by International Research Fellowship 0700410 from the National Science Foundation and Grants SFB 740, HE 2704/1-1, and SO 1037/1-1 from the Deutsche Forschungsgemeinschaft.	Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; CONE RA, 1972, NATURE-NEW BIOL, V236, P39, DOI 10.1038/newbio236039a0; Edrington TC, 2008, BIOPHYS J, V95, P2859, DOI 10.1529/biophysj.108.128868; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Heck M, 2000, METHOD ENZYMOL, V315, P329; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; KUHN H, 1982, METHOD ENZYMOL, V81, P489; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lewis JW, 1997, VISION RES, V37, P1, DOI 10.1016/S0042-6989(96)00138-1; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; Schertler GFX, 2005, CURR OPIN STRUC BIOL, V15, P408, DOI 10.1016/j.sbi.2005.07.010; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Wachtler T, 2004, VISION RES, V44, P2843, DOI 10.1016/j.visres.2004.06.016; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	55	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7359	7369		10.1074/jbc.M110.204941	http://dx.doi.org/10.1074/jbc.M110.204941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169358	Green Published, hybrid			2022-12-25	WOS:000287737300052
J	Doczi, J; Turiak, L; Vajda, S; Mandi, M; Torocsik, B; Gerencser, AA; Kiss, G; Konrad, C; Adam-Vizi, V; Chinopoulos, C				Doczi, Judit; Turiak, Lilla; Vajda, Szilvia; Mandi, Miklos; Toeroecsik, Beata; Gerencser, Akos A.; Kiss, Gergely; Konrad, Csaba; Adam-Vizi, Vera; Chinopoulos, Christos			Complex Contribution of Cyclophilin D to Ca2+-induced Permeability Transition in Brain Mitochondria, with Relation to the Bioenergetic State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; IN-SITU; LIVER-MITOCHONDRIA; MATRIX PH; PORE; MODULATION; INHIBITION; CALCIUM; MECHANISMS; APOPTOSIS	Cyclophilin D (cypD)-deficient mice exhibit resistance to focal cerebral ischemia and to necrotic but not apoptotic stimuli. To address this disparity, we investigated isolated brain and in situ neuronal and astrocytic mitochondria from cypD-deficient and wild-type mice. Isolated mitochondria were challenged by high Ca2+, and the effects of substrates and respiratory chain inhibitors were evaluated on permeability transition pore opening by light scatter. In situ neuronal and astrocytic mitochondria were visualized by mito-DsRed2 targeting and challenged by calcimycin, and the effects of glucose, NaCN, and an uncoupler were evaluated by measuring mitochondrial volume. In isolated mitochondria, Ca2+ caused a large cypD-dependent change in light scatter in the absence of substrates that was insensitive to Ruthenium red or Ru360. Uniporter inhibitors only partially affected the entry of free Ca2+ in the matrix. Inhibition of complex III/IV negated the effect of substrates, but inhibition of complex I was protective. Mitochondria within neurons and astrocytes exhibited cypD-independent swelling that was dramatically hastened when NaCN and 2-deoxyglucose were present in a glucose-free medium during calcimycin treatment. In the presence of an uncoupler, cypD-deficient astrocytic mitochondria performed better than wild-type mitochondria, whereas the opposite was observed in neurons. Neuronal mitochondria were examined further during glutamate-induced delayed Ca2+ deregulation. CypD-knock-out mitochondria exhibited an absence or a delay in the onset of mitochondrial swelling after glutamate application. Apparently, some conditions involving deenergization render cypD an important modulator of PTP in the brain. These findings could explain why absence of cypD protects against necrotic (deenergized mitochondria), but not apoptotic (energized mitochondria) stimuli.	[Doczi, Judit; Turiak, Lilla; Vajda, Szilvia; Mandi, Miklos; Toeroecsik, Beata; Kiss, Gergely; Konrad, Csaba; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Biochem Med, H-1094 Budapest, Hungary; [Gerencser, Akos A.] Buck Inst Age Res, Novato, CA 94945 USA	Semmelweis University; Buck Institute for Research on Aging	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Biochem Med, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Mándi, Miklós/AGF-9798-2022	Mandi, Miklos/0000-0002-0971-7695; Chinopoulos, Christos/0000-0003-0183-4149; Torocsik, Beata/0000-0002-9838-3710; Adam-Vizi, Vera/0000-0002-8350-8701	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) [NNF78905]; Magyar Tudomanyos Akademia (MTA); Nemzeti Kutatasi es Technologiai Hivatal (NKTH); Egeszsegugyi Tudomanyos Tanacs (ETT) [55160]; Semmelweis University [63320]; OTKA-NKTH [NF68294]	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Magyar Tudomanyos Akademia (MTA); Nemzeti Kutatasi es Technologiai Hivatal (NKTH)(National Office for Research and Technology); Egeszsegugyi Tudomanyos Tanacs (ETT); Semmelweis University; OTKA-NKTH(National Office for Research and TechnologyOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA), Magyar Tudomanyos Akademia (MTA), Nemzeti Kutatasi es Technologiai Hivatal (NKTH), and Egeszsegugyi Tudomanyos Tanacs (ETT) (to V. A.-V.) and Semmelweis University Research Grant 63320, OTKA-NKTH Grant NF68294, OTKA Grant NNF78905, and ETT Grant 55160 (to C. C.).	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gerencser AA, 2008, BIOPHYS J, V95, P2583, DOI 10.1529/biophysj.107.118620; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leverve XM, 2001, IUBMB LIFE, V52, P221; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MOORE GA, 1983, FEBS LETT, V153, P289, DOI 10.1016/0014-5793(83)80626-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; RIGOBELLO MP, 1995, ARCH BIOCHEM BIOPHYS, V319, P225, DOI 10.1006/abbi.1995.1286; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Vajda S, 2009, FEBS J, V276, P2713, DOI 10.1111/j.1742-4658.2009.06995.x; Volbracht C, 1999, MOL MED, V5, P477; Yamamoto T, 2008, J BIOENERG BIOMEMBR, V40, P619, DOI 10.1007/s10863-008-9190-6; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	45	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6345	6353		10.1074/jbc.M110.196600	http://dx.doi.org/10.1074/jbc.M110.196600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173147	hybrid, Green Published			2022-12-25	WOS:000287476400045
J	Guo, JF; Gertsberg, Z; Ozgen, N; Sabri, A; Steinberg, SF				Guo, Jianfen; Gertsberg, Zoya; Ozgen, Nazira; Sabri, Abdelkarim; Steinberg, Susan F.			Protein Kinase D Isoforms Are Activated in an Agonist-specific Manner in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; ELEMENT-BINDING PROTEIN; G(Q)-COUPLED RECEPTORS; SER(748) PHOSPHORYLATION; CATALYTIC ACTIVATION; LOOP SER(744); LOCALIZATION; HYPERTROPHY; MECHANISMS; EXPRESSION	Protein kinase D (PKD) exists as a family of structurally related enzymes that are activated through similar phosphorylation-dependent mechanisms involving protein kinase C (PKC). While individual PKD isoforms could in theory mediate distinct biological functions, previous studies identify a high level of functional redundancy for PKD1 and PKD2 in various cellular contexts. This study shows that PKD1 and PKD2 are activated in a stimulus-specific manner in neonatal cardiomyocytes. The alpha(1)-adrenergic receptor agonist norepinephrine selectively activates PKD1, thrombin and PDGF selectively activate PKD2, and endothelin-1 and PMA activate both PKD1 and PKD2. PKC activity is implicated in the alpha(1)-adrenergic receptor pathway that activates PKD1 and the thrombin- and PDGF-dependent pathways that activate PKD2. Endothelin-1 activates PKD via both rapid PKC-dependent and more sustained PKC-independent mechanisms. The functional consequences of PKD activation were assessed by tracking phosphorylation of CREB and cardiac troponin I (cTnI), two physiologically relevant PKD substrates in cardiomyocytes. We show that overexpression of an activated PKD1-S744E/S748E transgene increases CREB-Ser(133) and cTnI-Ser(23)/Ser(24) phosphorylation, but agonist-dependent pathways that activate native PKD1 or PKD2 selectively increase CREB-Ser(133) phosphorylation; there is no associated increase in cTnI-Ser(23)/Ser(24) phosphorylation. Gene silencing studies provide unanticipated evidence that PKD1 down-regulation leads to a compensatory increase in PKD2 activity and that down-regulation of PKD1 (alone or in combination with PKD2) leads to an increase in CREB-Ser(133) phosphorylation. Collectively, these studies identify distinct roles for native PKD1 and PKD2 enzymes in stress-dependent pathways that influence cardiac remodeling and the progression of heart failure.	[Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Guo, Jianfen; Sabri, Abdelkarim] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			USPHS-NHLBI, National Institutes of Health [HL77860, HL-67101, HL-28958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028958, R01HL077860, R01HL067101, R01HL112388] Funding Source: NIH RePORTER	USPHS-NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by USPHS-NHLBI, National Institutes of Health Grants HL77860, HL-67101, and HL-28958.	Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	26	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6500	6509		10.1074/jbc.M110.208058	http://dx.doi.org/10.1074/jbc.M110.208058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156805	hybrid, Green Published			2022-12-25	WOS:000287476400060
J	Liu, JY; Stevens, PD; Gao, TY				Liu, Jianyu; Stevens, Payton D.; Gao, Tianyan			mTOR-Dependent Regulation of PHLPP Expression Controls the Rapamycin Sensitivity in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT ISOFORMS; AKT/PKB; COMPLEX; GROWTH; RICTOR; RAPTOR; PHOSPHORYLATION; PROLIFERATION; TUMORIGENESIS; INHIBITION	PHLPP belongs to a novel family of protein phosphatases that serve as negative regulators of Akt. There are two isoforms, PHLPP1 and PHLPP2, identified in this family. Our previous studies indicated a tumor suppressor role of both PHLPP isoforms in colon cancer. Here we report that the expression of PHLPP is controlled by mTOR-dependent protein translation in colon and breast cancer cells. Treating cells with rapamycin or knockdown of mTOR using RNAi results in a marked decrease of PHLPP protein expression. In contrast, stable knockdown of TSC2, a negative regulator of mTOR activity, increases PHLPP expression. The rapamycin-mediated down-regulation of PHLPP is blocked by expression of a rapamycin-insensitive mutant of p70S6K. In addition, depletion of 4E-BP1 expression by RNAi results in an increase of PHLPP expression and resistance to rapamycin-induced down-regulation. Moreover, inhibition of mTOR activity by amino acid or glucose starvation reduces PHLPP expression in cells. Functionally, we show that rapamycin-mediated inhibition of PHLPP expression contributes to rapamycin resistance in colon cancer cells. Thus, our studies identify a compensatory feedback regulation in which the activation of Akt is inhibited by up-regulation of PHLPP through mTOR, and this mTOR-dependent expression of PHLPP subsequently determines the rapamycin sensitivity of cancer cells.	[Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01 CA133429-01A1]; American Cancer Society [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133429-01A1 (to T. G.). This work was also supported by American Cancer Society Grant RSG0822001TBE (to T. G.).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hirano I, 2009, J BIOL CHEM, V284, P22155, DOI 10.1074/jbc.M808182200; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833	41	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6510	6520		10.1074/jbc.M110.183087	http://dx.doi.org/10.1074/jbc.M110.183087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177869	Green Published, hybrid			2022-12-25	WOS:000287476400061
J	Mast, N; Annalora, AJ; Lodowski, DT; Palczewski, K; Stout, CD; Pikuleva, IA				Mast, Natalia; Annalora, Andrew J.; Lodowski, David T.; Palczewski, Krzysztof; Stout, C. David; Pikuleva, Irina A.			Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENOCORTICAL PREPARATIONS; F-G LOOP; SUBSTRATE-SPECIFICITY; ADRENODOXIN-BINDING; CYTOCHROME-P450 46A1; P450SCC CYP11A1; PREGNENOLONE; SITE; INHIBITION; CONVERSION	Mitochondrial cytochrome P450 11A1 (CYP11A1 or P450 11A1) is the only known enzyme that cleaves the side chain of cholesterol, yielding pregnenolone, the precursor of all steroid hormones. Pregnenolone is formed via three sequential monooxygenation reactions that involve the progressive production of 22R-hydroxycholesterol (22HC) and 20 alpha,22R-dihydroxycholesterol, followed by the cleavage of the C20-C22 bond. Herein, we present the 2.5-angstrom crystal structure of CYP11A1 in complex with the first reaction intermediate, 22HC. The active site cavity in CYP11A1 represents a long curved tube that extends from the protein surface to the heme group, the site of catalysis. 22HC occupies two-thirds of the cavity with the 22R-hydroxyl group nearest the heme, 2.56 angstrom from the iron. The space at the entrance to the active site is not taken up by 22HC but filled with ordered water molecules. The network formed by these water molecules allows the "soft" recognition of the 22HC 3 beta-hydroxyl. Such a mode of 22HC binding suggests shuttling of the sterol intermediates between the active site entrance and the heme group during the three-step reaction. Translational freedom of 22HC and torsional motion of its aliphatic tail are supported by solution studies. The CYP11A1-22HC co-complex also provides insight into the structural basis of the strict substrate specificity and high catalytic efficiency of the enzyme and highlights conserved structural motifs involved in redox partner interactions by mitochondrial P450s.	[Annalora, Andrew J.; Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Lodowski, David T.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Scripps Research Institute; Case Western Reserve University; Case Western Reserve University	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dave@scripps.edu; iap8@case.edu		Annalora, Andrew J./0000-0001-6415-8921; Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882, AG024336, EY019718, EY0090339]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources, National Institutes of Health; NIGMS; NATIONAL EYE INSTITUTE [K99EY019718, R00EY019718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants GM62882 and AG024336 (to I. A. P.), EY019718 (to D. T. L.), and EY0090339 (to K. P.). Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, by the Biomedical Technology Program of the National Center for Research Resources, National Institutes of Health, and by NIGMS.	Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; ARINGER L, 1979, J STEROID BIOCHEM, V11, P1271, DOI 10.1016/0022-4731(79)90196-1; BURSTEIN S, 1976, STEROIDS, V27, P361, DOI 10.1016/0039-128X(76)90057-X; BURSTEIN S, 1975, J BIOL CHEM, V250, P9028; DEGENHART HJ, 1984, J STEROID BIOCHEM, V21, P447, DOI 10.1016/0022-4731(84)90310-8; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Headlam MJ, 2003, BBA-BIOMEMBRANES, V1617, P96, DOI 10.1016/j.bbamem.2003.09.007; HEYL BL, 1986, J BIOL CHEM, V261, P2743; KOBAYASHI S, 1969, J BIOCHEM, V66, P51, DOI 10.1093/oxfordjournals.jbchem.a129119; LAMBETH JD, 1983, J BIOL CHEM, V258, P5596; LAMBETH JD, 1986, ENDOCR RES, V12, P371, DOI 10.3109/07435808609035446; LAMBETH JD, 1982, J BIOL CHEM, V257, P1876; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; LAMBETH JD, 1980, J BIOL CHEM, V255, P138; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; MORISAKI M, 1980, J STEROID BIOCHEM, V13, P545; MORISAKI M, 1982, J STEROID BIOCHEM, V16, P101; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; OMURA T, 1964, J BIOL CHEM, V239, P2370; ORMEJOHNSON NR, 1979, J BIOL CHEM, V254, P2103; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Pikuleva IA, 2004, MOL CELL ENDOCRINOL, V215, P161, DOI 10.1016/j.mce.2003.11.005; PIKULEVA IA, 1995, ARCH BIOCHEM BIOPHYS, V322, P189, DOI 10.1006/abbi.1995.1451; Pikuleva IA, 1999, J BIOL CHEM, V274, P2045, DOI 10.1074/jbc.274.4.2045; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Pikuleva I, 2008, LIPIDS, V43, P1127, DOI 10.1007/s11745-008-3234-x; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SHEETS JJ, 1983, J BIOL CHEM, V258, P1720; SIMPSON ER, 1967, EUR J BIOCHEM, V2, P275, DOI 10.1111/j.1432-1033.1967.tb00136.x; TROUT EC, 1971, P SOC EXP BIOL MED, V136, P469; TSUBAKI M, 1988, BIOCHEMISTRY-US, V27, P4856, DOI 10.1021/bi00413a041; TSUBAKI M, 1989, BIOCHEMISTRY-US, V28, P6899, DOI 10.1021/bi00443a019; TUCKEY RC, 1983, J BIOL CHEM, V258, P4232; TULS J, 1989, J BIOL CHEM, V264, P16421; Urushino N, 2006, BIOCHEMISTRY-US, V45, P4405, DOI 10.1021/bi060072o; WADA A, 1992, J BIOL CHEM, V267, P22877	40	98	99	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5607	5613		10.1074/jbc.M110.188433	http://dx.doi.org/10.1074/jbc.M110.188433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159775	Green Published, hybrid			2022-12-25	WOS:000287230600070
J	Weatherspoon-Griffin, N; Zhao, GA; Kong, W; Kong, Y; Morigen; Andrews-Polymenis, H; McClelland, M; Shi, YX				Weatherspoon-Griffin, Natasha; Zhao, Guang; Kong, Wei; Kong, Ying; Morigen; Andrews-Polymenis, Helene; McClelland, Michael; Shi, Yixin			The CpxR/CpxA Two-component System Up-regulates Two Tat-dependent Peptidoglycan Amidases to Confer Bacterial Resistance to Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN; EXPORT; IDENTIFICATION; RECOGNITION; TRANSPORT; PROTAMINE; MAGAININS; SEQUENCE; MELITTIN	We demonstrate that the twin arginine translocation (Tat) system contributes to bacterial resistance to cationic antimicrobial peptides (CAMPs). Our results show that a deletion at the tatC gene, which encodes a subunit of the Tat complex, caused Salmonella and Escherichia coli to become susceptible to protamine. We screened chromosomal loci that encode known and predicted Tat-dependent proteins and found that two N-acetylmuramoyl-L-alanine amidases, encoded by amiA and amiC, elevated bacterial resistance to protamine and alpha-helical peptides magainin 2 and melittin but not to beta-sheet defensin HNP-1 and lipopeptide polymyxin B. Genetic analysis suggests that transcription of both amiA and amiC loci in Salmonella is up-regulated by the CpxR/CpxA two-component system when nlpE is overexpressed. A footprinting analysis reveals that CpxR protein can interact with amiA and amiC promoters at the CpxR box, which is localized between the predicted -10 and -35 regions but present on different strands in these two genes. In addition, our results show that activation of the CpxR/CpxA system can facilitate protamine resistance because nlpE overexpression elevates this resistance in the wild-type strain but not the cpxR deletion mutant. Thus, we uncover a new transcriptional regulation pathway in which the Cpx envelope stress response system modulates the integrity of the cell envelope in part by controlling peptidoglycan amidase activity, which confers bacterial resistance to protamine and alpha-helical CAMPs. Our studies have important implications for understanding transcriptional regulation of peptidoglycan metabolism and also provide new insights into the role of the bacterial envelope in CAMP resistance.	[Weatherspoon-Griffin, Natasha; Zhao, Guang; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Kong, Wei; Shi, Yixin] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Kong, Ying] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian 116044, Liaoning, Peoples R China; [Morigen] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China; [Andrews-Polymenis, Helene] Texas A&M Univ Syst Hlth Sci Ctr, Coll Med, College Stn, TX 77843 USA; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA 92121 USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Dalian Medical University; Inner Mongolia University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California Irvine	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	zhao, guang/E-4702-2013; McClelland, Michael/A-8583-2011; SHI, YIXIN/M-5751-2019	zhao, guang/0000-0003-0002-5972; Morigen, Morigen/0000-0001-5782-376X; McClelland, Michael/0000-0003-1788-9347	National Institutes of Health [U01A152237-05, R01AI07397-01, R01AI039557-11, R01AI075093-01, R21AI083964-01, 1R01AI083646-01, 1R56AI077645, R01 AI075093]; Center for Infectious Diseases and Vaccinology in the Biodesign Institute; Arizona State University; National Natural Science Foundation of China [30770483, 30970646]; United States Department of Agriculture [AFRI CSREES 2009-03579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R21AI083964, R56AI077645, R01AI075093, R01AI083646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Infectious Diseases and Vaccinology in the Biodesign Institute; Arizona State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants U01A152237-05, R01AI07397-01, R01AI039557-11, and R01AI075093-01) (to M. M.) and R21AI083964-01, 1R01AI083646-01, 1R56AI077645, and R01 AI075093 (to H. A.-P.). This study was also supported by research funds from the Center for Infectious Diseases and Vaccinology in the Biodesign Institute (to G. Z.) and Arizona State University (to Y. S.) and National Natural Science Foundation of China Grants 30770483 and 30970646 (to Y. K.) and United States Department of Agriculture Grant AFRI CSREES 2009-03579 (to H. A.-P.).	Ando T, 1973, Mol Biol Biochem Biophys, V12, P1; Aspedon A, 1996, MICROBIOL-SGM, V142, P3389, DOI 10.1099/13500872-142-12-3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bauer R, 2005, INT J FOOD MICROBIOL, V101, P201, DOI 10.1016/j.ijfoodmicro.2004.11.007; Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Palmer T, 2007, PERIPLASM, P16; PARRALOPEZ C, 1994, EMBO J, V13, P3964, DOI 10.1002/j.1460-2075.1994.tb06712.x; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; TOMIOKA S, 1983, J BACTERIOL, V156, P463, DOI 10.1128/JB.156.1.463-465.1983; VAARA M, 1983, ANTIMICROB AGENTS CH, V24, P107, DOI 10.1128/AAC.24.1.107; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang L, 1998, BIOPHYS J, V75, P641, DOI 10.1016/S0006-3495(98)77554-X; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	53	74	78	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5529	5539		10.1074/jbc.M110.200352	http://dx.doi.org/10.1074/jbc.M110.200352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149452	hybrid, Green Published			2022-12-25	WOS:000287230600062
J	Li, MJ; Ma, FW; Liang, D; Li, JA; Wang, YL				Li, Mingjun; Ma, Fengwang; Liang, Dong; Li, Juan; Wang, Yanlei			Ascorbate Biosynthesis during Early Fruit Development Is the Main Reason for Its Accumulation in Kiwi	PLOS ONE			English	Article							GAMMA-LACTONE DEHYDROGENASE; VITAMIN-C; ARABIDOPSIS-THALIANA; MONODEHYDROASCORBATE REDUCTASE; ACID BIOSYNTHESIS; GDP-MANNOSE; PLANT; EXPRESSION; GENES; L-GALACTONO-1,4-LACTONE	Background: Ascorbic acid (AsA) is a unique antioxidant as well as an enzyme cofactor. Although it has multiple roles in plants, it is unclear how its accumulation is controlled at the expression level, especially in sink tissues. Kiwifruit (Actinidia) is well-known for its high ascorbate content. Our objective was to determine whether AsA accumulates in the fruits primarily through biosynthesis or because it is imported from the foliage. Methodology/Principal Findings: We systematically investigated AsA levels, biosynthetic capacity, and mRNA expression of genes involved in AsA biosynthesis in kiwi (A. deliciosa cv. Qinmei). Recycling and AsA localization were also monitored during fruit development and among different tissue types. Over time, the amount of AsA, with its capacity for higher biosynthesis and lower recycling, peaked at 30 days after anthesis (DAA), and then decreased markedly up to 60 DAA before declining more slowly. Expression of key genes showed similar patterns of change, except for L-galactono-1,4-lactone dehydrogenase and L-galactose-1-phosphate phosphatase (GPP). However, GPP had good correlation with the rate of AsA accumulation. The expression of these genes could be detected in phloem of stem as well as petiole of leaf and fruit. Additionally, fruit petioles had greater ascorbate amounts, although that was the site of lowest expression by most genes. Fruit microtubule tissues also had higher AsA. However, exogenous applications of AsA to those petioles did not lead to its transport into fruits, and distribution of ascorbate was cell-specific in the fruits, with more accumulation occurring in larger cells. Conclusions: These results suggest that AsA biosynthesis in kiwi during early fruit development is the main reason for its accumulation in the fruits. We also postulate here that GPP is a good candidate for regulating AsA biosynthesis whereas GDP-L-galactose-1-phosphate phosphorylase is not.	[Li, Mingjun; Ma, Fengwang; Liang, Dong; Li, Juan; Wang, Yanlei] NW A&F Univ, Coll Hort, Yangling, Peoples R China	Northwest A&F University - China	Li, MJ (corresponding author), NW A&F Univ, Coll Hort, Yangling, Peoples R China.	fwm64@sina.com	Li, Mingjun/D-4705-2011	Li, Mingjun/0000-0001-5508-895X	National Natural Science Foundation of China [30871700]; Research Fund for the Doctoral Program of Higher Education [20090204110009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (30871700) and The Research Fund for the Doctoral Program of Higher Education (20090204110009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Badejo AA, 2009, J PLANT PHYSIOL, V166, P652, DOI 10.1016/j.jplph.2008.09.004; Badejo AA, 2009, PLANT CELL PHYSIOL, V50, P423, DOI 10.1093/pcp/pcn206; Bartoli CG, 2005, PLANT CELL ENVIRON, V28, P1073, DOI 10.1111/j.1365-3040.2005.01338.x; Bermudez L, 2008, J EXP BOT, V59, P2875, DOI 10.1093/jxb/ern146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; CHATTERJEE IB, 1960, BIOCHEM J, V74, P193, DOI 10.1042/bj0740193; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; CHINOY NJ, 1969, HISTOCHEMISTRY, V20, P105, DOI 10.1007/BF00268703; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; DIMATTEO A, 2003, COMP BIOCH PHYSL A, V134, pS155; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Franceschi VR, 2002, PLANT PHYSIOL, V130, P649, DOI 10.1104/pp.007062; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Hancock RD, 2005, CRIT REV PLANT SCI, V24, P167, DOI 10.1080/07352680591002165; Hancock RD, 2008, PHYTOCHEMISTRY, V69, P1850, DOI 10.1016/j.phytochem.2008.03.022; Hancock RD, 2007, FUNCT PLANT BIOL, V34, P1080, DOI 10.1071/FP07221; Hancock Robert D., 2003, BMC Plant Biology, V3, P7, DOI 10.1186/1471-2229-3-7; Imai T, 2009, PHYSIOL PLANTARUM, V136, P139, DOI 10.1111/j.1399-3054.2009.01213.x; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Ishikawa T, 2006, PHYSIOL PLANTARUM, V126, P343, DOI 10.1111/j.1399-3054.2006.00640.x; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li MJ, 2008, PLANT SCI, V174, P606, DOI 10.1016/j.plantsci.2008.03.008; Li MJ, 2010, PLANT PHYSIOL BIOCH, V48, P216, DOI 10.1016/j.plaphy.2010.01.015; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Loscos J, 2008, PLANT PHYSIOL, V146, P1282, DOI 10.1104/pp.107.114066; Ma FW, 2003, PLANT SCI, V165, P819, DOI 10.1016/S0168-9452(03)00277-2; Maruta T, 2008, J BIOL CHEM, V283, P28842, DOI 10.1074/jbc.M805538200; Maurino VG, 2006, PLANT CELL PHYSIOL, V47, P1381, DOI 10.1093/pcp/pcl011; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Pallanca JE, 1999, PLANT PHYSIOL, V120, P453, DOI 10.1104/pp.120.2.453; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Rokni Zadeh H, 2007, Commun Agric Appl Biol Sci, V72, P269; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; Tedone Luigi, 2004, BMC Plant Biology, V4, P16, DOI 10.1186/1471-2229-4-16; Torabinejad J, 2009, PLANT PHYSIOL, V150, P951, DOI 10.1104/pp.108.135129; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	51	51	62	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14281	10.1371/journal.pone.0014281	http://dx.doi.org/10.1371/journal.pone.0014281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151561	Green Submitted, Green Published, gold			2022-12-25	WOS:000285135800012
J	Ruhe, ZC; Hayes, CS				Ruhe, Zachary C.; Hayes, Christopher S.			The N-Terminus of GalE Induces tmRNA Activity in Escherichia coli	PLOS ONE			English	Article							MESSENGER-RNA CLEAVAGE; MEDIATED TRANS-TRANSLATION; PEPTIDE-TAGGING ACTIVITY; A-SITE; STOP CODONS; BACILLUS-SUBTILIS; PROTEIN-SYNTHESIS; NASCENT-PEPTIDE; TAGGED PROTEINS; QUALITY-CONTROL	Background: The tmRNA quality control system recognizes stalled translation complexes and facilitates ribosome recycling in a process termed 'ribosome rescue'. During ribosome rescue, nascent chains are tagged with the tmRNA-encoded SsrA peptide, which targets tagged proteins for degradation. In Escherichia coli, tmRNA rescues ribosomes arrested on truncated messages, as well as ribosomes that are paused during elongation and termination. Methodology/Principal Findings: Here, we describe a new translational pausing determinant that leads to SsrA peptide tagging of the E. coli GalE protein (UDP-galactose 4-epimerase). GalE chains are tagged at more than 150 sites, primarily within distinct clusters throughout the C-terminal domain. These tagging sites do not correspond to rare codon clusters and synonymous recoding of the galE gene had little effect on tagging. Moreover, tagging was largely unaffected by perturbations that either stabilize or destabilize the galE transcript. Examination of GalE-thioredoxin (TrxA) fusion proteins showed that the GalE C-terminal domain is no longer tagged when fused to an N-terminal TrxA domain. Conversely, the N-terminus of GalE induced tagging within the fused C-terminal TrxA domain. Conclusions/Significance: These findings suggest that translation of the GalE N-terminus induces subsequent tagging of the C-terminal domain. We propose that co-translational maturation of the GalE N-terminal domain influences ribosome pausing and subsequent tmRNA activity.	[Ruhe, Zachary C.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Ruhe, ZC (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009		National Institutes of Health (NIH) [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an award from the National Institutes of Health (NIH)(GM078634). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; ALIX JH, 1993, P NATL ACAD SCI USA, V90, P9725, DOI 10.1073/pnas.90.20.9725; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen T, 2009, PROTEIN SCI, V18, P1377, DOI 10.1002/pro.157; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Du T, 2004, CURRENT PROTOCOLS MO; Fujihara A, 2002, GENES CELLS, V7, P343, DOI 10.1046/j.1365-2443.2002.00523.x; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; REGNIER P, 1990, BIOCHIMIE, V72, P825, DOI 10.1016/0300-9084(90)90192-J; REGNIER P, 1989, J MOL BIOL, V210, P293, DOI 10.1016/0022-2836(89)90331-8; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	65	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15207	10.1371/journal.pone.0015207	http://dx.doi.org/10.1371/journal.pone.0015207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151867	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800010
J	He, M; Su, HR; Gao, WW; Johansson, SM; Liu, Q; Wu, XY; Liao, JY; Young, AA; Bartfai, T; Wang, MW				He, Min; Su, Haoran; Gao, Weiwei; Johansson, Stina M.; Liu, Qing; Wu, Xiaoyan; Liao, Jiayu; Young, Andrew A.; Bartfai, Tamas; Wang, Ming-Wei			Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice	PLOS ONE			English	Article							BETA-CELL; GLUCOSE-TRANSPORT; LIPID-METABOLISM; BODY-WEIGHT; HIGH-FAT; EXENATIDE EXENDIN-4; ENERGY HOMEOSTASIS; HEPATIC BIOMARKERS; DIABETES-MELLITUS; HDL CHOLESTEROL	Background: Glucagon-like peptide-1 (GLP-1) is recognized as an important regulator of glucose homeostasis. Efforts to utilize GLP-1 mimetics in the treatment of diabetes have yielded clinical benefits. A major hurdle for an effective oral therapy has been the difficulty of finding a non-peptidic GLP-1 receptor (GLP-1R) agonist. While its oral bioavailability still poses significant challenges, Boc5, one of the first such compounds, has demonstrated the attainment of GLP-1R agonism in diabetic mice. The present work was to investigate whether subchronic Boc5 treatment can restore glycemic control and induce sustainable weight loss in diet-induced obese (DIO) mice, an animal model of human obesity and insulin resistance. Methodology/Principal Findings: DIO mice were treated three times a week with Boc5 (0.3, 1 and 3 mg) for 12 weeks. Body weight, body mass index (BMI), food intake, fasting glucose, intraperitoneal glucose tolerance and insulin induced glucose clearance were monitored regularly throughout the treatment. Glucose-stimulated insulin secretion, beta-cell mass, islet size, body composition, serum metabolic profiles, lipogenesis, lipolysis, adipose hypertrophy and lipid deposition in the liver and muscle were also measured after 12 weeks of dosing. Boc5 dose-dependently reduced body weight, BMI and food intake in DIO mice. These changes were associated with significant decreases in fat mass, adipocyte hypertrophy and peripheral tissue lipid accumulation. Boc5 treatment also restored glycemic control through marked improvement of insulin sensitivity and normalization of beta-cell mass. Administration of Boc5 (3 mg) reduced basal but enhanced insulin-mediated glucose incorporation and noradrenaline-stimulated lipolysis in isolated adipocytes from obese mice. Furthermore, circulating leptin, adiponectin, triglyceride, total cholesterol, nonesterified fatty acid and high-density lipoprotein/low-density lipoprotein ratio were normalized to various extents by Boc5 treatment. Conclusions/Significance: Boc5 may produce metabolic benefits via multiple synergistic mechanisms and may represent an attractive tool for therapeutic intervention of obesity and diabetes, by means of non-peptidic GLP-1R agonism.	[He, Min; Su, Haoran; Gao, Weiwei; Johansson, Stina M.; Liu, Qing; Wu, Xiaoyan; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [He, Min; Liu, Qing; Wu, Xiaoyan; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Bartfai, Tamas; Wang, Ming-Wei] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute	He, M (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.	wangmw@mail.shcnc.ac.cn	Liu, Qing/AAO-8151-2020	Liu, Qing/0000-0003-1825-6760	Ministry of Science and Technology of China [2009ZX09302-001]; Chinese Academy of Sciences [KSCX1-YW-02-2, KSCX2-YW-R-17]; Natural Science Foundation of China [30628024, 30623008]; Shanghai Science and Technology Development Fund [08DZ2291300, 09DZ2291200, 074319114]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund	This work was supported in part by grants from the Ministry of Science and Technology of China (2009ZX09302-001), the Chinese Academy of Sciences (KSCX1-YW-02-2 and KSCX2-YW-R-17), the Natural Science Foundation of China (30628024 and 30623008), Shanghai Science and Technology Development Fund (08DZ2291300, 09DZ2291200 and 074319114) and the CAS-Novo Nordisk Research Fund. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2007, REGUL PEPTIDES, V143, P97, DOI 10.1016/j.regpep.2007.03.008; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; ARNER P, 1987, AM J PHYSIOL, V253, pE193, DOI 10.1152/ajpendo.1987.253.2.E193; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Colagiuri S, 2010, DIABETES OBES METAB, V12, P463, DOI 10.1111/j.1463-1326.2009.01182.x; Crowe S, 2008, ENDOCRINOLOGY, V149, P2546, DOI 10.1210/en.2007-1447; Dietz WH, 1998, J PEDIATR-US, V132, P191; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Field BCT, 2008, DRUGS, V68, P147, DOI 10.2165/00003495-200868020-00002; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREDHOLM BB, 1985, METHOD PHARMACOL, P337; Gale SM, 2004, J NUTR, V134, P295, DOI 10.1093/jn/134.2.295; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; HARRIS RBS, 1984, AM J PHYSIOL, V247, pR380, DOI 10.1152/ajpregu.1984.247.2.R380; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Inuwa IM, 2005, J ANAT, V206, P185, DOI 10.1111/j.1469-7580.2005.00367.x; Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x; JohanssonA SM, 2008, EUR J PHARMACOL, V597, P92, DOI 10.1016/j.ejphar.2008.08.022; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; LAURELL S, 1966, CLIN CHIM ACTA, V13, P317, DOI 10.1016/0009-8981(66)90210-5; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Maggio CA, 2003, ENDOCRIN METAB CLIN, V32, P805, DOI 10.1016/S0889-8529(03)00071-9; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; MERIDA E, 1993, J CLIN ENDOCR METAB, V77, P1654, DOI 10.1210/jc.77.6.1654; Mizuno A, 1997, METABOLISM, V46, P745, DOI 10.1016/S0026-0495(97)90117-7; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Murphy KG, 2007, P NATL ACAD SCI USA, V104, P689, DOI 10.1073/pnas.0610679104; Olleros ML, 2008, CYTOKINE, V44, P118, DOI 10.1016/j.cyto.2008.07.001; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pajvani Utpal B, 2003, Curr Diab Rep, V3, P207, DOI 10.1007/s11892-003-0065-2; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Parkes D, 2001, DRUG DEVELOP RES, V53, P260, DOI 10.1002/ddr.1195; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Sancho V, 2006, INT J MOL MED, V17, P1133; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Severinsen T, 1999, ACTA PHYSIOL SCAND, V165, P299, DOI 10.1046/j.1365-201x.1999.00488.x; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stone NJ, 2000, MED CLIN N AM, V84, P95, DOI 10.1016/S0025-7125(05)70209-1; Su HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002892; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Tiessen RG, 2008, INT J CLIN PHARM TH, V46, P443; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Winzell MS, 2004, DIABETES, V53, pA359; Wolf G, 1996, NUTR REV, V54, P34; Wren AM, 2008, FRONT HORM RES, V36, P165, DOI 10.1159/000115364; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031; Young AA, 2002, FRONT ANIM DIAB RES, V5, P235; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	97	45	50	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14205	10.1371/journal.pone.0014205	http://dx.doi.org/10.1371/journal.pone.0014205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151924	Green Submitted, Green Published, gold			2022-12-25	WOS:000284939600002
J	Najafi, I; Attari, F; Islami, F; Shakeri, R; Malekzadeh, F; Salahi, R; Gharavi, MY; Hosseini, M; Broumand, B; Haghighi, AN; Larijani, B; Malekzadeh, R				Najafi, Iraj; Attari, Fatemeh; Islami, Farhad; Shakeri, Ramin; Malekzadeh, Fatemeh; Salahi, Rasool; Gharavi, Mina Yapan; Hosseini, Mostafa; Broumand, Behrooz; Haghighi, Ali Nobakht; Larijani, Bagher; Malekzadeh, Reza			Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; UNITED-STATES; SERUM CREATININE; PREVALENCE; POPULATION; ADULTS; EPIDEMIOLOGY; HYPERTENSION	Introduction: The incidence of end-stage renal disease is increasing worldwide. Earlier studies reported high prevalence rates of obesity and hypertension, two major risk factors of chronic kidney disease (CKD), in Golestan Province, Iran. We aimed to investigate prevalence of moderate to severe CKD and its risk factors in the region. Methods: Questionnaire data and blood samples were collected from 3591 participants (>= 18 years old) from the general population. Based on serum creatinine levels, glomerular filtration rate (GFR) was estimated. Results: High body mass index (BMI) was common: 35.0% of participants were overweight (BMI 25-29.9) and 24.5% were obese (BMI >= 30). Prevalence of CKD stages 3 to 5 (CKD-S3-5), i.e., GFR,60 mL/min/1.73 m(2), was 4.6%. The odds ratio (OR) and 95% confidence interval (95% CI) for the risk of CKD-S3-5 associated with every year increase in age was 1.13 (1.11-1.15). Men were at lower risk of CKD-S3-5 than women (OR = 0.28; 95% CI 0.18-0.45). Obesity (OR = 1.78; 95% CI 1.04-3.05) and self-reported diabetes (OR = 1.70; 95% CI 1.00-2.86), hypertension (OR = 3.16; 95% CI 2.02-4.95), ischemic heart disease (OR = 2.73; 95% CI 1.55-4.81), and myocardial infarction (OR = 2.69; 95% CI 1.14-6.32) were associated with increased risk of CKD-S3-5 in the models adjusted for age and sex. The association persisted for self-reported hypertension even after adjustments for BMI and history of diabetes (OR = 2.85; 95% CI 1.77-4.59). Conclusion: A considerable proportion of inhabitants in Golestan have CKD-S3-5. Screening of individuals with major risk factors of CKD, in order to early detection and treatment of impaired renal function, may be plausible. Further studies on optimal risk prediction of future end-stage renal disease and effectiveness of any screening program are warranted.	[Najafi, Iraj; Attari, Fatemeh] Univ Tehran Med Sci, Shariati Hosp, Nephrol Res Ctr, Tehran, Iran; [Islami, Farhad; Shakeri, Ramin; Malekzadeh, Fatemeh; Gharavi, Mina Yapan; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Islami, Farhad] Int Agcy Res Canc, F-69372 Lyon, France; [Salahi, Rasool] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Broumand, Behrooz; Haghighi, Ali Nobakht] IR Iran Acad Med Sci, Clin Sci Study Grp Iran, Tehran, Iran; [Larijani, Bagher] Univ Tehran Med Sci, Shariati Hosp, Endocrinol & Metab Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); Golestan University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Najafi, I (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Nephrol Res Ctr, Tehran, Iran.	rshakeri@gmail.com	larijani, Bagher/ABE-3315-2020; Malekzadeh, Reza/U-1382-2017	larijani, Bagher/0000-0001-5386-7597; Malekzadeh, Reza/0000-0002-9820-6335; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; , Ramin/0000-0003-0487-3629; hosseini, mostafa/0000-0002-1334-246X	Iranian Academy of Medical Sciences [1/3152]	Iranian Academy of Medical Sciences	The study was funded by the Iranian Academy of Medical Sciences. The grant number is 1/3152. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-158; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Brosnahan G, 2010, SOUTH MED J, V103, P140, DOI 10.1097/SMJ.0b013e3181c99438; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chambers John C, 2002, Semin Vasc Med, V2, P199, DOI 10.1055/s-2002-32043; Chen J, 2005, KIDNEY INT, V68, P2837, DOI 10.1111/j.1523-1755.2005.00757.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DUBIOS D, 1916, ANN INTERN MED, V17, P9; Ebrahimi M, 2010, J HYPERTENS, V28, P1620, DOI 10.1097/HJH.0b013e32833a38f2; Eknoyan G, 2001, POSTGRAD MED, V110, P23, DOI 10.3810/pgm.2001.09.1024; Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x; Guarnieri G, 2010, J RENAL NUTR, V20, pS19, DOI 10.1053/j.jrn.2010.05.006; Hallan SI, 2010, J NEPHROL, V23, P147; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Itoh K, 2003, ANN NUCL MED, V17, P561, DOI 10.1007/BF03006669; Kausz AT, 2001, J AM SOC NEPHROL, V12, P1501, DOI 10.1681/ASN.V1271501; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; MAHDAVIMAZDEH M, REN FAIL, V32, P62; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; McClellan WM, 1997, AM J KIDNEY DIS, V29, P368, DOI 10.1016/S0272-6386(97)90197-9; Minino A M, 2001, Natl Vital Stat Rep, V49, P1; Nomura I, 2009, VASC HEALTH RISK MAN, V5, P315; Ong-Ajyooth L, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-35; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Ramirez SPB, 2002, J AM SOC NEPHROL, V13, P1907, DOI 10.1097/01.ASN.0000018406.20282.C8; Safarinejad MR, 2009, J NEPHROL, V22, P99; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; VARMA PP, 2010, NEPHROL DIAL TRANSPL; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	40	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14216	10.1371/journal.pone.0014216	http://dx.doi.org/10.1371/journal.pone.0014216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151983	Green Submitted, Green Published, gold			2022-12-25	WOS:000284939600009
J	van Herpen, TWJM; Cankar, K; Nogueira, M; Bosch, D; Bouwmeester, HJ; Beekwilder, J				van Herpen, Teun W. J. M.; Cankar, Katarina; Nogueira, Marilise; Bosch, Dirk; Bouwmeester, Harro J.; Beekwilder, Jules			Nicotiana benthamiana as a Production Platform for Artemisinin Precursors	PLOS ONE			English	Article							ANTIMALARIAL-DRUG ARTEMISININ; EXPRESSION SYSTEM; MOLECULAR-CLONING; PLANTS; BIOSYNTHESIS; ANNUA; REDUCTASE; TOBACCO; YIELD; ACID	Background: Production of pharmaceuticals in plants provides an alternative for chemical synthesis, fermentation or natural sources. Nicotiana benthamiana is deployed at commercial scale for production of therapeutic proteins. Here the potential of this plant is explored for rapid production of precursors of artemisinin, a sesquiterpenoid compound that is used for malaria treatment. Methodology/Principal Findings: Biosynthetic genes leading to artemisinic acid, a precursor of artemisinin, were combined and expressed in N. benthamiana by agro-infiltration. The first committed precursor of artemisinin, amorpha-4,11-diene, was produced upon infiltration of a construct containing amorpha-4,11-diene synthase, accompanied by 3-hydroxy-3-methylglutaryl-CoA reductase and farnesyl diphosphate synthase. Amorpha-4,11-diene was detected both in extracts and in the headspace of the N. benthamiana leaves. When the amorphadiene oxidase CYP71AV1 was co-infiltrated with the amorphadiene-synthesizing construct, the amorpha-4,11-diene levels strongly decreased, suggesting it was oxidized. Surprisingly, no anticipated oxidation products, such as artemisinic acid, were detected upon GC-MS analysis. However, analysis of leaf extracts with a non-targeted metabolomics approach, using LC-QTOF-MS, revealed the presence of another compound, which was identified as artemisinic acid-12-beta-diglucoside. This compound accumulated to 39.5 mg.kg(-1) fwt. Apparently the product of the heterologous pathway that was introduced, artemisinic acid, is further metabolized efficiently by glycosyl transferases that are endogenous to N. benthamiana. Conclusion/Significance: This work shows that agroinfiltration of N. bentamiana can be used as a model to study the production of sesquiterpenoid pharmaceutical compounds. The interaction between the ectopically introduced pathway and the endogenous metabolism of the plant is discussed.	[van Herpen, Teun W. J. M.; Cankar, Katarina; Nogueira, Marilise; Bouwmeester, Harro J.; Beekwilder, Jules] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Bosch, Dirk; Beekwilder, Jules] Plant Res Int, Wageningen, Netherlands; [Bosch, Dirk] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; Utrecht University	van Herpen, TWJM (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands.	jules.beekwilder@wur.nl	Beekwilder, Jules/A-6802-2011; Bouwmeester, Harro J/C-1414-2008	Beekwilder, Jules/0000-0003-3238-4427; Bouwmeester, Harro/0000-0003-0907-2732; Cankar, Katarina/0000-0001-5149-4192	Dutch science foundation NWO [053.63.305]; Dafra Pharma RD	Dutch science foundation NWO(Netherlands Organization for Scientific Research (NWO)); Dafra Pharma RD	This work has been supported by grant 053.63.305 of the IBOS (Integration of Biosynthesis and Organic Synthesis) program of the ACTS (Advanced Chemical Technologies for Sustainability) platform, funded by the Dutch science foundation NWO. Additional support was supplied by Dafra Pharma R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, TRENDS PLANT SCI, V10, P594, DOI 10.1016/j.tplants.2005.10.005; [Anonymous], 2008, WORLD MAL REP 2008; Bartholomew DM, 2002, PLANT PHYSIOL, V130, P1562, DOI 10.1104/pp.008334; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Cui LW, 2009, EXPERT REV ANTI-INFE, V7, P999, DOI [10.1586/eri.09.68, 10.1586/ERI.09.68]; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Fraissinet-Tachet L, 1998, FEBS LETT, V437, P319, DOI 10.1016/S0014-5793(98)01257-5; Geu-Flores F, 2009, PLANTA, V229, P261, DOI 10.1007/s00425-008-0825-y; Geu-Flores F, 2009, NAT CHEM BIOL, V5, P575, DOI 10.1038/nchembio.185; Gils M, 2005, PLANT BIOTECHNOL J, V3, P613, DOI 10.1111/j.1467-7652.2005.00154.x; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Harker M, 2003, PLANT BIOTECHNOL J, V1, P113, DOI 10.1046/j.1467-7652.2003.00011.x; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Lucker J, 2004, PLANT J, V39, P135, DOI 10.1111/j.1365-313X.2004.02113.x; Moglia A, 2010, METAB ENG, V12, P223, DOI 10.1016/j.ymben.2009.11.003; Ralley L, 2004, PLANT J, V39, P477, DOI 10.1111/j.1365-313X.2004.02151.x; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wallaart TE, 2001, PLANTA, V212, P460, DOI 10.1007/s004250000428; Whitty C, 2008, TROP DOCT, V38, P1, DOI 10.1258/td.2008.080013; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	35	116	121	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14222	10.1371/journal.pone.0014222	http://dx.doi.org/10.1371/journal.pone.0014222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151979	Green Published, gold			2022-12-25	WOS:000284939600015
J	Iyegbe, CO; Abiola, OO; Towlson, C; Powell, JF; Whatley, SA				Iyegbe, Conrad O.; Abiola, Oduola O.; Towlson, Chris; Powell, John F.; Whatley, Steven A.			Evidence for Varied Aetiologies Regulating the Transmission of Prion Disease: Implications for Understanding the Heritable Basis of Prion Incubation Times	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; QUANTITATIVE-TRAIT-LOCI; CREUTZFELDT-JAKOB-DISEASE; GENETIC DISSECTION; MONOZYGOTIC TWINS; COMPLEX TRAITS; GENOME-WIDE; MICE; SCRAPIE; METAANALYSIS	Background: Transmissible Spongiform Encephalopathies (TSEs) are a group of progressive fatal neurodegenerative disorders, triggered by abnormal folding of the endogenous prion protein molecule. The encoding gene is a major biological factor influencing the length of the asymptomatic period after infection. It remains unclear the extent to which the variation between quantitative trait loci (QTLs) reported in mouse models is due to methodological differences between approaches or genuine differences between traits. With this in mind, our approach to identifying genetic factors has sought to extend the linkage mapping approach traditionally applied, to a series of additional traits, while minimising methodological variability between them. Our approach allows estimations of heritability to be derived, as well as predictions to be made about possible existence of genetic overlap between the various traits. Methodology/Principal Findings: Our data indicate a surprising degree of heritability (up to 60%). Correlations between traits are also identified. A series of QTLs on chromosomes 1, 2, 3, 4, 6, 11 and 18 accompany our heritability estimates. However, only a locus on chromosome 11 has a general effect across all 4 models explored. Conclusions/Significance: We have achieved some success in detecting novel and pre-existing QTLs associated with incubation time. However, aside from the general effects described, the model-specific nature of the broader host genetic architecture has also been brought into clearer focus. This suggests that genetic overlap can only partially account for the general heritability of incubation time when factors, such as the nature of the TSE agent and the route of administration are considered. This point is highly relevant to vCJD (a potential threat to public health) where the route of primary importance is oral, while the QTLs being sought derive exclusively from studies of the ic route. Our results highlight the limitations of a single-model approach to QTL-mapping of TSEs.	[Iyegbe, Conrad O.] Kings Coll London, Inst Psychiat, Psychosis Ctr, London WC2R 2LS, England; [Iyegbe, Conrad O.; Towlson, Chris; Powell, John F.; Whatley, Steven A.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Iyegbe, CO (corresponding author), Kings Coll London, Inst Psychiat, Psychosis Ctr, London WC2R 2LS, England.	c.iyegbe@iop.kcl.ac.uk	Powell, John F/G-4412-2011	Powell, John F/0000-0001-6124-439X	Medical Research Council, United Kingdom [G9627297]	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was carried out with the support of grant number G9627297 of the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2009, PROTEIN PEPTIDE LETT, V16, P247, DOI 10.2174/092986609787601642; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Falconer DS, 1996, QUANTITATIVE GENETIC; Field A., 2009, DISCOVERING STAT USI; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Gillies M, 2009, VOX SANG, V97, P211, DOI 10.1111/j.1423-0410.2009.01222.x; Hamasaki S, 1998, LANCET, V352, P1358, DOI 10.1016/S0140-6736(05)60749-0; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANTOS PL, 1992, NEUROSCI LETT, V147, P67, DOI 10.1016/0304-3940(92)90776-4; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; LLOYD SE, 2009, NEUROGENETICS   1001; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moreno CR, 2003, GENETICS, V165, P2085; MOULD DL, 1967, J COMP PATHOL, V77, P387, DOI 10.1016/0021-9975(67)90023-0; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; OUTRAM GW, 1973, J COMP PATHOL, V83, P19, DOI 10.1016/0021-9975(73)90023-6; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; PLOMIN R, 1993, BEHAV GENET, V23, P197, DOI 10.1007/BF01067425; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; ROSENTHAL R, 1991, PSYCHOSOM MED, V53, P247, DOI 10.1097/00006842-199105000-00001; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Webb T, 2009, NEUROPATH APPL NEURO, V35, P427, DOI 10.1111/j.1365-2990.2009.01012.x; Webb TEF, 2009, AM J MED GENET B, V150B, P496, DOI 10.1002/ajmg.b.30844; 2007, EUROSURVEILL, V12	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14186	10.1371/journal.pone.0014186	http://dx.doi.org/10.1371/journal.pone.0014186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152031	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000009
J	Stamatakis, EA; Adapa, RM; Absalom, AR; Menon, DK				Stamatakis, Emmanuel A.; Adapa, Ram M.; Absalom, Anthony R.; Menon, David K.			Changes in Resting Neural Connectivity during Propofol Sedation	PLOS ONE			English	Article							ANTERIOR THALAMIC NUCLEI; DEFAULT-MODE NETWORK; CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; GENERAL-ANESTHESIA; HUMAN BRAIN; CONSCIOUSNESS; SLEEP; TASK; SEVOFLURANE	Background: The default mode network consists of a set of functionally connected brain regions (posterior cingulate, medial prefrontal cortex and bilateral parietal cortex) maximally active in functional imaging studies under "no task" conditions. It has been argued that the posterior cingulate is important in consciousness/awareness, but previous investigations of resting interactions between the posterior cingulate cortex and other brain regions during sedation and anesthesia have produced inconsistent results. Methodology/Principal Findings: We examined the connectivity of the posterior cingulate at different levels of consciousness. "No task" fMRI (BOLD) data were collected from healthy volunteers while awake and at low and moderate levels of sedation, induced by the anesthetic agent propofol. Our data show that connectivity of the posterior cingulate changes during sedation to include areas that are not traditionally considered to be part of the default mode network, such as the motor/somatosensory cortices, the anterior thalamic nuclei, and the reticular activating system. Conclusions/Significance: This neuroanatomical signature resembles that of non-REM sleep, and may be evidence for a system that reduces its discriminable states and switches into more stereotypic patterns of firing under sedation.	[Stamatakis, Emmanuel A.; Adapa, Ram M.; Absalom, Anthony R.; Menon, David K.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England	University of Cambridge	Stamatakis, EA (corresponding author), Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England.	eas46@cam.ac.uk	Absalom, Anthony/GPG-1582-2022; Adapa, Ram/D-7925-2012	Adapa, Ram/0000-0002-9845-8532; Absalom, Anthony/0000-0001-7563-9157; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Queens' College Cambridge; Wellcome Trust; Raymond and Beverly Sackler Studentship; BOC; National Institute for Health Research; Medical Research Council [G0001237, G0600986, G9439390] Funding Source: researchfish; MRC [G0001237, G0600986, G9439390] Funding Source: UKRI	Queens' College Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Raymond and Beverly Sackler Studentship; BOC; National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EAS is funded by the Stephen Erskine Fellowship, Queens' College Cambridge. RMA is supported by a Wellcome Trust Clinical Research Training Fellowship, and the Raymond and Beverly Sackler Studentship. ARA and DKM are funded by the BOC Professorship of the Royal College of Anaesthetists. DKM is funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalom AR, 2009, BRIT J ANAESTH, V103, P26, DOI 10.1093/bja/aep143; Absalom AR, 2009, CRIT CARE, V13, DOI 10.1186/cc7776; AGGLETON JP, 1993, NEUROPSYCHOLOGIA, V31, P1001, DOI 10.1016/0028-3932(93)90029-Y; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Fiset P, 1999, J NEUROSCI, V19, P5506; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haenggi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7723; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huotari AM, 2004, BRIT J ANAESTH, V92, P18, DOI 10.1093/bja/aeh022; Johnston AJ, 2003, BRIT J ANAESTH, V91, P781, DOI 10.1093/bja/aeg256; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leslie K, 2009, ANESTHESIOLOGY, V111, P547, DOI 10.1097/ALN.0b013e3181adf768; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maquet P, 2000, J SLEEP RES, V9, P207; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Ogawa K, 2003, ANESTHESIOLOGY, V98, P1101, DOI 10.1097/00000542-200305000-00012; Olson D, 2007, NEUROCRIT CARE, V7, P227, DOI 10.1007/s12028-007-0069-x; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paus T, 2000, PROG BRAIN RES, V126, P65; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Qiu ML, 2008, MAGN RESON MED, V60, P987, DOI 10.1002/mrm.21759; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schlunzen L, 2004, ACTA ANAESTH SCAND, V48, P1268, DOI 10.1111/j.1399-6576.2004.00505.x; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Talairach J., 1988, COPLANAR STEREOTAXIC; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Veselis RA, 2005, ANESTHESIOLOGY, V102, P26, DOI 10.1097/00000542-200501000-00008; Veselis RA, 2009, ANESTHESIOLOGY, V110, P295, DOI 10.1097/ALN.0b013e3181942ef0; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Ying SW, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-2; 2006, ANESTHESIOL, V104, P847	74	122	124	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14224	10.1371/journal.pone.0014224	http://dx.doi.org/10.1371/journal.pone.0014224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688QY	21151992	gold, Green Published, Green Submitted			2022-12-25	WOS:000284868000022
J	Dong, S; Corre, B; Nika, K; Pellegrini, S; Michel, F				Dong, Shen; Corre, Beatrice; Nika, Konstantina; Pellegrini, Sandra; Michel, Frederique			T Cell Receptor Signal Initiation Induced by Low-Grade Stimulation Requires the Cooperation of LAT in Human T Cells	PLOS ONE			English	Article							SRC-FAMILY KINASES; LIPID RAFTS; TYROSINE PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; CROSS-LINKING; LCK ACTIVITY; ACTIVATION; CD45; FYN; LYMPHOCYTES	Background: One of the earliest activation events following stimulation of the T cell receptor (TCR) is the phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) within the CD3-associated complex by the Src family kinase Lck. There is accumulating evidence that a large pool of Lck is constitutively active in T cells but how the TCR is connected to Lck and to the downstream signaling cascade remains elusive. Methodology/Principal Findings: We have analyzed the phosphorylation state of Lck and Fyn and TCR signaling in human naive CD4(+) T cells and in the transformed T cell line, Hut-78. The latter has been shown to be similar to primary T cells in TCR-inducible phosphorylations and can be highly knocked down by RNA interference. In both T cell types, basal phosphorylation of Lck and Fyn on their activatory tyrosine was observed, although this was much less pronounced in Hut-78 cells. TCR stimulation led to the co-precipitation of Lck with the transmembrane adaptor protein LAT (linker for activation of T cells), Erk-mediated phosphorylation of Lck and no detectable dephosphorylation of Lck inhibitory tyrosine. Strikingly, upon LAT knockdown in Hut-78 cells, we found that LAT promoted TCR-induced phosphorylation of Lck and Fyn activatory tyrosines, TCR zeta chain phosphorylation and Zap-70 activation. Notably, LAT regulated these events at low strength of TCR engagement. Conclusions/Significance: Our results indicate for the first time that LAT promotes TCR signal initiation and suggest that this adaptor may contribute to maintain active Lck in proximity of their substrates.	[Dong, Shen; Corre, Beatrice; Pellegrini, Sandra; Michel, Frederique] Inst Pasteur, Dept Immunol, Unit Cytokine Signaling, F-75724 Paris, France; [Dong, Shen; Corre, Beatrice; Pellegrini, Sandra; Michel, Frederique] CNRS, URA 1961, Paris, France; [Nika, Konstantina] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Oxford	Dong, S (corresponding author), Inst Pasteur, Dept Immunol, Unit Cytokine Signaling, F-75724 Paris, France.	frederique.michel@pasteur.fr	Pellegrini, Sandra -/G-5546-2015; Pellegrini, Sandra/Y-6351-2019; Dong, Shen/ABC-2875-2020	Pellegrini, Sandra -/0000-0001-5837-7589; Pellegrini, Sandra/0000-0001-5837-7589; dong, Shen/0000-0001-8839-7046; Michel, Frederique/0000-0002-3524-2232; Nika, Konstantina/0000-0002-9620-0263	Institut Pasteur; Association pour la Recherche sur le Cancer (ARC); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T)	Institut Pasteur(European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T)	This work was supported by grants from the Institut Pasteur, Association pour la Recherche sur le Cancer (ARC) and Centre National de la Recherche Scientifique (CNRS). S. Dong is a PhD student financed by Ministere de l'Education Nationale de la Recherche et de Technologie (M.E.N.R.T) and ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; BIFFEN M, 1994, EMBO J, V13, P1920, DOI 10.1002/j.1460-2075.1994.tb06461.x; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Filipp D, 2008, J BIOL CHEM, V283, P26409, DOI 10.1074/jbc.M710372200; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GAZDAR AF, 1980, BLOOD, V55, P409; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Jiang YX, 2007, LEUKEMIA RES, V31, P541, DOI 10.1016/j.leukres.2006.07.010; Kabouridis PS, 2003, BIOCHEM J, V371, P907, DOI 10.1042/BJ20021578; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kumar L, 2005, P NATL ACAD SCI USA, V102, P19063, DOI 10.1073/pnas.0509176102; Lapinski PE, 2009, IMMUNOL REV, V232, P240, DOI 10.1111/j.1600-065X.2009.00829.x; LIU H, 1970, P NATL ACAD SCI USA, V107, P10166; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; Nika K, 2007, J BIOL CHEM, V282, P36000, DOI 10.1074/jbc.M702779200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; WATTS JD, 1993, J BIOL CHEM, V268, P23275; WEIL R, 1994, J BIOL CHEM, V269, P22830; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	56	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15114	10.1371/journal.pone.0015114	http://dx.doi.org/10.1371/journal.pone.0015114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152094	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100077
J	Schroder, A; Eichner, J; Supper, J; Eichner, J; Wanke, D; Henneges, C; Zell, A				Schroeder, Adrian; Eichner, Johannes; Supper, Jochen; Eichner, Jonas; Wanke, Dierk; Henneges, Carsten; Zell, Andreas			Predicting DNA-Binding Specificities of Eukaryotic Transcription Factors	PLOS ONE			English	Article							ACID SUBSTITUTION MATRICES; OPEN-ACCESS DATABASE; SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; SEQUENCE-ANALYSIS; PROFILES; ANNOTATION; RECOGNITION; SIMILARITY; PROTEINS	Today, annotated amino acid sequences of more and more transcription factors (TFs) are readily available. Quantitative information about their DNA-binding specificities, however, are hard to obtain. Position frequency matrices (PFMs), the most widely used models to represent binding specificities, are experimentally characterized only for a small fraction of all TFs. Even for some of the most intensively studied eukaryotic organisms (i.e., human, rat and mouse), roughly one-sixth of all proteins with annotated DNA-binding domain have been characterized experimentally. Here, we present a new method based on support vector regression for predicting quantitative DNA-binding specificities of TFs in different eukaryotic species. This approach estimates a quantitative measure for the PFM similarity of two proteins, based on various features derived from their protein sequences. The method is trained and tested on a dataset containing 1 239 TFs with known DNA-binding specificity, and used to predict specific DNA target motifs for 645 TFs with high accuracy.	[Schroeder, Adrian; Eichner, Johannes; Supper, Jochen; Eichner, Jonas; Henneges, Carsten; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany; [Wanke, Dierk] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Schroder, A (corresponding author), Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany.	adrian.schroeder@uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019		National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany [0313323, 0313080 L]	National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany	This work was funded by the National Genome Research Network (NGFN II) of the Federal Ministry of Education and Research in Germany under contract numbers 0313323 and 0313080 L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Andrade MA, 1999, BIOINFORMATICS, V15, P391, DOI 10.1093/bioinformatics/15.5.391; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BALDI P, 1994, P NATL ACAD SCI USA, V91, P1059, DOI 10.1073/pnas.91.3.1059; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Boutet Emmanuel, 2007, V406, P89; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Gerlt JA, 2000, GENOME BIOL, V1; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Juncker AS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-206; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Leontovich AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-31; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Mahony S, 2005, BIOINFORMATICS, V21, pI283, DOI 10.1093/bioinformatics/bti1025; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MEHTA PK, 1995, PROTEIN SCI, V4, P2517, DOI 10.1002/pro.5560041208; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; MIYAZAWA S, 1993, PROTEIN ENG, V6, P267, DOI 10.1093/protein/6.3.267; Moll A, 2005, J COMPUT AID MOL DES, V19, P791, DOI 10.1007/s10822-005-9027-x; Mungall C. J., 2002, GENOME BIOL, V3; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; NIEFIND K, 1991, J MOL BIOL, V219, P481, DOI 10.1016/0022-2836(91)90188-C; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Piipari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-348; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; SHENTAL N, 2003, LEARNING DISTANCE FU, P11; Stegmaier Philip, 2004, Genome Inform, V15, P276; Supper J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-334; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Waterhouse A.M., 2009, BIOINFORMATICS; Wei L, 1997, Pac Symp Biocomput, P465; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wingender E, 1997, MOL BIOL+, V31, P483; Wrzodek C, 2010, BIOSYSTEMS, V99, P79, DOI 10.1016/j.biosystems.2009.09.005; Zhou D., 2004, ADV NEURAL INFORM PR, V16; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	79	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13876	10.1371/journal.pone.0013876	http://dx.doi.org/10.1371/journal.pone.0013876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152420	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100002
J	Wang, X; Lu, H; Urvalek, AM; Li, T; Yu, L; Lamar, J; DiPersio, CM; Feustel, PJ; Zhao, J				Wang, X.; Lu, H.; Urvalek, A. M.; Li, T.; Yu, L.; Lamar, J.; DiPersio, C. M.; Feustel, P. J.; Zhao, J.			KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9	ONCOGENE			English	Article							FOCAL ADHESION KINASE; MATRIX-METALLOPROTEINASE INHIBITORS; KRUPPEL-LIKE FACTOR-8; E-CADHERIN; TUMOR-CELLS; REGULATES MMP-9; BONE METASTASIS; UP-REGULATION; CYCLIN D1; EXPRESSION	Epithelial to mesenchymal transition (EMT) and extracellular matrix degradation are critical for the initiation and progression of tumor invasion. We have recently identified Kruppel-like factor 8 (KLF8) as a critical inducer of EMT and invasion. KLF8 induces EMT primarily by repressing E-cadherin transcription. However, how KLF8 promotes invasion is unknown. Here, we report a novel KLF8-to-matrix metalloproteinase (MMP) 9 signaling that promotes human breast cancer invasion. To identify the potential KLF8 regulation of MMPs in breast cancer, we established two inducible cell lines that allow either KLF8 overexpression in MCF-10A or knockdown in MDA-MB-231 cells. KLF8 overexpression induced a strong increase in MMP9 expression and activity as determined by quantitative real-time PCR and zymography. This induction was well correlated with the MMP inhibitor-sensitive Matrigel invasion. Conversely, KLF8 knockdown caused the opposite changes that could be partially prevented by MMP9 overexpression. Promoter-reporter assays and chromatin and oligonucleotide precipitations determined that KLF8 directly bound and activated the human MMP9 gene promoter. Three-dimensional (3D) glandular culture showed that KLF8 expression disrupted the normal acinus formation, which could be prevented by the MMP inhibitor, whereas KLF8 knockdown corrected the abnormal 3D architecture, which could be protected by MMP9 overexpression. KLF8 knockdown promoted MDA-MB-231 cell aggregation in suspension culture, which could be prevented by MMP9 overexpression. KLF8 knockdown inhibited the lung metastasis of MDA-MB-231 cells in nude mice. Immunohistochemical staining strongly correlated the co-expression of KLF8 and MMP9 with the patient tumor invasion, metastasis and poor survival. Taken together, this work identified the KLF8 activation of MMP9 as a novel and critical signaling mechanism underlying human breast cancer invasion and metastasis. Oncogene (2011) 30, 1901-1911; doi: 10.1038/onc.2010.563; published online 13 December 2010	[Wang, X.; Lu, H.; Urvalek, A. M.; Li, T.; Yu, L.; Zhao, J.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Lamar, J.; DiPersio, C. M.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Feustel, P. J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	State University System of Florida; University of Central Florida; Albany Medical College; Albany Medical College	Zhao, J (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA.	jizhao@mail.ucf.edu	Li, Tianshu/L-6426-2014; Feustel, Paul/AAW-5157-2021; Lamar, John Michael/R-5053-2019	Li, Tianshu/0000-0002-9972-4644; Feustel, Paul/0000-0002-6963-4349; Lamar, John Michael/0000-0001-5406-8391	NCI [CA132977, CA129637]; Susan G Komen for Cure [KG090444 and KG080616]; NATIONAL CANCER INSTITUTE [R01CA129637, R01CA132977] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate Dr Joan Massague for kindly providing the 4175 cells and Dr Chunhong Yan and Qingfen Li and Beihai Jiang of Zhao lab for helpful comments. This work was supported by grants from NCI (CA132977) and Susan G Komen for Cure (KG090444 and KG080616) to JZ and a grant from NCI (CA129637) to CMD. XW is a Komen postdoctoral fellow.	Ara T, 2000, CANCER LETT, V157, P115, DOI 10.1016/S0304-3835(00)00494-8; Balzer EM, 2010, BREAST CANCER RES TR, V121, P65, DOI 10.1007/s10549-009-0457-3; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Cristofanilli M, 2006, SEMIN ONCOL, V33, pS9, DOI 10.1053/j.seminoncol.2006.03.016; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Dwivedi DJ, 2006, AM J PATHOL, V168, P69, DOI 10.2353/ajpath.2006.041089; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Evans PM, 2010, CELL CYCLE, V9, P649; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lloyd JA, 2010, CELL CYCLE, V9, P650; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Rahman KMW, 2006, MOL CANCER THER, V5, P2747, DOI 10.1158/1535-7163.MCT-06-0221; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	45	117	130	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1901	1911		10.1038/onc.2010.563	http://dx.doi.org/10.1038/onc.2010.563			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21151179	hybrid, Green Accepted			2022-12-25	WOS:000289777700006
J	Das, S; Samant, RS; Shevde, LA				Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.			Hedgehog Signaling Induced by Breast Cancer Cells Promotes Osteoclastogenesis and Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; BONE SIALOPROTEIN; CATHEPSIN-K; SHORT-RANGE; OSTEOPONTIN; METASTASIS; EXPRESSION; DIFFERENTIATION; OSTEOBLASTS; PATHWAY	Bone integrity is maintained by a dynamic equilibrium between the activities of bone-forming osteoblasts and bone-resorbing osteoclasts. Osteolytic lesions are a painful consequence of metastasis of breast cancer cells to bone in an overwhelming majority of breast cancer patients. Factors secreted by breast cancer cells propel a cascade of events that trigger osteoclastogenesis and elevated bone resorption. In the present study, we show that the Hedgehog (Hh) ligands secreted by breast cancer cells promote osteoclast differentiation and potentiate the activity of mature osteoclasts. Paracrine Hh signaling induced by breast cancer cells mediates a detrimental chain of events by the up-regulation of osteopontin (OPN), which in turn enhances osteoclastic activity by up-regulating cathepsin K and MMP9. Hh signaling is essential for osteoclasts because blocking the Hh pathway using the pharmacological Hh inhibitor, cyclopamine, results in an overall decrease in osteoclastogenesis and resorptive activity. Our studies suggest that inhibiting Hh signaling interferes with the ability of pre-osteoclasts to respond to the stimulatory effects of the breast cancer cells, indicating that Hh signaling is vital to osteoclast activity.	[Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA	University of South Alabama	Shevde, LA (corresponding author), 1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	Department of Defense [07-01-0400]; National Institutes of Health [1R01CA140472-01A1]; Mitchell Cancer Institute, University of South Alabama; NATIONAL CANCER INSTITUTE [R01CA140472] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitchell Cancer Institute, University of South Alabama; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Department of Defense IDEA Award 07-01-0400 (to L. A. S.). This work was also supported by National Institutes of Health Grant 1R01CA140472-01A1 (to R. S. S.) and support from the Mitchell Cancer Institute, University of South Alabama.	ABELOFF MD, 1995, CLIN ONCOLOGY; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; CASEY G, 2006, CLIN EXP METASTAS, V23, P123; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; HARADA M, 1992, ADV EXP MED BIOL, V324, P83; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Shijubo N, 2000, CRIT REV ONCOGENESIS, V11, P135; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; Standal T, 2004, EXP ONCOL, V26, P179; Stecca B, 2005, TRENDS MOL MED, V11, P199, DOI 10.1016/j.molmed.2005.03.004; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wysolmerski JJ, 2002, J BONE MINER RES, V17, P1164, DOI 10.1359/jbmr.2002.17.7.1164; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	47	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9612	9622		10.1074/jbc.M110.174920	http://dx.doi.org/10.1074/jbc.M110.174920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21169638	Green Published, hybrid			2022-12-25	WOS:000288247700086
J	Meux, E; Prosper, P; Ngadin, A; Didierjean, C; Morel, M; Dumarcay, S; Lamant, T; Jacquot, JP; Favier, F; Gelhaye, E				Meux, Edgar; Prosper, Pascalita; Ngadin, Andrew; Didierjean, Claude; Morel, Melanie; Dumarcay, Stephane; Lamant, Tiphaine; Jacquot, Jean-Pierre; Favier, Frederique; Gelhaye, Eric			Glutathione Transferases of Phanerochaete chrysosporium S-GLUTATHIONYL-p-HYDROQUINONE REDUCTASE BELONGS TO A NEW STRUCTURAL CLASS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OMEGA-CLASS; CRYSTAL-STRUCTURE; ANTIOXIDANT SYSTEMS; DEHALOGENASE SYSTEM; THIOREDOXIN-H; CONJUGATE; MECHANISM; LIGNIN; MODEL; CHLORINATION	The white rot fungus Phanerochaete chrysosporium, a saprophytic basidiomycete, possesses a large number of cytosolic glutathione transferases, eight of them showing similarity to the Omega class. PcGSTO1 (subclass I, the bacterial homologs of which were recently proposed, based on their enzymatic function, to constitute a new class of glutathione transferase named S-glutathionyl-(chloro)hydroquinone reductases) and PcGSTO3 (subclass II related to mammalian homologs) have been investigated in this study. Biochemical investigations demonstrate that both enzymes are able to catalyze deglutathionylation reactions thanks to the presence of a catalytic cysteinyl residue. This reaction leads to the formation of a disulfide bridge between the conserved cysteine and the removed glutathione from their substrate. The substrate specificity of each isoform differs. In particular PcGSTO1, in contrast to PcGSTO3, was found to catalyze deglutathionylation of S-glutathionyl-p-hydroquinone substrates. The three-dimensional structure of PcGSTO1 presented here confirms the hypothesis that it belongs not only to a new biological class but also to a new structural class that we propose to name GST xi. Indeed, it shows specific features, the most striking ones being a new dimerization mode and a catalytic site that is buried due to the presence of long loops and that contains the catalytic cysteine.	[Prosper, Pascalita; Didierjean, Claude; Favier, Frederique] Nancy Univ, Fac Sci & Tech, Inst Jean Barriol, CRM2,Equipe Biocristallog,CNRS UHP,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Meux, Edgar; Ngadin, Andrew; Morel, Melanie; Lamant, Tiphaine; Jacquot, Jean-Pierre; Gelhaye, Eric] Nancy Univ, Fac Sci & Tech, UMR INRA UHP Interactions Arbres Microorganismes, Ecosyst Forestiers Agroressources Bioprocedes & A, F-54506 Vandoeuvre Les Nancy, France; [Dumarcay, Stephane] Nancy Univ, Fac Sci & Tech, Lab Etud & Rech Mat Bois, EA UHP 4370, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CHU de Nancy; Universite de Lorraine; INRAE; Universite de Lorraine; Universite de Lorraine	Favier, F (corresponding author), Nancy Univ, Fac Sci & Tech, Inst Jean Barriol, CRM2,Equipe Biocristallog,CNRS UHP,UMR 7036, F-54506 Vandoeuvre Les Nancy, France.	Frederique.Favier@crm2.uhp-nancy.fr; Eric.Gelhaye@lcb.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; gelhaye, eric/K-7390-2013; Jacquot, Jean-Pierre/A-1571-2012; Ngadin, Andrew Anak/ABG-3668-2020; Favier, Frederique/B-3090-2013	DIDIERJEAN, Claude/0000-0002-3176-8974; gelhaye, eric/0000-0002-0699-9113; Jacquot, Jean-Pierre/0000-0003-4975-8587; Ngadin, Andrew Anak/0000-0002-1070-6934; Favier, Frederique/0000-0003-3249-997X; Morel-Rouhier, Melanie/0000-0001-5149-0474	Agence Nationale de la Recherche [ANR-06-BLAN-0386, ANR-09-BLAN-0012]; Ministere de l'Enseignement Superieur de la Recherche et de la Technologie; Institut National de la Recherche Agronomique; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur de la Recherche et de la Technologie; Institut National de la Recherche Agronomique; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Agence Nationale de la Recherche Research Grants ANR-06-BLAN-0386 and ANR-09-BLAN-0012, Ministere de l'Enseignement Superieur de la Recherche et de la Technologie, Institut National de la Recherche Agronomique, and CNRS.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; BRUNMARK A, 1988, CHEM-BIOL INTERACT, V68, P273, DOI 10.1016/0009-2797(88)90021-X; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2002, PHYSIOL PLANTARUM, V114, P165, DOI 10.1034/j.1399-3054.2002.1140202.x; Herrero E, 2006, PHOTOSYNTH RES, V89, P127, DOI 10.1007/s11120-006-9079-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasai N, 2010, APPL MICROBIOL BIOT, V86, P773, DOI 10.1007/s00253-009-2413-x; Kasai N, 2009, BIOCHEM BIOPH RES CO, V387, P103, DOI 10.1016/j.bbrc.2009.06.134; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Matsuzaki F, 2004, BIOCHEM BIOPH RES CO, V324, P387, DOI 10.1016/j.bbrc.2004.09.062; Mauzeroll J, 2004, P NATL ACAD SCI USA, V101, P7862, DOI 10.1073/pnas.0402556101; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Morel M, 2009, ADV BOT RES, V52, P153, DOI 10.1016/S0065-2296(10)52006-8; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICKERSON WJ, 1963, BIOCHEMISTRY-US, V2, P537, DOI 10.1021/bi00903a025; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Ortiz-Bermudez P, 2003, APPL ENVIRON MICROB, V69, P5015, DOI 10.1128/AEM.69.8.5015-5018.2003; Ortiz-Bermudez P, 2007, P NATL ACAD SCI USA, V104, P3895, DOI 10.1073/pnas.0610074104; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Patskovsky Y, 2006, BIOCHEMISTRY-US, V45, P3852, DOI 10.1021/bi051823+; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; RAO DNR, 1988, J BIOL CHEM, V263, P17981; Reddy GVB, 2001, ARCH BIOCHEM BIOPHYS, V391, P271; Reddy GVB, 1999, BIOCHEM BIOPH RES CO, V257, P901, DOI 10.1006/bbrc.1999.0561; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder P, 2007, ENVIRON SCI POLLUT R, V14, P114, DOI 10.1065/espr2006.10.352; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Song Y, 2009, P NATL ACAD SCI USA, V106, P9725, DOI 10.1073/pnas.0810352106; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Vararattanavech A, 2007, BIOCHEM J, V406, P247, DOI 10.1042/BJ20070422; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h	56	34	34	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9162	9173		10.1074/jbc.M110.194548	http://dx.doi.org/10.1074/jbc.M110.194548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177852	Green Published, hybrid			2022-12-25	WOS:000288247700047
J	Huckaba, TM; Gennerich, A; Wilhelm, JE; Chishti, AH; Vale, RD				Huckaba, Thomas M.; Gennerich, Arne; Wilhelm, James E.; Chishti, Athar H.; Vale, Ronald D.			Kinesin-73 Is a Processive Motor That Localizes to Rab5-containing Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS END; LARGE TUMOR-SUPPRESSOR; CAP-GLY DOMAINS; MONOMERIC MOTOR; MEMBRANE-TRANSPORT; AXONAL-TRANSPORT; NERVOUS-SYSTEM; IN-VIVO; PROTEIN; MOTILITY	Drosophila Kinesin-73 (Khc-73), which plays a role in mitotic spindle polarity in neuroblasts, is a metazoan-specific member of the Kinesin-3 family of motors, which includes mammalian KIF1A and Caenorhabditis elegans Unc-104. The mechanism of Kinesin-3 motors has been controversial because some studies have reported that they transport cargo as monomers whereas other studies have suggested a dimer mechanism. Here, we have performed single-molecule motility and cell biological studies of Khc-73. We find that constructs containing the motor and the conserved short stretches of putative coiled-coil-forming regions are predominantly monomeric in vitro, but that dimerization allows for fast, processive movement and high force production (7 piconewtons). In Drosophila cell lines, we present evidence that Khc-73 can dimerize in vivo. We also show that Khc-73 is recruited specifically to Rab5-containing endosomes through its "tail" domain. Our results suggest that the N-terminal half of Khc-73 can undergo a monomer-dimer transition to produce a fast processive motor and that its C-terminal half possesses a specific Rab5-vesicle binding domain.	[Huckaba, Thomas M.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gennerich, Arne] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Gennerich, Arne] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Wilhelm, James E.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Chishti, Athar H.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; Tufts University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019		National Institutes of Health [38499, CA094414]; NATIONAL CANCER INSTITUTE [R01CA094414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 38499 (to R. D. V.) and CA094414 (to A. H. C.).	Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Asaba N, 2003, J BIOL CHEM, V278, P8395, DOI 10.1074/jbc.M210362200; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RECKPETERSON SL, 2010, COLD SPRING HARBOR P; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; UITEI K, 1994, NEUROSCI LETT, V174, P85, DOI 10.1016/0304-3940(94)90125-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	45	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7457	7467		10.1074/jbc.M110.167023	http://dx.doi.org/10.1074/jbc.M110.167023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169635	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000287737300060
J	Ge, CR; Georgiev, A; Ohman, A; Wieslander, A; Kelly, AA				Ge, Changrong; Georgiev, Alexander; Ohman, Anders; Wieslander, Ake; Kelly, Amelie A.			Tryptophan Residues Promote Membrane Association for a Plant Lipid Glycosyltransferase Involved in Phosphate Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL TRANSMEMBRANE PROTEINS; ACHOLEPLASMA-LAIDLAWII; ESCHERICHIA-COLI; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; DIGALACTOSYLDIACYLGLYCEROL SYNTHASE; PHOTOSYNTHETIC MEMBRANES; CRYSTAL-STRUCTURE; SWISS-MODEL; BINDING; BILAYER	Chloroplast membranes contain a substantial excess of the nonbilayer-prone monogalactosyldiacylglycerol (GalDAG) over the biosynthetically consecutive, bilayer-forming digalactosyldiacylglycerol (GalGalDAG), yielding a high membrane curvature stress. During phosphate shortage, plants replace phospholipids with GalGalDAG to rescue phosphate while maintaining membrane homeostasis. Here we investigate how the activity of the corresponding glycosyltransferase (GT) in Arabidopsis thaliana (atDGD2) depends on local bilayer properties by analyzing structural and activity features of recombinant protein. Fold recognition and sequence analyses revealed a two-domain GT-B monotopic structure, present in other plant and bacterial glycolipid GTs, such as the major chloroplast GalGalDAG GT atDGD1. Modeling led to the identification of catalytically important residues in the active site of atDGD2 by site-directed mutagenesis. The DGD synthases share unique bilayer interface segments containing conserved tryptophan residues that are crucial for activity and for membrane association. More detailed localization studies and liposome binding analyses indicate differentiated anchor and substrate-binding functions for these separated enzyme interface regions. Anionic phospholipids, but not curvature-increasing nonbilayer lipids, strongly stimulate enzyme activity. From our studies, we propose a model for bilayer "control" of enzyme activity, where two tryptophan segments act as interface anchor points to keep the substrate region close to the membrane surface. Binding of the acceptor substrate is achieved by interaction of positive charges in a surface cluster of lysines, arginines, and histidines with the surrounding anionic phospholipids. The diminishing phospholipid fraction during phosphate shortage stress will then set the new GalGalDAG/phospholipid balance by decreasing stimulation of atDGD2.	[Ge, Changrong; Georgiev, Alexander; Wieslander, Ake; Kelly, Amelie A.] Stockholm Univ, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Ohman, Anders] Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden	Stockholm University; Umea University	Kelly, AA (corresponding author), HRI Univ Warwick, Warwick CV35 9EF, England.	a.a.b.kelly@warwick.ac.uk	Georgiev, Alexander/D-3258-2011	Georgiev, Alexander/0000-0001-5669-5962	Wenner-Gren Foundation; Royal Swedish Academy of Sciences; European Commission; Swedish Research Council	Wenner-Gren Foundation; Royal Swedish Academy of Sciences; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Wenner-Gren Foundation, the Royal Swedish Academy of Sciences, European Commission FP6 Marie-Curie Action BIOCONTROL, and the Swedish Research Council.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Barkan L, 2006, PLANT PHYSIOL, V141, P1012, DOI 10.1104/pp.106.080481; Barreras M, 2008, J BIOL CHEM, V283, P25027, DOI 10.1074/jbc.M801227200; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Bhardwaj N, 2006, J MOL BIOL, V359, P486, DOI 10.1016/j.jmb.2006.03.039; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Buser CA, 1998, METH MOL B, V84, P267; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; DEMEL RA, 1995, MOL MEMBR BIOL, V12, P255, DOI 10.3109/09687689509072425; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyen JR, 2008, PROSTAG OTH LIPID M, V85, P134, DOI 10.1016/j.prostaglandins.2007.12.001; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Gaude N, 2004, J BIOL CHEM, V279, P34624, DOI 10.1074/jbc.M404098200; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Georgiev A., 2008, THESIS STOCKHOLM U; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Goss R, 2007, BBA-BIOMEMBRANES, V1768, P67, DOI 10.1016/j.bbamem.2006.06.006; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; JENSEN JW, 1988, BIOCHEMISTRY-US, V27, P6315, DOI 10.1021/bi00417a017; Johansson ACV, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3129863; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; Kelly A. A., 2003, THESIS U POTSDAM GER; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Kelly AA, 2002, J BIOL CHEM, V277, P1166, DOI 10.1074/jbc.M110066200; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; KELLY AA, 2007, CURRENT ADV BIOCH CE, P25; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Linde K, 2004, FEBS LETT, V575, P77, DOI 10.1016/j.febslet.2004.08.038; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Marsico A, 2010, NUCLEIC ACIDS RES, V38, pD181, DOI 10.1093/nar/gkp1042; Matsumoto K, 1998, J BACTERIOL, V180, P100, DOI 10.1128/JB.180.1.100-106.1998; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MINNIKIN DE, 1972, FEBS LETT, V27, P16, DOI 10.1016/0014-5793(72)80398-3; MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200; Mizusawa N, 2009, FEBS LETT, V583, P718, DOI 10.1016/j.febslet.2009.01.021; Mock T, 2002, PHYTOCHEMISTRY, V61, P41, DOI 10.1016/S0031-9422(02)00216-9; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; NAVARRO J, 1984, BIOCHEMISTRY-US, V23, P130, DOI 10.1021/bi00296a021; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; Sanderson JM, 2004, PHYS CHEM CHEM PHYS, V6, P1012, DOI 10.1039/b312184d; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; SUSS KH, 1986, PLANT PHYSIOL, V81, P192, DOI 10.1104/pp.81.1.192; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; van den Brink-van der Laan E, 2001, BIOCHEMISTRY-US, V40, P9677, DOI 10.1021/bi002903a; VANWALRAVEN HS, 1984, EUR J BIOCHEM, V144, P563; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; WILLIAMS WP, 1987, J BIOENERG BIOMEMBR, V19, P605, DOI 10.1007/BF00762299; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	91	25	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6669	6684		10.1074/jbc.M110.138495	http://dx.doi.org/10.1074/jbc.M110.138495			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156807	Green Published, hybrid			2022-12-25	WOS:000287476400075
J	Coloff, JL; Mason, EF; Altman, BJ; Gerriets, VA; Liu, TY; Nichols, AN; Zhao, YX; Wofford, JA; Jacobs, SR; Ilkayeva, O; Garrison, SP; Zambetti, GP; Rathmell, JC				Coloff, Jonathan L.; Mason, Emily F.; Altman, Brian J.; Gerriets, Valerie A.; Liu, Tingyu; Nichols, Amanda N.; Zhao, Yuxing; Wofford, Jessica A.; Jacobs, Sarah R.; Ilkayeva, Olga; Garrison, Sean P.; Zambetti, Gerard P.; Rathmell, Jeffrey C.			Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER-CELLS; MITOCHONDRIAL HEXOKINASE; AEROBIC GLYCOLYSIS; SIGNALING PATHWAY; GROWTH; ACTIVATION; SURVIVAL; PHOSPHORYLATION; PROTEIN	The PI3K/Akt pathway is activated in stimulated cells and in many cancers to promote glucose metabolism and prevent cell death. Although inhibition of Akt-mediated cell survival may provide a means to eliminate cancer cells, this survival pathway remains incompletely understood. In particular, unlike anti-apoptotic Bcl-2 family proteins that prevent apoptosis independent of glucose, Akt requires glucose metabolism to inhibit cell death. This glucose dependence may occur in part through metabolic regulation of pro-apoptotic Bcl-2 family proteins. Here, we show that activated Akt relies on glycolysis to inhibit induction of Puma, which was uniquely sensitive to metabolic status among pro-apoptotic Bcl-2 family members and was rapidly up-regulated in glucose-deficient conditions. Importantly, preventing Puma expression was critical for Akt-mediated cell survival, as Puma deficiency protected cells from glucose deprivation and Akt could not readily block Puma-mediated apoptosis. In contrast, the pro-apoptotic Bcl-2 family protein Bim was induced normally even when constitutively active Akt was expressed, yet Akt could provide protection from Bim cytotoxicity. Up-regulation of Puma appeared mediated by decreased availability of mitochondrial metabolites rather than glycolysis itself, as alternative mitochondrial fuels could suppress Puma induction and apoptosis upon glucose deprivation. Metabolic regulation of Puma was mediated through combined p53-dependent transcriptional induction and control of Puma protein stability, with Puma degraded in nutrient-replete conditions and long lived in nutrient deficiency. Together, these data identify a key role for Bcl-2 family proteins in Akt-mediated cell survival that may be critical in normal immunity and in cancer through Akt-dependent stimulation of glycolysis to suppress Puma expression.	[Zhao, Yuxing; Wofford, Jessica A.; Jacobs, Sarah R.; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ilkayeva, Olga; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Sarah W Stedman Ctr Nutr & Metab, Durham, NC 27710 USA; [Garrison, Sean P.; Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	Duke University; Duke University; Duke University; St Jude Children's Research Hospital	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	jeff.rathmell@duke.edu	Zambetti, Gerard/N-8093-2018; Gerriets, Valerie/AAD-6611-2019; Altman, Brian J./X-2783-2019	Zambetti, Gerard/0000-0002-0929-5007; Altman, Brian J./0000-0002-3954-4916; Gerriets, Valerie/0000-0002-1553-2590	National Institutes of Health [R01CA123350, R01AI063345, R01GM083159, F30HL094044]; American Asthma Foundation; Leukemia and Lymphoma Society; Gabrielle's Angel Foundation for Cancer Research; Alex's Lemonade Stand; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Gabrielle's Angel Foundation for Cancer Research; Alex's Lemonade Stand; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA123350 and R01AI063345 (to J. C. R.), R01GM083159 (to G. P. Z.), and F30HL094044 (to E. F. M.). This work was also supported by American Asthma Foundation (to J. C. R.), Leukemia and Lymphoma Society scholar award (to J. C. R.), Gabrielle's Angel Foundation for Cancer Research (to J. C. R.), Alex's Lemonade Stand (to J. C. R.), and the American Lebanese Syrian Associated Charities (to G. P. Z.).	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Frias M, 2009, HAEMATOL-HEMATOL J, V94, P1698, DOI 10.3324/haematol.2008.004028; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Frauwirth KA, 2002, FASEB J, V16, pA711; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mason EF, 2010, CANCER RES, V70, P8066, DOI 10.1158/0008-5472.CAN-10-0608; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	57	72	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5921	5933		10.1074/jbc.M110.179101	http://dx.doi.org/10.1074/jbc.M110.179101			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159778	Green Published, hybrid			2022-12-25	WOS:000287230600101
J	Frank, DJ; Denisov, IG; Sligar, SG				Frank, Daniel J.; Denisov, Ilia G.; Sligar, Stephen G.			Analysis of Heterotropic Cooperativity in Cytochrome P450 3A4 Using alpha-Naphthoflavone and Testosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; DRUG-INTERACTIONS; ACTIVE-SITE; IN-VITRO; KINETICS; CYP3A4; MODEL; P450; MODULATION; ACTIVATION	Cytochrome P450 3A4 (CYP3A4) displays non-Michaelis-Menten kinetics for many of the substrates it metabolizes, including testosterone (TST) and alpha-naphthoflavone (ANF). Heterotropic effects between these two substrates can further complicate the metabolic profile of the enzyme. In this work, monomeric CYP3A4 solubilized in Nanodiscs has been studied for its ability to interact with varying molar ratios of ANF and TST. Comparison of the observed heme spin state, NADPH consumption, and product formation rates with a non-cooperative model calculated from a linear combination of the global analysis of each substrate reveals a detailed landscape of the heterotropic interactions and indicates negligible binding cooperativity between ANF and TST. The observed effect of ANF on the kinetics of TST metabolism is due to the additive action of the second substrate with no specific allosteric effects.	[Frank, Daniel J.; Denisov, Ilia G.; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, 116 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.	s-sligar@uiuc.edu	Frank, Daniel/G-5821-2010; Denisov, Ilia G/J-6590-2013	Frank, Daniel/0000-0003-0063-7557; Denisov, Ilia G/0000-0002-7878-2626; Frank, Daniel/0000-0002-9774-5580	National Institutes of Health [GM31756, GM33775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031756, R37GM031756, R01GM033775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31756 and GM33775 (to S. G. S.).	Atkins WM, 2006, EXPERT OPIN DRUG MET, V2, P573, DOI 10.1517/17425255.2.4.573; Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Borek-Dohalska L, 2010, COLLECT CZECH CHEM C, V75, P201, DOI 10.1135/cccc2009525; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Denisov IG, 2011, BBA-PROTEINS PROTEOM, V1814, P223, DOI 10.1016/j.bbapap.2010.05.017; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; Di Cera E., 1995, THERMODYNAMIC THEORY; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Frank DJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P146, DOI 10.1016/j.abb.2009.06.013; Grinkova YV, 2010, BIOCHEM BIOPH RES CO, V398, P194, DOI 10.1016/j.bbrc.2010.06.058; Guengerich F. P., 2005, CYTOCHROME P450 STRU, P337; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644; Klotz I. M., 1997, LIGAND RECEPTOR ENER; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Sligar SG, 2007, DRUG METAB REV, V39, P567, DOI 10.1080/03602530701498521; STRAUME M, 1992, METHOD ENZYMOL, V210, P117; Tellinghuisen J, 2009, METHOD ENZYMOL, V467, P499, DOI 10.1016/S0076-6879(09)67019-1; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736	31	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5540	5545		10.1074/jbc.M110.182055	http://dx.doi.org/10.1074/jbc.M110.182055			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21177853	Green Published, hybrid			2022-12-25	WOS:000287230600063
J	Jeon, Y; Ko, E; Lee, KY; Ko, MJ; Park, SY; Kang, J; Jeon, CH; Lee, H; Hwang, DS				Jeon, Yoon; Ko, Eun; Lee, Kyung Yong; Ko, Min Ji; Park, Seo Young; Kang, Jeeheon; Jeon, Chang Hwan; Lee, Ho; Hwang, Deog Su			TopBP1 Deficiency Causes an Early Embryonic Lethality and Induces Cellular Senescence in Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING PROTEIN TOPBP1; S-PHASE CHECKPOINT; DNA-REPLICATION; BUDDING YEAST; GENOME INTEGRITY; DAMAGE RESPONSE; ATR; PHOSPHORYLATION; DOMAIN; ACTIVATION	TopBP1 plays important roles in chromosome replication, DNA damage response, and other cellular regulatory functions in vertebrates. Although the roles of TopBP1 have been studied mostly in cancer cell lines, its physiological function remains unclear in mice and untransformed cells. We generated conditional knock-out mice in which exons 5 and 6 of the TopBP1 gene are flanked by loxP sequences. Although TopBP1-deficient embryos developed to the blastocyst stage, no homozygous mutant embryos were recovered at E8.5 or beyond, and completely resorbed embryos were frequent at E7.5, indicating that mutant embryos tend to die at the peri-implantation stage. This finding indicated that TopBP1 is essential for cell proliferation during early embryogenesis. Ablation of TopBP1 in TopBP1(flox/flox) mouse embryonic fibroblasts and 3T3 cells using Cre recombinase-expressing retrovirus arrests cell cycle progression at the G(1), S, and G(2)/M phases. The TopBP1-ablated mouse cells exhibit phosphorylation of H2AX and Chk2, indicating that the cells contain DNA breaks. The TopBP1-ablated mouse cells enter cellular senescence. Although RNA interference-mediated knockdown of TopBP1 induced cellular senescence in human primary cells, it induced apoptosis in cancer cells. Therefore, TopBP1 deficiency in untransformed mouse and human primary cells induces cellular senescence rather than apoptosis. These results indicate that TopBP1 is essential for cell proliferation and maintenance of chromosomal integrity.	[Ko, Eun; Lee, Kyung Yong; Ko, Min Ji; Kang, Jeeheon; Hwang, Deog Su] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Lee, Ho] Natl Canc Ctr, Canc Expt Resources Branch, Goyang Si 410769, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC)	Hwang, DS (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	dshwang@snu.ac.kr			Brain Korea 21 Project; Ministry of Education, Science, and Technology [2010-0002209, 0020879, 0029782]; National Cancer Center of Korea [NCC-0810082]; government of Korea [2009-0053226]; National Research Foundation of Korea [2009-0078699]	Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Cancer Center of Korea; government of Korea(Korean Government); National Research Foundation of Korea(National Research Foundation of Korea)	Supported by the second stage of the Brain Korea 21 Project.; Supported by the Pioneer Research Center Program (2010-0002209, 0020879, 0029782) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology and by the National Cancer Center of Korea (NCC-0810082). To whom correspondence may be addressed. E-mail: ho25lee@ncc.re.kr.; Supported by grants from the National Research Foundation Grant funded by the government of Korea (2009-0053226) and the Nuclear R&D Program of the National Research Foundation of Korea (2009-0078699). To whom correspondence may be addressed. E-mail: dshwang@snu.ac.kr.	Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Chen QM, 2000, J CELL SCI, V113, P4087; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jeon Y, 2007, J BIOL CHEM, V282, P14882, DOI 10.1074/jbc.M609116200; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nowak RA, 1999, BIOL REPROD, V60, P85, DOI 10.1095/biolreprod60.1.85; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wakeman TP, 2006, MUTAT RES-GEN TOX EN, V610, P14, DOI 10.1016/j.mrgentox.2006.06.007; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zheng P, 2005, BIOL REPROD, V72, P1359, DOI 10.1095/biolreprod.104.039073	44	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5414	5422		10.1074/jbc.M110.189704	http://dx.doi.org/10.1074/jbc.M110.189704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149450	Green Published, hybrid			2022-12-25	WOS:000287230600050
J	deWaard, JR; Mitchell, A; Keena, MA; Gopurenko, D; Boykin, LM; Armstrong, KF; Pogue, MG; Lima, J; Floyd, R; Hanner, RH; Humble, LM				deWaard, Jeremy R.; Mitchell, Andrew; Keena, Melody A.; Gopurenko, David; Boykin, Laura M.; Armstrong, Karen F.; Pogue, Michael G.; Lima, Joao; Floyd, Robin; Hanner, Robert H.; Humble, Leland M.			Towards a Global Barcode Library for Lymantria (Lepidoptera: Lymantriinae) Tussock Moths of Biosecurity Concern	PLOS ONE			English	Article							DNA BARCODES; GYPSY MOTHS; UNITED-STATES; IDENTIFICATION; POPULATIONS; INVASIONS; GENETICS; DIPTERA; MODEL; LIFE	Background: Detecting and controlling the movements of invasive species, such as insect pests, relies upon rapid and accurate species identification in order to initiate containment procedures by the appropriate authorities. Many species in the tussock moth genus Lymantria are significant forestry pests, including the gypsy moth Lymantria dispar L., and consequently have been a focus for the development of molecular diagnostic tools to assist in identifying species and source populations. In this study we expand the taxonomic and geographic coverage of the DNA barcode reference library, and further test the utility of this diagnostic method, both for species/subspecies assignment and for determination of geographic provenance of populations. Methodology/Principal Findings: Cytochrome oxidase I (COI) barcodes were obtained from 518 individuals and 36 species of Lymantria, including sequences assembled and generated from previous studies, vouchered material in public collections, and intercepted specimens obtained from surveillance programs in Canada. A maximum likelihood tree was constructed, revealing high bootstrap support for 90% of species clusters. Bayesian species assignment was also tested, and resulted in correct assignment to species and subspecies in all instances. The performance of barcoding was also compared against the commonly employed NB restriction digest system (also based on COI); while the latter is informative for discriminating gypsy moth subspecies, COI barcode sequences provide greater resolution and generality by encompassing a greater number of haplotypes across all Lymantria species, none shared between species. Conclusions/Significance: This study demonstrates the efficacy of DNA barcodes for diagnosing species of Lymantria and reinforces the view that the approach is an under-utilized resource with substantial potential for biosecurity and surveillance. Biomonitoring agencies currently employing the NB restriction digest system would gather more information by transitioning to the use of DNA barcoding, a change which could be made relatively seamlessly as the same gene region underlies both protocols.	[deWaard, Jeremy R.; Humble, Leland M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [deWaard, Jeremy R.] Royal British Columbia Museum, Victoria, BC, Canada; [Mitchell, Andrew] Australian Museum, Sydney, NSW 2000, Australia; [Keena, Melody A.] USDA, No Res Stn, Hamden, CT USA; [Gopurenko, David] Wagga Wagga Agr Inst, Wagga Wagga, NSW, Australia; [Boykin, Laura M.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Christchurch, New Zealand; [Pogue, Michael G.] USDA, Systemat Entomol Lab, Washington, DC 20250 USA; [Lima, Joao; Floyd, Robin; Hanner, Robert H.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Humble, Leland M.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada	University of British Columbia; Australian Museum; United States Department of Agriculture (USDA); Lincoln University - New Zealand; Smithsonian Institution; United States Department of Agriculture (USDA); University of Guelph; Natural Resources Canada; Canadian Forest Service	deWaard, JR (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	jdewaard@interchange.ubc.ca	Armstrong, Karen F/J-3460-2013; Keena, Melody A./W-7124-2019; Boykin, Laura/H-8876-2014; Gopurenko, David/H-3341-2014; Mitchell, Andrew/B-7018-2008; deWaard, Jeremy R/G-8112-2014	Armstrong, Karen F/0000-0003-4973-2651; Keena, Melody A./0000-0003-3099-6243; Boykin, Laura/0000-0002-6101-1921; Gopurenko, David/0000-0003-2886-1614; Mitchell, Andrew/0000-0001-5022-5898; 	Forest Investment Account - Forest Science Program; NSERC; Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC; New Zealand Tertiary Education Commission; Australian Department of Agriculture, Food and Fisheries; NSW Agricultural Genomics Centre	Forest Investment Account - Forest Science Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); New Zealand Tertiary Education Commission; Australian Department of Agriculture, Food and Fisheries(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Agricultural Genomics Centre	Funding was provided by a Forest Investment Account - Forest Science Program Student Grant and an NSERC Graduate Scholarship (to JRD); the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC (to LMH and RHH), and other sponsors listed at www.BOLNET.ca; the New Zealand Tertiary Education Commission (to LB and KFA); the Australian Department of Agriculture, Food and Fisheries (to AM); and the NSW Agricultural Genomics Centre (to AM and DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 2003, N Z PLANT PROTECT-SE, V56, P16, DOI 10.30843/nzpp.2003.56.6025; Ball SL, 2006, CAN J FOREST RES, V36, P337, DOI 10.1139/X05-276; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Bogdanowicz SM, 1997, ANN ENTOMOL SOC AM, V90, P768, DOI 10.1093/aesa/90.6.768; Bogdanowicz SM, 2000, MOL PHYLOGENET EVOL, V15, P487, DOI 10.1006/mpev.1999.0744; BOGDANOWICZ SM, 1993, ANN ENTOMOL SOC AM, V86, P710, DOI 10.1093/aesa/86.6.710; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brockerhoff EG, 2010, NEW ZEAL J ECOL, V34, P158; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; DeWaard Jeremy R., 2008, V410, P275; *FAO, 2006, INT STAND PHYT MEAS, V27, P11; Floyd R, 2010, BIOL INVASIONS, V12, P2947, DOI 10.1007/s10530-010-9709-8; Garner KJ, 1996, INSECT MOL BIOL, V5, P81, DOI 10.1111/j.1365-2583.1996.tb00043.x; Gilligan TM, 2009, LBAM ID TOOLS DIAGNO; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Humble LM, 2006, CAN J PLANT PATHOL, V28, pS256, DOI 10.1080/07060660609507383; Humble Leland M., 2009, Journal of the Entomological Society of British Columbia, V106, P61; Keena MA, 2008, ENVIRON ENTOMOL, V37, P636, DOI 10.1603/0046-225X(2008)37[636:WDOFFA]2.0.CO;2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koshio C, 2002, APPL ENTOMOL ZOOL, V37, P309, DOI 10.1303/aez.2002.309; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Liebhold A., 1989, Bulletin of the Entomological Society of America, V35, P20; Liebhold A. M., 1995, FOREST SCI MONOGR, V41, pa0001; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nadel RL, 2010, BIOL INVASIONS, V12, P1067, DOI 10.1007/s10530-009-9524-2; PFEIFER TA, 1995, CAN ENTOMOL, V127, P49, DOI 10.4039/Ent12749-1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pogue MG, 2007, PUBLICATION USDA; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reineke A, 1999, ANN ENTOMOL SOC AM, V92, P737, DOI 10.1093/aesa/92.5.737; Ross MG, 2005, RESPONSE GYPSY MOTH; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Schintlmeister A., 2004, Quadrifina, V7, P1; Siddall ME, 2005, CONSERV GENET, V6, P467, DOI 10.1007/s10592-005-4986-y; Simonsen TJ, 2008, ANN ENTOMOL SOC AM, V101, P899, DOI 10.1603/0013-8746(2008)101[899:TAIPOC]2.0.CO;2; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; WALLNER WE, 1995, J ECON ENTOMOL, V88, P337, DOI 10.1093/jee/88.2.337; Weese DA, 2009, ANIM CONSERV, V12, P13, DOI 10.1111/j.1469-1795.2008.00215.x; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	54	55	62	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14280	10.1371/journal.pone.0014280	http://dx.doi.org/10.1371/journal.pone.0014280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151562	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800011
J	Kato, T; Kasai, A; Mizuno, M; Liang, FY; Shintani, N; Maeda, S; Yokoyama, M; Ozaki, M; Nawa, H				Kato, Taisuke; Kasai, Atsushi; Mizuno, Makoto; Liang Fengyi; Shintani, Norihito; Maeda, Sadaaki; Yokoyama, Minesuke; Ozaki, Miwako; Nawa, Hiroyuki			Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1	PLOS ONE			English	Article							RISK GENE NEUREGULIN-1; MUTANT MICE; DOPAMINERGIC-NEURONS; PREFRONTAL CORTEX; SOCIAL-BEHAVIOR; NERVOUS-SYSTEM; MESSENGER-RNA; KNOCKOUT MICE; SCHIZOPHRENIA; EXPRESSION	Background: Neuregulin-1 (NRG1) is one of the susceptibility genes for schizophrenia and implicated in the neurotrophic regulation of GABAergic and dopaminergic neurons, myelination, and NMDA receptor function. Postmortem studies often indicate a pathologic association of increased NRG1 expression or signaling with this illness. However, the psychobehavioral implication of NRG1 signaling has mainly been investigated using hypomorphic mutant mice for individual NRG1 splice variants. Methodology/Principal Findings: To assess the behavioral impact of hyper NRG1 signaling, we generated and analyzed two independent mouse transgenic (Tg) lines carrying the transgene of green fluorescent protein (GFP)-tagged type-1 NRG1 cDNA. The promoter of elongation-factor 1 alpha gene drove ubiquitous expression of GFP-tagged NRG1 in the whole brain. As compared to control littermates, both heterozygous NRG1-Tg lines showed increased locomotor activity, a nonsignificant trend toward decreasing prepulse inhibition, and decreased context-dependent fear learning but exhibited normal levels of tone-dependent learning. In addition, social interaction scores in both Tg lines were reduced in an isolation-induced resident-intruder test. There were also phenotypic increases in a GABAergic marker (parvalbumin) as well as in myelination markers (myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase) in their frontal cortex, indicating the authenticity of NRG1 hyper-signaling, although there were marked decreases in tyrosine hydroxylase levels and dopamine content in the hippocampus. Conclusions: These findings suggest that aberrant hyper-signals of NRG1 also disrupt various cognitive and behavioral processes. Thus, neuropathological implication of hyper NRG1 signaling in psychiatric diseases should be evaluated with further experimentation.	[Kato, Taisuke; Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan; [Kasai, Atsushi; Maeda, Sadaaki] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Osaka, Japan; [Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Liang Fengyi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Shintani, Norihito] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropharmacol, Osaka, Japan; [Yokoyama, Minesuke] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Niigata, Japan; [Ozaki, Miwako] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Tokyo, Japan; [Ozaki, Miwako] Waseda Bioscience Inst Singapore WABIOS, Neurosci & Neuroengn Grp, Helios, Singapore	Niigata University; Setsunan University; Niigata University; National University of Singapore; Osaka University; Niigata University; Waseda University	Kato, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan.	hnawa@bri.niigata-u.ac.jp	Kasai, Atsushi/C-8073-2011; Liang, Fengyi/A-7521-2018; Shintani, Norihito/N-1600-2019; Shintani, Norihito/D-5860-2014	Kasai, Atsushi/0000-0002-1612-3078; Liang, Fengyi/0000-0003-1162-6212; Shintani, Norihito/0000-0002-7850-9064; Shintani, Norihito/0000-0002-7850-9064; Kato, Taisuke/0000-0001-5696-7104	Health and Labor Sciences Research Grants; Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan; Astrazeneca Pharmaceutical; Astrazeneca Pharmaceutical, Inc.	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Astrazeneca Pharmaceutical(AstraZeneca); Astrazeneca Pharmaceutical, Inc.(AstraZeneca)	This work was supported by Health and Labor Sciences Research Grants, a grant for Promotion of Nigata University Research Projects, Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency, and a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan. Hiroyuki Nawa was a recipient of research grants from Astrazeneca Pharmaceutical. No funders had a role in either the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HN was a recipient of the research grants from Astrazeneca Pharmaceutical, Inc. This does not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Clemens KJ, 2004, PSYCHOPHARMACOLOGY, V173, P318, DOI 10.1007/s00213-004-1786-x; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Ehrlichman RS, 2009, BRAIN RES, V1294, P116, DOI 10.1016/j.brainres.2009.07.065; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kasai Atsushi, 2007, Folia Pharmacologica Japonica, V130, P281, DOI 10.1254/fpj.130.281; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Lachman HM, 2006, AM J MED GENET B, V141B, P102, DOI 10.1002/ajmg.b.30242; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meuer S, 2001, RAPID CYCLE REAL TIM, P21, DOI 10.1007/978-3-642-59524-0; Mizuno M, 2007, J NEUROSCI, V27, P10116, DOI 10.1523/JNEUROSCI.2368-07.2007; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; O'Tuathaigh CM, 2006, NEUROREPORT, V17, P79, DOI 10.1097/01.wnr.0000192738.31029.0a; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Ozaki M, 2000, J NEUROSCI RES, V59, P612; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Prevot V, 2003, J NEUROSCI, V23, P230; Rimer M, 2005, NEUROREPORT, V16, P271, DOI 10.1097/00001756-200502280-00014; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; SamsDodd F, 1996, BEHAV PHARMACOL, V7, P3; SAMSDODD F, 1995, BEHAV PHARMACOL, V6, P55; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V29, P1; Volkow ND, 2001, J NEUROSCI, V21, pU1; Yurek DM, 2004, BRAIN RES, V1028, P116, DOI 10.1016/j.brainres.2004.08.066; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zheng YJ, 2009, PROG NEURO-PSYCHOPH, V33, P701, DOI 10.1016/j.pnpbp.2009.03.021	57	88	91	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14185	10.1371/journal.pone.0014185	http://dx.doi.org/10.1371/journal.pone.0014185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151609	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800001
J	Ishiguro, M; Mishiro, K; Fujiwara, Y; Chen, HY; Izuta, H; Tsuruma, K; Shimazawa, M; Yoshimura, S; Satoh, M; Iwama, T; Hara, H				Ishiguro, Mitsunori; Mishiro, Keisuke; Fujiwara, Yasuyuki; Chen, Huayue; Izuta, Hiroshi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Yoshimura, Shinichi; Satoh, Masahiko; Iwama, Toru; Hara, Hideaki			Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; CILOSTAZOL PROTECTS; NEURONAL DAMAGE; RAT-BRAIN; STROKE; THROMBOLYSIS; PHOSPHORYLATION	The purpose of the present study was to investigate whether cilostazol, a phosphodiesterase-III inhibitor and antiplatelet drug, would prevent tPA-associated hemorrhagic transformation. Mice subjected to 6-h middle cerebral artery occlusion were treated with delayed tPA alone at 6 h, with combined tPA plus cilostazol at 6 h, or with vehicle at 6 h. We used multiple imaging (electron microscopy, spectroscopy), histological and neurobehavioral measures to assess the effects of the treatment at 18 h and 7 days after the reperfusion. To further investigate the mechanism of cilostazol to beneficial effect, we also performed an in vitro study with tPA and a phosphodiesterase-III inhibitor in human brain microvascular endothelial cells, pericytes, and astrocytes. Combination therapy with tPA plus cilostazol prevented development of hemorrhagic transformation, reduced brain edema, prevented endothelial injury via reduction MMP-9 activity, and prevented the blood-brain barrier opening by inhibiting decreased claudin-5 expression. These changes significantly reduced the morbidity and mortality at 18 h and 7 days after the reperfusion. Also, the administration of both drugs prevented injury to brain human endothelial cells and human brain pericytes. The present study indicates that a phosphodiesterase-III inhibitor prevents the hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.	[Ishiguro, Mitsunori; Mishiro, Keisuke; Izuta, Hiroshi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Ishiguro, Mitsunori; Yoshimura, Shinichi; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Fujiwara, Yasuyuki; Satoh, Masahiko] Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Aichi, Japan; [Chen, Huayue] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan	Gifu Pharmaceutical University; Gifu University; Aichi Gakuin University; Gifu University	Ishiguro, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Fujiwara, Yasuyuki/AAB-8775-2020	Fujiwara, Yasuyuki/0000-0003-0028-0658; Iwama, Toru/0000-0002-9426-284X; Chen, Huayue/0000-0001-6758-1995	Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding was provided by the Gifu Pharmaceutical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1124; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HARA H, 1990, STROKE, V21, P102; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nonaka Y, 2009, J PHARMACOL EXP THER, V330, P13, DOI 10.1124/jpet.109.151548; Nonaka Y, 2009, NEUROSCI LETT, V452, P156, DOI 10.1016/j.neulet.2009.01.039; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; TANAKA K, 1989, STROKE, V20, P668, DOI 10.1161/01.STR.20.5.668; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wakida K, 2006, BRAIN RES, V1116, P187, DOI 10.1016/j.brainres.2006.07.125; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Wilhite DB, 2003, J VASC SURG, V38, P710, DOI 10.1016/S0741-5214(03)01029-2; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yoeruek E, 2008, INVEST OPHTH VIS SCI, V49, P1392, DOI 10.1167/iovs.07-1079; Yoshimoto T, 2009, NEUROL MED-CHIR, V49, P235, DOI 10.2176/nmc.49.235; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058; ZHAO Y, 2009, NEUROL RES      0805	39	69	71	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15178	10.1371/journal.pone.0015178	http://dx.doi.org/10.1371/journal.pone.0015178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151895	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300020
J	Job, B; Bernheim, A; Beau-Faller, M; Camilleri-Broet, S; Girard, P; Hofman, P; Mazieres, J; Toujani, S; Lacroix, L; Laffaire, J; Dessen, P; Fouret, P				Job, Bastien; Bernheim, Alain; Beau-Faller, Michele; Camilleri-Broet, Sophie; Girard, Philippe; Hofman, Paul; Mazieres, Julien; Toujani, Saloua; Lacroix, Ludovic; Laffaire, Julien; Dessen, Philippe; Fouret, Pierre		LG Investigators	Genomic Aberrations in Lung Adenocarcinoma in Never Smokers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN CANCER; CHROMOSOMAL-ABERRATIONS; SOMATIC MUTATIONS; TOBACCO EXPOSURE; ARRAY-CGH; GENE; NONSMOKERS; GEFITINIB; ERLOTINIB	Background: Lung cancer in never smokers would rank as the seventh most common cause of cancer death worldwide. Methods and Findings: We performed high-resolution array comparative genomic hybridization analysis of lung adenocarcinoma in sixty never smokers and identified fourteen new minimal common regions (MCR) of gain or loss, of which five contained a single gene (MOCS2, NSUN3, KHDRBS2, SNTG1 and ST18). One larger MCR of gain contained NSD1. One focal amplification and nine gains contained FUS. NSD1 and FUS are oncogenes hitherto not known to be associated with lung cancer. FISH showed that the amplicon containing FUS was joined to the next telomeric amplicon at 16p11.2. FUS was over-expressed in 10 tumors with gain of 16p11.2 compared to 30 tumors without that gain. Other cancer genes present in aberrations included ARNT, BCL9, CDK4, CDKN2B, EGFR, ERBB2, MDM2, MDM4, MET, MYC and KRAS. Unsupervised hierarchical clustering with adjustment for false-discovery rate revealed clusters differing by the level and pattern of aberrations and displaying particular tumor characteristics. One cluster was strongly associated with gain of MYC. Another cluster was characterized by extensive losses containing tumor suppressor genes of which RB1 and WRN. Tumors in that cluster frequently harbored a central scar-like fibrosis. A third cluster was associated with gains on 7p and 7q, containing ETV1 and BRAF, and displayed the highest rate of EGFR mutations. SNP array analysis validated copy-number aberrations and revealed that RB1 and WRN were altered by recurrent copy-neutral loss of heterozygosity. Conclusions: The present study has uncovered new aberrations containing cancer genes. The oncogene FUS is a candidate gene in the 16p region that is frequently gained in never smokers. Multiple genetic pathways defined by gains of MYC, deletions of RB1 and WRN or gains on 7p and 7q are involved in lung adenocarcinoma in never smokers.	[Job, Bastien] Inst Rech Integree Cancerol Villejuif, Villejuif, France; [Bernheim, Alain; Toujani, Saloua; Dessen, Philippe; Fouret, Pierre] INSERM, INSERM Genet Tumeurs U985, Villejuif, France; [Beau-Faller, Michele] CHU Strasbourg, Hop Hautepierre, Lab Biochim & Biol Mol, F-67000 Strasbourg, France; [Camilleri-Broet, Sophie] INSERM, INSERM JE2492, Le Kremlin Bicetre, France; [Camilleri-Broet, Sophie; Dessen, Philippe] Univ Paris Sud, Le Kremlin Bicetre, France; [Girard, Philippe] Inst Mutualiste Montsouris, Dept Thorac, Paris, France; [Hofman, Paul] CHU Nice, Hop Pasteur, Lab Pathol Clin & Expt, Nice, France; [Mazieres, Julien] CHU Toulouse, Hop Larrey, Unite Cancerol Cervico Thorac, Toulouse, France; [Lacroix, Ludovic] Inst Cancerol Gustave Roussy, Lab Rech Translat, Villejuif, France; [Laffaire, Julien] Ligue Natl Canc, Paris, France; [Fouret, Pierre] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU de Toulouse; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite	Job, B (corresponding author), Inst Rech Integree Cancerol Villejuif, Villejuif, France.	pierre.fouret@psl.aphp.fr	Hofman, Paul/P-7654-2018; Beau-Faller, Michèle/R-3052-2016; MAZIERES, JULIEN/M-3986-2014	Hofman, Paul/0000-0003-0431-9353; MAZIERES, JULIEN/0000-0002-5921-7613; RICHON, Catherine/0000-0002-3556-3941	Institut National du Cancer; Ligue Nationale contre le cancer	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer)	This work is part of the Programme National d'Excellence Specialise Poumon funded by the Institut National du Cancer and of the Programme Cartes d'Identite des Tumeurs funded by the Ligue Nationale contre le cancer (grants to Pierre Fouret). The Institut National du Cancer has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ligue Nationale contre le Cancer conducted the hybridization experiments to SNP arrays as part of its program Carte d'Identite des tumeurs. JL is employed by the Ligue Nationale contre le Cancer and analyzed the SNP array data.	Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Gazdar AF, 2007, J CLIN ONCOL, V25, P469, DOI 10.1200/JCO.2006.09.4623; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; International Federation of Red Cross and Red Crescent Societies, 2007, WORLD DISASTERS REPO, P97; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kanoe H, 1999, ONCOGENE, V18, P721, DOI 10.1038/sj.onc.1202364; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Rudin CM, 2009, CLIN CANCER RES, V15, P5622, DOI 10.1158/1078-0432.CCR-09-0373; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Toh CK, 2007, J CLIN PATHOL, V60, P337, DOI 10.1136/jcp.2006.040576; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Toyooka S, 2006, CANCER RES, V66, P1371, DOI 10.1158/0008-5472.CAN-05-2625; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wong MP, 2002, CANCER RES, V62, P4464; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	50	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15145	10.1371/journal.pone.0015145	http://dx.doi.org/10.1371/journal.pone.0015145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151896	Green Submitted, gold, Green Published			2022-12-25	WOS:000284995300018
J	Lu, D; Lian, H; Zhang, XJ; Shao, HT; Huang, L; Qin, CA; Zhang, LF				Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Huang, Lan; Qin, Chuan; Zhang, Lianfeng			LMNA E82K Mutation Activates FAS and Mitochondrial Pathways of Apoptosis in Heart Tissue Specific Transgenic Mice	PLOS ONE			English	Article							LAMIN-A/C GENE; RAT VENTRICULAR MYOCYTES; A-TYPE LAMINS; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; NATRIURETIC PEPTIDE; NUCLEAR-ENVELOPE; DISEASE; EXPRESSION; PHENOTYPE	The lamin A/C (LMNA), nuclear intermediate filament proteins, is a basic component of the nuclear lamina. Mutations in LMNA are associated with a broad range of laminopathies, congenital diseases affecting tissue regeneration and homeostasis. Heart tissue specific transgenic mice of human LMNA E82K, a mutation causing dilated cardiomyopathy, were generated. Lmna(E82K) transgenic mouse lines exhibited thin-walled, dilated left and right ventricles, a progressive decrease of contractile function assessed by echocardiography. Abnormalities of the conduction system, myocytes disarray, collagen accumulation and increased levels of B-type natriuretic peptide (BNP), procollagen type III alpha 1 (Col3 alpha 1) and skeletal muscle actin alpha 1 (Act alpha 1) were detected in the hearts of Lmna(E82K) transgenic mice. The LMNA E82K mutation caused mislocation of LMNA in the nucleus and swollen mitochondria with loss of critae, together with the loss of nuclear envelope integrity. Most interestingly, we found that the level of apoptosis was 8.5-fold higher in the Lmna(E82K) transgenic mice than that of non-transgenic (NTG) mice. In the presence of the LMNA E82K, both of FAS and mitochondrial pathways of apoptosis were activated consistent with the increase of FAS expression, the release of cytochrome c from mitochondria to cytosol and activation of caspase-8, -9 and -3. Our results suggested that the apoptosis, at least for the LMNA E82K or the mutations in the rod region of Lamin A/C, might be an important mechanism causing continuous loss of myocytes and lead to myocardial dysfunction. It could be a potential therapeutic means to suppress and/or prevent inappropriate cardiac cell death in patients carrying LMNA mutation.	[Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100037, Peoples R China; [Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Huang, Lan; Qin, Chuan; Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Huang, Lan; Qin, Chuan; Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Anim Model, State Adm Tradit Chinese Med, Inst Lab Anim Sci, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Lu, D (corresponding author), Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100037, Peoples R China.	Zhanglf@cnilas.org		LU, Dan/0000-0002-5204-2574	Ministry of Health Foundation [200802036]; National Science and Technology Major Projects [2009ZX09501-026]	Ministry of Health Foundation; National Science and Technology Major Projects	This work was supported in part by the Ministry of Health Foundation (200802036) and the National Science and Technology Major Projects (2009ZX09501-026). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Anselmi A, 2008, J CARDIOVASC MED, V9, P227, DOI 10.2459/JCM.0b013e328277f1d7; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Barac YD, 2005, CARDIOVASC RES, V68, P75, DOI 10.1016/j.cardiores.2005.05.015; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Botto N, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-9; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Eichhorn EJ, 1996, CIRCULATION, V94, P2285, DOI 10.1161/01.CIR.94.9.2285; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; Henriques-Pons A, 2009, J CARDIOVASC PHARM, V53, P94, DOI 10.1097/FJC.0b013e318198fe46; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lanfear DE, 2007, CARDIOVASC DRUG THER, V21, P55, DOI 10.1007/s10557-007-6007-5; Lee SD, 2007, OBESITY, V15, P2407, DOI 10.1038/oby.2007.286; Mestroni L, 2008, J AM COLL CARDIOL, V52, P1261, DOI 10.1016/j.jacc.2008.07.021; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Mounkes L, 2004, CURR TOP DEV BIOL, V61, P191, DOI 10.1016/S0070-2153(04)61008-8; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; van der Kooi AJ, 2002, NEUROLOGY, V59, P620, DOI 10.1212/WNL.59.4.620; Wang H, 2006, BIOCHEM BIOPH RES CO, V344, P17, DOI 10.1016/j.bbrc.2006.03.149; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Yaniv G, 2002, CARDIOVASC RES, V54, P611, DOI 10.1016/S0008-6363(02)00264-X	45	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15167	10.1371/journal.pone.0015167	http://dx.doi.org/10.1371/journal.pone.0015167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151901	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300019
J	Jana, S; Campbell, H; Woodliff, J; Waukau, J; Jailwala, P; Ghorai, J; Ghosh, S; Glisic, S				Jana, Srikanta; Campbell, Hope; Woodliff, Jeffrey; Waukau, Jill; Jailwala, Parthav; Ghorai, Jugal; Ghosh, Soumitra; Glisic, Sanja			The Type of Responder T-Cell Has a Significant Impact in a Human In Vitro Suppression Assay	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY CELLS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; MEDIATED SUPPRESSION; CUTTING EDGE; ACTIVATION; IL-2	Background: In type 1 diabetes (T1D), a prototypic autoimmune disease, effector T cells destroy beta cells. Normally, CD4(+)CD25(+high), or natural regulatory T cells (Tregs), counter this assault. In autoimmunity, the failure to suppress CD4(+)CD25(low) T cells is important for disease development. However, both Treg dysfunction and hyperactive responder T-cell proliferation contribute to disease. Methods/Principal Findings: We investigated human CD4(+)CD25(low) T cells and compared them to CD4(+)CD25(-) T cells in otherwise equivalent in vitro proliferative conditions. We then asked whether these differences in suppression are exacerbated in T1D. In both single and co-culture with Tregs, the CD4(+)CD25(low) T cells divided more rapidly than CD4(+)CD25 T cells, which manifests as increased proliferation/reduced suppression. Time-course experiments showed that this difference could be explained by higher IL-2 production from CD4+CD25(low) compared to CD4+CD25- T cells. There was also a significant increase in CD4+CD25(low) T-cell proliferation compared to CD4+CD25- T cells during suppression assays from RO T1D and at-risk subjects (n = 28, p = 0.015 and p = 0.024 respectively). Conclusions/Significance: The in vitro dual suppression assays proposed here could highlight the impaired sensitivity of certain responder T cells to the suppressive effect of Tregs in human autoimmune diseases.	[Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet & Human, Milwaukee, WI 53226 USA; [Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Med Coll Wisconsin, Ctr Mol Genet, Milwaukee, WI 53226 USA; [Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Ghorai, Jugal] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Campbell, Hope] Blood Res Inst, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; University of Wisconsin System; University of Wisconsin Milwaukee; Versiti Blood Center of Wisconsin	Jana, S (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	sglisic@mcw.edu			Max McGee Fund; Children's Research Institute; National Institutes of Health [GCRC MO1-RR00058]; RAC MCW [409-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER	Max McGee Fund; Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RAC MCW; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Max McGee Fund, Children's Research Institute, a grant from GCRC MO1-RR00058 from the National Institutes of Health and RAC MCW grant (409-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bijl M, 2001, LUPUS, V10, P866, DOI 10.1191/096120301701548517; Black APB, 2002, ARTHRITIS RES, V4, P177, DOI 10.1186/ar403; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; CROFT M, 1994, J IMMUNOL, V152, P2675; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; De Boer RJ, 2005, J COMPUT APPL MATH, V184, P140, DOI 10.1016/j.cam.2004.08.020; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hansen JD, 2009, MOL IMMUNOL, V46, P457, DOI 10.1016/j.molimm.2008.10.007; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hidaka T, 1999, Ther Apher, V3, P178, DOI 10.1046/j.1526-0968.1999.00136.x; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Jensen J, 2004, J NEUROIMMUNOL, V149, P202, DOI 10.1016/j.jneuroim.2003.12.019; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Khoury SJ, 2000, ARCH NEUROL-CHICAGO, V57, P1183, DOI 10.1001/archneur.57.8.1183; Klein S, 2010, J INVEST DERMATOL, V130, P492, DOI 10.1038/jid.2009.313; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Peakman M, 1996, DIABETES CARE, V19, P1177, DOI 10.2337/diacare.19.11.1177; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; van Amelsfort JM, 2004, ARTHRITIS RHEUM-US, V50, pS526; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	51	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15154	10.1371/journal.pone.0015154	http://dx.doi.org/10.1371/journal.pone.0015154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151941	Green Published, Green Submitted, gold			2022-12-25	WOS:000284939600028
J	Tang, Y; Xiang, W; Terry, L; Kretzschmar, HA; Windl, O				Tang, Yue; Xiang, Wei; Terry, Linda; Kretzschmar, Hans A.; Windl, Otto			Transcriptional Analysis Implicates Endoplasmic Reticulum Stress in Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CREUTZFELDT-JAKOB-DISEASE; ABNORMAL PRION PROTEIN; ER STRESS; GENE-EXPRESSION; CELL-DEATH; ARABIDOPSIS-THALIANA; CEREBROSPINAL-FLUID; VARIANT CJD; SCRAPIE	Bovine spongiform encephalopathy (BSE) is a fatal, transmissible, neurodegenerative disease of cattle. To date, the disease process is still poorly understood. In this study, brain tissue samples from animals naturally infected with BSE were analysed to identify differentially regulated genes using Affymetrix GeneChip Bovine Genome Arrays. A total of 230 genes were shown to be differentially regulated and many of these genes encode proteins involved in immune response, apoptosis, cell adhesion, stress response and transcription. Seventeen genes are associated with the endoplasmic reticulum (ER) and 10 of these 17 genes are involved in stress related responses including ER chaperones, Grp94 and Grp170. Western blotting analysis showed that another ER chaperone, Grp78, was up-regulated in BSE. Up-regulation of these three chaperones strongly suggests the presence of ER stress and the activation of the unfolded protein response (UPR) in BSE. The occurrence of ER stress was also supported by changes in gene expression for cytosolic proteins, such as the chaperone pair of Hsp70 and DnaJ. Many genes associated with the ubiquitin-proteasome pathway and the autophagy-lysosome system were differentially regulated, indicating that both pathways might be activated in response to ER stress. A model is presented to explain the mechanisms of prion neurotoxicity using these ER stress related responses. Clustering analysis showed that the differently regulated genes found from the naturally infected BSE cases could be used to predict the infectious status of the samples experimentally infected with BSE from the previous study and vice versa. Proof-of-principle gene expression biomarkers were found to represent BSE using 10 genes with 94% sensitivity and 87% specificity.	[Tang, Yue; Terry, Linda; Windl, Otto] Vet Labs Agcy, Dept Mol Pathogenesis & Genet, Surrey, England; [Xiang, Wei] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, Erlangen, Germany; [Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-8000 Munich, Germany	Veterinary Laboratories Agency; University of Erlangen Nuremberg; University of Munich	Tang, Y (corresponding author), Vet Labs Agcy, Dept Mol Pathogenesis & Genet, Surrey, England.	y.tang@vla.defra.gsi.gov.uk; o.windl@vla.defra.gsi.gov.uk	Windl, Otto/C-6760-2011; Xiang, Wei/Y-3171-2019; Tang, Yue/C-7094-2011; Terry, Linda A/C-2338-2011		Veterinary Laboratories Agency UK	Veterinary Laboratories Agency UK	This work was supported by a development grant of Veterinary Laboratories Agency UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Bates PW, 1999, PLANT J, V20, P183, DOI 10.1046/j.1365-313x.1999.00590.x; Booth S, 2004, BIOCHEM BIOPH RES CO, V325, P1339, DOI 10.1016/j.bbrc.2004.10.150; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Collins S, 2000, J CLIN NEUROSCI, V7, P203, DOI 10.1054/jocn.1999.0193; Doh-ura K, 2000, J NEUROPATH EXP NEUR, V59, P774, DOI 10.1093/jnen/59.9.774; Dron M, 2005, EUR J NEUROSCI, V22, P133, DOI 10.1111/j.1460-9568.2005.04172.x; Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fazi B, 2009, ONCOGENE, V28, P3814, DOI 10.1038/onc.2009.233; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; Ironside JW, 1998, FEMS IMMUNOL MED MIC, V21, P91, DOI 10.1111/j.1574-695X.1998.tb01153.x; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Keith RJ, 2009, CHEM-BIOL INTERACT, V178, P242, DOI 10.1016/j.cbi.2008.10.055; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kuang E, 2006, EXP CELL RES, V312, P1983, DOI 10.1016/j.yexcr.2006.02.024; Kuo TH, 1997, CELL CALCIUM, V21, P399, DOI 10.1016/S0143-4160(97)90051-8; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lisbona F, 2009, CELL CYCLE, V8, P1643; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Marteijn JAF, 2007, BLOOD, V110, P3128, DOI 10.1182/blood-2006-11-058602; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Okushima Y, 2002, PLANT CELL PHYSIOL, V43, P532, DOI 10.1093/pcp/pcf063; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajan SS, 2007, INDIAN J MED RES, V125, P411; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sanchez JC, 2004, PROTEOMICS, V4, P2229, DOI 10.1002/pmic.200300799; Sasaki K, 2006, J PATHOL, V209, P484, DOI 10.1002/path.2009; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; Theil D, 1999, J COMP PATHOL, V121, P357, DOI 10.1053/jcpa.1999.0333; Vonk LA, 2010, BIOCHEM CELL BIOL, V88, P539, DOI [10.1139/O09-174, 10.1139/o09-174]; WADA I, 1991, J BIOL CHEM, V266, P19599; Wan QW, 2007, APOPTOSIS, V12, P319, DOI 10.1007/s10495-006-0574-y; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells Gerald A. H., 2004, VVolume 41, P595; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x	66	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14207	10.1371/journal.pone.0014207	http://dx.doi.org/10.1371/journal.pone.0014207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151970	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600004
J	Wang, Y; Abarbanell, AM; Herrmann, JL; Weil, BR; Manukyan, MC; Poynter, JA; Meldrum, DR				Wang, Yue; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Weil, Brent R.; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Meldrum, Daniel R.			TLR4 Inhibits Mesenchymal Stem Cell (MSC) STAT3 Activation and Thereby Exerts Deleterious Effects on MSC-Mediated Cardioprotection	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOLL-LIKE RECEPTORS; BONE-MARROW; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; CARDIAC REPAIR; ISCHEMIA/REPERFUSION INJURY; CD34 EXPRESSION; CXC CHEMOKINES; STROMAL CELLS	Background: Bone marrow-derived mesenchymal stem cells (MSC) improve myocardial recovery after ischemia/reperfusion (I/R) injury. These effects are mediated in part by the paracrine secretion of angiogenic and tissue growth-promoting factors. Toll-like receptor 4 (TLR4) is expressed by MSC and induces apoptosis and inhibits proliferation in neuronal progenitors as well as many other cell types. It is unknown whether knock-out (KO) of TLR4 will change the paracrine properties of MSC and in turn improve MSC-associated myocardial protection. Methodology/Principal Findings: This study explored the effect of MSC TLR4 on the secretion of angiogenic factors and chemokines in vitro by using ELISA and cytokine array assays and investigated the role of TLR4 on MSC-mediated myocardial recovery after I/R injury in an isolated rat heart model. We observed that MSC isolated from TLR4 KO mice exhibited a greater degree of cardioprotection in a rat model of myocardial I/R injury. This enhanced protection was associated with increased angiogenic factor production, proliferation and differentiation. TLR4-dificiency was also associated with decreased phosphorylation of PI-3K and AKT, but increased activation of STAT3. siRNA targeting of STAT3 resulted in attenuation of the enhanced cardioprotection of TLR4-deficient MSC. Conclusions/Significance: This study indicates that TLR4 exerts deleterious effects on MSC-derived cardioprotection following I/R by a STAT3 inhibitory mechanism.	[Wang, Yue; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Weil, Brent R.; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Meldrum, Daniel R.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Meldrum, Daniel R.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Meldrum, Daniel R.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wang, Y (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA.	dmeldrum@iupui.edu		Herrmann, Jeremy/0000-0001-7818-0548; Abarbanell, Aaron/0000-0003-0694-8081	NIH [R01GM070628, R01HL085595, F32 HL092718, F32 HL092719, F32 HL093987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL092718, F32HL093987, R01HL085595, F32HL092719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070628] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the following NIH grants: R01GM070628, R01HL085595, F32 HL092718, F32 HL092719 and F32 HL093987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Belo AV, 2005, MICROCIRCULATION, V12, P597, DOI 10.1080/10739680500253535; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5; Copland I, 2008, EXP HEMATOL, V36, P93, DOI 10.1016/j.exphem.2007.08.032; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dill T, 2009, AM HEART J, V157, P541, DOI 10.1016/j.ahj.2008.11.011; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Frangogiannis NG, 2004, CIRCULATION, V110, P1341, DOI 10.1161/01.CIR.0000141560.18364.63; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Guedez L, 1998, BLOOD, V92, P1342, DOI 10.1182/blood.V92.4.1342.416k22_1342_1349; Haider HK, 2005, AM J PHYSIOL-HEART C, V288, pH2557, DOI 10.1152/ajpheart.01215.2004; Hossain M, 2005, BIOMATERIALS, V26, P2595, DOI 10.1016/j.biomaterials.2004.07.051; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Markel TA, 2008, AM J PHYSIOL-REG I, V295, pR1124, DOI 10.1152/ajpregu.90508.2008; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x; Nourse MB, ARTERIOSCLER THROMB, V30, P80; Osada-Oka M, 2008, J ATHEROSCLER THROMB, V15, P26, DOI 10.5551/jat.E533; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Sanchez-Tillo E, 2006, EUR J IMMUNOL, V36, P2515, DOI 10.1002/eji.200535270; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; SIMMONS PJ, 1991, BLOOD, V78, P2848; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; WALLER EK, 1995, BLOOD, V86, P710, DOI 10.1182/blood.V86.2.710.bloodjournal862710; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang MJ, 2009, P NATL ACAD SCI USA, V106, P17499, DOI 10.1073/pnas.0908924106; Wang MJ, 2009, J THORAC CARDIOV SUR, V138, P163, DOI 10.1016/j.jtcvs.2009.03.010; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; Wang Y, 2009, SURGERY, V146, P198, DOI 10.1016/j.surg.2009.04.013; Weil BR, 2009, AM J PHYSIOL-REG I, V296, pR1735, DOI 10.1152/ajpregu.90876.2008; Weimar IS, 1998, LEUKEMIA, V12, P1195, DOI 10.1038/sj.leu.2401080; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zeller CN, 2009, ANN THORAC SURG, V87, P812, DOI 10.1016/j.athoracsur.2008.12.033	57	6	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14206	10.1371/journal.pone.0014206	http://dx.doi.org/10.1371/journal.pone.0014206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151968	Green Published, gold, Green Submitted			2022-12-25	WOS:000284939600003
J	Garcia, JR; MacKillop, J; Aller, EL; Merriwether, AM; Wilson, DS; Lum, JK				Garcia, Justin R.; MacKillop, James; Aller, Edward L.; Merriwether, Ann M.; Wilson, David Sloan; Lum, J. Koji			Associations between Dopamine D4 Receptor Gene Variation with Both Infidelity and Sexual Promiscuity	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EXTRA-PAIR PATERNITY; DRD4; PERSPECTIVE; STRATEGIES; SELECTION; PARTNERS; NUMBER; BIRDS	Background: Human sexual behavior is highly variable both within and between populations. While sex-related characteristics and sexual behavior are central to evolutionary theory (sexual selection), little is known about the genetic bases of individual variation in sexual behavior. The variable number tandem repeats (VNTR) polymorphism in exon III of the human dopamine D4 receptor gene (DRD4) has been correlated with an array of behavioral phenotypes and may be predicatively responsible for variation in motivating some sexual behaviors, particularly promiscuity and infidelity. Methodology/Principal Findings: We administered an anonymous survey on personal history of sexual behavior and intimate relationships to 181 young adults. We also collected buccal wash samples and genotyped the DRD4 VNTR. Here we show that individuals with at least one 7-repeat allele (7R+) report a greater categorical rate of promiscuous sexual behavior (i.e., having ever had a "one-night stand'') and report a more than 50% increase in instances of sexual infidelity. Conclusions/Significance: DRD4 VNTR genotype varies considerably within and among populations and has been subject to relatively recent, local selective pressures. Individual differences in sexual behavior are likely partially mediated by individual genetic variation in genes coding for motivation and reward in the brain. Conceptualizing these findings in terms of r/K selection theory suggests a mechanism for selective pressure for and against the 7R+ genotype that may explain the considerable global allelic variation for this polymorphism.	[Garcia, Justin R.; Aller, Edward L.; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY 13902 USA; [Garcia, Justin R.; Aller, Edward L.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA; [Garcia, Justin R.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Garcia, Justin R.; Merriwether, Ann M.; Wilson, David Sloan; Lum, J. Koji] SUNY Binghamton, Inst Evolutionary Studies, Binghamton, NY USA; [MacKillop, James] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [MacKillop, James] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Merriwether, Ann M.] SUNY Binghamton, Dept Psychol, Binghamton, NY USA; [Merriwether, Ann M.] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University System of Georgia; University of Georgia; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Garcia, JR (corresponding author), SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY 13902 USA.	justin.r.garcia@gmail.com	, James/ABI-3641-2020	, James/0000-0002-8695-1071; Lauwereyns, Jan/0000-0003-0551-2550; Garcia, Justin/0000-0002-5198-4578	Binghamton University's Foundation; Binghamton University; National Institutes of Health [K23 AA016936, P30 DA027827]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA016936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027827] Funding Source: NIH RePORTER	Binghamton University's Foundation; Binghamton University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Harpur College Research Awards from Binghamton University's Foundation to JRG and ELA, Binghamton University startup funds to JKL, and grants from the National Institutes of Health to JM (K23 AA016936; P30 DA027827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2006, CURR ANTHROPOL, V47, P513, DOI 10.1086/504167; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Baker R.R., 1995, HUMAN SPERM COMPETIT; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buss DM., 2003, EVOLUTION DESIRE; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Cherkas LF, 2004, TWIN RES, V7, P649, DOI 10.1375/1369052042663922; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Eisenberg DTA, 2010, SOC COGN AFFECT NEUR, V5, P194, DOI 10.1093/scan/nsp026; EISENBERG DTA, 2007, EVOLUTIONARY PSYCHOL, V5, P696; Feigelson HS, 2001, CANCER EPIDEM BIOMAR, V10, P1005; Fisher HE, 2002, ARCH SEX BEHAV, V31, P413, DOI 10.1023/A:1019888024255; Fisher HE., 1992, ANATOMY LOVE NATURAL; Garcia JR., 2008, J SOC EVOL CULT PSYC, V2, DOI [10.1037/h0099345, DOI 10.1037/H0099345]; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Halpern CT, 2007, ARCH SEX BEHAV, V36, P543, DOI 10.1007/s10508-006-9084-9; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Hamer D, 2000, MOL PSYCHIATR, V5, P11, DOI 10.1038/sj.mp.4000662; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; JANKOWIAK WR, 1992, ETHNOLOGY, V31, P149, DOI 10.2307/3773618; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kitchen AM, 2006, ANIM BEHAV, V71, P1029, DOI 10.1016/j.anbehav.2005.06.015; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; MAC ARTHUR ROBERT H., 1967; MacKillop J, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-11; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; NEUMAN MG, 2008, TRUTH CHEATING WHY M; Peterson RL, 2005, BRAIN RES BULL, V67, P391, DOI 10.1016/j.brainresbull.2005.06.015; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; REICHARD U, 1995, ETHOLOGY, V100, P99; Schmitt DP, 2004, J PERS SOC PSYCHOL, V86, P560, DOI 10.1037/0022-3514.86.4.560; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wilson M, 1993, Violence Vict, V8, P271; Zietsch BP, 2010, BEHAV GENET, V40, P12, DOI 10.1007/s10519-009-9300-1	46	66	67	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14162	10.1371/journal.pone.0014162	http://dx.doi.org/10.1371/journal.pone.0014162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152404	gold, Green Published			2022-12-25	WOS:000284755100039
J	Iwamura, T; Wilson, KA; Venter, O; Possingham, HP				Iwamura, Takuya; Wilson, Kerrie A.; Venter, Oscar; Possingham, Hugh P.			A Climatic Stability Approach to Prioritizing Global Conservation Investments	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES DISTRIBUTIONS; FUTURE; SHIFTS; RANGE; UNCERTAINTY; RICHNESS; PATTERNS; IMPACTS	Climate change is impacting species and ecosystems globally. Many existing templates to identify the most important areas to conserve terrestrial biodiversity at the global scale neglect the future impacts of climate change. Unstable climatic conditions are predicted to undermine conservation investments in the future. This paper presents an approach to developing a resource allocation algorithm for conservation investment that incorporates the ecological stability of ecoregions under climate change. We discover that allocating funds in this way changes the optimal schedule of global investments both spatially and temporally. This allocation reduces the biodiversity loss of terrestrial endemic species from protected areas due to climate change by 22% for the period of 2002-2052, when compared to allocations that do not consider climate change. To maximize the resilience of global biodiversity to climate change we recommend that funding be increased in ecoregions located in the tropics and/or mid-elevation habitats, where climatic conditions are predicted to remain relatively stable. Accounting for the ecological stability of ecoregions provides a realistic approach to incorporating climate change into global conservation planning, with potential to save more species from extinction in the long term.	[Iwamura, Takuya; Wilson, Kerrie A.; Venter, Oscar; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia	University of Queensland	Iwamura, T (corresponding author), Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia.	t.iwamura@uq.edu.au	Venter, Oscar/G-6893-2011; POSSINGHAM, HUGH/R-8310-2019; Wilson, Kerrie/W-4181-2019; Possingham, Hugh/B-1337-2008; Venter, Oscar/ABE-1477-2021; Wilson, Kerrie A/C-8058-2009; Iwamura, Takuya/D-1125-2018	POSSINGHAM, HUGH/0000-0001-7755-996X; Wilson, Kerrie/0000-0002-0092-935X; Possingham, Hugh/0000-0001-7755-996X; Wilson, Kerrie A/0000-0002-0092-935X; Iwamura, Takuya/0000-0002-3740-7758	Commonwealth Department of Sustainability, Environment, Water, Population and Communities; Australian Government; Australian Research Council	Commonwealth Department of Sustainability, Environment, Water, Population and Communities; Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council)	This research was partly supported by a Commonwealth Environmental Research Facility grant from the Commonwealth Department of Sustainability, Environment, Water, Population and Communities. T. I. and O.V. were funded by the Australian Government's Endeavour Program. K. A. W. and H. P. P. were funded by fellowships from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; BARTHOLOME E, 2002, GLC 2000 GLOB LAND C; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Brooks T, 2004, NATURE, V431, P1046, DOI 10.1038/4311046a; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BROWN J, 1997, REORGANIZATION ARID, P9729; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GOLDEWIJK K, 2009, GLOBAL ECOL IN PRESS; Guilhaumon F, 2008, P NATL ACAD SCI USA, V105, P15458, DOI 10.1073/pnas.0803610105; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; HIJMANS RJ, WORLDCLIM INTERPOLAT; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Lee TM, 2008, P ROY SOC B-BIOL SCI, V275, P1261, DOI 10.1098/rspb.2007.1732; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Mitchell T., 2003, J CLIMATE; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MITTERMEIER RA, 1993, BIODIVERS CONSERV, V2, P637, DOI 10.1007/BF00051964; Mulongoy K.J., 2004, PROTECTED AREAS BIOD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Nakicenovic N, 2000, PNNLSA39650; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; *UNEP WCMC, 2009, WORLD DAT PROT AR WD; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Willis SG, 2009, ENVIRON MANAGE, V43, P836, DOI 10.1007/s00267-008-9125-3; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; WWF, 2006, WILDFINDER ONL DAT S; Zimmerer KS, 2004, AMBIO, V33, P520, DOI 10.1639/0044-7447(2004)033[0520:GAMTIT]2.0.CO;2	54	40	40	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15103	10.1371/journal.pone.0015103	http://dx.doi.org/10.1371/journal.pone.0015103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152095	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100073
J	Kruewel, T; Schenone, S; Radi, M; Maga, G; Rohrbeck, A; Botta, M; Borlak, J				Kruewel, Thomas; Schenone, Silvia; Radi, Marco; Maga, Giovanni; Rohrbeck, Astrid; Botta, Maurizio; Borlak, Juergen			Molecular Characterization of c-Abl/c-Src Kinase Inhibitors Targeted against Murine Tumour Progenitor Cells that Express Stem Cell Markers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MYELOGENOUS LEUKEMIA-CELLS; CHRONIC MYELOID-LEUKEMIA; LUNG-CANCER CELLS; TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; BIOLOGICAL EVALUATION; BREAST-CANCER; DNA-DAMAGE; IN-VITRO	Background: The non-receptor tyrosine kinases c-Abl and c-Src are overexpressed in various solid human tumours. Inhibition of their hyperactivity represents a molecular rationale in the combat of cancerous diseases. Here we examined the effects of a new family of pyrazolo [3,4-d] pyrimidines on a panel of 11 different murine lung tumour progenitor cell lines, that express stem cell markers, as well as on the human lung adenocarcinoma cell line A549, the human hepatoma cell line HepG2 and the human colon cancer cell line CaCo2 to obtain insight into the mode of action of these experimental drugs. Methodology/Principal Findings: Treatment with the dual kinase inhibitors blocked c-Abl and c-Src kinase activity efficiently in the nanomolar range, induced apoptosis, reduced cell viability and caused cell cycle arrest predominantly at G0/G1 phase while western blot analysis confirmed repressed protein expression of c-Abl and c-Src as well as the interacting partners p38 mitogen activated protein kinase, heterogenous ribonucleoprotein K, cyclin dependent kinase 1 and further proteins that are crucial for tumour progression. Importantly, a significant repression of the epidermal growth factor receptor was observed while whole genome gene expression analysis evidenced regulation of many cell cycle regulated genes as well integrin and focal adhesion kinase (FAK) signalling to impact cytoskeleton dynamics, migration, invasion and metastasis. Conclusions/Significance: Our experiments and recently published in vivo engraftment studies with various tumour cell lines revealed the dual kinase inhibitors to be efficient in their antitumour activity.	[Kruewel, Thomas; Rohrbeck, Astrid; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany; [Schenone, Silvia] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy; [Radi, Marco; Botta, Maurizio] Univ Siena, Dept Chem & Pharmaceut Technol, I-53100 Siena, Italy; [Maga, Giovanni] Inst Mol Genet IMG CNR, Pavia, Italy; [Kruewel, Thomas; Rohrbeck, Astrid; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany	Hannover Medical School; University of Genoa; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Fraunhofer Gesellschaft	Kruewel, T (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany.	borlak@item.fraunhofer.de	Maga, Giovanni/C-5409-2009; Radi, Marco/P-1457-2017	Maga, Giovanni/0000-0001-8092-1552; Radi, Marco/0000-0002-0874-6697	Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]; EU [CM0602]	Ministry of Science and Culture, Lower Saxony, Germany; EU(European Commission)	Funding was provided by the Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak and EU COST (European Cooperation in Science and Technology) Action CM0602 "Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Bruno O, 2007, J MED CHEM, V50, P3618, DOI 10.1021/jm0704402; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Carraro F, 2006, J MED CHEM, V49, P1549, DOI 10.1021/jm050603r; Carraro F, 2004, J MED CHEM, V47, P1595, DOI 10.1021/jm034257u; Choi D, 2009, WORLD J GASTROENTERO, V15, P2258, DOI 10.3748/wjg.15.2258; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Fabarius A, 2008, HAEMATOL-HEMATOL J, V93, P1145, DOI 10.3324/haematol.12793; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huynh H, 2010, EXPERT OPIN EMERG DR, V15, P13, DOI 10.1517/14728210903571659; Ischenko I, 2008, ONCOGENE, V27, P7212, DOI 10.1038/onc.2008.326; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jia HY, 2009, LEUKEMIA RES, V33, P1512, DOI 10.1016/j.leukres.2009.03.033; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson FM, 2010, CANCER-AM CANCER SOC, V116, P1582, DOI 10.1002/cncr.24927; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Krystal GW, 2001, DRUG RESIST UPDATE, V4, P16, DOI 10.1054/drup.2000.0176; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Lindstrom AK, 2009, ANTICANCER RES, V29, P2577; Manetti F, 2007, J MED CHEM, V50, P5579, DOI 10.1021/jm061449r; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Nautiyal J, 2009, CANCER LETT, V283, P143, DOI 10.1016/j.canlet.2009.03.035; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Oh JW, 2009, BIOL PHARM BULL, V32, P573, DOI 10.1248/bpb.32.573; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007315; Saad F, 2010, CANCER TREAT REV, V36, P177, DOI 10.1016/j.ctrv.2009.11.005; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Schenone S, 2004, EUR J MED CHEM, V39, P153, DOI 10.1016/j.ejmech.2003.11.007; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Thom I, 2009, ANTICANCER RES, V29, P249; Walenkamp AME, 2009, NEOPLASIA, V11, P333, DOI 10.1593/neo.81508; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8; Yardley DA, 2009, CLIN BREAST CANCER, V9, P237, DOI 10.3816/CBC.2009.n.040; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang Xiaozhu, 2008, Int J Med Sci, V5, P209; Zhu AX, 2008, CANCER-AM CANCER SOC, V112, P250, DOI 10.1002/cncr.23175; Zhu AX, 2009, CANCER J, V15, P263, DOI 10.1097/PPO.0b013e3181af5e35	68	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14143	10.1371/journal.pone.0014143	http://dx.doi.org/10.1371/journal.pone.0014143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152443	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100023
J	Lin, HF; Tsai, PC; Lin, RT; Khor, GT; Sheu, SH; Juo, SHH				Lin, Hsiu-Fen; Tsai, Pei-Chien; Lin, Ruey-Tay; Khor, Gim-Thean; Sheu, Sheng-Hsiung; Juo, Suh-Hang Hank			Sex Differential Genetic Effect of Chromosome 9p21 on Subclinical Atherosclerosis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; ENVIRONMENTAL CONTRIBUTIONS; ASSOCIATION ANALYSIS; RISK; PLAQUE; HERITABILITY; PHENOTYPES; VARIANTS	Background: Chromosome 9p21 has recently been shown to be a risk region for a broad range of vascular diseases. Since carotid intima-media thickness (IMT) and plaque are independent predictors for vascular diseases, the association between 9p21 and these two phenotypes was investigated. Methodology/Principal Findings: Carotid segment-specific IMT and plaques were obtained in 1083 stroke-and myocardial infarction-free volunteers. We tested the genotypes and haplotypes of key single nucleotide polymorphisms (SNPs) on chromosome 9p21 for the associations with carotid IMT and plaque. Multivariate permutation analyses demonstrated that carriers of the T allele of SNP rs1333040 were significantly associated with thicker common carotid artery (CCA) IMT (p = 0.021) and internal carotid artery (ICA) IMT (p = 0.033). The risk G allele of SNP rs2383207 was associated with ICA IMT (p = 0.007). Carriers of the C allele of SNP rs1333049 were found to be significantly associated with thicker ICA IMT (p = 0.010) and the greater risk for the presence of carotid plaque (OR = 1.57 for heterozygous carriers; OR = 1.75 for homozygous carriers). Haplotype analysis showed a global p value of 0.031 for ICA IMT and 0.115 for the presence of carotid plaque. Comparing with the other haplotypes, the risk TGC haplotype yielded an adjusted p value of 0.011 and 0.017 for thicker ICA IMT and the presence of carotid plaque respectively. Further analyzing the data separated by sex, the results were significant only in men but not in women. Conclusions: Chromosome 9p21 had a significant association with carotid atherosclerosis, especially ICA IMT. Furthermore, such genetic effect was in a gender-specific manner in the Han Chinese population.	[Lin, Hsiu-Fen; Lin, Ruey-Tay; Khor, Gim-Thean] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lin, Hsiu-Fen; Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Tsai, Pei-Chien; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Coll Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lin, HF (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.	hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009	Lin, Hsiu-Fen/0000-0001-6343-826X; Tsai, Pei-Chien/0000-0002-5044-6727	National Health Research Institutes, Taiwan [NHRI-Ex96-9607PI]; National Science Council, Taiwan [NSC 97-2314-B-037-019, NSC 98-2314-B-037-048]; Kaohsiung Medical University [KMUH98-8I11]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This work was supported by the following grants: National Health Research Institutes, Taiwan (NHRI-Ex96-9607PI); National Science Council, Taiwan (NSC 97-2314-B-037-019; NSC 98-2314-B-037-048) and Kaohsiung Medical University intramural grant (KMUH98-8I11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bjorck HM, 2009, J INTERN MED, V265, P373, DOI 10.1111/j.1365-2796.2008.02020.x; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Cunnington MS, 2009, ATHEROSCLEROSIS, V203, P41, DOI 10.1016/j.atherosclerosis.2008.06.025; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Homma S, 2001, STROKE, V32, P830, DOI 10.1161/01.STR.32.4.830; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; Juo SHH, 2004, STROKE, V35, P2243, DOI 10.1161/01.STR.0000142132.20442.d8; Kornet L, 1998, ARTERIOSCL THROM VAS, V18, P1877, DOI 10.1161/01.ATV.18.12.1877; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2008, ARTERIOSCL THROM VAS, V28, P1679, DOI 10.1161/ATVBAHA.108.170332; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Spence JD, 2004, STROKE, V35, pE87, DOI 10.1161/01.STR.0000125715.47831.37; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Stork S, 2004, CIRCULATION, V110, P344, DOI 10.1161/01.CIR.0000134966.10793.C9; Tzeng JY, 2006, AM J HUM GENET, V78, P231, DOI 10.1086/500025; Yamagishi K, 2009, EUR HEART J, V30, P1222, DOI 10.1093/eurheartj/ehp087; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Zureik M, 2000, ARTERIOSCL THROM VAS, V20, P1622, DOI 10.1161/01.ATV.20.6.1622	29	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15124	10.1371/journal.pone.0015124	http://dx.doi.org/10.1371/journal.pone.0015124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152093	gold, Green Submitted, Green Published			2022-12-25	WOS:000284755100082
J	Roongapinun, S; Oh, SY; Wu, F; Panthong, A; Zheng, T; Zhu, Z				Roongapinun, Sukit; Oh, Sun-Young; Wu, Fan; Panthong, Ampai; Zheng, Tao; Zhu, Zhou			Role of SHIP-1 in the Adaptive Immune Responses to Aeroallergen in the Airway	PLOS ONE			English	Article							INOSITOL PHOSPHATASE SHIP; PHOSPHOINOSITIDE 3-KINASE; ALLERGIC INFLAMMATION; NEGATIVE REGULATOR; ASTHMA MODEL; IN-VIVO; ACTIVATION; SURVIVAL; HYPERRESPONSIVENESS; P110-DELTA	Background: Th2-dominated inflammatory response in the airway is an integral component in the pathogenesis of allergic asthma. Accumulating evidence supports the notion that the phosphoinositide 3-kinase (PI3K) pathway is involved in the process. We previously reported that SHIP-1, a negative regulator of the PI3K pathway, is essential in maintaining lung immunohomeostasis, potentially through regulation of innate immune cells. However, the function of SHIP-1 in adaptive immune response in the lung has not been defined. We sought to determine the role of SHIP-1 in adaptive immunity in response to aeroallergen stimulation in the airway. Methodology/Principal Findings: SHIP-1 knockout (SHIP-1(-/-)) mice on BALB/c background were immunized with ovalbumin (OVA) plus aluminum hydroxide, a strong Th2-inducing immunization, and challenged with OVA. Airway and lung inflammation, immunoglobulin response, Th2 cytokine production and lymphocyte response were analyzed and compared with wild type mice. Even though there was mild spontaneous inflammation in the lung at baseline, SHIP-1(-/-) mice showed altered responses, including less cell infiltration around the airways but more in the parenchyma, less mucus production, decreased Th2 cytokine production, and diminished serum OVA-specific IgE, IgG1, but not IgG2a. Naive and OVA sensitized SHIP-1(-/-) T cells produced a lower amount of IL-4. In vitro differentiated SHIP-1(-/-) Th2 cells produced less IL-4 compared to wild type Th2 cells upon T cell receptor stimulation. Conclusions/Significance: These findings indicate that, in contrast to its role as a negative regulator in the innate immune cells, SHIP-1 acts as a positive regulator in Th2 cells in the adaptive immune response to aeroallergen. Thus any potential manipulation of SHIP-1 activity should be adjusted according to the specific immune response.	[Roongapinun, Sukit; Oh, Sun-Young; Wu, Fan; Zheng, Tao; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Roongapinun, Sukit; Panthong, Ampai] Chiang Mai Univ, Dept Pharmacol, Fac Med, Chiang Mai 50000, Thailand	Johns Hopkins University; Johns Hopkins Medicine; Chiang Mai University	Roongapinun, S (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	zzhu@jhmi.edu	Roongapinun, Sukit/O-1577-2018	Roongapinun, Sukit/0000-0003-2062-610X	National Institutes of Health (NIH) [HL079349, AI075025]; Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants HL079349 to Z.Z. and AI075025 and the AAAAI Women's Award to T.Z. S.R. is a recipient of a training grant from the Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCHNER BS, 1994, ANNU REV IMMUNOL, V12, P295; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; CUTZ E, 1978, HISTOPATHOLOGY, V2, P407, DOI 10.1111/j.1365-2559.1978.tb01735.x; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; MacDonald SM, 2002, MOL IMMUNOL, V38, P1323, DOI 10.1016/S0161-5890(02)00082-2; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pinho V, 2005, J LEUKOCYTE BIOL, V77, P800, DOI 10.1189/jlb.0704386; Rohrschneider LR, 2000, GENE DEV, V14, P505; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Zhang TT, 2008, J ALLERGY CLIN IMMUN, V122, P811, DOI 10.1016/j.jaci.2008.08.008; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	23	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14174	10.1371/journal.pone.0014174	http://dx.doi.org/10.1371/journal.pone.0014174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151496	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100050
J	dos Santos, RMZ; Amador, A; de Souza, WV; de Albuquerque, MFPM; Dawson, SP; Ruffino-Netto, A; Zarate-Blades, CR; Silva, CL				Zorzenon dos Santos, Rita M.; Amador, Ana; de Souza, Wayner V.; de Albuquerque, Maria Fatima P. M.; Ponce Dawson, Silvina; Ruffino-Netto, Antonio; Zarate-Blades, Carlos R.; Silva, Celio L.			A Dynamic Analysis of Tuberculosis Dissemination to Improve Control and Surveillance	PLOS ONE			English	Article							INFECTIOUS-DISEASES; GIS; EPIDEMIOLOGY; HEALTH; SPACE	Background: Detailed analysis of the dynamic interactions among biological, environmental, social, and economic factors that favour the spread of certain diseases is extremely useful for designing effective control strategies. Diseases like tuberculosis that kills somebody every 15 seconds in the world, require methods that take into account the disease dynamics to design truly efficient control and surveillance strategies. The usual and well established statistical approaches provide insights into the cause-effect relationships that favour disease transmission but they only estimate risk areas, spatial or temporal trends. Here we introduce a novel approach that allows figuring out the dynamical behaviour of the disease spreading. This information can subsequently be used to validate mathematical models of the dissemination process from which the underlying mechanisms that are responsible for this spreading could be inferred. Methodology/Principal Findings: The method presented here is based on the analysis of the spread of tuberculosis in a Brazilian endemic city during five consecutive years. The detailed analysis of the spatio-temporal correlation of the yearly geo-referenced data, using different characteristic times of the disease evolution, allowed us to trace the temporal path of the aetiological agent, to locate the sources of infection, and to characterize the dynamics of disease spreading. Consequently, the method also allowed for the identification of socio-economic factors that influence the process. Conclusions/Significance: The information obtained can contribute to more effective budget allocation, drug distribution and recruitment of human skilled resources, as well as guiding the design of vaccination programs. We propose that this novel strategy can also be applied to the evaluation of other diseases as well as other social processes.	[Zorzenon dos Santos, Rita M.; Amador, Ana] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil; [Amador, Ana; Ponce Dawson, Silvina] Univ Buenos Aires, FCEN UBA, Dept Fis, Buenos Aires, DF, Argentina; [de Souza, Wayner V.; de Albuquerque, Maria Fatima P. M.] Fiocruz MS, Ctr Pesquisa Ageu Magalhaes, Recife, PE, Brazil; [de Albuquerque, Maria Fatima P. M.] Univ Fed Pernambuco, Dept Med, BR-50739 Recife, PE, Brazil; [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, Sao Paulo, Brazil; [Zarate-Blades, Carlos R.; Silva, Celio L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Sao Paulo, Brazil	Universidade Federal de Pernambuco; University of Buenos Aires; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Universidade de Sao Paulo	dos Santos, RMZ (corresponding author), Univ Fed Pernambuco, Dept Fis, Cidade Univ, BR-50739 Recife, PE, Brazil.	rita.zorzenon@gmail.com; clsilva@cpt.fmrp.usp.br	Silva, Celio/C-4639-2012; Souza, Wayner V/H-3798-2013; Zárate-Bladés, Carlos R/C-9663-2015	Silva, Celio/0000-0002-0043-4568; Zárate-Bladés, Carlos R/0000-0002-7728-7869; Ponce Dawson, Silvina/0000-0001-6550-4267; Souza, Wayner/0000-0002-0939-9332; Amador, Ana/0000-0002-1040-2359	Instituto do Milenio REDE-TB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [0012-05.03/04, 0203-1.05/08]	Instituto do Milenio REDE-TB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This study received financial support from the following Brazilian institutions: the Instituto do Milenio REDE-TB, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br), and the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE, http://www.facepe.br-Pronex-EDT 0012-05.03/04 and Pronex-APQ 0203-1.05/08). Additional support was provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, http://www.agencia.gov.ar) of Argentina. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BAILEY T, 1995, INTERACTIVE SPATIAL, P73; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Cromley EK, 2003, ANNU REV PUBL HEALTH, V24, P7, DOI 10.1146/annurev.publhealth.24.012902.141019; Frieden TR, 2005, CLIN CHEST MED, V26, P197, DOI 10.1016/j.ccm.2005.02.001; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; *IBGE, DEM CENS 2000; Knorr-Held L, 2003, J R STAT SOC C-APPL, V52, P169, DOI 10.1111/1467-9876.00396; Krieger N, 2003, EPIDEMIOLOGY, V14, P384, DOI 10.1097/01.ede.0000071473.69307.8a; Lawson AB, 2006, STAT METHODS SPATIAL; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Ruffino-Netto A, 2001, Rev Panam Salud Publica, V9, P306, DOI 10.1590/S1020-49892001000500004; Souza W V, 2000, Rev Panam Salud Publica, V8, P403, DOI 10.1590/S1020-49892000001100005; Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI 10.1590/S0034-89102005000100011; STAUFFER D, 1994, INTRO PERCOLATION TH; STYBLO K, 1967, B WORLD HEALTH ORGAN, V37, P819; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Wang XH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000250; *WHO, 2009, GLOB TUB CONTR SHORT; DATA OBTAINED NATL D	25	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14140	10.1371/journal.pone.0014140	http://dx.doi.org/10.1371/journal.pone.0014140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152440	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100020
J	Heil, A; Nazmi, AR; Koltzscher, M; Poeter, M; Austermann, J; Assard, N; Baudier, J; Kaibuchi, K; Gerke, V				Heil, Annika; Nazmi, Ali Reza; Koltzscher, Max; Poeter, Michaela; Austermann, Judith; Assard, Nicole; Baudier, Jacques; Kaibuchi, Kozo; Gerke, Volker			S100P Is a Novel Interaction Partner and Regulator of IQGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATES CA2+/CALMODULIN; BINDING PROTEIN; B-RAF; CDC42; CALMODULIN; ACTIVATION; MIGRATION; CYTOSKELETON; ADHESION; SCAFFOLD	Ca2+-binding proteins of the S100 family participate in intracellular Ca2+ signaling by binding to and regulating specific cellular targets in their Ca2+-loaded conformation. Because the information on specific cellular targets of different S100 proteins is still limited, we developed an affinity approach that selects for protein targets only binding to the physiologically active dimer of an S100 protein. Using this approach, we here identify IQGAP1 as a novel and dimer-specific target of S100P, a member of the S100 family enriched in the cortical cytoskeleton. The interaction between S100P and IQGAP1 is strictly Ca2+-dependent and characterized by a dissociation constant of 0.2 mu M. Binding occurs primarily through the IQ domain of IQGAP1 and the first EF hand loop of S100P, thus representing a novel structural principle of S100-target protein interactions. Upon cell stimulation, S100P and IQGAP1 co-localize at or in close proximity to the plasma membrane, and complex formation can be linked to altered signal transduction properties of IQGAP1. Specifically, the EGF-induced tyrosine phosphorylation of IQGAP1 that is thought to function in assembling signaling intermediates at IQGAP1 scaffolds in the subplasmalemmal region is markedly reduced in cells overexpressing S100P but not in cells expressing an S100P mutant deficient in IQGAP1 binding. Furthermore, B-Raf binding to IQGAP1 and MEK1/2 activation occurring downstream of IQGAP1 in EGF-triggered signaling cascades are compromised at elevated S100P levels. Thus, S100P is a novel Ca2+-dependent regulator of IQGAP1 that can down-regulate the function of IQGAP1 as a signaling intermediate by direct interaction.	[Heil, Annika; Nazmi, Ali Reza; Koltzscher, Max; Poeter, Michaela; Austermann, Judith; Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany; [Assard, Nicole; Baudier, Jacques] INSERM, U873, Lab Transduct Signal, F-38054 Grenoble, France; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Aichi 4668550, Japan	University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); Nagoya University	Gerke, V (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de	Baudier, Jacques/O-2183-2016; jacques, baudier/T-3300-2019	Nazmi, Ali Reza/0000-0003-1262-5078; jacques, baudier/0000-0001-8427-4444	Interdisciplinary Centre for Clinical Research of the Muenster University Medical School [Ge2/016/10]	Interdisciplinary Centre for Clinical Research of the Muenster University Medical School	This work was supported by Grant Ge2/016/10 from the Interdisciplinary Centre for Clinical Research of the Muenster University Medical School (to V. G.).	Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; DONATO T, 1999, BIOCHIM BIOPHYS ACTA, V1450, P191; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Koltzscher M, 2000, BIOCHEMISTRY-US, V39, P9533, DOI 10.1021/bi000257+; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zobiack N, 2001, FEBS LETT, V500, P137, DOI 10.1016/S0014-5793(01)02604-7	33	34	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7227	7238		10.1074/jbc.M110.135095	http://dx.doi.org/10.1074/jbc.M110.135095			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177863	Green Published, hybrid			2022-12-25	WOS:000287737300039
J	Yang, M; Ge, W; Chowdhury, R; Claridge, TDW; Kramer, HB; Schmierer, B; McDonough, MA; Gong, LZ; Kessler, BM; Ratcliffe, PJ; Coleman, ML; Schofield, CJ				Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; Kramer, Holger B.; Schmierer, Bernhard; McDonough, Michael A.; Gong, Lingzhi; Kessler, Benedikt M.; Ratcliffe, Peter J.; Coleman, Mathew L.; Schofield, Christopher J.			Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE ANION-EXCHANGER; DOMAIN-CONTAINING PROTEINS; KAPPA-B-ALPHA; REPEAT DOMAIN; HIF FIH; TRANSCRIPTIONAL ACTIVITY; TRYPTOPHAN RESIDUES; CYTOPLASMIC DOMAIN; BETA-HYDROXYLATION; CRYSTAL-STRUCTURE	Factor-inhibiting hypoxia-inducible factor (FIH) catalyzes the beta-hydroxylation of an asparagine residue in the C-terminal transcriptional activation domain of the hypoxia inducible factor (HIF), a modification that negatively regulates HIF transcriptional activity. FIH also catalyzes the hydroxylation of highly conserved Asn residues within the ubiquitous ankyrin repeat domain (ARD)-containing proteins. Hydroxylation has been shown to stabilize localized regions of the ARD fold in the case of a three-repeat consensus ankyrin protein, but this phenomenon has not been demonstrated for the extensive naturally occurring ARDs. Here we report that the cytoskeletal ankyrin family are substrates for FIH-catalyzed hydroxylations. We show that the ARD of ankyrinR is multiply hydroxylated by FIH both in vitro and in endogenous proteins purified from human and mouse erythrocytes. Hydroxylation of the D34 region of ankyrinR ARD (ankyrin repeats 13-24) increases its conformational stability and leads to a reduction in its interaction with the cytoplasmic domain of band 3 (CDB3), demonstrating the potential for FIH-catalyzed hydroxylation to modulate protein-protein interactions. Unexpectedly we found that aspartate residues in ankyrinR and ankyrinB are hydroxylated and that FIH-catalyzed aspartate hydroxylation also occurs in other naturally occurring AR sequences. The crystal structure of an FIH variant in complex with an Asp-substrate peptide together with NMR analyses of the hydroxylation product identifies the 3S regio- and stereoselectivity of the FIH-catalyzed Asp hydroxylation, revealing a previously unprecedented posttranslational modification.	[Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; McDonough, Michael A.; Gong, Lingzhi; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; McDonough, Michael A.; Gong, Lingzhi; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Schmierer, Bernhard] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schmierer, Bernhard] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Kramer, Holger B.; Kessler, Benedikt M.; Ratcliffe, Peter J.; Coleman, Mathew L.] Univ Oxford, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	McDonough, Michael/N-8913-2019; McDonough, Michael A/G-2744-2013; Coleman, Mathew L/C-1676-2014; Schmierer, Bernhard/P-4208-2019; Kessler, Benedikt/AAY-8614-2021; Kramer, Holger/AAL-4433-2020; Schmierer, Bernhard/C-1416-2009; Claridge, Tim/A-8324-2018; Chowdhury, Rashed/I-7697-2014	McDonough, Michael/0000-0003-4664-6942; McDonough, Michael A/0000-0003-4664-6942; Coleman, Mathew L/0000-0001-6020-9023; Schmierer, Bernhard/0000-0002-9082-7022; Kessler, Benedikt/0000-0002-8160-2446; Kramer, Holger/0000-0002-6400-0945; Schmierer, Bernhard/0000-0002-9082-7022; Claridge, Tim/0000-0001-5583-6460; Chowdhury, Rashed/0000-0002-8058-6149; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council; European Union; OAK Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/G014124/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); OAK Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, the European Union, the OAK Foundation, and the Wellcome Trust.	Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bienvenut WV, 2002, PROTEOMICS, V2, P868, DOI 10.1002/1615-9861(200207)2:7<868::AID-PROT868>3.0.CO;2-D; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; DAVIS L, 1989, J BIOL CHEM, V264, P9665; Ding Y, 2004, PROTEIN EXPRES PURIF, V34, P167, DOI 10.1016/j.pep.2003.10.019; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; KURODA M, 1975, J BIOCHEM-TOKYO, V78, P641, DOI 10.1093/oxfordjournals.jbchem.a130951; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104	53	54	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7648	7660		10.1074/jbc.M110.193540	http://dx.doi.org/10.1074/jbc.M110.193540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177872	hybrid, Green Published			2022-12-25	WOS:000287737300078
J	D'Aniello, S; Somorjai, I; Garcia-Fernandez, J; Topo, E; D'Aniello, A				D'Aniello, Salvatore; Somorjai, Ildiko; Garcia-Fernandez, Jordi; Topo, Enza; D'Aniello, Antimo			D-Aspartic acid is a novel endogenous neurotransmitter	FASEB JOURNAL			English	Article						nervous system; D-amino acids; L-amino acids; synaptic vesicles; receptors	L-AMINO-ACIDS; D-SERINE; LUTEINIZING-HORMONE; CEREBROSPINAL-FLUID; POSTNATAL CHANGES; INDUCED RELEASE; RAT-BRAIN; OXIDASE; GLUTAMATE; ALZHEIMER	D-Aspartic acid (D-Asp) is present in invertebrate and vertebrate neuroendocrine tissues, where it carries out important physiological functions and is implicated in nervous system development. We show here that D-Asp is a novel endogenous neurotransmitter in two distantly related animals, a mammal (Rattus norvegicus) and a mollusk (Loligo vulgaris). Our main findings demonstrate that D-Asp is present in high concentrations in the synaptic vesicles of axon terminals; synthesis for this amino acid occurs in neurons by conversion of L-Asp to D-Asp via D-aspartate racemase; depolarization of nerve endings with K+ ions evokes an immediate release of D-Asp in a Ca2+ dependent manner; specific receptors for D-Asp occur at the postsynaptic membrane, as demonstrated by binding assays and by the expansion of squid skin chromatophores; D-aspartate oxidase, the specific enzyme that oxidizes D-Asp, is present in the postsynaptic membranes; and stimulation of nerve endings with D-Asp triggers signal transduction by increasing the second messenger cAMP. Taken together, these data demonstrate that D-Asp fulfills all criteria necessary to be considered a novel endogenous neurotransmitter. Given its known role in neurogenesis, learning, and neuropathologies, our results have important implications for biomedical and clinical research.-D'Aniello, S., Somorjai, I., Garcia-Fernandez, J., Topo, E., D'Aniello, A. D-Aspartic acid is a novel endogenous neurotransmitter. FASEB J. 25, 1014-1027 (2011). www.fasebj.org	[Topo, Enza; D'Aniello, Antimo] Stn Zool A Dohrn, Dept Neurobiol, I-80121 Naples, Italy; [D'Aniello, Salvatore; Somorjai, Ildiko; Garcia-Fernandez, Jordi] Univ Barcelona, Fac Biol, Dept Genet, Inst Biomed, Barcelona, Spain; [D'Aniello, Salvatore] Stn Zool A Dohrn, Dept Cellular & Dev Biol, I-80121 Naples, Italy; [D'Aniello, Antimo] Ist Nazl Previdenza Sociale, Rome, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Barcelona; Stazione Zoologica Anton Dohrn di Napoli	D'Aniello, A (corresponding author), Stn Zool A Dohrn, Dept Neurobiol, I-80121 Naples, Italy.	daniello.antimo@gmail.com	Garcia-Fernandez, Jordi/B-3839-2013	Garcia-Fernandez, Jordi/0000-0001-5677-5970; Somorjai, Ildiko/0000-0001-5243-6664	Spanish Ministerior de Ciencia e Innovacion [BMC2008-03776]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Prize (Generalitat de Catalunya)	Spanish Ministerior de Ciencia e Innovacion; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Prize (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	The authors thank Dr. Euan Brown (Animal Physiology and Evolution Department, Zoological Station Anton Dohrn, Naples, Italy) for useful discussions about the manuscript. The authors also thank Franco Iamunno for technical assistance in electron microscopy and Gabriele Ferrandino for technical assistance in HPLC analysis. The J.G.-F. laboratory is funded by grant BMC2008-03776 from the Spanish Ministerior de Ciencia e Innovacion and by the Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Prize (Generalitat de Catalunya).	Cavallero A, 2009, J NEUROCHEM, V110, P924, DOI 10.1111/j.1471-4159.2009.06187.x; D'Aniello A, 1998, NEUROSCI LETT, V250, P131, DOI 10.1016/S0304-3940(98)00451-0; D'Aniello A, 2000, FASEB J, V14, P699, DOI 10.1096/fasebj.14.5.699; D'Aniello A, 1998, FEBS LETT, V436, P23, DOI 10.1016/S0014-5793(98)01087-4; D'Aniello A, 2003, FEBS LETT, V552, P193, DOI 10.1016/S0014-5793(03)00921-9; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; D'Aniello S, 2007, AMINO ACIDS, V32, P21, DOI 10.1007/s00726-006-0347-5; D'Aniello S, 2005, BIOCHEM J, V386, P331, DOI 10.1042/BJ20041070; DAniello A, 1996, LIFE SCI, V59, P97, DOI 10.1016/0024-3205(96)00266-4; DANIELLO A, 1977, J NEUROCHEM, V29, P1053, DOI 10.1111/j.1471-4159.1977.tb06508.x; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; DAVIES LP, 1975, J NEUROCHEM, V25, P299; DOWDALL MJ, 1973, J NEUROCHEM, V20, P921, DOI 10.1111/j.1471-4159.1973.tb00063.x; DUNLOP DS, 1986, BIOCHEM BIOPH RES CO, V141, P27, DOI 10.1016/S0006-291X(86)80329-1; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; Errico F, 2008, MOL CELL NEUROSCI, V37, P236, DOI 10.1016/j.mcn.2007.09.012; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Fisher G, 1998, AMINO ACIDS, V15, P263, DOI 10.1007/BF01318865; FISHER GH, 1994, MOL CHEM NEUROPATHOL, V23, P115, DOI 10.1007/BF02815405; FISHER GH, 1991, BRAIN RES BULL, V26, P983, DOI 10.1016/0361-9230(91)90266-M; FOSTER AC, 1987, EUR J PHARMACOL, V133, P291, DOI 10.1016/0014-2999(87)90025-2; GUNDERSEN V, 1995, J NEUROSCI, V15, P4417; HASHIMOTO A, 1993, J NEUROCHEM, V61, P348, DOI 10.1111/j.1471-4159.1993.tb03575.x; HASHIMOTO A, 1993, FEBS LETT, V331, P4, DOI 10.1016/0014-5793(93)80286-4; HASHIMOTO A, 1995, EUR J NEUROSCI, V7, P1657, DOI 10.1111/j.1460-9568.1995.tb00687.x; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; HOLOPAINEN I, 1990, NEUROSCIENCE, V36, P115, DOI 10.1016/0306-4522(90)90355-8; IMAI K, 1995, BIOMED CHROMATOGR, V9, P106, DOI 10.1002/bmc.1130090211; ISHIDA AT, 1981, P NATL ACAD SCI-BIOL, V78, P5890, DOI 10.1073/pnas.78.9.5890; KANAY Y, 1992, NATURE, V30, P467; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Lima PA, 2003, EUR J NEUROSCI, V17, P507, DOI 10.1046/j.1460-9568.2003.02477.x; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Miao H, 2006, J NEUROCHEM, V97, P595, DOI 10.1111/j.1471-4159.2006.03791.x; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Nagata Y, 1999, FEBS LETT, V444, P160, DOI 10.1016/S0014-5793(99)00045-9; NEIDLE A, 1990, LIFE SCI, V46, P1517, DOI 10.1016/0024-3205(90)90424-P; Pampillo M, 2002, NEUROREPORT, V13, P2341, DOI 10.1097/00001756-200212030-00034; Raiteri L, 2007, J NEUROCHEM, V103, P952, DOI 10.1111/j.1471-4159.2007.04784.x; Raucci F, 2005, J ENDOCRINOL, V187, P347, DOI 10.1677/joe.1.06115; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, P NATL ACAD SCI USA, V94, P2013, DOI 10.1073/pnas.94.5.2013; Shibata K, 2003, COMP BIOCHEM PHYS B, V134, P307, DOI 10.1016/S1096-4959(02)00267-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Spinelli P, 2006, J CELL PHYSIOL, V206, P672, DOI 10.1002/jcp.20513; TEDESCHI G, 1994, BBA-PROTEIN STRUCT M, V1207, P217, DOI 10.1016/0167-4838(94)00071-9; Topo E, 2010, AMINO ACIDS, V38, P1561, DOI 10.1007/s00726-009-0369-x; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Wolosker H, 2000, NEUROSCIENCE, V100, P183, DOI 10.1016/S0306-4522(00)00321-3; Zaar K, 2002, J COMP NEUROL, V450, P272, DOI 10.1002/cne.10320	56	74	75	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1014	1027		10.1096/fj.10-168492	http://dx.doi.org/10.1096/fj.10-168492			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21163862				2022-12-25	WOS:000287806200021
J	Araki, T; Kusakabe, M; Nishida, E				Araki, Tetsuro; Kusakabe, Morioh; Nishida, Eisuke			A Transmembrane Protein EIG121L Is Required for Epidermal Differentiation during Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPULSIVE GUIDANCE MOLECULE; TGF-BETA; XENOPUS; CHORDIN; GENE; INHIBITION; INDUCTION; SIGNALS; BINDS; EXPRESSION	Epidermal differentiation in the ventral ectoderm of Xenopus embryos is regulated by the bone morphogenetic protein (BMP) pathway. However, it remains unclear how the BMP pathway is activated and induces the epidermal fate in the ventral ectoderm. Here, we identify a novel player in the BMP pathway that is required for epidermal differentiation during Xenopus early embryonic development. We show that Xenopus EIG121L (xEIG121L) protein, an evolutionarily conserved transmembrane protein, is expressed in the ventral ectoderm at the gastrula and neurula stages. Almost complete knockdown of xEIG121L protein with antisense morpholino oligonucleotides in early Xenopus embryos results in severe developmental defects, including the inhibition of epidermal differentiation and the induction of neural genes. Remarkably, our analysis shows that BMP/Smad1 signaling is severely suppressed in the xEIG121L knockdown ectoderm. Moreover, immunoprecipitation and immunostaining experiments suggest that xEIG121L protein physically interacts, and co-localizes, with BMP receptors. Thus, our results identify a novel regulator of the BMP pathway that has a positive role in BMP signaling and plays an essential role in epidermal differentiation during early embryonic development.	[Kusakabe, Morioh] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Kusakabe, Morioh; Nishida, Eisuke] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kusakabe, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	morioh@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp		Araki, Tetsuro/0000-0001-8933-2156	Kao Foundation for Arts and Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22770211, 21227004] Funding Source: KAKEN	Kao Foundation for Arts and Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Kao Foundation for Arts and Sciences (to M. K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. N. and M. K.).	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Araki T, 2007, GENE EXPR PATTERNS, V7, P666, DOI 10.1016/j.modgep.2007.03.004; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Deng L, 2005, CLIN CANCER RES, V11, P8258, DOI 10.1158/1078-0432.CCR-05-1189; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Suzuki A, 1997, DEVELOPMENT, V124, P3037; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	40	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6760	6768		10.1074/jbc.M110.177907	http://dx.doi.org/10.1074/jbc.M110.177907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177533	Green Published, hybrid			2022-12-25	WOS:000287476400083
J	Deleris, P; Trost, M; Topisirovic, I; Tanguay, PL; Borden, KLB; Thibault, P; Meloche, S				Deleris, Paul; Trost, Matthias; Topisirovic, Ivan; Tanguay, Pierre-Luc; Borden, Katherine L. B.; Thibault, Pierre; Meloche, Sylvain			Activation Loop Phosphorylation of ERK3/ERK4 by Group I p21-activated Kinases (PAKs) Defines a Novel PAK-ERK3/4-MAPK-activated Protein Kinase 5 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN REARRANGEMENT; NUCLEAR EXPORT; ERK3; MK5; EXPRESSION; PROTEIN-KINASE-5; LOCALIZATION; TRANSDUCTION; SPECIFICITY; INVOLVEMENT	Classical mitogen-activated protein (MAP) kinases are activated by dual phosphorylation of the Thr-Xxx-Tyr motif in their activation loop, which is catalyzed by members of the MAP kinase kinase family. The atypical MAP kinases extracellular signal-regulated kinase 3 (ERK3) and ERK4 contain a single phospho-acceptor site in this segment and are not substrates of MAP kinase kinases. Previous studies have shown that ERK3 and ERK4 are phosphorylated on activation loop residue Ser-189/Ser-186, resulting in their catalytic activation. However, the identity of the protein kinase mediating this regulatory event has remained elusive. We have used an unbiased biochemical purification approach to isolate the kinase activity responsible for ERK3 Ser-189 phosphorylation. Here, we report the identification of group I p21-activated kinases (PAKs) as ERK3/ERK4 activation loop kinases. We show that group I PAKs phosphorylate ERK3 and ERK4 on Ser-189 and Ser-186, respectively, both in vitro and in vivo, and that expression of activated Rac1 augments this response. Reciprocally, silencing of PAK1/2/3 expression by RNA interference (RNAi) completely abolishes Rac1-induced Ser-189 phosphorylation of ERK3. Importantly, we demonstrate that PAK-mediated phosphorylation of ERK3/ERK4 results in their enzymatic activation and in downstream activation of MAP kinase-activated protein kinase 5 (MK5) in vivo. Our results reveal that group I PAKs act as upstream activators of ERK3 and ERK4 and unravel a novel PAK-ERK3/ERK4-MK5 signaling pathway.	[Deleris, Paul; Trost, Matthias; Topisirovic, Ivan; Tanguay, Pierre-Luc; Borden, Katherine L. B.; Thibault, Pierre; Meloche, Sylvain] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Tanguay, Pierre-Luc; Meloche, Sylvain] Univ Montreal, Dept Mol Biol, Montreal, PQ H3C 3J7, Canada; [Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Meloche, S (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada.	sylvain.meloche@umontreal.ca	Trost, Matthias/A-9999-2009; Topisirovic, Ivan/A-9426-2008	Trost, Matthias/0000-0002-5732-700X; Topisirovic, Ivan/0000-0002-5510-9762	National Institutes of Health [98781]; Fonds de la Recherche en Sante du Quebec; Fondation pour la Recherche Medicale; Leukemia and Lymphoma Society; Canadian Institutes for Health Research; NATIONAL CANCER INSTITUTE [R01CA080728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 98781 (to K. L. B. B.). This work was also supported by the Fonds de la Recherche en Sante du Quebec and the Fondation pour la Recherche Medicale (to P. D.), the Leukemia and Lymphoma Society (to I. T.), and the Canadian Institutes for Health Research (to S. M. and P.-L. T.).	Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604	31	44	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6470	6478		10.1074/jbc.M110.181529	http://dx.doi.org/10.1074/jbc.M110.181529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177870	Green Published, hybrid			2022-12-25	WOS:000287476400057
J	Grass, J; Pabst, M; Kolarich, D; Poltl, G; Leonard, R; Brecker, L; Altmann, F				Grass, Josephine; Pabst, Martin; Kolarich, Daniel; Poeltl, Gerald; Leonard, Renaud; Brecker, Lothar; Altmann, Friedrich			Discovery and Structural Characterization of Fucosylated Oligomannosidic N-Glycans in Mushrooms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ASTRAEUS-HYGROMETRICUS; GRAPHITIC CARBON; LINKED GLYCANS; GLYCOPROTEINS; NMR; OLIGOSACCHARIDES; FUCOSE; GLYCOSYLATION	L-Fucose is a common constituent of Asn-linked glycans in vertebrates, invertebrates, and plants, but in fungal glycoproteins, fucose has not been found so far. However, by mass spectrometry we detected N-glycans and O-glycans containing one to six deoxyhexose residues in fruit bodies of several basidiomycetes. The N-glycans of chanterelles (Cantharellus cibarius) contained a deoxyhexose chromatographically identical to fucose and sensitive to alpha-L-fucosidase. Analysis of individual glycan species by tandem MS, glycosidase digestion, and finally H-1 NMR revealed the presence of L-fucose in alpha 1,6-linkage to an alpha 1,6-mannose of oligomannosidic N-glycans. The substitution by alpha 1,6-mannose of alpha 1,2-mannosyl residues of the canonical precursor structure was yet another hitherto unknown modification. No indication for the occurrence of yet other modifications, e. g. bisecting N-acetylglucosamine, was seen. Besides fucosylated N-glycans, short O-linked mannan chains substituted with fucose were present on chanterelle proteins. Although undiscovered so far, L-fucose appears to represent a prominent feature of protein-linked glycans in the fungal kingdom.	[Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Brecker, Lothar] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Vienna	Altmann, F (corresponding author), BOKU, Muthgasse 18, A-1190 Vienna, Austria.	friedrich.altmann@boku.ac.at	Kolarich, Daniel/B-6893-2012; Kolarich, Daniel/AAJ-3550-2020; Pabst, Martin/GOH-1766-2022	Kolarich, Daniel/0000-0002-8452-1350; Kolarich, Daniel/0000-0002-8452-1350; Pabst, Martin/0000-0001-9897-0723; Altmann, Friedrich/0000-0002-0112-7877; Leonard, Renaud/0000-0001-5023-1032				Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Berends E, 2009, APPL ENVIRON MICROB, V75, P4648, DOI 10.1128/AEM.00352-09; Bilan MI, 2008, CARBOHYD RES, V343, P2605, DOI 10.1016/j.carres.2008.06.001; BRUCH RC, 1982, J BIOL CHEM, V257, P3409; Brull LP, 1998, RAPID COMMUN MASS SP, V12, P1520; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; Chakraborty I, 2007, CARBOHYD RES, V342, P982, DOI 10.1016/j.carres.2007.02.004; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gminder A., 2008, HDB PILZSAMMLER ARTE; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Maiti D, 2008, CARBOHYD RES, V343, P817, DOI 10.1016/j.carres.2007.12.003; Mondal S, 2008, CARBOHYD RES, V343, P1062, DOI 10.1016/j.carres.2008.02.017; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pabst M, 2010, CARBOHYD RES, V345, P1389, DOI 10.1016/j.carres.2010.02.017; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Petrescu AJ, 1997, EMBO J, V16, P4302, DOI 10.1093/emboj/16.14.4302; Ren Y, 2010, BIOCHEM BIOPH RES CO, V391, P1663, DOI 10.1016/j.bbrc.2009.12.116; Rendic D, 2007, ELECTROPHORESIS, V28, P4484, DOI 10.1002/elps.200700098; Roitinger A, 1998, GLYCOCONJUGATE J, V15, P89, DOI 10.1023/A:1006951802623; Sandstrom C, 2004, BIOCHEMISTRY-US, V43, P13926, DOI 10.1021/bi048676k; Sato H, 2008, CARBOHYD RES, V343, P1333, DOI 10.1016/j.carres.2008.03.008; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Taylor AM, 2006, PROTEOMICS, V6, P2936, DOI 10.1002/pmic.200500331; VANHALBEEK H, 1980, FEBS LETT, V121, P65; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Wuhrer M, 2009, ANAL CHEM, V81, P4422, DOI 10.1021/ac900278q; Ye LB, 2009, FOOD CHEM, V112, P962, DOI 10.1016/j.foodchem.2008.07.017; Zhang LY, 2003, J CHROMATOGR B, V793, P159, DOI 10.1016/S1570-0232(03)00373-8	37	23	23	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5977	5984		10.1074/jbc.M110.191304	http://dx.doi.org/10.1074/jbc.M110.191304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169363	Green Published, hybrid			2022-12-25	WOS:000287476400005
J	Inoue, J; Nagae, T; Mishima, M; Ito, Y; Shibata, T; Mikawa, T				Inoue, Jin; Nagae, Takayuki; Mishima, Masaki; Ito, Yutaka; Shibata, Takehiko; Mikawa, Tsutomu			A Mechanism for Single-stranded DNA-binding Protein (SSB) Displacement from Single-stranded DNA upon SSB-RecO Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SSB; DEINOCOCCUS-RADIODURANS; GENETIC-RECOMBINATION; BREAK REPAIR; CRYSTAL-STRUCTURE; DUPLEX DNA; THERMUS-THERMOPHILUS; EXONUCLEASE-I; REPLICATION; POLYMERASE	Displacement of single-stranded DNA (ssDNA)-binding protein (SSB) from ssDNA is necessary for filament formation of RecA on ssDNA to initiate homologous recombination. The interaction between RecO and SSB is considered to be important for SSB displacement; however, the interaction has not been characterized at the atomic level. In this study, to clarify the mechanism underlying SSB displacement from ssDNA upon RecO binding, we examined the interaction between Thermus thermophilus RecO and cognate SSB by NMR analysis. We found that SSB interacts with the C-terminal positively charged region of RecO. Based on this result, we constructed some RecO mutants. The R127A mutant had considerably decreased binding affinity for SSB and could not anneal SSB-coated ssDNAs. Further, the mutant in the RecOR complex prevented the recovery of ssDNA-dependent ATPase activity of RecA from inhibition by SSB. These results indicated that the region surrounding Arg-127 is the binding site of SSB. We also performed NMR analysis using the C-terminal peptide of SSB and found that the acidic region of SSB is involved in the interaction with RecO, as seen in other protein-SSB interactions. Taken together with the findings of previous studies, we propose a model for SSB displacement from ssDNA where the acidic C-terminal region of SSB weakens the ssDNA binding affinity of SSB when the dynamics of the C-terminal region are suppressed by interactions with other proteins, including RecO.	[Mikawa, Tsutomu] Yokohama City Univ, Grad Sch Nanobiosci, RIKEN Adv Sci Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Inoue, Jin; Shibata, Takehiko; Mikawa, Tsutomu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Nagae, Takayuki; Mishima, Masaki; Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	RIKEN; Yokohama City University; RIKEN; Tokyo Metropolitan University; RIKEN	Mikawa, T (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, RIKEN Adv Sci Inst, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	mikawa@riken.jp	Mikawa, Tsutomu/E-6510-2013; Ito, Yutaka/P-2604-2015	Mikawa, Tsutomu/0000-0003-2325-5084; Ito, Yutaka/0000-0002-1030-4660	Grant-in-Aid for Scientific Research on Innovative Areas [21200058]	Grant-in-Aid for Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (21200058).	Arad G, 2008, J BIOL CHEM, V283, P8274, DOI 10.1074/jbc.M710290200; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Eggington JM, 2006, BIOCHEMISTRY-US, V45, P14490, DOI 10.1021/bi061178m; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kato R, 1999, EUR J BIOCHEM, V259, P592, DOI 10.1046/j.1432-1327.1999.00044.x; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; LLOYD RG, 1985, J BACTERIOL, V164, P836, DOI 10.1128/JB.164.2.836-844.1985; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rajesh S, 1999, BIOCHEMISTRY-US, V38, P9242, DOI 10.1021/bi9903953; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; TSENG YC, 1994, MUTAT RES, V315, P1; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	58	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6720	6732		10.1074/jbc.M110.164210	http://dx.doi.org/10.1074/jbc.M110.164210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169364	Green Published, hybrid			2022-12-25	WOS:000287476400079
J	Riano-Umbarila, L; Contreras-Ferrat, G; Olamendi-Portugal, T; Morelos-Juarez, C; Corzo, G; Possani, LD; Becerril, B				Riano-Umbarila, Lidia; Contreras-Ferrat, Gabriel; Olamendi-Portugal, Timoteo; Morelos-Juarez, Citlalli; Corzo, Gerardo; Possani, Lourival D.; Becerril, Baltazar			Exploiting Cross-reactivity to Neutralize Two Different Scorpion Venoms with One Single Chain Antibody Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; CENTRUROIDES-NOXIUS HOFFMANN; LIMPIDUS-LIMPIDUS KARSCH; DIRECTED EVOLUTION; MONOCLONAL-ANTIBODIES; FUNCTIONAL-EVALUATION; PHAGE DISPLAY; FV ANTIBODIES; NA+-CHANNELS; TOXIN CN2	We report the optimization of a family of human single chain antibody fragments (scFv) for neutralizing two scorpion venoms. The parental scFv 3F recognizes the main toxins of Centruroides noxius Hoffmann (Cn2) and Centruroides suffusus suffusus (Css2), albeit with low affinity. This scFv was subjected to independent processes of directed evolution to improve its recognition toward Cn2 (Riano-Umbarila, L., Juarez-Gonzalez, V. R., Olamendi-Portugal, T., Ortiz-Leon, M., Possani, L. D., and Becerril, B. (2005) FEBS J. 272, 2591-2601) and Css2 (this work). Each evolved variant showed strong cross-reactivity against several toxins, and was capable of neutralizing Cn2 and Css2. Furthermore, each variant neutralized the whole venoms of the above species. As far as we know, this is the first report of antibodies with such characteristics. Maturation processes revealed key residue changes to attain expression, stability, and affinity improvements as compared with the parental scFv. Combination of these changes resulted in the scFv LR, which is capable of rescuing mice from severe envenomation by 3 LD50 of freshly prepared whole venom of C. noxius (7.5 mu g/20 g of mouse) and C. suffusus (26.25 mu g/20 g of mouse), with surviving rates between 90 and 100%. Our research is leading to the formulation of an antivenom consisting of a discrete number of human scFvs endowed with strong cross-reactivity and low immunogenicity.	[Riano-Umbarila, Lidia; Contreras-Ferrat, Gabriel; Olamendi-Portugal, Timoteo; Morelos-Juarez, Citlalli; Corzo, Gerardo; Possani, Lourival D.; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Becerril, B (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	baltazar@ibt.unam.mx	Possani, Lourival D/J-2397-2013; Corzo, Gerardo/B-3778-2014	Corzo, Gerardo/0000-0002-9513-1622; Riano-Umbarila, Lidia/0000-0002-2531-9232	Instituto Bioclon [P-156]	Instituto Bioclon	This work was supported by Grant P-156 from the Instituto Bioclon.	Adams GP, 1998, CANCER RES, V58, P485; ALAGON AC, 1988, COMP BIOCHEM PHYS B, V89, P153, DOI 10.1016/0305-0491(88)90277-5; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2; Devaux C, 1997, FEBS LETT, V412, P456, DOI 10.1016/S0014-5793(97)00826-0; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Dubreuil O, 2005, J BIOL CHEM, V280, P24880, DOI 10.1074/jbc.M500048200; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Harvey BR, 2006, J IMMUNOL METHODS, V308, P43, DOI 10.1016/j.jim.2005.09.017; Hernandez-Salgado K, 2009, IMMUNOL LETT, V125, P93, DOI 10.1016/j.imlet.2009.06.001; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P291, DOI 10.1081/CLT-120021114; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Korpimaki T, 2003, PROTEIN ENG, V16, P37, DOI 10.1093/proeng/gzg010; Leung D. W., 1989, TECHNIQUE, V1, P11; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miyazaki C, 1999, PROTEIN ENG, V12, P407, DOI 10.1093/protein/12.5.407; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Oppezzo P, 2004, EUR J IMMUNOL, V34, P1423, DOI 10.1002/eji.200424936; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; RAMIREZ AN, 1994, TOXICON, V32, P479, DOI 10.1016/0041-0101(94)90300-X; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schier R, 1996, GENE, V169, P147, DOI 10.1016/0378-1119(95)00821-7; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Selisko B, 2004, TOXICON, V43, P43, DOI 10.1016/j.toxicon.2003.10.015; Selisko B, 1999, PROTEINS, V37, P130, DOI 10.1002/(SICI)1097-0134(19991001)37:1&lt;130::AID-PROT13&gt;3.0.CO;2-S; Seo MJ, 2009, PROTEIN SCI, V18, P259, DOI 10.1002/pro.31; Short MK, 2001, PROTEIN ENG, V14, P287, DOI 10.1093/protein/14.4.287; Weaver-Feldhaus JM, 2005, PROTEIN ENG DES SEL, V18, P527, DOI 10.1093/protein/gzi060; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	49	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6143	6151		10.1074/jbc.M110.189175	http://dx.doi.org/10.1074/jbc.M110.189175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156801	Green Published, hybrid			2022-12-25	WOS:000287476400023
J	Sun, J; Conn, CS; Han, Y; Yeung, V; Qian, SB				Sun, Jun; Conn, Crystal S.; Han, Yan; Yeung, Vincent; Qian, Shu-Bing			PI3K-mTORC1 Attenuates Stress Response by Inhibiting Cap-independent Hsp70 Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; LIFE-SPAN; MOLECULAR CHAPERONES; PREFERENTIAL TRANSLATION; BINDING PARTNER; CELL STRESS; MTOR; TOR; INITIATION; KINASE	Protein synthesis is a key regulated cellular process that links nutrient availability and organismal growth. It has long been known that some cellular proteins continue to be synthesized under conditions where global translation is severely compromised. One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions. Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined. Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling. Despite the transcriptional up-regulation, the translation of Hsp70 mRNA is deficient in cells lacking tuberous sclerosis complex 2. Conversely, Hsp70 synthesis is enhanced under the reduced PI3K-mTORC1 signaling. We found that the 5' UTR of Hsp70 mRNA contributes to cap-independent translation without exhibiting typical features of internal ribosome entry site. Our findings imply a plausible mechanism for how persistent PI3K-mTORC1 signaling favors the development of age-related pathologies by attenuating stress resistance.	[Conn, Crystal S.; Qian, Shu-Bing] Cornell Univ, Grad Field Genet & Dev, Ithaca, NY 14853 USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Qian, SB (corresponding author), Cornell Univ, Grad Field Genet & Dev, 301 Biotech, Ithaca, NY 14853 USA.	sq38@cornell.edu	Conn, Crystal S/ABF-8464-2020	Conn, Crystal S/0000-0003-3209-0445	National Institutes of Health; Ellison Medical Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported, in whole or in part, by a National Institutes of Health grant and the Ellison Medical Foundation (to S.- B. Q.).	Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOSELEY PL, 1993, AM J PHYSIOL, V264, pL533, DOI 10.1152/ajplung.1993.264.6.L533; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Neef DW, 2009, MOL MICROBIOL, V73, P1032, DOI 10.1111/j.1365-2958.2009.06827.x; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	63	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6791	6800		10.1074/jbc.M110.172882	http://dx.doi.org/10.1074/jbc.M110.172882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177857	Green Published, hybrid			2022-12-25	WOS:000287476400086
J	Bolusani, S; Young, BA; Cole, NA; Tibbetts, AS; Momb, J; Bryant, JD; Solmonson, A; Appling, DR				Bolusani, Swetha; Young, Blake A.; Cole, Nicola A.; Tibbetts, Anne S.; Momb, Jessica; Bryant, Joshua D.; Solmonson, Ashley; Appling, Dean R.			Mammalian MTHFD2L Encodes a Mitochondrial Methylenetetrahydrofolate Dehydrogenase Isozyme Expressed in Adult Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; SERINE HYDROXYMETHYLTRANSFERASE ISOZYMES; C-13 NMR ANALYSIS; SACCHAROMYCES-CEREVISIAE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; C-1-TETRAHYDROFOLATE SYNTHASE; 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE; SUBMITOCHONDRIAL LOCALIZATION; C1-TETRAHYDROFOLATE SYNTHASE; HOMOCYSTEINE REMETHYLATION	Previous studies in our laboratory showed that isolated, intact adult rat liver mitochondria are able to oxidize the 3-carbon of serine and the N-methyl carbon of sarcosine to formate without the addition of any other cofactors or substrates. Conversion of these 1-carbon units to formate requires several folate-interconverting enzymes in mitochondria. The enzyme(s) responsible for conversion of 5,10-methylene-tetrahydrofolate (CH2-THF) to 10-formyl-THF in adult mammalian mitochondria are currently unknown. A new mitochondrial CH2-THF dehydrogenase isozyme, encoded by the MTHFD2L gene, has now been identified. The recombinant protein exhibits robust NADP(+)-dependent CH2-THF dehydrogenase activity when expressed in yeast. The enzyme is localized to mitochondria when expressed in CHO cells and behaves as a peripheral membrane protein, tightly associated with the matrix side of the mitochondrial inner membrane. The MTHFD2L gene is subject to alternative splicing and is expressed in adult tissues in humans and rodents. This CH2-THF dehydrogenase isozyme thus fills the remaining gap in the pathway from CH2-THF to formate in adult mammalian mitochondria.	[Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu		Solmonson, Ashley/0000-0001-8863-4558	National Institutes of Health [DK61425, GM086856]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61425 and GM086856 (to D. R. A.).	Alonso G, 1997, CELL TISSUE RES, V288, P59, DOI 10.1007/s004410050792; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BELANGER C, 1989, J BIOL CHEM, V264, P4837; Bergeron F, 1998, EUR J BIOCHEM, V257, P556, DOI 10.1046/j.1432-1327.1998.2570556.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Greenawalt J W, 1974, Methods Enzymol, V31, P310; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Howard KM, 2003, GENE, V319, P85, DOI 10.1016/S0378-1119(03)00796-0; HUM DW, 1988, J BIOL CHEM, V263, P15946; KAO FT, 1975, GENETICS, V79, P343; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Nair JR, 2005, BBA-MOL CELL RES, V1746, P38, DOI 10.1016/j.bbamcr.2005.08.004; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Pasternack LB, 1996, ARCH BIOCHEM BIOPHYS, V326, P158, DOI 10.1006/abbi.1996.0060; PASTERNACK LB, 1994, BIOCHEMISTRY-US, V33, P74, DOI 10.1021/bi00167a010; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; WEST MG, 1993, J BIOL CHEM, V268, P153; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	58	44	50	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5166	5174		10.1074/jbc.M110.196840	http://dx.doi.org/10.1074/jbc.M110.196840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163947	Green Published, hybrid			2022-12-25	WOS:000287230600025
J	Kang, YH; Zhang, Y; Liang, T; Leung, YM; Ng, B; Xie, HL; Chang, N; Chan, J; Shyng, SL; Tsushima, RG; Gaisano, HY				Kang, Youhou; Zhang, Yi; Liang, Tao; Leung, Yuk-Man; Ng, Betty; Xie, Huanli; Chang, Nathan; Chan, Joseph; Shyng, Show-Ling; Tsushima, Robert G.; Gaisano, Herbert Y.			ATP Modulates Interaction of Syntaxin-1A with Sulfonylurea Receptor 1 to Regulate Pancreatic beta-Cell K-ATP Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; CONGENITAL HYPERINSULINISM; EXOCYTOTIC PROTEINS; POTASSIUM CHANNELS; INSULIN-SECRETION; SENSITIVITY; ACTIVATION; SUR1; EXCITABILITY; TRAFFICKING	ATP-sensitive potassium (K-ATP) channels are regulated by a variety of cytosolic factors (adenine nucleotides, Mg2+, phospholipids, and pH). We previously reported that K-ATP channels are also regulated by endogenous membrane-bound SNARE protein syntaxin-1A (Syn-1A), which binds both nucleotide-binding folds of sulfonylurea receptor (SUR) 1 and 2A, causing inhibition of K-ATP channel activity in pancreatic islet beta-cells and cardiac myocytes, respectively. In this study, we show that ATP dose-dependently inhibits Syn-1A binding to SUR1 at physiological concentrations, with the addition of Mg2+ causing a decrease in the ATP-induced inhibitory effect. This ATP disruption of Syn-1A binding to SUR1 was confirmed by FRET analysis in living HEK293 cells. Electrophysiological studies in pancreatic beta-cells demonstrated that reduced ATP concentrations increased K-ATP channel sensitivity to Syn-1A inhibition. Depletion of endogenous Syn-1A in insulinoma cells by botulinum neurotoxin C1 proteolysis followed by rescue with exogenous Syn-1A showed that Syn-1A modulates K-ATP channel sensitivity to ATP. Thus, our data indicate that although both ATP and Syn-1A independently inhibit beta-cell K-ATP channel gating, they could also influence the sensitivity of K-ATP channels to each other. These findings provide new insight into an alternate mechanism by which ATP regulates pancreatic beta-cell K-ATP channel activity, not only by its direct actions on Kir6.2 pore subunit, but also via ATP modulation of Syn-1A binding to SUR1.	[Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Hlth Network, Toronto, ON M5S 1A8, Canada; [Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Tsushima, Robert G.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Oregon Health & Science University; York University - Canada	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 69083]; Heart and Stroke Foundation of Ontario [T-6064]; National Institutes of Health [R01DK066485]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Canadian Institutes for Health Research (MOP 69083), the Heart and Stroke Foundation of Ontario (T-6064) ( to H.Y.G.), and the National Institutes of Health (R01DK066485 to S.-L.S.).	ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; Flechtner I, 2008, BEST PRACT RES CL EN, V22, P17, DOI 10.1016/j.beem.2007.08.003; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; James C, 2009, J MED GENET, V46, P289, DOI 10.1136/jmg.2008.064337; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kang YH, 2006, J BIOL CHEM, V281, P19019, DOI 10.1074/jbc.M513160200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; McHugh D, 1996, J PHYSIOL-LONDON, V492, P359, DOI 10.1113/jphysiol.1996.sp021314; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Tarasov AI, 2006, DIABETES, V55, P2446, DOI 10.2337/db06-0360; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Webster NJ, 2008, ENDOCRINOLOGY, V149, P3679, DOI 10.1210/en.2007-1138; Wu J, 2002, J MEMBRANE BIOL, V190, P105, DOI 10.1007/s00232-002-1029-1; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	35	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5876	5883		10.1074/jbc.M109.089607	http://dx.doi.org/10.1074/jbc.M109.089607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173146	Green Published, hybrid			2022-12-25	WOS:000287230600096
J	Varedi, SM; Ventura, AC; Merajver, SD; Lin, XN				Varedi K, S. Marjan; Ventura, Alejandra C.; Merajver, Sofia D.; Lin, Xiaoxia Nina			Multisite Phosphorylation Provides an Effective and Flexible Mechanism for Switch-Like Protein Degradation	PLOS ONE			English	Article							CDK INHIBITOR SIC1; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; RETINOBLASTOMA PROTEIN; COVALENT MODIFICATION; POLYVALENT LIGAND; KINASE; COMPLEX; ULTRASENSITIVITY	Phosphorylation-triggered degradation is a common strategy for elimination of regulatory proteins in many important cell signaling processes. Interesting examples include cyclin-dependent kinase inhibitors such as p27 in human and Sic1 in yeast, which play crucial roles during the G1/S transition in the cell cycle. In this work, we have modeled and analyzed the dynamics of multisite-phosphorylation-triggered protein degradation systematically. Inspired by experimental observations on the Sic1 protein and a previous intriguing theoretical conjecture, we develop a model to examine in detail the degradation dynamics of a protein featuring multiple phosphorylation sites and a threshold site number for elimination in response to a kinase signal. Our model explains the role of multiple phosphorylation sites, compared to a single site, in the regulation of protein degradation. A single-site protein cannot convert a graded input of kinase increase to much sharper output, whereas multisite phosphorylation is capable of generating a highly switch-like temporal profile of the substrate protein with two characteristics: a temporal threshold and rapid decrease beyond the threshold. We introduce a measure termed temporal response coefficient to quantify the extent to which a response in the time domain is switch-like and further investigate how this property is determined by various factors including the kinase input, the total number of sites, the threshold site number for elimination, the order of phosphorylation, the kinetic parameters, and site preference. Some interesting and experimentally verifiable predictions include that the non-degradable fraction of the substrate protein exhibits a more switch-like temporal profile; a sequential system is more switch-like, while a random system has the advantage of increased robustness; all the parameters, including the total number of sites, the threshold site number for elimination and the kinetic parameters synergistically determine the exact extent to which the degradation profile is switch-like. Our results suggest design principles for protein degradation switches which might be a widespread mechanism for precise regulation of cellular processes such as cell cycle progression.	[Varedi K, S. Marjan; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Ventura, Alejandra C.; Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.; Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Varedi, SM (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu	Ganji, Davood Domiri/Z-3664-2019	Ganji, Davood Domiri/0000-0002-2344-526X	University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB); Department of Defense; Burroughs Wellcome Fund; Breast Cancer Research Foundation; NIH [RO1 CA77612]; NATIONAL CANCER INSTITUTE [R01CA077612] Funding Source: NIH RePORTER	University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB)(University of Michigan System); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Michigan, Center of Computational Medicine and Bioinformatics (CCMB) 2007 Pilot Grant. ACV was supported by the Department of Defense Breast Cancer Research Program. SDM was funded by the Burroughs Wellcome Fund, the Breast Cancer Research Foundation and the NIH (RO1 CA77612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Bao MZ, 2010, EUKARYOT CELL, V9, P31, DOI 10.1128/EC.00250-09; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Coccetti P, 2006, BIOCHEM BIOPH RES CO, V346, P786, DOI 10.1016/j.bbrc.2006.05.171; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krishnamurthy S, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-13; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XF, 2010, BIOPHYS J, V98, P1396, DOI 10.1016/j.bpj.2009.12.4307; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Qian H, 2008, BIOCHEMISTRY-US, V47, P2211, DOI 10.1021/bi702125s; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sedgwick C, 2006, BIOCHEM J, V399, P151, DOI 10.1042/BJ20060363; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang SQ, 2007, LEUKEMIA RES, V31, P839, DOI 10.1016/j.leukres.2006.08.016; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	75	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14029	10.1371/journal.pone.0014029	http://dx.doi.org/10.1371/journal.pone.0014029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179196	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900001
J	Wong, SSC; Truong, K				Wong, Stanley S. C.; Truong, Kevin			Fluorescent Protein-Based Methods for On-Plate Screening of Gene Insertion	PLOS ONE			English	Article								Background: Unlike the commonly used method of blue-white screening for gene insertion, a fluorescent protein-based screening method offers a gain-of-function screening process without using any co-factors and a gene fusion product with a fluorescent protein reporter that is further useful in cell imaging studies. However, complications related to protein-folding efficiencies of the gene insert in fusion with fluorescent protein reporters prevent effective on-plate bacterial colony selection leading to its limited use. Methodology/Principal Findings: Here, we present three methods to tackle this problem. Our first method promotes the folding of the gene insert by using an N-terminal protein such as calmodulin that is well folded and expressed. Under this method, fluorescence was increased more than 30x over control allowing for enhanced screening. Our second method creates a fluorescent protein that is N-terminal to the gene upon insertion, thereby reducing the dependency of the fluorescent protein reporter on the folding of the gene insert. Our third method eliminates any dependence of the fluorescent protein reporter on the folding of the gene insert by using a stop and start sequence for protein translation. Conclusions/Significance: The three methods together will expand the usefulness of fluorescence on-plate screening and offer a powerful alternative to blue-white screening.	[Wong, Stanley S. C.; Truong, Kevin] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Truong, Kevin] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto	Wong, SSC (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	kevin.truong@utoronto.ca		Truong, Kevin/0000-0002-9520-2144	Canadian Institutes of Health Research [81262]; Heart and Stroke Foundation [NA6241]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by grants to KT from the Canadian Institutes of Health Research (# 81262) and Heart and Stroke Foundation (# NA6241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; CABANTOUS S, 2005, NAT BIOTECHNOL, V23, P6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DAS A, 1984, NUCLEIC ACIDS RES, V12, P12; Gerth ML, 2004, PROTEIN ENG DES SEL, V17, P595, DOI 10.1093/protein/gzh068; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P5; KEESE P, 1996, NUCLEIC ACIDS RES, V24, P2; Kim HK, 1998, BRAIN RES BULL, V47, P35, DOI 10.1016/S0361-9230(98)00020-3; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; PAPINA M, 2002, COMP BIOCH PHYSL B, V131, P8; PEDELACQ JD, 2006, NAT BIOTECHNOL, V24, P11; RIZZO MA, 2004, NAT BIOTECHNOL, V22, P5; SHINE J, 1975, NAT BIOTECHNOL, V254, P5; STEEGE DA, 1977, P NATL ACAD SCI USA, V74, P4163, DOI 10.1073/pnas.74.10.4163; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; TSIEN RY, 1998, ANNU REV BIOCHEM, V67, P38; WALDO GS, 1999, NAT BIOTECHNOL, V17, P5; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14274	10.1371/journal.pone.0014274	http://dx.doi.org/10.1371/journal.pone.0014274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170317	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400006
J	Panza, G; Luers, L; Stohr, J; Nagel-Steger, L; Weiss, J; Riesner, D; Willbold, D; Birkmann, E				Panza, Giannantonio; Luers, Lars; Stoehr, Jan; Nagel-Steger, Luitgard; Weiss, Juergen; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva			Molecular Interactions between Prions as Seeds and Recombinant Prion Proteins as Substrates Resemble the Biological Interspecies Barrier In Vitro	PLOS ONE			English	Article							MAMMALIAN PRIONS; SCRAPIE; CONVERSION; DISEASE; PRPSC; BSE; MECHANISMS; STRAINS; PATHWAY; FORM	Prion diseases like Creutzfeldt-Jakob disease in humans, Scrapie in sheep or bovine spongiform encephalopathy are fatal neurodegenerative diseases, which can be of sporadic, genetic, or infectious origin. Prion diseases are transmissible between different species, however, with a variable species barrier. The key event of prion amplification is the conversion of the cellular isoform of the prion protein (PrPC) into the pathogenic isoform (PrPSc). We developed a sodiumdodecylsulfate-based PrP conversion system that induces amyloid fibril formation from soluble alpha-helical structured recombinant PrP (recPrP). This approach was extended applying pre-purified PrPSc as seeds which accelerate fibrillization of recPrP. In the present study we investigated the interspecies coherence of prion disease. Therefore we used PrPSc from different species like Syrian hamster, cattle, mouse and sheep and seeded fibrillization of recPrP from the same or other species to mimic in vitro the natural species barrier. We could show that the in vitro system of seeded fibrillization is in accordance with what is known from the naturally occurring species barriers.	[Panza, Giannantonio; Luers, Lars; Stoehr, Jan; Nagel-Steger, Luitgard; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany; [Weiss, Juergen] Deutsch Diabet Zentrum, Inst Klin Biochem & Pathobiochem, Dusseldorf, Germany; [Willbold, Dieter; Birkmann, Eva] Forschungszentrum Julich, Inst Strukturbiol & Biophys 3, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Helmholtz Association; Research Center Julich	Panza, G (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany.	e.birkmann@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Stöhr, Jan/A-9638-2009; Birkmann, Eva/H-6019-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Stöhr, Jan/0000-0003-2610-7458; Birkmann, Eva/0000-0002-2069-0630; Willbold, Dieter/0000-0002-0065-7366	European Union [FOOD-CT-2004-506579]; Presidentenfond der Helmholtzgemeinschaft (HGF, "Virtual Institute of Structural Biology"); Food Standards Agency UK [M03R0005/004]; Deutsche Forschungsgemeinschaft (DFG)	European Union(European Commission); Presidentenfond der Helmholtzgemeinschaft (HGF, "Virtual Institute of Structural Biology"); Food Standards Agency UK; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This authors were funded by the European Union: (Network of Excellence "NeuroPrion", FOOD-CT-2004-506579, http://www.neuroprion.org/en/index. html); "Presidentenfond der Helmholtzgemeinschaft" (HGF, "Virtual Institute of Structural Biology"), http://www.vibs-rhine-ruhr.org/; and Food Standards Agency UK (M03R0005/004) http://www.food.gov.uk/. Lars Luers was a fellow of the Graduiertenkolleg 1033. Jan Stohr was supported by a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Birkmann E, 2006, BIOL CHEM, V387, P95, DOI 10.1515/BC.2006.013; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Laurent M, 1997, FEBS LETT, V407, P1, DOI 10.1016/S0014-5793(97)00310-4; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li L, 2007, BIOCHEM BIOPH RES CO, V364, P796, DOI 10.1016/j.bbrc.2007.10.087; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Panza G, 2008, BIOCHEM BIOPH RES CO, V373, P493, DOI 10.1016/j.bbrc.2008.06.059; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Wells GAH, 1991, BRAIN PATHOL, V1, P69, DOI 10.1111/j.1750-3639.1991.tb00642.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14283	10.1371/journal.pone.0014283	http://dx.doi.org/10.1371/journal.pone.0014283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151607	Green Published, gold			2022-12-25	WOS:000285135800013
J	Shimazawa, M; Tanaka, H; Ito, Y; Morimoto, N; Tsuruma, K; Kadokura, M; Tamura, S; Inoue, T; Yamada, M; Takahashi, H; Warita, H; Aoki, M; Hara, H				Shimazawa, Masamitsu; Tanaka, Hirotaka; Ito, Yasushi; Morimoto, Nobutaka; Tsuruma, Kazuhiro; Kadokura, Michinori; Tamura, Shigeki; Inoue, Teruyoshi; Yamada, Mitsunori; Takahashi, Hitoshi; Warita, Hitoshi; Aoki, Masashi; Hara, Hideaki			An Inducer of VGF Protects Cells against ER Stress-Induced Cell Death and Prolongs Survival in the Mutant SOD1 Animal Models of Familial ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC MOUSE MODEL; MOTOR-NEURON DISEASE; CSF BIOMARKERS; GENE VGF; PEPTIDE; INDUCTION; PATHWAYS; BRAIN	Amyotrophic lateral sclerosis (ALS) is the most frequent adult-onset motor neuron disease, and recent evidence has suggested that endoplasmic reticulum (ER) stress signaling is involved in the pathogenesis of ALS. Here we identified a small molecule, SUN N8075, which has a marked protective effect on ER stress-induced cell death, in an in vitro cell-based screening, and its protective mechanism was mediated by an induction of VGF nerve growth factor inducible (VGF): VGF knockdown with siRNA completely abolished the protective effect of SUN N8075 against ER-induced cell death, and overexpression of VGF inhibited ER-stress-induced cell death. VGF level was lower in the spinal cords of sporadic ALS patients than in the control patients. Furthermore, SUN N8075 slowed disease progression and prolonged survival in mutant SOD1 transgenic mouse and rat models of ALS, preventing the decrease of VGF expression in the spinal cords of ALS mice. These data suggest that VGF plays a critical role in motor neuron survival and may be a potential new therapeutic target for ALS, and SUN N8075 may become a potential therapeutic candidate for treatment of ALS.	[Shimazawa, Masamitsu; Tanaka, Hirotaka; Ito, Yasushi; Morimoto, Nobutaka; Tsuruma, Kazuhiro; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Kadokura, Michinori; Tamura, Shigeki; Inoue, Teruyoshi] Asubio Pharma Co Ltd, Biomed Res Labs, Osaka, Japan; [Yamada, Mitsunori] Saigata Natl Hosp, Natl Hosp Org, Dept Clin Res, Niigata, Japan; [Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Warita, Hitoshi; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	Gifu Pharmaceutical University; Asubio Pharma Co., Ltd.; Niigata University; Tohoku University	Shimazawa, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Warita, Hitoshi/T-1970-2019	Warita, Hitoshi/0000-0001-7934-3863; INOUE, TERUYOSHI/0000-0002-1785-6062	Japanese Ministry of Health Labor and Welfare; Takeda Science Foundation	Japanese Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Japanese Ministry of Health Labor and Welfare and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alder J, 2003, J NEUROSCI, V23, P10800; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Annoura H, 2000, J MED CHEM, V43, P3372, DOI 10.1021/jm000143w; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Jiang YH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-70; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; LIU JW, 1994, ENDOCRINOLOGY, V135, P2742, DOI 10.1210/en.135.6.2742; Maruyama W, 2002, NEUROTOXICOL TERATOL, V24, P675, DOI 10.1016/S0892-0362(02)00221-0; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagata T, 2007, NEUROL RES, V29, P767, DOI 10.1179/016164107X229803; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; PIORO EP, 1995, CLIN NEUROSCI, V3, P375; POSSENTI R, 1989, EMBO J, V8, P2217, DOI 10.1002/j.1460-2075.1989.tb08345.x; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Succu S, 2005, NEUROPHARMACOLOGY, V49, P1017, DOI 10.1016/j.neuropharm.2005.05.015; Sun W, 2002, J NEUROSCI, V22, P6537; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhao Zhong, 2008, Int J Med Sci, V5, P92	41	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15307	10.1371/journal.pone.0015307	http://dx.doi.org/10.1371/journal.pone.0015307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151573	Green Submitted, Green Published, gold			2022-12-25	WOS:000285135800024
J	Kilpinen, S; Ojala, K; Kallioniemi, O				Kilpinen, Sami; Ojala, Kalle; Kallioniemi, Olli			Analysis of Kinase Gene Expression Patterns across 5681 Human Tissue Samples Reveals Functional Genomic Taxonomy of the Kinome	PLOS ONE			English	Article							VACCINIA-RELATED KINASE-1; PROTEIN-KINASE; MICROARRAY PLATFORMS; MAMMALIAN-CELLS; BREAST-CANCER; DIFFERENTIATION; CHECKPOINT; REGULATORS; ARRAYS; P53	Kinases play key roles in cell signaling and represent major targets for drug development, but the regulation of their activation and their associations with health and disease have not been systematically analyzed. Here, we carried out a bioinformatic analysis of the expression levels of 459 human kinase genes in 5681 samples consisting of 44 healthy and 55 malignant human tissues. Defining the tissues where the kinase genes were transcriptionally active led to a functional genomic taxonomy of the kinome and a classification of human tissues and disease types based on the similarity of their kinome gene expression. The co-expression network around each of the kinase genes was defined in order to determine the functional context, i.e. the biological processes that were active in the cells and tissues where the kinase gene was expressed. Strong associations for individual kinases were found for mitosis (69 genes, including AURKA and BUB1), cell cycle control (73 genes, including PLK1 and AURKB), DNA repair (49 genes, including CHEK1 and ATR), immune response (72 genes, including MATK), neuronal (131 genes, including PRKCE) and muscular (72 genes, including MYLK2) functions. We then analyzed which kinase genes gain or lose transcriptional activity in the development of prostate and lung cancers and elucidated the functional associations of individual cancer associated kinase genes. In summary, we report here a systematic classification of kinases based on the bioinformatic analysis of their expression in human tissues and diseases, as well as grouping of tissues and tumor types according to the similarity of their kinome transcription.	[Kilpinen, Sami; Ojala, Kalle; Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	University of Helsinki	Kilpinen, S (corresponding author), Univ Helsinki, FIMM, Helsinki, Finland.	sami.k.kilpinen@helsinki.fi	Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Kilpinen, Sami/0000-0003-3444-2539	Academy of Finland (Centres of Excellence) [213502]; Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University	Academy of Finland (Centres of Excellence)(Academy of Finland); Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University	Academy of Finland (Centres of Excellence funding no. 213502) Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed E, 2009, FUTURE ONCOL, V5, P779, DOI [10.2217/fon.09.55, 10.2217/FON.09.55]; Aiuti A, 1998, EXP HEMATOL, V26, P143; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; BAKER J, EXP CELL RES, P1856; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Byrne GJ, 2000, J NATL CANCER I, V92, P1329, DOI 10.1093/jnci/92.16.1329; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Eusebi V, 2000, AM J SURG PATHOL, V24, P223, DOI 10.1097/00000478-200002000-00008; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hallstrom TMKA, 2008, PROSTATE, V68, P902, DOI 10.1002/pros.20746; Hendriks BS, 2005, J BIOL CHEM, V280, P6157, DOI 10.1074/jbc.M410491200; Houreih MA, 2009, INT J SURG PATHOL, V17, P135, DOI 10.1177/1066896908319444; Hu PZ, 2007, NAT REV CANCER, V7, P23, DOI 10.1038/nrc2036; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Hwang KB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-159; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2005, NAT METHODS, V2, P477, DOI 10.1038/nmeth0605-477b; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lee BC, 2006, BLOOD, V108, P904, DOI 10.1182/blood-2005-12-4885; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lenz Heinz-Josef, 2006, Oncology (Williston Park), V20, P5; Li JX, 2004, BIOCHEM GENET, V42, P129, DOI 10.1023/B:BIGI.0000020468.96238.54; Liu LL, 2005, MOL CELLS, V19, P39; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Martinez-Lara I, 1996, Acta Stomatol Belg, V93, P29; McLean LA, 2004, CLIN CANCER RES, V10, P155, DOI 10.1158/1078-0432.CCR-0784-3; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; OHISHI T, 2001, CANCER RES, V70, P2041; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; PHILIPPE E, 1986, DEV BRAIN RES, V27, P275, DOI 10.1016/0165-3806(86)90255-5; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Radzikowska E, 2003, EUR RESPIR J, V21, P552, DOI 10.1183/09031936.03.00035502; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; TAIRA M, 2005, J ORAL TISSUE ENG, V3, P25; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Widakowich C, 2007, ONCOLOGIST, V12, P1443, DOI 10.1634/theoncologist.12-12-1443; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; [No title captured]	82	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15068	10.1371/journal.pone.0015068	http://dx.doi.org/10.1371/journal.pone.0015068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151926	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600023
J	Thysell, E; Surowiec, I; Hornberg, E; Crnalic, S; Widmark, A; Johansson, AI; Stattin, P; Bergh, A; Moritz, T; Antti, H; Wikstro, P				Thysell, Elin; Surowiec, Izabella; Hornberg, Emma; Crnalic, Sead; Widmark, Anders; Johansson, Annika I.; Stattin, Paer; Bergh, Anders; Moritz, Thomas; Antti, Henrik; Wikstro, Pernilla			Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; LOWERING DRUGS; LINOLEIC-ACID; SCID MICE; IN-VITRO; RISK; CELLS; SPECTROMETRY; GROWTH; GC/MS	Background: Metastasis to the bone is one clinically important features of prostate cancer (PCa). Current diagnostic methods cannot predict metastatic PCa at a curable stage of the disease. Identification of metabolic pathways involved in the growth of bone metastases therefore has the potential to improve PCa prognostication as well as therapy. Methodology/Principal Findings: Metabolomics was applied for the study of PCa bone metastases (n = 20) in comparison with corresponding normal bone (n = 14), and furthermore of malignant (n = 13) and benign (n = 17) prostate tissue and corresponding plasma samples obtained from patients with (n = 15) and without (n = 13) diagnosed metastases and from men with benign prostate disease (n = 30). This was done using gas chromatography-mass spectrometry for sample characterization, and chemometric bioinformatics for data analysis. Results were verified in a separate test set including metastatic and normal bone tissue from patients with other cancers (n = 7). Significant differences were found between PCa bone metastases, bone metastases of other cancers, and normal bone. Furthermore, we identified metabolites in primary tumor tissue and in plasma which were significantly associated with metastatic disease. Among the metabolites in PCa bone metastases especially cholesterol was noted. In a test set the mean cholesterol level in PCa bone metastases was 127.30 mg/g as compared to 81.06 and 35.85 mg/g in bone metastases of different origin and normal bone, respectively (P = 0.0002 and 0.001). Immunohistochemical staining of PCa bone metastases showed intense staining of the low density lipoprotein receptor and variable levels of the scavenger receptor class B type 1 and 3-hydroxy-3-methylglutaryl-coenzyme reductase in tumor epithelial cells, indicating possibilities for influx and de novo synthesis of cholesterol. Conclusions/Significance: We have identified metabolites associated with PCa metastasis and specifically identified high levels of cholesterol in PCa bone metastases. Based on our findings and the previous literature, this makes cholesterol a possible therapeutic target for advanced PCa.	[Thysell, Elin; Surowiec, Izabella; Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden; [Hornberg, Emma; Bergh, Anders; Wikstro, Pernilla] Umea Univ, Dept Med Biosci, Umea, Sweden; [Crnalic, Sead; Stattin, Paer] Umea Univ, Dept Pathol Surg & Perioperat Sci, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Urol & Androl & Orthoped & Radiat Sci, Umea, Sweden; [Johansson, Annika I.; Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Umea University; Umea University; Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University	Thysell, E (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	henrik.antti@chem.umu.se; pernilla.wikstrom@medbio.umu.se	Crnalic, Sead/AAF-3475-2021	Moritz, Thomas/0000-0002-4258-3190; Johansson, Annika/0000-0001-5000-1288	Swedish Cancer Society; Swedish Research Council; Lions Cancer Research foundation; KEMPE foundation; Knut and Alice Wallenberg foundation; Northern Sweden Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Research foundation; KEMPE foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Northern Sweden Cancer Foundation	Grant support: the Swedish Cancer Society, the Swedish Research Council, the Lions Cancer Research foundation, KEMPE foundation, Knut and Alice Wallenberg foundation, and the Northern Sweden Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Awad AB, 2001, EUR J CANCER PREV, V10, P507, DOI 10.1097/00008469-200112000-00005; Bravi F, 2006, UROLOGY, V67, P1205, DOI 10.1016/j.urology.2006.01.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Cesano A, 1998, ANTICANCER RES, V18, P1429; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; CONNOLLY JM, 1992, PROSTATE, V20, P151, DOI 10.1002/pros.2990200210; Cook LS, 1999, J UROLOGY, V161, P152, DOI 10.1016/S0022-5347(01)62086-X; CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8; CRNALIC S, ENDOCRINE; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; FOWLER AH, 1992, MAGN RESON MED, V25, P140, DOI 10.1002/mrm.1910250114; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Jacobs EJ, 2007, CANCER EPIDEM BIOMAR, V16, P2213, DOI 10.1158/1055-9965.EPI-07-0448; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Klotz Laurence, 2006, Curr Treat Options Oncol, V7, P355, DOI 10.1007/s11864-006-0003-z; KURHANEWICZ J, 1993, MAGN RESON MED, V29, P149, DOI 10.1002/mrm.1910290202; Lopergolo A, 2009, CANCER-AM CANCER SOC, V115, P3058, DOI 10.1002/cncr.24346; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; *NIST, NIST MS SEARCH US GU; Parekh DJ, 2007, J UROLOGY, V178, P2252, DOI 10.1016/j.juro.2007.08.055; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Takarada T, 2008, J PHARMACOL SCI, V106, P536, DOI 10.1254/jphs.FM0070243; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Zakian KL, 2008, CANCER BIOMARK, V4, P263, DOI 10.3233/CBM-2008-44-508; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	50	115	120	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14175	10.1371/journal.pone.0014175	http://dx.doi.org/10.1371/journal.pone.0014175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151972	Green Published, Green Submitted, gold			2022-12-25	WOS:000284939600001
J	Tian, JA; Zhang, XY; Liang, BG; Li, SW; Wu, ZX; Wang, QH; Leng, CX; Dong, JL; Wang, T				Tian, Juan; Zhang, Xueyan; Liang, Benguo; Li, Shanwei; Wu, Zhixia; Wang, Qianhua; Leng, Chunxu; Dong, Jiangli; Wang, Tao			Expression of Baculovirus Anti-Apoptotic Genes p35 and op-iap in Cotton (Gossypium hirsutum L.) Enhances Tolerance to Verticillium Wilt	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VACUOLAR PROCESSING ENZYME; HYPERSENSITIVE RESPONSE; CASPASE ACTIVATION; TRANSGENIC COTTON; FUNGAL-INFECTION; ALBO-ATRUM; DAHLIAE; PLANTS; DISEASE	Background: Programmed cell death plays an important role in mediating plant adaptive responses to the environment such as the invasion of pathogens. Verticillium wilt, caused by the necrotrophic pathogen Verticillium dahliae, is a serious vascular disease responsible for great economic losses to cotton, but the molecular mechanisms of verticillium disease and effective, safe methods of resistance to verticillium wilt remain unexplored. Methodology/Principal Findings: In this study, we introduced baculovirus apoptosis inhibitor genes p35 and op-iap into the genome of cotton via Agrobacterium-mediated transformation and analyzed the response of transgenic plants to verticillium wilt. Results showed that p35 and op-iap constructs were stably integrated into the cotton genome, expressed in the transgenic lines, and inherited through the T-3 generation. The transgenic lines had significantly increased tolerance to verticillium wilt throughout the developmental stages. The disease index of T-1-T-3 generation was lower than 19, significantly (P < 0.05) better than the negative control line z99668. After treatment with 250 mg/L VD-toxins for 36 hours, DNA from negative control leaves was fragmented, whereas fragmentation in the transgenic leaf DNA did not occur. The percentage of cell death in transgenic lines increased by 7.11% after 60 mg/L VD-toxin treatment, which was less than that of the negative control lines's 21.27%. This indicates that p35 and op-iap gene expression partially protects cells from VD-toxin induced programmed cell death (PCD). Conclusion/Significance: Verticillium dahliae can trigger plant cells to die through induction of a PCD mechanism involved in pathogenesis. This paper provides a potential strategy for engineering broad-spectrum necrotrophic disease resistance in plants.	[Tian, Juan; Leng, Chunxu; Dong, Jiangli; Wang, Tao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Xueyan; Wu, Zhixia; Wang, Qianhua] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Peoples R China; [Liang, Benguo] Xinyang Agr Coll, Dept Hort, Xinyang, Peoples R China; [Li, Shanwei] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Tian, JA (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	dongjl@cau.edu.cn			Major projects of genetically modified organisms breeding of China [2008ZX08005-003, 2008ZX08009-002]	Major projects of genetically modified organisms breeding of China	This work was supported by the major projects of genetically modified organisms breeding of China (2008ZX08005-003 and 2008ZX08009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BejaranoAlcazar J, 1997, PLANT PATHOL, V46, P168, DOI 10.1046/j.1365-3059.1997.d01-221.x; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHNER V, 1982, FEBS LETT, V138, P261, DOI 10.1016/0014-5793(82)80456-0; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; Chu ZQ, 1999, ACTA BOT SIN, V41, P972; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; de Freitas DS, 2007, BIOTECHNOL LETT, V29, P79, DOI 10.1007/s10529-006-9201-9; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; GOUR HN, 1985, PHYSIOL PLANT PATHOL, V27, P109, DOI 10.1016/0048-4059(85)90060-8; Hansen G, 2000, MOL PLANT MICROBE IN, V13, P649, DOI 10.1094/MPMI.2000.13.6.649; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; HUISMAN OC, 1982, ANNU REV PHYTOPATHOL, V20, P303, DOI 10.1146/annurev.py.20.090182.001511; Khurana SMP, 2005, CURR SCI INDIA, V88, P740; Kim M, 2006, PLANT CELL, V18, P2341, DOI 10.1105/tpc.106.041509; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Lincoln JE, 2002, P NATL ACAD SCI USA, V99, P15217, DOI 10.1073/pnas.232579799; Means JC, 2008, FUTURE VIROL, V3, P383, DOI 10.2217/17460794.3.4.383; MEYER R, 1993, FEBS LETT, V335, P203, DOI 10.1016/0014-5793(93)80730-I; MEYER R, 1994, PHYTOCHEMISTRY, V35, P1449, DOI 10.1016/S0031-9422(00)86872-7; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; Mlejnek P, 2002, PLANTA, V215, P158, DOI 10.1007/s00425-002-0733-5; Murray F, 1999, MOL BREEDING, V5, P219, DOI 10.1023/A:1009625801909; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Palmer CS, 2005, PHYSIOL MOL PLANT P, V67, P308, DOI 10.1016/j.pmpp.2006.05.003; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PEGG GF, 1965, NATURE, V208, P1228, DOI 10.1038/2081228b0; Rajasekaran K, 2005, PLANT BIOTECHNOL J, V3, P545, DOI 10.1111/j.1467-7652.2005.00145.x; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Stein JC, 1999, PLANT PHYSIOL, V121, P71, DOI 10.1104/pp.121.1.71; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; Sun YL, 1999, FEBS LETT, V462, P317, DOI 10.1016/S0014-5793(99)01539-2; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Wang W, 1999, ACTA BOT SIN, V41, P1072; Wang YQ, 2004, PLANT BREEDING, V123, P454, DOI 10.1111/j.1439-0523.2004.01005.x; Wang Zhihua, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1707, DOI 10.1016/S1872-2075(08)60070-9; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Wijayanto T, 2009, PLANT BIOTECHNOL J, V7, P778, DOI 10.1111/j.1467-7652.2009.00443.x; Zhang Y. S., 1989, Acta Mycologica Sinica, V8, P140; Zhen XH, 2004, J PLANT PHYSIOL, V161, P1367, DOI 10.1016/j.jplph.2004.04.007	53	23	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14218	10.1371/journal.pone.0014218	http://dx.doi.org/10.1371/journal.pone.0014218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151969	Green Submitted, gold, Green Published			2022-12-25	WOS:000284939600011
J	Cheng, MC; Lu, CL; Luu, SU; Tsai, HM; Hsu, SH; Chen, TT; Chen, CH				Cheng, Min-Chih; Lu, Chao-Lin; Luu, Sy-Ueng; Tsai, Ho-Min; Hsu, Shih-Hsin; Chen, Tzu-Ting; Chen, Chia-Hsiang			Genetic and Functional Analysis of the DLG4 Gene Encoding the Post-Synaptic Density Protein 95 in Schizophrenia	PLOS ONE			English	Article							NMDA RECEPTOR SUBUNIT; PREFRONTAL CORTEX; SYNONYMOUS MUTATIONS; PSD-95; EXPRESSION; ASSOCIATION; GLUTAMATE; LINKAGE; THALAMUS; PHENCYCLIDINE	Hypofunction of N-methyl-D-aspartate (NMDA) receptor-mediated signal transduction has been implicated in the pathophysiology of schizophrenia. Post-synaptic density protein 95 (PSD95) plays a critical role in regulating the trafficking and activity of the NMDA receptor and altered expression of the PSD95 has been detected in the post-mortem brain of patients with schizophrenia. The study aimed to examine whether the DLG4 gene that encodes the PSD95 may confer genetic susceptibility to schizophrenia. We re-sequenced the core promoter, all the exons, and 3' untranslated regions (UTR) of the DLG4 gene in 588 Taiwanese schizophrenic patients and conducted an association study with 539 non-psychotic subjects. We did not detect any rare mutations at the protein-coding sequences of the DLG4 gene associated with schizophrenia. Nevertheless, we identified four polymorphic markers at the core promoter and 5' UTR and one single nucleotide polymorphism (SNP) at the 3'UTR of the DLG4 gene in this sample. Genetic analysis showed an association of a haplotype (C-D) derived from 2 polymorphic markers at the core promoter (odds ratio = 1.26, 95% confidence interval = 1.06-1.51, p = 0.01), and a borderline association of the T allele of the rs13331 at 3'UTR with schizophrenia (odds ratio = 1.19, 95% confidence interval = 0.99-1.43, p = 0.06). Further reporter gene assay showed that the C-D-C-C and the T allele of the rs13331 had significant lower activity than their counter parts. Our data indicate that the expression of the DLG4 gene is subject to regulation by the polymorphic markers at the core promoter region, 5' and 3'UTR of the gene, and is associated with the susceptibility of schizophrenia.	[Cheng, Min-Chih; Chen, Tzu-Ting] Yuli Vet Hosp, Yuli Mental Hlth Res Ctr, Dept Psychiat, Yuli Township, Peoples R China; [Lu, Chao-Lin] Hualien Armed Forces Gen Hosp, Dept Psychiat, Xincheng Township, Peoples R China; [Luu, Sy-Ueng] Taoyuan Armed Forces Gen Hosp, Dept Psychiat, Longtan Township, Peoples R China; [Tsai, Ho-Min; Hsu, Shih-Hsin; Chen, Chia-Hsiang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Longtan Township, Peoples R China; [Chen, Chia-Hsiang] Tzu Chi Univ, Inst Med Sci, Yuli Township, Peoples R China; [Chen, Chia-Hsiang] Chang Gung Mem Hosp, Dept Psychiat, Linkou, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Sch Med, Gueishan Township, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Cheng, MC (corresponding author), Yuli Vet Hosp, Yuli Mental Hlth Res Ctr, Dept Psychiat, Yuli Township, Peoples R China.	cchen@nhri.org.tw	Chen, Chia-Hsiang/E-3939-2010; Cheng, Min-Chih/B-1363-2013	Cheng, Min-Chih/0000-0002-2962-0911	National Science Council; National Health Research Institutes, China	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, China(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Science Council and National Health Research Institutes, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beneyto M, 2008, NEUROPSYCHOPHARMACOL, V33, P2175, DOI 10.1038/sj.npp.1301604; Clinton SM, 2006, J NEUROCHEM, V98, P1114, DOI 10.1111/j.1471-4159.2006.03954.x; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Coyle JT, 2002, CNS NEUROL DISORD-DR, V1, P183, DOI 10.2174/1568007024606212; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Funk AJ, 2009, NEUROREPORT, V20, P1019, DOI 10.1097/WNR.0b013e32832d30d9; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Kajimoto Y, 2003, NEUROPSYCHOPHARMACOL, V28, P1831, DOI 10.1038/sj.npp.1300212; Kawashima R, 2006, NEUROSCI LETT, V400, P168, DOI 10.1016/j.neulet.2006.02.036; Klei L, 2005, HUM GENET, V117, P349, DOI 10.1007/s00439-005-1320-1; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Lane HY, 2008, BIOL PSYCHIAT, V63, P9, DOI 10.1016/j.biopsych.2007.04.038; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mueller HT, 2004, MOL BRAIN RES, V121, P60, DOI 10.1016/j.molbrainres.2003.11.004; Ohnuma T, 2000, NEUROREPORT, V11, P3133, DOI 10.1097/00001756-200009280-00019; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shim SS, 2007, EUR ARCH PSY CLIN N, V258, P16, DOI 10.1007/s00406-007-0757-8; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stephenson FA, 2006, BIOCHEM SOC T, V34, P877, DOI 10.1042/BST0340877; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsai SJ, 2007, J NEURAL TRANSM, V114, P423, DOI 10.1007/s00702-006-0587-2; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200; Zhang JP, 2009, J NEUROSCI, V29, P2948, DOI 10.1523/JNEUROSCI.4424-08.2009	43	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15107	10.1371/journal.pone.0015107	http://dx.doi.org/10.1371/journal.pone.0015107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151988	gold, Green Published, Green Submitted			2022-12-25	WOS:000284868000024
J	Bonaccorsi, I; Cantoni, C; Carrega, P; Oliveri, D; Lui, G; Conte, R; Navarra, M; Cavaliere, R; Traggiai, E; Gattorno, M; Martini, A; Mingari, MC; Moretta, A; Ferlazzo, G				Bonaccorsi, Irene; Cantoni, Claudia; Carrega, Paolo; Oliveri, Daniela; Lui, Gabrielle; Conte, Romana; Navarra, Michele; Cavaliere, Riccardo; Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto; Mingari, Maria Cristina; Moretta, Alessandro; Ferlazzo, Guido			The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN alpha Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN SUPERFAMILY; AUTOIMMUNE-DISEASES; I INTERFERONS; T-CELLS; DIFFERENTIATION; ACTIVATION; LYMPHOCYTES; PRECURSORS	Plasmacytoid dendritic cells (pDCs) are a subset of dendritic cells endowed with the capacity of producing large amounts of IFN alpha. Here we show that the Leukocyte-Associated Ig-like Receptor-1 (LAIR-1) is abundantly expressed on pDCs (the highest expression among all leukocytes) and its cross-linking inhibits IFNa production in response to Toll-like receptor ligands. Remarkably, LAIR-1 expression in pDCs is down-regulated in the presence of interleukin (IL)-3, thus indicating coordinated functions with NKp44, another pDC inhibitory receptor, which is conversely induced by IL-3. Nevertheless, the expression of NKp44 in pDCs isolated from secondary lymphoid organs, which is thought to be influenced by IL-3, is not coupled to a decreased expression of LAIR-1. Interestingly, pDCs isolated from peripheral blood of systemic lupus erithematosus (SLE) patients express lower levels of LAIR-1 while displaying slight but consistent expression of NKp44, usually undetectable on pDCs derived from healthy donors. Using sera derived from SLE patients, we show that LAIR-1 and NKp44 display synergistic inhibitory effects on IFNa production by interleukin IL-3 cultured pDCs stimulated with DNA immunocomplexes. In conclusion, our results indicate that the inhibitory function of LAIR-1 may play a relevant role in the mechanisms controlling IFNa production by pDCs both in normal and pathological innate immune responses.	[Bonaccorsi, Irene; Oliveri, Daniela; Cavaliere, Riccardo; Ferlazzo, Guido] Univ Messina, Dept Human Pathol, Lab Immunol & Biotherapy, Messina, Italy; [Cantoni, Claudia; Mingari, Maria Cristina; Moretta, Alessandro] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy; [Cantoni, Claudia; Moretta, Alessandro] Univ Genoa, CERB, Genoa, Italy; [Cantoni, Claudia; Carrega, Paolo; Lui, Gabrielle; Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Conte, Romana; Mingari, Maria Cristina] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Navarra, Michele] Univ Messina, Pharmaco Biol Dept, Messina, Italy; [Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto] Univ Genoa, Dept Pediat, Genoa, Italy	University of Messina; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Messina; University of Genoa	Bonaccorsi, I (corresponding author), Univ Messina, Dept Human Pathol, Lab Immunol & Biotherapy, Messina, Italy.	guido.ferlazzo@unime.it	Cantoni, Claudia/J-8732-2018; Gattorno, Marco/AAL-2974-2020; Carrega, Paolo/G-4883-2018; Mingari, Maria Cristina/AAB-1315-2019; Bonaccorsi, Irene/J-7409-2016	Cantoni, Claudia/0000-0001-6471-1424; Gattorno, Marco/0000-0003-0704-1916; Carrega, Paolo/0000-0001-8541-9115; Bonaccorsi, Irene/0000-0002-2893-0117; Ferlazzo, Guido/0000-0002-3874-8554; MARTINI, Alberto/0000-0001-7642-1459; Navarra, Michele/0000-0002-6492-7820	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 5624]; Ministero Italiano della Salute; Regione Sicilia, Ricerca Sanitaria Regionale	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute(Ministry of Health, Italy); Regione Sicilia, Ricerca Sanitaria Regionale	Research in the authors' laboratories is supported by: Associazione Italiana per la Ricerca sul Cancro (AIRC) project IG 5624(http://www.airc.it); Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica (http://www.ministerosalute.it/); Regione Sicilia, Ricerca Sanitaria Regionale 2007 (http://www. regione.sicilia.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bave U, 2000, J IMMUNOL, V165, P3519, DOI 10.4049/jimmunol.165.6.3519; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Campbell KS, 2004, J IMMUNOL, V172, P899, DOI 10.4049/jimmunol.172.2.899; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fuchs A, 2005, BLOOD, V106, P2076, DOI 10.1182/blood-2004-12-4802; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Jansen CA, 2007, EUR J IMMUNOL, V37, P914, DOI 10.1002/eji.200636678; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; POGGI A, 1995, EUR J IMMUNOL, V25, P369, DOI 10.1002/eji.1830250210; Poggi A, 1998, EUR J IMMUNOL, V28, P2086, DOI 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T; Poggi A, 1997, INT IMMUNOL, V9, P1271, DOI 10.1093/intimm/9.9.1271; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wu PP, 2008, CLIN IMMUNOL, V129, P40, DOI 10.1016/j.clim.2008.06.004	35	53	56	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15080	10.1371/journal.pone.0015080	http://dx.doi.org/10.1371/journal.pone.0015080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151495	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100063
J	Fiori, LM; Wanner, B; Jomphe, V; Croteau, J; Vitaro, F; Tremblay, RE; Bureau, A; Turecki, G				Fiori, Laura M.; Wanner, Brigitte; Jomphe, Valerie; Croteau, Jordie; Vitaro, Frank; Tremblay, Richard E.; Bureau, Alexandre; Turecki, Gustavo			Association of Polyaminergic Loci With Anxiety, Mood Disorders, and Attempted Suicide	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW SCHEDULE; SPERMINE SYNTHASE; MAJOR DEPRESSION; SAT-1-1415T/C POLYMORPHISM; LINKAGE DISEQUILIBRIUM; MENTAL-DISORDERS; CHILDHOOD ABUSE; GENE-EXPRESSION; YOUNG-ADULTS; RISK-FACTORS	Background: The polyamine system has been implicated in a number of psychiatric conditions, which display both alterations in polyamine levels and altered expression of genes related to polyamine metabolism. Studies have identified associations between genetic variants in spermidine/spermine N1-acetyltransferase (SAT1) and both anxiety and suicide, and several polymorphisms appear to play important roles in determining gene expression. Methodology/Principal Findings: We genotyped 63 polymorphisms, spread across four polyaminergic genes (SAT1, spermine synthase (SMS), spermine oxidase (SMOX), and ornithine aminotransferase like-1 (OATL1)), in 1255 French-Canadian individuals who have been followed longitudinally for 22 years. We assessed univariate associations with anxiety, mood disorders, and attempted suicide, as assessed during early adulthood. We also investigated the involvement of gene-environment interactions in terms of childhood abuse, and assessed internalizing and externalizing symptoms as endophenotypes mediating these interactions. Overall, each gene was associated with at least one main outcome: anxiety (SAT1, SMS), mood disorders (SAT1, SMOX), and suicide attempts (SAT1, OATL1). Several SAT1 polymorphisms displayed disease-specific risk alleles, and polymorphisms in this gene were involved in gene-gene interactions with SMS to confer risk for anxiety disorders, as well as gene-environment interactions between childhood physical abuse and mood disorders. Externalizing behaviors demonstrated significant mediation with regards to the association between OATL1 and attempted suicide, however there was no evidence that externalizing or internalizing behaviors were appropriate endophenotypes to explain the associations with mood or anxiety disorders. Finally, childhood sexual abuse did not demonstrate mediating influences on any of our outcomes. Conclusions/Significance: These results demonstrate that genetic variants in polyaminergic genes are associated with psychiatric conditions, each of which involves a set of separate and distinct risk alleles. As several of these polymorphisms are associated with gene expression, these findings may provide mechanisms to explain the alterations in polyamine metabolism which have been observed in psychiatric disorders.	[Fiori, Laura M.; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Wanner, Brigitte; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Jomphe, Valerie; Croteau, Jordie; Bureau, Alexandre] Univ Laval, Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland	McGill University; Universite de Montreal; Laval University; University College Dublin	Fiori, LM (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Turecki, Gustavo/K-5100-2015; Tremblay, Richard E./O-1360-2014	Bureau, Alexandre/0000-0001-8220-9999; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research [MOPs 79253, 53321]; Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institute of Health Research (www.cihr-irsc.gc.ca) MOPs 79253 and 53321. LMF received a scholarship from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) and AB and GT received scientist awards from the Fonds de la recherche en sante du Quebec (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermudo-Soriano CR, 2009, PROG NEURO-PSYCHOPH, V33, P345, DOI 10.1016/j.pnpbp.2008.12.015; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Breton JJ, 1998, J AM ACAD CHILD PSY, V37, P1167, DOI 10.1097/00004583-199811000-00016; BREZO J, 2009, MOL PSYCHIAT; Brezo J, 2008, ARCH PEDIAT ADOL MED, V162, P1015, DOI 10.1001/archpedi.162.11.1015; Brezo J, 2008, BRIT J PSYCHIAT, V193, P134, DOI 10.1192/bjp.bp.107.037994; Brezo J, 2008, PSYCHIAT CLIN N AM, V31, P179, DOI 10.1016/j.psc.2008.01.008; Brezo J, 2007, PSYCHOL MED, V37, P1563, DOI 10.1017/S003329170700058X; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chen GG, 2010, NEUROPSYCHOPHARMACOL, V35, P1477, DOI 10.1038/npp.2010.17; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De La Vega Francisco M, 2006, Pac Symp Biocomput, P487, DOI 10.1142/9789812701626_0045; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Fiori LM, 2008, J PSYCHIATR NEUROSCI, V33, P102; Fiori LM, 2010, INT J NEUROPSYCHOPH, V13, P725, DOI 10.1017/S1461145709991167; Fiori LM, 2010, AM J MED GENET B, V153B, P825, DOI 10.1002/ajmg.b.31040; FIORI LM, 2009, MOL PSYCHIA IN PRESS; Fisher SA, 2001, GENET EPIDEMIOL, V21, pS18, DOI 10.1002/gepi.2001.21.s1.s18; Flori LM, 2009, BIOL PSYCHIAT, V66, P460, DOI 10.1016/j.biopsych.2009.04.002; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; Guipponi M, 2009, AM J MED GENET B, V150B, P799, DOI 10.1002/ajmg.b.30901; HEYER E, 1995, AM J HUM GENET, V56, P970; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Kesler SR, 2009, NEUROGENETICS, V10, P299, DOI 10.1007/s10048-009-0184-2; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kim CD, 2005, AM J PSYCHIAT, V162, P1017, DOI 10.1176/appi.ajp.162.5.1017; Kim CD, 2003, PSYCHOL MED, V33, P1299, DOI 10.1017/S0033291703008146; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Klempan TA, 2009, AM J MED GENET B, V150B, P934, DOI 10.1002/ajmg.b.30920; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McGirr A, 2007, J CLIN PSYCHIAT, V68, P721, DOI 10.4088/JCP.v68n0509; McGirr A, 2008, SCHIZOPHR RES, V98, P217, DOI 10.1016/j.schres.2007.09.009; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; ROBINS LN, 1982, PSYCHOL MED, V12, P855, DOI 10.1017/S0033291700049151; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Turecki G, 2003, AM J MED GENET B, V118B, P36, DOI 10.1002/ajmg.b.10006; Vaquero-Lorenzo C, 2009, AM J MED GENET B, V150B, P515, DOI 10.1002/ajmg.b.30850; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29	65	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15146	10.1371/journal.pone.0015146	http://dx.doi.org/10.1371/journal.pone.0015146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	687DK	21152090	gold, Green Published			2022-12-25	WOS:000284755100084
J	Nagai, K; Yamamoto, K; Fujiwara, H; An, J; Ochi, T; Suemori, K; Yasumi, T; Tauchi, H; Koh, K; Sato, M; Morimoto, A; Heike, T; Ishii, E; Yasukawa, M				Nagai, Kozo; Yamamoto, Ken; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Suemori, Koichiro; Yasumi, Takahiro; Tauchi, Hisamichi; Koh, Katsuyoshi; Sato, Maho; Morimoto, Akira; Heike, Toshio; Ishii, Eiichi; Yasukawa, Masaki			Subtypes of Familial Hemophagocytic Lymphohistiocytosis in Japan Based on Genetic and Functional Analyses of Cytotoxic T Lymphocytes	PLOS ONE			English	Article							MUTATIONS; PERFORIN; MUNC13-4; IDENTIFICATION; EXOCYTOSIS; EXPRESSION; GUIDELINES; DEFECTS; LINKAGE; FUSION	Background: Familial hemophagocytic lymphohistiocytosis (FHL) is a rare disease of infancy or early childhood. To clarify the incidence and subtypes of FHL in Japan, we performed genetic and functional analyses of cytotoxic T lymphocytes (CTLs) in Japanese patients with FHL. Design and Methods: Among the Japanese children with hemophagocytic lymphohistiocytosis (HLH) registered at our laboratory, those with more than one of the following findings were eligible for study entry under a diagnosis of FHL: positive for known genetic mutations, a family history of HLH, and impaired CTL-mediated cytotoxicity. Mutations of the newly identified causative gene for FHL5, STXBP2, and the cytotoxicity and degranulation activity of CTLs in FHL patients, were analyzed. Results: Among 31 FHL patients who satisfied the above criteria, PRF1 mutation was detected in 17 (FHL2) and UNC13D mutation was in 10 (FHL3). In 2 other patients, 3 novel mutations of STXBP2 gene were confirmed (FHL5). Finally, the remaining 2 were classified as having FHL with unknown genetic mutations. In all FHL patients, CTL-mediated cytotoxicity was low or deficient, and degranulation activity was also low or absent except FHL2 patients. In 2 patients with unknown genetic mutations, the cytotoxicity and degranulation activity of CTLs appeared to be deficient in one patient and moderately impaired in the other. Conclusions: FHL can be diagnosed and classified on the basis of CTL-mediated cytotoxicity, degranulation activity, and genetic analysis. Based on the data obtained from functional analysis of CTLs, other unknown gene(s) responsible for FHL remain to be identified.	[Nagai, Kozo; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Suemori, Koichiro; Yasukawa, Masaki] Ehime Univ, Dept Bioregulatory Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Nagai, Kozo; Ishii, Eiichi] Ehime Univ, Dept Pediat, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Yamamoto, Ken] Kyushu Univ, Dept Mol Genet, Med Inst Bioregulat, Fukuoka 812, Japan; [Fujiwara, Hiroshi; Yasukawa, Masaki] Ehime Univ, Proteomed Res Ctr, Matsuyama, Ehime 790, Japan; [Yasumi, Takahiro; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan; [Koh, Katsuyoshi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Sato, Maho] Osaka Med Ctr, Dept Pediat, Osaka, Japan; [Sato, Maho] Res Inst Maternal & Child Hlth, Osaka, Japan; [Morimoto, Akira] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Tochigi, Japan	Ehime University; Ehime University; Kyushu University; Ehime University; Kyoto University; University of Tokyo; Osaka Medical Center for Cancer & Cardiovascular Diseases; Jichi Medical University	Nagai, K (corresponding author), Ehime Univ, Dept Bioregulatory Med, Grad Sch Med, Matsuyama, Ehime 790, Japan.	ishiei@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp		Yasumi, Takahiro/0000-0003-3257-5071	Ministry of Health and Labor; Ministry of Education, Culture, Sports, Science and Technology, Japan; Medical Institute of Bioregulation, Kyushu University; Grants-in-Aid for Scientific Research [22591159] Funding Source: KAKEN	Ministry of Health and Labor; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Institute of Bioregulation, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Cancer Research from the Ministry of Health and Labor, and grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the patients and their family members who participated in this study. We also wish to thank all members of the Japan FHL study group. This work was performed as part of the Cooperative Research project program of the Medical Institute of Bioregulation, Kyushu University.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Caballes RL, 1997, PATHOLOGY, V29, P92, DOI 10.1080/00313029700169644; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Dufourcq-Lagelouse R, 1999, AM J HUM GENET, V64, P172, DOI 10.1086/302194; Ericson KG, 2001, AM J HUM GENET, V68, P590, DOI 10.1086/318796; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Filipovich AH, 1997, J PEDIATR-US, V130, P337; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Ishii E, 2005, BLOOD, V105, P3442, DOI 10.1182/blood-2004-08-3296; Ishii E, 2007, INT J HEMATOL, V86, P58, DOI 10.1532/IJH97.07012; JANKA GE, 1983, EUR J PEDIATR, V140, P221, DOI 10.1007/BF00443367; LOY TS, 1991, SEMIN ONCOL, V18, P34; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Ohadi M, 1999, AM J HUM GENET, V64, P165, DOI 10.1086/302187; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suga N, 2002, BRIT J HAEMATOL, V116, P346, DOI 10.1046/j.1365-2141.2002.03266.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ueda I, 2006, PEDIATR BLOOD CANCER, V46, P482, DOI 10.1002/pbc.20511; Ueda I, 2003, BRIT J HAEMATOL, V121, P503, DOI 10.1046/j.1365-2141.2003.04298.x; Valdez AC, 1999, J CELL SCI, V112, P845; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yamamoto K, 2005, J HUM GENET, V50, P600, DOI 10.1007/s10038-005-0293-1; Yamamoto K, 2004, J MED GENET, V41, P763, DOI 10.1136/jmg.2004.021121; Yanai F, 2003, J IMMUNOL, V170, P2205, DOI 10.4049/jimmunol.170.4.2205; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	35	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14173	10.1371/journal.pone.0014173	http://dx.doi.org/10.1371/journal.pone.0014173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152410	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100049
J	Salani, B; Passalacqua, M; Maffioli, S; Briatore, L; Hamoudane, M; Contini, P; Cordera, R; Maggi, D				Salani, Barbara; Passalacqua, Mario; Maffioli, Sara; Briatore, Lucia; Hamoudane, Meriem; Contini, Paola; Cordera, Renzo; Maggi, Davide			IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSCRIPT RELEASE FACTOR; RECEPTOR INTERNALIZATION; SIGNAL-TRANSDUCTION; POLYMERASE-I; LIPID RAFTS; INSULIN; PTRF; ENDOCYTOSIS; PHOSPHORYLATION	Background: Insulin-like growth factor-I receptor (IGF-IR) is a tyrosine kinase receptor (RTK) associated with caveolae, invaginations of the plasma membrane that regulate vesicular transport, endocytosis and intracellular signaling. IGF-IR internalization represents a key mechanism of down-modulation of receptors number on plasma membrane. IGF-IR interacts directly with Caveolin-1 (Cav-1), the most relevant protein of caveolae. Recently it has been demonstrated that the Polymerase I and Transcript Release Factor I (PTRF/Cavin) is required for caveolae biogenesis and function. The role of Cav-1 and PTRF/Cavin in IGF-IR internalization is still to be clarified. Methodology/Principal Findings: We have investigated the interaction of IGF-IR with Cav-1 and PTRF/Cavin in the presence of IGF1in human Hacat cells. We show that IGF-IR internalization triggers Cav-1 and PTRF/Cavin translocation from plasma membrane to cytosol and increases IGF-IR interaction with these proteins. In fact, Cav-1 and PTRF/Cavin co-immunoprecipitate with IGF-IR during receptor internalization. We found a different time course of co-immunoprecipitation between IGF-IR and Cav-1 compared to IGF-IR and PTRF/Cavin. Cav-1 and PTRF/Cavin silencing by siRNA differently affect surface IGF-IR levels following IGF1 treatment: Cav-1 and PTRF/Cavin silencing significantly affect IGF-IR rate of internalization, while PTRF/Cavin silencing also decreases IGF-IR plasma membrane recovery. Since Cav-1 phosphorylation could have a role in IGF-IR internalization, the mutant Cav-1Y14F lacking Tyr14 was transfected. Cav-1Y14F transfected cells showed a reduced internalization of IGF-IR compared with cells expressing wild type Cav-1. Receptor internalization was not impaired by Clathrin silencing. These findings support a critical role of caveolae in IGF-IR intracellular traveling. Conclusions/Significance: These data indicate that Caveolae play a role in IGF-IR internalization. Based on these findings, Cav-1 and PTRF/Cavin could represent two relevant and distinct targets to modulate IGF-IR function.	[Salani, Barbara; Maffioli, Sara; Briatore, Lucia; Hamoudane, Meriem; Cordera, Renzo; Maggi, Davide] Univ Genoa, Dept Endocrinol & Med DiSEM, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med DIMES, Ctr Excellence Biomed Res, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Italian Inst Biostruct & Biosyst INBB, Genoa, Italy; [Contini, Paola] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa	Salani, B (corresponding author), Univ Genoa, Dept Endocrinol & Med DiSEM, Genoa, Italy.	davide.maggi@unige.it	maggi, davide/AAL-4687-2020; contini, paola/AAB-7625-2019; Cordera, Renzo/I-7229-2017; Passalacqua, Mario/W-1973-2019	Cordera, Renzo/0000-0002-5280-9691; Passalacqua, Mario/0000-0003-2779-6259; MAGGI, DAVIDE CARLO/0000-0003-3928-1295	Ministero dell'Universita e della Ricerca (MIUR); Fondi Italiani per la Ricerca di Base (FIRB); Fondazione CARIGE; University of Genova	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondi Italiani per la Ricerca di Base (FIRB); Fondazione CARIGE(Fondazione Carige); University of Genova	This work was supported by grants from Ministero dell'Universita e della Ricerca (MIUR), Fondi Italiani per la Ricerca di Base (FIRB), Fondazione CARIGE and University of Genova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Biedi C, 2003, ENDOCRINOLOGY, V144, P5497, DOI 10.1210/en.2003-0417; Chadda R, 2008, CELL, V132, P23, DOI 10.1016/j.cell.2007.12.021; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; DAVALOS A, MOL CELL PROTEOMICS, V9, P2109; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Maggi D, 2002, BIOCHEM BIOPH RES CO, V295, P1085, DOI 10.1016/S0006-291X(02)00809-4; Maggi D, 1999, DIABETOLOGIA, V42, P435, DOI 10.1007/s001250051176; Matthews LC, 2005, ENDOCRINOLOGY, V146, P5463, DOI 10.1210/en.2005-0236; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; ORLICHENKO L, 2005, J BIOL CHEM; Panetta D, 2004, BIOCHEM BIOPH RES CO, V316, P240, DOI 10.1016/j.bbrc.2004.02.037; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Repetto S, 2005, BIOCHEM BIOPH RES CO, V337, P849, DOI 10.1016/j.bbrc.2005.09.125; SALANI B, 2007, ENDOCRINOLOGY; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	38	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14157	10.1371/journal.pone.0014157	http://dx.doi.org/10.1371/journal.pone.0014157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152401	Green Submitted, gold, Green Published			2022-12-25	WOS:000284755100035
J	Sissoko, D; Ezzedine, K; Giry, C; Moendandze, A; Lernout, T; D'Ortenzio, E; Pettinelli, F; Malvy, D				Sissoko, Daouda; Ezzedine, Khaled; Giry, Claude; Moendandze, Amrat; Lernout, Tinne; D'Ortenzio, Eric; Pettinelli, Francois; Malvy, Denis			Seroepidemiology of Dengue Virus in Mayotte, Indian Ocean, 2006	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SOUTHERN VIETNAM; REUNION ISLAND; RISK-FACTORS; EPIDEMIC; SEROPREVALENCE; INFECTION; OUTBREAK; COMOROS; ARBOVIRUSES	Background: Although Dengue virus (DENV) circulation had been documented in neighbouring South-western Indian Ocean Islands, its presence in Mayotte is poorly characterised. To address this issue, we aimed to assess the seroprevalence of dengue IgG antibodies (DENV-IgG Ab) among the population and to investigate potential associations with individual and household characteristics. Methods/Principal Findings: In November-December 2006 we conducted a cross-sectional serologic survey in Mayotte among 1,154 inhabitants aged >= 2 years by using a multistage cluster random sampling method. The overall prevalence of DENV-specific IgG antibodies (ELISA) was 22.73% (95% CI, 18.16-27.31). The age-specific seroprevalence increased with age (chi(2) for trend = 11.86, P<0.0006), and was linked with previous known outbreaks in this region. In multivariate analysis, older age, being born in the Comoros and living in a household with a low socioeconomic index were positively associated with DENV IgG antibody positivity. Conclusions: These findings document substantial prior exposure of the population of Mayotte to DENV and highlight the risk of severe illness due to the possibility of sequential DENV infections. Further investigations characterizing current DENV circulation patterns and associated serotypes are needed.	[Sissoko, Daouda; Malvy, Denis] Univ Victor Segalen Bordeaux 2, Ctr Rene Labusquiere, Bordeaux, France; [Ezzedine, Khaled] Ctr Hosp Univ, Serv Dermatol, Hop St Andre, Bordeaux, France; [Giry, Claude; Pettinelli, Francois] Ctr Hosp Mayotte, Biol Lab, Mamoudzou, Mayotte, France; [Moendandze, Amrat] Direct Sante & PMI, Conseil Gen Mayotte, Mamoudzou, Mayotte, France; [Lernout, Tinne] Cellule Inst Veille Sanitaire Reg Ocean Indien, Mayotte, France; [D'Ortenzio, Eric] Cellule Inst Veille Sanitaire Reg Ocean Indien, La Reunion, France; [Malvy, Denis] Ctr Hosp Univ, Serv Med Interne & Malad Trop, Hop St Andre, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institute of Public Health Surveillance; Institute of Public Health Surveillance; CHU Bordeaux	Sissoko, D (corresponding author), Univ Victor Segalen Bordeaux 2, Ctr Rene Labusquiere, Bordeaux, France.	khaled.ezzedine@chu-bordeaux.fr	MALVY, Denis/T-7930-2019; Ezzedine, Khaled/A-3072-2009; Ezzedine, Khaled/F-2716-2017; Sissoko, Daouda/L-9193-2013	Ezzedine, Khaled/0000-0002-5468-4589; Sissoko, Daouda/0000-0002-8890-7170; D'Ortenzio, Eric/0000-0002-4527-6209	French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs); French Institute of Public Health Surveillance	French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs); French Institute of Public Health Surveillance	This study was funded by the French Ministry of Health (Regional Bureau of Hospitalization, Local Bureau of Welfare and Social Affairs) and the French Institute of Public Health Surveillance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Bartley LM, 2002, EPIDEMIOL INFECT, V128, P213, DOI 10.1017/S0950268801006495; BOISIER P, 1994, ANN SOC BELG MED TR, V74, P217; Catteau C, 2005, Med Trop (Mars), V65, P515; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KLES V, 1994, B SOC PATHOL EXOT, V87, P71; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; McBride WJH, 1998, AM J TROP MED HYG, V59, P457, DOI 10.4269/ajtmh.1998.59.457; MCCARTHY DD, 1946, E AFR MED J, P293; Messer WB, 2003, EMERG INFECT DIS, V9, P800; METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x; Renault P, 2007, AM J TROP MED HYG, V77, P727; SALMON CT, 1983, PUBLIC OPIN QUART, V47, P270, DOI 10.1086/268785; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Sissoko D, 2003, Med Trop (Mars), V63, P553; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529; Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56	33	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14141	10.1371/journal.pone.0014141	http://dx.doi.org/10.1371/journal.pone.0014141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152441	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100021
J	Svensson, L; McDowall, A; Giles, KM; Stanley, P; Feske, S; Hogg, N				Svensson, Lena; McDowall, Alison; Giles, Katherine M.; Stanley, Paula; Feske, Stefan; Hogg, Nancy			Calpain 2 Controls Turnover of LFA-1 Adhesions on Migrating T Lymphocytes	PLOS ONE			English	Article							CELL-ADHESION; PLASMA-MEMBRANE; TRPC CHANNELS; CA2+ ENTRY; CALCIUM; ACTIVATION; INHIBITOR; PROTEASE; MOBILITY; INVOLVEMENT	The immune cells named T lymphocytes circulate around the body fulfilling their role in immunosurveillance by monitoring the tissues for injury or infection. To migrate from the blood into the tissues, they make use of the integrin LFA-1 which is exclusively expressed by immune cells. These highly motile cells attach and migrate on substrates expressing the LFA-1 ligand ICAM-1. The molecular events signaling LFA-1 activation and adhesion are now reasonably well identified, but the process of detaching LFA-1 adhesions is less understood. The cysteine protease calpain is involved in turnover of integrinmediated adhesions in less motile cell types. In this study we have explored the involvement of calpain in turnover of LFA-1mediated adhesions of T lymphocytes. Using live cell imaging and immunohistochemistry, we demonstrate that turnover of adhesions depends on the Ca(2+)-dependent enzyme, calpain 2. Inhibition of calpain activity by means of siRNA silencing or pharmacological inhibition results in inefficient disassembly of LFA-1 adhesions causing T lymphocyte elongation and shedding of LFA-1 clusters behind the migrating T lymphocytes. We show that calpain 2 is distributed throughout the T lymphocyte, but is most active at the trailing edge as detected by expression of its fluorescent substrate CMAC, t-BOC-Leu-Met. Extracellular Ca(2+) entry is essential for the activity of calpain 2 that is constantly maintained as the T lymphocytes migrate. Use of T cells from a patient with mutation in ORAI1 revealed that the major calcium-release-activated-calcium channel is not the ion channel delivering the Ca(2+). We propose a model whereby Ca(2+) influx, potentially through stretch activated channels, is sufficient to activate calpain 2 at the trailing edge of a migrating T cell and this activity is essential for the turnover of LFA-1 adhesions.	[Svensson, Lena; McDowall, Alison; Giles, Katherine M.; Stanley, Paula; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London, England; [Feske, Stefan] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Cancer Research UK; New York University; NYU Langone Medical Center	Svensson, L (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Acad Dept Rheumatol, London WC2R 2LS, England.	nancy.hogg@cancer.org.uk	Pawson, Mark C/A-6085-2010; Feske, stefan/ABB-3554-2021; Markides, Constantinos/E-1816-2015	Feske, stefan/0000-0001-5431-8178; McDowall, Alison/0000-0003-2018-1462	Cancer Research UK; Marie Curie individual fellowship	Cancer Research UK(Cancer Research UK); Marie Curie individual fellowship(European Commission)	work was supported by Cancer Research UK and a Marie Curie individual fellowship to LS. These organisations had no role in the design of the study, data collection and analysis, decision to publish or in the preparation of the manuscript.	Bleijs DA, 2001, J BIOL CHEM, V276, P10338, DOI 10.1074/jbc.M008967200; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedrich P, 2004, BIOCHEM BIOPH RES CO, V323, P1131, DOI 10.1016/j.bbrc.2004.08.194; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; HARA J, 1988, J CLIN INVEST, V81, P989, DOI 10.1172/JCI113453; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; KASAI Y, 1986, J BIOCHEM-TOKYO, V100, P183, DOI 10.1093/oxfordjournals.jbchem.a121691; Kim K, 2009, J BIOL CHEM, V284, P22149, DOI 10.1074/jbc.M109.000752; KUO WN, 1994, MOL CELL BIOCHEM, V136, P157, DOI 10.1007/BF00926076; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tompa P, 1996, J BIOL CHEM, V271, P33161, DOI 10.1074/jbc.271.52.33161; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WenzelSeifert K, 1996, BIOCHEM J, V314, P679, DOI 10.1042/bj3140679; Wernimont SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010513; Winslow MM, 2005, SCIENCE, V307, P56, DOI 10.1126/science.1108163; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198	52	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15090	10.1371/journal.pone.0015090	http://dx.doi.org/10.1371/journal.pone.0015090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152086	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100067
J	Brisson, L; Gillet, L; Calaghan, S; Besson, P; Le Guennec, JY; Roger, S; Gore, J				Brisson, L.; Gillet, L.; Calaghan, S.; Besson, P.; Le Guennec, J-Y; Roger, S.; Gore, J.			Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolae	ONCOGENE			English	Article						cancer; caveolae; invasion; Na (broken vertical bar)/H (broken vertical bar) exchanger; voltage-gated sodium channels	GATED SODIUM-CHANNELS; CATHEPSIN-B; EXPRESSION; EXCHANGER	Na(V)1.5 sodium channels enhance the invasiveness of breast cancer cells through the acidic-dependent activation of cysteine cathepsins. Here, we showed that the Na+/H+ exchanger type 1 (NHE1) was an important regulator of H+ efflux in breast cancer cells MDA-MB-231 and that its activity was increased by Na(V)1.5. Na(V)1.5 and NHE1 were colocalized in membrane rafts containing caveolin-1. The inhibition of Na(V)1.5 or NHE1 induced a similar reduction in cell invasiveness and extracellular matrix degradation; no additive effect was observed when they were simultaneously inhibited. Our study suggests that NaV1.5 and NHE1 are functionally coupled and enhance the invasiveness of cancer cells by increasing H+ efflux. Oncogene (2011) 30, 2070-2076; doi:10.1038/onc.2010.574; published online 20 December 2010	[Brisson, L.; Gillet, L.; Besson, P.; Roger, S.; Gore, J.] Univ Tours, Fac Med, INSERM, U921, F-37032 Tours, Region Center, France; [Calaghan, S.] Univ Leeds, Inst Syst & Membrane Biol, Leeds, W Yorkshire, England; [Le Guennec, J-Y] Univ Montpellier 2, INSERM, Physiopathol cardiovasc U637, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Leeds; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Roger, S (corresponding author), Univ Tours, Fac Med, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, Region Center, France.	sebastien.roger@univ-tours.fr	Brisson, Lucie/R-1179-2016; LE GUENNEC, Jean-Yves/P-1067-2016	Brisson, Lucie/0000-0001-7811-1382; Roger, Sebastien/0000-0002-9852-5248; Gillet, Ludovic/0000-0002-4990-6212; Calaghan, Sarah/0000-0002-9145-2576	Ministere de la Recherche et des Technologies; 'Institut National de la Sante et de la Recherche Medicale' (Inserm); Association CANCEN; Ligue Nationale Contre le Cancer; Region Centre	Ministere de la Recherche et des Technologies; 'Institut National de la Sante et de la Recherche Medicale' (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association CANCEN; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Centre(Region Centre-Val de Loire)	We thank Dr Lin-Hua Jiang (University of Leeds, UK) for comments about the manuscript. We are grateful to Dr Ming Lei (University of Manchester, UK) for the generous gift of the anti-Na<INF>V</INF>1.5 antibody. This work was supported by the 'Ministere de la Recherche et des Technologies' and the 'Institut National de la Sante et de la Recherche Medicale' (Inserm), the 'Association CANCEN' and a grant from the 'Ligue Nationale Contre le Cancer'. Lucie Brisson and Ludovic Gillet were recipients of fellowships from the 'Region Centre'.	Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Diaz D, 2007, J CELL PHYSIOL, V210, P469, DOI 10.1002/jcp.20871; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Giusti I, 2008, NEOPLASIA, V10, P481, DOI 10.1593/neo.08178; GORE J, 1994, AM J PHYSIOL, V266, pC110, DOI 10.1152/ajpcell.1994.266.1.C110; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kraus M, 1996, TUMOR BIOL, V17, P133, DOI 10.1159/000217977; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laniado ME, 1997, AM J PATHOL, V150, P1213; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roger S, 2003, BBA-BIOMEMBRANES, V1616, P107, DOI 10.1016/j.bbamem.2003.07.001; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; Roger S, 2006, CURR PHARM DESIGN, V12, P3681, DOI 10.2174/138161206778522047; ROZHIN J, 1994, CANCER RES, V54, P6517; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Tekpli X, 2008, J CELL PHYSIOL, V216, P207, DOI 10.1002/jcp.21395; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	27	135	144	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	17					2070	2076		10.1038/onc.2010.574	http://dx.doi.org/10.1038/onc.2010.574			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	755YL	21170089	Green Submitted			2022-12-25	WOS:000289977400010
J	Ghanta, KS; Pakala, SB; Reddy, SDN; Li, DQ; Nair, SS; Kumar, R				Ghanta, Krishna Sumanth; Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Li, Da-Qiang; Nair, Sujit S.; Kumar, Rakesh			MTA1 Coregulation of Transglutaminase 2 Expression and Function during Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSACTIVATOR PROTEIN HBX; TISSUE TRANSGLUTAMINASE; BREAST-CANCER; METASTASIS; CELLS; ADENOCARCINOMA; COACTIVATOR; ACTIVATION; CIRCUITRY	Although both metastatic tumor antigen 1 (MTA1), a master chromatin modifier, and transglutaminase 2 (TG2), a multifunctional enzyme, are known to be activated during inflammation, it remains unknown whether these molecules regulate inflammatory response in a coordinated manner. Here we investigated the role of MTA1 in the regulation of TG2 expression in bacterial lipopolysaccharide (LPS)-stimulated mammalian cells. While studying the impact of MTA1 status on global gene expression, we unexpectedly discovered that MTA1 depletion impairs the basal as well as the LPS-induced expression of TG2 in multiple experimental systems. We found that TG2 is a chromatin target of MTA1 and of NF-kappa B signaling in LPS-stimulated cells. In addition, LPS-mediated stimulation of TG2 expression is accompanied by the enhanced recruitment of MTA1, p65RelA, and RNA polymerase II to the NF-kappa B consensus sites in the TG2 promoter. Interestingly, both the recruitment of p65 and TG2 expression are effectively blocked by a pharmacological inhibitor of the NF-kappa B pathway. These findings reveal an obligatory coregulatory role of MTA1 in the regulation of TG2 expression and of the MTA1-TG2 pathway, at least in part, in LPS modulation of the NF-kappa B signaling in stimulated macrophages.	[Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017; sirigiri, divijendranathareddy/A-9857-2010; Ghanta, Krishna S./M-1307-2019	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Ghanta, Krishna S./0000-0001-7502-3141; Pakala, Suresh Babu/0000-0002-5679-4837	National Institute of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants CA98823 and CA98823-S1 (to R. K.).	Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Bui-Nguyen TM, 2010, J BIOL CHEM, V285, P6980, DOI 10.1074/jbc.M109.065987; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Kausar T, 2011, CANCER INVEST, V29, P42, DOI 10.3109/07357907.2010.512597; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kishida Y, 2007, CLIN CANCER RES, V13, P59, DOI 10.1158/1078-0432.CCR-06-1559; KOJIMA S, 1993, J CELL BIOL, V121, P439, DOI 10.1083/jcb.121.2.439; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Murthy SNP, 1999, P NATL ACAD SCI USA, V96, P11815, DOI 10.1073/pnas.96.21.11815; Nardacci R, 2003, AM J PATHOL, V162, P1293, DOI 10.1016/S0002-9440(10)63925-9; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pakala SB, 2010, J BIOL CHEM, V285, P32787, DOI 10.1074/jbc.M110.151340; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOH Y, 1994, J BIOL CHEM, V269, P22958; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	37	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7132	7138		10.1074/jbc.M110.199273	http://dx.doi.org/10.1074/jbc.M110.199273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21156794	hybrid, Green Published			2022-12-25	WOS:000287737300030
J	Shimomura, T; Irie, K; Nagura, H; Imai, T; Fujiyoshi, Y				Shimomura, Takushi; Irie, Katsumasa; Nagura, Hitoshi; Imai, Tomoya; Fujiyoshi, Yoshinori			Arrangement and Mobility of the Voltage Sensor Domain in Prokaryotic Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; PORE DOMAIN; GATING-CHARGE; S4 SEGMENT; POTASSIUM CHANNEL; LIPID-MEMBRANE; ION CHANNELS; NA+ CHANNEL; RESIDUES; MOVEMENT	Prokaryotic voltage-gated sodium channels (Na(V)s) form homotetramers with each subunit contributing six transmembrane alpha-helices (S1-S6). Helices S5 and S6 form the ion-conducting pore, and helices S1-S4 function as the voltage sensor with helix S4 thought to be the essential element for voltage-dependent activation. Although the crystal structures have provided insight into voltage-gated K channels (K(V)s), revealing a characteristic domain arrangement in which the voltage sensor domain of one subunit is close to the pore domain of an adjacent subunit in the tetramer, the structural and functional information on Na(V)s remains limited. Here, we show that the domain arrangement in NaChBac, a firstly cloned prokaryotic Na-V, is similar to that in K(V)s. Cysteine substitutions of three residues in helix S4, Q107C, T110C, and R113C, effectively induced intersubunit disulfide bond formation with a cysteine introduced in helix S5, M164C, of the adjacent subunit. In addition, substituting two acidic residues with lysine, E43K and D60K, shifted the activation of the channel to more positive membrane potentials and consistently shifted the preferentially formed disulfide bond from T110C/M164C to Q107C/M164C. Because Gln-107 is located closer to the extracellular side of helix S4 than Thr-110, this finding suggests that the functional shift in the voltage dependence of activation is related to a restriction of the position of helix S4 in the lipid bilayer. The domain arrangement and vertical mobility of helix S4 in NaChBac indicate that the structure and the mechanism of voltage-dependent activation in prokaryotic Na(V)s are similar to those in canonical K(V)s.	[Shimomura, Takushi; Irie, Katsumasa; Nagura, Hitoshi; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Irie, Katsumasa; Fujiyoshi, Yoshinori] Japan Biol Informat Consortium, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Tomoya] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Fujiyoshi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Fujiyoshi, Yoshinori/E-5989-2012; 今井, 友也/M-1834-2019; Irie, Katsumasa/D-7332-2013	Fujiyoshi, Yoshinori/0000-0002-8070-1493; 今井, 友也/0000-0001-7026-0287; Irie, Katsumasa/0000-0002-8178-1552	Japan New Energy and Industrial Technology Development Organization; Kyoto University	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Kyoto University	This work was supported by Grants-in-Aid for Scientific Research, the Japan New Energy and Industrial Technology Development Organization, and the Kyoto University Global COE Program, Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Blanchet J, 2007, BIOPHYS J, V92, P3513, DOI 10.1529/biophysj.106.090464; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M, 2004, J MEMBRANE BIOL, V201, P9, DOI 10.1007/s00232-004-0701-z; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Nagura H, 2010, BIOCHEM BIOPH RES CO, V399, P341, DOI 10.1016/j.bbrc.2010.07.070; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Paldi T, 2010, BIOPHYS J, V99, P456, DOI 10.1016/j.bpj.2010.04.053; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wahlberg E, 2006, J AM CHEM SOC, V128, P7651, DOI 10.1021/ja060933g; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; YU FH, 2004, SCI STKE; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101	39	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7409	7417		10.1074/jbc.M110.186510	http://dx.doi.org/10.1074/jbc.M110.186510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177850	hybrid, Green Published			2022-12-25	WOS:000287737300056
J	Ebihara, A; Nitta, JH; Ito, M				Ebihara, Atsushi; Nitta, Joel H.; Ito, Motomi			Molecular Species Identification with Rich Floristic Sampling: DNA Barcoding the Pteridophyte Flora of Japan	PLOS ONE			English	Article							CHLOROPLAST DNA; FERN; HYMENOPHYLLACEAE; GAMETOPHYTES; POPULATION; PHYLOGENY; COMPLEX; GENUS; RBCL; SPOROPHYTES	Background: DNA barcoding is expected to be an effective identification tool for organisms with heteromorphic generations such as pteridophytes, which possess a morphologically simple gametophyte generation. Although a reference data set including complete coverage of the target local flora/fauna is necessary for accurate identification, DNA barcode studies including such rich taxonomic sampling on a countrywide scale are lacking. Methodology/Principal Findings: The Japanese pteridophyte flora (733 taxa including subspecies and varieties) was used to test the utility of two plastid DNA barcode regions (rbcL and trnH-psbA) with the intention of developing an identification system for native gametophytes. DNA sequences were obtained from each of 689 (94.0%) taxa for rbcL and 617 (84.2%) taxa for trnH-psbA. Mean interspecific divergence values across all taxon pairs (K2P genetic distances) did not reveal a significant difference in rate between trnH-psbA and rbcL, but mean K2P distances of each genus showed significant heterogeneity according to systematic position. The minimum fail rate of taxon discrimination in an identification test using BLAST (12.52%) was obtained when rbcL and trnH-psbA were combined, and became lower in datasets excluding infraspecific taxa or apogamous taxa, or including sexual diploids only. Conclusions/Significance: This study demonstrates the overall effectiveness of DNA barcodes for species identification in the Japanese pteridophyte flora. Although this flora is characterized by a high occurrence of apogamous taxa that pose a serious challenge to identification using DNA barcodes, such taxa are limited to a small number of genera, and only minimally detract from the overall success rate. In the case that a query sequence is matched to a known apogamous genus, routine species identification may not be possible. Otherwise, DNA barcoding is a practical tool for identification of most Japanese pteridophytes, and is especially anticipated to be helpful for identification of non-hybridizing gametophytes.	[Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Nitta, Joel H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Dept Syst Sci, Meguro Ku, Tokyo, Japan	National Museum of Nature and Science; University of California System; University of California Berkeley; University of Tokyo	Ebihara, A (corresponding author), Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan.	ebihara@kahaku.go.jp	Nitta, Joel/J-5467-2019	Nitta, Joel/0000-0003-4719-7472				Andrew RL, 2003, AUST SYST BOT, V16, P69, DOI 10.1071/SB01043; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Ebihara A, 2003, SYST BOT, V28, P228; Ebihara A, 2007, BOT J LINN SOC, V155, P1, DOI 10.1111/j.1095-8339.2007.00684.x; Ebihara A, 2009, MOL ECOL, V18, P4904, DOI 10.1111/j.1365-294X.2009.04406.x; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; FARRAR DR, 1967, SCIENCE, V155, P1266, DOI 10.1126/science.155.3767.1266; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Grant V., 1981, PLANT SPECIATION, Vsecond; Guo QF, 2003, ECOGRAPHY, V26, P129, DOI 10.1034/j.1600-0587.2003.03379.x; Haufler CH, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P303, DOI 10.1017/CBO9780511541827.013; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Holman JE, 2000, AUST J BOT, V48, P569, DOI 10.1071/BT98032; Horandl E, 2004, INT J PLANT SCI, V165, P615, DOI 10.1086/386557; Ishikawa Hiroshi, 2003, APG Acta Phytotaxonomica et Geobotanica, V54, P59; IWATSUKI K, 1995, FLORA JAPAN, V1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; MOMOSE S, 1967, GAMETOPHYTES JAPANES; NAKAIKE T, 1992, NEW FLORA JAPAN PTER; NAKAIKE T, 2004, J NIPPON FERNIST S2, V3; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; Nitta JH, 2009, BRITTONIA, V61, P392, DOI 10.1007/s12228-009-9097-5; Park CH, 2003, J PLANT RES, V116, P93, DOI 10.1007/s10265-003-0081-y; Pryer KM, 2001, AM J BOT, V88, P1118, DOI 10.2307/2657095; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Robertson A, 2004, MOL ECOL, V13, P123, DOI 10.1046/j.1365-294X.2003.02025.x; RUMSEY FJ, 1996, PTERIDOLOGY PERSPECT, P563; SATO T, 1981, CAN J BOT, V59, P604, DOI 10.1139/b81-085; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Sheffield E, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P49, DOI 10.1017/CBO9780511541827.003; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STEIN DB, 1990, ANN MO BOT GARD, V77, P334, DOI 10.2307/2399548; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAKAMIYA M, 1996, INDEX CHROMOSOMES JA; Tate JA, 2003, SYST BOT, V28, P723; Vogel JC, 1998, BOT ACTA, V111, P247, DOI 10.1111/j.1438-8677.1998.tb00704.x; Watkins JE, 2009, AM FERN J, V99, P162, DOI 10.1640/0002-8444-99.3.162; Yatabe Y, 2001, AM J BOT, V88, P1517, DOI 10.2307/3558459	58	105	118	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15136	10.1371/journal.pone.0015136	http://dx.doi.org/10.1371/journal.pone.0015136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170336	Green Published, gold, Green Submitted			2022-12-25	WOS:000285084100020
J	Erdely, A; Kepka-Lenhart, D; Salmen-Muniz, R; Chapman, R; Hulderman, T; Kashon, M; Simeonova, PP; Morris, SM				Erdely, Aaron; Kepka-Lenhart, Diane; Salmen-Muniz, Rebecca; Chapman, Rebecca; Hulderman, Tracy; Kashon, Michael; Simeonova, Petia P.; Morris, Sidney M., Jr.			Arginase Activities and Global Arginine Bioavailability in Wild-Type and ApoE-Deficient Mice: Responses to High Fat and High Cholesterol Diets	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; OXIDE-MEDIATED DILATION; LIVER-TYPE ARGINASE; UREA CYCLE ENZYMES; NITRIC-OXIDE; ATHEROGENIC DIET; ENDOTHELIAL DYSFUNCTION; GENE-EXPRESSION; ATHEROSCLEROTIC LESIONS; CORONARY ARTERIOLES	Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease.	[Erdely, Aaron; Salmen-Muniz, Rebecca; Chapman, Rebecca; Hulderman, Tracy; Simeonova, Petia P.] NIOSH, Toxicol & Mol Biol Branch, Morgantown, WV USA; [Erdely, Aaron; Salmen-Muniz, Rebecca; Hulderman, Tracy] NIOSH, Lab Occupat Cardiovasc Toxicol, Morgantown, WV USA; [Kepka-Lenhart, Diane; Morris, Sidney M., Jr.] NIOSH, Biostat & Epidemiol Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Kashon, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Erdely, A (corresponding author), NIOSH, Toxicol & Mol Biol Branch, Morgantown, WV USA.	efi4@cdc.gov	Erdely, Aaron/A-3518-2013; Morris, Sidney M/I-3440-2015		National Institutes of Health [RO1 GM57384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grant RO1 GM57384 to SMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; Durante W, 1997, J BIOL CHEM, V272, P30154, DOI 10.1074/jbc.272.48.30154; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Erdely A, 2006, AM J PHYSIOL-LUNG C, V290, pL534, DOI 10.1152/ajplung.00326.2005; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Ikemoto M, 2001, CLIN CHEM, V47, P946; Ikemoto M, 1998, CLIN CHIM ACTA, V271, P11, DOI 10.1016/S0009-8981(97)00226-X; Johnson FK, 2005, AM J PHYSIOL-REG I, V288, pR1057, DOI 10.1152/ajpregu.00758.2004; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; LIAO F, 1993, J CLIN INVEST, V91, P2572, DOI 10.1172/JCI116495; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marathe C, 2006, J BIOL CHEM, V281, P32197, DOI 10.1074/jbc.M605237200; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MORRIS SM, 1992, ANNU REV NUTR, V12, P81, DOI 10.1146/annurev.nu.12.070192.000501; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Preli RB, 2002, ATHEROSCLEROSIS, V162, P1, DOI 10.1016/S0021-9150(01)00717-1; Qureshi AA, 2001, J NUTR, V131, P2606, DOI 10.1093/jn/131.10.2606; Reid KM, 2007, AM J PHYSIOL-GASTR L, V292, pG512, DOI 10.1152/ajpgi.00227.2006; ROTH E, 1994, TRANSPLANTATION, V57, P665, DOI 10.1097/00007890-199403150-00006; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Santhanam L, 2007, CIRC RES, V101, P692, DOI 10.1161/CIRCRESAHA.107.157727; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wei LH, 2001, P NATL ACAD SCI USA, V98, P9260, DOI 10.1073/pnas.161294898; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8; Zhang CH, 2004, HYPERTENSION, V44, P935, DOI 10.1161/01.HYP.0000146907.82869.f2; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zheng SQ, 2008, EUR J PHARMACOL, V584, P118, DOI 10.1016/j.ejphar.2008.01.045	47	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15253	10.1371/journal.pone.0015253	http://dx.doi.org/10.1371/journal.pone.0015253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151916	Green Published, gold, Green Accepted			2022-12-25	WOS:000284995300024
J	Hasan, N; Corbin, D; Hu, CA				Hasan, Nazarul; Corbin, Deborah; Hu, Chuan			Fusogenic Pairings of Vesicle-Associated Membrane Proteins (VAMPs) and Plasma Membrane t-SNAREs-VAMP5 as the Exception	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; 3 SNARE COMPLEXES; EPITHELIAL-CELLS; MEDIATED CLEAVAGE; HUMAN PLATELETS; SYNTAXIN 4; IN-VITRO; FUSION; EXOCYTOSIS; CELLUBREVIN	Background: Intracellular vesicle fusion is mediated by the interactions of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins on vesicles (v-SNAREs) and on target membranes (t-SNAREs). The vesicle-associated membrane proteins (VAMPs) are v-SNAREs that reside in various post-Golgi vesicular compartments. To fully understand the specific role of each VAMP in vesicle trafficking, it is important to determine if VAMPs have differential membrane fusion activities. Methodology/Principal Findings: In this study, we developed a cell fusion assay that quantifies SNARE-mediated membrane fusion events by activated expression of beta-galactosidase, and examined fusogenic pairings between the seven VAMPs, i.e., VAMPs 1, 2, 3, 4, 5, 7 and 8, and two plasma membrane t-SNARE complexes, syntaxin1/SNAP-25 and syntaxin4/SNAP-25. VAMPs 1, 2, 3, 4, 7 and 8 drove fusion efficiently, whereas VAMP5 was unable to mediate fusion with the t-SNAREs. By expressing VAMPs 1, 3, 4, 7 and 8 at the same level, we further compared their membrane fusion activities. VAMPs 1 and 3 had comparable and the highest fusion activities, whereas VAMPs 4, 7 and 8 exhibited 30-50% lower fusion activities. Moreover, we determined the dependence of cell fusion activity on VAMP1 expression level. Analysis of the dependence data suggested that there was no cooperativity of VAMP proteins in the cell fusion reaction. Conclusions/Significance: These data indicate that VAMPs have differential membrane fusion capacities, and imply that with the exception of VAMP5, VAMPs are essentially redundant in mediating fusion with plasma membrane t-SNAREs.	[Hasan, Nazarul; Corbin, Deborah; Hu, Chuan] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Louisville	Hasan, N (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	chuan.hu@louisville.edu			American Heart Association; University of Louisville School of Medicine; National Institutes of Health [CA135123]; NATIONAL CANCER INSTITUTE [R03CA135123] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Louisville School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a scientist development grant from the American Heart Association, a startup fund from the University of Louisville School of Medicine and CA135123 from the National Institutes of Health (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Feng D, 2002, BLOOD, V99, P4006, DOI 10.1182/blood.V99.11.4006; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu C, 2007, EXP CELL RES, V313, P3198, DOI 10.1016/j.yexcr.2007.06.008; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jagadish MN, 1996, BIOCHEM J, V317, P945, DOI 10.1042/bj3170945; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Morgenthaler FD, 2003, EUR J NEUROSCI, V17, P1365, DOI 10.1046/j.1460-9568.2003.02572.x; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rowe J, 2001, J CELL SCI, V114, P3323; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; Zeng Q, 2003, J BIOL CHEM, V278, P23046, DOI 10.1074/jbc.M303214200; Zeng Q, 1998, MOL BIOL CELL, V9, P2423, DOI 10.1091/mbc.9.9.2423	54	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14238	10.1371/journal.pone.0014238	http://dx.doi.org/10.1371/journal.pone.0014238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151919	gold, Green Submitted, Green Published			2022-12-25	WOS:000284995300010
J	Barnett, A; Abrantes, KG; Stevens, JD; Bruce, BD; Semmens, JM				Barnett, Adam; Abrantes, Katya G.; Stevens, John D.; Bruce, Barry D.; Semmens, Jayson M.			Fine-Scale Movements of the Broadnose Sevengill Shark and Its Main Prey, the Gummy Shark	PLOS ONE			English	Article							PACIFIC SLEEPER SHARK; NOTORYNCHUS-CEPEDIANUS; SOMNIOSUS-MICROCEPHALUS; ACOUSTIC TRACKING; PREDATOR; BEHAVIOR; DIET; ECOLOGY; HABITAT; RISK	Information on the fine-scale movement of predators and their prey is important to interpret foraging behaviours and activity patterns. An understanding of these behaviours will help determine predator-prey relationships and their effects on community dynamics. For instance understanding a predator's movement behaviour may alter pre determined expectations of prey behaviour, as almost any aspect of the prey's decisions from foraging to mating can be influenced by the risk of predation. Acoustic telemetry was used to study the fine-scale movement patterns of the Broadnose Sevengill shark Notorynchus cepedianus and its main prey, the Gummy shark Mustelus antarcticus, in a coastal bay of southeast Tasmania. Notorynchus cepedianus displayed distinct diel differences in activity patterns. During the day they stayed close to the substrate (sea floor) and were frequently inactive. At night, however, their swimming behaviour continually oscillated through the water column from the substrate to near surface. In contrast, M. antarcticus remained close to the substrate for the entire diel cycle, and showed similar movement patterns for day and night. For both species, the possibility that movement is related to foraging behaviour is discussed. For M. antarcticus, movement may possibly be linked to a diet of predominantly slow benthic prey. On several occasions, N. cepedianus carried out a sequence of burst speed events (increased rates of movement) that could be related to chasing prey. All burst speed events during the day were across the substrate, while at night these occurred in the water column. Overall, diel differences in water column use, along with the presence of oscillatory behaviour and burst speed events suggest that N. cepedianus are nocturnal foragers, but may opportunistically attack prey they happen to encounter during the day.	[Barnett, Adam; Abrantes, Katya G.; Semmens, Jayson M.] Univ Tasmania, Marine Res Labs, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia; [Barnett, Adam; Stevens, John D.; Bruce, Barry D.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Abrantes, Katya G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Barnett, A (corresponding author), Univ Tasmania, Marine Res Labs, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia.	adam.barnett@utas.edu.au		, Adam/0000-0001-7430-8428; abrantes, katya/0000-0001-8648-8817; Semmens, Jayson/0000-0003-1742-6692	Save Our Seas Foundation; Winifred Violet Scott Foundation; Holsworth Wildlife Research Endowment	Save Our Seas Foundation; Winifred Violet Scott Foundation; Holsworth Wildlife Research Endowment	This study was supported by grants from the Save Our Seas Foundation (www.saveourseas.com), Winifred Violet Scott Foundation (no website available) and the Holsworth Wildlife Research Endowment (http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/). No grant numbers are available at present due to finance department restructuring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069&lt;0298:SSRSBR&gt;2.0.CO;2; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Barnett A, 2010, J FISH BIOL, V77, P1688, DOI 10.1111/j.1095-8649.2010.02810.x; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Braccini JM, 2008, MAR ECOL PROG SER, V371, P273, DOI 10.3354/meps07684; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; CROCKER GE, 2001, J ZOOL LOND, V254, P267; Davis RW, 2007, PHILOS T R SOC B, V362, P2141, DOI 10.1098/rstb.2007.2107; EBERT DA, 1989, CALIF FISH GAME, V75, P102; Ebert DA, 2002, MAR FRESHWATER RES, V53, P517, DOI 10.1071/MF01143; EBERT DA, 1991, S AFR J MARINE SCI, V11, P565, DOI 10.2989/025776191784287547; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; Frid A, 2009, OECOLOGIA, V158, P775, DOI 10.1007/s00442-008-1189-5; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, MAR ECOL PROG SER, V209, P307, DOI 10.3354/meps209307; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; HOLTS DB, 1993, AUST J MAR FRESH RES, V44, P901; Hulbert LB, 2006, J FISH BIOL, V69, P406, DOI 10.1111/j.1095-8649.2006.01175.x; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Johnson CJ, 2002, ECOL APPL, V12, P1840, DOI 10.1890/1051-0761(2002)012[1840:AMBATU]2.0.CO;2; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Last PR, 2009, SHARKS RAYS AUSTR; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; Macia A, 2003, J EXP MAR BIOL ECOL, V291, P29, DOI 10.1016/S0022-0981(03)00097-2; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Nams VO, 2005, OECOLOGIA, V143, P179, DOI 10.1007/s00442-004-1804-z; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Sigler MF, 2006, J FISH BIOL, V69, P392, DOI 10.1111/j.1095-8649.2006.01096.x; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stevens J. D., 1997, 93061 CSIRO FISH RES; Stokesbury MJW, 2005, MAR BIOL, V148, P159, DOI 10.1007/s00227-005-0061-y; Strong WR, 1996, GREAT WHITE SHARKS, P229, DOI 10.1016/B978-012415031-7/50022-7; Sundstrom LF, 2002, J FISH BIOL, V61, P834, DOI 10.1006/jfbi.2002.2058; Sundstrom LF, 2001, ENVIRON BIOL FISH, V60, P225, DOI 10.1023/A:1007657505099; TRICAS TC, 1981, COPEIA, P904, DOI 10.2307/1444199; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; WILLIAMS H, 1992, AUST J MAR FRESH RES, V43, P237, DOI 10.1071/MF9920237; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016; Yang MS, 1999, FISH B-NOAA, V97, P406; Yano K, 2007, J FISH BIOL, V70, P374, DOI 10.1111/j.1095-8649.2007.01308.x; YICK J, THESIS U TASMANIA	61	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15464	10.1371/journal.pone.0015464	http://dx.doi.org/10.1371/journal.pone.0015464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151925	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000284939600035
J	Hamilton, DW; Oates, CJ; Hasanzadeh, A; Mittler, S				Hamilton, Douglas W.; Oates, Christine J.; Hasanzadeh, Abdollah; Mittler, Silvia			Migration of Periodontal Ligament Fibroblasts on Nanometric Topographical Patterns: Influence of Filopodia and Focal Adhesions on Contact Guidance	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; CYTOSKELETAL ORGANIZATION; OSTEOBLAST ADHESION; SURFACE-TOPOGRAPHY; NANOTOPOGRAPHY; PHOSPHORYLATION; MECHANISMS; IMPLANTS; TISSUE	Considered to be the "holy grail'' of dentistry, regeneration of the periodontal ligament in humans remains a major clinical problem. Removal of bacterial biofilms is commonly achieved using EDTA gels or lasers. One side effect of these treatment regimens is the etching of nanotopographies on the surface of the tooth. However, the response of periodontal ligament fibroblasts to such features has received very little attention. Using laser interference lithography, we fabricated precisely defined topographies with continuous or discontinuous nanogrooves to assess the adhesion, spreading and migration of PDL fibroblasts. PDL fibroblasts adhered to and spread on all tested surfaces, with initial spreading and focal adhesion formation slower on discontinuous nanogrooves. Cells had a significantly smaller planar area on both continuous and discontinuous nanogrooves in comparison with cells on non-patterned controls. At 24 h post seeding, cells on both types of nanogrooves were highly elongated parallel to the groove long axis. Time-lapse video microscopy revealed that PDL fibroblast movement was guided on both types of grooves, but migration velocity was not significantly different from cells cultured on non-patterned controls. Analysis of filopodia formation using time-lapse video microscopy and labeling of vinculin and F-actin revealed that on nanogrooves, filopodia were highly aligned at both ends of the cell, but with increasing time filopodia and membrane protrusions developed at the side of the cell perpendicular to the cell long axis. We conclude that periodontal ligament fibroblasts are sensitive to nanotopographical depths of 85-100 mu m, which could be utilized in regeneration of the periodontal ligament.	[Hamilton, Douglas W.; Oates, Christine J.; Mittler, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Grad Program Biomed Engn, London, ON, Canada; [Hamilton, Douglas W.] Univ Western Ontario, Schulich Sch Med & Dent, Div Oral Biol, London, ON, Canada; [Hasanzadeh, Abdollah; Mittler, Silvia] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hamilton, DW (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Grad Program Biomed Engn, London, ON, Canada.	dhamil2@uwo.ca	Mittler, Silvia/B-5639-2015; Hamilton, Douglas W/L-8932-2015	Mittler, Silvia/0000-0001-8998-1877; Hamilton, Douglas W/0000-0002-9798-5197	Canadian Foundation [18742]; Natural Sciences and Engineering Research Council of Canada [R4091A06]	Canadian Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors thank Dr Wankei Wan for financial support of CJO. This work was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund (18742) and the Natural Sciences and Engineering Research Council of Canada Discovery Grants Program R4091A06 (D. W. Hamilton). www.nserc-crsng.gc.ca. www.innovation.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003; Babay N, 2000, Indian J Dent Res, V11, P53; Babay N, 2001, J Contemp Dent Pract, V2, P13; Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9; Blomlof J, 1996, J CLIN PERIODONTOL, V23, P50, DOI 10.1111/j.1600-051X.1996.tb00504.x; Blomlof J, 1996, J CLIN PERIODONTOL, V23, P12, DOI 10.1111/j.1600-051X.1996.tb00498.x; BRECKENRIDGE LJ, 1995, J NEUROSCI RES, V42, P266, DOI 10.1002/jnr.490420215; Bruckmann C, 2005, BIOMATERIALS, V26, P339, DOI 10.1016/j.biomaterials.2004.02.031; Chehroudi B, 1997, J BIOMED MATER RES, V34, P279; CHOU LS, 1995, J CELL SCI, V108, P1563; Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415; Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001; Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004; Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139; Davies JE, 1998, INT J PROSTHODONT, V11, P391; Drisko C L, 1991, Curr Opin Dent, V1, P74; Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918; Gamal Ahmed Y, 2003, J Int Acad Periodontol, V5, P11; Gonzales Silverio-Ruiz K, 2007, CYTOKINE, V39, P130, DOI 10.1016/j.cyto.2007.06.009; Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x; Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041; Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026; Hamilton DW, 2005, EXP CELL RES, V309, P429, DOI 10.1016/j.yexcr.2005.06.015; Hamilton DW, 2005, CELL BIOL INT, V29, P605, DOI 10.1016/j.cellbi.2005.03.013; Hamilton DW, 2005, CELL BIOL INT, V29, P408, DOI 10.1016/j.cellbi.2004.12.008; Kalkwarf K L, 1991, Curr Opin Dent, V1, P87; Karring T, 2000, J Int Acad Periodontol, V2, P101; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P44; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P36; Kassab M, 2003, COMPEND CONTIN ED DE, V24, P40; Kassab Moawia, 2003, Compend Contin Educ Dent, V24, P31; Kokubu E, 2009, J BIOMED MATER RES A, V91A, P663, DOI 10.1002/jbm.a.32273; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; OAKLEY C, 1995, CELL MOTIL CYTOSKEL, V31, P45, DOI 10.1002/cm.970310106; OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8; Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; Schwarz F, 2003, LASER SURG MED, V33, P140, DOI 10.1002/lsm.10201; Sculean A, 2004, INT J PERIODONT REST, V24, P327; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H	49	51	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15129	10.1371/journal.pone.0015129	http://dx.doi.org/10.1371/journal.pone.0015129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152020	Green Submitted, Green Published, gold			2022-12-25	WOS:000284821300018
J	Ralainirina, N; Brons, NHC; Ammerlaan, W; Hoffmann, C; Hentges, F; Zimmer, J				Ralainirina, Natacha; Brons, Nicolaas H. C.; Ammerlaan, Wim; Hoffmann, Celine; Hentges, Francois; Zimmer, Jacques			Mouse Natural Killer (NK) Cells Express the Nerve Growth Factor Receptor TrkA, which Is Dynamically Regulated	PLOS ONE			English	Article							CD107A; ASTHMA	Background: Nerve growth factor (NGF) is a neurotrophin crucial for the development and survival of neurons. It also acts on cells of the immune system which express the NGF receptors TrkA and p75(NTR) and can be produced by them. However, mouse NK cells have not yet been studied in this context. Methodology/Principal Findings: We used cell culture, flow cytometry, confocal microscopy and ELISA assays to investigate the expression of NGF receptors by NK cells and their secretion of NGF. We show that resting NK cells express TrkA and that the expression is different on NK cell subpopulations defined by the relative presence of CD27 and CD11b. Expression of TrkA is dramatically increased in IL-2-activated NK cells. The p75 NTR is expressed only on a very low percentage of NK cells. Functionally, NGF moderately inhibits NK cell degranulation, but does not influence proliferation or cytokine production. NK cells do not produce NGF. Conclusions/Significance: We demonstrate for the first time that mouse NK cells express the NGF receptor TrkA and that this expression is dynamically regulated.	[Ralainirina, Natacha; Hentges, Francois; Zimmer, Jacques] CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg; [Brons, Nicolaas H. C.; Ammerlaan, Wim] CRP Sante, Core Facil Flow Cytometry, Luxembourg, Luxembourg; [Hoffmann, Celine] CRP Sante, Plant Mol Biol Lab, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Health; Luxembourg Institute of Health	Ralainirina, N (corresponding author), CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg.	jacques.zimmer@crp-sante.lu	Hoffmann, Céline/F-3741-2016	Hoffmann, Céline/0000-0002-7564-2329; Zimmer, Jacques/0000-0002-7118-6944	Luxembourgish National Research Fund (FNR)	Luxembourgish National Research Fund (FNR)(Luxembourg National Research Fund)	The work of Natacha Ralainirina was supported by an AFR Grant from the Luxembourgish National Research Fund (FNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arredondo LR, 2001, EUR J IMMUNOL, V31, P625; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Caroleo MC, 2001, J NEUROIMMUNOL, V113, P193, DOI 10.1016/S0165-5728(00)00441-0; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Frossard N, 2004, EUR J PHARMACOL, V500, P453, DOI 10.1016/j.ejphar.2004.07.044; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lambiase A, 1997, J ALLERGY CLIN IMMUN, V100, P408, DOI 10.1016/S0091-6749(97)70256-2; Lambiase A, 2004, CURR OPIN ALLERGY CL, V4, P425, DOI 10.1097/00130832-200410000-00015; Nassenstein C, 2006, EUR J PHARMACOL, V533, P195, DOI 10.1016/j.ejphar.2005.12.061; Nassenstein C, 2006, EXP TOXICOL PATHOL, V57, P55, DOI 10.1016/j.etp.2006.02.008; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; SAMAH B, 2008, CLIN EXP IMMUNOL, V131, P80; Samah B, 2009, J NEUROVIROL, V15, P71, DOI 10.1080/13550280802482575; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yokoyama WM, 2010, BIOL BLOOD MARROW TR, V16, pS97, DOI 10.1016/j.bbmt.2009.10.009	21	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e15053	10.1371/journal.pone.0015053	http://dx.doi.org/10.1371/journal.pone.0015053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152021	Green Published, gold, Green Submitted			2022-12-25	WOS:000284821300014
J	Brinkhof, MWG; Spycher, BD; Yiannoutsos, C; Weigel, R; Wood, R; Messou, E; Boulle, A; Egger, M; Sterne, JAC				Brinkhof, Martin W. G.; Spycher, Ben D.; Yiannoutsos, Constantin; Weigel, Ralf; Wood, Robin; Messou, Eugene; Boulle, Andrew; Egger, Matthias; Sterne, Jonathan A. C.		Int Epidemiological Database Evalu	Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RAPID SCALE-UP; ANTIRETROVIRAL THERAPY; SURVIVAL CURVES; COHORT PROFILE; RISK-FACTORS; LOW-INCOME; OUTCOMES; AIDS; CARE	Background: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because many patients are lost to follow-up. Outcomes in these patients are generally unknown but studies tracing patients have shown mortality to be high. We adjusted programme-level mortality in the first year of antiretroviral treatment (ART) for excess mortality in patients lost to follow-up. Methods and Findings: Treatment-naive patients starting combination ART in five programmes in Cote d'Ivoire, Kenya, Malawi and South Africa were eligible. Patients whose last visit was at least nine months before the closure of the database were considered lost to follow-up. We filled missing survival times in these patients by multiple imputation, using estimates of mortality from studies that traced patients lost to follow-up. Data were analyzed using Weibull models, adjusting for age, sex, ART regimen, CD4 cell count, clinical stage and treatment programme. A total of 15,915 HIV-infected patients (median CD4 cell count 110 cells/mu L, median age 35 years, 68% female) were included; 1,001 (6.3%) were known to have died and 1,285 (14.3%) were lost to follow-up in the first year of ART. Crude estimates of mortality at one year ranged from 5.7% (95% CI 4.9-6.5%) to 10.9% (9.6-12.4%) across the five programmes. Estimated mortality hazard ratios comparing patients lost to follow-up with those remaining in care ranged from 6 to 23. Adjusted estimates based on these hazard ratios ranged from 10.2% (8.9-11.6%) to 16.9% (15.0-19.1%), with relative increases in mortality ranging from 27% to 73% across programmes. Conclusions: Naive survival analysis ignoring excess mortality in patients lost to follow-up may greatly underestimate overall mortality, and bias ART programme evaluations. Adjusted mortality estimates can be obtained based on excess mortality rates in patients lost to follow-up.	[Brinkhof, Martin W. G.; Spycher, Ben D.; Egger, Matthias] Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland; [Yiannoutsos, Constantin] Indiana Univ, Div Biostat, Indianapolis, IN 46204 USA; [Weigel, Ralf] Kamuzu Cent Hosp, Lighthouse Trust, Lilongwe, Malawi; [Weigel, Ralf] Minist Hlth, Lilongwe, Malawi; [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire; [Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bern; Indiana University System; Indiana University-Purdue University Indianapolis; University of Cape Town; University of Cape Town; University of Bristol	Brinkhof, MWG (corresponding author), Univ Bern, Div Int & Environm Hlth, ISPM, Bern, Switzerland.	egger@ispm.unibe.ch	Weigel, Ralf/ABD-2310-2020; Wood, Robin/G-8509-2011; Sterne, Jonathan/Z-3106-2019; Boulle, Andrew/C-1413-2008; Spycher, Ben D/B-3308-2008	Weigel, Ralf/0000-0001-9034-2634; Sterne, Jonathan/0000-0001-8496-6053; Boulle, Andrew/0000-0002-7713-8062; Spycher, Ben D/0000-0002-1430-5695; Brinkhof, Martin/0000-0002-9319-665X; Egger, Matthias/0000-0001-7462-5132	Office of AIDS Research (OAR) of the National Institutes of Health (NIH); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS); National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069924, U01-AI069911, U01-AI069919]; United Kingdom Medical Research Council (MRC) [G0600599]; NIH [U01-AI069911-04S2]; Medical Research Council [G0600599] Funding Source: researchfish; MRC [G0600599] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, U01AI069919, U01AI069911] Funding Source: NIH RePORTER	Office of AIDS Research (OAR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Office of AIDS Research (OAR) of the National Institutes of Health (NIH), the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), and the National Institute of Allergy and Infectious Diseases (NIAID, grants U01-AI069924, U01-AI069911, U01-AI069919). JACS was supported by United Kingdom Medical Research Council (MRC) grant G0600599. CY was supported by NIH grant U01-AI069911-04S2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P657; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; BRINKHOF MW, 2008, B WORLD HEALTH ORGAN, V86, P497; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; HOCHGESANG M, 2006, AIDS 2006 16 INT AID; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; PHIRI S, 2004, LIGHTHOUSE CTR COMPR; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	35	66	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14149	10.1371/journal.pone.0014149	http://dx.doi.org/10.1371/journal.pone.0014149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152392	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100028
J	Hoelen, H; Kleizen, B; Schmidt, A; Richardson, J; Charitou, P; Thomas, PJ; Braakman, I				Hoelen, Hanneke; Kleizen, Bertrand; Schmidt, Andre; Richardson, John; Charitou, Paraskevi; Thomas, Philip J.; Braakman, Ineke			The Primary Folding Defect and Rescue of Delta F508 CFTR Emerge during Translation of the Mutant Domain	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; GENE; MUTATION; CHANNEL; DEGRADATION; DISRUPTION; PROTEASOME; PHENOTYPE	In the vast majority of cystic fibrosis (CF) patients, deletion of residue F508 from CFTR is the cause of disease. F508 resides in the first nucleotide binding domain (NBD1) and its absence leads to CFTR misfolding and degradation. We show here that the primary folding defect arises during synthesis, as soon as NBD1 is translated. Introduction of either the I539T or G550E suppressor mutation in NBD1 partially rescues Delta F508 CFTR to the cell surface, but only I539T repaired Delta F508 NBD1. We demonstrated rescue of folding and stability of NBD1 from full-length Delta F508 CFTR expressed in cells to isolated purified domain. The co-translational rescue of Delta F508 NBD1 misfolding in CFTR by I539T advocates this domain as the most important drug target for cystic fibrosis.	[Hoelen, Hanneke; Kleizen, Bertrand; Charitou, Paraskevi; Braakman, Ineke] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Schmidt, Andre; Richardson, John; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Utrecht University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hoelen, H (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@uu.nl	Thomas, Philip J/F-7115-2012	Kleizen, Bertrand/0000-0002-4640-1796; Braakman, Ineke/0000-0003-1592-4364	Netherlands Organisation for Scientific Research (NWO); Division of Health Research and Development (ZonMW); Cystic Fibrosis Foundation; National Institutes of Health [DK49835, DE12309]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Division of Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Netherlands Organisation for Scientific Research (NWO), Division of Health Research and Development (ZonMW) (IB), the Cystic Fibrosis Foundation (IB and PJT) and by National Institutes of Health (PJT; DK49835 and DE12309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Buchner J, 2005, PROTEIN FOLDING HANDBOOK, P1, DOI 10.1002/9783527619498; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Myerson JW, 2010, FASEB J, V24; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THIBODEAU PH, 2010, J BIOL CHEM; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	50	69	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15458	10.1371/journal.pone.0015458	http://dx.doi.org/10.1371/journal.pone.0015458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152102	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100086
J	Zhang, K; Harada, Y; Wei, XR; Shukla, D; Rajendran, A; Tawansy, K; Bedell, M; Lim, S; Shaw, PX; He, X; Yang, ZL				Zhang, Kang; Harada, Yuko; Wei, Xinran; Shukla, Dhananjay; Rajendran, Anand; Tawansy, Khaled; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.; He, Xi; Yang, Zhenglin			An Essential Role of the Cysteine-rich Domain of FZD4 in Norrin/Wnt Signaling and Familial Exudative Vitreoretinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORRIE-DISEASE GENE; WILD-TYPE; FRIZZLED-4; MUTATIONS; LRP5; PROTEIN; RETINA; NDP	The Wnt pathway plays important yet diverse roles in health and disease. Mutations in the Wnt receptor FZD4 gene have been confirmed to cause familial exudative vitreoretinopathy (FEVR). FEVR is characterized by incomplete vascularization of the peripheral retina, which can lead to vitreous bleeding, tractional retinal detachment, and blindness. We screened for mutations in the FZD4 gene in five families with FEVR and identified five mutations (C45Y, Y58C, W226X, C204R, and W496X), including three novel mutations (C45Y, Y58C, and W226X). In the retina, Norrin serves as a ligand and binds to FZD4 to activate the Wnt signaling pathway in normal angiogenesis and vascularization. The cysteine-rich domain (CRD) of FZD4 has been shown to play a critical role in Norrin-FZD4 binding. We investigated the effect of mutations in the FZD4 CRD in Norrin binding and signaling in vitro and in vivo. Wild-type and mutant FZD4 proteins were assayed for Norrin binding and Norrin-dependent activation of the canonical Wnt pathway by cell-surface and overlay binding assays and luciferase reporter assays. In HEK293 transfection studies, C45Y, Y58C, and C204R mutants did not bind to Norrin and failed to transduce FZD4-mediated Wnt/beta-catenin signaling. In vivo studies using Xenopus embryos showed that these FZD4 mutations disrupt Norrin/beta-catenin signaling as evidenced by decreased Siamois and Xnr3 expression. This study identified a new class of FZD4 gene mutations in human disease and demonstrates a critical role of the CRD in Norrin binding and activation of the beta-catenin pathway.	[Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Harada, Yuko; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Childrens Hosp Boston, Boston, MA 02115 USA; [Shukla, Dhananjay; Rajendran, Anand] Aravind Eye Hosp, Madurai 625020, Tamil Nadu, India; [Shukla, Dhananjay; Rajendran, Anand] Postgrad Inst Ophthalmol, Madurai 625020, Tamil Nadu, India; [Tawansy, Khaled] Childrens Retina Inst Calif, Los Angeles, CA 90041 USA; [Yang, Zhenglin] Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Chengdu 610041, Sichuan, Peoples R China; [Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhang, K (corresponding author), Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China.	kangzhang@gmail.com; zliny@yahoo.com	Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	National Institutes of Health [GM57603, RO1EY021374, RO1EY018860, RO1EY019270, RO1EY014428]; Leukemia and Lymphoma Society; Chinese National 985 Project; West China Hospital; Veterans Administration; Research to Prevent Blindness; BWF; National Natural Science Foundation of China; NATIONAL EYE INSTITUTE [R01EY014428, R01EY021374, R01EY019270, R01EY018660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603, R55GM057603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Chinese National 985 Project; West China Hospital; Veterans Administration(US Department of Veterans Affairs); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); BWF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57603 (to X. H.) and RO1EY021374, RO1EY018860, RO1EY019270, and RO1EY014428 (to K. Z.). This work was also supported by a Leukemia and Lymphoma Society scholarship (to X. H.); by a grant from the Chinese National 985 Project to Sichuan University and West China Hospital, a Veterans Administration merit award, a grant from Research to Prevent Blindness, and the BWF Clinical Scientist Award in Translational Research (to K. Z.); and by grants from the National Natural Science Foundation of China (to Z. Y.).	CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Karan G, 2004, MOL VIS, V10, P248; Kato Y, 1999, J NEUROSCI, V19, P9364; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Nikopoulos K, 2010, HUM MUTAT, V31, P656, DOI 10.1002/humu.21250; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pendergast SD, 1998, OPHTHALMOLOGY, V105, P1015, DOI 10.1016/S0161-6420(98)96002-X; Pendergast SD, 1998, ARCH OPHTHALMOL-CHIC, V116, P381; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; VANNOUHUYS CE, 1991, AM J OPHTHALMOL, V111, P34, DOI 10.1016/S0002-9394(14)76893-X; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	21	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10210	10215		10.1074/jbc.M110.194399	http://dx.doi.org/10.1074/jbc.M110.194399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177847	hybrid, Green Published			2022-12-25	WOS:000288547000037
J	Maillard, PV; Zoete, V; Michielin, O; Trono, D				Maillard, Pierre V.; Zoete, Vincent; Michielin, Olivier; Trono, Didier			Homology-based Identification of Capsid Determinants That Protect HIV1 from Human TRIM5 alpha Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; AMINO-TERMINAL DOMAIN; MULTIPLE SEQUENCE ALIGNMENT; TRIM FAMILY PROTEINS; HUMAN CYCLOPHILIN-A; OLD-WORLD MONKEY; RETROVIRUS RESTRICTION; B30.2/SPRY DOMAIN; CRYSTAL-STRUCTURE	The tropism of retroviruses relies on their ability to exploit cellular factors for their replication as well as to avoid host-encoded inhibitory activities such as TRIM5 alpha. N-tropic murine leukemia virus is sensitive to human TRIM5 alpha (huTRIM5 alpha) restriction, whereas human immunodeficiency virus type 1 (HIV1) escapes this antiviral factor. We previously revealed that mutation of four critical amino acid residues within the capsid can render murine leukemia virus resistant to huTRIM5 alpha. Here, we exploit the high degree of conservation in the tertiary structure of retroviral capsids to map the corresponding positions on the HIV1 capsid. We then demonstrated that, when changes were introduced at some of these positions, HIV1 becomes sensitive to huTRIM5 alpha restriction, a phenomenon reinforced by additionally mutating the nearby cyclophilin A binding loop of the viral protein. These results indicate that retroviruses have evolved similar mechanisms to escape TRIM5 alpha restriction via the interference of structurally homologous determinants in the viral capsid.	[Maillard, Pierre V.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci & Frontiers Genet, Natl Ctr Competence Res, CH-1015 Lausanne, Switzerland; [Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Michielin, Olivier] Ludwig Inst Canc Res Ltd, CH-1066 Epalinges, Switzerland; [Michielin, Olivier] Lausanne Univ Hosp CHUV, Pluridisciplinary Ctr Clin Oncol CePO, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Trono, D (corresponding author), EPFL SV GHI LVG, SV 3805,Batiment SV,Stn 19, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Maillard, Pierre V/V-4305-2019; Michielin, Olivier/ABE-7924-2020	Maillard, Pierre V/0000-0003-4611-388X; 	Swiss National Science Foundation; Infectigen Association; Strauss Foundation; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Association; Strauss Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Swiss National Science Foundation, the Infectigen Association, and the Strauss Foundation.; We thank Greg Towers for the pCXCR-sqTRIM5 alpha plasmid, Priscilla Turelli for advice, Helen Rowe for reading the manuscript, and Sujana Nylakonda and Charlene Raclot for technical assistance. The modeling part of this work was performed within the Protein Modeling Facility of the University of Lausanne. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1996, J VIROL, V70, P5170, DOI 10.1128/JVI.70.8.5170-5176.1996; Braaten D, 1996, J VIROL, V70, P4220, DOI 10.1128/JVI.70.7.4220-4227.1996; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Bukovsky AA, 1997, P NATL ACAD SCI USA, V94, P10943, DOI 10.1073/pnas.94.20.10943; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Diaz-Griffero F, 2008, VIROLOGY, V378, P233, DOI 10.1016/j.virol.2008.05.008; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Goldschmidt V, 2008, J VIROL, V82, P2089, DOI 10.1128/JVI.01828-07; Grutter C, 2006, FEBS LETT, V580, P99, DOI 10.1016/j.febslet.2005.11.076; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Lin TY, 2008, VIROLOGY, V379, P335, DOI 10.1016/j.virol.2008.06.037; Lin TY, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-70; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Maillard PV, 2010, J VIROL, V84, P5790, DOI 10.1128/JVI.02413-09; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Mortuza GB, 2008, J MOL BIOL, V376, P1493, DOI 10.1016/j.jmb.2007.12.043; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wilson SJ, 2008, J VIROL, V82, P7243, DOI 10.1128/JVI.00307-08; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035	96	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8128	8140		10.1074/jbc.M110.187609	http://dx.doi.org/10.1074/jbc.M110.187609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21169362	Green Published, hybrid			2022-12-25	WOS:000288013300043
J	Guilherme, L; Alba, MP; Ferreira, FM; Oshiro, SE; Higa, F; Patarroyo, ME; Kalil, J				Guilherme, Luiza; Alba, Martha P.; Ferreira, Frederico Moraes; Oshiro, Sandra Emiko; Higa, Fabio; Patarroyo, Manuel E.; Kalil, Jorge			Anti-Group A Streptococcal Vaccine Epitope STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATIC HEART-DISEASE; M-PROTEIN; SECONDARY-STRUCTURE; COIL TRANSITION; CELL EPITOPES; INTRANASAL; HELIX; IMMUNOGENICITY; ANTIBODIES; INFECTION	Streptococcus pyogenes infections remain a health problem in several countries due to poststreptococcal sequelae. We developed a vaccine epitope (StreptInCor) composed of 55 amino acids residues of the C-terminal portion of the M protein that encompasses both T and B cell protective epitopes. The nuclear magnetic resonance (NMR) structure of the StreptInCor peptide showed that the structure was composed of two microdomains linked by an 18-residue alpha-helix. A chemical stability study of the StreptInCor folding/unfolding process using far-UV circular dichroism showed that the structure was chemically stable with respect to pH and the concentration of urea. The T cell epitope is located in the first microdomain and encompasses 11 out of the 18 alpha-helix residues, whereas the B cell epitope is in the second microdomain and showed no alpha-helical structure. The prediction of StreptInCor epitope binding to different HLA class II molecules was evaluated based on an analysis of the 55 residues and the theoretical possibilities for the processed peptides to fit into the P1, P4, P6, and P9 pockets in the groove of several HLA class II molecules. We observed 7 potential sites along the amino acid sequence of StreptInCor that were capable of recognizing HLA class II molecules (DRB1*, DRB3*, DRB4*, and DRB5*). StreptInCoroverlapping peptides induced cellular and humoral immune responses of individuals bearing different HLA class II molecules and could be considered as a universal vaccine epitope.	[Guilherme, Luiza; Oshiro, Sandra Emiko; Higa, Fabio; Kalil, Jorge] Univ Sao Paulo, Heart Inst InCor, BR-5403903 Sao Paulo, Brazil; [Guilherme, Luiza; Oshiro, Sandra Emiko; Higa, Fabio; Kalil, Jorge] Univ Sao Paulo, Inst Invest Immunol, Natl Inst Sci & Technol, BR-5403903 Sao Paulo, Brazil; [Kalil, Jorge] Univ Sao Paulo, Dept Clin Med, Sch Med, BR-01246000 Sao Paulo, Brazil; [Ferreira, Frederico Moraes] Univ Sao Paulo, Lab Cellular Genet & Mol Nephrol, Dept Clin Med, Sch Med, BR-01246000 Sao Paulo, Brazil; [Alba, Martha P.; Patarroyo, Manuel E.] Fdn Inst Immunol Colombia FIDIC, Bogota 020304, Zona Can, Colombia; [Alba, Martha P.] Univ Rosario, Bogota 020304, Zona Can, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota 020304, Zona Can, Colombia	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad del Rosario; Universidad Nacional de Colombia	Guilherme, L (corresponding author), Inst Coracao HC FMUSP, Lab Imunol, Av Dr Eneas de Carvalho Aguiar,44-9 Andar, BR-05403903 Sao Paulo, Brazil.	luizagui@usp.br	Ferreira, Frederico/A-4622-2013; Guglielmi, Luiza G/E-7676-2013; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; KALIL, JORGE/C-8029-2012	Ferreira, Frederico/0000-0002-7403-9165; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; KALIL, JORGE/0000-0001-8415-4274; Alba, Martha patricia/0000-0003-0641-5162	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Colombia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Colombia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)" and "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil and Colombia.	Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BESSEN D, 1988, INFECT IMMUN, V56, P2666, DOI 10.1128/IAI.56.10.2666-2672.1988; Brandau DT, 2003, J PHARM SCI-US, V92, P218, DOI 10.1002/jps.10296; Brandt ER, 2000, NAT MED, V6, P455, DOI 10.1038/74719; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cunningham MW, 1997, INFECT IMMUN, V65, P3913, DOI 10.1128/IAI.65.9.3913-3923.1997; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAJANI AS, 1994, CIRCULATION, V89, P916, DOI 10.1161/01.CIR.89.2.916; Dale JB, 2005, CLIN DIAGN LAB IMMUN, V12, P833, DOI 10.1128/CDLI.12.7.833-836.2005; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; FISCHETTI VA, 1988, REV INFECT DIS, V10, pS356; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026; GUILHERME L, 1991, CIRCULATION, V83, P1995, DOI 10.1161/01.CIR.83.6.1995; Guilherme L, 2009, METHODS, V49, P316, DOI 10.1016/j.ymeth.2009.03.024; Guilherme L, 2001, INFECT IMMUN, V69, P5345, DOI 10.1128/IAI.69.9.5345-5351.2001; GUILHERME L, 1995, CIRCULATION, V92, P415, DOI 10.1161/01.CIR.92.3.415; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kotloff KL, 2005, INFECT IMMUN, V73, P2360, DOI 10.1128/IAI.73.4.2360-2366.2005; MANJULA BN, 1985, P NATL ACAD SCI USA, V82, P1064, DOI 10.1073/pnas.82.4.1064; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; MEDAGLINI D, 1995, P NATL ACAD SCI USA, V92, P6868, DOI 10.1073/pnas.92.15.6868; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Olive C, 2005, VACCINE, V23, P2298, DOI 10.1016/j.vaccine.2005.01.041; OOI T, 1991, P NATL ACAD SCI USA, V88, P2859, DOI 10.1073/pnas.88.7.2859; Pace C N, 1986, Methods Enzymol, V131, P266; Pandey M, 2009, IMMUNOL CELL BIOL, V87, P391, DOI 10.1038/icb.2009.29; PRUKSAKORN S, 1994, INT IMMUNOL, V6, P1235, DOI 10.1093/intimm/6.8.1235; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROBINSON JH, 1991, INFECT IMMUN, V59, P4324, DOI 10.1128/IAI.59.12.4324-4331.1991; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; SEGREST JP, 1992, J LIPID RES, V33, P141; Shaila MS, 2007, VACCINE, V25, P3567, DOI 10.1016/j.vaccine.2007.01.079; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009; WHO, 2008, PHARMAFORUM 0121; WUTHRICK K, 1986, NMR PROTEINS NUCL AC	46	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6989	6998		10.1074/jbc.M110.132118	http://dx.doi.org/10.1074/jbc.M110.132118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169359	hybrid, Green Published			2022-12-25	WOS:000287737300015
J	Lee, JW; Chen, H; Pullikotil, P; Quon, MJ				Lee, Ji-Won; Chen, Hui; Pullikotil, Philomena; Quon, Michael J.			Protein Kinase A-alpha Directly Phosphorylates FoxO1 in Vascular Endothelial Cells to Regulate Expression of Vascular Cellular Adhesion Molecule-1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FORKHEAD TRANSCRIPTION FACTORS; STIMULATES PHOSPHORYLATION; CAMP; PKA; ANGIOGENESIS; INVOLVEMENT; METABOLISM; ACTIVATION; MECHANISMS	FoxO1, a forkhead box O class transcription factor, is abundant in insulin-responsive tissues. Akt, downstream from phosphatidylinositol 3-kinase in insulin signaling, phosphorylates FoxO1 at Thr(24), Ser(256), and Ser(319), negatively regulating its function. We previously reported that dehydroepiandrosterone-stimulated phosphorylation of FoxO1 in endothelial cells requires cAMP-dependent protein kinase alpha (PKA-alpha). Therefore, we hypothesized that FoxO1 is a novel direct substrate for PKA-alpha. Using an immune complex kinase assay with [gamma-P-32] ATP, purified PKA-alpha directly phosphorylated wildtype FoxO1 but not FoxO1-AAA (mutant with alanine substitutions at known Akt phosphorylation sites). Phosphorylation of wild-type FoxO1 (but not FoxO1-AAA) was detectable using phospho-specific antibodies. Similar results were obtained using purified GST-FoxO1 protein as the substrate. Thus, FoxO1 is a direct substrate for PKA-alpha in vitro. In bovine aortic endothelial cells, interaction between endogenous PKA-alpha and endogenous FoxO1 was detected by co-immunoprecipitation. In human aortic endothelial cells (HAEC), pretreatment with H89 (PKA inhibitor) or siRNA knockdown of PKA-alpha decreased forskolin-or prostaglandin E-2-stimulated phosphorylation of FoxO1. In HAEC transfected with a FoxO-promoter luciferase reporter, co-expression of the catalytic domain of PKA-alpha, catalytically inactive mutant PKA-alpha, or siRNA against PKA-alpha caused corresponding increases or decreases in trans-activation of the FoxO promoter. Expression of vascular cellular adhesion molecule-1 mRNA, up-regulated by FoxO1 in endothelial cells, was enhanced by siRNA knockdown of PKA-alpha or treatment of HAEC with the PKA inhibitor H89. Adhesion of monocytes to endothelial cells was enhanced by H89 treatment or overexpression of FoxO1-AAA, similar to effects of TNF-alpha treatment. We conclude that FoxO1 is a novel physiological substrate for PKA-alpha in vascular endothelial cells.	[Lee, Ji-Won; Chen, Hui; Pullikotil, Philomena; Quon, Michael J.] NIH, Diabet Unit, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Quon, MJ (corresponding author), Univ Maryland, Div Endocrinol Diabet & Nutr, 660 W Redwood St,HH 495, Baltimore, MD 21201 USA.	quonm@medicine.umaryland.edu		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Center for Complementary and Alternative Medicine, National Institutes of Health	National Center for Complementary and Alternative Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported in part by funds from the Intramural Research Program, National Center for Complementary and Alternative Medicine, National Institutes of Health (to M. J. Q.).	Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson P, 2010, MOL CELL BIOL, V30, P2537, DOI 10.1128/MCB.01282-09; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; CARLOS TM, 1990, BLOOD, V76, P965; Chen H, 2008, J BIOL CHEM, V283, P29228, DOI 10.1074/jbc.M802906200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Madsen L, 2010, ANN NY ACAD SCI, V1190, P1, DOI 10.1111/j.1749-6632.2009.05262.x; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Niisato N, 1999, AM J PHYSIOL-LUNG C, V277, pL727, DOI 10.1152/ajplung.1999.277.4.L727; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190	32	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6423	6432		10.1074/jbc.M110.180661	http://dx.doi.org/10.1074/jbc.M110.180661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177856	Green Published, hybrid			2022-12-25	WOS:000287476400053
J	Luse, DS; Spangler, LC; Ujvari, A				Luse, Donal S.; Spangler, Lisa C.; Ujvari, Andrea			Efficient and Rapid Nucleosome Traversal by RNA Polymerase II Depends on a Combination of Transcript Elongation Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HISTONES; CHROMATIN TEMPLATES; DNA INTERACTIONS; PAF1 COMPLEX; PROMOTER; DSIF; CLEAVAGE; RECONSTITUTION; ACTIVATION; BARRIER	The nucleosome is generally found to be a strong barrier to transcript elongation by RNA polymerase II (pol II) in vitro. The elongation factors TFIIF and TFIIS have been shown to cooperate in maintaining pol II in the catalytically competent state on pure DNA templates. We now show that although TFIIF or TFIIS alone is modestly stimulatory for nucleosome traversal, both factors together increase transcription through nucleosomes in a synergistic manner. We also studied the effect of TFIIF and TFIIS on transcription of nucleosomes containing a Sin mutant histone. The Sin point mutations reduce critical histone-DNA contacts near the center of the nucleosome. Significantly, we found that nucleosomes with a Sin mutant histone are traversed to the same extent and at nearly the same rate as equivalent pure DNA templates if both TFIIS and TFIIF are present. Thus, the nucleosome is not necessarily an insurmountable barrier to transcript elongation by pol II. If unfolding of template DNA from the nucleosome surface is facilitated and the tendency of pol II to retreat from barriers is countered, transcription of nucleosomal templates can be rapid and efficient.	[Luse, Donal S.; Spangler, Lisa C.; Ujvari, Andrea] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, NE20,9500 Euclid Ave, Cleveland, OH 44195 USA.	lused@ccf.org			National Science Foundation [0743298]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0743298 (to D. S. L.).	Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; REINES D, 1992, J BIOL CHEM, V267, P15516; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2008, J BIOL CHEM, V283, P32236, DOI 10.1074/jbc.M806636200; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; WANG BQ, 1993, PROTEIN EXPRES PURIF, V4, P207, DOI 10.1006/prep.1993.1027; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	51	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6040	6048		10.1074/jbc.M110.174722	http://dx.doi.org/10.1074/jbc.M110.174722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177855	Green Published, hybrid			2022-12-25	WOS:000287476400012
J	Wellhauser, L; Luna-Chavez, C; D'Antonio, C; Tainer, J; Bear, CE				Wellhauser, Leigh; Luna-Chavez, Cesar; D'Antonio, Christina; Tainer, John; Bear, Christine E.			ATP Induces Conformational Changes in the Carboxyl-terminal Region of ClC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; X-RAY-SCATTERING; CHLORIDE CHANNEL; DENTS-DISEASE; CYTOPLASMIC DOMAIN; ADENINE-NUCLEOTIDES; CYSTIC-FIBROSIS; MOLECULAR-BASIS; P-GLYCOPROTEIN; TRANSPORTER	ATP binding enhances the activity of ClC-5, the transporter mutated in Dent disease, a disease affecting the renal proximal tubule. Previously, the ATP binding site was revealed in x-ray crystal structures of the cytoplasmic region of this membrane protein. Disruption of this site by mutagenesis (Y617A-ClC-5) reduced the functional expression and ATP-dependent regulation of the full-length transporter in Xenopus oocytes. However, insight into the conformational changes underlying ATP-dependent regulation is lacking. Here, we show that ATP binding induces a change in protein conformation. Specifically, small angle x-ray scattering experiments indicate that ATP binding promotes a clamp-like closure of the isolated ClC-5 carboxyl-terminal region. Limited proteolysis studies show that ATP binding induces conformational compaction of the carboxyl-terminal region in the intact membrane protein as well. In the context of fibroblasts and proximal tubule epithelial cells, disruption of the ATP binding site in full-length ClC-5 (Y617A-ClC-5) led to a defect in processing and trafficking out of the endoplasmic reticulum. These latter findings account for the decrease in functional expression previously reported for this ATP-binding mutant and prompt future study of a model whereby conformational compaction caused by ATP binding promotes biosynthetic maturation.	Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Wellhauser, Leigh; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Luna-Chavez, Cesar; Tainer, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lib, Berkeley, CA 94720 USA; [Tainer, John] Scripps Res Inst, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [D'Antonio, Christina; Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute; University of Toronto	Bear, CE (corresponding author), 555 Univ Ave, Toronto, ON M5S 1X8, Canada.	bear@sickkids.on.ca	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Energy [DE-AC02-05CH11231]	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Kidney Foundation of Canada (to C.E.B.) and a postgraduate studentship from the Natural Sciences and Engineering Research Council of Canada (to L.W.). Support for advancement of SAXS technologies at the Lawrence Berkeley National Laboratory SIBYLS beamline came from the Integrated Diffraction Analysis Technologies program under Contract DE-AC02-05CH11231 with the U.S. Department of Energy.	Bell SP, 2006, BIOCHEMISTRY-US, V45, P6773, DOI 10.1021/bi0523815; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Drumm K, 2001, EUR J MED RES, V6, P422; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GARBOCZI DN, 1990, J BIOL CHEM, V265, P14632; Grand T, 2009, KIDNEY INT, V76, P999, DOI 10.1038/ki.2009.305; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; He LP, 2006, BIOPHYS J, V90, P3570, DOI 10.1529/biophysj.105.078295; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jentsch TJ, 2005, J AM SOC NEPHROL, V16, P1549, DOI 10.1681/ASN.2005020207; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Landolt-Marticorena C, 1999, J BIOL CHEM, V274, P26057, DOI 10.1074/jbc.274.37.26057; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lucas M, 2008, ACTA CRYSTALLOGR F, V64, P936, DOI 10.1107/S1744309108027930; LUCKOW VA, 1988, VIROLOGY, V167, P56, DOI 10.1016/0042-6822(88)90054-2; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2009, J CELL SCI, V122, P1229, DOI 10.1242/jcs.037317; Moncoq K, 2004, BIOPHYS J, V87, P4056, DOI 10.1529/biophysj.104.048645; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schulz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012585; Segel DJ, 1999, BIOCHEMISTRY-US, V38, P15352, DOI 10.1021/bi991337k; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 1998, BIOCHEM CELL BIOL, V76, P695, DOI 10.1139/bcb-76-5-695; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wellhauser L, 2006, BIOCHEM J, V398, P289, DOI 10.1042/BJ20060142; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; WRONG OM, 1994, Q J MED, V87, P473; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Zifarelli G, 2009, EMBO REP, V10, P1111, DOI 10.1038/embor.2009.159	47	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6733	6741		10.1074/jbc.M110.175877	http://dx.doi.org/10.1074/jbc.M110.175877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173145	hybrid, Green Published			2022-12-25	WOS:000287476400080
J	Matsuo, A; Bellier, JP; Nishimura, M; Yasuhara, O; Saito, N; Kimura, H				Matsuo, Akinori; Bellier, Jean-Pierre; Nishimura, Masaki; Yasuhara, Osamu; Saito, Naoaki; Kimura, Hiroshi			Nuclear Choline Acetyltransferase Activates Transcription of a High-affinity Choline Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; NERVE GROWTH-FACTOR; GENE-EXPRESSION; PERIPHERAL-TYPE; SIGNALING PATHWAYS; SYNAPTIC VESICLES; MOLECULAR-CLONING; ALZHEIMER-DISEASE; PLASMA-MEMBRANE; SPLICE VARIANT	Choline acetyltransferase (ChAT) synthesizes the neurotransmitter, acetylcholine, at cholinergic nerve terminals. ChAT contains nuclear localization signals and is also localized in the nuclei of neural and non-neuronal cells. Nuclear ChAT might have an as yet unidentified function, such as transcriptional regulation. In this study, we investigated the alteration of candidate gene transcription by ChAT. We chose high affinity choline transporter (CHT1) and vesicular acetylcholine transporter (VACHT) as candidate genes, which function together with ChAT in acetylcholine production. Using SH-SY5Y human neuroblastoma cells stably expressing wild-type human ChAT, we found that overexpressed ChAT enhanced transcription of the CHT1 gene but not the VACHT gene. In contrast, nuclear localization signal disrupted, and catalytically inactive mutant ChATs could not induce, CHT1 expression. Additionally, ChAT did not alter CHT1 expression in non-neuronal HEK293 cells. Our results suggest that ChAT activates the transcription of selected target genes in neuronal cells. Both enzymatic activity and nuclear translocation of ChAT are required for its transcriptional enhancement.	Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan; [Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	Shiga University of Medical Science; Kobe University		akimatsu@belle.shiga-med.ac.jp	Bellier, Jean-Pierre/M-4845-2019	Bellier, Jean-Pierre/0000-0002-8758-8075	Shiga University of Medical Science	Shiga University of Medical Science(Shiga University of Medical Science)	This work was supported, in part, by a presidential Grant-in-aid from the Shiga University of Medical Science.	ADEM A, 1987, DEV BRAIN RES, V33, P235, DOI 10.1016/0165-3806(87)90156-8; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Apparsundaram S, 2001, BIOCHEM SOC T, V29, P711, DOI 10.1042/0300-5127:0290711; Augusti-Tocco G, 2006, J MOL NEUROSCI, V30, P45, DOI 10.1385/JMN:30:1:45; Bellier JP, 2007, J NEUROCHEM, V101, P1607, DOI 10.1111/j.1471-4159.2007.04458.x; BERRARD S, 1995, J NEUROCHEM, V65, P939; Berse B, 1999, BIOCHEM J, V342, P301, DOI 10.1042/0264-6021:3420301; Berse B, 2005, DEV BRAIN RES, V157, P132, DOI 10.1016/j.devbrainres.2005.03.013; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brock M, 2007, BRAIN RES, V1145, P1, DOI 10.1016/j.brainres.2007.01.119; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; CARBINI LA, 1993, J NEUROCHEM, V61, P247, DOI 10.1111/j.1471-4159.1993.tb03561.x; CHIREUX MA, 1995, J NEUROSCI RES, V40, P427, DOI 10.1002/jnr.490400402; De Jaco A, 2000, J NEUROCHEM, V75, P1123; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Ferguson SM, 2004, MOL INTERV, V4, P22, DOI 10.1124/mi.4.1.22; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Fujii T, 2003, LIFE SCI, V72, P2131, DOI 10.1016/S0024-3205(03)00073-0; Gill SK, 2007, NEUROBIOL AGING, V28, P1028, DOI 10.1016/j.neurobiolaging.2006.05.011; Gill SK, 2003, J BIOL CHEM, V278, P20217, DOI 10.1074/jbc.M213153200; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Haberberger RV, 2002, J INVEST DERMATOL, V119, P943, DOI 10.1046/j.1523-1747.2002.00182.x; Hanna-Mitchell AT, 2007, LIFE SCI, V80, P2298, DOI 10.1016/j.lfs.2007.02.010; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; Kimura S, 2007, NEUROCHEM INT, V50, P251, DOI 10.1016/j.neuint.2006.08.011; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; LAMBERT DG, 1989, EUR J PHARMACOL, V165, P71, DOI 10.1016/0014-2999(89)90771-1; Lecomte MJ, 2005, MOL CELL NEUROSCI, V28, P303, DOI 10.1016/j.mcn.2004.09.014; LIND GJ, 1993, INVEST OPHTH VIS SCI, V34, P2943; LIND GJ, 1995, INVEST OPHTH VIS SCI, V36, P1492; Lips KS, 2003, J HISTOCHEM CYTOCHEM, V51, P1645, DOI 10.1177/002215540305101208; Lips KS, 2002, CELL TISSUE RES, V307, P275, DOI 10.1007/s00441-002-0520-4; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Madziar B, 2008, J NEUROCHEM, V107, P1284, DOI 10.1111/j.1471-4159.2008.05681.x; Matsuo A, 2005, NEUROCHEM INT, V46, P423, DOI 10.1016/j.neuint.2004.11.006; Misawa H, 1997, MOL BRAIN RES, V44, P323, DOI 10.1016/S0169-328X(96)00231-8; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; ODA Y, 1992, MOL BRAIN RES, V16, P287, DOI 10.1016/0169-328X(92)90237-6; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; OKUDA H, 1993, BRAIN RES, V625, P145, DOI 10.1016/0006-8993(93)90147-F; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Okuda T, 2002, J BIOL CHEM, V277, P45315, DOI 10.1074/jbc.M207742200; Pfeil U, 2003, LIFE SCI, V72, P2087, DOI 10.1016/S0024-3205(03)00088-2; Resendes MC, 1999, J BIOL CHEM, V274, P19417, DOI 10.1074/jbc.274.27.19417; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Tooyama I, 2000, J CHEM NEUROANAT, V17, P217, DOI 10.1016/S0891-0618(99)00043-5; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3; Xie J, 2004, J BIOL CHEM, V279, P28266, DOI 10.1074/jbc.M401495200	58	14	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5836	5845		10.1074/jbc.M110.147611	http://dx.doi.org/10.1074/jbc.M110.147611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163949	hybrid, Green Published			2022-12-25	WOS:000287230600092
J	Takahashi, T; Kurebayashi, Y; Ikeya, K; Mizuno, T; Fukushima, K; Kawamoto, H; Kawaoka, Y; Suzuki, Y; Suzuki, T				Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Kawaoka, Yoshihiro; Suzuki, Yasuo; Suzuki, Takashi			The Low-pH Stability Discovered in Neuraminidase of 1918 Pandemic Influenza A Virus Enhances Virus Replication	PLOS ONE			English	Article							SIALIDASE ACTIVITY; VIRULENCE; INFECTION; CELLS; HEMAGGLUTININ; ENDOCYTOSIS; MECHANISM; CALCIUM; GENES; DUCK	The "Spanish" pandemic influenza A virus, which killed more than 20 million worldwide in 1918-19, is one of the serious pathogens in recorded history. Characterization of the 1918 pandemic virus reconstructed by reverse genetics showed that PB1, hemagglutinin (HA), and neuraminidase (NA) genes contributed to the viral replication and virulence of the 1918 pandemic influenza virus. However, the function of the NA gene has remained unknown. Here we show that the avian-like low-pH stability of sialidase activity discovered in the 1918 pandemic virus NA contributes to the viral replication efficiency. We found that deletion of Thr at position 435 or deletion of Gly at position 455 in the 1918 pandemic virus NA was related to the low-pH stability of the sialidase activity in the 1918 pandemic virus NA by comparison with the sequences of other human N1 NAs and sialidase activity of chimeric constructs. Both amino acids were located in or near the amino acid resides that were important for stabilization of the native tetramer structure in a low-pH condition like the N2 NAs of pandemic viruses that emerged in 1957 and 1968. Two reverse-genetic viruses were generated from a genetic background of A/WSN/33 (H1N1) that included low-pH-unstable N1 NA from A/USSR/92/77 (H1N1) and its counterpart N1 NA in which sialidase activity was converted to a low-pH-stable property by a deletion and substitutions of two amino acid residues at position 435 and 455 related to the low-pH stability of the sialidase activity in 1918 NA. The mutant virus that included "Spanish Flu" like low-pH-stable NA showed remarkable replication in comparison with the mutant virus that included low-pH-unstable N1 NA. Our results suggest that the avian-like low-pH stability of sialidase activity in the 1918 pandemic virus NA contributes to the viral replication efficiency.	[Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Suzuki, Takashi] Global COE Program Innovat Human Hlth Sci, Shizuoka, Japan; [Takahashi, Tadanobu; Ikeya, Kumiko; Kawamoto, Hiroko; Kawaoka, Yoshihiro; Suzuki, Yasuo; Suzuki, Takashi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Suzuki, Yasuo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan	University of Shizuoka; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Chubu University	Takahashi, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	Suzukit@u-shizuoka-ken.ac.jp		Yasuo, Suzuki/0000-0003-3518-5642	Japan Science and Technology Agency [18390142, 20790357]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid from the Scientific Research (B 18390142), Young Scientist (B; 20790357), CREST (Japan Science and Technology Agency), The Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Sasakawa Scientific Research Grant from The Japan Science Society, The SRI (Shizuoka Research Institute) academic research grant, and the Gobal COE Program from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; CHONG AKJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P65, DOI 10.1016/0167-4838(91)90526-6; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Uhlendorff J, 2009, ARCH VIROL, V154, P945, DOI 10.1007/s00705-009-0393-x	25	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15556	10.1371/journal.pone.0015556	http://dx.doi.org/10.1371/journal.pone.0015556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151571	Green Submitted, Green Published, gold			2022-12-25	WOS:000285135800030
J	Gao, F; Zhou, BJ; Li, GY; Jia, PS; Li, H; Zhao, YL; Zhao, P; Xia, GX; Guo, HS				Gao, Feng; Zhou, Bang-Jun; Li, Guo-Ying; Jia, Pei-Song; Li, Hui; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan			A Glutamic Acid-Rich Protein Identified in Verticillium dahliae from an Insertional Mutagenesis Affects Microsclerotial Formation and Pathogenicity	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; MAGNAPORTHE-ORYZAE; LIPOPOLYSACCHARIDE COMPLEX; BLAST FUNGUS; HYDROPHOBIN GENE; POTATO ISOLATE; COTTON PLANT; ALBO-ATRUM; HOST-RANGE; TUMEFACIENS	Verticillium dahliae Kleb. is a phytopathogenic fungus that causes wilt disease in a wide range of crops, including cotton. The life cycle of V. dahliae includes three vegetative phases: parasitic, saprophytic and dormant. The dormant microsclerotia are the primary infectious propagules, which germinate when they are stimulated by root exudates. In this study, we report the first application of Agrobacterium tumefaciens-mediated transformation (ATMT) for construction of insertional mutants from a virulent defoliating isolate of V. dahliae (V592). Changes in morphology, especially a lack of melanized microsclerotia or pigmentation traits, were observed in mutants. Together with the established laboratory unimpaired root dip-inoculation approach, we found insertional mutants to be affected in their pathogenicities in cotton. One of the genes tagged in a pathogenicity mutant encoded a glutamic acid-rich protein (VdGARP1), which shared no significant similarity to any known annotated gene. The vdgarp1 mutant showed vigorous mycelium growth with a significant delay in melanized microsclerotial formation. The expression of VdGARP1 in the wild type V529 was organ-specific and differentially regulated by different stress agencies and conditions, in addition to being stimulated by cotton root extract in liquid culture medium. Under extreme infertile nutrient conditions, VdGARP1 was not necessary for melanized microsclerotial formation. Taken together, our data suggest that VdGARP1 plays an important role in sensing infertile nutrient conditions in infected cells to promote a transfer from saprophytic to dormant microsclerotia for long-term survival. Overall, our findings indicate that insertional mutagenesis by ATMT is a valuable tool for the genome-wide analysis of gene function and identification of pathogenicity genes in this important cotton pathogen.	[Gao, Feng; Zhou, Bang-Jun; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Gao, Feng; Zhou, Bang-Jun; Li, Hui; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Microbiol, Beijing, Peoples R China; [Gao, Feng; Li, Guo-Ying; Jia, Pei-Song; Li, Hui] Shihezi Univ, Key Lab Prevent & Control Oasis Crop Dis, Shihezi, Peoples R China; [Zhou, Bang-Jun; Zhao, Yun-Long; Zhao, Pan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shihezi University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, F (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	guohs@im.ac.cn	/AAJ-4923-2021; zhou, Bangjun/AAN-7883-2020	Zhou, Bangjun/0000-0003-2986-6310	China Transgenic Research and Commercialization Key Special Project [2009ZX08010-001B]; Ministry of Science and Technology [2011CB100703]	China Transgenic Research and Commercialization Key Special Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by grants from China Transgenic Research and Commercialization Key Special Project (grant 2009ZX08010-001B)for construction of V. dahliae insertional mutant library and the Ministry of Science and Technology (grant 2011CB100703) for functional study of V. dahliae genes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Blaise F, 2007, FUNGAL GENET BIOL, V44, P123, DOI 10.1016/j.fgb.2006.07.006; Bowman D. T., 1999, Journal of Cotton Science, V3, P139; BUCHNER V, 1982, FEBS LETT, V138, P261, DOI 10.1016/0014-5793(82)80456-0; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Dobinson KF, 2004, CURR GENET, V45, P104, DOI 10.1007/s00294-003-0464-6; GARBER RH, 1966, PHYTOPATHOLOGY, V56, P1121; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GERIK JS, 1988, PHYTOPATHOLOGY, V78, P1174, DOI 10.1094/Phyto-78-1174; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; KEEN NT, 1972, PHYSIOL PLANT PATHOL, V2, P317, DOI 10.1016/S0048-4059(72)80006-7; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Koroleva OV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P960, DOI 10.1023/A:1012357223083; Li GH, 2007, CURR GENET, V51, P233, DOI 10.1007/s00294-007-0122-5; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; Li L, 2007, MOL PLANT MICROBE IN, V20, P448, DOI 10.1094/MPMI-20-4-0448; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Meng Y, 2007, FUNGAL GENET BIOL, V44, P1050, DOI 10.1016/j.fgb.2007.04.002; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; NACHMIAS A, 1982, POTATO RES, V25, P321, DOI 10.1007/BF02357289; NACHMIAS A, 1985, PHYSIOL PLANT PATHOL, V26, P43, DOI 10.1016/0048-4059(85)90029-3; NACHMIAS A, 1987, PHYTOPATHOLOGY, V77, P506, DOI 10.1094/Phyto-77-506; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; SCHNATHORST WC, 1966, PHYTOPATHOLOGY, V56, P1155; Schnathorst WC, 1981, COMPENDIUM COTTON DI, P41; Talhinhas P, 2008, MOL BIOTECHNOL, V39, P57, DOI 10.1007/s12033-007-9028-1; Tsuji Gento, 2003, Journal of General Plant Pathology, V69, P230, DOI 10.1007/s10327-003-0040-4; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Xia ZJ, 1998, EUR J PLANT PATHOL, V104, P871, DOI 10.1023/A:1008628209867; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	43	73	99	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15319	10.1371/journal.pone.0015319	http://dx.doi.org/10.1371/journal.pone.0015319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151869	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800016
J	Bereswill, S; Munoz, M; Fischer, A; Plickert, R; Haag, LM; Otto, B; Kuhl, AA; Loddenkemper, C; Gobel, UB; Heimesaat, MM				Bereswill, Stefan; Munoz, Melba; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Kuehl, Anja A.; Loddenkemper, Christoph; Goebel, Ulf B.; Heimesaat, Markus M.			Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation	PLOS ONE			English	Article							BOWEL-DISEASE; TOXOPLASMA-GONDII; EXPERIMENTAL COLITIS; ORAL INFECTION; RATS; MICE; STATINS; CELLS; PRAVASTATIN; ACTIVATION	Background: The health beneficial effects of Resveratrol, Curcumin and Simvastatin have been demonstrated in various experimental models of inflammation. We investigated the potential anti-inflammatory and immunomodulatory mechanisms of the above mentioned compounds in a murine model of hyper-acute Th1-type ileitis following peroral infection with Toxoplasma gondii. Methodology/Principal Findings: Here we show that after peroral administration of Resveratrol, Curcumin or Simvastatin, mice were protected from ileitis development and survived the acute phase of inflammation whereas all Placebo treated controls died. In particular, Resveratrol treatment resulted in longer-term survival. Resveratrol, Curcumin or Simvastatin treated animals displayed significantly increased numbers of regulatory T cells and augmented intestinal epithelial cell proliferation/regeneration in the ileum mucosa compared to placebo control animals. In contrast, mucosal T lymphocyte and neutrophilic granulocyte numbers in treated mice were reduced. In addition, levels of the anti-inflammatory cytokine IL-10 in ileum, mesenteric lymph nodes and spleen were increased whereas pro-inflammatory cytokine expression (IL-23p19, IFN-gamma, TNF-alpha, IL-6, MCP-1) was found to be significantly lower in the ileum of treated animals as compared to Placebo controls. Furthermore, treated animals displayed not only fewer pro-inflammatory enterobacteria and enterococci but also higher anti-inflammatory lactobacilli and bifidobacteria loads. Most importantly, treatment with all three compounds preserved intestinal barrier functions as indicated by reduced bacterial translocation rates into spleen, liver, kidney and blood. Conclusion/Significance: Oral treatment with Resveratrol, Curcumin or Simvastatin ameliorates acute small intestinal inflammation by down-regulating Th1-type immune responses and prevents bacterial translocation by maintaining gut barrier function. These findings provide novel and potential prophylaxis and treatment options of patients with inflammatory bowel diseases.	[Bereswill, Stefan; Munoz, Melba; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Goebel, Ulf B.; Heimesaat, Markus M.] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Inst Pathol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bereswill, S (corresponding author), Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Kuhl, Anja/0000-0003-2293-5387; Munoz, Melba/0000-0003-3386-4502; Heimesaat, Markus/0000-0001-6399-651X; Haag, Lea-Maxie/0000-0002-3754-5317	German Research Foundation (DFG) [SFB633, TP B6, TP A7, TP Z1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG, SFB633) to MMH and MM (TP B6), AF, SB, and UBG (TP A7), AAK and CL (TP Z1), BO and L-MH (GRACO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Ahn J, 2007, BIOCHEM BIOPH RES CO, V364, P972, DOI 10.1016/j.bbrc.2007.10.109; Basset Christelle, 2002, Science Progress, V85, P33, DOI 10.3184/003685002783238861; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Calabrese Vittorio, 2003, Ital J Biochem, V52, P177; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Claramunt RM, 2009, BIOORGAN MED CHEM, V17, P1290, DOI 10.1016/j.bmc.2008.12.029; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; GERDES J, 1991, AM J PATHOL, V138, P867; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jahovic N, 2006, SCAND J GASTROENTERO, V41, P954, DOI 10.1080/00365520600554444; Jain SK, 1994, CIBA F SYMP, V185, P164; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Jobin C, 1999, J IMMUNOL, V163, P3474; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Kouri TT, 2000, CLIN CHIM ACTA, V297, P305, DOI 10.1016/S0009-8981(00)00256-4; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Lubbad A, 2009, MOL CELL BIOCHEM, V322, P127, DOI 10.1007/s11010-008-9949-4; Ma ZH, 2005, INFLAMM RES, V54, P522, DOI 10.1007/s00011-005-1388-z; Maher BM, 2009, J LEUKOCYTE BIOL, V85, P186, DOI 10.1189/jlb.0608382; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Medina C, 2006, J LEUKOCYTE BIOL, V79, P954, DOI 10.1189/jlb.1005544; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rapin JR, 2010, CLINICS, V65, P635, DOI 10.1590/S1807-59322010000600012; SANCHEZFIDALGO S, EUR J PHARM, V633, P78; Simes J, 2002, EUR HEART J, V23, P207, DOI 10.1053/euhj.2001.2775; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; UNG VY, DIG DIS SCI, V55, P1272; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993	40	198	215	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15099	10.1371/journal.pone.0015099	http://dx.doi.org/10.1371/journal.pone.0015099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151942	gold, Green Submitted, Green Published			2022-12-25	WOS:000284939600024
J	Bottcher, B				Boettcher, Bjoern			Feller Processes: The Next Generation in Modeling. Brownian Motion, Levy Processes and Beyond	PLOS ONE			English	Article							MARKOV; APPROXIMATION; CONSTRUCTION	We present a simple construction method for Feller processes and a framework for the generation of sample paths of Feller processes. The construction is based on state space dependent mixing of Levy processes. Brownian Motion is one of the most frequently used continuous time Markov processes in applications. In recent years also Levy processes, of which Brownian Motion is a special case, have become increasingly popular. Levy processes are spatially homogeneous, but empirical data often suggest the use of spatially inhomogeneous processes. Thus it seems necessary to go to the next level of generalization: Feller processes. These include Levy processes and in particular Brownian motion as special cases but allow spatial inhomogeneities. Many properties of Feller processes are known, but proving the very existence is, in general, very technical. Moreover, an applicable framework for the generation of sample paths of a Feller process was missing. We explain, with practitioners in mind, how to overcome both of these obstacles. In particular our simulation technique allows to apply Monte Carlo methods to Feller processes.	Tech Univ Dresden, Inst Math Stochast, Dresden, Germany	Technische Universitat Dresden	Bottcher, B (corresponding author), Tech Univ Dresden, Inst Math Stochast, Dresden, Germany.	bjoern.boettcher@tu-dresden.de	Böttcher, Björn/AAH-5218-2020	Böttcher, Björn/0000-0002-3045-5829				[Anonymous], 2010, R LANG ENV STAT COMP; Baeumer B, 2005, P AM MATH SOC, V133, P2273, DOI 10.1090/S0002-9939-05-07949-9; BASS RF, 1988, PROBAB THEORY REL, V79, P271, DOI 10.1007/BF00320922; Bottcher B, 2008, J LOND MATH SOC, V78, P605, DOI 10.1112/jlms/jdn043; Bottcher B, 2009, STOCH DYNAM, V9, P71, DOI 10.1142/S0219493709002555; Bottcher B, 2005, MATH NACHR, V278, P1235, DOI 10.1002/mana.200310304; Bottcher B, 2003, PROBABILISTIC METHODS IN FLUIDS, PROCEEDINGS, P35, DOI 10.1142/9789812703989_0003; Cont R., 2004, FINANCIAL MODELLING; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; Doney RA, 2005, ANN APPL PROBAB, V15, P1445, DOI 10.1214/105051605000000016; Feller W., 1951, P 2 BERK S MATH STAT, P227; Gonchar VY, 2003, PLASMA PHYS REP+, V29, P380, DOI 10.1134/1.1575308; GRIGELIONIS B, 2001, LITH MATH J, V41, P239; GRIGELIONIS B, 1999, LITH MATH J, V39, P33, DOI 10.1007/BF02465533; Hoh W, 1998, THESIS U BIELEFELD; IKEDA N, 1989, MATH LIB, V24; Jacob N., 2001, PSEUDODIFFERENTIAL O, V1-3; Jacod J., 2002, LIMIT THEOREMS STOCH, V2nd; Janssen HK, 1999, EUR PHYS J B, V7, P137, DOI 10.1007/s100510050596; KOCHUBEJ A. N, 1989, MATH USSR IZV, V33, P233; Kolokoltsov V, 2000, P LOND MATH SOC, V80, P725, DOI 10.1112/S0024611500012314; Ma ZM, 1998, ANN I H POINCARE-PR, V34, P1, DOI 10.1016/S0246-0203(98)80011-3; Meerschaert MM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.060102; Protter P, 1997, ANN PROBAB, V25, P393; Reeves DM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006069; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sato K., 1999, CAMBRIDGE STUDIES AD, V68; Scalas E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011107; Schilling RL, 2010, ELECTRON J PROBAB, V15, P1369, DOI 10.1214/EJP.v15-807; Stroock DW., 2003, MARKOV PROCESSES K I; Woyczynski WA, 2001, LEVY PROCESSES: THEORY AND APPLICATIONS, P241; Zhang Y, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004912; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	38	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15102	10.1371/journal.pone.0015102	http://dx.doi.org/10.1371/journal.pone.0015102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151931	Green Published, Green Submitted, gold			2022-12-25	WOS:000284939600025
J	Carlini, F; Ridolfi, B; Molinari, A; Parisi, C; Bozzuto, G; Toccacieli, L; Formisano, G; De Orsi, D; Paradisi, S; Grober, OMV; Ravo, M; Weisz, A; Arcieri, R; Vella, S; Gaudi, S				Carlini, Francesca; Ridolfi, Barbara; Molinari, Agnese; Parisi, Chiara; Bozzuto, Giuseppina; Toccacieli, Laura; Formisano, Giuseppe; De Orsi, Daniela; Paradisi, Silvia; Grober, Oli Maria Victoria; Ravo, Maria; Weisz, Alessandro; Arcieri, Romano; Vella, Stefano; Gaudi, Simona			The Reverse Transcription Inhibitor Abacavir Shows Anticancer Activity in Prostate Cancer Cell Lines	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; L1 RETROTRANSPOSITION; NUCLEOSIDE ANALOG; CARCINOMA-CELLS; IN-VITRO; EXPRESSION; DIFFERENTIATION; PROTEIN; DNA; ANNOTATION	Background: Transposable Elements (TEs) comprise nearly 45% of the entire genome and are part of sophisticated regulatory network systems that control developmental processes in normal and pathological conditions. The retroviral/retrotransposon gene machinery consists mainly of Long Interspersed Nuclear Elements (LINEs-1) and Human Endogenous Retroviruses (HERVs) that code for their own endogenous reverse transcriptase (RT). Interestingly, RT is typically expressed at high levels in cancer cells. Recent studies report that RT inhibition by non-nucleoside reverse transcriptase inhibitors (NNRTIs) induces growth arrest and cell differentiation in vitro and antagonizes growth of human tumors in animal model. In the present study we analyze the anticancer activity of Abacavir (ABC), a nucleoside reverse transcription inhibitor (NRTI), on PC3 and LNCaP prostate cancer cell lines. Principal Findings: ABC significantly reduces cell growth, migration and invasion processes, considerably slows S phase progression, induces senescence and cell death in prostate cancer cells. Consistent with these observations, microarray analysis on PC3 cells shows that ABC induces specific and dose-dependent changes in gene expression, involving multiple cellular pathways. Notably, by quantitative Real-Time PCR we found that LINE-1 ORF1 and ORF2 mRNA levels were significantly up-regulated by ABC treatment. Conclusions: Our results demonstrate the potential of ABC as anticancer agent able to induce antiproliferative activity and trigger senescence in prostate cancer cells. Noteworthy, we show that ABC elicits up-regulation of LINE-1 expression, suggesting the involvement of these elements in the observed cellular modifications.	[Carlini, Francesca; Ridolfi, Barbara; Parisi, Chiara; De Orsi, Daniela; Arcieri, Romano; Vella, Stefano; Gaudi, Simona] Ist Super Sanita, Dept Therapeut Res & Drug Evaluat, I-00161 Rome, Italy; [Molinari, Agnese; Bozzuto, Giuseppina; Toccacieli, Laura; Formisano, Giuseppe] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Paradisi, Silvia] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Grober, Oli Maria Victoria; Ravo, Maria; Weisz, Alessandro] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Weisz, Alessandro] Univ Salerno, Fac Med, Mol Med Lab, I-84100 Salerno, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; University of Salerno	Carlini, F (corresponding author), Ist Super Sanita, Dept Therapeut Res & Drug Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	simona.gaudi@iss.it	Molinari, Agnese/AAC-2918-2021; parisi, Chiara/K-6330-2016; RIDOLFI, BARBARA/D-7967-2016; CARLINI, FRANCESCA/D-7945-2016; Molinari, Agnese/E-7588-2015; Arcieri, Romano/O-4289-2014; Vella, Stefano/GZM-0519-2022; Weisz, Alessandro/A-1317-2014; VELLA, STEFANO/ABI-3368-2020; Bozzuto, Giuseppina/E-9094-2015	Molinari, Agnese/0000-0002-9592-5465; parisi, Chiara/0000-0003-1350-3929; RIDOLFI, BARBARA/0000-0002-6443-5500; Molinari, Agnese/0000-0002-9592-5465; Weisz, Alessandro/0000-0003-0455-2083; Bozzuto, Giuseppina/0000-0002-9761-3326; Carlini, Francesca/0000-0002-2409-6284; Ravo, Maria/0000-0003-1003-2922; Arcieri, Romano/0000-0002-9041-8202	National Institute of Health in Rome (ISS); Ministry of University and Research, Regione Campania; Associazione Italiana per la Ricerca sul Cancro (AIRC); Second University of Naples; University of Cagliari	National Institute of Health in Rome (ISS); Ministry of University and Research, Regione Campania; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Second University of Naples; University of Cagliari	Funding was provided by from the National Institute of Health in Rome (ISS), Ricerca Finalizzata 2004, Collaboration program ISS/NIH-USA and Ricerca Corrente 2007-2008, ISS. Other fundings are from Ministry of University and Research, Regione Campania, Associazione Italiana per la Ricerca sul Cancro (AIRC) and the PhD programs: "Pathology of Cell Signal Transduction" (OMVG) of the Second University of Naples and "Toxicology, Oncology and Molecular Pathology" of the University of Cagliari (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Asch HL, 1996, ONCOL RES, V8, P239; Banerjee G, 2005, PHOTODERMATOL PHOTO, V21, P32, DOI 10.1111/j.1600-0781.2005.00136.x; Banerjee S, 2000, BBA-PROTEIN STRUCT M, V1480, P1, DOI 10.1016/S0167-4838(00)00080-7; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; CAPORALE LH, 2006, IMPLICIT GENOME; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Daluge SM, 1997, ANTIMICROB AGENTS CH, V41, P1082, DOI 10.1128/AAC.41.5.1082; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DERAGON JM, 1990, EMBO J, V9, P3363, DOI 10.1002/j.1460-2075.1990.tb07537.x; El-Sawy M, 2005, J MOL BIOL, V354, P246, DOI 10.1016/j.jmb.2005.09.050; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landriscina M, 2008, INT J CANCER, V122, P2842, DOI 10.1002/ijc.23197; Landriscina M, 2009, PROSTATE, V69, P744, DOI 10.1002/pros.20923; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Mangiacasale R, 2003, ONCOGENE, V22, P2750, DOI 10.1038/sj.onc.1206354; Nangia-Makker P, 1998, BREAST CANCER RES TR, V49, P171, DOI 10.1023/A:1005913810250; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Pittoggi C, 2003, MOL REPROD DEV, V66, P225, DOI 10.1002/mrd.10349; Ramos KS, 2007, GENOMICS, V90, P176, DOI 10.1016/j.ygeno.2007.04.003; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Shi X, 2007, MOL CELL BIOL, V27, P1264, DOI 10.1128/MCB.01888-06; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spadafora C, 2008, SYST BIOL REPROD MED, V54, P11, DOI 10.1080/19396360701876815; Stribinskis V, 2006, CANCER RES, V66, P2616, DOI 10.1158/0008-5472.CAN-05-3478; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Teneng I, 2007, GENES CELLS, V12, P1101, DOI 10.1111/j.1365-2443.2007.01117.x; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007	51	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14221	10.1371/journal.pone.0014221	http://dx.doi.org/10.1371/journal.pone.0014221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151977	Green Submitted, gold, Green Published			2022-12-25	WOS:000284939600014
J	Crawford, JE; Guelbeogo, WM; Sanou, A; Traore, A; Vernick, KD; Sagnon, N; Lazzaro, BP				Crawford, Jacob E.; Guelbeogo, Wamdaogo M.; Sanou, Antoine; Traore, Alphonse; Vernick, Kenneth D.; Sagnon, N'Fale; Lazzaro, Brian P.			De Novo Transcriptome Sequencing in Anopheles funestus Using Illumina RNA-Seq Technology	PLOS ONE			English	Article							PROTEIN FAMILIES; MALARIA VECTOR; TOOL; DATABASE; GAMBIAE; ANNOTATION; GENERATION; EVOLUTION; ALIGNMENT; REVEALS	Background: Anopheles funestus is one of the primary vectors of human malaria, which causes a million deaths each year in sub-Saharan Africa. Few scientific resources are available to facilitate studies of this mosquito species and relatively little is known about its basic biology and evolution, making development and implementation of novel disease control efforts more difficult. The An. funestus genome has not been sequenced, so in order to facilitate genome-scale experimental biology, we have sequenced the adult female transcriptome of An. funestus from a newly founded colony in Burkina Faso, West Africa, using the Illumina GAIIx next generation sequencing platform. Methodology/Principal Findings: We assembled short Illumina reads de novo using a novel approach involving iterative de novo assemblies and "target-based" contig clustering. We then selected a conservative set of 15,527 contigs through comparisons to four Dipteran transcriptomes as well as multiple functional and conserved protein domain databases. Comparison to the Anopheles gambiae immune system identified 339 contigs as putative immune genes, thus identifying a large portion of the immune system that can form the basis for subsequent studies of this important malaria vector. We identified 5,434 1: 1 orthologues between An. funestus and An. gambiae and found that among these 1: 1 orthologues, the protein sequence of those with putative immune function were significantly more diverged than the transcriptome as a whole. Short read alignments to the contig set revealed almost 367,000 genetic polymorphisms segregating in the An. funestus colony and demonstrated the utility of the assembled transcriptome for use in RNA-seq based measurements of gene expression. Conclusions/Significance: We developed a pipeline that makes de novo transcriptome sequencing possible in virtually any organism at a very reasonable cost ($6,300 in sequencing costs in our case). We anticipate that our approach could be used to develop genomic resources in a diversity of systems for which full genome sequence is currently unavailable. Our An. funestus contig set and analytical results provide a valuable resource for future studies in this non-model, but epidemiologically critical, vector insect.	[Crawford, Jacob E.; Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Guelbeogo, Wamdaogo M.; Sanou, Antoine; Traore, Alphonse; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Vernick, Kenneth D.] Inst Pasteur, Dept Parasitol & Mycol, CNRS, Unit Hosts Vectors & Infect Agents URA3012, Paris, France; [Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN USA	Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities	Crawford, JE (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jc598@cornell.edu		Crawford, Jacob/0000-0002-6745-9145; Sanou, Antoine/0000-0002-3598-8800	National Institutes of Health [AI062995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant AI062995 from the National Institutes of Health. Additional support to JEC came from The Grace Griswold Endowment at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; *AN GEN CLUST COMM, 2008, GEN AN VECT CAP MAJ; [Anonymous], 1968, ANOPHELINAE AFR S SA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costantini C., 1999, Parassitologia (Rome), V41, P595; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; *DR 12 GEN CONS, 2007, SCIENCE, V450, P203; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Grimaldi David, 2005, pi; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jiang R, 2009, GENETICS, V181, P187, DOI 10.1534/genetics.107.080630; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Obbard DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-117; R Development Core Team, 2009, R FDN STAT COMP; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; *WHO UNICEF, 2009, WORLD MAL REP; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	119	125	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14202	10.1371/journal.pone.0014202	http://dx.doi.org/10.1371/journal.pone.0014202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151993	gold, Green Published, Green Submitted			2022-12-25	WOS:000284868000016
J	Makita, K; Fevre, EM; Waiswa, C; Eisler, MC; Welburn, SC				Makita, Kohei; Fevre, Eric M.; Waiswa, Charles; Eisler, Mark C.; Welburn, Susan C.			How Human Brucellosis Incidence in Urban Kampala Can Be Reduced Most Efficiently? A Stochastic Risk Assessment of Informally-Marketed Milk	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; SEROLOGICAL DIAGNOSIS; MACROPHAGES; INFECTION; ABORTUS; UGANDA; AREAS; COWS	Background: In Kampala, Uganda, studies have shown a significant incidence of human brucellosis. A stochastic risk assessment involving two field surveys (cattle farms and milk shops) and a medical record survey was conducted to assess the risk of human brucellosis infection through consumption of informally marketed raw milk potentially infected with Brucella abortus in Kampala and to identify the best control options. Methodology/Principal Findings: In the cattle farm survey, sera of 425 cows in 177 herds in the Kampala economic zone were sampled and tested for brucellosis using a competitive enzyme-linked immunosorbent assay (CELISA). Farmers were interviewed for dairy information. In the milk shop surveys, 135 milk sellers in the urban areas were interviewed and 117 milk samples were collected and tested using an indirect enzyme-linked immunosorbent assay (IELISA). A medical record survey was conducted in Mulago National Referral Hospital for serological test results. A risk model was developed synthesizing data from these three surveys. Possible control options were prepared based on the model and the reduction of risk was simulated for each scenario. Overall, 12.6% (6.8-18.9: 90% CI) of informally marketed milk in urban Kampala was contaminated with B. abortus at purchase and the annual incidence rate was estimated to be 5.8 (90% CI: 5.3-6.2) per 10,000 people. The best control option would be the construction of a milk boiling centre either in Mbarara, the largest source of milk, or in peri-urban Kampala and to ensure that milk traders always sell milk to the boiling centre; 90% success in enforcing these two options would reduce risk by 47.4% (21.6-70.1: 90% CI) and 82.0% (71.0-89.0: 90% CI), respectively. Conclusion/Significance: This study quantifies the risk of human brucellosis infection through informally marketed milk and estimates the incidence rate in Kampala for the first time; risk-based mitigation strategies are outlined to assist in developing policy.	[Makita, Kohei; Eisler, Mark C.; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis,Div Pathway Med, Edinburgh, Midlothian, Scotland; [Fevre, Eric M.] Univ Edinburgh, Sch Biol Sci, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Waiswa, Charles] Makerere Univ, Fac Vet Med, Kampala, Uganda	University of Edinburgh; University of Edinburgh; Makerere University	Makita, K (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis,Div Pathway Med, Edinburgh, Midlothian, Scotland.	kmakita@rakuno.ac.jp	Eisler, Mark/AAK-1119-2020	Eisler, Mark/0000-0001-6843-3345; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086	UK Department for International Development (DFID); Japan International Cooperation Agency (JICA); Wellcome Trust [085308]	UK Department for International Development (DFID); Japan International Cooperation Agency (JICA); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors would like to thank the UK Department for International Development (DFID, http://www.dfid.gov.uk/) Animal Health Programme (KM, EMF, MCE, SCW) for support for this work, although the views expressed are not necessarily those of DFID. KM thanks the Japan International Cooperation Agency (JICA, http://www.jica.go.jp/english/) for research grant support (Overseas Long-term Programme). EMF is funded by the Wellcome Trust (085308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STAT ABSTR 2005; Arimi SM, 2005, ACTA TROP, V96, P1, DOI 10.1016/j.actatropica.2005.05.012; Bartholomew MJ, 2005, RISK ANAL, V25, P99, DOI 10.1111/j.0272-4332.2005.00570.x; Codex Alimentarius Commission, 1999, PRINC GUID COND MICR; COLLINS CH, 1987, IRISH VET J, V41, P363; Ellis F, 1998, WORLD DEV, V26, P213, DOI 10.1016/S0305-750X(97)10042-0; *EUR FOOD SAF AUTH, 2010, NEW STORY       0512; EYER JM, 1986, AM J PUBLIC HEALTH, V76, P573; *FAO, 1953, MILK PAST PLANN PLAN; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Gall D, 2004, REV SCI TECH OIE, V23, P989; GRACE D, 2008, HLTH CITY HARVESTS G; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Kangethe EK, 2007, E AFR MED J, V84, P96; KAPLAN J, 1982, J CELL BIOL, V94, P12, DOI 10.1083/jcb.94.1.12; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Kyebambe Peterson S, 2005, Afr Health Sci, V5, P69; Makita K, 2010, LAND USE POLICY, V27, P888, DOI 10.1016/j.landusepol.2009.12.003; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Mwiine F. N., 2004, THESIS MAKERERE U KA; NAKAVUMA J, 1994, THESIS MAKERERE U KA; Nations United, 2004, REP UG PUBL ADM COUN; Ndyabahinduka D G, 1978, Ann Ist Super Sanita, V14, P229; Nero LA, 2008, ZOONOSES PUBLIC HLTH, V55, P299, DOI 10.1111/j.1863-2378.2008.01130.x; NEWTON FJ, 1974, BRIT VET J, V130, P249, DOI 10.1016/S0007-1935(17)35889-X; Oloffs A, 1988, REV ELEV MED VET PAY, V51, P101; Portanti O, 2006, J VET MED B, V53, P494, DOI 10.1111/j.1439-0450.2006.00971.x; Rivera DY, 2003, REV SCI TECH OIE, V22, P1065, DOI 10.20506/rst.22.3.1454; SCHLESINGER RB, 1992, FUND APPL TOXICOL, V19, P584, DOI 10.1016/0272-0590(92)90097-2; STAAL SJ, 2003, UGANDA DAIRY SUBSECT; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; *WHO, 2009, ZOON VET PUBL HLTH; WHO FAO OIE, 2006, BRUC HUM AN; Wilson G., 1942, PASTEURIZATION MILK; ZUNIGA EA, 2005, REV LATINOARM MICROB, V47, P88	38	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2010	5	12							e14188	10.1371/journal.pone.0014188	http://dx.doi.org/10.1371/journal.pone.0014188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688AU	21152072	Green Published, Green Submitted, gold			2022-12-25	WOS:000284821300006
J	Lima, BL; Santos, EJC; Fernandes, GR; Merkel, C; Mello, MRB; Gomes, JPA; Soukoyan, M; Kerkis, A; Massironi, SMG; Visintin, JA; Pereira, LV				Lima, Bruno L.; Santos, Enrico J. C.; Fernandes, Gustavo R.; Merkel, Christian; Mello, Marco R. B.; Gomes, Juliana P. A.; Soukoyan, Marina; Kerkis, Alexandre; Massironi, Silvia M. G.; Visintin, Jose A.; Pereira, Lygia V.			A New Mouse Model for Marfan Syndrome Presents Phenotypic Variability Associated with the Genetic Background and Overall Levels of Fbn1 Expression	PLOS ONE			English	Article							PATHOGENESIS; FIBRILLIN-1; MUTATION; MODIFIER; MICE; MICROFIBRILS; FRAGMENTS; SURVIVAL; REVEALS; FAMILY	Marfan syndrome is an autosomal dominant disease of connective tissue caused by mutations in the fibrillin-1 encoding gene FBN1. Patients present cardiovascular, ocular and skeletal manifestations, and although being fully penetrant, MFS is characterized by a wide clinical variability both within and between families. Here we describe a new mouse model of MFS that recapitulates the clinical heterogeneity of the syndrome in humans. Heterozygotes for the mutant Fbn1 allele mg Delta(loxPneo), carrying the same internal deletion of exons 19-24 as the mg Delta mouse model, present defective microfibrillar deposition, emphysema, deterioration of aortic wall and kyphosis. However, the onset of a clinical phenotypes is earlier in the 129/Sv than in C57BL/6 background, indicating the existence of genetic modifiers of MFS between these two mouse strains. In addition, we characterized a wide clinical variability within the 129/Sv congenic heterozygotes, suggesting involvement of epigenetic factors in disease severity. Finally, we show a strong negative correlation between overall levels of Fbn1 expression and the severity of the phenotypes, corroborating the suggested protective role of normal fibrillin-1 in MFS pathogenesis, and supporting the development of therapies based on increasing Fbn1 expression.	[Lima, Bruno L.; Santos, Enrico J. C.; Fernandes, Gustavo R.; Merkel, Christian; Gomes, Juliana P. A.; Soukoyan, Marina; Kerkis, Alexandre; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, BR-05508 Sao Paulo, Brazil; [Massironi, Silvia M. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Mello, Marco R. B.; Visintin, Jose A.] Univ Sao Paulo, Fac Vet & Zootecnia, Dept Anim Reprod, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Lima, BL (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, BR-05508 Sao Paulo, Brazil.	lpereira@usp.br	visintin, jose a/D-8608-2012; Merkel, Christian/K-7057-2012; Pereira, Lygia V/C-1049-2012; Santos, Enrico/B-7398-2017; Gomes, Juliana/K-6153-2016; Fernandes, Gustavo/C-8683-2013; Massironi, Silvia/N-4881-2017	Pereira, Lygia V/0000-0002-0002-725X; Gomes, Juliana/0000-0002-2000-4848; MELLO, MARCO ROBERTO/0000-0002-9790-4764; Fernandes, Gustavo/0000-0003-4667-9947; Massironi, Silvia/0000-0003-4690-1755	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP: www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; Booms P, 2000, HUM GENET, V107, P216, DOI 10.1007/s004390000368; Buoni S, 2004, ANN HUM GENET, V68, P633, DOI 10.1046/j.1529-8817.2004.00113.x; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; GRAY JR, 1994, J MED GENET, V31, P51, DOI 10.1136/jmg.31.1.51; HOGAN A, 1994, MANIPULATING MOUSE E; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAINULAINEN K, 1991, ANN MED, V23, P395, DOI 10.3109/07853899109148080; KAINULAINEN K, 1991, AM J HUM GENET, V49, P662; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MURAISHI H, NIPPON HOSHASEN GIJU, V66, P260; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; OTSURU S, 2010, EXP HEMATOL; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pu WT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000643; Pyeritz R E, 1979, Birth Defects Orig Artic Ser, V15, P155; PYERITZ RE, 1986, AM FAM PHYSICIAN, V34, P83; PYERITZ RE, 1990, NEW ENGL J MED, V323, P987, DOI 10.1056/NEJM199010043231409; PYERITZ RE, 1981, NEW ENGL J MED, V305, P1011, DOI 10.1056/NEJM198110223051711; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SILVERMAN DI, 1995, J AM COLL CARDIOL, V26, P1062, DOI 10.1016/0735-1097(95)00258-0; Sukoyan MA, 2002, BRAZ J MED BIOL RES, V35, P535, DOI 10.1590/S0100-879X2002000500004; Sunaga S, 1997, MOL REPROD DEV, V46, P109, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;109::AID-MRD1&gt;3.0.CO;2-U; SWEET A, 1992, BIOCHEM MED METAB B, V47, P97, DOI 10.1016/0885-4505(92)90011-M; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081; Yang TX, 2005, AM J PHYSIOL-RENAL, V288, pF1125, DOI 10.1152/ajprenal.00219.2004; ZANGALA T, 2007, J VIS EXP	36	45	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14136	10.1371/journal.pone.0014136	http://dx.doi.org/10.1371/journal.pone.0014136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152435	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100017
J	Milotti, E; Chignola, R				Milotti, Edoardo; Chignola, Roberto			Emergent Properties of Tumor Microenvironment in a Real-Life Model of Multicell Tumor Spheroids	PLOS ONE			English	Article							CELL POPULATIONS; VORONOI DIAGRAMS; GROWTH; DYNAMICS; SIMULATION; OXYGENATION; METABOLISM; CARCINOMA; THERAPY; CULTURE	Multicellular tumor spheroids are an important in vitro model of the pre-vascular phase of solid tumors, for sizes well below the diagnostic limit: therefore a biophysical model of spheroids has the ability to shed light on the internal workings and organization of tumors at a critical phase of their development. To this end, we have developed a computer program that integrates the behavior of individual cells and their interactions with other cells and the surrounding environment. It is based on a quantitative description of metabolism, growth, proliferation and death of single tumor cells, and on equations that model biochemical and mechanical cell-cell and cell-environment interactions. The program reproduces existing experimental data on spheroids, and yields unique views of their microenvironment. Simulations show complex internal flows and motions of nutrients, metabolites and cells, that are otherwise unobservable with current experimental techniques, and give novel clues on tumor development and strong hints for future therapies.	[Milotti, Edoardo] Univ Trieste, Dipartimento Fis, Trieste, Italy; [Milotti, Edoardo; Chignola, Roberto] Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy; [Chignola, Roberto] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy	University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Verona	Milotti, E (corresponding author), Univ Trieste, Dipartimento Fis, Trieste, Italy.	edoardo.milotti@ts.infn.it	Milotti, Edoardo/AAA-7076-2020	CHIGNOLA, Roberto/0000-0001-6981-6890; Milotti, Edoardo/0000-0001-7348-9765	Italian Institute for Nuclear Physics (INFN)	Italian Institute for Nuclear Physics (INFN)(Istituto Nazionale di Fisica Nucleare (INFN))	This work has been supported by the Italian Institute for Nuclear Physics (INFN) under the names VIRTUS, VBL and VBL-Rad. Relevant information can be found on the INFN website, http://www.infn.it/indexen.php. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER H, 1987, CANCER RES, V47, P3504; Alberts B, 2008, MOL BIOL CELL; Alvarez-Perez J, 2005, MAGN RESON MATER PHY, V18, P293, DOI 10.1007/s10334-005-0013-z; Bjerkvig R., 1992, SPHEROID CULTURE CAN; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; CASCIARI JJ, 1992, CELL PROLIFERAT, V25, P1, DOI 10.1111/j.1365-2184.1992.tb01433.x; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIGNOLA R, 1995, BRIT J CANCER, V72, P607, DOI 10.1038/bjc.1995.381; Chignola R, 2005, PHYS BIOL, V2, P8, DOI 10.1088/1478-3967/2/1/002; Chignola R, 2004, PHYSICA A, V338, P261, DOI 10.1016/j.physa.2004.02.049; Chignola R, 2007, PHYS BIOL, V4, P114, DOI 10.1088/1478-3975/4/2/005; Chignola R, 2006, PHYSICA A, V371, P463, DOI 10.1016/j.physa.2006.03.044; Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, DOI 10.1016/C2013-0-04130-8; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; DORIE MJ, 1982, EXP CELL RES, V141, P201, DOI 10.1016/0014-4827(82)90082-9; DWYER RA, 1991, DISCRETE COMPUT GEOM, V6, P343, DOI 10.1007/BF02574694; Engelberg JA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-110; Flekkoy EG, 2000, PHYS REV E, V62, P2140, DOI 10.1103/PhysRevE.62.2140; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Gottfried E, 2006, CELL CYCLE, V5, P691, DOI 10.4161/cc.5.7.2624; GUIBAS LJ, 1992, ALGORITHMICA, V7, P381, DOI 10.1007/BF01758770; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Milotti E, 2007, PHYSICA A, V379, P133, DOI 10.1016/j.physa.2006.12.034; Milotti E, 2009, COMPUT PHYS COMMUN, V180, P2166, DOI 10.1016/j.cpc.2009.06.021; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; MUELLERKLIESER W, 1986, BRIT J CANCER, V53, P345, DOI 10.1038/bjc.1986.58; NEDERMAN T, 1984, CANCER RES, V44, P3090; O'Rourke J, 1998, COMPUTATIONAL GEOMET; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schaller G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051910; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Venkatasubramanian R, 2006, J THEOR BIOL, V242, P440, DOI 10.1016/j.jtbi.2006.03.011; Walenta S, 2000, J HISTOCHEM CYTOCHEM, V48, P509, DOI 10.1177/002215540004800409; Wolfram Research I, 2008, MATH; Yu P, 2003, APPL PHYS LETT, V83, P575, DOI 10.1063/1.1594830; YUHAS JM, 1977, CANCER RES, V37, P3639	44	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e13942	10.1371/journal.pone.0013942	http://dx.doi.org/10.1371/journal.pone.0013942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152429	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100003
J	Olsen, CM; Childs, DS; Stanwood, GD; Winder, DG				Olsen, Christopher M.; Childs, Daniel S.; Stanwood, Gregg D.; Winder, Danny G.			Operant Sensation Seeking Requires Metabotropic Glutamate Receptor 5 (mGluR5)	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; NULL MUTANT MICE; ANTAGONIST MPEP; ALLOSTERIC MODULATORS; ALCOHOL DEPENDENCE; VISUAL-STIMULI; COCAINE; BEHAVIOR; REINFORCEMENT; ANXIETY	Pharmacological and genetic studies have suggested that the metabotropic glutamate receptor 5 (mGluR5) is critically involved in mediating the reinforcing effects of drugs of abuse, but not food. The purpose of this study was to use mGluR5 knockout (KO), heterozygous (Het), and wildtype (WT) mice to determine if mGluR5 modulates operant sensation seeking (OSS), an operant task that uses varied sensory stimuli as a reinforcer. We found that mGluR5 KO mice had significantly reduced OSS responding relative to WT mice, while Het mice displayed a paradoxical increase in OSS responding. Neither KO nor Het mice exhibited altered operant responding for food as a reinforcer. Further, we assessed mGluR5 KO, Het and WT mice across a battery of cocaine locomotor, place preference and anxiety related tests. Although KO mice showed expected differences in some locomotor and anxiety measures, Het mice either exhibited no phenotype or an intermediate one. In total, these data demonstrate a key role for mGluR5 in OSS, indicating an important role for this receptor in reinforcement-based behavior.	[Olsen, Christopher M.; Childs, Daniel S.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Olsen, Christopher M.; Stanwood, Gregg D.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA; [Olsen, Christopher M.; Stanwood, Gregg D.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Olsen, CM (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	chris.olsen@vanderbilt.edu	Olsen, Christopher/C-3542-2008; Winder, Danny G./H-4857-2013; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310; Olsen, Christopher/0000-0003-2700-0310; Stanwood, Gregg/0000-0001-6005-1203; Childs, Daniel/0000-0001-7643-2836	NIH [DA19112, DA026994];  [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026994, R01DA019112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by NIH grants DA19112 (DGW) and DA026994 (CMO). Behavioral work was performed at the Vanderbilt Murine Neurobehavioral Laboratory, which is supported in part by P30HD15052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; BARON A, 1962, J COMP PHYSIOL PSYCH, V55, P1011, DOI 10.1037/h0044286; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bisaga A, 2008, EUR NEUROPSYCHOPHARM, V18, P794, DOI 10.1016/j.euroneuro.2008.05.004; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Brodkin J, 2002, EUR J NEUROSCI, V16, P2241, DOI 10.1046/j.1460-9568.2002.02294.x; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Colby CR, 2003, J NEUROSCI, V23, P2488; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Gass JT, 2009, NEUROPSYCHOPHARMACOL, V34, P820, DOI 10.1038/npp.2008.140; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Kumaresan V, 2009, BEHAV BRAIN RES, V202, P238, DOI 10.1016/j.bbr.2009.03.039; LAPIERRE YD, 1982, CURR THER RES CLIN E, V31, P95; Lu YM, 1997, J NEUROSCI, V17, P5196; Marino MJ, 2006, CURR OPIN PHARMACOL, V6, P98, DOI 10.1016/j.coph.2005.09.006; Martin-Fardon R, 2009, J PHARMACOL EXP THER, V329, P1084, DOI 10.1124/jpet.109.151357; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; OCONNOR EC, 2010, NEUROPSYCHOPHARMACOL; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Olsen CM, 2006, PSYCHOPHARMACOLOGY, V187, P13, DOI 10.1007/s00213-006-0388-1; Olsen CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1685, DOI 10.1038/npp.2008.226; OLSEN CM, J VISUALIZED E UNPUB; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Paterson NE, 2005, PSYCHOPHARMACOLOGY, V179, P255, DOI 10.1007/s00213-004-2070-9; PECKNOLD JC, 1982, J CLIN PSYCHOPHARM, V2, P129; Platt DM, 2008, PSYCHOPHARMACOLOGY, V200, P167, DOI 10.1007/s00213-008-1191-y; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Schramm-Sapyta NL, 2006, NEUROPSYCHOPHARMACOL, V31, P1444, DOI 10.1038/sj.npp.1300918; Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826; Spooren W, 2004, DRUG NEWS PERSPECT, V17, P251, DOI 10.1358/dnp.2004.17.4.829052; STEWART J, 1960, J COMP PHYSIOL PSYCH, V53, P187, DOI 10.1037/h0047315; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; THOMPSON TI, 1963, SCIENCE, V141, P55, DOI 10.1126/science.141.3575.55; van der Kam EL, 2007, BEHAV PHARMACOL, V18, pS21	46	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15085	10.1371/journal.pone.0015085	http://dx.doi.org/10.1371/journal.pone.0015085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152045	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100066
J	Petersen, B; Lundegaard, C; Petersen, TN				Petersen, Bent; Lundegaard, Claus; Petersen, Thomas Nordahl			NetTurnP - Neural Network Prediction of Beta-turns by Use of Evolutionary Information and Predicted Protein Sequence Features	PLOS ONE			English	Article							SECONDARY STRUCTURE; GAMMA-TURNS; ACCURACY; EPITOPES; PROGRAM; SET	beta-turns are the most common type of non-repetitive structures, and constitute on average 25% of the amino acids in proteins. The formation of beta-turns plays an important role in protein folding, protein stability and molecular recognition processes. In this work we present the neural network method NetTurnP, for prediction of two-class beta-turns and prediction of the individual beta-turn types, by use of evolutionary information and predicted protein sequence features. It has been evaluated against a commonly used dataset BT426, and achieves a Matthews correlation coefficient of 0.50, which is the highest reported performance on a two-class prediction of beta-turn and not-beta-turn. Furthermore NetTurnP shows improved performance on some of the specific beta-turn types. In the present work, neural network methods have been trained to predict beta-turn or not and individual beta-turn types from the primary amino acid sequence. The individual beta-turn types I, I', II, II', VIII, VIa1, VIa2, VIba and IV have been predicted based on classifications by PROMOTIF, and the two-class prediction of beta-turn or not is a superset comprised of all beta-turn types. The performance is evaluated using a golden set of non-homologous sequences known as BT426. Our two-class prediction method achieves a performance of: MCC = 0.50, Q(total) = 82.1%, sensitivity = 75.6%, PPV = 68.8% and AUC = 0.864. We have compared our performance to eleven other prediction methods that obtain Matthews correlation coefficients in the range of 0.17 - 0.47. For the type specific beta-turn predictions, only type I and II can be predicted with reasonable Matthews correlation coefficients, where we obtain performance values of 0.36 and 0.31, respectively. Conclusion: The NetTurnP method has been implemented as a webserver, which is freely available at http://www.cbs.dtu.dk/services/NetTurnP/. NetTurnP is the only available webserver that allows submission of multiple sequences.	[Petersen, Bent; Lundegaard, Claus; Petersen, Thomas Nordahl] Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Petersen, B (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark.	tnp@cbs.dtu.dk	Lundegaard, Claus/B-3938-2012	Petersen, Bent/0000-0002-2472-8317; Petersen, Thomas Nordahl/0000-0002-2484-5716				Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Armitage P., 2002, STAT METHODS MED RES; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CHOU PY, 1979, BIOPHYSICAL J, V26; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Ettmayer P, 1999, J MED CHEM, V42, P971, DOI 10.1021/jm9811007; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GARNIER J, 1989, PREDICTION PROTEIN S; Guruprasad K, 2000, J BIOSCIENCES, V25, P143, DOI 10.1007/BF03404909; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hu XZ, 2008, J COMPUT CHEM, V29, P1867, DOI 10.1002/jcc.20929; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kaur H, 2002, BIOINFORMATICS, V18, P1508, DOI 10.1093/bioinformatics/18.11.1508; Kim S, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/btg368; KIRSCHNER A, 2008, GENE; Kountouris P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-407; KRCHNAK V, 1989, METHOD ENZYMOL, V178, P586; KRCHNAK V, 1987, ANAL BIOCHEM, V165, P200, DOI 10.1016/0003-2697(87)90220-X; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu LR, 2009, PROTEIN J, V28, P175, DOI 10.1007/s10930-009-9181-4; Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241; Lund O, 2005, IMMUNOLOGICAL BIOINF; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MCGREGOR MJ, 1989, PROTEIN ENG, V2, P521, DOI 10.1093/protein/2.7.521; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILNERWHITE EJ, 1987, TRENDS BIOCHEM SCI, V12, P189; Pellequer J. L., 1991, V203, P176; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2000, PROTEINS, V41, P17, DOI 10.1002/1097-0134(20001001)41:1<17::AID-PROT40>3.0.CO;2-F; Pham Tho Hoan, 2003, Genome Inform, V14, P196; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Shepherd AJ, 1999, PROTEIN SCI, V8, P1045, DOI 10.1110/ps.8.5.1045; Swets JA, 1996, SCI PSYCH S; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Zhang CT, 1997, BIOPOLYMERS, V41, P673, DOI 10.1002/(SICI)1097-0282(199705)41:6<673::AID-BIP7>3.0.CO;2-N; Zhang QD, 2005, BIOINFORMATICS, V21, P2370, DOI 10.1093/bioinformatics/bti358; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430	47	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15079	10.1371/journal.pone.0015079	http://dx.doi.org/10.1371/journal.pone.0015079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152409	gold, Green Submitted, Green Published			2022-12-25	WOS:000284755100062
J	Astro, V; Asperti, C; Cangi, G; Doglioni, C; de Curtis, I				Astro, V.; Asperti, C.; Cangi, G.; Doglioni, C.; de Curtis, I.			Liprin-alpha 1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation	ONCOGENE			English	Article						cell migration; invadopodia; invasion; lamellipodia; liprins	PROTEIN-TYROSINE-PHOSPHATASE; SUPPRESSOR GENE; IDENTIFICATION; CORTACTIN; ADHESION; LIPRINS	Migration of cells and degradation of the extracellular matrix (ECM) are required for efficient tumor cell invasion, but the underlying molecular mechanisms are only partially known. The PPFIA1 gene for liprin-alpha 1 is frequently amplified in human breast cancers. We recently demonstrated that liprin-alpha 1 is an important regulator of cell edge dynamics during motility. We show, herein, that the liprin-alpha 1 protein is highly expressed in human breast tumors. Functional analysis shows that liprin-alpha 1 is specifically required for the migration and invasion of highly invasive human breast cancer MDA-MB-231 cells. We used time-lapse analysis to demonstrate defects in the motility of liprin-alpha 1-depleted cells that include a striking instability of the lamellipodia. Liprin-alpha 1 levels altered by either RNA interference or overexpression affected also cell spreading and the number of invadopodia per cell, but not the density of invadopodia per unit of surface area. On the other hand, silencing of liprin-alpha 1 inhibited the degradation of the ECM, whereas its overexpression enhanced degradation, resulting in significant negative or positive effects, respectively, on the area of degradation per invadopodium. Transfection of fluorescent-labeled cortactin revealed that depletion of liprin-alpha 1 also affected the assembly and disassembly of invadopodia, with decrease of their lifetime. Our results strongly support a novel important role of liprin-alpha 1 in the regulation of human tumor cell invasion. Oncogene (2011) 30, 1841-1849; doi:10.1038/onc.2010.562; published online 13 December 2010	[Astro, V.; Asperti, C.; de Curtis, I.] Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy; [Astro, V.; Asperti, C.; Cangi, G.; Doglioni, C.; de Curtis, I.] San Raffaele Univ, Milan, Italy; [Cangi, G.; Doglioni, C.] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	de Curtis, I (corresponding author), Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, Via Olgettina 58, I-20132 Milan, Italy.	decurtis.ivan@hsr.it	Asperti, Claudia/ABG-5481-2020; Cangi, M.Giulia/CAF-1459-2022	Cangi, M.Giulia/0000-0002-9472-0935; Astro, Veronica/0000-0001-7852-7046; DE CURTIS, Ivanmatteo/0000-0002-7651-1515; DOGLIONI, Claudio/0000-0002-4969-5216	AIRC (Italian Association for Cancer Research) [5060]; Italian Telethon Foundation [GGP09078]	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Italian Telethon Foundation(Fondazione Telethon)	Support to I de Curtis by the AIRC (Italian Association for Cancer Research, grant no. 5060) and by the Italian Telethon Foundation (grant no. GGP09078) is gratefully acknowledged. The plasmid for DsRed-Cortactin was generously provided by Mark A McNiven (Mayo Clinic, Rochester, MN, USA). We thank Cesare Covino of the Alembic facility at our Institute for his support in the morphological analysis, Rosanna Latino and Maurizio Ferrari for the cytogenetic analysis, and Jacopo Meldolesi for critical reading of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; de Curtis I, 2011, EXP CELL RES, V317, P1, DOI 10.1016/j.yexcr.2010.09.014; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Katoh M, 2005, INT J ONCOL, V27, P281; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Nachat R, 2009, J CELL SCI, V122, P4035, DOI 10.1242/jcs.047266; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shaw Leslie M., 2004, V294, P97; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Tan KD, 2008, GENE CHROMOSOME CANC, V47, P353, DOI 10.1002/gcc.20539; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028	23	42	42	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	15					1841	1849		10.1038/onc.2010.562	http://dx.doi.org/10.1038/onc.2010.562			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21151172				2022-12-25	WOS:000289512200011
J	Jiang, R; Shi, ZG; Johnson, JJ; Liu, YY; Stack, MS				Jiang, Rong; Shi, Zonggao; Johnson, Jeffrey J.; Liu, Yueying; Stack, M. Sharon			Kallikrein-5 Promotes Cleavage of Desmoglein-1 and Loss of Cell-Cell Cohesion in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; PROTEOLYTIC CASCADE; SERINE PROTEASES; DESMOSOMAL CADHERINS; IN-VITRO; EXPRESSION; MODEL; SKIN; DIFFERENTIATION; DEGRADATION	Oral squamous cell carcinoma (OSCC) ranks among the top 8 causes of cancer death worldwide, with only a 60% 5-year survival rate, highlighting the need for discovery of novel biomarkers and therapeutic targets. We have previously reported that expression of a panel of serine proteinase kallikreins (KLK 5, 7, 8, and 10) is correlated with formation of more aggressive OSCC tumors in a murine orthotopic OSCC model and is elevated in human OSCC. Current studies focus on understanding the potential role of KLK5 in OSCC progression. In initial studies, KLK levels in malignant OSCC cells (SCC25) were compared with cells from normal oral mucosa (OKF/6) and pre-malignant oral keratinocytes (pp126) using qPCR. A marked elevation of all KLKs was observed in aggressive SCC25 cells relative to OKF/6 cells. In normal skin, KLKs are involved in desquamation during epidermal differentiation via proteolytic cleavage of the desmosomal cadherin component desmoglein 1 (Dsg1). As loss of cell-cell cohesion is prevalent in tumor metastasis, Dsg1 integrity was evaluated. Results show that SCC25 cells exhibit cleavage of Dsg1, which is blocked by proteinase inhibitor treatment as well as by siRNA silencing of KLK5 expression. Furthermore, cell-cell aggregation assays demonstrate that silencing of KLK5 enforces cell-cell adhesion; conversely, overexpression of KLK5 in normal oral mucosal cells (OKF/6) enhances cell dispersal. These data suggest that KLK5 may promote metastatic dissemination of OSCC by promoting loss of junctional integrity through cleavage of desmoglein 1.	[Jiang, Rong; Shi, Zonggao; Johnson, Jeffrey J.; Liu, Yueying; Stack, M. Sharon] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Stack, MS (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, 1 Hosp Dr,M214C Med Sci Bldg, Columbia, MO 65212 USA.	stackm@missouri.edu	Jiang, Rong/K-4143-2013	Shi, Zonggao/0000-0001-7503-2953	NCI, National Institutes of Health [CA085870]; NATIONAL CANCER INSTITUTE [R01CA085870] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Research Grant CA085870 (to M. S. S.) from the NCI, National Institutes of Health.	ARNEMANN J, 1993, J CELL SCI, V104, P741; BEYNON R, 2001, PROTEOLYTIC ENZYMES, P320; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Buxton R S, 1992, Semin Cell Biol, V3, P157; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cheng X, 2004, J DERMATOL, V31, P171, DOI 10.1111/j.1346-8138.2004.tb00654.x; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; EGELRUD T, 1993, J INVEST DERMATOL, V101, P200, DOI 10.1111/1523-1747.ep12363804; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; Garrod D, 1996, CURR OPIN CELL BIOL, V8, P670, DOI 10.1016/S0955-0674(96)80108-6; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; Getsios S, 2004, DIFFERENTIATION, V72, P419, DOI 10.1111/j.1432-0436.2004.07208008.x; Ghosh S, 2010, MOL CANCER RES, V8, P145, DOI 10.1158/1541-7786.MCR-09-0045; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; HARADA T, 1992, INT J ORAL MAX SURG, V21, P346, DOI 10.1016/S0901-5027(05)80759-3; HORNER MJ, 2009, SEER CANC STAT REV; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; IMAI K, 1995, HEAD NECK-J SCI SPEC, V17, P204, DOI 10.1002/hed.2880170307; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KOCH PJ, 1994, CURR OPIN CELL BIOL, V6, P682, DOI 10.1016/0955-0674(94)90094-9; Kowalczyk AP, 1996, J INVEST DERMATOL, V107, P293, DOI 10.1111/1523-1747.ep12363000; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LUNDSTROM A, 1990, ARCH DERMATOL RES, V282, P234, DOI 10.1007/BF00371642; LUNDSTROM A, 1988, J INVEST DERMATOL, V91, P340, DOI 10.1111/1523-1747.ep12475679; LUNDSTROM A, 1990, J INVEST DERMATOL, V94, P216, DOI 10.1111/1523-1747.ep12874531; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; North AJ, 1999, J CELL SCI, V112, P4325; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rusthoven K, 2008, CANCER-AM CANCER SOC, V112, P345, DOI 10.1002/cncr.23183; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Shi ZG, 2007, BIOCHEM J, V407, P153, DOI 10.1042/BJ20071037; Shi Z, 2010, HISTOL HISTOPATHOL, V25, P917, DOI 10.14670/HH-25.917; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; ZHAO H, 2010, HEAD NECK IN PRESS	46	47	51	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9127	9135		10.1074/jbc.M110.191361	http://dx.doi.org/10.1074/jbc.M110.191361			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21163944	Green Published, hybrid			2022-12-25	WOS:000288247700043
J	Grasso, D; Ropolo, A; Lo Re, A; Boggio, V; Molejon, MI; Iovanna, JL; Gonzalez, CD; Urrutia, R; Vaccaro, MI				Grasso, Daniel; Ropolo, Alejandro; Lo Re, Andrea; Boggio, Veronica; Molejon, Maria I.; Iovanna, Juan L.; Gonzalez, Claudio D.; Urrutia, Raul; Vaccaro, Maria I.			Zymophagy, a Novel Selective Autophagy Pathway Mediated by VMP1-USP9x-p62, Prevents Pancreatic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; TRYPSINOGEN ACTIVATION; ENZYME ACTIVATION; VACUOLE FORMATION; PROTEIN; MYELOPEROXIDASE; DEGRADATION; PREMATURE; SCAFFOLD; MICE	Autophagy has recently elicited significant attention as a mechanism that either protects or promotes cell death, although different autophagy pathways, and the cellular context in which they occur, remain to be elucidated. We report a thorough cellular and biochemical characterization of a novel selective autophagy that works as a protective cell response. This new selective autophagy is activated in pancreatic acinar cells during pancreatitis-induced vesicular transport alteration to sequester and degrade potentially deleterious activated zymogen granules. We have coined the term "zymophagy" to refer to this process. The autophagy-related protein VMP1, the ubiquitin-protease USP9x, and the ubiquitin-binding protein p62 mediate zymophagy. Moreover, VMP1 interacts with USP9x, indicating that there is a close cooperation between the autophagy pathway and the ubiquitin recognition machinery required for selective autophagosome formation. Zymophagy is activated by experimental pancreatitis in genetically engineered mice and cultured pancreatic acinar cells and by acute pancreatitis in humans. Furthermore, zymophagy has pathophysiological relevance by controlling pancreatitis-induced intracellular zymogen activation and helping to prevent cell death. Together, these data reveal a novel selective form of autophagy mediated by the VMP1-USP9x-p62 pathway, as a cellular protective response.	[Grasso, Daniel; Ropolo, Alejandro; Lo Re, Andrea; Boggio, Veronica; Molejon, Maria I.; Gonzalez, Claudio D.; Vaccaro, Maria I.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina; [Iovanna, Juan L.] INSERM, U624, F-13288 Marseille, France; [Urrutia, Raul] Mayo Clin, Chromatin Dynam & Epigenet Lab, Rochester, MN 55905 USA	University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); Mayo Clinic	Vaccaro, MI (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, 956 Junin,C1113AAD, Buenos Aires, DF, Argentina.	mvaccaro@ffyb.uba.ar	Vaccaro, Maria I./L-8348-2017; Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237; Vaccaro, Maria/0000-0002-2456-747X; GRASSO, DANIEL/0000-0002-8932-716X; Gonzalez, Claudio/0000-0002-3772-8850	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT-PICT01627]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET-PIP2527]; University of Buenos Aires [UBA-UBACyTM072]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT-PICT01627, Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant CONICET-PIP2527, and the University of Buenos Aires Grant UBA-UBACyTM072.	Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P100, DOI 10.4161/auto.6.1.10697; CHANSON M, 1989, J CELL PHYSIOL, V139, P147, DOI 10.1002/jcp.1041390121; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dawra R, 2008, PANCREAS, V37, P62, DOI 10.1097/MPA.0b013e3181607761; De Lisle RC, 2005, AM J PHYSIOL-CELL PH, V289, pC1169, DOI 10.1152/ajpcell.00099.2005; DiMagno MJ, 2004, AM J PHYSIOL-GASTR L, V287, pG80, DOI 10.1152/ajpgi.00525.2003; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fortunato F, 2009, AUTOPHAGY, V5, P850, DOI 10.4161/auto.8839; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; HOWELL KE, 1989, METHOD CELL BIOL, V31, P265; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Thrower E, 2008, CURR OPIN GASTROEN, V24, P580, DOI 10.1097/MOG.0b013e32830b10e6; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vaccaro MI, 2008, PANCREATOLOGY, V8, P425, DOI 10.1159/000151480; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c	41	142	147	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8308	8324		10.1074/jbc.M110.197301	http://dx.doi.org/10.1074/jbc.M110.197301			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21173155	Green Published, hybrid			2022-12-25	WOS:000288013300060
J	Hobbs, RP; Amargo, EV; Somasundaram, A; Simpson, CL; Prakriya, M; Denning, MF; Green, KJ				Hobbs, Ryan P.; Amargo, Evangeline V.; Somasundaram, Agila; Simpson, Cory L.; Prakriya, Murali; Denning, Mitchell F.; Green, Kathleen J.			The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKC alpha signaling	FASEB JOURNAL			English	Article						desmosome; Darier's disease; intracellular Ca2+; cell-cell contact	HAILEY-HAILEY-DISEASE; PROTEIN-KINASE-C; INTERMEDIATE-FILAMENT NETWORKS; CULTURED EPITHELIAL-CELLS; DARIERS-DISEASE; IN-VITRO; HUMAN KERATINOCYTES; TOPICAL CALCITRIOL; PLASMA-MEMBRANE; DESMOSOMES	Darier's disease (DD) is an inherited autosomal-dominant skin disorder characterized histologically by loss of adhesion between keratinocytes. DD is typically caused by mutations in sarcoendoplasmic reticulum Ca2+-ATPase isoform 2 (SERCA2), a major regulator of intracellular Ca2+ homeostasis in the skin. However, a defined role for SERCA2 in regulating intercellular adhesion remains poorly understood. We found that diminution of SERCA2 function by pharmacological inhibition or siRNA silencing in multiple human epidermal-derived cell lines was sufficient to disrupt desmosome assembly and weaken intercellular adhesive strength. Specifically, SERCA2-deficient cells exhibited up to a 60% reduction in border translocation of desmoplakin (DP), the desmosomal cytolinker protein necessary for intermediate filament (IF) anchorage to sites of robust cell-cell adhesion. In addition, loss of SERCA2 impaired the membrane translocation of protein kinase C alpha (PKC alpha), a known regulator of DP-IF association and desmosome assembly, to the plasma membrane by up to 70%. Exogenous activation of PKC alpha in SERCA2-deficient cells was sufficient to rescue the defective DP localization, desmosome assembly, and intercellular adhesive strength to levels comparable to controls. Our findings indicate that SERCA2-deficiency is sufficient to impede desmosome assembly and weaken intercellular adhesive strength via a PKC alpha-dependent mechanism, implicating SERCA2 as a novel regulator of PKC alpha signaling.-Hobbs, R. P., Amargo, E. V., Somasundaram, A., Simpson, C. L., Prakriya, M., Denning, M. F., Green, K. J. The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKC alpha signaling. FASEB J. 25, 990-1001 (2011). www.fasebj.org	[Hobbs, Ryan P.; Amargo, Evangeline V.; Simpson, Cory L.; Green, Kathleen J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Somasundaram, Agila; Prakriya, Murali] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Green, Kathleen J.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Green, Kathleen J.] Northwestern Univ, Feinberg Sch Med, RH Lurie Canc Ctr, Chicago, IL 60611 USA; [Denning, Mitchell F.] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Loyola University Chicago	Green, KJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	kgreen@northwestern.edu		Simpson, Cory/0000-0002-3933-6404; Prakriya, Murali/0000-0003-0781-4480	NIH [RO1 AR043380, RO1 AR041836, RO1 NS057499, F30 ES14990]; American Heart Association [0810061Z]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR043380, R01AR041836, R01AR043380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES014990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Lisa Godsel and Spiro Getsios (Northwestern University) for their valued advice, support, and comments on the paper. This work was supported by NIH grants to K.J.G. (RO1 AR043380 and RO1 AR041836), M.P. (RO1 NS057499), and C.L.S. (F30 ES14990), as well as an American Heart Association fellowship to R.P.H (0810061Z). The authors declare no conflicts of interest.	Amagai M, 2003, J AM ACAD DERMATOL, V48, P244, DOI 10.1067/mjd.2003.7; ANGST BD, 1990, J CELL SCI, V97, P247; Aoki T, 1998, BRIT J DERMATOL, V139, P897; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bianchi L, 2004, J AM ACAD DERMATOL, V51, P475, DOI 10.1016/j.jaad.2003.10.668; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; BURGE SM, 1991, BRIT J DERMATOL, V124, P242, DOI 10.1111/j.1365-2133.1991.tb00568.x; Cooper SM, 2003, AM J CLIN DERMATOL, V4, P97, DOI 10.2165/00128071-200304020-00003; DEDOBBELEER G, 1979, J CUTAN PATHOL, V6, P418; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Dhitavat J, 2004, BRIT J DERMATOL, V150, P821, DOI 10.1111/j.1365-2133.2004.05904.x; Dhitavat J, 2003, J INVEST DERMATOL, V121, P1349, DOI 10.1046/j.1523-1747.2003.12557.x; Foggia L, 2006, J CELL SCI, V119, P671, DOI 10.1242/jcs.02781; Foggia L, 2004, AM J MED GENET C, V131C, P20, DOI 10.1002/ajmg.c.30031; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; HANAFIN NM, 1995, J CELL BIOCHEM, V57, P362, DOI 10.1002/jcb.240570220; Hayashi K, 1999, J CELL SCI, V112, P1149; HEDBLAD MA, 1991, ACTA DERM-VENEREOL, V71, P108; Hovnanian A., 2007, V45, P337; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; JEGASOTHY BV, 1981, J INVEST DERMATOL, V76, P129, DOI 10.1111/1523-1747.ep12525466; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Leinonen PT, 2009, J INVEST DERMATOL, V129, P1379, DOI 10.1038/jid.2008.381; Mayuzumi N, 2005, BRIT J DERMATOL, V152, P920, DOI 10.1111/j.1365-2133.2005.06394.x; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Muller EJ, 2006, J INVEST DERMATOL, V126, P721, DOI 10.1038/sj.jid.5700091; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Pani B, 2008, CELL MOL LIFE SCI, V65, P205, DOI 10.1007/s00018-007-7397-z; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; PASDAR M, 1995, CELL MOTIL CYTOSKEL, V30, P108, DOI 10.1002/cm.970300203; PASDAR M, 1988, J CELL BIOL, V106, P677, DOI 10.1083/jcb.106.3.677; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Rajpara SM, 2005, BRIT J DERMATOL, V152, P816, DOI 10.1111/j.1365-2133.2005.06489.x; Rasband W., 2006, IMAGEJ; Sabala Pawel, 1993, Acta Biochimica Polonica, V40, P309; SHEU HM, 1989, EXP CELL RES, V185, P176, DOI 10.1016/0014-4827(89)90047-5; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; Stokes DL, 2007, CURR OPIN CELL BIOL, V19, P565, DOI 10.1016/j.ceb.2007.09.003; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Usachev YM, 2006, J NEUROSCI, V26, P311, DOI 10.1523/JNEUROSCI.2920-05.2006; VANDERZWAAG P, 2010, ARVC DATABASE; Wallis S, 2000, MOL BIOL CELL, V11, P1077, DOI 10.1091/mbc.11.3.1077; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	55	45	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					990	1001		10.1096/fj.10-163261	http://dx.doi.org/10.1096/fj.10-163261			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21156808	Green Published, Bronze			2022-12-25	WOS:000287806200019
J	Higashi, Y; Kutchan, TM; Smith, TJ				Higashi, Yasuhiro; Kutchan, Toni M.; Smith, Thomas J.			Atomic Structure of Salutaridine Reductase from the Opium Poppy (Papaver somniferum)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE GLUTAMATE-DEHYDROGENASE; CARBONYL REDUCTASE; COMPLEXES; PURIFICATION	The opium poppy (Papaver somniferum L.) is one of the oldest known medicinal plants. In the biosynthetic pathway for morphine and codeine, salutaridine is reduced to salutaridinol by salutaridine reductase (SalR; EC 1.1.1.248) using NADPH as coenzyme. Here, we report the atomic structure of SalR to a resolution of similar to 1.9 angstrom in the presence of NADPH. The core structure is highly homologous to other members of the short chain dehydrogenase/reductase family. The major difference is that the nicotinamide moiety and the substrate-binding pocket are covered by a loop (residues 265-279), on top of which lies a large "flap"-like domain (residues 105-140). This configuration appears to be a combination of the two common structural themes found in other members of the short chain dehydrogenase/reductase family. Previous modeling studies suggested that substrate inhibition is due to mutually exclusive productive and nonproductive modes of substrate binding in the active site. This model was tested via site-directed mutagenesis, and a number of these mutations abrogated substrate inhibition. However, the atomic structure of SalR shows that these mutated residues are instead distributed over a wide area of the enzyme, and many are not in the active site. To explain how residues distal to the active site might affect catalysis, a model is presented whereby SalR may undergo significant conformational changes during catalytic turnover.	[Higashi, Yasuhiro; Kutchan, Toni M.; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Higashi, Yasuhiro/C-9726-2017; Smith, Thomas J/K-9086-2013; Kutchan, Toni/L-4625-2013	Higashi, Yasuhiro/0000-0003-0784-7960; Smith, Thomas J/0000-0003-3528-6793; 	Donald Danforth Plant Science Center; Mallinckrodt Foundation, St. Louis; Uehara Memorial Foundation	Donald Danforth Plant Science Center; Mallinckrodt Foundation, St. Louis; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by start-up funds from the Donald Danforth Plant Science Center (to T. J. S.), by the Mallinckrodt Foundation, St. Louis (to T. M. K.), and by a Uehara Memorial Foundation postdoctoral fellowship (to Y. H.).	Afonine PV, 2005, CCP4 NEWSL, V42; BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; BARTON DHR, 1965, J CHEM SOC, P2423, DOI 10.1039/jr9650002423; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Higashi Y, 2010, ACTA CRYSTALLOGR F, V66, P163, DOI 10.1107/S174430910904932X; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kempe K, 2009, PHYTOCHEMISTRY, V70, P579, DOI 10.1016/j.phytochem.2009.03.002; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOTTER H, 1992, TETRAHEDRON LETT, V33, P2443, DOI 10.1016/S0040-4039(00)92210-X; MacKenzie AK, 2007, BIOCHEMISTRY-US, V46, P1523, DOI 10.1021/bi061978x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	35	12	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6532	6541		10.1074/jbc.M110.168633	http://dx.doi.org/10.1074/jbc.M110.168633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169353	Green Published, hybrid			2022-12-25	WOS:000287476400063
J	Jiang, H; Wang, HM; Tan, ZH; Hu, SW; Wang, H; Shi, BZ; Yang, L; Li, PY; Gu, JR; Wang, HY; Li, ZH				Jiang, Hua; Wang, Huamao; Tan, Zhonghua; Hu, Suwen; Wang, Hai; Shi, Bizhi; Yang, Lin; Li, Peiyong; Gu, Jianren; Wang, Hongyang; Li, Zonghai			Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFERS ENHANCED TUMORIGENICITY; FACTOR-ALPHA; BCL-XL; CANCER; EXPRESSION; EGFR; THERAPY; LIVER; OVEREXPRESSION; AMPLIFICATION	Human hepatocellular carcinoma (HCC) is considered difficult to cure because it is resistant to radio-and chemotherapy and has a high recurrence rate after curative liver resection. Epidermal growth factor receptor variant III (EGFRvIII) has been reported to express in HCC tissues and cell lines. This article describes the efficacy of an anti-EGFRvIII monoclonal antibody (mAb CH12) in the treatment of HCC xenografts with EGFRvIII expression and the underlying mechanism of EGFRvIII as an oncogene in HCC. The results demonstrated that CH12 bound preferentially to EGFRvIII with a dissociation constant (K-d) of 1.346 nm/liter. In addition, CH12 induces strong antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in Huh7-EGFRvIII (with exogenous expression of EGFRvIII) and SMMC-7721 (with endogenous expression of EGFRvIII) cells. Notably, CH12 significantly inhibited the growth of Huh7-EGFRvIII and SMMC-7721 xenografts in vivo with a growth inhibition ratio much higher than C225, a U.S. Food and Drug Administration-approved anti-EGFR antibody. Treatment of the two HCC xenografts with CH12 significantly suppressed tumor proliferation and angiogenesis. Mechanistically, in vivo treatment with CH12 reduced the phosphorylation of constitutively active EGFRvIII, Akt, and ERK. Down-regulation of the apoptotic protectors Bcl-x(L), Bcl-2, and the cell cycle regulator cyclin D1, as well as up-regulation of the cell-cycle inhibitor p27, were also observed after in vivo CH12 treatment. Collectively, these results indicate that the monoclonal antibody CH12 is a promising therapeutic agent for HCC with EGFRvIII expression.	[Jiang, Hua; Wang, Huamao; Hu, Suwen; Wang, Hai; Shi, Bizhi; Yang, Lin; Gu, Jianren; Wang, Hongyang; Li, Zonghai] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China; [Wang, Huamao] Zhejiang Acad Med Sci, Inst Bioengn, Hangzhou 310013, Zhejiang, Peoples R China; [Tan, Zhonghua; Li, Peiyong] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China; [Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China	Shanghai Jiao Tong University; Zhejiang Academy of Medical Sciences; Shanghai Jiao Tong University; Naval Medical University	Wang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, 25 Ln 2200,Xie Tu Rd, Shanghai 200032, Peoples R China.	Zonghaili@shsmu.edu.cn			"Eleventh Five-year Plan" for Science & Technology Research of China [2008ZX10002-024, 2009ZX09103-701]; National Basic Research Program [2010CB529902]; National High Technology Research and Development Program of China [2007AA021203]; State Key Laboratory of Oncogenes and Related Genes [91-09-05]; National Natural Science Foundation [30901820]; Foundation of Institutions of Higher Education of China [20090073120109]	"Eleventh Five-year Plan" for Science & Technology Research of China; National Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Laboratory of Oncogenes and Related Genes; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation of Institutions of Higher Education of China	This work was supported by a supporting program of the "Eleventh Five-year Plan" for Science & Technology Research of China (Grant 2008ZX10002-024 and 2009ZX09103-701), the National Basic Research Program (Grant 2010CB529902), the National High Technology Research and Development Program of China (Grant 2007AA021203), the research fund of the State Key Laboratory of Oncogenes and Related Genes (Grant 91-09-05), the National Natural Science Foundation (Grant 30901820), and the doctoral program of the Foundation of Institutions of Higher Education of China (Grant 20090073120109).	Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Daveau M, 2003, MOL CARCINOGEN, V36, P130, DOI 10.1002/mc.10103; DeCicco LA, 1997, CANCER LETT, V111, P149, DOI 10.1016/S0304-3835(96)04524-7; Faloppi L, 2011, CANCER TREAT REV, V37, P169, DOI 10.1016/j.ctrv.2010.08.001; Fiorentino M, 2000, CLIN CANCER RES, V6, P3966; Gainet M, 2003, Cancer Radiother, V7, P195, DOI 10.1016/S1278-3218(03)00019-2; Harari PM, 2004, ENDOCR-RELAT CANCER, V11, P689, DOI 10.1677/erc.1.00600; Hopfner M., 2004, J HEPATOL, V41, P1008; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Kira S, 1997, LIVER, V17, P177; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Luwor RB, 2001, CANCER RES, V61, P5355; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Moser GJ, 1997, TOXICOL PATHOL, V25, P275, DOI 10.1177/019262339702500305; Nagane M, 1996, CANCER RES, V56, P5079; NISHIDA N, 1994, CANCER RES, V54, P3107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Nygren P, 2005, ACTA ONCOL, V44, P203, DOI 10.1080/02841860510029798; Okamoto I, 2003, CANCER SCI, V94, P50, DOI 10.1111/j.1349-7006.2003.tb01351.x; Ou Chao, 2005, Ai Zheng, V24, P166; Panousis C, 2005, BRIT J CANCER, V92, P1069, DOI 10.1038/sj.bjc.6602470; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Wang HM, 2009, CANCER LETT, V279, P30, DOI 10.1016/j.canlet.2009.01.019; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Worns MA, 2009, J CLIN GASTROENTEROL, V43, P489, DOI 10.1097/MCG.0b013e31818ddfc6; Yang L, 2010, CANCER IMMUNOL IMMUN, V59, P1481, DOI 10.1007/s00262-010-0872-7; Yu XT, 2007, J CANCER RES CLIN, V133, P145, DOI 10.1007/s00432-006-0139-z; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350; Zhao Yin-Nong, 2004, Ai Zheng, V23, P762; Zhou M, 2010, LIVER INT, V30, P925, DOI 10.1111/j.1478-3231.2010.02233.x; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	40	39	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5913	5920		10.1074/jbc.M110.192252	http://dx.doi.org/10.1074/jbc.M110.192252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163950	hybrid, Green Published			2022-12-25	WOS:000287230600100
J	Kramer, LB; Shim, J; Previtera, ML; Isack, NR; Lee, MC; Firestein, BL; Rongo, C				Kramer, Lawrence B.; Shim, Jaegal; Previtera, Michelle L.; Isack, Nora R.; Lee, Ming-Chih; Firestein, Bonnie L.; Rongo, Christopher			UEV-1 Is an Ubiquitin-Conjugating Enzyme Variant That Regulates Glutamate Receptor Trafficking in C. elegans Neurons	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; VENTRAL NERVE CORD; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; POLYUBIQUITIN CHAINS; SYNAPTIC PLASTICITY; CRYSTAL-STRUCTURE; ENDOCYTOSIS; COMPLEX; BINDING	The regulation of AMPA-type glutamate receptor (AMPAR) membrane trafficking is a key mechanism by which neurons regulate synaptic strength and plasticity. AMPAR trafficking is modulated through a combination of receptor phosphorylation, ubiquitination, endocytosis, and recycling, yet the factors that mediate these processes are just beginning to be uncovered. Here we identify the ubiquitin-conjugating enzyme variant UEV-1 as a regulator of AMPAR trafficking in vivo. We identified mutations in uev-1 in a genetic screen for mutants with altered trafficking of the AMPAR subunit GLR-1 in C. elegans interneurons. Loss of uev-1 activity results in the accumulation of GLR-1 in elongated accretions in neuron cell bodies and along the ventral cord neurites. Mutants also have a corresponding behavioral defect-a decrease in spontaneous reversals in locomotion-consistent with diminished GLR-1 function. The localization of other synaptic proteins in uev-1-mutant interneurons appears normal, indicating that the GLR-1 trafficking defects are not due to gross deficiencies in synapse formation or overall protein trafficking. We provide evidence that GLR-1 accumulates at RAB-10-containing endosomes in uev-1 mutants, and that receptors arrive at these endosomes independent of clathrin-mediated endocytosis. UEV-1 homologs in other species bind to the ubiquitin-conjugating enzyme Ubc13 to create K63-linked polyubiquitin chains on substrate proteins. We find that whereas UEV-1 can interact with C. elegans UBC-13, global levels of K63-linked ubiquitination throughout nematodes appear to be unaffected in uev-1 mutants, even though UEV-1 is broadly expressed in most tissues. Nevertheless, ubc-13 mutants are similar in phenotype to uev-1 mutants, suggesting that the two proteins do work together to regulate GLR-1 trafficking. Our results suggest that UEV-1 could regulate a small subset of K63-linked ubiquitination events in nematodes, at least one of which is critical in regulating GLR-1 trafficking.	[Kramer, Lawrence B.; Isack, Nora R.; Lee, Ming-Chih; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA; [Shim, Jaegal] Natl Canc Ctr, Canc Expt Resources Branch, Goyang, South Korea; [Previtera, Michelle L.; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Kramer, Lawrence B.; Previtera, Michelle L.] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ USA	Rutgers State University New Brunswick; National Cancer Center - Korea (NCC); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kramer, LB (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA.	rongo@waksman.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565	National Institutes of Health [R01 NS42023]; National Science Foundation [IBN-0548543, DGE-0333196]; IGERT; Louis Bevier Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); IGERT(National Science Foundation (NSF)); Louis Bevier Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The manuscript was funded by a grant from the National Institutes of Health (R01 NS42023) to CGR and a grant from the National Science Foundation (IBN-0548543) to BLF. MLP was supported by the IGERT Program on Biointerfaces, by National Science Foundation grant DGE-0333196, and by a Louis Bevier Dissertation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Boelens J, 2007, IN VIVO, V21, P215; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Feldman M, 2009, TRENDS CELL BIOL, V19, P357, DOI 10.1016/j.tcb.2009.05.005; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Govindan JA, 2006, CURR BIOL, V16, P1257, DOI 10.1016/j.cub.2006.05.020; Grunwald ME, 2004, P NATL ACAD SCI USA, V101, P3190, DOI 10.1073/pnas.0306156101; Gudgen M, 2004, BIOCHEM BIOPH RES CO, V325, P479, DOI 10.1016/j.bbrc.2004.10.047; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hoseki J, J BIOCH, V147, P19; Howard RA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-32; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Jones D, 2001, GENOME BIOL, V3; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Lauwers E, 2010, TRENDS CELL BIOL; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malerod L, 2007, CURR BIOL, V17, pR42, DOI 10.1016/j.cub.2006.12.009; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rumpel S, 2005, POSTSYNAPTIC RECEPTO; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Tan JM, 2007, HUM MOL GENET; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Thomson TM, 1998, FEBS LETT, V423, P49, DOI 10.1016/S0014-5793(98)00060-X; Trujillo G, 2010, GENETICS, V186, P135, DOI 10.1534/genetics.110.117341; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Umemura T, 2005, J CELL SCI, V118, P3327, DOI 10.1242/jcs.02457; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Villalobo E, 2002, MOL BIOL EVOL, V19, P39, DOI 10.1093/oxfordjournals.molbev.a003980; Wen R, 2008, PLANT CELL; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	100	19	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14291	10.1371/journal.pone.0014291	http://dx.doi.org/10.1371/journal.pone.0014291			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179194	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900005
J	Dai, RJ; Zhang, Y; Khan, D; Heid, B; Caudell, D; Crasta, O; Ahmed, SA				Dai, Rujuan; Zhang, Yan; Khan, Deena; Heid, Bettina; Caudell, David; Crasta, Oswald; Ahmed, S. Ansar			Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; RHEUMATOID-ARTHRITIS; SIGNALING PROTEINS; INTERFERON-GAMMA; CELL-DEVELOPMENT; IMMUNE-SYSTEM; NITRIC-OXIDE; PLASMA-CELLS; AUTOIMMUNITY	Background: Recent reports have shown that microRNAs (miRNAs) regulate vital immunological processes and have emerged as key regulators of immune system development and function. Therefore, it is important to determine miRNA dysregulation and its pathogenic contribution in autoimmune diseases, an aspect not adequately addressed thus far. Methodology/Principal Findings: In this study, we profiled miRNA expressions in splenic lymphocytes from three murine lupus models (MRL-lpr, B6-lpr and NZB/W-F1) with different genetic background by miRNA microarray assays and Real-time RT-PCR. Despite the genetic differences among these three lupus stains, a common set of dysregulated miRNAs (miR-182-96-183 cluster, miR-31, and miR-155) was identified in splenocytes when compared with age-matched control mice. The association of these miRNAs with the disease was highlighted by our observation that this miRNA expression pattern was evident in NZB/W mice only at an age when lupus disease is manifested. Further, we have shown that the miRNA dysregulation in MRL-lpr mice was not simply due to the activation of splenocytes. By Real-time RT-PCR, we confirmed that these miRNAs were upregulated in both purified splenic B and T cells from MRL-lpr mice. miR-127 and miR-379, which were greatly upregulated in splenocytes from lpr mice, were moderately increased in diseased NZB/W mice. In addition, Real-time RT-PCR revealed that miR-146a, miR-101a, and miR-17-92 were also markedly upregulated in splenic T, but not B cells from MRL-lpr mice. Conclusions/Significance: The identification of common lupus disease-associated miRNAs now forms the basis for the further investigation of the pathogenic contribution of these miRNAs in autoimmune lupus, which will advance our knowledge of the role of miRNAs in autoimmunity. Given that miRNAs are conserved, with regard to both evolution and function, our observation of a common lupus disease-associated miRNA expression pattern in murine lupus models is likely to have significant pathogenic, diagnostic, and/or therapeutic implications in human lupus.	[Dai, Rujuan; Khan, Deena; Heid, Bettina; Caudell, David; Ahmed, S. Ansar] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, CMMID, Blacksburg, VA 24061 USA; [Zhang, Yan; Crasta, Oswald] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Dai, RJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, CMMID, Blacksburg, VA 24061 USA.	rdai05@vt.edu; ansrahmd@vt.edu	zhang, yan/AAG-7349-2019	zhang, yan/0000-0003-0906-9410	Lupus Foundation of America [208-11-110B-033-918-1]; Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) [IRC 17385]; National Institutes of Health [1 RO1 AI051880]; NIAID, NIH [HHSN272200900040C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051880] Funding Source: NIH RePORTER	Lupus Foundation of America; Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Lupus Foundation of America Novel Pilot Project (208-11-110B-033-918-1), Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) Intramural Research Competition Grant (IRC 17385), and in part by National Institutes of Health (1 RO1 AI051880). YZ and OC were supported by NIAID, NIH award under contract No. HHSN272200900040C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; DAI Y, 2008, RHEUMATOL INT; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Jonsson MV, 2007, CLIN REV ALLERG IMMU, V32, P215, DOI 10.1007/s12016-007-8012-7; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Kono DH, 2006, SPRINGER SEMIN IMMUN, V28, P83, DOI 10.1007/s00281-006-0030-7; Koopman W J, 1988, Scand J Rheumatol Suppl, V75, P284; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Liu K, 2006, CLIN IMMUNOL, V119, P123, DOI 10.1016/j.clim.2006.01.014; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pan Q, 2010, MOL HUM REPROD, V16, P215, DOI 10.1093/molehr/gap093; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Reilly CM, 2006, EUR J IMMUNOL, V36, P1296, DOI 10.1002/eji.200535245; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang Y, 1997, AM J PATHOL, V151, P1791; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	49	122	131	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14302	10.1371/journal.pone.0014302	http://dx.doi.org/10.1371/journal.pone.0014302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170274	gold, Green Published, Green Submitted			2022-12-25	WOS:000285181400015
J	Bonetti, C; Surace, EM				Bonetti, Ciro; Surace, Enrico Maria			Mouse Embryonic Retina Delivers Information Controlling Cortical Neurogenesis	PLOS ONE			English	Article							RAT VISUAL-CORTEX; TOPOGRAPHIC MAPS; SPINDLE BURSTS; WAVES; CELLS; SPECIFICATION; AREAS; MICE	The relative contribution of extrinsic and intrinsic mechanisms to cortical development is an intensely debated issue and an outstanding question in neurobiology. Currently, the emerging view is that interplay between intrinsic genetic mechanisms and extrinsic information shape different stages of cortical development [1]. Yet, whereas the intrinsic program of early neocortical developmental events has been at least in part decoded [2], the exact nature and impact of extrinsic signaling are still elusive and controversial. We found that in the mouse developing visual system, acute pharmacological inhibition of spontaneous retinal activity (retinal waves-RWs) during embryonic stages increase the rate of corticogenesis (cell cycle withdrawal). Furthermore, early perturbation of retinal spontaneous activity leads to changes of cortical layer structure at a later time point. These data suggest that mouse embryonic retina delivers long-distance information capable of modulating cell genesis in the developing visual cortex and that spontaneous activity is the candidate long-distance acting extrinsic cue mediating this process. In addition, these data may support spontaneous activity to be a general signal coordinating neurogenesis in other developing sensory pathways or areas of the central nervous system.	[Bonetti, Ciro; Surace, Enrico Maria] Telethon Inst Genet & Med TIGEM, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Bonetti, C (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.	surace@tigem.it		Surace, Enrico Maria/0000-0002-2975-942X	Telethon [TIGEM-P21]; National Eye Institute, National Institute of Health (NEI) [R01EY015136-01]; NATIONAL EYE INSTITUTE [R01EY015136] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); National Eye Institute, National Institute of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants from Telethon (TIGEM-P21) and R01EY015136-01 from the National Eye Institute, National Institute of Health (NEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Bansal A, 2000, J NEUROSCI, V20, P7672; BLANKENSHIP AG, NAT REV NEUROSCI, V11, P18; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clandinin TR, 2009, CURR OPIN NEUROBIOL, V19, P174, DOI 10.1016/j.conb.2009.04.011; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Hanganu IL, 2007, J NEUROSCI, V27, P5694, DOI 10.1523/JNEUROSCI.5233-06.2007; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Polleux F, 1997, J COMP NEUROL, V385, P95; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Surace EM, 2003, J VIROL, V77, P7957, DOI 10.1128/JVI.77.14.7957-7963.2003; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015	29	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15211	10.1371/journal.pone.0015211	http://dx.doi.org/10.1371/journal.pone.0015211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170332	gold, Green Submitted, Green Published			2022-12-25	WOS:000285084100030
J	Diegelmann, J; Beigel, F; Zitzmann, K; Kaul, A; Goke, B; Auernhammer, CJ; Bartenschlager, R; Diepolder, HM; Brand, S				Diegelmann, Julia; Beigel, Florian; Zitzmann, Kathrin; Kaul, Artur; Goeke, Burkhard; Auernhammer, Christoph J.; Bartenschlager, Ralf; Diepolder, Helmut M.; Brand, Stephan			Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus	PLOS ONE			English	Article							IFN-LAMBDA; GENE-EXPRESSION; III IFN; PROTEIN; ALPHA; INTERLEUKIN-29; HEPATOCYTES; RECOGNITION; FRACTALKINE; PROTECTION	Background: Specific differences in signaling and antiviral properties between the different Lambda-interferons, a novel group of interferons composed of IL-28A, IL-28B and IL-29, are currently unknown. This is the first study comparatively investigating the transcriptome and the antiviral properties of the Lambda-interferons IL-28A and IL-29. Methodology/Principal Findings: Expression studies were performed by microarray analysis, quantitative PCR (qPCR), reporter gene assays and immunoluminometric assays. Signaling was analyzed by Western blot. HCV replication was measured in Huh-7 cells expressing subgenomic HCV replicon. All hepatic cell lines investigated as well as primary hepatocytes expressed both IFN-lambda receptor subunits IL-10R2 and IFN-lambda R1. Both, IL-28A and IL-29 activated STAT1 signaling. As revealed by microarray analysis, similar genes were induced by both cytokines in Huh-7 cells (IL-28A: 117 genes; IL-29: 111 genes), many of them playing a role in antiviral immunity. However, only IL-28A was able to significantly down-regulate gene expression (n = 272 down-regulated genes). Both cytokines significantly decreased HCV replication in Huh-7 cells. In comparison to liver biopsies of patients with non-viral liver disease, liver biopsies of patients with HCV showed significantly increased mRNA expression of IL-28A and IL-29. Moreover, IL-28A serum protein levels were elevated in HCV patients. In a murine model of viral hepatitis, IL-28 expression was significantly increased. Conclusions/Significance: IL-28A and IL-29 are up-regulated in HCV patients and are similarly effective in inducing antiviral genes and inhibiting HCV replication. In contrast to IL-29, IL-28A is a potent gene repressor. Both IFN-lambda s may have therapeutic potential in the treatment of chronic HCV.	[Diegelmann, Julia; Beigel, Florian; Zitzmann, Kathrin; Goeke, Burkhard; Auernhammer, Christoph J.; Diepolder, Helmut M.; Brand, Stephan] Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany; [Kaul, Artur; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, Heidelberg, Germany	University of Munich; Ruprecht Karls University Heidelberg	Diegelmann, J (corresponding author), Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Zitzmann, Kathrin/AAF-6898-2020; Bartenschlager, Ralf/L-2582-2015	Bartenschlager, Ralf/0000-0001-5601-9307	Else Kroner-Fresenius-Stiftung [P50/05/EKMS05/62]; Deutsche Forschungsgemeinschaft (DFG) [BR 1912/5-1]; DCCV; Ludwig-Maximilians-University Munich; Ministry for Research and Education [01 KI 1008A]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DCCV; Ludwig-Maximilians-University Munich; Ministry for Research and Education	S. Brand was supported by grants from the Else Kroner-Fresenius-Stiftung (Else Kroner Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), the Deutsche Forschungsgemeinschaft (DFG, BR 1912/5-1), by the Ludwig-Demling Grant 2007 from DCCV e. V., and by grants from the Ludwig-Maximilians-University Munich (Excellence Initiative - Investment Fund 2008 and FoFoLe program 2007 and 2008). F. Beigel was supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe program 2008). Ralf Bartenschlager was supported by a grant of the Ministry for Research and Education (01 KI 1008A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Auernhammer CJ, 2003, ENDOCRINOLOGY, V144, P1202, DOI 10.1210/en.2002-220933; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berghall H, 2006, MICROBES INFECT, V8, P2138, DOI 10.1016/j.micinf.2006.04.005; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Almeida GMD, 2008, ANTIVIR RES, V80, P302, DOI 10.1016/j.antiviral.2008.06.016; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; HENSON D, 1966, AM J PATHOL, V49, P871; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; THOMAS DL, 2009, NATURE; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	55	70	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15200	10.1371/journal.pone.0015200	http://dx.doi.org/10.1371/journal.pone.0015200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170333	Green Published, Green Submitted, gold			2022-12-25	WOS:000285084100028
J	Oshiumi, H; Ikeda, M; Matsumoto, M; Watanabe, A; Takeuchi, O; Akira, S; Kato, N; Shimotohno, K; Seya, T				Oshiumi, Hiroyuki; Ikeda, Masanori; Matsumoto, Misako; Watanabe, Ayako; Takeuchi, Osamu; Akira, Shizuo; Kato, Nobuyuki; Shimotohno, Kunitada; Seya, Tsukasa			Hepatitis C Virus Core Protein Abrogates the DDX3 Function That Enhances IPS-1-Mediated IFN-Beta Induction	PLOS ONE			English	Article							BOX RNA HELICASE; ANTIVIRAL SIGNALING PROTEIN; TOLL-LIKE RECEPTOR-3; RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; PATHWAY; REPLICATION; REQUIREMENT; CELLS	The DEAD box helicase DDX3 assembles IPS-1 (also called Cardif, MAVS, or VISA) in non-infected human cells where minimal amounts of the RIG-I-like receptor (RLR) protein are expressed. DDX3 C-terminal regions directly bind the IPS-1 CARD-like domain as well as the N-terminal hepatitis C virus (HCV) core protein. DDX3 physically binds viral RNA to form IPS-1-containing spots, that are visible by confocal microscopy. HCV polyU/UC induced IPS-1-mediated interferon (IFN)-beta promoter activation, which was augmented by co-transfected DDX3. DDX3 spots localized near the lipid droplets (LDs) where HCV particles were generated. Here, we report that HCV core protein interferes with DDX3-enhanced IPS-1 signaling in HEK293 cells and in hepatocyte Oc cells. Unlike the DEAD box helicases RIG-I and MDA5, DDX3 was constitutively expressed and colocalized with IPS-1 around mitochondria. In hepatocytes (O cells) with the HCV replicon, however, DDX3/IPS-1-enhanced IFN-beta-induction was largely abrogated even when DDX3 was co-expressed. DDX3 spots barely merged with IPS-1, and partly assembled in the HCV core protein located near the LD in O cells, though in some O cells IPS-1 was diminished or disseminated apart from mitochondria. Expression of DDX3 in replicon-negative or core-less replicon-positive cells failed to cause complex formation or LD association. HCV core protein and DDX3 partially colocalized only in replicon-expressing cells. Since the HCV core protein has been reported to promote HCV replication through binding to DDX3, the core protein appears to switch DDX3 from an IFN-inducing mode to an HCV-replication mode. The results enable us to conclude that HCV infection is promoted by modulating the dual function of DDX3.	[Oshiumi, Hiroyuki; Matsumoto, Misako; Watanabe, Ayako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama, Japan; [Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 565, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Hokkaido University; Okayama University; Osaka University; Chiba Institute of Technology	Oshiumi, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Oshiumi, Hiroyuki/G-1645-2012; Akira, Shizuo/C-3134-2009; IKEDA, Masanori/B-2279-2011; Takeuchi, Osamu/AAG-9359-2019; Seya, Tsukasa/A-4336-2012; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Oshiumi, Hiroyuki/0000-0003-1567-8722	Founding Research Centers for Emerging and Reemerging Infectious Diseases; MEXT; Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the MEXT; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Mochida Foundation; Yakult Foundation; NorthTec Foundation; Waxman Foundation	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mochida Foundation; Yakult Foundation; NorthTec Foundation; Waxman Foundation	This work was supported in part by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Sapporo Biocluster "Bio-S", the Knowledge Cluster Initiative of the MEXT, Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, Mochida Foundation, Yakult Foundation, NorthTec Foundation and Waxman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mulhern O, 2010, EUR J IMMUNOL, V40, P933, DOI 10.1002/eji.201040447; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	47	59	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14258	10.1371/journal.pone.0014258	http://dx.doi.org/10.1371/journal.pone.0014258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170385	Green Published, gold			2022-12-25	WOS:000285084100012
J	Gold, L; Ayers, D; Bertino, J; Bock, C; Bock, A; Brody, EN; Carter, J; Dalby, AB; Eaton, BE; Fitzwater, T; Flather, D; Forbes, A; Foreman, T; Fowler, C; Gawande, B; Goss, M; Gunn, M; Gupta, S; Halladay, D; Heil, J; Heilig, J; Hicke, B; Husar, G; Janjic, J; Jarvis, T; Jennings, S; Katilius, E; Keeney, TR; Kim, N; Koch, TH; Kraemer, S; Kroiss, L; Le, N; Levine, D; Lindsey, W; Lollo, B; Mayfield, W; Mehan, M; Mehler, R; Nelson, SK; Nelson, M; Nieuwlandt, D; Nikrad, M; Ochsner, U; Ostroff, RM; Otis, M; Parker, T; Pietrasiewicz, S; Resnicow, DI; Rohloff, J; Sanders, G; Sattin, S; Schneider, D; Singer, B; Stanton, M; Sterkel, A; Stewart, A; Stratford, S; Vaught, JD; Vrkljan, M; Walker, JJ; Watrobka, M; Waugh, S; Weiss, A; Wilcox, SK; Wolfson, A; Wolk, SK; Zhang, C; Zichi, D				Gold, Larry; Ayers, Deborah; Bertino, Jennifer; Bock, Christopher; Bock, Ashley; Brody, Edward N.; Carter, Jeff; Dalby, Andrew B.; Eaton, Bruce E.; Fitzwater, Tim; Flather, Dylan; Forbes, Ashley; Foreman, Trudi; Fowler, Cate; Gawande, Bharat; Goss, Meredith; Gunn, Magda; Gupta, Shashi; Halladay, Dennis; Heil, Jim; Heilig, Joe; Hicke, Brian; Husar, Gregory; Janjic, Nebojsa; Jarvis, Thale; Jennings, Susan; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Koch, Tad H.; Kraemer, Stephan; Kroiss, Luke; Le, Ngan; Levine, Daniel; Lindsey, Wes; Lollo, Bridget; Mayfield, Wes; Mehan, Mike; Mehler, Robert; Nelson, Sally K.; Nelson, Michele; Nieuwlandt, Dan; Nikrad, Malti; Ochsner, Urs; Ostroff, Rachel M.; Otis, Matt; Parker, Thomas; Pietrasiewicz, Steve; Resnicow, Daniel I.; Rohloff, John; Sanders, Glenn; Sattin, Sarah; Schneider, Daniel; Singer, Britta; Stanton, Martin; Sterkel, Alana; Stewart, Alex; Stratford, Suzanne; Vaught, Jonathan D.; Vrkljan, Mike; Walker, Jeffrey J.; Watrobka, Mike; Waugh, Sheela; Weiss, Allison; Wilcox, Sheri K.; Wolfson, Alexey; Wolk, Steven K.; Zhang, Chi; Zichi, Dom			Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery	PLOS ONE			English	Article							IN-VITRO SELECTION; SYSTEMATIC EVOLUTION; STATISTICAL-MODEL; KIDNEY-FUNCTION; RNA LIGANDS; PROTEINS; OLIGONUCLEOTIDES; DIAGNOSTICS; PEGAPTANIB; BINDING	Background The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. Methodology/Principal Findings We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 mu L of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (similar to 100 fM-1 mu M), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. Conclusions/Significance We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.	[Gold, Larry; Ayers, Deborah; Bertino, Jennifer; Bock, Christopher; Bock, Ashley; Brody, Edward N.; Carter, Jeff; Dalby, Andrew B.; Fitzwater, Tim; Flather, Dylan; Forbes, Ashley; Foreman, Trudi; Fowler, Cate; Gawande, Bharat; Goss, Meredith; Gunn, Magda; Gupta, Shashi; Halladay, Dennis; Heil, Jim; Heilig, Joe; Hicke, Brian; Husar, Gregory; Janjic, Nebojsa; Jarvis, Thale; Jennings, Susan; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Kraemer, Stephan; Kroiss, Luke; Le, Ngan; Lindsey, Wes; Lollo, Bridget; Mayfield, Wes; Mehan, Mike; Mehler, Robert; Nelson, Sally K.; Nelson, Michele; Nieuwlandt, Dan; Nikrad, Malti; Ochsner, Urs; Ostroff, Rachel M.; Otis, Matt; Pietrasiewicz, Steve; Resnicow, Daniel I.; Rohloff, John; Sanders, Glenn; Sattin, Sarah; Schneider, Daniel; Singer, Britta; Stanton, Martin; Sterkel, Alana; Stewart, Alex; Stratford, Suzanne; Vaught, Jonathan D.; Vrkljan, Mike; Walker, Jeffrey J.; Watrobka, Mike; Waugh, Sheela; Weiss, Allison; Wilcox, Sheri K.; Wolfson, Alexey; Wolk, Steven K.; Zhang, Chi; Zichi, Dom] SomaLogic, Boulder, CO USA; [Gold, Larry] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Levine, Daniel; Parker, Thomas] Cornell Univ, Rogosin Inst, New York, NY USA; [Levine, Daniel; Parker, Thomas] Cornell Univ, Weill Med Coll, New York, NY USA; [Eaton, Bruce E.; Koch, Tad H.] Univ Colorado, Dept Chem & Biochem, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder	Gold, L (corresponding author), SomaLogic, Boulder, CO USA.	lgold@somalogic.com; jwalker@somalogic.com		Flather, Dylan Paul/0000-0003-3268-5385	SomaLogic	SomaLogic	This work was funded by SomaLogic. SomaLogic had no role in the original prospective CKD study. SomaLogic, with input from D.L. and T.P., designed the retrospective CKD study with archived samples, collected and analyzed the data, decided to publish, and prepared the manuscript. The National Institutes of Health (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	20090004667 US, 2009, ZICHI D; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/NMETH.F.255, 10.1038/nmeth.f.255]; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Borrebaeck CAK, 2007, EXPERT REV MOL DIAGN, V7, P673, DOI 10.1586/14737159.7.5.673; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chaudhary K, 2010, CURR DIABETES REP, V10, P37, DOI 10.1007/s11892-009-0080-z; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; DEWEY TM, 1995, J AM CHEM SOC, V117, P8474, DOI 10.1021/ja00137a027; Doggrell SA, 2005, EXPERT OPIN PHARMACO, V6, P1421, DOI 10.1517/14656566.6.8.1421; Eaton BE, 1997, CURR OPIN CHEM BIOL, V1, P10, DOI 10.1016/S1367-5931(97)80103-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Giannelli SV, 2007, J AM GERIATR SOC, V55, P816, DOI 10.1111/j.1532-5415.2007.01196.x; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gugliotti LA, 2004, SCIENCE, V304, P850, DOI 10.1126/science.1095678; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liotta L. A., 2010, CLIN PROTEOM, V6, P4, DOI [10.1007/s12014-010-9045-0, DOI 10.1007/S12014-010-9045-0]; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; PASCUAL M, 1988, KIDNEY INT, V34, P529, DOI 10.1038/ki.1988.214; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Schneider D, 2009, Multiplexed analyses of test samples, Patent No. [US2009/0042206, 20090042206]; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Service RF, 2008, SCIENCE, V321, P1758, DOI [10.1126/science.321.5897.1758, 10.1126/science.321.5897.1760]; Silberring J, 2010, TRAC-TREND ANAL CHEM, V29, P128, DOI 10.1016/j.trac.2009.11.007; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tarasow TM, 1997, NATURE, V389, P54, DOI 10.1038/37950; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Riemsdijk-van Overbeeke IC, 2000, CLIN NEPHROL, V53, P115; Vanholder R, 2008, J NEPHROL, V21, P146; Vaught JD, 2004, J AM CHEM SOC, V126, P11231, DOI 10.1021/ja049009h; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	46	865	932	3	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15004	10.1371/journal.pone.0015004	http://dx.doi.org/10.1371/journal.pone.0015004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21165148	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800017
J	Volkow, ND; Fowler, JS; Wang, GJ; Shumay, E; Telang, F; Thanos, PK; Alexoff, D				Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Shumay, Elena; Telang, Frank; Thanos, Peter K.; Alexoff, David			Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications	PLOS ONE			English	Article							AMPHETAMINE; PET; DOPAMINE; SMOKING; COCAINE; BINDING; MICE	Background: Methamphetamine is one of the most toxic of the drugs of abuse, which may reflect its distribution and accumulation in the body. However no studies have measured methamphetamine's organ distribution in the human body. Methods: Positron Emission Tomography (PET) was used in conjunction with [(11)C]d-methamphetamine to measure its whole-body distribution and bioavailability as assessed by peak uptake (% Dose/cc), rate of clearance (time to reach 50% peak-clearance) and accumulation (area under the curve) in healthy participants (9 Caucasians and 10 African Americans). Results: Methamphetamine distributed through most organs. Highest uptake (whole organ) occurred in lungs (22% Dose; weight similar to 1246 g), liver (23%; weight similar to 1677 g) and intermediate in brain (10%; weight similar to 1600 g). Kidneys also showed high uptake (per/cc basis) (7%; weight 305 g). Methamphetamine's clearance was fastest in heart and lungs (7-16 minutes), slowest in brain, liver and stomach (>75 minutes), and intermediate in kidneys, spleen and pancreas (22-50 minutes). Lung accumulation of [(11)C]d-methamphetamine was 30% higher for African Americans than Caucasians (p<0.05) but did not differ in other organs. Conclusions: The high accumulation of methamphetamine, a potent stimulant drug, in most body organs is likely to contribute to the medical complications associated with methamphetamine abuse. In particular, we speculate that methamphetamine's high pulmonary uptake could render this organ vulnerable to infections (tuberculosis) and pathology (pulmonary hypertension). Our preliminary findings of a higher lung accumulation of methamphetamine in African Americans than Caucasians merits further investigation and questions whether it could contribute to the infrequent use of methamphetamine among African Americans.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Thanos, Peter K.] Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD USA; [Fowler, Joanna S.; Wang, Gene-Jack; Shumay, Elena; Alexoff, David] Brookhaven Natl Lab, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse [K05DA020001]; Department of Energy;  [MO1RR10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Energy(United States Department of Energy (DOE)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse (K05DA020001) and infrastructure support from the Department of Energy and GCRC grant MO1RR10710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; CALDWELL J, 1972, BIOCHEM J, V129, P25, DOI 10.1042/bj1290025; Chin KM, 2006, CHEST, V130, P1657, DOI 10.1378/chest.130.6.1657; CITRON B P, 1972, Clinical Research, V20, P236; COOK CE, 1993, DRUG METAB DISPOS, V21, P717; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DEAN D, 2000, CROSS SECTIONAL HUMA, P8; Desai RI, 2010, J PHARMACOL EXP THER, V333, P834, DOI 10.1124/jpet.110.165746; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Fowler JS, 2007, J NUCL MED, V48, P1724, DOI 10.2967/jnumed.107.040279; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; ISHIYAMA I, 1987, J FORENSIC SCI, V32, P658; Karch SB, 1999, J FORENSIC SCI, V44, P359; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kim I, 2004, THER DRUG MONIT, V26, P664, DOI 10.1097/00007691-200412000-00013; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Mankatittham W, 2009, SE ASIAN J TROP MED, V40, P93; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; MCMAHON EM, 1971, SCIENCE, V174, P66, DOI 10.1126/science.174.4004.66; MERKI HS, 1988, GASTROENTEROLOGY, V94, P887, DOI 10.1016/0016-5085(88)90543-4; Mooney LJ, 2009, METHAMPHETAMINE ADDI, P117; Newton TF, 2005, PHARMACOL BIOCHEM BE, V82, P90, DOI 10.1016/j.pbb.2005.07.012; PEVZNER ES, 2010, AM J PUBLIC HLT 0218; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Sexton Rocky L, 2005, J Ethn Subst Abuse, V4, P77, DOI 10.1300/J233v04n01_06; SHIUE CY, 1993, NUCL MED BIOL, V20, P973, DOI 10.1016/0969-8051(93)90098-F; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2007, DAWN SER D, VD-29; Takano A, 2007, ANN NUCL MED, V21, P349, DOI 10.1007/s12149-007-0031-1; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; VOLKOW ND, 1992, J NUCL MED, V33, P521; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x	36	98	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15269	10.1371/journal.pone.0015269	http://dx.doi.org/10.1371/journal.pone.0015269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151866	gold, Green Published, Green Submitted			2022-12-25	WOS:000285041800013
J	Vagasi, CI; Pap, PL; Barta, Z				Vagasi, Csongor I.; Pap, Peter L.; Barta, Zoltan			Haste Makes Waste: Accelerated Molt Adversely Affects the Expression of Melanin-Based and Depigmented Plumage Ornaments in House Sparrows	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; MALE COLLARED FLYCATCHERS; DIET QUALITY AFFECTS; PASSER-DOMESTICUS; BADGE SIZE; TRADE-OFF; PIED FLYCATCHER; FEATHER QUALITY; STATUS SIGNAL; BROOD SIZE	Background: Many animals display colorful signals in their integument which convey information about the quality of their bearer. Theoretically, these ornaments incur differential production and/or maintenance costs that enforce their honesty. However, the proximate mechanisms of production costs are poorly understood and contentious in cases of non-carotenoid-based plumage ornaments like the melanin-based badge and depigmented white wing-bar in house sparrows Passer domesticus. Costly life-history events are adaptively separated in time, thus, when reproduction is extended, the time available for molt is curtailed and, in turn, molt rate is accelerated. Methodology/Principal Findings: We experimentally accelerated the molt rate by shortening the photoperiod in order to test whether this environmental constraint is mirrored in the expression of plumage ornaments. Sparrows which had undergone an accelerated molt developed smaller badges and less bright wing-bars compared to conspecifics that molted at a natural rate being held at natural-like photoperiod. There was no difference in the brightness of the badge or the size of the wing-bar. Conclusions/Significance: These results indicate that the time available for molt and thus the rate at which molt occurs may constrain the expression of melanin-based and depigmented plumage advertisements. This mechanism may lead to the evolution of honest signaling if the onset of molt is condition-dependent through the timing of and/or trade-off between breeding and molt.	[Vagasi, Csongor I.; Pap, Peter L.; Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary; [Vagasi, Csongor I.; Pap, Peter L.] Univ Babes Bolyai, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania	University of Debrecen; Babes Bolyai University from Cluj	Vagasi, CI (corresponding author), Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary.	csongor.vagasi@vocs.unideb.hu	Vágási, Csongor I./AAU-4548-2020	Vágási, Csongor I./0000-0002-8736-2391; Barta, Zoltan/0000-0002-7121-9865	Hungarian Ministry of Education and Culture [FNFRDL060701DN 46/2006]; Hungarian Academy of Sciences [2009A00031E]; Romanian Ministry of Education and Research [ET94/2006, PNII-RU TE 291/2010]; OTKA [NF61143]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund; European Regional Development Fund	Hungarian Ministry of Education and Culture; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission)	This work was supported by PhD scholarships from the Hungarian Ministry of Education and Culture (#FNFRDL060701DN 46/2006 to CIV) and the Hungarian Academy of Sciences (#2009A00031E to CIV), the CEEX research grant (#ET94/2006) of the Romanian Ministry of Education and Research (to PLP) and an OTKA grant (#NF61143 to ZB), and partially supported by a research grant (CNCSIS-UEFISCSU #PNII-RU TE 291/2010 to PLP and CIV) of the Romanian Ministry of Education and Research and the TAMOP project (# 4.2.1./B-09/1/KONV-2010-0007 to ZB), which is implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2007, J EVOLUTION BIOL, V20, P1277, DOI 10.1111/j.1420-9101.2007.01354.x; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; BENSCH S, 1985, ORNIS SCAND, V16, P151, DOI 10.2307/3676481; Bojarinova JG, 1999, J AVIAN BIOL, V30, P437, DOI 10.2307/3677016; Bokony V, 2008, IBIS, V150, P139; Bokony V, 2006, ETHOLOGY, V112, P947, DOI 10.1111/j.1439-0310.2006.01246.x; Buchanan KL, 2010, J AVIAN BIOL, V41, P445, DOI 10.1111/j.1600-048X.2010.04929.x; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Buchanan KL, 2003, BEHAV ECOL SOCIOBIOL, V55, P50, DOI 10.1007/s00265-003-0682-4; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Griffith SC, 2000, P ROY SOC B-BIOL SCI, V267, P1115, DOI 10.1098/rspb.2000.1116; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; Hanssen SA, 2006, ANIM BEHAV, V71, P337, DOI 10.1016/j.anbehav.2005.04.021; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hinsley SA, 2003, IBIS, V145, P337, DOI 10.1046/j.1474-919X.2003.00167.x; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jensen H, 2004, J ANIM ECOL, V73, P599, DOI 10.1111/j.0021-8790.2004.00837.x; Johnstone Rufus A., 1997, P155; LESSELLS CM, 1986, J ANIM ECOL, V55, P669, DOI 10.2307/4747; Liker A, 2001, CONDOR, V103, P151, DOI 10.1650/0010-5422(2001)103[0151:MBSPDA]2.0.CO;2; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ., 2006, BIRD COLORATION, P243; MOLLER AP, 1990, ANIM BEHAV, V39, P458, DOI 10.1016/S0003-3472(05)80409-9; MOLLER AP, 1988, BEHAV ECOL SOCIOBIOL, V22, P373; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Moreno-Rueda G, 2005, ARDEA, V93, P109; Moreno-Rueda G, 2010, J AVIAN BIOL, V41, P229, DOI 10.1111/j.1600-048X.2009.04859.x; MORTON GA, 1990, CONDOR, V92, P813, DOI 10.2307/1368717; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2008, BIOL LETTERS, V4, P667, DOI 10.1098/rsbl.2008.0349; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; NEWTON I, 1966, IBIS, V108, P41, DOI 10.1111/j.1474-919X.1966.tb07251.x; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Pap PL, 2009, J EXP BIOL, V212, P3228, DOI 10.1242/jeb.031948; Parejo D, 2009, J EXP BIOL, V212, P3576, DOI 10.1242/jeb.033654; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Prum RO, 2006, BIRD COLORATION, V1, P295; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Roulin A, 2008, ANIM BEHAV, V75, P1351, DOI 10.1016/j.anbehav.2007.09.007; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Shawkey MD, 2003, P ROY SOC B-BIOL SCI, V270, P1455, DOI 10.1098/rspb.2003.2390; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stewart IRK, 2010, AUK, V127, P549, DOI 10.1525/auk.2010.10048; Stoehr AM, 2006, FUNCT ECOL, V20, P276, DOI 10.1111/j.1365-2435.2006.01090.x; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; Torok J, 2003, BEHAV ECOL, V14, P382, DOI 10.1093/beheco/14.3.382; Vaclav R, 2006, ZOOL SCI, V23, P1073, DOI 10.2108/zsj.23.1073; Veiga JP, 1996, P ROY SOC B-BIOL SCI, V263, P229, DOI 10.1098/rspb.1996.0036; Veiga JP, 1996, BEHAV ECOL SOCIOBIOL, V39, P345, DOI 10.1007/s002650050299; VEIGA JP, 1993, EVOLUTION, V47, P1161, DOI 10.1111/j.1558-5646.1993.tb02143.x; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	75	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14215	10.1371/journal.pone.0014215	http://dx.doi.org/10.1371/journal.pone.0014215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151981	Green Published, gold, Green Submitted			2022-12-25	WOS:000284939600008
J	Wagner, S; Kufleitner, J; Zensi, A; Dadparvar, M; Wien, S; Bungert, J; Vogel, T; Worek, F; Kreuter, J; von Briesen, H				Wagner, Sylvia; Kufleitner, Juergen; Zensi, Anja; Dadparvar, Miriam; Wien, Sascha; Bungert, Judith; Vogel, Tikva; Worek, Franz; Kreuter, Joerg; von Briesen, Hagen			Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model	PLOS ONE			English	Article							ALBUMIN HSA NANOPARTICLES; APOLIPOPROTEIN-A-I; ORGANOPHOSPHATE PESTICIDES; CHOLINESTERASE INHIBITORS; ENDOTHELIAL-CELLS; DRUG TRANSPORT; ACETYLCHOLINESTERASE; ENTER; WORLD; HI-6	Background: Due to the use of organophosphates (OP) as pesticides and the availability of OP-type nerve agents, an effective medical treatment for OP poisonings is still a challenging problem. The acute toxicity of an OP poisoning is mainly due to the inhibition of acetylcholinesterase (AChE) in the peripheral and central nervous systems (CNS). This results in an increase in the synaptic concentration of the neurotransmitter acetylcholine, overstimulation of cholinergic receptors and disorder of numerous body functions up to death. The standard treatment of OP poisoning includes a combination of a muscarinic antagonist and an AChE reactivator (oxime). However, these oximes can not cross the blood-brain barrier (BBB) sufficiently. Therefore, new strategies are needed to transport oximes over the BBB. Methodology/Principal Findings: In this study, we combined different oximes (obidoxime dichloride and two different HI 6 salts, HI 6 dichloride monohydrate and HI 6 dimethanesulfonate) with human serum albumin nanoparticles and could show an oxime transport over an in vitro BBB model. In general, the nanoparticulate transported oximes achieved a better reactivation of OP-inhibited AChE than free oximes. Conclusions/Significance: With these nanoparticles, for the first time, a tool exists that could enable a transport of oximes over the BBB. This is very important for survival after severe OP intoxication. Therefore, these nanoparticulate formulations are promising formulations for the treatment of the peripheral and the CNS after OP poisoning.	[Wagner, Sylvia; Wien, Sascha; Bungert, Judith; von Briesen, Hagen] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, Sankt Ingbert, Germany; [Kufleitner, Juergen; Zensi, Anja; Dadparvar, Miriam; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany; [Vogel, Tikva] Biotechnol Gen Ltd, Rehovot, Israel; [Worek, Franz] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany	Fraunhofer Gesellschaft; Goethe University Frankfurt	Wagner, S (corresponding author), Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, Sankt Ingbert, Germany.	hagen.briesen@ibmt.fraunhofer.de		Wagner, Sylvia/0000-0001-7922-977X; Worek, Franz/0000-0003-3531-3616	German Bundesamt Wehrtechnik und Beschaffung [U2.3 E/UR3G/5G031/5A802]	German Bundesamt Wehrtechnik und Beschaffung	This work was financially supported by the German Bundesamt Wehrtechnik und Beschaffung (U2.3 E/UR3G/5G031/5A802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge W. N., 1972, ENZYME INHIBITORS SU; Amr MM, 1999, TOXICOL LETT, V107, P1, DOI 10.1016/S0378-4274(99)00026-0; BROWN SK, 1989, ARCH ENVIRON HEALTH, V44, P34, DOI 10.1080/00039896.1989.9935870; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cocker J, 2002, TOXICOL LETT, V134, P97, DOI 10.1016/S0378-4274(02)00168-6; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FIREMARK H, 1964, J PHARMACOL EXP THER, V145, P252; FORGET G, 1991, J TOXICOL ENV HEALTH, V32, P11, DOI 10.1080/15287399109531462; FUKUSHIMA H, 1990, IN VITRO CELL DEV B, V26, P612, DOI 10.1007/BF02624211; Gaillard Pieter J, 2005, Expert Opin Drug Deliv, V2, P299, DOI 10.1517/17425247.2.2.299; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; HOBBIGER F, 1967, BIOCHEM PHARMACOL, V16, P455, DOI 10.1016/0006-2952(67)90093-7; HOLMSTEDT B, 1959, PHARMACOL REV, V11, P567; JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J; Kreuter J, 2007, J CONTROL RELEASE, V118, P54, DOI 10.1016/j.jconrel.2006.12.012; Kwong TC, 2002, THER DRUG MONIT, V24, P144, DOI 10.1097/00007691-200202000-00022; Langer K, 2008, INT J PHARMACEUT, V347, P109, DOI 10.1016/j.ijpharm.2007.06.028; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; LIGTENSTEIN DA, 1988, TOXICOL APPL PHARM, V92, P324, DOI 10.1016/0041-008X(88)90392-4; LIGTENSTEIN DA, 1983, TOXICOL APPL PHARM, V71, P177, DOI 10.1016/0041-008X(83)90334-4; LUNDY PM, 1990, ARCH TOXICOL, V64, P377, DOI 10.1007/BF01973459; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; Marrs T. C., 2007, CHEM WARFARE AGENTS; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Nagao M, 1997, TOXICOL APPL PHARM, V144, P198, DOI 10.1006/taap.1997.8110; Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; Sachs L., 1984, ANGEW STAT ANWENDUNG, V6, DOI [10.1007/978-3-662-05748-3, DOI 10.1007/978-3-662-05748-3]; SU CT, 1986, FUND APPL TOXICOL, V6, P506, DOI 10.1016/0272-0590(86)90224-1; Taylor P, 1995, TOXICOL LETT, V82-3, P453, DOI 10.1016/0378-4274(95)03575-3; Thiermann H, 1999, TOXICOL LETT, V107, P233, DOI 10.1016/S0378-4274(99)00052-1; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Zenker D, 2003, J PHYSIOL-LONDON, V551, P1023, DOI 10.1113/jphysiol.2003.045880; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; [No title captured]; [No title captured]	46	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14213	10.1371/journal.pone.0014213	http://dx.doi.org/10.1371/journal.pone.0014213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151975	Green Published, gold, Green Submitted			2022-12-25	WOS:000284939600007
J	Kim, SM; Park, YY; Park, ES; Cho, JY; Izzo, JG; Zhang, D; Kim, SB; Lee, JH; Bhutani, MS; Swisher, SG; Wu, XF; Coombes, KR; Maru, D; Wang, KK; Buttar, NS; Ajani, JA; Lee, JS				Kim, Soo Mi; Park, Yun-Yong; Park, Eun Sung; Cho, Jae Yong; Izzo, Julie G.; Zhang, Di; Kim, Sang-Bae; Lee, Jeffrey H.; Bhutani, Manoop S.; Swisher, Stephen G.; Wu, Xifeng; Coombes, Kevin R.; Maru, Dipen; Wang, Kenneth K.; Buttar, Navtej S.; Ajani, Jaffer A.; Lee, Ju-Seog			Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MATRICELLULAR PROTEIN; EXPRESSION; SPARC; SURVIVAL; CANCER; OSTEOPONTIN; PROGRESSION; MATRIX; GROWTH	Background: Despite many attempts to establish pre-treatment prognostic markers to understand the clinical biology of esophageal adenocarcinoma (EAC), validated clinical biomarkers or parameters remain elusive. We generated and analyzed tumor transcriptome to develop a practical biomarker prognostic signature in EAC. Methodology/Principal Findings: Untreated esophageal endoscopic biopsy specimens were obtained from 64 patients undergoing surgery and chemoradiation. Using DNA microarray technology, genome-wide gene expression profiling was performed on 75 untreated cancer specimens from 64 EAC patients. By applying various statistical and informatical methods to gene expression data, we discovered distinct subgroups of EAC with differences in overall gene expression patterns and identified potential biomarkers significantly associated with prognosis. The candidate marker genes were further explored in formalin-fixed, paraffin-embedded tissues from an independent cohort (52 patients) using quantitative RT-PCR to measure gene expression. We identified two genes whose expression was associated with overall survival in 52 EAC patients and the combined 2-gene expression signature was independently associated with poor outcome (P < 0.024) in the multivariate Cox hazard regression analysis. Conclusions/Significance: Our findings suggest that the molecular gene expression signatures are associated with prognosis of EAC patients and can be assessed prior to any therapy. This signature could provide important improvement for the management of EAC patients.	[Kim, Soo Mi; Park, Yun-Yong; Park, Eun Sung; Cho, Jae Yong; Kim, Sang-Bae; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Izzo, Julie G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Zhang, Di; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lee, Jeffrey H.; Bhutani, Manoop S.; Maru, Dipen; Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Swisher, Stephen G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Kenneth K.; Buttar, Navtej S.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Barrett Esophagus Unit, Rochester, MN USA; [Kim, Soo Mi] Chonbuk Natl Univ Med Sch & Hosp, Dept Physiol, Jeonju, South Korea	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Jeonbuk National University; Jeonbuk National University Hospital	Kim, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	jlee@mdanderson.org	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753; Coombes, Kevin/0000-0002-7630-2123	National Institutes of Health [CA127672, CA129906, CA138671, CA150229]; University of Texas MD Anderson Cancer Center; Chonbuk National University; Dallas Family; Cantu Family; Smith Family; Park Family; Myer Family; Kevin Fund; River Creek Foundation; NATIONAL CANCER INSTITUTE [R01CA150229, R21CA129906, R21CA127672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; Chonbuk National University; Dallas Family; Cantu Family; Smith Family; Park Family; Myer Family; Kevin Fund; River Creek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by a grant from National Institutes of Health (CA127672, CA129906, CA138671, and CA150229); Multidisciplinary Research Program grants from University of Texas MD Anderson Cancer Center; Institute for Personalized Cancer Treatment grant from University of Texas MD Anderson Cancer Center; faculty start-up fund from University of Texas MD Anderson Cancer Center; intramural research fund of Chonbuk National University; Dallas, Cantu, Smith, Park, and Myer Families; the Kevin Fund; and the River Creek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; DE MG, 2003, EUR J SURG ONCOL, V29, P506; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Izzo JG, 2007, CANCER EPIDEM BIOMAR, V16, P1200, DOI 10.1158/1055-9965.EPI-06-1083; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim SY, 2002, MOL CELLS, V13, P429; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Mariette C, 2003, CANCER-AM CANCER SOC, V97, P1616, DOI 10.1002/cncr.11228; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Rempel SA, 1999, CLIN CANCER RES, V5, P237; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Yamashita K, 2003, CANCER, V97, P2412, DOI 10.1002/cncr.11368	25	105	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15074	10.1371/journal.pone.0015074	http://dx.doi.org/10.1371/journal.pone.0015074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152079	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100061
J	Lindsley, WG; Blachere, FM; Thewlis, RE; Vishnu, A; Davis, KA; Cao, G; Palmer, JE; Clark, KE; Fisher, MA; Khakoo, R; Beezhold, DH				Lindsley, William G.; Blachere, Francoise M.; Thewlis, Robert E.; Vishnu, Abhishek; Davis, Kristina A.; Cao, Gang; Palmer, Jan E.; Clark, Karen E.; Fisher, Melanie A.; Khakoo, Rashida; Beezhold, Donald H.			Measurements of Airborne Influenza Virus in Aerosol Particles from Human Coughs	PLOS ONE			English	Article							TRANSMISSION; INFECTION; DISEASE	Influenza is thought to be communicated from person to person by multiple pathways. However, the relative importance of different routes of influenza transmission is unclear. To better understand the potential for the airborne spread of influenza, we measured the amount and size of aerosol particles containing influenza virus that were produced by coughing. Subjects were recruited from patients presenting at a student health clinic with influenza-like symptoms. Nasopharyngeal swabs were collected from the volunteers and they were asked to cough three times into a spirometer. After each cough, the cough-generated aerosol was collected using a NIOSH two-stage bioaerosol cyclone sampler or an SKC BioSampler. The amount of influenza viral RNA contained in the samplers was analyzed using quantitative real-time reverse-transcription PCR (qPCR) targeting the matrix gene M1. For half of the subjects, viral plaque assays were performed on the nasopharyngeal swabs and cough aerosol samples to determine if viable virus was present. Fifty-eight subjects were tested, of whom 47 were positive for influenza virus by qPCR. Influenza viral RNA was detected in coughs from 38 of these subjects (81%). Thirty-five percent of the influenza RNA was contained in particles >4 mu m in aerodynamic diameter, while 23% was in particles 1 to 4 mu m and 42% in particles <1 mu m. Viable influenza virus was detected in the cough aerosols from 2 of 21 subjects with influenza. These results show that coughing by influenza patients emits aerosol particles containing influenza virus and that much of the viral RNA is contained within particles in the respirable size range. The results support the idea that the airborne route may be a pathway for influenza transmission, especially in the immediate vicinity of an influenza patient. Further research is needed on the viability of airborne influenza viruses and the risk of transmission.	[Lindsley, William G.; Blachere, Francoise M.; Thewlis, Robert E.; Cao, Gang; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Vishnu, Abhishek] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Davis, Kristina A.; Fisher, Melanie A.; Khakoo, Rashida] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA; [Palmer, Jan E.; Clark, Karen E.] W Virginia Univ, Well WVU Student Hlth, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; West Virginia University; West Virginia University	Lindsley, WG (corresponding author), NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Morgantown, WV USA.	wlindsley@cdc.gov		Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747; Vishnu, Abhishek/0000-0003-3573-4090	National Institute for Occupational Safety and Health (NIOSH; US Centers for Disease Control and Prevention); US Environmental Protection Agency (EPA) [DW7592259701]	National Institute for Occupational Safety and Health (NIOSH; US Centers for Disease Control and Prevention)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was supported by internal funds from the National Institute for Occupational Safety and Health (NIOSH; part of the US Centers for Disease Control and Prevention) and by an interagency agreement with the US Environmental Protection Agency (EPA; DW7592259701). NIOSH employees were involved in conducting the study, analyzing the results, and preparing the manuscript.	ACGIH, 2001, DOC THRESH LIM VAL B; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CAO G, 2010, AAAR 29 ANN C OCT 25; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; GOLDSMITH WT, 2001, ANN FALL M BMES OCT; JENNISON MW, 1942, AEROBIOLOGY, P106; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Liverman C. T., 2009, RESP PROTECTION HEAL; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; MILTON DK, 2010, SWINE ORIGIN H1N1 VI; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Raphael D., 2008, HARRISONS PRINCIPLES, P1127; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x	25	277	284	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15100	10.1371/journal.pone.0015100	http://dx.doi.org/10.1371/journal.pone.0015100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152051	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100071
J	Willems, A; Batlouni, SR; Esnal, A; Swinnen, JV; Saunders, PTK; Sharpe, RM; Franca, LR; De Gendt, K; Verhoeven, G				Willems, Ariane; Batlouni, Sergio R.; Esnal, Arantza; Swinnen, Johannes V.; Saunders, Philippa T. K.; Sharpe, Richard M.; Franca, Luiz R.; De Gendt, Karel; Verhoeven, Guido			Selective Ablation of the Androgen Receptor in Mouse Sertoli Cells Affects Sertoli Cell Maturation, Barrier Formation and Cytoskeletal Development	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; BLOOD-TESTIS BARRIER; TESTICULAR GENE-EXPRESSION; MALE-MICE LACKING; GERM-CELL; IMMUNOGLOBULIN SUPERFAMILY; MUTANT MOUSE; FUNCTIONAL MATURATION; POSTNATAL-DEVELOPMENT; BINDING PROTEINS	The observation that mice with a selective ablation of the androgen receptor (AR) in Sertoli cells (SC) (SCARKO mice) display a complete block in meiosis supports the contention that SC play a pivotal role in the control of germ cell development by androgens. To delineate the physiological and molecular mechanism responsible for this control, we compared tubular development in pubertal SCARKO mice and littermate controls. Particular attention was paid to differences in SC maturation, SC barrier formation and cytoskeletal organization and to the molecular mediators potentially involved. Functional analysis of SC barrier development by hypertonic perfusion and lanthanum permeation techniques and immunohistochemical analysis of junction formation showed that SCARKO mice still attempt to produce a barrier separating basal and adluminal compartment but that barrier formation is delayed and defective. Defective barrier formation was accompanied by disturbances in SC nuclear maturation (immature shape, absence of prominent, tripartite nucleoli) and SC polarization (aberrant positioning of SC nuclei and cytoskeletal elements such as vimentin). Quantitative RT-PCR was used to study the transcript levels of genes potentially related to the described phenomena between day 8 and 35. Differences in the expression of SC genes known to play a role in junction formation could be shown from day 8 for Cldn11, from day 15 for Cldn3 and Espn, from day 20 for Cdh2 and Jam3 and from day 35 for ZO-1. Marked differences were also noted in the transcript levels of several genes that are also related to cell adhesion and cytoskeletal dynamics but that have not yet been studied in SC (Actn3, Ank3, Anxa9, Scin, Emb, Mpzl2). It is concluded that absence of a functional AR in SC impedes the remodeling of testicular tubules expected at the onset of spermatogenesis and interferes with the creation of the specific environment needed for germ cell development.	[Willems, Ariane; Swinnen, Johannes V.; De Gendt, Karel; Verhoeven, Guido] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium; [Batlouni, Sergio R.] Sao Paulo State Univ, Aquaculture Ctr CAUNESP, Sao Paulo, Brazil; [Esnal, Arantza; Saunders, Philippa T. K.; Sharpe, Richard M.] MRC, Ctr Reprod Biol, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Franca, Luiz R.] Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Inst Biol Sci, Belo Horizonte, MG, Brazil	KU Leuven; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Willems, A (corresponding author), Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium.	guido.verhoeven@med.kuleuven.be	Batlouni, Sergio r/D-2324-2017; DE FRANCA, LUIZ/AAA-6923-2021; Batlouni, Sergio r/F-6357-2010; Saunders, Philippa TK/C-7489-2013; Swinnen, Johannes V/AAA-2214-2022; De Gendt, Karel/A-6332-2009; Sharpe, Richard M/D-2725-2013	Batlouni, Sergio r/0000-0003-3579-2530; Batlouni, Sergio r/0000-0003-3579-2530; Saunders, Philippa TK/0000-0001-9051-9380; Swinnen, Johannes V/0000-0002-7720-5077; Sharpe, Richard M/0000-0003-1686-8085	Katholieke Universiteit Leuven [OT/07/068A]; Fund for Scientific Research Flanders (FWO) [G.0458.05N]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [SB-73064]; MRC [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: UKRI; Medical Research Council [MC_U127684422, MC_U127685844, MC_U127685841] Funding Source: researchfish	Katholieke Universiteit Leuven(KU Leuven); Fund for Scientific Research Flanders (FWO)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described here was supported by a research grant from the Research Fund of the Katholieke Universiteit Leuven (OT/07/068A; www.kuleuven.be), by a grant and a postdoctoral fellowship (to K. De Gendt; G.0458.05N) from the Fund for Scientific Research Flanders (FWO; www.fwo.be) and by a Ph.D. grant (to A. Willems; SB-73064) from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen; www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boukari K, 2009, J CLIN ENDOCR METAB, V94, P1818, DOI 10.1210/jc.2008-1909; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; CAVICCHIA JC, 1991, ANAT REC, V230, P361, DOI 10.1002/ar.1092300309; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chatterjee G, 2008, BIOCHEM BIOPH RES CO, V372, P412, DOI 10.1016/j.bbrc.2008.05.053; CHEMES HE, 1979, BIOL REPROD, V21, P251, DOI 10.1095/biolreprod21.1.251; Chemes HE, 2008, J CLIN ENDOCR METAB, V93, P4408, DOI 10.1210/jc.2008-0915; Chlystun M, 2004, BBA-MOL CELL RES, V1742, P141, DOI 10.1016/j.bbamcr.2004.08.017; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DEFRANCA LR, 1994, ANAT REC, V240, P225; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; Florin A, 2005, ENDOCRINOLOGY, V146, P1532, DOI 10.1210/en.2004-0834; FRITZ IB, 1983, J REPROD FERTIL, V67, P359, DOI 10.1530/jrf.0.0670359; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goebeler V, 2003, FEBS LETT, V546, P359, DOI 10.1016/S0014-5793(03)00634-3; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GROOTEGOED JA, 1977, MOL CELL ENDOCRINOL, V9, P159, DOI 10.1016/0303-7207(77)90117-4; Guenette RS, 1997, DEV GENET, V21, P268, DOI 10.1002/(SICI)1520-6408(1997)21:4<268::AID-DVG4>3.0.CO;2-5; Guttinger M, 1998, J CELL BIOL, V141, P1061, DOI 10.1083/jcb.141.4.1061; Gye MC, 2003, INT J ANDROL, V26, P271, DOI 10.1046/j.1365-2605.2003.00423.x; Harrison SMW, 1998, DEV BIOL, V195, P174, DOI 10.1006/dbio.1998.8848; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; ISMAIL N, 1992, MICROSC RES TECHNIQ, V20, P43, DOI 10.1002/jemt.1070200106; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Komljenovic D, 2009, CELL TISSUE RES, V337, P281, DOI 10.1007/s00441-009-0809-7; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; KUROHMARU M, 1992, TISSUE CELL, V24, P895, DOI 10.1016/0040-8166(92)90024-2; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; LYON MF, 1975, NATURE, V258, P620, DOI 10.1038/258620a0; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Myers M, 2005, J ANAT, V207, P797, DOI 10.1111/j.1469-7580.2005.00493.x; NAGANO T, 1977, LAB INVEST, V36, P8; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; NEAVES WB, 1973, J CELL BIOL, V59, P559, DOI 10.1083/jcb.59.3.559; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; SETCHELL BP, 1988, DEV FUNCTION REPROD, V2, P77; Sharpe Richard M., 1994, P1363; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Sneddon SF, 2005, ENDOCRINOLOGY, V146, P5304, DOI 10.1210/en.2005-0914; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Verhoeven G., 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P2, DOI 10.2174/187152208783790750; Vogl AW, 1993, SERTOLI CELL, P39; Wang GS, 2009, J ANDROL, V30, P338, DOI 10.2164/jandrol.108.006890; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	74	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14168	10.1371/journal.pone.0014168	http://dx.doi.org/10.1371/journal.pone.0014168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152390	Green Published, Green Submitted, gold			2022-12-25	WOS:000284755100045
J	Xu, R; Zhen, ZL; Liu, J				Xu, Rui; Zhen, Zonglei; Liu, Jia			Mapping Informative Clusters in a Hierarchial Framework of fMRI Multivariate Analysis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SURFACE-BASED ANALYSIS; SELECTION; FACES; CLASSIFICATION; IDENTIFICATION; RECOGNITION; PATTERNS; CORTEX; STATES	Pattern recognition methods have become increasingly popular in fMRI data analysis, which are powerful in discriminating between multi-voxel patterns of brain activities associated with different mental states. However, when they are used in functional brain mapping, the location of discriminative voxels varies significantly, raising difficulties in interpreting the locus of the effect. Here we proposed a hierarchical framework of multivariate approach that maps informative clusters rather than voxels to achieve reliable functional brain mapping without compromising the discriminative power. In particular, we first searched for local homogeneous clusters that consisted of voxels with similar response profiles. Then, a multi-voxel classifier was built for each cluster to extract discriminative information from the multi-voxel patterns. Finally, through multivariate ranking, outputs from the classifiers were served as a multi-cluster pattern to identify informative clusters by examining interactions among clusters. Results from both simulated and real fMRI data demonstrated that this hierarchical approach showed better performance in the robustness of functional brain mapping than traditional voxel-based multivariate methods. In addition, the mapped clusters were highly overlapped for two perceptually equivalent object categories, further confirming the validity of our approach. In short, the hierarchical framework of multivariate approach is suitable for both pattern classification and brain mapping in fMRI studies.	[Xu, Rui; Liu, Jia] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Zhen, Zonglei; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University	Xu, R (corresponding author), Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China.	zhenzonglei@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Xu, Rui/0000-0001-8526-3392; Liu, Jia/0000-0003-0383-0934	Chinese Academy of Sciences; National Basic Research Program of China [2010CB833903, 2011CB505402]; National Natural Science Foundation of China [30800295]; Fundamental Research Funds for the Central Universities	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is funded by the 100 Talents Program of the Chinese Academy of Sciences, the National Basic Research Program of China (2010CB833903, 2011CB505402), the National Natural Science Foundation of China (30800295), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; BENALI H, 1994, P SOC PHOTO-OPT INS, V2299, P336, DOI 10.1117/12.179264; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2010, NEUROIMAGE, V49, P1949, DOI 10.1016/j.neuroimage.2009.06.040; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Ku SP, 2008, MAGN RESON IMAGING, V26, P1007, DOI 10.1016/j.mri.2008.02.016; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Martinez-Ramon M, 2006, NEUROIMAGE, V31, P1129, DOI 10.1016/j.neuroimage.2006.01.022; Meyer FG, 2005, MED IMAGE ANAL, V9, P51, DOI 10.1016/j.media.2004.07.002; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck HP, 2010, NEUROIMAGE, V50, P567, DOI 10.1016/j.neuroimage.2009.12.072; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; van Gerven M, 2009, NEUROIMAGE, V46, P665, DOI 10.1016/j.neuroimage.2009.02.041; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; ZEKI S, 1991, J NEUROSCI, V11, P641; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15065	10.1371/journal.pone.0015065	http://dx.doi.org/10.1371/journal.pone.0015065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152081	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100057
J	Osawa, Y; Seki, E; Kodama, Y; Suetsugu, A; Miura, K; Adachi, M; Ito, H; Shiratori, Y; Banno, Y; Olefsky, JM; Nagaki, M; Moriwaki, H; Brenner, DA; Seishima, M				Osawa, Yosuke; Seki, Ekihiro; Kodama, Yuzo; Suetsugu, Atsushi; Miura, Kouichi; Adachi, Masayuki; Ito, Hiroyasu; Shiratori, Yoshimune; Banno, Yoshiko; Olefsky, Jerrold M.; Nagaki, Masahito; Moriwaki, Hisataka; Brenner, David A.; Seishima, Mitsuru			Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression	FASEB JOURNAL			English	Article						sphingosine-1-phosphate; glucose intolerance; glucose transporter 2; glycogen synthase kinase-3 beta	SPHINGOSINE 1-PHOSPHATE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; FATTY LIVER; TNF-ALPHA; CELLS; CERAMIDE; PATHWAY; ROLES; TRANSLOCATION	Acid sphingomyelinase (ASM) regulates the homeostasis of sphingolipids, including ceramides and sphingosine-1-phosphate (S1P). Because sphingolipids regulate AKT activation, we investigated the role of ASM in hepatic glucose and lipid metabolism. Initially, we overexpressed ASM in the livers of wild-type and diabetic db/db mice by adenovirus vector (Ad5ASM). In these mice, glucose tolerance was improved, and glycogen and lipid accumulation in the liver were increased. Using primary cultured hepatocytes, we confirmed that ASM increased glucose uptake, glycogen deposition, and lipid accumulation through activation of AKT and glycogen synthase kinase-3 beta. In addition, ASM induced up-regulation of glucose transporter 2 accompanied by suppression of AMP-activated protein kinase (AMPK) phosphorylation. Loss of sphingosine kinase-1 (SphK1) diminished ASM-mediated AKT phosphorylation, but exogenous S1P induced AKT activation in hepatocytes. In contrast, SphK1 deficiency did not affect AMPK activation. These results suggest that the SphK/S1P pathway is required for ASM-mediated AKT activation but not for AMPK inactivation. Finally, we found that treatment with high-dose glucose increased glycogen deposition and lipid accumulation in wild-type hepatocytes but not in ASM(-/-) cells. This result is consistent with glucose intolerance in ASM(-/-) mice. In conclusion, ASM modulates AKT activation and AMPK inactivation, thus regulating glucose and lipid metabolism in the liver.-Osawa, Y., Seki, E., Kodama, Y., Suetsugu, A., Miura, K., Adachi, M., Ito, H., Shiratori, Y., Banno, Y., Olefsky, J. M., Nagaki, M., Moriwaki, H., Brenner, D. A., Seishima, M. Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression. FASEB J. 25, 1133-1144 (2011). www.fasebj.org	[Osawa, Yosuke; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Osawa, Yosuke; Suetsugu, Atsushi; Shiratori, Yoshimune; Nagaki, Masahito; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan; [Banno, Yoshiko] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu 5011194, Japan; [Seki, Ekihiro; Kodama, Yuzo; Miura, Kouichi; Adachi, Masayuki; Olefsky, Jerrold M.; Brenner, David A.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Gifu University; Gifu University; Gifu University; University of California System; University of California San Diego	Osawa, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, 1-1 Yanagido, Gifu 5011194, Japan.	osawa-gif@umin.ac.jp	Seki, Ekihiro/K-2481-2016; Shiratori, Yoshimune/I-6206-2014	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19790478, 21790657, 21390179]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252, R24DK090962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020172] Funding Source: NIH RePORTER	Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Jacek Bielawski (Medical University of South Carolina, Charleston, SC, USA) for sphingolipid measurement, Dr. Yoko Sugiyama (Gifu University Graduate School of Medicine, Gifu, Japan) for measurement of adenylate cyclase activity, and Dr. Kenneth Walsh (Boston University, Boston, MA, USA) for adenoviruses encoding CA-AMPK and DN-AMPK. This work was supported by grants from Mitsubishi Pharma Research Foundation and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (19790478 and 21790657 to Y.O. and 21390179 to M.S.).	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; David TS, 1998, AM J PHYSIOL-REG I, V274, pR1446, DOI 10.1152/ajpregu.1998.274.5.R1446; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Gorska M, 2003, HORM METAB RES, V35, P506; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Igarashi J, 2009, AM J PHYSIOL-CELL PH, V297, pC1263, DOI 10.1152/ajpcell.00109.2009; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; LIANGPUNSAKUL S, AM J PHYSL GASTROINT, V298, pG1004; Liu P, 2004, AM J PHYSIOL-CELL PH, V286, pC317, DOI 10.1152/ajpcell.00073.2003; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Rapizzi E, 2009, CELL MOL LIFE SCI, V66, P3207, DOI 10.1007/s00018-009-0106-3; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Sebastian BM, 2005, AM J PHYSIOL-ENDOC M, V289, pE1077, DOI 10.1152/ajpendo.00296.2005; Siehler S, 2002, BBA-MOL CELL BIOL L, V1582, P94, DOI 10.1016/S1388-1981(02)00142-7; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225	44	39	40	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1133	1144		10.1096/fj.10-168351	http://dx.doi.org/10.1096/fj.10-168351			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21163859	hybrid, Green Published			2022-12-25	WOS:000288982800003
J	Iram, SH; Cole, SPC				Iram, Surtaj H.; Cole, Susan P. C.			Expression and Function of Human MRP1 (ABCC1) Is Dependent on Amino Acids in Cytoplasmic Loop 5 and Its Interface with Nucleotide Binding Domain 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; P-GLYCOPROTEIN; CYSTIC-FIBROSIS; SUBSTRATE-SPECIFICITY; TRANSPORT ACTIVITY; MONOCLONAL-ANTIBODIES; INTRACELLULAR LOOP; MEMBRANE TOPOLOGY	Multidrug resistance protein 1 (MRP1) is an ATP-binding cassette transporter that effluxes drugs and organic anions across the plasma membrane. The 17 transmembrane helices of MRP1 are linked by extracellular and cytoplasmic loops (CLs), but their role in coupling the ATPase activity of MRP1 to the translocation of its substrates is poorly understood. Here we have examined the importance of CL5 by mutating eight conserved charged residues and the helix-disrupting Gly(511) in this region. Ala substitution of Lys(513), Lys(516), Glu(521), and Glu(535) markedly reduced MRP1 levels. Because three of these residues are predicted to lie at the interface of CL5 and the second nucleotide binding domain (NBD2), a critical role is indicated for this region in the plasma membrane expression of MRP1. Further support for this idea was obtained by mutating NBD2 amino acids His(1364) and Arg(1367) at the CL5 interface, which also resulted in reduced MRP1 levels. In contrast, mutation of Arg(501), Lys(503), Glu(507), Arg(532), and Gly(511) had no effect on MRP1 levels. Except for K503A, however, transport by these mutants was reduced by 50 to 75%, an effect largely attributable to reduced substrate binding and affinity. Studies with P-32-labeled azido-ATP also indicated that whereas ATP binding by the G511I mutant was unchanged, vanadate-induced trapping of azido-ADP was reduced, indicating changes in the catalytic activity of MRP1. Together, these data demonstrate the multiple roles for CL5 in the membrane expression and function of MRP1.	[Iram, Surtaj H.; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Iram, Surtaj Hussain/T-5510-2019; Cole, Susan P.C./I-6389-2017	Cole, Susan P.C./0000-0001-6571-6884; Iram, Surtaj/0000-0002-0672-0936	Canadian Institutes of Health Research [MOP-10519]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-10519 from the Canadian Institutes of Health Research.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Conseil G, 2005, BIOCHEM PHARMACOL, V69, P451, DOI 10.1016/j.bcp.2004.10.014; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; HIPFNER DR, 1994, CANCER RES, V54, P5788; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; Kwan T, 1998, BIOCHEMISTRY-US, V37, P3337, DOI 10.1021/bi972680x; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; MERCIER B, 1995, AM J HUM GENET, V56, P272; Muller M, 2002, BIOCHEMISTRY-US, V41, P10123, DOI 10.1021/bi026075s; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Ren XQ, 2006, J BIOCHEM, V140, P313, DOI 10.1093/jb/mvj155; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Roth J, 2008, HISTOCHEM CELL BIOL, V129, P163, DOI 10.1007/s00418-007-0366-7; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; XIE JX, 1995, J BIOL CHEM, V270, P28084; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7202	7213		10.1074/jbc.M110.166959	http://dx.doi.org/10.1074/jbc.M110.166959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177244	Green Published, hybrid			2022-12-25	WOS:000287737300037
J	Hernandez, JA; Phillips, AH; Erbil, WK; Zhao, DH; Demuez, M; Zeymer, C; Pelton, JG; Wemmer, DE; Rubio, LM				Hernandez, Jose A.; Phillips, Aaron H.; Erbil, W. Kaya; Zhao, Dehua; Demuez, Marie; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.; Rubio, Luis M.			A Sterile alpha-Motif Domain in NafY Targets Apo-NifDK for Iron-Molybdenum Cofactor Delivery via a Tethered Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGENASE MOFE PROTEIN; IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII; KLEBSIELLA-PNEUMONIAE; APODINITROGENASE; PURIFICATION; CLUSTER; DINITROGENASE; BIOSYNTHESIS; SPECTROSCOPY	NafY participates in the final steps of nitrogenase maturation, having a dual role as iron-molybdenum cofactor (FeMo-co) carrier and as chaperone to the FeMo-co-deficient apo-NifDK (apo-dinitrogenase). NafY contains an N-terminal domain of unknown function (n-NafY) and a C-terminal domain (core-NafY) necessary for FeMo-co binding. We show here that n-NafY and core-NafY have very weak interactions in intact NafY. The NMR structure of n-NafY reveals that it belongs to the sterile alpha-motif (SAM) family of domains, which are frequently involved in protein-protein interactions. The presence of a SAM domain in NafY was unexpected and could not be inferred from its amino acid sequence. Although SAM domains are very commonly found in eukaryotic proteins, they have rarely been identified in prokaryotes. The n-NafY SAM domain binds apo-NifDK. As opposed to full-length NafY, n-NafY impaired FeMo-co insertion when present in molar excess relative to FeMo-co and apo-NifDK. The implications of these observations are discussed to offer a plausible mechanism of FeMo-co insertion. NafY domain structure, molecular tumbling, and interdomain motion, as well as NafY interaction with apo-NifDK are consistent with the function of NafY in FeMo-co delivery to apo-NifDK.	[Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Wemmer, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; Midwestern Univ Arizona, Arizona Coll Osteopath Med, Dept Biochem, Glendale, AZ 85308 USA; [Zhao, Dehua] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Rubio, Luis M.] Inst Madrileno Estudios Avanzados IMDEA Energia, Madrid 28223, Spain	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Midwestern University; University of California System; University of California San Francisco; IMDEA Energy	Wemmer, DE (corresponding author), Univ Calif Berkeley, Dept Chem, MC-1460, Berkeley, CA 94720 USA.	dewemmer@lbl.gov; luis.rubio@imdea.org	Demuez, Marie/L-1266-2016; Demuez, Marie/L-1134-2014; Rubio, Luis M./B-5827-2009	Demuez, Marie/0000-0002-8702-1001; Rubio, Luis M./0000-0003-1596-2475; Zeymer, Cathleen/0000-0001-7138-381X	National Institutes of Health [GM-35332]; NIGMS [62163]; European Research Council [205442]; Ministerio de Ciencia e Innovacion de Espana [BIO2009-12661]; Midwestern University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035332, R37GM035332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Midwestern University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35332 (to Paul Ludden) and Grant 62163 from NIGMS (to D. E. W.). This work was also supported by European Research Council Starting Grant 205442 and Ministerio de Ciencia e Innovacion de Espana Grant BIO2009-12661 (to L. M. R.) and by Midwestern University intramural funds (to J. A. H.).	Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bernado P, 2004, J BIOMOL NMR, V29, P21, DOI 10.1023/B:JNMR.0000019499.60777.6e; Bonin I, 2004, P NATL ACAD SCI USA, V101, P13762, DOI 10.1073/pnas.0405883101; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fischer MWF, 1999, BIOCHEMISTRY-US, V38, P9013, DOI 10.1021/bi9905213; George SJ, 2008, J AM CHEM SOC, V130, P5673, DOI 10.1021/ja0755358; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hernandez JA, 2007, MOL MICROBIOL, V63, P177, DOI 10.1111/j.1365-2958.2006.05514.x; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu Y, 2007, P NATL ACAD SCI USA, V104, P10424, DOI 10.1073/pnas.0704297104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwan JJ, 2004, J MOL BIOL, V342, P681, DOI 10.1016/j.jmb.2004.06.064; Magnuson JK, 1997, TETRAHEDRON, V53, P11971, DOI 10.1016/S0040-4020(97)00710-2; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rubio LM, 2004, J BIOL CHEM, V279, P19739, DOI 10.1074/jbc.M400965200; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; Tosi T, 2009, FEBS LETT, V583, P1581, DOI 10.1016/j.febslet.2009.04.033; WHITE TC, 1992, J BIOL CHEM, V267, P24007; Zhao DH, 2007, J BIOL CHEM, V282, P37016, DOI 10.1074/jbc.M708097200	34	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6321	6328		10.1074/jbc.M110.168732	http://dx.doi.org/10.1074/jbc.M110.168732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156797	hybrid, Green Published			2022-12-25	WOS:000287476400042
J	Hsieh, CY; Hsu, MJ; Hsiao, G; Wang, YH; Huang, CW; Chen, SAW; Jayakumar, T; Chiu, PT; Chiu, YH; Sheu, JR				Hsieh, Cheng Y.; Hsu, Ming J.; Hsiao, George; Wang, Yi H.; Huang, Chi W.; Chen, Shiuan W.; Jayakumar, Thanasekaran; Chiu, Pei T.; Chiu, Yi H.; Sheu, Joen R.			Andrographolide Enhances Nuclear Factor-kappa B Subunit p65 Ser(536) Dephosphorylation through Activation of Protein Phosphatase 2A in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMYELINASE-CERAMIDE PATHWAY; NITRIC-OXIDE; NEOINTIMAL HYPERPLASIA; SIGNALING PATHWAYS; INFLAMMATION; INHIBITION; EXPRESSION; APOPTOSIS; DISEASE; DEATH	Recent studies have demonstrated that transcription factor nuclear factor (NF)-kappa B inhibition may contribute to the protective anti-inflammatory actions of andrographolide, an abundant component of plants of the genus Andrographis. However, the precise mechanism by which andrographolide inhibits NF-kappa B signaling remains unclear. We thus investigated the mechanism involved in andrographolide suppression of NF-kappa B signaling in rat vascular smooth muscle cells (VSMCs) exposed to proinflammatory stimuli, LPS, and IFN-gamma. Andrographolide was shown to suppress LPS/IFN-gamma-induced inducible nitric-oxide synthase and matrix metalloprotease 9 expression in rat VSMCs. Andrographolide also inhibited LPS/IFN-gamma-induced p65 nuclear translocation, DNA binding activity, p65 Ser(536) phosphorylation, and NF-kappa B reporter activity. However, IKK phosphorylation and downstream inhibitory kappa B alpha phosphorylation and degradation were not altered by the presence of andrographolide in LPS/IFN-gamma-stimulated VSMCs. These andrographolide inhibitory actions could be prevented by selective inhibition of neutral sphingomyelinase and protein phosphatase 2A (PP2A). Furthermore, andrographolide was demonstrated to increase ceramide formation and PP2A activity in VSMCs and to inhibit neointimal formation in rat carotid injury models. These results suggest that andrographolide caused neutral sphingomyelinase-mediated ceramide formation and PP2A activation to dephosphorylate p65 Ser(536), leading to NF-kappa B inactivation and subsequent inducible nitric-oxide synthase down-regulation in rat VSMCs stimulated by LPS and IFN-gamma.	[Hsieh, Cheng Y.; Hsu, Ming J.; Hsiao, George; Wang, Yi H.; Huang, Chi W.; Chen, Shiuan W.; Jayakumar, Thanasekaran; Sheu, Joen R.] Taipei Med Univ, Grad Inst Med Sci, Dept Pharmacol, Taipei 11031, Taiwan; [Hsu, Ming J.; Hsiao, George; Chiu, Pei T.; Sheu, Joen R.] Taipei Med Univ, Coll Med, Sch Med, Taipei 11031, Taiwan; [Chiu, Yi H.] Taipei Med Univ, Off Res & Dev, Instrument Ctr, Taipei 11031, Taiwan; [Wang, Yi H.] Natl Chengchi Univ, Inst Law & Interdiscipline, Taipei 11605, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; National Chengchi University	Sheu, JR (corresponding author), 250 Wu Hsing St, Taipei 11031, Taiwan.	sheujr@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	National Science Council of Taiwan [NSC93-2321-B-038-001, 94-2321-B-038-001, 97-2320-B-038-016-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grants NSC93-2321-B-038-001, 94-2321-B-038-001, and 97-2320-B-038-016-MY3.	Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; BEASLEY D, 1991, J CLIN INVEST, V87, P602, DOI 10.1172/JCI115036; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boos CJ, 2006, CLIN PHARMACOL THER, V79, P20, DOI 10.1016/j.clpt.2005.10.004; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen BC, 2009, J BIOL CHEM, V284, P20562, DOI 10.1074/jbc.M109.028084; Chiou WF, 2000, BRIT J PHARMACOL, V129, P1553, DOI 10.1038/sj.bjp.0703191; Chung AWY, 2009, CARDIOVASC RES, V84, P494, DOI 10.1093/cvr/cvp242; Desmet C, 2004, J IMMUNOL, V173, P5766, DOI 10.4049/jimmunol.173.9.5766; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Hattori Y, 2004, CARDIOVASC RES, V63, P31, DOI 10.1016/j.cardiores.2004.03.014; Hsiao G, 2003, BIOCHEM PHARMACOL, V65, P1383, DOI 10.1016/S0006-2952(03)00070-4; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iruretagoyena MI, 2005, J PHARMACOL EXP THER, V312, P366, DOI 10.1124/jpet.104.072512; Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Lee CS, 2009, ARTERIOSCL THROM VAS, V29, P472, DOI 10.1161/ATVBAHA.108.176230; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Negi AS, 2008, MED RES REV, V28, P746, DOI 10.1002/med.20115; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu J, 1998, J BIOL CHEM, V273, P16521, DOI 10.1074/jbc.273.26.16521; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071	43	65	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5942	5955		10.1074/jbc.M110.123968	http://dx.doi.org/10.1074/jbc.M110.123968			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169355	Green Published, hybrid			2022-12-25	WOS:000287476400002
J	Alves, E; Bartlett, PJ; Garcia, CRS; Thomas, AP				Alves, Eduardo; Bartlett, Paula J.; Garcia, Celia R. S.; Thomas, Andrew P.			Melatonin and IP3-induced Ca2+ Release from Intracellular Stores in the Malaria Parasite Plasmodium falciparum within Infected Red Blood Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL SYNTHASE; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE HYDROLYSIS; CALCIUM; CYCLE; MEMBRANE; KINASE; METABOLISM; RECEPTORS	IP3-dependent Ca2+ signaling controls a myriad of cellular processes in higher eukaryotes and similar signaling pathways are evolutionarily conserved in Plasmodium, the intracellular parasite that causes malaria. We have reported that isolated, permeabilized Plasmodium chabaudi, releases Ca2+ upon addition of exogenous IP3. In the present study, we investigated whether the IP3 signaling pathway operates in intact Plasmodium falciparum, the major disease-causing human malaria parasite. P. falciparum-infected red blood cells (RBCs) in the trophozoite stage were simultaneously loaded with the Ca2+ indicator Fluo-4/AM and caged-IP3. Photolytic release of IP3 elicited a transient Ca2+ increase in the cytosol of the intact parasite within the RBC. The intracellular Ca2+ pools of the parasite were selectively discharged, using thapsigargin to deplete endoplasmic reticulum (ER) Ca2+ and the antimalarial chloroquine to deplete Ca2+ from acidocalcisomes. These data show that the ER is the major IP3-sensitive Ca2+ store. Previous work has shown that the human host hormone melatonin regulates P. falciparum cell cycle via a Ca2+-dependent pathway. In the present study, we demonstrate that melatonin increases inositol-polyphosphate production in intact intraerythrocytic parasite. Moreover, the Ca2+ responses to melatonin and uncaging of IP3 were mutually exclusive in infected RBCs. Taken together these data provide evidence that melatonin activates PLC to generate IP3 and open ER-localized IP3-sensitive Ca2+ channels in P. falciparum. This receptor signaling pathway is likely to be involved in the regulation and synchronization of parasite cell cycle progression.	[Garcia, Celia R. S.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508900 Sao Paulo, Brazil; [Alves, Eduardo; Bartlett, Paula J.; Thomas, Andrew P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Alves, Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Parasitol, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade de Sao Paulo	Garcia, CRS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508900 Sao Paulo, Brazil.	cgarcia@usp.br; thomasap@umdnj.edu	Garcia, Celia R. S./A-4093-2011; Inbeqmedi, Inct/I-1929-2013; 4, INCT/H-4499-2013; Thomas, Andrew/C-6755-2013	Garcia, Celia R. S./0000-0003-2825-1701; Thomas, Andrew/0000-0002-9026-7467	Thomas P. Infusino Endowment; National Institutes of Health [DK082954]; Fapesp [07/52924-0]; Malaria Pronex; INCT-INBqMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082954] Funding Source: NIH RePORTER	Thomas P. Infusino Endowment; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Malaria Pronex; INCT-INBqMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Thomas P. Infusino Endowment (to A.P.T.), National Institutes of Health Grant DK082954, Fapesp (07/52924-0), Malaria Pronex, and INCT-INBqMed.	Bagnaresi P, 2009, INT J GEN MED, V2, P47; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Beraldo FH, 2005, J PINEAL RES, V39, P224, DOI 10.1111/j.1600-079X.2005.00249.x; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Biagini GA, 2003, J BIOL CHEM, V278, P27910, DOI 10.1074/jbc.M304193200; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Budu A, 2007, J PINEAL RES, V42, P261, DOI 10.1111/j.1600-079X.2006.00414.x; Dakin K, 2007, CELL CALCIUM, V42, P291, DOI 10.1016/j.ceca.2006.12.003; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; DUBOCOVICH ML, 1988, J PHARMACOL EXP THER, V246, P902; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; ELABBADI N, 1994, MOL BIOCHEM PARASIT, V63, P179, DOI 10.1016/0166-6851(94)90054-X; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Garcia CRS, 2008, INT REV CEL MOL BIO, V266, P85, DOI 10.1016/S1937-6448(07)66003-1; Garcia CRS, 2001, J BIOL RHYTHM, V16, P436, DOI 10.1177/074873001129002114; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2004, BIOCHEM BIOPH RES CO, V321, P138, DOI 10.1016/j.bbrc.2004.06.141; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; IRVINE RF, 1985, BIOCHEM J, V229, P505, DOI 10.1042/bj2290505; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kooij TWA, 2006, NAT REV MICROBIOL, V4, P344, DOI 10.1038/nrmicro1392; Koyama FC, 2009, MOL BIOCHEM PARASIT, V165, P1, DOI 10.1016/j.molbiopara.2009.01.003; KRISHNA S, 1990, PARASITOL TODAY, V6, P196, DOI 10.1016/0169-4758(90)90356-9; Lai FPL, 2002, J NEUROCHEM, V80, P736, DOI 10.1046/j.0022-3042.2002.00767.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; MARTIN SK, 1994, J PARASITOL, V80, P371, DOI 10.2307/3283406; Mullins UL, 1997, CELL SIGNAL, V9, P169, DOI 10.1016/S0898-6568(96)00137-4; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; POUVELLE B, 1991, NATURE, V353, P73, DOI 10.1038/353073a0; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Srinivasan V, 2010, J PINEAL RES, V48, P1, DOI 10.1111/j.1600-079X.2009.00728.x; Steffens F, 2003, MOL ENDOCRINOL, V17, P2103, DOI 10.1210/me.2003-0047; SUGDEN D, 1992, EUR J PHARMACOL, V213, P405, DOI 10.1016/0014-2999(92)90629-I; THOMAS AP, 1984, J BIOL CHEM, V259, P5574; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsim ST, 1997, J CELL SCI, V110, P1387; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Wengelnik K, 2007, RES MICROBIOL, V158, P51, DOI 10.1016/j.resmic.2006.11.005	64	80	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5905	5912		10.1074/jbc.M110.188474	http://dx.doi.org/10.1074/jbc.M110.188474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149448	Green Published, hybrid			2022-12-25	WOS:000287230600099
J	Venner, E; Lisewski, AM; Erdin, S; Ward, RM; Amin, SR; Lichtarge, O				Venner, Eric; Lisewski, Andreas Martin; Erdin, Serkan; Ward, R. Matthew; Amin, Shivas R.; Lichtarge, Olivier			Accurate Protein Structure Annotation through Competitive Diffusion of Enzymatic Functions over a Network of Local Evolutionary Similarities	PLOS ONE			English	Article							GENE ONTOLOGY ANNOTATION; FUNCTION PREDICTION; BINDING-SITES; TRACE; SEQUENCE; RECEPTOR; RESIDUES; DOMAIN; RESOURCE; ESTERASE	High-throughput Structural Genomics yields many new protein structures without known molecular function. This study aims to uncover these missing annotations by globally comparing select functional residues across the structural proteome. First, Evolutionary Trace Annotation, or ETA, identifies which proteins have local evolutionary and structural features in common; next, these proteins are linked together into a proteomic network of ETA similarities; then, starting from proteins with known functions, competing functional labels diffuse link-by-link over the entire network. Every node is thus assigned a likelihood z-score for every function, and the most significant one at each node wins and defines its annotation. In high-throughput controls, this competitive diffusion process recovered enzyme activity annotations with 99% and 97% accuracy at half-coverage for the third and fourth Enzyme Commission (EC) levels, respectively. This corresponds to false positive rates 4-fold lower than nearest-neighbor and 5-fold lower than sequence-based annotations. In practice, experimental validation of the predicted carboxylesterase activity in a protein from Staphylococcus aureus illustrated the effectiveness of this approach in the context of an increasingly drug-resistant microbe. This study further links molecular function to a small number of evolutionarily important residues recognizable by Evolutionary Tracing and it points to the specificity and sensitivity of functional annotation by competitive global network diffusion. A web server is at http://mammoth.bcm.tmc.edu/networks.	[Venner, Eric; Lisewski, Andreas Martin; Erdin, Serkan; Ward, R. Matthew; Amin, Shivas R.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Venner, Eric; Ward, R. Matthew; Lichtarge, Olivier] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Venner, Eric; Erdin, Serkan; Ward, R. Matthew; Lichtarge, Olivier] WM Keck Ctr Interdisciplinary Biosci Training, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Venner, E (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lichtarge@bcm.edu	Erdin, Serkan/AAE-4288-2019; Erdin, Serkan/B-4988-2008	Erdin, Serkan/0000-0001-6587-2625	National Science Foundation, NSF [CCF-0905536]; National Institutes of Health [NIH-GM079656, NIH-GM066099, T90 DA022885, R90 DA023418, NLM 5T15LM07093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, K12GM084897, R01GM066099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885, R90DA023418] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Science Foundation, NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Science Foundation (http://www.nsf.gov/) NSF CCF-0905536; National Institutes of Health (http://www.nih.gov/) NIH-GM079656, NIH-GM066099, T90 DA022885, R90 DA023418, NLM 5T15LM07093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Almonacid DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000700; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chiang RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000142; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Erdin S, 2010, J MOL BIOL, V396, P1451, DOI 10.1016/j.jmb.2009.12.037; Ferre F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-194; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Furnham N, 2009, NAT CHEM BIOL, V5, P521, DOI 10.1038/nchembio0809-521; Gherardini Pier Federico, 2008, Briefings in Functional Genomics & Proteomics, V7, P291, DOI 10.1093/bfgp/eln030; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Glazer DS, 2009, STRUCTURE, V17, P919, DOI 10.1016/j.str.2009.05.010; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gu PL, 2005, J BIOL CHEM, V280, P31818, DOI 10.1074/jbc.M501924200; Hennig S, 2003, NUCLEIC ACIDS RES, V31, P3712, DOI 10.1093/nar/gkg582; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Hu PZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S64; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; KRISCH K, 1966, BIOCHIM BIOPHYS ACTA, V122, P265, DOI 10.1016/0926-6593(66)90067-1; Kristensen DM, 2006, PROTEIN SCI, V15, P1530, DOI 10.1110/ps.062152706; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Levy ED, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-302; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mihalek I, 2006, PROTEINS, V63, P87, DOI 10.1002/prot.20866; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; MUKHERJEE JJ, 1993, BIOCHEM J, V295, P81, DOI 10.1042/bj2950081; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Pandit SB, 2010, BIOINFORMATICS, V26, P687, DOI 10.1093/bioinformatics/btq006; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Redfern OC, 2007, PLOS COMPUT BIOL, V3, P2333, DOI 10.1371/journal.pcbi.0030232; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Sadowski MI, 2009, CURR OPIN STRUC BIOL, V19, P357, DOI 10.1016/j.sbi.2009.03.008; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shin HJ, 2007, BIOINFORMATICS, V23, P3217, DOI 10.1093/bioinformatics/btm511; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wang K, 2005, BIOINFORMATICS, V21, P2969, DOI 10.1093/bioinformatics/bti471; Ward RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002136; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Wilkins AD, 2010, PROTEIN SCI, V19, P1296, DOI 10.1002/pro.406; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Zhou DY, 2004, ADV NEUR IN, V16, P321	96	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14286	10.1371/journal.pone.0014286	http://dx.doi.org/10.1371/journal.pone.0014286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179190	Green Submitted, gold, Green Published			2022-12-25	WOS:000285246900004
J	Dai, Y; DeSano, J; Tang, WH; Meng, XJ; Meng, Y; Burstein, E; Lawrence, TS; Xu, LA				Dai, Yao; DeSano, Jeffrey; Tang, Wenhua; Meng, Xiaojie; Meng, Yang; Burstein, Ezra; Lawrence, Theodore S.; Xu, Liang			Natural Proteasome Inhibitor Celastrol Suppresses Androgen-Independent Prostate Cancer Progression by Modulating Apoptotic Proteins and NF-kappaB	PLOS ONE			English	Article							B ACTIVATION; CONSTITUTIVE ACTIVATION; MELANOMA-CELLS; BORTEZOMIB; MCL-1; GROWTH; NOXA; TRITERPENE; INDUCTION; PATHWAY	Background: Celastrol is a natural proteasome inhibitor that exhibits promising anti-tumor effects in human malignancies, especially the androgen-independent prostate cancer (AIPC) with constitutive NF-kappa B activation. Celastrol induces apoptosis by means of proteasome inhibition and suppresses prostate tumor growth. However, the detailed mechanism of action remains elusive. In the current study, we aim to test the hypothesis that celastrol suppresses AIPC progression via inhibiting the constitutive NF-kappa B activity as well as modulating the Bcl-2 family proteins. Methodology/Principal Findings: We examined the efficacy of celastrol both in vitro and in vivo, and evaluated the role of NF-kappa B in celastrol-mediated AIPC regression. We found that celastrol inhibited cell proliferation in all three AIPC cell lines (PC-3, DU145 and CL1), with IC50 in the range of 1-2 mu M. Celastrol also suppressed cell migration and invasion. Celastrol significantly induced apoptosis as evidenced by increased sub-G1 population, caspase activation and PARP cleavage. Moreover, celastrol promoted cleavage of the anti-apoptotic protein Mcl-1 and activated the pro-apoptotic protein Noxa. In addition, celastrol rapidly blocked cytosolic I kappa B alpha degradation and nuclear translocation of RelA. Likewise, celastrol inhibited the expression of multiple NF-kappa B target genes that are involved in proliferation, invasion and anti-apoptosis. Celastrol suppressed AIPC tumor progression by inhibiting proliferation, increasing apoptosis and decreasing angiogenesis, in PC-3 xenograft model in nude mouse. Furthermore, increased cellular I kappa B alpha and inhibited expression of various NF-kappa B target genes were observed in tumor tissues. Conclusions/Significance: Our data suggest that, via targeting the proteasome, celastrol suppresses proliferation, invasion and angiogenesis by inducing the apoptotic machinery and attenuating constitutive NF-kappa B activity in AIPC both in vitro and in vivo. Celastrol as an active ingredient of traditional herbal medicine could thus be developed as a new therapeutic agent for hormone-refractory prostate cancer.	[Dai, Yao; DeSano, Jeffrey; Tang, Wenhua; Meng, Xiaojie; Meng, Yang; Lawrence, Theodore S.; Xu, Liang] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Ann Arbor, MI 48109 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Mol Biosci, Lawrence, KS 66045 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Urol, Lawrence, KS 66045 USA; [Tang, Wenhua; Meng, Xiaojie; Xu, Liang] Univ Kansas, Ctr Canc, Dept Radiat Oncol, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; University of Kansas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Kansas; University of Kansas	Dai, Y (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Radiat Oncol, Gainesville, FL 32611 USA.	xul@ku.edu	Burstein, Ezra/B-7247-2016	Burstein, Ezra/0000-0003-4341-6367	Department of Defense [W81XWH-06-1-0010]; National Institutes of Health (NIH) National Cancer Institute [R01 CA121830(S1), R21 CA128220, R01 CA134655]; NIH through a University of Michigan Cancer Center [5 P30 CA46592]; NATIONAL CANCER INSTITUTE [R21CA128220, R01CA134655, P30CA046592, R01CA121830] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH through a University of Michigan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Department of Defense Prostate Cancer Research Program [W81XWH-06-1-0010] and National Institutes of Health (NIH) National Cancer Institute [R01 CA121830(S1), R21 CA128220 and R01 CA134655] to LX, and by NIH through a University of Michigan Cancer Center Support Grant [5 P30 CA46592]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen M, 2009, MOL CANCER RES, V7, P1946, DOI 10.1158/1541-7786.MCR-09-0243; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Dai Y, 2008, CLIN CANCER RES, V14, P7701, DOI 10.1158/1078-0432.CCR-08-0188; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gasparian AV, 2002, J CELL SCI, V115, P141; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Karnak D, 2010, CURR DRUG TARGETS, V11, P699, DOI 10.2174/138945010791170888; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; LIAN J, 2010, CELL DEATH IN PRESS; LIAN J, 2010, AUTOPHAGY IN PRESS, V6; Liu AY, 2004, PROSTATE, V60, P98, DOI 10.1002/pros.20031; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pajonk F, 1999, J NATL CANCER I, V91, P1956, DOI 10.1093/jnci/91.22.1956; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Williams S, 2003, MOL CANCER THER, V2, P835; Wu XQ, 2010, BIOORGAN MED CHEM, V18, P3812, DOI 10.1016/j.bmc.2010.04.046; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zhou YX, 2009, CHINESE MED J-PEKING, V122, P1666, DOI 10.3760/cma.j.issn.0366-6999.2009.14.012	45	82	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14153	10.1371/journal.pone.0014153	http://dx.doi.org/10.1371/journal.pone.0014153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170316	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400002
J	Kimberley, TJ; Di Fabio, RP				Kimberley, Teresa Jacobson; Di Fabio, Richard P.			Visualizing the Effects of rTMS in a Patient Sample: Small N vs. Group Level Analysis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERINDIVIDUAL VARIABILITY; HAND DYSTONIA; EXCITABILITY; RELIABILITY; MODULATION; RESPONSES; CURVES	The use of transcranial magnetic stimulation (TMS) to assess changes in cortical excitability is a tool used with increased prevalence in healthy and impaired populations. One factor of concern with this technique is how to achieve adequate statistical power given constraints of a small number of subjects and variability in responses. This paper compares a single pulse excitability measure using traditional group-level statistics vs single subject analyses in a patient population of subjects with focal hand dystonia, pre and post repetitive TMS (rTMS). Results show significant differences in cortical excitability for 4/5 subjects using a split middle line analysis on plots of individual subject data. Group level statistics (ANOVA), however, did not detect any significant findings. The consideration of single subject statistics for TMS excitability measures may assist researchers in describing the variably of rTMS outcome measures.	[Kimberley, Teresa Jacobson; Di Fabio, Richard P.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kimberley, TJ (corresponding author), Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA.	tjk@umn.edu	Kimberley, Teresa/AAL-1893-2020	Kimberley, Teresa/0000-0001-6397-4054	Dystonia Medical Research Foundation; National Center for Research Resources (NCRR) in the National Institutes of Health [M01 RR00400]	Dystonia Medical Research Foundation; National Center for Research Resources (NCRR) in the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dystonia Medical Research Foundation (http://www.dystonia-foundation.org/pages/2010_solicitation_for_research_support_from_dod/364.php) and partial support from: National Center for Research Resources (NCRR) M01 RR00400 in the National Institutes of Health (http://www.ncrr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461; Carey JR, 2010, NEUROSCI LETT, V469, P338, DOI 10.1016/j.neulet.2009.12.023; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Duque J, 2008, CEREB CORTEX, V18, P1395, DOI 10.1093/cercor/bhm173; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FITZGERALD PB, 2002, CLIN NEUROPHYSIOLOGY, V113; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; HINZE J, 2007, NCSS HELP SYSTEM; Kimberley TJ, 2009, NEUROSCI LETT, V464, P84, DOI 10.1016/j.neulet.2009.08.029; KOH THHG, 1988, ARCH DIS CHILD, V63, P1347, DOI 10.1136/adc.63.11.1347; Maeda F, 2002, CLIN NEUROPHYSIOL, V113, P376, DOI 10.1016/S1388-2457(02)00008-1; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Moll GH, 1999, EEG CL N SU, P243; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Murase N, 2005, BRAIN, V128, P104, DOI 10.1093/brain/awh315; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; OTTENBACHER KJ, 1986, AM J OCCUP THER, V40, P464, DOI 10.5014/ajot.40.7.464; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Stinear CM, 2004, HUM MOVEMENT SCI, V23, P527, DOI 10.1016/j.humov.2004.08.022; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15155	10.1371/journal.pone.0015155	http://dx.doi.org/10.1371/journal.pone.0015155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21151629	gold, Green Published, Green Submitted			2022-12-25	WOS:000285084100023
J	Britzen-Laurent, N; Bauer, M; Berton, V; Fischer, N; Syguda, A; Reipschlager, S; Naschberger, E; Herrmann, C; Sturzl, M				Britzen-Laurent, Nathalie; Bauer, Michael; Berton, Valeria; Fischer, Nicole; Syguda, Adrian; Reipschlaeger, Simone; Naschberger, Elisabeth; Herrmann, Christian; Stuerzl, Michael			Intracellular Trafficking of Guanylate-Binding Proteins Is Regulated by Heterodimerization in a Hierarchical Manner	PLOS ONE			English	Article							NUCLEOTIDE-BINDING; INTERFERON-GAMMA; ENDOTHELIAL-CELLS; VESICLE FORMATION; PLASMA-MEMBRANE; INDUCED GTPASES; GTP HYDROLYSIS; RAS TRAFFICS; PRENYLATION; GOLGI	Guanylate-binding proteins (GBPs) belong to the dynamin family of large GTPases and represent the major IFN-gamma-induced proteins. Here we systematically investigated the mechanisms regulating the subcellular localization of GBPs. Three GBPs (GBP-1, GBP-2 and GBP-5) carry a C-terminal CaaX-prenylation signal, which is typical for small GTPases of the Ras family, and increases the membrane affinity of proteins. In this study, we demonstrated that GBP-1, GBP-2 and GBP-5 are prenylated in vivo and that prenylation is required for the membrane association of GBP-1, GBP-2 and GBP-5. Using co-immunoprecipitation, yeast-two-hybrid analysis and fluorescence complementation assays, we showed for the first time that GBPs are able to homodimerize in vivo and that the membrane association of GBPs is regulated by dimerization similarly to dynamin. Interestingly, GBPs could also heterodimerize. This resulted in hierarchical positioning effects on the intracellular localization of the proteins. Specifically, GBP-1 recruited GBP-5 and GBP-2 into its own cellular compartment and GBP-5 repositioned GBP-2. In addition, GBP-1, GBP-2 and GBP-5 were able to redirect non-prenylated GBPs to their compartment in a prenylation-dependent manner. Overall, these findings prove in vivo the ability of GBPs to dimerize, indicate that heterodimerization regulates sub-cellular localization of GBPs and underscore putative membrane-associated functions of this family of proteins.	[Britzen-Laurent, Nathalie; Bauer, Michael; Berton, Valeria; Fischer, Nicole; Reipschlaeger, Simone; Naschberger, Elisabeth; Stuerzl, Michael] Univ Erlangen Nurnberg, Div Mol & Expt Surg, Univ Med Ctr Erlangen, Erlangen, Germany; [Syguda, Adrian; Herrmann, Christian] Ruhr Univ Bochum, Fac Chem & Biochem, Bochum, Germany	University of Erlangen Nuremberg; Ruhr University Bochum	Britzen-Laurent, N (corresponding author), Univ Erlangen Nurnberg, Div Mol & Expt Surg, Univ Med Ctr Erlangen, Erlangen, Germany.	michael.stuerzl@uk-erlangen.de	Stürzl, Michael/B-3019-2015; Naschberger, Elisabeth/AAV-5289-2021; Britzen-Laurent, Nathalie/M-3982-2013	Stürzl, Michael/0000-0002-9276-2824; Naschberger, Elisabeth/0000-0003-1291-622X; Britzen-Laurent, Nathalie/0000-0002-0494-7117	Deutsche Forschungsgemeinschaft [DFG-GK 1071, DFG 317/2-1]; Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg; German Ministry for Education and Research (BMBF); European commission [FP7]; University of Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European commission(European CommissionEuropean Commission Joint Research Centre); University of Erlangen-Nuremberg	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG-GK 1071 and DFG 317/2-1; http://www.dfg.de/), the Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg (http://www.izkf.med.uni-erlangen.de/) and the German Ministry for Education and Research (BMBF; http://www.bmbf.de/) to M.S.; N.B.-L. was supported by an intra-European fellowship of the European commission (Marie-Curie actions, FP7; http://cordis.europa.eu/fp7/home_en.html) and a grant of the ELAN fonds of the University of Erlangen-Nuremberg (http://www.elan.med.unierlangen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fres JM, 2010, J LIPID RES, V51, P2454, DOI 10.1194/jlr.D005397; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; ITSUI Y, 2009, HEPATOLOGY; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kunzelmann S, 2006, J BIOL CHEM, V281, P28627, DOI 10.1074/jbc.M604911200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nantais DE, 1996, J LEUKOCYTE BIOL, V60, P423, DOI 10.1002/jlb.60.3.423; Naschberger E, 2006, AM J PATHOL, V169, P1088, DOI 10.2353/ajpath.2006.060244; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V303, P1, DOI 10.1016/S0006-291X(03)00323-1; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; VOPEL T, 2010, J MOL BIOL; WEHNER M, 2010, FEBS J; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	56	81	86	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14246	10.1371/journal.pone.0014246	http://dx.doi.org/10.1371/journal.pone.0014246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151871	gold, Green Published, Green Submitted			2022-12-25	WOS:000285041800005
J	Opsteegh, L; Soer, R; Reinders-Messelink, HA; Reneman, MF; van der Sluis, CK				Opsteegh, Lonneke; Soer, Remko; Reinders-Messelink, Heleen A.; Reneman, Michiel F.; van der Sluis, Corry K.			Validity of the Dictionary of Occupational Titles for Assessing Upper Extremity Work Demands	PLOS ONE			English	Article							HAND; FRACTURE; TIME	Objectives: The Dictionary of Occupational Titles (DOT) is used in vocational rehabilitation to guide decisions about the ability of a person with activity limitations to perform activities at work. The DOT has categorized physical work demands in five categories. The validity of this categorization is unknown. Aim of this study was to investigate whether the DOT could be used validly to guide decisions for patients with injuries to the upper extremities. Four hypotheses were tested. Methods: A database including 701 healthy workers was used. All subjects filled out the Dutch Musculoskeletal Questionnaire, from which an Upper Extremity Work Demands score (UEWD) was derived. First, relation between the DOT-categories and UEWD-score was analysed using Spearman correlations. Second, variance of the UEWD-score in occupational groups was tested by visually inspecting boxplots and assessing kurtosis of the distribution. Third, it was investigated whether occupations classified in one DOT-category, could significantly differ on UEWD-scores. Fourth, it was investigated whether occupations in different DOT-categories could have similar UEWD-scores using Mann Whitney U-tests (MWU). Results: Relation between the DOT-categories and the UEWD-score was weak (r(sp) = 0.40; p < .01). Overlap between categories was found. Kurtosis exceeded +/- 1.0 in 3 occupational groups, indicating large variance. UEWD-scores were significantly different within one DOT-category (MWU = 1.500; p < .001). UEWD scores between DOT-categories were not significantly different (MWU = 203.000; p = .49). Conclusion: All four hypotheses could not be rejected. The DOT appears to be invalid for assessing upper extremity work demands.	[Opsteegh, Lonneke; Soer, Remko; Reinders-Messelink, Heleen A.; Reneman, Michiel F.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands; [Reinders-Messelink, Heleen A.] Ctr Rehabil Revalidatie Friesland, Beetsterzwaag, Netherlands	University of Groningen	Opsteegh, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands.	l.opsteegh@cvr.umcg.nl		Soer, Remko/0000-0003-4154-1711	Stichting Instituut GAK [2100304]	Stichting Instituut GAK	This work was supported by the Stichting Instituut GAK: www.stichtinginstituutgak.nl, grant number: 2100304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dale AM, 2010, INT J OCCUP ENV HEAL, V16, P1; Field A, 2002, DISCOVERING STAT USI; Frings-Dresen MHW, 2003, J OCCUP REHABIL, V13, P233, DOI 10.1023/A:1026268620904; HILDEBRANDT VH, 2001, THESIS VRIJE U AMSTE; HILDEBRANDT VH, 2001, PREVENTION WORK RELA, P33; Innes Ev, 1999, Work, V13, P125; KASDAN ML, 1993, J OCCUP ENVIRON MED, V35, P132, DOI 10.1097/00043764-199302000-00013; MacDermid JC, 2007, J OCCUP REHABIL, V17, P47, DOI 10.1007/s10926-007-9069-0; Meiners PM, 2005, DISABIL REHABIL, V27, P617, DOI 10.1080/09638280500030423; Miller A. R., 1980, WORK JOBS OCCUPATION; Pennathur A, 2001, J OCCUP REHABIL, V11, P281, DOI 10.1023/A:1013348609126; Pennathur A, 1999, J OCCUP REHABIL, V9, P227, DOI 10.1023/A:1021327617705; Skov O, 1999, J HAND SURG-BRIT EUR, V24B, P187, DOI 10.1054/jhsb.1998.0180; Soer R, 2006, Work, V26, P273; Soer R, 2009, ARCH PHYS MED REHAB, V90, P1785, DOI 10.1016/j.apmr.2009.05.008; *US EMPL TRAIN ADM, 1991, DICT OCC TITL; Waters T., 1994, APPL MANUAL REVISED, V94	17	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15158	10.1371/journal.pone.0015158	http://dx.doi.org/10.1371/journal.pone.0015158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151934	Green Published, gold			2022-12-25	WOS:000284939600029
J	Kim, EY; Shin, HY; Kim, JY; Kim, DG; Choi, YM; Kwon, HK; Rhee, DK; Kim, YS; Choi, S				Kim, Eun-Young; Shin, Hye Young; Kim, Joo-Young; Kim, Dong-Gun; Choi, Yong-Min; Kwon, Hyuk-Kwon; Rhee, Dong-Kwon; Kim, You-Sun; Choi, Sangdun			ATF3 Plays a Key Role in Kdo(2)-Lipid A-Induced TLR4-Dependent Gene Expression via NF-kappa B Activation	PLOS ONE			English	Article							INDUCIBLE NUCLEAR-PROTEIN; TLR-SIGNALING PATHWAYS; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR-3; NEGATIVE REGULATION; ESCHERICHIA-COLI; TRANSDUCTION; MACROPHAGES; ENDOTOXIN; BINDING	Background: Activating transcription factor 3 (ATF3) is a negative regulator of proinflammatory cytokine expression in macrophages, and ATF3 deficient mice are more susceptible to endotoxic shock. This study addresses the role of ATF3 in the Kdo(2)-Lipid A-induced Toll-like receptor 4 (TLR4) signaling pathway in mouse embryonic fibroblasts (MEF). Kdo(2)-Lipid A upregulates ATF3 expression in wild type MEF cells and induces both nuclear factor kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) activation via the TLR4 signaling pathway, while neither of these pathways is activated in ATF3-/- MEF cells. Interestingly, in contrast to Kdo(2)-Lipid A, the activation of both NF-kappa B and JNK by TNF-alpha was normal in ATF3-/- MEF cells. Methodology/Principal Findings: We found that several genes were dramatically upregulated in ATF3+/+ MEF cells in response to Kdo(2)-Lipid A treatment, while little difference was observed in the ATF3-/- MEF cells. However, we also found that the signal intensities of I kappa B zeta in ATF3-/- MEF cells were substantially higher than those in wild type MEF cells upon microarray analyses, and upregulated I kappa B zeta expression was detected in the cytosol fraction. Conclusions/Significance: Our findings indicate that ATF3 deficiency affects Kdo(2)-Lipid A-induced TLR4 signaling pathways in MEF cells, that it may upregulate I kappa B zeta expression and that the high levels of I kappa B zeta expression in ATF3-/- cells disrupts Kdo(2)-Lipid A-mediated signaling pathways.	[Kim, Eun-Young; Shin, Hye Young; Choi, Yong-Min; Kwon, Hyuk-Kwon; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Kim, Joo-Young; Kim, Dong-Gun; Kim, You-Sun] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea; [Rhee, Dong-Kwon] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Ajou University; Ajou University; Sungkyunkwan University (SKKU)	Kim, EY (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	yousunkim@ajou.ac.kr; sangdunchoi@ajou.ac.kr	kwon, hyuk-kwon/AAS-4154-2021; kwon, hyukkwon/GRS-1775-2022	kwon, hyuk-kwon/0000-0002-4723-4061; Kim, Dong-Gun/0000-0002-0780-6301	Ministry of Education, Science, and Technology [2009-0067084, 2010-0015356]; Korea Food AND Drug Administration [10182KFDA992]; National Research Foundation of Korea (NRF) [2010-0028294]; Korea Science and Engineering Foundation [WCU R33-10045]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food AND Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0067084 to YSK and 2010-0015356 to SC). This work was also partly supported by a grant (10182KFDA992) from Korea Food AND Drug Administration, the Priority Research Centers Program through the National Research Foundation of Korea (NRF) (2010-0028294) and a grant (WCU R33-10045) from the Korea Science and Engineering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; AKIRA S, 2003, BIOCH SOC T, V31; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chung JY, 2002, J CELL SCI, V115, P679; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; GODOWSKI P, 1999, J EXP MED, V189, P1437; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hai T, 1999, GENE EXPRESSION, V7, P321; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim SH, 2004, TOXICOL APPL PHARM, V196, P47, DOI 10.1016/j.taap.2003.11.020; Konadu E, 1999, INFECT IMMUN, V67, P6191, DOI 10.1128/IAI.67.11.6191-6193.1999; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li LM, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-49; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakagomi S, 2003, J NEUROSCI, V23, P5187; NILSSON M, 1995, J BIOL CHEM, V270, P12210, DOI 10.1074/jbc.270.20.12210; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Wang ZL, 2008, CELL BIOL INT, V32, P484, DOI 10.1016/j.cellbi.2007.10.009; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	42	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14181	10.1371/journal.pone.0014181	http://dx.doi.org/10.1371/journal.pone.0014181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152039	Green Published, gold, Green Submitted			2022-12-25	WOS:000284868000007
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Liu, F; Huang, D; Fu, ZY; Ma, XA; Chen, BD; Huang, Y				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Liu, Fen; Huang, Ding; Fu, Zhen-Yan; Ma, Xiang; Chen, Bang-Dang; Huang, Ying			Alcohol Consumption and Ankle-to-Brachial Index: Results from the Cardiovascular Risk Survey	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; CAROTID ATHEROSCLEROSIS; OLDER-ADULTS; ASSOCIATION; MORTALITY; EXPRESSION; DRINKING	Background and Methodology: A low ankle-to-brachial index (ABI) is a strong correlate of cardiovascular disease and subsequent mortality. The relationship between ABI and alcohol consumption remains unclear. Data are from the Cardiovascular Risk Survey (CRS), a multiple-ethnic, community-based, cross-sectional study of 14 618 Chinese people (5 757 Hans, 4 767 Uygurs, and 4 094 Kazakhs) aged 35 years and over at baseline from Oct. 2007 to March 2010. The relationship between alcohol intake and ABI was determined by use of analysis of covariance and multivariable regressions. Principal Findings: In men, alcohol consumption was significantly associated with ABI (P<0.001). After adjusted for the confounding factors, such as age, sex, ethnicity, body mass index, smoking, work stress, diabetes, and fasting blood glucose, the difference remained significant (P<0.001); either the unadjusted or multivariate-adjusted odds ratio (OR) for peripheral artery disease (PAD) was significantly higher in men who consumed >60.0 g/d [OR = 3.857, (95% CI: 2.555-5.824); OR = 2.797, (95% CI: 1.106-3.129); OR = 2.878, (95% CI: 1.215-4.018); respectively] and was significantly lower in men who consumed 20.1-40.0 g/d [OR = 0.330, (95% CI: 0.181-0.599); OR = 0.484, (95% CI: 0.065-0.894); OR = 0.478, (95% CI: 0.243-1.534); respectively] and 40.1-60.0 g/d [OR = 0.306, (95% CI: 0.096-0.969); OR = 0.267, (95% CI: 0.087-0.886); OR = 0.203, (95% CI: 0.113-0.754); respectively] compared with never drinking, respectively (all P<0.01). Neither in unadjusted nor in multivariate-adjusted model was the association between ABI and alcohol consumption significant (all P>0.05) in women. Similarly, PAD was not correlated with alcohol intake in women (all P>0.05). Conclusions/Significance: Our results indicated that in Chinese men, alcohol consumption was associated with peripheral artery disease, and consumption of less than 60 g/d had an inverse association with peripheral atherosclerosis whereas consumption of 60 g/d or more had a positive association.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Huang, Ding; Fu, Zhen-Yan; Ma, Xiang; Huang, Ying] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Liu, Fen; Fu, Zhen-Yan; Ma, Xiang; Chen, Bang-Dang] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Xie, X (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Great Technology Special Item Foundation of Xinjiang, China [200733146-3]	Great Technology Special Item Foundation of Xinjiang, China	This work was supported financially by grants from the Great Technology Special Item Foundation of Xinjiang, China(200733146-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2009, VASC MED, V14, P215, DOI 10.1177/1358863X08101999; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Chalmers J, 1999, J HYPERTENS, V17, P151; Conte MS, 2008, CIRCULATION, V117, P717, DOI 10.1161/CIRCULATIONAHA.107.754598; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Damiani IT, 2004, ARQ NEURO-PSIQUIAT, V62, P1022, DOI 10.1590/S0004-282X2004000600017; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Djousse L, 2002, STROKE, V33, P1357, DOI 10.1161/01.STR.0000014325.54063.1A; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; DOOBAY AV, 2005, ARTERIOSCLER THROMB, V25, P1; Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377; Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Greenland P, 2000, CIRCULATION, V101, P723; JEPSON RG, 1995, EUR J EPIDEMIOL, V11, P9, DOI 10.1007/BF01719940; JUONALA M, 2008, ATHEROSCLEROSIS, V204, pE93; Kauhanen J, 1999, ARTERIOSCL THROM VAS, V19, P3001, DOI 10.1161/01.ATV.19.12.3001; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Laurin D, 2007, CIRCULATION, V116, P2269, DOI 10.1161/CIRCULATIONAHA.106.686477; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Migliacci R, 2008, FAM PRACT, V25, P228, DOI 10.1093/fampra/cmn035; Mukamal KJ, 2008, AM J EPIDEMIOL, V167, P34, DOI 10.1093/aje/kwm274; Mukamal KJ, 2003, ARTERIOSCL THROM VAS, V23, P2252, DOI 10.1161/01.ATV.0000101183.58453.39; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Nunez D, 2010, REV ESP CARDIOL, V63, P54, DOI 10.1016/S0300-8932(10)70009-9; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Olsen TS, 2010, GENDER MED, V7, P284, DOI 10.1016/j.genm.2010.08.001; Sacanella E, 2003, ADDICT BIOL, V8, P371, DOI 10.1080/13556210310001656376; Schminke U, 2005, STROKE, V36, P1746, DOI 10.1161/01.STR.0000173159.65228.68; Smith S C Jr, 2000, Circulation, V101, P111; Traish AM, 2011, ATHEROSCLEROSIS, V214, P244, DOI 10.1016/j.atherosclerosis.2010.08.078; Vliegenthart R, 2002, AM J EPIDEMIOL, V155, P332, DOI 10.1093/aje/155.4.332; Wallerath T, 2003, J AM COLL CARDIOL, V41, P471, DOI 10.1016/S0735-1097(02)02826-7; Wild SH, 2006, DIABETES CARE, V29, P637, DOI 10.2337/diacare.29.03.06.dc05-1637; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9; Zureik M, 2004, STROKE, V35, P2770, DOI 10.1161/01.STR.0000147968.48379.c3	43	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15181	10.1371/journal.pone.0015181	http://dx.doi.org/10.1371/journal.pone.0015181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152041	gold, Green Published, Green Submitted			2022-12-25	WOS:000284868000031
J	Kama, A; Tannenbaum, E				Kama, Amit; Tannenbaum, Emmanuel			Effect of the SOS Response on the Mean Fitness of Unicellular Populations: A Quasispecies Approach	PLOS ONE			English	Article							LANDSCAPES; MUTATION; GENOMES	The goal of this paper is to develop a mathematical model that analyzes the selective advantage of the SOS response in unicellular organisms. To this end, this paper develops a quasispecies model that incorporates the SOS response. We consider a unicellular, asexually replicating population of organisms, whose genomes consist of a single, double-stranded DNA molecule, i.e. one chromosome. We assume that repair of post-replication mismatched base-pairs occurs with probability lambda, and that the SOS response is triggered when the total number of mismatched base-pairs is at least l(S). We further assume that the per-mismatch SOS elimination rate is characterized by a first-order rate constant kappa(SOS). For a single fitness peak landscape where the master genome can sustain up to l mismatches and remain viable, this model is analytically solvable in the limit of infinite sequence length. The results, which are confirmed by stochastic simulations, indicate that the SOS response does indeed confer a fitness advantage to a population, provided that it is only activated when DNA damage is so extensive that a cell will die if it does not attempt to repair its DNA.	[Kama, Amit; Tannenbaum, Emmanuel] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel	Ben Gurion University	Tannenbaum, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.	emanuelt@bgu.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by an Alon Fellowship, Israel Science Foundation (http://www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash R.B., 1990, INFORM THEORY; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Brumer Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061909; Brumer Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061912; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Kessler DA, 1998, PHYS REV LETT, V80, P2012, DOI 10.1103/PhysRevLett.80.2012; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Nilsson M, 2000, PHYS REV LETT, V84, P191, DOI 10.1103/PhysRevLett.84.191; Sasaki A, 2003, J THEOR BIOL, V224, P241, DOI 10.1016/S0022-5193(03)00161-9; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061915; Tannenbaum E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138105; Tannenbaum E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061916; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021903; Tannenbaum E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011902; Tannenbaum E, 2005, PHYS LIFE REV, V2, P290, DOI 10.1016/j.plrev.2005.08.001; Tannenbaum E, 2006, J THEOR BIOL, V241, P791, DOI 10.1016/j.jtbi.2006.01.016; Voet D., 2005, BIOCHEMISTRY-US; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44	19	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14113	10.1371/journal.pone.0014113	http://dx.doi.org/10.1371/journal.pone.0014113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152423	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100005
J	Hu, D; Wan, Y				Hu, Dong; Wan, Yong			Regulation of Kruppel-like Factor 4 by the Anaphase Promoting Complex Pathway Is Involved in TGF-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; DNA-DAMAGE; GROWTH-INHIBITION; FACTOR EXPRESSION; UBIQUITIN LIGASE; GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER; DEGRADATION	Kruppel-like factor 4 (KLF4), a zinc finger-containing transcriptional factor, regulates a variety of biological processes, including cell proliferation, differentiation, apoptosis, and stem cell reprogramming. Post-translational modifications of KLF4, including phosphorylation, acetylation, and sumoylation, regulate its transcriptional activity. Most recent studies also demonstrate that KLF4 is targeted for ubiquitin-dependent proteolysis during cell cycle progression. However, the underlying mechanism remains largely unknown. In this study, we demonstrated that KLF4 is profoundly degraded in response to TGF-beta signaling. We have identified the Cdh1-anaphase promoting complex as a putative E3 ligase that governs TGF-beta-induced KLF4 degradation. The TGF-beta-induced KLF4 degradation is mediated by the destruction box on the KLF4. Either depletion of Cdh1 by RNA interference or stabilization of KLF4 by disruption of its destruction box significantly attenuates TGF-beta-induced ubiquitylation and degradation. In addition, depletion of Cdh1 or stabilization of KLF4 antagonizes TGF-beta-induced activation of transcription. Determining the role of KLF4 proteolysis in response to TGF-beta signaling has opened a new perspective to understand the TGF-beta signaling pathway.	[Wan, Yong] Univ Pittsburgh, Hillman Canc Ctr, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wan, Y (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Sch Med, Dept Cell Biol & Physiol, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu	hu, dong/F-8812-2011		National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA154695, R01CA115943] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943.	ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Chen YG, 2009, CELL, V139, P658, DOI 10.1016/j.cell.2009.10.038; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chen ZY, 2002, J BIOL CHEM, V277, P46831, DOI 10.1074/jbc.M204816200; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Datto M, 2005, CELL, V121, P2, DOI 10.1016/j.cell.2005.03.017; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stroschein SL, 2001, GENE DEV, V15, P2822; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	67	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6890	6901		10.1074/jbc.M110.179952	http://dx.doi.org/10.1074/jbc.M110.179952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177849	Green Published, hybrid			2022-12-25	WOS:000287737300004
J	Garcia, MT; Blazquez, MA; Ferrandiz, MJ; Sanz, MJ; Silva-Martin, N; Hermoso, JA; de la Campa, AG				Teresa Garcia, Maria; Amparo Blazquez, Maria; Jose Ferrandiz, Maria; Jesus Sanz, Maria; Silva-Martin, Noella; Hermoso, Juan A.; de la Campa, Adela G.			New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL FRAGMENT; PROTEIN; FLUOROQUINOLONES; CRYSTALLOGRAPHY; RESISTANCE; GENOME	Streptococcus pneumoniae has two type II DNA-topoisomerases (DNA-gyrase and DNA topoisomerase IV) and a single type I enzyme (DNA-topoisomerase I, TopA), as demonstrated here. Although fluoroquinolones target type II enzymes, antibiotics efficiently targeting TopA have not yet been reported. Eighteen alkaloids (seven aporphine and 11 phenanthrenes) were semisynthesized from boldine and used to test inhibition both of TopA activity and of cell growth. Two phenanthrenes (seconeolitsine and N-methyl-seconeolitsine) effectively inhibited both TopA activity and cell growth at equivalent concentrations (similar to 17 mu M). Evidence for in vivo TopA targeting by seconeolitsine was provided by the protection of growth inhibition in a S. pneumoniae culture in which the enzyme was overproduced. Additionally, hypernegative supercoiling was observed in an internal plasmid after drug treatment. Furthermore, a model of pneumococcal TopA was made based on the crystal structure of Escherichia coli TopA. Docking calculations indicated strong interactions of the alkaloids with the nucleotide-binding site in the closed protein conformation, which correlated with their inhibitory effect. Finally, although seconeolitsine and N-methyl-seconeolitsine inhibited TopA and bacterial growth, they did not affect human cell viability. Therefore, these new alkaloids can be envisaged as new therapeutic candidates for the treatment of S. pneumoniae infections resistant to other antibiotics.	[de la Campa, Adela G.] Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid 28220, Spain; [de la Campa, Adela G.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid 28220, Spain; [Amparo Blazquez, Maria; Jesus Sanz, Maria] Univ Valencia, Fac Farm, Dept Farmacol, Valencia 46100, Spain; [Silva-Martin, Noella; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, E-28006 Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	de la Campa, AG (corresponding author), Carretera & Pozuelo Km 2, Madrid 28220, Spain.	agcampa@isciii.es	Ferrandiz, Maria-Jose/K-2820-2014; de la Campa, Adela G/K-1654-2014; Hermoso, Juan/J-3433-2012	Ferrandiz, Maria-Jose/0000-0003-1428-9506; de la Campa, Adela G/0000-0002-3598-2548; Hermoso, Juan/0000-0002-1862-8950; Sanz, Maria Jesus/0000-0002-8885-294X; Blazquez, M. Amparo/0000-0001-7673-9328	Comunidad de Madrid [CM-BIO0260-2006, COMBACT]; Spanish Ministry of Science and Innovation [BIO2008-02154, BFU2008-01711, SAF2008-03477]; Spanish Ministry of Health, Carlos III Health Institute [RIER, RD08/0075/0016]	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health, Carlos III Health Institute	The work was supported by Comunidad de Madrid Grant CM-BIO0260-2006, COMBACT (to J. H. and A. G. C.); Spanish Ministry of Science and Innovation Grants BIO2008-02154 (to A. G. C.), BFU2008-01711 (to J. A. H.), and SAF2008-03477 (to M. J. S.); and Spanish Ministry of Health, Carlos III Health Institute Grants RIER, RD08/0075/0016 (to M. J. S.).	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caron P R, 1994, Adv Pharmacol, V29B, P271; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng BK, 2007, J ANTIMICROB CHEMOTH, V59, P640, DOI 10.1093/jac/dkl556; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Feinberg H, 1999, NAT STRUCT BIOL, V6, P918; Fernandez-Moreira E, 2000, MICROB DRUG RESIST, V6, P259, DOI 10.1089/mdr.2000.6.259; Ferrandiz MJ, 2010, NUCLEIC ACIDS RES, V38, P3570, DOI 10.1093/nar/gkq106; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLER W, 1975, P NATL ACAD SCI USA, V72, P2550, DOI 10.1073/pnas.72.7.2550; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Martin-Parras L, 1998, NUCLEIC ACIDS RES, V26, P3424, DOI 10.1093/nar/26.14.3424; Mateo T, 2007, BLOOD, V110, P1895, DOI 10.1182/blood-2007-01-070607; Milian L, 2004, CHEM PHARM BULL, V52, P696, DOI 10.1248/cpb.52.696; Munoz R, 1996, ANTIMICROB AGENTS CH, V40, P2252, DOI 10.1128/AAC.40.10.2252; National Committee for Clinical Laboratory Standards, 2004, M100S14 NAT COMM CLI; Nieto C, 2000, PLASMID, V43, P205, DOI 10.1006/plas.2000.1465; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHARMA A, 1994, STRUCTURE, V2, P767, DOI 10.1016/S0969-2126(94)00077-8; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; YU LP, 1995, BIOCHEMISTRY-US, V34, P7622, DOI 10.1021/bi00023a008	33	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6402	6413		10.1074/jbc.M110.148148	http://dx.doi.org/10.1074/jbc.M110.148148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169356	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000287476400051
J	Encarnacao, M; Kollmann, K; Trusch, M; Braulke, T; Pohl, S				Encarnacao, Marisa; Kollmann, Katrin; Trusch, Maria; Braulke, Thomas; Pohl, Sandra			Post-translational Modifications of the gamma-Subunit Affect Intracellular Trafficking and Complex Assembly of GlcNAc-1-phosphotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; LYSOSOMAL-ENZYMES; ENDOPLASMIC-RETICULUM; WEB SERVER; III GAMMA; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE	GlcNAc-1-phosphotransferase plays a key role in the generation of mannose 6-phosphate, a recognition marker essential for efficient transport of lysosomal hydrolases to lysosomes. The enzyme complex is composed of six subunits (alpha(2)beta(2)gamma(2)). The alpha-and beta-subunits are catalytically active, whereas the function of the gamma-subunit is still unclear. We have investigated structural properties, localization, and intracellular transport of the human and mouse gamma-subunits and the molecular requirements for the assembly of the phosphotransferase complex. The results showed that endogenous and overexpressed gamma-subunits were localized in the cis-Golgi apparatus. Secreted forms of gamma-subunits were detectable in media of cultured cells as well as in human serum. The gamma-subunit contains two in vivo used N-glycosylation sites at positions 88 and 115, equipped with high mannose-type oligosaccharides. S-35 pulse-chase experiments and size exclusion chromatography revealed that the majority of non-glycosylated gamma-subunit mutants were integrated in high molecular mass complexes, failed to exit the endoplasmic reticulum (ER), and were rapidly degraded. The substitution of cysteine 245 involved in dimerization of gamma-subunits impaired neither ER exit nor trafficking through the secretory pathway. Monomeric gamma-subunits failed, however, to associate with other GlcNAc-1-phosphotransferase subunits. The data provide evidence that assembly of the GlcNAc-1-phosphotransferase complex takes place in the ER and requires dimerization of the gamma-subunits.	[Encarnacao, Marisa; Kollmann, Katrin; Braulke, Thomas; Pohl, Sandra] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany; [Trusch, Maria] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pohl, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Bldg N27,Martinistr 52, D-20246 Hamburg, Germany.	s.pohl@uke.uni-hamburg.de	Pohl, Sandra/AAF-1943-2020; Braulke, Thomas/AAV-9121-2020; Encarnação, Marisa/P-4261-2016; Encarnação, Marisa/AAY-4609-2020; Riedner, Maria/W-5546-2019	Braulke, Thomas/0000-0002-2336-8532; Encarnação, Marisa/0000-0002-3726-2851; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [GRK1459, FOR885, SFB877]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants GRK1459, FOR885, and SFB877.	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hogan B, 1986, MANIPULATING MOUSE E, P89; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tiede Stephan, 2004, Hum Mutat, V24, P535, DOI 10.1002/humu.9293; WAHEED A, 1981, J BIOL CHEM, V256, P4150; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381	23	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5311	5318		10.1074/jbc.M110.202382	http://dx.doi.org/10.1074/jbc.M110.202382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173149	hybrid, Green Published			2022-12-25	WOS:000287230600039
J	Moreno, E; Hoffmann, H; Gonzalez-Sepulveda, M; Navarro, G; Casado, V; Cortes, A; Mallol, J; Vignes, M; McCormick, PJ; Canela, EI; Lluis, C; Moratalla, R; Ferre, S; Ortiz, J; Franco, R				Moreno, Estefana; Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; Vignes, Michel; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Moratalla, Rosario; Ferre, Sergi; Ortiz, Jordi; Franco, Rafael			Dopamine D-1-histamine H-3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; HISTAMINE H-3; RAT-BRAIN; INHIBITION; AGONIST; D-1; H3; NEUROTRANSMITTER; PHARMACOLOGY; HALOPERIDOL	Previously, using artificial cell systems, we identified receptor heteromers between the dopamine D-1 or D-2 receptors and the histamine H-3 receptor. In addition, we demonstrated two biochemical characteristics of the dopamine D-1 receptor-histamine H-3 receptor heteromer. We have now extended this work to show the dopamine D-1 receptor-histamine H-3 receptor heteromer exists in the brain and serves to provide a novel link between the MAPK pathway and the GABAergic neurons in the direct striatal efferent pathway. Using the biochemical characteristics identified previously, we found that the ability of H-3 receptor activation to stimulate p44 and p42 extracellular signal-regulated MAPK (ERK 1/2) phosphorylation was only observed in striatal slices of mice expressing D-1 receptors but not in D-1 receptor-deficient mice. On the other hand, the ability of both D-1 and H-3 receptor antagonists to block MAPK activation induced by either D-1 or H-3 receptor agonists was also found in striatal slices. Taken together, these data indicate the occurrence of D-1-H-3 receptor complexes in the striatum and, more importantly, that H-3 receptor agonist-induced ERK 1/2 phosphorylation in striatal slices is mediated by D-1-H-3 receptor heteromers. Moreover, H-3 receptor-mediated phospho-ERK 1/2 labeling co-distributed with D-1 receptor-containing but not with D-2 receptor-containing striatal neurons. These results indicate that D-1-H-3 receptor heteromers work as processors integrating dopamine-and histamine-related signals involved in controlling the function of striatal neurons of the direct striatal pathway.	[Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain; [Moreno, Estefana; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Biol, E-08028 Barcelona, Spain; [Moreno, Estefana; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Ortiz, Jordi] Univ Autonoma Barcelona, Fac Med, Inst Neurosci, Bellaterra 08193, Spain; [Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Ortiz, Jordi] Univ Autonoma Barcelona, Fac Med, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Vignes, Michel] Univ Montpellier 2, Univ Montpellier 1&2, Max Mousseron Biomol Inst, CNRS,UMR 5247, F-34095 Montpellier, France; [Ferre, Sergi] Natl Inst Drug Abuse, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Moratalla, Rosario] CSIC, Inst Cajal, E-28002 Madrid, Spain	University of Navarra; CIBERNED; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Franco, R (corresponding author), Univ Navarra, Ctr Invest Med Aplicada, Pio 12,5, I-31008 Pamplona, Italy.	rfranco@unav.es	Guillén, Estefanía Moreno/ABE-4371-2020; Mallol, Josefa/I-4194-2015; McCormick, Peter/E-7387-2012; Vignes, Michel/AAA-7693-2019; Canela, Enric I./M-8726-2013; Ortiz, Jordi/E-9018-2011; Franco, Rafael/C-3694-2015; Ferre, Sergi/K-6115-2014; Casadó, Vicent/K-1660-2014; Navarro, Gemma/AAO-7866-2021; Moratalla, Rosario V/H-9280-2015; Hoffmann, Hanne/W-6557-2019	Mallol, Josefa/0000-0002-2479-4162; McCormick, Peter/0000-0002-2225-5181; Vignes, Michel/0000-0003-0969-2966; Canela, Enric I./0000-0003-4992-7440; Ortiz, Jordi/0000-0002-9748-2290; Franco, Rafael/0000-0003-2549-4919; Ferre, Sergi/0000-0002-1747-1779; Casadó, Vicent/0000-0002-1764-3825; Navarro, Gemma/0000-0003-4654-0873; Moratalla, Rosario V/0000-0002-7623-8010; Gonzalez Sepulveda, Marta/0000-0002-5627-847X; Moreno, Estefania/0000-0002-2491-5753; Hoffmann, Hanne Mette/0000-0003-1555-1369	Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2008-03229-E, SAF2009-07276, SAF2006-08240, SAF2009-12510]; Centre National de la Recherche Scintifique; French Ministry of Research and Higher Education; Red de Transtornos Adictivos [RD06/0001/0015]; Fundacio La Marato de TV3 [060110]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centre National de la Recherche Scintifique; French Ministry of Research and Higher Education; Red de Transtornos Adictivos; Fundacio La Marato de TV3; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by Grants SAF2008-00146, SAF2008-03229-E, SAF2009-07276, SAF2006-08240, and SAF2009-12510 from the Spanish Ministerio de Ciencia y Tecnologia, the Centre National de la Recherche Scintifique, the French Ministry of Research and Higher Education, Red de Transtornos Adictivos RD06/0001/0015, Grant 060110 from Fundacio La Marato de TV3 and the Intramural Funds of the National Institute on Drug Abuse.	Albin Roger L., 1995, Trends in Neurosciences, V18, P63, DOI 10.1016/0166-2236(95)93872-U; Arias-Montano JA, 2001, BRIT J PHARMACOL, V133, P165, DOI 10.1038/sj.bjp.0704053; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Franco R, 2008, BRIT J PHARMACOL, V153, pS90, DOI 10.1038/sj.bjp.0707571; Franco R, 2009, BRIT J PHARMACOL, V158, P23, DOI 10.1111/j.1476-5381.2009.00181.x; Garcia-Ramirez M, 2004, BEHAV BRAIN RES, V154, P409, DOI 10.1016/j.bbr.2004.03.007; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; Hasbi A, 2010, CURR OPIN PHARMACOL, V10, P93, DOI 10.1016/j.coph.2009.09.011; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hussain N, 2002, NEUROSCIENCE, V112, P427, DOI 10.1016/S0306-4522(02)00069-6; Leurs R, 2005, NAT REV DRUG DISCOV, V4, P107, DOI 10.1038/nrd1631; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreno-Delgado D, 2006, NEUROPHARMACOLOGY, V51, P517, DOI 10.1016/j.neuropharm.2006.04.010; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Pillot C, 2002, J NEUROSCI, V22, P7272; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; RYU JH, 1994, NEUROREPORT, V5, P621, DOI 10.1097/00001756-199401000-00022; Sanchez-Lemus E, 2004, NEUROSCI LETT, V364, P179, DOI 10.1016/j.neulet.2004.04.045; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Torrent A, 2005, MOL PHARMACOL, V67, P195, DOI 10.1124/mol.104.005652; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	32	95	96	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5846	5854		10.1074/jbc.M110.161489	http://dx.doi.org/10.1074/jbc.M110.161489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173143	Green Published, hybrid			2022-12-25	WOS:000287230600093
J	Beitelshees, AL; Johnson, JA; Hames, ML; Gong, Y; Cooper-DeHoff, RM; Wu, J; Cresci, S; Ma, CX; Pepine, CJ; Province, MA; Spertus, JA; McLeod, HL				Beitelshees, Amber L.; Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.; Wu, Jun; Cresci, Sharon; Ma, Cynthia X.; Pepine, Carl J.; Province, Michael A.; Spertus, John A.; McLeod, Howard L.			Aromatase Gene Polymorphisms Are Associated with Survival among Patients with Cardiovascular Disease in a Sex-Specific Manner	PLOS ONE			English	Article							ACUTE-CORONARY-SYNDROME; ESTROGEN-RELATED GENES; GENDER-DIFFERENCES; BLOOD-PRESSURE; OUTCOMES; EXPRESSION; TESTOSTERONE; EVOLUTION; GENOTYPE; HORMONES	Introduction: CYP19A1 encodes aromatase, the enzyme responsible for the conversion of androgens to estrogens, and may play a role in variation in outcomes among men and women with cardiovascular disease. We sought to examine genetic variation in CYP19A1 for its potential role in sex differences in cardiovascular disease outcomes. Methods: Caucasian individuals from two independent populations were assessed: 1) a prospective cohort of patients with acute coronary syndromes with 3-year mortality follow-up (n = 568) and 2) a nested case-control study from a randomized, controlled trial of hypertension patients with stable coronary disease in which the primary outcome was death, nonfatal myocardial infarction (MI) or nonfatal stroke (n = 619). Six CYP19A1 SNPs were genotyped (-81371 C>T, -45965 G>C, M201T, R264C, 80 A>G, and + 32226 G>A). The sex*genotype interaction term was assessed for the primary outcome and compared by genotype in men and women when a significant interaction term was identified. Results: We identified a significant interaction between -81371 C>T and sex (p = 0.025) in the ACS population. The variant allele was associated with a 78% increase in mortality in men (HR 1.78, 95% confidence interval [CI] 1.08-2.94) and a nonsignificant 42% decrease in mortality among women (HR 0.58, 95% CI 0.22-1.54). We identified a similar association in the hypertensive CAD group, the -81371 C>T*sex interaction term was p<0.0001, with an associated 65% increase in death, MI, or stroke (HR 1.65, 95% CI 1.00-2.73) in men and a 69% decrease (HR 0.31, 95% CI 0.16-0.6) in women. Conclusions: Using two independent populations, this study is the first to document a significant interaction between CYP19A1 genotype and sex on cardiovascular outcomes. These findings could illuminate potential mechanisms of sex differences in cardiovascular disease outcomes.	[Beitelshees, Amber L.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Johnson, Julie A.; Hames, Megan L.; Gong, Yan; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL USA; [Wu, Jun; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Cresci, Sharon] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA; [Cresci, Sharon] Washington Univ, Cardiovasc Res Ctr, Sch Med, St Louis, MO USA; [Ma, Cynthia X.; McLeod, Howard L.] Washington Univ, Div Oncol, Sch Med, St Louis, MO USA; [Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA; [Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA	University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida; University of Missouri System; University of Missouri Kansas City; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute	Beitelshees, AL (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	abeitels@medicine.umaryland.edu	Spertus, John/ABD-3075-2021; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Heart, Lung, and Blood Institute [HL091120, HL077113, HL074730]; National Institutes of Health [RR017568]; University of Florida; Abbott Laboratories; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL091120, P50HL077113, R01HL074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); Abbott Laboratories(Abbott Laboratories); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Heart, Lung, and Blood Institute: HL091120, HL077113 and HL074730; RR017568 from the National Institutes of Health, and grants from the University of Florida Opportunity Fund and Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitelshees AL, 2007, PHARMACOGENET GENOM, V17, P719, DOI 10.1097/FPC.0b013e32810f2e3c; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Pacanowski MA, 2008, CLIN PHARMACOL THER, V84, P715, DOI 10.1038/clpt.2008.139; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Peter I, 2005, J HYPERTENS, V23, P2193, DOI 10.1097/01.hjh.0000188728.66183.92; Peter I, 2008, J CLIN ENDOCR METAB, V93, P2779, DOI 10.1210/jc.2008-0106; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Ramirez-Lorca R, 2007, HYPERTENSION, V50, P884, DOI 10.1161/HYPERTENSIONAHA.107.096263; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Shaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105	18	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15180	10.1371/journal.pone.0015180	http://dx.doi.org/10.1371/journal.pone.0015180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170323	Green Published, gold			2022-12-25	WOS:000285181400021
J	Sefah, K; Meng, L; Lopez-Colon, D; Jimenez, E; Liu, C; Tan, WH				Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Liu, Chen; Tan, Weihong			DNA Aptamers as Molecular Probes for Colorectal Cancer Study	PLOS ONE			English	Article							IN-VITRO SELECTION; RNA APTAMERS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; FLOW-CYTOMETRY; LIVE CELLS; LIGANDS; RECOGNITION; VIRUS; LYMPHOMA	Background: Understanding the molecular features of specific tumors can increase our knowledge about the mechanism(s) underlying disease development and progression. This is particularly significant for colorectal cancer, which is a heterogeneous complex of diseases developed in a sequential manner through a multistep carcinogenic process. As such, it is likely that tumors with similar characteristics might originate in the same manner and have a similar molecular behavior. Therefore, specific mapping of the molecular features can be potentially useful for both tumor classification and the development of appropriate therapeutic regimens. However, this can only be accomplished by developing high-affinity molecular probes with the ability to recognize specific markers associated with different tumors. Aptamers can most easily meet this challenge based on their target diversity, flexible manipulation and ease of development. Methodology and Results: Using a method known as cell-based Systematic Evolution of Ligands by Exponential enrichment (cell-SELEX) and colorectal cancer cultured cell lines DLD-1 and HCT 116, we selected a panel of target-specific aptamers. Binding studies by flow cytometry and confocal microscopy showed that these aptamers have high affinity and selectivity. Our data further show that these aptamers neither recognize normal colon cells (cultured and fresh), nor do they recognize most other cancer cell lines tested. Conclusion/Significance: The selected aptamers can identify specific biomarkers associated with colorectal cancers. We believe that these probes could be further developed for early disease detection, as well as prognostic markers, of colorectal cancers.	[Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, Dept Chem, Dept Physiol & Funct Genom, Shands Canc Ctr,UF Genet Inst, Gainesville, FL 32611 USA; [Sefah, Kwame; Meng, Ling; Lopez-Colon, Dalia; Jimenez, Elizabeth; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Tan, Weihong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sefah, K (corresponding author), Univ Florida, Dept Chem, Dept Physiol & Funct Genom, Shands Canc Ctr,UF Genet Inst, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Jimenez, Elizabeth/GQB-5576-2022; Meng, Ling/B-4170-2012	Tan, Weihong/0000-0002-8066-1524; Jimenez, Elizabeth/0000-0001-7798-2194; 	NIH [R01 GM079359];  [NIH CA122648]; NATIONAL CANCER INSTITUTE [R21CA122648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was funded by the following: NIH:R01 GM079359: Development of Molecular Probes for Biomedical Applications; NIH CA122648, Enrichment and Detection of Exfoliated Cancer Cells. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2007, ANN ONCOL, V18, P77, DOI 10.1093/annonc/mdl336; Arber DA, 2000, J MOL DIAGN, V2, P178, DOI 10.1016/S1525-1578(10)60636-8; Bagg A, 1999, AM J CLIN PATHOL, V112, pS76; Bruno JG, 1999, BIOSENS BIOELECTRON, V14, P457, DOI 10.1016/S0956-5663(99)00028-7; Casado E, 2007, CLIN TRANSL ONCOL, V9, P549, DOI 10.1007/s12094-007-0102-8; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; Diederichsen ACP, 1998, APMIS, V106, P562, DOI 10.1111/j.1699-0463.1998.tb01385.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Faca V, 2007, BIOTECHNIQUES, V43, P279, DOI 10.2144/000112541; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Hamula CLA, 2008, ANAL CHEM, V80, P7812, DOI 10.1021/ac801272s; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hofmann HP, 1997, RNA, V3, P1289; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; KIM HJ, 2008, BMB REPORTS, P685; Kim SY, 2007, CARCINOGENESIS, V28, P1387, DOI 10.1093/carcin/bgm086; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; KUBIK MF, 1994, NUCLEIC ACIDS RES, V22, P2619, DOI 10.1093/nar/22.13.2619; Kumar PKR, 1997, VIROLOGY, V237, P270, DOI 10.1006/viro.1997.8773; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mallikaratchy P, 2006, CHEM COMMUN, P3229, DOI 10.1039/b604778e; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; PAN WH, 1995, P NATL ACAD SCI USA, V92, P11509, DOI 10.1073/pnas.92.25.11509; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Rajendran M, 2008, ANAL BIOANAL CHEM, V390, P1067, DOI 10.1007/s00216-007-1735-8; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; TUERK C, 1992, P NATL ACAD SCI USA, V89, P6988, DOI 10.1073/pnas.89.15.6988; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Umar A, 2004, DIS MARKERS, V20, P87, DOI 10.1155/2004/303016; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Wallace ST, 1998, RNA, V4, P112; Wang CL, 2003, J BIOTECHNOL, V102, P15, DOI 10.1016/S0168-1656(02)00360-7; Williams KP, 1997, P NATL ACAD SCI USA, V94, P11285, DOI 10.1073/pnas.94.21.11285	48	62	72	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14269	10.1371/journal.pone.0014269	http://dx.doi.org/10.1371/journal.pone.0014269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170319	Green Published, gold, Green Submitted			2022-12-25	WOS:000285181400003
J	Gong, P; Pirooznia, M; Guan, X; Perkins, EJ				Gong, Ping; Pirooznia, Mehdi; Guan, Xin; Perkins, Edward J.			Design, Validation and Annotation of Transcriptome-Wide Oligonucleotide Probes for the Oligochaete Annelid Eisenia fetida	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; LARGE GENOMES; EARTHWORM; DISCOVERY; CLONING; BIOMARKERS; RESPONSES; EXPOSURE; CADMIUM	High density oligonucleotide probe arrays have increasingly become an important tool in genomics studies. In organisms with incomplete genome sequence, one strategy for oligo probe design is to reduce the number of unique probes that target every non-redundant transcript through bioinformatic analysis and experimental testing. Here we adopted this strategy in making oligo probes for the earthworm Eisenia fetida, a species for which we have sequenced transcriptome-scale expressed sequence tags (ESTs). Our objectives were to identify unique transcripts as targets, to select an optimal and non-redundant oligo probe for each of these target ESTs, and to annotate the selected target sequences. We developed a streamlined and easy-to-follow approach to the design, validation and annotation of species-specific array probes. Four 244K-formatted oligo arrays were designed using eArray and were hybridized to a pooled E. fetida cRNA sample. We identified 63,541 probes with unsaturated signal intensities consistently above the background level. Target transcripts of these probes were annotated using several sequence alignment algorithms. Significant hits were obtained for 37,439 (59%) probed targets. We validated and made publicly available 63.5K oligo probes so the earthworm research community can use them to pursue ecological, toxicological, and other functional genomics questions. Our approach is efficient, cost-effective and robust because it (1) does not require a major genomics core facility; (2) allows new probes to be easily added and old probes modified or eliminated when new sequence information becomes available, (3) is not bioinformatics-intensive upfront but does provide opportunities for more in-depth annotation of biological functions for target genes; and (4) if desired, EST orthologs to the UniGene clusters of a reference genome can be identified and selected in order to improve the target gene specificity of designed probes. This approach is particularly applicable to organisms with a wealth of EST sequences but unfinished genome.	[Gong, Ping; Guan, Xin] SpecPro Inc, Environm Serv, Vicksburg, MS USA; [Pirooznia, Mehdi] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Perkins, Edward J.] USA, Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA	Johns Hopkins University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Gong, P (corresponding author), SpecPro Inc, Environm Serv, Vicksburg, MS USA.	Ping.Gong@usace.army.mil	Pirooznia, Mehdi/AAG-1878-2019	Pirooznia, Mehdi/0000-0002-4210-6458	U.S. Army Engineer Research and Development Center (ERDC)	U.S. Army Engineer Research and Development Center (ERDC)(United States Department of DefenseUnited States Army)	This work was supported by the U.S. Army Environmental Quality Technology Basic Research Program of U.S. Army Engineer Research and Development Center (ERDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SpecPro Inc. supported Ping Gong and Xin Guan through a contract granted by ERDC, and through this employment is considered by PLoS ONE to have played a role in the research. Permission to publish this information was granted by the Chief of Engineers.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Borup RHA, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-33; Brulle F, 2006, ENVIRON SCI TECHNOL, V40, P2844, DOI 10.1021/es052299x; Cerda J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-508; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Chou HH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-347; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; Demuynck S, 2007, COMP BIOCHEM PHYS C, V145, P658, DOI 10.1016/j.cbpc.2007.03.001; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Edwards Clive A., 2004, P3; Ferraresso S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-580; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Gershon D, 2005, NATURE, V437, P1195, DOI 10.1038/4371195a; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gong P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S15; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Lee MS, 2005, BIOCHEM BIOPH RES CO, V328, P1196, DOI 10.1016/j.bbrc.2005.01.079; Leparc GG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1001; Li Weizhong, 2009, V533, P289, DOI 10.1007/978-1-60327-136-3_14; Li Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013715; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Myohara M, 2006, DEV DYNAM, V235, P2051, DOI 10.1002/dvdy.20849; Noh SJ, 2006, DNA RES, V13, P229, DOI 10.1093/dnares/dsl011; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Pariset L, 2009, NEW BIOTECHNOL, V25, P272, DOI 10.1016/j.nbt.2009.03.013; Pirooznia M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S7; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Reinecke Andriaan J., 2004, P299; Ricketts HJ, 2004, ECOTOX ENVIRON SAFE, V57, P4, DOI 10.1016/j.ecoenv.2003.08.008; Ruan YJ, 2004, TRENDS BIOTECHNOL, V22, P23, DOI 10.1016/j.tibtech.2003.11.002; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shaffer C, 2007, NAT BIOTECHNOL, V25, P149, DOI 10.1038/nbt0207-149; Spurgeon DJ, 2005, ENVIRON POLLUT, V136, P443, DOI 10.1016/j.envpol.2005.01.013; Sturzenbaum SR, 2009, P ROY SOC B-BIOL SCI, V276, P789, DOI 10.1098/rspb.2008.1510; Sugimoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P1575, DOI 10.1271/bbb.65.1575; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wallace JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-28; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	54	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14266	10.1371/journal.pone.0014266	http://dx.doi.org/10.1371/journal.pone.0014266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21170345	gold, Green Published			2022-12-25	WOS:000285084100016
J	Gonzalez, R; Kerbel, B; Chun, A; Unniappan, S				Gonzalez, Ronald; Kerbel, Brent; Chun, Alexander; Unniappan, Suraj			Molecular, Cellular and Physiological Evidences for the Anorexigenic Actions of Nesfatin-1 in Goldfish	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SATIETY MOLECULE; GENOME DUPLICATION; NEUROPEPTIDE-Y; IMMUNOREACTIVITY; EXPRESSION; PITUITARY; RECEPTOR; NEURONS; FISH	Background: Nesfatin-1 is a recently discovered anorexigen encoded in the precursor peptide, nucleobindin-2 (NUCB2) in mammals. To date, nesfatin-1 has not been described in any non-mammalian species, although some information is available in the sequenced genomes of several species. Our objective was to characterize nesfatin-1 in fish. Methodology/Principal Findings: In the present study, we employed molecular, immunohistochemical, and physiological studies to characterize the structure, distribution, and appetite regulatory effects of nesfatin-1 in a non-mammalian vertebrate. A very high conservation in NUCB2 sequences, especially in the nesfatin-1 region was found in lower vertebrates. Abundant expression of NUCB2 mRNA was detected in several tissues including the brain and liver of goldfish. Nesfatin-1-like immunoreactive cells are present in the feeding regulatory nucleus of the hypothalamus and in the gastrointestinal tract of goldfish. Approximately 6-fold increase in NUCB2 mRNA levels was found in the liver after 7-day food-deprivation, and a similar increase was also found after short-term fasting. This points toward a possible liver specific role for NUCB2 in the control of metabolism during food-deprivation. Meanwhile, similar to 2-fold increase at 1 and 3 h post-feeding and an similar to 3-fold reduction after a 7-day food-deprivation was observed in NUCB2 mRNA in the goldfish hypothalamus. In vivo, a single intraperitoneal injection of the full-length native (goldfish; gf) nesfatin-1 at a dose of 50 ng/g body weight induced a 23% reduction of food intake one hour post-injection in goldfish. Furthermore, intracerebroventricular injection of gfnesfatin-1 at a dose of 5 ng/g body weight resulted in similar to 50% reduction in food intake. Conclusions/Significance: Our results provide molecular, anatomical and functional evidences to support potential anorectic and metabolic roles for endogenous nesfatin-1 in goldfish. Collectively, we provide novel information on NUCB2 in non-mammals and an anorexigenic role for nesfatin-1 in goldfish.	[Gonzalez, Ronald; Kerbel, Brent; Chun, Alexander; Unniappan, Suraj] York Univ, Lab Integrat Neuroendocrinol, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Gonzalez, R (corresponding author), York Univ, Lab Integrat Neuroendocrinol, Dept Biol, Toronto, ON M3J 2R7, Canada.	suraju@yorku.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Ontario Graduate Scholarship; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada through a Discovery Grant, and two Research Tools and Instruments Grants to SU. SU is a recipient of the New Investigator Award from the Canadian Institutes of Health Research and the Early Researcher Award from the Ontario Ministry of Research and Innovation. RG is a recipient of the Ontario Graduate Scholarship. BK is a recipient of the Undergraduate Summer Research Award from the NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, p9S, DOI 10.1038/oby.2006.276; ANGLADE I, 1993, CELL TISSUE RES, V273, P345, DOI 10.1007/BF00312837; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; BURNSTOCK G, 1958, J PHYSIOL-LONDON, V141, P35, DOI 10.1113/jphysiol.1958.sp005953; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Gonzalez R, 2010, GEN COMP ENDOCR, V166, P273, DOI 10.1016/j.ygcen.2009.09.008; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Hrytsenko O, 2007, BRAIN RES, V1135, P31, DOI 10.1016/j.brainres.2006.12.009; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Moon Thomas W., 1995, V4, P65; Morash MG, 2009, GEN COMP ENDOCR, V162, P179, DOI 10.1016/j.ygcen.2009.03.013; MORATA P, 1982, COMP BIOCHEM PHYS B, V72, P543, DOI 10.1016/0305-0491(82)90503-X; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; PETER RE, 1990, J EXP ZOOL, P84; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKAVANCE LC, 1992, J CHEM NEUROANAT, V5, P221, DOI 10.1016/0891-0618(92)90047-T; Price CJ, 2008, J NEUROENDOCRINOL, V20, P245, DOI 10.1111/j.1365-2826.2007.01641.x; Price CJ, 2008, BRAIN RES, V1230, P99, DOI 10.1016/j.brainres.2008.06.084; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Rao SD, 1996, GEN COMP ENDOCR, V102, P210, DOI 10.1006/gcen.1996.0062; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unniappan S, 2004, GEN COMP ENDOCR, V136, P200, DOI 10.1016/j.ygcen.2003.12.010; Unniappan S, 2008, AM J PHYSIOL-REG I, V295, pR51, DOI 10.1152/ajpregu.00234.2007; VANDENTHILLART G, 1984, J COMP PHYSIOL, V154, P477, DOI 10.1007/BF02515152; Yosten GLC, 2010, AM J PHYSIOL-REG I, V298, pR1642, DOI 10.1152/ajpregu.00804.2009	46	95	101	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15201	10.1371/journal.pone.0015201	http://dx.doi.org/10.1371/journal.pone.0015201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151928	gold, Green Published, Green Submitted			2022-12-25	WOS:000284939600032
J	Fu, Y; Springer, NM; Ying, K; Yeh, CT; Iniguez, AL; Richmond, T; Wu, W; Barbazuk, B; Nettleton, D; Jeddeloh, J; Schnable, PS				Fu, Yan; Springer, Nathan M.; Ying, Kai; Yeh, Cheng-Ting; Iniguez, A. Leonardo; Richmond, Todd; Wu, Wei; Barbazuk, Brad; Nettleton, Dan; Jeddeloh, Jeff; Schnable, Patrick S.			High-Resolution Genotyping via Whole Genome Hybridizations to Microarrays Containing Long Oligonucleotide Probes	PLOS ONE			English	Article							SINGLE-FEATURE POLYMORPHISM; GENETIC-MAP; DISCOVERY; IDENTIFICATION; TRANSCRIPTOME; DIVERSITY; MARKERS; ARRAYS; MAIZE	To date, microarray-based genotyping of large, complex plant genomes has been complicated by the need to perform genome complexity reduction to obtain sufficiently strong hybridization signals. Genome complexity reduction techniques are, however, tedious and can introduce unwanted variables into genotyping assays. Here, we report a microarray-based genotyping technology for complex genomes (such as the 2.3 GB maize genome) that does not require genome complexity reduction prior to hybridization. Approximately 200,000 long oligonucleotide probes were identified as being polymorphic between the inbred parents of a mapping population and used to genotype two recombinant inbred lines. While multiple hybridization replicates provided similar to 97% accuracy, even a single replicate provided similar to 95% accuracy. Genotyping accuracy was further increased to >99% by utilizing information from adjacent probes. This microarray-based method provides a simple, high-density genotyping approach for large, complex genomes.	[Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Ying, Kai] Iowa State Univ, Interdept Genet Grad Program, Ames, IA USA; [Ying, Kai; Schnable, Patrick S.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Iniguez, A. Leonardo; Richmond, Todd; Jeddeloh, Jeff] Roche NimbleGen Inc, Madison, WI USA; [Barbazuk, Brad] Univ Florida, Dept Biol, Gainesville, FL USA; [Barbazuk, Brad] Univ Florida, Genet Inst, Gainesville, FL USA; [Nettleton, Dan] Iowa State Univ, Dept Stat, Ames, IA USA	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University; Iowa State University; Roche Holding; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University		schnable@iastate.edu	Springer, Nathan/F-2680-2013	Springer, Nathan/0000-0002-7301-4759; Yeh, Cheng-Ting/0000-0002-1392-2018; Nettleton, Dan/0000-0002-6045-1036; Schnable, Patrick/0000-0001-9169-5204	Hatch Act funds	Hatch Act funds(United States Department of Agriculture (USDA))	This project was supported in part by Hatch Act funds to Iowa, Minnesota and Florida. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche NimbleGen, Inc. (http://www.nimblegen.com/) provided support for this study through the donation of reagents and team-member time. Roles of Roche NimbleGen authors in the work are as follows: A. Leonardo Iniguez participated in experimental design and experimental execution; Todd Richmond participated in experimental and array design; Jeffrey A. Jeddeloh participated in experimental design array design, data interpretation and manuscript preparation.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Edwards JD, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-13; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Flibotte S, 2009, GENETICS, V181, P33, DOI 10.1534/genetics.108.096487; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hsia AP, 2005, THEOR APPL GENET, V111, P218, DOI 10.1007/s00122-005-1997-5; Kidgell C, 2005, CHROMOSOME RES, V13, P225, DOI 10.1007/s10577-005-1503-6; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194	29	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14178	10.1371/journal.pone.0014178	http://dx.doi.org/10.1371/journal.pone.0014178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21152036	Green Submitted, gold, Green Published			2022-12-25	WOS:000284868000004
J	Wertheimer, AM; Uhrlaub, JL; Hirsch, A; Medigeshi, G; Sprague, J; Legasse, A; Wilk, J; Wiley, CA; Didier, P; Tesh, RB; Murray, KO; Axthelm, MK; Wong, SW; Nikolich-Zugich, J				Wertheimer, Anne M.; Uhrlaub, Jennifer L.; Hirsch, Alec; Medigeshi, Guruprasad; Sprague, Jerald; Legasse, Alfred; Wilk, Jennifer; Wiley, Clayton A.; Didier, Peter; Tesh, Robert B.; Murray, Kristy O.; Axthelm, Michael K.; Wong, Scott W.; Nikolich-Zugich, Janko			Immune Response to the West Nile Virus in Aged Non-Human Primates	PLOS ONE			English	Article							T-CELLS; INFECTION; EPIDEMIC; ENCEPHALITIS; MONKEYS	Background: Risk of encephalitis from West Nile virus (WNV) infection increases dramatically with age. Understanding the basis of this susceptibility requires development of suitable animal models. Here, we investigated the immune response to WNV in old non-human primates. Methodology/Principal Findings: We investigated clinical, immunological and virological correlates of WNV infection in aging non-human primates. Aged (17-30yrs) and adult (6-9yrs) Rhesus macaques (RM) were challenged with WNV in the presence or the absence of the mosquito salivary gland extract (SGE) to approximate natural infection. None of the 26 animals exhibited clinical signs of the disease. Quantitative PCR suggested discrete and short-lived viremia, but infectious virus was never isolated. There was markedly increased, age-independent, proliferation of CD3(-) non-B cells, followed by B-cell proliferation, which correlated to the loss of detectable WNV genomes. Moreover, animals primed with mosquito salivary gland extract exhibited reduced circulating WNV RNA. While we found the expected age-associated reduction in T cell proliferation, adaptive immunity did not correlate with infection outcome. That was further confirmed in a cohort of thymectomized and/or CD8 T-cell depleted Cynomolgus macaques (CM; N = 15), who also failed to develop WNV disease. Conclusions/significance: Results are consistent with strong and age-independent innate resistance of macaques against WNV challenge. This animal model is therefore not suitable for vaccine and therapeutic testing against WNV. However, understanding the basis of their innate resistance against WNV in macaques could provide helpful clues to improve anti-WNV protection of older adults.	[Wertheimer, Anne M.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Arizona Ctr Aging, Tucson, AZ 85721 USA; [Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Hirsch, Alec; Medigeshi, Guruprasad; Sprague, Jerald; Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Legasse, Alfred; Wilk, Jennifer; Axthelm, Michael K.; Wong, Scott W.; Nikolich-Zugich, Janko] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Wiley, Clayton A.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Didier, Peter] Tulane Natl Primate Res Ctr, Covington, LA USA; [Tesh, Robert B.] Univ Texas Med Branch, Galveston, TX USA; [Murray, Kristy O.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA	University of Arizona; University of Arizona; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tulane University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Wertheimer, AM (corresponding author), Univ Arizona, Arizona Ctr Aging, Tucson, AZ 85721 USA.	nikolich@email.arizona.edu	Wertheimer, Anne/E-5132-2019; Wertheimer, Anne/ABF-7802-2021; Medigeshi, Guruprasad/V-1566-2019	Wertheimer, Anne/0000-0002-6627-4974; Nikolich-Zugich, Janko/0000-0001-5830-5323; Medigeshi, Guruprasad/0000-0001-5333-9743; Uhrlaub, Jennifer/0000-0002-7745-0179	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [N01 50027 HHSN266200500027C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050027] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, under Contract N01 50027 HHSN266200500027C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; CICINSAIN L, J IMMUNOL, V184, P6739; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; Li F, 2002, EUR J IMMUNOL, V32, P1650, DOI 10.1002/1521-4141(200206)32:6<1650::AID-IMMU1650>3.0.CO;2-Q; Malan AK, 2003, AM J CLIN PATHOL, V119, P508, DOI 10.1309/WJJ7UE42DFHTTF1X; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128; Ratterree MS, 2004, J INFECT DIS, V189, P669, DOI 10.1086/381461; Ratterree MS, 2003, EMERG INFECT DIS, V9, P1388, DOI 10.3201/eid0911.030226; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Throsby M, 2007, EXPERT REV VACCINES, V6, P183, DOI 10.1586/14760584.6.2.183; Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033	27	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15514	10.1371/journal.pone.0015514	http://dx.doi.org/10.1371/journal.pone.0015514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151986	Green Published, Green Accepted, gold			2022-12-25	WOS:000284868000034
J	Ribeiro, TL; Copelli, M; Caixeta, F; Belchior, H; Chialvo, DR; Nicolelis, MAL; Ribeiro, S				Ribeiro, Tiago L.; Copelli, Mauro; Caixeta, Fabio; Belchior, Hindiael; Chialvo, Dante R.; Nicolelis, Miguel A. L.; Ribeiro, Sidarta			Spike Avalanches Exhibit Universal Dynamics across the Sleep-Wake Cycle	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; NEURONAL AVALANCHES; PROPOFOL ANALOGS; GABA(A) RECEPTOR; VISUAL-CORTEX; IN-VIVO; RAT; BRAIN; NETWORKS; RANGE	Background: Scale-invariant neuronal avalanches have been observed in cell cultures and slices as well as anesthetized and awake brains, suggesting that the brain operates near criticality, i.e. within a narrow margin between avalanche propagation and extinction. In theory, criticality provides many desirable features for the behaving brain, optimizing computational capabilities, information transmission, sensitivity to sensory stimuli and size of memory repertoires. However, a thorough characterization of neuronal avalanches in freely-behaving (FB) animals is still missing, thus raising doubts about their relevance for brain function. Methodology/Principal Findings: To address this issue, we employed chronically implanted multielectrode arrays (MEA) to record avalanches of action potentials (spikes) from the cerebral cortex and hippocampus of 14 rats, as they spontaneously traversed the wake-sleep cycle, explored novel objects or were subjected to anesthesia (AN). We then modeled spike avalanches to evaluate the impact of sparse MEA sampling on their statistics. We found that the size distribution of spike avalanches are well fit by lognormal distributions in FB animals, and by truncated power laws in the AN group. FB data surrogation markedly decreases the tail of the distribution, i.e. spike shuffling destroys the largest avalanches. The FB data are also characterized by multiple key features compatible with criticality in the temporal domain, such as 1/f spectra and long-term correlations as measured by detrended fluctuation analysis. These signatures are very stable across waking, slow-wave sleep and rapid-eye-movement sleep, but collapse during anesthesia. Likewise, waiting time distributions obey a single scaling function during all natural behavioral states, but not during anesthesia. Results are equivalent for neuronal ensembles recorded from visual and tactile areas of the cerebral cortex, as well as the hippocampus. Conclusions/Significance: Altogether, the data provide a comprehensive link between behavior and brain criticality, revealing a unique scale-invariant regime of spike avalanches across all major behaviors.	[Ribeiro, Tiago L.; Copelli, Mauro] Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil; [Copelli, Mauro; Caixeta, Fabio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta] Fed Univ Rio Grande Norte UFRN, Grad Program Neurosci, Natal, RN, Brazil; [Caixeta, Fabio; Belchior, Hindiael; Nicolelis, Miguel A. L.; Ribeiro, Sidarta] Edmond & Lily Safra Int Inst Neurosci Natal ELS I, Natal, RN, Brazil; [Belchior, Hindiael; Ribeiro, Sidarta] Fed Univ Rio Grande Norte UFRN, Dept Physiol, Natal, RN, Brazil; [Chialvo, Dante R.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Ctr Neuroengn, Dept Neurobiol, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Brain Sci, Durham, NC 27706 USA	Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Northwestern University; Duke University; Duke University; Duke University	Ribeiro, TL (corresponding author), Fed Univ Pernambuco UFPE, Dept Phys, Recife, PE, Brazil.	ribeiro@natalneuro.org.br	Caixeta, Fabio V/J-9048-2014; Copelli, Mauro/AAG-8110-2020; Chialvo, Dante R./P-5279-2019; Caixeta, Fabio V/N-9405-2019; Chialvo, Dante R/A-4658-2009; Copelli, Mauro/C-6336-2009; Ribeiro, Sidarta/C-5794-2016	Caixeta, Fabio V/0000-0003-0919-342X; Chialvo, Dante R./0000-0002-1038-3637; Caixeta, Fabio V/0000-0003-0919-342X; Chialvo, Dante R/0000-0002-1038-3637; Copelli, Mauro/0000-0001-7441-2858; Ribeiro, Sidarta/0000-0001-9325-9545	Associacao Alberto Santos Dumont para Apoio a Pesquisa; Financiadora de Estudos e Projetos [01.06.1092.00]; Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina [704134/2009]; Edital Universal [481506/2007-1, 472861/2008-5]; Programa de Apoio a Nucleos de Excelencia; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [APQ-1140-1.05/08]; Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Pew Latin-American Program in Biomedical Science; National Institute of Dental and Craniofacial Research (NIDCR) [R01-DE011451]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451] Funding Source: NIH RePORTER	Associacao Alberto Santos Dumont para Apoio a Pesquisa; Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina; Edital Universal; Programa de Apoio a Nucleos de Excelencia; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pew Latin-American Program in Biomedical Science; National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos 01.06.1092.00, Instituto Nacional de Ciencia e Tecnologia em Interfaces Cerebro Maquina, 704134/2009, Edital Universal 481506/2007-1 and 472861/2008-5, Programa de Apoio a Nucleos de Excelencia, Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco APQ-1140-1.05/08, Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, graduate fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and the Pew Latin-American Program in Biomedical Science. The project described was supported by Grant Number R01-DE011451 from the National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCR or the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Assis VRV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011923; Baiesi M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.051103; Bak P., 1997, NATURE WORKS SCI SEL; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Christensen K, 2002, P NATL ACAD SCI USA, V99, P2509, DOI 10.1073/pnas.012581099; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Corral A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.035102; Corral A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016101; Davidsen J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.125502; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Haeseler G, 2003, EUR J ANAESTH, V20, P220, DOI 10.1097/00003643-200303000-00007; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; HARTMAN BK, 1972, P NATL ACAD SCI USA, V69, P2722, DOI 10.1073/pnas.69.9.2722; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Horvath TL, 1999, J COMP NEUROL, V415, P145; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jensen H., 1998, SELF ORGANIZED CRITI; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; LEPPAVUORI A, 1980, BRAIN RES, V193, P95, DOI 10.1016/0006-8993(80)90948-8; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Omori F, 1894, J COLL SCI IMP U TOK, V7, P111; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; PLENZ D, 2009, ARXIV09125369V1; Press W. H., 1992, ART SCI COMPUTING; Priesemann V, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-40; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Rash JE, 2007, NEUROSCIENCE, V147, P938, DOI 10.1016/j.neuroscience.2007.04.061; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; ROTHBLAT LA, 1991, BEHAV BRAIN RES, V42, P25, DOI 10.1016/S0166-4328(05)80036-1; Sanchez R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.068302; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHULTZ W, 1986, J NEUROPHYSIOL, V55, P660, DOI 10.1152/jn.1986.55.4.660; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STEZHKA VV, 1995, EXP BRAIN RES, V105, P383; THOMSON AM, 1985, NATURE, V313, P479, DOI 10.1038/313479a0; Trapani G, 1998, J MED CHEM, V41, P1846, DOI 10.1021/jm970681h; Vahle-Hinz C, 2002, BRIT J ANAESTH, V89, P123, DOI 10.1093/bja/aef166; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	74	126	126	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14129	10.1371/journal.pone.0014129	http://dx.doi.org/10.1371/journal.pone.0014129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152422	Green Submitted, Green Published, gold			2022-12-25	WOS:000284755100010
J	Tuna, M; Smid, M; Zhu, DK; Martens, JWM; Amos, CI				Tuna, Musaffe; Smid, Marcel; Zhu, Dakai; Martens, John W. M.; Amos, Christopher I.			Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NUCLEOTIDE POLYMORPHISM ANALYSIS; COPY NUMBER ALTERATIONS; ACUTE MYELOID LEUKEMIAS; COLORECTAL CANCERS; ARRAY ANALYSIS; CARCINOMA; HETEROZYGOSITY; TUMORS; ISODISOMY	Background: Genetic alterations in cellular signaling networks are a hallmark of cancer, however, effective methods to discover them are lacking. A novel form of abnormality called acquired uniparental disomy (aUPD) was recently found to pinpoint the region of mutated genes in various cancers, thereby identifying the region for next-generation sequencing. Methods/Principal Findings: We retrieved large genomic data sets from the Gene Expression Omnibus database to perform genome-wide analysis of aUPD in breast tumor samples and cell lines using approaches that can reliably detect aUPD. aUPD was identified in 52.29% of the tumor samples. The most frequent aUPD regions were located at chromosomes 2q, 3p, 5q, 9p, 9q, 10q, 11q, 13q, 14q and 17q. We evaluated the data for any correlation between the most frequent aUPD regions and HER2/neu, ER, and PR status, and found a statistically significant correlation between the recurrent regions of aUPD and triple negative (TN) breast cancers. aUPD at chromosome 17q (VEZF1, WNT3), 3p (SUMF1, GRM7), 9p (MTAP, NFIB) and 11q (CASP1, CASP4, CASP5) are predictors for TN. The frequency of aUPD was found to be significantly higher in TN breast cancer cases compared to HER2/neu-positive and/or ER or PR-positive cases. Furthermore, using previously published mutation data, we found TP53 homozygously mutated in cell lines having aUPD in that locus. Conclusions/Significance: We conclude that aUPD is a common and non-random molecular feature of breast cancer that is most prominent in triple negative cases. As aUPD regions are different among the main pathological subtypes, specific aUPD regions may aid the sub-classification of breast cancer. In addition, we provide statistical support using TP53 as an example that identifying aUPD regions can be an effective approach in finding aberrant genes. We thus conclude that a genome-wide scale analysis of aUPD regions for homozygous sequence alterations can provide valuable insights into breast tumorigenesis.	[Tuna, Musaffe; Zhu, Dakai; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Smid, Marcel; Martens, John W. M.] Erasmus Med Ctr Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Smid, Marcel; Martens, John W. M.] Canc Genom Ctr, Rotterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center	Tuna, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	mtuna9@gmail.com		Smid, Marcel/0000-0003-0605-1901	National Institutes of Health [R01CA133996]; NATIONAL CANCER INSTITUTE [R01CA133996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by National Institutes of Health grant R01CA133996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bush Nancy Jo, 2007, Semin Oncol Nurs, V23, P46, DOI 10.1016/j.soncn.2006.11.008; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Flotho C, 2007, ONCOGENE, V26, P5816, DOI 10.1038/sj.onc.1210361; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths M, 2005, LEUKEMIA, V19, P2355, DOI 10.1038/sj.leu.2403988; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Ittmann M, 2009, NEOPLASIA, V11, P305, DOI 10.1593/neo.81530; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Karow A, 2007, LEUKEMIA, V21, P1303, DOI 10.1038/sj.leu.2404651; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kratz CP, 2007, HUM MOL GENET, V16, P374, DOI 10.1093/hmg/ddl458; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Mohamedali AM, 2009, J CLIN ONCOL, V27, P4002, DOI 10.1200/JCO.2009.22.6985; Mullighan CG, 2008, LANCET, V372, P1448, DOI 10.1016/S0140-6736(08)61342-2; Murthy SK, 2002, MODERN PATHOL, V15, P1241, DOI 10.1097/01.MP.0000032535.62750.D1; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; O'Shea D, 2009, BLOOD, V113, P2298, DOI 10.1182/blood-2008-08-174953; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Ponzone R, 2006, ANN NY ACAD SCI, V1089, P143, DOI 10.1196/annals.1386.037; Raghavan M, 2005, CANCER RES, V65, P375; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; SZPURKA H, 2008, LEUKEMIA; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Volchenboum SL, 2009, CANCER RES, V69, P4143, DOI 10.1158/0008-5472.CAN-08-3112; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; White VA, 1996, GENE CHROMOSOME CANC, V15, P138, DOI 10.1002/(SICI)1098-2264(199602)15:2<138::AID-GCC10>3.3.CO;2-F; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wouters BJ, 2007, LEUKEMIA, V21, P2382, DOI 10.1038/sj.leu.2404795; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	66	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15094	10.1371/journal.pone.0015094	http://dx.doi.org/10.1371/journal.pone.0015094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152100	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100069
J	Xia, ZQ; Chibnik, LB; Glanz, BI; Liguori, M; Shulman, JM; Tran, D; Khoury, SJ; Chitnis, T; Holyoak, T; Weiner, HL; Guttmann, CRG; De Jager, PL				Xia, Zongqi; Chibnik, Lori B.; Glanz, Bonnie I.; Liguori, Maria; Shulman, Joshua M.; Tran, Dong; Khoury, Samia J.; Chitnis, Tanuja; Holyoak, Todd; Weiner, Howard L.; Guttmann, Charles R. G.; De Jager, Philip L.			A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; CLINICALLY ISOLATED SYNDROMES; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; IDENTIFIES VARIANTS; MRI; SUSCEPTIBILITY; SEVERITY; GENES	Background: Brain atrophy and cognitive dysfunction are neurodegenerative features of Multiple Sclerosis (MS). We used a candidate gene approach to address whether genetic variants implicated in susceptibility to late onset Alzheimer's Disease (AD) influence brain volume and cognition in MS patients. Methods/Principal Findings: MS subjects were genotyped for five single nucleotide polymorphisms (SNPs) associated with susceptibility to AD: PICALM, CR1, CLU, PCK1, and ZNF224. We assessed brain volume using Brain Parenchymal Fraction (BPF) measurements obtained from Magnetic Resonance Imaging (MRI) data and cognitive function using the Symbol Digit Modalities Test (SDMT). Genotypes were correlated with cross-sectional BPF and SDMT scores using linear regression after adjusting for sex, age at symptom onset, and disease duration. 722 MS patients with a mean (+/- SD) age at enrollment of 41 (+/- 10) years were followed for 44 (+/- 28) months. The AD risk-associated allele of a non-synonymous SNP in the PCK1 locus (rs8192708(G)) is associated with a smaller average brain volume (P = 0.0047) at the baseline MRI, but it does not impact our baseline estimate of cognition. PCK1 is additionally associated with higher baseline T2-hyperintense lesion volume (P = 0.0088). Finally, we provide technical validation of our observation in a subset of 641 subjects that have more than one MRI study, demonstrating the same association between PCK1 and smaller average brain volume (P = 0.0089) at the last MRI visit. Conclusion/Significance: Our study provides suggestive evidence for greater brain atrophy in MS patients bearing the PCK1 allele associated with AD-susceptibility, yielding new insights into potentially shared neurodegenerative process between MS and late onset AD.	[Xia, Zongqi; Chibnik, Lori B.; Shulman, Joshua M.; Tran, Dong; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Xia, Zongqi; Chibnik, Lori B.; Shulman, Joshua M.; Tran, Dong; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Liguori, Maria; Guttmann, Charles R. G.] Brigham & Womens Hosp, Dept Radiol, Ctr Neurol Imaging, Boston, MA 02115 USA; [Xia, Zongqi; Shulman, Joshua M.; Khoury, Samia J.; Chitnis, Tanuja; Weiner, Howard L.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Holyoak, Todd] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Liguori, Maria] CNR, Inst Neurol Sci, Mangone, Italy	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Kansas; University of Kansas Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR)	Xia, ZQ (corresponding author), Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Guttmann, Charles RG/J-3093-2018; Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022; Liguori, Maria/D-4390-2016	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; khoury, samia/0000-0003-3198-6063; Chibnik, Lori/0000-0001-6293-806X; Guttmann, Charles/0000-0002-7006-9762; Liguori, Maria/0000-0003-4338-0392	National Multiple Sclerosis Society [JF2138A1]; National Institutes of Health (NIH) [AI074549-02]; National MS Society (NMSS); American Academy of Neurology (AAN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG034290] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society (NMSS)(National Multiple Sclerosis Society); American Academy of Neurology (AAN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. De Jager is a Harry Weaver Neuroscience Scholar Award Recipient of the National Multiple Sclerosis Society (JF2138A1). Dr. Xia was supported by the National Institutes of Health (NIH) (AI074549-02) and is a recipient of the Clinician Scientist Development Award from the National MS Society (NMSS) and American Academy of Neurology (AAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; COLOMBO G, 1978, BIOCHEMISTRY-US, V17, P5321, DOI 10.1021/bi00618a001; Cooper GF, 1997, DATA MIN KNOWL DISC, V1, P203, DOI 10.1023/A:1009787925236; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Drake AS, 2010, MULT SCLER J, V16, P228, DOI 10.1177/1352458509354552; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Gauthier SA, 2007, NEUROLOGY, V68, P2059, DOI 10.1212/01.wnl.0000264890.97479.b1; Glanz BI, 2007, MULT SCLER J, V13, P1004, DOI 10.1177/1352458507077943; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HEALY BC, 2010, NEUROLOGY IN PRESS; JOHNSON TA, 2010, BIOCHEMISTRY; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liu LF, 2005, J NEUROIMAGING, V15, p103S, DOI 10.1177/1051228405282864; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Martola J, 2010, NEURORADIOLOGY, V52, P109, DOI 10.1007/s00234-009-0593-9; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meier DS, 2006, NEUROIMAGE, V32, P531, DOI 10.1016/j.neuroimage.2006.04.181; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi J, 2008, NEUROLOGY, V70, P185, DOI 10.1212/01.wnl.0000264004.62612.44; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Tiehuis AM, 2008, STROKE, V39, P1600, DOI 10.1161/STROKEAHA.107.506089; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; Wei XC, 2002, J MAGN RESON IMAGING, V15, P203, DOI 10.1002/jmri.10053; Zipoli V, 2010, MULT SCLER J, V16, P62, DOI 10.1177/1352458509350311; Zivadinov R, 2007, INT REV NEUROBIOL, V79, P521, DOI 10.1016/S0074-7742(07)79023-2	38	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14169	10.1371/journal.pone.0014169	http://dx.doi.org/10.1371/journal.pone.0014169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152065	Green Published, gold			2022-12-25	WOS:000284755100046
J	Yang, F; Waters, KM; Miller, JH; Gritsenko, MA; Zhao, R; Du, XX; Livesay, EA; Purvine, SO; Monroe, ME; Wang, YC; Camp, DG; Smith, RD; Stenoien, DL				Yang, Feng; Waters, Katrina M.; Miller, John H.; Gritsenko, Marina A.; Zhao, Rui; Du, Xiuxia; Livesay, Eric A.; Purvine, Samuel O.; Monroe, Matthew E.; Wang, Yingchun; Camp, David G., II; Smith, Richard D.; Stenoien, David L.			Phosphoproteomics Profiling of Human Skin Fibroblast Cells Reveals Pathways and Proteins Affected by Low Doses of Ionizing Radiation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; RADIOADAPTIVE RESPONSE; MASS-SPECTROMETRY; COMPLEX FACT; KAPPA-B; PHOSPHORYLATION; EXPRESSION; ACTIVATION; APOPTOSIS	Background: High doses of ionizing radiation result in biological damage; however, the precise relationships between long-term health effects, including cancer, and low-dose exposures remain poorly understood and are currently extrapolated using high-dose exposure data. Identifying the signaling pathways and individual proteins affected at the post-translational level by radiation should shed valuable insight into the molecular mechanisms that regulate dose-dependent responses to radiation. Principal Findings: We have identified 7117 unique phosphopeptides (2566 phosphoproteins) from control and irradiated (2 and 50 cGy) primary human skin fibroblasts 1 h post-exposure. Semi-quantitative label-free analyses were performed to identify phosphopeptides that are apparently altered by radiation exposure. This screen identified phosphorylation sites on proteins with known roles in radiation responses including TP53BP1 as well as previously unidentified radiation-responsive proteins such as the candidate tumor suppressor SASH1. Bioinformatic analyses suggest that low and high doses of radiation affect both overlapping and unique biological processes and suggest a role for MAP kinase and protein kinase A (PKA) signaling in the radiation response as well as differential regulation of p53 networks at low and high doses of radiation. Conclusions: Our results represent the most comprehensive analysis of the phosphoproteomes of human primary fibroblasts exposed to multiple doses of ionizing radiation published to date and provide a basis for the systems-level identification of biological processes, molecular pathways and individual proteins regulated in a dose dependent manner by ionizing radiation. Further study of these modified proteins and affected networks should help to define the molecular mechanisms that regulate biological responses to radiation at different radiation doses and elucidate the impact of low-dose radiation exposure on human health.	[Yang, Feng; Waters, Katrina M.; Gritsenko, Marina A.; Zhao, Rui; Du, Xiuxia; Livesay, Eric A.; Purvine, Samuel O.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.; Stenoien, David L.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Miller, John H.] Washington State Univ Tricities, Richland, WA USA; [Wang, Yingchun] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yang, F (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	david.stenoien@pnl.gov	Smith, Richard D/J-3664-2012; Monroe, Matthew/L-1157-2019; Miller, John J/GZG-5663-2022; Purvine, Samuel O/O-3358-2017	Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Waters, Katrina/0000-0003-4696-5396	Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory [RR18522]; Battelle [DE-AC05-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory; Battelle; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the Department of Energy Low Dose Radiation Research Program National Institutes of Health/National Center for Research Resources Proteomics Center at Pacific Northwest National Laboratory (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. William Morgan for helpful advice during the preparation of this manuscript. Experiments and data analyses were performed in the Environmental Molecular Sciences Laboratory, a DOE national scientific user facility located at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is a multiprogram national laboratory operated by Battelle for the DOE under Contract DE-AC05-76RLO 1830.	Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Averbeck D, 2009, HEALTH PHYS, V97, P493, DOI 10.1097/HP.0b013e3181b08a20; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; BAGGETTA R, 2010, EUR J IMMUNOL; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Brooks AL, 2003, HEALTH PHYS, V85, P85, DOI 10.1097/00004032-200307000-00016; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Du XX, 2008, J PROTEOME RES, V7, P2195, DOI 10.1021/pr070510t; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; FERAMISCO JR, 1980, J BIOL CHEM, V255, P4240; Franco N, 2005, RADIAT RES, V163, P623, DOI 10.1667/RR3391; Ham BM, 2008, J PROTEOME RES, V7, P2215, DOI 10.1021/pr700575m; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kumari A, 2009, J CELL BIOCHEM, V108, P508, DOI 10.1002/jcb.22280; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lindvall JM, 2005, CELL IMMUNOL, V235, P46, DOI 10.1016/j.cellimm.2005.07.001; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; McCarthy J, 2003, J PROTEOME RES, V2, P239, DOI 10.1021/pr025564b; Mitsushima M, 2007, EXP CELL RES, V313, P1830, DOI 10.1016/j.yexcr.2007.03.001; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; NHEK S, MOL BIOL CELL; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Rogers LD, 2009, MOL BIOSYST, V5, P1122, DOI 10.1039/b905580k; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schwartz JL, 2007, INT J RADIAT BIOL, V83, P153, DOI 10.1080/09553000601146949; Shi SDH, 2001, ANAL CHEM, V73, P19, DOI 10.1021/ac000703z; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Warters RL, 2009, RADIAT RES, V172, P82, DOI 10.1667/RR1677.1; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; WONG JW, METHODS MOL BIOL, V604, P273; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yang F, 2006, J PROTEOME RES, V5, P1252, DOI 10.1021/pr060028v; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200; Zhao R, 2009, J CHROMATOGR B, V877, P663, DOI 10.1016/j.jchromb.2008.12.068	65	16	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14152	10.1371/journal.pone.0014152	http://dx.doi.org/10.1371/journal.pone.0014152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152398	Green Published, gold			2022-12-25	WOS:000284755100031
J	Melis, JPM; Hoogervorst, EM; van Oostrom, CTM; Zwart, E; Breit, TM; Pennings, JLA; de Vries, A; van Steeg, H				Melis, J. P. M.; Hoogervorst, E. M.; van Oostrom, C. T. M.; Zwart, E.; Breit, T. M.; Pennings, J. L. A.; de Vries, A.; van Steeg, H.			Genotoxic exposure: novel cause of selection for a functional Delta N-p53 isoform	ONCOGENE			English	Article						DNA damage; gene expression; N-terminal p53 isoform (Delta N-p53, p44, p47); nonsense mutations; mouse urinary bladder tumor	P53 TUMOR-SUPPRESSOR; WILD-TYPE P53; MOUSE MODELS; MUTANT P53; EXTRACELLULAR-MATRIX; CANCER; MUTATIONS; MICE; TRANSLATION; INDUCTION	The p53 gene is frequently mutated in cancers and it is vital for cell cycle control, homeostasis and carcinogenesis. We describe a novel p53 mutational spectrum, different to those generally observed in human and murine tumors. Our study shows a high prevalence of nonsense mutations in the p53 N terminus of 2-acetylaminofluorene (2-AAF)-induced urinary bladder tumors. These nonsense mutations forced downstream translation initiation at codon 41 of Trp53, resulting in the aberrant expression of the p53 isoform Delta N-p53 (or p44). We propose a novel mechanism for the origination and the selection for this isoform. We show that chemical exposure can act as a novel cause of selection for this truncated protein. In addition, our data suggest that the occurrence of Delta N-p53 accounts, at least in mice, for a cancer phenotype. We also show that gene expression profiles of embryonic stem (ES) cells carrying the Delta N-p53 isoform in a p53-null background are divergent from p53 knockout ES cells, and therefore postulate that Delta N-p53 itself has functional transcriptional properties. Oncogene (2011) 30, 1764-1772; doi:10.1038/onc.2010.552; published online 13 December 2010	[Melis, J. P. M.; Hoogervorst, E. M.; van Oostrom, C. T. M.; Zwart, E.; Pennings, J. L. A.; de Vries, A.; van Steeg, H.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Utrecht, Netherlands; [Breit, T. M.] Univ Amsterdam, Fac Sci, MicroArray Dept, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam	van Steeg, H (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, POB 1, NL-3720 BA Utrecht, Netherlands.	Harry.van.Steeg@rivm.nl		Pennings, Jeroen L.A./0000-0002-9188-6358	NIH/NIEHS (Comparative Mouse Genomics Centers Consortium) [1UO1 ES11044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER	NIH/NIEHS (Comparative Mouse Genomics Centers Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the Animal Facilities of the Netherlands Vaccine Institute (NVI) for their skillful (bio)technical support. The work presented here was in part financially supported by NIH/NIEHS (Comparative Mouse Genomics Centers Consortium) Grant 1UO1 ES11044.	Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; de Leeuw Wim C, 2008, BMC Res Notes, V1, P66, DOI 10.1186/1756-0500-1-66; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hoogervorst EM, 2005, MUTAT RES-FUND MOL M, V574, P3, DOI 10.1016/j.mrfmmm.2005.01.018; Hoogervorst EM, 2005, CANCER RES, V65, P3610, DOI 10.1158/0008-5472.CAN-04-4328; Hoogervorst EM, 2004, CANCER RES, V64, P5118, DOI 10.1158/0008-5472.CAN-04-0350; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwakuma T, 2007, ONCOGENE, V26, P2177, DOI 10.1038/sj.onc.1210278; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Ross JA, 1998, MUTAGENESIS, V13, P173, DOI 10.1093/mutage/13.2.173; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; VOUSDEN KH, 1986, P NATL ACAD SCI USA, V83, P1222, DOI 10.1073/pnas.83.5.1222; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801	40	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	15					1764	1772		10.1038/onc.2010.552	http://dx.doi.org/10.1038/onc.2010.552			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21151170				2022-12-25	WOS:000289512200004
J	Oroz, J; Valbuena, A; Vera, AM; Mendieta, J; Gomez-Puertas, P; Carrion-Vazquez, M				Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Mendieta, Jesus; Gomez-Puertas, Paulino; Carrion-Vazquez, Mariano			Nanomechanics of the Cadherin Ectodomain "CANALIZATION" BYCa2 BINDING RESULTS IN A NEW MECHANICAL ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; EXTRACELLULAR CALCIUM; MOLECULAR-DYNAMICS; HOMOPHILIC BINDING; FORCE; PROTEIN; STABILITY; ACTIN; ELASTICITY; STRENGTH	Cadherins form a large family of calcium-dependent cell-cell adhesion receptors involved in development, morphogenesis, synaptogenesis, differentiation, and carcinogenesis through signal mechanotransduction using an adaptor complex that connects them to the cytoskeleton. However, the molecular mechanisms underlying mechanotransduction through cadherins remain unknown, although their extracellular region (ectodomain) is thought to be critical in this process. By single molecule force spectroscopy, molecular dynamics simulations, and protein engineering, here we have directly examined the nanomechanics of the C-cadherin ectodomain and found it to be strongly dependent on the calcium concentration. In the presence of calcium, the ectodomain extends through a defined ("canalized") pathway that involves two mechanical resistance elements: a mechanical clamp from the cadherin domains and a novel mechanostable component from the interdomain calcium-binding regions ("calcium rivet") that is abolished by magnesium replacement and in a mutant intended to impede calcium coordination. By contrast, in the absence of calcium, the mechanical response of the ectodomain becomes largely "decanalized" and destabilized. The cadherin ectodomain may therefore behave as a calcium-switched "mechanical antenna" with very different mechanical responses depending on calcium concentration (which would affect its mechanical integrity and force transmission capability). The versatile mechanical design of the cadherin ectodomain and its dependence on extracellular calcium facilitate a variety of mechanical responses that, we hypothesize, could influence the various adhesive properties mediated by cadherins in tissue morphogenesis, synaptic plasticity, and disease. Our work represents the first step toward the mechanical characterization of the cadherin system, opening the door to understanding the mechanical bases of its mechanotransduction.	[Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Carrion-Vazquez, Mariano] CSIC, Inst Cajal, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28002 Madrid, Spain; [Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Carrion-Vazquez, Mariano] Inst Madrileno Estudios Avanzados IMDEA Nanocienc, E-28002 Madrid, Spain; [Mendieta, Jesus; Gomez-Puertas, Paulino] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Mendieta, Jesus] Biomol Informat SL, E-28049 Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Carrion-Vazquez, M (corresponding author), CSIC, Inst Cajal, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Ave Doctor Arce 37, E-28002 Madrid, Spain.	mcarrion@cajal.csic.es	Mendieta, Jesús/P-4802-2016; Gomez-Puertas, Paulino/G-8821-2014; Valbuena, Alejandro/G-9682-2012; Oroz, Javier/J-3297-2015; Carrion-Vazquez, Mariano/Y-3741-2018	Mendieta, Jesús/0000-0002-5498-0871; Gomez-Puertas, Paulino/0000-0003-3131-729X; Valbuena, Alejandro/0000-0002-6801-640X; Oroz, Javier/0000-0003-2687-3013; Mendieta, Jesus/0000-0001-9286-2166; Vera, Andres Manuel/0000-0002-3932-8236; Carrion-Vazquez, Mariano/0000-0001-7319-406X	Ministerio de Ciencia e Innovacion, MICINN [BIO2007-67116, SAF2007-61926]; Consejeria de Educacion de la Comunidad de Madrid, CECM [S-0505/MAT/0283, S-BIO-0260/2006-COMBACT]; CSIC [200620F00]; European Union [FP7-223431]; Fundacion Areces; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion de la Comunidad de Madrid, CECM; CSIC; European Union(European Commission); Fundacion Areces; Fundacion Ramon Areces	This work was supported in part by grants from the Ministerio de Ciencia e Innovacion, MICINN (Grant BIO2007-67116), Consejeria de Educacion de la Comunidad de Madrid, CECM (Grant S-0505/MAT/0283), and CSIC (Grant 200620F00) (to M.C.-V.) and from the MICINN (Grant SAF2007-61926), the CECM (Grant S-BIO-0260/2006-COMBACT), and the European Union (Grant FP7-223431) (to P.G.-P.).; Recipient of a fellowship from the CECM.; Recipient of a fellowship from the Fundacion Areces.; We thank B. Gumbiner (University of Virginia, Charlottesville, VA) for kindly providing both the C-cadherin ectodomain and its cDNA clone. We thank also the members of the Carrion-Vazquez laboratory for discussion and critical reading of the manuscript. Financial support from the "Fundacion Ramon Areces" to the Centro de Biologia Molecular is also acknowledged.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1; Arias-Moreno X, 2010, PROTEINS, V78, P950, DOI 10.1002/prot.22619; Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Bayas M V, 2004, Mech Chem Biosyst, V1, P101; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cailliez F, 2006, BIOPHYS J, V91, P3964, DOI 10.1529/biophysj.106.087213; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Carrion-Vazquez Mariano, 2006, V10, P163; CASE DA, 2002, AMBER7; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; CHOI YS, 1990, J CELL BIOL, V110, P1575, DOI 10.1083/jcb.110.5.1575; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GINSBERG D, 1991, DEVELOPMENT, V111, P315; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Hewat EA, 2007, J MOL BIOL, V365, P744, DOI 10.1016/j.jmb.2006.10.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Maurer P, 1997, MATRIX BIOL, V15, P569, DOI 10.1016/S0945-053X(97)90033-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Prasad A, 2006, PROTEINS, V62, P111, DOI 10.1002/prot.20657; Prasad A, 2005, BIOCHEMISTRY-US, V44, P13692, DOI 10.1021/bi0510274; RADER C, 1999, 1G SUPERFAMILY MOL N, P1; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Shin JB, 2009, P NATL ACAD SCI USA, V106, P4959, DOI 10.1073/pnas.0902008106; Sivasankar S, 2009, STRUCTURE, V17, P1075, DOI 10.1016/j.str.2009.06.012; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Troyanovsky RB, 1999, J CELL SCI, V112, P4379; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wiest MC, 2000, J NEUROPHYSIOL, V83, P1329, DOI 10.1152/jn.2000.83.3.1329; Yagi T, 2000, GENE DEV, V14, P1169; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	93	31	33	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9405	9418		10.1074/jbc.M110.170399	http://dx.doi.org/10.1074/jbc.M110.170399			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177864	Green Published, hybrid			2022-12-25	WOS:000288247700069
J	Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; Michaud, M; Menger, L; Gdoura, A; Tajeddine, N; Tesniere, A; Zitvogel, L; Kroemer, G				Martins, I.; Kepp, O.; Schlemmer, F.; Adjemian, S.; Tailler, M.; Shen, S.; Michaud, M.; Menger, L.; Gdoura, A.; Tajeddine, N.; Tesniere, A.; Zitvogel, L.; Kroemer, G.			Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress	ONCOGENE			English	Article						apoptosis; autophagy; ER stress; necrosis; stress granules	CALRETICULIN EXPOSURE; TUMOR-CELLS; APOPTOSIS; CARCINOMA; PROTEINS; IMMUNITY; SURFACE; DNA; TRANSLOCATION; CHEMOTHERAPY	In contrast to other cytotoxic agents including anthracyclins and oxaliplatin (OXP), cisplatin (CDDP) fails to induce immunogenic tumor cell death that would allow to stimulate an anticancer immune response and hence to amplify its therapeutic efficacy. This failure to induce immunogenic cell death can be attributed to CDDP's incapacity to elicit the translocation of calreticulin (CRT) from the lumen of the endoplasmic reticulum (ER) to the cell surface. Here, we show that, in contrast to OXP, CDDP is unable to activate the protein kinase-like ER kinase (PERK)-dependent phosphorylation of the eukaryotic translation initiation factor 2 alpha (eIF2 alpha). Accordingly, CDDP also failed to stimulate the formation of stress granules and macroautophagy, two processes that only occur after eIF2 alpha phosphorylation. Using a screening method that monitors the voyage of CRT from the ER lumen to the cell surface, we identified thapsigargin (THAPS), an inhibitor of the sarco/ER Ca2+-ATPase as a molecule that on its own does not stimulate CRT exposure, yet endows CDDP with the capacity to do so. The combination of ER stress inducers (such as THAPS or tunicamycin) and CDDP effectively induced the translocation of CRT to the plasma membrane, as well as immunogenic cell death, although ER stress or CDDP alone was insufficient to induce CRT exposure and immunogenic cell death. Altogether, our results underscore the contribution of the ER stress response to the immunogenicity of cell death. Oncogene (2011) 30, 1147-1158; doi:10.1038/onc.2010.500; published online 13 December 2010	[Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, Val De Marne, France; [Martins, I.; Kepp, O.; Schlemmer, F.; Adjemian, S.; Tailler, M.; Shen, S.; Michaud, M.; Menger, L.; Gdoura, A.; Tajeddine, N.; Tesniere, A.; Zitvogel, L.] Univ Paris 11, Villejuif, France; [Zitvogel, L.] INSERM, U1015, Villejuif, France; [Zitvogel, L.] CICBT507, Villejuif, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, G.] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, Pavillon Rech 1,39 Rue Camille Desmoulins, F-94805 Villejuif, Val De Marne, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Kepp, Oliver/GPX-8627-2022; KROEMER, Guido/B-4263-2013; ADJEMIAN, Sandy/K-7632-2012; SHEN, Shensi/AAW-2735-2020; Kepp, Oliver/N-2763-2017	KROEMER, Guido/0000-0002-9334-4405; ADJEMIAN, Sandy/0000-0001-5594-5499; SHEN, Shensi/0000-0002-5087-8220; Kepp, Oliver/0000-0002-6081-9558; Menger, Laurie/0000-0003-0949-6607; ZITVOGEL, laurence/0000-0003-1596-0998; Schlemmer, Frederic/0000-0003-2113-7113	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR); European Commission (Apo-Sys, ChemoRes, Apop-Train); Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; AICR; FRM	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Apo-Sys, ChemoRes, Apop-Train)(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); AICR; FRM(Fondation pour la Recherche Medicale)	GK is supported by the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche (ANR), European Commission (Apo-Sys, ChemoRes, Apop-Train), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa) and Canceropole Ile-de-France. IM is supported by the Ligue Nationale contre le Cancer, OK is supported by AICR and FS by FRM.	Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Delmastro DA, 1997, CANCER CHEMOTH PHARM, V39, P245; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gourdier I, 2004, ONCOGENE, V23, P7449, DOI 10.1038/sj.onc.1208047; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kepp O, 2010, CELL CYCLE, V9, P3072, DOI 10.4161/cc.9.15.12459; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Orvedahl A, 2009, CURR TOP MICROBIOL, V335, P267, DOI 10.1007/978-3-642-00302-8_13; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; Rello-Varona S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.6; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Vandenabeele P, 2008, TRENDS BIOCHEM SCI, V33, P352, DOI 10.1016/j.tibs.2008.05.007; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	36	259	267	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	10					1147	1158		10.1038/onc.2010.500	http://dx.doi.org/10.1038/onc.2010.500			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	732QD	21151176				2022-12-25	WOS:000288202400002
J	Magnan, R; Masri, B; Escrieut, C; Foucaud, M; Cordelier, P; Fourmy, D				Magnan, Remi; Masri, Bernard; Escrieut, Chantal; Foucaud, Magali; Cordelier, Pierre; Fourmy, Daniel			Regulation of Membrane Cholecystokinin-2 Receptor by Agonists Enables Classification of Partial Agonists as Biased Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; B RECEPTOR; CARBOXYL-TERMINUS; ARRESTIN; INTERNALIZATION; ENDOCYTOSIS; TRAFFICKING; GASTRIN; DESENSITIZATION; ACTIVATION	Given the importance of G-protein-coupled receptors as pharmacological targets in medicine, efforts directed at understanding the molecular mechanism by which pharmacological compounds regulate their presence at the cell surface is of paramount importance. In this context, using confocal microscopy and bioluminescence resonance energy transfer, we have investigated internalization and intracellular trafficking of the cholecystokinin-2 receptor (CCK2R) in response to both natural and synthetic ligands with different pharmacological features. We found that CCK and gastrin, which are full agonists on CCK2R-induced inositol phosphate production, rapidly and abundantly stimulate internalization. Internalized CCK2R did not rapidly recycle to plasma membrane but instead was directed to late endosomes/lysosomes. CCK2R endocytosis involves clathrin-coated pits and dynamin and high affinity and prolonged binding of beta-arrestin1 or -2. Partial agonists and antagonists on CCK2R-induced inositol phosphate formation and ERK1/2 phosphorylation did not stimulate CCK2R internalization or beta-arrestin recruitment to the CCK2R but blocked full agonist-induced internalization and beta-arrestin recruitment. The extreme C-terminal region of the CCK2R (and more precisely phosphorylatable residues Ser(437)-Xaa(438-)Thr(439)-Thr(440)-Xaa(441)-Ser(442)-Thr(443)) were critical for beta-arrestin recruitment. However, this region and beta-arrestins were dispensable for CCK2R internalization. In conclusion, this study allowed us to classify the human CCK2R as a member of class B G-protein-coupled receptors with regard to its endocytosis features and identified biased agonists of the CCK2R. These new important insights will allow us to investigate the role of internalized CCK2R.beta-arrestin complexes in cancers expressing this receptor and to develop new diagnosis and therapeutic strategies targeting this receptor.	[Fourmy, Daniel] INSERM, U858 I2MR, Unite 858, F-31432 Toulouse 4, France; Univ Toulouse 3118, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Federale Toulouse Midi-Pyrenees (ComUE)	Fourmy, D (corresponding author), INSERM, U858 I2MR, Unite 858, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	Daniel.Fourmy@inserm.fr	Fourmy, Daniel/AAE-3703-2019; Masri, Bernard/N-9856-2018; Cordelier, Pierre/D-1150-2014	Fourmy, Daniel/0000-0001-9910-4827; Masri, Bernard/0000-0002-4027-2604; Cordelier, Pierre/0000-0003-2096-7967	Association pour la Recherche contre le Cancer [4870]; Ligue Nationale Contre le Cancer (Comite 31)	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (Comite 31)	This work was supported by Association pour la Recherche contre le Cancer Grant 4870 and the Ligue Nationale Contre le Cancer (Comite 31).	Arnould M, 2004, FEBS LETT, V568, P89, DOI 10.1016/j.febslet.2004.05.012; Bierkamp C, 2002, ONCOGENE, V21, P7656, DOI 10.1038/sj.onc.1205999; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Foucaud M, 2008, J BIOL CHEM, V283, P35860, DOI 10.1074/jbc.M805513200; FOURMY D, 1989, EUR J BIOCHEM, V185, P397, DOI 10.1111/j.1432-1033.1989.tb15128.x; Giebing G, 2005, CIRC RES, V97, P707, DOI 10.1161/01.RES.0000184670.58688.9F; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Herranz R, 2003, MED RES REV, V23, P559, DOI 10.1002/med.10042; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; Kalindjian SB, 2001, J MED CHEM, V44, P1125, DOI 10.1021/jm0010668; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Lan HX, 2009, MOL PHARMACOL, V75, P19, DOI 10.1124/mol.108.050542; Langer I, 2009, MOL PHARMACOL, V75, P502, DOI 10.1124/mol.108.051607; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MORODER L, 1981, H-S Z PHYSIOL CHEM, V362, P929, DOI 10.1515/bchm2.1981.362.2.929; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Noble F, 1999, PHARMACOL REV, V51, P745; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pohl M, 1997, J BIOL CHEM, V272, P18179, DOI 10.1074/jbc.272.29.18179; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tarasova NI, 1997, CELL TISSUE RES, V287, P325, DOI 10.1007/s004410050757; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vatinel S, 2006, BBA-MOL CELL RES, V1763, P1098, DOI 10.1016/j.bbamcr.2006.07.003; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	51	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6707	6719		10.1074/jbc.M110.196048	http://dx.doi.org/10.1074/jbc.M110.196048			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156802	Green Published, hybrid			2022-12-25	WOS:000287476400078
J	Dumitrescu, D; Oudiz, RJ; Karpouzas, G; Hovanesyan, A; Jayasinghe, A; Hansen, JE; Rosenkranz, S; Wasserman, K				Dumitrescu, Daniel; Oudiz, Ronald J.; Karpouzas, George; Hovanesyan, Arsen; Jayasinghe, Amali; Hansen, James E.; Rosenkranz, Stephan; Wasserman, Karlman			Developing Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise Testing	PLOS ONE			English	Article							VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; VENOOCCLUSIVE DISEASE; ANAEROBIC THRESHOLD; HEART-FAILURE; GAS-EXCHANGE; PATHOPHYSIOLOGY; LIMITATION; LUNG	Background: Patients with systemic sclerosis (SSc) may develop exercise intolerance due to musculoskeletal involvement, restrictive lung disease, left ventricular dysfunction, or pulmonary vasculopathy (PV). The latter is particularly important since it may lead to lethal pulmonary arterial hypertension (PAH). We hypothesized that abnormalities during cardiopulmonary exercise testing (CPET) in patients with SSc can identify PV leading to overt PAH. Methods: Thirty SSc patients from the Harbor-UCLA Rheumatology clinic, not clinically suspected of having significant pulmonary vascular disease, were referred for this prospective study. Resting pulmonary function and exercise gas exchange were assessed, including peakVO(2), anaerobic threshold (AT), heart rate-VO2 relationship (O-2-pulse), exercise breathing reserve and parameters of ventilation-perfusion mismatching, as evidenced by elevated ventilatory equivalent for CO2 (VE/VCO2) and reduced end-tidal pCO(2) (PETCO2) at the AT. Results: Gas exchange patterns were abnormal in 16 pts with specific cardiopulmonary disease physiology: Eleven patients had findings consistent with PV, while five had findings consistent with left-ventricular dysfunction (LVD). Although both groups had low peak VO2 and AT, a higher VE/VCO2 at AT and decreasing PETCO2 during early exercise distinguished PV from LVD. Conclusions: Previously undiagnosed exercise impairments due to LVD or PV were common in our SSc patients. Cardiopulmonary exercise testing may help to differentiate and detect these disorders early in patients with SSc.	[Dumitrescu, Daniel; Oudiz, Ronald J.; Karpouzas, George; Hovanesyan, Arsen; Jayasinghe, Amali; Hansen, James E.; Wasserman, Karlman] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Dumitrescu, Daniel; Jayasinghe, Amali; Hansen, James E.; Wasserman, Karlman] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Resp & Crit Care Med & Physiol, Cologne, Germany; [Oudiz, Ronald J.; Hovanesyan, Arsen] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Cardiol, Cologne, Germany; [Karpouzas, George] Herzzentrum Univ Koeln, Innere Med Klin 3, Div Rheumatol, Cologne, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Cologne; University of Cologne; University of Cologne	Dumitrescu, D (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	daniel.dumitrescu@dd-it.de	Dumitrescu, Daniel/ABG-3576-2020; Karpouzas, George/AAE-3343-2019		Actelion Pharmaceuticals	Actelion Pharmaceuticals	This work was partly supported by an unrestricted grant from Actelion Pharmaceuticals (http://www.actelion.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 2008, WMA DECL HELS ETH PR; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Davis JA, 1997, EUR J APPL PHYSIOL O, V76, P157, DOI 10.1007/s004210050228; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Hansen JE, 2007, CHEST, V132, P977, DOI 10.1378/chest.07-0619; Hansen JE, 2004, CHEST, V126, P816, DOI 10.1378/chest.126.3.816; Hansen JE, 1996, CHEST, V109, P1566, DOI 10.1378/chest.109.6.1566; HUSZCZUK A, 1990, EUR RESPIR J, V3, P465; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kleber FX, 2000, CIRCULATION, V101, P2803, DOI 10.1161/01.CIR.101.24.2803; Kovacs G, 2009, AM J RESP CRIT CARE, V180, P881, DOI 10.1164/rccm.200904-0563OC; Markowitz DH, 2004, J HEART LUNG TRANSPL, V23, P88, DOI 10.1016/S1053-2498(03)00064-0; MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; Montani D, 2010, RESP MED, V104, pS23, DOI 10.1016/j.rmed.2010.03.014; Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088; Nishida M, 2004, J CARDIOVASC PHARM, V44, P187, DOI 10.1097/00005344-200408000-00007; Schwaiblmair M, 1996, CHEST, V110, P1520, DOI 10.1378/chest.110.6.1520; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101; Wasserman K, 2005, PRINCIPLES EXERCISE, P104; Wasserman K, 2007, CHEST, V132, P250, DOI 10.1378/chest.06-2872; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637	28	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14293	10.1371/journal.pone.0014293	http://dx.doi.org/10.1371/journal.pone.0014293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179195	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900007
J	Hong, CJ; Tsai, PJ; Cheng, CY; Chou, CK; Jheng, HF; Chuang, YC; Yang, CN; Lin, YT; Hsu, CW; Cheng, IH; Chen, SY; Tsai, SJ; Liou, YJ; Tsai, YS				Hong, Chen-Jee; Tsai, Pei-Jane; Cheng, Chih-Ya; Chou, Chuan-Kai; Jheng, Huei-Fen; Chuang, You-Chung; Yang, Chia-Ning; Lin, Ya-Tzu; Hsu, Chih-Wei; Cheng, Irene H.; Chen, Shiow-Yi; Tsai, Shih-Jen; Liou, Ying-Jay; Tsai, Yau-Sheng			ENU Mutagenesis Identifies Mice with Morbid Obesity and Severe Hyperinsulinemia Caused by a Novel Mutation in Leptin	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; RECEPTOR ACTIVATION; RECOMBINANT HUMAN; BINDING DOMAIN; GENE; COMPLICATIONS; PURIFICATION; INVOLVEMENT; DEFICIENCY; ANTAGONIST	Background: Obesity is a multifactorial disease that arises from complex interactions between genetic predisposition and environmental factors. Leptin is central to the regulation of energy metabolism and control of body weight in mammals. Methodology/Principal Findings: To better recapitulate the complexity of human obesity syndrome, we applied N-ethyl-N-nitrosourea (ENU) mutagenesis in combination with a set of metabolic assays in screening mice for obesity. Mapping revealed linkage to the chromosome 6 within a region containing mouse Leptin gene. Sequencing on the candidate genes identified a novel T-to-A mutation in the third exon of Leptin gene, which translates to a V145E amino acid exchange in the leptin propeptide. Homozygous Leptin(145E/145E) mutant mice exhibited morbid obesity, accompanied by adipose hypertrophy, energy imbalance, and liver steatosis. This was further associated with severe insulin resistance, hyperinsulinemia, dyslipidemia, and hyperleptinemia, characteristics of human obesity syndrome. Hypothalamic leptin actions in inhibition of orexigenic peptides NPY and AgRP and induction of SOCS1 and SOCS3 were attenuated in Leptin(145E/145E) mice. Administration of exogenous wild-type leptin attenuated hyperphagia and body weight increase in Leptin(145E/145E) mice. However, mutant V145E leptin coimmunoprecipitated with leptin receptor, suggesting that the V145E mutation does not affect the binding of leptin to its receptor. Molecular modeling predicted that the mutated residue would form hydrogen bond with the adjacent residues, potentially affecting the structure and formation of an active complex with leptin receptor within that region. Conclusions/Significance: Thus, our evolutionary, structural, and in vivo metabolic information suggests the residue 145 as of special function significance. The mouse model harboring leptin V145E mutation will provide new information on the current understanding of leptin biology and novel mouse model for the study of human obesity syndrome.	[Hong, Chen-Jee; Lin, Ya-Tzu; Hsu, Chih-Wei; Cheng, Irene H.] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen; Liou, Ying-Jay] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Cheng, Chih-Ya; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chou, Chuan-Kai] Natl Appl Res Labs, Natl Lab Anim Ctr, Taipei, Taiwan; [Jheng, Huei-Fen; Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chuang, You-Chung; Yang, Chia-Ning] Natl Kaohsiung Univ Appl Sci, Inst Biotechnol, Kaohsiung 807, Taiwan; [Chen, Shiow-Yi] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Chilung, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; National Applied Research Laboratories - Taiwan; National Cheng Kung University; National Kaohsiung University of Science & Technology; National Taiwan Ocean University; National Cheng Kung University	Hong, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan.	yaustsai@mail.ncku.edu.tw	Tsai, Pei-Jane/G-3563-2011; Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X	National Health Research Institute [EX98-9823SC]; National Science Council [97-2314-B-075-002-MY3, 98-2320-B-006-009-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Health Research Institute to YST (EX98-9823SC) and National Science Council to CJH (97-2314-B-075-002-MY3) and YST (98-2320-B-006-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brunner L, 1999, INT J OBESITY, V23, P463, DOI 10.1038/sj.ijo.0800842; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Echwald SM, 1997, INT J OBESITY, V21, P321, DOI 10.1038/sj.ijo.0800408; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Haluzik M, 2004, PHYSIOL RES, V53, P123; Hinney A, 1998, MOL PSYCHIATR, V3, P539, DOI 10.1038/sj.mp.4000394; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Leiter EH, 2007, OBESITY, V15, P1961, DOI 10.1038/oby.2007.234; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Onions KL, 1998, HYPERTENSION, V31, P1230, DOI 10.1161/01.HYP.31.6.1230; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Strosberg AD, 1999, TRENDS PHARMACOL SCI, V20, P227, DOI 10.1016/S0165-6147(99)01313-9; Tsai YS, 2009, MOL ENDOCRINOL, V23, P1787, DOI 10.1210/me.2009-0073; Verploegen SABW, 1997, FEBS LETT, V405, P237, DOI 10.1016/S0014-5793(97)00192-0; Wang Y, 2009, J ENDOCRINOL, V202, P17, DOI 10.1677/JOE-09-0079; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15333	10.1371/journal.pone.0015333	http://dx.doi.org/10.1371/journal.pone.0015333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151569	Green Published, gold, Green Submitted			2022-12-25	WOS:000285135800025
J	Xie, C; Tang, XX; Xu, WM; Diao, RY; Cai, ZM; Chan, HC				Xie, Chen; Tang, Xiaoxiao; Xu, Wenming; Diao, Ruiying; Cai, Zhiming; Chan, Hsiao Chang			A Host Defense Mechanism Involving CFTR-Mediated Bicarbonate Secretion in Bacterial Prostatitis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SOLUBLE ADENYLYL-CYCLASE; CYSTIC-FIBROSIS; FERTILIZING-CAPACITY; CL-/HCO3-EXCHANGE; MESSENGER-RNA; PH; TRACT; FLUID; TRANSLATION	Background: Prostatitis is associated with a characteristic increase in prostatic fluid pH; however, the underlying mechanism and its physiological significance have not been elucidated. Methodology/Principal Findings: In this study a primary culture of rat prostatic epithelial cells and a rat prostatitis model were used. Here we reported the involvement of CFTR, a cAMP-activated anion channel conducting both Cl- and O-3(-), in mediating prostate HCO3- secretion and its possible role in bacterial killing. Upon Escherichia coli (E coli)-LPS challenge, the expression of CFTR and carbonic anhydrase II (CA II), along with several pro-inflammatory cytokines was up-regulated in the primary culture of rat prostate epithelial cells. Inhibiting CFTR function in vitro or in vivo resulted in reduced bacterial killing by prostate epithelial cells or the prostate. High HCO3- content (>50 mM), rather than alkaline pH, was found to be responsible for bacterial killing. The direct action of HCO3- on bacterial killing was confirmed by its ability to increase cAMP production and suppress bacterial initiation factors in E coli. The relevance of the CFTR-mediated HCO3- secretion in humans was demonstrated by the upregulated expression of CFTR and CAII in human prostatitis tissues. Conclusions/Significance: The CFTR and its mediated HCO3- secretion may be up-regulated in prostatitis as a host defense mechanism.	[Xie, Chen; Tang, Xiaoxiao; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Xu, Wenming; Chan, Hsiao Chang] Sichuan Univ, W China Univ Hosp 2, Chinese Univ Hong Kong Joint Lab Reprod Med, Hong Kong, Hong Kong, Peoples R China; [Diao, Ruiying; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod & Genet, Shenzhen, Peoples R China	Chinese University of Hong Kong; Sichuan University; Peking University	Xie, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016		Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajonuma LC, 2008, CELL BIOL INT, V32, P801, DOI 10.1016/j.cellbi.2008.03.010; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Beeler Jeff A., 2003, V237, P39; BHATTACHARYA A, 1977, BIOCHEM BIOPH RES CO, V77, P1438, DOI 10.1016/S0006-291X(77)80140-X; BLACKLOCK NJ, 1974, BRIT J UROL, V46, P537, DOI 10.1111/j.1464-410X.1974.tb03853.x; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; Chan HC, 2006, MOL CELL ENDOCRINOL, V250, P106, DOI 10.1016/j.mce.2005.12.032; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; CHANDIOK S, 1992, INT J STD AIDS, V3, P188, DOI 10.1177/095646249200300306; Chen J, 2007, UROL INT, V78, P230, DOI 10.1159/000099343; Chen MH, 2010, HUM REPROD, V25, P1744, DOI 10.1093/humrep/deq094; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; CORRAL LG, 1988, J FOOD SCI, V53, P981, DOI 10.1111/j.1365-2621.1988.tb09005.x; Craig SB, 1999, PLAST RECONSTR SURG, V103, P666, DOI 10.1097/00006534-199902000-00047; CUMMINGS HS, 1994, J BACTERIOL, V176, P198, DOI 10.1128/JB.176.1.198-205.1994; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; DELAROSETTE JJMCH, 1993, UROLOGY, V41, P301, DOI 10.1016/0090-4295(93)90584-W; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Drake DR, 1995, AM J DENT, V8, P308; Erdogan S, 2008, RES VET SCI, V84, P18, DOI 10.1016/j.rvsc.2007.02.003; FAIR WR, 1978, J UROLOGY, V120, P695, DOI 10.1016/S0022-5347(17)57333-4; GIAMARELLOU H, 1984, ANDROLOGIA, V16, P417; Grill S, 2001, FEBS LETT, V495, P167, DOI 10.1016/S0014-5793(01)02378-X; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; He LY, 2010, UROLOGY, V75, P654, DOI 10.1016/j.urology.2009.09.061; He Q, 2010, FERTIL STERIL, V93, P2608, DOI 10.1016/j.fertnstert.2010.01.040; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; Ishiguro Hiroshi, 2007, Shengli Xuebao, V59, P465; Jang TL, 2003, WORLD J UROL, V21, P95, DOI 10.1007/s00345-003-0335-2; Jarvis GN, 2001, LETT APPL MICROBIOL, V33, P196, DOI 10.1046/j.1472-765x.2001.00976.x; Johansen TEB, 1998, EUR UROL, V34, P457; KAUL R, 1990, BIOCHIM BIOPHYS ACTA, V1053, P106, DOI 10.1016/0167-4889(90)90032-9; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; LEIB Z, 1994, FERTIL STERIL, V61, P1109; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Mitsumori K, 1999, J INFECT DIS, V180, P1378, DOI 10.1086/314976; PFAU A, 1978, J UROLOGY, V119, P384, DOI 10.1016/S0022-5347(17)57497-2; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Qiao D, 2008, J CYST FIBROS, V7, P210, DOI 10.1016/j.jcf.2007.07.011; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; SCHAEFFER AJ, 1981, J UROLOGY, V125, P215, DOI 10.1016/S0022-5347(17)54976-9; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; SNOW DC, 2010, PHARMACOTHERAPY PROS; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; TAJIMA Y, 1987, BIOCHIM BIOPHYS ACTA, V924, P519; TAKETA S, 1990, PROSTATE, V17, P207, DOI 10.1002/pros.2990170304; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; THIN RN, 1991, GENITOURIN MED, V67, P279; THOMPSON KD, 1993, J DERMATOL SURG ONC, V19, P216, DOI 10.1111/j.1524-4725.1993.tb00339.x; Trevani AS, 1999, J IMMUNOL, V162, P4849; Wagenlehner FME, 2005, INT J ANTIMICROB AG, V26, P1, DOI 10.1016/j.ijantimicag.2005.04.013; WALKER J, 1995, J CELL SCI, V108, P2433; Wang XF, 2003, NAT CELL BIOL, V5, P902, DOI 10.1038/ncb1047; WEIDNER W, 1992, INFECTION, V20, pS227, DOI 10.1007/BF01704386; WHITE MA, 1975, P ROY SOC MED, V68, P511, DOI 10.1177/003591577506800815; WINNINGHAM DG, 1968, NATURE, V219, P139, DOI 10.1038/219139a0; WOLFF H, 1991, J ANDROL, V12, P331; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Zhou Chen-Xi, 2005, Shengli Xuebao, V57, P115	69	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15255	10.1371/journal.pone.0015255	http://dx.doi.org/10.1371/journal.pone.0015255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151921	Green Published, Green Submitted, gold			2022-12-25	WOS:000285041800011
J	Ebeling, W; Natoli, RC; Hemmi, JM				Ebeling, Wiebke; Natoli, Riccardo C.; Hemmi, Jan M.			Diversity of Color Vision: Not All Australian Marsupials Are Trichromatic	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; OPSIN GENE DUPLICATION; SMINTHOPSIS-CRASSICAUDATA; MONOCLONAL-ANTIBODIES; SPECTRAL SENSITIVITY; MOLECULAR EVOLUTION; ROD OPSIN; NEW-WORLD; RETINA; RHODOPSIN	Color vision in marsupials has recently emerged as a particularly interesting case among mammals. It appears that there are both dichromats and trichromats among closely related species. In contrast to primates, marsupials seem to have evolved a different type of trichromacy that is not linked to the X-chromosome. Based on microspectrophotometry and retinal whole-mount immunohistochemistry, four trichromatic marsupial species have been described: quokka, quenda, honey possum, and fat-tailed dunnart. It has, however, been impossible to identify the photopigment of the third cone type, and genetically, all evidence so far suggests that all marsupials are dichromatic. The tammar wallaby is the only Australian marsupial to date for which there is no evidence of a third cone type. To clarify whether the wallaby is indeed a dichromat or trichromatic like other Australian marsupials, we analyzed the number of cone types in the "dichromatic" wallaby and the "trichromatic" dunnart. Employing identical immunohistochemical protocols, we confirmed that the wallaby has only two cone types, whereas 20-25% of cones remained unlabeled by S-and LM-opsin antibodies in the dunnart retina. In addition, we found no evidence to support the hypothesis that the rod photopigment (rod opsin) is expressed in cones which would have explained the absence of a third cone opsin gene. Our study is the first comprehensive and quantitative account of color vision in Australian marsupials where we now know that an unexpected diversity of different color vision systems appears to have evolved.	Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; Australian Natl Univ, Ctr Visual Sci, Res Sch Biol, ANU Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University; Australian National University	Ebeling, W (corresponding author), Univ Tasmania, Ctr Marine Sci, Hobart, Tas, Australia.	Wiebke.Ebeling@utas.edu.au	Hemmi, Jan M/B-6458-2008	Hemmi, Jan M/0000-0003-4629-9362; Natoli, Riccardo/0000-0002-9350-0439	Australian Research Council through the ARC Centre of Excellence in Vision Science [CE0561903]; Department of Education, Employment and Workplace Relations (DEEWR); Australian National University; ARC Centre of Excellence in Vision Science	Australian Research Council through the ARC Centre of Excellence in Vision Science(Australian Research Council); Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National University(Australian National University); ARC Centre of Excellence in Vision Science(Australian Research Council)	This research was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903). W. E. was funded through stipends from the Department of Education, Employment and Workplace Relations (DEEWR), the Australian National University, and the ARC Centre of Excellence in Vision Science. These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; Applebury ML, 2001, TRENDS NEUROSCI, V24, P250, DOI 10.1016/S0166-2236(00)01772-0; Arrese C, 1999, BRAIN BEHAV EVOLUT, V53, P111, DOI 10.1159/000006588; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2005, P ROY SOC B-BIOL SCI, V272, P791, DOI 10.1098/rspb.2004.3009; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bennis M, 2005, EXP EYE RES, V80, P623, DOI 10.1016/j.exer.2004.11.004; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; De Araujo MFP, 2006, AM J PRIMATOL, V68, P1129, DOI 10.1002/ajp.20312; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Dulai KS, 1999, GENOME RES, V9, P629; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Fasick JI, 1998, VISUAL NEUROSCI, V15, P643, DOI 10.1017/S0952523898154056; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Glosmann M, 2002, BRAIN RES, V929, P139, DOI 10.1016/S0006-8993(02)02267-9; Granneman JG, 1998, MOL PHARMACOL, V54, P687; Hemmi JM, 1999, J COMP PHYSIOL A, V185, P509, DOI 10.1007/s003590050411; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Hunt DM, 2003, GENE, V323, P157, DOI 10.1016/j.gene.2003.09.016; Jacobs GH, 2010, J COMP PHYSIOL A, V196, P379, DOI 10.1007/s00359-010-0519-3; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; JACOBS GH, 2009, P ROY SOC LOND B BIO, V34, P2957, DOI DOI 10.1098/RSTB.2009.0039; JIANG MS, 1995, EXP EYE RES, V60, P401, DOI 10.1016/S0014-4835(05)80096-X; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MCDEVITT DS, 1993, ANAT REC, V237, P299, DOI 10.1002/ar.1092370302; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Muller B, 2007, BRAIN BEHAV EVOLUT, V70, P90, DOI 10.1159/000102971; Muller B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006390; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; ODDY AY, 2003, DIRECT SUBMISSION GE; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; Peichl L, 2001, EUR J NEUROSCI, V13, P1520, DOI 10.1046/j.0953-816x.2001.01533.x; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8; Strachan J, 2004, VISUAL NEUROSCI, V21, P223, DOI 10.1017/S0952523804213281; Sumner P, 2005, J EXP BIOL, V208, pIII, DOI 10.1242/jcb.01646; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; Wang DY, 2004, MOL BIOL EVOL, V21, P295, DOI 10.1093/molbev/msh015; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Xiao M, 2000, J COMP NEUROL, V425, P545; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	62	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14231	10.1371/journal.pone.0014231	http://dx.doi.org/10.1371/journal.pone.0014231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151905	Green Published, Green Submitted, gold			2022-12-25	WOS:000284995300003
J	Xue, JA; Bao, YY; Li, BL; Cheng, YB; Peng, ZY; Liu, H; Xu, HJ; Zhu, ZR; Lou, YG; Cheng, JA; Zhang, CX				Xue, Jian; Bao, Yan-Yuan; Li, Bao-ling; Cheng, Yan-Bing; Peng, Zhi-Yu; Liu, Hang; Xu, Hai-Jun; Zhu, Zeng-Rong; Lou, Yong-Gen; Cheng, Jia-An; Zhang, Chuan-Xi			Transcriptome Analysis of the Brown Planthopper Nilaparvata lugens	PLOS ONE			English	Article							WING DIMORPHISM; INSECTICIDE RESISTANCE	Background: The brown planthopper (BPH) Nilaparvata lugens (Stal) is one of the most serious insect pests of rice in Asia. However, little is known about the mechanisms responsible for the development, wing dimorphism and sex difference in this species. Genomic information for BPH is currently unavailable, and, therefore, transcriptome and expression profiling data for this species are needed as an important resource to better understand the biological mechanisms of BPH. Methodology/Principal Findings: In this study, we performed de novo transcriptome assembly and gene expression analysis using short-read sequencing technology (Illumina) combined with a tag-based digital gene expression (DGE) system. The transcriptome analysis assembles the gene information for different developmental stages, sexes and wing forms of BPH. In addition, we constructed six DGE libraries: eggs, second instar nymphs, fifth instar nymphs, brachypterous female adults, macropterous female adults and macropterous male adults. Illumina sequencing revealed 85,526 unigenes, including 13,102 clusters and 72,424 singletons. Transcriptome sequences larger than 350 bp were subjected to Gene Orthology (GO) and KEGG Orthology (KO) annotations. To analyze the DGE profiling, we mainly compared the gene expression variations between eggs and second instar nymphs; second and fifth instar nymphs; fifth instar nymphs and three types of adults; brachypterous and macropterous female adults as well as macropterous female and male adults. Thousands of genes showed significantly different expression levels based on the various comparisons. And we randomly selected some genes to confirm their altered expression levels by quantitative real-time PCR (qRT-PCR). Conclusions/Significance: The obtained BPH transcriptome and DGE profiling data provide comprehensive gene expression information at the transcriptional level that could facilitate our understanding of the molecular mechanisms from various physiological aspects including development, wing dimorphism and sex difference in BPH.	[Xue, Jian; Bao, Yan-Yuan; Li, Bao-ling; Xu, Hai-Jun; Zhu, Zeng-Rong; Lou, Yong-Gen; Cheng, Jia-An; Zhang, Chuan-Xi] Zhejiang Univ, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, State Key Lab Rice Biol,Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Yan-Bing; Peng, Zhi-Yu; Liu, Hang] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Beijing Genomics Institute (BGI)	Zhang, CX (corresponding author), Zhejiang Univ, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, State Key Lab Rice Biol,Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chxzhang@zju.edu.cn	Peng, Zhiyu/GXV-5301-2022; Zhang, Chuan-Xi/K-7978-2019; Jian, Xue/M-2381-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Xu, Hai-Jun/0000-0002-7314-377X; Liu, Hang/0000-0003-3012-6061	National Basic Research Program of China (973 Program) [2010CB126200]; National Natural Science Foundation of China [31070136]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funders include the National Basic Research Program of China (973 Program, No. 2010CB126200) (website: http://www.973.gov.cn/English/Index.aspx), and the National Natural Science Foundation of China (No. 31070136) (website: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bauer H, 2002, J BIOL CHEM, V277, P17457, DOI 10.1074/jbc.M200636200; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; [程家安 Cheng Jiaan], 2006, [植物保护, Plant Protection], V32, P1; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Jansen S, 2001, CELLS TISSUES ORGANS, V168, P82, DOI 10.1159/000016809; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu Guang-Jie, 2000, Entomological Knowledge, V37, P186; Matsumura M, 1996, HEREDITY, V76, P229, DOI 10.1038/hdy.1996.36; McIntyre LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r79; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; NOVOTNY V, 1995, ENTOMOL EXP APPL, V76, P233, DOI 10.1007/BF02382989; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu ZH, 2004, CROP PROT, V23, P1131, DOI 10.1016/j.cropro.2004.04.005; ROBERT F, 1986, ECOLOGY, V67, P116; Schoonjans K, 1996, J LIPID RES, V37, P907; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101	25	183	204	3	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14233	10.1371/journal.pone.0014233	http://dx.doi.org/10.1371/journal.pone.0014233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151909	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300005
J	Das, P; Lahiri, A; Lahiri, A; Sen, M; Iyer, N; Kapoor, N; Balaji, KN; Chakravortty, D				Das, Priyanka; Lahiri, Amit; Lahiri, Ayan; Sen, Minakshi; Iyer, Namrata; Kapoor, Nisha; Balaji, Kithiganahalli Narayanaswamy; Chakravortty, Dipshikha			Cationic Amino Acid Transporters and Salmonella Typhimurium ArgT Collectively Regulate Arginine Availability towards Intracellular Salmonella Growth	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; NITRIC-OXIDE PRODUCTION; MURINE MACROPHAGES; ESCHERICHIA-COLI; GENE-EXPRESSION; INFECTION; CELLS; TRAFFICKING; HOMEOSTASIS; METABOLISM	Cationic amino acid transporters (mCAT1 and mCAT2B) regulate the arginine availability in macrophages. How in the infected cell a pathogen can alter the arginine metabolism of the host remains to be understood. We reveal here a novel mechanism by which Salmonella exploit mCAT1 and mCAT2B to acquire host arginine towards its own intracellular growth within antigen presenting cells. We demonstrate that Salmonella infected bone marrow derived macrophages and dendritic cells show enhanced arginine uptake and increased expression of mCAT1 and mCAT2B. We show that the mCAT1 transporter is in close proximity to Salmonella containing vacuole (SCV) specifically by live intracellular Salmonella in order to access the macrophage cytosolic arginine pool. Further, Lysosome associated membrane protein 1, a marker of SCV, also was found to colocalize with mCAT1 in the Salmonella infected cell. The intra vacuolar Salmonella then acquire the host arginine via its own arginine transporter, ArgT for growth. The argT knockout strain was unable to acquire host arginine and was attenuated in growth in both macrophages and in mice model of infection. Together, these data reveal survival strategies by which virulent Salmonella adapt to the harsh conditions prevailing in the infected host cells.	[Das, Priyanka; Lahiri, Amit; Lahiri, Ayan; Sen, Minakshi; Iyer, Namrata; Kapoor, Nisha; Balaji, Kithiganahalli Narayanaswamy; Chakravortty, Dipshikha] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res & Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Das, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res & Biosafety Labs, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; Iyer, Namrata/GQO-7833-2022	Chakravortty, Dipshikha/0000-0002-7838-5145; LAHIRI, AMIT/0000-0003-0307-3478; Iyer, Namrata/0000-0002-5263-7092; Lahiri, Ayan/0000-0003-1621-2051	Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology (DBT), India [197, 172]	Indian Institute of Science, Bangalore, India; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172), India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARDESHIR F, 1980, J SUPRAMOL STR CELL, V13, P117, DOI 10.1002/jss.400130111; ARDESHIR F, 1981, J BACTERIOL, V147, P401, DOI 10.1128/JB.147.2.401-409.1981; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Das P, PLOS PATHOG, V6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; Lahiri A, 2008, MICROBES INFECT, V10, P1166, DOI 10.1016/j.micinf.2008.06.008; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; MacLeod CL, 1996, BIOCHEM SOC T, V24, P846, DOI 10.1042/bst0240846; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Munder M, 1999, J IMMUNOL, V163, P3771; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Peteroy-Kelly M, 2001, INFECT IMMUN, V69, P5823, DOI 10.1128/IAI.69.9.5823-5831.2001; Peteroy-Kelly MA, 2003, INFECT IMMUN, V71, P1011, DOI 10.1128/IAI.71.2.1011-1015.2003; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Rogers M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000555; Rothenberg ME, 2006, P NATL ACAD SCI USA, V103, P14895, DOI 10.1073/pnas.0605478103; Simmons WW, 1996, J BIOL CHEM, V271, P11694, DOI 10.1074/jbc.271.20.11694; Stevens BR, 1996, J BIOL CHEM, V271, P24017, DOI 10.1074/jbc.271.39.24017; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07	36	33	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15466	10.1371/journal.pone.0015466	http://dx.doi.org/10.1371/journal.pone.0015466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151933	Green Submitted, Green Published, gold			2022-12-25	WOS:000284939600036
J	Bonetti, D; Clerici, M; Manfrini, N; Lucchini, G; Longhese, MP				Bonetti, Diego; Clerici, Michela; Manfrini, Nicola; Lucchini, Giovanna; Longhese, Maria Pia			The MRX Complex Plays Multiple Functions in Resection of Yku- and Rif2-Protected DNA Ends	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; TELOMERE LENGTH REGULATION; SACCHAROMYCES-CEREVISIAE; DAMAGE RESPONSE; CHECKPOINT ACTIVATION; EXONUCLEASE ACTIVITY; MRE11 COMPLEX; BUDDING YEAST; REPAIR; EXO1	The ends of both double-strand breaks (DSBs) and telomeres undergo tightly regulated 59 to 39 resection. Resection of DNA ends, which is specifically inhibited during the G1 cell cycle phase, requires the MRX complex, Sae2, Sgs1 and Exo1. Moreover, it is negatively regulated by the non-homologous end-joining component Yku and the telomeric protein Rif2. Here, we investigate the nuclease activities that are inhibited at DNA ends by Rif2 and Yku in G1 versus G2 by using an inducible short telomere assay. We show that, in the absence of the protective function of Rif2, resection in G1 depends primarily on MRX nuclease activity and Sae2, whereas Exo1 and Sgs1 bypass the requirement of MRX nuclease activity only if Yku is absent. In contrast, Yku-mediated inhibition is relieved in G2, where resection depends on Mre11 nuclease activity, Exo1 and, to a minor extent, Sgs1. Furthermore, Exo1 compensates for a defective MRX nuclease activity more efficiently in the absence than in the presence of Rif2, suggesting that Rif2 inhibits not only MRX but also Exo1. Notably, the presence of MRX, but not its nuclease activity, is required and sufficient to override Yku-mediated inhibition of Exo1 in G2, whereas it is required but not sufficient in G1. Finally, the integrity of MRX is also necessary to promote Exo1- and Sgs1-dependent resection, possibly by facilitating Exo1 and Sgs1 recruitment to DNA ends. Thus, resection of DNA ends that are protected by Yku and Rif2 involves multiple functions of the MRX complex that do not necessarily require its nuclease activity.	[Bonetti, Diego; Clerici, Michela; Manfrini, Nicola; Lucchini, Giovanna; Longhese, Maria Pia] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milano-Bicocca	Bonetti, D (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	mariapia.longhese@unimib.it	Clerici, Michela/AAK-2807-2020; Manfrini, Nicola/A-1371-2019; Pia, Maria/AAK-2693-2020	Bonetti, Diego/0000-0003-4131-8042; Longhese, Maria Pia/0000-0003-1726-2034	Associazione Italiana per la Ricerca sul Cancro [IG5636]; MIUR/Universita di Milano-Bicocca; Fondazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR/Universita di Milano-Bicocca(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (grant IG5636) to MPL and Cofinanziamenti 2007 and 2008 MIUR/Universita di Milano-Bicocca to GL and MPL, respectively. DB was supported by a fellowship from Fondazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chakhparonian M, 2003, TRENDS GENET, V19, P439, DOI 10.1016/S0168-9525(03)00135-5; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Longhese MP, 2006, MOL MICROBIOL, V60, P1099, DOI 10.1111/j.1365-2958.2006.05186.x; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moreau S, 1999, MOL CELL BIOL, V19, P556; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Rattray AJ, 2001, GENETICS, V158, P109; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	56	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14142	10.1371/journal.pone.0014142	http://dx.doi.org/10.1371/journal.pone.0014142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152442	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100022
J	Feng, JH; Li, MF; Huang, YZ; Xiao, Y				Feng, Jianhui; Li, Mingfeng; Huang, Yanzhao; Xiao, Yi			Symmetric Key Structural Residues in Symmetric Proteins with Beta-Trefoil Fold	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; RICIN B-CHAIN; GENE DUPLICATION; STRUCTURE ALIGNMENT; NONLINEAR-ANALYSIS; EVOLUTION; FAMILY; PATTERNS; SCAFFOLD; KUNITZ	To understand how symmetric structures of many proteins are formed from asymmetric sequences, the proteins with two repeated beta-trefoil domains in Plant Cytotoxin B-chain family and all presently known beta-trefoil proteins are analyzed by structure-based multi-sequence alignments. The results show that all these proteins have similar key structural residues that are distributed symmetrically in their structures. These symmetric key structural residues are further analyzed in terms of inter-residues interaction numbers and B-factors. It is found that they can be distinguished from other residues and have significant propensities for structural framework. This indicates that these key structural residues may conduct the formation of symmetric structures although the sequences are asymmetric.	[Feng, Jianhui; Li, Mingfeng; Huang, Yanzhao; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biophys & Mol Modeling Grp, Wuhan 430074, Peoples R China; [Li, Mingfeng] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Li, Mingfeng] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA	Huazhong University of Science & Technology; Yale University; Yale University	Feng, JH (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biophys & Mol Modeling Grp, Wuhan 430074, Peoples R China.	yxiao@mail.hust.edu.cn			National Natural Science Foundation of China [30870678, 11074084, 30525037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported partly by the National Natural Science Foundation of China (www.nsfc.gov.cn) under Grant No. 30870678, 11074084 and 30525037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Brych SR, 2001, PROTEIN SCI, V10, P2587, DOI 10.1110/ps.ps.34701; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Chen CJ, 2007, BIOPOLYMERS, V85, P28, DOI 10.1002/bip.20600; Chen CJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.041926; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Giuliani A, 2002, CHEM REV, V102, P1471, DOI 10.1021/cr0101499; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Huang YZ, 2007, CHAOS SOLITON FRACT, V34, P782, DOI 10.1016/j.chaos.2006.03.080; Huang YZ, 2007, PROTEINS, V68, P267, DOI 10.1002/prot.21330; Ji XF, 2007, COMPUT BIOL CHEM, V31, P61, DOI 10.1016/j.compbiolchem.2007.01.002; KUMAR S, 2004, BRIEF BIOINFORMATICS; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Laskin AA, 2005, COMPUT BIOL CHEM, V29, P229, DOI 10.1016/j.compbiolchem.2005.04.003; Li MF, 2005, CHAOS SOLITON FRACT, V25, P491, DOI 10.1016/j.chaos.2004.11.049; Li MF, 2008, PROTEINS, V72, P1161, DOI 10.1002/prot.22010; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCLACHLAN AD, 1976, J MOL BIOL, V107, P159, DOI 10.1016/S0022-2836(76)80024-1; MCLACHLAN AD, 1979, J MOL BIOL, V133, P557, DOI 10.1016/0022-2836(79)90408-X; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rackovsky S, 1998, P NATL ACAD SCI USA, V95, P8580, DOI 10.1073/pnas.95.15.8580; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Shih ESC, 2004, PROTEINS, V56, P519, DOI 10.1002/prot.20124; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; STILL VC, 1990, J AM CHEM SOC, V112, P6127; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XC, 2008, J MOL GRAPH MODEL, V26, P829, DOI 10.1016/j.jmgm.2007.04.014; Xu RZ, 2005, COMPUT BIOL CHEM, V29, P79, DOI 10.1016/j.compbiolchem.2004.12.003; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14138	10.1371/journal.pone.0014138	http://dx.doi.org/10.1371/journal.pone.0014138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152439	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100019
J	Hernandez, G; Breton, YA; Conover, K; Shizgal, P				Hernandez, Giovanni; Breton, Yannick-Andre; Conover, Kent; Shizgal, Peter			At What Stage of Neural Processing Does Cocaine Act to Boost Pursuit of Rewards?	PLOS ONE			English	Article							BRAIN-STIMULATION REWARD; MEDIAL FOREBRAIN-BUNDLE; INTRACRANIAL SELF-STIMULATION; NUCLEUS-ACCUMBENS DOPAMINE; TRAIN-DURATION THRESHOLDS; DECISION-MAKING; ELECTRICAL-STIMULATION; PARAMETRIC ANALYSIS; MATCHING LAW; RAT	Dopamine-containing neurons have been implicated in reward and decision making. One element of the supporting evidence is that cocaine, like other drugs that increase dopaminergic neurotransmission, powerfully potentiates reward seeking. We analyze this phenomenon from a novel perspective, introducing a new conceptual framework and new methodology for determining the stage(s) of neural processing at which drugs, lesions and physiological manipulations act to influence reward-seeking behavior. Cocaine strongly boosts the proclivity of rats to work for rewarding electrical brain stimulation. We show that the conventional conceptual framework and methods do not distinguish between three conflicting accounts of how the drug produces this effect: increased sensitivity of brain reward circuitry, increased gain, or decreased subjective reward costs. Sensitivity determines the stimulation strength required to produce a reward of a given intensity (a measure analogous to the K-M of an enzyme) whereas gain determines the maximum intensity attainable (a measure analogous to the v(max) of an enzyme-catalyzed reaction). To distinguish sensitivity changes from the other determinants, we measured and modeled reward seeking as a function of both stimulation strength and opportunity cost. The principal effect of cocaine was a two-fourfold increase in willingness to pay for the electrical reward, an effect consistent with increased gain or decreased subjective cost. This finding challenges the long-standing view that cocaine increases the sensitivity of brain reward circuitry. We discuss the implications of the results and the analytic approach for theories of how dopaminergic neurons and other diffuse modulatory brain systems contribute to reward pursuit, and we explore the implications of the conceptual framework for the study of natural rewards, drug reward, and mood.	[Hernandez, Giovanni] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Breton, Yannick-Andre; Conover, Kent; Shizgal, Peter] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	University System of Maryland; University of Maryland Baltimore; Concordia University - Canada	Hernandez, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	peter.shizgal@concordia.ca	Shizgal, Peter/V-5602-2019; Shizgal, Peter/H-9823-2013	Shizgal, Peter/0000-0003-4265-0792; 	Canadian Institutes of Health Research [MOP-74577]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	The research was supported by a grant to PS from the Canadian Institutes of Health Research (#MOP-74577) and by a group grant from the "Fonds de la Recherche en Sante du Quebec'' to the "Groupe de Recherche en Neurobiologie Comportementale''/Center for Studies in Behavioural Neurobiology (Barbara Woodside, p.i.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Anderson RM, 1996, BRAIN RES, V718, P83, DOI 10.1016/0006-8993(96)00038-8; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Arvanitogiannis A, 2008, BEHAV NEUROSCI, V122, P1126, DOI 10.1037/a0012679; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bauco P, 1997, J PHARMACOL EXP THER, V283, P1160; BAUM WM, 1969, J EXP ANAL BEHAV, V12, P861, DOI 10.1901/jeab.1969.12-861; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Breton YA, 2009, BEHAV BRAIN RES, V202, P77, DOI 10.1016/j.bbr.2009.03.019; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; CHUHMA N, 2005, CELLSCIENCE REV, V2; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; CROW TJ, 1970, LIFE SCI, V9, P375, DOI 10.1016/0024-3205(70)90190-6; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; EDMONDS DE, 1974, J COMP PHYSIOL PSYCH, V87, P876, DOI 10.1037/h0037217; EDMONDS DE, 1977, J COMP PHYSIOL PSYCH, V91, P962, DOI 10.1037/h0077391; Efron B, 1993, INTRO BOOTSTRAP, pxvi; ESPOSITO R, 1977, SCIENCE, V195, P189, DOI 10.1126/science.831268; ESPOSITO RU, 1978, PHARMACOL BIOCHEM BE, V8, P437, DOI 10.1016/0091-3057(78)90082-5; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; FIORILLO C, 2010, ATTENTION TIME, P273; FOURIEZOS G, 1990, BEHAV BRAIN RES, V37, P1, DOI 10.1016/0166-4328(90)90066-N; FRANK RA, 1985, PHARMACOL BIOCHEM BE, V22, P527, DOI 10.1016/0091-3057(85)90269-2; FRANK RA, 1988, PHARMACOL BIOCHEM BE, V29, P755, DOI 10.1016/0091-3057(88)90199-2; FULTON S, 2006, BEHAV BRAIN RES; GALLISTEL CR, 1981, PSYCHOL REV, V88, P228, DOI 10.1037/0033-295X.88.3.228; GALLISTEL CR, 1974, J COMP PHYSIOL PSYCH, V87, P848, DOI 10.1037/h0037220; GALLISTEL CR, 1978, J COMP PHYSIOL PSYCH, V92, P977, DOI 10.1037/h0077513; Glimcher PW, 2003, BRADFORD BOOKS, P205; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; GREEN L, 1991, J EXP ANAL BEHAV, V55, P133, DOI 10.1901/jeab.1991.55-133; GRENHOFF J, 1993, J NEURAL TRANSM-GEN, V93, P11, DOI 10.1007/BF01244934; Hayes DJ, 2009, EUR J PHARMACOL, V604, P74, DOI 10.1016/j.ejphar.2008.12.023; Hayes DJ, 2009, BEHAV BRAIN RES, V197, P323, DOI 10.1016/j.bbr.2008.08.034; HERNANDEZ GA, 2009, WHAT STAGE PROCESSIN; Hernandez G, 2008, J NEUROSCI METH, V175, P79, DOI 10.1016/j.jneumeth.2008.08.005; Hernandez G, 2006, BEHAV NEUROSCI, V120, P888, DOI 10.1037/0735-7044.120.4.888; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HEYMAN G, 1988, BIOL DETERMINANTS RE, V7, P157; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Ishida Y, 2001, EUR J NEUROSCI, V13, P1600, DOI 10.1046/j.0953-816x.2001.01520.x; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; KEESEY RE, 1968, J EXP ANAL BEHAV, V11, P293, DOI 10.1901/jeab.1968.11-293; KILLEEN P, 1972, J EXP ANAL BEHAV, V17, P489, DOI 10.1901/jeab.1972.17-489; KIM K, 2010, OPTICAL ACTIVATION D; KOKKINIDIS L, 1990, PHARMACOL BIOCHEM BE, V36, P463, DOI 10.1016/0091-3057(90)90242-A; LEON M, 1992, BEHAV BRAIN RES, V52, P183, DOI 10.1016/S0166-4328(05)80229-3; LIEBMAN JM, 1974, N-S ARCH PHARMACOL, V284, P167, DOI 10.1007/BF00501121; Lin Y, 2007, NEUROPSYCHOPHARMACOL, V32, P835, DOI 10.1038/sj.npp.1301145; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; MILIARESSIS E, 1986, PHYSIOL BEHAV, V37, P85, DOI 10.1016/0031-9384(86)90388-4; MILLER HL, 1976, J EXP ANAL BEHAV, V26, P335, DOI 10.1901/jeab.1976.26-335; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; Moisan J, 1998, BRAIN RES, V786, P143, DOI 10.1016/S0006-8993(97)01457-1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; OLDS J, 1956, SCIENCE, V124, P265, DOI 10.1126/science.124.3215.265; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS J, 1958, J COMP PHYSIOL PSYCH, V51, P675, DOI 10.1037/h0039616; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petry NM, 1997, BEHAV PROCESS, V39, P39, DOI 10.1016/S0376-6357(96)00043-5; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shizgal P, 2001, INT J OBESITY, V25, pS17, DOI 10.1038/sj.ijo.0801906; Shizgal P, 1996, CURR DIR PSYCHOL SCI, V5, P37, DOI 10.1111/1467-8721.ep10772715; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P., 1989, NEUROPHARMACOLOGICAL, P106; SIMMONS JM, 1994, BEHAV NEUROSCI, V108, P151, DOI 10.1037/0735-7044.108.1.151; SOLOMON RB, 2007, ESTIMATION SUBJECTIV; Sonnenschein B, 2003, BEHAV NEUROSCI, V117, P978, DOI 10.1037/0735-7044.117.5.978; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Steffensen SC, 2008, EUR J NEUROSCI, V28, P2028, DOI 10.1111/j.1460-9568.2008.06479.x; Sutton MA, 1999, PSYCHOPHARMACOLOGY, V144, P95, DOI 10.1007/s002130050982; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; VALENSTEIN ES, 1964, J COMP PHYSIOL PSYCH, V57, P52, DOI 10.1037/h0048638; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WISE RA, 1980, PHARMACOL BIOCHEM BE, V13, P213, DOI 10.1016/S0091-3057(80)80033-5; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; YEOMANS JS, 1988, BRAIN RES, V450, P86, DOI 10.1016/0006-8993(88)91547-8; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	101	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15081	10.1371/journal.pone.0015081	http://dx.doi.org/10.1371/journal.pone.0015081			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152097	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000284755100064
J	Mokry, M; Hatzis, P; de Bruijn, E; Koster, J; Versteeg, R; Schuijers, J; van de Wetering, M; Guryev, V; Clevers, H; Cuppen, E				Mokry, Michal; Hatzis, Pantelis; de Bruijn, Ewart; Koster, Jan; Versteeg, Rogier; Schuijers, Jurian; van de Wetering, Marc; Guryev, Victor; Clevers, Hans; Cuppen, Edwin			Efficient Double Fragmentation ChIP-seq Provides Nucleotide Resolution Protein-DNA Binding Profiles	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; GENOME-WIDE ANALYSIS; BETA-CATENIN; SITES	Immunoprecipitated crosslinked protein-DNA fragments typically range in size from several hundred to several thousand base pairs, with a significant part of chromatin being much longer than the optimal length for next-generation sequencing (NGS) procedures. Because these larger fragments may be non-random and represent relevant biology that may otherwise be missed, but also because they represent a significant fraction of the immunoprecipitated material, we designed a double-fragmentation ChIP-seq procedure. After conventional crosslinking and immunoprecipitation, chromatin is de-crosslinked and sheared a second time to concentrate fragments in the optimal size range for NGS. Besides the benefits of increased chromatin yields, the procedure also eliminates a laborious size-selection step. We show that the double-fragmentation ChIP-seq approach allows for the generation of biologically relevant genome-wide protein-DNA binding profiles from sub-nanogram amounts of TCF7L2/TCF4, TBP and H3K4me3 immunoprecipitated material. Although optimized for the AB/SOLiD platform, the same approach may be applied to other platforms.	[Mokry, Michal; Hatzis, Pantelis; de Bruijn, Ewart; Schuijers, Jurian; van de Wetering, Marc; Guryev, Victor; Clevers, Hans; Cuppen, Edwin] Hubrecht Inst, Canc Genom Ctr, Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Mokry, M (corresponding author), Hubrecht Inst, Canc Genom Ctr, Utrecht, Netherlands.	e.cuppen@hubrecht.e	Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008; Mokry, Michal/AAN-3809-2021; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Mokry, Michal/B-6695-2011	Koster, Jan/0000-0002-0890-7585; Mokry, Michal/0000-0002-5298-4852; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Guryev, Victor/0000-0002-5810-6022; Schuijers, Jurian/0000-0003-2531-3516; Versteeg, Rogier/0000-0001-7172-0388	Cancer Genomics Center (Netherlands Genomics Initiative); Human Frontier Science Program Organization	Cancer Genomics Center (Netherlands Genomics Initiative); Human Frontier Science Program Organization(Human Frontier Science Program)	This work was financially supported by the Cancer Genomics Center (Netherlands Genomics Initiative). P. H. was supported by a Human Frontier Science Program Organization long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	24	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15092	10.1371/journal.pone.0015092	http://dx.doi.org/10.1371/journal.pone.0015092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152096	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100068
J	Ralhan, R; He, HCH; So, AKC; Tripathi, SC; Kumar, M; Hasan, MR; Kaur, J; Kashat, L; MacMillan, C; Chauhan, SS; Freeman, JL; Walfish, PG				Ralhan, Ranju; He, Helen C. -H.; So, Anthony K. -C.; Tripathi, Satyendra C.; Kumar, Manish; Hasan, Md. Raghibul; Kaur, Jatinder; Kashat, Lawrence; MacMillan, Christina; Chauhan, Shyam Singh; Freeman, Jeremy L.; Walfish, Paul G.			Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; EPCAM EXPRESSION; ADHESION MOLECULE; COLORECTAL-CANCER; RANDOMIZED-TRIAL; ADJUVANT THERAPY; POOR-PROGNOSIS; ANTIGEN EPCAM	Background: We previously demonstrated that nuclear and cytoplasmic accumulation of the intracellular domain (Ep-ICD) of epithelial cell adhesion molecule (EpCAM) accompanied by a reciprocal reduction of its extracellular domain (EpEx), occurs in aggressive thyroid cancers. This study was designed to determine whether similar accumulation of Ep-ICD is a common event in other epithelial cancers. Methodology and Results: Ten epithelial cancers were immunohistochemically analyzed using Ep-ICD and EpEx domain-specific antibodies. The subcellular localization of EpEx and Ep-ICD in the human colon adenocarcinoma cell line CX-1 was observed using immunofluorescence. Nuclear and cytoplasmic Ep-ICD expression was increased in cancers of the breast (31 of 38 tissues, 82%), prostate (40 of 49 tissues, 82%), head and neck (37 of 57 tissues, 65%) and esophagus (17 of 46 tissues, 37%) compared to their corresponding normal tissues that showed membrane localization of the protein. Importantly, Ep-ICD was not detected in the nuclei of epithelial cells in most normal tissues. High nuclear and cytoplasmic Ep-ICD accumulation also occurred in the other six epithelial cancer types analyzed-lung, colon, liver, bladder, pancreatic, and ovarian. A concomitant reduction in membrane EpEx expression was observed in a subset of all cancer types. Receiver operating characteristic curve analysis revealed nuclear Ep-ICD distinguished breast cancers with 82% sensitivity and 100% specificity and prostate cancers with 82% sensitivity and 78% specificity. Similar findings were observed for cytoplasmic accumulation of Ep-ICD in these cancers. We provide clinical evidence of increased nuclear and cytoplasmic Ep-ICD accumulation and a reduction in membranous EpEx in these cancers. Conclusions: Increased nuclear and cytoplasmic Ep-ICD was observed in all epithelial cancers analyzed and distinguished them from normal tissues with high-sensitivity, specificity, and AUC. Development of a robust high throughput assay for Ep-ICD will facilitate the determination of its diagnostic, prognostic and therapeutic relevance in epithelial cancers.	[Ralhan, Ranju; Freeman, Jeremy L.; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg Program, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; He, Helen C. -H.; So, Anthony K. -C.; Kashat, Lawrence; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Freeman, Jeremy L.; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Freeman, Jeremy L.; Walfish, Paul G.] Univ Toronto, Sch Med, Toronto, ON M5S 1A1, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada; [Ralhan, Ranju; Tripathi, Satyendra C.; Kumar, Manish; Hasan, Md. Raghibul; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Ralhan, Ranju; Kashat, Lawrence; Walfish, Paul G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg Program, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Tripathi, Satyendra Chandra/L-9352-2017; Kumar, Manish/L-3404-2019; Bhurji, Jatinder K/B-6767-2013	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Mount Sinai Hospital Department of Medicine; Alex and Simona Shnaider Laboratory in Molecular Oncology; Temmy Latner Dynacare Family Foundation	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Mount Sinai Hospital Department of Medicine; Alex and Simona Shnaider Laboratory in Molecular Oncology; Temmy Latner Dynacare Family Foundation	This work was financially supported by the Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, Mount Sinai Hospital Department of Medicine Research Fund, Alex and Simona Shnaider Laboratory in Molecular Oncology, and Temmy Latner Dynacare Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Kimura H, 2007, INT J ONCOL, V30, P171; Kurtz JE, 2010, EXPERT OPIN BIOL TH, V10, P951, DOI 10.1517/14712598.2010.482098; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; Riethmuller G, 1998, J CLIN ONCOL, V16, P1788, DOI 10.1200/JCO.1998.16.5.1788; Schmelzer E, 2008, FRONT BIOSCI-LANDMRK, V13, P3096, DOI 10.2741/2911; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Weismann P, 2009, NEOPLASMA, V56, P230; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924	37	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14130	10.1371/journal.pone.0014130	http://dx.doi.org/10.1371/journal.pone.0014130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152431	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100011
J	Zeng, YF; Liao, WJ; Petit, RJ; Zhang, DY				Zeng, Yan-Fei; Liao, Wan-Jin; Petit, Remy J.; Zhang, Da-Yong			Exploring Species Limits in Two Closely Related Chinese Oaks	PLOS ONE			English	Article							PETRAEA MATT. LIEBL.; QUERCUS-ROBUR L; MULTILOCUS GENOTYPE DATA; INTERSPECIFIC GENE FLOW; EUROPEAN WHITE OAKS; POPULATION-STRUCTURE; HYBRID ZONE; MICROSATELLITE LOCI; PUBESCENS WILLD.; DNA VARIATION	Background: The species status of two closely related Chinese oaks, Quercus liaotungensis and Q. mongolica, has been called into question. The objective of this study was to investigate the species status and to estimate the degree of introgression between the two taxa using different approaches. Methodology/Principal Findings: Using SSR (simple sequence repeat) and AFLP (amplified fragment length polymorphism) markers, we found that interspecific genetic differentiation is significant and higher than the differentiation among populations within taxa. Bayesian clusters, principal coordinate analysis and population genetic distance trees all classified the oaks into two main groups consistent with the morphological differentiation of the two taxa rather than with geographic locations using both types of markers. Nevertheless, a few individuals in Northeast China and many individuals in North China have hybrid ancestry according to Bayesian assignment. One SSR locus and five AFLPs are significant outliers against neutral expectations in the interspecific F(ST) simulation analysis, suggesting a role for divergent selection in differentiating species. Main Conclusions/Significance: All results based on SSRs and AFLPs reached the same conclusion: Q. liaotungensis and Q. mongolica maintain distinct gene pools in most areas of sympatry. They should therefore be considered as discrete taxonomic units. Yet, the degree of introgression varies between the two species in different contact zones, which might be caused by different population history or by local environmental factors.	[Zeng, Yan-Fei] Chinese Acad Forestry, Res Inst Forestry, Key Lab Silviculture, State Forestry Adm, Beijing, Peoples R China; [Zeng, Yan-Fei; Liao, Wan-Jin; Zhang, Da-Yong] Beijing Normal Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China; [Petit, Remy J.] INRA, UMR Biodivers Genes & Ecosyst, Cestas, France; [Petit, Remy J.] Univ Bordeaux, UMR Biodivers Genes & Ecosyst, Cestas, France	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Beijing Normal University; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Zeng, YF (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Silviculture, State Forestry Adm, Beijing, Peoples R China.	zhangdy@bnu.edu.cn	Petit, Rémy/A-8842-2008; Zhang, Da-Yong/B-3078-2011; Petit, Remy/AAD-9078-2019	Petit, Rémy/0000-0002-4809-1453; Zhang, Da-Yong/0000-0003-1056-8735; 	National Natural Science Foundation of China [30430160]; Beijing Normal University; European Union	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; European Union(European Commission)	This work was financially supported by the National Natural Science Foundation of China (30430160) and Beijing Normal University. RJP's research is supported by the European Union-sponsored Network of Excellence EVOLTREE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Aldridge G, 2009, HEREDITY, V102, P257, DOI 10.1038/hdy.2008.112; [Anonymous], 2005, PHYLIP PHYLOGENY INF; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beljaev E. A., 2004, Botanicheskii Zhurnal (St. Petersburg), V89, P1665; BENSON L, 1967, AM J BOT, V54, P1017, DOI 10.2307/2440726; Bodenes C, 1997, HEREDITY, V78, P433, DOI 10.1038/hdy.1997.67; Bodenes C, 1997, MOL ECOL, V6, P713, DOI 10.1046/j.1365-294X.1997.00240.x; Bruschi P, 2000, ANN BOT-LONDON, V85, P325, DOI 10.1006/anbo.1999.1046; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Chen HY, 1998, QUERCUS, P213; Coart E, 2002, THEOR APPL GENET, V105, P431, DOI 10.1007/s00122-002-0920-6; Coyne JA, 2004, SPECIATION, V37; Craft KJ, 2002, AM J BOT, V89, P1792, DOI 10.3732/ajb.89.11.1792; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Curtu AL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-284; Dodd RS, 2004, EVOLUTION, V58, P261, DOI 10.1111/j.0014-3820.2004.tb01643.x; DOW BD, 1995, THEOR APPL GENET, V91, P137, DOI 10.1007/BF00220870; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Dumolin-Lapegue S, 1999, EVOLUTION, V53, P1406, DOI [10.2307/2640887, 10.1111/j.1558-5646.1999.tb05405.x]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; GARDINER AS, 1970, FORESTRY, V43, P151, DOI 10.1093/forestry/43.2.151; Gonzalez-Rodriguez A, 2004, AM J BOT, V91, P401, DOI 10.3732/ajb.91.3.401; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grant V., 1981, PLANT SPECIATION, Vsecond; Gugerli F, 2008, ANN BOT-LONDON, V102, P855, DOI 10.1093/aob/mcn164; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; Howard DJ, 1997, EVOLUTION, V51, P747, DOI 10.1111/j.1558-5646.1997.tb03658.x; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Huang CJ., 1999, FLORA CHINA, V4, P314; Ishida TA, 2003, AM J BOT, V90, P769, DOI 10.3732/ajb.90.5.769; Jensen J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009058; JENSEN RJ, 1993, AM J BOT, V80, P1358, DOI 10.2307/2445721; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Kremer A, 2002, ANN FOR SCI, V59, P777, DOI 10.1051/forest:2002065; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Mariette S, 2002, SILVAE GENET, V51, P72; Mishima K, 2006, MOL ECOL NOTES, V6, P695, DOI 10.1111/j.1471-8286.2006.01313.x; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Muir G, 2005, MOL ECOL, V14, P549, DOI 10.1111/j.1365-294X.2004.02418.x; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; MULLER CH, 1952, EVOLUTION, V6, P147, DOI 10.2307/2405620; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUSHTON BS, 1993, ANN SCI FOREST, V50, P73, DOI DOI 10.1051/FOREST:19930707; Salvini D, 2009, PLANT BIOLOGY, V11, P758, DOI 10.1111/j.1438-8677.2008.00158.x; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; SILLIMAN FE, 1958, AM J BOT, V45, P730, DOI 10.2307/2439732; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Tomlinson PT, 2000, AM MIDL NAT, V143, P154, DOI 10.1674/0003-0031(2000)143[0154:DWTSCI]2.0.CO;2; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valbuena-Carabana M, 2005, HEREDITY, V95, P457, DOI 10.1038/sj.hdy.6800752; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WANG HX, 1997, GENETIC DIVERSITY AN, P155; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHITTEMORE AT, 1991, P NATL ACAD SCI USA, V88, P2540, DOI 10.1073/pnas.88.6.2540; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Yun R, 1998, ACTA BOT SIN, V40, P1040; Zanetto A., 1994, Forest Genetics, V1, P111; ZENG YF, 2008, SPECIES STATUS PHYLO; Zhang YT, 2000, HIGHER PLANTS CHINA, P177; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	88	44	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15529	10.1371/journal.pone.0015529	http://dx.doi.org/10.1371/journal.pone.0015529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152084	Green Published, gold, Green Submitted			2022-12-25	WOS:000284755100092
J	Kawaguchi, S; Hsu, CL; Ng, DTW				Kawaguchi, Shinichi; Hsu, Chia-Ling; Ng, Davis T. W.			Interplay of Substrate Retention and Export Signals in Endoplasmic Reticulum Quality Control	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MISFOLDED PROTEINS; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; INTRACELLULAR-TRANSPORT; UBIQUITIN-LIGASE; PLASMA-MEMBRANE; LUMINAL PROTEIN	Background: Endoplasmic reticulum (ER) quality control mechanisms are part of a comprehensive system to manage cell stress. The flux of molecules is monitored to retain folding intermediates and target misfolded molecules to ER-associated degradation (ERAD) pathways. The mechanisms of sorting remain unclear. While some proteins are retained statically, the classical model substrate CPY* is found in COPII transport vesicles, suggesting a retrieval mechanism for retention. However, its management can be even more dynamic. If ERAD is saturated under stress, excess CPY* traffics to the vacuole for degradation. These observations suggest that misfolded proteins might display different signals for their management. Methodology/Principal Findings: Here, we report the existence of a functional ER exit signal in the pro-domain of CPY*. Compromising its integrity causes ER retention through exclusion from COPII vesicles. The signal co-exists with other signals used for retention and degradation. Physiologically, the export signal is important for stress tolerance. Disabling it converts a benign protein into one that is intrinsically cytotoxic. Conclusions/Significance: These data reveal the remarkable interplay between opposing signals embedded within ERAD substrate molecules and the mechanisms that decipher them. Our findings demonstrate the diversity of mechanisms deployed for protein quality control and maintenance of protein homeostasis.	[Kawaguchi, Shinichi; Hsu, Chia-Ling; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	davis@tll.org.sg			Temasek Trust; Singapore Millennium Foundation	Temasek Trust; Singapore Millennium Foundation	Funding was provided by the Temasek Trust and the Singapore Millennium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sambrook J., 2002, MOL CLONING LAB MANU; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15532	10.1371/journal.pone.0015532	http://dx.doi.org/10.1371/journal.pone.0015532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21151492	gold, Green Submitted, Green Published			2022-12-25	WOS:000284572000037
J	Christian, F; Szaszak, M; Friedl, S; Drewianka, S; Lorenz, D; Goncalves, A; Furkert, J; Vargas, C; Schmieder, P; Gotz, F; Zuhlke, K; Moutty, M; Gottert, H; Joshi, M; Reif, B; Haase, H; Morano, I; Grossmann, S; Klukovits, A; Verli, J; Robert, G; Noack, C; Bergmann, M; Kass, R; Hampel, K; Kashin, D; Genieser, HG; Herberg, FW; Willoughby, D; Cooper, DMF; Baillie, GS; Houslay, MD; von Kries, JP; Zimmermann, B; Rosenthal, W; Klussmann, E				Christian, Frank; Szaszak, Marta; Friedl, Sabine; Drewianka, Stephan; Lorenz, Dorothea; Goncalves, Andrey; Furkert, Jens; Vargas, Carolyn; Schmieder, Peter; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Goettert, Hendrikje; Joshi, Mangesh; Reif, Bernd; Haase, Hannelore; Morano, Ingo; Grossmann, Solveig; Klukovits, Anna; Verli, Judit; Robert Gaspar; Noack, Claudia; Bergmann, Martin; Kass, Robert; Hampel, Kornelia; Kashin, Dmitry; Genieser, Hans-Gottfried; Herberg, Friedrich W.; Willoughby, Debbie; Cooper, Dermot M. F.; Baillie, George S.; Houslay, Miles D.; von Kries, Jens Peter; Zimmermann, Bastian; Rosenthal, Walter; Klussmann, Enno			Small Molecule AKAP-Protein Kinase A (PKA) Interaction Disruptors That Activate PKA Interfere with Compartmentalized cAMP Signaling in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; POTENTIAL-DRUG TARGETS; ANCHORING PROTEIN; REGULATORY SUBUNITS; SCAFFOLDING PROTEINS; POTASSIUM CHANNEL; ADENYLYL CYCLASES; CA(V)1.2 CHANNELS; TROPONIN-I; PHOSPHORYLATION	A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3'-diamino-4,4'-dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating beta-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMP-API-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.	[Christian, Frank; Szaszak, Marta; Friedl, Sabine; Lorenz, Dorothea; Goncalves, Andrey; Furkert, Jens; Vargas, Carolyn; Schmieder, Peter; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Goettert, Hendrikje; Joshi, Mangesh; Reif, Bernd; Grossmann, Solveig; von Kries, Jens Peter; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Drewianka, Stephan; Hampel, Kornelia; Zimmermann, Bastian] Biaffin GmbH & Co KG, D-34132 Kassel, Germany; [Goncalves, Andrey; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Haase, Hannelore; Morano, Ingo; Noack, Claudia; Bergmann, Martin; Rosenthal, Walter; Klussmann, Enno] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Klukovits, Anna; Verli, Judit; Robert Gaspar] Univ Szeged, Dept Pharmacodynam & Biopharm, H-6720 Szeged, Hungary; [Kass, Robert] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Kashin, Dmitry; Genieser, Hans-Gottfried] Biol Life Sci Inst, D-28199 Bremen, Germany; [Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34109 Kassel, Germany; [Willoughby, Debbie; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Rosenthal, Walter] Charite, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Szeged University; Columbia University; Universitat Kassel; University of Cambridge; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klussmann, E (corresponding author), Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	enno.klussmann@mdc-berlin.de	Gaspar, Robert/G-7954-2011; Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020; Herberg, Friedrich W/B-5572-2015; Szaszak, Marta/G-7957-2011	Gaspar, Robert/0000-0002-1571-7579; Herberg, Friedrich W/0000-0001-7117-7653; Reif, Bernd/0000-0001-7368-7198; Houslay, Miles/0000-0002-3826-8091; Klussmann, Jens Peter/0000-0002-8223-7954; Genieser, Hans-Gottfried/0000-0002-4904-5790; Christian, Frank/0000-0001-8208-5930; Schmieder, Peter/0000-0001-9968-9327	Deutsche Forschungsgemeinschaft [KL1415/4-1, KL1415/4-2]; European Union [037189]; German Ministry of Education and Science [FKZ 0315097, 0315516]; Medical Research Council UK [G0600765]; Fondation Leducq [06CVD02]; Wellcome Trust [RG31760]; MRC [G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Ministry of Education and Science; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Forschergruppe 806 Projects KL1415/4-1 and/4-2, European Union Project thera cAMP-proposals 037189, GoBio program of the German Ministry of Education and Science Grants FKZ 0315097 and 0315516, Medical Research Council UK Grant G0600765, Fondation Leducq Grant 06CVD02, and Wellcome Trust Grant RG31760.	Abdelaziz AI, 2004, J MOL MED-JMM, V82, P265, DOI 10.1007/s00109-004-0525-4; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Buchwald P, 2010, IUBMB LIFE, V62, P724, DOI 10.1002/iub.383; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Dodge KL, 1999, ENDOCRINOLOGY, V140, P5165, DOI 10.1210/en.140.11.5165; Dodge KL, 1999, MOL ENDOCRINOL, V13, P1977, DOI 10.1210/me.13.12.1977; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hundsrucker C., 2008, V186, P483, DOI 10.1007/978-3-540-72843-6_20; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McCahill A. C., 2008, V186, P125, DOI 10.1007/978-3-540-72843-6_6; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Meyer B, 2004, E SCHERING RES FDN W, V44, P149; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sanborn BM, 1998, REV REPROD, V3, P196; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Wang WH, 1999, AM J PHYSIOL-RENAL, V277, pF826, DOI 10.1152/ajprenal.1999.277.6.F826; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002	59	77	87	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9079	9096		10.1074/jbc.M110.160614	http://dx.doi.org/10.1074/jbc.M110.160614			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177871	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000288247700039
J	Wijeyesakere, SJ; Gafni, AA; Raghavan, M				Wijeyesakere, Sanjeeva J.; Gafni, Ari A.; Raghavan, Malini			Calreticulin Is a Thermostable Protein with Distinct Structural Responses to Different Divalent Cation Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HEAT-SHOCK; IN-VITRO; CHAPERONE CALRETICULIN; CA2+ STORE; P-DOMAIN; CALCIUM; CALNEXIN; CONFORMATION; RECOGNITION	Calreticulin is a soluble calcium-binding chaperone of the endoplasmic reticulum (ER) that is also detected on the cell surface and in the cytosol. Calreticulin contains a single high affinity calcium-binding site within a globular domain and multiple low affinity sites within a C-terminal acidic region. We show that the secondary structure of calreticulin is remarkably thermostable at a given calcium concentration. Rather than corresponding to complete unfolding events, heat-induced structural transitions observed for calreticulin relate to tertiary structural changes that expose hydrophobic residues and reduce protein rigidity. The thermostability and the overall secondary structure content of calreticulin are impacted by the divalent cation environment, with the ER range of calcium concentrations enhancing stability, and calcium-depleting or high calcium environments reducing stability. Furthermore, magnesium competes with calcium for binding to calreticulin and reduces thermostability. The acidic domain of calreticulin is an important mediator of calcium-dependent changes in secondary structure content and thermostability. Together, these studies indicate interactions between the globular and acidic domains of calreticulin that are impacted by divalent cations. These interactions influence the structure and stability of calreticulin, and are likely to determine the multiple functional activities of calreticulin in different subcellular environments.	[Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gafni, Ari A.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI 066131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 066131.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bouvier M, 2000, BIOCHEMISTRY-US, V39, P14950, DOI 10.1021/bi0019545; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; CONWAY EM, 1995, J BIOL CHEM, V270, P17011, DOI 10.1074/jbc.270.28.17011; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Fasolato C, 1998, MOL BIOL CELL, V9, P1513, DOI 10.1091/mbc.9.6.1513; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; KELEPOURIS E, 1993, MINER ELECTROL METAB, V19, P277; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LE AQ, 1994, J BIOL CHEM, V269, P7514; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Mancino L, 2002, P NATL ACAD SCI USA, V99, P5931, DOI 10.1073/pnas.092031799; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Giraldo AMV, 2010, J BIOL CHEM, V285, P4544, DOI 10.1074/jbc.M109.034512; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yu CM, 2004, EXP EYE RES, V79, P249, DOI 10.1016/j.exer.2004.04.006; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	46	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8771	8785		10.1074/jbc.M110.169193	http://dx.doi.org/10.1074/jbc.M110.169193			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177861	hybrid, Green Published			2022-12-25	WOS:000288247700008
J	Banerjee, D; Mandal, SM; Das, A; Hegde, ML; Das, S; Bhakat, KK; Boldogh, I; Sarkar, PS; Mitra, S; Hazra, TK				Banerjee, Dibyendu; Mandal, Santi M.; Das, Aditi; Hegde, Muralidhar L.; Das, Soumita; Bhakat, Kishor K.; Boldogh, Istvan; Sarkar, Partha S.; Mitra, Sankar; Hazra, Tapas K.			Preferential Repair of Oxidized Base Damage in the Transcribed Genes of Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HUMAN DNA GLYCOSYLASE; EXCISION-REPAIR; ESCHERICHIA-COLI; HNRNP-U; COCKAYNE-SYNDROME; ENDONUCLEASE-III; AP-ENDONUCLEASE; COUPLED REPAIR; ACTIVE GENE	Preferential repair of bulky DNA adducts from the transcribed genes via nucleotide excision repair is well characterized in mammalian cells. However, definitive evidence is lacking for similar repair of oxidized bases, the major endogenous DNA lesions. Here we show that the oxidized base-specific human DNA glycosylase NEIL2 associates with RNA polymerase II and the transcriptional regulator heterogeneous nuclear ribonucleoprotein-U (hnRNP-U), both in vitro and in cells. NEIL2 immunocomplexes from cell extracts preferentially repaired the mutagenic cytosine oxidation product 5-hydroxyuracil in the transcribed strand. In a reconstituted system, we also observed NEIL2-initiated transcription-dependent base excision repair of 5-hydroxyuracil in the transcribed strand, with hnRNP-U playing a critical role. Chromatin immunoprecipitation/reimmunoprecipitation studies showed association of NEIL2, RNA polymerase II, and hnRNP-U on transcribed but not on transcriptionally silent genes. Furthermore, NEIL2-depleted cells accumulated more DNA damage in active than in silent genes. These results strongly support the preferential role of NEIL2 in repairing oxidized bases in the transcribed genes of mammalian cells.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm Allergy & Crit Care Med, Dept Internal Med, Galveston, TX 77555 USA; [Banerjee, Dibyendu; Mandal, Santi M.; Das, Aditi; Hegde, Muralidhar L.; Das, Soumita; Bhakat, Kishor K.; Mitra, Sankar; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm Allergy & Crit Care Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	Mandal, Santi M./AAF-7156-2020; BANERJEE, DIBYENDU/C-6656-2012; Bhakat, Kishor/C-8072-2012; Classen, Scott/AAY-8176-2020; Banerjee, Dibyendu/Y-4652-2019	Hegde, Muralidhar/0000-0001-7333-8123; Banerjee, Dibyendu/0000-0003-4244-9714	National Institutes of Health [CA102271, ES017353, CA81063]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063, R01CA102271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R21ES017353, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.) and CA81063 (to S. M.).	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Mattern KA, 1996, J CELL BIOCHEM, V62, P275, DOI 10.1002/(SICI)1097-4644(199608)62:2<275::AID-JCB15>3.0.CO;2-K; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 1996, P NATL ACAD SCI USA, V93, P1292, DOI 10.1073/pnas.93.3.1292; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; PARODI MT, 1989, CANCER CHEMOTH PHARM, V25, P114, DOI 10.1007/BF00692350; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	52	114	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6006	6016		10.1074/jbc.M110.198796	http://dx.doi.org/10.1074/jbc.M110.198796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169365	Green Published, hybrid			2022-12-25	WOS:000287476400008
J	Brooks, IM; Tavalin, SJ				Brooks, Ian M.; Tavalin, Steven J.			Ca2+/Calmodulin-dependent Protein Kinase II Inhibitors Disrupt AKAP79-dependent PKC Signaling to GluA1 AMPA Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; GLUR1 SUBUNIT; REGULATORY PHOSPHORYLATION; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; GATING DOMAIN; CAMKII-ALPHA; K+ CHANNELS; CALMODULIN; AKAP79	GluA1 (formerly GluR1) AMPA receptor subunit phosphorylation at Ser-831 is an early biochemical marker for long-term potentiation and learning. This site is a substrate for Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and protein kinase C (PKC). By directing PKC to GluA1, A-kinase anchoring protein 79 (AKAP79) facilitates Ser-831 phosphorylation and makes PKC a more potent regulator of GluA1 than CaMKII. PKC and CaM bind to residues 31-52 of AKAP79 in a competitive manner. Here, we demonstrate that common CaMKII inhibitors alter PKC and CaM interactions with AKAP79(31-52). Most notably, the classical CaMKII inhibitors KN-93 and KN-62 potently enhanced the association of CaM to AKAP79(31-52) in the absence (apoCaM) but not the presence of Ca2+. In contrast, apoCaM association to AKAP79(31-52) was unaffected by the control compound KN-92 or a mechanistically distinct CaMKII inhibitor (CaMKIINtide). In vitro studies demonstrated that KN-62 and KN-93, but not the other compounds, led to apoCaM-dependent displacement of PKC from AKAP79(31-52). In the absence of CaMKII activation, complementary cellular studies revealed that KN-62 and KN-93, but not KN-92 or CaMKIINtide, inhibited PKC-mediated phosphorylation of GluA1 in hippocampal neurons as well as AKAP79-dependent PKC-mediated augmentation of recombinant GluA1 currents. Buffering cellular CaM attenuated the ability of KN-62 and KN-93 to inhibit AKAP79-anchored PKC regulation of GluA1. Therefore, by favoring apoCaM binding to AKAP79, KN-62 and KN-93 derail the ability of AKAP79 to efficiently recruit PKC for regulation of GluA1. Thus, AKAP79 endows PKC with a pharmacological profile that overlaps with CaMKII.	[Brooks, Ian M.; Tavalin, Steven J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	stavalin@uthsc.edu		Brooks, Ian/0000-0003-2724-936X	National Institutes of Health [NS46661]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS46661 (to S.J.T.).	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Ba MW, 2006, NEUROCHEM RES, V31, P1337, DOI 10.1007/s11064-006-9177-9; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bevilaqua LR, 2005, NEUROSCIENCE, V136, P397, DOI 10.1016/j.neuroscience.2005.08.007; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fang L, 2003, MOL BRAIN RES, V118, P160, DOI 10.1016/j.molbrainres.2003.08.002; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Fu XZ, 2004, NEUROSCI RES, V48, P85, DOI 10.1016/j.neures.2003.09.009; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Guan Y, 2004, NEUROSCI LETT, V366, P201, DOI 10.1016/j.neulet.2004.05.051; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; HUBER KM, 1995, NEUROREPORT, V6, P1281, DOI 10.1097/00001756-199506090-00013; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jones TL, 2005, PAIN, V117, P259, DOI 10.1016/j.pain.2005.06.003; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200; Lecrux C, 2007, STROKE, V38, P3007, DOI 10.1161/STROKEAHA.107.491126; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Marley PD, 1996, BIOCHEM BIOPH RES CO, V221, P15, DOI 10.1006/bbrc.1996.0536; Menard C, 2005, NEUROSCI LETT, V389, P51, DOI 10.1016/j.neulet.2005.07.012; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Oh JD, 2003, BRAIN RES, V971, P18, DOI 10.1016/S0006-8993(03)02348-5; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sharp JW, 2004, NEUROSCIENCE, V126, P1053, DOI 10.1016/j.neuroscience.2004.03.066; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Smyth JT, 2002, J BIOL CHEM, V277, P35061, DOI 10.1074/jbc.M202928200; Stanton PK, 1996, J NEUROPHYSIOL, V76, P2097, DOI 10.1152/jn.1996.76.3.2097; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Takagi Y, 2003, NEUROSCI LETT, V341, P33, DOI 10.1016/S0304-3940(03)00153-8; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yue CP, 2001, MOL CELL ENDOCRINOL, V175, P149, DOI 10.1016/S0303-7207(01)00383-5; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004	80	19	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6697	6706		10.1074/jbc.M110.183558	http://dx.doi.org/10.1074/jbc.M110.183558			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156788	Green Published, hybrid			2022-12-25	WOS:000287476400077
J	Ovchinnikov, IV; Kholina, OI				Ovchinnikov, Igor V.; Kholina, Olga I.			Genome Digging: Insight into the Mitochondrial Genome of Homo	PLOS ONE			English	Article							DNA POLYMORPHISMS; MIDDLE PLEISTOCENE; DIVERGENCE TIMES; NEANDERTHAL DNA; SEQUENCE; EVOLUTION; RECONSTRUCTION; SCHIZOPHRENIA; PSEUDOGENES; DIVERSITY	Background: A fraction of the Neanderthal mitochondrial genome sequence has a similarity with a 5,839-bp nuclear DNA sequence of mitochondrial origin (numt) on the human chromosome 1. This fact has never been interpreted. Although this phenomenon may be attributed to contamination and mosaic assembly of Neanderthal mtDNA from short sequencing reads, we explain the mysterious similarity by integration of this numt (mtAncestor-1) into the nuclear genome of the common ancestor of Neanderthals and modern humans not long before their reproductive split. Principal Findings: Exploiting bioinformatics, we uncovered an additional numt (mtAncestor-2) with a high similarity to the Neanderthal mtDNA and indicated that both numts represent almost identical replicas of the mtDNA sequences ancestral to the mitochondrial genomes of Neanderthals and modern humans. In the proteins, encoded by mtDNA, the majority of amino acids distinguishing chimpanzees from humans and Neanderthals were acquired by the ancestral hominins. The overall rate of nonsynonymous evolution in Neanderthal mitochondrial protein-coding genes is not higher than in other lineages. The model incorporating the ancestral hominin mtDNA sequences estimates the average divergence age of the mtDNAs of Neanderthals and modern humans to be 450,000-485,000 years. The mtAncestor-1 and mtAncestor-2 sequences were incorporated into the nuclear genome approximately 620,000 years and 2,885,000 years ago, respectively. Conclusions: This study provides the first insight into the evolution of the mitochondrial DNA in hominins ancestral to Neanderthals and humans. We hypothesize that mtAncestor-1 and mtAncestor-2 are likely to be molecular fossils of the mtDNAs of Homo heidelbergensis and a stem Homo lineage. The d(N)/d(S) dynamics suggests that the effective population size of extinct hominins was low. However, the hominin lineage ancestral to humans, Neanderthals and H. heidelbergensis, had a larger effective population size and possessed genetic diversity comparable with those of chimpanzee and gorilla.	[Ovchinnikov, Igor V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Ovchinnikov, Igor V.] Univ N Dakota, Forens Sci Program, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Ovchinnikov, IV (corresponding author), Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA.	igor.ovtchinnikov@und.edu						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2003, J MOL EVOL, V57, P343, DOI 10.1007/s00239-003-2485-7; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Crow TJ, 1995, EUR NEUROPSYCHOPHARM, V5, P59, DOI 10.1016/0924-977X(95)00032-K; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Herrnstadt C, 1999, GENOMICS, V60, P67, DOI 10.1006/geno.1999.5907; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; JURKA J, 1995, NUCLEIC ACIDS RES, V23, P170, DOI 10.1093/nar/23.1.170; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Lascaro D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-267; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Premo LS, 2009, P NATL ACAD SCI USA, V106, P33, DOI 10.1073/pnas.0809194105; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rightmire G.P., 2000, Human Evolution, V15, P63, DOI 10.1007/BF02436235; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14278	10.1371/journal.pone.0014278	http://dx.doi.org/10.1371/journal.pone.0014278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151557	gold, Green Submitted, Green Published			2022-12-25	WOS:000285135800010
J	Rosen, O; Manor, R; Weil, S; Gafni, O; Linial, A; Aflalo, ED; Ventura, T; Sagi, A				Rosen, Ohad; Manor, Rivka; Weil, Simy; Gafni, Ohad; Linial, Assaf; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir			A Sexual Shift Induced by Silencing of a Single Insulin-Like Gene in Crayfish: Ovarian Upregulation and Testicular Degeneration	PLOS ONE			English	Article							CHERAX-QUADRICARINATUS DECAPODA; ANDROGENIC GLAND HORMONE; RED CLAW CRAYFISH; REPRODUCTIVE-SYSTEM; MOLECULAR-CLONING; GROWTH-FACTOR; INTERSEX; IMPLANTATION; CDNA; DISRUPTION	In sequential hermaphrodites, intersexuality occurs naturally, usually as a transition state during sexual re-differentiation processes. In crustaceans, male sexual differentiation is controlled by the male-specific androgenic gland (AG). An AG-specific insulin-like gene, previously identified in the red-claw crayfish Cherax quadricarinatus (designated Cq-IAG), was found in this study to be the prominent transcript in an AG cDNA subtractive library. In C. quadricarinatus, sexual plasticity is exhibited by intersex individuals in the form of an active male reproductive system and male secondary sex characters, along with a constantly arrested ovary. This intersexuality was exploited to follow changes caused by single gene silencing, accomplished via dsRNA injection. Cq-IAG silencing induced dramatic sex-related alterations, including male feature feminization, a reduction in sperm production, extensive testicular degeneration, expression of the vitellogenin gene, and accumulation of yolk proteins in the developing oocytes. Upon silencing of the gene, AG cells hypertrophied, possibly to compensate for low hormone levels, as reflected in the poor production of the insulin-like hormone (and revealed by immunohistochemistry). These results demonstrate both the functionality of Cq-IAG as an androgenic hormone-encoding gene and the dependence of male gonad viability on the Cq-IAG product. This study is the first to provide evidence that silencing an insulin-like gene in intersex C. quadricarinatus feminizes male-related phenotypes. These findings, moreover, contribute to the understanding of the regulation of sexual shifts, whether naturally occurring in sequential hermaphrodites or abnormally induced by endocrine disruptors found in the environment, and offer insight into an unusual gender-related link to the evolution of insulins.	[Rosen, Ohad; Manor, Rivka; Weil, Simy; Gafni, Ohad; Linial, Assaf; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Rosen, Ohad; Manor, Rivka; Gafni, Ohad; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Rosen, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Aflalo, Eliahu/F-1484-2012; Ventura, T./H-9832-2019	Ventura, T./0000-0002-0777-2367; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	United States-Israel Binational Agricultural Research and Development Fund (BARD) [QB-9308-06]; Australia-Israel Scientific Exchange Foundation (AISEF)	United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Australia-Israel Scientific Exchange Foundation (AISEF)	This research was supported by Research Grant No. QB-9308-06 from the United States-Israel Binational Agricultural Research and Development Fund (BARD) and a fellowship (to O.R.) from the Australia-Israel Scientific Exchange Foundation (AISEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, GEN COMP ENDOCR, V127, P263, DOI 10.1016/S0016-6480(02)00053-9; Aflalo ED, 2006, AQUACULTURE, V256, P468, DOI 10.1016/j.aquaculture.2006.01.035; BAUER RT, 1986, BIOL BULL, V170, P11, DOI 10.2307/1541377; Bauer RT, 2002, BIOL BULL-US, V203, P347, DOI 10.2307/1543577; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Boscolo H. K., 2005, Braz. J. Biol., V65, P29, DOI 10.1590/S1519-69842005000100006; BROOK HJ, 1994, BIOL BULL, V187, P99, DOI 10.2307/1542169; Charniaux-Cotton H., 1988, Endocrinology of selected invertebrate types., P279; CHARNIAUX-COTTON HELENE, 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P241, DOI 10.1016/0016-6480(62)90095-3; CHARNIAUXCOTTON H, 1958, CR HEBD ACAD SCI, V246, P2814; CHARNIAUXCOTTON H, 1954, CR HEBD ACAD SCI, V238, P953; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Khalaila I, 1999, J EXP ZOOL, V283, P286, DOI 10.1002/(SICI)1097-010X(19990215)283:3&lt;286::AID-JEZ6&gt;3.0.CO;2-R; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Khalaila I, 2001, GEN COMP ENDOCR, V121, P242, DOI 10.1006/gcen.2001.7607; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Kokokiris L, 2006, GEN COMP ENDOCR, V149, P42, DOI 10.1016/j.ygcen.2006.05.002; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Lugo JM, 2006, FEBS J, V273, P5669, DOI 10.1111/j.1742-4658.2006.05555.x; Maniatis T., 1982, MOL CLONING LAB MANU; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Nakahara Y, 2006, J INSECT PHYSIOL, V52, P105, DOI 10.1016/j.jinsphys.2005.09.009; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Ohira T, 2003, ZOOL SCI, V20, P75, DOI 10.2108/zsj.20.75; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Okuno A, 1999, BIOCHEM BIOPH RES CO, V264, P419, DOI 10.1006/bbrc.1999.1522; Olmstead AW, 2007, INT J BIOL SCI, V3, P77; Parnes S, 2003, GENET RES, V82, P107, DOI 10.1017/S0016672303006372; Sagi A, 1999, GEN COMP ENDOCR, V115, P37, DOI 10.1006/gcen.1999.7277; Sagi A, 1996, BIOL BULL, V190, P16, DOI 10.2307/1542672; Sagi A, 2002, INVERTEBR REPROD DEV, V41, P27, DOI 10.1080/07924259.2002.9652732; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Suzuki S, 1998, GEN COMP ENDOCR, V111, P367, DOI 10.1006/gcen.1998.7121; Taketomi Y, 1996, J CRUSTACEAN BIOL, V16, P232, DOI 10.2307/1548879; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; THORNE M J, 1991, Memoirs of the Queensland Museum, V31, P277; Uchida D, 2002, J EXP BIOL, V205, P711; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; WARNER RR, 1975, AM NAT, V109, P61, DOI 10.1086/282974	44	111	117	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15281	10.1371/journal.pone.0015281	http://dx.doi.org/10.1371/journal.pone.0015281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151555	Green Published, Green Submitted, gold			2022-12-25	WOS:000285135800023
J	Simpson-Lavy, KJ; Brandeis, M				Simpson-Lavy, Kobi J.; Brandeis, Michael			Cdk1 and SUMO Regulate Swe1 Stability	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SYNAPTONEMAL COMPLEX; BUDDING YEAST; PROTEIN SMT3P; DNA-REPAIR; SUMOYLATION; LIGASE; PHOSPHORYLATION; RECOMBINATION; MORPHOGENESIS	The Swe1/Wee1 kinase phosphorylates and inhibits Cdk1-Clb2 and is a major mitotic switch. Swe1 levels are controlled by ubiquitin mediated degradation, which is regulated by interactions with various mitotic kinases. We have recently reported that Swe1 levels are capable of sensing the progress of the cell cycle by measuring the levels of Cdk1-Clb2, Cdc5 and Hsl1. We report here a novel mechanism that regulates the levels of Swe1. We show that S. cerevisiae Swe1 is modified by Smt3/SUMO on residue K594 in a Cdk1 dependant manner. A degradation of the swe1(K594R) mutant that cannot be modified by Smt3 is considerably delayed in comparison to wild type Swe1. Swe1(K594R) cells express elevated levels of Swe1 protein and demonstrate higher levels of Swe1 activity as manifested by Cdk1-Y19 phosphorylation. Interestingly this mutant is not targeted, like wild type Swe1, to the bud neck where Swe1 degradation takes place. We show that Swe1 is SUMOylated by the Siz1 SUMO ligase, and consequently siz1 Delta cells express elevated levels of Swe1 protein and activity. Finally we show that swe1(K594R) cells are sensitive to osmotic stress, which is in line with their compromised regulation of Swe1 degradation.	[Simpson-Lavy, Kobi J.; Brandeis, Michael] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Simpson-Lavy, KJ (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	brandeis@cc.huji.ac.il			US-Israel Binational Science Foundation [BSF 2007288]; Israel Cancer Research Fund (ICRF)	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund (ICRF)	This research was funded by grant BSF 2007288 from the US-Israel Binational Science Foundation, and a grant from the Israel Cancer Research Fund (ICRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hood-DeGrenier JK, 2007, CURR GENET, V51, P1, DOI 10.1007/s00294-006-0102-1; Hu FF, 2005, P NATL ACAD SCI USA, V102, P8910, DOI 10.1073/pnas.0406987102; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kats ES, 2009, MOL CELL BIOL, V29, P5226, DOI 10.1128/MCB.00894-09; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; SIMPSONLAVY KJA, 2010, CELL CYCLE IN PRESS; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15089	10.1371/journal.pone.0015089	http://dx.doi.org/10.1371/journal.pone.0015089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151918	Green Published, gold, Green Submitted			2022-12-25	WOS:000284995300014
J	Maioli, M; Santaniello, S; Montella, A; Bandiera, P; Cantoni, S; Cavallini, C; Bianchi, F; Lionetti, V; Rizzolio, F; Marchesi, I; Bagella, L; Ventura, C				Maioli, Margherita; Santaniello, Sara; Montella, Andrea; Bandiera, Pasquale; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Lionetti, Vincenzo; Rizzolio, Flavio; Marchesi, Irene; Bagella, Luigi; Ventura, Carlo			Hyaluronan Esters Drive Smad Gene Expression and Signaling Enhancing Cardiogenesis in Mouse Embryonic and Human Mesenchymal Stem Cells	PLOS ONE			English	Article							TGF-BETA; HIGH-THROUGHPUT; MIXED ESTERS; IN-VITRO; HEART; NKX2-5; TRANSCRIPTION; DROSOPHILA; DIFFERENTIATION; MESODERM	Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) of stem cell commitment may have significant biomedical impact. We have recently developed hyaluronan mixed esters of butyric and retinoic acids (HBR), turning cardiovascular stem cell fate into a high-yield process. The HBR mechanism(s) remain still largely undefined. Methodology/Principal Findings: We show that in both mouse embryonic stem (ES) cells and human mesenchymal stem cells from fetal membranes of term placenta (FMhMSCs), HBR differentially affected the patterning of Smad proteins, one of the major conductors of stem cell cardiogenesis. Real-time RT-PCR and Western blot analyses revealed that in both cell types HBR enhanced gene and protein expression of Smad1,3, and 4, while down-regulating Smad7. HBR acted at the transcriptional level, as shown by nuclear run-off experiments in isolated nuclei. Immunofluorescence analysis indicated that HBR increased the fluorescent staining for Smad1,3, and 4, confirming that the transcriptional action of HBR encompassed the upregulation of the encoded Smad proteins. Chromatin immune precipitation and transcriptional analyses showed that HBR increased the transcription of the cardiogenic gene Nkx-2.5 through Smad4 binding to its own consensus Smad site. Treatment of mouse ES cells and FMhMSCs with HBR led to the concomitant overexpression of both Smad4 and alpha-sarcomeric actinin. Smad4 silencing by the aid of lentiviral-mediated Smad4 shRNA confirmed a dominant role of Smad4 in HBR-induced cardiogenesis. Conclusions/Significance: The use of HBR may pave the way to novel combinatorial strategies of molecular and stem cell therapy based on fine tuning of targeted Smad transciption and signaling leading to a high-throughput of cardiogenesis without the needs of gene transfer technologies.	[Maioli, Margherita; Santaniello, Sara; Montella, Andrea; Bandiera, Pasquale; Marchesi, Irene; Bagella, Luigi] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Maioli, Margherita; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Lionetti, Vincenzo; Ventura, Carlo] Univ Bologna, Natl Inst Biostruct & Biosyst, Bologna, Italy; [Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Ventura, Carlo] Univ Bologna, S Orsola Malpighi Hosp, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept,Natl Inst Biostruct & Biosyst, Bologna, Italy; [Lionetti, Vincenzo] CNR, Inst Clin Physiol, Scuola Super S Anna, Sector Med, I-56100 Pisa, Italy; [Rizzolio, Flavio; Marchesi, Irene; Bagella, Luigi] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Ventura, Carlo] Biosci Inst, Falciano, San Marino	University of Sassari; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Maioli, M (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	carlo.ventura@unibo.it	Lionetti, Vincenzo/G-9528-2014; Bianchi, Francesca/M-2205-2016; Bandiera, Pasquale/F-4276-2017; Montella, Andrea C/ABA-7073-2021; MARCHESI, Irene/H-8371-2019; Rizzolio, Flavio/K-2690-2018; Ventura, Carlo/AAV-3658-2020; Lionetti, Vincenzo/AAH-9503-2020; Lionetti, Vincenzo/AAN-1994-2020; Cantoni, Silvia/H-3938-2011	Bianchi, Francesca/0000-0001-6732-0533; Bandiera, Pasquale/0000-0002-0589-4539; MARCHESI, Irene/0000-0002-4383-6110; Rizzolio, Flavio/0000-0002-3400-4363; Lionetti, Vincenzo/0000-0002-0640-8651; MAIOLI, Margherita/0000-0003-0187-4968; Cavallini, Claudia/0000-0002-8079-9697; BAGELLA, Luigi/0000-0003-2815-037X; Cantoni, Silvia/0000-0002-3866-3307	Regione Emilia Romagna, Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna; Regione Autonoma della Sardegna, Italy	Regione Emilia Romagna, Italy(Regione Emilia Romagna); Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Regione Autonoma della Sardegna, Italy(Regione Sardegna)	This work was supported by Regione Emilia Romagna, Programma di Ricerca Regione - Universita 2007/2009, Area 1b "Medicina rigenerativa", Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Tavola Valdese, Rome, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Fondazione Banco di Sardegna, and Regione Autonoma della Sardegna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1990, DEVELOPMENT, V110, P661; BODMER R, 1993, DEVELOPMENT, V118, P719; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Chen LG, 2007, DIFFERENTIATION, V75, P682, DOI 10.1111/j.1432-0436.2007.00169.x; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Daniel C, 2007, J CELL BIOCHEM, V102, P1420, DOI 10.1002/jcb.21361; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He JG, 2010, CLIN EXP PHARMACOL P, V37, P283, DOI 10.1111/j.1440-1681.2009.05281.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Lien CL, 1999, DEVELOPMENT, V126, P75; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lionetti V, 2010, J BIOL CHEM, V285, P9949, DOI 10.1074/jbc.M109.087254; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Maioli M, 2007, REGEN MED, V2, P193, DOI 10.2217/17460751.2.2.193; Massague J, 2000, GENE DEV, V14, P627; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moustakas A, 2001, J CELL SCI, V114, P4359; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAJASINGH J, 2007, CIRC RES, V101, pE68; Reecy JM, 1999, DEVELOPMENT, V126, P839; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Shen H, 2003, AM J PHYSIOL-GASTR L, V285, pG539, DOI 10.1152/ajpgi.00436.2002; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; Tanaka M, 1999, DEVELOPMENT, V126, P1439; Ventura C, 2000, CIRC RES, V87, P189, DOI 10.1161/01.RES.87.3.189; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Ventura C, 2003, CIRC RES, V92, P623, DOI 10.1161/01.RES.0000065169.23780.0E; Ventura C, 2003, CIRC RES, V92, P617, DOI 10.1161/01.RES.0000065168.31147.5B; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; Wang H, 2003, INT J EXP PATHOL, V84, P153, DOI 10.1046/j.1365-2613.2003.00347.x; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zhang JT, 2009, J APPL TOXICOL, V29, P364, DOI 10.1002/jat.1404; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhong H, 2009, INT J HEMATOL, V89, P438, DOI 10.1007/s12185-009-0293-6	45	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15151	10.1371/journal.pone.0015151	http://dx.doi.org/10.1371/journal.pone.0015151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152044	gold, Green Published			2022-12-25	WOS:000284755100085
J	Zhan, YY; Maung, SW; Shao, B; Myat, MM				Zhan, Yaoyao; Maung, Saw W.; Shao, Bing; Myat, Monn Monn			The bHLH Transcription Factor, Hairy, Refines the Terminal Cell Fate in the Drosophila Embryonic Trachea	PLOS ONE			English	Article							FGF RECEPTOR HOMOLOG; BRANCHING MORPHOGENESIS; NOTCH; GENE; EXPRESSION; GROWTH; BREATHLESS; MIGRATION; ENCODES; PROTEIN	Background: The pair-rule gene, hairy, encodes a basic helix-loop-helix transcription factor and is required for patterning of the early Drosophila embryo and for morphogenesis of the embryonic salivary gland. Although hairy was shown to be expressed in the tracheal primordia and in surrounding mesoderm, whether hairy plays a role in tracheal development is not known. Principal Findings: Here, we report that hairy is required for refining the terminal cell fate in the embryonic trachea and that hairy's tracheal function is distinct from its earlier role in embryonic patterning. In hairy mutant embryos where the repressive activity of hairy is lost due to lack of its co-repressor binding site, extra terminal cells are specified in the dorsal branches. We show that hairy functions in the muscle to refine the terminal cell fate to a single cell at the tip of the dorsal branch by limiting the expression domain of branchless (bnl), encoding the FGF ligand, in surrounding muscle cells. Abnormal activation of the Bnl signaling pathway in hairy mutant tracheal cells is exemplified by increased number of dorsal branch cells expressing Bnl receptor, Breathless (Btl) and Pointed, a downstream target of the Bnl/Btl signaling pathway. We also show that hairy genetically interacts with bnl in TC fate restriction and that overexpression of bnl in a subset of the muscle surrounding tracheal cells phenocopied the hairy mutant phenotype. Conclusions/Significance: Our studies demonstrate a novel role for Hairy in restriction of the terminal cell fate by limiting the domain of bnl expression in surrounding muscle cells such that only a single dorsal branch cell becomes specified as a terminal cell. These studies provide the first evidence for Hairy in regulation of the FGF signaling pathway during branching morphogenesis.	[Zhan, Yaoyao; Maung, Saw W.; Shao, Bing; Myat, Monn Monn] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University	Zhan, YY (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	mmm2005@med.cornell.edu			Irma T. Hirschl Trust	Irma T. Hirschl Trust	Funding: Irma T. Hirschl Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Bellusci S, 1997, DEVELOPMENT, V124, P4867; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guillemin K, 1996, DEVELOPMENT, V122, P1353; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HOOPER KL, 1989, DEVELOPMENT, V107, P489; Ikeya T, 1999, DEVELOPMENT, V126, P4455; INGHAM PW, 1985, GENETICS, V111, P463; JIMENEZ G, 1996, EMBO J, V16; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kokubo H, 2005, TRENDS CARDIOVAS MED, V15, P190, DOI 10.1016/j.tcm.2005.05.005; LEHMANN R, 1994, SITU HYBRIDIZATION R; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; REUTER R, 1990, DEVELOPMENT, V110, P1031; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; WAINWRIGHT SM, 1992, MOL CELL BIOL, V12, P2475, DOI 10.1128/MCB.12.6.2475; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14134	10.1371/journal.pone.0014134	http://dx.doi.org/10.1371/journal.pone.0014134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152432	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100015
J	Luo, GZ; Costanzo, M; Boone, C; Dickson, RC				Luo, Guangzuo; Costanzo, Michael; Boone, Charles; Dickson, Robert C.			Nutrients and the Pkh1/2 and Pkc1 Protein Kinases Control mRNA Decay and P-body Assembly in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; CYTOPLASMIC PROCESSING BODIES; TERMINATION FACTOR ERF3; SACCHAROMYCES-CEREVISIAE; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; DEADENYLASE COMPLEX; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CCR4-NOT COMPLEX	Regulated mRNA decay is essential for eukaryotic survival but the mechanisms for regulating global decay and coordinating it with growth, nutrient, and environmental cues are not known. Here we show that a signal transduction pathway containing the Pkh1/Pkh2 protein kinases and one of their effector kinases, Pkc1, is required for and regulates global mRNA decay at the deadenylation step in Saccharomyces cerevisiae. Additionally, many stresses disrupt protein synthesis and release mRNAs from polysomes for incorporation into P-bodies for degradation or storage. We find that the Pkh1/2-Pkc1 pathway is also required for stress-induced P-body assembly. Control of mRNA decay and P-body assembly by the Pkh-Pkc1 pathway only occurs in nutrient-poor medium, suggesting a novel role for these processes in evolution. Our identification of a signaling pathway for regulating global mRNA decay and P-body assembly provides a means to coordinate mRNA decay with other cellular processes essential for growth and long-term survival. Mammals may use similar regulatory mechanisms because components of the decay apparatus and signaling pathways are conserved.	[Luo, Guangzuo; Dickson, Robert C.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Luo, Guangzuo; Dickson, Robert C.] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Kentucky; University of Kentucky; University of Toronto; University of Toronto	Dickson, RC (corresponding author), 741 S Limestone, Lexington, KY 40536 USA.	bobd@uky.edu		Luo, Guangzuo/0000-0002-8518-5766	National Institutes of Health [GM41302]; National Center for Research Resources [P20-RR020171]; Canadian Institutes of Health and Research, Genome Canada; Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health and Research, Genome Canada(Genome CanadaCanadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41302 and core facilities Grant P20-RR020171 from the National Center for Research Resources (to R. C. D.) and grants from the Canadian Institutes of Health and Research, Genome Canada, and the Ontario Genomics Institute (to C. B.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller J, 2008, METHOD ENZYMOL, V448, P267, DOI 10.1016/S0076-6879(08)02614-1; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Drgonova J, 1999, J CELL BIOL, V146, P373, DOI 10.1083/jcb.146.2.373; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2008, METHOD ENZYMOL, V448, P77, DOI 10.1016/S0076-6879(08)02605-0; Gowrishankar G, 2006, BIOL CHEM, V387, P323, DOI 10.1515/BC.2006.043; Hata H, 1998, GENETICS, V148, P571; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Ohn T, 2007, NUCLEIC ACIDS RES, V35, P3002, DOI 10.1093/nar/gkm196; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896, DOI 10.1128/MCB.12.11.4896; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Passos DO, 2008, METHOD ENZYMOL, V448, P409, DOI 10.1016/S0076-6879(08)02620-7; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Rendl LM, 2008, RNA, V14, P1328, DOI 10.1261/rna.955508; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Seay D, 2006, RNA, V12, P1594, DOI 10.1261/rna.145306; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Valentini SR, 2002, GENETICS, V160, P393; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yao G, 2007, MOL CELL BIOL, V27, P6243, DOI 10.1128/MCB.00734-07; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	79	23	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8759	8770		10.1074/jbc.M110.196030	http://dx.doi.org/10.1074/jbc.M110.196030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21163942	hybrid, Green Published			2022-12-25	WOS:000288247700007
J	Nagata, S; Morooka, N; Asaoka, K; Nagasawa, H				Nagata, Shinji; Morooka, Nobukatsu; Asaoka, Kiyoshi; Nagasawa, Hiromichi			Identification of a Novel Hemolymph Peptide That Modulates Silkworm Feeding Motivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO HORNWORM CATERPILLARS; MANDUCA-SEXTA; BOMBYX-MORI; LOCUSTA-MIGRATORIA; ARTIFICIAL DIET; BEHAVIOR; LARVAE; DROSOPHILA; STIMULATION; MECHANISMS	Phytophagous insects do not constantly chew their diets; most of their time is spent in a non-feeding quiescent state even though they live on or around their diets. Following starvation, phytophagous insect larvae exhibit enhanced foraging behaviors such as nibbling and walking similar to the sequential behavior that occurs prior to each meal. Although extensive physiological studies have revealed regularly occurring feeding behaviors in phytophagous insects, little has been elucidated regarding the mechanism at the molecular level. Here, we report identification and characterization of a novel 62-amino acid peptide, designated as hemolymph major anionic peptide (HemaP), from the hemolymph of Bombyx mori larvae that induces foraging behaviors. The endogenous HemaP levels are significantly increased by diet deprivation, whereas re-feeding after starvation returns them to basal levels. In larvae fed ad libitum, hemolymph HemaP levels fluctuate according to the feeding cycle, indicating that locomotor-associated feeding behaviors of B. mori larvae are initiated when HemaP levels exceed an unidentified threshold. Furthermore, administration of exogenous HemaP mimics the starvation-experienced state by affecting dopamine levels in the suboesophageal ganglion, which coordinates neck and mandible movements. These data strongly suggest that fluctuation of hemolymph HemaP levels modulates the regularly occurring feeding-motivated behavior in B. mori by triggering feeding initiation.	[Nagata, Shinji; Morooka, Nobukatsu; Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Asaoka, Kiyoshi] Natl Inst Agribiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Nagata, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anagashi@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [18780083, 22780099]; NAITO Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NAITO Foundation(Naito Memorial Foundation)	This work was supported in part by Grants-in-Aid for Scientific Research (18780083 and 22780099) from the Ministry of Education, Science, Sports, and Culture of Japan, and supported the NAITO Foundation.	Agrawal N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006652; Bernays EA, 1998, PHYSIOL ENTOMOL, V23, P295, DOI 10.1046/j.1365-3032.1998.00103.x; Bernays EA, 2000, J INSECT PHYSIOL, V46, P825, DOI 10.1016/S0022-1910(99)00172-9; BOWDAN E, 1988, Journal of Insect Behavior, V1, P31, DOI 10.1007/BF01052502; BOWDAN E, 1988, ENTOMOL EXP APPL, V47, P127, DOI 10.1007/BF00367478; BRADY J, 1974, ADV INSECT PHYSIOL, V10, P1, DOI DOI 10.1016/S0065-2806(08)60129-0; Braunig P, 2004, J COMP NEUROL, V478, P164, DOI 10.1002/cne.20287; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; HIRAO T, 1981, J SERICULTURAL SCI J, V50, P335; Hirashima A, 2007, J INSECT PHYSIOL, V53, P1242, DOI 10.1016/j.jinsphys.2007.06.018; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Hwang JS, 2003, BIOTECHNOL LETT, V25, P997, DOI 10.1023/A:1024035424317; Kaufmann L, 2004, COMP BIOCHEM PHYS C, V138, P469, DOI 10.1016/j.cca.2004.08.007; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Miles CI, 1998, J EXP BIOL, V201, P1785; Nagata S, 2006, J INSECT PHYSIOL, V52, P807, DOI 10.1016/j.jinsphys.2006.04.008; REYNOLDS SE, 1986, PHYSIOL ENTOMOL, V11, P39, DOI 10.1111/j.1365-3032.1986.tb00389.x; ROHRBACHER J, 1994, J COMP PHYSIOL A, V175, P619; Sasaki K, 2005, NEUROSCI LETT, V374, P166, DOI 10.1016/j.neulet.2004.10.049; Sasaki K, 2006, J INSECT PHYSIOL, V52, P528, DOI 10.1016/j.jinsphys.2006.02.001; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Simpson S.J., 1990, P73; Simpson S.J., 1995, P137; SIMPSON SJ, 1986, ANIM BEHAV, V34, P480, DOI 10.1016/S0003-3472(86)80117-8; SIMPSON SJ, 1982, PHYSIOL ENTOMOL, V7, P325, DOI 10.1111/j.1365-3032.1982.tb00305.x; SIMPSON SJ, 1985, PHYSIOL ENTOMOL, V10, P443, DOI 10.1111/j.1365-3032.1985.tb00066.x; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; Socha R, 2008, COMP BIOCHEM PHYS B, V151, P305, DOI 10.1016/j.cbpb.2008.07.014; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TIMMINS WA, 1988, PHYSIOL ENTOMOL, V13, P303, DOI 10.1111/j.1365-3032.1988.tb00482.x; TIMMINS WA, 1992, PHYSIOL ENTOMOL, V17, P81, DOI 10.1111/j.1365-3032.1992.tb00993.x; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1	35	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7161	7170		10.1074/jbc.M110.176016	http://dx.doi.org/10.1074/jbc.M110.176016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177851	Green Published, hybrid			2022-12-25	WOS:000287737300033
J	Hsu, RJ; Lin, CC; Su, YF; Tsai, HJ				Hsu, Ren-Jun; Lin, Chiu-Chun; Su, Ying-Fang; Tsai, Huai-Jen			dickkopf-3-related Gene Regulates the Expression of Zebrafish myf5 Gene through Phosphorylated p38a-dependent Smad4 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA SIGNAL-TRANSDUCTION; SUMO-1 MODIFICATION; CELL-MEMBRANE; CROSS-TALK; PATHWAY; MUSCLE; INDUCTION; PROTEINS; FAMILY; DIFFERENTIATION	Myf5 is a myogenic regulatory factor that functions in myogenesis. An intronic microRNA, miR-In300, located within zebrafish myf5 intron I, has been reported to silence myf5 through the targeting of dickkopf-3-related gene (dkk3r). However, the molecular mechanism underlying the control of myf5 expression by dkk3r is unknown. By injecting dkk3r-specific morpholino-oligonucleotide (dkk3r-MO) to knock down Dkk3r, we found that the phosphorylated p38a protein was reduced. Knockdown of p38a resulted in malformed somites and reduced myf5 transcripts, which photocopied the defects induced by injection of dkk3r-MO. To block the MAPK pathway, phosphorylation of p38 was inhibited by introduction of SB203580, which caused the down-regulation of myf5 expression. The GFP signal was dramatically decreased in somites when we injected p38a-MO into embryos derived from transgenic line Tg(myf5(80K):GFP), in which the GFP was driven by the myf5 promoter. Although these p38a-MO-induced defects were rescued by co-injection with p38a mRNA, they were not rescued with p38a mRNA containing a mutation at the phosphorylation domain. Moreover, overexpression of Smad2 or Smad3a enhanced myf5 expression, but the defects induced by the dominant negative form of either Smad2 or Smad3a equaled those of embryos injected with either dkk3r-MO or p38a-MO. These results support the involvement of Smad2 . Smad3a in p38a mediation. Overexpression of Smad4 enabled the rescue of myf5 defects in the dkk3r-MO-injected embryos, but knockdown of either dkk3r or p38a caused Smad4 protein to lose stability. Therefore, we concluded that Dkk3r regulates p38a phosphorylation to maintain Smad4 stability, in turn enabling the Smad2.Smad3a.Smad4 complex to form and activate the myf5 promoter.	[Hsu, Ren-Jun; Lin, Chiu-Chun; Su, Ying-Fang; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 106, Taiwan	National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sect 4,Roosevelt Rd, Taipei 106, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Republic of China [NSC-97-2313-B-002-036-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Republic of China, Grant NSC-97-2313-B-002-036-MY3.	BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Chen YH, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-1; Chen YH, 2001, GENESIS, V29, P22, DOI 10.1002/1526-968X(200101)29:1<22::AID-GENE1002>3.0.CO;2-Z; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Dziembowska M, 2007, BIOCHEM BIOPH RES CO, V354, P1101, DOI 10.1016/j.bbrc.2007.01.113; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hacker A, 1998, DEVELOPMENT, V125, P3461; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Hsu RJ, 2010, NUCLEIC ACIDS RES, V38, P4384, DOI 10.1093/nar/gkq148; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lin CY, 2009, DEV BIOL, V331, P152, DOI 10.1016/j.ydbio.2009.04.029; Lin CY, 2004, GENE, V334, P63, DOI 10.1016/j.gene.2004.03.016; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meriane M, 2002, BIOL CELL, V94, P535, DOI 10.1016/S0248-4900(02)00023-0; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Pinsky BA, 2002, DEV CELL, V3, P4, DOI 10.1016/S1534-5807(02)00214-9; Pogoda HM, 2002, DEV DYNAM, V224, P334, DOI 10.1002/dvdy.10113; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	38	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6855	6864		10.1074/jbc.M110.161638	http://dx.doi.org/10.1074/jbc.M110.161638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159776	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000287476400092
J	Marq, JB; Hausmann, S; Veillard, N; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Hausmann, Stephane; Veillard, Nicolas; Kolakofsky, Daniel; Garcin, Dominique			Short Double-stranded RNAs with an Overhanging 5 ' ppp-Nucleotide, as Found in Arenavirus Genomes, Act as RIG-I Decoys	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL RESPONSES; 5'-TRIPHOSPHATE RNA; INNATE IMMUNITY; RECOGNITION; VIRUSES; HELICASE; ACTIVATION; INDUCTION; PROMOTER; LIGAND	Arenavirus RNA genomes are initiated by a "prime and re-align" mechanism, such that the initiating GTP is found as a single unpaired (overhanging) nucleotide when the complementary genome ends anneal to form double-stranded (ds) RNA panhandle structures. dsRNAs modeled on these structures do not induce interferon (IFN), as opposed to blunt-ended (5') (ppp)dsRNA. This study examines whether these viral structures can also act as decoys, by trapping RIG-I in inactive dsRNA complexes. We examined the ability of various dsRNAs to activate the RIG-I ATPase (presumably a measure of helicase translocation on dsRNA) relative to their ability to induce IFN. We found that there is no simple relationship between these two properties, as if RIG-I can translocate on short dsRNAs without inducing IFN. Moreover, we found that (5') (ppp)dsRNAs with a single unpaired 5' ppp-nucleotide can in fact competitively inhibit the ability of blunt-ended (5') (ppp)dsRNAs to induce IFN when co-transfected into cells and that this inhibition is strongly dependent on the presence of the 5' ppp. In contrast, (5') (ppp)dsRNAs with a single unpaired 5' ppp-nucleotide does not inhibit poly(I-C)-induced IFN activation, which is independent of the presence of a 5' ppp group.	[Marq, Jean-Baptiste; Hausmann, Stephane; Veillard, Nicolas; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Sch Med, CMU, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Daniel.Kolakofsky@unige.ch			Swiss National Science Fund	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Fund.	Albarino CG, 2009, J VIROL, V83, P5606, DOI 10.1128/JVI.00276-09; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KING P, 1994, J BIOL CHEM, V269, P30609; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Marq JB, 2009, J BIOL CHEM, V284, P25471, DOI 10.1074/jbc.M109.018895; Matranga C, 2010, J BIOL CHEM, V285, P25363, DOI 10.1074/jbc.M110.117010; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; PALMER EL, 1977, J GEN VIROL, V36, P541, DOI 10.1099/0022-1317-36-3-541; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zheng C, 2010, STRUCTURE, V18, P894, DOI 10.1016/j.str.2010.07.002; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	31	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6108	6116		10.1074/jbc.M110.186262	http://dx.doi.org/10.1074/jbc.M110.186262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159780	Green Published, hybrid			2022-12-25	WOS:000287476400020
J	Nishitsuji, K; Hosono, T; Uchimura, K; Michikawa, M				Nishitsuji, Kazuchika; Hosono, Takashi; Uchimura, Kenji; Michikawa, Makoto			Lipoprotein Lipase Is a Novel Amyloid beta (A beta)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of A beta in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; RAT-BRAIN; MESSENGER-RNA; EXTRACELLULAR-MATRIX; DEGRADATION; MACROPHAGES; MICROGLIA	Lipoprotein lipase (LPL) is a member of a lipase family known to hydrolyze triglyceride molecules in plasma lipoprotein particles. LPL also plays a role in the binding of lipoprotein particles to cell-surface molecules, including sulfated glycosaminoglycans (GAGs). LPL is predominantly expressed in adipose and muscle but is also highly expressed in the brain where its specific roles are unknown. It has been shown that LPL is colocalized with senile plaques in Alzheimer disease (AD) brains, and its mutations are associated with the severity of AD pathophysiological features. In this study, we identified a novel function of LPL; that is, LPL binds to amyloid beta protein (A beta) and promotes cell-surface association and uptake of A beta in mouse primary astrocytes. The internalized A beta was degraded within 12 h, mainly in a lysosomal pathway. We also found that sulfated GAGs were involved in the LPL-mediated cellular uptake of A beta. Apolipoprotein E was dispensable in the LPL-mediated uptake of A beta. Our findings indicate that LPL is a novel A beta-binding protein promoting cellular uptake and subsequent degradation of A beta.	[Nishitsuji, Kazuchika; Hosono, Takashi; Uchimura, Kenji; Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, Aichi 4748511, Japan; [Uchimura, Kenji] Natl Ctr Geriatr & Gerontol, Sect Pathophysiol & Neurobiol, Aichi 4748511, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Michikawa, M (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, Gengo 35, Aichi 4748511, Japan.	michi@ncgg.go.jp	Uchimura, Kenji/AFV-1802-2022; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation; Ministry of Health, Labor, and Welfare of Japan [H20-007]; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [21300145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on priority areas (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, a grant from the Ministry of Health, Labor, and Welfare of Japan (Research on Dementia, Health, and Labor Sciences Research Grant H20-007), and a grant from the Japan Health Sciences Foundation (Research on Publicly Essential Drugs and Medical Devices).	AlAli SY, 1996, J ANAT, V188, P257; Auerbach BJ, 1996, J BIOL CHEM, V271, P1329, DOI 10.1074/jbc.271.3.1329; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Baum L, 1999, AM J MED GENET, V88, P136, DOI 10.1002/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D; BENGTSSON G, 1980, BIOCHEM J, V189, P625, DOI 10.1042/bj1890625; Blain JF, 2006, EUR J NEUROSCI, V24, P1245, DOI 10.1111/j.1460-9568.2006.05007.x; BRECHER P, 1979, J LIPID RES, V20, P464; Chua T, 1998, FEBS LETT, V436, P439, DOI 10.1016/S0014-5793(98)01161-2; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; ECKEL RH, 1984, P NATL ACAD SCI-BIOL, V81, P7604, DOI 10.1073/pnas.81.23.7604; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; EDWARDS IJ, 1993, J LIPID RES, V34, P1155; EISENBERG S, 1992, J CLIN INVEST, V90, P2013, DOI 10.1172/JCI116081; FernandezBorja M, 1996, J LIPID RES, V37, P464; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GOLDBERG IJ, 1989, J LIPID RES, V30, P1569; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koch S, 2001, J LIPID RES, V42, P1143; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; MULDER M, 1993, J BIOL CHEM, V268, P9369; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Pillarisetti S, 1997, J BIOL CHEM, V272, P15753, DOI 10.1074/jbc.272.25.15753; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009; YACOUB LK, 1990, J LIPID RES, V31, P1845; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	45	50	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6393	6401		10.1074/jbc.M110.172106	http://dx.doi.org/10.1074/jbc.M110.172106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177248	hybrid, Green Published			2022-12-25	WOS:000287476400050
J	Sun, T; Guo, J; Shallow, H; Yang, TH; Xu, JM; Li, WT; Hanson, C; Wu, JG; Li, XA; Massaeli, H; Zhang, ST				Sun, Tao; Guo, Jun; Shallow, Heidi; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Hanson, Christian; Wu, James G.; Li, Xian; Massaeli, Hamid; Zhang, Shetuan			The Role of Monoubiquitination in Endocytic Degradation of Human Ether-a-go-go-related Gene (hERG) Channels under Low K+ Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KR; UBIQUITIN ISOPEPTIDASE; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNELS; EXTRACELLULAR K+; MEMBRANE-PROTEIN; RECEPTOR; PROTEASOME; TRAFFICKING; SUFFICIENT	A reduction in extracellular K+ concentration ([K+](o)) causes cardiac arrhythmias and triggers internalization of the cardiac rapidly activating delayed rectifier potassium channel (I-Kr) encoded by the human ether-a-go-go-related gene (hERG). We investigated the role of ubiquitin (Ub) in endocytic degradation of hERG channels stably expressed in HEK cells. Under low K+ conditions, UbKO, a lysine-less mutant Ub that only supports monoubiquitination, preferentially interacted and selectively enhanced degradation of the mature hERG channels. Overexpression of Vps24 protein, also known as charged multivesicular body protein 3, significantly accelerated degradation of mature hERG channels, whereas knockdown of Vps24 impeded this process. Moreover, the lysosomal inhibitor bafilomycin A1 inhibited degradation of the internalized mature hERG channels. Thus, monoubiquitination directs mature hERG channels to degrade through the multivesicular body/lysosome pathway. Interestingly, the protease inhibitor lactacystin inhibited the low K+-induced hERG endocytosis and concomitantly led to an accumulation of monoubiquitinated mature hERG channels, suggesting that deubiquitination is also required for the endocytic degradation. Consistently, overexpression of the endosomal deubiquitinating enzyme signal transducing adaptor molecule-binding protein significantly accelerated whereas knockdown of endogenous signal transducing adaptor molecule-binding protein impeded degradation of the mature hERG channels under low K+ conditions. Thus, monoubiquitin dynamically mediates endocytic degradation of mature hERG channels under low K+ conditions.	[Sun, Tao; Guo, Jun; Shallow, Heidi; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Hanson, Christian; Wu, James G.; Li, Xian; Massaeli, Hamid; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]; Heart and Stroke Foundation of Ontario [T 6612]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported in part by Canadian Institutes of Health Research Grant MOP 72911 and Heart and Stroke Foundation of Ontario Grant T 6612 (to S.Z.).	Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gang H, 2006, J GEN PHYSIOL, V128, P55, DOI 10.1085/jgp.200609500; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin DH, 2009, J BIOL CHEM, V284, P29614, DOI 10.1074/jbc.M109.041582; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6751	6759		10.1074/jbc.M110.198408	http://dx.doi.org/10.1074/jbc.M110.198408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177251	Green Published, hybrid			2022-12-25	WOS:000287476400082
J	Santoriello, C; Gennaro, E; Anelli, V; Distel, M; Kelly, A; Koster, RW; Hurlstone, A; Mione, M				Santoriello, Cristina; Gennaro, Elisa; Anelli, Viviana; Distel, Martin; Kelly, Amanda; Koester, Reinhard W.; Hurlstone, Adam; Mione, Marina			Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish	PLOS ONE			English	Article							MALIGNANT-MELANOMA; GENE-EXPRESSION; CANCER; PROTEIN; MUTATIONS; REGULATOR; PATHWAYS; TUMORS; CELLS; MODEL	Background: Melanoma is the most aggressive and lethal form of skin cancer. Because of the increasing incidence and high lethality of melanoma, animal models for continuously observing melanoma formation and progression as well as for testing pharmacological agents are needed. Methodology and Principal Findings: Using the combinatorial Gal4 - UAS system, we have developed a zebrafish transgenic line that expresses oncogenic HRAS under the kita promoter. Already at 3 days transgenic kita-GFP-RAS larvae show a hyper-pigmentation phenotype as earliest evidence of abnormal melanocyte growth. By 2-4 weeks, masses of transformed melanocytes form in the tail stalk of the majority of kita-GFP-RAS transgenic fish. The adult tumors evident between 1-3 months of age faithfully reproduce the immunological, histological and molecular phenotypes of human melanoma, but on a condensed time-line. Furthermore, they show transplantability, dependence on mitfa expression and do not require additional mutations in tumor suppressors. In contrast to kita expressing melanocyte progenitors that efficiently develop melanoma, mitfa expressing progenitors in a second Gal4-driver line were 4 times less efficient in developing melanoma during the three months observation period. Conclusions and Significance: This indicates that zebrafish kita promoter is a powerful tool for driving oncogene expression in the right cells and at the right level to induce early onset melanoma in the presence of tumor suppressors. Thus our zebrafish model provides a link between kita expressing melanocyte progenitors and melanoma and offers the advantage of a larval phenotype suitable for large scale drug and genetic modifier screens.	[Santoriello, Cristina; Gennaro, Elisa; Anelli, Viviana; Mione, Marina] IFOM Fdn, FIRC Inst Mol Oncol, Milan, Italy; [Distel, Martin; Koester, Reinhard W.] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Kelly, Amanda; Hurlstone, Adam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	IFOM - FIRC Institute of Molecular Oncology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Manchester	Santoriello, C (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol, Milan, Italy.	marina.mione@ifom-ieo-campus.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021; Distel, Martin/AAN-6408-2020	Distel, Martin/0000-0001-5942-0817; ANELLI, Viviana Vittoria/0000-0003-1964-3252; Mione, Maria Caterina/0000-0002-9040-3705; Hurlstone, Adam/0000-0001-5260-9457; Koster, Reinhard/0000-0001-6593-8196	Cariplo Foundation [2007-5500]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-8916]; German Ministry of Education and Research (BMBF) [0311889]; Helmholtz Association; Cancer Research UK [C11876/A4495]; Studienstiftung des deutschen Volkes; BBSRC (Biotechnology and Biological Sciences Research Council, U.K.)	Cariplo Foundation(Fondazione Cariplo); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Cancer Research UK(Cancer Research UK); Studienstiftung des deutschen Volkes; BBSRC (Biotechnology and Biological Sciences Research Council, U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Cariplo Foundation (grant no. 2007-5500), AIRC (Associazione Italiana per la Ricerca sul Cancro, grant no. IG-8916) to MM; German Ministry of Education and Research (BMBF 0311889) and Helmholtz Association to RK; Cancer Research UK (C11876/A4495) to AH; Fellowship of the Studienstiftung des deutschen Volkes to MD, AIRC to CS and BBSRC (Biotechnology and Biological Sciences Research Council, U.K. to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli V, 2009, ZEBRAFISH, V6, P417, DOI 10.1089/zeb.2009.0612; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Ashida A, 2009, INT J CANCER, V124, P862, DOI 10.1002/ijc.24048; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; Dahm R., 2002, ZEBRAFISH PRACTICAL, pxviii; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; DOVEY M, 2009, ZEBRAFISH; Dovey MC, 2009, METHODS MOL BIOL, V568, P1, DOI 10.1007/978-1-59745-280-9_1; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; GOWN AM, 1986, AM J PATHOL, V123, P195; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lister JA, 1999, DEVELOPMENT, V126, P3757; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; MIONE M, 2010, DIS MODELS MECH, V3; Nonaka D, 2008, J CUTAN PATHOL, V35, P1014, DOI 10.1111/j.1600-0560.2007.00953.x; Orchard GE, 1998, BRIT J BIOMED SCI, V55, P8; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/j.cub.2003.11.038; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Richardson J, 2008, ZEBRAFISH, V5, P289, DOI 10.1089/zeb.2008.0541; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Singh M, 2008, BRIT J DERMATOL, V158, P15, DOI 10.1111/j.1365-2133.2007.08316.x; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang ZQ, 2009, AM J HUM GENET, V84, P672, DOI 10.1016/j.ajhg.2009.03.019; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Xu XW, 2003, ARCH PATHOL LAB MED, V127, P1083; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	46	99	102	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15170	10.1371/journal.pone.0015170	http://dx.doi.org/10.1371/journal.pone.0015170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21170325	gold, Green Submitted, Green Published			2022-12-25	WOS:000285181400020
J	Glynn, JR; Kayuni, N; Floyd, S; Banda, E; Francis-Chizororo, M; Tanton, C; Molesworth, A; Hemmings, J; Crampin, AC; French, N				Glynn, Judith R.; Kayuni, Ndoliwe; Floyd, Sian; Banda, Emmanuel; Francis-Chizororo, Monica; Tanton, Clare; Molesworth, Anna; Hemmings, Joanne; Crampin, Amelia C.; French, Neil			Age at Menarche, Schooling, and Sexual Debut in Northern Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PREMARITAL SEX; HIV-INFECTION; 1ST SEX; TRENDS; BEHAVIOR; HEALTH; TANZANIA; MARRIAGE; KARONGA	Background: Age at sexual debut is a key behavioural indicator used in HIV behavioural surveillance. Early age at menarche may precipitate early sex through perceived readiness for sex, or through school drop-out, but this is rarely studied. We investigated trends and circumstances of sexual debut in relation to schooling and age at menarche. Methods and Findings: A cross-sectional sexual behaviour survey was conducted on all individuals age 15-59 within a demographic surveillance site in Karonga District, Malawi. Time trends were assessed using birth cohorts. Survival analysis was used to estimate the median age at menarche, sexual debut and first marriage. The 25(th) centile was used to define "early" sex, and analyses of risk factors for early sex were restricted to those who had reached that age, and were done using logistic regression. Of the 8232 women and 7338 men resident in the area, 88% and 78%, respectively, were seen, and, 94% and 92% of these were interviewed. The median reported age at first sex was 17.5 for women and 18.8 for men. For women, ages at menarche, sexual debut and first marriage did not differ by birth cohort. For men, age at sexual debut and first marriage decreased slightly in later birth cohorts. For both men and women increased schooling was associated with later sexual debut and a longer delay between sexual debut and first marriage, but the associations were stronger for women. Earlier age at menarche was strongly associated with earlier sexual debut and marriage and lower schooling levels. In women early sexual debut (<16 years) was less likely in those with menarche at age 14-15 (odds ratio (OR) 0.31, 95%CI 0.26-0.36), and >= 16 (OR 0.04, 95%CI 0.02-0.05) compared to those with menarche at <14. The proportion of women who completed primary school was 46% in those with menarche at <14, 60% in those with menarche at 14-15 and 70% in those with menarche at >= 16. The association between age at menarche and schooling was partly explained by age at sexual debut. The association between age at menarche and early sex was not altered by adjusting for schooling. Conclusions: Women with early menarche start sex and marry early, leading to school drop-out. It is important to find ways to support those who reach menarche early to access the same opportunities as other young women.	[Glynn, Judith R.; Floyd, Sian; Francis-Chizororo, Monica; Molesworth, Anna; Hemmings, Joanne; Crampin, Amelia C.; French, Neil] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Kayuni, Ndoliwe; Banda, Emmanuel; Francis-Chizororo, Monica; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Tanton, Clare] UCL, Ctr Sexual Hlth & HIV Res, Res Dept Infect & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; University of London; University College London	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	judith.glynn@lshtm.ac.uk	French, Neil/A-2994-2012	Crampin, Amelia/0000-0002-1513-4330; French, Neil/0000-0003-4814-8293; Tanton, Clare/0000-0002-4612-1858	Wellcome Trust [079828/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by The Wellcome Trust (079828/Z/06/Z) with contributions from LEPRA (www.leprahealthinaction.org; no grant number used by LEPRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, SOCIAL DYNAMICS ADOL; Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Biddlecom A, 2008, STUD FAMILY PLANN, V39, P337, DOI 10.1111/j.1728-4465.2008.00179.x; Boileau C, 2009, SEX TRANSM INFECT, V85, pI27, DOI 10.1136/sti.2008.033969; Buga GAB, 1996, S AFR MED J, V86, P523; Cremin I, 2009, SEX TRANSM INFECT, V85, pI34, DOI 10.1136/sti.2008.033431; Downing J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-446; DOWSETT G, 2009, YOUNG PEOPLE RISK TA; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; LLOYD CB, 2008, MARRIAGE CHILDBIRTH; Mensch BS, 2001, STUD FAMILY PLANN, V32, P285, DOI 10.1111/j.1728-4465.2001.00285.x; Morris B, 2000, ANIMALS ANCESTORS ET; Munthali Alister C, 2007, Afr J Reprod Health, V11, P150, DOI 10.2307/25549737; Pearson J., 2008, WATERLINES, V27, P48, DOI DOI 10.3362/1756-3488.2008.005; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; SOMMER M, 2009, J ADOLESC; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; *UNAIDS WHO, 2000, 2 GEN SURV HIV NEXT; UNICEF, 2010, WAT SAN HYG ANN REP; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Wringe A, 2009, SEX TRANSM INFECT, V85, pI56, DOI 10.1136/sti.2008.033423; Zaba B, 2009, SEX TRANSM INFECT, V85, pI20, DOI 10.1136/sti.2008.033704	25	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15334	10.1371/journal.pone.0015334	http://dx.doi.org/10.1371/journal.pone.0015334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692ES	21151570	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000285135800026
J	Harling, G; Msisha, W; Subramanian, SV				Harling, Guy; Msisha, Wezi; Subramanian, S. V.			No Association between HIV and Intimate Partner Violence among Women in 10 Developing Countries	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; DAR-ES-SALAAM; RISK BEHAVIOR; SEXUAL RISK; SOUTH-AFRICA; PREVENTION; INFECTION; HIV/AIDS; TANZANIA; KENYA	Background: Intimate Partner Violence (IPV) has been reported to be a determinant of women's risk for HIV. We examined the relationship between women's self-reported experiences of IPV in their most recent relationship and their laboratory-confirmed HIV serostatus in ten low-to middle-income countries. Methodology/Principal Findings: Data for the study came from the most recent Demographic and Health Surveys conducted in Dominican Republic, Haiti, India, Kenya, Liberia, Malawi, Mali, Rwanda, Zambia and Zimbabwe. Each survey population was a cross-sectional sample of women aged 15-49 years. Information on IPV was obtained by a face-to-face interview with the mother with an 81.1% response rate; information on HIV serostatus was obtained from blood samples with an 85.3% response rate. Demographic and socioeconomic variables were considered as potentially confounding covariates. Logistic regression models accounting for multi-stage survey design were estimated individually for each country and as a pooled total with country fixed effects (n = 60,114). Country-specific adjusted odds ratios (OR) for physical or sexual IPV compared to neither ranged from 0.45 [95% confidence interval (CI): 0.23-0.90] in Haiti to 1.35 [95% CI: 0.95-1.90] in India; the pooled association was 1.03 [95% CI: 0.94-1.13]. Country-specific adjusted ORs for physical and sexual IPV compared to no sexual IPV ranged from 0.41 [95% CI: 0.12-1.36] in Haiti to 1.41 [95% CI: 0.26-7.77] in Mali; the pooled association was 1.05 [95% CI: 0.90-1.22]. Conclusions: IPV and HIV were not found to be consistently associated amongst ever-married women in national population samples in these lower income countries, suggesting that IPV is not consistently associated with HIV prevalence worldwide. More research is needed to understand the circumstances in which IPV and HIV are and are not associated with one another.	[Harling, Guy; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Msisha, Wezi] World Bank, Europe & Cent Asia Human Dev Sector, Washington, DC 20433 USA	Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Harling, G (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Harling, Guy/0000-0001-6604-491X	National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. SVS, however, is partially supported by a Career Development Award from the National Institutes of Health (NHLBI K25 HL081275), and would like to acknowledge that support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; Andersson N, 2008, AIDS, V22, pS73, DOI 10.1097/01.aids.0000341778.73038.86; Ariane van der Straten RK, 1998, AIDS BEHAV, V2, P61; BARAHONASTRITTM.A, 2008, MULTIPLE FACES INTER; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Cayemittes M., 2007, ENQUETE MORTALITE MO; Centro de Estudios Sociales y Demograficos (CESDEM) y Macro International Inc, 2008, ENC DEM SAL 2007; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Decker MR, 2009, SEX TRANSM INFECT, V85, P555, DOI 10.1136/sti.2009.036368; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; [DNdlSedlIdMrdlEc Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS)], 2007, ENQ DEM SANT MAL 200; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Garcia-Moreno C, 2000, AIDS, V14, pS253; Heise L, 2002, INT J GYNECOL OBSTET, V78, pS5, DOI 10.1016/S0020-7292(02)00038-3; Institut National de la Statistique du Rwanda (INSR) and ORC Macro, 2006, RWAND DEM HLTH SURV; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2010, LANCET; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Lary H, 2004, INT FAM PLAN PERSPEC, V30, P200, DOI 10.1363/3020004; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare National AIDS Control Program Macro International Inc, 2008, LIB DEM HLTH SURV 20; *MACR INC, 2008, HIV PREV EST DEM HLT; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 2004, LANCET, V363, P1410, DOI 10.1016/S0140-6736(04)16133-3; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; NSO ICF, 2005, MAL DEM HLTH SURV 20; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Rutstein S. O., 2004, DHS WEALTH INDEX; Senn TE, 2008, CLIN PSYCHOL REV, V28, P711, DOI 10.1016/j.cpr.2007.10.002; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; *UNAIDS, 2008, UNAIDS WHO EP FACT S; World Health Organization UNAIDS, 2004, INF B SER, P1; DEMOGRAPHIC HLTH SUR	41	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e14257	10.1371/journal.pone.0014257	http://dx.doi.org/10.1371/journal.pone.0014257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691MJ	21170389	gold, Green Published, Green Submitted			2022-12-25	WOS:000285084100011
J	Peng, H; Qi, J; Dong, ZZ; Zhang, JT				Peng, Hui; Qi, Jing; Dong, Zizheng; Zhang, Jian-Ting			Dynamic vs Static ABCG2 Inhibitors to Sensitize Drug Resistant Cancer Cells	PLOS ONE			English	Article							MEDIATED PROTEASOMAL DEGRADATION; MULTIDRUG TRANSPORTER ABCG2; AMINO-TERMINUS; BINDING; OLIGOMERIZATION; PROTEIN; DOMAIN	Human ABCG2, a member of the ATP-binding cassette transporter superfamily, plays a key role in multidrug resistance and protecting cancer stem cells. ABCG2-knockout had no apparent adverse effect on the development, biochemistry, and life of mice. Thus, ABCG2 is an interesting and promising target for development of chemo-sensitizing agents for better treatment of drug resistant cancers and for eliminating cancer stem cells. Previously, we reported a novel two mode-acting ABCG2 inhibitor, PZ-39, that induces ABCG2 degradation in addition to inhibiting its activity. In this manuscript, we report our recent progresses in identifying two different groups of ABCG2 inhibitors with one inhibiting only ABCG2 function (static) and the other induces ABCG2 degradation in lysosome in addition to inhibiting its function (dynamic). Thus, the inhibitor-induced ABCG2 degradation may be more common than we previously anticipated and further investigation of the dynamic inhibitors that induce ABCG2 degradation may provide a more effective way of sensitizing ABCG2-mediated MDR in cancer chemotherapy.	[Peng, Hui; Qi, Jing; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Jian-Ting] Indiana Univ, Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Peng, H (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015		National Institutes of Health [CA113384, CA120221]; Showalter Foundation; Department of Defense Breast Cancer Research; NNSF of China [30873083]; NATIONAL CANCER INSTITUTE [R01CA113384, R01CA120221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Foundation; Department of Defense Breast Cancer Research(United States Department of Defense); NNSF of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants CA113384 and CA120221 (JTZ) and by a Showalter Foundation grant (ZD). Jing Qi is a recipient of the Department of Defense Breast Cancer Research Program Postdoctoral Fellowship. Hui Peng is currently supported, in part, by NNSF of China grant No. 30873083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2006, ANTI-CANCER DRUG, V17, P239, DOI 10.1097/00001813-200603000-00001; Chen Q, 2006, J BIOL CHEM, V281, P31152, DOI 10.1074/jbc.M603529200; Dai CL, 2009, BIOCHEM PHARMACOL, V78, P355, DOI 10.1016/j.bcp.2009.04.023; Dai CL, 2009, CANCER LETT, V279, P74, DOI 10.1016/j.canlet.2009.01.027; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Henrich CJ, 2009, ACS CHEM BIOL, V4, P637, DOI 10.1021/cb900134c; Horton JK, 1998, CELL PHYSIOL BIOCHEM, V8, P246, DOI 10.1159/000016287; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Xu JK, 2007, CURR MED CHEM, V14, P689, DOI 10.2174/092986707780059580; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang Jian-Ting, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P531; Zheng LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005172	23	32	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15276	10.1371/journal.pone.0015276	http://dx.doi.org/10.1371/journal.pone.0015276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151870	gold, Green Submitted, Green Published			2022-12-25	WOS:000285041800014
J	Orr, MT; Wu, J; Fang, M; Sigal, LJ; Spee, P; Egebjerg, T; Dissen, E; Fossum, S; Phillips, JH; Lanier, LL				Orr, Mark T.; Wu, Jun; Fang, Min; Sigal, Luis J.; Spee, Pieter; Egebjerg, Thomas; Dissen, Erik; Fossum, Sigbjorn; Phillips, Joseph H.; Lanier, Lewis L.			Development and Function of CD94-Deficient Natural Killer Cells	PLOS ONE			English	Article							MHC CLASS-I; HUMAN CYTOMEGALOVIRUS-INFECTION; C-TYPE LECTINS; INHIBITORY RECEPTORS; NK CELLS; CD94 DEFINES; RECOGNITION; CD94/NKG2A; EXPRESSION; BINDING	The CD94 transmembrane-anchored glycoprotein forms disulfide-bonded heterodimers with the NKG2A subunit to form an inhibitory receptor or with the NKG2C or NKG2E subunits to assemble a receptor complex with activating DAP12 signaling proteins. CD94 receptors expressed on human and mouse NK cells and T cells have been proposed to be important in NK cell tolerance to self, play an important role in NK cell development, and contribute to NK cell-mediated immunity to certain infections including human cytomegalovirus. We generated a gene-targeted CD94-deficient mouse to understand the role of CD94 receptors in NK cell biology. CD94-deficient NK cells develop normally and efficiently kill NK cell-susceptible targets. Lack of these CD94 receptors does not alter control of mouse cytomegalovirus, lymphocytic choriomeningitis virus, vaccinia virus, or Listeria monocytogenes. Thus, the expression of CD94 and its associated NKG2A, NKG2C, and NKG2E subunits is dispensable for NK cell development, education, and many NK cell functions.	[Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Wu, Jun; Phillips, Joseph H.] DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA USA; [Fang, Min; Sigal, Luis J.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Spee, Pieter; Egebjerg, Thomas] Novo Nordisk AS, Dept NK Cell Biol, Malov, Denmark; [Dissen, Erik; Fossum, Sigbjorn] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Fox Chase Cancer Center; Novo Nordisk; University of Oslo	Orr, MT (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	Lewis.Lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014; Sigal, Luis/AAL-1849-2021	Lanier, Lewis L/0000-0003-1308-3952; Orr, Mark/0000-0003-2684-4722; Sigal, Luis/0000-0001-6642-5472; Fang, Min/0000-0002-5278-1430	Merck; Novo Nordisk; National Institute of Allergy and Infectious Diseases (NIAID) [R21AI077021, R01AI065544]; National Institutes of Health (NIH) [AI066897]; National Cancer Institute (NCI) [CA006927]; William J. Avery Fellowship; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065544, R21AI077021, R37AI066897] Funding Source: NIH RePORTER	Merck(Merck & Company); Novo Nordisk(Novo Nordisk); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William J. Avery Fellowship; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.H.P. is an employee of Merck; P. S. and T. E. are employees of Novo Nordisk. Merck and Novo Nordisk provided salary support for the authors, as indicated, and provided financial support for some experiments performed in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by National Institute of Allergy and Infectious Diseases (NIAID) grants R21AI077021 and R01AI065544 to L.J.S., National Institutes of Health (NIH) grant AI066897 to L.L.L. and National Cancer Institute (NCI) grant CA006927 to FCCC. M.F. was partly supported by the William J. Avery Fellowship. M.T.O. was supported by a fellowship from the Cancer Research Institute. L.L.L. is an American Cancer Society Professor.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Berg SF, 1998, EUR J IMMUNOL, V28, P444, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;444::AID-IMMU444&gt;3.0.CO;2-M; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Cavanaugh VJ, 2007, J GEN VIROL, V88, P1440, DOI 10.1099/vir.0.82444-0; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kuboto A, 1999, J IMMUNOL, V163, P212; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, J IMMUNOL, V160, P4951; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Makrigiannis AP, 2001, J IMMUNOL, V166, P5034, DOI 10.4049/jimmunol.166.8.5034; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; ORR MT, 2010, CURR TOP MI IN PRESS; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rodriguez A, 1998, IMMUNOGENETICS, V47, P305, DOI 10.1007/s002510050362; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Yu JH, 2009, J IMMUNOL, V183, P4968, DOI 10.4049/jimmunol.0900907	53	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15184	10.1371/journal.pone.0015184	http://dx.doi.org/10.1371/journal.pone.0015184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151939	Green Submitted, Green Published, gold			2022-12-25	WOS:000284939600030
J	Chuang, YC; Chang, SC; Wang, WK				Chuang, Yu-Chung; Chang, Shan-Chwen; Wang, Wei-Kung			High and Increasing Oxa-51 DNA Load Predict Mortality in Acinetobacter baumannii Bacteremia: Implication for Pathogenesis and Evaluation of Therapy	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; REAL-TIME PCR; STAPHYLOCOCCUS-AUREUS BACTEREMIA; BLOOD-STREAM INFECTIONS; NOSOCOMIAL BACTEREMIA; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; RISK-FACTORS; DISEASE; EPIDEMIOLOGY	Background: While quantification of viral loads has been successfully employed in clinical medicine and has provided valuable insights and useful markers for several viral diseases, the potential of measuring bacterial DNA load to predict outcome or monitor therapeutic responses remains largely unexplored. We tested this possibility by investigating bacterial loads in Acinetobacter baumannii bacteremia, a rapidly increasing nosocomial infection characterized by high mortality, drug resistance, multiple and complicated risk factors, all of which urged the need of good markers to evaluate therapeutics. Methods and Findings: We established a quantitative real-time PCR assay based on an A. baumannii-specific gene, Oxa-51, and conducted a prospective study to examine A. baumannii loads in 318 sequential blood samples from 51 adults patients (17 survivors, 34 nonsurvivors) with culture-proven A. baumannii bacteremia in the intensive care units. Oxa-51 DNA loads were significantly higher in the nonsurvivors than survivors on day 1, 2 and 3 (P = 0.03, 0.001 and 0.006, respectively). Compared with survivors, nonsurvivors had higher maximum Oxa-51 DNA load and a trend of increase from day 0 to day 3 (P, 0.001), which together with Pitt bacteremia score were independent predictors for mortality by multivariate analysis (P = 0.014 and 0.016, for maximum Oxa-51 DNA and change of Oxa-51 DNA, respectively). Kaplan-Meier analysis revealed significantly different survival curves in patients with different maximum Oxa-51 DNA and change of Oxa-51 DNA from day 0 to day 3. Conclusions: High Oxa-51 DNA load and its initial increase could predict mortality. Moreover, monitoring Oxa-51 DNA load in blood may provide direct parameters for evaluating new regimens against A. baumannii in future clinical studies.	[Chuang, Yu-Chung; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chuang, Yu-Chung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Douliou City, Taiwan; [Wang, Wei-Kung] Natl Taiwan Univ, Inst Microbiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chuang, YC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	changsc@ntu.edu.tw; wangwk@hawaii.edu	CHUANG, YU-CHUNG/F-4627-2016	CHUANG, YU-CHUNG/0000-0003-3094-8276; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council, Taiwan [NSC-95-2745-B-002-007]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (NSC-95-2745-B-002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo LA, 2005, J CLIN MICROBIOL, V43, P903, DOI 10.1128/JCM.43.2.903-905.2005; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2003, INFECTION, V31, P331, DOI 10.1007/s15010-003-3223-1; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falagas ME, 2006, CLIN INFECT DIS, V43, P389, DOI 10.1086/505599; Feldman C, 2009, CLIN MICROBIOL INFEC, V15, P850, DOI 10.1111/j.1469-0691.2009.02901.x; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Garcia-Garmendia JL, 2001, CLIN INFECT DIS, V33, P939, DOI 10.1086/322584; Garcia-Garmendia JL, 1999, CRIT CARE MED, V27, P1794, DOI 10.1097/00003246-199909000-00015; Glerant JC, 1999, RESP MED, V93, P208, DOI 10.1016/S0954-6111(99)90010-0; Gomez J, 1999, EUR J CLIN MICROBIOL, V18, P358, DOI 10.1007/PL00015019; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Ho YC, 2009, J CLIN MICROBIOL, V47, P1443, DOI 10.1128/JCM.01197-08; Jones RN, 2007, J CLIN MICROBIOL, V45, P227, DOI 10.1128/JCM.01588-06; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Poutanen SM, 1997, EUR J CLIN MICROBIOL, V16, P737, DOI 10.1007/BF01709254; SCHONHEYDER HC, 1995, SCAND J INFECT DIS, V27, P19, DOI 10.3109/00365549509018967; Schreckenberger PC, 2000, MANUAL CLIN MICROBIO, P539; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; SULLIVAN TD, 1982, PEDIATRICS, V69, P699; Tsai Tung-Yuan, 2007, Journal of Microbiology Immunology and Infection, V40, P481; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Wang JT, 2007, EMERG INFECT DIS, V13, P494, DOI 10.3201/eid1303.060247; Wang JT, 2004, J HOSP INFECT, V58, P97, DOI 10.1016/j.jhin.2004.06.005	35	35	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14133	10.1371/journal.pone.0014133	http://dx.doi.org/10.1371/journal.pone.0014133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152436	Green Submitted, gold, Green Published			2022-12-25	WOS:000284755100014
J	Diez, RR; Rodrigues-Diez, R; Lavoz, C; Rayego-Mateos, S; Civantos, E; Rodriguez-Vita, J; Mezzano, S; Ortiz, A; Egido, J; Ruiz-Ortega, M				Rodrigues Diez, Raul; Rodrigues-Diez, Raquel; Lavoz, Carolina; Rayego-Mateos, Sandra; Civantos, Esther; Rodriguez-Vita, Juan; Mezzano, Sergio; Ortiz, Alberto; Egido, Jesus; Ruiz-Ortega, Marta			Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-beta-Independent Process	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; TIMP-1 EXPRESSION; GENE-EXPRESSION; SMAD PATHWAY; ANG-II; KEY	We have recently described that in an experimental model of atherosclerosis and in vascular smooth muscle cells (VSMCs) statins increased the activation of the Smad pathway by transforming growth factor-beta (TGF-beta), leading to an increase in TGF-beta-dependent matrix accumulation and plaque stabilization. Angiotensin II (AngII) activates the Smad pathway and contributes to vascular fibrosis, although the in vivo contribution of TGF-beta has not been completely elucidated. Our aim was to further investigate the mechanisms involved in AngII-induced Smad activation in the vasculature, and to clarify the beneficial effects of statins on AngII-induced vascular fibrosis. Infusion of AngII into rats for 3 days activates the Smad pathway and increases fibrotic-related factors, independently of TGF-beta, in rat aorta. Treatment with atorvastatin or simvastatin inhibited AngII-induced Smad activation and related-fibrosis. In cultured rat VSMCs, direct AngII/Smad pathway activation was mediated by p38 MAPK and ROCK activation. Preincubation of VSMCs with statins inhibited AngII-induced Smad activation at all time points studied (from 20 minutes to 24 hours). All these data show that statins inhibited several AngII-activated intracellular signaling systems, including p38-MAPK and ROCK, which regulates the AngII/Smad pathway and related profibrotic factors and matrix proteins, independently of TGF-beta responses. The inhibitory effect of statins on the AngII/Smad pathway could explain, at least in part, their beneficial effects on hypertension-induced vascular damage.	[Rodrigues Diez, Raul; Rodrigues-Diez, Raquel; Lavoz, Carolina; Rayego-Mateos, Sandra; Civantos, Esther; Rodriguez-Vita, Juan; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile; [Ortiz, Alberto] Fdn Jimenez Diaz, Dialysis Unit, E-28040 Madrid, Spain; [Egido, Jesus] Univ Autonoma Madrid, Fdn Jimenez Diaz, Renal Res Lab, Madrid, Spain	Autonomous University of Madrid; Universidad Austral de Chile; Autonomous University of Madrid	Diez, RR (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain.	mruizo@fjd.es	MATEOS, SANDRA RAYEGO/AAI-2123-2019; ortiz, alberto/Y-7582-2018; Rodriguez-Vita, Juan/K-2407-2014; Díez, Raquel Rodrigues/ABE-9703-2020; Rodriguez-Vita, Juan/U-6337-2019; Ortega, Marta Ruiz/AAN-2136-2020; Ruiz-Ortega, Marta/D-3584-2012; ruiz-ortega, marta/D-3584-2012	ortiz, alberto/0000-0002-9805-9523; Rodriguez-Vita, Juan/0000-0001-9547-5508; Díez, Raquel Rodrigues/0000-0002-6348-1505; Rodriguez-Vita, Juan/0000-0001-9547-5508; Ortega, Marta Ruiz/0000-0002-1495-6535; Ruiz-Ortega, Marta/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690; Rodrigues Diez, Raul/0000-0002-2456-6709; Rayego-Mateos, Sandra/0000-0001-6874-2359	Sociedad Espanola de Cardiologia, FIS [PI081564, PS09/00447, 2007/63648]; Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo [SCIII-RETIC RD06/0016]; EU [LSHB-CT-2007-036644]; PCI Iberoamerica [A/9571/07]; FONDECYT, Chile [1080083]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)	Sociedad Espanola de Cardiologia, FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); EU(European Commission); PCI Iberoamerica; FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III)	This work has been supported by grants from Sociedad Espanola de Cardiologia, FIS (PI081564, PS09/00447), SAF 2007/63648 and Red tematica de Investigacion Renal, REDINREN (ISCIII-RETIC RD06/0016) from the Instituto de Salud Carlos III from Ministerio de Sanidad y Consumo, Fondos Feder, the EU project DIALOK: LSHB-CT-2007-036644, PCI Iberoamerica (A/9571/07) and FONDECYT, Chile (1080083). Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. RRD and CL-V are fellows of FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Barrios Vivencio, 2009, Expert Rev Cardiovasc Ther, V7, P1317, DOI 10.1586/erc.09.119; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710; Burke JP, 2009, BRIT J SURG, V96, P541, DOI 10.1002/bjs.6577; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Castoldi G, 2003, AM J PHYSIOL-HEART C, V284, pH635, DOI 10.1152/ajpheart.00986.2001; Chade AR, 2008, J HYPERTENS, V26, P1651, DOI 10.1097/HJH.0b013e328302833a; Gressner OA, 2009, HEPATOLOGY, V49, P2021, DOI 10.1002/hep.22850; Ikedo H, 2003, INT J MOL MED, V11, P645; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KIM SK, 1995, J PHARMACOL EXP THER, V273, P509; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin CX, 2008, AM J PHYSIOL-HEART C, V295, pH1253, DOI 10.1152/ajpheart.00481.2008; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nachtigal P, 2009, J ATHEROSCLER THROMB, V16, P265, DOI 10.5551/jat.E745; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2003, CIRCULATION, V108, P1499, DOI 10.1161/01.CIR.0000089129.51288.BA; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Sanchez-Lopez E, 2009, NEFROLOGIA, V29, P382, DOI 10.3265/Nefrologia.2009.29.5.5429.en.full; Touyz RM, 2000, PHARMACOL REV, V52, P639; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhang GY, 2009, EXP DERMATOL, V18, P947, DOI 10.1111/j.1600-0625.2009.00880.x	36	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14145	10.1371/journal.pone.0014145	http://dx.doi.org/10.1371/journal.pone.0014145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21152444	gold, Green Published, Green Submitted			2022-12-25	WOS:000284755100025
J	Prasanna, SJ; Gopalakrishnan, D; Shankar, SR; Vasandan, AB				Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu			Pro-Inflammatory Cytokines, IFN gamma and TNF alpha, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; NECROSIS-FACTOR-ALPHA; STROMAL CELLS; LIFE-SPAN; IMMUNOGENICITY; FETAL; TRANSPLANTATION; REJECTION; RESPONSES; SUPPRESSION	Background: Wharton's jelly derived stem cells (WJMSCs) are gaining attention as a possible clinical alternative to bone marrow derived mesenchymal stem cells (BMMSCs) owing to better accessibility, higher expansion potential and low immunogenicity. Usage of allogenic mesenchymal stem cells (MSC) could be permissible in vivo only if they retain their immune properties in an inflammatory setting. Thus the focus of this study is to understand and compare the immune properties of BMMSCs and WJMSCs primed with key pro-inflammatory cytokines, Interferon-gamma (IFN gamma) and Tumor Necrosis Factor-alpha (TNF alpha). Methodology/Principal Findings: Initially the effect of priming on MSC mediated suppression of alloantigen and mitogen induced lymphoproliferation was evaluated in vitro. Treatment with IFN gamma or TNF alpha, did not ablate the immune-suppression caused by both the MSCs. Extent of immune-suppression was more with WJMSCs than BMMSCs in both the cases. Surprisingly, priming BMMSCs enhanced suppression of mitogen driven lymphoproliferation only; whereas IFN gamma primed WJMSCs were better suppressors of MLRs. Further, kinetic analysis of cytokine profiles in co-cultures of primed/unprimed MSCs and Phytohematoagglutinin (PHA) activated lymphocytes was evaluated. Results indicated a decrease in levels of pro-inflammatory cytokines. Interestingly, a change in kinetics and thresholds of Interleukin-2 (IL-2) secretion was observed only with BMMSCs. Analysis of activation markers on PHA-stimulated lymphocytes indicated different expression patterns in co-cultures of primed/unprimed WJMSCs and BMMSCs. Strikingly, co-culture with WJMSCs resulted in an early activation of a negative co-stimulatory molecule, CTLA4, which was not evident with BMMSCs. A screen for immune suppressive factors in primed/unprimed WJMSCs and BMMSCs indicated inherent differences in IFN gamma inducible Indoleamine 2, 3-dioxygenase (IDO) activity, Hepatocyte growth factor (HGF) and Prostaglandin E-2 (PGE2) levels which could possibly influence the mechanism of immune-modulation. Conclusion/Significance: This study demonstrates that inflammation affects the immune properties of MSCs distinctly. Importantly different tissue derived MSCs could utilize unique mechanisms of immune-modulation.	[Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu] Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Prasanna, SJ (corresponding author), Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India.	jyothi.prasanna@manipal.edu			Department of Biotechnology, India [BT/PR7091/MED/14/941/2006]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grant BT/PR7091/MED/14/941/2006 obtained from Department of Biotechnology, India (dbtindia.nic.in). The funders have no role in the study design, data analysis and collection, decision to publish or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; CARTER A, 1990, BRIT J HAEMATOL, V74, P424, DOI 10.1111/j.1365-2141.1990.tb06330.x; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chan WK, 2008, EXP HEMATOL, V36, P1545, DOI 10.1016/j.exphem.2008.06.008; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fang LB, 2006, TRANSPLANTATION, V82, P1370, DOI 10.1097/01.tp.0000232450.62408.f9; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; JOHANNISSON A, 1995, CYTOMETRY, V19, P343, DOI 10.1002/cyto.990190409; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kadam SS, 2009, IN VITRO CELL DEV-AN, V45, P23, DOI 10.1007/s11626-008-9155-4; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; ROTH MD, 1994, J EXP MED, V179, P857, DOI 10.1084/jem.179.3.857; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Xuan Min, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P433; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; YOO KH, 2009, CELL IMMUNOL; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	63	399	423	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9016	10.1371/journal.pone.0009016	http://dx.doi.org/10.1371/journal.pone.0009016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	21152066	Green Submitted, gold, Green Published			2022-12-25	WOS:000274207200013
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000281815700006
